PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Daillere, R; Vetizou, M; Waldschmitt, N; Yamazaki, T; Isnard, C; Poirier-Colame, V; Duong, CPM; Flament, C; Lepage, P; Roberti, MP; Routy, B; Jacquelot, N; Apetoh, L; Becharef, S; Rusakiewicz, S; Langella, P; Sokol, H; Kroemer, G; Enot, D; Roux, A; Eggermont, A; Tartour, E; Johannes, L; Woerther, PL; Chachaty, E; Soria, JC; Golden, E; Formenti, S; Plebanski, M; Madondo, M; Rosenstiel, P; Raoult, D; Cattoir, V; Boneca, IG; Chamaillard, M; Zitvogel, L				Daillere, Romain; Vetizou, Marie; Waldschmitt, Nadine; Yamazaki, Takahiro; Isnard, Christophe; Poirier-Colame, Vichnou; Duong, Connie P. M.; Flament, Caroline; Lepage, Patricia; Roberti, Maria Paula; Routy, Bertrand; Jacquelot, Nicolas; Apetoh, Lionel; Becharef, Sonia; Rusakiewicz, Sylvie; Langella, Philippe; Sokol, Harry; Kroemer, Guido; Enot, David; Roux, Antoine; Eggermont, Alexander; Tartour, Eric; Johannes, Ludger; Woerther, Paul-Louis; Chachaty, Elisabeth; Soria, Jean-Charles; Golden, Encouse; Formenti, Silvia; Plebanski, Magdalena; Madondo, Mutsa; Rosenstiel, Philip; Raoult, Didier; Cattoir, Vincent; Boneca, Ivo Gomperts; Chamaillard, Mathias; Zitvogel, Laurence			Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects	IMMUNITY			English	Article							INTESTINAL MICROBIOTA; DENDRITIC CELLS; TRANSLOCATION; BLOCKADE; CANCER	The efficacy of the anti-cancer immunomodulatory agent cyclophosphamide (CTX) relies on intestinal bacteria. How and which relevant bacterial species are involved in tumor immunosurveillance, and their mechanism of action are unclear. Here, we identified two bacterial species, Enterococcus hirae and Barnesiella intestinihominis that are involved during CTX therapy. Whereas E. hirae translocated from the small intestine to secondary lymphoid organs and increased the intratumoral CD8/ Treg ratio, B. intestinihominis accumulated in the colon and promoted the infiltration of IFN-gamma-producing gamma delta Tau cells in cancer lesions. The immune sensor, NOD2, limited CTX-induced cancer immunosurveillance and the bioactivity of these microbes. Finally, E. hirae and B. intestinihominis specific-memory Th1 cell immune responses selectively predicted longer progression-free survival in advanced lung and ovarian cancer patients treated with chemo-immunotherapy. Altogether, E. hirae and B. intestinihominis represent valuable ''oncomicrobiotics'' ameliorating the efficacy of the most common alkylating immunomodulatory compound.	[Daillere, Romain; Vetizou, Marie; Yamazaki, Takahiro; Poirier-Colame, Vichnou; Duong, Connie P. M.; Flament, Caroline; Roberti, Maria Paula; Routy, Bertrand; Jacquelot, Nicolas; Becharef, Sonia; Rusakiewicz, Sylvie; Enot, David; Roux, Antoine; Eggermont, Alexander; Soria, Jean-Charles; Zitvogel, Laurence] Inst Cancerol Gustave Roussy Canc Campus GRCC, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; [Daillere, Romain; Vetizou, Marie; Yamazaki, Takahiro; Poirier-Colame, Vichnou; Duong, Connie P. M.; Flament, Caroline; Roberti, Maria Paula; Routy, Bertrand; Jacquelot, Nicolas; Becharef, Sonia; Rusakiewicz, Sylvie; Roux, Antoine; Zitvogel, Laurence] GRCC, INSERM, U1015, F-94805 Villejuif, France; [Daillere, Romain; Vetizou, Marie; Poirier-Colame, Vichnou; Routy, Bertrand; Jacquelot, Nicolas; Roux, Antoine; Eggermont, Alexander; Soria, Jean-Charles; Zitvogel, Laurence] Univ Paris Saclay, F-94270 Le Kremlin Bicetre, France; [Waldschmitt, Nadine; Chamaillard, Mathias] Univ Lille, INSERM, Inst Pasteur Lille, CNRS,CHRU Lille,U1019,UMR 8204,CIIL, F-59000 Lille, France; [Isnard, Christophe; Cattoir, Vincent] Univ Caen Basse Normandie, EA4655, U2RM, Equipe Antibioresistance, F-14033 Caen, France; [Isnard, Christophe; Cattoir, Vincent] CHU Caen, Microbiol Serv, F-14033 Caen, France; [Duong, Connie P. M.; Flament, Caroline; Roberti, Maria Paula; Becharef, Sonia; Rusakiewicz, Sylvie; Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, F-94805 Villejuif, France; [Lepage, Patricia; Langella, Philippe; Sokol, Harry; Roux, Antoine] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Apetoh, Lionel] INSERM, U866, Canc, Lipids,Nutr, F-21078 Dijon, France; [Apetoh, Lionel] Univ Bourgogne Franche Comte, Dept Med, F-21078 Dijon, France; [Apetoh, Lionel] Ctr Georges Francois Leclerc, Dept Oncol, F-21000 Dijon, France; [Sokol, Harry] UPMC, Fac Med, AVENIR Team Gut Microbiota & Immun, ERL,INSERM,U 1157,UMR 7203, F-75012 Paris, France; [Sokol, Harry] Hop St Antoine, AP HP, Serv Gastroenterol, F-75012 Paris, France; [Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido; Enot, David] Inst Gustave Roussy, Metabol Platform, F-94805 Villejuif, France; [Kroemer, Guido] INSERM, Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, U 1138, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido; Roux, Antoine] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Kroemer, Guido] Karolinska Inst, Dept Womens & Childrens Hlth, Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Tartour, Eric] Univ Paris 05, Sorbonne Paris Cite, Paris Cardiovasc Res Ctr, INSERM,U970, F-75015 Paris, France; [Tartour, Eric] Hop Europeen Georges Pompidou, Serv Immunol Biol, F-75015 Paris, France; [Johannes, Ludger] INSERM, U1143, F-75005 Paris, France; [Johannes, Ludger] PSL Res Univ, Inst Curie, Endocyt Trafficking & Therapeut Delivery Grp, F-75248 Paris, France; [Johannes, Ludger] CNRS, UMR 3666, F-75005 Paris, France; [Woerther, Paul-Louis; Chachaty, Elisabeth] GRCC, Microbiol Serv, F-94805 Villejuif, France; [Golden, Encouse; Formenti, Silvia] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA; [Plebanski, Magdalena; Madondo, Mutsa] Monash Univ, Dept Immunol & Pathol, Alfred Hosp Precinct, Prahran, Vic 3181, Australia; [Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Campus Kiel, D-24105 Kiel, Germany; [Rosenstiel, Philip] Univ Hosp Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany; [Raoult, Didier] AIX MARSEILLE UNIV, UMR 7278, URMITE Unite Rech Malad Infect & Trop Emergentes, INSERM 1095,IRD 198,Fac Med, F-13005 Marseille, France; [Cattoir, Vincent] CNR Resistance Antibiot, Lab Associe Enterocoques, F-14033 Caen, France; [Boneca, Ivo Gomperts] Inst Pasteur, Unit Biol & Genet Bacterial Cell Wall, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Cornell University; Monash University; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zitvogel, L (corresponding author), Inst Cancerol Gustave Roussy Canc Campus GRCC, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.; Zitvogel, L (corresponding author), GRCC, INSERM, U1015, F-94805 Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Saclay, F-94270 Le Kremlin Bicetre, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc CICBT 1428, F-94805 Villejuif, France.	laurence.zitvogel@gustaveroussy.fr	RAOULT, Didier/A-8434-2008; Apetoh, Lionel/AIC-2384-2022; ISNARD, Christophe/A-6320-2016; Cattoir, Vincent/AAD-8353-2019; Jacquelot, Nicolas/AAY-6937-2020; Plebanski, Magdalena/AAU-3144-2021; sokol, harry/ABA-8991-2020; Langella, Philippe/N-8368-2017; Johannes, Ludger/M-9778-2017; KROEMER, Guido/B-4263-2013; Sokol, Harry/E-2290-2019; Kroemer, Guido/AAY-9859-2020; Chamaillard, Mathias/L-6542-2013; Apetoh, Lionel/G-3310-2014; Rosenstiel, Philip/A-5137-2009; Woerther, Paul-Louis/ABD-9084-2020; Johannes, Ludger/W-8593-2019; Boneca, Ivo G/H-1677-2014; Soria, Jean-Charles/F-3619-2014; Lepage, Patricia/D-4362-2014; WOERTHER, Paul-Louis/AAC-4637-2019; tartour, eric/O-7957-2017	RAOULT, Didier/0000-0002-0633-5974; Apetoh, Lionel/0000-0002-2774-438X; ISNARD, Christophe/0000-0002-2317-2345; sokol, harry/0000-0002-2914-1822; Langella, Philippe/0000-0001-5960-4341; Johannes, Ludger/0000-0002-2168-0004; KROEMER, Guido/0000-0002-9334-4405; Sokol, Harry/0000-0002-2914-1822; Chamaillard, Mathias/0000-0002-0243-9717; Apetoh, Lionel/0000-0002-2774-438X; Rosenstiel, Philip/0000-0002-9692-8828; Woerther, Paul-Louis/0000-0002-6957-9482; Johannes, Ludger/0000-0002-2168-0004; Boneca, Ivo G/0000-0001-8122-509X; Lepage, Patricia/0000-0002-9501-6771; Duong, Connie/0000-0002-9067-8557; tartour, eric/0000-0002-7323-468X; ZITVOGEL, laurence/0000-0003-1596-0998; , Magdalena/0000-0001-6889-3667; Jacquelot, Nicolas/0000-0003-0282-1892; YAMAZAKI, Takahiro/0000-0002-7420-4394	La Ligue contre le cancer; Ligue Nationale contre le Cancer (Equipes labellisees); European Research Council Advanced Investigator Grant; Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Fondation de France; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC; Paris Alliance of Cancer Research Institutes (PACRI); ISREC; Swiss Bridge Foundation; NIH [R01 CA161879]; FRM [DEQ20130326475]; INCa [Plbio-2012-106]; Agence Nationale de la Recherche [ANR- 13-BSV3-0014-01]; Association pour la Recherche contre le cancer [PGA120140200851]; Ministere de l'enseignement superieur et de la recherche; Institut de veille sanitaire (InVS); Interreg IVA France (Manche) - Angleterre (Risk Manche); Anti-Cancer Fund; Monash PhD Scholarship; NHMRC SRF Award; DFG CE Inflammation at Interfaces; European Union's FP7 [305564, SFB1182 TP C2]; NATIONAL CANCER INSTITUTE [R01CA161879] Funding Source: NIH RePORTER	La Ligue contre le cancer(Ligue nationale contre le cancer); Ligue Nationale contre le Cancer (Equipes labellisees); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC; Paris Alliance of Cancer Research Institutes (PACRI); ISREC; Swiss Bridge Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRM(Fondation pour la Recherche Medicale); INCa(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de l'enseignement superieur et de la recherche(Estonian Research CouncilEuropean Commission); Institut de veille sanitaire (InVS); Interreg IVA France (Manche) - Angleterre (Risk Manche); Anti-Cancer Fund; Monash PhD Scholarship; NHMRC SRF Award(National Health and Medical Research Council (NHMRC) of Australia); DFG CE Inflammation at Interfaces; European Union's FP7; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank patients who participated to this study. R.D. and M.V. were supported by La Ligue contre le cancer. G.K. and L.Z. were supported by the Ligue Nationale contre le Cancer (Equipes labellisees), European Research Council Advanced Investigator Grant (to G.K.), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Fondation de France, the LabEx Immuno-Oncology, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC, and the Paris Alliance of Cancer Research Institutes (PACRI), ISREC, and Swiss Bridge Foundation. S.F. was supported by NIH (R01 CA161879 PI). M.C. was supported by the FRM (DEQ20130326475) and INCa (Plbio-2012-106). NW was a recipient of a postdoctoral fellowship from Agence Nationale de la Recherche (ANR- 13-BSV3-0014-01). L.Z., M.C., P.L., and I.G.B. are all sponsored by Association pour la Recherche contre le cancer (PGA120140200851). V.C. was supported by the Ministere de l'enseignement superieur et de la recherche, the Institut de veille sanitaire (InVS), and the Interreg IVA France (Manche) - Angleterre (Risk Manche). We are grateful to the staff of the animal facility of Gustave Roussy and Institut Pasteur. We thank K. LeRoux (INRA) for technical help. We thank M.J. Smyth for the MC38-OVA<SUP>dim</SUP>. Thanks to Professor Quinn, Professor Amant, and Ms. Silvers for clinical support and Dr. Tuyaerts for processing some of the PBMC and the Anti-Cancer Fund. M. M. is a recipient of a Monash PhD Scholarship and MP an NHMRC SRF Award. P.R. has been supported by DFG CE Inflammation at Interfaces, the European Union's FP7/2007-2013 under grant agreement no 305564 (SysmedIBD) and the SFB1182 TP C2. G.K., A.E., and L.Z. are the founders of the biotech company EverImmune.	Arokiyaraj S, 2014, WORLD J MICROB BIOT, V30, P2111, DOI 10.1007/s11274-014-1625-0; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Berman David, 2010, Cancer Immun, V10, P11; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ghosh A, 2013, J CLIN MICROBIOL, V51, P3567, DOI 10.1128/JCM.00481-13; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Jacquelot N, 2016, J CLIN INVEST, V126, P921, DOI 10.1172/JCI80071; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Maier I, 2014, RADIAT RES, V181, P45, DOI 10.1667/RR13352.1; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Nes I.F., 2014, ENTEROCOCCI COMMENSA; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Rossini A, 2006, CANCER RES, V66, P6219, DOI 10.1158/0008-5472.CAN-05-4592; Rubio-Godoy V, 2002, J IMMUNOL, V169, P5696, DOI 10.4049/jimmunol.169.10.5696; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sandoval F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004888; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Ubeda C, 2013, INFECT IMMUN, V81, P965, DOI 10.1128/IAI.01197-12; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vingert B, 2006, EUR J IMMUNOL, V36, P1124, DOI 10.1002/eji.200535443; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	37	403	433	21	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					931	943		10.1016/j.immuni.2016.09.009	http://dx.doi.org/10.1016/j.immuni.2016.09.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27717798	Bronze			2022-12-18	WOS:000389473200022
J	Hanash, AM; Dudakov, JA; Hua, GQ; O'Connor, MH; Young, LF; Singer, NV; West, ML; Jenq, RR; Holland, AM; Kappel, LW; Ghosh, A; Tsai, JJ; Rao, UK; Yim, NL; Smith, OM; Velardi, E; Hawryluk, EB; Murphy, GF; Liu, C; Fouser, LA; Kolesnick, R; Blazar, BR; van den Brink, MRM				Hanash, Alan M.; Dudakov, Jarrod A.; Hua, Guoqiang; O'Connor, Margaret H.; Young, Lauren F.; Singer, Natalie V.; West, Mallory L.; Jenq, Robert R.; Holland, Amanda M.; Kappel, Lucy W.; Ghosh, Arnab; Tsai, Jennifer J.; Rao, Uttam K.; Yim, Nury L.; Smith, Odette M.; Velardi, Enrico; Hawryluk, Elena B.; Murphy, George F.; Liu, Chen; Fouser, Lynette A.; Kolesnick, Richard; Blazar, Bruce R.; van den Brink, Marcel R. M.			Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; ALLOREACTIVE T-CELLS; MARROW-TRANSPLANTATION; TH17 CELLS; IL-22; EXPRESSION; INFLAMMATION; HOMEOSTASIS; COLITIS; MICE	Little is known about the maintenance of intestinal stem cells (ISCs) and progenitors during immune-mediated tissue damage or about the susceptibility of transplant recipients to tissue damage mediated by the donor immune system during graft versus host disease (GVHD). We demonstrate here that deficiency of recipient-derived IL-22 increased acute GVHD tissue damage and mortality, that ISCs were eliminated during GVHD, and that ISCs as well as their downstream progenitors expressed the IL-22 receptor. Intestinal IL-22 was produced after bone marrow transplant by IL-23-responsive innate lymphoid cells (ILCs) from the transplant recipients, and intestinal IL-22 increased in response to pre-transplant conditioning. However, ILC frequency and IL-22 amounts were decreased by GVHD. Recipient IL-22 deficiency led to increased crypt apoptosis, depletion of ISCs, and loss of epithelial integrity. Our findings reveal IL-22 as a critical regulator of tissue sensitivity to GVHD and a protective factor for ISCs during inflammatory intestinal damage.	[Hanash, Alan M.; Jenq, Robert R.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Dudakov, Jarrod A.; O'Connor, Margaret H.; Young, Lauren F.; Singer, Natalie V.; West, Mallory L.; Holland, Amanda M.; Kappel, Lucy W.; Ghosh, Arnab; Tsai, Jennifer J.; Rao, Uttam K.; Yim, Nury L.; Smith, Odette M.; Velardi, Enrico; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Hua, Guoqiang] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol, New York, NY 10065 USA; [Hawryluk, Elena B.; Murphy, George F.] Harvard Univ, Brigham & Womens Hosp, Program Dermatopathol, Sch Med, Boston, MA 02115 USA; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Fouser, Lynette A.] Pfizer Worldwide Res & Dev, Inflammat & Immunol Res Unit, Biotherapeut Res & Dev, Cambridge, MA 02140 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; University of Florida; Pfizer; University of Minnesota System; University of Minnesota Twin Cities	Hanash, AM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	hanasha@mskcc.org; vandenbm@mskcc.org	Velardi, Enrico/AAB-7443-2019; van den Brink, Marcel R. M./HGB-9434-2022; velardi, Enrico/AAC-5440-2022	Velardi, Enrico/0000-0001-8383-0453; Ghosh, Arnab/0000-0003-3355-5427; Hawryluk, Elena/0000-0002-0862-3339; Kolesnick, Richard/0000-0002-1686-6162; Dudakov, Jarrod/0000-0001-6220-5632	National Institutes of Health [R01-HL069929, R01-CA107096, R01-AI080455, R01-AI 34495, R01-HL56067, K08-KHL115355A]; American Society of Hematology; American Society for Blood and Marrow Transplantation/Celgene; AACR Judah Folkman Fellowship for Angiogenesis Research [10-40-18-GHOS]; US Department of Defense: USAMRAA [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund; Memorial Sloan-Kettering Cancer Center [NCI P30-CA008748]; NATIONAL CANCER INSTITUTE [R01CA072669, P01CA142106, P30CA008748, R01CA107096] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL056067, K08HL115355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455, R01AI034495, P01AI056299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; American Society for Blood and Marrow Transplantation/Celgene; AACR Judah Folkman Fellowship for Angiogenesis Research; US Department of Defense: USAMRAA(United States Department of Defense); Radiation Effects Research Foundation (RERF-NIAID); Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Peter Solomon Fund; Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Lgr5-LacZ mice were generously provided by H. Clevers. This research was supported by National Institutes of Health award numbers R01-HL069929 (M.v.d.B.), R01-CA107096 (M.R.M.v.d.B.), R01-AI080455 (M.R.M.v.d.B.), R01-AI 34495 (B.B.), R01-HL56067 (B.B.), and K08-KHL115355A (A.M. Hanash). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the American Society of Hematology Research Training Award for Fellows (A.M. Hanash), the American Society for Blood and Marrow Transplantation/Celgene New Investigator Award (A.M. Hanash), the AACR Judah Folkman Fellowship for Angiogenesis Research: 10-40-18-GHOS (A.G.), the US Department of Defense: USAMRAA Award W81XWH-09-1-0294 (M.R.M.v.d.B.), the Radiation Effects Research Foundation (RERF-NIAID) (M.R.M.v.d.B.), The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin, The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center, and The Peter Solomon Fund. We appreciate the invaluable help of the Laboratory cif Comparative Pathology and the Molecular Cytology Core Facility (supported by Cancer Center Support Grant NCI P30-CA008748) of Memorial Sloan-Kettering Cancer Center. L.F. had recent employment at Pfizer.	Asplund S, 1998, MODERN PATHOL, V11, P513; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Dalle JH, 2008, BONE MARROW TRANSPL, V42, pS51, DOI 10.1038/bmt.2008.284; Das R, 2009, BLOOD, V113, P2352, DOI 10.1182/blood-2008-08-175448; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin M, 2003, NEW ENGL J MED, V349, P2201, DOI 10.1056/NEJMoa022060; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; NASH RA, 1992, BLOOD, V80, P1838; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Simons BD, 2011, EXP CELL RES, V317, P2719, DOI 10.1016/j.yexcr.2011.07.010; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Tachiiri A, 2003, GENES IMMUN, V4, P153, DOI 10.1038/sj.gene.6363934; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; van Ampting MTJ, 2012, INFECT IMMUN, V80, P1115, DOI 10.1128/IAI.06165-11; Wingard JR, 2011, J CLIN ONCOL, V29, P2230, DOI 10.1200/JCO.2010.33.7212; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	47	403	423	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					339	350		10.1016/j.immuni.2012.05.028	http://dx.doi.org/10.1016/j.immuni.2012.05.028			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921121	Bronze, Green Accepted			2022-12-18	WOS:000308261800017
J	Snapper, SB; Rosen, FS; Mizoguchi, E; Cohen, P; Khan, W; Liu, CH; Hagemann, TL; Kwan, SP; Ferrini, R; Davidson, L; Bhan, AK; Alt, FW				Snapper, SB; Rosen, FS; Mizoguchi, E; Cohen, P; Khan, W; Liu, CH; Hagemann, TL; Kwan, SP; Ferrini, R; Davidson, L; Bhan, AK; Alt, FW			Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation	IMMUNITY			English	Article							SRC HOMOLOGY-3 DOMAINS; ANTIGEN-RECEPTOR; ACTIN POLYMERIZATION; TYROSINE KINASES; GENE; MUTATIONS; IDENTIFICATION; LYMPHOCYTES; VAV; THROMBOCYTOPENIA	The Wiskott-Aldrich syndrome (WAS) is a human X-linked immunodeficiency resulting from mutations in a gene (WASP) encoding a cytoplasmic protein implicated in regulating the actin cytoskeleton. To elucidate WASP function, we disrupted the WASP gene in mice by gene-targeted mutation. WASP-deficient mice showed apparently normal lymphocyte development, normal serum immunoglobulin levels, and the capacity to respond to both T-dependent and T-indepedent type II antigens. However, these mice did have decreased peripheral blood lymphocyte and platelet numbers and developed chronic colitis. Moreover, purified WASP-deficient T cells showed markedly impaired proliferation and antigen receptor cap formation in response to anti-CD3 epsilon stimulation. Yet, purified WASP-deficient B cells showed normal responses to anti-Ig stimulation. We discuss the implications of our findings regarding WASP function in-receptor signaling and cytoskeletal reorganization in T and B cells and compare the effects of WASP deficiency in mice and humans.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Immunopathol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Rush Univ, Rush Presbyterian St Lukes Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Rush University	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, K08HL003749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03749, HL59561] Funding Source: Medline; NIAID NIH HHS [AI20047] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; BLAESE RM, 1968, LANCET, V1, P1056; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COOPER MD, 1968, AM J MED, V44, P499, DOI 10.1016/0002-9343(68)90051-X; Cory GOC, 1996, J IMMUNOL, V157, P3791; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DEPETRIS S, 1974, NATURE, V250, P54, DOI 10.1038/250054a0; DERRY JMJ, 1995, GENOMICS, V29, P471, DOI 10.1006/geno.1995.9979; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Finan PM, 1996, J BIOL CHEM, V271, P26291, DOI 10.1074/jbc.271.42.26291; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HENRIQUEZ NV, 1994, J IMMUNOL, V153, P395; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; HSIEH KH, 1988, ANN ALLERGY, V60, P429; KAMMER GM, 1983, J IMMUNOL, V130, P38; KENNEY D, 1986, BLOOD, V68, P1329; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KWAN SP, 1991, GENOMICS, V10, P29, DOI 10.1016/0888-7543(91)90480-3; KWAN SP, 1995, P NATL ACAD SCI USA, V92, P4706, DOI 10.1073/pnas.92.10.4706; KWAN SP, 1995, HUM MOL GENET, V4, P1995, DOI 10.1093/hmg/4.10.1995; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MELAMED I, 1991, J IMMUNOL, V147, P1139; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mizoguchi E, 1997, LAB INVEST, V76, P385; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; MOLINA IJ, 1992, J EXP MED, V176, P867, DOI 10.1084/jem.176.3.867; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Morales VM, 1996, CURR OPIN GASTROEN, V12, P577, DOI 10.1097/00001574-199611000-00015; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OCHS HD, 1980, BLOOD, V55, P243; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; PARSEY MV, 1993, J IMMUNOL, V151, P1881; PHATAK PD, 1994, J CELL PHYSIOL, V159, P365, DOI 10.1002/jcp.1041590220; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; RemoldODonnell E, 1997, J IMMUNOL, V158, P4021; RemoldODonnell E, 1996, BLOOD, V87, P2621, DOI 10.1182/blood.V87.7.2621.bloodjournal8772621; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; ROSEN FS, 1995, NEW ENGL J MED, V333, P431, DOI 10.1056/NEJM199508173330707; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schwarz K, 1996, IMMUNOL TODAY, V17, P496, DOI 10.1016/0167-5699(96)30061-3; SELLIAH N, 1995, J NEUROIMMUNOL, V56, P107, DOI 10.1016/0165-5728(94)00142-B; Shomer NH, 1997, INFECT IMMUN, V65, P4858, DOI 10.1128/IAI.65.11.4858-4864.1997; SIMON HU, 1992, J CLIN INVEST, V90, P1396, DOI 10.1172/JCI116006; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; Ward JM, 1996, LAB ANIM SCI, V46, P15; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhu Qili, 1997, Blood, V90, P2680; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	63	403	414	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					81	91		10.1016/S1074-7613(00)80590-7	http://dx.doi.org/10.1016/S1074-7613(00)80590-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697838	Bronze			2022-12-18	WOS:000075066600008
J	MORITA, CT; BECKMAN, EM; BUKOWSKI, JF; TANAKA, Y; BAND, H; BLOOM, BR; GOLAN, DE; BRENNER, MB				MORITA, CT; BECKMAN, EM; BUKOWSKI, JF; TANAKA, Y; BAND, H; BLOOM, BR; GOLAN, DE; BRENNER, MB			DIRECT PRESENTATION OF NONPEPTIDE PRENYL PYROPHOSPHATE ANTIGENS TO HUMAN GAMMA-DELTA T-CELLS	IMMUNITY			English	Article							HEAT-SHOCK PROTEIN; CLASS-I; PERIPHERAL-BLOOD; MYCOBACTERIUM-TUBERCULOSIS; LYMPHOCYTES BEARING; ALPHA-BETA; PLASMODIUM-FALCIPARUM; RECOGNITION; RECEPTOR; EXPRESSION	Human V gamma 2V delta 2(+) T cells recognize mycobacterial nonpeptide antigens, such as isopentenyl pyrophosphate, and their synthetic analogs, such as monoethyl phosphate, through a TCR-dependent process. Here, we examine the presentation of these antigens. V gamma 2V delta 2(+) T cells recognized secreted prenyl pyrophosphate antigens in the absence of other accessory cells but, under such conditions, required T cell-T cell contact. Recognition required neither the expression of classical MHC class I, MHC class II, or CD1a, CD1b, and CD1c molecules, nor MHC class I or class II peptide loading pathways. Fixed accessory cells also presented the prenyl pyrophosphate antigens to gamma delta T cells. Thus, in contrast with the presentation of conventional peptide antigens, protein antigens, and superantigens to alpha beta T cells, prenyl pyrophosphate antigens are presented to gamma delta T cells through a novel extracellular pathway that does not require antigen uptake, antigen processing, or MHC class I or class II expression. This pathway allows for the rapid recognition of bacteria by gamma delta T cells and suggests that gamma delta T cells play a role in the early response to bacterial infection.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; YESHIVA UNIV ALBERT EINSTEIN COLL MED,HOWARD HUGHES MED INST,DEPT MICROBIOL,BRONX,NY 10461	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	MORITA, CT (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV RHEUMATOL & IMMUNOL,75 FRANCIS ST,BOSTON,MA 02115, USA.		Morita, Craig T/C-1365-2011	Morita, Craig T/0000-0001-8496-8294; Tanaka, Yoshimasa/0000-0002-5024-0614	NATIONAL CANCER INSTITUTE [R01CA047724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI028508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036308] Funding Source: NIH RePORTER; NCI NIH HHS [CA47724] Funding Source: Medline; NIAID NIH HHS [AI28508] Funding Source: Medline; NIAMS NIH HHS [AR36308] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BALBI B, 1993, AM REV RESPIR DIS, V148, P1685, DOI 10.1164/ajrccm/148.6_Pt_1.1685; BARNES PF, 1992, J INFECT DIS, V165, P506, DOI 10.1093/infdis/165.3.506; BEHR C, 1992, INT IMMUNOL, V4, P361, DOI 10.1093/intimm/4.3.361; BENDER A, 1992, CLIN EXP IMMUNOL, V89, P301, DOI 10.1111/j.1365-2249.1992.tb06949.x; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; EMOTO M, 1992, J EXP MED, V176, P363, DOI 10.1084/jem.176.2.363; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; FISCH P, 1990, SCIENCE, V250, P1269, DOI 10.1126/science.1978758; FOLLOWS GA, 1992, INFECT IMMUN, V60, P1229, DOI 10.1128/IAI.60.3.1229-1231.1992; FU YX, 1993, P NATL ACAD SCI USA, V90, P322, DOI 10.1073/pnas.90.1.322; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GLADSTONE P, 1978, NATURE, V271, P459, DOI 10.1038/271459a0; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; HO M, 1990, IMMUNOL LETT, V25, P139, DOI 10.1016/0165-2478(90)90105-Y; HOLOSHITZ J, 1992, J CLIN INVEST, V89, P308, DOI 10.1172/JCI115577; HOLOSHITZ J, 1993, INT IMMUNOL, V5, P1437, DOI 10.1093/intimm/5.11.1437; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; HOSKEN NA, 1989, J IMMUNOL, V142, P1079; INOUE T, 1991, J IMMUNOL, V146, P2754; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; KABELITZ D, 1990, J IMMUNOL, V145, P2827; KABELITZ D, 1990, J EXP MED, V171, P667, DOI 10.1084/jem.171.3.667; KABELITZ D, 1991, J EXP MED, V173, P1331, DOI 10.1084/jem.173.6.1331; KOZBOR D, 1989, J EXP MED, V169, P1847, DOI 10.1084/jem.169.5.1847; LASALLE JM, 1993, J IMMUNOL, V151, P649; LOGAN DM, 1972, J LIPID RES, V13, P137; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORITA CT, 1994, J IMMUNOL, V153, P3979; MORITA CT, 1986, J IMMUNOL, V137, P2139; MORITA CT, 1991, EUR J IMMUNOL, V21, P2999, DOI 10.1002/eji.1830211215; MUNK ME, 1990, J IMMUNOL, V145, P2434; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; PFEFFER K, 1990, EUR J IMMUNOL, V20, P1175, DOI 10.1002/eji.1830200534; PICHLER WJ, 1994, IMMUNOL TODAY, V15, P312, DOI 10.1016/0167-5699(94)90078-7; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; RAO A, 1984, CELL, V36, P889, DOI 10.1016/0092-8674(84)90038-2; RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; RONCAROLO MG, 1988, J EXP MED, V168, P2139, DOI 10.1084/jem.168.6.2139; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SCHOEL B, 1994, EUR J IMMUNOL, V24, P1886, DOI 10.1002/eji.1830240826; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; SHERMAN LA, 1992, J EXP MED, V175, P1221, DOI 10.1084/jem.175.5.1221; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SILICIANO RF, 1986, CELL, V47, P161, DOI 10.1016/0092-8674(86)90439-3; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; SPITS H, 1991, J IMMUNOL, V147, P1180; SU MWC, 1993, J IMMUNOL, V151, P658; SUHRBIER A, 1993, J IMMUNOL, V150, P2169; SUMIDA T, 1992, INFECT IMMUN, V60, P2554, DOI 10.1128/IAI.60.6.2554-2558.1992; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; TSUJI M, 1991, P NATL ACAD SCI USA, V91, P345; WYSSCORAY T, 1992, EUR J IMMUNOL, V22, P2295, DOI 10.1002/eji.1830220918; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5	79	403	414	0	10	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					495	507		10.1016/1074-7613(95)90178-7	http://dx.doi.org/10.1016/1074-7613(95)90178-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584140	Bronze			2022-12-18	WOS:A1995TB60800010
J	Lee, SY; Reichlin, A; Santana, A; Sokol, KA; Nussenzweig, MC; Choi, Y				Lee, SY; Reichlin, A; Santana, A; Sokol, KA; Nussenzweig, MC; Choi, Y			TRAF2 is essential for JNK but not NF-kappa B activation and regulates lymphocyte proliferation and survival	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCING PROTEINS; RECEPTOR-ASSOCIATED FACTORS; DOMAIN-CONTAINING RECEPTOR; DEATH-DOMAIN; CELL-DEATH; CYTOPLASMIC DOMAIN; INDUCED APOPTOSIS; TRANSGENIC MICE; BINDING-SITES	TRAF2 is believed to mediate the activation of NF-kappa B and JNK induced by the tumor necrosis factor receptor (TNFR) superfamily, which elicits pleiotropic responses in lymphocytes. We have investigated the physiological roles of TRAF2 in these processes by expressing a lymphocyte-specific dominant negative form of TRAF2, thereby blocking this protein's effector function. We find that the TNFR superfamily signals require TRAF2 for activation of JNK but not NF-kappa B. In addition, we show that TRAF2 induces NF-kappa B-independent anti-apoptotic pathways during TNF-induced apoptosis. Inhibition of TRAF2 leads to splenomegaly, lymphadenopathy, and an increased number of B cells. These findings indicate that TRAF2 is involved in the regulation of lymphocyte function and growth in vivo.	ROCKEFELLER UNIV,IMMUNOL LAB,NEW YORK,NY 10021; ROCKEFELLER UNIV,LAB MOL IMMUNOL,NEW YORK,NY 10021; ROCKEFELLER UNIV,LAB ANIM RES CTR,NEW YORK,NY 10021; ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021	Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University			Nussenzweig, Michel/AAE-7292-2019					Baker SJ, 1996, ONCOGENE, V12, P1; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Foy T M, 1994, Semin Immunol, V6, P259, DOI 10.1006/smim.1994.1034; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; ITOH N, 1993, J BIOL CHEM, V268, P10932; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Lee SY, 1996, J EXP MED, V183, P669, DOI 10.1084/jem.183.2.669; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; MOISALOS G, 1995, CELL, V80, P389; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Noelle RJ, 1996, IMMUNITY, V4, P415, DOI 10.1016/S1074-7613(00)80408-2; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; PENNINGER JM, 1994, IMMUNOL REV, V142, P230; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SONG HY, 1995, BIOCHEM J, V809, P825; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	69	402	409	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					703	713		10.1016/S1074-7613(00)80390-8	http://dx.doi.org/10.1016/S1074-7613(00)80390-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390693	Bronze			2022-12-18	WOS:A1997YH55400012
J	van Beelen, AJ; Zelinkova, Z; Taanman-Kueter, EW; Muller, FJ; Hommes, DW; Zaat, SAJ; Kapsenberg, ML; de Jong, EC				van Beelen, Astrid J.; Zelinkova, Zuzana; Taanman-Kueter, Esther W.; Muller, Fernke J.; Hommes, Daniel W.; Zaat, Sebastian A. J.; Kapsenberg, Martien L.; de Jong, Esther C.			Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; AUTOIMMUNE ENCEPHALOMYELITIS; KLEBSIELLA-PNEUMONIAE; ADAPTIVE IMMUNITY; HELPER TYPE-1; HOST-DEFENSE; IN-VITRO; IL-23; EXPRESSION	How the development of antibacterial T helper 17 (Thl 7) cells is selectively promoted by antigen-presenting dendritic cells (DCs) is unclear. We showed that bacteria, but not viruses, primed human DCs to promote IL-17 production in memory Th cells through the nucleoticle oligomerization domain 2 (NOD2)-ligand muramyldipeptide (MDP), a derivative of bacterial peptidoglycan. MDP enhanced obligate bacterial Toll-like receptor (TLR) agonist induction of IL-23 and IL-1, which promoted IL-1 7 expression in T cells. The role of NOD2 in this IL-23-IL-1 -IL17 axis could be confirmed in NOD2-deficient DCs, such as DCs from selected Crohn's disease patients. Thus, antibacterial Thl 7-mediated immunity in humans is orchestrated by DCs upon sensing bacterial NOD2-ligand MDP.	Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Microbiol, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Microbiol, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Jong, EC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	m.l.kapsenberg@amc.uva.nl; e.c.dejong@amc.uva.nl						Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Child NJA, 2003, BIOCHEM SOC T, V31, P652, DOI 10.1042/bst0310652; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kelsall B, 2005, NAT MED, V11, P383, DOI 10.1038/nm0405-383; Kidoya H, 2005, J IMMUNOL, V175, P8024, DOI 10.4049/jimmunol.175.12.8024; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sousa CRE, 2004, CURR OPIN IMMUNOL, V16, P21, DOI 10.1016/j.coi.2003.11.007; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	45	401	418	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					660	669		10.1016/j.immuni.2007.08.013	http://dx.doi.org/10.1016/j.immuni.2007.08.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17919942	Bronze			2022-12-18	WOS:000250490700016
J	Ogura, H; Murakami, M; Okuyama, Y; Tsuruoka, M; Kitabayashi, C; Kanamoto, M; Nishihara, M; Iwakura, Y; Hirano, T				Ogura, Hideki; Murakami, Masaaki; Okuyama, Yuko; Tsuruoka, Mineko; Kitabayashi, Chika; Kanamoto, Minoru; Nishihara, Mika; Iwakura, Yoichiro; Hirano, Toshio			Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction	IMMUNITY			English	Article							T-CELL TOLERANCE; GENE-EXPRESSION; TNF-ALPHA; RHEUMATOID-ARTHRITIS; CYTOKINE MILIEU; POINT MUTATION; IMMUNE-SYSTEM; TGF-BETA; IL-6; RECEPTOR	Dysregulated cytokine expression and signaling are major contributors to a number of autoimmune diseases. Interleukin-17A (IL-17A) and IL-6 are important in many disorders characterized by immune self-recognition, and IL-6 is known to induce the differentiation of T helper 17 (Th17) cells. Here we described an IL-17A-triggered positive-feed back loop of IL-6 signaling, which involved the activation of the transcription factors nuclear factor (NF)-kappa B and signal transducer and activator of transcription 3 (STAT3) in fibroblasts. Importantly, enhancement of this loop caused by disruption of suppressor of cytokine signaling 3 (SOCS3)-dependent negative regulation of the IL-6 signal transducer gp130 contributed to the development of arthritis. Because this mechanism also enhanced experimental autoimmune encephalomyelitis (EAE) in wild-type mice, it may be a general etiologic process underlying other Th17 cell-mediated autoimmune diseases.	[Hirano, Toshio] RIKEN, Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Univ Tokyo, Japan Sci & Technol Agcy, CREST Program, Tokyo 1088639, Japan; [Ogura, Hideki; Murakami, Masaaki; Okuyama, Yuko; Tsuruoka, Mineko; Kitabayashi, Chika; Kanamoto, Minoru; Nishihara, Mika; Hirano, Toshio] Osaka Univ, Lab Dev Immunol, Osaka 5650871, Japan; [Ogura, Hideki; Murakami, Masaaki; Okuyama, Yuko; Tsuruoka, Mineko; Kitabayashi, Chika; Kanamoto, Minoru; Nishihara, Mika; Hirano, Toshio] Osaka Univ, Japan Sci & Technol Agcy, CREST Program, Grad Sch Frontier Biosci,Grad Sch Med, Osaka 5650871, Japan; [Ogura, Hideki; Murakami, Masaaki; Okuyama, Yuko; Tsuruoka, Mineko; Kitabayashi, Chika; Kanamoto, Minoru; Nishihara, Mika; Hirano, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University	Hirano, T (corresponding author), Osaka Univ, Lab Dev Immunol, Osaka 5650871, Japan.	hirano@molonc.med.osaka-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Hirano, Toshio/C-8194-2009	Iwakura, Yoichiro/0000-0002-9934-5775; , Masaaki/0000-0001-7159-7279; Ogura, Hideki/0000-0002-2116-0340	KAKENHI; Uehara Foundation; Osaka Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Foundation(Uehara Memorial Foundation); Osaka Foundation	We thank M. Kopf (Max-Planck-Institute of Immunobiology, Germany) for IL-6-deficient mice, G. Karsenty (Baylor College of Medicine, Houston, TX for type I collagen-Cre mice, S. Akira (Osaka University, Japan) for STAT3<SUP>flox/flox</SUP> mice, and A. Kumanogo (Osaka University, Japan) for kind advice about the induction of EAE. We appreciate the excellent technical assistance provided by J. Jiang, R. Sato, E. Iketani, and T. Hayashi and thank R. Masuda for her excellent secretarial assistance. We thank D. Kamimura for careful reading of this manuscript. This work was supported by KAKENHI (H.O., M.M., and T.H.), Uehara Foundation (M.M.), and the Osaka Foundation for the Promotion of Clinical Immunology (M.M. and T.H.). The authors declare they have no conflicting financial interests.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Andersson A, 2005, AUTOIMMUNITY, V38, P209, DOI 10.1080/08916930500050269; Andreakos ET, 2002, CYTOKINE GROWTH F R, V13, P299, DOI 10.1016/S1359-6101(02)00018-7; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Awane M, 1999, J IMMUNOL, V162, P5337; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boe A, 1999, CYTOKINE, V11, P1057, DOI 10.1006/cyto.1999.0502; CAMPBELL IL, 1991, J CLIN INVEST, V87, P739, DOI 10.1172/JCI115055; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Glimcher LH, 2000, GENE DEV, V14, P1693; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirano T, 2002, CYTOKINE GROWTH F R, V13, P297, DOI 10.1016/S1359-6101(02)00017-5; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Ishihara K, 2004, INT IMMUNOL, V16, P455, DOI 10.1093/intimm/dxh045; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Okada M, 2007, NEUROSCI RES, V58, P371, DOI 10.1016/j.neures.2007.04.009; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; Sawa S, 2006, J EXP MED, V203, P1459, DOI 10.1084/jem.20052187; SUZUKI H, 1993, EUR J IMMUNOL, V23, P1078, DOI 10.1002/eji.1830230515; Takeda K, 1998, J IMMUNOL, V161, P4652; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	58	400	437	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					628	636		10.1016/j.immuni.2008.07.018	http://dx.doi.org/10.1016/j.immuni.2008.07.018			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18848474	Bronze			2022-12-18	WOS:000260316700015
J	Kalia, V; Sarkar, S; Subramaniam, S; Haining, WN; Smith, KA; Ahmed, R				Kalia, Vandana; Sarkar, Surojit; Subramaniam, Shruti; Haining, W. Nicholas; Smith, Kendall A.; Ahmed, Rafi			Prolonged Interleukin-2R alpha Expression on Virus-Specific CD8(+) T Cells Favors Terminal-Effector Differentiation In Vivo	IMMUNITY			English	Article							CLONAL EXPANSION; GENE-EXPRESSION; IL-2 RECEPTOR; MEMORY; ACTIVATION; BLIMP-1; PROLIFERATION; LYMPHOCYTES; PERFORIN; IMMUNITY	CD25, the high-affinity interleukin-2 (IL-2) receptor alpha chain, is rapidly upregulated by antigen-specific CD8(+) T cells after T cell receptor stimulation. Here, we demonstrate that during an acute viral infection, CD25 expression is quite dynamic-after initial upregulation, a subset of virus-specific T cells sustains CD25 expression longer than the rest. At this time when there is distinct heterogeneity in CD25 expression, examination of the in vivo fate of effector cells revealed that CD25(lo) cells, which are relatively less sensitive to IL-2, preferentially upregulate CD127 and CD62L and give rise to functional long-lived memory cells. In contrast, CD25(hi) cells perceiving prolonged IL-2 signals proliferate more rapidly, are prone to apoptosis, exhibit a more pronounced effector phenotype, and appear to be terminally differentiated. Consistent with this, sustained IL-2 receptor signaling during expansion drove terminal-effector differentiation. These data support the hypothesis that prolonged IL-2 signals during priming promote terminal-effector differentiation.	[Kalia, Vandana; Sarkar, Surojit; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Subramaniam, Shruti] Loma Linda Univ, Loma Linda, CA 92350 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Childrens Hosp, Boston, MA 02115 USA; [Smith, Kendall A.] Cornell Univ, New York, NY 14853 USA	Emory University; Loma Linda University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Cornell University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu		Altan-Bonnet, Gregoire/0000-0002-7283-3162	NIH [AI30048]; Bill and Melinda Gates Foundation [CAVD 38645]; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge support from NIH Grant AI30048 (RA), Bill and Melinda Gates Foundation Grant CAVD 38645 (R.A.), and Elizabeth Glaser Pediatric AIDS Foundation Scholar awards (S.S. and V.K.). We wish to thank B.T. Konieczny, R. Karaffa and M. Hulsey for their excellent technical assistance.	Ahmed R, 2006, IMMUNOL REV, V211, P5, DOI 10.1111/j.0105-2896.2006.00424.x; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cheng LE, 2002, J IMMUNOL, V169, P4990, DOI 10.4049/jimmunol.169.9.4990; Cheng LE, 2002, P NATL ACAD SCI USA, V99, P3001, DOI 10.1073/pnas.052676899; COUSENS LP, 1995, J IMMUNOL, V155, P5690; GILLIS S, 1978, J IMMUNOL, V120, P2027; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LIU CC, 1989, J EXP MED, V170, P2105, DOI 10.1084/jem.170.6.2105; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	45	399	405	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					91	103		10.1016/j.immuni.2009.11.010	http://dx.doi.org/10.1016/j.immuni.2009.11.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20096608	Bronze			2022-12-18	WOS:000274119900014
J	Iwama, A; Oguro, H; Negishi, M; Kato, Y; Morita, Y; Tsukui, H; Ema, H; Kamijo, T; Katoh-Fukui, Y; Koseki, H; van Lohuizen, M; Nakauchi, H				Iwama, A; Oguro, H; Negishi, M; Kato, Y; Morita, Y; Tsukui, H; Ema, H; Kamijo, T; Katoh-Fukui, Y; Koseki, H; van Lohuizen, M; Nakauchi, H			Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1	IMMUNITY			English	Article							LINEAGE COMMITMENT; INK4A LOCUS; EX-VIVO; PROLIFERATION; EXPANSION; MICE; DIFFERENTIATION; PROGENITORS; EXPRESSION; COMPLEX	The Polycomb group (PcG) gene Bmi-1 has recently been implicated in the maintenance of hematopoietic stem cells (HSC) from loss-of-function analysis. Here, we demonstrate that increased expression of Bmi-1 promotes HSC self-renewal. Forced expression of Bmi-1 enhanced symmetrical cell division of HSCs and mediated a higher probability of inheritance of stemness through cell division. Correspondingly, forced expression of Bmi-1, but not the other PcG genes, led to a striking ex vivo expansion of multipotential progenitors and marked augmentation of HSC repopulating capacity in vivo. Loss-of-function analyses revealed that among PcG genes, absence of Bmi-1 is preferentially linked With a profound defect in HSC self-renewal. Our findings define Bmi-1 as a central player in HSC self-renewal and demonstrate that Bmi-1 is a target for therapeutic manipulation of HSCs.	Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo 1088639, Japan; Shinshu Univ, Sch Med, Dept Pediat, Nagano 3908621, Japan; Natl Inst Basic Biol, Dept Dev Biol, Okazaki 4448585, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	University of Tokyo; Shinshu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); RIKEN; Netherlands Cancer Institute	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo 1088639, Japan.	aiwama@ims.u-tokyo.ac.jp	Morita, Yohei/N-1260-2014; Koseki, Haruhiko/I-3825-2014; Oguro, Hideyuki/Q-5478-2019; Katoh-Fukui, Yuko/Y-5383-2019	Morita, Yohei/0000-0003-4163-5080; Koseki, Haruhiko/0000-0001-8424-5854; Oguro, Hideyuki/0000-0002-9070-4575; Katoh-Fukui, Yuko/0000-0001-6858-3693				Akasaka T, 1996, DEVELOPMENT, V122, P1513; Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bel S, 1998, DEVELOPMENT, V125, P3543; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kaneko S, 2001, HUM GENE THER, V12, P35, DOI 10.1089/104303401450942; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	37	399	425	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					843	851		10.1016/j.immuni.2004.11.004	http://dx.doi.org/10.1016/j.immuni.2004.11.004			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589172	Bronze			2022-12-18	WOS:000225901600011
J	Shiloh, MU; MacMicking, JD; Nicholson, S; Brause, JE; Potter, S; Marino, M; Fang, F; Dinauer, M; Nathan, C				Shiloh, MU; MacMicking, JD; Nicholson, S; Brause, JE; Potter, S; Marino, M; Fang, F; Dinauer, M; Nathan, C			Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase	IMMUNITY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; MOUSE PERITONEAL-MACROPHAGES; ATHYMIC NUDE-MICE; LISTERIA-MONOCYTOGENES; SALMONELLA-TYPHIMURIUM; BACTERIAL-INFECTION; MURINE LISTERIOSIS; INTRACELLULAR BACTERIUM; INFLAMMATORY RESPONSES; TOXOPLASMA-GONDII	The two genetically established antimicrobial mechanisms of macrophages are production of reactive oxygen intermediates by phagocyte oxidase (phox) and reactive nitrogen intermediates by inducible nitric oxide synthase (NOS2). Mice doubly deficient in both enzymes (gp91(phox-/-)/NOS2(-/-)) formed massive abscesses containing commensal organisms, mostly enteric bacteria, even when reared under specific pathogen-free conditions with antibiotics. Neither parental strain showed such infections. Thus, phox and NOS2 appear to compensate for each other's deficiency in providing resistance to indigenous bacteria, and no other pathway does so fully. Macrophages from gp91(phox-/-) NOS2(-/-)mice could not kill virulent Listeria. Their killing of S. typhimurium, E. coli, and attenuated Listeria was markedly diminished but demonstrable, establishing the existence of a mechanism of macrophage antibacterial activity independent of phox and NOS2.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA; Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA; Indiana Univ, Ctr Canc, Dept Pediat, Indianapolis, IN 46202 USA	Cornell University; Cornell University; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Indiana University System; Indiana University-Purdue University Indianapolis	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.		Aizer, Juliet/ADN-0489-2022; Shiloh, Michael/AAS-8883-2020	Shiloh, Michael/0000-0003-4329-2253; Fang, Ferric/0000-0002-3243-110X	NHLBI NIH HHS [HL51967] Funding Source: Medline; NIAID NIH HHS [AI34543] Funding Source: Medline; NIGMS NIH HHS [GM53921] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034543, R21AI034543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053921] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498, DOI 10.1002/jlb.53.5.498; BLANDEN RV, 1966, J EXP MED, V124, P585, DOI 10.1084/jem.124.4.585; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; CHEERS C, 1975, J IMMUNOL, V115, P844; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; CONLAN JW, 1991, J EXP MED, V174, P741, DOI 10.1084/jem.174.3.741; CZUPRYNSKI CJ, 1985, INFECT IMMUN, V50, P425, DOI 10.1128/IAI.50.2.425-430.1985; Dai WJ, 1997, J IMMUNOL, V158, P5297; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; DELAHARPE J, 1985, J IMMUNOL METHODS, V78, P323, DOI 10.1016/0022-1759(85)90089-4; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Dinauer MC, 1997, J IMMUNOL, V158, P5581; DING AH, 1988, J IMMUNOL, V141, P2407; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GERVAIS F, 1984, J IMMUNOL, V132, P2078; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; INOUE S, 1995, INFECT IMMUN, V63, P1876, DOI 10.1128/IAI.63.5.1876-1886.1995; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Karupiah G, 1998, J VIROL, V72, P7703, DOI 10.1128/JVI.72.9.7703-7706.1998; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCCALL TB, 1991, EUR J IMMUNOL, V21, P2523, DOI 10.1002/eji.1830211032; McInnes IB, 1998, J IMMUNOL, V160, P308; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN CF, 1983, T ROY SOC TROP MED H, V77, P620, DOI 10.1016/0035-9203(83)90190-6; NICKOL AD, 1977, INFECT IMMUN, V18, P636, DOI 10.1128/IAI.18.3.636-645.1977; North RJ, 1997, IMMUNOL REV, V158, P27, DOI 10.1111/j.1600-065X.1997.tb00989.x; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; SHILOH MU, 1999, PHAGOCYTOSIS PATHOGE; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Weih F, 1997, J IMMUNOL, V158, P5211; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Zaragoza C, 1998, P NATL ACAD SCI USA, V95, P2469, DOI 10.1073/pnas.95.5.2469	67	399	406	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1999	10	1					29	38		10.1016/S1074-7613(00)80004-7	http://dx.doi.org/10.1016/S1074-7613(00)80004-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023768	Bronze			2022-12-18	WOS:000078428700004
J	Melief, CJM				Melief, Cornelis J. M.			Cancer immunotherapy by dendritic cells	IMMUNITY			English	Review							CD8(+) T-CELLS; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; HUMAN-PAPILLOMAVIRUS TYPE-16; JSI-124 CUCURBITACIN-I; FC-GAMMA RECEPTORS; NF-KAPPA-B; CROSS-PRESENTATION; ANTITUMOR IMMUNITY; TUMOR-CELLS; CERVICAL-CANCER	Cancerous lesions promote tumor growth, motility, invasion, and angiogenesis via oncogene-driven immunosuppressive leukocyte infiltrates, mainly myeloid-derived suppressor cells, tumor-associated macrophages, and immature dendritic cells (DCs). In addition, many tumors express or induce immunosuppressive cytokines such as TGF-beta and IL-10. As a result, tumor-antigen crosspresentation by DCs induces T cell anergy or deletion and regulatory T cells instead of antitumor immunity. Tumoricidal effector cells can be generated after vigorous DC activation by Toll-like receptor ligands or CD40 agonists. However, no single immunotherapeutic modality is effective in established cancer. Rather, chemotherapies, causing DC activation, enhanced cross presentation, lymphodepletion, and reduction of immunosuppressive leukocytes, act synergistically with vaccines or adoptive T cell transfer. Here, I discuss the considerations for generating promising therapeutic antitumor vaccines that use DCs.	[Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol, NL-2300 RC Leiden, Netherlands; [Melief, Cornelis J. M.] ISA Pharmaceut, NL-3723 MB Bilthoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Melief, CJM (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol, NL-2300 RC Leiden, Netherlands.	c.melief@lumc.nl						Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Angeletti PC, 2008, ADV PHARMACOL, V56, P509, DOI 10.1016/S1054-3589(07)56016-3; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Atreya R, 2008, CURR DRUG TARGETS, V9, P369, DOI 10.2174/138945008784221116; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Becker Y, 1993, In Vivo, V7, P187; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Berg M, 2006, EUR J IMMUNOL, V36, P2960, DOI 10.1002/eji.200636033; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Binder RJ, 2007, J IMMUNOL, V179, P7254, DOI 10.4049/jimmunol.179.11.7254; Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264; Bins AD, 2007, J IMMUNOL, V179, P2126, DOI 10.4049/jimmunol.179.4.2126; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boonman ZFHM, 2005, J IMMUNOL, V175, P4247, DOI 10.4049/jimmunol.175.7.4247; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Brode S, 2008, CRIT REV IMMUNOL, V28, P109, DOI 10.1615/CritRevImmunol.v28.i2.20; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; Chen Z, 2005, J GENE MED, V7, P506, DOI 10.1002/jgm.692; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Dumortier H, 2005, J IMMUNOL, V175, P855, DOI 10.4049/jimmunol.175.2.855; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fonseca C, 2008, CLIN CANCER RES, V14, P1603, DOI 10.1158/1078-0432.CCR-07-2245; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gerner MY, 2008, J IMMUNOL, V181, P155, DOI 10.4049/jimmunol.181.1.155; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hamzah J, 2008, J CLIN INVEST, V118, P1691, DOI 10.1172/JCI33201; Hargadon KM, 2006, J IMMUNOL, V177, P6081, DOI 10.4049/jimmunol.177.9.6081; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kavanagh B, 2008, BLOOD, V112, P1175, DOI 10.1182/blood-2007-11-125435; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Konda A, 2008, GASTROENTEROL CLIN N, V37, P191, DOI 10.1016/j.gtc.2007.12.013; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lesterhuis WJ, 2008, CRIT REV ONCOL HEMAT, V66, P118, DOI 10.1016/j.critrevonc.2007.12.007; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Liu CW, 2008, J CLIN INVEST, V118, P1165, DOI 10.1172/JCI33583; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Longman RS, 2007, BLOOD, V109, P1113, DOI 10.1182/blood-2006-05-023465; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mokyr MB, 2006, CANCER IMMUNOL IMMUN, V55, P459, DOI 10.1007/s00262-005-0029-2; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Muranski P, 2006, NAT CLIN PRACT ONCOL, V3, P668, DOI 10.1038/ncponc0666; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Nowak AK, 2003, J IMMUNOL, V170, P4905, DOI 10.4049/jimmunol.170.10.4905; Nowak AK, 2003, CANCER RES, V63, P4490; Nowak AK, 2006, ADV DRUG DELIVER REV, V58, P975, DOI 10.1016/j.addr.2006.04.002; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Schuurhuis DH, 2006, INT ARCH ALLERGY IMM, V140, P53, DOI 10.1159/000092002; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shi HZ, 2006, J IMMUNOL, V176, P2134, DOI 10.4049/jimmunol.176.4.2134; Shi XZ, 2006, BRIT J HAEMATOL, V135, P26, DOI 10.1111/j.1365-2141.2006.06259.x; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tacken PJ, 2008, J IMMUNOL, V180, P7687, DOI 10.4049/jimmunol.180.11.7687; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vainer GW, 2008, CANCER LETT, V267, P182, DOI 10.1016/j.canlet.2008.03.016; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; van der Most RG, 2008, CELL DEATH DIFFER, V15, P13, DOI 10.1038/sj.cdd.4402255; van Kester MS, 2008, J INVEST DERMATOL, V128, P1691, DOI 10.1038/sj.jid.5701246; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753; Wang DZ, 2008, CANCER LETT, V267, P197, DOI 10.1016/j.canlet.2008.03.004; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Welters MJP, 2006, INT J CANCER, V118, P950, DOI 10.1002/ijc.21459; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	151	398	439	1	95	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					372	383		10.1016/j.immuni.2008.08.004	http://dx.doi.org/10.1016/j.immuni.2008.08.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799145	Bronze			2022-12-18	WOS:000259708900006
J	Tagaya, Y; Bamford, RN; DeFilippis, AP; Waldmann, TA				Tagaya, Y; Bamford, RN; DeFilippis, AP; Waldmann, TA			IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels	IMMUNITY			English	Review							RECEPTOR GAMMA-CHAIN; MESSENGER-RNA; INTERLEUKIN-7; TRANSLATION; SEQUENCES; GENE				Tagaya, Y (corresponding author), NCI,METAB BRANCH,NATL INST HLTH,BETHESDA,MD 20892, USA.		Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660				ANDERSON DM, 1995, GENOMICS, V25, P701, DOI 10.1016/0888-7543(95)80013-C; ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARRICK BA, 1991, MOL CELL BIOL, V11, P4306, DOI 10.1128/MCB.11.9.4306; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BAMFORD RN, 1996, IN PRESS P NATL ACAD; BAMFORD RN, 1995, P NATL ACAD SCI USA, V43, pA497; BATES B, 1991, MOL CELL BIOL, V11, P1840, DOI 10.1128/MCB.11.4.1840; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Carson WE, 1995, J CLIN INVEST, V96, P2578, DOI 10.1172/JCI118321; Doherty TM, 1996, J IMMUNOL, V156, P735; Flamand L, 1996, J CLIN INVEST, V97, P1373, DOI 10.1172/JCI118557; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1992, CRIT REV BIOCHEM MOL, V27, P385, DOI 10.3109/10409239209082567; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUMAKI S, 1995, BLOOD, V86, P1428, DOI 10.1182/blood.V86.4.1428.bloodjournal8641428; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MOHAMADZADEH M, 1995, J IMMUNOL, V155, P4492; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Nishimura H, 1996, J IMMUNOL, V156, P663; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; QUINN LS, 1995, ENDOCRINOLOGY, V136, P3669, DOI 10.1210/en.136.8.3669; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SATO N, 1994, CURR OPIN CELL BIOL, V6, P174, DOI 10.1016/0955-0674(94)90133-3; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SEIKI M, 1985, SCIENCE, V228, P1532, DOI 10.1126/science.2990031; TAGAYA Y, 1996, IN PRESS INVEST MED; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; WILKINSON PC, 1995, J EXP MED, V181, P1255, DOI 10.1084/jem.181.3.1255; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	42	398	414	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					329	336		10.1016/S1074-7613(00)80246-0	http://dx.doi.org/10.1016/S1074-7613(00)80246-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612127	Bronze			2022-12-18	WOS:A1996UH52200001
J	Van Opdenbosch, N; Lamkanfi, M				Van Opdenbosch, Nina; Lamkanfi, Mohamed			Caspases in Cell Death, Inflammation, and Disease	IMMUNITY			English	Review							NF-KAPPA-B; NLRP3 INFLAMMASOME; AIM2 INFLAMMASOME; GASDERMIN D; NUCLEAR-FACTOR; MYELOID CELLS; K+ EFFLUX; ACTIVATION; APOPTOSIS; PYROPTOSIS	Caspases are an evolutionary conserved family of cysteine proteases that are centrally involved in cell death and inflammation responses. A wealth of foundational insight into the molecular mechanisms that control caspase activation has emerged in recent years. Important advancements include the identification of additional inflammasome platforms and pathways that regulate activation of inflammatory caspases; the discovery of gasdermin D as the effector of pyroptosis and interleukin (IL)-1 and IL-18 secretion; and the existence of substantial crosstalk between inflammatory and apoptotic initiator caspases. A better understanding of the mechanisms regulating caspase activation has supported initial efforts to modulate dysfunctional cell death and inflammation pathways in a suite of communicable, inflammatory, malignant, metabolic, and neurode-generative diseases. Here, we review current understanding of caspase biology with a prime focus on the inflammatory caspases and outline important topics for future experimentation.	[Van Opdenbosch, Nina; Lamkanfi, Mohamed] Pharmaceut Co Johnson & Johnson, Janssen Immunosci, World Dis Accelerator, B-2340 Beerse, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium	Johnson & Johnson; Ghent University	Lamkanfi, M (corresponding author), Pharmaceut Co Johnson & Johnson, Janssen Immunosci, World Dis Accelerator, B-2340 Beerse, Belgium.; Lamkanfi, M (corresponding author), Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium.	mlamkanf@its.jnj.com			European Research Council [683144]	European Research Council(European Research Council (ERC)European Commission)	We apologize to colleagues whose work was not cited because of space constraints. This work was supported by European Research Council Grant 683144 (PyroPop) to M.L.	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Aubert DF, 2016, CELL HOST MICROBE, V19, P664, DOI 10.1016/j.chom.2016.04.004; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cornelis S, 2007, CURR PHARM DESIGN, V13, P367, DOI 10.2174/138161207780163006; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; deVasconcelos N. M., 2019, DPP8 DPP9 INHIBITION; Di AK, 2018, IMMUNITY, V49, P56, DOI 10.1016/j.immuni.2018.04.032; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dorstyn L, 2018, CELL DEATH DIFFER, V25, P1194, DOI 10.1038/s41418-017-0025-z; Erlich Z, 2019, NAT IMMUNOL, V20, P397, DOI 10.1038/s41590-019-0313-5; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fava LL, 2017, GENE DEV, V31, P34, DOI 10.1101/gad.289728.116; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; Fulda S, 2017, INT REV CEL MOL BIO, V330, P157, DOI 10.1016/bs.ircmb.2016.09.004; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Galloway JB, 2011, RHEUMATOLOGY, V50, P1341, DOI 10.1093/rheumatology/ker146; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Garcia-Tsao G, 2019, HEPATOLOGY, V69, P717, DOI 10.1002/hep.30199; Girardot T, 2017, APOPTOSIS, V22, P295, DOI 10.1007/s10495-016-1325-3; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Halaby R., 2012, AUTOIMMUNE DIS; Harapas CR, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0750-4; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Horn S, 2017, CELL REP, V19, P785, DOI 10.1016/j.celrep.2017.04.010; Hoste E, 2013, J INVEST DERMATOL, V133, P742, DOI 10.1038/jid.2012.350; Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Kachapati Kritika, 2006, Hum Mutat, V27, P975, DOI 10.1002/humu.9448; Kanneganti A, 2018, J EXP MED, V215, P1519, DOI 10.1084/jem.20172060; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kudelova J, 2015, J PHYSIOL PHARMACOL, V66, P473; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lagrange B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02682-y; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lamkanfi M, 2017, NATURE, V548, P534, DOI 10.1038/548534a; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Lee BL, 2018, J EXP MED, V215, P2279, DOI 10.1084/jem.20180589; Lee BL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21998-3; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Luksch H, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0520-5; Luksch H, 2013, HUM MUTAT, V34, P122, DOI 10.1002/humu.22169; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mahajan A, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00035; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Manda P, 2018, IMMUNITY, V49, P42, DOI 10.1016/j.immuni.2018.06.011; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Masters SL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1471; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McGeough MD, 2017, J CLIN INVEST, V127, P4488, DOI 10.1172/JCI90699; Mehta G, 2018, J CLIN EXP HEPATOL, V8, P224, DOI 10.1016/j.jceh.2017.11.006; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Meynier S, 2019, IMMUNOL REV, V287, P50, DOI 10.1111/imr.12720; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Opferman JT, 2016, FEBS J, V283, P2661, DOI 10.1111/febs.13472; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Ramirez MLG, 2018, SEMIN CELL DEV BIOL, V82, P79, DOI 10.1016/j.semcdb.2018.01.002; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Ratner D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006035; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Reynolds SL, 2015, BIOCHEM J, V468, P17, DOI 10.1042/BJ20141506; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Saavedra PHV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07386-5; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Surup F, 2018, ACS CHEM BIOL, V13, P2981, DOI 10.1021/acschembio.8b00659; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Tsuchiya K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09753-2; Tummers B, 2017, IMMUNOL REV, V277, P76, DOI 10.1111/imr.12541; Van Gorp H, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028563; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; Van Opdenbosch N, 2017, CELL REP, V21, P3427, DOI 10.1016/j.celrep.2017.11.088; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Vande Walle L, 2016, CURR BIOL, V26, pR568, DOI 10.1016/j.cub.2016.02.019; Vande Walle L, 2016, NATURE, V534, pE1, DOI 10.1038/nature17649; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vanden Berghe T, 2014, AM J RESP CRIT CARE, V189, P282, DOI 10.1164/rccm.201308-1535OC; Vince JE, 2018, CELL REP, V25, P2339, DOI 10.1016/j.celrep.2018.10.103; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003; Xiao JQ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000047; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yurdagul A, 2018, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00086; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zhu QF, 2018, J IMMUNOL, V201, P3662, DOI 10.4049/jimmunol.1800788	146	397	400	20	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1352	1364		10.1016/j.immuni.2019.05.020	http://dx.doi.org/10.1016/j.immuni.2019.05.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216460	Green Accepted, Bronze			2022-12-18	WOS:000471876100008
J	Princiotta, MF; Finzi, D; Qian, SB; Gibbs, J; Schuchmann, S; Buttgereit, F; Bennink, JR; Yewdell, JW				Princiotta, MF; Finzi, D; Qian, SB; Gibbs, J; Schuchmann, S; Buttgereit, F; Bennink, JR; Yewdell, JW			Quantitating protein synthesis, degradation, and endogenous antigen processing	IMMUNITY			English	Article							MHC CLASS-I; PROTEASOMAL DEGRADATION; PRESENTED PEPTIDES; CODON USAGE; GENERATION; MOLECULES; CELLS; LOCALIZATION; MECHANISM; COMPLEXES	Using L929 cells, we quantitated the macroeconomics of protein synthesis and degradation and the micro-economics of producing MHC class I associated peptides from viral translation products. To maintain a content of 2.6 x 10(9) proteins, each cell's 6 x 10(6) ribosomes produce 4 x 10(6) proteins min(-1). Each of the cell's 8 x 10(5) proteasomes degrades 2.5 substrates min(-1), creating one MHC class I-peptide complex for each 500-3000 viral translation products degraded. The efficiency of complex formation is similar in dendritic cells and macrophages, which play a critical role in activating T cells in vivo. Proteasomes create antigenic peptides at different efficiencies from two distinct substrate pools: rapidly degraded newly synthesized proteins that clearly represent defective ribosomal products (DRiPs) and a less rapidly degraded pool in which DRiPs may also predominate.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; Humboldt Univ, Dept Rheumatol & Clin Immunol, Charite Univ Hosp, D-10117 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@nih.gov	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Buttgereit, Frank/0000-0003-2534-550X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000653, ZIAAI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alberts B, 1994, MOL BIOL CELL; Anton LC, 1998, J IMMUNOL, V160, P4859; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Anton LC, 1997, J IMMUNOL, V158, P2535; BUTTGEREIT F, 1992, BIOSCIENCE REP, V12, P109, DOI 10.1007/BF02351215; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; LILJENSTROM H, 1987, J THEOR BIOL, V124, P43, DOI 10.1016/S0022-5193(87)80251-5; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; Montoya M, 1999, J IMMUNOL, V163, P1914; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; NISSENMEYER J, 1976, J MOL BIOL, V101, P211, DOI 10.1016/0022-2836(76)90373-9; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sijts AJAM, 1996, J IMMUNOL, V156, P685; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; WHEATLEY DN, 1989, RBC-CELL BIOL REV, V21, P377; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Yewdell JW, 2001, J CELL SCI, V114, P845; Zwickey HL, 1999, J IMMUNOL, V162, P6341	35	397	404	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					343	354		10.1016/S1074-7613(03)00051-7	http://dx.doi.org/10.1016/S1074-7613(03)00051-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648452	Bronze			2022-12-18	WOS:000181713700005
J	Delneste, Y; Magistrelli, G; Gauchat, JF; Haeuw, JF; Aubry, JP; Nakamura, K; Kawakami-Honda, N; Goetsch, L; Sawamura, T; Bonnefoy, JY; Jeannin, P				Delneste, Y; Magistrelli, G; Gauchat, JF; Haeuw, JF; Aubry, JP; Nakamura, K; Kawakami-Honda, N; Goetsch, L; Sawamura, T; Bonnefoy, JY; Jeannin, P			Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation	IMMUNITY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEAT-SHOCK PROTEINS; I PRESENTATION PATHWAY; SCAVENGER RECEPTORS; PSEUDOMONAS EXOTOXIN; ENDOTHELIAL RECEPTOR; PRESENTING CELLS; FUSION PROTEINS; IMMUNE-RESPONSE; CUTTING EDGE	Some exogenous antigens, such as heat shock proteins or apoptotic bodies, gain access to the MHO class I processing pathway and initiate CTL responses, a process called cross-priming. To be efficient in vivo, this process requires endocytosis of the antigen by dendritic cells via receptors which remain unidentified. Here, we report that scavenger receptors are the main HSP binding structures on human dendritic cells and identify LOX-1 as one of these molecules. A neutralizing anti-LOX-1 mAb inhibits Hsp70 binding to dendritic cells and Hsp70-induced antigen cross-presentation. In vivo, to target LOX-1 with a tumor antigen using an anti-LOX-1 mAb induces antitumor immunity. Thus, the scavenger receptor LOX-1 is certainly a promising target for cancer immunotherapy.	Ctr Immunol Pierre Fabre, F-74160 St Julien en Genevois, France; Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Suita, Osaka 5650871, Japan; Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 5658565, Japan	Centre d'Immunologie Pierre Fabre; Osaka University; National Cerebral & Cardiovascular Center - Japan	Jeannin, P (corresponding author), Ctr Immunol Pierre Fabre, 5 Ave Napoleon III, F-74160 St Julien en Genevois, France.		Delneste, Yves/O-3956-2016; Sawamura, Tatsuya/E-7103-2010; JEANNIN, Pascale/K-8656-2015; DELNESTE, Yves/K-7367-2015	DELNESTE, Yves/0000-0002-2142-596X; JEANNIN, Pascale/0000-0002-3666-3856				ABRAHAM R, 1995, J IMMUNOL, V154, P1; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bansal P, 1999, J IMMUNOL, V162, P4430; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Dhaliwal BS, 1999, CLIN CHIM ACTA, V286, P191, DOI 10.1016/S0009-8981(99)00101-1; DONNELLY JJ, 1993, P NATL ACAD SCI USA, V90, P3530, DOI 10.1073/pnas.90.8.3530; Draude G, 1999, BIOCHEM PHARMACOL, V57, P383, DOI 10.1016/S0006-2952(98)00313-X; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Goletz TJ, 1997, HUM IMMUNOL, V54, P129, DOI 10.1016/S0198-8859(97)00081-5; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI13992; Huang Q, 2000, J EXP MED, V191, P403, DOI 10.1084/jem.191.2.403; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Lipsker D, 2002, EUR J IMMUNOL, V32, P322, DOI 10.1002/1521-4141(200202)32:2<322::AID-IMMU322>3.0.CO;2-0; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Moriwaki H, 1998, ARTERIOSCL THROM VAS, V18, P1541, DOI 10.1161/01.ATV.18.10.1541; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Sondermann H, 2000, BIOL CHEM, V381, P1165, DOI 10.1515/BC.2000.144; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzue K, 1997, P NATL ACAD SCI USA, V94, P13146, DOI 10.1073/pnas.94.24.13146; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Todryk S, 1999, J IMMUNOL, V163, P1398; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wassenberg JJ, 1999, J CELL SCI, V112, P2167; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Zha XH, 1997, ARTERIOSCL THROM VAS, V17, P1421, DOI 10.1161/01.ATV.17.7.1421; ZHOU F, 1992, CANCER RES, V52, P6287	56	397	427	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					353	362		10.1016/S1074-7613(02)00388-6	http://dx.doi.org/10.1016/S1074-7613(02)00388-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354387	Bronze			2022-12-18	WOS:000178163100011
J	Hirano, T; Murakami, M				Hirano, Toshio; Murakami, Masaaki			COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome	IMMUNITY			English	Editorial Material							ANGIOTENSIN-CONVERTING ENZYME-2; SARS; CORONAVIRUS; INSIGHTS; ACE2	Zhou et al. (Nature) and Hoffmann et al. (Cell) identify ACE2 as a SARS-CoV-2 receptor, and the latter show its entry mechanism depends on cellular serine protease TMPRSS2. These results may explain proinflammatory cytokine release via the associated angiotestin II pathway and a possible therapeutic target via the IL-6-STAT3 axis.	[Hirano, Toshio] Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan; [Hirano, Toshio; Murakami, Masaaki] Hokkaido Univ, Inst Med Genet, Div Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan; [Hirano, Toshio; Murakami, Masaaki] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan	National Institutes for Quantum Science & Technology; Hokkaido University; Hokkaido University	Hirano, T (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan.; Hirano, T (corresponding author), Hokkaido Univ, Inst Med Genet, Div Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.; Hirano, T (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0600815, Japan.	hirano.toshio@qst.go.jp		, Masaaki/0000-0001-7159-7279				de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Eguchi S, 2018, HYPERTENSION, V71, P804, DOI 10.1161/HYPERTENSIONAHA.118.10266; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	11	396	408	5	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					731	733		10.1016/j.immuni.2020.04.003	http://dx.doi.org/10.1016/j.immuni.2020.04.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32325025	Bronze, Green Published			2022-12-18	WOS:000535371100006
J	Lazear, HM; Schoggins, JW; Diamond, MS				Lazear, Helen M.; Schoggins, John W.; Diamond, Michael S.			Shared and Distinct Functions of Type I and Type III Interferons	IMMUNITY			English	Review							CHRONIC HEPATITIS-C; REGULATORY FACTOR FAMILY; T-CELL RESPONSES; IFN-LAMBDA; ZIKA VIRUS; ADJUVANT THERAPY; PEGINTERFERON ALPHA-2A; STIMULATED GENES; PEGYLATED INTERFERON-ALPHA-2B; ANTIVIRAL PROTECTION	Type I interferons (IFNs) (IFN-alpha,IFN-beta) and type III IFNs (IFN-lambda) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune primin anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and hignlignt gaps in understanding of the biology of type I and type III IFNs in health and disease.	[Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Schoggins, John W.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	helen.lazear@med.unc.edu; mdiamond@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165	NIH [R01AI139512, DP2AI117922, R01AI073755, R01AI127828, R01HD091218]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD091218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI117922, R01AI139512, R01AI073755, R01AI127828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the authors' laboratories is supported in part by NIH grants R01AI139512 to H.M.L.; DP2AI117922 to J.W.S.; and R01AI073755, R01AI127828, and R01HD091218 to M.S.D.	Aboulnasr F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141655; Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Alspach E., 2018, COLD SPRING HARB PER, V11; Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114; Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bamford CGG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007307; Bayas Antonios, 2003, Journal of Neurology, V250, P3; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Booy S, 2015, J INTERF CYTOK RES, V35, P327, DOI 10.1089/jir.2014.0157; Borden EC, 2019, NAT REV DRUG DISCOV, V18, P219, DOI 10.1038/s41573-018-0011-2; Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Budhwani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00322; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2; Cascinelli N, 2001, LANCET, V358, P866, DOI 10.1016/S0140-6736(01)06068-8; Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR; de Weerd NA, 2017, J BIOL CHEM, V292, P7554, DOI 10.1074/jbc.M116.773788; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Dhib-Jalbut S, 2010, NEUROLOGY, V74, pS17, DOI 10.1212/WNL.0b013e3181c97d99; Di Trolio R, 2015, CYTOKINE GROWTH F R, V26, P203, DOI 10.1016/j.cytogfr.2014.11.008; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115; Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114; Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Espinosa V, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5357; Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Fox JM, 2015, J INTERF CYTOK RES, V35, P554, DOI 10.1089/jir.2014.0052; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Good C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4255; Goodin DS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001972; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14; Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; GREENBERG HB, 1976, NEW ENGL J MED, V295, P517, DOI 10.1056/NEJM197609022951001; Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902; Grine L, 2015, CYTOKINE GROWTH F R, V26, P25, DOI 10.1016/j.cytogfr.2014.10.009; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Hansson J, 2011, LANCET ONCOL, V12, P144, DOI 10.1016/S1470-2045(10)70288-6; Harris BD, 2018, J BIOL CHEM, V293, P16057, DOI 10.1074/jbc.RA118.003617; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Hendricks MR, 2016, P NATL ACAD SCI USA, V113, P1642, DOI 10.1073/pnas.1516979113; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Huang Y, 2017, HEPATOB PANCREAT DIS, V16, P470, DOI 10.1016/S1499-3872(17)60044-4; Hwang M, 2018, J VIROL, V92, DOI 10.1128/JVI.01901-17; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Ingle H., 2018, VIRUSES, V10, pE46; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; JACOBS L, 1981, SCIENCE, V214, P1026, DOI 10.1126/science.6171035; Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012; Jakimovski D, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a032003; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Johansson C, 2007, J EXP MED, V204, P1349, DOI 10.1084/jem.20061587; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Khan UT, 2015, EXPERT OPIN BIOL TH, V15, P1077, DOI 10.1517/14712598.2015.1053206; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2017, J BIOL CHEM, V292, P7295, DOI 10.1074/jbc.R117.777102; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krause CD, 2015, CYTOKINE, V76, P480, DOI 10.1016/j.cyto.2015.07.019; Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lasfar A, 2016, IMMUNOTHERAPY-UK, V8, P877, DOI 10.2217/imt-2015-0021; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lee SJ, 2012, INT J MOL MED, V30, P945, DOI 10.3892/ijmm.2012.1064; LeMessurier KS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003727; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Lin JD, 2016, PLOS PATHOG, V12, DOI [10.1371/journal.ppat.1005600, 10.1371/journal.ppat.1005726]; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Mahony R, 2017, CELL MOL LIFE SCI, V74, P1755, DOI 10.1007/s00018-016-2435-3; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Martin PK, 2018, NAT MICROBIOL, V3, P1131, DOI 10.1038/s41564-018-0229-0; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Newsome SD, 2016, J NEUROL, V263, P1778, DOI 10.1007/s00415-016-8182-4; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Odendall C, 2017, J IMMUNOL, V199, P3270, DOI 10.4049/jimmunol.1700250; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Okanoue T, 1996, J HEPATOL, V25, P283, DOI 10.1016/S0168-8278(96)80113-9; Oke V, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1344-7; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pervolaraki K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007420; Pervolaraki K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00459; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Phillips S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00621; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Reichard O, 1998, LANCET, V351, P83, DOI 10.1016/S0140-6736(97)06088-1; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; Sancho-Shimizu V, 2011, CURR OPIN VIROL, V1, P487, DOI 10.1016/j.coviro.2011.10.016; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins John W, 2018, F1000Res, V7, P309, DOI 10.12688/f1000research.12450.1; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Schreiber G, 2017, J BIOL CHEM, V292, P7285, DOI 10.1074/jbc.R116.774562; Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorgeloos F, 2013, VIRUSES-BASEL, V5, P834, DOI 10.3390/v5030834; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Svensson A, 2007, J REPROD IMMUNOL, V74, P114, DOI 10.1016/j.jri.2006.09.002; Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Tezuka Y, 2012, LUNG CANCER, V78, P185, DOI 10.1016/j.lungcan.2012.09.005; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Thorlacius GE, 2018, CURR OPIN RHEUMATOL, V30, P471, DOI 10.1097/BOR.0000000000000524; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; Voigt EA, 2015, J INTERF CYTOK RES, V35, P734, DOI 10.1089/jir.2015.0008; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wells AI, 2018, TRENDS IMMUNOL, V39, P848, DOI 10.1016/j.it.2018.08.008; Wilcox DR, 2016, MBIO, V7, DOI 10.1128/mBio.00437-16; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Witte E, 2016, J MOL MED, V94, P391, DOI 10.1007/s00109-015-1367-y; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Wongthida P, 2010, CANCER RES, V70, P4539, DOI 10.1158/0008-5472.CAN-09-4658; Wu Q, 2013, AUTOIMMUNITY, V46, P40, DOI 10.3109/08916934.2012.730587; Wu Q, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3363; Yan N, 2017, J INTERF CYTOK RES, V37, P198, DOI 10.1089/jir.2016.0086; Yao JC, 2017, J CLIN ONCOL, V35, P1695, DOI 10.1200/JCO.2016.70.4072; Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017; Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Zanoni I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01661; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	223	396	419	16	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					907	923		10.1016/j.immuni.2019.03.025	http://dx.doi.org/10.1016/j.immuni.2019.03.025			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995506	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000464660800010
J	Bengsch, B; Johnson, AL; Kurachi, M; Odorizzi, PM; Pauken, KE; Attanasio, J; Stelekati, E; McLane, LM; Paley, MA; Delgoffe, GM; Wherry, EJ				Bengsch, Bertram; Johnson, Andy L.; Kurachi, Makoto; Odorizzi, Pamela M.; Pauken, Kristen E.; Attanasio, John; Stelekati, Erietta; McLane, Laura M.; Paley, Michael A.; Delgoffe, Greg M.; Wherry, E. John			Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; DISTINCT MECHANISMS; EFFECTOR FUNCTION; IMMUNE-RESPONSES; MEMORY; CHECKPOINT; DIFFERENTIATION; ACTIVATION; GLYCOLYSIS; EXPRESSION	Dynamic reprogramming of metabolism is essential for T cell effector function and memory formation. However, the regulation of metabolism in exhausted CD8(+) T (Tex) cells is poorly understood. We found that during the first week of chronic lymphocytic choriomeningitis virus (LCMV) infection, before severe dysfunction develops, virus-specific CD8(+) T cells were already unable to match the bioenergetics of effector T cells generated during acute infection. Suppression of T cell bioenergetics involved restricted glucose uptake and use, despite persisting mechanistic target of rapamycin (mTOR) signaling and upregulation of many anabolic pathways. PD-1 regulated early glycolytic and mitochondrial alterations and repressed transcriptional coactivator PGC-1 alpha. Improving bioenergetics by overexpression of PGC-1 alpha enhanced function in developing Tex cells. Therapeutic reinvigoration by anti-PD-L1 reprogrammed metabolism in a subset of Tex cells. These data highlight a key metabolic control event early in exhaustion and suggest that manipulating glycolytic and mitochondrial metabolism might enhance checkpoint blockade outcomes.	[Bengsch, Bertram; Johnson, Andy L.; Kurachi, Makoto; Odorizzi, Pamela M.; Pauken, Kristen E.; Attanasio, John; Stelekati, Erietta; McLane, Laura M.; Paley, Michael A.; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bengsch, Bertram; Johnson, Andy L.; Kurachi, Makoto; Odorizzi, Pamela M.; Pauken, Kristen E.; Attanasio, John; Stelekati, Erietta; McLane, Laura M.; Paley, Michael A.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Tumor Microenvironm Ctr, Inst Canc, Pittsburgh, PA 15232 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Pauken, Kristen E./ABA-9363-2020; Delgoffe, Greg M./HCH-2805-2022; Bengsch, Bertram/ABF-2142-2020	Delgoffe, Greg M./0000-0002-2957-8135; Bengsch, Bertram/0000-0003-2552-740X; Paley, Michael/0000-0001-8724-3176	German Research Foundation fellowship [BE5496/1-1]; Sidney Kimmel Foundation for Cancer Research [SKF-015-039]; Samuel and Emma Winters Foundation; NIH (Skin Cancer SPORE) [P50CA121973]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; Philadelphia Foundation's Brody Family Medical Trust Fund fellowship; NIH [AI105343, AI082630, AI095608, AI112521, AI115712, AI117718, AI108545, AI2010085]; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [P50CA097190, P50CA121973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105343, P01AI108545, R21AI117718, R01AI115712, U19AI082630, U01AI095608, P01AI112521] Funding Source: NIH RePORTER	German Research Foundation fellowship(German Research Foundation (DFG)); Sidney Kimmel Foundation for Cancer Research; Samuel and Emma Winters Foundation; NIH (Skin Cancer SPORE); Robertson Foundation/Cancer Research Institute Irvington Fellowship; Philadelphia Foundation's Brody Family Medical Trust Fund fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.-E. Lee and K. Foskett for help with flux analyses, M. Reuter for help with the Imagestream, D. Williams, for electron microscopy, M. Bohnert for sharing her mitochondrial expertise, and J. Kurachi for technical support. Tetramers were obtained from the NIH tetramer core. B.B. was supported by German Research Foundation fellowship BE5496/1-1, G.M.D. by the Sidney Kimmel Foundation for Cancer Research (SKF-015-039), the Samuel and Emma Winters Foundation, and the NIH (P50CA121973 Skin Cancer SPORE), K.E.P. by a Robertson Foundation/Cancer Research Institute Irvington Fellowship and A.L.J. by a Philadelphia Foundation's Brody Family Medical Trust Fund fellowship. This work was supported by NIH grants AI105343, AI082630, AI095608, AI112521, AI115712, AI117718, AI108545, and AI2010085 to E.J.W. This research was supported by the Parker Institute for Cancer Immunotherapy. E.J.W. has a patent licensing agreement on the PD-1 pathway.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Belikov AV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0194-3; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chemnitz JM, 2004, BLOOD, V104, p726A; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okoye I, 2015, SCIENCE, V348, P995, DOI 10.1126/science.aaa7516; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Patsoukis N, 2012, CELL CYCLE, V11, P4305, DOI 10.4161/cc.22135; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Picard M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7259; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wolchok JD, 2014, NATURE, V515, P496, DOI 10.1038/515496a; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	39	396	408	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					358	373		10.1016/j.immuni.2016.07.008	http://dx.doi.org/10.1016/j.immuni.2016.07.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496729	Bronze, Green Accepted			2022-12-18	WOS:000382267300017
J	von Bulow, GU; van Deursen, JM; Bram, RJ				von Bulow, GU; van Deursen, JM; Bram, RJ			Regulation of the T-independent humoral response by TACI	IMMUNITY			English	Article							NECROSIS-FACTOR FAMILY; B-CELL; DENDRITIC CELLS; MICE DEFICIENT; TNF FAMILY; RECEPTOR; MEMBER; CD40; LIGAND; BAFF	TACI is a TNFR homolog expressed by mature B lymphocytes that has been implicated in the positive regulation of B cell growth and antibody production, as well as in the development of autoimmune disease. Its biology is complex due to the existence of two ligands, BLyS and APRIL, and a homologous receptor, BCMA, that similarly binds both ligands. To determine its critical biological role, we generated TACI knockout mice. Surprisingly, these mice demonstrated a 2-fold increase in numbers of circulating and splenic B cells, apparently due to increased proliferation rate. Maturation of B cells and T-dependent antibody production was normal, but responses to T-independent type II antigens were almost completely abolished. It appears that TACI provides an essential costimulatory signal for the T-independent humoral response.	Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Bram, RJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	bram.richard2@mayo.edu			NCI NIH HHS [R01 CA 76274] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076274] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kikuchi T, 2000, NAT MED, V6, P1154, DOI 10.1038/80498; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Laman JD, 1996, CRIT REV IMMUNOL, V16, P59, DOI 10.1615/CritRevImmunol.v16.i1.40; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; PRIOR L, 1994, IMMUNOLOGY, V83, P180; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; von Bulow GU, 2000, MAMM GENOME, V11, P628, DOI 10.1007/s003350010125; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	34	396	408	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					573	582		10.1016/S1074-7613(01)00130-3	http://dx.doi.org/10.1016/S1074-7613(01)00130-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371359	Bronze			2022-12-18	WOS:000168880900009
J	Grogan, JL; Mohrs, M; Harmon, B; Lacy, DA; Sedat, JW; Locksley, RM				Grogan, JL; Mohrs, M; Harmon, B; Lacy, DA; Sedat, JW; Locksley, RM			Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets	IMMUNITY			English	Article							T-HELPER-2 POPULATIONS; HISTONE DEACETYLASE; IL-4 PRODUCTION; TH2 CELLS; IN-VIVO; EXPRESSION; MICE; CHROMATIN; RESPONSES; INTERLEUKIN-4	Naive CD4(+) T cells activated through TCR/CD28 under Th1 or Th2 conditions expressed canonical cytokine patterns irrespective of cell division. Only cells that had divided fewer than four times were capable of reexpressing alternative cytokines when restimulated under opposing conditions. Although T cells transcribed both IFN-gamma and IL-4 within hours in a Stat4-/Stat6-independent manner, neither T-bet nor GATA-3 was induced optimally without Stat signals, and polarized cytokine expression was not sustained. Cytokine genes were positioned apart from heterochromatin in resting T cell nuclei, consistent with rapid expression. After polarization, the majority of silenced cytokine alleles were repositioned to heterochromatin. Naive T cells transit through sequential stages of cytokine activation, commitment, silencing, and physical stabilization during polarization into differentiated effector subsets.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056385, P01HL056385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025101] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56385] Funding Source: Medline; NIAID NIH HHS [AI30663] Funding Source: Medline; NIGMS NIH HHS [GM25101] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dernburg AF, 1998, METHOD CELL BIOL, V53, P187; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; Kaplan MH, 1999, J IMMUNOL, V163, P6536; Kaplan MH, 1998, J EXP MED, V188, P1191, DOI 10.1084/jem.188.6.1191; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Symula DJ, 1999, NAT GENET, V23, P241, DOI 10.1038/13880; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; WEIER HU, 1991, BIOTECHNIQUES, V10, P498; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	40	396	412	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2001	14	3					205	215		10.1016/S1074-7613(01)00103-0	http://dx.doi.org/10.1016/S1074-7613(01)00103-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290331	Bronze			2022-12-18	WOS:000167959500001
J	Crawford, F; Kozono, H; White, J; Marrack, P; Kappler, J				Crawford, F; Kozono, H; White, J; Marrack, P; Kappler, J			Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes	IMMUNITY			English	Article							ALPHA-BETA; MONOCLONAL-ANTIBODY; POSITIVE SELECTION; ESCHERICHIA-COLI; RECEPTOR; BINDING; RECOGNITION; MOLECULES; HYBRIDOMAS; AFFINITY	Multimeric soluble MHC class II molecules stably occupied with covalently attached peptides bind with appropriate specificity to T cell hybridomas and T cells from T cell receptor transgenic mice. There is a direct correlation between soluble T cell receptor affinity for monomeric MHC/peptide and level of binding of multimeric MHC/peptide to T cells. While binding of the multimeric MHC/peptide complex is proportional to T cell receptor affinity and expression level, there is little influence of T cell CD4.	Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Div Basic Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem Biophys & Genet, Denver, CO 80262 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kappler, J (corresponding author), Natl Jewish Ctr Immunol & Resp Med, Howard Hughes Med Inst, Div Basic Immunol, 1400 Jackson St, Denver, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; , Haruo/0000-0003-3352-0638	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R37AI017134, R37AI018785, R01AI018785, R56AI018785, P01AI022295, R56AI017134] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-17134, AI-22295, AI-18785] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BIOZZI G, 1967, PATHOL BIOL, V15, P402; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; Fremont DH, 1996, CURR OPIN IMMUNOL, V8, P93, DOI 10.1016/S0952-7915(96)80111-7; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GAY D, 1988, P NATL ACAD SCI USA, V85, P5629, DOI 10.1073/pnas.85.15.5629; GOODNOW C, 1990, SCIENCE, V238, P1373; GREENSTEIN JL, 1980, J IMMUNOL, V124, P1472; HOGQUIST KA, 1994, CURR OPIN IMMUNOL, V6, P273, DOI 10.1016/0952-7915(94)90101-5; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KAYE J, 1992, J IMMUNOL, V148, P3342; Khandekar SS, 1997, MOL IMMUNOL, V34, P493, DOI 10.1016/S0161-5890(97)00044-8; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; KUBO RT, 1989, J IMMUNOL, V142, P2736; Liu CP, 1997, J EXP MED, V186, P1441, DOI 10.1084/jem.186.9.1441; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; McHeyzerWilliams MG, 1996, IMMUNOL REV, V150, P5, DOI 10.1111/j.1600-065X.1996.tb00693.x; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; PORTOLES P, 1989, EUR J IMMUNOL, P83; REAY PA, 1994, J IMMUNOL, V152, P3946; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SCHWARTZ RH, 1985, J IMMUNOL, V135, P2598; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Seibel JL, 1997, J EXP MED, V185, P1919, DOI 10.1084/jem.185.11.1919; SERCARZ EE, 1968, SCIENCE, V159, P884, DOI 10.1126/science.159.3817.884; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WHITE J, 1983, J IMMUNOL, V130, P1033; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; WHITE J, 1989, J IMMUNOL, V143, P1822	47	396	415	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					675	682		10.1016/S1074-7613(00)80572-5	http://dx.doi.org/10.1016/S1074-7613(00)80572-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655481	Bronze			2022-12-18	WOS:000074396300003
J	Diefenbach, A; Colonna, M; Koyasu, S				Diefenbach, Andreas; Colonna, Marco; Koyasu, Shigeo			Development, Differentiation, and Diversity of Innate Lymphoid Cells	IMMUNITY			English	Review							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR GATA3; ROR-GAMMA-T; TISSUE-INDUCER CELLS; B-CELL; NK CELLS; HELPER-CELLS; ADAPTIVE IMMUNITY; TYPE-2 IMMUNITY; INTESTINAL INFLAMMATION	Recent years have witnessed the discovery of an unprecedented complexity in innate lymphocyte lineages, now collectively referred to as innate lymphoid cells (ILCs). ILCs are preferentially located at barrier surfaces and are important for protection against pathogens and for the maintenance of organ homeostasis. Inappropriate activation of ILCs has been linked to the pathogenesis of inflammatory and autoimmune disorders. Recent evidence suggests that ILCs can be grouped into two separate lineages, cytotoxic ILCs represented by conventional natural killer (cNK) cells and cytokine-producing helper-like ILCs (i.e., ILC1s, ILC2s, ILC3s). We will focus here on current work in humans and mice that has identified core transcriptional circuitry required for the commitment of lymphoid progenitors to the ILC lineage. The striking similarities in transcriptional control of ILC and T cell lineages reveal important insights into the evolution of transcriptional programs required to protect multicellular organisms against infections and to fortify barrier surfaces.	[Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Res Ctr Immunol & Immunotherapy, D-55131 Mainz, Germany; [Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Koyasu, Shigeo] RIKEN Res Ctr Integrat Med Sci IMS, Lab Immune Cell Syst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Koyasu, Shigeo] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Washington University (WUSTL); RIKEN; Keio University	Diefenbach, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Res Ctr Immunol & Immunotherapy, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	diefenbach@uni-mainz.de	Diefenbach, Andreas/T-2589-2018; Koyasu, Shigeo/J-5583-2015	Diefenbach, Andreas/0000-0002-9176-9530; Koyasu, Shigeo/0000-0001-9585-3038; Colonna, Marco/0000-0001-5222-4987	European Research Council (NutrImmune) [311377]; Deutsche Forschungsgemeinschaft [Di764/3-1, SPP1656]; National Institutes of Health [1U01AI095542, R01DE021255, R21CA16719]; Japan Society for the Promotion of Science (JSPS) [22229004]; Grants-in-Aid for Scientific Research [22229004] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R21CA167192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER	European Research Council (NutrImmune)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to C.S.N. Klose and M. Flach for comments on the manuscript. Work in the Diefenbach laboratory is supported by grants from the European Research Council (NutrImmune, #311377) and the Deutsche Forschungsgemeinschaft (Di764/3-1 and SPP1656). The Colonna laboratory is supported by grants from the National Institutes of Health (1U01AI095542, R01DE021255, and R21CA16719). The Koyasu laboratory is supported by a Grant-in-Aid for Scientific Research (S) (22229004) from the Japan Society for the Promotion of Science (JSPS). S.K. is a consultant for Medical and Biological Laboratories.	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Aliahmad P, 2012, CURR OPIN IMMUNOL, V24, P173, DOI 10.1016/j.coi.2011.12.001; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Crotta S, 2014, J IMMUNOL, V192, P2677, DOI 10.4049/jimmunol.1302765; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2013, EUR J MICROBIOL IMMU, V3, P143, DOI 10.1556/EuJMI.3.2013.3.1; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gentek R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00334; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Koyasu S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00101; Koyasu S, 2010, ADV IMMUNOL, V108, P21, DOI 10.1016/S0065-2776(10)08002_8; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Ribeiro VSG, 2010, J IMMUNOL, V185, P4993, DOI 10.4049/jimmunol.1002273; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tanriver Y, 2014, INT IMMUNOL, V26, P119, DOI 10.1093/intimm/dxt063; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	122	395	414	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					354	365		10.1016/j.immuni.2014.09.005	http://dx.doi.org/10.1016/j.immuni.2014.09.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238093	Green Accepted, Bronze			2022-12-18	WOS:000342626500007
J	Persson, EK; Uronen-Hansson, H; Semmrich, M; Rivollier, A; Hagerbrand, K; Marsal, J; Gudjonsson, S; Hakansson, U; Reizis, B; Kotarsky, K; Agace, WW				Persson, Emma K.; Uronen-Hansson, Heli; Semmrich, Monika; Rivollier, Aymeric; Hagerbrand, Karin; Marsal, Jan; Gudjonsson, Sigurdur; Hakansson, Ulf; Reizis, Boris; Kotarsky, Knut; Agace, William W.			IRF4 Transcription-Factor-Dependent CD103(+)CD11b(+) Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation	IMMUNITY			English	Article							INTERFERON REGULATORY FACTOR-4; COLONY-STIMULATING FACTOR; DEFECTIVE DEVELOPMENT; SIGNALING CONTROLS; ORAL TOLERANCE; IMMUNE-SYSTEM; IN-VIVO; EXPRESSION; SUBSETS; GENERATION	CD103(+)CD11b(+) dendritic cells (DCs) represent the major migratory DC population within the small intestinal lamina propria (SI-LP), but their in vivo function remains unclear. Here we demonstrate that intestinal CD103(+)CD11b(+) DC survival was dependent on interferon regulatory factor 4 (IRF4). Mice with a DC deletion in Irf4 displayed reduced numbers of intestinal interleukin 17 (IL-17)-secreting helper T 17 (Th17) cells and failed to support Th17 cell differentiation in draining mesenteric lymph nodes (MLN) following immunization. The latter was associated with a selective reduction in CD103(+)CD11b(+) MLN DCs and DC derived IL-6. Immunized Il6(-/-) mice failed to support Th17 cell differentiation in MLN in vivo and CD103(+)CD11b(+) MLN DCs supported IL-6-dependent Th17 cell differentiation in vitro. Together, our results suggest a central role for IRF4-dependent, IL-6 producing CD103(+)CD11b(+) DCs in intestinal Th17 cell differentiation.	[Persson, Emma K.; Uronen-Hansson, Heli; Semmrich, Monika; Rivollier, Aymeric; Hagerbrand, Karin; Kotarsky, Knut; Agace, William W.] Lund Univ, Immunol Sect, S-22184 Lund, Sweden; [Marsal, Jan] Skane Univ Hosp, Dept Gastroenterol & Nutr, S-20502 Malmo, Sweden; [Gudjonsson, Sigurdur; Hakansson, Ulf] Skane Univ Hosp, Dept Urol, S-20502 Malmo, Sweden; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Agace, William W.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Columbia University; University of Copenhagen	Agace, WW (corresponding author), Lund Univ, Immunol Sect, S-22184 Lund, Sweden.	william.agace@med.lu.se	Marsal, Jan/AFK-7491-2022; Gudjonsson, S./K-6878-2015; Persson, Emma/N-1342-2015	Marsal, Jan/0000-0003-4808-0014; Gudjonsson, S./0000-0002-5147-595X; Rivollier, Aymeric Marie Christian/0000-0001-8734-2916; Kotarsky, Knut/0000-0003-3785-0327; Agace, william/0000-0003-3823-5772; Reizis, Boris/0000-0003-1140-7853	Swedish Medical Research Council; Goran Gustafsson; Crafoordska; Torsten and Ragnar Soderbergs; Kocks; Osterlund; Swartz; IngaBritt Foundation; Arne Lundbergs Foundation; Royal Physiographic Society; Swedish National Health Service; Swedish Foundation for Strategic Research FFL-2 program	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Goran Gustafsson; Crafoordska; Torsten and Ragnar Soderbergs; Kocks; Osterlund; Swartz; IngaBritt Foundation; Arne Lundbergs Foundation; Royal Physiographic Society; Swedish National Health Service; Swedish Foundation for Strategic Research FFL-2 program	We would like to thank A.-C. Selberg for animal care, M. Brenner (Brigham and Women's Hospital, Boston,) and C. Reis e Sousa (Cancer Research UK, London Research Institute, London) for providing the CD103 (28C12) and DNGR-1 antibodies, respectively, and A. Mowat (Glasgow University, Glasgow) for constructive comments on the manuscript prior to submission. This work was supported by grants from the Swedish Medical Research Council, the Goran Gustafsson, Crafoordska, Torsten and Ragnar Soderbergs, Kocks, Osterlund, Swartz, Richard and Ruth Julins, and the IngaBritt and Arne Lundbergs Foundations, the Royal Physiographic Society, a clinical grant from the Swedish National Health Service, and the Swedish Foundation for Strategic Research FFL-2 program.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda K, 2009, MUCOSAL IMMUNOL, V2, P187, DOI 10.1038/mi.2009.8; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kusunoki T, 2003, J ALLERGY CLIN IMMUN, V111, P136, DOI 10.1067/mai.2003.29; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Mach N, 2000, CANCER RES, V60, P3239; Mahida YR, 1997, CLIN EXP IMMUNOL, V109, P377, DOI 10.1046/j.1365-2249.1997.4481346.x; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; Persson EK, 2010, IMMUNOBIOLOGY, V215, P692, DOI 10.1016/j.imbio.2010.05.013; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	68	395	405	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					958	969		10.1016/j.immuni.2013.03.009	http://dx.doi.org/10.1016/j.immuni.2013.03.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23664832	Bronze			2022-12-18	WOS:000330942500014
J	Schneider-Brachert, W; Tchikov, V; Neumeyer, J; Jakob, M; Winoto-Morbach, S; Held-Feindt, J; Heinrich, M; Merkel, O; Ehrenschwander, M; Adam, D; Mentlein, R; Kabelitz, D; Schutze, S				Schneider-Brachert, W; Tchikov, V; Neumeyer, J; Jakob, M; Winoto-Morbach, S; Held-Feindt, J; Heinrich, M; Merkel, O; Ehrenschwander, M; Adam, D; Mentlein, R; Kabelitz, D; Schutze, S			Compartmentalization of TNF receptor 1 signaling: Internalized TNF receptosomes as death signaling vesicles	IMMUNITY			English	Article							NF-KAPPA-B; NEUTRAL SPHINGOMYELINASE; ACID SPHINGOMYELINASE; INDUCED APOPTOSIS; COMPLEX DISC; RECEPTOR-1; PROTEIN; ACTIVATION; CASPASE-8; PATHWAY	The molecular regulation of the recruitment of initial signaling complexes at the TNF-R1 is poorly defined. We demonstrate here that within minutes internalized TNF-R1 (TNF receptosomes) recruits TRADD, FADD, and caspase-8 to establish the "death-inducing signaling complex" (DISC). In addition, we identified the TNF-R1 internalization domain (TRID) required for receptor endocytosis and provide evidence that TNF-R1 internalization, DISC formation, and apoptosis are inseparable events. Analyzing cell lines expressing an internalization-deficient receptor (TNF-R1 DeltaTRID) revealed that recruitment of RIP-1 and TRAF-2 to TNF-R1 occurred at the level of the plasma membrane. In contrast, aggregation of TRADD, FADD, and caspase-8 to establish the TNF-R1-associated DISC is critically dependent on receptor endocytosis. Furthermore, fusion of TNF receptosomes with trans-Golgi vesicles results in activation of acid sphingomyelinase and cathepsin D. Thus, TNF receptosomes establish the different TNF signaling pathways by compartmentalization of plasma membrane-derived endocytic vesicles harboring the TNF-R1-associated DISC.	Univ Hosp Schleswig Holstein, Inst Immunol, D-24105 Kiel, Germany; Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany; Univ Hosp Schleswig Holstein, Dept Neurosurg, D-24105 Kiel, Germany; Univ Kiel, Dept Anat, D-24118 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Schutze, S (corresponding author), Univ Hosp Schleswig Holstein, Inst Immunol, Campus Kiel, D-24105 Kiel, Germany.	schuetze@immunologie.uni-kiel.de	Heinrich, Michael/C-3727-2013; Kabelitz, Dieter/A-2757-2010; Adam, Dieter/E-9763-2010; Held-Feindt, Janka/E-4690-2010; Schütze, Stefan/C-8596-2011; Mentlein, Rolf/B-1613-2010; Kabelitz, Dieter/AAB-4199-2021	Heinrich, Michael/0000-0003-2611-6303; Adam, Dieter/0000-0002-5668-5032; Mentlein, Rolf/0000-0002-6350-3911; Ehrenschwender, Martin/0000-0003-4681-8628				Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Baetu TM, 2002, CYTOKINE GROWTH F R, V13, P199, DOI 10.1016/S1359-6101(02)00006-0; Barnhart BC, 2003, CELL, V114, P148, DOI 10.1016/S0092-8674(03)00561-0; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SCHUTZE S, 2003, Patent No. 10144291; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Tchikov V, 2001, J MAGN MAGN MATER, V225, P285, DOI 10.1016/S0304-8853(00)01252-X; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5	32	395	415	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					415	428		10.1016/j.immuni.2004.08.017	http://dx.doi.org/10.1016/j.immuni.2004.08.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357952	Bronze			2022-12-18	WOS:000224034900012
J	Hodge, MR; Ranger, AM; delaBrousse, FC; Hoey, T; Grusby, MJ; Glimcher, LH				Hodge, MR; Ranger, AM; delaBrousse, FC; Hoey, T; Grusby, MJ; Glimcher, LH			Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice	IMMUNITY			English	Article							T-CELLS; GENES; IDENTIFICATION; ACTIVATION; ANTIBODY; MOUSE	NF-ATp is a member of a family of genes that encodes the cytoplasmic component of the nuclear factor of activated T cells (NF-AT). In this study, we show that mice with a null mutation in the NF-ATp gene have splenomegaly with hyperproliferation of both B and T cells. They also display early defects in the transcription of multiple genes encoding cytokines and cell surface receptors, including CD40L and Fast. A striking defect in early IL-4 production was observed after ligation of the TCR complex by treatment with anti-CD3 in vivo. The transcription of other cytokines including IL-13, GM-CSF, and TNF alpha was also affected, though to a lesser degree. Interestingly, the cytokines IL-2 and IFN gamma were minimally affected. Despite this early defect in IL-4 transcription, Th2 development was actually enhanced at later timepoints as evidenced by increased IL-4 production and IgE levels in situations that favor the formation of Th2 cells both in vitro and in vivo. These data suggest that NF-ATp may be involved in cell growth, and that it is important for the balanced transcription of the IL-4 gene during the course of an immune response.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; TULARIK INC,S SAN FRANCISCO,CA 94080	Harvard University; Harvard Medical School	Hodge, MR (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115, USA.				NIAID NIH HHS [AI37650] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARDING SR, 1991, IMMUNOL TODAY, V12, P239, DOI 10.1016/0167-5699(91)90037-T; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; HO AM, 1994, J BIOL CHEM, V269, P28181; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; MIYATAKE S, 1985, EMBO J, V4, P2561, DOI 10.1002/j.1460-2075.1985.tb03971.x; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; SCOTT DE, 1990, J IMMUNOL, V145, P2183; SEN J, 1994, J EXP MED, V180, P2321, DOI 10.1084/jem.180.6.2321; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TSITSIKOV EN, 1994, MOL IMMUNOL, V31, P895, DOI 10.1016/0161-5890(94)90009-4; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228	32	395	405	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					397	405		10.1016/S1074-7613(00)80253-8	http://dx.doi.org/10.1016/S1074-7613(00)80253-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612134	Bronze			2022-12-18	WOS:A1996UH52200008
J	Lambrecht, BN; Hammad, H; Fahy, JV				Lambrecht, Bart N.; Hammad, Hamida; Fahy, John V.			The Cytokines of Asthma	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; THYMIC STROMAL LYMPHOPOIETIN; HOUSE-DUST MITE; ALLERGIC AIRWAY INFLAMMATION; NATURAL HELPER-CELLS; NECROSIS-FACTOR-ALPHA; T-CELLS; DENDRITIC CELLS; DOUBLE-BLIND; TYPE-2 INFLAMMATION	Asthma is a chronic inflammatory airway disease associated with type 2 cytokincs interleukin-4 (IL-4), IL. and IL-13, whicn promote airway eosinophilia, mucus overproduction, bronchial hyperresponsiveness (BHR), and immunogloubulin E (IgE) synthesis. However, only half of asthma patients exhibit signs of an exacerbated Type 2 response. "Type 2-low" asthma has different immune features: airway neutrophilia, obesity-related systemic inflammation, or in some cases, few signs of immune activation. Here, we review the cytokine networks driving asthma, placing these in cellular context and incorporating insights from cytokine-targeting therapies in the clinic. We discuss established and emerging paradigms in the context of the growing appreciation of disease heterogeneity and argue that the development of new and improved therapeutics require understanding the diverse mechanisms underlying the spectrum of asthma pathologies.	[Lambrecht, Bart N.; Hammad, Hamida] VIB Ctr Inflammat Res, Lab Immunoregulat, Ghent, Belgium; [Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Fahy, John V.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [Fahy, John V.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lambrecht, BN (corresponding author), VIB Ctr Inflammat Res, Lab Immunoregulat, Ghent, Belgium.; Lambrecht, BN (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.; Lambrecht, BN (corresponding author), Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands.	bart.lambrecht@ugent.vib.be	Hammad, Hamida/J-9391-2015; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Lambrecht, Bart N/0000-0003-4376-6834				Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Barnes PJ, 2018, NAT REV IMMUNOL, V18, P454, DOI 10.1038/s41577-018-0006-6; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bartsch S, 2017, CAMBRIDGE COMPANION TO THE AGE OF NERO, P1, DOI 10.1111/cea.12988; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Bellini A, 2012, MUCOSAL IMMUNOL, V5, P140, DOI 10.1038/mi.2011.60; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Beuraud C, 2019, ALLERGY, V74, P933, DOI 10.1111/all.13679; Bhakta NR, 2018, AM J RESP CRIT CARE, V197, P313, DOI 10.1164/rccm.201706-1070OC; Bjermer L, 2016, CHEST, V150, P789, DOI 10.1016/j.chest.2016.03.032; Bleck B, 2015, J ALLERGY CLIN IMMUN, V136, P619, DOI 10.1016/j.jaci.2014.12.1950; Bleecker ER, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00936-2018; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Bousquet J, 2005, ALLERGY, V60, P302, DOI 10.1111/j.1398-9995.2004.00770.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BROIDE DH, 1991, J CLIN INVEST, V88, P1048, DOI 10.1172/JCI115366; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; Busse W, 2019, J ALLERGY CLIN IMMUN, V143, P190, DOI 10.1016/j.jaci.2018.08.031; Busse WW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00948-2018; Busse WW, 2019, LANCET RESP MED, V7, P46, DOI 10.1016/S2213-2600(18)30406-5; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chen T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5196; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Contoli M, 2015, ALLERGY, V70, P910, DOI 10.1111/all.12627; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cooper PJ, 2008, ALLERGY, V63, P409, DOI 10.1111/j.1398-9995.2007.01601.x; Coquet JM, 2015, IMMUNITY, V43, P318, DOI 10.1016/j.immuni.2015.07.015; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Corren J, 2016, CHEST, V150, P799, DOI 10.1016/j.chest.2016.03.018; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Dell'Aringa M, 2018, MUCOSAL IMMUNOL, V11, P1079, DOI 10.1038/s41385-018-0012-9; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; Denlinger LC, 2017, AM J RESP CRIT CARE, V195, P302, DOI 10.1164/rccm.201602-0419OC; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Dullaers M, 2017, J ALLERGY CLIN IMMUN, V140, P76, DOI 10.1016/j.jaci.2016.09.020; Dunican EM, 2018, ANN AM THORAC SOC, V15, pS184, DOI 10.1513/AnnalsATS.201807-485AW; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Dunican EM, 2015, ANN AM THORAC SOC, V12, pS144, DOI 10.1513/AnnalsATS.201506-377AW; Duvall MG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam5446; Eastman JJ, 2017, J ALLERGY CLIN IMMUN, V140, P101, DOI 10.1016/j.jaci.2016.11.023; Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Esquivel A, 2017, AM J RESP CRIT CARE, V196, P985, DOI 10.1164/rccm.201701-0120OC; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Gauthier M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94580; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Gill MA, 2018, J ALLERGY CLIN IMMUN, V141, P1735, DOI 10.1016/j.jaci.2017.07.035; Godar M, 2018, J ALLERGY CLIN IMMUN, V142, P1185, DOI 10.1016/j.jaci.2018.06.002; Gordon ED, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87871; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Gras D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02399-2016; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Hinks TSC, 2017, AM J RESP CELL MOL, V57, P745, DOI 10.1165/rcmb.2017-0201LE; Ho J, 2015, CLIN EXP ALLERGY, V45, P394, DOI 10.1111/cea.12462; Hogan SP, 1997, IMMUNOL CELL BIOL, V75, P284, DOI 10.1038/icb.1997.43; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jensen ME, 2013, EUR RESPIR J, V42, P1012, DOI 10.1183/09031936.00124912; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Kolbeck R, 2010, J ALLERGY CLIN IMMUN, V125, P1344, DOI 10.1016/j.jaci.2010.04.004; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Krishnamoorthy N., SCI IMMUNOL, V3, P3; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; KUNG TT, 1995, AM J RESP CELL MOL, V13, P360, DOI 10.1165/ajrcmb.13.3.7654390; Kupczyk M, 2014, CLIN EXP ALLERGY, V44, P212, DOI 10.1111/cea.12179; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132, P1086, DOI 10.1016/j.jaci.2013.05.020; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Li BWS, 2016, EUR J IMMUNOL, V46, P1392, DOI 10.1002/eji.201546119; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lima LC, 2019, CYTOKINE, V113, P177, DOI 10.1016/j.cyto.2018.07.004; Little SA, 2002, AM J MED, V112, P446, DOI 10.1016/S0002-9343(02)01047-1; Liu SC, 2018, J ALLERGY CLIN IMMUN, V141, P257, DOI 10.1016/j.jaci.2017.03.032; Long A, 2014, J ALLERGY CLIN IMMUN, V134, P560, DOI 10.1016/j.jaci.2014.02.007; Lu YX, 2018, MUCOSAL IMMUNOL, V11, P1640, DOI 10.1038/s41385-018-0057-9; Manni ML, 2014, MUCOSAL IMMUNOL, V7, P1186, DOI 10.1038/mi.2014.8; Maric J., 2018, J ALLERGY CLIN IMMUN; McCrae C, 2018, AM J RESP CRIT CARE, V197; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Molfino NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007709; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Moon HG, 2018, IMMUNITY, V49, P275, DOI 10.1016/j.immuni.2018.06.009; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morjaria JB, 2008, THORAX, V63, P584, DOI 10.1136/thx.2007.086314; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Mousas A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006925; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; NAKAJIMA H, 1994, J EXP MED, V179, P1145, DOI 10.1084/jem.179.4.1145; O'Leary C. E., 2018, ANN REV IMMUNOL; Oeser K, 2015, ALLERGY, V70, P1440, DOI 10.1111/all.12705; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Oriss TB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91019; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Panettieri RA, 2018, LANCET RESP MED, V6, P511, DOI 10.1016/S2213-2600(18)30184-X; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; Persson H, 2015, J ALLERGY CLIN IMMUN, V136, P638, DOI 10.1016/j.jaci.2015.02.026; Peters MC, 2019, AM J RESP CRIT CARE, V199, P465, DOI 10.1164/rccm.201807-1291OC; Peters MC, 2019, J ALLERGY CLIN IMMUN, V143, P104, DOI 10.1016/j.jaci.2017.12.1009; Peters MC, 2016, EUR RESPIR J, V48, P291, DOI 10.1183/13993003.01132-2016; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Ramirez-Carrozzi V, 2017, J ALLERGY CLIN IMMUN, V139, P705, DOI 10.1016/j.jaci.2016.08.026; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Ravanetti L., 2018, J ALLERGY CLIN IMMUN; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Reader JR, 2003, AM J RESP CELL MOL, V28, P664, DOI 10.1165/rcmb.2002-0207OC; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Ritz SA, 2002, TRENDS IMMUNOL, V23, P396, DOI 10.1016/S1471-4906(02)02278-0; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Roediger B, 2015, J ALLERGY CLIN IMMUN, V136, P1653, DOI 10.1016/j.jaci.2015.03.043; Russell RJ, 2018, LANCET RESP MED, V6, P499, DOI 10.1016/S2213-2600(18)30201-7; Saglani S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan4128; Salimi M, 2017, J ALLERGY CLIN IMMUN, V140, P1090, DOI 10.1016/j.jaci.2016.12.958; Sallmann E, 2011, J IMMUNOL, V187, P164, DOI 10.4049/jimmunol.1003392; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schuijs MJ, 2019, TRENDS IMMUNOL, V40, P22, DOI 10.1016/j.it.2018.11.001; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Seumois G, 2014, NAT IMMUNOL, V15, P777, DOI 10.1038/ni.2937; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Singanayagam A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04574-1; Siracusa MC, 2013, IMMUNITY, V39, P1158, DOI 10.1016/j.immuni.2013.09.016; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006659; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sugita K, 2018, J ALLERGY CLIN IMMUN, V141, P300, DOI 10.1016/j.jaci.2017.02.038; Sui P, 2018, SCIENCE, V360, P6393; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V136, P1476, DOI 10.1016/j.jaci.2015.09.008; Teague WG, 2018, J ALLER CL IMM-PRACT, V6, P545, DOI 10.1016/j.jaip.2017.05.032; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; van Rift LS, 2004, J ALLERGY CLIN IMMUN, V114, P166, DOI 10.1016/j.jaci.2004.03.044; Verma M, 2018, J ALLERGY CLIN IMMUN, V142, P793, DOI 10.1016/j.jaci.2017.10.020; Verstraete K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14937; Verstraete K, 2014, NAT STRUCT MOL BIOL, V21, P375, DOI 10.1038/nsmb.2794; Wadsworth SJ, 2011, J ASTHMA ALLERGY, V4, P77, DOI 10.2147/JAA.S15081; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; WALKER C, 1991, J IMMUNOL, V146, P1829; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang W, 2018, J IMMUNOL, V201, P2221, DOI 10.4049/jimmunol.1800709; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weinstein SF, 2019, J ALLER CL IMM-PRACT, V7, P589, DOI 10.1016/j.jaip.2018.08.021; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Winkler C., 2019, J ALLERGY CLIN IMMUN; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wu W., 2019, AM J RESP CRIT CARE, V139; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yancey SW, 2017, J ALLERGY CLIN IMMUN, V139, P1167, DOI 10.1016/j.jaci.2016.08.008; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zein J. G., PLOS ONE, V10; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	236	394	415	23	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					975	991		10.1016/j.immuni.2019.03.018	http://dx.doi.org/10.1016/j.immuni.2019.03.018			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995510	Bronze			2022-12-18	WOS:000464660800014
J	Dupaul-Chicoine, J; Yeretssian, G; Doiron, K; Bergstrom, KSB; McIntire, CR; LeBlanc, PM; Meunier, C; Turbide, C; Gros, P; Beauchemin, N; Vallance, BA; Saleh, M				Dupaul-Chicoine, Jeremy; Yeretssian, Garabet; Doiron, Karine; Bergstrom, Kirk S. B.; McIntire, Christian R.; LeBlanc, Philippe M.; Meunier, Charles; Turbide, Claire; Gros, Philippe; Beauchemin, Nicole; Vallance, Bruce A.; Saleh, Maya			Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases	IMMUNITY			English	Article							CROHNS-DISEASE; ACTIVATION; IL-18; INTERLEUKIN-18; PROLIFERATION; TUMORIGENESIS; EXPRESSION; INFECTION; IMMUNITY; ADAPTERS	Inflammatory caspases are essential effectors of inflammation and cell death. Here, we investigated their roles in colitis and colorectal cancer and report a bimodal regulation of intestinal homeostasis, inflammation and tumorigenesis by caspases-1 and -12. Casp1(-/-) mice exhibited defects in mucosa, tissue repair and succumbed rapidly after dextran sulfate sodium administration. This phenotype was rescued by administration of exogenous interleukin-18 and was partially reproduced in mice deficient in the inflammasome adaptor ASC. Casp12(-/-) mice, in which the inflammasome is derepressed, were resistant to acute colitis and showed signs of enhanced repair. Together with their increased inflammatory response, the enhanced repair response of Casp12(-/-) mice rendered them more susceptible to colorectal cancer induced by azoxymethane (AOM)+DSS. Taken together, our results indicate that the inflammatory caspases are critical in the induction of inflammation in the gut after injury, which is necessary for tissue repair and maintenance of immune tolerance.	[Dupaul-Chicoine, Jeremy; McIntire, Christian R.; Meunier, Charles; Gros, Philippe; Beauchemin, Nicole; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Yeretssian, Garabet; Doiron, Karine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Bergstrom, Kirk S. B.; Vallance, Bruce A.] Univ British Columbia, Div Gastroenterol, Vancouver, BC V6T 1Z4, Canada; [Bergstrom, Kirk S. B.; Vallance, Bruce A.] BC Childrens Hosp, Vancouver, BC V6T 1Z4, Canada; [LeBlanc, Philippe M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Turbide, Claire; Gros, Philippe; Beauchemin, Nicole] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; University of British Columbia; BC Childrens Hospital; University of British Columbia; McGill University; McGill University	Saleh, M (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	maya.saleh@mcgill.ca	Bergstrom, Kirk/AAZ-8856-2021	Vallance, Bruce/0000-0003-1345-6747; Saleh, Maya/0000-0003-1538-9146	Canadian Institute of Health Research [MOP68984, MOP82801]; Burroughs Wellcome Foundation; CHILD Foundation; Canada Research Chair; Canadian Society for Immunology; McGill University Health Centre	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); CHILD Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Society for Immunology; McGill University Health Centre	This work was supported by grants from the Canadian Institute of Health Research to N.B., (MOP68984), to B.V, (MOP82801), and to M.S. and the Burroughs Wellcome Foundation to M.S. B.V. is the CHILD Foundation Research Scholar and a Canada Research Chair (Tier 2), and M.S. is a CIHR New Investigator. J.D.C. was supported by a Canadian Society for Immunology summer studentship and a McGill University Health Centre graduate studentship. We thank R. Flavell and V. Dixit for providing Casp1<SUP>-/-</SUP> and Asc<SUP>-/-</SUP> mice breeder pairs. We also thank P. D'Arcy and M.-L. Goulet for technical assistance and the McGill University and Genome Quebec Innovation Centre for hybridization of the microarray.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Kampfer H, 1999, J INVEST DERMATOL, V113, P369, DOI 10.1046/j.1523-1747.1999.00704.x; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yeretssian G, 2008, CYTOKINE, V43, P380, DOI 10.1016/j.cyto.2008.07.015	33	394	414	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					367	378		10.1016/j.immuni.2010.02.012	http://dx.doi.org/10.1016/j.immuni.2010.02.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20226691	Bronze			2022-12-18	WOS:000276125400010
J	Balachandran, S; Roberts, PC; Brown, LE; Truong, H; Pattnaik, AK; Archer, DR; Barber, GN				Balachandran, S; Roberts, PC; Brown, LE; Truong, H; Pattnaik, AK; Archer, DR; Barber, GN			Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection	IMMUNITY			English	Article							VESICULAR STOMATITIS-VIRUS; FACTOR 2-ALPHA KINASE; TARGETED DISRUPTION; CYTOCHROME-C; MICE REVEALS; INTERFERON; CELLS; APOPTOSIS; GENE; DEATH	The double-stranded (ds) RNA-dependent protein kinase PKR is considered to play an important role in interferon's (IFN's) response to viral infection. Here, we demonstrate that mice lacking PKR are predisposed to lethal intranasal infection by the usually innocuous vesicular stomatitis virus, and also display increased susceptibility to influenza virus infection. Our data indicate that in normal cells, PKR primarily prevents virus replication by inhibiting the translation of viral mRNAs through phosphorylation of elF2 alpha, while concomitantly assisting in the production of autocrine IFN and the establishment of an antiviral state. These results show that PKR is an essential component of innate immunity that acts early in host defense prior to the onset of IFN counteraction and the acquired immune response.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; Wayne State Univ, Dept Microbiol & Immunol, Detroit, MI 48201 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Miami; University of Miami; Wayne State University; Emory University	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	gbarber@med.miami.edu	Pattnaik, Asit K./X-1531-2019	Pattnaik, Asit K./0000-0002-9581-6787	NATIONAL CANCER INSTITUTE [R01CA086431] Funding Source: NIH RePORTER; NCI NIH HHS [CA86431] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Donze O, 1999, VIROLOGY, V256, P322, DOI 10.1006/viro.1999.9618; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FREER G, 1994, J VIROL, V68, P3650, DOI 10.1128/JVI.68.6.3650-3655.1994; Garcia-Sastre A, 1998, J VIROL, V72, P8550; GRESSER I, 1975, J GEN VIROL, V27, P395, DOI 10.1099/0022-1317-27-3-395; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HEREMANS H, 1980, INFECT IMMUN, V30, P513; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; KATZE MG, 1993, SEMIN VIROL, V4, P259, DOI 10.1006/smvy.1993.1022; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KRUST B, 1982, VIROLOGY, V120, P240, DOI 10.1016/0042-6822(82)90022-8; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; MUNDSCHAU LJ, 1995, J BIOL CHEM, V270, P3100, DOI 10.1074/jbc.270.7.3100; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Pattnaik AK, 1997, J VIROL, V71, P8167, DOI 10.1128/JVI.71.11.8167-8175.1997; Ronni T, 1997, J IMMUNOL, V158, P2363; SEN GC, 1998, TRANSCRIPTION REGULA; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEWART WE, 1972, P NATL ACAD SCI USA, V69, P1851, DOI 10.1073/pnas.69.7.1851; Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; Wagner RR., 1996, FIELDS VIROLOGY, V1, P1121; WYDE PR, 1984, ANTIMICROB AGENTS CH, V26, P450, DOI 10.1128/AAC.26.4.450; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	44	393	406	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					129	141		10.1016/S1074-7613(00)00014-5	http://dx.doi.org/10.1016/S1074-7613(00)00014-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933401	Bronze			2022-12-18	WOS:000088463600013
J	Cook, DN; Prosser, DM; Forster, R; Zhang, J; Kuklin, NA; Abbondanzo, SJ; Niu, XD; Chen, SC; Manfra, DJ; Wiekowski, MT; Sullivan, LM; Smith, SR; Greenberg, HB; Narula, SK; Lipp, M; Lira, SA				Cook, DN; Prosser, DM; Forster, R; Zhang, J; Kuklin, NA; Abbondanzo, SJ; Niu, XD; Chen, SC; Manfra, DJ; Wiekowski, MT; Sullivan, LM; Smith, SR; Greenberg, HB; Narula, SK; Lipp, M; Lira, SA			CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue	IMMUNITY			English	Article							INFLAMMATORY PROTEIN 3-ALPHA; REGULATED CHEMOKINE LARC; MURINE PEYERS PATCH; MOLECULAR-CLONING; T-CELLS; RECEPTOR; EXPRESSION; SPLEEN; DIFFERENTIATION; MIP-3-ALPHA	Chemokine-directed migration of leukocyte subsets may contribute to the qualitative differences between systemic and mucosal immunity. Here, we demonstrate that in mice lacking the chemokine receptor CCR6, dendritic cells expressing CD11c and CD11b are absent from the subepithelial dome of Peyer's patches. These mice also have an impaired humoral immune response to orally administered antigen and to the enteropathic virus rotavirus. In addition, CCR6(-/-) mice have a 2-fold to 15-fold increase in cells of select T lymphocyte populations within the mucosa, including CD4(+) and CD8(+) alpha beta-TCR T cells. By contrast, systemic immune responses to subcutaneous antigens in CCR6(-/-) mice are normal. These findings demonstrate that CCR6 is a mucosa-specific regulator of humoral immunity and lymphocyte homeostasis in the intestinal mucosa.	Schering Plough Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Merck & Company; Schering-Plough Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Stanford University; Stanford University	Lira, SA (corresponding author), Schering Plough Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA.	sergio.lira@spcorp.com	Lipp, Martin/G-2235-2010; Förster, Reinhold/D-6770-2011; Cook, Donald/E-5079-2019	Cook, Donald/0000-0002-0052-3755; Forster, Reinhold/0000-0001-6190-7923; greenberg, harry/0000-0002-2128-9080; Lipp, Martin/0000-0002-0087-2672	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI021632] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 21632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Everson MP, 1998, J INTERF CYTOK RES, V18, P103, DOI 10.1089/jir.1998.18.103; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; GLASS RI, 1994, SCIENCE, V265, P1389, DOI 10.1126/science.8073280; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; GREENBERG HB, 1994, ROTAVIRUSES, P255; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Hromas R, 1997, BLOOD, V89, P3315; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Liao F, 1999, J IMMUNOL, V162, P186; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROSE J, 1998, J VIROL, V72, P4227; Rossi DL, 1997, J IMMUNOL, V158, P1033; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; SPALDING DM, 1986, CELL, V44, P507, DOI 10.1016/0092-8674(86)90472-1; SPALDING DM, 1984, J EXP MED, V160, P941, DOI 10.1084/jem.160.3.941; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STROBER W, 1999, MUCOSAL IMMUNOLOGY, P1101; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Zaballos A, 1996, BIOCHEM BIOPH RES CO, V227, P846, DOI 10.1006/bbrc.1996.1595; Zhang JW, 1997, DEV BIOL, V192, P375, DOI 10.1006/dbio.1997.8750; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	32	393	405	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					495	503		10.1016/S1074-7613(00)80201-0	http://dx.doi.org/10.1016/S1074-7613(00)80201-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843382	Bronze			2022-12-18	WOS:000087356400005
J	Sciammas, R; Shaffer, AL; Schatz, JH; Zhao, H; Staudt, LM; Singh, H				Sciammas, Roger; Shaffer, A. L.; Schatz, Jonathan H.; Zhao, Hong; Staudt, Louis M.; Singh, Harinder			Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation	IMMUNITY			English	Article							SEQUENCE-BINDING-PROTEIN; B-CELLS; TRANSCRIPTION FACTOR; LYMPHOCYTE DIFFERENTIATION; GENE-EXPRESSION; MATURE B; SECRETING CELLS; IRF FAMILY; BLIMP-1; ACTIVATOR	Molecular mechanisms underlying the coordination of isotype switching with plasma cell differentiation are poorly understood. We show that interferon regulatory factor-4 (IRF-4) regulates both processes by controlling the expression of the Aicda and Prdm1 genes, which encode AID and Blimp-1, respectively. Genome-wide analysis demonstrated that Irf4(-/-) B cells failed to induce the entire Blimp-1 -dependent plasma cell program. Restoration of AID or Blimp-1 expression in Irf4(-/-) B cells promoted isotype switching or secretion, respectively. IRF-4 was expressed in a graded manner in differentiating B cells and targeted Prdm1. Higher concentration of IRF-4 induced Prdm1 and consequently the transition from a germinal center gene expression program to that of a plasma cell. We propose a gene-regulatory network in which graded expression of IRF-4 developmentally coordinates isotype switching with plasma cell differentiation.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	lstaudt@mail.nih.gov; hsingh@uchicago.edu	Staudt, Louis/AAC-5324-2019	Schatz, Jonathan/0000-0003-1842-228X	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC004024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; CORCORAN LM, 1994, IMMUNITY, V1, P635, DOI 10.1016/1074-7613(94)90035-3; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Marecki S, 1999, J IMMUNOL, V163, P2713; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagulapalli S, 1998, MOL CELL BIOL, V18, P4639, DOI 10.1128/MCB.18.8.4639; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SNAPPER CM, 1987, J IMMUNOL, V139, P10; Staudt LM, 2004, NATURE, V431, P919, DOI 10.1038/431919a; Tangye SG, 2004, IMMUNOLOGY, V112, P509, DOI 10.1111/j.1365-2567.2004.01950.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2	39	392	397	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					225	236		10.1016/j.immuni.2006.07.009	http://dx.doi.org/10.1016/j.immuni.2006.07.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16919487	Bronze			2022-12-18	WOS:000240047500009
J	Zhang, P; Iwasaki-Arai, J; Iwasaki, H; Fenyus, ML; Dayaram, T; Owens, BM; Shigematsu, H; Levantini, E; Huettner, CS; Lekstrom-Himes, JA; Akashi, K; Tenen, DG				Zhang, P; Iwasaki-Arai, J; Iwasaki, H; Fenyus, ML; Dayaram, T; Owens, BM; Shigematsu, H; Levantini, E; Huettner, CS; Lekstrom-Himes, JA; Akashi, K; Tenen, DG			Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.	IMMUNITY			English	Article							BINDING-PROTEIN-ALPHA; COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; IN-VIVO; GRANULOCYTIC DIFFERENTIATION; LINEAGE COMMITMENT; DEFICIENT MICE; KNOCKOUT MICE; GENE; GRANULOPOIESIS	The transcription factor C/EBPalpha is required for granulopoiesis and frequently disrupted in human acute myeloid leukemia (AML). Here, we show disruption of C/EBPalpha blocks the transition from the common myeloid to the granulocyte/monocyte progenitor but is not required beyond this stage for terminal granulocyte maturation. C/EBPalpha-deficient hematopoietic stem cells (HSCs) have increased expression of Bmi-1 and enhanced competitive repopulating activity. Bone marrow in adult C/EBPa-deficient mice was filled with myeloblasts, similar to human AML, supporting the notion that disruption of C/EBPalpha cooperates with other events in the development of leukemia. Therefore, C/EBPalpha is not only essential for granulocyte development but, in addition, is a regulator of hematopoietic stem cell activity.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Inst Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; NIAID, Host Def Lab, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Inst Med, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu	Levantini, Elena/AGY-0242-2022; levantini, elena/AAK-7201-2021	levantini, elena/0000-0003-4612-3105; Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA72009, CA78045] Funding Source: Medline; NHLBI NIH HHS [HL56745] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009, P01CA078045] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, HEMATOL J, V4, P31; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; HIGUCHI M, 2002, CANCER CELL, V1, P75; Ichikawa M, 2002, BLOOD, V100, p130A; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Kimura Y, 2002, J EXP MED, V195, P941, DOI 10.1084/jem.20011522; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nakajima H, 2001, BLOOD, V98, P897, DOI 10.1182/blood.V98.4.897; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Petrovick HS, 1998, MOL CELL BIOL, V18, P3915, DOI 10.1128/MCB.18.7.3915; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Truong BTH, 2003, BLOOD, V101, P1141, DOI 10.1182/blood-2002-05-1374; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; Zhang P, 2002, BLOOD, V99, P4406, DOI 10.1182/blood.V99.12.4406	42	392	417	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					853	863		10.1016/j.immuni.2004.11.006	http://dx.doi.org/10.1016/j.immuni.2004.11.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589173	Bronze			2022-12-18	WOS:000225901600012
J	Kayagaki, N; Yan, MH; Seshasayee, D; Wang, H; Lee, W; French, DM; Grewal, IS; Cochran, AG; Gordon, NC; Yin, JP; Starovasnik, MA; Dixit, VM				Kayagaki, N; Yan, MH; Seshasayee, D; Wang, H; Lee, W; French, DM; Grewal, IS; Cochran, AG; Gordon, NC; Yin, JP; Starovasnik, MA; Dixit, VM			BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappa B2	IMMUNITY			English	Article							NECROSIS-FACTOR FAMILY; LYMPHOCYTE STIMULATOR; AUTOIMMUNE-DISEASE; TNF-RECEPTOR; SPLENIC MICROARCHITECTURE; TRANSGENIC MICE; DEFICIENT MICE; BETA-HAIRPINS; TACI; ACTIVATION	The TNF-like ligand BAFF/BLyS is a potent survival factor for B cells. It binds three receptors: TACI, BCMA, and BR3. We show that BR3 signaling promotes processing of the transcription factor NF-kappaB2/p100 to p52. NF-kappaB2/p100 cleavage was abrogated in B cells from A/WySnJ mice possessing a mutant BR3 gene, but not in TACI or BCMA null B cells. Furthermore, wild-type mice injected with BAFF-neutralizing BR3-Fc protein showed reduced basal NF-kappaB2 activation. BR3-Fc treatment of NZB/WF1 mice, which develop a fatal lupus-like syndrome, inhibited NF-kappaB2 processing and attenuated the disease process. Since inhibiting the BR3-BAFF interaction has therapeutic ramifications, the ligand binding interface of BR3 was investigated and found to reside within a 26 residue core domain. When stabilized within a structured beta-hairpin peptide, six of these residues were sufficient to confer binding to BAFF.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Starovasnik, MA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Grewal, Iqbal S/0000-0002-4775-055X; Cochran, Andrea/0000-0001-6469-795X				BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Cochran AG, 2001, J AM CHEM SOC, V123, P625, DOI 10.1021/ja003369x; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; Hertz M, 1998, CURR OPIN IMMUNOL, V10, P208, DOI 10.1016/S0952-7915(98)80250-1; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Russell SJ, 2000, J AM CHEM SOC, V122, P12600, DOI 10.1021/ja002085+; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Starovasnik MA, 1996, BIOCHEMISTRY-US, V35, P15558, DOI 10.1021/bi961409x; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	42	392	430	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					515	524		10.1016/S1074-7613(02)00425-9	http://dx.doi.org/10.1016/S1074-7613(02)00425-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387744	Bronze			2022-12-18	WOS:000178667100011
J	Kasaian, MT; Whitters, MJ; Carter, LL; Lowe, LD; Jussif, JM; Deng, BJ; Johnson, KA; Witek, JS; Senices, M; Konz, RF; Wurster, AL; Donaldson, DD; Collins, M; Young, DA; Grusby, MJ				Kasaian, MT; Whitters, MJ; Carter, LL; Lowe, LD; Jussif, JM; Deng, BJ; Johnson, KA; Witek, JS; Senices, M; Konz, RF; Wurster, AL; Donaldson, DD; Collins, M; Young, DA; Grusby, MJ			IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; MICE LACKING; IFN-GAMMA; RECEPTOR; EXPANSION; PROLIFERATION; STIMULATION; INTERLEUKIN-15; LYMPHOCYTES	IFNalpha/beta, IL-12, and IL-15 regulate NK cell activation and expansion, but signals triggering resolution of the NK response upon induction of adaptive immunity remain to be defined. We now report that IL-21, a product of activated T cells, may serve this function. Mice lacking IL-21 R (IL-21 R-/-) had normal NK cell development but no detectable responses to IL-21. IL-21 enhanced cytotoxic activity and IFNgamma production by activated murine NK cells but did not support their viability, thus limiting their duration of activation. Furthermore, IL-21 blocked IL-15-induced expansion of resting NK cells, thus preventing the initiation of further innate responses. In contrast, IL-21 enhanced the proliferation, IFNgamma production, and cytotoxic function of CD8(+) effector T cells in an allogeneic MLR. These observations suggest that IL-21 promotes the transition between innate and adaptive immunity.	Wyeth Res, Genet Inst, Cambridge, MA 02140 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Pfizer; Harvard University; Harvard T.H. Chan School of Public Health	Young, DA (corresponding author), Wyeth Res, Genet Inst, Cambridge, MA 02140 USA.	dyoung@wyeth.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040171, R01AI040171] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 40171] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Colucci F, 2000, BLOOD, V95, P984, DOI 10.1182/blood.V95.3.984.003k40_984_991; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; DORSHKIND K, 1985, J IMMUNOL, V134, P3798; Fehniger TA, 1997, BLOOD, V90, P3647, DOI 10.1182/blood.V90.9.3647; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; LONDON L, 1986, J IMMUNOL, V137, P3845; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Muench MO, 2000, EXP HEMATOL, V28, P961, DOI 10.1016/S0301-472X(00)00490-2; NASSIRY L, 1987, NAT IMMUN CELL GROW, V6, P250; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pierson BA, 1996, BLOOD, V87, P180, DOI 10.1182/blood.V87.1.180.bloodjournal871180; SEAMAN WE, 1981, EXP HEMATOL, V9, P691; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; SU HC, 1993, J IMMUNOL, V151, P4874; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Turner SJ, 2001, J IMMUNOL, V167, P2753, DOI 10.4049/jimmunol.167.5.2753; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vosshenrich CAJ, 2001, CURR BIOL, V11, pR175, DOI 10.1016/S0960-9822(01)00087-2; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	36	392	432	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					559	569		10.1016/S1074-7613(02)00295-9	http://dx.doi.org/10.1016/S1074-7613(02)00295-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970879	Bronze			2022-12-18	WOS:000175109600007
J	Waldmann, TA; Dubois, S; Tagaya, Y				Waldmann, TA; Dubois, S; Tagaya, Y			Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy	IMMUNITY			English	Review							T-CELL PROLIFERATION; RETRACTED ARTICLE. SEE; RECEPTOR-BETA-CHAIN; ALPHA-CHAIN; MONOCLONAL-ANTIBODY; HUMANIZED ANTIBODY; INTERLEUKIN 15; IN-VIVO; HOMEOSTASIS; ACTIVATION		NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waldmann, TA (corresponding author), NCI, Metab Branch, NIH, Bethesda, MD 20892 USA.		Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222				ARIMA N, 1991, J IMMUNOL, V147, P3396; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Bamford RN, 1998, J IMMUNOL, V160, P4418; Bamford RN, 1996, P NATL ACAD SCI USA, V93, P2897, DOI 10.1073/pnas.93.7.2897; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Bulfone-Paus S, 1999, FASEB J, V13, P1575, DOI 10.1096/fasebj.13.12.1575; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; DiSanto JP, 1997, CURR BIOL, V7, pR424, DOI 10.1016/S0960-9822(06)00208-9; Dooms H, 2000, BLOOD, V96, P1006, DOI 10.1182/blood.V96.3.1006.015k27_1006_1012; Dooms H, 1998, J IMMUNOL, V161, P2141; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim YS, 1998, J IMMUNOL, V160, P5742; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KUZIEL WA, 1993, J IMMUNOL, V150, P3357; Lehky TJ, 1998, ANN NEUROL, V44, P942, DOI 10.1002/ana.410440613; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MAEDA M, 1987, BLOOD, V70, P1407; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; Naora H, 1999, CELL DEATH DIFFER, V6, P1002, DOI 10.1038/sj.cdd.4400575; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; Oppenheimer-Marks N, 1998, J CLIN INVEST, V101, P1261, DOI 10.1172/JCI1986; Phillips KE, 2000, CANCER RES, V60, P6977; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Ruchatz H, 1998, J IMMUNOL, V160, P5654; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; STEVENS AC, 1997, AM J PHYSIOL, V35, pG1201; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; TINUBU SA, 1994, J IMMUNOL, V153, P4330; TSUDO M, 1987, P NATL ACAD SCI USA, V84, P5394, DOI 10.1073/pnas.84.15.5394; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; WALDMANN TA, 1993, BLOOD, V82, P1701; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	49	392	424	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2001	14	2					105	110		10.1016/S1074-7613(09)00091-0	http://dx.doi.org/10.1016/S1074-7613(09)00091-0			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239443	Bronze			2022-12-18	WOS:000167092500001
J	Deutschman, CS; Tracey, KJ				Deutschman, Clifford S.; Tracey, Kevin J.			Sepsis: Current Dogma and New Perspectives	IMMUNITY			English	Review							HEART-RATE-VARIABILITY; GUT BARRIER DYSFUNCTION; TOLL-LIKE RECEPTORS; GATED CA2+ CURRENT; NLRP3 INFLAMMASOME; T-CELLS; MITOCHONDRIAL DYSFUNCTION; PROLONGED LYMPHOPENIA; COGNITIVE IMPAIRMENT; CARDIAC-FUNCTION	Sepsis, a clinical syndrome occurring in patients following infection or injury, is a leading cause of morbidity andmortality worldwide. Current immunological mechanisms do not explain the basis of cellular dysfunction and organ failure, the ultimate cause of death. Here we review current dogma and argue that it is time to delineate novel immunometabolic and neurophysiological mechanisms underlying the altered cellular bioenergetics and failure of epithelial and endothelial barriers that produce organ dysfunction and death. These mechanisms might hold the key to future therapeutic strategies.	[Deutschman, Clifford S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Deutschman, Clifford S.] Univ Penn, Perelman Sch Med, Crit Care & Surg & Sepsis Res Program, Philadelphia, PA 19104 USA; [Tracey, Kevin J.] Feinstein Inst Med Res, Manhasset, NY 11030 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Northwell Health	Deutschman, CS (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA.	deutschcl@uphs.upenn.edu; kjtracey@nshs.edu	Deutschman, Clifford/AAN-2742-2021	Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM062508] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; Andersson Ulf, 2012, Cerebrum, V2012, P3; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Antoine D.J., 2014, MOL MED; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Buchan CA, 2012, CURR INFECT DIS REP, V14, P512, DOI 10.1007/s11908-012-0282-4; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chen WL, 2007, ACAD EMERG MED, V14, P392, DOI 10.1197/j.aem.2006.12.015; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Dwyer J., 2012, NY TIMES, pA25; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Frasure-Smith N, 2009, BRAIN BEHAV IMMUN, V23, P1140, DOI 10.1016/j.bbi.2009.07.005; Goehler LE, 1997, BRAIN RES BULL, V43, P357, DOI 10.1016/S0361-9230(97)00020-8; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kaukonen K. M., 2014, J AM MED ASS; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P9, DOI 10.1016/j.intimp.2009.10.003; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lehrer P, 2010, APPL PSYCHOPHYS BIOF, V35, P303, DOI 10.1007/s10484-010-9139-5; Levy RJ, 2007, CRIT CARE MED, V35, pS468, DOI 10.1097/01.CCM.0000278604.93569.27; Liu SG, 2006, AM J PHYSIOL-CELL PH, V290, pC990, DOI 10.1152/ajpcell.00308.2005; Liu T, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-16; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Lukewich M. K., 2014, SEMIN IMMUNOL; Ma SF, 2011, AM J RESP CELL MOL, V45, P1203, DOI 10.1165/rcmb.2011-0179OC; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Motagally MA, 2009, J PHYSIOL-LONDON, V587, P2623, DOI 10.1113/jphysiol.2009.172312; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nierhaus A, 2003, INTENS CARE MED, V29, P646, DOI 10.1007/s00134-003-1666-6; Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7; NIIJIMA A, 1991, J AUTONOM NERV SYST, V36, P183, DOI 10.1016/0165-1838(91)90042-2; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Peruchi BB, 2011, J SURG RES, V167, pE333, DOI 10.1016/j.jss.2010.11.893; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Thayer Julian F, 2009, Cleve Clin J Med, V76 Suppl 2, pS23, DOI 10.3949/ccjm.76.s2.05; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Verma R, 2009, CRIT CARE MED, V37, P1397, DOI 10.1097/CCM.0b013e31819cecd6; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Ward PA, 2012, AM J PATHOL, V181, P2, DOI 10.1016/j.ajpath.2012.05.003; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Werdan K, 2009, CAN J PHYSIOL PHARM, V87, P266, DOI 10.1139/Y09-012; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yanai H, 2011, P NATL ACAD SCI USA, V108, P11542, DOI 10.1073/pnas.1108535108; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Ye CT, 2012, P NATL ACAD SCI USA, V109, P21052, DOI 10.1073/pnas.1216195109; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	111	391	415	1	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					464	476		10.1016/j.immuni.2014.04.001	http://dx.doi.org/10.1016/j.immuni.2014.04.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745331	Bronze			2022-12-18	WOS:000334849400006
J	Motz, GT; Coukos, G				Motz, Greg T.; Coukos, George			Deciphering and Reversing Tumor Immune Suppression	IMMUNITY			English	Review							ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; LONG-TERM SURVIVAL; ANTI-VEGF THERAPY; MHC CLASS-I; NITRIC-OXIDE; OVARIAN-CARCINOMA; INDOLEAMINE 2,3-DIOXYGENASE; CHEMOKINE EXPRESSION	Generating an anti-tumor immune response is a multi-step process that is executed by effector T cells that can recognize and kill tumor targets. However, tumors employ multiple strategies to attenuate the effectiveness of T-cell-mediated attack. They achieve this by interfering with nearly every step required for effective immunity, from deregulation of antigen-presenting cells to establishment of a physical barrier at the vasculature that prevents homing of effector tumor-rejecting cells and the suppression of effector lymphocytes through the recruitment and activation of immunosuppressive cells such as myeloid-derived suppressor cells, tolerogenic monocytes, and T regulatory cells. Here, we review the ways in which tumors exert immune suppression and highlight the new therapies that seek to reverse this phenomenon and promote anti-tumor immunity. Understanding anti-tumor immunity, and how it becomes disabled by tumors, will ultimately lead to improved immune therapies and prolonged survival of patients.	[Motz, Greg T.; Coukos, George] Univ Penn, Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Coukos, George] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland; [Coukos, George] Univ Lausanne, Dept Oncol, CH-1015 Lausanne, Switzerland	University of Pennsylvania; University of Lausanne; University of Lausanne	Coukos, G (corresponding author), Univ Penn, Sch Med, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	george.coukos@chuv.ch	Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367	National Institutes of Health Transformative [R01 CA156695]; Ovarian Cancer Research Fund; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA156695, T32CA009140] Funding Source: NIH RePORTER	National Institutes of Health Transformative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by National Institutes of Health Transformative R01 CA156695 (GC), a grant by the Ovarian Cancer Research Fund (GTM), and the Ludwig Institute for Cancer Research.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Almand B, 2000, CLIN CANCER RES, V6, P1755; Bagnato A, 1999, CANCER RES, V59, P720; Bagnato A, 2008, INT J BIOCHEM CELL B, V40, P1443, DOI 10.1016/j.biocel.2008.01.022; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Batista CEA, 2009, MOL IMAGING BIOL, V11, P460, DOI 10.1007/s11307-009-0225-0; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Blaschitz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021774; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chang CC, 2005, ADV CANCER RES, V93, P189, DOI 10.1016/S0065-230X(05)93006-6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; de Chaisemartin L, 2011, CANCER RES, V71, P6391, DOI 10.1158/0008-5472.CAN-11-0952; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Della Porta M, 2005, ONCOLOGY-BASEL, V68, P276, DOI 10.1159/000086784; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Dirkx AEM, 2003, CANCER RES, V63, P2322; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dranoff G, 2013, CURR OPIN IMMUNOL, V25, P189, DOI 10.1016/j.coi.2013.02.012; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Fricke I, 2007, CLIN CANCER RES, V13, P4840, DOI 10.1158/1078-0432.CCR-07-0409; Frommer KW, 2008, RHEUMATOLOGY, V47, pV27, DOI 10.1093/rheumatology/ken274; Fu H, 2011, EUR J IMMUNOL, V41, P2997, DOI 10.1002/eji.201141683; Fukumura D, 1997, AM J PATHOL, V150, P713; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geissmann F, 1999, J IMMUNOL, V162, P4567; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; Griffioen AW, 1996, CANCER RES, V56, P1111; Griffioen AW, 1996, BLOOD, V88, P667, DOI 10.1182/blood.V88.2.667.bloodjournal882667; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hirano F, 2005, CANCER RES, V65, P1089; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang XY, 2010, J EXP MED, V207, P505, DOI 10.1084/jem.20090397; Huarte E, 2008, CANCER RES, V68, P7684, DOI 10.1158/0008-5472.CAN-08-1167; Hwang WT, 2012, GYNECOL ONCOL, V124, P192, DOI 10.1016/j.ygyno.2011.09.039; Ibberson M., 2013, CLIN CANC RES; Ishida T, 1998, J IMMUNOL, V161, P4842; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kalinski P, 1997, J IMMUNOL, V159, P28; Kammertoens T, 2005, TRENDS MOL MED, V11, P225, DOI 10.1016/j.molmed.2005.03.002; Kandalaft LE, 2011, CANCER METAST REV, V30, P141, DOI 10.1007/s10555-011-9289-9; Kato T, 2001, BREAST CANCER RES TR, V70, P65, DOI 10.1023/A:1012534724488; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kim R, 2007, IMMUNOLOGY, V121, P149, DOI 10.1111/j.1365-2567.2007.02579.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Kwon ED, 1999, P NATL ACAD SCI USA, V96, P15074, DOI 10.1073/pnas.96.26.15074; Labidi-Galy SI, 2011, CANCER RES, V71, P5423, DOI 10.1158/0008-5472.CAN-11-0367; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; Loser K, 2007, J IMMUNOL, V179, P365, DOI 10.4049/jimmunol.179.1.365; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Ma CL, 2012, J IMMUNOL, V189, P5029, DOI 10.4049/jimmunol.1201892; Ma LA, 2010, P NATL ACAD SCI USA, V107, P19461, DOI 10.1073/pnas.1011748107; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; Meidan R, 2007, TRENDS ENDOCRIN MET, V18, P379, DOI 10.1016/j.tem.2007.09.002; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Mulligan JK, 2009, HUM IMMUNOL, V70, P375, DOI 10.1016/j.humimm.2009.01.014; Mulligan JK, 2010, CANCER IMMUNOL IMMUN, V59, P267, DOI 10.1007/s00262-009-0747-y; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Muthuswamy R, 2012, CANCER RES, V72, P3735, DOI 10.1158/0008-5472.CAN-11-4136; Muthuswamy R, 2010, BLOOD, V116, P1454, DOI 10.1182/blood-2009-12-258038; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Naito Y, 1998, CANCER RES, V58, P3491; Neller MA, 2008, SEMIN IMMUNOL, V20, P286, DOI 10.1016/j.smim.2008.09.006; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; O'Brien LA, 2008, ARTERIOSCL THROM VAS, V28, pE5, DOI 10.1161/ATVBAHA.107.158949; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Pirtskhalaishvili G, 2000, PROSTATE, V44, P77; Pivarcsi A, 2007, P NATL ACAD SCI USA, V104, P19055, DOI 10.1073/pnas.0705673104; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Propper DJ, 2003, CLIN CANCER RES, V9, P84; Ren X, 2007, CELL DEATH DIFFER, V14, P2076, DOI 10.1038/sj.cdd.4402220; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Rosano L, 2003, CANCER RES, V63, P2447; SAIDA K, 1989, J BIOL CHEM, V264, P14613; Sainz-Perez A, 2012, CANCER RES, V72, P3557, DOI 10.1158/0008-5472.CAN-12-0277; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Sata M, 1998, NAT MED, V4, P415, DOI 10.1038/nm0498-415; Sawant A, 2012, J IMMUNOL, V189, P4258, DOI 10.4049/jimmunol.1101855; Schlienger K, 2003, CLIN CANCER RES, V9, P1517; Secchiero P, 2008, ARTERIOSCL THROM VAS, V28, pE4, DOI 10.1161/ATVBAHA.107.158451; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Selby M.J., 2013, CANC IMMUNOLOGY RES; Seo N, 2001, IMMUNOLOGY, V103, P449, DOI 10.1046/j.1365-2567.2001.01279.x; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi A, 2004, CANCER IMMUNOL IMMUN, V53, P543, DOI 10.1007/s00262-003-0466-8; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Valzasina B, 2006, CANCER RES, V66, P4488, DOI 10.1158/0008-5472.CAN-05-4217; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watchmaker PB, 2010, J IMMUNOL, V184, P591, DOI 10.4049/jimmunol.0902062; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Whiteside TL, 2002, SEMIN CANCER BIOL, V12, P43, DOI 10.1006/scbi.2001.0402; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zitvogel L, 2009, J CLIN INVEST, V119, P2127, DOI 10.1172/JCI39991; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	182	391	420	5	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					61	73		10.1016/j.immuni.2013.07.005	http://dx.doi.org/10.1016/j.immuni.2013.07.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890064	Green Accepted, Bronze			2022-12-18	WOS:000330948300006
J	Liu, SY; Aliyari, R; Chikere, K; Li, GM; Marsden, MD; Smith, JK; Pernet, O; Guo, HT; Nusbaum, R; Zack, JA; Freiberg, AN; Su, LS; Lee, B; Cheng, GH				Liu, Su-Yang; Aliyari, Roghiyh; Chikere, Kelechi; Li, Guangming; Marsden, Matthew D.; Smith, Jennifer K.; Pernet, Olivier; Guo, Haitao; Nusbaum, Rebecca; Zack, Jerome A.; Freiberg, Alexander N.; Su, Lishan; Lee, Benhur; Cheng, Genhong			Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol	IMMUNITY			English	Article							BETA-LACTAMASE; CHOLESTEROL; MEMBRANE; FUSION; VIRUS; MACROPHAGES; OXYSTEROLS; PROTEINS; RELEASE; CELLS	Interferons (IFN) are essential antiviral cytokines that establish the cellular antiviral state through upregulation of hundreds of interferon-stimulated genes (ISGs), most of which have uncharacterized functions and mechanisms. We identified cholesterol-25-hydroxylase (CH25H) as a broadly antiviral ISG. CH25H converts cholesterol to a soluble antiviral factor, 25-hydroxycholesterol (25HC). 25HC treatment in cultured cells broadly inhibited growth of enveloped viruses including VSV, HSV, HIV, and MHV68 and acutely pathogenic EBOV, RVFV, RSSEV, and Nipah viruses under BSL4 conditions. It suppressed viral growth by blocking membrane fusion between virus and cell. In animal models, Ch25h-deficient mice were more susceptible to MHV68 lytic infection. Moreover, administration of 25HC in humanized mice suppressed HIV replication and reversed T cell depletion. Thus, our studies demonstrate a unique mechanism by which IFN achieves its antiviral state through the production of a natural oxysterol to inhibit viral entry and implicate membrane-modifying oxysterols as potential antiviral therapeutics.	[Liu, Su-Yang; Aliyari, Roghiyh; Chikere, Kelechi; Pernet, Olivier; Zack, Jerome A.; Lee, Benhur; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.; Lee, Benhur] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Marsden, Matthew D.; Zack, Jerome A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Li, Guangming; Guo, Haitao; Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Smith, Jennifer K.; Nusbaum, Rebecca; Freiberg, Alexander N.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; University of Texas Medical Branch Galveston	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	gcheng@mednet.ucla.edu	Li, Guangming/C-5830-2015; Lee, Benhur/A-8554-2016	Li, Guangming/0000-0002-5983-3256; Lee, Benhur/0000-0003-0760-1709; Pernet, Olivier/0000-0003-0633-7360; Freiberg, Alexander N/0000-0001-8413-8960; Nusbaum, Rebecca/0000-0002-8378-8037	NIH [R01 AI078389, AI069120, AI080432, AI095097, AI077454, AI070010, AI028697]; Tumor Immunology Training Grant; Warsaw Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078389, R01AI080432, R01AI070010, U54AI065359, R01AI069120, P30AI028697, R01AI078389, R01AI095097, R01AI077454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tumor Immunology Training Grant; Warsaw Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Russell (UT Southwestern) for providing Ch25h<SUP>-/-</SUP> bone marrow cells and E. Tarling, P. Edwards, and S. Bensinger at UCLA for Srebp plasmids. We thank G. Boxx and S. Iyer for access to experimental samples and RNAseq data and R. Modlin for his editorial advice. This project was funded by NIH Grants R01 AI078389, AI069120, AI080432, AI095097, AI077454, AI070010, and AI028697 (the UCLA CFAR), Tumor Immunology Training Grant, and the Warsaw Fellowship.	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Degols G, 2007, BIOCHIMIE, V89, P831, DOI 10.1016/j.biochi.2007.03.006; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Holmes RS, 2011, 3 BIOTECH, V1, P99, DOI 10.1007/s13205-011-0013-9; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; LANGE Y, 1995, J LIPID RES, V36, P1092; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Moog C, 1998, ANTIVIR CHEM CHEMOTH, V9, P491, DOI 10.1177/095632029800900605; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pecheur EI, 1999, BIOCHEMISTRY-US, V38, P364, DOI 10.1021/bi981389u; Pezacki John Paul, 2009, BMC Chemical Biology, V9, P2, DOI 10.1186/1472-6769-9-2; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x; Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260; Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107; Wolf MC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-119; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	28	391	409	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					92	105		10.1016/j.immuni.2012.11.005	http://dx.doi.org/10.1016/j.immuni.2012.11.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23273844	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000314195500012
J	Duprez, L; Takahashi, N; Van Hauwermeiren, F; Vandendriessche, B; Goossens, V; Vanden Berghe, T; Declercq, W; Libert, C; Cauwels, A; Vandenabeele, P				Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter			RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome	IMMUNITY			English	Article							CELL-DEATH; CECAL LIGATION; TNF; RECEPTOR; APOPTOSIS; SEPSIS; CASPASES; SHOCK; NECROPTOSIS; ACTIVATION	Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death. An additional switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis. We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS). Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS. However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amounts of circulating damage-associated molecular patterns. Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect. These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS. RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clinical relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.	[Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter] Flanders Inst Biotechnol VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), Flanders Inst Biotechnol VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.ugent.be	Vandendriessche, Benjamin/N-2415-2013; Berghe, Tom Vanden/N-2902-2019; Vanden Berghe, Tom/C-4916-2009; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Vandendriessche, Benjamin/0000-0003-0672-0327; Berghe, Tom Vanden/0000-0002-1633-0974; Vanden Berghe, Tom/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; Takahashi, Nozomi/0000-0002-3751-4203	FWO; IWT; Flanders Institute for Biotechnology (VIB); Flemish Government [BOF09/01M00709];  [MRTN-CT-035624];  [FP7-200767];  [IAP 6/18];  [FWO G.0875.11];  [FWO G.0973.11]	FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flanders Institute for Biotechnology (VIB); Flemish Government(European Commission); ; ; ; ; 	F.V.H. and B.V. performed crucial experiments and should be considered as equal coauthors. We are indebted gratefully to K. Newton and V.M. Dixit for providing Ripk3<SUP>-/-</SUP> mice. We thank W. Burm, A. Meeuws, and E. Parthoens for technical assistance, A. Bredan for editorial assistance, and R. Vanden-broucke for helpful discussions. L.D. obtained a fellowship from the FWO; F.V. and B.V. are the holders of IWT grants. T.V.B. holds a postdoctoral fellowship from the FWO; research in the Vandenabeele group is supported by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (MRP, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB). P.V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. L.D., N.T., A.C., C.L., and P.V. conceived the research plan. L.D., N.T., F.V.H., V.G.., B.V., and A.C. planned and performed the experiments. T.V.B. and W.D. created the conditional Casp7<SUP>-/-</SUP> mice. L.D., N.T., A.C., W.D., and P.V. wrote the manuscript.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; BAKER CC, 1983, SURGERY, V94, P331; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; EVERAERDT B, 1994, J IMMUNOL, V152, P5041; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jaeschke H, 1998, J IMMUNOL, V160, P3480; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Kuenzler KA, 2002, J SURG RES, V108, P268, DOI 10.1006/jsre.2002.6542; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Piguet PF, 1999, LAB INVEST, V79, P495; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	65	391	419	5	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					908	918		10.1016/j.immuni.2011.09.020	http://dx.doi.org/10.1016/j.immuni.2011.09.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195746	Bronze			2022-12-18	WOS:000298777300010
J	Yeh, WC; Itie, A; Elia, AJ; Ng, M; Shu, HB; Wakeham, A; Mirtsos, C; Suzuki, N; Bonnard, M; Goeddel, DV; Mak, TW				Yeh, WC; Itie, A; Elia, AJ; Ng, M; Shu, HB; Wakeham, A; Mirtsos, C; Suzuki, N; Bonnard, M; Goeddel, DV; Mak, TW			Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; DOMAIN-CONTAINING RECEPTOR; INDUCED CELL-DEATH; ALPHA-INDUCED APOPTOSIS; SIGNALING COMPLEX DISC; FAS-MEDIATED APOPTOSIS; INHIBITORY PROTEIN; CASPASE-8 ACTIVATION; ENDOTHELIAL-CELLS	Gasper (c-FLIP) associates with FADD and caspase-8 in signaling complexes downstream of death receptors like Fas. We generated Casper-deficient mice and cells and noted a duality in the physiological functions of this molecule, casper(-/-) embryos do not survive past day 10.5 of embryogenesis and exhibit impaired heart development. This phenotype is reminiscent of that reported for FADD(-/-) and caspase-8(-/-) embryos. However, unlike FADD(-/-) and caspase-8(-/-) cells, casper(-/-) embryonic fibroblasts are highly sensitive to FasL- or TNF-induced apoptosis and show rapid induction of caspase activities. NF-kappa B and JNK/SAPK activation is intact in TNF-stimulated casper(-/-) cells. These results suggest that Gasper has two distinct roles: to cooperate with FADD and caspase-8 during embryonic development and to mediate cytoprotection against death factor-induced apoptosis.	Univ Toronto, Amgen Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Tularik Inc, S San Francisco, CA 94080 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Mak, TW (corresponding author), Univ Toronto, Amgen Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada.							Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Noble KE, 1999, J IMMUNOL, V162, P1376; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	68	391	409	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					633	642		10.1016/S1074-7613(00)80214-9	http://dx.doi.org/10.1016/S1074-7613(00)80214-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894163	Bronze			2022-12-18	WOS:000087937300005
J	Hildeman, DA; Mitchell, T; Teague, TK; Henson, P; Day, BJ; Kappler, J; Marrack, PC				Hildeman, DA; Mitchell, T; Teague, TK; Henson, P; Day, BJ; Kappler, J; Marrack, PC			Reactive oxygen species regulate activation-induced T cell apoptosis	IMMUNITY			English	Article							SUPEROXIDE-DISMUTASE; CYTOCHROME-C; PROTEASE INHIBITORS; POTENTIAL ROLE; IN-VIVO; DEATH; LYMPHOCYTES; FAS; MICE; CASPASES	Reactive oxygen species (ROS) mediate apoptosis in a number of cell types. We studied the role that ROS play in activated T cell apoptosis by activating T cells in vivo and then culturing them for a short time. Activated T cells died independently of Fas and TNF alpha. Their death was characterized by rapid loss of mitochondrial transmembrane potential (Delta psi(m)), caspase-dependent DNA fragmentation, and superoxide generation. A superoxide dismutase mimetic, Mn (III) tetrakis (5, 10, 15, 20-benzoic acid) porphyrin (MnTBAP), protected T cells from superoxide generation, caspase-dependent DNA loss, loss of Delta psi(m), and cell death. These results indicate that ROS can regulate signals involved in caspase activation and apoptosis and may contribute to peripheral T cell deletion.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem Biophys & Genet, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol & Med, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, PC (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, 4200 E 9th Ave, Denver, CO 80206 USA.	marrack@njc.org	Hildeman, David/AAA-1757-2020; Marrack, Philippa/AHE-6316-2022; Hildeman, David/I-4884-2015; Teague, T. Kent/A-2527-2008; Mitchell, Thomas C/B-4193-2013	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483; Teague, T. Kent/0000-0002-4680-5440; Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI-17134, AI-18785, AI-22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018785, P01AI022295, R01AI018785, R37AI018785, R01AI017134, R56AI017134, R37AI017134] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; BUTTKE TM, 1995, FREE RADICAL RES, V22, P389, DOI 10.3109/10715769509147548; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Deas O, 1998, J IMMUNOL, V161, P3375; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; ELKHATIB M, 1995, CELL IMMUNOL, V163, P237, DOI 10.1006/cimm.1995.1122; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; Halliwell B, 1985, FREE RADICAL BIO MED, P20; Haviv R, 1997, J NEUROSCI RES, V50, P69, DOI 10.1002/(SICI)1097-4547(19971001)50:1<69::AID-JNR8>3.0.CO;2-J; Ink B, 1997, MOL CELL BIOL, V17, P2468, DOI 10.1128/MCB.17.5.2468; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kunstle G, 1997, IMMUNOL LETT, V55, P5, DOI 10.1016/S0165-2478(96)02642-9; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McCarthy MJ, 1997, J CELL SCI, V110, P2165; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Miethke T, 1996, EUR J IMMUNOL, V26, P1459, DOI 10.1002/eji.1830260709; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0; Patel M, 1998, J NEUROCHEM, V71, P1068, DOI 10.1046/j.1471-4159.1998.71031068.x; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PATORINO JG, 1998, J BIOL CHEM, V273, P7770; Sarin A, 1996, J EXP MED, V184, P2445, DOI 10.1084/jem.184.6.2445; SCOTT DE, 1993, J IMMUNOL, V150, P664; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TAKEYAMA N, 1993, BIOCHEM J, V294, P719, DOI 10.1042/bj2940719; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zheng LX, 1998, J IMMUNOL, V160, P763; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	55	391	399	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					735	744		10.1016/S1074-7613(00)80072-2	http://dx.doi.org/10.1016/S1074-7613(00)80072-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403648	Bronze			2022-12-18	WOS:000081209600011
J	Gordon, S				Gordon, Siamon			Phagocytosis: An Immunobiologic Process	IMMUNITY			English	Review							IMMOBILIZED IMMUNE-COMPLEXES; DENDRITIC CELL-RECEPTOR; APOPTOTIC CELLS; MACROPHAGE RECEPTORS; SCAVENGER RECEPTOR; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; MEDIATED PHAGOCYTOSIS; NADPH OXIDASE; HOST-DEFENSE	It has been a century since the death of Elie Metchnikoff, who championed the role of phagocytosis in cellular immunity. Whereas others had observed the uptake of particles by cells from simple to complex organisms, he grasped its significance in the host response to injury and infection and established a firm basis for our understanding of inflammation and tissue homeostasis. The past century has brought improved tools of cellular and molecular biology to the study of phagocytosis and its contribution to physiological and pathological processes, including receptor function in innate and acquired immunity. In this review, I assess our present knowledge and consider opportunities for future research and therapeutic targeting.	[Gordon, Siamon] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 33302, Taiwan; [Gordon, Siamon] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England	Chang Gung University; University of Oxford	Gordon, S (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 33302, Taiwan.; Gordon, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	siamon.gordon@path.ox.ac.uk						Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Baxter AE, 2014, CELL HOST MICROBE, V16, P711, DOI 10.1016/j.chom.2014.10.010; Billings EA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac6250; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Boulais J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.80; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brown GC, 2015, CURR MOL MED, V15, P842, DOI 10.2174/156652401509151105130628; BROWN HE, 1956, ENDOCRINOLOGY, V58, P365, DOI 10.1210/endo-58-3-365; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Campbell-Valois FX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016378; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; CHERNYAK L, 1988, CELL IMMUNOL, V117, P218, DOI 10.1016/0008-8749(88)90090-1; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies JQ, 2011, ONCOL REP, V25, P619, DOI 10.3892/or.2010.1117; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Dill BD, 2015, MOL CELL PROTEOMICS, V14, P1334, DOI 10.1074/mcp.M114.044594; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Drummond R.A., 2015, MUCOSAL IMMUNOL; Dushek O, 2012, IMMUNOL REV, V250, P258, DOI 10.1111/imr.12008; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Fond AM, 2015, J CLIN INVEST, V125, P2748, DOI 10.1172/JCI80300; Freeman SA, 2016, CELL, V164, P128, DOI 10.1016/j.cell.2015.11.048; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gordon S., 2012, FUNDAMENTAL IMMUNOLO, P448; Gordon S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016378; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; Griffiths G, 2010, NAT REV MICROBIOL, V8, P827, DOI 10.1038/nrmicro2437; Hanc P, 2015, IMMUNITY, V42, P839, DOI 10.1016/j.immuni.2015.04.009; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Herweg JA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00048; Hirsch J.G., 1962, PHAGOCYTOSIS DEGRANU; HIRSCH JG, 1962, J EXP MED, V116, P827, DOI 10.1084/jem.116.6.827; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Janka GE, 2014, BLOOD REV, V28, P135, DOI 10.1016/j.blre.2014.03.002; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lecube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023366; Levine AP, 2013, DIGEST DIS, V31, P321, DOI 10.1159/000354686; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Loov C, 2015, GLIA, V63, P1997, DOI 10.1002/glia.22873; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520; Metchnikoff O., 1921, LIFE E METCHNIKOFF 1; Mevorach D, 2014, BIOL BLOOD MARROW TR, V20, P58, DOI 10.1016/j.bbmt.2013.10.010; MICHL J, 1983, J EXP MED, V157, P2121, DOI 10.1084/jem.157.6.2121; MICHL J, 1979, J EXP MED, V150, P607, DOI 10.1084/jem.150.3.607; Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Mortimer GM, 2014, ACS NANO, V8, P3357, DOI 10.1021/nn405830g; Munn DH, 2016, CURR OPIN IMMUNOL, V39, P1, DOI 10.1016/j.coi.2015.10.009; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nathan C, 2012, J CLIN INVEST, V122, P1189, DOI 10.1172/JCI62930; Neyen C, 2011, METHODS MOL BIOL, V748, P35, DOI 10.1007/978-1-61779-139-0_3; Neyen C, 2009, BIOCHEMISTRY-US, V48, P11858, DOI 10.1021/bi9013769; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Parinot C, 2016, ADV EXP MED BIOL, V854, P259, DOI 10.1007/978-3-319-17121-0_35; Paul D, 2013, BIOPHYS J, V105, P1143, DOI 10.1016/j.bpj.2013.07.036; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; Podinovskaia M., 2013, CURR PROTOC IMMUNOL, V102, P34; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Romao S, 2014, AUTOPHAGY, V10, P526, DOI 10.4161/auto.27606; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Shiratsuchi A, 2013, DRUG DISCOV THER, V7, P73, DOI 10.5582/ddt.2013.v7.2.73; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1994, J EXP MED, V179, P1, DOI 10.1084/jem.179.1.1; Stienstra R, 2014, DIABETES, V63, P4143, DOI 10.2337/db14-0256; Stranks AJ, 2015, J INNATE IMMUN, V7, P375, DOI 10.1159/000370112; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; SUNG SSJ, 1985, BIOCHIM BIOPHYS ACTA, V845, P204, DOI 10.1016/0167-4889(85)90178-8; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tan SM, 2015, IMMUNOL REV, V264, P233, DOI 10.1111/imr.12254; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Underhill DM, 2015, IMMUNITY, V43, P845, DOI 10.1016/j.immuni.2015.10.023; van der Meer JWM, 2015, MOL IMMUNOL, V68, P40, DOI 10.1016/j.molimm.2015.06.019; Van Rooijen N, 2008, J DRUG TARGET, V16, P529, DOI 10.1080/10611860802228426; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vikhanski L., 2016, IMMUNITY E METCHNIKO; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Williams-Herman D, 1999, ADV CELL MOL BIOL ME, V5, P47, DOI 10.1016/S1874-5172(99)80027-3; Wilson GJ, 2015, CELL HOST MICROBE, V17, P252, DOI 10.1016/j.chom.2015.01.004; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yamauchi S, 2012, FEBS LETT, V586, P3229, DOI 10.1016/j.febslet.2012.06.041; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yates RM, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P249; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	128	390	403	8	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					463	475		10.1016/j.immuni.2016.02.026	http://dx.doi.org/10.1016/j.immuni.2016.02.026			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982354	Bronze			2022-12-18	WOS:000372784200003
J	Sallusto, F; Lanzavecchia, A; Araki, K; Ahmed, R				Sallusto, Federica; Lanzavecchia, Antonio; Araki, Koichi; Ahmed, Rafi			From Vaccines to Memory and Back	IMMUNITY			English	Review							T-CELL MEMORY; HUMAN MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; DENGUE VIRUS; B-CELLS; NEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; HUMORAL IMMUNITY; INTERLEUKIN 22; EFFECTOR	Vaccines work by eliciting an immune response and consequent immunological memory that mediates protection from infection or disease Recently, new methods have been developed to dissect the immune response in experimental animals and humans, which have led to increased understanding of the molecular mechanisms that control differentiation and maintenance of memory T and B cells In this review we will provide an overview of the cellular organization of immune memory and underline some of the outstanding questions on immunological memory and how they pertain to vaccination strategies Finally we will discuss how we can learn about antigen design from the interrogation of our memory T and B cells a journey from vaccines to memory and back	[Sallusto, Federica; Lanzavecchia, Antonio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Emory University	Sallusto, F (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.			Araki, Koichi/0000-0003-3478-6315	NIAID NIH HHS [R01 AI030048, R01 AI030048-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2013, VACCINES-BASEL; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; CHEN LB, 1978, J CELL BIOL, V79, pA157; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coffman RL, 2010, SCIENCE, V328, P1116, DOI 10.1126/science.1192009; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Finley John H., 1951, COMPLETE WRITINGS TH; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; GOOD JKL, 2010, J IMMUNOL, V185, P3117; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gray D, 2002, NAT REV IMMUNOL, V2, P60, DOI 10.1038/nri706; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kassiotis G, 2009, IMMUNITY, V31, P450, DOI 10.1016/j.immuni.2009.08.017; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Levin MJ, 2008, VACCINES-BASEL, P1057; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perez OD, 2006, IMMUNOL REV, V210, P208, DOI 10.1111/j.0105-2896.2006.00364.x; Phan TG, 2009, CURR OPIN IMMUNOL, V21, P258, DOI 10.1016/j.coi.2009.05.006; Plotkin S., 2008, VACCINES, P1; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; TEW JG, 1980, IMMUNOL REV, V53, P175; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	130	390	401	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					451	463		10.1016/j.immuni.2010.10.008	http://dx.doi.org/10.1016/j.immuni.2010.10.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029957	Green Accepted, Bronze			2022-12-18	WOS:000284300200003
J	Ding, YH; Smith, KJ; Garboczi, DN; Utz, U; Biddison, WE; Wiley, DC				Ding, YH; Smith, KJ; Garboczi, DN; Utz, U; Biddison, WE; Wiley, DC			Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids	IMMUNITY			English	Article							MHC CLASS-I; LYMPHOTROPIC VIRUS TYPE-1; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; H-2K(B) MOLECULE; VIRAL PEPTIDES; ALPHA-BETA; RECOGNITION; ORIENTATION; LYMPHOCYTES	The three-dimensional structure of a human alpha beta T cell receptor (TCR), B7, bound to the HLA-A2 molecule/HTLV-1 Tax peptide complex was determined by x-ray crystallography. Although different from the A6 TCR, previously studied, in 16 of the 17 residues that contact HLA-A2/Tax, the B7 TCR binds in a similar diagonal manner, only slightly tipped and rotated, relative to the A6 TCR. The structure explains data from functional assays on the specificity differences between the B7 and A6 TCRs for agonist, partial agonist, and null peptides. The existence of a structurally similar diagonal binding mode for TCRs favors mechanisms based on the formation of geometrically defined supramolecular assemblies for initiating signaling.	Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA; Childrens Hosp, Howard Hughes Med Inst, Dept Med, Mol Med Lab, Boston, MA 02115 USA; Inst Rech Clin Montreal, Immunol Lab, Montreal, PQ H2W 1R7, Canada; NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wiley, DC (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA.	wiley@xtal0.harvard.edu	Smith, Katie Elizabeth/GXH-2114-2022					Arden Bernhard, 1995, Immunogenetics, V42, P455; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Blomberg K, 1996, J IMMUNOL METHODS, V193, P199, DOI 10.1016/0022-1759(96)00063-4; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; JANEWAY CA, 1989, COLD SH Q B, V54, P657; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS P, 1991, J APPL CRYSTALLOGR, V24, P924; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADDEN DR, 1992, CURR OPIN STRUC BIOL, V2, P300; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reid SW, 1996, J EXP MED, V184, P2279, DOI 10.1084/jem.184.6.2279; ROMAN GC, 1988, LANCET, V1, P651; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; SMITH KD, 1997, J IMMUNOL, V158, P2800; Smith KJ, 1996, IMMUNITY, V4, P215, DOI 10.1016/S1074-7613(00)80430-6; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	44	390	409	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					403	411		10.1016/S1074-7613(00)80546-4	http://dx.doi.org/10.1016/S1074-7613(00)80546-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586631	Bronze			2022-12-18	WOS:000073348000003
J	Staudt, V; Bothur, E; Klein, M; Lingnau, K; Reuter, S; Grebe, N; Gerlitzki, B; Hoffmann, M; Ulges, A; Taube, C; Dehzad, N; Becker, M; Stassen, M; Steinborn, A; Lohoff, M; Schild, H; Schmitt, E; Bopp, T				Staudt, Valerie; Bothur, Evita; Klein, Matthias; Lingnau, Karen; Reuter, Sebastian; Grebe, Nadine; Gerlitzki, Bastian; Hoffmann, Markus; Ulges, Alexander; Taube, Christian; Dehzad, Nina; Becker, Marc; Stassen, Michael; Steinborn, Andrea; Lohoff, Michael; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias			Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR; TGF-BETA; BRONCHIAL HYPERRESPONSIVENESS; MONOCLONAL-ANTIBODY; IL-9 EXPRESSION; GENE-EXPRESSION; WORM EXPULSION; FACTOR PU.1; ASTHMA	Interferon-regulatory factor 4 (IRF4) is essential for the development of T helper 2 (Th2) and Th17 cells. Herein, we report that IRF4 is also crucial for the development and function of an interleukin-9 (IL-9)-producing CD4(+) T cell subset designated Th9. IRF4-deficient CD4(+) T cells failed to develop into IL-9-producing Th9 cells, and IRF4-specific siRNA inhibited IL-9 production in wild-type CD4(+) T cells. Chromatin-immunoprecipitation (ChIP) analyses revealed direct IRF4 binding to the II9 promoter in Th9 cells. In a Th9-dependent asthma model, neutralization of IL-9 substantially ameliorated asthma symptoms. The relevance of these findings is emphasized by the fact that the induction of IL-9 production also occurs in human CD4(+) T cells accompanied by the upregulation of IRF4. Our data clearly demonstrate the central function of IRF4 in the development of Th9 cells and underline the contribution of this T helper cell subset to the pathogenesis of asthma.	[Staudt, Valerie; Klein, Matthias; Grebe, Nadine; Gerlitzki, Bastian; Hoffmann, Markus; Ulges, Alexander; Becker, Marc; Stassen, Michael; Schild, Hansjoerg; Schmitt, Edgar; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55131 Mainz, Germany; [Reuter, Sebastian; Taube, Christian; Dehzad, Nina] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ill Med Clin, D-55131 Mainz, Germany; [Bothur, Evita; Lohoff, Michael] Inst Med Mikrobiol & Krankenhaushyg, D-35043 Marburg, Germany; [Lingnau, Karen] Intercell AG, Vienna, Austria; [Steinborn, Andrea] Univ Heidelberg, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Intercell; Ruprecht Karls University Heidelberg	Bopp, T (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55131 Mainz, Germany.	boppt@uni-mainz.de	Reuter, Sebastian/L-1804-2013; Bopp, Tobias/A-4328-2018; Baumgart, Nadine/AAO-9686-2020	Bopp, Tobias/0000-0002-3232-8065; Reuter, Sebastian/0000-0002-1784-0124; Baumgart, Nadine/0000-0002-6684-0198	Deutsche Forschungsgemeinschaft DFG [SFB TR52 TPA1, SFB 548 A6, SFB TR22, GRK 767, GRK 1043]; International Graduate School of Immunotherapy; Carl Zeiss Foundation; Forschungszentrum Immunologie (FZI); Asthma Core Facility, JGU Mainz	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); International Graduate School of Immunotherapy; Carl Zeiss Foundation; Forschungszentrum Immunologie (FZI); Asthma Core Facility, JGU Mainz	We cordially thank T. Taniguchi for providing the IRF4 Delta RD plasmid. This study was funded by Deutsche Forschungsgemeinschaft DFG, grants SFB TR52 TPA1 (T.B. and E.S.), SFB 548 A6 (T.B. and E.S.), SFB TR22 (M.L.), GRK 767 (M.L.) the GRK 1043: International Graduate School of Immunotherapy (E.S. and T.B.), the Carl Zeiss Foundation (TB.), the "Forschungszentrum Immunologie (FZI)" of the university medical center (E.S. and T.B.), and the Asthma Core Facility (C.T.), JGU Mainz.	ABRAMS JS, 1992, IMMUNOL REV, V27, P5; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; BEHNKE JM, 1993, PARASITE IMMUNOL, V15, P415, DOI 10.1111/j.1365-3024.1993.tb00626.x; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Doull IJM, 1996, AM J RESP CRIT CARE, V153, P1280, DOI 10.1164/ajrccm.153.4.8616554; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Gupta S, 1999, J EXP MED, V190, P1837, DOI 10.1084/jem.190.12.1837; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holroyd KJ, 1998, GENOMICS, V52, P233, DOI 10.1006/geno.1998.5445; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Kulkarni AB, 1997, RES IMMUNOL, V148, P453, DOI 10.1016/S0923-2494(97)82669-7; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Leech MD, 2006, J IMMUNOL, V176, P2505, DOI 10.4049/jimmunol.176.4.2505; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Monteyne P, 1997, J IMMUNOL, V159, P2616; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Noguchi E, 1997, AM J RESP CRIT CARE, V156, P1390, DOI 10.1164/ajrccm.156.5.9702084; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Reuter S, 2008, EUR RESPIR J, V31, P773, DOI 10.1183/09031936.00058907; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; SCHMITT E, 1994, J IMMUNOL, V153, P3989; SCHMITT E, 1989, EUR J IMMUNOL, V19, P2167, DOI 10.1002/eji.1830191130; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wahl SA, 2003, IMMUNOL RES, V28, P167, DOI 10.1385/IR:28:3:167; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	55	388	421	5	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					192	202		10.1016/j.immuni.2010.07.014	http://dx.doi.org/10.1016/j.immuni.2010.07.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20674401	Bronze			2022-12-18	WOS:000281654900009
J	Jin, MS; Lee, JO				Jin, Mi Sun; Lee, Jie-Oh			Structures of the toll-like receptor family and its ligand complexes	IMMUNITY			English	Review							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; LEUCINE-RICH-REPEAT; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; LIPOTEICHOIC ACID LTA; DOUBLE-STRANDED-RNA; LIPID-A ANALOGS; NF-KAPPA-B; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IMMUNE-SYSTEM	Toll-like receptors (TLRs) play central roles in the innate immune response by recognizing conserved structural patterns in diverse microbial molecules. Here, we discuss ligand binding and activation mechanisms of the TLR family. Hydrophobic ligands of TLR1, TLR2, and TLR4 interact with internal protein pockets. In contrast, dsRNA, a hydrophilic ligand, interacts with the solvent-exposed surface of TLR3. Binding of agonistic ligands, lipopeptides or dsRNA, induces dimerization of the ectodomains of the various TLRs, forming dimers that are strikingly similar in shape. In these "m"-shaped complexes, the C termini of the extracellular domains of the TLRs converge in the middle. This observation suggests the hypothesis that dimerization of the extracellular domains forces the intracellular TIR domains to dimerize, and this initiates signaling by recruiting intracellular adaptor proteins.	[Jin, Mi Sun; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Jin, Mi Sun; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, 373-1 Kusong Dong, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Lee, Jie-Oh/AAG-4302-2020; Lee, Jie-Oh/C-1581-2011	Lee, Jie-Oh/0000-0001-6519-6049	Ministry of Education, Science and Technology; Korean Science and Engineering Foundation	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by the Creative Research Initiatives (Center for Membrane Receptor Research) of the Ministry of Education, Science and Technology and Korean Science and Engineering Foundation.	Abrahamson SL, 1997, J BIOL CHEM, V272, P2149; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Beamer LJ, 1998, PROTEIN SCI, V7, P906; Beamer LJ, 1999, BIOCHEM PHARMACOL, V57, P225, DOI 10.1016/S0006-2952(98)00279-2; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BERG M, 1994, AM J PHYSIOL, V266, pC1684, DOI 10.1152/ajpcell.1994.266.6.C1684; BESSLER WG, 1985, J IMMUNOL, V135, P1900; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MEDZHITOV R, 1997, NATURE, V388, P397; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Mulero JJ, 2002, IMMUNOGENETICS, V54, P293, DOI 10.1007/s00251-002-0467-3; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Muroi M, 2002, J BIOL CHEM, V277, P42372, DOI 10.1074/jbc.M205966200; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Rietschel E T, 1991, Infect Dis Clin North Am, V5, P753; Rietschel E T, 1987, Prog Clin Biol Res, V231, P25; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SEIFERT R, 1990, BIOCHEM J, V267, P795, DOI 10.1042/bj2670795; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; Stelter F, 1999, J IMMUNOL, V163, P6035; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; TANAMOTO K, 1984, INFECT IMMUN, V44, P421, DOI 10.1128/IAI.44.2.421-426.1984; THEOFAN G, 1994, J IMMUNOL, V152, P3623; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Uematsu Satoshi, 2008, V183, P1; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; WIESMULLER KH, 1992, INT J PEPT PROT RES, V40, P255; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; ZLOTNICK GW, 1988, J BIOL CHEM, V263, P9790	86	388	423	4	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					182	191		10.1016/j.immuni.2008.07.007	http://dx.doi.org/10.1016/j.immuni.2008.07.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701082	Bronze			2022-12-18	WOS:000258610800007
J	Davis, JM; Clay, H; Lewis, JL; Ghori, N; Herbomel, P; Ramakrishnan, L				Davis, JM; Clay, H; Lewis, JL; Ghori, N; Herbomel, P; Ramakrishnan, L			Real-time visualization of Mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos	IMMUNITY			English	Article							TUBERCULOSIS INFECTION; BRACHYDANIO-RERIO; INTERFERON-GAMMA; BCG INFECTION; DANIO-RERIO; BOVIS BCG; MARINUM; GENE; MICE; NECROSIS	Infection of vertebrate hosts with pathogenic Mycobacteria, the agents of tuberculosis, produces granulomas, highly organized structures containing differentiated macrophages and lymphocytes, that sequester the pathogen. Adult zebrafish are naturally susceptible to tuberculosis caused by Mycobacterium marinum. Here, we exploit the optical transparency of zebrafish embryos to image the events of M. marinum infection in vivo. Despite the fact that the embryos do not yet have lymphocytes, infection leads to the formation of macrophage aggregates with pathological hallmarks of granulomas and activation of previously identified granuloma-specific Mycobacterium genes. Thus, Mycobacterium-macrophage interactions can initiate granuloma formation solely in the context of innate immunity. Strikingly, infection can redirect normal embryonic macrophage migration, even recruiting macrophages seemingly committed to their developmentally dictated tissue sites.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; Stanford Univ, Sch Med, Ctr Electron Microscopy, Stanford, CA 94305 USA; Inst Pasteur, Unite Macrophages & Dev Immunite, F-75015 Paris, France	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Herbomel, P (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.			Ramakrishnan, Lalita/0000-0003-0692-5533; Davis, J. Muse/0000-0001-9959-6921	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 36396] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS DO, 1976, AM J PATHOL, V84, P164; ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Barker LP, 1997, INFECT IMMUN, V65, P1497, DOI 10.1128/IAI.65.4.1497-1504.1997; BARTLETT KH, 1977, APPL ENVIRON MICROB, V33, P1026, DOI 10.1128/AEM.33.5.1026-1029.1977; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; CLARK HF, 1963, J BACTERIOL, V86, P1057, DOI 10.1128/JB.86.5.1057-1069.1963; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Haffter P, 1996, DEVELOPMENT, V123, P1; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NORTH RJ, 1993, AM J PATHOL, V142, P1959; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; ONO H, 1992, P NATL ACAD SCI USA, V89, P11886, DOI 10.1073/pnas.89.24.11886; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Ramakrishnan L, 1997, INFECT IMMUN, V65, P767, DOI 10.1128/IAI.65.2.767-773.1997; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; REMINGTON JS, 1994, INFECT DIS FETUS NEW; Roach DR, 1999, INFECT IMMUN, V67, P5473, DOI 10.1128/IAI.67.10.5473-5476.1999; Seeger A, 1996, MOL IMMUNOL, V33, P511, DOI 10.1016/0161-5890(96)00002-8; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; TAKEUCHI H, 1995, IMMUNOGENETICS, V42, P77, DOI 10.1007/BF00178581; Talaat AM, 1998, INFECT IMMUN, V66, P2938, DOI 10.1128/IAI.66.6.2938-2942.1998; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Tonjum T, 1998, J CLIN MICROBIOL, V36, P918; TRAVIS WD, 1985, ARCH PATHOL LAB MED, V109, P1109; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Webb SE, 1996, J CELL SCI, V109, P793; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.0.CO;2-3; Willett CE, 1997, DEV BIOL, V182, P331, DOI 10.1006/dbio.1996.8446	54	388	400	4	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					693	702		10.1016/S1074-7613(02)00475-2	http://dx.doi.org/10.1016/S1074-7613(02)00475-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479816	Bronze			2022-12-18	WOS:000179985500002
J	van Boxel-Dezaire, AHH; Rani, MRS; Stark, GR				van Boxel-Dezaire, Anette H. H.; Rani, M. R. Sandhya; Stark, George R.			Complex modulation of cell type-specific signaling in response to type I Interferons	IMMUNITY			English	Review							ACTIVATED PROTEIN-KINASE; IFN-ALPHA-BETA; NF-KAPPA-B; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; CUTTING EDGE; T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE	The type I interferons (IFNs) are plelotropic cytokines that regulate many different cellular functions. The major signaling pathway activated by type I IFNs involves sequential phosphorylation of the tyrosine residues of the Janus kinase (JAK) and signal transducers and activators of transcription (STAT) proteins, providing the primary mechanism through which gene expression is induced. Recent work has shown that the responses are quite complex, as shown by different responses to specific subtypes of type I IFN, activation of kinases in addition to JAKs, patterns of activation of all seven STATs in different cells, and activation of transcription factors other than STATs. The type I IFNs use this complexity to regulate many different biological functions in different types of cells, by activating different specific signals and patterns of gene expression.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stark, GR (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	starkg@ccf.org	van Boxel-Dezaire, Anette/A-9399-2011		NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA062220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Barca O, 2003, J NEUROIMMUNOL, V139, P155, DOI 10.1016/S0165-5728(03)00160-7; Basu L, 1998, VIROLOGY, V242, P14, DOI 10.1006/viro.1997.9002; Borden, 1998, Oncologist, V3, P198; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Burfoot MS, 1997, J BIOL CHEM, V272, P24183, DOI 10.1074/jbc.272.39.24183; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Choi EA, 2003, CANCER RES, V63, P5299; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; Cull VS, 2003, BLOOD, V101, P2727, DOI 10.1182/blood-2002-05-1521; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; da Silva AJ, 2002, J INTERF CYTOK RES, V22, P173, DOI 10.1089/107999002753536149; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Deonarain R, 2002, CURR PHARM DESIGN, V8, P2131, DOI 10.2174/1381612023393288; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Domanski P, 1998, J BIOL CHEM, V273, P3144, DOI 10.1074/jbc.273.6.3144; Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fasler-Kan E, 1998, EUR J BIOCHEM, V254, P514, DOI 10.1046/j.1432-1327.1998.2540514.x; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Foster GR, 1996, J INTERF CYTOK RES, V16, P1027, DOI 10.1089/jir.1996.16.1027; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gibbs VC, 1996, J BIOL CHEM, V271, P28710, DOI 10.1074/jbc.271.45.28710; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Gongora R, 2000, J IMMUNOL, V165, P2362, DOI 10.4049/jimmunol.165.5.2362; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Gupta S, 1999, J IMMUNOL, V163, P3834; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Ivashkiv LB, 2003, AUTOIMMUNITY, V36, P473, DOI 10.1080/08916930310001605882; Kalvakolanu DV, 2005, J INTERF CYTOK RES, V25, P757, DOI 10.1089/jir.2005.25.757; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Krishnan K, 1996, ONCOGENE, V13, P125; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lesinski GB, 2004, J IMMUNOL, V172, P7368, DOI 10.4049/jimmunol.172.12.7368; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Liang SJ, 2003, CYTOKINE, V23, P190, DOI 10.1016/S1043-4666(03)00226-6; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G; Matsumoto K, 2005, J GASTROENTEROL, V40, P722, DOI 10.1007/s00535-005-1616-x; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Meraro D, 2002, J IMMUNOL, V168, P6224, DOI 10.4049/jimmunol.168.12.6224; Molnarfi N, 2005, J IMMUNOL, V174, P2974, DOI 10.4049/jimmunol.174.5.2974; Navarro A, 2003, J LEUKOCYTE BIOL, V73, P540, DOI 10.1189/jlb.1002508; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; OVERALL ML, 1992, J INTERFERON RES, V12, P281, DOI 10.1089/jir.1992.12.281; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; PLATANIAS LC, 1994, J BIOL CHEM, V269, P3143; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; Platis D, 2003, J INTERF CYTOK RES, V23, P655, DOI 10.1089/107999003322558791; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Radaeva S, 2004, BIOCHEM J, V379, P199, DOI 10.1042/BJ20031495; Rani MRS, 1996, J BIOL CHEM, V271, P22878, DOI 10.1074/jbc.271.37.22878; Rani MRS, 2005, J INTERF CYTOK RES, V25, P788, DOI 10.1089/jir.2005.25.788; Rani MRS, 1999, J BIOL CHEM, V274, P1891, DOI 10.1074/jbc.274.4.1891; Rani MRS, 2002, J BIOL CHEM, V277, P38456, DOI 10.1074/jbc.M203204200; Rani MRS, 2001, J BIOL CHEM, V276, P44365, DOI 10.1074/jbc.C100417200; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Ruuth K, 2001, BIOCHEM BIOPH RES CO, V284, P583, DOI 10.1006/bbrc.2001.5025; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; Sakamoto S, 2004, J BIOL CHEM, V279, P3245, DOI 10.1074/jbc.M309631200; Sanceau J, 2000, ONCOGENE, V19, P3372, DOI 10.1038/sj.onc.1203670; Schlaak JF, 2002, J BIOL CHEM, V277, P49428, DOI 10.1074/jbc.M205571200; Shimoda K, 2002, J IMMUNOL, V169, P4707, DOI 10.4049/jimmunol.169.9.4707; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Tian ZG, 2000, J IMMUNOL, V165, P3959, DOI 10.4049/jimmunol.165.7.3959; Torpey N, 2004, J BIOL CHEM, V279, P26789, DOI 10.1074/jbc.M401517200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 1997, BLOOD, V90, P2574; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Van de Wiele CJ, 2004, J INTERF CYTOK RES, V24, P169, DOI 10.1089/jir.2004.24.169; Wagner TC, 2002, J BIOL CHEM, V277, P1493, DOI 10.1074/jbc.M108928200; Wang KQ, 2003, J IMMUNOL, V171, P1035, DOI 10.4049/jimmunol.171.2.1035; Wellbrock C, 2005, CURR BIOL, V15, P1629, DOI 10.1016/j.cub.2005.08.036; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wong LH, 1998, J IMMUNOL, V160, P5475; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang J, 2005, CANCER RES, V65, P939; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	121	384	393	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					361	372		10.1016/j.immuni.2006.08.014	http://dx.doi.org/10.1016/j.immuni.2006.08.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979568	Bronze			2022-12-18	WOS:000240862200003
J	FINCO, TS; BALDWIN, AS				FINCO, TS; BALDWIN, AS			MECHANISTIC ASPECTS OF NF-KAPPA-B REGULATION - THE EMERGING ROLE OF PHOSPHORYLATION AND PROTEOLYSIS	IMMUNITY			English	Review							DNA-BINDING SUBUNIT; HUMAN IMMUNODEFICIENCY VIRUS; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR; C-REL; NUCLEAR-LOCALIZATION; PRECURSOR P105; DORSOVENTRAL PATTERN; DORSAL PROTEIN; ALPHA	Members of the NF-kappa B transcription factor family serve as a prototypical model of inducible transcription factors. As discussed below, NF-kappa B activity is primarily regulated by a group of structurally related proteins collectively referred to as I kappa B (for recent reviews on NF-kappa B and I kappa B, see Beg and Baldwin, 1993; Gilmore and Morin, 1993; Siebenlist et al., 1994; Baeuerle and Henkel, 1994; Thanes and Maniatis, 1995). The NF-KB transcription factor family is an important component in a variety of biological processes, most notably inflammation and immune responses. The requirement for NF-kappa B in these processes is indicated by its ability to regulate genes whose products are critical for these cellular events. These products include cytokines, immunoreceptors, cell adhesion molecules, and acute phase proteins (Siebenlist et al., 1994; Baeuerle and Henkel, 1994). In addition, recent research has shown dramatically that mice containing targeted disruptions of NF-kappa B subunits are compromised in various aspects of immune function and inflammatory responses (Weih at al., 1995; Sha et al., 1995; Burkly et al., 1995; Kontgen et al., 1995; also see Thanes and Maniatis, 1995). A number of pathogenic viruses, including the human immunodeficiency virus, also subvert NF-KB activity for the expression of essential viral genes (Nabel and Baltimore, 1987; Siebenlist et al., 1994; Baeuerle and Henkel, 1994). Finally, genetic alterations in the structure or expression of genes encoding NF-kappa B and I kappa B family members can render these proteins oncogenic, demonstrating an intimate relationship between NF-kappa B function and normal cellular proliferation (Siebenlist et al., 1994; Baeuerle and Henkel, 1994). In this review, we discuss the mechanisms regulating NF-kappa B activity. A particular emphasis has been placed on recent studies, which more clearly define how various modifications to I kappa B, specifically inducible phosphorylation, ubiquitination, and proteasome-driven degradation, contribute to NF-kappa B activation.	UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	FINCO, TS (corresponding author), UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599, USA.							ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; ARENZANASEISDED.F, 1995, MOL CELL BIOL, V15, P2689; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; BULL P, 1989, MOL CELL BIOL, V9, P5239, DOI 10.1128/MCB.9.11.5239; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Clechanover A., 1994, CELL, V79, P13; COGSWELL PC, 1993, J IMMUNOL, V150, P2794; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; CRESSMAN DE, 1993, ONCOGENE, V8, P2567; CRESSMAN DE, 1994, J BIOL CHEM, V269, P26594; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DIEHL JA, 1995, J BIOL CHEM, V270, P2703, DOI 10.1074/jbc.270.6.2703; DONALD R, 1995, J BIOL CHEM, V270, P9, DOI 10.1074/jbc.270.1.9; DRUKER BJ, 1994, J BIOL CHEM, V269, P5387; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; HANNINK M, 1990, ONCOGENE, V5, P1843; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HATADA EN, 1993, EMBO J, V12, P2781, DOI 10.1002/j.1460-2075.1993.tb05939.x; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HOHMANN HP, 1991, MOL CELL BIOL, V11, P259, DOI 10.1128/MCB.11.1.259; INOUE JI, 1992, P NATL ACAD SCI USA, V89, P4333, DOI 10.1073/pnas.89.10.4333; Ip T.Y., 1993, CELL, V75, P753; IP YT, 1994, CURR OPIN GENET DEV, V4, P672, DOI 10.1016/0959-437X(94)90133-N; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KONTGEN F, 1995, IN PRESS GENES DEV; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LI CCH, 1994, BIOCHEM J, V303, P499, DOI 10.1042/bj3030499; LI CCH, 1994, J BIOL CHEM, V269, P30089; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; MACHLEIDT T, 1994, J BIOL CHEM, V269, P13760; MACKMAN N, 1994, J BIOL CHEM, V269, P26363; MELLITS KH, 1993, NUCLEIC ACIDS RES, V21, P5059, DOI 10.1093/nar/21.22.5059; MERCURIO F, 1992, DNA CELL BIOL, V12, P685; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; MIYAMOTO S, 1994, MOL CELL BIOL, V14, P3276, DOI 10.1128/MCB.14.5.3276; MIYAMOTO S, 1944, P NATL ACAD SCI USA, V91, P12740; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; NEUMANN M, 1992, ONCOGENE, V7, P2095; NOLAN GP, 1991, CELL, V60, P961; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHEINMAN RI, 1993, MOL CELL BIOL, V13, P6089, DOI 10.1128/MCB.13.10.6089; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P725; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; UEBERLA K, 1993, J ACQ IMMUN DEF SYND, V6, P227; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	100	384	400	0	22	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					263	272		10.1016/1074-7613(95)90112-4	http://dx.doi.org/10.1016/1074-7613(95)90112-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552992	Green Submitted, Bronze			2022-12-18	WOS:A1995RX64500002
J	Swallow, MM; Wallin, JJ; Sha, WC				Swallow, MM; Wallin, JJ; Sha, WC			B7h, a novel costimulatory homolog of b7.1 and b7.2, is induced by TNF alpha	IMMUNITY			English	Article							TUMOR NECROSIS FACTOR; NF-KAPPA-B; T-CELL PROLIFERATION; TRANSGENIC MICE; CD80 B7-1; ACTIVATION ANTIGEN; IMMUNE-RESPONSES; EXPRESSION; CD28; CTLA-4	In a screen to identify genes induced by NF-kappa B/Rel transcription factors, we cloned a novel gene, b7h, that is a close homolog of B7 costimulatory ligands expressed on antigen-presenting cells. B7h can costimulate proliferation of purified T cells through a receptor on T cells distinct from CD28 or CTLA-4. Surprisingly, although B7h is expressed in unstimulated B cells, its expression is induced in both 3T3 cells and embryonic fibroblasts treated with TNF alpha, and it is upregulated in nonlymphoid tissues of mice treated with LPS, a potent activator of TNF alpha. These data define a novel costimulatory ligand for T cells and suggest that induction of B7h by TNF alpha may function as a mechanism to directly augment recognition of self during inflammation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Canc Res Lab, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sha, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Canc Res Lab, Div Immunol, Berkeley, CA 94720 USA.			Wallin, Jeffrey/0000-0002-5952-3813	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42252] Funding Source: Medline; NIGMS NIH HHS [GM07232-22] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; FLERS W, 1993, TUMOR NECROSIS FACTO; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guerder S, 1998, J IMMUNOL, V161, P2128; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HAWLEY RG, 1994, GENE THER, V1, P136; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Imagawa A, 1996, J AUTOIMMUN, V9, P391, DOI 10.1006/jaut.1996.0053; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; KORNBLUTH RS, 1986, J IMMUNOL, V137, P2585; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; LANTZ LM, 1995, BIOTECHNIQUES, V18, P56; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; McAdam AJ, 1998, IMMUNOL REV, V165, P231; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NASIR A, 1994, J CLIN INVEST, V94, P892, DOI 10.1172/JCI117411; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pechhold K, 1997, J IMMUNOL, V158, P4921; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SIMON JC, 1994, J INVEST DERMATOL, V103, P539, DOI 10.1111/1523-1747.ep12395743; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WILLIAMS IR, 1994, P NATL ACAD SCI USA, V91, P12780, DOI 10.1073/pnas.91.26.12780; WINDHAGEN A, 1995, J EXP MED, V182, P1985, DOI 10.1084/jem.182.6.1985	49	383	455	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1999	11	4					423	432		10.1016/S1074-7613(00)80117-X	http://dx.doi.org/10.1016/S1074-7613(00)80117-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549624	Bronze			2022-12-18	WOS:000083343100004
J	Bruttger, J; Karram, K; Wortge, S; Regen, T; Marini, F; Hoppmann, N; Klein, M; Blank, T; Yona, S; Wolf, Y; Mack, M; Pinteaux, E; Muller, W; Zipp, F; Binder, H; Bopp, T; Prinz, M; Jung, S; Waisman, A				Bruttger, Julia; Karram, Khalad; Woertge, Simone; Regen, Tommy; Marini, Federico; Hoppmann, Nicola; Klein, Matthias; Blank, Thomas; Yona, Simon; Wolf, Yochai; Mack, Matthias; Pinteaux, Emmanuel; Mueller, Werner; Zipp, Frauke; Binder, Harald; Bopp, Tobias; Prinz, Marco; Jung, Steffen; Waisman, Ari			Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System	IMMUNITY			English	Article							MOUSE SPINAL-CORD; HEMATOPOIETIC-CELLS; RESIDENT MICROGLIA; LANGERHANS CELLS; I RECEPTOR; BRAIN; MONOCYTES; MAINTENANCE; MACROPHAGES; PROLIFERATION	During early embryogenesis, microglia arise from yolk sac progenitors that populate the developing central nervous system (CNS), but how the tissue-resident macrophages are maintained throughout the organism's lifespan still remains unclear. Here, we describe a system that allows specific, conditional ablation of microglia in adult mice. We found that the microglial compartment was reconstituted within 1 week of depletion. Microglia repopulation relied on CNS-resident cells, independent from bone-marrow-derived precursors. During repopulation, microglia formed clusters of highly proliferative cells that migrated apart once steady state was achieved. Proliferating microglia expressed high amounts of the interleukin-1 receptor (IL-1R), and treatment with an IL-1R antagonist during the repopulation phase impaired microglia proliferation. Hence, microglia have the potential for efficient self-renewal without the contribution of peripheral myeloid cells, and IL-1R signaling participates in this restorative proliferation process.	[Bruttger, Julia; Karram, Khalad; Woertge, Simone; Regen, Tommy; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany; [Marini, Federico; Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, D-55131 Mainz, Germany; [Hoppmann, Nicola; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, D-55131 Mainz, Germany; [Klein, Matthias; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55131 Mainz, Germany; [Blank, Thomas; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79098 Freiburg, Germany; [Blank, Thomas; Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79098 Freiburg, Germany; [Yona, Simon; Wolf, Yochai; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mack, Matthias] Univ Hosp, Dept Internal Med, D-93042 Regensburg, Germany; [Pinteaux, Emmanuel; Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Freiburg; University of Freiburg; Weizmann Institute of Science; University of Regensburg; University of Manchester	Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	waisman@uni-mainz.de	Bopp, Tobias/A-4328-2018; Marini, Federico/AAQ-2427-2020; Muller, Werner/B-9044-2008; Müller, W. E. G./AAR-8651-2020; Waisman, Ari/C-7383-2015; Jung, Steffen/K-1409-2012; Binder, Harald/C-7413-2009; Regen, Tommy/GQH-6929-2022; Yona, Simon/ABE-6572-2020; Zipp, Frauke/C-9968-2015	Bopp, Tobias/0000-0002-3232-8065; Marini, Federico/0000-0003-3252-7758; Muller, Werner/0000-0002-1297-9725; Müller, W. E. G./0000-0002-8223-3689; Waisman, Ari/0000-0003-4304-8234; Jung, Steffen/0000-0003-4290-5716; Binder, Harald/0000-0002-5666-8662; Yona, Simon/0000-0002-3984-2008; Pinteaux, Emmanuel/0000-0002-9986-4401; Regen, Tommy/0000-0002-7275-3330; Wolf, Yochai/0000-0003-0270-2025; Zipp, Frauke/0000-0002-1231-1928	Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR) [1336]; Gemeinnutzige Hertie-Stiftung; International Graduate School of Immunotherapy (GRK) [1043]; Sixth Research Framework Programme of the European Union [MUGEN LSHG-CT-2005-005203]; MRC research grant [G0801296]; Mechanisms of the Interleukin action in neuronal injury;  [SFB/TRR128 TP A07];  [TP B04]; MRC [G0801296] Funding Source: UKRI; Medical Research Council [G0801296] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR)(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; International Graduate School of Immunotherapy (GRK); Sixth Research Framework Programme of the European Union(European Commission); MRC research grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mechanisms of the Interleukin action in neuronal injury; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Michaela Blanfeld for her excellent technical assistance and help in the performance of experiments and Sabrina Klebow and Judith Hauptmann for support in performance and analysis of experiments. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Research Unit (FOR) 1336 to A.W., S.J., and M.P.; by the SFB/TRR128 TP A07 to A.W. and TP B04 to T. Bopp and F.Z.; by the Gemeinnutzige Hertie-Stiftung to A.W. and M.P.; and the International Graduate School of Immunotherapy (GRK) 1043 to A.W. The generation of the Il1r1<SUP>fl/fl</SUP> mice was funded by the Sixth Research Framework Programme of the European Union, Project MUGEN (MUGEN LSHG-CT-2005-005203) to W.M. and the 2009-2012 MRC research grant (G0801296), "Mechanisms of the Interleukin action in neuronal injury'' to Nancy Rothwell, E.P., and Stuart Allan.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akash MSH, 2013, PHARM RES-DORDR, V30, P2951, DOI 10.1007/s11095-013-1118-0; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Andre R, 2006, GLIA, V53, P477, DOI 10.1002/glia.20302; Basu A, 2002, J NEUROSCI, V22, P6071; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chauhan NB, 2001, J NEUROSCI RES, V66, P231, DOI 10.1002/jnr.1215; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Labow M, 1997, J IMMUNOL, V159, P2452; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	46	382	384	5	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					92	106		10.1016/j.immuni.2015.06.012	http://dx.doi.org/10.1016/j.immuni.2015.06.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26163371	Bronze			2022-12-18	WOS:000360101100013
J	Hayday, AC				Hayday, Adrian C.			gamma delta T Cells and the Lymphoid Stress-Surveillance Response	IMMUNITY			English	Review							ALPHA-BETA; NK CELLS; IMMUNE-RESPONSE; NATURAL-KILLER; IN-VIVO; INTRAEPITHELIAL LYMPHOCYTES; INTRACELLULAR SEQUESTRATION; NKG2D LIGANDS; IFN-GAMMA; RECEPTOR	The investigation of gamma delta T cells has identified a rapid lymphoid stress-surveillance response to microbial and nonmicrobial tissue perturbation. In addition to providing local protection, this response provides an immediate source of cytokines, chemokines, and other functions that can substantially affect downstream, adaptive immunity. Recent studies have identified striking mechanisms by which gamma delta cells meet the requirements of stress surveillance. For example, high response frequencies can reflect a unique nature of antigen engagement by the T cell receptor (TCR), developmental focusing of the repertoire by selection events, or the use of nonclonotypic receptors to initiate responses. Likewise, rapid functional deployment can be facilitated by the preprogramming of gamma delta cells during development. Additionally, gamma delta cells can directly influence adaptive immunity by functioning as antigen-presenting cells. With lymphoid stress surveillance likely to underpin numerous aspects of inflammation, tumor immunology, infectious disease, and autoimmunity, this perspective considers its properties and its emerging potential for clinical manipulation.	[Hayday, Adrian C.] Canc Res UK, London Res Inst, London WC2A 3PX, England; [Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Hayday, Adrian C.] Kings Hlth Partners Guys Hosp, Biomed Res Ctr, London SE1 9RT, England	Cancer Research UK; University of London; King's College London; King's Health Partners	Hayday, AC (corresponding author), Canc Res UK, London Res Inst, London WC2A 3PX, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust; CRUK; MRC; NIHR; MRC [G0601387] Funding Source: UKRI; Medical Research Council [G0601387] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	I acknowledge the Wellcome Trust, CRUK, the MRC, and the NIHR for support and thank members of the laboratory and many colleagues and collaborators whose thoughts have helped distil this perspective.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Arapovic J, 2009, J VIROL, V83, P8198, DOI 10.1128/JVI.02549-08; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beetz S, 2007, IMMUNOL RES, V37, P97, DOI 10.1007/BF02685893; Born W, 1999, Adv Immunol, V71, P77; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; CALDWELL CW, 1995, AM J CLIN PATHOL, V103, P761; Cameron AL, 2002, ARCH DERMATOL RES, V294, P363, DOI 10.1007/s00403-002-0349-4; Campbell JA, 2007, J EXP MED, V204, P1311, DOI 10.1084/jem.20062026; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Collins RA, 1998, J LEUKOCYTE BIOL, V63, P707, DOI 10.1002/jlb.63.6.707; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; EDELBAUM D, 1995, J INVEST DERMATOL, V105, P837, DOI 10.1111/1523-1747.ep12326630; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FU YX, 1994, J IMMUNOL, V153, P3101; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gertner-Dardenne J, 2009, BLOOD, V113, P4875, DOI 10.1182/blood-2008-08-172296; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Gougeon ML, 2002, VACCINE, V20, P1938, DOI 10.1016/S0264-410X(02)00070-1; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hampl J, 1999, J IMMUNOL, V163, P288; Hayday A, 1997, CURR OPIN IMMUNOL, V9, P884, DOI 10.1016/S0952-7915(97)80193-8; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hogg AE, 2009, VACCINE, V27, P270, DOI 10.1016/j.vaccine.2008.10.053; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; King DP, 1999, J IMMUNOL, V162, P5033; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Leggat JA, 2008, J ALLERGY CLIN IMMUN, V122, P1014, DOI 10.1016/j.jaci.2008.08.011; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lopez-Vazquez A, 2002, GUT, V50, P336, DOI 10.1136/gut.50.3.336; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miyagawa F, 2001, J IMMUNOL, V166, P5508, DOI 10.4049/jimmunol.166.9.5508; Monkkonen H, 2007, LIFE SCI, V81, P1066, DOI 10.1016/j.lfs.2007.08.007; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PFEFFER K, 1990, EUR J IMMUNOL, V20, P1175, DOI 10.1002/eji.1830200534; Poccia F, 1997, J LEUKOCYTE BIOL, V62, P287, DOI 10.1002/jlb.62.3.287; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; REGAN GM, 2008, J ALLERGY CLIN IMMUN, V122, P689; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; Siegers GM, 2007, J EXP MED, V204, P2537, DOI 10.1084/jem.20070782; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Den Broeck T, 2008, BLOOD, V112, P5046, DOI 10.1182/blood-2008-06-164350; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; WITHERDEN DA, 2009, J IMMUNOL, V182, P135; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yang X, 1998, IMMUNOLOGY, V94, P469; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198	130	382	395	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					184	196		10.1016/j.immuni.2009.08.006	http://dx.doi.org/10.1016/j.immuni.2009.08.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699170	Bronze			2022-12-18	WOS:000269338600006
J	Villarino, A; Hibbert, L; Lieberman, L; Wilson, E; Mak, T; Yoshida, H; Kastelein, RA; Saris, C; Hunter, CA				Villarino, A; Hibbert, L; Lieberman, L; Wilson, E; Mak, T; Yoshida, H; Kastelein, RA; Saris, C; Hunter, CA			The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection	IMMUNITY			English	Article							INTERFERON-GAMMA; TOXOPLASMA-GONDII; IFN-GAMMA; INDEPENDENT MECHANISMS; RESISTANCE; INTERLEUKIN-12; CYTOKINE; MICE; BET; RESPONSES	Although recent studies have described IL-27 and its receptor, WSX-1, as promoters of Th1 differentiation in naive CD4(+) T cells, the data presented here indicate that signaling through this receptor is involved in limiting the intensity and duration of T cell activity. When WSX-1-deficient mice are infected with the intracellular pathogen Toxoplasma gondii, they establish protective T cell responses, characterized by production of inflammatory cytokines and control of parasite replication. However, infected INSX-1(-/-) mice are unable to downregulate these protective responses, and develop a lethal, T cell-mediated inflammatory disease. This pathology was characterized by the excessive production of IFN-gamma, persistence of highly activated T cells, and enhanced T cell proliferation in vivo. Together, these findings demonstrate that WSX-1 is not required for the generation of IFN-gamma-mediated immunity to this parasitic infection and identify a novel function for this receptor as a potent antagonist of T cell-mediated, immune hyperactivity.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	University of Pennsylvania; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Japan Science & Technology Agency (JST); Kyushu University; Amgen; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.	chunter@phl.vet.upenn.edu	Villarino, Alejandro/AAE-3517-2020; Hunter, Christopher/H-1970-2011	Villarino, Alejandro/0000-0001-8068-2176; 	PHS HHS [41158] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Cai GF, 2000, J IMMUNOL, V165, P2619, DOI 10.4049/jimmunol.165.5.2619; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dalton DK, 2000, J EXP MED, V192, P117, DOI 10.1084/jem.192.1.117; de Jong R, 1998, SCIENCE, V280, P1435; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Doyle AM, 2001, J EXP MED, V194, P893, DOI 10.1084/jem.194.7.893; Ely KH, 1999, J IMMUNOL, V162, P5449; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hunter CA, 1997, J IMMUNOL, V158, P3311; Lee CK, 2000, J IMMUNOL, V164, P1286, DOI 10.4049/jimmunol.164.3.1286; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Neyer LE, 1997, INFECT IMMUN, V65, P1675, DOI 10.1128/IAI.65.5.1675-1682.1997; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	44	382	404	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2003	19	5					645	655		10.1016/S1074-7613(03)00300-5	http://dx.doi.org/10.1016/S1074-7613(03)00300-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614852	Bronze			2022-12-18	WOS:000186672200005
J	Peters, A; Storb, U				Peters, A; Storb, U			Somatic hypermutation of immunoglobulin genes is linked to transcription initiation	IMMUNITY			English	Article							VARIABLE-REGION GENES; TRANSGENIC MICE; MESSENGER-RNA; ANTIPHOSPHORYLCHOLINE ANTIBODIES; POINT MUTATIONS; GLOBIN GENE; KAPPA; DNA; PROMOTER; MU	To identify DNA sequences that target the somatic hypermutation process, the immunoglobulin gene promoter located upstream of the variable (V region was duplicated upstream of the constant (C) region of a kappa transgene. Normally, kappa genes are somatically mutated only in the VJ region, but not in the C region. In B cell hybridomas from mice with this kappa transgene (P5'C), both the VJ region and the C region, but not the region between them, were mutated at similar frequencies, suggesting that the mutation mechanism is related to transcription. The downstream promoter was not occluded by transcripts from the upstream promoter. In fact, the levels of transcripts originating from the two promoters were similar, supporting a mutation model based on initiation of transcripts. Several ''hotspots'' of somatic mutation were noted, further demonstrating that this transgene has the hallmarks of somatic mutation of endogenous immunoglobulin genes. A model linking somatic mutation to transcription-coupled DNA repair is proposed.	UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637	University of Chicago	Peters, A (corresponding author), UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637, USA.				NIGMS NIH HHS [GM07183, GM38649] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038649] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; CHIEN NC, 1988, J EXP MED, V167, P954, DOI 10.1084/jem.167.3.954; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; DOGLIO L, 1994, DEV IMMUNOL, V4, P1; EDENBERG H, 1972, BIOCHIM BIOPHYS ACTA, V272, P361, DOI 10.1016/0005-2787(72)90389-9; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; FRIEDBERG E, 1996, IN PRESS ANN REV BIO; Gearhart P. J., 1991, Somatic hypermutation in V-regions., P29; GEARHART PJ, 1983, P NATL ACAD SCI-BIOL, V80, P3439, DOI 10.1073/pnas.80.11.3439; GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797; HACKETT J, 1990, J EXP MED, V172, P131, DOI 10.1084/jem.172.1.131; HACKETT J, 1992, J EXP MED, V176, P225, DOI 10.1084/jem.176.1.225; HAMLYN PH, 1981, NUCLEIC ACIDS RES, V9, P4485, DOI 10.1093/nar/9.18.4485; HANAWALT PC, 1995, MUTAT RES-DNA REPAIR, V336, P101, DOI 10.1016/0921-8777(94)00061-A; HANAWALT PC, 1994, SCIENCE, V266, P1967; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; Kornberg A., 1992, DNA REPLICATION; KWOK S, 1994, PCR METH APPL, V3, pS39; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Maniatis T., 1984, MOL CLONING; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Moore DD, 1995, GLOB MOB SURV; MOTOYAMA N, 1991, P NATL ACAD SCI USA, V88, P7933, DOI 10.1073/pnas.88.18.7933; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; OBRIEN RL, 1987, NATURE, V326, P405, DOI 10.1038/326405a0; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; RADA C, 1994, EUR J IMMUNOL, V24, P1453, DOI 10.1002/eji.1830240632; ROGERSON B, 1991, EMBO J, V10, P4331, DOI 10.1002/j.1460-2075.1991.tb05011.x; ROGERSON BJ, 1994, MOL IMMUNOL, V31, P83, DOI 10.1016/0161-5890(94)90081-7; RUDIN CM, 1992, MOL CELL BIOL, V12, P309, DOI 10.1128/MCB.12.1.309; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0; SHUTT D, 1993, THESIS U CHICAGO CHI; SIEDE W, 1995, DNA REPAIR MUTAGENES; SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493; STEELE EJ, 1987, MOL IMMUNOL, V24, P667, DOI 10.1016/0161-5890(87)90049-6; STORB U, 1987, ANNU REV IMMUNOL, V5, P151, DOI 10.1146/annurev.iy.05.040187.001055; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; STORB U, 1996, IN PRESS CURR OPIN I, P8; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579; WEBER JS, 1991, J IMMUNOL, V146, P3218; WEBER JS, 1991, J IMMUNOL, V146, P3652; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; YELAMOS J, 1995, NATURE, V376, P225; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	59	382	384	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					57	65		10.1016/S1074-7613(00)80298-8	http://dx.doi.org/10.1016/S1074-7613(00)80298-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574852	Bronze			2022-12-18	WOS:A1996TT31900006
J	Greter, M; Lelios, I; Pelczar, P; Hoeffel, G; Price, J; Leboeuf, M; Kundig, TM; Frei, K; Ginhoux, F; Merad, M; Becher, B				Greter, Melanie; Lelios, Iva; Pelczar, Pawel; Hoeffel, Guillaume; Price, Jeremy; Leboeuf, Marylene; Kuendig, Thomas M.; Frei, Karl; Ginhoux, Florent; Merad, Miriam; Becher, Burkhard			Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR-1; DELTA T-CELLS; C-FMS; RECEPTOR; IL-34; SKIN; MONOCYTES; TISSUE; CSF-1; MACROPHAGES	Colony stimulating factor-1 (Csf-1) receptor and its ligand Csf-1 control macrophage development, maintenance, and function. The development of both Langerhans cells (LCs) and microglia is highly dependent on Csf-1 receptor signaling but independent of Csf-1. Here we show that in both mice and humans, interleukin-34 (IL-34), an alternative ligand for Csf-1 receptor, is produced by keratinocytes in the epidermis and by neurons in the brain. Mice lacking IL-34 displayed a marked reduction of LCs and a decrease of microglia, whereas monocytes, dermal, and lymphoid tissue macrophages and DCs were unaffected. We identified IL-34 as a nonredundant cytokine for the development of LCs during embryogenesis as well as for their homeostasis in the adult skin. Whereas inflammation-induced repopulation of LCs appears to be dependent on Csf-1, once inflammation is resolved, LC survival is again IL-34-dependent. In contrast, microglia and their yolk sac precursors develop independently of IL-34 but rely on it for their maintenance in the adult brain.	[Greter, Melanie; Lelios, Iva; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8006 Zurich, Switzerland; [Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, CH-8006 Zurich, Switzerland; [Hoeffel, Guillaume; Ginhoux, Florent] BIOPOLIS, Agcy Sci Technol & Res ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Price, Jeremy; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Price, Jeremy; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Kuendig, Thomas M.] Univ Zurich Hosp, Clin Tumor Biol & Immunotherapy Unit, CH-8091 Zurich, Switzerland; [Frei, Karl] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8006 Zurich, Switzerland.	greter@immunology.uzh.ch; miriam.merad@mssm.edu	Becher, Burkhard/ABE-4225-2020; Hoeffel, Guillaume/ABG-4881-2021; Price, Jeremy G/G-1612-2013	Becher, Burkhard/0000-0002-1541-7867; Hoeffel, Guillaume/0000-0002-2534-4972; Price, Jeremy G/0000-0003-0491-3176; Greter, Melanie/0000-0002-7220-5369	Swiss National Science Foundation; European Union [279017]; NIH [CA112100, HL086899, A1080884]; Forschung-skredit of the University of Zurich; Singapore Immunology Network core grant; NATIONAL CANCER INSTITUTE [R01CA112100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884, U01AI095611] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forschung-skredit of the University of Zurich; Singapore Immunology Network core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.B. is supported by the Swiss National Science Foundation and the European Union FP7 project Target Brain (279017). M.M. is supported by NIH grants CA112100, HL086899, and A1080884. M.G. is supported by the Forschung-skredit of the University of Zurich. F.G. is supported by the Singapore Immunology Network core grant. We also acknowledge the Neuroscience Center Zurich, University of Zurich, and ETH Zurich, Switzerland. We thank Andrew L. Croxford for critical reading of the manuscript.	Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Sudo T, 1995, ONCOGENE, V11, P2469; Taveirne S, 2011, J LEUKOCYTE BIOL, V90, P61, DOI 10.1189/jlb.1010581; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828	28	380	390	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1050	1060		10.1016/j.immuni.2012.11.001	http://dx.doi.org/10.1016/j.immuni.2012.11.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23177320	Green Accepted, Bronze			2022-12-18	WOS:000312575000013
J	Gutierrez-Vazquez, C; Quintana, FJ				Gutierrez-Vazquez, Cristina; Quintana, Francisco J.			Regulation of the Immune Response by the Aryl Hydrocarbon Receptor	IMMUNITY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEAT-SHOCK-PROTEIN; INNATE LYMPHOID-CELLS; BREAST-CANCER CELLS; T-HELPER-CELLS; HALOGENATED AROMATIC-HYDROCARBONS; CENTRAL-NERVOUS-SYSTEM; FACTOR C-MAF; AH RECEPTOR; DENDRITIC CELLS	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is activated by small molecules provided by the diet, microorganisms, metabolism, and pollutants. AhR is expressed by a number of immune cells, and thus AhR signaling provides a molecular pathway that integrates the effects of the environment and metabolism on the immune response. Studies have shown that AhR signaling plays important roles in the immune system in health and disease. As its activity is regulated by small molecules, AhR also constitutes a potential target for therapeutic immunomodulation. In this review we discuss the role of AhR in the regulation of the immune response in the context of autoimmunity, infection, and cancer, as well as the potential opportunities and challenges of developing AhR-targeted therapeutics.	[Gutierrez-Vazquez, Cristina; Quintana, Francisco J.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Quintana, Francisco J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Quintana, FJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Quintana, FJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		NIH [NS087867, ES025530, AI126880, AI093903]; National MS Society [RG4111A1, JF2161A-5]; American Cancer Society [RSG-14-198-01-LIB]; International Progressive MS Alliance [PA-1604-08459]; Alfonso Martin Escudero Foundation postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075285, R01AI126880, R01AI093903, R00AI075285, R56AI093903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society(National Multiple Sclerosis Society); American Cancer Society(American Cancer Society); International Progressive MS Alliance; Alfonso Martin Escudero Foundation postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all members of the Quintana laboratory for helpful discussions. F.J.Q. acknowledges support by the NIH (NS087867, ES025530, AI126880, and AI093903), the National MS Society (RG4111A1 and JF2161A-5), the American Cancer Society (RSG-14-198-01-LIB), and the International Progressive MS Alliance (PA-1604-08459). C.G.-V. is supported by an Alfonso Martin Escudero Foundation postdoctoral fellowship.	Adachi J, 2001, J BIOL CHEM, V276, P31475, DOI 10.1074/jbc.C100238200; Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Bankoti J, 2010, TOXICOL APPL PHARM, V246, P18, DOI 10.1016/j.taap.2010.03.013; Bankoti J, 2010, TOXICOL SCI, V115, P422, DOI 10.1093/toxsci/kfq063; Barroso A, 2016, INFECT IMMUN, V84, P3071, DOI 10.1128/IAI.00575-16; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Bergander LV, 2012, MOL ENDOCRINOL, V26, P1542, DOI 10.1210/me.2011-1351; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bittinger MA, 2003, MOL PHARMACOL, V64, P550, DOI 10.1124/mol.64.3.550; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Campbell SJ, 2005, J BIOL CHEM, V280, P5828, DOI 10.1074/jbc.M412899200; Capdevila JH, 2002, CELL MOL LIFE SCI, V59, P780, DOI 10.1007/s00018-002-8466-y; Carver LA, 1997, J BIOL CHEM, V272, P11452; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Chinen I, 2015, INT IMMUNOL, V27, P405, DOI 10.1093/intimm/dxv015; Chng SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23820; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dant TA, 2017, BLOOD, V130, P348, DOI 10.1182/blood-2016-08-734244; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Degner SC, 2009, J NUTR, V139, P26, DOI 10.3945/jn.108.099259; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Diani-Moore S, 2011, CHEM-BIOL INTERACT, V193, P119, DOI 10.1016/j.cbi.2011.05.010; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; DURRIN LK, 1987, J CELL BIOCHEM, V35, P153, DOI 10.1002/jcb.240350208; Ettmayer P, 2006, AM J RESP CRIT CARE, V173, P599, DOI 10.1164/rccm.200503-468OC; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Furman DP, 2009, COMPUT BIOL CHEM, V33, P465, DOI 10.1016/j.compbiolchem.2009.10.004; Gabriely G, 2017, TRENDS ENDOCRIN MET, V28, P428, DOI 10.1016/j.tem.2017.02.009; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Garcia GR, 2017, MOL PHARMACOL, V91, P609, DOI 10.1124/mol.117.108233; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Goldstone HMH, 2012, ZEBRAFISH, V9, P15, DOI 10.1089/zeb.2011.0722; Gordon MW, 2015, MOL CARCINOGEN, V54, P1060, DOI 10.1002/mc.22175; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Han Z, 2008, CARDIOVASC RES, V77, P809, DOI 10.1093/cvr/cvm095; Hanieh H, 2013, EUR J IMMUNOL, V43, P2771, DOI 10.1002/eji.201343486; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang Z, 2013, MOL IMMUNOL, V53, P335, DOI 10.1016/j.molimm.2012.09.007; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Ikuta T, 2004, BIOCHEM BIOPH RES CO, V317, P545, DOI 10.1016/j.bbrc.2004.03.076; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Ikuta T, 2000, J BIOCHEM, V127, P503, DOI 10.1093/oxfordjournals.jbchem.a022633; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin GB, 2014, EUR J IMMUNOL, V44, P1685, DOI 10.1002/eji.201343980; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Jin UH, 2015, CHEM RES TOXICOL, V28, P907, DOI 10.1021/tx5005198; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kadow S, 2011, J IMMUNOL, V187, P3104, DOI 10.4049/jimmunol.1100912; KAPITULNIK J, 1993, MOL PHARMACOL, V43, P722; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2002, TOXICOL APPL PHARM, V185, P146, DOI 10.1006/taap.2002.9537; KERKVLIET NI, 1990, FUND APPL TOXICOL, V14, P532, DOI 10.1016/0272-0590(90)90257-K; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lawrence BP, 2008, BLOOD, V112, P1158, DOI 10.1182/blood-2007-08-109645; Lawrence BP, 2006, J IMMUNOL, V177, P5819, DOI 10.4049/jimmunol.177.9.5819; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lees MJ, 2003, J BIOL CHEM, V278, P35878, DOI 10.1074/jbc.M302430200; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3; Litzenburger UM, 2014, ONCOTARGET, V5, P1038, DOI 10.18632/oncotarget.1637; Liu YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15207; Longhi MS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92791; LOUB WD, 1975, J NATL CANCER I, V54, P985; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Marshall NB, 2008, J IMMUNOL, V181, P2382, DOI 10.4049/jimmunol.181.4.2382; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Metz R, 2012, ONCOIMMUNOLOGY, V1, P1460, DOI 10.4161/onci.21716; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Morales-Hernandez A, 2016, NUCLEIC ACIDS RES, V44, P4665, DOI 10.1093/nar/gkw095; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Murray IA, 2005, ARCH BIOCHEM BIOPHYS, V442, P59, DOI 10.1016/j.abb.2005.07.014; Murray IA, 2010, MOL PHARMACOL, V77, P247, DOI 10.1124/mol.109.061788; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nugent LF, 2013, INVEST OPHTH VIS SCI, V54, P7463, DOI 10.1167/iovs.12-11479; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ociepa-Zawal M, 2007, ACTA BIOCHIM POL, V54, P113, DOI 10.18388/abp.2007_3276; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okudaira N, 2010, P NATL ACAD SCI USA, V107, P18487, DOI 10.1073/pnas.1001252107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Peng TL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-27; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2015, CELL DEATH DIFFER, V22, P215, DOI 10.1038/cdd.2014.125; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2017, NAT IMMUNOL, V18, P8, DOI 10.1038/ni.3637; Quintana FJ, 2014, CELL RES, V24, P1155, DOI 10.1038/cr.2014.96; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Rouse M, 2013, BRIT J PHARMACOL, V169, P1305, DOI 10.1111/bph.12205; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Sanchez Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/505694; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Singh NP, 2016, J IMMUNOL, V196, P1108, DOI 10.4049/jimmunol.1501727; Singh NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023522; Smirnova A, 2016, CHEM RES TOXICOL, V29, P75, DOI 10.1021/acs.chemrestox.5b00416; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stanford EA, 2016, MOL CANCER RES, V14, P696, DOI 10.1158/1541-7786.MCR-16-0069; Stockinger B, 2009, EUR J IMMUNOL, V39, P652, DOI 10.1002/eji.200839134; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takenaka MC, 2017, SEMIN IMMUNOPATHOL, V39, P113, DOI 10.1007/s00281-016-0587-8; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Thatcher TH, 2016, IMMUNOLOGY, V147, P41, DOI 10.1111/imm.12540; Thordardottir S, 2014, STEM CELLS DEV, V23, P955, DOI 10.1089/scd.2013.0521; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tsuji N, 2014, FEBS OPEN BIO, V4, P796, DOI 10.1016/j.fob.2014.09.003; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vogel CFA, 2007, AM J PATHOL, V171, P1538, DOI 10.2353/ajpath.2007.070406; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Vorderstrasse BA, 2006, INFECT IMMUN, V74, P5679, DOI 10.1128/IAI.00837-06; Wang K, 2013, CANCER LETT, V340, P63, DOI 10.1016/j.canlet.2013.06.026; Wang S, 2002, J BIOL CHEM, V277, P11821, DOI 10.1074/jbc.M110122200; Warren TK, 2000, TOXICOL SCI, V56, P114, DOI 10.1093/toxsci/56.1.114; Weems JM, 2010, CHEM RES TOXICOL, V23, P696, DOI 10.1021/tx9004506; Whiteside TL, 2014, EXPERT OPIN BIOL TH, V14, P1411, DOI 10.1517/14712598.2014.927432; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Winans B, 2015, J IMMUNOL, V194, P4446, DOI 10.4049/jimmunol.1402044; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023618; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XH, 2008, J CELL BIOCHEM, V104, P402, DOI 10.1002/jcb.21630; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Yosef N, 2016, SCIENCE, V354, P64, DOI 10.1126/science.aaf5453; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	223	378	388	13	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					19	33		10.1016/j.immuni.2017.12.012	http://dx.doi.org/10.1016/j.immuni.2017.12.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343438	Bronze, Green Accepted			2022-12-18	WOS:000422751600008
J	Okoye, IS; Coomes, SM; Pelly, VS; Czieso, S; Papayannopoulos, V; Tolmachova, T; Seabra, MC; Wilson, MS				Okoye, Isobel S.; Coomes, Stephanie M.; Pelly, Victoria S.; Czieso, Stephanie; Papayannopoulos, Venizelos; Tolmachova, Tanya; Seabra, Miguel C.; Wilson, Mark S.			MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells	IMMUNITY			English	Article							IFN-GAMMA; IN-VITRO; RNA; DIFFERENTIATION; MECHANISMS; VESICLES; RELEASE; INTERFERENCE; CONTRIBUTES; EXPRESSION	Foxp3(+) T regulatory (Treg) cells prevent inflammatory disease but the mechanistic basis of suppression is not understood completely. Gene silencing by RNA interference can act in a cell-autonomous and non-cell-autonomous manner, providing mechanisms of intercellular regulation. Here, we demonstrate that non-cell-autonomous gene silencing, mediated by miRNA-containing exosomes, is a mechanism employed by Treg cells to suppress T-cell-mediated disease. Treg cells transferred microRNAs (miRNA) to various immune cells, including T helper 1 (Th1) cells, suppressing Th1 cell proliferation and cytokine secretion. Use of Dicer-deficient or Rab27a and Rab27b double-deficient Treg cells to disrupt miRNA biogenesis or the exosomal pathway, respectively, established a requirement for miRNAs and exosomes for Treg-cell-mediated suppression. Transcriptional analysis and miRNA inhibitor studies showed that exosome-mediated transfer of Let-7d from Treg cell to Th1 cells contributed to suppression and prevention of systemic disease. These studies reveal a mechanism of Treg-cell-mediated suppression mediated by miRNA-containing exosomes.	[Okoye, Isobel S.; Coomes, Stephanie M.; Pelly, Victoria S.; Czieso, Stephanie; Papayannopoulos, Venizelos; Wilson, Mark S.] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Tolmachova, Tanya; Seabra, Miguel C.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England	MRC National Institute for Medical Research; Imperial College London	Wilson, MS (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England.	mwilson@nimr.mrc.ac.uk	Seabra, Miguel C/M-3280-2013; Seabra, Miguel/AAC-3099-2019	Seabra, Miguel C/0000-0002-6404-4892; Tolmachova, Tanya/0000-0002-8841-0797; Pelly, Victoria S/0000-0001-7323-4105; Papayannopoulos, Venizelos/0000-0002-3741-8190	Medical Research Council (MRC) [MC_UP_A253_1028]; MRC [MC_UP_A253_1028] Funding Source: UKRI; Medical Research Council [MC_UP_A253_1028] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. O'Garra, V. Tybulewicz, B. Stockinger, and G. Kassiotis for critically reading the manuscript; to D. Anastasiou for help with hypoxia experiments; to A. Sessay, H. Jani, and L. Bhaw-Rosun in the Systems biology department for help with microarray experiments; to R. Mahmood and R. Anand for help with histology; to S. Kelada, Chapel Hill, UNC, for help with microarray analysis; to A. Potocnik for R26<SUP>eFP635</SUP> mice; to G. Preece, W. Turnbull, and Bhavik Patel for assistance with flow cytometry-related work; to T. Norton, K. Williams, A. Adekoya, and B2, Dunkin, and building C staff for animal husbandry; and to J. Perez-Lloret for assistance with experiments. This work was supported by the Medical Research Council (MRC File Reference number MC_UP_A253_1028).	Alonso MA, 2001, J CELL SCI, V114, P3957; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bolasco G, 2011, AM J PHYSIOL-CELL PH, V300, pC466, DOI 10.1152/ajpcell.00446.2010; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brewer JA, 2003, NAT MED, V9, P1318, DOI 10.1038/nm895; Bryniarski K, 2013, J ALLERGY CLIN IMMUN, V132, P170, DOI 10.1016/j.jaci.2013.04.048; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Clark LB, 1999, J IMMUNOL, V162, P2546; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Druz A, 2011, BIOTECHNOL BIOENG, V108, P1651, DOI 10.1002/bit.23092; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iniguez MA, 1999, J IMMUNOL, V163, P111; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kue CS, 2013, IMMUNOBIOLOGY, V218, P952, DOI 10.1016/j.imbio.2012.11.003; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Muthian G, 2006, J CLIN IMMUNOL, V26, P73, DOI 10.1007/s10875-006-8787-y; Ni J, 2007, J NEUROIMMUNOL, V186, P94, DOI 10.1016/j.jneuroim.2007.03.012; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Paiotti APR, 2012, J MOL HISTOL, V43, P307, DOI 10.1007/s10735-012-9400-8; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sarkies P, 2013, SCIENCE, V341, P467, DOI 10.1126/science.1243175; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Yang XY, 2012, PHARMAZIE, V67, P645, DOI 10.1691/ph.2012.1704; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Zrieki A, 2010, EUR J PHARMACOL, V636, P189, DOI 10.1016/j.ejphar.2010.03.039	56	378	401	6	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					89	103		10.1016/j.immuni.2014.05.019	http://dx.doi.org/10.1016/j.immuni.2014.05.019			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	28903020	Green Published, hybrid			2022-12-18	WOS:000341444200013
J	Hazenbos, WLW; Gessner, JE; Hofhuis, FMA; Kuipers, H; Meyer, D; Heijnen, IAFM; Schmidt, RE; Sandor, M; Capel, PJA; Daeron, M; vandeWinkel, JGJ; Verbeek, JS				Hazenbos, WLW; Gessner, JE; Hofhuis, FMA; Kuipers, H; Meyer, D; Heijnen, IAFM; Schmidt, RE; Sandor, M; Capel, PJA; Daeron, M; vandeWinkel, JGJ; Verbeek, JS			Impaired IgG-dependent anaphylaxis and arthus reaction in Fc gamma RIII (CD16) deficient mice	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; MAST-CELLS; RECEPTOR; CHAIN; ASSOCIATION; EXPRESSION; ACTIVATION; POPULATION; MACROPHAGE; SUBUNIT	The family of receptors for IgG (Fc gamma R) plays an essential role in antibody-mediated effector functions of the immune system. However, the specific contribution of each of the Fc gamma R classes to in vivo immune reactions is still unclear. Here, we demonstrate that mice deficient for the ligand-binding a chain of Fc gamma RIII lack NK cell-mediated antibody-dependent cytotoxicity and phagocytosis of IgG1-coated particles by macrophages. Strikingly, these mice lack IgG-mediated mast cell degranulation, are resistant to IgG-dependent passive cutaneous anaphylaxis, and exhibit an impaired Arthus reaction. These results indicate a prominent role for Fc gamma RIII in inflammatory and anaphylactic responses, making this receptor a potential target in immunotherapy.	INST CURIE,INSERM U255,LAB IMMUNOL CELLULAIRE & CLIN,F-75005 PARIS,FRANCE; HANNOVER MED SCH,DEPT CLIN IMMUNOL,D-30625 HANNOVER,GERMANY; UNIV WISCONSIN,PATHOL & LAB MED,MADISON,WI 53706	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Hannover Medical School; University of Wisconsin System; University of Wisconsin Madison	Hazenbos, WLW (corresponding author), UNIV UTRECHT HOSP,DEPT IMMUNOL,POB 85500,NL-3508 GA UTRECHT,NETHERLANDS.							BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Coffman R L, 1982, Immunol Rev, V69, P5; COLTEN HR, 1994, NATURE, V371, P474, DOI 10.1038/371474a0; DAERON M, 1992, J IMMUNOL, V149, P1365; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1993, INT IMMUNOL, V5, P1393, DOI 10.1093/intimm/5.11.1393; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; JONES SL, 1996, HUMAN IGG FC RECEPTO, P149; KUZIEL WA, 1991, EUR J IMMUNOL, V21, P1563, DOI 10.1002/eji.1830210635; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; MASON L, 1988, J IMMUNOL, V140, P4403; MORTON HC, 1995, J BIOL CHEM, V270, P29781; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; OVARY Z, 1963, J EXP MED, V117, P951, DOI 10.1084/jem.117.6.951; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; van de Winkel JG, 1996, HUMAN IGG FC RECEPTO; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; VANDIJK H, 1980, J IMMUNOL METHODS, V39, P257; VAZ NM, 1969, PROG ALLERGY, V13, P111, DOI 10.1159/000287497; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; WERSHIL BK, 1987, J IMMUNOL, V139, P2605	32	378	398	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					181	188		10.1016/S1074-7613(00)80494-X	http://dx.doi.org/10.1016/S1074-7613(00)80494-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769481	Bronze			2022-12-18	WOS:A1996VE58900008
J	Cerutti, A; Rescigno, M				Cerutti, Andrea; Rescigno, Maria			The biology of intestinal immunoglobulin A responses	IMMUNITY			English	Review							GROWTH-FACTOR-BETA; FC-ALPHA-RI; COMMON VARIABLE IMMUNODEFICIENCY; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; MUCOSAL IGA RESPONSES; GUT LAMINA PROPRIA; NAIVE B-CELLS; DENDRITIC CELLS; EPITHELIAL-CELLS	The gut mucosa is exposed to a large community of commensal bacteria that are required for the processing of nutrients and the education of the local immune system. Conversely, the gut immune system generates innate and adaptive responses that shape the composition of the local microbiota. One striking feature of intestinal adaptive immunity is its ability to generate massive amounts of noninflammatory immunoglobulin A (IgA) antibodies through multiple follicular and extrafollicular pathways that operate in the presence or absence of cognate T-B cell interactions. Here we discuss the role of intestinal IgA in host-commensal mutualism, immune protection, and tolerance and summarize recent advances on the role of innate immune cells in intestinal IgA production.	[Cerutti, Andrea] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Cerutti, Andrea] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Rescigno, Maria] IEO, Dept Expt Oncol, I-20141 Milan, Italy	Cornell University; Cornell University; IRCCS European Institute of Oncology (IEO)	Cerutti, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA.	acerutti@med.cornell.edu; maria.rescigno@ifom-ieo-campus.it	Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X; Cerutti, Andrea/0000-0003-3026-4704	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074378, R01AI057653] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057653-02, R01 AI057653-02S1, R01 AI074378-03, R01 AI074378-02, R01 AI057653, R01 AI074378-01A1, R01 AI074378, R01 AI057653-S1, R01 AI057653-03] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; BRANDTZAEG P, 1974, NATURE, V252, P418, DOI 10.1038/252418a0; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, MUCOSAL IMMUNOL, V1, P8, DOI 10.1038/mi.2007.8; Cerutti A, 1998, J IMMUNOL, V160, P2145; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chang SY, 2008, J IMMUNOL, V180, P1609, DOI 10.4049/jimmunol.180.3.1609; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Cunningham-Rundies C, 2007, IMMUNOL RES, V38, P78, DOI 10.1007/s12026-007-0024-0; Daniels JA, 2007, AM J SURG PATHOL, V31, P1800, DOI 10.1097/PAS.0b013e3180cab60c; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Fayette J, 1997, J EXP MED, V185, P1909, DOI 10.1084/jem.185.11.1909; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Gardby E, 2003, J IMMUNOL, V170, P55, DOI 10.4049/jimmunol.170.1.55; Geissmann F, 2001, J IMMUNOL, V166, P346, DOI 10.4049/jimmunol.166.1.346; Gonnella PA, 1998, J IMMUNOL, V160, P4708; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; HE SR, 2006, J EXP MED, V203, P2541; Heystek HC, 2002, J IMMUNOL, V168, P102, DOI 10.4049/jimmunol.168.1.102; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huang YT, 2005, J IMMUNOL, V174, P4828, DOI 10.4049/jimmunol.174.8.4828; ISLAM KB, 1991, INT IMMUNOL, V3, P1099, DOI 10.1093/intimm/3.11.1099; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Kanamaru Y, 2008, J IMMUNOL, V180, P2669, DOI 10.4049/jimmunol.180.4.2669; Kanamaru Y, 2007, EUR J IMMUNOL, V37, P1116, DOI 10.1002/eji.200636826; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; MESTECKY J, 1971, SCIENCE, V171, P1163, DOI 10.1126/science.171.3976.1163; Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nathan C, 2006, SCIENCE, V312, P1874; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 1999, CURR TOP MICROBIOL, V236, P17; Ng LG, 2006, EUR J IMMUNOL, V36, P1837, DOI 10.1002/eji.200635956; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Okahashi N, 1996, INFECT IMMUN, V64, P1516, DOI 10.1128/IAI.64.5.1516-1525.1996; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2006, IMMUNITY, V24, P508, DOI 10.1016/j.immuni.2006.05.005; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Ryffel B, 1998, Dev Immunol, V6, P253, DOI 10.1155/1998/76963; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; SHOCKETT P, 1991, J IMMUNOL, V147, P4374; STEVENS SK, 1982, J IMMUNOL, V128, P844; Stoel M, 2005, J IMMUNOL, V174, P1046, DOI 10.4049/jimmunol.174.2.1046; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Zan H, 1998, J IMMUNOL, V161, P5217; Zholudev A, 2004, AM J GASTROENTEROL, V99, P2235, DOI 10.1111/j.1572-0241.2004.40369.x	119	376	389	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2008	28	6					740	750		10.1016/j.immuni.2008.05.001	http://dx.doi.org/10.1016/j.immuni.2008.05.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549797	Green Accepted, Bronze			2022-12-18	WOS:000256760200006
J	NICHOLSON, LB; GREER, JM; SOBEL, RA; LEES, MB; KUCHROO, VK				NICHOLSON, LB; GREER, JM; SOBEL, RA; LEES, MB; KUCHROO, VK			AN ALTERED PEPTIDE LIGAND MEDIATES IMMUNE DEVIATION AND PREVENTS AUTOIMMUNE ENCEPHALOMYELITIS	IMMUNITY			English	Article							T-CELL RECEPTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN PROTEOLIPID PROTEIN; BASIC-PROTEIN; MICE; EXPRESSION; INHIBITION; SECRETION; CYTOKINES; INTERLEUKIN-4	In experimental autoimmune encephalomyelitis (EAE) induced with myelin proteolipid protein (PLP) peptide 139-151, we have previously shown that the disease is mediated by Th1 cells, which recognize tryptophan 144 as the primary TCR contact point. Here we describe an altered peptide ligand (APL), generated by a single amino acid substitution (tryptophan to glutamine) at position 144 (Q144), which inhibits the development of EAE induced with the native PLP 139-151 peptide (W144). We show that the APL induces T cells that are cross-reactive with the native peptide and that these cells produce Th2 (IL-4 and IL-10) and Th0 (IFN gamma and IL-10) cytokines. Adoptive transfer of T cell lines generated with the APL confer protection from EAE. These data show that changing a single amino acid in an antigenic peptide can significantly influence T cell differentiation and suggest that immune deviation may be one of the mechanisms by which APLs can inhibit an autoimmune disease.	BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA 02254; HARVARD UNIV,SCH MED,WALTHAM,MA 02254; STANFORD UNIV,VET ADM MED CTR,SCH MED,PALO ALTO,CA 94304	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Greer, Judith/C-4945-2009	Greer, Judith/0000-0003-4440-4309; Sobel, Raymond/0000-0002-0477-9002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016945, R01NS030843, R29NS030843, R37NS030843, R01NS026773] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16945, NS 30843, NS 26773] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; BENNUN A, 1982, J IMMUNOL, V129, P303; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FRANCO A, 1994, EUR J IMMUNOL, V24, P940, DOI 10.1002/eji.1830240424; GAUTAM AM, 1992, J IMMUNOL, V148, P3049; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JANEWAY CA, 1988, IMMUNOL REV, V101, P39, DOI 10.1111/j.1600-065X.1988.tb00732.x; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JANEWAY CA, 1989, NATURE, V341, P342; KARPUS WJ, 1992, EUR J IMMUNOL, V22, P1757, DOI 10.1002/eji.1830220714; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; KUCHROO VK, 1994, J EXP MED, V179, P1659, DOI 10.1084/jem.179.5.1659; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LAMONT AG, 1990, J IMMUNOL, V145, P1687; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MATZINGER P, 1994, NATURE, V369, P605, DOI 10.1038/369605a0; MERRILL JE, 1992, P NATL ACAD SCI USA, V89, P574, DOI 10.1073/pnas.89.2.574; MILLER SD, 1994, IMMUNOL TODAY, V15, P356, DOI 10.1016/0167-5699(94)90173-2; MOSMANN TR, 1994, SCIENCE, V265, P193, DOI 10.1126/science.8023139; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURRAY JS, 1992, EUR J IMMUNOL, V22, P559, DOI 10.1002/eji.1830220239; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SAKAI K, 1989, P NATL ACAD SCI USA, V86, P9470, DOI 10.1073/pnas.86.23.9470; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SETTE A, 1994, NATURE, V363, P156; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; SOBEL RA, 1994, NEUROCHEM RES, V19, P915, DOI 10.1007/BF00968701; STREET NE, 1994, FASEB J, V5, P171; SWAIN SL, 1993, CURR BIOL, V3, P115, DOI 10.1016/0960-9822(93)90169-O; WAUBEN MHM, 1992, J EXP MED, V176, P667, DOI 10.1084/jem.176.3.667; WAUBEN MHM, 1994, J IMMUNOL, V152, P4211; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	51	376	398	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					397	405		10.1016/1074-7613(95)90169-8	http://dx.doi.org/10.1016/1074-7613(95)90169-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584131	Bronze			2022-12-18	WOS:A1995TB60800001
J	Blagih, J; Coulombe, F; Vincent, EE; Dupuy, F; Galicia-Vazquez, G; Yurchenko, E; Raissi, TC; van der Windt, GJW; Viollet, B; Pearce, EL; Pelletier, J; Piccirillo, CA; Krawczyk, CM; Divangahi, M; Jones, RG				Blagih, Julianna; Coulombe, Francois; Vincent, Emma E.; Dupuy, Fanny; Galicia-Vazquez, Gabriela; Yurchenko, Ekaterina; Raissi, Thomas C.; van der Windt, Gerritje J. W.; Viollet, Benoit; Pearce, Erika L.; Pelletier, Jerry; Piccirillo, Ciriaco A.; Krawczyk, Connie M.; Divangahi, Maziar; Jones, Russell G.			The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo	IMMUNITY			English	Article							LYMPHOCYTE ACTIVATION; GLUTAMINE-METABOLISM; ANTIVIRAL IMMUNITY; GLUCOSE-METABOLISM; KINASE ACTIVATION; MEMORY; DIFFERENTIATION; PROLIFERATION; PATHWAYS; PROTEIN	Naive T cells undergo metabolic reprogramming to support the increased energetic and biosynthetic demands of effector T cell function. However, how nutrient availability influences T cell metabolism and function remains poorly understood. Here we report plasticity in effector T cell metabolism in response to changing nutrient availability. Activated T cells were found to possess a glucose-sensitive metabolic checkpoint controlled by the energy sensor AMP-activated protein kinase (AMPK) that regulated mRNA translation and glutamine-dependent mitochondrial metabolism to maintain T cell bioenergetics and viability. T cells lacking AMPK alpha 1 displayed reduced mitochondrial bioenergetics and cellular ATP in response to glucose limitation in vitro or pathogenic challenge in vivo. Finally, we demonstrated that AMPKa1 is essential for T helper 1 (Th1) and Th17 cell development and primary T cell responses to viral and bacterial infections in vivo. Our data highlight AMPK-dependent regulation of metabolic homeostasis as a key regulator of T cell-mediated adaptive immunity.	[Blagih, Julianna; Vincent, Emma E.; Dupuy, Fanny; Galicia-Vazquez, Gabriela; Raissi, Thomas C.; Pelletier, Jerry; Krawczyk, Connie M.; Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Blagih, Julianna; Raissi, Thomas C.; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Coulombe, Francois; Divangahi, Maziar] McGill Univ Hlth Ctr & Res Inst, McGill Int TB Ctr, Dept Med Microbiol & Immunol, Montreal, PQ H2X 2P2, Canada; [Coulombe, Francois; Divangahi, Maziar] McGill Univ Hlth Ctr & Res Inst, McGill Int TB Ctr, Dept Pathol, Montreal, PQ H2X 2P2, Canada; [Dupuy, Fanny; Galicia-Vazquez, Gabriela; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Yurchenko, Ekaterina; Piccirillo, Ciriaco A.; Krawczyk, Connie M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Yurchenko, Ekaterina; Piccirillo, Ciriaco A.] McGill Univ, Ctr Hlth, Res Inst, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [van der Windt, Gerritje J. W.; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Viollet, Benoit] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Viollet, Benoit] Sorbonne Paris Cite, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jones, RG (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada.	russell.jones@mcgill.ca	Viollet, Benoit/N-2397-2019; Jones, Russell/AAC-2861-2022; Viollet, Benoit/O-6927-2017; Jones, Russell Graham/ABD-5261-2021	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Jones, Russell Graham/0000-0003-2250-4675; Vincent, Emma/0000-0002-8917-7384; GALICIA VAZQUEZ, GABRIELA/0000-0001-6706-7742	Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQS); McGill Integrated Cancer Research Training Program (MICRTP); NIAID [5R01AI091965]; Arthritis Society [RG-11-017]; CIHR [MOP-93799]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); McGill Integrated Cancer Research Training Program (MICRTP); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Society; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Maya Poffenberger, Orval Mamer, and Eric Ma for review of the manuscript; Bozena Samborska, Rosalie Michaud, and Breanna Flynn for animal husbandry; and Daina Avizonis, Gaelle Bridon, and Luc Choiniere of the GCRC Metabolic Core Facility for technical support. Salary support from the Canadian Institutes of Health Research (CIHR, to R.G.J.), the Fonds de Recherche du Quebec-Sante (FRQS, to J.B.), and the McGill Integrated Cancer Research Training Program (MICRTP, to J.B.) is acknowledged. Grant support was provided by the NIAID (5R01AI091965, to E. L. P.), the Arthritis Society (RG-11-017, to R.G.J.), and the CIHR (MOP-93799, to R.G.J.). This work is dedicated to the memory of Rosalind Goodman.	ARDAWI MSM, 1983, BIOCHEM J, V212, P835, DOI 10.1042/bj2120835; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Dupuy F, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-18; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Krawczyk CM, 2007, J IMMUNOL, V178, P4080, DOI 10.4049/jimmunol.178.7.4080; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; McGuirk S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-22; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nath N, 2009, BIOCHEM BIOPH RES CO, V386, P16, DOI 10.1016/j.bbrc.2009.05.106; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vincent EE, 2014, ONCOGENE; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002	49	375	389	6	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					41	54		10.1016/j.immuni.2014.12.030	http://dx.doi.org/10.1016/j.immuni.2014.12.030			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607458	Green Published, Bronze			2022-12-18	WOS:000348197500010
J	Egen, JG; Allison, JP				Egen, JG; Allison, JP			Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength	IMMUNITY			English	Article							CELL-SURFACE EXPRESSION; CLATHRIN-ASSOCIATED PROTEIN; TYROSINE PHOSPHORYLATION; CYTOPLASMIC TAIL; CTLA-4; ACTIVATION; RECEPTOR; RECOGNITION; CD28; STIMULATION	CD28 and CTLA-4 engagement with B7 expressed by APCs generates critical regulatory signals for T cell activation. CD28 is expressed on the T cell surface and enhances T cell expansion, while CTLA-4 localizes primarily to an intracellular compartment and inhibits T cell proliferation. We demonstrate that CTLA-4 has several unique trafficking properties that may regulate its ability to attenuate a T cell response. Importantly, accumulation of CTLA-4 at the immunological synapse is proportional to the strength of the TCR signal, suggesting that cells receiving stronger stimuli are more susceptible to CTLA-4-mediated inhibition. This may represent a novel feedback control mechanism in which a stimulatory signal regulates the recruitment of an inhibitory receptor to a functionally relevant site on the cell surface.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Allison, JP (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA.			Egen, Jackson/0000-0003-2053-0837; Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [R37CA040041, R01CA040041] Funding Source: NIH RePORTER; NCI NIH HHS [CA40041] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOLSE LS, 1995, IMMUNITY, V3, P87; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brunner MC, 1999, J IMMUNOL, V162, P5813; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Cefai D, 1998, J IMMUNOL, V160, P2223; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chuang E, 1997, J IMMUNOL, V159, P144; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greene JAL, 1996, J BIOL CHEM, V271, P26762, DOI 10.1074/jbc.271.43.26762; GROSS JA, 1990, J IMMUNOL, V144, P3201; HAWLEY RG, 1994, GENE THER, V1, P136; Huang J, 2000, EUR J IMMUNOL, V30, P50, DOI 10.1002/1521-4141(200001)30:1<50::AID-IMMU50>3.3.CO;2-9; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuhns MS, 2000, P NATL ACAD SCI USA, V97, P12711, DOI 10.1073/pnas.220423597; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Malhotra V, 2000, J AM SOC ECHOCARDIOG, V13, P771, DOI 10.1067/mje.2000.106078; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Oki S, 1999, INT IMMUNOL, V11, P1563, DOI 10.1093/intimm/11.9.1563; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; REAY PA, 1994, J IMMUNOL, V152, P3946; Rogers PR, 1999, J IMMUNOL, V163, P1205; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Schaefer BC, 1999, IMMUNITY, V11, P411, DOI 10.1016/S1074-7613(00)80116-8; Schneider H, 1999, J IMMUNOL, V163, P1868; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Zhang LM, 1997, PARASITE, V4, P94	50	375	386	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					23	35		10.1016/S1074-7613(01)00259-X	http://dx.doi.org/10.1016/S1074-7613(01)00259-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825563	Bronze			2022-12-18	WOS:000173575700004
J	Zhang, SQ; Kovalenko, A; Cantarella, G; Wallach, D				Zhang, SQ; Kovalenko, A; Cantarella, G; Wallach, D			Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKK gamma) upon receptor stimulation	IMMUNITY			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; KINASE COMPLEX; INTERLEUKIN-1 RECEPTOR; SIGNALING COMPLEX; DEATH DOMAIN; CELL-DEATH; ACTIVATION; ALPHA; PHOSPHORYLATION	The adapter protein RIP plays a crucial role in NF-KB activation by TNF. Here we show that triggering of the p55 TNF receptor induces binding of RIP to NEMO (IKK gamma), a component of the I-kappa-B-kinase (IKK) "signalosome" complex, as well as recruitment of RIP to the receptor together with the three major signalosome components, NEMO, IKK1 and 1KK2, and some kind of covalent modification of the recruited RIP molecules. It also induces binding of NEMO to the signaling inhibitor A20, and recruitment of A20 to the receptor. Enforced expression of NEMO in cells revealed that NEMO can both promote and block NF-kappa B activation and dramatically augments the phosphorylation of c-Jun. The findings suggest that the signaling activities of the IKK signalosome are regulated through binding of NEMO to RIP and A20 within the p55 TNF receptor complex.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Cantarella, Giuseppina/AHD-9609-2022					Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jaattela M, 1996, J IMMUNOL, V156, P1166; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Li XX, 1999, MOL CELL BIOL, V19, P4643; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Natoli G, 1997, J BIOL CHEM, V272, P26079, DOI 10.1074/jbc.272.42.26079; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	44	375	399	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					301	311		10.1016/S1074-7613(00)80183-1	http://dx.doi.org/10.1016/S1074-7613(00)80183-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755617	Bronze			2022-12-18	WOS:000086292100008
J	Ahn, K; Gruhler, A; Galocha, B; Jones, TR; Wiertz, EJHJ; Ploegh, HL; Peterson, PA; Yang, Y; Fruh, K				Ahn, K; Gruhler, A; Galocha, B; Jones, TR; Wiertz, EJHJ; Ploegh, HL; Peterson, PA; Yang, Y; Fruh, K			The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN PRESENTATION; TRANSMEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; ENCODED TRANSPORTER; NUCLEOTIDE-BINDING; EXPRESSION; MOLECULES; RETENTION; REGION	Human cytomegalovirus (HCMV) inhibits MHC class I antigen presentation by a sequential multistep process involving a family of unique short (US) region-encoded glycoproteins. US3 retains class I molecules, whereas US2 and US11 mediate the cytosolic degradation of heavy chains by the proteosomes. In US6-transfected cells, however, intracellular transport of class I molecules is impaired because of defective peptide translocation by transporters associated with antigen processing (TAP). Peptide transport is restored in HCMV mutants lacking US6. In contrast to the cytosolic herpes simplex virus protein ICP47, US6 interacts with TAP inside the endoplasmic reticulum lumen, as shown by US6 derivatives lacking the transmembrane and cytoplasmic domains and by the observation that US6 does not prevent peptides from binding to TAP. Thus, HCMV targets TAP for immune escape by a molecular mechanism different from that of herpes simplex virus.	RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA; MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA; WYETH AYERST RES, DEPT BIOL MOL, INFECT DIS SECT, PEARL RIVER, NY 10965 USA	Johnson & Johnson; Johnson & Johnson USA; Massachusetts Institute of Technology (MIT); Pfizer				Frueh, Klaus/0000-0001-8014-3877				Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; FLECKENSTEIN B, 1982, GENE, V18, P39, DOI 10.1016/0378-1119(82)90054-3; Fruh K, 1997, J MOL MED-JMM, V75, P18, DOI 10.1007/s001090050082; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gilbert MJ, 1996, NATURE, V383, P720, DOI 10.1038/383720a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hengel H, 1996, J GEN VIROL, V77, P2287, DOI 10.1099/0022-1317-77-9-2287; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; JONES TR, 1991, J VIROL, V65, P2024, DOI 10.1128/JVI.65.4.2024-2036.1991; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; MULLER KM, 1994, J BIOL CHEM, V269, P14032; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; PARHAM P, 1983, METHOD ENZYMOL, V92, P110; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WANG K, 1994, FEBS LETT, V350, P337, DOI 10.1016/0014-5793(94)00806-X; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; YANG Y, 1995, J BIOL CHEM, V270, P27687, DOI 10.1074/jbc.270.46.27687; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	47	375	386	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1997	6	5					613	621		10.1016/S1074-7613(00)80349-0	http://dx.doi.org/10.1016/S1074-7613(00)80349-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175839	Bronze			2022-12-18	WOS:A1997XB81900012
J	Sato, S; Miller, AS; Inaoki, M; Bock, CB; Jansen, PJ; Tang, MLK; Tedder, TF				Sato, S; Miller, AS; Inaoki, M; Bock, CB; Jansen, PJ; Tang, MLK; Tedder, TF			CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; HEMATOPOIETIC-CELL PHOSPHATASE; T-CELLS; IMMUNOGLOBULIN SUPERFAMILY; MEMBRANE IMMUNOGLOBULIN; MONOCLONAL-ANTIBODY; TRANSGENIC MICE; CROSS-LINKING; MOLECULE CD22; SH2 DOMAIN	B cell activation following antigen receptor cross-linking can be augmented in vitro by ligation of cell surface CD22, which associates with the SHP1 protein tyrosine phosphatase. The targeted deletion of CD22 in mice demonstrated that CD22 differentially regulates antigen receptor signaling in resting and antigen-stimulated B lymphocytes. a cells from CD22-deficient mice exhibited the cell surface phenotype and augmented intracellular calcium responses characteristic of chronically stimulated B cells, as occurs in SHP1-defective mice. Thus, CD22 negatively regulates antigen receptor signaling in the absence of antigen. However, activation of CD22-deficient B lymphocytes by prolonged IgM cross-linking resulted in modest B cell proliferation, demonstrating that CD22 positively regulates antigen receptor signaling in the presence of antigen.	DUKE UNIV,MED CTR,DEPT IMMUNOL,DURHAM,NC 27710	Duke University				Tang, Mimi/0000-0002-3839-5293	NATIONAL CANCER INSTITUTE [R55CA054464, R01CA054464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL050985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026872] Funding Source: NIH RePORTER; NCI NIH HHS [CA-54464] Funding Source: Medline; NHLBI NIH HHS [HL-50985] Funding Source: Medline; NIAID NIH HHS [AI-26872] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; BRUNSWICK M, 1994, CELL IMMUNOL, V156, P240, DOI 10.1006/cimm.1994.1168; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DORKEN B, 1986, J IMMUNOL, V136, P4470; ENGEL P, 1993, J IMMUNOL, V150, P4719; ENGEL P, 1995, J EXP MED, V181, P1581, DOI 10.1084/jem.181.4.1581; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Erickson LD, 1996, INT IMMUNOL, V8, P1121, DOI 10.1093/intimm/8.7.1121; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; HEMPEL WM, 1992, J IMMUNOL, V148, P3021; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; LANE PJL, 1991, J IMMUNOL, V146, P715; LANKESTER AC, 1995, J BIOL CHEM, V270, P20305, DOI 10.1074/jbc.270.35.20305; LAW CL, 1993, J IMMUNOL, V151, P175; LAW CL, 1994, IMMUNOL TODAY, V15, P442, DOI 10.1016/0167-5699(94)90275-5; LAW CL, 1995, J IMMUNOL, V155, P3368; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LAZARUS AH, 1991, J IMMUNOL, V147, P1739; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; PADEH S, 1991, J CLIN INVEST, V87, P1114, DOI 10.1172/JCI115074; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; PEZZUTTO A, 1987, J IMMUNOL, V138, P98; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; POWELL LD, 1993, J BIOL CHEM, V268, P7019; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P481, DOI 10.1002/eji.1830190311; RIJKERS GT, 1990, P NATL ACAD SCI USA, V87, P8766, DOI 10.1073/pnas.87.22.8766; ROIFMAN CM, 1992, BIOCHEM BIOPH RES CO, V183, P411, DOI 10.1016/0006-291X(92)90496-8; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1996, J IMMUNOL, V157, P4371; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; Schultz Leonard D., 1993, Cell, V73, P1445; SCHWARTING R, 1985, BLOOD, V65, P974; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SGROI D, 1993, J BIOL CHEM, V268, P7011; SGROI D, 1995, P NATL ACAD SCI USA, V92, P4026, DOI 10.1073/pnas.92.9.4026; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SIDMAN CL, 1978, J IMMUNOL, V121, P2399; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; SYMINGTON FW, 1982, IMMUNOGENETICS, V16, P381, DOI 10.1007/BF00372098; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; ZHOU LJ, 1991, J IMMUNOL, V147, P1424; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	66	375	393	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					551	562		10.1016/S1074-7613(00)80270-8	http://dx.doi.org/10.1016/S1074-7613(00)80270-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986715	Bronze			2022-12-18	WOS:A1996WA65100006
J	DAERON, M; LATOUR, S; MALBEC, O; ESPINOSA, E; PINA, P; PASMANS, S; FRIDMAN, WH				DAERON, M; LATOUR, S; MALBEC, O; ESPINOSA, E; PINA, P; PASMANS, S; FRIDMAN, WH			THE SAME TYROSINE-BASED INHIBITION MOTIF, IN THE INTRACYTOPLASMIC DOMAIN OF FC-GAMMA-RIIB, REGULATES NEGATIVELY BCR-DEPENDENT, TCR-DEPENDENT, AND FCR-DEPENDENT CELL ACTIVATION	IMMUNITY			English	Article							AFFINITY IGE RECEPTOR; T-CELL; MAST-CELLS; KINASE ACTIVATION; CYTOPLASMIC TAIL; LYMPHOCYTES-B; CROSS-LINKING; EPSILON-RI; IMMUNOGLOBULIN; EXPRESSION	The cell-triggering properties of BCR, TCR and FcR depend on structurally related immunoreceptor tyrosine-based activation motifs (ITAMs). Fc gamma RIIB have no ITAM and do not trigger cell activation, When coaggregated to BCR, they inhibit B cell activation. We show here that, when coaggregated to these receptors, Fc gamma RIIB inhibit Fc epsilon RI-, Fc gamma RIIA-, and TCR-dependent cell activation, Inhibition also affected cell activation by single ITAMs, in isolated FcR or TCR subunits, The same tyrosine-based inhibitory motif (ITIM), which is highly conserved in murine and human Fc gamma RIIB and that was previously shown to inhibit BCR-dependent B cell activation, was required to regulate TCR- and FcR-dependent cell activation, Our findings endow Fc gamma RIIB, and thus IgG antibodies, with general immunoregulatory properties susceptible to act on all ITAM-containing receptors.	NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT ALLERGY,AMSTERDAM,NETHERLANDS		DAERON, M (corresponding author), INST CURIE,IMMUL CELLULAIRE & CLIN LAB,INSERM,U255,PARIS,FRANCE.		espinosa, eric/E-4872-2013; Pasmans, Suzanne/AAI-6016-2021; Latour, Sylvain/H-3652-2017	espinosa, eric/0000-0002-3512-0921; Pasmans, Suzanne/0000-0003-1018-4475; fridman, wolf herman/0000-0002-1332-0973; Latour, Sylvain/0000-0001-8238-4391				AMIGORENA S, 1989, EUR J IMMUNOL, V19, P1379, DOI 10.1002/eji.1830190805; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; ANSELMINO LM, 1989, J ALLERGY CLIN IMMUN, V84, P907, DOI 10.1016/0091-6749(89)90388-6; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BENHAMOU M, 1990, J IMMUNOL, V144, P3071; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BONNEROT C, 1992, EMBO J, V11, P2747, DOI 10.1002/j.1460-2075.1992.tb05340.x; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CAPEL PJA, 1979, J IMMUNOL, V122, P421; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; CONRAD DH, 1983, J IMMUNOL, V130, P327; DAERON M, 1992, J IMMUNOL, V149, P1365; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1993, INT IMMUNOL, V5, P1393, DOI 10.1093/intimm/5.11.1393; DAERON M, 1994, J IMMUNOL, V152, P783; DAERON M, 1985, EUR J IMMUNOL, V15, P662, DOI 10.1002/eji.1830150705; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; FA C, 1989, NATURE, V341, P752; FETH MG, 1989, NATURE, V338, P383; FRANK SJ, 1990, SCIENCE, V249, P174, DOI 10.1126/science.2371564; FUBIN LA, 1985, HYBRIDIOMA, V4, P91; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GLEICH GJ, 1978, J ALLERGY CLIN IMMUN, V62, P261; GREENMAN J, 1991, MOL IMMUNOL, V28, P1243, DOI 10.1016/0161-5890(91)90011-8; GUTHMANN MD, 1995, IN PRESS INT ARCH AL; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HENRY C, 1968, J EXP MED, V128, P133, DOI 10.1084/jem.128.1.133; HIBBS ML, 1988, P NATL ACAD SCI USA, V85, P2240, DOI 10.1073/pnas.85.7.2240; HIBBS ML, 1986, P NATL ACAD SCI USA, V83, P6980, DOI 10.1073/pnas.83.18.6980; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; IRVIN GL, 1967, J IMMUNOL, V99, P1185; ISHIZAKA T, 1979, J IMMUNOL, V123, P138; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KALISS N, 1958, CANCER RES, V18, P992; KOLANUS W, 1992, EMBO J, V11, P4861, DOI 10.1002/j.1460-2075.1992.tb05592.x; KUROSAKI T, 1991, P NATL ACAD SCI USA, V88, P3837, DOI 10.1073/pnas.88.9.3837; KUROSAKI T, 1992, J EXP MED, V175, P447, DOI 10.1084/jem.175.2.447; LATOUR S, 1992, J IMMUNOL, V149, P2155; LECLERC JC, 1977, EUR J IMMUNOL, V7, P543, DOI 10.1002/eji.1830070810; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; LIU FT, 1980, J IMMUNOL, V124, P2728; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOONEY RJ, 1986, J IMMUNOL, V136, P1641; LUO HY, 1991, J IMMUNOL, V146, P2122; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; MORGAN EL, 1978, J IMMUNOL, V120, P1669; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; PHILLIPS NE, 1983, J IMMUNOL, V130, P602; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; SCHOLL PR, 1993, P NATL ACAD SCI USA, V90, P8847, DOI 10.1073/pnas.90.19.8847; SIDMAN CL, 1979, J IMMUNOL, V122, P406; SINCLAIR NRS, 1971, ADV EXP MED BIOL, V12, P609; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANDENHERIKOUDI.IE, 1994, J IMMUNOL, V152, P574; VANTOORENENBERG.AW, 1981, INT ARCH ALLER A IMM, V65, P432; VOISIN GA, 1966, NATURE, V210, P138, DOI 10.1038/210138a0; WARMERDAM PAM, 1990, J EXP MED, V172, P19, DOI 10.1084/jem.172.1.19; WARMERDAM PAM, 1993, INT IMMUNOL, V3, P239; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B	70	375	407	0	16	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					635	646		10.1016/1074-7613(95)90134-5	http://dx.doi.org/10.1016/1074-7613(95)90134-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584153	Bronze			2022-12-18	WOS:A1995TG28100011
J	Ahern, PP; Schiering, C; Buonocore, S; McGeachy, MJ; Cua, DJ; Maloy, KJ; Powrie, F				Ahern, Philip P.; Schiering, Chris; Buonocore, Sofia; McGeachy, Mandy J.; Cua, Dan J.; Maloy, Kevin J.; Powrie, Fiona			Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; BOWEL-DISEASE; HELPER-CELLS; TH17 CELLS; IL-23; DIFFERENTIATION; CYTOKINE; T(H)17; RECEPTOR; DISTINCT	Mutations in the IL23R gene are linked to inflammatory bowel disease susceptibility. Experimental models have shown that interleukin-23 (IL-23) orchestrates innate and T cell-dependent colitis; however, the cell populations it acts on to induce intestinal immune pathology are unknown. Here, using 1123r(-/-) T cells, we demonstrated that T cell reactivity to IL-23 was critical for development of intestinal pathology, but not for systemic inflammation. Through direct signaling into T cells, IL-23 drove intestinal T cell proliferation, promoted intestinal Th17 cell accumulation, and enhanced the emergence of an IL-17A(+)IFN-gamma(+) population of T cells. Furthermore, IL-23R signaling in intestinal T cells suppressed the differentiation of Foxp3(+) cells and T cell IL-10 production. Although 1123r(-/-) T cells displayed unimpaired Th1 cell differentiation, these cells showed impaired proliferation and failed to accumulate in the intestine. Together, these results highlight the multiple functions of IL-23 signaling in T cells that contribute to its colitogenic activity.	[Ahern, Philip P.; Schiering, Chris; Buonocore, Sofia; Maloy, Kevin J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Schiering, Chris; Powrie, Fiona] John Radcliffe Hosp, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [McGeachy, Mandy J.; Cua, Dan J.] Merck Res Labs, Palo Alto, CA 94304 USA	University of Oxford; University of Oxford; Merck & Company	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	fiona.powrie@path.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688; Schiering, Chris/0000-0001-7902-6024	Wellcome Trust; Marie Curie European Union [MRTN-CT-2004-005632]; Merck Research Laboratories	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie European Union; Merck Research Laboratories(Merck & Company)	We would like to thank N. Rust for cell sorting, R. Stillion for histology, the staff of the University of Oxford for excellent animal care and K. Siddiqui, S. Laffont-Pradines, M. Barnes, A. Izcue, and A. Geremia for technical help and critical reading of the manuscript. This work was supported by grants from the Wellcome Trust (C.S., K.J.M., and F.P.) and the Marie Curie European Union Research Training Network Program (MRTN-CT-2004-005632 to P.P.A., S.B., K.J.M., and F.P.). M.J.M. and D.J.C. are members of Merck Research Laboratories.	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	46	374	384	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					279	288		10.1016/j.immuni.2010.08.010	http://dx.doi.org/10.1016/j.immuni.2010.08.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732640	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000281654900016
J	Mempel, TR; Pittet, MJ; Khazaie, K; Weninger, W; Weissleder, R; von Boehmer, H; von Andrian, UH				Mempel, Thorsten R.; Pittet, Mikael J.; Khazaie, Khashayarsha; Weninger, Wolfgang; Weissleder, Ralph; von Boehmer, Harald; von Andrian, Ulrich H.			Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LYTIC GRANULE EXOCYTOSIS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; LYMPH-NODES; IN-VIVO; TOLL-LIKE; TUMOR; CD8; BETA	Mechanisms of dominant tolerance have evolved within the mammalian immune system to prevent inappropriate immune responses. CD4(+)CD25(+) regulatory T (T-reg) cells have emerged as central constituents of this suppressive activity. By using multiphoton intravital microscopy in lymph nodes (LNs) of anesthetized mice, we have analyzed how cytotoxic T lymphocytes (CTLs) interact with antigen-presenting target cells in the presence or absence of activated T-reg cells. Nonregulated CTLs killed their targets at a 6.6-fold faster rate than regulated CTLs. In spite of this compromised effector activity, regulated CTLs exhibited no defect in proliferation, induction of cytotoxic effector molecules and secretory granules, in situ motility, or ability to form antigen-dependent conjugates with target cells. Only granule exocytosis by CTLs was markedly impaired in the presence of T-reg cells. This selective form of regulation did not require prolonged contact between CTLs and T-reg cells but depended on CTL responsiveness to transforming growth factor-beta. CTLs quickly regained full killing capacity in LNs upon selective removal of T-reg cells. Thus, T-reg cells reversibly suppress CTL-mediated immunity by allowing acquisition of full effector potential but withholding the license to kill.	Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Mol Imaging Res, Bldg 149,13th St, Charlestown, MA 02129 USA.	mpittet@hms.harvard.edu	Pittet, Mikael/ABD-6300-2021; von Andrian, Ulrich H/A-5775-2008	/0000-0003-0828-4143; Weninger, Wolfgang/0000-0003-3133-8699	NATIONAL CANCER INSTITUTE [P50CA086355, R01CA096978, R24CA092782, R01CA104547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, T32HL066987, R01HL054936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061663, R01AI069259, R37AI053102] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA104547, R01-CA96978, P50-CA-86355, R24-CA92782] Funding Source: Medline; NHLBI NIH HHS [P01-HL56949, R01-HL54936, T32-HL-066987-04] Funding Source: Medline; NIAID NIH HHS [R37 AI53102, R01-AI-061663] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Gunzer M, 2004, BLOOD, V104, P2801, DOI 10.1182/blood-2004-03-1193; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Klein L, 2003, EUR J IMMUNOL, V33, P806, DOI 10.1002/eji.200323800; Kohler M, 2003, DIABETES, V52, P2943, DOI 10.2337/diabetes.52.12.2943; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Morgan DJ, 1996, J IMMUNOL, V157, P978; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Waldmann H, 2004, SEMIN IMMUNOL, V16, P119, DOI 10.1016/j.smim.2003.12.007; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zelinskyy G, 2005, J VIROL, V79, P10619, DOI 10.1128/JVI.79.16.10619-10626.2005; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	50	374	386	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					129	141		10.1016/j.immuni.2006.04.015	http://dx.doi.org/10.1016/j.immuni.2006.04.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860762	Bronze			2022-12-18	WOS:000239713000016
J	Park, JH; Yu, Q; Erman, B; Appelbaum, JS; Montoya-Durango, D; Grimes, JL; Singer, A				Park, JH; Yu, Q; Erman, B; Appelbaum, JS; Montoya-Durango, D; Grimes, JL; Singer, A			Suppression of IL7R alpha transcription by IL-7 and other prosurvival cytokines: A novel mechanism for maximizing IL-7-dependent T cell survival	IMMUNITY			English	Article							ZINC-FINGER PROTEIN; IN-VIVO; HOMEOSTATIC PROLIFERATION; RECEPTOR SIGNALS; REPRESSOR GFI1; NAIVE; INTERLEUKIN-7; EXPRESSION; ACTIVATION; CHAIN	Survival of naive T cells is dependent upon IL-7, which is present in vivo in limiting amounts with the result that naive T cells must compete for IL-7-mediated survival signals. It would seem imperative during T cell homeostasis that limiting IL-7 be shared by the greatest possible number of T cells. We now describe a novel regulatory mechanism that specifically suppresses IL7Ralpha transcription in response to IL-7 and other prosurvival cytokines (IL-2, IL-4, IL-6, and IL-15). Consequently, IL7R expression is reduced on T cells that have received cytokine-mediated survival signals so they do not compete with unsignaled T cells for remaining IL-7. Interestingly, cytokine-mediated suppression of IL7Ralpha transcription involves different molecular mechanisms in CD4(+) and CD8(+) T cells, as CD8(+) T cells utilize the transcriptional repressor GFI1 while CD4(+) T cells do not. We suggest that this homeostatic regulatory mechanism promotes survival of the maximum possible number of T cells for the amount of IL-7 available.	NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; Univ Louisville, Dept Surg, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Inst Cellular Therapeut, Sch Med, Louisville, KY 40202 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Louisville; University of Louisville	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bldg 10,Room 4B36, Bethesda, MD 20892 USA.	singera@nih.gov	erman, batu/AAE-1963-2020; Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055; Appelbaum, Jacob/0000-0002-4362-7773; Grimes, H. Leighton/0000-0001-8162-6758	NATIONAL CANCER INSTITUTE [Z01BC009273, ZICBC009255, ZIABC009273, Z01BC009255] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cibotti R, 2000, MOL CELL BIOL, V20, P3852, DOI 10.1128/MCB.20.11.3852-3859.2000; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Doan LL, 2003, J IMMUNOL, V170, P2356, DOI 10.4049/jimmunol.170.5.2356; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Khaled AR, 2002, BIOTECHNIQUES, P40; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Porter BO, 2001, J IMMUNOL, V166, P262, DOI 10.4049/jimmunol.166.1.262; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Stockinger B, 2004, IMMUNOLOGY, V111, P241, DOI 10.1111/j.1365-2567.2004.01831.x; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Teague TK, 1997, J IMMUNOL, V158, P5791; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; YU Q, 2004, IN PRESS J EXP MED; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	38	374	389	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					289	302		10.1016/j.immuni.2004.07.016	http://dx.doi.org/10.1016/j.immuni.2004.07.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308108	Bronze			2022-12-18	WOS:000223441900016
J	Hladik, F; Sakchalathorn, P; Ballweber, L; Lentz, G; Fialkow, M; Eschenbach, D; McElrath, MJ				Hladik, Florian; Sakchalathorn, Polachai; Ballweber, Lamar; Lentz, Gretchen; Fialkow, Michael; Eschenbach, David; McElrath, M. Juliana			Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1	IMMUNITY			English	Article							CD4(+) T-CELLS; HUMAN CERVICAL TISSUE; DC-SIGN; DENDRITIC CELLS; HIV-1 INFECTION; RHESUS MACAQUES; INTRAVAGINAL INOCULATION; SYNAPSE FORMATION; CELLULAR TARGETS; GENITAL-TRACT	Understanding the initial events in the establishment of vaginal human immunodeficiency virus type-1 (HIV-1) entry and infection has been hampered by the lack of appropriate experimental models. Here, we show in an ex vivo human organ culture system that upon contact in situ, HIV-1 rapidly penetrated both intraepithelial vaginal Langerhans and CD4(+) T cells. HIV-1 entered CD4(+) T cells almost exclusively by CD4 and CCR5 receptor-mediated direct fusion, without requiring passage from Langerhans cells, and overt productive infection ensued. By contrast, HIV-1 entered CD1a(+) Langerhans cells primarily by endocytosis, by means of multiple receptors, and virions persisted intact within the cytoplasm for several days. Our findings shed light on the very earliest steps of mucosal HIV infection in vivo and may guide the design of effective strategies to block local transmission and prevent HIV-1 spread.	Fred Hutchinson Canc Res Ctr, Program Infect Dis, Clin Res Div, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Obstet & Gynaecol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathobiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McElrath, MJ (corresponding author), Fred Hutchinson Canc Res Ctr, Program Infect Dis, Clin Res Div, Seattle, WA 98109 USA.	jmcelrat@fhcrc.org	Hladik, Florian/AAR-8852-2021; Hladik, Florian/G-1041-2012	Hladik, Florian/0000-0002-0375-2764; Hladik, Florian/0000-0002-0375-2764	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K08AI051980, R01AI035605, R37AI035605] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35605, AI27757, K08 AI051980, AI51980, R37 AI035605, P30 AI027757] Funding Source: Medline; NICHD NIH HHS [R01 HD051455, HD51455] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; DIMITROV DS, 1993, J VIROL, V67, P1647, DOI 10.1128/JVI.67.3.1647-1652.1993; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Hladik F, 1999, J IMMUNOL, V163, P2306; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Rottman JB, 1997, AM J PATHOL, V151, P1341; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Veazey RS, 2005, NAT MED, V11, P469, DOI 10.1038/nm0505-469; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zetterstrom CK, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000023175.89966.9E; Zhang LQ, 1998, J VIROL, V72, P5035, DOI 10.1128/JVI.72.6.5035-5045.1998; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zheng NN, 2001, AIDS RES HUM RETROV, V17, P1501, DOI 10.1089/08892220152644205	35	373	386	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2007	26	2					257	270		10.1016/j.immuni.2007.01.007	http://dx.doi.org/10.1016/j.immuni.2007.01.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17306567	Green Published, hybrid			2022-12-18	WOS:000244628600015
J	Hall, JA; Bouladoux, N; Sun, CM; Wohlfert, EA; Blank, RB; Zhu, Q; Grigg, ME; Berzofsky, JA; Belkaid, Y				Hall, Jason A.; Bouladoux, Nicolas; Sun, Cheng Ming; Wohlfert, Elizabeth A.; Blank, Rebecca B.; Zhu, Qing; Grigg, Michael E.; Berzofsky, Jay A.; Belkaid, Yasmine			Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune Responses	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; ENCEPHALITOZOON-CUNICULI INFECTION; INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; CROHNS-DISEASE; ESCHERICHIA-COLI; RETINOIC-ACID; EPITHELIAL-CELLS; TOXOPLASMA-GONDII; ORAL INFECTION	The intestinal tract is in intimate contact with the commensal microflora. Nevertheless, how commensals communicate with cells to ensure immune homeostasis is still unclear. In this study, we found that gut flora DNA (gfDNA) plays a major role in intestinal homeostasis through Toll-like receptor 9 (TLR9) engagement. Tlr9(-/-) mice displayed increased frequencies of CD4(+)Foxp3(+) regulatory T (Treg) cells within intestinal effector sites and reduced Constitutive IL-17-and IFN-gamma-producing effector T (Teff) cells. Complementing this, gfDNA limited lamina propria dendritic cell-induced Treg cell conversion in vitro. Further, Treg/Teff cell disequilibrium in Tlr9(-/-) mice led to impaired immune responses to oral infection and to oral vaccination. Impaired intestinal immune responses were recapitulated in mice treated with antibiotics and were reversible after reconstitution with gfDNA. Together, these data point to gfDNA as a natural adjuvant for priming intestinal responses via modulation of Treg/Teff cell equilibrium.	[Hall, Jason A.; Bouladoux, Nicolas; Sun, Cheng Ming; Wohlfert, Elizabeth A.; Blank, Rebecca B.; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, Jason A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Zhu, Qing; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Grigg, Michael E.] NIAID, Mol Parasitol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	wohlfert, beth/ABA-2255-2020; Sun, Cheng-Ming/G-6505-2018	Sun, Cheng-Ming/0000-0002-2392-7701; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X	Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC004020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001017, ZIAAI001115, ZIAAI000955] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. We thank the MAID sorting facility and K. Beacht for technical assistance. We would like to thank A. Sher and D. Chou for critical reading of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bouladoux N, 2003, J MICROBIOL METH, V53, P377, DOI 10.1016/S0167-7012(02)00258-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chong C, 1998, VACCINE, V16, P732, DOI 10.1016/S0264-410X(97)00255-7; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Khan IA, 1999, INFECT IMMUN, V67, P1887; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; MEDZHITOV R, 1997, NATURE, V388, P397; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moretto M, 2004, J IMMUNOL, V172, P4402, DOI 10.4049/jimmunol.172.7.4402; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; SCHALASTA G, 1990, MOL CELL BIOL, V10, P5558, DOI 10.1128/MCB.10.10.5558; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Weiss LM, 1998, ADV PARASIT, V40, P351, DOI 10.1016/S0065-308X(08)60127-X; Wu WH, 2006, EUR J IMMUNOL, V36, P3238, DOI 10.1002/eji.200636472; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	71	372	387	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					637	649		10.1016/j.immuni.2008.08.009	http://dx.doi.org/10.1016/j.immuni.2008.08.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18835196	Green Accepted, Bronze			2022-12-18	WOS:000260316700016
J	Carman, CV; Sage, PT; Sciuto, TE; de la Fuente, MA; Geha, RS; Ochs, HD; Dvorak, HF; Dvorak, AM; Springer, TA				Carman, Christopher V.; Sage, Peter T.; Sciuto, Tracey E.; de la Fuente, Miguel A.; Geha, Raif S.; Ochs, Hans D.; Dvorak, Harold F.; Dvorak, Ann M.; Springer, Timothy A.			Transcellular diapedesis is initiated by invasive podosomes	IMMUNITY			English	Article							ENDOTHELIAL-CELLS; LYMPHOCYTE MIGRATION; NEUTROPHIL MIGRATION; SYNDROME PROTEIN; ADHESION; VENULES; ICAM-1; SIGNALS; PATHWAY; PATHOGENESIS	Diapedesis is critical for immune system function and inflammatory responses. This occurs by migration of blood leukocytes either directly through individual microvascular endothelial cells (the "transcellular" route) or between them (the "paracellular" route). Mechanisms for transcellular pore formation in endothelium remain unknown. Here we demonstrate that lymphocytes used podosomes and extended "invasive podosomes" to palpate the surface of, and ultimately form transcellular pores through, the endothelium. In lymphocytes, these structures were dependent on Src kinase and the actin regulatory protein WASP; inhibition of podosome formation selectively blocked the transcellular route of diapedesis. In endothelium, membrane fusion events dependent on the SNARE-containing membrane fusion complex and intracellular calcium were required for efficient transcellular pore formation in response to podosomes. These findings provide insights into basic mechanisms for leukocyte trafficking and the functions of podosomes.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, Boston, MA 02115 USA.	springer@cbr.med.harvard.edu	Carman, Christopher V./AAX-8995-2020; de la Fuente, Miguel A/C-7478-2013; Carman, Christopher/L-8108-2016	Carman, Christopher V./0000-0001-7358-2548; de la Fuente, Miguel A/0000-0003-4619-8756; Carman, Christopher/0000-0001-7358-2548	NCI NIH HHS [R37 CA031798, R37 CA031798-27] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031798] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamson P, 1999, J IMMUNOL, V162, P2964; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; DEBRUYN PPH, 1989, AM J ANAT, V186, P115, DOI 10.1002/aja.1001860202; DVORAK AM, 1993, IMMUNOPHARMACOLOGY M, P153; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Feng D, 2002, MICROSC RES TECHNIQ, V57, P289, DOI 10.1002/jemt.10087; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; FUJITA S, 1991, CANCER, V68, P2169, DOI 10.1002/1097-0142(19911115)68:10<2169::AID-CNCR2820681014>3.0.CO;2-F; GREENWOOD J, 1994, LAB INVEST, V70, P39; HUANG AJ, 1993, J CELL BIOL, V120, P1371, DOI 10.1083/jcb.120.6.1371; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; MARCHESI VT, 1961, Q J EXP PHYSIOL CMS, V46, P115, DOI 10.1113/expphysiol.1961.sp001522; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; NAGY JA, 1995, CANCER RES, V55, P360; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OLAH I, 1985, POULTRY SCI, V64, P159, DOI 10.3382/ps.0640159; RAINE CS, 1990, LAB INVEST, V63, P476; Richard L, 1998, EXP CELL RES, V240, P1, DOI 10.1006/excr.1998.3936; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wolburg H, 2005, ACTA NEUROPATHOL, V109, P181, DOI 10.1007/s00401-004-0928-x; WOLOSEWICK JJ, 1984, CELL TISSUE RES, V236, P517; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0	40	372	383	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					784	797		10.1016/j.immuni.2007.04.015	http://dx.doi.org/10.1016/j.immuni.2007.04.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17570692	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000247646900014
J	Wu, L; D'Amico, A; Winkel, KD; Suter, M; Lo, D; Shortman, K				Wu, L; D'Amico, A; Winkel, KD; Suter, M; Lo, D; Shortman, K			RelB is essential for the development of myeloid-related CD8 alpha(-) dendritic cells but not of lymphoid-related CD8 alpha(+) dendritic cells	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; LIGAND-TREATED MICE; T-CELLS; SURFACE-MARKERS; MOUSE THYMUS; IN-VIVO; EXPRESSION; MATURATION; PHENOTYPE; PATHWAYS	The transcription factor RelB had been shown to be important for dendritic cell (DC) development, but the type of DC involved was not clear. Here, we report that RelB mRNA is expressed strongly in CD8 alpha(-) DEC-205(-) DC but only weakly in CD8 alpha(+) DEC-205(+) DC. In addition, CD8 alpha(+) DEC-205(+) DC are present and functional in RelB null mice, the DC deficiency being mainly in the CD8 alpha(-) DEC-205(-) population. By constructing bone-marrow chimeric mice, we demonstrate that the partial deficiency in RelB null thymic DC is a secondary effect of disrupted thymic architecture. However, the deficiency in splenic CD8 alpha(-) DEC-205(-) DC is a direct, stem cell intrinsic effect of the RelB mutation. Thus, RelB selectively regulates a myeloid-related DC lineage.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Zurich, Inst Virol, CH-8057 Zurich, Switzerland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Zurich; Scripps Research Institute	Wu, L (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, PO, Melbourne, Vic 3050, Australia.		Winkel, Kenneth D./K-8489-2013	Winkel, Kenneth D./0000-0001-8282-6938				ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CROWLEY MT, 1998, IN PRESS DENDRITIC C; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Kronin V, 1996, J IMMUNOL, V157, P3819; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Pulendran B, 1997, J IMMUNOL, V159, P2222; Saunders D, 1996, J EXP MED, V184, P2185, DOI 10.1084/jem.184.6.2185; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Shortman K, 1997, STEM CELLS, V15, P409, DOI 10.1002/stem.150409; Snapper CM, 1996, J EXP MED, V184, P1537, DOI 10.1084/jem.184.4.1537; Strunk D, 1996, BLOOD, V87, P1292, DOI 10.1182/blood.V87.4.1292.bloodjournal8741292; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Vremec D, 1997, J IMMUNOL, V159, P565; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217	24	372	382	2	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					839	847		10.1016/S1074-7613(00)80649-4	http://dx.doi.org/10.1016/S1074-7613(00)80649-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881974	Bronze			2022-12-18	WOS:000077836600009
J	Liu, FL; Wu, HY; Wesselschmidt, R; Kornaga, T; Link, DC				Liu, FL; Wu, HY; Wesselschmidt, R; Kornaga, T; Link, DC			Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice	IMMUNITY			English	Article							PERIPHERAL-BLOOD; STEM-CELLS; IN-VIVO; ANNEXIN-V; INTERLEUKIN-6; KINETICS; INVIVO; GENE; PHOSPHATIDYLSERINE; PROGENITORS	We have generated mice carrying a homozygous null mutation in the granulocyte colony-stimulating factor receptor (G-CSFR) gene. G-CSFR-deficient mice have decreased numbers of phenotypically normal circulating neutrophils. Hematopoietic progenitors are decreased in the bone marrow, and the expansion and terminal differentiation of these progenitors into granulocytes is impaired. Neutrophils isolated from G-CSFR-deficient mice have an increased susceptibility to apoptosis, suggesting that the G-CSFR may also regulate neutrophil survival. These data confirm a role for the G-CSFR as a major regulator of granulopoiesis in vivo and provide evidence that the G-CSFR may regulate granulopoiesis by several mechanisms. However, the data also suggest that G-CSFR-independent mechanisms of granulopoiesis must exist.	WASHINGTON UNIV,SCH MED,DEPT MED,DIV BONE MARROW TRANSPLANTAT & STEM CELL BIOL,ST LOUIS,MO 63110	Washington University (WUSTL)								Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; BERLINER N, 1995, BLOOD, V85, P799, DOI 10.1182/blood.V85.3.799.bloodjournal853799; BUNGART B, 1990, BRIT J HAEMATOL, V76, P174, DOI 10.1111/j.1365-2141.1990.tb07868.x; CHATTA GS, 1994, BLOOD, V84, P2923; COLOTTA F, 1992, BLOOD, V80, P2012; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; DANDREA AD, 1994, CURR OPIN CELL BIOL, V6, P804, DOI 10.1016/0955-0674(94)90048-5; DEHAAN G, 1995, BLOOD, V86, P2986, DOI 10.1182/blood.V86.8.2986.bloodjournal8682986; DEMETRI GD, 1991, BLOOD, V78, P2791; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; GILMORE GL, 1995, EXP HEMATOL, V23, P1319; GRESHAM HD, 1991, J IMMUNOL, V146, P3911; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; HAYLOCK DN, 1992, BLOOD, V80, P1405; HOMBURG CHE, 1995, BLOOD, V85, P532; Hug BA, 1996, MOL CELL BIOL, V16, P2906; IKEBUCHI K, 1988, BLOOD, V72, P2007; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KOSTMANN RO, 1956, ACTA PAEDIATR SC   S, V105, P1; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; LORD BI, 1991, BLOOD, V77, P2154; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Price TH, 1996, BLOOD, V88, P335; REX JH, 1995, TRANSFUSION, V35, P605, DOI 10.1046/j.1537-2995.1995.35795357886.x; RODEL JE, 1996, BLOOD, V86, P858; SETO Y, 1992, J IMMUNOL, V148, P259; Seymour J. F., 1995, Blood, V86, p593A; SHIMODA K, 1992, RES EXP MED, V192, P245, DOI 10.1007/BF02576281; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; ULICH TR, 1989, BLOOD, V73, P108; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1	36	372	379	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					491	501		10.1016/S1074-7613(00)80504-X	http://dx.doi.org/10.1016/S1074-7613(00)80504-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934575	Bronze			2022-12-18	WOS:A1996VV65800009
J	Ansel, KM; Harris, RBS; Cyster, JG				Ansel, KM; Harris, RBS; Cyster, JG			CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity	IMMUNITY			English	Article							MESOTHELIAL CELLS; IMMUNOGLOBULIN-M; CHEMOKINE; MICE; EXPRESSION; RECEPTOR; B-1; DIFFERENTIATION; LYMPHOCYTES; PROTEIN	B1 cells are a predominant cell type in body cavities and an important source of natural antibody. Here we report that in mice lacking the chemokine, CXCL13, B1 cells are deficient in peritoneal and pleural cavities but not in spleen. CXCL13 is produced by cells in the omentum and by peritoneal macrophages, and in adoptive transfers, B1 cells home to the omentum and the peritoneal cavity in a CXCL13-dependent manner. CXCL13(-/-) mice are deficient in preexisting phosphorylcholine (PC)-specific antibodies and in their ability to mount an anti-PC response to peritoneal streptococcal antigen. These findings provide insight into the mechanism of B1 cell homing and establish a critical role for B1 cell compartmentalization in the production of natural antibodies and for body cavity immunity.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Georgia, Dept Foods & Nutr, Athens, GA 30602 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Georgia; University of Georgia	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	cyster@itsa.ucsf.edu			NIAID NIH HHS [AI45073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; AVRAMEAS S, 1995, RES IMMUNOL, V146, P235, DOI 10.1016/0923-2494(96)80259-8; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P601; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Chumley MJ, 2000, J IMMUNOL, V164, P4586, DOI 10.4049/jimmunol.164.9.4586; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 1999, CURR TOP MICROBIOL, V246, P87; DOHERTY NS, 1995, INFLAMM RES, V44, P169, DOI 10.1007/BF01782815; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; GEARHART PJ, 1975, J EXP MED, V141, P56, DOI 10.1084/jem.141.1.56; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Harris RBS, 1997, AM J PHYSIOL-REG I, V272, pR1800, DOI 10.1152/ajpregu.1997.272.6.R1800; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; HODEL C, 1970, EUR SURG RES, V2, P435, DOI 10.1159/000127543; Ishikawa S, 2001, J EXP MED, V193, P1393, DOI 10.1084/jem.193.12.1393; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; LIEBERMAN R, 1974, J EXP MED, V139, P983, DOI 10.1084/jem.139.4.983; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; NAKATANI T, 1988, ANAT REC, V220, P132, DOI 10.1002/ar.1092200204; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; PECQUET SS, 1992, INFECT IMMUN, V60, P503, DOI 10.1128/IAI.60.2.503-509.1992; Qian Y, 2001, J IMMUNOL, V166, P2412, DOI 10.4049/jimmunol.166.4.2412; SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543; Suzuki S, 1998, EUR J IMMUNOL, V28, P3719, DOI 10.1002/(SICI)1521-4141(199811)28:11<3719::AID-IMMU3719>3.3.CO;2-F; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Williams R, 1986, Curr Probl Surg, V23, P789; Wortis HH, 2001, J IMMUNOL, V166, P2163, DOI 10.4049/jimmunol.166.4.2163	42	371	382	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2002	16	1					67	76		10.1016/S1074-7613(01)00257-6	http://dx.doi.org/10.1016/S1074-7613(01)00257-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825566	Bronze			2022-12-18	WOS:000173575700007
J	Chan, VWF; Meng, FY; Soriano, P; DeFranco, AL; Lowell, CA				Chan, VWF; Meng, FY; Soriano, P; DeFranco, AL; Lowell, CA			Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; FAMILY TYROSINE KINASE; SRC-FAMILY; NEGATIVE SELECTION; AUTOIMMUNE-DISEASE; CROSS-LINKING; T-CELL; ACTIVATION; PROTEIN; SYK	Lyn-deficient mice were generated to analyze the role of Lyn in B cell antigen receptor (BCR) signaling. These mice had a reduced number of peripheral B cells with a greater proportion of immature cells and a higher than normal turnover rate. Aged lyn(-/-) mice developed splenomegaly, produced autoantibodies, and had an expanded population of B lymphoblasts of the B1 lineage. Splenic B cells from young lyn(-/-) mice initiated early BCR signaling events, although in a delayed fashion. Unexpectedly, lyn(-/-) B cells exhibited an enhanced MAP kinase activation and an increased proliferative response to BCR engagement. Stimulation of lyn(-/-) B cells with intact and F(ab')(2) anti-IgM revealed defects in at least two mechanisms that negatively regulate BCR signaling, one of which involves Fc gamma RIIb1.	UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA; FRED HUTCHINSON CANC RES CTR, DIV MOL MED, SEATTLE, WA 98104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center			Chan, Vivien W/N-7980-2019; Soriano, Philippe M/E-5797-2015; Chan, Vivien/C-2166-2014	Chan, Vivien W/0000-0001-7663-1130; Soriano, Philippe M/0000-0002-0427-926X; Chan, Vivien/0000-0001-7663-1130	NHLBI NIH HHS [HL54476] Funding Source: Medline; NIAID NIH HHS [AI20038] Funding Source: Medline; NIDDK NIH HHS [DK50267] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020038, R56AI020038, R01AI020038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050267] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi M, 1996, CELL, V85, P15; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; Bewarder N, 1996, MOL CELL BIOL, V16, P4735; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BURG DL, 1994, J BIOL CHEM, V269, P28136; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Crowley MT, 1996, J BIOL CHEM, V271, P1145, DOI 10.1074/jbc.271.2.1145; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DAVIDSON WF, 1979, J IMMUNOL, V122, P884; DEFRANCO AL, 1995, SCIENCE, V268, P263, DOI 10.1126/science.7716518; DEFRANCO AL, 1982, J EXP MED, V155, P1523, DOI 10.1084/jem.155.5.1523; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; DEFRANCO AL, 1994, CURR OPIN IMMUNOL, V6, P364, DOI 10.1016/0952-7915(94)90114-7; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; GOLD MR, 1992, BIOCHEM J, V287, P269, DOI 10.1042/bj2870269; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HIBBS ML, 1995, GENE, V156, P175, DOI 10.1016/0378-1119(95)00022-X; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KUMAR G, 1995, BIOCHEM J, V307, P215, DOI 10.1042/bj3070215; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; LAW DA, 1993, CURR BIOL, V3, P645, DOI 10.1016/0960-9822(93)90062-S; LAW DA, 1992, MOL IMMUNOL, V29, P917, DOI 10.1016/0161-5890(92)90130-P; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NAGAI K, 1995, J BIOL CHEM, V270, P6824, DOI 10.1074/jbc.270.12.6824; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; PEZZUTTO A, 1987, J IMMUNOL, V138, P98; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1994, CURR OPIN IMMUNOL, V6, P3, DOI 10.1016/0952-7915(94)90026-4; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SAXTON TM, 1994, J IMMUNOL, V153, P623; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; SEFTON BM, 1994, CURR OPIN IMMUNOL, V6, P372, DOI 10.1016/0952-7915(94)90115-5; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WECHSLER RJ, 1995, J IMMUNOL, V154, P3234; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	63	371	374	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1997	7	1					69	81		10.1016/S1074-7613(00)80511-7	http://dx.doi.org/10.1016/S1074-7613(00)80511-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252121	Bronze			2022-12-18	WOS:A1997XN69300007
J	Rolink, A; Melchers, F; Andersson, J				Rolink, A; Melchers, F; Andersson, J			The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching	IMMUNITY			English	Article							HUMAN B-CELLS; PROTEIN-TYROSINE PHOSPHORYLATION; ANTI-CD40 MONOCLONAL-ANTIBODY; GROWTH-FACTOR RECEPTOR; CD40 LIGAND; T-CELLS; INTERFERON-GAMMA; CROSS-LINKING; LYMPHOCYTES-B; MOUSE CD40	We have investigated the capacity of precursor B cells from normal (BDF1) and V(D)J recombinase-deficient (RAG-2T) or defective (SCID) mice to be induced by a CD40-specific monoclonal antibody and IL-4 to epsilon H chain gene transcription and to S mu-S epsilon switch recombination. In differentiating precursor B cells from all three strains of mice, the development of similar numbers of CD19(+), CD23(+), CD40(+), and MHC class II+ expressing B lineage cells and similar levels of epsilon H chain gene transcription were induced. Efficient S mu-S epsilon switching occurred in normal and RAG-2-deficient, but not in SCID, precursor B cells. Thus, the transcription of the epsilon H chain is independent of the RAG-2 and the SCID gene product, while the S mu-S epsilon switch recombination requires the SCID gene-encoded DNA-dependent protein kinase, but not the RAG-2 protein.	BASEL INST IMMUNOL, CH-4005 BASEL, SWITZERLAND									ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; ARMITAGE RJ, 1992, EUR J IMMUNOL, V22, P2071, DOI 10.1002/eji.1830220817; ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BARRETT TB, 1991, J IMMUNOL, V146, P1722; BERBERICH I, 1994, J IMMUNOL, V153, P4357; BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; Castigli E, 1996, INT IMMUNOL, V8, P405, DOI 10.1093/intimm/8.3.405; CASTLE BE, 1993, J IMMUNOL, V151, P1777; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; CLARK EA, 1990, TISSUE ANTIGENS, V36, P33, DOI 10.1111/j.1399-0039.1990.tb01795.x; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ESSER C, 1989, EMBO J, V8, P483, DOI 10.1002/j.1460-2075.1989.tb03401.x; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; GRAF D, 1992, EUR J IMMUNOL, V22, P3191, DOI 10.1002/eji.1830221226; Grawunder U, 1995, INT IMMUNOL, V7, P1915, DOI 10.1093/intimm/7.12.1915; GRAWUNDER U, 1993, EUR J IMMUNOL, V23, P544, DOI 10.1002/eji.1830230237; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; HOLDER MJ, 1993, EUR J IMMUNOL, V23, P2368, DOI 10.1002/eji.1830230948; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; JUMPER MD, 1994, J IMMUNOL, V152, P438; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KLAUS GGB, 1994, EUR J IMMUNOL, V24, P2714, DOI 10.1002/eji.1830241121; KNOX KA, 1993, EUR J IMMUNOL, V23, P2578, DOI 10.1002/eji.1830231030; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; LANE P, 1993, IMMUNOLOGY, V80, P56; LEPTIN M, 1985, EUR J IMMUNOL, V15, P131, DOI 10.1002/eji.1830150206; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; PARKHOUSE RME, 1992, IMMUNOLOGY, V76, P535; PAULIE S, 1989, J IMMUNOL, V142, P590; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672, DOI 10.1128/MCB.10.4.1672; ROY M, 1993, J IMMUNOL, V151, P2497; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; STAVNEZER J, 1985, J EXP MED, V161, P577, DOI 10.1084/jem.161.3.577; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TORRES RM, 1992, J IMMUNOL, V148, P620; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; UCKUN FM, 1991, J BIOL CHEM, V266, P17478; VALLE A, 1989, EUR J IMMUNOL, V19, P1463, DOI 10.1002/eji.1830190818; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; XU LX, 1994, INT IMMUNOL, V6, P515, DOI 10.1093/intimm/6.4.515; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; YELTON DE, 1981, HYBRIDOMA, V1, P5, DOI 10.1089/hyb.1.1981.1.5; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x; ZHANG K, 1992, J EXP MED, V176, P233, DOI 10.1084/jem.176.1.233; ZHANG K, 1991, J IMMUNOL, V146, P1836	75	370	382	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1996	5	4					319	330		10.1016/S1074-7613(00)80258-7	http://dx.doi.org/10.1016/S1074-7613(00)80258-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VP444	8885865	Bronze			2022-12-18	WOS:A1996VP44400004
J	Radtke, F; Fasnacht, N; MacDonald, HR				Radtke, Freddy; Fasnacht, Nicolas; MacDonald, H. Robson			Notch Signaling in the Immune System	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; REGULATORY T-CELLS; NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DELTA-LIKE 4; IN-VIVO; DENDRITIC CELLS; LINEAGE COMMITMENT	The Notch signaling pathway regulates many aspects of embryonic development, as well as differentiation processes and tissue homeostasis in multiple adult organ systems. Disregulation of Notch signaling is associated with several human disorders, including cancer. In the last decade, it became evident that Notch signaling plays important roles within the hematopoietic and immune systems. Notch plays an essential role in the development of embryonic hematopoietic stem cells and influences multiple lineage decisions of developing lymphoid and myeloid cells. Moreover, recent evidence suggests that Notch is an important modulator of T cell-mediated immune responses. In this review, we discuss Notch signaling in hematopoiesis, lymphocyte development, and function as well as in T cell acute lymphoblastic leukemia.	[Radtke, Freddy; Fasnacht, Nicolas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [MacDonald, H. Robson] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Ludwig Institute for Cancer Research; University of Lausanne	Radtke, F (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Stn 19, CH-1015 Lausanne, Switzerland.	freddy.radtke@epfl.ch	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045	Swiss national science foundation; Oncosuisse	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse	This work was in part supported by the Swiss national science foundation and Oncosuisse.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; Alves NL, 2009, TRENDS IMMUNOL, V30, P468, DOI 10.1016/j.it.2009.07.010; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; BERNSTEIN ID, 2008, BIOL BLOOD MARROW S1, V14, P94; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campese AF, 2009, INT IMMUNOL, V21, P727, DOI 10.1093/intimm/dxp042; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Cho OH, 2009, J IMMUNOL, V182, P3380, DOI 10.4049/jimmunol.0802598; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Elyaman W, 2007, J IMMUNOL, V179, P5990, DOI 10.4049/jimmunol.179.9.5990; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Fiorini E, 2008, J IMMUNOL, V181, P8199, DOI 10.4049/jimmunol.181.12.8199; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jurynczyk M, 2008, J IMMUNOL, V180, P2634, DOI 10.4049/jimmunol.180.4.2634; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krawczyk CM, 2008, J IMMUNOL, V180, P7931, DOI 10.4049/jimmunol.180.12.7931; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Maillard I, 2006, BLOOD, V107, P3511, DOI 10.1182/blood-2005-08-3454; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MEDYOUF H, 2009, BLOOD; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Morgan TH, 1917, AM NAT, V51, P513, DOI 10.1086/279629; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Olivier A, 2006, BLOOD, V107, P2694, DOI 10.1182/blood-2005-03-0970; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; REYNOLDS TC, 1987, CELL, V50, P107, DOI 10.1016/0092-8674(87)90667-2; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Worsley AGF, 2008, EUR J IMMUNOL, V38, P1043, DOI 10.1002/eji.200737335; Wu L, 2007, BLOOD, V110, P3618, DOI 10.1182/blood-2007-06-097030; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	127	369	394	1	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					14	27		10.1016/j.immuni.2010.01.004	http://dx.doi.org/10.1016/j.immuni.2010.01.004			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152168	Bronze			2022-12-18	WOS:000274119900008
J	Deane, JA; Pisitkun, P; Barrett, RS; Feigenbaum, L; Town, T; Ward, JM; Flavell, RA; Bolland, S				Deane, Jonathan A.; Pisitkun, Prapaporn; Barrett, Rebecca S.; Feigenbaum, Lionel; Town, Terrence; Ward, Jerrold M.; Flavell, Richard A.; Bolland, Silvia			Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACTIVATE B-CELLS; MURINE LUPUS; AUTOANTIBODY PRODUCTION; DEFICIENT MICE; I INTERFERON; TLR7; RNA; INDUCTION; RESPONSES	Nucleic acid-binding innate immune receptors such as Toll-like receptor 7 (TLR7) and TLR9 have been implicated in the development of some autoimmune pathologies. The Y chromosome-linked genomic modifier Yaa, which correlates with a duplication of Tlr7 and 16 other genes, exacerbates lupus-like syndromes in several mouse strains. Here we demonstrated that duplication of the Tlr7 gene was the sole requirement for this accelerated autoimmunity, because reduction of Tlr7 gene dosage abolished the Yaa phenotype. Further, we described new transgenic lines that overexpressed TLR7 alone and found that spontaneous autoimmunity developed beyond a 2-fold increase in TLR7 expression. Whereas a modest increase in Tlr7 gene dosage promoted autoreactive lymphocytes with RNA specificities and myeloid cell proliferation, a substantial increase in TLR7 expression caused fatal acute inflammatory pathology and profound dendritic cell dysregulation. These results underscore the importance of tightly regulating expression of TLR7 to prevent spontaneous triggering of harmful autoreactive and inflammatory responses.	Immunogenet Lab, Rockville, MD 20852 USA; NIAID, NIH, Infect Dis Pathogenesis Sect, Comparat Med Branch, Rockville, MD 20852 USA; NCI, NIH, Sci Applicat Int Corp, Lab Anim Sci Program, Ft Detrick, MD 21702 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Yale University	Bolland, S (corresponding author), Immunogenet Lab, Rockville, MD 20852 USA.	sbolland@nih.gov			Intramural NIH HHS [Z01 AI000912-06] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000912] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amano H, 2005, ARTHRITIS RHEUM-US, V52, P2790, DOI 10.1002/art.21365; Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; D'Cruz DP, 2006, BMJ-BRIT MED J, V332, P890, DOI 10.1136/bmj.332.7546.890; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fields ML, 2006, J IMMUNOL, V176, P6491, DOI 10.4049/jimmunol.176.11.6491; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lartigue A, 2006, J IMMUNOL, V177, P1349, DOI 10.4049/jimmunol.177.2.1349; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Steinman RM, 2005, ADV EXP MED BIOL, V560, P83; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553	41	369	390	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	2007	27	5					801	810		10.1016/j.immuni.2007.09.009	http://dx.doi.org/10.1016/j.immuni.2007.09.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	17997333	Green Accepted, Bronze			2022-12-18	WOS:000251269000013
J	Negulescu, PA; Krasieva, TB; Khan, A; Kerschbaum, HH; Cahalan, MD				Negulescu, PA; Krasieva, TB; Khan, A; Kerschbaum, HH; Cahalan, MD			Polarity of T cell shape, motility, and sensitivity to antigen	IMMUNITY			English	Article							INTRACELLULAR CA2+ STORES; LYMPHOCYTES; ACTIVATION; THAPSIGARGIN; RELEASE; INFLUX	T cell activation requires contact with APCs. We used optical techniques to demonstrate T cell polarity on the basis of shape, motility, and localized sensitivity to antigen. An intracellular Ca2+ clamp showed that T cell shape and motility are extremely sensitive to changes in [Ca2+](i) (K-d = 200 nM), with immobilization and rounding occurring via a calcineurin-independent pathway. Ca2+-dependent immobilization prolonged T cell contact with the antigen-presenting B cell; buffering the [Ca2+](i) signal prevented the formation of stable cell pairs. Optical tweezers revealed spatial T cell sensitivity to antigen by controlling placement on the T cell surface of either B cells or alpha-CD3 MAb-coated beads. T cells were 4-fold more sensitive to contact made at the leading edge of the T cell compared with the tail. We conclude that motile T cells are polarized antigen sensors that respond physically to [Ca2+](i) signals to stabilize their interaction with APCs.	UNIV CALIF IRVINE,BECKMAN LASER INST & MED CLIN,IRVINE,CA 92717	University of California System; University of California Irvine	Negulescu, PA (corresponding author), UNIV CALIF IRVINE,DEPT PHYSIOL & BIOPHYS,IRVINE,CA 92717, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014609, R37NS014609] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41514] Funding Source: Medline; NINDS NIH HHS [NS14609] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADORINI L, 1988, P NATL ACAD SCI USA, V85, P5181, DOI 10.1073/pnas.85.14.5181; AGARWAL NGB, 1995, BIOPHYS J, V69, P1178; ARENCIBIA I, 1987, EXP CELL RES, V172, P124, DOI 10.1016/0014-4827(87)90099-1; BERNS MW, 1992, EXP CELL RES, V198, P375, DOI 10.1016/0014-4827(92)90395-O; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DILIBERTO PA, 1994, METHOD CELL BIOL, V40, P243; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; FOSKETT JK, 1988, AM J PHYSIOL, V255, pC566, DOI 10.1152/ajpcell.1988.255.4.C566; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; HESS SD, 1993, J IMMUNOL, V150, P2620; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; LECOMTE O, 1994, CELL IMMUNOL, V158, P376, DOI 10.1006/cimm.1994.1284; LEE JK, 1988, CELL, V55, P807, DOI 10.1016/0092-8674(88)90136-5; MANDEVILLE JTH, 1995, BIOPHYS J, V68, P1207, DOI 10.1016/S0006-3495(95)80336-X; Maxfield Frederick R., 1993, Trends in Cell Biology, V3, P386, DOI 10.1016/0962-8924(93)90088-I; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; SANCHEZMATEOS P, 1995, BLOOD, V86, P2238; SHIMIZU Y, 1991, FASEB J, V5, P2292, DOI 10.1096/fasebj.5.9.1860621; SJAASTAD MD, 1994, P NATL ACAD SCI USA, V91, P8214, DOI 10.1073/pnas.91.17.8214; SPRINGER TA, 1994, CELL, V76, P310; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; TAN JQ, 1995, J IMMUNOL, V154, P3742; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; THORP KM, 1994, IMMUNOLOGY, V81, P546; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	36	368	379	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1996	4	5					421	430		10.1016/S1074-7613(00)80409-4	http://dx.doi.org/10.1016/S1074-7613(00)80409-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630728	Bronze, Green Submitted			2022-12-18	WOS:A1996UM67800002
J	Vince, JE; Wong, WWL; Gentle, I; Lawlor, KE; Allam, R; O'Reilly, L; Mason, K; Gross, O; Ma, S; Guarda, G; Anderton, H; Castillo, R; Hacker, G; Silke, J; Tschopp, J				Vince, James E.; Wong, W. Wei-Lynn; Gentle, Ian; Lawlor, Kate E.; Allam, Ramanjaneyulu; O'Reilly, Lorraine; Mason, Kylie; Gross, Olaf; Ma, Stephen; Guarda, Greta; Anderton, Holly; Castillo, Rosa; Haecker, Georg; Silke, John; Tschopp, Juerg			Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation	IMMUNITY			English	Article							NF-KAPPA-B; PROGRAMMED NECROSIS; NALP3 INFLAMMASOME; CELL-DEATH; TNF; CIAP1; IL-1-BETA; RECEPTORS; COMPLEX; IDENTIFICATION	Interleukin-1 beta (IL-1 beta) is a potent inflammatory cytokine that is usually cleaved and activated by inflammasome-associated caspase-1. To determine whether IL-1 beta activation is regulated by inhibitor of apoptosis (IAP) proteins, we treated macrophages with an IAP-antagonist "Smac mimetic" compound or genetically deleted the genes that encode the three IAP family members cIAP1, cIAP2, and XIAP. After Toll-like receptor priming, IAP inhibition triggered cleavage of IL-1 beta that was mediated not only by the NLRP3-caspase-1 inflammasome, but also by caspase-8 in a caspase-1-independent manner. In the absence of IAPs, rapid and full generation of active IL-1 beta by the NLRP3-caspase-1 inflammasome, or by caspase-8, required the kinase RIP3 and reactive oxygen species production. These results demonstrate that activation of the cell death-inducing ripoptosome platform and RIP3 can generate bioactive IL-1 beta and implicate them as additional targets for the treatment of pathological IL-1-driven inflammatory responses.	[Vince, James E.; Wong, W. Wei-Lynn; Lawlor, Kate E.; O'Reilly, Lorraine; Mason, Kylie; Ma, Stephen; Anderton, Holly; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Vince, James E.; Allam, Ramanjaneyulu; Gross, Olaf; Guarda, Greta; Castillo, Rosa; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Wong, W. Wei-Lynn; Lawlor, Kate E.; O'Reilly, Lorraine; Mason, Kylie; Ma, Stephen; Anderton, Holly; Silke, John] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Gentle, Ian; Haecker, Georg] Inst Med Mikrobiol & Hyg, Abt Mikrobiol & Hyg, D-79104 Freiburg, Germany	Walter & Eliza Hall Institute; University of Lausanne; University of Melbourne	Vince, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	vince@wehi.edu.au	Guarda, Greta/G-1921-2011; Silke, John/B-7622-2008; Gentle, Ian/X-2888-2019; Gross, Olaf/E-4570-2010; Allam, Ramanjaneyulu/N-4053-2016; Wong, W. Wei-Lynn/A-6851-2015	Silke, John/0000-0002-7611-5774; Gentle, Ian/0000-0002-6707-7809; Gross, Olaf/0000-0001-8660-3619; Allam, Ramanjaneyulu/0000-0002-2789-3596; Wong, W. Wei-Lynn/0000-0003-3155-1211; Anderton, Holly/0000-0003-3913-9686; Guarda, Greta/0000-0001-9243-6116; Mason, Kylie/0000-0002-6238-4092; Lawlor, Kate/0000-0003-0471-6842	NHMRC [541901, 541902, 602516, 1009145]; Victorian State Government; Australian Government NHMRC IRIISS	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	Thanks to M. McKinlay and S.K. Chunduru for Smac mimetic compound (TetraLogic Pharmaceuticals) and D. Vaux, M. Leverkus, K. Schroder, and B. Croker for advice. We would also like to thank D. Huang (Walter and Eliza Hall Institute, Australia) for providing Bax and Bak knockout mice, V. Dixit (Genentech, USA) for Ripk3<SUP>-/-</SUP> mice, A. Strasser (Walter and Eliza Hall Institute, Australia) for Bid<SUP>-/-</SUP> mice, H. Korner (James Cook University, Australia) for Tnf<SUP>-/-</SUP> and Tnfrsfla<SUP>-/-</SUP> mice, B. Crocker (Waiter and Eliza Hall Institute, Australia) for the pEF IL-1-FLAG cDNA, and E. Latz (University of Massachusetts Medical School, USA) for the v-myc/v-raf immortalized macrophages. J.E.V. was supported by Human Frontiers and NHMRC C. J. Martin fellowships. G.H. is supported by a Deutsche Krebshilfe/Mildred Scheel-Stiftung grant and I.G. is supported by an EMBO Long Term Fellowship. J.S. is on the scientific advisory board at TetraLogic pharmaceuticals and is supported by NHMRC grants 541901, 541902, and 602516. L.O. is supported by NHMRC grant 1009145. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dynek JN, 2013, CANCER LETT, V332, P206, DOI 10.1016/j.canlet.2010.06.013; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gardam S, 2011, BLOOD, V117, P4041, DOI 10.1182/blood-2010-10-312793; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	62	367	382	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 24	2012	36	2					215	227		10.1016/j.immuni.2012.01.012	http://dx.doi.org/10.1016/j.immuni.2012.01.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365665	Green Accepted, Bronze			2022-12-18	WOS:000300812400010
J	Powell, JD; Delgoffe, GM				Powell, Jonathan D.; Delgoffe, Greg M.			The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism	IMMUNITY			English	Review							CLONAL ANERGY; TRANSCRIPTION FACTOR; CYCLE PROGRESSION; FOXP3 EXPRESSION; LYMPHOCYTE ACTIVATION; REGULATORY CELLS; CTLA-4 RECEPTORS; DENDRITIC CELLS; CUTTING EDGE; AMINO-ACIDS	In the two-signal model of T cell activation, the outcome of antigen recognition is determined by the integration of multiple cues in the immune microenvironment. mTOR is an evolutionarily conserved P13-kinase family member that plays a central role in integrating environmental cues in the form of amino acids, energy, and growth factors. Recently, an increasingly important role for mTOR in directing T cell activation and differentiation has become apparent. Here we review recent findings demonstrating the ability of mTOR to interpret signals in the immune microenvironment and program the generation of CD4(+) effector versus regulatory T cells, the generation of CD8(+) effector versus memory cells, T cell trafficking, and T cell activation versus anergy. The key theme to emerge from these studies is that the central role of mTOR provides a direct link between T cell metabolism and function.	[Powell, Jonathan D.; Delgoffe, Greg M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	poweljo@jhmi.edu	Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135	NIH [R01AI077610-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant R01AI077610-01A2. We thank D. Pardoll and R. Schwartz for their suggestions as well as the members of the J.D.P. lab.	Allen A, 2004, J IMMUNOL, V172, P4797, DOI 10.4049/jimmunol.172.8.4797; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cardoso CR, 2009, AM J PHYSIOL-GASTR L, V296, pG593, DOI 10.1152/ajpgi.90431.2008; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Colombetti S, 2002, J IMMUNOL, V169, P6178, DOI 10.4049/jimmunol.169.11.6178; Colombetti S, 2006, J IMMUNOL, V176, P2730, DOI 10.4049/jimmunol.176.5.2730; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hidayat S, 2003, BIOCHEM BIOPH RES CO, V301, P417, DOI 10.1016/S0006-291X(02)03052-8; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JENKINS MK, 1992, IMMUNOL TODAY, V13, P69, DOI 10.1016/0167-5699(92)90137-V; Jhun BS, 2005, BIOCHEM BIOPH RES CO, V332, P339, DOI 10.1016/j.bbrc.2005.04.126; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee JH, 2009, ANN DERMATOL, V21, P274, DOI 10.5021/ad.2009.21.3.274; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Mills RE, 2009, CELL CYCLE, V8, P545, DOI 10.4161/cc.8.4.7625; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Powell JD, 1999, J IMMUNOL, V162, P2775; Powell JD, 2006, CURR OPIN INVESTIG D, V7, P1002; Proud CG, 2007, BIOCHEM SOC T, V35, P1187, DOI 10.1042/BST0351187; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stephenson LM, 2005, J IMMUNOL, V175, P5178, DOI 10.4049/jimmunol.175.8.5178; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Swanson SJ, 2002, LANCET, V360, P1662, DOI 10.1016/S0140-6736(02)11606-0; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Vanasek TL, 2001, J IMMUNOL, V167, P5636, DOI 10.4049/jimmunol.167.10.5636; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510	103	367	382	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					301	311		10.1016/j.immuni.2010.09.002	http://dx.doi.org/10.1016/j.immuni.2010.09.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870173	Green Accepted, Bronze			2022-12-18	WOS:000282798500006
J	Van Parijs, L; Refaeli, Y; Lord, JD; Nelson, BH; Abbas, AK; Baltimore, D				Van Parijs, L; Refaeli, Y; Lord, JD; Nelson, BH; Abbas, AK; Baltimore, D			RETRACTED: Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death (Retracted article. See vol. 30, pg. 611, 2009)	IMMUNITY			English	Article; Retracted Publication							INTERLEUKIN-2 RECEPTOR-BETA; IMMUNE-RESPONSES; CHAIN; INDUCTION; APOPTOSIS; GROWTH; BCL-2; PHOSPHORYLATION; LYMPHOCYTES; BINDING	IL-2 is an important growth and survival factor for T lymphocytes but also sensitizes these cells to Fas-mediated activation-induced cell death (AICD). The molecular basis of these different effects of IL-2 was studied by introducing wild-type and mutant forms of the IL-2 receptor beta (IL-2R beta) chain that lacked specific signaling capacities into receptor-deficient T cells by retroviral gene transfer. Activation of Stat5 by IL-2 was found to be involved in T cell proliferation and promoted Pas ligand (FasL) expression and AICD. T cell survival was dependent on a receptor region that activated Akt and the expression of Bcl-2. Thus, distinct IL-2R beta chain signaling modules regulate T cell fate by stimulating growth and survival or by promoting apoptosis.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; Brigham & Womens Hosp, Div Immunol Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Washington, Virginia Mason Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	California Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Baltimore, D (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Nelson, Brad H/K-2622-2014	Nelson, Brad/0000-0002-4445-5539	NIAID NIH HHS [AI42100, AI35297] Funding Source: Medline; NIGMS NIH HHS [GM57931] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042100, P01AI035297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057931] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HAWLEY RG, 1994, GENE THER, V1, P136; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnson E W, 1995, J Back Musculoskelet Rehabil, V5, P3, DOI 10.3233/BMR-1995-5103; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Leonard WJ, 1996, ANNU REV MED, V47, P229; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lord JD, 1998, J IMMUNOL, V161, P4627; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; NABHOLZ M, 1995, IMMUNOBIOLOGY, V193, P259, DOI 10.1016/S0171-2985(11)80552-8; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Ravichandran KS, 1996, P NATL ACAD SCI USA, V93, P5275, DOI 10.1073/pnas.93.11.5275; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Van Parijs L, 1998, SCIENCE, V280, P243; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; VanParijs L, 1997, J IMMUNOL, V158, P3738; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Wang RD, 1996, EUR J IMMUNOL, V26, P2263, DOI 10.1002/eji.1830260944; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Zheng LX, 1998, J IMMUNOL, V160, P763	49	367	376	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	1999	11	3					281	288		10.1016/S1074-7613(00)80103-X	http://dx.doi.org/10.1016/S1074-7613(00)80103-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514006	Bronze			2022-12-18	WOS:000082918500003
J	Lyons, DS; Lieberman, SA; Hampl, J; Boniface, JJ; Chien, YH; Berg, LJ; Davis, MM				Lyons, DS; Lieberman, SA; Hampl, J; Boniface, JJ; Chien, YH; Berg, LJ; Davis, MM			A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists	IMMUNITY			English	Article							T-CELL RECEPTOR; SURFACE-PLASMON RESONANCE; LIPID-LINKED FORM; CLASS-I; ANTIGEN RECEPTOR; MHC COMPLEXES; RECOGNITION; SPECIFICITY; KINETICS; PROTEINS	T lymphocyte activation is mediated by the interaction of specific TCR with antigenic peptides bound to MHC molecules. Single amino acid substitutions are often capable of changing the effect of a peptide from stimulatory to antagonistic. Using surface plasmon resonance, we have analyzed the interaction between a complex consisting of variants of the MCC peptide bound to a mouse class II MHC (E(k)) and a specific TCR. Using both an improved direct binding method as well as a novel inhibition assay, we show that the affinities of three different antagonist peptide-E(k) complexes are similar to 10-50 times lower than that of the wild-type MCC-E(k) complex for the TCR, largely due to an increased off-rate. These results suggest that the biological effects of peptide antagonists and partial agonists may be largely based on kinetic parameters.	STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; HARVARD UNIV,DEPT MOL & CELLULAR BIOL,CAMBRIDGE,MA 02138	Howard Hughes Medical Institute; Stanford University; Harvard University	Lyons, DS (corresponding author), STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305, USA.			Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI019512] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19512] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALRAMADI BK, 1995, J IMMUNOL, V155, P662; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BONIFACE JJ, 1996, IN PRESS HDB EXPT IM; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; GOLDSTEIN A, 1987, MOL PHARMACOL, V31, P603; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; KANE KP, 1989, MOL IMMUNOL, V26, P759, DOI 10.1016/0161-5890(89)90036-9; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KHILKO SN, 1993, J BIOL CHEM, V268, P15425; Koenig Rolf, 1995, Journal of Experimental Medicine, V182, P779; KUBO RT, 1989, J IMMUNOL, V142, P2736; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; REAY PA, 1994, J IMMUNOL, V152, P3946; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Takemoto DK, 1996, VIROLOGY, V217, P452, DOI 10.1006/viro.1996.0139; VALLITUTTI S, 1995, NATURE, V375, P148; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; YOON ST, 1994, IMMUNITY, V1, P563	37	366	376	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					53	61		10.1016/S1074-7613(00)80309-X	http://dx.doi.org/10.1016/S1074-7613(00)80309-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758894	Bronze			2022-12-18	WOS:A1996UZ45400006
J	Martinez, GJ; Pereira, RM; Aijo, T; Kim, EY; Marangoni, F; Pipkin, ME; Togher, S; Heissmeyer, V; Zhang, YC; Crotty, S; Lamperti, ED; Ansel, KM; Mempel, TR; Lahdesmaki, H; Hogan, PG; Rao, A				Martinez, Gustavo J.; Pereira, Renata M.; Aijo, Tarmo; Kim, Edward Y.; Marangoni, Francesco; Pipkin, Matthew E.; Togher, Susan; Heissmeyer, Vigo; Zhang, Yi Chen; Crotty, Shane; Lamperti, Edward D.; Ansel, K. Mark; Mempel, Thorsten R.; Lahdesmaki, Harri; Hogan, Patrick G.; Rao, Anjana			The Transcription Factor NFAT Promotes Exhaustion of Activated CD8(+) T Cells	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; REGULATES PD-1 EXPRESSION; MOLECULAR-MECHANISMS; TOLERANCE; TIM-3; DNA; CALCINEURIN; PROTEINS; CALCIUM; MEMORY	During persistent antigen stimulation, CD8(+) T cells show a gradual decrease in effector function, referred to as exhaustion, which impairs responses in the setting of tumors and infections. Here we demonstrate that the transcription factor NFAT controls the program of T cell exhaustion. When expressed in cells, an engineered form of NFAT1 unable to interact with AP-1 transcription factors diminished T cell receptor (TCR) signaling, increased the expression of inhibitory cell surface receptors, and interfered with the ability of CD8(+) T cells to protect against Listeria infection and attenuate tumor growth in vivo. We defined the genomic regions occupied by endogenous and engineered NFAT1 in primary CD8(+) T cells and showed that genes directly induced by the engineered NFAT1 overlapped with genes expressed in exhausted CD8(+) T cells in vivo. Our data show that NFAT promotes T cell anergy and exhaustion by binding at sites that do not require cooperation with AP-1.	[Martinez, Gustavo J.; Pereira, Renata M.; Aijo, Tarmo; Pipkin, Matthew E.; Togher, Susan; Hogan, Patrick G.; Rao, Anjana] La Jolla Inst Allergy & Immunol, Dept Signaling & Gene Express, La Jolla, CA 92037 USA; [Aijo, Tarmo; Lahdesmaki, Harri] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Aalto 00076, Finland; [Kim, Edward Y.; Marangoni, Francesco; Mempel, Thorsten R.] Harvard Univ, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol,Med Sch, Boston, MA 02114 USA; [Pipkin, Matthew E.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Heissmeyer, Vigo] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Zhang, Yi Chen] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Radiol, New York, NY 10019 USA; [Crotty, Shane] La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA; [Lamperti, Edward D.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lamperti, Edward D.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA	La Jolla Institute for Immunology; Aalto University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Scripps Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; La Jolla Institute for Immunology; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of California System; University of California San Francisco	Lahdesmaki, H (corresponding author), Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Aalto 00076, Finland.	harri.lahdesmaki@aalto.fi; arao@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Marangoni, Francesco/I-9087-2012; Pereira, Renata/V-6194-2019	Crotty, Shane/0000-0002-6484-6262; Marangoni, Francesco/0000-0002-2490-849X; Pereira, Renata/0000-0002-7719-8356; Martinez, Gustavo/0000-0003-0178-3329; Pipkin, Matthew/0000-0002-9688-0190; Aijo, Tarmo/0000-0002-3008-4634; Heissmeyer, Vigo/0000-0002-2263-8545	NIH [R01 CA42471, R01 AI40127, AI84167, R01 CA150975, U19 CA179563, R01 AI095634]; EU FP7 [EC-FP7-SYBILLA-201106]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; German Research foundation [SFB 1054 TP A03]; Leukemia & Lymphoma Society; Jane Coffin Childs Memorial Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Finnish Doctoral Programme in Computational Sciences FICS; NATIONAL CANCER INSTITUTE [R01CA042471, U19CA179563, R01CA150975] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109976, R01AI109842, R01AI040127, R01AI084167, R01AI095634, R01AI072543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU FP7(European Commission); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; German Research foundation(German Research Foundation (DFG)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Jane Coffin Childs Memorial Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Finnish Doctoral Programme in Computational Sciences FICS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Stephan Feske and Ariel Quintana for help with calcium influx experiments, Drs. Camille Fos and Sara Trifari for help with signaling experiments, Ryan Hastie for help in maintaining the colony, and Drs. Runqiang Chen and James Scott-Browne for providing retroviral constructs containing shCD4 and shNFAT4. We thank C. Kim, K. Gunst, and L. Nosworthy at the La Jolla Institute Flow Cytometry Facility for help with cell sorting experiments and Dr. G. Seumois and J. Day of the La Jolla Institute Sequencing facility, and the Genomics Core at The Scripps Research Institute in Florida for help with next- generation sequencing. This work was funded by NIH grants R01 CA42471 (to A.R.), R01 AI40127 and AI84167 (to P.G.H. and A.R.), R01 CA150975 and U19 CA179563 ( to T.R.M), and R01 AI095634 ( to M.E.P.), by EU FP7 grant EC-FP7-SYBILLA-201106 and the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (to T.A. and H.L.), and by German Research foundation SFB 1054 TP A03 (to V.H.), and The Leukemia & Lymphoma Society (to K.M.A.). G.J.M. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund, R.M.P. by a postdoctoral fellowship from the Pew Latin American Fellows Program in the Biomedical Sciences, and T.A. by a graduate student fellowship from by the Finnish Doctoral Programme in Computational Sciences FICS.	Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Fehr T, 2010, BLOOD, V115, P1280, DOI 10.1182/blood-2009-07-230680; Giffin MJ, 2003, NAT STRUCT BIOL, V10, P800, DOI 10.1038/nsb981; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joshi RP, 2013, INT J MOL SCI, V14, P6649, DOI 10.3390/ijms14046649; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marangoni F, 2013, IMMUNITY, V38, P237, DOI 10.1016/j.immuni.2012.09.012; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoon SJ, 2011, MOL IMMUNOL, V48, P1778, DOI 10.1016/j.molimm.2011.05.004	48	365	372	9	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					265	278		10.1016/j.immuni.2015.01.006	http://dx.doi.org/10.1016/j.immuni.2015.01.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680272	Green Accepted, Bronze			2022-12-18	WOS:000349916400011
J	Akiyama, T; Shimo, Y; Yanai, H; Qin, J; Ohshima, D; Maruyama, Y; Asaumi, Y; Kitazawa, J; Takayanagi, H; Penninger, JM; Matsumoto, M; Nitta, T; Takahama, Y; Inoue, J				Akiyama, Taishin; Shimo, Yusuke; Yanai, Hiromi; Qin, Junwen; Ohshima, Daisuke; Maruyama, Yuya; Asaumi, Yukiko; Kitazawa, Juli; Takayanagi, Hiroshi; Penninger, Josef M.; Matsumoto, Mitsuru; Nitta, Takeshi; Takahama, Yousuke; Inoue, Jun-ichiro			The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance	IMMUNITY			English	Article							NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; EPITHELIAL-CELLS; LYMPHOTOXIN PATHWAY; KINASE-ALPHA; IKK-ALPHA; T-CELLS; ACTIVATION PATHWAYS; NEGATIVE SELECTION; AIRE EXPRESSION	Medullary thymic epithelial cells (mTECs) establish T cell self-tolerance through the expression of autoimmune regulator (Aire) and peripheral tissue-specific self-antigens. However, signals underlying mTEC development remain largely unclear. Here, we demonstrate crucial regulation of mTEC development by receptor activator of NF-kappa B (RANK) and CD40 signals. Whereas only RANK signaling was essential for mTEC development during embryogenesis, in postnatal mice, cooperation between CD40 and RANK signals was required for mTEC development to successfully establish the medullary microenvironment. Ligation of RANK or CD40 on fetal thymic stroma in vitro induced mTEC development in a tumor necrosis factor-associated factor 6 (TRAF6)-, NF-kappa B inducing kinase (NIK)-, and I kappa B kinase beta (IKK beta)-dependent manner. These results show that develop mental-stage-dependent cooperation between RANK and CD40 promotes mTEC development, thereby establishing self-tolerance.	[Akiyama, Taishin; Shimo, Yusuke; Yanai, Hiromi; Qin, Junwen; Ohshima, Daisuke; Maruyama, Yuya; Asaumi, Yukiko; Kitazawa, Juli; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo 1088639, Japan; [Akiyama, Taishin] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Nitta, Takeshi; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Tokushima University; Tokushima University	Akiyama, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, 4-6-1 Shirokane Dai, Tokyo 1088639, Japan.	taishin@ims.u-tokyo.ac.jp; jun-i@ims.u-tokyo.ac.jp	Takahama, Yousuke/A-5863-2010; Penninger, Josef M/I-6860-2013	Takahama, Yousuke/0000-0002-4992-9174; Penninger, Josef M/0000-0002-8194-3777; Shimo, Yusuke/0000-0003-4856-0579; Akiyama, Taishin/0000-0002-0341-6154	Japan Science and Technology Agency; Japanese Society for the Promotion of Science; Priority Area Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Institute of Molecular Biotechnology of the Austrian Academy Sciences; European Commission; EURO-THYMAIDE	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Priority Area Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Molecular Biotechnology of the Austrian Academy Sciences; European Commission(European CommissionEuropean Commission Joint Research Centre); EURO-THYMAIDE	This work was supported by a grand-in-aid for scientific research from the Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (T.A.); a grant from the Japanese Society for the Promotion of Science (T.A.); grants for Priority Area Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.A. and J.I.) and a grant for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (J.I.). J.M.P. is supported by Institute of Molecular Biotechnology of the Austrian Academy Sciences and by a grant by the European Commission, EURO-THYMAIDE. The authors thank R. Whittier for critical reading of the manuscript and other laboratory members for technical help and useful discussion.	Aaltonen J, 1999, ANN MED, V31, P111, DOI 10.3109/07853899708998786; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dunn RJ, 1997, J HISTOCHEM CYTOCHEM, V45, P129, DOI 10.1177/002215549704500116; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Qin J, 2007, J IMMUNOL, V179, P6799, DOI 10.4049/jimmunol.179.10.6799; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Seach N, 2008, J IMMUNOL, V180, P5384, DOI 10.4049/jimmunol.180.8.5384; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326; Zuklys S, 2000, J IMMUNOL, V165, P1976, DOI 10.4049/jimmunol.165.4.1976	56	365	380	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					423	437		10.1016/j.immuni.2008.06.015	http://dx.doi.org/10.1016/j.immuni.2008.06.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799149	Bronze			2022-12-18	WOS:000259708900013
J	Luther, SA; Lopez, T; Bai, W; Hanahan, D; Cyster, JG				Luther, SA; Lopez, T; Bai, W; Hanahan, D; Cyster, JG			BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis	IMMUNITY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; TRANSGENIC MICE; BETA-RECEPTOR; DEFICIENT MICE; T-CELL; CHEMOKINE; INFLAMMATION; ORGANS; LYMPHOCYTES	CXCR5, the receptor for B lymphocyte chemoattractant (BLC), is required for normal development of Peyer's patches, inguinal lymph nodes, and splenic follicles. To test the in vivo activity of BLC in isolation of other lymphoid organizers, transgenic mice were generated expressing BLC in the pancreatic islets. In addition to attracting B cells, BLC expression led to development of lymph node-like structures that contained B and T cell zones, high endothelial venules, stromal cells, and the chemokine SLC. Development of these features was strongly dependent on B lymphocytes and on lymphotoxin alpha 1 beta 2 and could be reversed by blocking lymphotoxin alpha 1 beta 2. These findings establish that BLC is sufficient to activate a pathway of events leading to formation of organized lymphoid tissue.	Univ Calif San Francisco, Hormone Res Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Hormone Res Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Hormone Res Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.		Luther, Sanjiv/AAP-6525-2020; Luther, Sanjiv A/B-4380-2016; , Sanjiv/B-4380-2016	Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; , Sanjiv/0000-0002-0614-561X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45073] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON J, 1992, EUR J IMMUNOL, V22, P1115, DOI 10.1002/eji.1830220503; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; CAMPBELL IL, 1994, AM J PATHOL, V145, P157; Cuff CA, 1999, J IMMUNOL, V162, P5965; CUFF CA, 1996, J IMMUNOL, V161, P6863; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DegliEsposti MA, 1997, J IMMUNOL, V158, P1756; DICOSMO BF, 1994, INT IMMUNOL, V6, P1829, DOI 10.1093/intimm/6.12.1829; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grewal IS, 1997, J IMMUNOL, V159, P401; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hochman PS, 1996, J INFLAMM, V46, P220; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; MCNAGNY KM, 1991, EUR J IMMUNOL, V21, P509, DOI 10.1002/eji.1830210238; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mueller R, 1997, LAB INVEST, V76, P117; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nishikawa S, 1998, CYTOKINE GROWTH F R, V9, P213, DOI 10.1016/S1359-6101(98)00014-8; Olson DC, 1998, CELL GROWTH DIFFER, V9, P557; Peschon JJ, 1998, J IMMUNOL, V160, P943; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Sacca R, 1997, J IMMUNOL, V159, P4252; Sacca R, 1998, J IMMUNOL, V160, P485; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; Togni PD, 1994, SCIENCE, V264, P703; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634, DOI 10.1002/jlb.62.5.634; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	49	365	380	3	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2000	12	5					471	481		10.1016/S1074-7613(00)80199-5	http://dx.doi.org/10.1016/S1074-7613(00)80199-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843380	Bronze			2022-12-18	WOS:000087356400003
J	Wang, HY; Lee, DA; Peng, GY; Guo, Z; Li, YC; Kiniwa, Y; Shevach, EM; Wang, RF				Wang, HY; Lee, DA; Peng, GY; Guo, Z; Li, YC; Kiniwa, Y; Shevach, EM; Wang, RF			Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy	IMMUNITY			English	Article							LUNG-CANCER; ANTIGEN; IDENTIFICATION; TOLERANCE; RESPONSES; IMMUNITY; AUTOIMMUNITY; INDUCTION; MECHANISM; BREAST	Regulatory T cells play an important role in the maintenance of immunological self-tolerance by suppressing immune responses against autoimmune diseases and cancer. Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells. Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients. Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4+ T cells to anti-CD3 antibody stimulation. Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4+ effector cells. These findings suggest that the presence of tumor-specific CD4(+) Treg cells at tumor sites may have a profound effect on the inhibition of T cell responses against cancer.	Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rongfuw@bcm.tmc.edu	Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000224, ZIAAI000224] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Houghton AN, 2001, CURR OPIN IMMUNOL, V13, P134, DOI 10.1016/S0952-7915(00)00195-3; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Levin S, 2002, FAM COMMUNITY HEALTH, V25, P10, DOI 10.1097/00003727-200210000-00005; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; MACDIC M, 2003, CANCER RES, V63, P6506; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McKee MD, 2000, J IMMUNOTHER, V23, P419, DOI 10.1097/00002371-200007000-00005; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Slager EH, 2003, J IMMUNOL, V170, P1490, DOI 10.4049/jimmunol.170.3.1490; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; VONHERRATH MG, 2003, NAT REV IMMUNOL, V22, P269; Wang HY, 2002, J EXP MED, V195, P1397, DOI 10.1084/jem.20020141; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wang RF, 1999, J EXP MED, V189, P1659, DOI 10.1084/jem.189.10.1659; Wang RF, 2002, IMMUNOL REV, V188, P65, DOI 10.1034/j.1600-065X.2002.18807.x; Wang RF, 1998, J IMMUNOL, V161, P3596; Wang RF, 2001, TRENDS IMMUNOL, V22, P269, DOI 10.1016/S1471-4906(01)01896-8; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Woo EY, 2001, CANCER RES, V61, P4766; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027	42	364	397	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					107	118		10.1016/S1074-7613(03)00359-5	http://dx.doi.org/10.1016/S1074-7613(03)00359-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738769	Bronze			2022-12-18	WOS:000221442200011
J	D'Adamio, F; Zollo, O; Moraca, R; Ayroldi, E; Bruscoli, S; Bartoli, A; Cannarile, L; Migliorati, G; Riccardi, C				D'Adamio, F; Zollo, O; Moraca, R; Ayroldi, E; Bruscoli, S; Bartoli, A; Cannarile, L; Migliorati, G; Riccardi, C			A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death	IMMUNITY			English	Article							INDUCED APOPTOSIS; THYMOCYTE APOPTOSIS; IL-2 PROTECTS; ACTIVATION; EXPRESSION; FAS; ENDONUCLEASE; DISEASE; ACID; AP-1	By comparing mRNA species expressed in dexamethasone (DEX)-treated and untreated murine thymocytes, we have identified a gene, glucocorticoid-induced leucine zipper (GILZ), encoding a new member of the leucine zipper family. GILZ was found expressed in normal lymphocytes from thymus, spleen, and lymph nodes, whereas low or no expression was detected in other nonlymphoid tissues, including brain, kidney, and liver. In thymocytes and peripheral T cells, GILZ gene expression is induced by DEX. Furthermore, GILZ expression selectively protects T cells from apoptosis induced by treatment with anti-CD3 monoclonal antibody but not by treatment with other apoptotic stimuli. This antiapoptotic effect correlates with inhibition of Fas and Fas ligand expression. Thus, GILZ is a candidate transcription factor involved in the regulation of apoptosis of T cells.	Univ Perugia, Dept Clin Med Pathol & Pharmacol, Pharmacol Sect, I-06100 Perugia, Italy	University of Perugia	Riccardi, C (corresponding author), Univ Perugia, Dept Clin Med Pathol & Pharmacol, Pharmacol Sect, Via Giochetto, I-06100 Perugia, Italy.	riccardi@unipg.it	Riccardi, Carlo/N-4610-2014	Riccardi, Carlo/0000-0001-9257-3997; bruscoli, stefano/0000-0003-0313-1615; MIGLIORATI, Graziella/0000-0002-9475-6399; Ayroldi, Emira/0000-0002-9073-7297; Bartoli, Andrea/0000-0002-9082-5801				Akbar AN, 1997, IMMUNOL TODAY, V18, P72, DOI 10.1016/S0167-5699(97)01003-7; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Ayroldi E, 1997, BLOOD, V89, P3717, DOI 10.1182/blood.V89.10.3717.3717_3717_3726; AYROLDI E, 1995, BLOOD, V86, P2672; BANSAL N, 1991, FASEB J, V5, P211, DOI 10.1096/fasebj.5.2.2004665; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; COHEN JJ, 1984, J IMMUNOL, V132, P38; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; GOLDSTONE SD, 1994, ONCOGENE, V9, P2305; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HURST HC, 1994, PROTEIN PROFILE, V1, P123; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JENKINSON EJ, 1989, EUR J IMMUNOL, V19, P2175, DOI 10.1002/eji.1830191132; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KING LB, 1995, IMMUNITY, V3, P647, DOI 10.1016/1074-7613(95)90135-3; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MARZLUFF WF, 1985, TRANSCRIPTION TRANSL, P89; MIGLIORATI G, 1993, BLOOD, V81, P1352; NICHOLAS SF, 1991, CELL, V64, P739; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NIETO MA, 1989, J IMMUNOL, V143, P4166; NIETO MA, 1990, J IMMUNOL, V145, P1364; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Osborne Barbara A., 1994, Trends in Cell Biology, V4, P394; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; TAKASHI S, 1996, BIOCHEMISTRY-US, V93, P2920; TAN Y, 1994, MOL CELL BIOL, V14, P7546, DOI 10.1128/MCB.14.11.7546; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YANG Y, 1995, J BIOL CHEM, V270, P18672, DOI 10.1074/jbc.270.31.18672; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037	52	364	373	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1997	7	6					803	812		10.1016/S1074-7613(00)80398-2	http://dx.doi.org/10.1016/S1074-7613(00)80398-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430225	Bronze			2022-12-18	WOS:000071351300007
J	HENKART, PA				HENKART, PA			LYMPHOCYTE-MEDIATED CYTOTOXICITY - 2 PATHWAYS AND MULTIPLE EFFECTOR MOLECULES	IMMUNITY			English	Article							ANTIGEN; CELLS; MICE				HENKART, PA (corresponding author), NCI,EXPTL IMMUNOL BRANCH,BLDG 10,BETHESDA,MD 20892, USA.							ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; BERKE G, 1991, IMMUNOL TODAY, V12, P396, DOI 10.1016/0167-5699(91)90138-J; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; HANABUCHI S, 1994, P NATL ACAD SCI USA, V91, P4930, DOI 10.1073/pnas.91.11.4930; HENKART PA, 1994, IN PRESS CURR TOPICS; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; JU ST, 1994, P NATL ACAD SCI USA, V91, P4185, DOI 10.1073/pnas.91.10.4185; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, IN PRESS SCIENCE; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; LANCKI DW, 1991, J IMMUNOL, V146, P3242; LYNCH DH, 1994, IMMUNITY, V1, P131, DOI 10.1016/1074-7613(94)90106-6; MORGAN BP, 1989, BIOCHEM J, V264, P1; NAKAJIMA H, 1994, J IMMUNOL, V152, P1057; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; STALDER T, 1994, J IMMUNOL, V152, P1127; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; VIGNAUX F, 1994, EUR J IMMUNOL, V24, P923, DOI 10.1002/eji.1830240421; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0	25	364	368	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					343	346		10.1016/1074-7613(94)90063-9	http://dx.doi.org/10.1016/1074-7613(94)90063-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882166				2022-12-18	WOS:A1994PK16800001
J	Esensten, JH; Helou, YA; Chopra, G; Weiss, A; Bluestone, JA				Esensten, Jonathan H.; Helou, Ynes A.; Chopra, Gaurav; Weiss, Arthur; Bluestone, Jeffrey A.			CD28 Costimulation: From Mechanism to Therapy	IMMUNITY			English	Review							REGULATORY T-CELLS; KAPPA-B ACTIVATION; TYROSINE PHOSPHORYLATION SITES; PROTEIN ARGININE METHYLATION; CUTTING EDGE; C-REL; PHOSPHATIDYLINOSITOL 3-KINASE; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; CYTOPLASMIC DOMAIN	Ligation of the CD28 receptor on T cells provides a critical second signal alongside T cell receptor (TCR) ligation for naive T cell activation. Here, we discuss the expression, structure, and biochemistry of CD28 and its ligands. CD28 signals play a key role in many T cell processes, including cytoskeletal remodeling, production of cytokines, survival, and differentiation. CD28 ligation leads to unique epigenetic, transcriptional, and post-translational changes in T cells that cannot be recapitulated by TCR ligation alone. We discuss the function of CD28 and its ligands in both effector and regulatory T cells. CD28 is critical for regulatory T cell survival and the maintenance of immune homeostasis. We outline the roles that CD28 and its family members play in human disease and we review the clinical efficacy of drugs that block CD28 ligands. Despite the centrality of CD28 and its family members and ligands to immune function, many aspects of CD28 biology remain unclear. Translation of a basic understanding of CD28 function into immunomodulatory therapeutics has been uneven, with both successes and failures. Such real-world results might stem from multiple factors, including complex receptor-ligand interactions among CD28 family members, differences between the mouse and human CD28 families, and cell-type specific roles of CD28 family members.	[Esensten, Jonathan H.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Helou, Ynes A.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA; [Chopra, Gaurav] Purdue Univ, Dept Chem, Purdue Ctr Drug Discovery, W Lafayette, IN 47907 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Esensten, JH (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.; Bluestone, JA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	jonathan.esensten@ucsf.edu; jeff.bluestone@ucsf.edu	Chopra, Gaurav/M-2327-2018	Chopra, Gaurav/0000-0003-0942-7898	Sean N. Parker Autoimmunity Research Laboratory; NIAID, NIH; NIH [RO1 AI114575]; JDRF [3-PDF-2014-205-A-N]; Purdue University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI114575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Sean N. Parker Autoimmunity Research Laboratory; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Purdue University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Sean N. Parker Autoimmunity Research Laboratory and the NIAID, NIH (J.A.B). This work was also supported in part by a grant from the NIH (RO1 AI114575, to A.W.). G.C. was supported by a JDRF fellowship award (3-PDF-2014-205-A-N) and acknowledges support from Purdue University start-up funds.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Alvarez-Quiroga C, 2011, J CLIN IMMUNOL, V31, P588, DOI 10.1007/s10875-011-9527-5; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Askanase AD, 2014, ARTHRITIS RHEUMATOL, V66, P3096, DOI 10.1002/art.38790; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Blanchet F, 2006, CURR OPIN IMMUNOL, V18, P321, DOI 10.1016/j.coi.2006.03.001; Bluestone JA, 2008, AM J TRANSPLANT, V8, P2086, DOI 10.1111/j.1600-6143.2008.02377.x; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Boise LH, 2010, J IMMUNOL, V185, P3788; BOLLING SF, 1994, J SURG RES, V57, P60, DOI 10.1006/jsre.1994.1110; Boomer JS, 2014, J IMMUNOL, V192, P3465, DOI 10.4049/jimmunol.1301240; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Borthwick NJ, 2000, INT IMMUNOL, V12, P1005, DOI 10.1093/intimm/12.7.1005; Boucher N, 1998, EXP GERONTOL, V33, P267, DOI 10.1016/S0531-5565(97)00132-0; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Broux B, 2012, TRENDS MOL MED, V18, P446, DOI 10.1016/j.molmed.2012.06.003; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Butte MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040032; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Cefai D, 1996, INT IMMUNOL, V8, P1609, DOI 10.1093/intimm/8.10.1609; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dilek N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083139; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Engelhardt JJ, 2006, J IMMUNOL, V177, P1052, DOI 10.4049/jimmunol.177.2.1052; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Ford ML, 2016, IMMUNITY, V44, P1020, DOI 10.1016/j.immuni.2016.04.012; Ford ML, 2014, NAT REV NEPHROL, V10, P14, DOI 10.1038/nrneph.2013.183; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Friend LD, 2006, J EXP MED, V203, P2121, DOI 10.1084/jem.20052230; Furie R, 2014, ARTHRITIS RHEUMATOL, V66, P379, DOI 10.1002/art.38260; Gardner DH, 2015, J IMMUNOL, V195, P2657, DOI 10.4049/jimmunol.1500306; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Girard T, 2014, IMMUNOL LETT, V161, P65, DOI 10.1016/j.imlet.2014.05.002; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Gu P, 2012, CELL MOL IMMUNOL, V9, P136, DOI 10.1038/cmi.2011.62; Guo F, 2008, J IMMUNOL, V181, P2285, DOI 10.4049/jimmunol.181.4.2285; Harada Y, 2001, J IMMUNOL, V166, P3797, DOI 10.4049/jimmunol.166.6.3797; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Hombach AA, 2007, J IMMUNOL, V179, P7924, DOI 10.4049/jimmunol.179.11.7924; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; JENKINS MK, 1988, J IMMUNOL, V140, P3324; JENKINS MK, 1991, J IMMUNOL, V147, P2461; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; King PD, 1997, J IMMUNOL, V158, P580; Klintmalm GB, 2014, AM J TRANSPLANT, V14, P1817, DOI 10.1111/ajt.12810; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Leitner J, 2015, J IMMUNOL, V195, P477, DOI 10.4049/jimmunol.1401917; Lekpa FK, 2012, JOINT BONE SPINE, V79, P47, DOI 10.1016/j.jbspin.2011.02.018; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Li CR, 2005, J IMMUNOL, V174, P4475, DOI 10.4049/jimmunol.174.8.4475; Liang YM, 2013, NAT IMMUNOL, V14, P858, DOI 10.1038/ni.2634; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Lohr J, 2003, NAT IMMUNOL, V4, P664, DOI 10.1038/ni939; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lu YN, 2012, BLOOD, V120, P4560, DOI 10.1182/blood-2012-04-421420; Lyddane C, 2006, J IMMUNOL, V176, P3306, DOI 10.4049/jimmunol.176.6.3306; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Maly K, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/348746; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Marinari B, 2004, P NATL ACAD SCI USA, V101, P6098, DOI 10.1073/pnas.0308688101; MARTIN PJ, 1986, J IMMUNOL, V136, P3282; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Mease P, 2011, ARTHRITIS RHEUM-US, V63, P939, DOI 10.1002/art.30176; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mirzoeva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101161; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; MUELLER DL, 1989, J IMMUNOL, V142, P2617; Muscolini M, 2015, J IMMUNOL, V194, P1323, DOI 10.4049/jimmunol.1401643; Njau MN, 2013, ADV EXP MED BIOL, V785, P67, DOI 10.1007/978-1-4614-6217-0_8; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Okkenhaug K, 1998, J BIOL CHEM, V273, P21194, DOI 10.1074/jbc.273.33.21194; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Pagan AJ, 2012, J IMMUNOL, V189, P2909, DOI 10.4049/jimmunol.1103231; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Parkin KG, 2002, J IMMUNOL, V169, P2292, DOI 10.4049/jimmunol.169.5.2292; Parulekar AD, 2013, AM J RESP CRIT CARE, V187, P494, DOI 10.1164/rccm.201207-1205OC; Pastor F, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.26; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Podojil JR, 2009, J IMMUNOL, V182, P766, DOI 10.4049/jimmunol.182.2.766; Poirier N, 2012, AM J TRANSPLANT, V12, P2630, DOI 10.1111/j.1600-6143.2012.04164.x; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Qu HQ, 2009, GENES IMMUN, V10, pS27, DOI 10.1038/gene.2009.88; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Ramachandran G, 2015, J INFECT DIS, V211, P995, DOI 10.1093/infdis/jiu556; Ramachandran G, 2013, J INFECT DIS, V207, P1869, DOI 10.1093/infdis/jit104; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; RAMOSMORALES F, 1995, ONCOGENE, V11, P1665; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Riley JL, 2002, P NATL ACAD SCI USA, V99, P11790, DOI 10.1073/pnas.162359999; Rochman Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122198; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P1792, DOI 10.1002/art.27431; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sabzevari H, 2001, J IMMUNOL, V166, P2505, DOI 10.4049/jimmunol.166.4.2505; Sadra A, 1999, J IMMUNOL, V162, P1966; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanchez-Lockhart M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089263; Sanchez-Lockhart M, 2011, J IMMUNOL, V187, P5515, DOI 10.4049/jimmunol.1102497; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Sandborn WJ, 2012, GASTROENTEROLOGY, V143, P62, DOI 10.1053/j.gastro.2012.04.010; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Schneider H, 2008, BIOCHEM BIOPH RES CO, V369, P616, DOI 10.1016/j.bbrc.2008.02.068; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427; Semple K, 2011, BLOOD, V117, P3096, DOI 10.1182/blood-2010-08-301275; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; STEIN PH, 1994, MOL CELL BIOL, V14, P3392, DOI 10.1128/MCB.14.5.3392; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takeda K, 2008, INT IMMUNOL, V20, P1507, DOI 10.1093/intimm/dxn108; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Thauland TJ, 2014, J IMMUNOL, V193, P5894, DOI 10.4049/jimmunol.1401752; Thaventhiran T, 2014, MABS-AUSTIN, V6, P1290, DOI 10.4161/mabs.29758; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Tian RJ, 2015, P NATL ACAD SCI USA, V112, pE1594, DOI 10.1073/pnas.1503286112; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; van Bergen J, 2009, J IMMUNOL, V182, P4175, DOI 10.4049/jimmunol.0800455; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Venuprasad K, 2001, EUR J IMMUNOL, V31, P1536, DOI 10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Vincenti F, 2010, J AM SOC NEPHROL, V21, P1587, DOI 10.1681/ASN.2009111109; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Watts TH, 2010, J IMMUNOL, V185, P3785, DOI 10.4049/jimmunol.1090085; WEISS A, 1986, J IMMUNOL, V137, P819; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Woerly G, 2004, CLIN EXP ALLERGY, V34, P1379, DOI 10.1111/j.1365-2222.2004.02036.x; Wofsy D, 2013, ARTHRITIS RHEUM-US, V65, P1586, DOI 10.1002/art.37940; WYSSCORAY T, 1993, EUR J IMMUNOL, V23, P2175, DOI 10.1002/eji.1830230919; Xu H, 2014, AM J TRANSPLANT, V14, P319, DOI 10.1111/ajt.12574; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Yong PFK, 2009, IMMUNOL REV, V229, P101, DOI 10.1111/j.1600-065X.2009.00764.x; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499	204	363	388	10	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					973	988		10.1016/j.immuni.2016.04.020	http://dx.doi.org/10.1016/j.immuni.2016.04.020			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192564	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000376478500002
J	Dorsett, Y; McBride, KM; Jankovic, M; Gazumyan, A; Thai, TH; Robbiani, DF; Di Virgilio, M; San-Martin, BR; Heidkamp, G; Schwickert, TA; Eisenreich, T; Rajewsky, K; Nussenzweig, MC				Dorsett, Yair; McBride, Kevin M.; Jankovic, Mila; Gazumyan, Anna; Thai, To-Ha; Robbiani, Davide F.; Di Virgilio, Michela; San-Martin, Bernardo Reina; Heidkamp, Gordon; Schwickert, Tanja A.; Eisenreich, Thomas; Rajewsky, Klaus; Nussenzweig, Michel C.			MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation	IMMUNITY			English	Article							CLASS SWITCH RECOMBINATION; KINASE-A PHOSPHORYLATION; B-CELL LYMPHOMAS; SOMATIC HYPERMUTATION; C-MYC; TRANSGENIC MICE; POSTTRANSCRIPTIONAL REGULATION; ANTIBODY DIVERSIFICATION; BURKITT-LYMPHOMA; GENE-EXPRESSION	MicroRNAs (miRNAs) are small noncoding RNAs that regulate vast networks of genes that share miRNA target sequences. To examine the physiologic effects of an individual miRNA-mRNA interaction in vivo, we generated mice that carry a mutation in the putative microRNA-155 (miR-155) binding site in the T-untranslated region of activation-induced cytidine deaminase (AID), designated Aicda(155) mice. AID Is required for immunoglobulin gene diversification in B lymphocytes, but it also promotes chromosomal translocations. Aicda(155) caused an increase in steady-state Aicda mRNA and protein amounts by increasing the half-life of the mRNA, resulting in a high degree of Myc-Igh translocations. A similar but more pronounced translocation phenotype was also found in miR-155-deficient mice. Our experiments indicate that miR-155 can act as a tumor suppressor by reducing potentially oncogenic translocations generated by AID.	[Dorsett, Yair; McBride, Kevin M.; Jankovic, Mila; Gazumyan, Anna; Robbiani, Davide F.; Di Virgilio, Michela; Heidkamp, Gordon; Schwickert, Tanja A.; Eisenreich, Thomas; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; [Thai, To-Ha; Rajewsky, Klaus] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; [San-Martin, Bernardo Reina] ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Rockefeller University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; mcbride, kevin/E-8230-2011; Di Virgilio, Michela/AAE-9298-2022; Robbiani, Davide F./AAF-7662-2019; Reina-San-Martin, Bernardo/I-9484-2016	Robbiani, Davide F./0000-0001-7379-3484; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Schwickert, Tanja/0000-0002-3371-2376; Rajewsky, Klaus/0000-0002-6633-6370; Di Virgilio, Michela/0000-0001-5189-0793	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345, R01AI037526] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI064345, R01 AI037526-07, R01 AI037526-10, R01 AI037526-13, R01 AI037526-09, R01 AI037526-14, R01 AI037526-06, R01 AI037526, R01 AI037526-15, AI06231, R01 AI064345, R01 AI037526-08, R01 AI037526-11, R01 AI037526-12] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Chatterji M, 2007, J IMMUNOL, V179, P5274, DOI 10.4049/jimmunol.179.8.5274; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Perez-Duran P, 2007, CARCINOGENESIS, V28, P2427, DOI 10.1093/carcin/bgm201; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wakae K, 2006, INT IMMUNOL, V18, P41, DOI 10.1093/intimm/dxh347; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	72	363	387	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					630	638		10.1016/j.immuni.2008.04.002	http://dx.doi.org/10.1016/j.immuni.2008.04.002			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18455451	Green Accepted, Bronze			2022-12-18	WOS:000256003900010
J	Wang, DM; Feng, J; Wen, RR; Marine, JC; Sangster, MY; Parganas, E; Hoffmeyer, A; Jackson, CW; Cleveland, JL; Murray, PJ; Ihle, JN				Wang, DM; Feng, J; Wen, RR; Marine, JC; Sangster, MY; Parganas, E; Hoffmeyer, A; Jackson, CW; Cleveland, JL; Murray, PJ; Ihle, JN			Phospholipase C gamma 2 is essential in the functions of B cell and several Fc receptors	IMMUNITY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; BRUTONS TYROSINE KINASE; PLATELET ACTIVATION; DEFICIENT MICE; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; LYMPHOCYTES-B; GAMMA-CHAIN; SRC FAMILY	Many receptors activate phospholipase C gamma 1 or -gamma 2. To assess the role of PLC gamma 2, we derived enzyme-deficient mice. The mice are viable but have decreased mature B cells, a block in pro-B cell differentiation, and B1 B cell deficiency. IgM receptor-induced Ca2+ flux and proliferation to B cell mitogens are absent. IgM, IgG2a, and IgG3 levels are reduced, and T cell-independent antibody production is absent. The similarity to Btk- or Blnk-deficient mice demonstrates that PLC gamma 2 is downstream in Btk/Blnk signaling. FcR gamma signaling is also defective, resulting in a loss of collagen-induced platelet aggregation, mast cell Fc epsilon R function, and NK cell Fc gamma RIII and 2B4 function. The results define a signal transduction pathway broadly utilized by immunoglobulin superfamily receptors.	St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Univ Tennessee, Sch Med, Dept Biochem, Memphis, TN 38063 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org	Marine, Jean Christophe/J-2237-2015; Marine, Jean-Christophe/K-3292-2016; Wang, Demin/AAX-4449-2020; Murray, Peter J/K-4725-2018	Marine, Jean-Christophe/0000-0003-2433-9837; Wang, Demin/0000-0001-5549-3795; Murray, Peter J/0000-0001-6329-9802; Sangster, Mark/0000-0002-1599-5894	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042932] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NHLBI NIH HHS [P01 HL53749] Funding Source: Medline; NIDDK NIH HHS [R01 DK42932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; HEMPEL WM, 1992, J IMMUNOL, V148, P3021; Hogan BLM, 1994, MANIPULATING MOUSE E; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; JI QS, 1997, MOL BIOL CELL, V9, P749; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; MIURA O, 1994, J BIOL CHEM, V269, P614; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SULTZMAN L, 1991, MOL CELL BIOL, V11, P2018, DOI 10.1128/MCB.11.4.2018; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VANDEURSEN J, 1991, NUCLEIC ACIDS RES, V19, P2637, DOI 10.1093/nar/19.10.2637; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wang DM, 1996, MOL CELL BIOL, V16, P6141; Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	52	362	368	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					25	35		10.1016/S1074-7613(00)00005-4	http://dx.doi.org/10.1016/S1074-7613(00)00005-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933392	Bronze			2022-12-18	WOS:000088463600004
J	Zigmond, E; Bernshtein, B; Friedlander, G; Walker, CR; Yona, S; Kim, KW; Brenner, O; Krauthgamer, R; Varol, C; Muller, W; Jung, S				Zigmond, Ehud; Bernshtein, Biana; Friedlander, Gilgi; Walker, Catherine R.; Yona, Simon; Kim, Ki-Wook; Brenner, Ori; Krauthgamer, Rita; Varol, Chen; Mueller, Werner; Jung, Steffen			Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis	IMMUNITY			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; DENDRITIC CELLS; LY6C(HI) MONOCYTES; AND/OR NEUTROPHILS; PROSTAGLANDIN E-2; NITRIC-OXIDE; MICE; EXPRESSION	Interleukin-10 (IL-10) is a pleiotropic anti-inflammatory cytokine produced and sensed by most hematopoietic cells. Genome-wide association studies and experimental animal models point at a central role of the IL-10 axis in inflammatory bowel diseases. Here we investigated the importance of intestinal macrophage production of IL-10 and their IL-10 exposure, as well as the existence of an IL-10-based autocrine regulatory loop in the gut. Specifically, we generated mice harboring IL-10 or IL-10 receptor (IL-10R alpha) mutations in intestinal lamina propria-resident chemokine receptor CX(3)CR1-expressing macrophages. We found macrophage-derived IL-10 dispensable for gut homeostasis and maintenance of colonic T regulatory cells. In contrast, loss of IL-10 receptor expression impaired the critical conditioning of these monocyte-derived macrophages and resulted in spontaneous development of severe colitis. Collectively, our results highlight IL-10 as a critical homeostatic macrophage-conditioning agent in the colon and define intestinal CX(3)CR1(hi) macrophages as a decisive factor that determines gut health or inflammation.	[Zigmond, Ehud; Bernshtein, Biana; Yona, Simon; Kim, Ki-Wook; Krauthgamer, Rita; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Zigmond, Ehud; Varol, Chen] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel; [Zigmond, Ehud; Varol, Chen] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Friedlander, Gilgi] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel; [Walker, Catherine R.; Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; University of Manchester; Weizmann Institute of Science	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Varol, Chen/AAW-4202-2021; Yona, Simon/ABE-6572-2020; Varol, Chen/ABH-6487-2020; Jung, Steffen/K-1409-2012; Muller, Werner/B-9044-2008	Jung, Steffen/0000-0003-4290-5716; Muller, Werner/0000-0002-1297-9725; Yona, Simon/0000-0002-3984-2008; /0000-0002-7207-4389	BSF; Helmsley Foundation; Lord Alliance Weizmann Manchester Life Science Programme; European Community [305564]	BSF(US-Israel Binational Science Foundation); Helmsley Foundation; Lord Alliance Weizmann Manchester Life Science Programme; European Community(European Commission)	We would like to thank all members of the Jung laboratory for discussion, the staff members of the Weizmann sorting facility for technical support, and Ron Rotkopf for advice concerning statistics. This work was supported by the BSF, the Helmsley Foundation, and a research grant from the Lord Alliance Weizmann Manchester Life Science Programme (to S.J. and W. M). S.J. was a Helmsley Scholar at the Crohn's & Colitis Foundation. C. R. W. and W. M received funding from the European Community's Seventh Framework Programme (FP7/2012-2017) under grant agreement no 305564 (SysmedIBD).	Antoniv TT, 2005, IMMUNOBIOLOGY, V210, P87, DOI 10.1016/j.imbio.2005.05.003; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Beck PL, 2004, AM J PHYSIOL-GASTR L, V286, pG137, DOI 10.1152/ajpgi.00309.2003; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ina K, 2005, J IMMUNOL, V175, P2000, DOI 10.4049/jimmunol.175.3.2000; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kucuk C, 2006, AM J SURG, V191, P77, DOI 10.1016/j.amjsurg.2005.10.005; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LAURITSEN K, 1988, GUT, V29, P1316, DOI 10.1136/gut.29.10.1316; Liu B., 2011, GASTROENTEROLOGY, V141, pe1; Liu B, 2011, GASTROENTEROLOGY, V141, P653, DOI 10.1053/j.gastro.2011.04.053; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Muthuswamy R, 2010, BLOOD, V116, P1454, DOI 10.1182/blood-2009-12-258038; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pils MC, 2011, INFLAMM BOWEL DIS, V17, P2038, DOI 10.1002/ibd.21587; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Watanabe N, 2003, DIGEST DIS SCI, V48, P408, DOI 10.1023/A:1021960401290; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	67	361	369	11	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					720	733		10.1016/j.immuni.2014.03.012	http://dx.doi.org/10.1016/j.immuni.2014.03.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24792913	Bronze			2022-12-18	WOS:000336026100011
J	Kollmann, TR; Levy, O; Montgomery, RR; Goriely, S				Kollmann, Tobias R.; Levy, Ofer; Montgomery, Ruth R.; Goriely, Stanislas			Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly	IMMUNITY			English	Review							BACILLUS-CALMETTE-GUERIN; DENDRITIC CELLS; OXIDATIVE STRESS; PRIMARY IMMUNODEFICIENCIES; PROINFLAMMATORY RESPONSE; INFLAMMATORY RESPONSE; ANTIBODY-RESPONSES; MONONUCLEAR-CELLS; BASIC MECHANISMS; OLDER PERSONS	Given the "inborn" nature of the innate immune system, it is surprising to find that innate immune function does in fact change with age. Similar patterns of distinct Toll-like-receptor-mediated immune responses come to light when one contrasts innate immune development at the beginning of life with that toward the end of life. Importantly, these developmental patterns of innate cytokine responses correlate with clinical patterns of susceptibility to disease: A heightened risk of suffering from excessive inflammation is often detected in prematurely born infants, disappears over the first few months of life, and reappears toward the end of life. In addition, risk periods for particular infections in early life reemerge in older adults. The near-mirror-image patterns that emerge in contrasts of early versus late innate immune ontogeny emphasize changes in host-environment interactions as the underlying molecular and teleologic drivers.	[Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V5Z 4H4, Canada; [Levy, Ofer] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Goriely, Stanislas] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Gosselies, Belgium	University of British Columbia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Yale University; Universite Libre de Bruxelles	Kollmann, TR (corresponding author), Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V5Z 4H4, Canada.	tkollm@mac.com		Goriely, Stanislas/0000-0002-7005-6195; Montgomery, Ruth/0000-0002-8661-4454; Kollmann, Tobias/0000-0003-2403-9762; Levy, Ofer/0000-0002-5859-1945	Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Michael Smith Foundation for Health Research Career Investigator Award; GlaxoSmithKline; Advaxis; U.S. National Institutes of Health (NIH) [RO1 AI067353-01A1]; American Recovery and Reinvestment Act Administrative Supplement [3R01AI067353-05S1]; Global Health Grant from The Bill & Melinda Gates Foundation [OPPGH5284]; VentiRx Pharmaceuticals; NIH [HHSN272201100019C, U19 AI 089992]; government of the Walloon Region; GlaxoSmithKline Biologicals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353, U19AI089992, R01AI100135] Funding Source: NIH RePORTER	Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Michael Smith Foundation for Health Research Career Investigator Award(Michael Smith Foundation for Health Research); GlaxoSmithKline(GlaxoSmithKline); Advaxis; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Administrative Supplement; Global Health Grant from The Bill & Melinda Gates Foundation; VentiRx Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T.R.K. is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, a Michael Smith Foundation for Health Research Career Investigator Award, an educational grant from GlaxoSmithKline, and a research grant from Advaxis. O.L. is supported by U.S. National Institutes of Health (NIH) RO1 AI067353-01A1, American Recovery and Reinvestment Act Administrative Supplement 3R01AI067353-05S1, Global Health Grant OPPGH5284 from The Bill & Melinda Gates Foundation, and sponsored support from VentiRx Pharmaceuticals. R.R.M. is supported by awards from the NIH (HHSN272201100019C and U19 AI 089992). S.G. is a research associate from le Fonds de la Recherche Scientifique-FNRS, Belgium; the Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. The authors are grateful to Pascal Lavoie, Albert Shaw, Nathalie Compte, and Arnaud Marchant for their helpful contributions and comments and to Kristin Johnson for graphic artwork.	Afrazi A, 2011, PEDIATR RES, V69, P183, DOI 10.1203/PDR.0b013e3182093280; Agrawal A, 2007, EXP GERONTOL, V42, P421, DOI 10.1016/j.exger.2006.11.007; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862; Azizia M, 2012, PEDIATRICS, V129, pE967, DOI 10.1542/peds.2011-1579; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Baxter D, 2010, HUM VACCINES, V6, P494, DOI 10.4161/hv.6.6.12008; Belderbos ME, 2012, PEDIAT ALLERG IMM-UK, V23, P65, DOI 10.1111/j.1399-3038.2011.01230.x; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Black A, 2012, EUR J IMMUNOL, V42, P311, DOI 10.1002/eji.201141847; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Bonafe M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104; Bouree P, 2003, PATHOL BIOL, V51, P581, DOI 10.1016/j.patbio.2003.09.004; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Bruunsgaard H, 1999, CLIN EXP IMMUNOL, V118, P235; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Buonaguro L, 2011, IMMUNOL REV, V239, P197, DOI 10.1111/j.1600-065X.2010.00971.x; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Canaday DH, 2010, J CLIN IMMUNOL, V30, P373, DOI 10.1007/s10875-010-9374-9; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Chang BA, 2011, CYTOKINE, V56, P621, DOI 10.1016/j.cyto.2011.08.028; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Ciaramella A, 2011, CELL IMMUNOL, V269, P82, DOI 10.1016/j.cellimm.2011.04.010; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/ERI.10.158, 10.1586/eri.10.158]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; D'Angio Carl T, 2007, Paediatr Drugs, V9, P17, DOI 10.2165/00148581-200709010-00003; Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; De Paepe ME, 2011, PEDIATR DEVEL PATHOL, V14, P20, DOI 10.2350/09-09-0709-OA.1; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Dietert RR, 2011, REPROD TOXICOL, V31, P319, DOI 10.1016/j.reprotox.2010.09.006; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Drygiannakis I, 2011, IMMUNOL RES, V50, P69, DOI 10.1007/s12026-011-8207-0; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esposito S, 2009, EARLY HUM DEV, V85, pS43, DOI 10.1016/j.earlhumdev.2009.08.011; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Figueiredo CA, 2009, ENVIRON HEALTH PERSP, V117, P845, DOI 10.1289/ehp.0800366; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fleer A, 2007, NEONATOLOGY, V92, P145, DOI 10.1159/000102054; Fleming DM, 2005, VACCINE, V23, pS1, DOI 10.1016/j.vaccine.2005.04.018; Forsey RJ, 2003, MECH AGEING DEV, V124, P487, DOI 10.1016/S0047-6374(03)00025-3; Fortin CF, 2008, REJUV RES, V11, P873, DOI 10.1089/rej.2008.0750; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fulop T, 2010, ANN NY ACAD SCI, V1197, P158, DOI 10.1111/j.1749-6632.2009.05370.x; Gabrielsson S, 2001, CLIN EXP IMMUNOL, V126, P390, DOI 10.1046/j.1365-2249.2001.01703.x; Gaffen SL, 2011, IMMUNOL RES, V50, P181, DOI 10.1007/s12026-011-8226-x; Gan YH, 2005, J INFECT DIS, V192, P1845, DOI 10.1086/497382; Goldin LR, 2011, BLOOD, V117, P1670, DOI 10.1182/blood-2010-09-306274; Goldstein DR, 2012, J GERONTOL A-BIOL, V67, P242, DOI 10.1093/gerona/glr194; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gourlay DM, 2012, J SURG RES, V175, P51, DOI 10.1016/j.jss.2011.07.026; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Graham JE, 2006, J BEHAV MED, V29, P389, DOI 10.1007/s10865-006-9057-4; Hedayat M, 2011, LANCET INFECT DIS, V11, P702, DOI 10.1016/S1473-3099(11)70099-8; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6; Huang CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021067; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kenzel S, 2006, CURR OPIN INFECT DIS, V19, P264, DOI 10.1097/01.qco.0000224821.27482.bd; Kittan NA, 2007, J IMMUNOL, V179, P4219, DOI 10.4049/jimmunol.179.6.4219; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leavy O, 2010, NAT REV IMMUNOL, V10, P810, DOI 10.1038/nri2894; LeBouder E, 2006, J IMMUNOL, V176, P3742, DOI 10.4049/jimmunol.176.6.3742; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Leng J, 2010, MICROBES INFECT, V12, P1120, DOI 10.1016/j.micinf.2010.08.009; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lewis David B, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P189, DOI 10.1016/j.cppeds.2005.11.001; LIGTHART GJ, 1984, MECH AGEING DEV, V28, P47, DOI 10.1016/0047-6374(84)90152-0; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lisciandro JG, 2010, CLIN EXP ALLERGY, V40, P1719, DOI 10.1111/j.1365-2222.2010.03629.x; Lisciandro JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036793; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Malaguarnera L, 2010, CRIT REV ONCOL HEMAT, V74, P40, DOI 10.1016/j.critrevonc.2009.06.002; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martin CR, 2006, SEMIN FETAL NEONAT M, V11, P369, DOI 10.1016/j.siny.2006.03.002; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Melvan JN, 2010, INT REV IMMUNOL, V29, P315, DOI 10.3109/08830181003792803; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Mook P, 2012, EPIDEMIOL INFECT, V140, P706, DOI 10.1017/S0950268811001051; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Moore SE, 2006, TROP MED INT HEALTH, V11, P1529, DOI 10.1111/j.1365-3156.2006.01700.x; Mortellaro A, 2011, IMMUNOL CELL BIOL, V89, P332, DOI 10.1038/icb.2010.152; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Mysliwska J, 1998, MECH AGEING DEV, V100, P313, DOI 10.1016/S0047-6374(97)00154-1; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Nassi N, 2009, PEDIATR INT, V51, P183, DOI 10.1111/j.1442-200X.2008.02662.x; Nathe KE, 2009, PEDIATR RES, V66, P191, DOI 10.1203/PDR.0b013e3181aa33d7; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Netea MG, 2011, CURR OPIN PHARMACOL, V11, P412, DOI 10.1016/j.coph.2011.03.003; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Netea MG, 2011, NEW ENGL J MED, V364, P60, DOI 10.1056/NEJMra1001976; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nilsson C, 2004, CLIN EXP ALLERGY, V34, P373, DOI 10.1111/j.1365-2222.2004.01896.x; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Ongradi Joseph, 2010, Immun Ageing, V7, P7, DOI 10.1186/1742-4933-7-7; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Petrikin JE, 2010, PEDIATR RES, V68, P335, DOI 10.1203/00006450-201011001-00656; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Posfay-Barbe KM, 2009, SEMIN FETAL NEONAT M, V14, P228, DOI 10.1016/j.siny.2009.01.006; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Ravaglia G, 2007, NEUROBIOL AGING, V28, P1810, DOI 10.1016/j.neurobiolaging.2006.08.012; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Reece P, 2011, J ALLERGY CLIN IMMUN, V127, P447, DOI 10.1016/j.jaci.2010.11.006; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Reikie BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044763; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Ridda I, 2009, VACCINE, V27, P1628, DOI 10.1016/j.vaccine.2008.11.098; Romagne F, 2007, DRUG DISCOV TODAY, V12, P80, DOI 10.1016/j.drudis.2006.11.007; Rubartelli A, 2011, TRENDS IMMUNOL, V32, P559, DOI 10.1016/j.it.2011.08.005; Sampath V, 2011, J SURG RES, V169, pE51, DOI 10.1016/j.jss.2011.03.017; Schiffrin EJ, 2010, MUTAT RES-FUND MOL M, V690, P50, DOI 10.1016/j.mrfmmm.2009.07.011; Scholtes VPW, 2011, CLIN SCI, V121, P205, DOI 10.1042/CS20100601; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Shurin GV, 2007, CYTOKINE, V39, P123, DOI 10.1016/j.cyto.2007.06.006; Simpson AJH, 2003, CLIN INFECT DIS, V36, pE71, DOI 10.1086/367861; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Stout-Delgado HW, 2008, J IMMUNOL, V181, P6747, DOI 10.4049/jimmunol.181.10.6747; Strunk T, 2009, ARCH DIS CHILD-FETAL, V94, pF230, DOI 10.1136/adc.2008.143438; Strunk T, 2007, CURR OPIN INFECT DIS, V20, P370, DOI 10.1097/QCO.0b013e3281a7ec98; Strunk T, 2012, PEDIATR RES, V72, P10, DOI 10.1038/pr.2012.48; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Strunk T, 2012, JAMA-J AM MED ASSOC, V307, P32, DOI 10.1001/jama.2011.1952; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Taylor A, 2006, CLIN EXP ALLERGY, V36, P1218, DOI 10.1111/j.1365-2222.2006.02552.x; Taylor DN, 2011, VACCINE, V29, P4897, DOI 10.1016/j.vaccine.2011.05.001; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Travis J, 2011, SCIENCE, V334, P31, DOI 10.1126/science.334.6052.31; Trzonkowski P, 2004, BRAIN BEHAV IMMUN, V18, P135, DOI 10.1016/S0889-1591(03)00111-9; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Tsuda K, 2012, PEDIATR INT, V54, P64, DOI 10.1111/j.1442-200X.2011.03505.x; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Vallejo AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026558; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009; van den Biggelaar AHJ, 2009, J ALLERGY CLIN IMMUN, V124, P544, DOI 10.1016/j.jaci.2009.03.040; van Duin D, 2007, J INFECT DIS, V195, P1590, DOI 10.1086/516788; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Vellai T, 2009, CELL DEATH DIFFER, V16, P94, DOI 10.1038/cdd.2008.126; Vento S, 2009, LANCET ONCOL, V10, P528, DOI 10.1016/S1470-2045(09)70038-5; Volpe JJ, 2008, J PEDIATR, V153, P160, DOI 10.1016/j.jpeds.2008.04.057; Vuillermin PJ, 2009, ALLERGY, V64, P348, DOI 10.1111/j.1398-9995.2009.01970.x; Weyrich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013980; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wijsman CA, 2011, J GERONTOL A-BIOL, V66, P393, DOI 10.1093/gerona/glq212; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493; Wynn JL, 2008, BLOOD, V112, P1750, DOI 10.1182/blood-2008-01-130500; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Yanagisawa S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-50; YOSHIKAWA TT, 1981, WESTERN J MED, V135, P441; Zhang JP, 2010, PEDIATR RES, V68, P479, DOI 10.1203/PDR.0b013e3181f90810; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	202	361	371	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					771	783		10.1016/j.immuni.2012.10.014	http://dx.doi.org/10.1016/j.immuni.2012.10.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	042GP	23159225	Green Accepted, Bronze			2022-12-18	WOS:000311460000006
J	Marie, JC; Liggitt, D; Rudensky, AY				Marie, Julien C.; Liggitt, Denny; Rudensky, Alexander Y.			Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; TGF-BETA; II RECEPTOR; IN-VIVO; DISRUPTION; DEFICIENT; EXPRESSION; INDUCTION; GENE; DIFFERENTIATION	Transforming growth factor-beta (TGF-beta) has been implicated in the control of differentiation and proliferation of multiple cell types. However, a role for TGF-beta in the control of immune homeostasis is not fully understood because of its pleiotropic action. Here we report that complete ablation of the TGF-beta signaling in T cells engendered aggressive early-onset, multiorgan, autoimmune-associated lesions with 100% mortality. Peripheral CD4(+) and CD8(+) T cells with TGF-beta-receptor II (TGF-beta RII) deficiency activated cytolytic and T helper 1 (Th1) differentiation program in a cell-intrinsic T cell receptor (TCR)-specific fashion. Furthermore, TGF-beta RII deficiency blocked the development of canonical CD1d-restricted NKT cells. Instead, it facilitated generation of a highly pathogenic T cell subset exhibiting multiple hallmarks of NK cells and sharply elevated amounts of FasL, perforin, granzymes, and interferon-gamma. Thus, TGF-beta signaling in peripheral T cells is crucial in restraining TCR activation-dependent Th1, cytotoxic, and NK cell-like differentiation program which, when left unchecked, leads to rapidly progressing fatal autoimmunity.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA.	marie@cervi-lyon.inserm.fr; aruden@u.washington.edu	Marie, Julien/I-5084-2016	Marie, Julien/0000-0001-6713-7923				Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Leveen P, 2005, BLOOD, V106, P4234, DOI 10.1182/blood-2005-05-1871; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; MASSAGUE J, 1992, MOL REPROD DEV, V32, P99, DOI 10.1002/mrd.1080320204; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439	43	361	381	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					441	454		10.1016/j.immuni.2006.07.012	http://dx.doi.org/10.1016/j.immuni.2006.07.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973387	Bronze			2022-12-18	WOS:000240862200013
J	Kwong, PD; Mascola, JR				Kwong, Peter D.; Mascola, John R.			Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies	IMMUNITY			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; GP120 ENVELOPE GLYCOPROTEIN; HIV-1-INFECTED INDIVIDUALS; POTENT NEUTRALIZATION; BROAD NEUTRALIZATION; CD4-BINDING SITE; RATIONAL DESIGN; 2G12 RECOGNIZES; GLYCAN SHIELD	Antibodies that neutralize diverse strains of HIV-1 develop in similar to 20% of HIV-1-infected individuals, and isolation and structural characterization of these antibodies are revealing how they recognize the envelope glycoprotein spike. Broadly reactive neutralizing antibodies utilize just a few sites of spike vulnerability and converge on select modes of recognition. These antibodies have unusual features: uncommonly long complementarity-determining loops, extensive somatic mutation, or both. Recent advances in next(7) generation sequencing of antibody-gene transcripts are providing genetic records of the development of neutralizing antibodies. These records inform an understanding of the naive B cell repertoire, of somatic mutation, and of the resulting antibody features that are critical to effective HIV-1 neutralization; based on these, we propose an ontogeny and structure-based system of antibody classification. The human immune system is capable of developing antibodies that broadly neutralize HIV-1-and an increasingly detailed view is accumulating for how effective immunity against HIV-1 can be generated.	[Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov	Mascola, John/AAI-7193-2021		Vaccine Research Center, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005095, ZIAAI005022] Funding Source: NIH RePORTER	Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Boyington for glycan modeling; D. Burton, G. Nabel, and I. Wilson for discussions and comments; M. Connors for sharing 10E8 results; J. Stuckey for assistance with the figures, table, and movie; X. Wu for assistance with antibody sequence analysis; and members of the Structural Biology Section, the Structural Bioinformatics Core, and the Humoral Immunology Section, Vaccine Research Center, for discussions and comments on the manuscript. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blish CA, 2007, AIDS, V21, P693, DOI 10.1097/QAD.0b013e32805e8727; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang J., 2012, NATURE; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kabat EA, 1991, SEQUENCES PROTEINS I; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kong Leopold, 2012, J AIDS Clin Res, VS8, P3; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LERNER RA, 1991, P NATL ACAD SCI USA, V88, P9705, DOI 10.1073/pnas.88.21.9705; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2011, NAT STRUCT MOL BIOL, V18, P1317, DOI 10.1038/nsmb.2194; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; WRIN T, 1995, J VIROL, V69, P39, DOI 10.1128/JVI.69.1.39-48.1995; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	115	360	395	2	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					412	425		10.1016/j.immuni.2012.08.012	http://dx.doi.org/10.1016/j.immuni.2012.08.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999947	Bronze, Green Accepted			2022-12-18	WOS:000309199000004
J	Bennasser, Y; Le, SY; Benkirane, M; Jeang, KT				Bennasser, Y; Le, SY; Benkirane, M; Jeang, KT			Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; TRANSACTIVATOR GENE; VIRAL SUPPRESSOR; TAT; IMMUNITY; PROTEIN; INHIBITION; INDUCTION	In plants and invertebrate animals, RNA silencing is a form of nucleic acid-based adaptive immunity. By contrast, jawed vertebrates have evolved complex protein-based adaptive immunity. Although short interfering RNAs (siRNAs) have been used as artificial tools to silence viral infection in human cells, it remains unknown whether mammalian viruses naturally elicit such immunity in vertebral cells. Here, we report the evidence that HIV-1 encodes viral siRNA precursors in its genome and that natural HIV-1 infection provokes nucleic acid-based immunity in human cells. To combat this cellular defense, HIV-1 has evolved in its Tat protein a suppressor of RNA silencing (SRS) function. Tat abrogates the cell's RNA-silencing defense by subverting the ability of Dicer to process precursor double-stranded RNAs into siRNAs.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; NCI, Lab Expt & Computat Biol, Canc Res Ctr, Frederick, MD 21702 USA; CNRS, Mol Virol Lab, Inst Genet Humaine, UPR 1142, Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008; Bennasser, Yamina/M-4833-2017		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baulcombe DC, 2004, TRENDS BIOCHEM SCI, V29, P279, DOI 10.1016/j.tibs.2004.04.007; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Carmichael GG, 2002, NATURE, V418, P379, DOI 10.1038/418379a; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Grabarek JB, 2003, BIOTECHNIQUES, V34, P734, DOI 10.2144/03344st02; Haasnoot J, 2003, J BIOMED SCI, V10, P607, DOI 10.1007/BF02256311; Hannon, 2003, RNAI GUIDE GENE SILE; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; HUANG LM, 1994, EMBO J, V13, P2886, DOI 10.1002/j.1460-2075.1994.tb06583.x; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; LAFERRIERE A, 1994, COMPUT APPL BIOSCI, V10, P211; Le SY, 2002, NUCLEIC ACIDS RES, V30, P3574, DOI 10.1093/nar/gkf473; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lindenbach BD, 2002, MOL CELL, V9, P925, DOI 10.1016/S1097-2765(02)00539-7; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; McManus MT, 2004, IMMUNITY, V21, P747, DOI 10.1016/j.immuni.2004.11.007; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mujeeb A, 1999, FEBS LETT, V458, P387, DOI 10.1016/S0014-5793(99)01183-7; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Perelson AS, 1997, AIDS, V11, pS17; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Phuphuakrat A, 2003, AIDS RES HUM RETROV, V19, P569, DOI 10.1089/088922203322230932; Piguet V, 2001, SEMIN IMMUNOL, V13, P51, DOI 10.1006/smim.2000.0295; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Robertson HD, 1996, J VIROL, V70, P5611, DOI 10.1128/JVI.70.8.5611-5617.1996; Saksela K, 2003, TRENDS MICROBIOL, V11, P345, DOI 10.1016/S0966-842X(03)00158-6; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Silva JM, 2002, TRENDS MOL MED, V8, P505, DOI 10.1016/S1471-4914(02)02421-8; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019; Zamore PD, 2004, CURR BIOL, V14, pR198, DOI 10.1016/j.cub.2004.02.021	55	360	394	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					607	619		10.1016/j.immuni.2005.03.010	http://dx.doi.org/10.1016/j.immuni.2005.03.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894278	Bronze			2022-12-18	WOS:000229447200010
J	Flugel, A; Berkowicz, T; Ritter, T; Labeur, M; Jenne, DE; Li, ZX; Ellwart, JW; Willem, M; Lassmann, H; Wekerle, H				Flugel, A; Berkowicz, T; Ritter, T; Labeur, M; Jenne, DE; Li, ZX; Ellwart, JW; Willem, M; Lassmann, H; Wekerle, H			Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; ENCEPHALITOGENIC T-CELLS; ACTIVATED RAT; GENE-TRANSFER; ANTIGEN RECOGNITION; REACTIVE CELLS; LEWIS RAT; LYMPHOCYTES; BRAIN	Homing behavior and function of autoimmune CD4(+) T cells in vivo was analyzed before and during EAE, using MBP-specific T cells retrovirally engineered to express the gene of green fluorescent protein. The cells migrate from parathymic lymph nodes to blood and to the spleen. Preceding disease onset, large numbers of effector cells invade the CNS, with only negligible numbers left in the periphery. In early EAE, most (> 90%) infiltrating CD4+ cells were effector cells. Migratory effector cells downregulate activation markers (CD25, OX-40) but upregulate several chemokine receptors and adsorb MHC class II on their membranes. Within the CNS, the effector cells are reactivated, with upregulated proinflammatory cytokines and downmodulated T cell receptor-associated structures, presumably reflecting autoantigen recognition in situ.	Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; Humboldt Univ, Charite, Inst Med Immunol, D-10098 Berlin, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, D-81377 Munich, Germany; Univ Munich, Adolf Butenandt Inst, Dept Biochem, D-80336 Munich, Germany; Univ Vienna, Brain Res Inst, A-1090 Vienna, Austria	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Vienna	Flugel, A (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany.		Jenne, Dieter Erich/AAP-1414-2020; Ritter, Thomas/C-1695-2009; Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052; Ritter, Thomas/0000-0001-7709-8489				AlShamkhani A, 1996, EUR J IMMUNOL, V26, P1695, DOI 10.1002/eji.1830260805; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013; Bauer J, 1998, AM J PATHOL, V153, P715, DOI 10.1016/S0002-9440(10)65615-5; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berger T, 1997, LAB INVEST, V76, P355; BROEREN CPM, 1995, IMMUNOLOGY, V84, P193; CROSS AH, 1991, J NEUROIMMUNOL, V33, P237, DOI 10.1016/0165-5728(91)90111-J; FALLIS RJ, 1987, J NEUROIMMUNOL, V14, P205, DOI 10.1016/0165-5728(87)90055-5; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Flugel A, 2000, BRAIN PATHOL, V10, P353; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; GOLD DP, 1994, CURR OPIN IMMUNOL, V6, P907, DOI 10.1016/0952-7915(94)90012-4; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hafler DA, 1999, J CLIN INVEST, V104, P527, DOI 10.1172/JCI8193; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KLINKERT WEF, 1987, J IMMUNOL, V139, P1030; KOJIMA K, 1994, J EXP MED, V180, P817, DOI 10.1084/jem.180.3.817; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; MOR F, 1992, J CLIN INVEST, V90, P2447, DOI 10.1172/JCI116136; Patel DM, 1999, J IMMUNOL, V163, P5201; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; REIZIS B, 1994, EUR J IMMUNOL, V24, P2796, DOI 10.1002/eji.1830241133; RESKE K, 1987, EUR J IMMUNOL, V17, P909, DOI 10.1002/eji.1830170703; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; SCHMIED M, 1993, AM J PATHOL, V143, P446; Seddon B, 1996, INT IMMUNOL, V8, P1185, DOI 10.1093/intimm/8.8.1185; Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253; TABI Z, 1995, INT IMMUNOL, V7, P967, DOI 10.1093/intimm/7.6.967; TABI Z, 1994, EUR J IMMUNOL, V24, P2609, DOI 10.1002/eji.1830241107; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; TSUCHIDA M, 1993, EUR J IMMUNOL, V23, P2399, DOI 10.1002/eji.1830231004; Weinberg AD, 1998, SEMIN IMMUNOL, V10, P471, DOI 10.1006/smim.1998.0146; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wekerle H, 1993, Curr Opin Neurobiol, V3, P779, DOI 10.1016/0959-4388(93)90153-P; WEKERLE H, 1994, ANN NEUROL, V36, P547; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	48	360	373	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2001	14	5					547	560		10.1016/s1074-7613(01)00143-1	http://dx.doi.org/10.1016/s1074-7613(01)00143-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371357	Bronze			2022-12-18	WOS:000168880900007
J	Teng, G; Hakimpour, P; Landgraf, P; Rice, A; Tuschl, T; Casellas, R; Papavasiliou, FN				Teng, Grace; Hakimpour, Paul; Landgraf, Pablo; Rice, Amanda; Tuschl, Thomas; Casellas, Rafael; Papavasiliou, F. Nina			MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase	IMMUNITY			English	Article							MATURE B-CELLS; SOMATIC HYPERMUTATION; GENE-EXPRESSION; ANTIBODY DIVERSIFICATION; AID; PHOSPHORYLATION; TARGETS; RNA; LYMPHOMAS; MIR-150	B lymphocytes perform somatic hypermutation and class-switch recombination (CSR) of the immunoglobulin locus to generate an antibody repertoire diverse in both affinity and function. These somatic diversification processes are catalyzed by activation-induced cytidine deaminase (AID), a potent DNA mutator whose expression and function are highly regulated. Here we show that AID was regulated post-transcriptionally by a lymphocyte-specific microRNA, miR-155. We found that miR-155 was upregulated in murine B lymphocytes undergoing CSR and that it targeted a conserved site in the 3'-untranslated region of the mRNA encoding AID. Disruption of this target site in vivo resulted in quantitative and temporal deregulation of AID expression, along with functional consequences for CSR and affinity maturation. Thus, miR-155, which has recently been shown to play important roles in regulating the germinal-center reaction, does so in part by directly downmodulating AID expression.	[Teng, Grace; Hakimpour, Paul; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA; [Landgraf, Pablo; Rice, Amanda; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Casellas, Rafael] NIAMS, Genom Integr & Immun, NIH, Bethesda, MD 20892 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, 1230 York Ave, New York, NY 10065 USA.	papavasiliou@rockefeller.edu		Hakimata, Paul/0000-0002-2526-6003	Intramural NIH HHS [Z01 AR041149-03] Funding Source: Medline; NCI NIH HHS [R01 CA098495-05, R01 CA098495, CA098495] Funding Source: Medline; NIGMS NIH HHS [GM066699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041148, ZIAAR041149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2007, ADV EXP MED BIOL, V596, P129; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hatten ME, 2005, ANNU REV NEUROSCI, V28, P89, DOI 10.1146/annurev.neuro.26.041002.131436; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; TAKETANI M, 1995, MOL IMMUNOL, V32, P983, DOI 10.1016/0161-5890(95)00057-L; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	42	359	384	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					621	629		10.1016/j.immuni.2008.03.015	http://dx.doi.org/10.1016/j.immuni.2008.03.015			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18450484	Bronze, Green Accepted			2022-12-18	WOS:000256003900009
J	Cardoso, RMF; Zwick, MB; Stanfield, RL; Kunert, R; Binley, JM; Katinger, H; Burton, DR; Wilson, IA				Cardoso, RMF; Zwick, MB; Stanfield, RL; Kunert, R; Binley, JM; Katinger, H; Burton, DR; Wilson, IA			Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41	IMMUNITY			English	Article							TYPE-1 ENVELOPE GLYCOPROTEIN; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; PROXIMAL EXTERNAL REGION; ENV-MEDIATED FUSION; CRYSTAL-STRUCTURE; PROTEIN; ECTODOMAIN; PROGRAM; EPITOPE	Broadly neutralizing monoclonal antibodies to HIV-1 are rare but invaluable for vaccine design. 4E10 is the broadest neutralizing antibody known and recognizes a contiguous and highly conserved epitope in the membrane-proximal region of gp41. The crystal structure of Fab 4E10 was determined at 2.2 Angstrom resolution in complex with a 13-residue peptide containing the gp41 core epitope (NWFDIT). The bound peptide adopts a helical conformation in which the key contact residues, Trp(P672), Phe(P673), Ile(P675), and Thr(P676), map to one face of the helix. The peptide binds in a hydrophobic pocket that may emulate its potential interaction with the host cell membrane. The long CDR H3 of the antibody extends beyond the bound peptide in an orientation that suggests that its apex could contact the viral membrane when 4E10 is bound to its membrane-proximal epitope. These structural insights should assist in the design of immunogens to elicit 4E10-like neutralizing responses.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; Univ Bodenkultur Wien, Inst Appl Microbiol, A-1190 Vienna, Austria	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California; University of Natural Resources & Life Sciences, Vienna	Burton, DR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	Cheng, Yushao/E-6256-2011; Kunert, Renate E/B-9185-2018; Stanfield, Robyn/AAH-3190-2019	Kunert, Renate E/0000-0002-3397-3621; 	NIAID NIH HHS [AI-33292] Funding Source: Medline; NIGMS NIH HHS [GM-46192] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033292, R01AI033292] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonin PV, 2001, PROTEIN SCI, V10, P1514, DOI 10.1110/ps.3101; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Dimitrov AS, 2003, BIOCHEMISTRY-US, V42, P14150, DOI 10.1021/bi035154g; Ferrantelli F, 2002, CURR OPIN IMMUNOL, V14, P495, DOI 10.1016/S0952-7915(02)00362-X; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kabat EA, 1991, SEQUENCES PROTEINS I; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Kunert R, 2000, BIOTECHNOL BIOENG, V67, P97, DOI 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI E, 2000, Patent No. 0061618; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; van den Elsen JMH, 1999, P NATL ACAD SCI USA, V96, P13679, DOI 10.1073/pnas.96.24.13679; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	48	359	398	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					163	173		10.1016/j.immuni.2004.12.011	http://dx.doi.org/10.1016/j.immuni.2004.12.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723805	Bronze			2022-12-18	WOS:000227509600003
J	Hall, JA; Grainger, JR; Spencer, SP; Belkaid, Y				Hall, Jason A.; Grainger, John R.; Spencer, Sean P.; Belkaid, Yasmine			The Role of Retinoic Acid in Tolerance and Immunity	IMMUNITY			English	Review							REGULATORY T-CELLS; CD103(+) DENDRITIC CELLS; VITAMIN-A-DEFICIENCY; LAMINA-PROPRIA; X-RECEPTOR; FUNCTIONAL SPECIALIZATION; FOXP3 EXPRESSION; SMALL-INTESTINE; DOWN-REGULATION; TH17 CELLS	Vitamin A elicits a broad array of immune responses through its metabolite, retinoic acid (RA). Recent evidence indicates that loss of RA leads to impaired immunity, whereas excess RA can potentially promote inflammatory disorders. In this review, we discuss recent advances showcasing the crucial contributions of RA to both immunological tolerance and the elicitation of adaptive immune responses. Further, we provide a comprehensive overview of the cell types and factors that control the production of RA and discuss how host perturbations may affect the ability of this metabolite to control tolerance and immunity or to instigate pathology.	[Hall, Jason A.; Grainger, John R.; Spencer, Sean P.; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, Jason A.; Spencer, Sean P.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Hall, JA (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	halljas@niaid.nih.gov; ybelkaid@mail.nih.gov		Spencer, Sean/0000-0002-7328-5399; Grainger, John/0000-0002-4052-5923; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Office of Dietary Supplements	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the Office of Dietary Supplements. We thank E. Wohlfert and T. Hand for helpful discussions and critical reading of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Ahmad SM, 2009, BRIT J NUTR, V102, P797, DOI 10.1017/S0007114509316165; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Cantorna MT, 1996, J IMMUNOL, V156, P2674; CANTORNA MT, 1995, EUR J IMMUNOL, V25, P1673, DOI 10.1002/eji.1830250629; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHUN TY, 1992, J NUTR, V122, P1062, DOI 10.1093/jn/122.5.1062; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; Dawson H, 2009, INFECT IMMUN, V77, P2576, DOI 10.1128/IAI.00827-07; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Dzhagalov I, 2007, J IMMUNOL, V178, P2113, DOI 10.4049/jimmunol.178.4.2113; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Engedal N, 2006, J IMMUNOL, V177, P2851, DOI 10.4049/jimmunol.177.5.2851; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Feng T, 2010, J IMMUNOL, V185, P5915, DOI 10.4049/jimmunol.1001233; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kang SG, 2011, MUCOSAL IMMUNOL, V4, P66, DOI 10.1038/mi.2010.42; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee HY, 1999, MOL CELL BIOL, V19, P1973; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MALKOVSKY M, 1983, P NATL ACAD SCI-BIOL, V80, P6322, DOI 10.1073/pnas.80.20.6322; MALKOVSKY M, 1983, NATURE, V302, P338, DOI 10.1038/302338a0; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maruya M, 2011, P NATL ACAD SCI USA, V108, P722, DOI 10.1073/pnas.1014697108; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Reddy D, 2006, AM J GASTROENTEROL, V101, P1569, DOI 10.1111/j.1572-0241.2006.00632.x; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; SOMMER A, 1986, LANCET, V1, P1169; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stephensen CB, 2004, J NUTR, V134, P2660, DOI 10.1093/jn/134.10.2660; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Stock A, 2011, J EXP MED, V208, P761, DOI 10.1084/jem.20101967; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016089; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Wolf G, 1996, FASEB J, V10, P1102, DOI 10.1096/fasebj.10.9.8801174; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	129	358	371	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					13	22		10.1016/j.immuni.2011.07.002	http://dx.doi.org/10.1016/j.immuni.2011.07.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21777796	Bronze, Green Accepted			2022-12-18	WOS:000293107300006
J	HOEY, T; SUN, YL; WILLIAMSON, K; XU, X				HOEY, T; SUN, YL; WILLIAMSON, K; XU, X			ISOLATION OF 2 NEW MEMBERS OF THE NF-AT GENE FAMILY AND FUNCTIONAL-CHARACTERIZATION OF THE NF-AT PROTEINS	IMMUNITY			English	Article							ACTIVATED T-CELLS; DNA-BINDING PROTEINS; CYCLOSPORINE-A; NUCLEAR FACTOR; INTERLEUKIN-2 ENHANCER; KAPPA-B; IDENTIFICATION; LYMPHOCYTE; EXPRESSION; COMPLEX	The activation of cytokine genes in response to antigenic stimulation of T cells is mediated by NF-AT proteins. Previous studies have identified two NF-AI proteins, NF-ATp and NF-ATc, that are homologous within a 290 aa domain distantly related to the Rel domain. We have isolated two additional members of this gene family, NF-AT3 and NF-AT4, which encode proteins 65% identical to the other NF-AT proteins within the Rel domain. The four NF-AT genes are transcribed in different sets of tissues that included many sites of expression outside the immune system. The Rel homology domain is sufficient for DNA recognition and cooperative binding interactions with AP-1. Although other members of the Rel family bind DNA as dimers, NF-AT proteins are monomers in solution or bound to DNA. Transfection assays indicate that each of the four NF-AT proteins can activate the IL-2 promoter in T cells.			HOEY, T (corresponding author), TULARIK INC,270 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.							Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BRABLETZ T, 1991, NUCLEIC ACIDS RES, V19, P61, DOI 10.1093/nar/19.1.61; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; JAIN JN, 1993, J IMMUNOL, V151, P837; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MOUZAKI A, 1994, BLOOD, V84, P2612; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; RANDAK C, 1990, EMBO J, V9, P2529, DOI 10.1002/j.1460-2075.1990.tb07433.x; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; YASEEN NR, 1993, J BIOL CHEM, V268, P14285; YASEEN NR, 1994, MOL CELL BIOL, V14, P6886, DOI 10.1128/MCB.14.10.6886	49	358	368	1	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					461	472		10.1016/1074-7613(95)90027-6	http://dx.doi.org/10.1016/1074-7613(95)90027-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749981	Bronze			2022-12-18	WOS:A1995QZ43000004
J	Scharping, NE; Menk, AV; Moreci, RS; Whetstone, RD; Dadey, RE; Watkins, SC; Ferris, RL; Delgoffe, GM				Scharping, Nicole E.; Menk, Ashley V.; Moreci, Rebecca S.; Whetstone, Ryan D.; Dadey, Rebekah E.; Watkins, Simon C.; Ferris, Robert L.; Delgoffe, Greg M.			The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction	IMMUNITY			English	Article							NF-KAPPA-B; PGC-1-ALPHA; EXHAUSTION; LYMPHOCYTES; EXPRESSION; PD-1; TRANSCRIPTION; COACTIVATORS; INFLAMMATION; ACTIVATION	Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1 alpha (PGC1 alpha), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1 alpha resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.	[Scharping, Nicole E.; Menk, Ashley V.; Moreci, Rebecca S.; Whetstone, Ryan D.; Dadey, Rebekah E.; Ferris, Robert L.; Delgoffe, Greg M.] Univ Pittsburgh, Tumor Microenvironm Ctr, Inst Canc, Pittsburgh, PA 15261 USA; [Scharping, Nicole E.; Whetstone, Ryan D.; Dadey, Rebekah E.; Watkins, Simon C.; Ferris, Robert L.; Delgoffe, Greg M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Ferris, Robert L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Delgoffe, GM (corresponding author), Univ Pittsburgh, Tumor Microenvironm Ctr, Inst Canc, Pittsburgh, PA 15261 USA.; Delgoffe, GM (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	gdelgoffe@pitt.edu	Watkins, Simon/ABG-2590-2021; Delgoffe, Greg M./HCH-2805-2022	Watkins, Simon/0000-0003-4092-1552; Delgoffe, Greg M./0000-0002-2957-8135; Scharping, Nicole/0000-0001-9373-4617	CCSG [P30CA047904]; Sidney Kimmel Foundation for Cancer Research [SKF-015-039]; NIH [1S10OD016236-01]; NIH (Head and Neck Cancer SPORE) [P50 CA097190]; NIH (Skin Cancer SPORE [developmental research award]) [P50CA121973]; NATIONAL CANCER INSTITUTE [P50CA121973, P50CA097190, P30CA047904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016236] Funding Source: NIH RePORTER	CCSG; Sidney Kimmel Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Head and Neck Cancer SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Skin Cancer SPORE [developmental research award])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dario Vignali, Larry Kane, and Jonathan Powell for critical reading and comments on this manuscript. We also thank the UPCI Flow Cytometry (especially E. Michael Meyer and Batta Janjic), Cell and Tissue Imaging (Mara Sullivan and Donna Beer Stolz), and Animal Facilities (supported by CCSG P30CA047904). This work was supported in part by the Sidney Kimmel Foundation for Cancer Research (SKF-015-039 to G.M.D.) and the NIH (1S10OD016236-01 to S.C.W., P50 CA097190 Head and Neck Cancer SPORE to R.L.F., and P50CA121973 Skin Cancer SPORE [developmental research award] to G.M.D.).	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Delgoffe GM, 2015, MOL IMMUNOL, V68, P492, DOI 10.1016/j.molimm.2015.07.026; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Haghikia A, 2015, MULT SCLER J, V21, P1262, DOI 10.1177/1352458514561909; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; La-Beck NM, 2015, PHARMACOTHERAPY, V35, P963, DOI 10.1002/phar.1643; Legat A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00455; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081903; Liu C, 2016, FEBS J, V283, P2731, DOI 10.1111/febs.13656; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Spiegelman B.M., 2007, NOVART FDN SYMP, V286, P6; Spiegelman BM, 2007, NOVART FDN SYMP, V286, P196, DOI DOI 10.1002/9780470985571.CH2; Spiegelman BM, 2007, NOVART FDN SYMP, V286, P162; Spiegelman Bruce M, 2007, Novartis Found Symp, V286, P3; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xiao B, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00076; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313	48	357	368	7	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					374	388		10.1016/j.immuni.2016.07.009	http://dx.doi.org/10.1016/j.immuni.2016.07.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496732	Green Accepted, Bronze			2022-12-18	WOS:000382267300018
J	Alvarez, D; Vollmann, EH; von Andrian, UH				Alvarez, David; Vollmann, Elisabeth H.; von Andrian, Ulrich H.			Mechanisms and consequences of dendritic cell migration	IMMUNITY			English	Review							EPIDERMAL LANGERHANS CELLS; SECONDARY LYMPHOID ORGANS; STEADY-STATE CONDITIONS; CADHERIN-MEDIATED ADHESION; HIGH ENDOTHELIAL VENULES; MICE LACKING EXPRESSION; NECROSIS-FACTOR-ALPHA; HOMING IN-VIVO; MEMORY T-CELLS; CHEMOKINE RECEPTOR	Dendritic cells (DCs) are critical for adaptive immunity and tolerance. Most DCs are strategically positioned as immune sentinels poised to respond to invading pathogens in tissues throughout the body. Differentiated DCs and their precursors also circulate in blood and can get rapidly recruited to sites of challenge. Within peripheral tissues, DCs collect antigenic material and then traffic to secondary lymphoid organs, where they communicate with lymphocytes to orchestrate adaptive immune responses. Hence, the migration and accurate positioning of DCs is indispensable for immune surveillance. Here, we review the molecular traffic signals that govern the migration of DCs throughout their life cycle.	[Alvarez, David; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vollmann, Elisabeth H.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Alvarez, David/D-2992-2012; von Andrian, Ulrich H/A-5775-2008		National Institutes of Health [R01 A1069259, R01 A1072252, P01 A1078897, P01 HL56949]; Canadian Institutes of Health Research; Austrian Academy of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, R01AI069259, R01AI072252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Austrian Academy of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by National Institutes of Health grants R01 A1069259, R01 A1072252, P01 A1078897, and P01 HL56949 (to U.H.v.A.), a fellowship from the Canadian Institutes of Health Research (to D.A.), and a fellowship from the Austrian Academy of Sciences (to E.H.V.). The authors would like to thank Irina Mazo, E. Ashley Moseman, and Silke Paust for helpful comments on the manuscript.	Antonopoulos H, 2001, J IMMUNOL, V166, P3672, DOI 10.4049/jimmunol.166.6.3672; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; AUSTYN JM, 1988, J EXP MED, V167, P646, DOI 10.1084/jem.167.2.646; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baumjohann D, 2006, IMMUNOBIOLOGY, V211, P587, DOI 10.1016/j.imbio.2006.05.011; BELL EB, 1979, IMMUNOLOGY, V38, P797; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; BRAND CU, 1992, J INVEST DERMATOL, V99, pS109, DOI 10.1111/1523-1747.ep12669997; BUJDOSO R, 1989, J EXP MED, V170, P1285, DOI 10.1084/jem.170.4.1285; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Colvin BL, 2004, J LEUKOCYTE BIOL, V75, P275, DOI 10.1189/jlb.1202613; CUMBERBATCH M, 1995, IMMUNOLOGY, V84, P31; Cumberbatch M, 1999, ARCH DERMATOL RES, V291, P357, DOI 10.1007/s004030050422; Cumberbatch M, 1997, ARCH DERMATOL RES, V289, P277, DOI 10.1007/s004030050193; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Czeloth N, 2007, J IMMUNOL, V179, P5855, DOI 10.4049/jimmunol.179.9.5855; DANDIE GW, 1994, IMMUNOL CELL BIOL, V72, P79, DOI 10.1038/icb.1994.12; Darmanin S, 2007, J IMMUNOL, V179, P4616, DOI 10.4049/jimmunol.179.7.4616; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Del Prete A, 2007, BLOOD, V109, P626, DOI 10.1182/blood-2006-02-003665; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; ELBE A, 1989, J IMMUNOL, V143, P2431; ENK AH, 1993, J IMMUNOL, V150, P3698; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 1999, J IMMUNOL, V162, P4567; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Gollmann G, 2008, INT IMMUNOL, V20, P911, DOI 10.1093/intimm/dxn050; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hammad H, 2007, ADV IMMUNOL, V93, P265, DOI 10.1016/S0065-2776(06)93007-7; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; HOLT PG, 1994, J IMMUNOL, V153, P256; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Idzko M, 2002, FASEB J, V16, P625, DOI 10.1096/fj.01-0625fje; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jahnsen FL, 2000, J IMMUNOL, V165, P4062, DOI 10.4049/jimmunol.165.7.4062; Jakob T, 1998, J IMMUNOL, V160, P4067; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Johng HM, 2007, EVID-BASED COMPL ALT, V4, P77, DOI 10.1093/ecam/nel057; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klesney-Tait J, 2007, AM J PHYSIOL-LUNG C, V293, pL1374, DOI 10.1152/ajplung.00415.2007; Kobayashi Y, 1999, J IMMUNOL, V163, P5989; KOWALA MC, 1986, J ANAT, V148, P25; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lebre MC, 1999, ARCH DERMATOL RES, V291, P447, DOI 10.1007/s004030050436; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lim YC, 1998, J IMMUNOL, V161, P2501; Lin CL, 1998, EUR J IMMUNOL, V28, P4114, DOI 10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Morse MA, 1999, CANCER RES, V59, P56; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pack M, 2008, IMMUNOLOGY, V123, P438, DOI 10.1111/j.1365-2567.2007.02710.x; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pendl GG, 2002, BLOOD, V99, P946, DOI 10.1182/blood.V99.3.946; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SILBERBERGSINAKIN I, 1976, CELL IMMUNOL, V25, P137, DOI 10.1016/0008-8749(76)90105-2; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; SMITH JB, 1970, J PATHOL, V100, P21, DOI 10.1002/path.1711000104; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sozzani S, 1997, J IMMUNOL, V159, P1993; SOZZANI S, 1995, J IMMUNOL, V155, P3292; Sozzani S, 1998, J IMMUNOL, V161, P1083; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Stutte S, 2008, J INVEST DERMATOL, V128, P1470, DOI 10.1038/sj.jid.5701228; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.bi.59.070190.001321; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Walzer T, 2005, INT IMMUNOL, V17, P943, DOI 10.1093/intimm/dxh274; Wang BH, 1997, J IMMUNOL, V159, P6148; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wethmar K, 2006, EUR J IMMUNOL, V36, P2781, DOI 10.1002/eji.200526311; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Wu Q, 1999, J EXP MED, V190, P629, DOI 10.1084/jem.190.5.629; Xu H, 2001, EUR J IMMUNOL, V31, P3085, DOI 10.1002/1521-4141(2001010)31:10<3085::AID-IMMU3085>3.0.CO;2-B; Yamagami S, 2005, INVEST OPHTH VIS SCI, V46, P1201, DOI 10.1167/iovs.04-0658; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244	178	357	380	4	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					325	342		10.1016/j.immuni.2008.08.006	http://dx.doi.org/10.1016/j.immuni.2008.08.006			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799141	Green Accepted, Bronze			2022-12-18	WOS:000259708900002
J	Mohrs, M; Shinkai, K; Mohrs, K; Locksley, RM				Mohrs, M; Shinkai, K; Mohrs, K; Locksley, RM			Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter	IMMUNITY			English	Article							CD4(+) T-CELLS; IN-VIVO; CD1D TETRAMERS; RESPONSES; TH2; MICE; EXPRESSION; EFFECTORS; MEMORY; STAT6	Effector T cells mediate adaptive immunity and immunopathology, but methods for tracking such cells in vivo are limited. We engineered knockin mice expressing IL-4 linked via a viral IRES element with enhanced green fluorescent protein (EGFP). Reporter T cells primed under Th2 conditions showed sensitive and faithful EGFP expression and maintained endogenous IL-4. After Nippostrongylus infection, reporter expression demonstrated the evolution of type 2 immunity from tissue lymphocytes and thence to lymph node CD4(+) T cells, which subsequently migrated into tissue. The appearance of EGFP(+) CD4(+) T cells in tissue, but not in lymph nodes, was Stat6-dependent. Transferred EGFP(+) CD4(+) T cells from infected animals conferred protection against Nippostrongylus to immunodeficient mice. These mice will provide a valuable reagent for assessing immunity in vivo.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			NHLBI NIH HHS [HL56385] Funding Source: Medline; NIAID NIH HHS [AI30663] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056385, P01HL056385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Bix M, 1998, J EXP MED, V188, P2289, DOI 10.1084/jem.188.12.2289; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Ho IC, 1999, INT IMMUNOL, V11, P243, DOI 10.1093/intimm/11.2.243; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kambayashi T, 2001, EUR J IMMUNOL, V31, P1523, DOI 10.1002/1521-4141(200105)31:5<1523::AID-IMMU1523>3.0.CO;2-S; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	43	357	365	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2001	15	2					303	311		10.1016/S1074-7613(01)00186-8	http://dx.doi.org/10.1016/S1074-7613(01)00186-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520464	Bronze			2022-12-18	WOS:000170717200011
J	Gu, YS; Seidl, KJ; Rathbun, GA; Zhu, CM; Manis, JP; vanderStoep, N; Davidson, L; Cheng, HL; Sekiguchi, JM; Frank, K; StanhopeBaker, P; Schlissel, MS; Roth, DB; Alt, FW				Gu, YS; Seidl, KJ; Rathbun, GA; Zhu, CM; Manis, JP; vanderStoep, N; Davidson, L; Cheng, HL; Sekiguchi, JM; Frank, K; StanhopeBaker, P; Schlissel, MS; Roth, DB; Alt, FW			Growth retardation and leaky SCID phenotype of Ku70-deficient mice	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; DNA END-BINDING; PRE-B CELLS; SHORT SEQUENCE HOMOLOGIES; X-RAY RESISTANCE; V(D)J RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT	Ku70, Ku80, and DNA-PKcs are subunits of the DNA-dependent protein kinase (DNA-PK), an enzyme implicated in DNA double-stranded break repair and V(D)J recombination. Our Ku70-deficient mice were about 50% the size of control littermates, and their fibroblasts were ionizing radiation sensitive and displayed premature senescence associated with the accumulation of nondividing cells. Ku70-deficient mice lacked mature B cells or serum immunoglobulin but, unexpectedly, reproducibly developed small populations of thymic and peripheral alpha/beta T lineage cells and had a significant incidence of thymic lymphomas. In association with B and T cell developmental defects, Ku70-deficient cells were severely impaired for joining of V(D)J coding and recombination signal sequences. These unanticipated features of the Ku70-deficient phenotype with respect to lymphocyte development and V(D)J recombination may reflect differential functions of the three DNA-PK components.	HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CHILDRENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CTR BLOOD RES,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT MICROBIOL & IMMUNOL,HOUSTON,TX 77030; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Baylor College of Medicine; Howard Hughes Medical Institute; Johns Hopkins University				Sekiguchi, JoAnn/0000-0002-7178-4258	PHS HHS [A.I.35714, A.I.36420, A.I.20047] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; BLACKWELL TK, 1989, EMBO J, V8, P735, DOI 10.1002/j.1460-2075.1989.tb03433.x; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOUBNOV NV, 1995, P NATL ACAD SCI USA, V92, P890, DOI 10.1073/pnas.92.3.890; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; CARROLL AM, 1989, J IMMUNOL, V143, P1087; CHANG Y, 1995, IMMUNITY, V2, P607, DOI 10.1016/1074-7613(95)90005-5; CHEN J, 1994, TRANSGENESIS TARGETE, P35; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; CUSTER RP, 1985, AM J PATHOL, V120, P464; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Errami A, 1996, MOL CELL BIOL, V16, P1519; FERRIER P, 1990, J EXP MED, V171, P1909, DOI 10.1084/jem.171.6.1909; GETTS RC, 1994, J BIOL CHEM, V269, P15981; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Han JO, 1997, MOL CELL BIOL, V17, P2226, DOI 10.1128/MCB.17.4.2226; HENDRICKSON EA, 1990, MOL CELL BIOL, V10, P5397, DOI 10.1128/MCB.10.10.5397; HESSE JE, 1987, CELL, V49, P775, DOI 10.1016/0092-8674(87)90615-5; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hogan BLM, 1994, MANIPULATING MOUSE E; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Jin SF, 1997, CANCER SURV, V29, P221; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Livak F, 1996, MOL CELL BIOL, V16, P609; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mizuta R, 1996, INT IMMUNOL, V8, P1467, DOI 10.1093/intimm/8.9.1467; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Rathmell WK, 1997, CANCER RES, V57, P68; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; RULEY HE, 1983, NATURE, V304, P181, DOI 10.1038/304181a0; SATOH M, 1995, EUR J CELL BIOL, V66, P127; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Siede W, 1996, GENETICS, V142, P91; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; SIPLEY JD, 1995, P NATL ACAD SCI USA, V92, P7515, DOI 10.1073/pnas.92.16.7515; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TACCIOLI GE, 1994, J BIOL CHEM, V269, P1; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; WILER R, 1995, P NATL ACAD SCI USA, V92, P11485, DOI 10.1073/pnas.92.25.11485; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	73	357	364	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					653	665		10.1016/S1074-7613(00)80386-6	http://dx.doi.org/10.1016/S1074-7613(00)80386-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390689	hybrid			2022-12-18	WOS:A1997YH55400008
J	Murayama, E; Kissa, K; Zapata, A; Mordelet, E; Briolat, V; Lin, HF; Handin, RI; Herbomel, P				Murayama, Emi; Kissa, Karima; Zapata, Agustin; Mordelet, Elodie; Briolat, Valerie; Lin, Hui-Feng; Handin, Robert I.; Herbomel, Philippe			Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development	IMMUNITY			English	Article							EARLY MACROPHAGES; LYMPHOID ORGANS; CELL; ENGRAFTMENT; CLOCHE	Although the ontogeny of hematopoietic stem cells (HSCs) in vertebrates has been studied intensely, a lineage relationship between the HSCs found in the developmentally successive hematopoietic organs remains to be shown. By using an in situ photoactivatable cell tracer in the transparent zebrafish embryo, we demonstrated that definitive blood precursors appeared between the dorsal aorta and axial vein, validating the homology of this tissue with the AGM (aorta-gonad-mesonephros) of amniotes. These cells first migrated through the blood to a previously undescribed caudal hematopoietic tissue (CHT), where they differentiated, expanded, and further migrated to seed the definitive hematopoietic organs, the thymus and kidney. Immigrants on the way to the thymus expressed c-myb and ikaros but not rag1; they were probably no longer HSCs, however, because they lacked scl and runx1 expression, unlike immigrants to the kidney. The CHT thus has a hematopoietic function similar to that of the mammalian fetal liver.	Inst Pasteur, CNRS, Unite Macrophages & Dev Immunite, URA 2578, F-75724 Paris 15, France; Univ Complutense, Dept Cell Biol, Fac Biol, E-28040 Madrid, Spain; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Complutense University of Madrid; Harvard University; Brigham & Women's Hospital	Herbomel, P (corresponding author), Inst Pasteur, CNRS, Unite Macrophages & Dev Immunite, URA 2578, 25 Rue Dr Roux, F-75724 Paris 15, France.	herbomel@pasteur.fr	Kissa, Karima/N-6801-2018	Kissa, Karima/0000-0002-7683-3661; Zapata, Agustin G/0000-0003-0576-2672; Murayama, Emi/0000-0002-5311-1594				Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gritsman K, 2000, DEVELOPMENT, V127, P921; Herbomel P, 2004, METH MOLEC MED, V105, P199; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Willett CE, 1999, DEV DYNAM, V214, P323, DOI 10.1002/(SICI)1097-0177(199904)214:4<323::AID-AJA5>3.0.CO;2-3; ZAPATA A, 1981, DEV COMP IMMUNOL, V5, P685, DOI 10.1016/S0145-305X(81)80043-2; ZAPATA AG, 1995, HISTOL HISTOPATHOL, V10, P761	25	356	368	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					963	975		10.1016/j.immuni.2006.10.015	http://dx.doi.org/10.1016/j.immuni.2006.10.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17157041	Bronze			2022-12-18	WOS:000243087500015
J	Gao, YJ; Chaudhuri, J; Zhu, CM; Davidson, L; Weaver, DT; Alt, FW				Gao, YJ; Chaudhuri, J; Zhu, CM; Davidson, L; Weaver, DT; Alt, FW			A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND-BREAK-REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; HUMAN CELL-LINE; CATALYTIC SUBUNIT; SACCHAROMYCES-CEREVISIAE; SCID MUTATION; CODING ENDS; MOUSE; MICE	The DNA-dependent protein kinase (DNA-PK) consists of Ku70, Ku80, and a large catalytic subunit, DNA-PKcs. Targeted inactivation of the Ku70 or Ku80 genes results in elevated ionizing radiation (IR) sensitivity and inability to perform both V(D)J coding-end and signal (RS)-end joining in cells, with severe growth retardation plus immunodeficiency in mice. In contrast, we now demonstrate that DNA-PKcs-null mice generated by gene-targeted mutation, while also severely immunodeficient, exhibit no growth retardation. Furthermore, DNA-PKcs-null cells are blocked for V(D)J coding-end joining, but retain normal RS-end joining. Finally, while DNA-PK-null fibroblasts exhibited increased IR sensitivity, DNA-PKcs-deficient ES cells did not. We conclude that Ku70 and Ku80 may have functions in V(D)J recombination and DNA repair that are independent of DNA-PKcs.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Blood Res, Boston, MA 02115 USA.				NIAID NIH HHS [AI20047, AI35714] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, R01AI020047, P01AI035714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AllalunisTurner J, 1997, RADIAT RES, V147, P284, DOI 10.2307/3579334; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1989, CURR TOP MICROBIOL, P3; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Danska JS, 1996, MOL CELL BIOL, V16, P5507; ERRAMI A, 1998, IN PRESS NUCL ACID R; Fujimori A, 1997, GENOMICS, V45, P194, DOI 10.1006/geno.1997.4919; Fukumura R, 1998, J BIOL CHEM, V273, P13058, DOI 10.1074/jbc.273.21.13058; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GELLERT M, 1992, TRENDS GENET, V8, P408, DOI 10.1016/0168-9525(92)90322-U; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENDRICKSON EA, 1988, GENE DEV, V2, P817, DOI 10.1101/gad.2.7.817; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; Jin SF, 1997, EMBO J, V16, P6874, DOI 10.1093/emboj/16.22.6874; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lieber MR, 1997, CURR OPIN GENET DEV, V7, P99, DOI 10.1016/S0959-437X(97)80116-5; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; Peterson SR, 1997, J BIOL CHEM, V272, P10227; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Shin EK, 1997, J IMMUNOL, V158, P3565; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Taccioli G E, 1992, Curr Top Microbiol Immunol, V182, P107; TACCIOLI GE, 1994, J BIOL CHEM, V269, P7439; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; WILER R, 1995, P NATL ACAD SCI USA, V92, P11485, DOI 10.1073/pnas.92.25.11485; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; ZHOU XY, 1995, GENE DEV, V9, P2623, DOI 10.1101/gad.9.21.2623; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	64	356	361	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					367	376		10.1016/S1074-7613(00)80619-6	http://dx.doi.org/10.1016/S1074-7613(00)80619-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768756	Bronze			2022-12-18	WOS:000076202300009
J	Brennan, P; Babbage, JW; Burgering, BMT; Groner, B; Reif, K; Cantrell, DA				Brennan, P; Babbage, JW; Burgering, BMT; Groner, B; Reif, K; Cantrell, DA			Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN T-CELLS; SIGNAL-TRANSDUCTION; TYROSINE PHOSPHORYLATION; STAT PROTEINS; IL-2 RECEPTOR; TH2 CELLS; C-MYC; GENE; PROLIFERATION	Cell cycle progression initiated by interleukin-2 (IL-2) in T cells is critical for lymphoproliferation and an immune response. Phosphatidyl inositol 3-kinase (PI3K) is activated by IL-2. However, nuclear targets for PI3K are not known. Here we identify the cell cycle regulator E2F as an IL-2 target in T lymphocytes and PI3K as the critical signaling pathway. We eliminate both Stat5 and Raf/MEK pathways from E2F regulation. Protein kinase B (PKB) is activated by IL-2 via PI3K. The expression of an active PKB is sufficient to induce E2F activity. Inhibition of PI3K inhibits phosphorylation of Rb, induction of cyclin D3, and degradation of p27(kip1). These results establish a crucial PI3K/PKB-mediated link between the IL-2 receptor and the cell cycle machinery.	UNIV UTRECHT, PHYSIOL CHEM LAB, NL-3548 CG UTRECHT, NETHERLANDS; UNIV FREIBURG, TUMOR BIOL CTR, INST EXPT CANC RES, D-79106 FREIBURG, GERMANY; UNIV FREIBURG, DEPT BIOL, D-79106 FREIBURG, GERMANY	Utrecht University; University of Freiburg; University of Freiburg	Brennan, P (corresponding author), IMPERIAL CANC RES FUND, LYMPHOCYTE ACTIVAT LAB, 44 LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND.		Brennan, Paul/ABB-9196-2021; Brennan, Paul/B-9210-2009; Reif, Karin/AAD-4692-2020	Brennan, Paul/0000-0001-8792-0499; Brennan, Paul/0000-0001-8792-0499; Reif, Karin/0000-0001-5490-8389				Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; Botz J, 1996, MOL CELL BIOL, V16, P3401; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHITTENDEN T, 1993, MOL CELL BIOL, V13, P3975, DOI 10.1128/MCB.13.7.3975; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; FAIRHURST RM, 1993, IMMUNOLOGY, V79, P112; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Gaffen SL, 1996, J BIOL CHEM, V271, P21381, DOI 10.1074/jbc.271.35.21381; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GRAVES JD, 1992, J IMMUNOL, V148, P2417; HAMEL PA, 1992, ONCOGENE, V7, P693; HORI T, 1987, BLOOD, V70, P1069; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LOEKEN MR, 1989, J BIOL CHEM, V264, P6572; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MINAMI Y, 1995, IMMUNITY, V2, P89, DOI 10.1016/1074-7613(95)90081-0; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Moberg K, 1996, MOL CELL BIOL, V16, P1436; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; MORICE WG, 1993, J BIOL CHEM, V268, P22737; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MURTHY SCS, 1985, P NATL ACAD SCI USA, V82, P2230, DOI 10.1073/pnas.82.8.2230; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; OHTANI K, 1994, MOL CELL BIOL, V14, P1603, DOI 10.1128/MCB.14.3.1603; Panayotou George, 1992, Trends in Cell Biology, V2, P358, DOI 10.1016/0962-8924(92)90042-L; PASTOR MI, 1995, IMMUNOL TODAY, V16, P159, DOI 10.1016/0167-5699(95)80134-0; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; TURNER JM, 1993, INT IMMUNOL, V5, P1199, DOI 10.1093/intimm/5.10.1199; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; WILLIAMS DH, 1995, EUR J IMMUNOL, V25, P42, DOI 10.1002/eji.1830250109; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4	63	356	364	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1997	7	5					679	689		10.1016/S1074-7613(00)80388-X	http://dx.doi.org/10.1016/S1074-7613(00)80388-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390691	Bronze			2022-12-18	WOS:A1997YH55400010
J	Anahtar, MN; Byme, EH; Doherty, KE; Bowman, BA; Yamamoto, HS; Soumillon, M; Padavattan, N; Ismail, N; Moodley, A; Sabatini, ME; Ghebremichael, MS; Nusbaum, C; Huttenhower, C; Virgin, HW; Ndung'u, T; Dong, KL; Walker, BD; Fichorova, RN; Kwon, DS				Anahtar, Melis N.; Byme, Elizabeth H.; Doherty, Kathleen E.; Bowman, Brittany A.; Yamamoto, Hidemi S.; Soumillon, Magali; Padavattan, Nikita; Ismail, Nasreen; Moodley, Amber; Sabatini, Mary E.; Ghebremichael, Musie S.; Nusbaum, Chad; Huttenhower, Curtis; Virgin, Herbert W.; Ndung'u, Thumbi; Dong, Krista L.; Walker, Bruce D.; Fichorova, Raina N.; Kwon, Douglas S.			Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; DIFFERENTIAL EXPRESSION; NEISSERIA-GONORRHOEAE; VAGINAL MICROBIOME; EPITHELIAL-CELLS; VAGINOSIS; WOMEN; INFECTION; INTERLEUKIN-6; CYTOKINE	Colonization by Lactobacillus in the female genital tract is thought to be critical for maintaining genital health. However, little is known about how genital microbiota influence host immune function and modulate disease susceptibility. We studied a cohort of asymptomatic young South African women and found that the majority of participants had genital communities with low Lactobacillus abundance and high ecological diversity. High-diversity communities strongly correlated with genital pro-inflammatory cytokine concentrations in both cross-sectional and longitudinal analyses. Transcriptional profiling suggested that genital antigen-presenting cells sense gram-negative bacterial products in situ via Toll-like receptor 4 signaling, contributing to genital inflammation through activation of the NF-kappa B signaling pathway and recruitment of lymphocytes by chemokine production. Our study proposes a mechanism by which cervicovaginal microbiota impact genital inflammation and thereby might affect a woman's reproductive health, including her risk of acquiring HIV.	[Anahtar, Melis N.; Byme, Elizabeth H.; Doherty, Kathleen E.; Bowman, Brittany A.; Ghebremichael, Musie S.; Ndung'u, Thumbi; Dong, Krista L.; Walker, Bruce D.; Kwon, Douglas S.] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Anahtar, Melis N.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA; [Yamamoto, Hidemi S.; Fichorova, Raina N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Soumillon, Magali; Nusbaum, Chad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Padavattan, Nikita; Ismail, Nasreen; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, HIV Pathogenesis Programme, ZA-4001 Durban, KwaZulu Natal, South Africa; [Moodley, Amber; Dong, Krista L.] Females Rising Educ Support & Hlth, ZA-4066 Durban, KwaZulu Natal, South Africa; [Sabatini, Mary E.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, KwaZulu Natal, South Africa; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Walker, Bruce D.; Kwon, Douglas S.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); University of Kwazulu Natal; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Kwon, DS (corresponding author), Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dkwon@mgh.harvard.edu	Anahtar, Melis/AAT-6231-2020	Bowman, Brittany/0000-0003-1101-163X; Ndung'u, Thumbi/0000-0003-2962-3992; Virgin, Herbert/0000-0001-8580-7628	Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI) [UKZNRSA1001]; NIAID [1R01AI111918, RO1AI067073, 5R01AI079085]; Burroughs Wellcome Fund; NIGMS [T32GM007753]; Paul and Daisy Soros Fellowship; South African Research Chairs Initiative; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111918, R01AI079085, R01AI067073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; South African Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the FRESH participants; T. Cele for performing the pelvic exams; T. Sikhakhane, S. Ngcobo, and S. Zungu for clinical support; H. Shen for flow cytometric assistance; A. Lisanti for performing tissue staining; B. Corleis, C. Gosmann, and G. Olson for critical feedback and assistance; S. Karim, L. Liebenberg, N. Samsunder, and N. Garrett for helpful discussions regarding mucosal sampling; C. Monaco and S. Handley for discussions about sample preparation and sequencing; and L. Hoisington-Lopez for sequencing support. This work was supported by the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative (IAVI) (UKZNRSA1001), and the NIAID (1R01AI111918 and RO1AI067073). D.S.K. received additional support from the Burroughs Wellcome Fund. M.N.A. was supported by award number T32GM007753 from the NIGMS, and the Paul and Daisy Soros Fellowship. R.N.F. and H.S.Y were supported by the NIAID (5R01AI079085). T.N. received additional support from the South African Research Chairs Initiative and an International Early Career Scientist Award from the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the NIH.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2013, CLIN INFECT DIS, V56, P777, DOI 10.1093/cid/cis1030; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Cule E, 2013, GENET EPIDEMIOL, V37, P704, DOI 10.1002/gepi.21750; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delaney ML, 2001, OBSTET GYNECOL, V98, P79, DOI 10.1016/S0029-7844(01)01402-8; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Drell T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054379; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Ghartey JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096659; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; INGLIS SR, 1994, AM J OBSTET GYNECOL, V171, P5, DOI 10.1016/S0002-9378(94)70069-9; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; LOCKWOOD CJ, 1994, AM J OBSTET GYNECOL, V171, P1097, DOI 10.1016/0002-9378(94)90043-4; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Masson L, 2015, CLIN INFECT DIS; MCGEE ZA, 1992, MICROB PATHOGENESIS, V12, P333, DOI 10.1016/0882-4010(92)90096-7; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; Rampersaud R, 2011, J BACTERIOL, V193, P1034, DOI 10.1128/JB.00694-10; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; van Oudenaarden, 2014, BIORXIV; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	46	355	379	5	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					965	976		10.1016/j.immuni.2015.04.019	http://dx.doi.org/10.1016/j.immuni.2015.04.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992865	Bronze, Green Accepted			2022-12-18	WOS:000354827400021
J	Gall, A; Treuting, P; Elkon, KB; Loo, YM; Gale, M; Barber, GN; Stetson, DB				Gall, Alevtina; Treuting, Piper; Elkon, Keith B.; Loo, Yueh-Ming; Gale, Michael, Jr.; Barber, Glen N.; Stetson, Daniel B.			Autoimmunity Initiates in Nonhematopoietic Cells and Progresses via Lymphocytes in an Interferon-Dependent Autoimmune Disease	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; I INTERFERONS; EXONUCLEASE TREX1; T-CELLS; CLONAL EXPANSION; CYTOSOLIC DNA; B-CELLS; GENE; MUTATIONS; ALPHA	The type I interferon (IFN) response initiated by detection of nucleic acids is important for antiviral defense but is also associated with specific autoimmune diseases. Mutations in the human 3' repair exonuclease 1 (Trexl) gene cause Aicardi-Goutieres syndrome (AGS), an IFN-associated autoimmune disease. However, the source of the type I IFN response and the precise mechanisms of disease in AGS remain unknown. Here, we demonstrate that Trex1 is an essential negative regulator of the STING-dependent antiviral response. We used an in vivo reporter of IFN activity in Trex1-deficient mice to localize the initiation of disease to nonhematopoietic cells. These IFNs drove T cell-mediated inflammation and an autoantibody response that targeted abundant, tissue-restricted autoantigens. However, B cells contributed to mortality independently of T cell-mediated tissue damage. These findings reveal a stepwise progression of autoimmune disease in Trex1-deficient mice, with implications for the treatment of AGS and related disorders.	[Gall, Alevtina; Elkon, Keith B.; Loo, Yueh-Ming; Gale, Michael, Jr.; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Elkon, Keith B.] Univ Washington, Sch Med, Div Rheumatol, Seattle, WA 98195 USA; [Barber, Glen N.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Barber, Glen N.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Miami; University of Miami	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	stetson@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Loo, Yueh-Ming/0000-0001-6294-7273; Gale, Michael/0000-0002-6332-7436; Gall, Alevtina/0000-0001-6386-7566	NIH [AI084914, AR48796]; European Union [241779]; Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to D. Barnes and T. Lindahl for providing Trex1-deficient mice; to A. Rudensky for Rosa26-YFP reporter mice; to K. Rajewsky for Mx-Cre mice; to M.-K. Kaja for CD45.1 congenic Ifnar1<SUP>-/-</SUP> mice; to M. Prlic and N. Zhang for help with bone marrow chimeras; to D. Winant and the Stanford PAN facility for mass spec analysis; to B. Johnson for expert histology preparation; to L. Reinhardt for help with immunofluorescence; and to Y. Crow and the D.B.S. lab for helpful discussions. D.B.S. is a scholar of the Rita Allen Foundation. This work was supported by grants from the NIH (AI084914 to D.B.S.; AR48796 to K.B.E.), the European Union (FP7/2007-2013) grant agreement number 241779 (NIMBL: http://www.NIMBLeu/ni/home), and the Lupus Research Institute (all to D.B.S.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Chan O, 1998, J IMMUNOL, V160, P51; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Vries B, 2010, ANN RHEUM DIS, V69, P1886, DOI 10.1136/ard.2009.114157; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Looney RJ, 2010, DRUGS, V70, P529, DOI 10.2165/11535420-000000000-00000; Martin DA, 2007, J IMMUNOL, V179, P5819, DOI 10.4049/jimmunol.179.9.5819; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takahashi I, 1999, J IMMUNOL, V162, P1843; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	36	355	370	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					120	131		10.1016/j.immuni.2011.11.018	http://dx.doi.org/10.1016/j.immuni.2011.11.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284419	Green Accepted, Bronze			2022-12-18	WOS:000299766000015
J	Shelly, S; Lukinova, N; Bambina, S; Berman, A; Cherry, S				Shelly, Spencer; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Cherry, Sara			Autophagy Is an Essential Component of Drosophila Immunity against Vesicular Stomatitis Virus	IMMUNITY			English	Article							INHIBITS CELL-GROWTH; TOXOPLASMA-GONDII; VIRAL RECOGNITION; INNATE IMMUNITY; RNA VIRUSES; FAT-BODY; PATHWAY; PROTEIN; MELANOGASTER; PARTICLES	Intrinsic innate immune mechanisms are the first line of defense against pathogens and exist to control infection autonomously in infected cells. Here, we showed that autophagy, an intrinsic mechanism that can degrade cytoplasmic components, played a direct antiviral role against the mammalian viral pathogen vesicular stomatitis virus (VSV) in the model organism Drosophila. We found that the surface glycoprotein, VSV-G, was likely the pathogen-associated molecular pattern (PAMP) that initiated this cell-autonomous response. Once activated, autophagy decreased viral replication, and repression of autophagy led to increased viral replication and pathogenesis in cells and animals. Lastly, we showed that the antiviral response was controlled by the phosphatidylinositol 3-kinase (P13K)-Akt-signaling pathway, which normally regulates autophagy in response to nutrient availability. Altogether, these data uncover an intrinsic antiviral program that links viral recognition to the evolutionarily conserved nutrient-signaling and autophagy pathways.	[Shelly, Spencer; Lukinova, Nina; Bambina, Shelly; Berman, Allison; Cherry, Sara] Univ Penn, Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu		cherry, sara/0000-0003-3956-6610	NIH [1R01AI07451, U54AI057168];  [T32AI07324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074951, R56AI074951, U54AI057168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tudor, S. Ross, N. Bonini, J. DiAngelo, and members of the Cherry laboratory for critically reading the manuscript; P. Bates for helpful suggestions; J. Rose for VSV-GFP; T. Neufeld for Atg snapback transgenic flies; J. DiAngelo and M. Birnbaum for Akt pathway transgenic flies; the Vienna Drosophila RNAi Center (VDRC) for Atg18 and Akt snapback transgenic flies; the Bloomington Stock Center for other fly stocks; R. Doms for anti-VSV G antibody; D. Lyles and R. Hardy for anti-VSV M antibody; and N. Shah for technical assistance and electron microscopy support. This work was supported by a training grant T32AI07324 to S.S. and by NIH grants 1R01AI07451 and U54AI057168 to S.C.	Abe A, 1998, J VIROL, V72, P6356, DOI 10.1128/JVI.72.8.6356-6361.1998; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; DUBOVI EJ, 1976, J VIROL, V18, P534, DOI 10.1128/JVI.18.2.534-541.1976; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; GUPTA AK, 1995, J GEN VIROL, V76, P365, DOI 10.1099/0022-1317-76-2-365; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Iwasaki A, 2007, AUTOPHAGY, V3, P354, DOI 10.4161/auto.4114; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Palese P, 1996, P NATL ACAD SCI USA, V93, P11354, DOI 10.1073/pnas.93.21.11354; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; ROLLS MM, 1994, CELL, V79, P497, DOI 10.1016/0092-8674(94)90258-5; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Seay M, 2005, MODULATION OF HOST GENE EXPRESSION AND INNATE IMMUNITY BY VIRUSES, P245, DOI 10.1007/1-4020-3242-0_11; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stephan JS, 2006, AUTOPHAGY, V2, P146, DOI 10.4161/auto.2.2.2485; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	55	355	369	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					588	598		10.1016/j.immuni.2009.02.009	http://dx.doi.org/10.1016/j.immuni.2009.02.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19362021	Green Accepted, Bronze			2022-12-18	WOS:000265319000015
J	Jensen, KDC; Su, X; Shin, S; Li, L; Youssef, S; Yarnasaki, S; Steinman, L; Saito, T; Locksley, RM; Davis, MM; Baumgarth, N; Chien, YH				Jensen, Kirk D. C.; Su, Xiaoqin; Shin, Sunny; Li, Luke; Youssef, Sawsan; Yarnasaki, Sho; Steinman, Lawrence; Saito, Takashi; Locksley, Richard M.; Davis, Mark M.; Baumgarth, Nicole; Chien, Yueh-Hsiu			Thymic selection determines gamma delta T cell effector fate: Antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma	IMMUNITY			English	Article							ALPHA-BETA; INTRAEPITHELIAL LYMPHOCYTES; POSITIVE SELECTION; NONCLASSICAL MHC; IL-17 PRODUCTION; IMMUNE-RESPONSE; GENE-EXPRESSION; LYMPHOID ORGANS; NK-CELLS; RECEPTOR	gamma delta T cells uniquely contribute to host immune defense, but how this is accomplished remains unclear. Here, we analyzed the nonclassical major histocompatibility complex class I T10 and T22-specific gamma delta T cells in mice and found that encountering antigen in the thymus was neither required nor inhibitory for their development. But when triggered through the T cell receptor, ligand-naive lymphoid-gamma delta T cells produced IL-17, whereas ligand-experienced cells made IFN-gamma. Immediately after immunization, a large fraction of IL-17(+) gamma delta T cells were found in the draining lymph nodes days before the appearance of antigen-specific IL-17(+) alpha beta T cells. Thus, thymic selection determines the effector fate of gamma delta T cells rather than constrains their antigen specificities. The swift IL-17 response mounted by antigen-naive gamma delta T cells suggests a critical role for these cells at the onset of an acute inflammatory response to novel antigens.	[Jensen, Kirk D. C.; Su, Xiaoqin; Shin, Sunny; Li, Luke; Davis, Mark M.; Chien, Yueh-Hsiu] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Youssef, Sawsan; Steinman, Lawrence; Davis, Mark M.; Chien, Yueh-Hsiu] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Youssef, Sawsan; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Yarnasaki, Sho; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Yokohama, Kanagawa 2300045, Japan; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med & Microbiol Immunobiol, San Francisco, CA 94143 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Baumgarth, Nicole] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Stanford University; Stanford University; Stanford University; RIKEN; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; University of California System; University of California Davis	Chien, YH (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	chien@stanford.edu	Baumgarth, Nicole/AAI-6949-2020; Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Steinman, Lawrence/0000-0002-2437-2250; Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI033431] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI033431, R01 AI033431-13, R01 AI033431-14, R01 AI033431-15, R01 AI033431-11, R01 AI033431-12, U19 AI 057229] Funding Source: Medline; PHS HHS [A1 33431] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Baccala R, 2005, J IMMUNOL, V174, P4606, DOI 10.4049/jimmunol.174.8.4606; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; BONNEVILLE M, 1990, NATURE, V344, P163, DOI 10.1038/344163a0; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; CROWLEY MP, 1998, CHARACTERIZATION LIG; DENT AL, 1990, NATURE, V343, P714, DOI 10.1038/343714a0; DEPAOLI P, 1990, J INFECT DIS, V161, P1013, DOI 10.1093/infdis/161.5.1013; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; French JD, 2005, P NATL ACAD SCI USA, V102, P14741, DOI 10.1073/pnas.0507520102; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; HANKE T, 1994, J EXP MED, V180, P1629, DOI 10.1084/jem.180.5.1629; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayes SM, 2007, IMMUNOL REV, V215, P8, DOI 10.1111/j.1600-065X.2006.00476.x; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; HO M, 1990, IMMUNOL LETT, V25, P139, DOI 10.1016/0165-2478(90)90105-Y; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; ITO K, 1990, CELL, V62, P549, DOI 10.1016/0092-8674(90)90019-B; Jason J, 2000, J INFECT DIS, V182, P474, DOI 10.1086/315740; King DP, 1999, J IMMUNOL, V162, P5033; Koohsari H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-21; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; PEREIRA P, 1992, EMBO J, V11, P25, DOI 10.1002/j.1460-2075.1992.tb05023.x; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Sciammas R, 1998, J IMMUNOL, V161, P5187; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Toth B, 2004, J LEUKOCYTE BIOL, V76, P545, DOI 10.1189/jlb.0404219; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WEINTRAUB BC, 1994, J IMMUNOL, V153, P3051; WELLS FB, 1991, SCIENCE, V253, P903, DOI 10.1126/science.1831565; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	60	355	363	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					90	100		10.1016/j.immuni.2008.04.022	http://dx.doi.org/10.1016/j.immuni.2008.04.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18585064	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000257905400013
J	Schmid, D; Munz, C				Schmid, Dorothee; Munz, Christian			Innate and adaptive immunity through autophagy	IMMUNITY			English	Review							CLASS-II PRESENTATION; LYSOSOMAL PROTEIN-DEGRADATION; GENOME-WIDE ASSOCIATION; PROGRAMMED CELL-DEATH; ALA REPEAT DOMAIN; T-CELLS; NUCLEAR ANTIGEN; DENDRITIC CELLS; IN-VIVO; ENDOPLASMIC-RETICULUM	The two main proteolytic machineries of eukaryotic cells, lysosomes; and proteasomes, receive substrates by different routes. Polyubiquitination targets proteins for proteasonnal degradation, whereas autophagy delivers intracellular material for lysosomal hydrolysis. The importance of autophagy for cell survival has long been appreciated, but more recently, its essential role in both innate and adaptive immunity has been characterized. Autophagy is now recognized to restrict viral infections and replication of intracellular bacteria and parasites. Additionally, this pathway delivers cytoplasmic antigens for MHC class II presentation to the adaptive immune system, which then in turn is able to regulate autophagy. At the same time, autophagy plays a role in the survival and the cell death of T cells. Thus, the immune system utilizes autophagic degradation of cytoplasmic material, to both restrict intracellular pathogens and regulate adaptive immunity.	Rockefeller Univ, Lab Viral Immunobiol, New York, NY 10021 USA; Rockefeller Univ, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Munz, C (corresponding author), Rockefeller Univ, Lab Viral Immunobiol, 1230 York Ave, New York, NY 10021 USA.	munzc@rockefeller.edu		Munz, Christian/0000-0001-6419-1940; Dormann, Dorothee/0000-0002-9260-2775	NCI NIH HHS [R01CA108609, R01 CA108609, R01 CA101741, R01CA101741] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA101741, R01CA108609] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Al-Younes HM, 2004, INFECT IMMUN, V72, P4751, DOI 10.1128/IAI.72.8.4751-4762.2004; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; DICE JF, 1975, ARCH BIOCHEM BIOPHYS, V170, P213, DOI 10.1016/0003-9861(75)90112-5; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fengsrud M, 2000, BIOCHEM J, V352, P773, DOI 10.1042/0264-6021:3520773; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gueguen M, 1996, P NATL ACAD SCI USA, V93, P14692, DOI 10.1073/pnas.93.25.14692; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; HENELL F, 1987, EXP MOL PATHOL, V46, P1, DOI 10.1016/0014-4800(87)90026-8; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee CY, 2004, IEEE T EVOLUT COMPUT, V8, P1, DOI 10.1109/TEVC.2003.816583; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Meyers G, 1998, J VIROL, V72, P4139, DOI 10.1128/JVI.72.5.4139-4148.1998; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MIZUSHIMA N, 2007, IN PRESS ANN REV NUT; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakashima A, 2006, VIROLOGY, V349, P254, DOI 10.1016/j.virol.2006.03.029; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schaible UE, 1999, J CELL SCI, V112, P681; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tellam J, 2001, J BIOL CHEM, V276, P33353, DOI 10.1074/jbc.M104535200; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Walker DH, 1997, LAB INVEST, V76, P129; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	104	355	370	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					11	21		10.1016/j.immuni.2007.07.004	http://dx.doi.org/10.1016/j.immuni.2007.07.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17663981	Green Published, Bronze			2022-12-18	WOS:000248398100005
J	Ward, SG; Bacon, K; Westwick, J				Ward, SG; Bacon, K; Westwick, J			Chemokines and T lymphocytes: More than an attraction	IMMUNITY			English	Review							HIV-1 INFECTION; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS; PHOSPHOLIPASE-D; CELLS; ACTIVATION; EXPRESSION; RANTES; KINASE; CCR-5		Univ Bath, Dept Pharm & Pharmacol, Pharmacol Grp, Bath BA2 7AY, Avon, England; Neurocrine Biosci, San Diego, CA 92121 USA	University of Bath; Neurocrine Biosciences	Ward, SG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Pharmacol Grp, Claverton Down, Bath BA2 7AY, Avon, England.	prssgw@bath.ac.uk	Ward, Stephen/AAE-4341-2020	Ward, Stephen G./0000-0002-6795-6002	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; BACON KB, 1995, J IMMUNOL, V154, P3654; Bacon KB, 1998, J IMMUNOL, V160, P1894; Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BACON KB, 1993, BLOOD, V81, P430; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Carroll RG, 1997, SCIENCE, V276, P273, DOI 10.1126/science.276.5310.273; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chen JD, 1997, NAT MED, V3, P1110, DOI 10.1038/nm1097-1110; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dairaghi DJ, 1998, J IMMUNOL, V160, P426; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Gonzalo JA, 1996, IMMUNITY, V4, P1, DOI 10.1016/S1074-7613(00)80293-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris N, 1997, J EXP MED, V185, P177, DOI 10.1084/jem.185.1.177; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Herold KC, 1997, J IMMUNOL, V159, P4150; Horuk R, 1998, J BIOL CHEM, V273, P386, DOI 10.1074/jbc.273.1.386; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; LINDLEY IJD, 1993, IMMUNOL TODAY, V14, P24; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Matsuo T, 1996, BIOCHEM J, V315, P505, DOI 10.1042/bj3150505; Moriuchi H, 1997, J IMMUNOL, V158, P3483; Oravecz T, 1996, J IMMUNOL, V157, P1329; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695; Qin SX, 1996, EUR J IMMUNOL, V26, P640, DOI 10.1002/eji.1830260320; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Quillent C, 1998, LANCET, V351, P14, DOI 10.1016/S0140-6736(97)09185-X; Riley JL, 1997, J IMMUNOL, V158, P5545; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Siveke JT, 1998, J IMMUNOL, V160, P550; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Szabo MC, 1997, EUR J IMMUNOL, V27, P1061, DOI 10.1002/eji.1830270504; Taub DD, 1996, J IMMUNOL, V156, P2095; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; TURNER L, 1995, J IMMUNOL, V155, P2437; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; WECHSLER AS, 1994, J IMMUNOL, V153, P2515; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wong M, 1998, J BIOL CHEM, V273, P309, DOI 10.1074/jbc.273.1.309; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yang AG, 1997, P NATL ACAD SCI USA, V94, P11567, DOI 10.1073/pnas.94.21.11567; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577	82	355	367	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1998	9	1					1	11		10.1016/S1074-7613(00)80583-X	http://dx.doi.org/10.1016/S1074-7613(00)80583-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697831	Bronze			2022-12-18	WOS:000075066600001
J	Tiller, T; Tsuiji, M; Yurasov, S; Velinzon, K; Nussenzweig, MC; Wardemann, H				Tiller, Thomas; Tsuiji, Makoto; Yurasov, Sergey; Velinzon, Klara; Nussenzweig, Michel C.; Wardemann, Hedda			Autoreactivity in human IgG(+) memory B cells	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNOGLOBULIN-M ANTIBODIES; GERMINAL-CENTERS; PLASMA-CELL; ADAPTIVE IMMUNITY; SOMATIC MUTATION; DNA AUTOANTIBODY; CLONAL SELECTION; MARGINAL ZONE	More than half of the nascent B cells in humans initially express autoreactive antibodies. However, most of these autoantibodies are removed from the repertoire at two checkpoints before maturation into naive B cells. A third checkpoint excludes remaining autoantibodies from the antigen -experienced IgM(+) memory B cell pool. Nevertheless, low-affinity self-reactive antibodies are frequently found in the serum of normal humans. To determine the source of these antibodies, we cloned and expressed antibodies from circulating human IgG(+) memory B cells. Surprisingly, we found that self-reactive antibodies including anti-nuclear antibodies were frequently expressed by IgG(+) memory B cells in healthy donors. Most of these antibodies were created de novo by somatic hypermutation during the transition between mature naive and IgG(+) memory B cells. We conclude that deregulation of self-reactive IgG(+) memory B cells may be associated with autoimmunity.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Max Planck Inst Infect Biol, D-10117 Berlin, Germany; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Max Planck Society; Memorial Sloan Kettering Cancer Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu; wardemann@mpiib-berlin.mpg.de	Tsuiji, Makoto/G-1411-2010; Nussenzweig, Michel/AAE-7292-2019	Tsuiji, Makoto/0000-0002-5607-4880; Wardemann, Hedda/0000-0003-3921-5933	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, U19AI056362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056362, R01 AI037526] Funding Source: Medline; NIAMS NIH HHS [P50 AR054083] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; CAMBIER JC, 1974, PREP BIOCHEM, V4, P31, DOI 10.1080/00327487408068184; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CASSON LP, 1995, J EXP MED, V182, P743, DOI 10.1084/jem.182.3.743; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; Egner W, 2000, J CLIN PATHOL, V53, P424, DOI 10.1136/jcp.53.6.424; GUILBERT B, 1982, J IMMUNOL, V128, P2779; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Jang YJ, 1998, MOL IMMUNOL, V35, P1207, DOI 10.1016/S0161-5890(98)00095-9; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; Lecerf JM, 1998, J IMMUNOL, V161, P1274; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; PLEBANI A, 1989, EUR J PEDIATR, V149, P164, DOI 10.1007/BF01958271; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; SEIGNEURIN JM, 1988, BLOOD, V71, P581; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; Wellmann U, 2005, P NATL ACAD SCI USA, V102, P9258, DOI 10.1073/pnas.0500132102; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	353	362	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2007	26	2					205	213		10.1016/j.immuni.2007.01.009	http://dx.doi.org/10.1016/j.immuni.2007.01.009			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17306569	Green Accepted, Bronze			2022-12-18	WOS:000244628600011
J	Legler, DF; Micheau, O; Doucey, MA; Tschopp, J; Bron, C				Legler, DF; Micheau, O; Doucey, MA; Tschopp, J; Bron, C			Recruitment of TNF receptor 1 to lipid rafts is essential for TNF alpha-mediated NF-kappa B activation	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; RICH MEMBRANE RAFTS; CELL-DEATH; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; KINASE RIP; DOMAIN; CD40; APOPTOSIS; DISTINCT	Engagement of TNF receptor 1 by TNFalpha activates the transcription factor NF-kappaB but can also induce apoptosis. Here we show that upon TNFalpha binding, TNFR1 translocates to cholesterol- and sphingolipid-enriched membrane microdomains, termed lipid rafts, where it associates with the Ser/Thr kinase RIP and the adaptor proteins TRADD and TRAF2, forming a signaling complex. In lipid rafts, TNFR1 and RIP are ubiquitylated. Furthermore, we provide evidence that translocation to lipid rafts precedes ubiquitylation, which leads to the degradation via the proteasome pathway. Interfering with lipid raft organization not only abolishes ubiquitylation but switches TNFalpha signaling from NF-kappaB activation to apoptosis. We suggest that lipid rafts are crucial for the outcome of TNFalpha-activated signaling pathways.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland; Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany	University of Lausanne; University of Konstanz	Legler, DF (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland.		micheau, olivier/C-3574-2011	micheau, olivier/0000-0001-8499-7984; Legler, Daniel F./0000-0001-8610-4764				Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balkwill Fran, 2000, Immunology Today, V21, P470, DOI 10.1016/S0167-5699(00)01722-9; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BOLDIN MP, 1995, FEBS LETT, V367, P39, DOI 10.1016/0014-5793(95)00534-G; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cottin V, 2002, J IMMUNOL, V168, P4095, DOI 10.4049/jimmunol.168.8.4095; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; DHEIN J, 1992, J IMMUNOL, V149, P3166; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Grassme H, 2001, BIOCHEM BIOPH RES CO, V284, P1016, DOI 10.1006/bbrc.2001.5045; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hueber AO, 2002, EMBO REP, V3, P190, DOI 10.1093/embo-reports/kvf022; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Ko YG, 1999, J IMMUNOL, V162, P7217; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Natoli G, 1998, BIOCHEM PHARMACOL, V56, P915, DOI 10.1016/S0006-2952(98)00154-3; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SEDWICK CE, 2002, ORDERED JUST SO LIPI; Shen ZH, 1997, J IMMUNOL, V158, P2723; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	56	353	368	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					655	664		10.1016/S1074-7613(03)00092-X	http://dx.doi.org/10.1016/S1074-7613(03)00092-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753742	Green Submitted, Bronze			2022-12-18	WOS:000182962200010
J	Igarashi, H; Gregory, SC; Yokota, T; Sakaguchi, N; Kincade, PW				Igarashi, H; Gregory, SC; Yokota, T; Sakaguchi, N; Kincade, PW			Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; B-CELL; FETAL LIVER; PRECURSOR CELLS; CUTTING EDGE; IN-VITRO; PRO-B; EXPRESSION; LINEAGE; GENE	Viable Lin(-) CD27(+) c-kit(Hi) SCa-1(Hi) GFP(+) cells recovered from heterozygous RAG1/GFP knockin mice progressed through previously defined stages of B, T, and NK cell lineage differentiation. In contrast to the GFP(-) cohort, there was minimal myeloid or erythroid potential in cells with an active RAG1 locus. Partial overlap with TdT(+) cells suggested that distinctive early lymphocyte characteristics are not synchronously acquired. Rearrangement of Ig genes initiates before typical lymphoid lineage patterns of gene expression are established, and activation of the RAG1 locus transiently occurs in a large fraction of cells destined to become NK cells. These early lymphocyte progenitors (ELP) are distinct from stem cells, previously described prolymphocytes, or progenitors corresponding to other blood cell lineages.	Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; Kumamoto Univ, Sch Med, Dept Immunol, Kumamoto 8600811, Japan	Oklahoma Medical Research Foundation; Kumamoto University	Kincade, PW (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			NCRR NIH HHS [P20-RR15577] Funding Source: Medline; NIAID NIH HHS [AI-20069] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; Arias AM, 1999, CURR OPIN GENET DEV, V9, P447, DOI 10.1016/S0959-437X(99)80068-9; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Billia F, 2001, BLOOD, V97, P2257, DOI 10.1182/blood.V97.8.2257; BORN W, 1988, J IMMUNOL, V140, P3228; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; Cheng H, 1996, CONNECT TISSUE RES, V34, P87, DOI 10.3109/03008209609021494; CHERVENAK R, 1993, J IMMUNOL, V151, P4486; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CROSS MA, 1994, ONCOGENE, V9, P3013; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; FREDRICKSON GG, 1989, J EXP MED, V169, P1473, DOI 10.1084/jem.169.4.1473; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hardy RR, 2000, CURR TOP MICROBIOL, V252, P25; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2001, BLOOD, V97, P2680, DOI 10.1182/blood.V97.9.2680; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Kawamoto H, 1999, J IMMUNOL, V162, P2725; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kawamoto H, 1998, J IMMUNOL, V161, P3799; KINCADE PW, 2002, IN PRESS IMMUNOL REV; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; KOURO T, 2002, IN PRESS BLOOD; Kuboto A, 1999, J IMMUNOL, V163, P212; Kuwata N, 1999, J IMMUNOL, V163, P6355; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Medina KL, 2000, BLOOD, V95, P2059, DOI 10.1182/blood.V95.6.2059; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Michie AM, 1998, J IMMUNOL, V160, P1735; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; OKADA S, 1992, BLOOD, V80, P3044; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; PARK YH, 1989, EUR J IMMUNOL, V19, P2139, DOI 10.1002/eji.1830191125; Payne KJ, 1999, BLOOD, V94, P713, DOI 10.1182/blood.V94.2.713.414k15_713_723; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1034/j.1600-065X.2000.017512.x; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Smithson G, 1998, J IMMUNOL, V161, P27; SMITHSON G, 1994, J EXP MED, V180, P717, DOI 10.1084/jem.180.2.717; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Wang H, 1998, P NATL ACAD SCI USA, V95, P6831, DOI 10.1073/pnas.95.12.6831; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; WILSON CA, 1995, BLOOD, V85, P1535, DOI 10.1182/blood.V85.6.1535.bloodjournal8561535; WINEMAN JP, 1992, BLOOD, V80, P1717; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	80	353	357	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					117	130		10.1016/S1074-7613(02)00366-7	http://dx.doi.org/10.1016/S1074-7613(02)00366-7			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196284	Bronze			2022-12-18	WOS:000177669400001
J	Batista, FD; Neuberger, MS				Batista, FD; Neuberger, MS			Affinity dependence of the B cell response to antigen: A threshold, a ceiling, and the importance of off-rate	IMMUNITY			English	Article							SITE-DIRECTED MUTAGENESIS; PEPTIDE-MHC COMPLEXES; 3-DIMENSIONAL STRUCTURE; IMMUNE-RESPONSE; LYMPHOCYTES-B; ANTIBODY; LYSOZYME; RECEPTOR; BINDING; SPECIFICITY	Initiation and affinity maturation of the humoral immune response is driven by antigen interaction with BCR. To study how signaling and antigen presentation through BCR depend on antigen/BCR affinity, lysozyme-specific B cell transfectants were challenged with mutated lysozymes differing in their binding kinetics. For detectable triggering, the antigen/BCR complex needed a K-a > 10(6) M-1 (dissociation half-life > similar to 1 s). Mutated lysozymes whose binding was below this threshold could nevertheless be presented if complexed with soluble antibody. Above the threshold, the concentration of antigen required to trigger a response decreased as the affinity (particularly dissociation half-life) increased. However, a plateau was reached at K(a)s > similar to 10(10) M-1 (dissociation half-life > 0.5 hr), supporting the idea of a ceiling to affinity maturation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							ADORINI L, 1993, J IMMUNOL, V151, P3576; Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1993, J MOL BIOL, V237, P513; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GEARHART PJ, 1981, NATURE, V291, P29, DOI 10.1038/291029a0; GOLDBAUM FA, 1994, J MOL BIOL, V241, P739, DOI 10.1006/jmbi.1994.1549; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JERNE N K, 1951, Acta Pathol Microbiol Scand Suppl, V87, P1; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; JUSTEMENT LB, 1989, J IMMUNOL, V143, P881; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; KIM KJ, 1979, J IMMUNOL, V122, P549; LAVOIE T, 1989, LYSOZYME MODEL, P151; LAVOIE TB, 1992, J IMMUNOL, V148, P503; MARIUZZA RA, 1983, J MOL BIOL, V170, P1055, DOI 10.1016/S0022-2836(83)80206-X; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; MOLLER G, 1987, IMMUNOL REV, P96; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SMITHGILL SJ, 1982, J IMMUNOL, V128, P314; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; TELLO D, 1990, BIOCHIMIE, V72, P507, DOI 10.1016/0300-9084(90)90114-V; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WATTS C, 1993, J EXP MED, V178, P1459, DOI 10.1084/jem.178.4.1459; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; WILLIAMS GT, 1990, J EXP MED, V171, P947, DOI 10.1084/jem.171.3.947	42	353	371	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					751	759		10.1016/S1074-7613(00)80580-4	http://dx.doi.org/10.1016/S1074-7613(00)80580-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655489	Bronze			2022-12-18	WOS:000074396300011
J	Mchedlidze, T; Waldner, M; Zopf, S; Walker, J; Rankin, AL; Schuchmann, M; Voehringer, D; McKenzie, ANJ; Neurath, MF; Pflanz, S; Wirtz, S				Mchedlidze, Tamar; Waldner, Maximilian; Zopf, Steffen; Walker, Jennifer; Rankin, Andrew L.; Schuchmann, Marcus; Voehringer, David; McKenzie, Andrew N. J.; Neurath, Markus F.; Pflanz, Stefan; Wirtz, Stefan			Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis	IMMUNITY			English	Article							RECEPTOR ACCESSORY PROTEIN; IN-VIVO; IL-33; CYTOKINE; EXPRESSION; ST2; INFLAMMATION; POPULATION; MECHANISMS; FATE	Liver fibrosis is a consequence of chronic liver diseases and thus a major cause of mortality and morbidity. Clinical evidence and animal studies suggest that local tissue homeostasis is disturbed due to immunological responses to chronic hepatocellular stress. Poorly defined stress-associated inflammatory networks are thought to mediate gradual accumulation of extracellular-matrix components, ultimately leading to fibrosis and liver failure. Here we have reported that hepatic expression of interleukin-33 (IL-33) was both required and sufficient for severe hepatic fibrosis in vivo. We have demonstrated that IL-33's profibrotic effects related to activation and expansion of liver resident innate lymphoid cells (ILC2). We identified ILC2-derived IL-13, acting through type-II IL-4 receptor-dependent signaling via the transcription factor STAT6 and hepatic stellate-cell activation, as a critical downstream cytokine of IL-33-dependent pathologic tissue remodeling and fibrosis. Our data reveal key immunological networks implicated in hepatic fibrosis and support the concept of modulation of IL-33 bioactivity for therapeutic purposes.	[Mchedlidze, Tamar; Waldner, Maximilian; Zopf, Steffen; Neurath, Markus F.; Wirtz, Stefan] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Rankin, Andrew L.; Pflanz, Stefan] Merck Res Labs, Palo Alto, CA 94304 USA; [Schuchmann, Marcus] Johannes Gutenberg Univ Mainz, Dept Med 1, D-55131 Mainz, Germany; [Voehringer, David] Univ Erlangen Nurnberg, Inst Med Microbiol Immunol & Hyg, Dept Infect Biol, D-91054 Erlangen, Germany; [Walker, Jennifer; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Erlangen Nuremberg; Merck & Company; Johannes Gutenberg University of Mainz; University of Erlangen Nuremberg; MRC Laboratory Molecular Biology	Wirtz, S (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany.	stefan.wirtz@uk-erlangen.de	Voehringer, David/K-2776-2019	Wirtz, Stefan/0000-0001-6936-7431	Collaborative Research Center (DFG) [SFB796]; ERC [PAS_241506]; Interdisciplinary Center for Clinical Research (IZKF); ELAN program of the University Medical Center of Erlangen; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	Collaborative Research Center (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Interdisciplinary Center for Clinical Research (IZKF); ELAN program of the University Medical Center of Erlangen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank D. Freytag, C. Lindner, and A. Taut for excellent technical assistance. We thank the Institute of Pathology, University Medical Center Mainz (T. Hansen) for assistance and the NIAID Schistosoma Resource Center for materials and technical support. This work was supported by the Collaborative Research Center (SFB796 of the DFG to T.M., S.W., and M.F.N.), by an ERC starting grant (PAS_241506 to D.V.), and by the Interdisciplinary Center for Clinical Research (IZKF) and the ELAN program of the University Medical Center of Erlangen (to S.W).	Arshad MI, 2011, EUR J IMMUNOL, V41, P2341, DOI 10.1002/eji.201041332; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Blank WA, 2010, J PARASITOL, V96, P900, DOI 10.1645/GE-2463.1; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; Koyasu S, 2011, CURR OPIN ALLERGY CL, V11, P109, DOI 10.1097/ACI.0b013e3283448808; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yanaba K, 2011, CLIN RHEUMATOL, V30, P825, DOI 10.1007/s10067-011-1686-5	51	352	378	8	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					357	371		10.1016/j.immuni.2013.07.018	http://dx.doi.org/10.1016/j.immuni.2013.07.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23954132	Green Accepted, Bronze			2022-12-18	WOS:000330948800017
J	Ravichandran, KS				Ravichandran, Kodi S.			Beginnings of a Good Apoptotic Meal: The Find-Me and Eat-Me Signaling Pathways	IMMUNITY			English	Review							PHOSPHATIDYLSERINE RECEPTOR TIM-4; CELL-DEATH; PHAGOSOME MATURATION; DENDRITIC CELLS; MACROPHAGE RECOGNITION; VITRONECTIN RECEPTOR; ENGULFMENT RECEPTOR; CYTOKINE PRODUCTION; CORPSE CLEARANCE; ATP RELEASE	Prompt and efficient clearance of apoptotic cells is necessary to prevent secondary necrosis of dying cells and to avoid immune responses to autoantigens. Recent studies have shed light on how apoptotic cells through soluble "find-me" signals advertise their presence to phagocytes at the earliest stages of cell death. Phagocytes sense the find-me signal gradient, and in turn the presence of dying cells, and migrate to their vicinity. The apoptotic cells also expose specific "eat-me" signals on their surface that are recognized by phagocytes through specific engulfment receptors. This review covers the recent progress in the areas of find-me and eat-me signals and how these relate to prompt and immunologically silent clearance of apoptotic cells.	[Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410	National Institutes of Health [GM064709]; American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055761, R01GM064709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.S.R. acknowledges funding from the National Institutes of Health (GM064709) and the American Asthma Foundation. K.S.R. is a William Benter Senior Fellow of the American Asthma Foundation.	Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Appelt U, 2005, CELL DEATH DIFFER, V12, P194, DOI 10.1038/sj.cdd.4401527; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; Beer A, 2008, CYTOM PART A, V73A, P139, DOI 10.1002/cyto.a.20510; Blume KE, 2009, J IMMUNOL, V183, P8138, DOI 10.4049/jimmunol.0902250; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fadeel B, 2007, HFSP J, V1, P225, DOI 10.2976/1.2800110; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Franz S, 2007, CELL DEATH DIFFER, V14, P733, DOI 10.1038/sj.cdd.4402066; Franz Sandra, 2006, Curr Rheumatol Rep, V8, P245, DOI 10.1007/s11926-006-0001-y; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galluzzi L, 2011, CELL DEATH IN PRESS; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gregory CD, 2005, NAT CELL BIOL, V7, P1161, DOI 10.1038/ncb1205-1161; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hanayama R, 2006, CURR DIRECT AUTOIMMU, V9, P162; Hasko G, 2000, BRIT J PHARMACOL, V129, P909, DOI 10.1038/sj.bjp.0703134; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Imachi H, 2000, LAB INVEST, V80, P263, DOI 10.1038/labinvest.3780029; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Knowles AF, 2011, PURINERG SIGNAL, V7, P21, DOI 10.1007/s11302-010-9214-7; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; LU Z, 2011, NAT CELL BI IN PRESS; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; MEYORACH D, 2000, ANN NY ACAD SCI, V926, P226; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; PARK D, 2011, NATURE IN PRESS; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Peter C, 2010, J MOL CELL BIOL, V2, P78, DOI 10.1093/jmcb/mjp045; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1991, CHEST, V99, pS6, DOI 10.1378/chest.99.3_Supplement.6S-a; Schetinger MRC, 2007, BIOFACTORS, V31, P77, DOI 10.1002/biof.5520310205; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Wilkin F, 2002, EUR J IMMUNOL, V32, P2409, DOI 10.1002/1521-4141(200209)32:9<2409::AID-IMMU2409>3.0.CO;2-H; Witte Owen N, 2005, Science, V307, P206; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yamamoto T, 2007, PATHOL INT, V57, P1, DOI 10.1111/j.1440-1827.2007.02049.x; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	102	352	362	4	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					445	455		10.1016/j.immuni.2011.09.004	http://dx.doi.org/10.1016/j.immuni.2011.09.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035837	Green Accepted, Bronze			2022-12-18	WOS:000296657700002
J	Li, MO; Flavell, RA				Li, Ming O.; Flavell, Richard A.			Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10	IMMUNITY			English	Review							T-CELL RESPONSES; TGF-BETA; RETINOIC-ACID; AUTOIMMUNE INFLAMMATION; CUTTING EDGE; IN-VIVO; INTESTINAL INFLAMMATION; CHRONIC ENTEROCOLITIS; DEPENDENT MECHANISM; LETHAL PHENOTYPE	Transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) are regulatory cytokines with pleiotropic roles in the immune system. The prominent function of TGF-beta is to maintain T cell tolerance to self or innocuous environmental antigens via its direct effects on the differentiation and homeostasis of effector and regulatory T cells. A critical route for the regulation of T cells by TGF-beta is via activation of a T cell-produced latent form of TGF-beta 1 by dendritic cell-expressed av beta 8 integrin. IL-10 operates primarily as a feedback inhibitor of exuberant T cell responses to microbial antigens. T cells are also the principal producers of IL-10, the expression of which is regulated by IL-27, IL-6, and TGF-beta. The collective activity of TGF-beta and IL-10 ensures a controlled inflammatory response specifically targeting pathogens without evoking excessive immunopathology to self-tissues.	[Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Memorial Sloan Kettering Cancer Center; Yale University; Howard Hughes Medical Institute; Yale University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org; richard.flavell@yale.edu		li, ming/0000-0002-1383-0535	NIAMS NIH HHS [R01 AR060723] Funding Source: Medline; NIDDK NIH HHS [R01 DK51665] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; Boivin GP, 1997, TRANSGENIC RES, V6, P197, DOI 10.1023/A:1018490007745; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Calado DP, 2006, J IMMUNOL, V177, P5358, DOI 10.4049/jimmunol.177.8.5358; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hunter CA, 1997, J IMMUNOL, V158, P3311; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Kobayashi S, 1999, J IMMUNOL, V163, P4013; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Longenecker G, 2002, CYTOKINE, V18, P43, DOI 10.1006/cyto.2002.1025; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; RUBTSOV, 2008, IMMUNITY, V28, P546; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	94	352	374	3	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					468	476		10.1016/j.immuni.2008.03.003	http://dx.doi.org/10.1016/j.immuni.2008.03.003			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400189	Bronze			2022-12-18	WOS:000254939400005
J	Los, M; Wesselborg, S; Schulze-Osthoff, K				Los, M; Wesselborg, S; Schulze-Osthoff, K			The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice	IMMUNITY			English	Review							INTERLEUKIN-1-BETA CONVERTING-ENZYME; DRUG-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; APO-1/FAS RECEPTOR/LIGAND SYSTEM; CYTOCHROME-C; IL-1-BETA-CONVERTING ENZYME; GENE CED-3; INTERACTING PROTEIN; ICE/CED-3 PROTEASE; ADAPTER MOLECULE		Univ Tubingen, Med Clin, Dept Internal Med 1, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schulze-Osthoff, K (corresponding author), Univ Munster, Div Cell Biol, Rontgenweg 21, D-48149 Munster, Germany.	kso@uni-muenster.de	Schulze-Osthoff, Klaus/N-9025-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Wesselborg, Sebastian/0000-0002-5236-942X; Los, Marek/0000-0001-9518-1411				Ahmad M, 1997, CANCER RES, V57, P615; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; Fantuzzi G, 1998, BLOOD, V91, P2118, DOI 10.1182/blood.V91.6.2118.2118_2118_2125; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Izquierdo M, 1999, EMBO J, V18, P156, DOI 10.1093/emboj/18.1.156; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Krammer P H, 1999, Adv Immunol, V71, P163; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li P, 1997, J CELL BIOCHEM, V64, P27, DOI 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Los M, 1997, BLOOD, V90, P3118, DOI 10.1182/blood.V90.8.3118; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Ng FWH, 1998, J BIOL CHEM, V273, P3140, DOI 10.1074/jbc.273.6.3140; Nguyen M, 1998, J BIOL CHEM, V273, P33099, DOI 10.1074/jbc.273.50.33099; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Norman J, 1997, J INTERF CYTOK RES, V17, P113, DOI 10.1089/jir.1997.17.113; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Watanabe Y, 1999, J CELL PHYSIOL, V179, P45, DOI 10.1002/(SICI)1097-4652(199904)179:1<45::AID-JCP6>3.0.CO;2-H; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	87	352	376	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					629	639		10.1016/S1074-7613(00)80062-X	http://dx.doi.org/10.1016/S1074-7613(00)80062-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403638	Green Submitted, Bronze			2022-12-18	WOS:000081209600001
J	LIU, GY; FAIRCHILD, PJ; SMITH, RM; PROWLE, JR; KIOUSSIS, D; WRAITH, DC				LIU, GY; FAIRCHILD, PJ; SMITH, RM; PROWLE, JR; KIOUSSIS, D; WRAITH, DC			LOW AVIDITY RECOGNITION OF SELF-ANTIGEN BY T-CELLS PERMITS ESCAPE FROM CENTRAL TOLERANCE	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; TRANSGENIC MICE; EXPRESSION; SELECTION; RECEPTOR; THYMOCYTES; INDUCTION; PEPTIDE; DELETION; ENCEPHALOMYELITIS	The immunodominant epitope of myelin basic protein, Ac1-9, is encephalitogenic in H-2(u) mice. We have previously demonstrated that this epitope displays low affinity for I-A(u) and have suggested that the avidity of T cell recognition in the thymus may be compromised, enabling autoreactive T cells to escape self-tolerance. We have addressed this hypothesis directly by constructing transgenic mice expressing an encephalitogenic T cell receptor(TCR), Parenteral admininstration of Ac1-9 had no discernable impact on developing thymocytes. In contrast, peptide analogs displaying far higher affinity for I-A(u), provoked deletion of CD4(+)CD8(+) cells and transient down-regulation of the TCR by mature CD4(+)CD8(-) thymocytes. The use of analogs of intermediate affinity permitted a margin of error to be defined for the induction of tolerance and confirmed that the affinity of Ac1-9 lies well below the critical threshold.	UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND; NATL INST MED RES,MOLEC IMMUNOL LAB,LONDON NW7 1AA,ENGLAND	University of Cambridge; MRC National Institute for Medical Research			Liu, Guang Yu/A-8802-2008; Prowle, John/D-5014-2009	Prowle, John/0000-0002-5002-2721; Wraith, David/0000-0003-2147-5614	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; DAWE K, 1993, SPRINGER SEMIN IMMUN, V14, P285; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; FAIRCHILD PJ, 1994, IMMUNOLOGY, V81, P487; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; GAMMON G, 1989, NATURE, V342, P183, DOI 10.1038/342183a0; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; HOMER RJ, 1993, INT IMMUNOL, V5, P1495, DOI 10.1093/intimm/5.12.1495; JOOSTEN I, 1994, INT IMMUNOL, V6, P751, DOI 10.1093/intimm/6.5.751; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KARACHUNSKI PI, 1994, IMMUNOLOGY, V82, P22; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; MAMULA MJ, 1993, J EXP MED, V177, P567, DOI 10.1084/jem.177.2.567; MASON K, 1995, J IMMUNOL, V154, P5216; MASON K, 1994, P NATL ACAD SCI USA, V91, P12463, DOI 10.1073/pnas.91.26.12463; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROTHENBERG EV, 1994, CURR OPIN IMMUNOL, V6, P257, DOI 10.1016/0952-7915(94)90099-X; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SPAIN LM, 1992, J EXP MED, V176, P213, DOI 10.1084/jem.176.1.213; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; WOOD PJ, 1987, J IMMUNOL, V139, P3236; WRAITH D C, 1990, International Reviews of Immunology, V6, P37, DOI 10.3109/08830189009056616; WRAITH DC, 1992, J IMMUNOL, V149, P3765; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; WRAITH DC, 1991, J AUTOIMMUN SA, V5, P103; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	41	352	358	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1995	3	4					407	415		10.1016/1074-7613(95)90170-1	http://dx.doi.org/10.1016/1074-7613(95)90170-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TB608	7584132	Bronze			2022-12-18	WOS:A1995TB60800002
J	Mantovani, A; Dinarello, CA; Molgora, M; Garlanda, C				Mantovani, Alberto; Dinarello, Charles A.; Molgora, Martina; Garlanda, Cecilia			Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; HEMATOPOIETIC STEM-CELLS; SEVERE HIDRADENITIS SUPPURATIVA; C-REACTIVE PROTEIN; CD4 T-CELLS; RECEPTOR ANTAGONIST; CLONAL HEMATOPOIESIS; CUTTING EDGE; IL-1 FAMILY; IFN-GAMMA	Forty years after its naming, interleukin-1 (IL-1) is experiencing a renaissance brought on by the growing understanding of its context-dependent roles and advances in the clinic. Recent studies have identified important roles for members of the IL-1 family-IL-18, IL-33, IL-36, IL-37, and IL-38-in inflammation and immunity. Here, we review the complex functions of IL-1 family members in the orchestration of innate and adaptive immune responses and their diversity and plasticity. We discuss the varied roles of IL-1 family members in immune homeostasis and their contribution to pathologies, including autoimmunity and auto-inflammation, dysmetabolism, cardiovascular disorders, and cancer. The trans-disease therapeutic activity of anti-IL-1 strategies argues for immunity and inflammation as a metanarrative of modern medicine.	[Mantovani, Alberto; Molgora, Martina; Garlanda, Cecilia] IRCCS Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano Milan, Italy; [Mantovani, Alberto; Garlanda, Cecilia] Humanitas Univ, Via Rita Levi Montalcini, I-20090 Pieve Emanuele Milan, Italy; [Mantovani, Alberto] Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen, Dept Med, Med Ctr, Nijmegen, Netherlands	Humanitas University; University of London; Queen Mary University London; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Radboud University Nijmegen	Mantovani, A; Garlanda, C (corresponding author), IRCCS Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano Milan, Italy.; Mantovani, A; Garlanda, C (corresponding author), Humanitas Univ, Via Rita Levi Montalcini, I-20090 Pieve Emanuele Milan, Italy.; Mantovani, A (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	alberto.mantovani@humanitasresearch.it; cecilia.garlanda@humanitasresearch.it	Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022	Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X	European Commission (ERC) [PHII-669415]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [PRIN 2015YYKPNN]; Italian Ministry of Health (Ricerca Finalizzata) [RF-2013-02355470]	European Commission (ERC)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy)	The contributions of the European Commission (ERC) (project PHII-669415) to A.M., Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project PRIN 2015YYKPNN), Associazione Italiana Ricerca sul Cancro (AIRC) AIRC IG 19014 to A.M., AIRC IG 21714 to C.G., and AIRC 5x1000 9962 and 21147 are appreciated. Fondazione Cariplo and the Italian Ministry of Health (Ricerca Finalizzata, RF-2013-02355470 to C.G.) is gratefully acknowledged.	Abbate A, 2015, EUR HEART J, V36, P337, DOI 10.1093/eurheartj/ehu369; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Amor Nadia Ghinelli, 2018, Oncotarget, V9, P30894, DOI 10.18632/oncotarget.25768; [Anonymous], 1979, J IMMUNOL, V123, P2928; Anselmo A, 2016, CARDIOVASC RES, V111, P373, DOI 10.1093/cvr/cvw162; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Arts RJW, 2016, SEMIN IMMUNOL, V28, P425, DOI 10.1016/j.smim.2016.09.002; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Becerra C, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.4_suppl.449; Bellora F, 2014, EUR J IMMUNOL, V44, P1814, DOI 10.1002/eji.201344130; Bellora F, 2012, EUR J IMMUNOL, V42, P1618, DOI 10.1002/eji.201142173; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Benjamin JT, 2018, J IMMUNOL, V201, P2873, DOI 10.4049/jimmunol.1801089; Berda-Haddad Y, 2011, P NATL ACAD SCI USA, V108, P20684, DOI 10.1073/pnas.1116848108; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bhat IA, 2014, META GENE, V2, P123, DOI 10.1016/j.mgene.2013.12.002; Bianchetti L, 2012, BIOCHEM BIOPH RES CO, V426, P116, DOI 10.1016/j.bbrc.2012.08.047; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Bottazzi B, 2018, SEMIN IMMUNOL, V40, P74, DOI 10.1016/j.smim.2018.10.011; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Burzynski LC, 2019, IMMUNITY, V50, P1033, DOI 10.1016/j.immuni.2019.03.003; Campesato LF, 2017, ONCOTARGET, V8, P49470, DOI 10.18632/oncotarget.17713; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chen CC, 2017, J ALLERGY CLIN IMMUN, V140, P1351, DOI 10.1016/j.jaci.2017.01.015; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; CHIRIVI RGS, 1993, CANCER RES, V53, P5051; Chudnovskiy A, 2016, CELL, V167, P444, DOI 10.1016/j.cell.2016.08.076; Ciabattini A, 2018, SEMIN IMMUNOL, V40, P83, DOI 10.1016/j.smim.2018.10.010; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; COLOTTA F, 1992, BLOOD, V80, P2012; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Costello DA, 2011, J NEUROSCI, V31, P3871, DOI 10.1523/JNEUROSCI.6676-10.2011; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; DeSena AD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1063-2; DINARELLO CA, 1974, J EXP MED, V139, P1369, DOI 10.1084/jem.139.6.1369; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ding L, 2018, CARCINOGENESIS, V39, P397, DOI 10.1093/carcin/bgy006; Dmitrieva-Posocco O, 2019, IMMUNITY, V50, P166, DOI 10.1016/j.immuni.2018.11.015; Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupaul-Chicoine J, 2015, IMMUNITY, V43, P751, DOI 10.1016/j.immuni.2015.08.013; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Elkabets M, 2010, EUR J IMMUNOL, V40, P3347, DOI 10.1002/eji.201041037; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101; Fu AKY, 2016, P NATL ACAD SCI USA, V113, pE2705, DOI 10.1073/pnas.1604032113; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Garlanda C, 2018, PHYSIOL REV, V98, P623, DOI 10.1152/physrev.00016.2017; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; GIAVAZZI R, 1990, CANCER RES, V50, P4771; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gulen MF, 2010, IMMUNITY, V32, P54, DOI 10.1016/j.immuni.2009.12.003; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halvorsen EC, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1527497; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hickish T, 2017, LANCET ONCOL, V18, P192, DOI 10.1016/S1470-2045(17)30006-2; Hong DS, 2015, INVEST NEW DRUG, V33, P621, DOI 10.1007/s10637-015-0226-6; Hong DS, 2014, LANCET ONCOL, V15, P656, DOI 10.1016/S1470-2045(14)70155-X; Hong J, 2019, J INTERF CYTOK RES, V39, P61, DOI 10.1089/jir.2018.0044; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Isambert N, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1474319; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jin ZQ, 2018, J IMMUNOL, V201, P3770, DOI 10.4049/jimmunol.1800627; Kanni T, 2018, J INVEST DERMATOL, V138, P795, DOI 10.1016/j.jid.2017.10.030; Kaplanov I, 2019, P NATL ACAD SCI USA, V116, P1361, DOI 10.1073/pnas.1812266115; Kaplanski G, 2018, IMMUNOL REV, V281, P138, DOI 10.1111/imr.12616; Khazim K, 2018, IMMUNOL REV, V281, P40, DOI 10.1111/imr.12620; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502; Kuan EL, 2018, NAT IMMUNOL, V19, P366, DOI 10.1038/s41590-018-0066-6; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Kurzrock R, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1551651; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Li Y, 2018, J IMMUNOL, V200, P2253, DOI 10.4049/jimmunol.1701455; Libby P, 2017, J AM COLL CARDIOL, V70, P2278, DOI 10.1016/j.jacc.2017.09.028; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2019.02.012, 10.1016/j.immuni.2018.12.012]; Liu XY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00008; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lopetuso LR, 2018, P NATL ACAD SCI USA, V115, pE9362, DOI 10.1073/pnas.1803613115; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Lust JA, 2016, AM J HEMATOL, V91, P571, DOI 10.1002/ajh.24352; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2018, SEMIN IMMUNOL, V36, P28, DOI 10.1016/j.smim.2017.12.006; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Marhaba R, 2008, INT J CANCER, V123, P134, DOI 10.1002/ijc.23503; McDonald JJ, 2018, CURR OPIN SUPPORT PA, V12, P453, DOI 10.1097/SPC.0000000000000398; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Melisi D, 2009, MOL CANCER RES, V7, P624, DOI 10.1158/1541-7786.MCR-08-0201; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molgora M, 2018, IMMUNOL REV, V281, P233, DOI 10.1111/imr.12609; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moorlag SJCFM, 2018, IMMUNOL REV, V281, P28, DOI 10.1111/imr.12617; Mora-Buch R, 2016, MUCOSAL IMMUNOL, V9, P950, DOI 10.1038/mi.2015.108; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00763; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pan W, 2017, IMMUNITY, V47, P284, DOI 10.1016/j.immuni.2017.07.020; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Popovic B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006345; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Rivers-Auty J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03362-1; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Russell SE, 2013, J IMMUNOL, V191, P3337, DOI 10.4049/jimmunol.1300828; Santarlasci V, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00182; Sarhan D, 2018, CANCER IMMUNOL RES, V6, P766, DOI 10.1158/2326-6066.CIR-17-0498; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tartey S, 2018, J IMMUNOL, V201, P1639, DOI 10.4049/jimmunol.1800760; Tjomsland V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070874; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Tomasoni R, 2017, ELIFE, V6, DOI 10.7554/eLife.21735; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Tzanetakou V, 2016, JAMA DERMATOL, V152, P52, DOI 10.1001/jamadermatol.2015.3903; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wen YH, 2019, CANCER IMMUNOL IMMUN, V68, P221, DOI 10.1007/s00262-018-2265-2; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Whiteley A, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.e15750; Wong R, 2019, BRAIN BEHAV IMMUN, V76, P126, DOI 10.1016/j.bbi.2018.11.012; Wu TC, 2018, CANCER RES, V78, P5243, DOI 10.1158/0008-5472.CAN-18-0413; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhao JJ, 2015, GASTROENTEROLOGY, V149, P1860, DOI 10.1053/j.gastro.2015.08.051; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhuang ZN, 2016, CLIN CANCER RES, V22, P1432, DOI 10.1158/1078-0432.CCR-14-3382; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695	209	351	367	15	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					778	795		10.1016/j.immuni.2019.03.012	http://dx.doi.org/10.1016/j.immuni.2019.03.012			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995499	Green Accepted, Bronze			2022-12-18	WOS:000464660800003
J	Kinnebrew, MA; Buffie, CG; Diehl, GE; Zenewicz, LA; Leiner, I; Hohl, TM; Flavell, RA; Littman, DR; Pamer, EG				Kinnebrew, Melissa A.; Buffie, Charlie G.; Diehl, Gretchen E.; Zenewicz, Lauren A.; Leiner, Ingrid; Hohl, Tobias M.; Flavell, Richard A.; Littman, Dan R.; Pamer, Eric G.			Interleukin 23 Production by Intestinal CD103(+)CD11b(+) Dendritic Cells in Response to Bacterial Flagellin Enhances Mucosa! Innate Immune Defense	IMMUNITY			English	Article							HOST-DEFENSE; IL-22; INFLAMMATION; MICE; MICROBIOTA; STAT3; IL-17	Microbial penetration of the intestinal epithelial barrier triggers inflammatory responses that include induction of the bactericidal C-type lectin RegIII gamma. Systemic administration of flagellin, a bacterial protein that stimulates Toll-like receptor 5 (TLR5), induces epithelial expression of RegIII gamma and protects mice from intestinal colonization with antibiotic-resistant bacteria. Flagellin-induced RegIII(gamma) expression is IL-22 dependent, but how TLR signaling leads to IL-22 expression is incompletely defined. By using conditional depletion of lamina propria dendritic cell (LPDC) subsets, we demonstrated that CD103(+) CD11b(+) LPDCs, but not monocyte-derived CD103(-) CD11b(+) LPDCs, expressed high amounts of IL-23 after bacterial flagellin administration and drove IL-22-dependent RegIII gamma production. Maximal expression of IL-23 subunits IL-23p19 and IL-12p40 occurred within 60 min of exposure to flagellin. IL-23 subsequently induced a burst of IL-22 followed by sustained RegIII gamma expression. Thus, CD103(+) CD11b(+) LPDCs, in addition to promoting long-term tolerance to ingested antigens, also rapidly produce IL-23 in response to detection of flagellin in the lamina propria.	[Kinnebrew, Melissa A.; Buffie, Charlie G.; Leiner, Ingrid; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Program Immunol, Dept Med, Infect Dis Serv, New York, NY 10065 USA; [Diehl, Gretchen E.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Zenewicz, Lauren A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Hohl, Tobias M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Flavell, Richard A.; Littman, Dan R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; New York University; Yale University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, Dept Med, Infect Dis Serv, New York, NY 10065 USA.	pamere@mskcc.org		Zenewicz, Lauren/0000-0002-8787-5955; Diehl, Gretchen/0000-0002-1841-2842; Hohl, Tobias/0000-0002-9097-5412	NIH [RO1-AI042135, R37-AI039031, PO1-CA023766, GM07739, AI07998]; NATIONAL CANCER INSTITUTE [P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI071998, R01AI042135, R37AI039031, R01AI080619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants RO1-AI042135, R37-AI039031, and PO1-CA023766 to E.G.P. M.A.K. and C.G.B. were supported by NIH Medical Scientist Training Program grant GM07739 to Cornell/RU/MSKCC Tri-Institutional MD-PhD Program. NIH K08 Fellowship AI07998 supported T.M.H.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P597; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Donskey CJ, 2004, CLIN INFECT DIS, V39, P219, DOI 10.1086/422002; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Honda K, 2009, MUCOSAL IMMUNOL, V2, P187, DOI 10.1038/mi.2009.8; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pabst O, 2010, EUR J IMMUNOL, V40, P2107, DOI 10.1002/eji.201040557; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	48	351	386	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 24	2012	36	2					276	287		10.1016/j.immuni.2011.12.011	http://dx.doi.org/10.1016/j.immuni.2011.12.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22306017	Bronze, Green Accepted			2022-12-18	WOS:000300812400015
J	Todd, JA				Todd, John A.			Etiology of Type 1 Diabetes	IMMUNITY			English	Review							GENOME-WIDE ASSOCIATION; T-CELLS; GENETIC-VARIANTS; INTESTINAL MICROBIOTA; LYMPHOCYTE DEPLETION; MULTIPLE-SCLEROSIS; INTERFERON-ALPHA; COMMON VARIANTS; BETA-CELLS; HLA-B	Recent genetic mapping and gene-phenotype studies have revealed the genetic architecture of type 1 diabetes. At least ten genes so far can be singled out as strong causal candidates. The known functions of these genes indicate the primary etiological pathways of this disease, including HLA class II and I molecules binding to preproinsulin peptides and T cell receptors, T and B cell activation, innate pathogen-viral responses, chemokine and cytokine signaling, and T regulatory and antigen-presenting cell functions. This review considers research in the field of type 1 diabetes toward identifying disease mechanisms using genetic approaches. The expression and functions of these pathways, and, therefore, disease susceptibility, will be influenced by epigenetic and environmental factors. Certain inherited immune phenotypes will be early precursors of type 1 diabetes and could be useful in future clinical trials.	Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England.		Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148	Wellcome Trust; Juvenile Diabetes Research Foundation; Cambridge Institute for Medical Research; National Institute for Health Research; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Cambridge Institute for Medical Research; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding from the Wellcome Trust, Juvenile Diabetes Research Foundation, the Cambridge Institute for Medical Research from its Wellcome Trust Strategic Award, and the National Institute for Health Research is gratefully acknowledged, as are enormous contributions of my colleagues. collaborators and participants to our ongoing research I apologise for the missing and incomplete citations, and the truncated and abbreviated discussions and ideas presented	Arai T, 2010, CLIN IMMUNOL, V136, P74, DOI 10.1016/j.clim.2010.02.016; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Atabani SF, 2005, EUR J IMMUNOL, V35, P2157, DOI 10.1002/eji.200526168; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; BERG H, 1993, J IMMUNOL METHODS, V164, P221, DOI 10.1016/0022-1759(93)90315-X; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; BONIFACIO E, 2008, NOVART FDN SYMP, V292, P199; BONIFACIO E, 2008, NOVART FDN SYMP, V292, P202; Bonifacio Ezio, 2008, Novartis Found Symp, V292, P187; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Brehm MA, 2010, CURR OPIN ENDOCRINOL, V17, P120, DOI 10.1097/MED.0b013e328337282f; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cooke A, 2009, BLOOD CELL MOL DIS, V42, P105, DOI 10.1016/j.bcmd.2008.10.004; Coulombe-Huntington J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000766; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Devendra D, 2004, CLIN IMMUNOL, V111, P225, DOI 10.1016/j.clim.2004.01.008; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Hennebry SC, 2010, MOL PSYCHIATR, V15, P234, DOI 10.1038/mp.2009.74; Hinks A, 2010, GENES IMMUN, V11, P194, DOI 10.1038/gene.2009.105; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kordonouri O, 2010, EXP CLIN ENDOCR DIAB, V118, P245, DOI 10.1055/s-0029-1246213; Kurreeman FAS, 2004, HUM MOL GENET, V13, P1755, DOI 10.1093/hmg/ddh187; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lesniewski ML, 2008, LEUKEMIA, V22, P2201, DOI 10.1038/leu.2008.234; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Long SA, 2009, EUR J IMMUNOL, V39, P612, DOI 10.1002/eji.200838819; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MacFarlane AJ, 2009, MAMM GENOME, V20, P624, DOI 10.1007/s00335-009-9213-6; Maier LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000322; Matesanz F, 2004, J NEUROIMMUNOL, V148, P212, DOI 10.1016/j.jneuroim.2003.12.001; McGuire HM, 2009, P NATL ACAD SCI USA, V106, P19438, DOI 10.1073/pnas.0903561106; Mellanby RJ, 2008, AUTOIMMUNITY, V41, P383, DOI 10.1080/08916930801991021; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; PICKRELL JK, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE08872; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Rafiq S, 2008, DIABETOLOGIA, V51, P2205, DOI 10.1007/s00125-008-1160-3; Rainbow DB, 2008, BIOCHEM SOC T, V36, P312, DOI 10.1042/BST0360312; Raj SM, 2009, DIABETOLOGIA, V52, P2109, DOI 10.1007/s00125-009-1391-y; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Siljander HTA, 2009, DIABETES, V58, P2835, DOI 10.2337/db08-1305; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Sutherland APR, 2009, DIABETES, V58, P1144, DOI 10.2337/db08-0882; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Verhagen J, 2009, P NATL ACAD SCI USA, V106, P3306, DOI 10.1073/pnas.0803186106; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; von Herrath M, 2009, NATURE, V459, P518, DOI 10.1038/459518a; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang XJ, 2008, J IMMUNOL, V180, P1929, DOI 10.4049/jimmunol.180.3.1929; Wang YM, 2010, J IMMUNOL, V184, P2751, DOI 10.4049/jimmunol.0903201; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; You S, 2008, ADV IMMUNOL, V100, P13, DOI 10.1016/S0065-2776(08)00802-X; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579; Zuvich RL, 2010, HUM GENET, V127, P525, DOI 10.1007/s00439-010-0789-4	119	351	360	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					457	467		10.1016/j.immuni.2010.04.001	http://dx.doi.org/10.1016/j.immuni.2010.04.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412756	Bronze			2022-12-18	WOS:000277171900003
J	Villadangos, JA; Young, L				Villadangos, Jose A.; Young, Louise			Antigen-presentation properties of plasmacytoid dendritic cells	IMMUNITY			English	Review							MHC CLASS-II; INTERFERON-PRODUCING CELLS; INFLAMED LYMPH-NODES; T-CELLS; CROSS-PRESENTATION; CUTTING EDGE; IN-VIVO; INFLUENZA-VIRUS; SELF-ANTIGENS; RECEPTOR	One of the remaining enigmas of the dendritic cell (DC) network is the potential contribution of plasmacytoid DCs (pDCs) to antigen presentation. Although the antigen-presentation capacity of conventional DCs (cDCs) is clearly defined, pDCs are generally attributed as having little, if any, antigen-presentation function. Instead, pDCs are regarded as immunomodulating cells, capable of directing the immune response through their secretion of large amounts of type I interferons. In this review, we examine the evidence for a potential role of pDC in antigen capture, processing, and presentation to T cells at sites of infection and in the lymph nodes.	[Villadangos, Jose A.; Young, Louise] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia; [Young, Louise] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Villadangos, JA (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia.	villadangos@wehi.edu.au	Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891	National Health and Medical Research Council of Australia; The University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The University of Melbourne(University of Melbourne)	We would like to thank U. von Andrian, I. Caminschi, F. Carbone, J. Connolly, B. Heath, B. Lambrecht, G. MacPherson, S. Nailk, K. Shortman, J. de Vries, and U. Yrlid for their insights and helpful comments. Our work is supported by the National Health and Medical Research Council of Australia (J.A.V.). L.J.Y. is a recipient of a scholarship of The University of Melbourne. J.A.V. is a Scholar of the Leukemia and Lymphoma Society.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Backer R, 2008, EUR J IMMUNOL, V38, P370, DOI 10.1002/eji.200737647; Baldwin T, 2004, INFECT IMMUN, V72, P1991, DOI 10.1128/IAI.72.4.1991-2001.2004; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Corbett AJ, 2005, EUR J IMMUNOL, V35, P2815, DOI 10.1002/eji.200526100; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dalgaard J, 2005, J LEUKOCYTE BIOL, V77, P689, DOI 10.1189/jlb.1204711; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Ito T, 1999, J IMMUNOL, V163, P1409; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jaehn PS, 2008, EUR J IMMUNOL, V38, P1822, DOI 10.1002/eji.200737552; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Morse MA, 1998, CANCER RES, V58, P2965; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Okada T, 2003, EUR J IMMUNOL, V33, P1012, DOI 10.1002/eji.200323616; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shen H, 2006, J CLIN INVEST, V116, P2237, DOI 10.1172/JCI28681; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Soumelis V, 2006, EUR J IMMUNOL, V36, P2286, DOI 10.1002/eji.200636026; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stent G, 2002, CYTOMETRY, V48, P167, DOI 10.1002/cyto.10118; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; Swiecki MK, 2007, EUR J IMMUNOL, V37, P3327, DOI 10.1002/eji.200737944; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Veeraswamy RK, 2003, J IMMUNOL, V170, P5367, DOI 10.4049/jimmunol.170.11.5367; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263; Wang JP, 2007, J IMMUNOL, V178, P3363, DOI 10.4049/jimmunol.178.6.3363; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Wollenberg A, 2002, J INVEST DERMATOL, V119, P1096, DOI 10.1046/j.1523-1747.2002.19515.x; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; YOUNG LJ, 2008, NAT IMMUNOL IN PRESS; Young LJ, 2007, P NATL ACAD SCI USA, V104, P17753, DOI 10.1073/pnas.0708622104; Yrlid U, 2006, J IMMUNOL, V177, P6115, DOI 10.4049/jimmunol.177.9.6115; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zwickey HL, 2006, INT IMMUNOL, V18, P199, DOI 10.1093/intimm/dxh363	126	351	361	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					352	361		10.1016/j.immuni.2008.09.002	http://dx.doi.org/10.1016/j.immuni.2008.09.002			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799143	Bronze			2022-12-18	WOS:000259708900004
J	Yang, Y; Liu, B; Dai, J; Srivastava, PK; Zammit, DJ; Lefrangois, L; Li, ZH				Yang, Yi; Liu, Bei; Dai, Jie; Srivastava, Pramod K.; Zammit, David J.; Lefrangois, Leo; Li, Zihai			Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages	IMMUNITY			English	Article							ENDOPLASMIC-RETICULUM; LISTERIA-MONOCYTOGENES; IMMUNE-RESPONSES; CUTTING EDGE; ANTIVIRAL RESPONSE; PEPTIDE BINDING; DENDRITIC CELLS; MOUSE; GENE; ACTIVATION	gp96 is an endoplasmic reticulum chaperone for cell-surface Toll-like receptors (TLRs). Little is known about its roles in chaperoning other TLRs or in the biology of macrophage in vivo. We generated a macrophage-specific gp96-deficient mouse. Despite normal development and activation by interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta, the mutant macrophages failed to respond to ligands of both cell-surface and intracellular TLRs including TLR2, TLR4, TLF15, TLR7, and TLR9. Furthermore, we found that TLR4 and TLR9 preferentially interacted with a super-glycosylated gp96 species. The categorical loss of TLRs in gp96-deficient macrophages operationally created a conditional and cell-specific TLR null mouse. These mice were resistant to endotoxin shock but were highly susceptible to Listeria monocytogenes. Our results demonstrate that gp96 is the master chaperone for TLRs and that macrophages, but not other myeloid cells, are the dominant source of proinflammatory cytokines during endotoxemia and Listeria infections.	Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Li, ZH (corresponding author), Univ Connecticut, Sch Med, Dept Immunol, MC 1601, Farmington, CT 06030 USA.	zli@up.uchc.edu		Srivastava, Pramod/0000-0003-2837-2861	NATIONAL CANCER INSTITUTE [R01CA100191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100191, CA100191] Funding Source: Medline; NIAID NIH HHS [P01-AI56172, P01 AI056172, P01 AI056172-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P10593, DOI 10.1073/pnas.0501165102; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kuznetsov G, 1996, P NATL ACAD SCI USA, V93, P8584, DOI 10.1073/pnas.93.16.8584; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; LEE AS, 1981, P NATL ACAD SCI-BIOL, V78, P4922, DOI 10.1073/pnas.78.8.4922; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Stoilova D, 2000, CELL STRESS CHAPERON, V5, P395; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Vandenbroeck K, 2006, CYTOKINE, V33, P264, DOI 10.1016/j.cyto.2006.02.004; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wang TY, 2006, J IMMUNOL, V176, P1355, DOI 10.4049/jimmunol.176.3.1355; Yang Y, 2005, MOL CELLS, V20, P173; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	50	351	368	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					215	226		10.1016/j.immuni.2006.12.005	http://dx.doi.org/10.1016/j.immuni.2006.12.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17275357	Green Accepted, Bronze			2022-12-18	WOS:000244628600012
J	Voehringer, D; Shinkai, K; Locksley, RM				Voehringer, D; Shinkai, K; Locksley, RM			Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production	IMMUNITY			English	Article							T-CELLS; NIPPOSTRONGYLUS-BRASILIENSIS; MESSENGER-RNA; SIGNAL TRANSDUCER; MOLECULAR-CLONING; HUMAN BASOPHILS; MOUSE MODEL; MAST-CELLS; IN-VIVO; INTERLEUKIN-4	Using IL-4 reporter mice we identified eosinophils, basophils, and Th2 cells as the three IL-4-producing cell types that appear in the lungs of mice infected with the migrating intestinal helminth, Nippostrongylus brasiliensis. Eosinophils were most prevalent, peaking by similar to1000-fold on day 9 after infection, with Th2 cells and basophils at 3- and 10-fold lower numbers, respectively. Eosinophil and basophil expansion in blood in response to parasites and their capacity for IL-4 expression required neither Stat6 nor T cells. Th2 induction and expansion in draining lymph nodes was also Stat6 independent. In contrast, eosinophil (and Th2 cell) recruitment to the lung was dependent on Stat6 expression by a bone marrow-derived tissue resident cell, whereas basophil recruitment was Stat6 and IL-4/IL-13 independent but T cell dependent. Primary type 2 immune responses in the lung represent the focal recruitment and activation of discrete cell populations from the blood that have previously committed to express IL-4.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Voehringer, David/K-2776-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072301, P50HL056385, P01HL056385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56385, HL072301] Funding Source: Medline; NIAID NIH HHS [AI30663] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Genovese A, 2003, J IMMUNOL, V170, P1854, DOI 10.4049/jimmunol.170.4.1854; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Hogaboam CM, 1999, J IMMUNOL, V162, P6071; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Ihaka Ross., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807]; Ikeda RK, 2003, J IMMUNOL, V171, P4860, DOI 10.4049/jimmunol.171.9.4860; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; KIRSHENBAUM AS, 1992, J IMMUNOL, V148, P772; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Luccioli S, 2002, J ALLERGY CLIN IMMUN, V110, P117, DOI 10.1067/mai.2002.125828; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; MACGLASHAN D, 1994, J IMMUNOL, V152, P3006; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOQBEL R, 1995, J IMMUNOL, V155, P4939; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; OGILVIE BM, 1968, J PARASITOL, V54, P1073, DOI 10.2307/3276966; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; TENTORI L, 1988, J IMMUNOL, V140, P1089; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Yoshida O, 1994, Int J Urol, V1, P1, DOI 10.1111/j.1442-2042.1994.tb00001.x; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	49	350	367	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					267	277		10.1016/S1074-7613(04)00026-3	http://dx.doi.org/10.1016/S1074-7613(04)00026-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030771	Bronze			2022-12-18	WOS:000221442600005
J	Kumano, K; Chiba, S; Kunisato, A; Sata, M; Saito, T; Nakagami-Yamaguchi, E; Yamaguchi, T; Masuda, S; Shimizu, K; Takahashi, T; Ogawa, S; Hamada, Y; Hirai, H				Kumano, K; Chiba, S; Kunisato, A; Sata, M; Saito, T; Nakagami-Yamaguchi, E; Yamaguchi, T; Masuda, S; Shimizu, K; Takahashi, T; Ogawa, S; Hamada, Y; Hirai, H			Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells	IMMUNITY			English	Article							GONAD-MESONEPHROS REGION; BONE MORPHOGENETIC PROTEIN-4; MOUSE EMBRYO; YOLK-SAC; GROWTH-FACTOR; IN-VITRO; CHROMOSOMAL TRANSLOCATIONS; PARAAORTIC SPLANCHNOPLEURA; INHIBITS DIFFERENTIATION; DEFINITIVE HEMATOPOIESIS	Hematopoietic stem cells (HSCs) are thought to arise in the aorta-gonad-mesonephros (AGM) region of embryo proper, although HSC activity can be detected in yolk sac (YS) and paraaortic splanchnopleura (P-Sp) when transplanted in newborn mice. We examined the role of Notch signaling in embryonic hematopoiesis. The activity of colony-forming cells in the YS from Notch1(-/-) embryos was comparable to that of wildtype embryos. However, in vitro and in vivo definitive hematopoietic activities from YS and P-Sp were severely impaired in Notch1(-/-) embryos. The population representing hemogenic endothelial cells, however, did not decrease. In contrast, Notch2(-/-) embryos showed no hematopoietic deficiency. These data indicate that Notch1, but not Notch2, is essential for generating hematopoietic stem cells from endothelial cells.	Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Hirai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Nakagami-Yamacuchi, Etsuko/ABB-9053-2020	Yamaguchi, Tomoyuki/0000-0002-4159-5448; Takahashi, Tokiharu/0000-0002-5785-8660; Nakagami-Yamaguchi, Etsuko/0000-0001-6718-4658				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Choi K, 1998, DEVELOPMENT, V125, P725; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Dyer MA, 2001, DEVELOPMENT, V128, P1717; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Endo Y, 2002, DEVELOPMENT, V129, P863; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KITAMURA T, IN PRESS EXP HEMATOL; Krebs LT, 2000, GENE DEV, V14, P1343; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Li F, 2001, BLOOD, V98, P335, DOI 10.1182/blood.V98.2.335; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; Marshall CJ, 1999, DEV DYNAM, V215, P139, DOI 10.1002/(SICI)1097-0177(199906)215:2<139::AID-DVDY6>3.0.CO;2-#; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MILNER LA, 1994, BLOOD, V83, P2057; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nakayama N, 2000, BLOOD, V95, P2275, DOI 10.1182/blood.V95.7.2275.007k30_2275_2283; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; Ogawa M, 1999, BLOOD, V93, P1168, DOI 10.1182/blood.V93.4.1168.404k12_1168_1177; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Palis J, 1999, DEVELOPMENT, V126, P5073; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499	70	350	362	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					699	711		10.1016/S1074-7613(03)00117-1	http://dx.doi.org/10.1016/S1074-7613(03)00117-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753746	Bronze			2022-12-18	WOS:000182962200014
J	Yoshida, H; Hamano, S; Senaldi, G; Covey, T; Faggioni, R; Mu, S; Xia, M; Wakeham, AC; Nishina, H; Potter, J; Saris, CJM; Mak, TW				Yoshida, H; Hamano, S; Senaldi, G; Covey, T; Faggioni, R; Mu, S; Xia, M; Wakeham, AC; Nishina, H; Potter, J; Saris, CJM; Mak, TW			WSX-1 is required for the initiation of Th1 responses and resistance to L-major infection	IMMUNITY			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; MURINE CYTOMEGALOVIRUS-INFECTION; I CYTOKINE RECEPTOR; LEISHMANIA-MAJOR; INTERFERON-GAMMA; INTERLEUKIN-6 FAMILY; SIGNAL TRANSDUCTION; CELL RESPONSE; T-CELLS; MICE	WSX-1 is a class I cytokine receptor with homology to the IL-12 receptors. The physiological role of WSX-1, which is expressed mainly in T cells, was investigated in gene-targeted WSX-1-deficient mice. IFN-gamma production was reduced in isolated WSX-1(-/-) T cells subjected to primary stimulation in vitro to induce Th1 differentiation but was normal in fully differentiated and activated WSX-1(-/-) Th1 cells that had received secondary stimulation. WSX-1(-/-) mice were remarkably susceptible to Leishmania major infection, showing impaired IFN-gamma production early in the infection. However, IFN-gamma production during the later phases of the infection was not impaired in the knockout. WSX-1(-/-) mice also showed poorly differentiated granulomas with dispersed accumulations of mononuclear cells when infected with bacillus Calmette-Guerin (BCG). Thus,WSX-1 is essential for the initial mounting of Th1 responses but dispensable for their maintenance.	Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Kyushu Univ, Fac Med Sci, Dept Parasitol, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Immunol, Higashi Ku, Fukuoka 8128582, Japan; Amgen Inc, Dept Pharmacol Pathol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Kyushu University; Kyushu University; Amgen; Amgen	Mak, TW (corresponding author), Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada.			Hamano, Shinjiro/0000-0003-3881-8337				BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Breinholt V, 1998, CHEM RES TOXICOL, V11, P622, DOI 10.1021/tx970170y; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DiSanto JP, 1995, IMMUNOL REV, V148, P19; FINKELMAN FD, 1991, IMMUNOL TODAY, V12, P62; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hamano S, 1998, MICROBIOL IMMUNOL, V42, P607, DOI 10.1111/j.1348-0421.1998.tb02331.x; HE XD, 1995, VIRUS RES, V36, P233, DOI 10.1016/0168-1702(95)00010-N; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MIYAJIMA A, 1992, INT J CELL CLONING, V10, P126, DOI 10.1002/stem.5530100302; MIYAZAKI T, 1991, EMBO J, V10, P3191, DOI 10.1002/j.1460-2075.1991.tb04881.x; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; ORME IM, 1992, J IMMUNOL, V148, P189; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Romani L, 1997, CLIN MICROBIOL REV, V10, P611, DOI 10.1128/CMR.10.4.611; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; SWIHART K, 1995, J EXP MED, V181, P961, DOI 10.1084/jem.181.3.961; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Wu CY, 1997, EUR J IMMUNOL, V27, P147, DOI 10.1002/eji.1830270122; YOSHIDA H, 1995, J VIROL, V69, P4769, DOI 10.1128/JVI.69.8.4769-4775.1995; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	34	350	371	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					569	578		10.1016/S1074-7613(01)00206-0	http://dx.doi.org/10.1016/S1074-7613(01)00206-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672539	Bronze			2022-12-18	WOS:000171757800008
J	Harris, J; De Haro, SA; Master, SS; Keane, J; Roberts, EA; Delgado, M; Deretic, V				Harris, James; De Haro, Sergio A.; Master, Sharon S.; Keane, Joseph; Roberts, Esteban A.; Delgado, Monica; Deretic, Vojo			T helper 2 Cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis	IMMUNITY			English	Article							IFN-GAMMA; T-CELLS; ALTERNATIVE ACTIVATION; TOXOPLASMA-GONDII; IL-13 RECEPTOR; INDUCTION; GROWTH; MACROAUTOPHAGY; MACROPHAGES; INFECTION	Autophagy is a recently recognized immune effector mechanism against intracellular pathogens. The role of autophagy in innate immunity has been well established, but the extent of its regulation by the adaptive immune response is less well understood. The T helper 1 (Th1) cell cytokine IFN-gamma induces autophagy in macrophages to eliminate Mycobacterium tuberculosis. Here, we report that Th2 cytokines affect autophagy in macrophages and their ability to control intracellular M. tuberculosis. IL-4 and IL-13 abrogated autophagy and autophagymediated killing of intracellular mycobacteria in murine and human macrophages. Inhibition of starvation-induced autophagy by IL-4 and IL-13 was dependent on Akt signaling, whereas the inhibition of IFN-gamma-induced autophagy was Akt independent and signal transducer and activator of transcription 6 (STAT6) dependent. These findings establish a mechanism through which Th1-Th2 polarization differentially affects the immune control of intracellular pathogens.	Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Ctr Hlth Sci, Albuquerque, NM 87131 USA; St James Hosp, Dublin 8, Ireland; Univ Dublin Trinity Coll, Dublin 8, Ireland; Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	University of New Mexico; Trinity College Dublin; Trinity College Dublin; University of New Mexico	Deretic, V (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Ctr Hlth Sci, 915 Camino Salud NE, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu	Keane, Joseph/AAX-6658-2021; De Haro, Sergio/B-1047-2009	Keane, Joseph/0000-0001-5313-385X; Deretic, Vojo/0000-0002-3624-5208; Harris, James/0000-0002-5634-9637	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045148, R01AI042999, R01AI069345] Funding Source: NIH RePORTER; NIAID NIH HHS [AI045148S1, AI069345, AI045148, AI042999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Baliko Z, 1998, FEMS IMMUNOL MED MIC, V22, P199, DOI 10.1016/S0928-8244(98)00089-3; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Chensue SW, 1997, J IMMUNOL, V159, P3565; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; Gingras AC, 2001, GENE DEV, V15, P2852; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HUANG SK, 1995, J IMMUNOL, V155, P2688; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sun YJ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-105; Taha RA, 1997, AM J RESP CRIT CARE, V155, P1135, DOI 10.1164/ajrccm.155.3.9116999; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200; Zhang JG, 1997, J BIOL CHEM, V272, P9474; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	61	349	370	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					505	517		10.1016/j.immuni.2007.07.022	http://dx.doi.org/10.1016/j.immuni.2007.07.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892853	Bronze			2022-12-18	WOS:000249843400016
J	Prasad, DVR; Richards, S; Mai, XM; Dong, C				Prasad, DVR; Richards, S; Mai, XM; Dong, C			B7S1, a novel B7 family member that negatively regulates T cell activation	IMMUNITY			English	Article							INDUCIBLE COSTIMULATOR; LYMPHOCYTE-ACTIVATION; RECEPTOR; ICOS; GENE; PROLIFERATION; EXPRESSION; INHIBITION; RESPONSES; MOLECULES	T cell activation by antigen-presenting cells (APC) is regulated by positive and negative costimulatory molecules in the B7 family. Here we describe a novel addition in this family, designated as B7S1, which is uniquely anchored to the cell membrane via a GPI linkage. B7S1 is expressed on professional APC and widely distributed in nonlymphoid tissues. A soluble B7S1-Ig fusion protein binds to activated but not naive T cells. B7S1-Ig inhibits T cell activation and IL-2 production. A monoclonal antibody-that blocks binding of B7S1 to its receptor enhances T cell proliferation in vitro and exacerbates experimental autoimmune encephalomyelitis in vivo. This study identifies a novel negative regulator of T cell activation and further reveals complex costimulatory regulation of immune responses.	Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Dong, C (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	chendong@u.washington.edu	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; DONG C, 1994, INT IMMUNOL, V6, P1353, DOI 10.1093/intimm/6.9.1353; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dong HD, 1999, NAT MED, V5, P1365; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liang L, 2002, J EXP MED, V196, P97, DOI 10.1084/jem.20020298; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nurieva RI, 2003, J CLIN INVEST, V111, P701, DOI 10.1172/JCI200317321; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhou XY, 2002, J IMMUNOL, V168, P3847, DOI 10.4049/jimmunol.168.8.3847	35	349	443	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					863	873		10.1016/S1074-7613(03)00147-X	http://dx.doi.org/10.1016/S1074-7613(03)00147-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818166	Bronze			2022-12-18	WOS:000183767700015
J	Devin, A; Cook, A; Lin, Y; Rodriguez, Y; Kelliher, M; Liu, ZG				Devin, A; Cook, A; Lin, Y; Rodriguez, Y; Kelliher, M; Liu, ZG			The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation	IMMUNITY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION PATHWAYS; DOMAIN KINASE RIP; DEATH DOMAIN; CELL-DEATH; FACTOR RECEPTORS; TERMINAL KINASE; FACTOR-ALPHA; PROTEIN	The death domain kinase RIP and the TNF receptor-associated factor 2 (TRAF2) are essential effecters in TNF signaling. To understand the mechanism by which RIP and TRAF2 regulate TNF-induced activation of the transcription factor NF-KB, we investigated their respective roles in TNF-R1-mediated IKK activation using both RIP-/- and TRAF2(-/-) fibroblasts. We found that TNF-R1-mediated IKK activation requires both RIP and TRAF2 proteins. Although TRAF2 or RIP can be independently recruited to the TNF-R1 complex, neither one of them alone is capable of transducing the TNF signal that leads to IKK activation. Moreover, we demonstrated that IKK is recruited to the TNF-R1 complex through TRAF2 upon TNF treatment and that IKK activation requires the presence of RIP in the same complex.	NCI, Dept Cell & Canc Biol, Med Branch, Div Clin Sci,NIH, Bethesda, MD 20892 USA; Univ Massachusetts, Med Ctr, Worcester, MA 01605 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester	Liu, ZG (corresponding author), NCI, Dept Cell & Canc Biol, Med Branch, Div Clin Sci,NIH, Bethesda, MD 20892 USA.				DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061298] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061298] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; HARFOW E, 1999, USING ANBIBODIES LAB; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Ozes ON, 1999, NATURE, V401, P82; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; ROTHE J, 1992, IMMUNOL RES, V11, P81, DOI 10.1007/BF02918612; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	52	349	369	2	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					419	429		10.1016/S1074-7613(00)80194-6	http://dx.doi.org/10.1016/S1074-7613(00)80194-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795740	Bronze			2022-12-18	WOS:000086757300007
J	STUBER, E; NEURATH, M; CALDERHEAD, D; FELL, HF; STROBER, W				STUBER, E; NEURATH, M; CALDERHEAD, D; FELL, HF; STROBER, W			CROSS-LINKING OF OX40 LIGAND, A MEMBER OF THE TNF/NGF CYTOKINE FAMILY, INDUCES PROLIFERATION AND DIFFERENTIATION IN MURINE SPLENIC B-CELLS	IMMUNITY			English	Article							TUMOR NECROSIS FACTOR; HELPER T-CELLS; DEPENDENT ACTIVATION; SENSITIVE METHOD; LYMPHOCYTES-B; ANTIGEN; CD40; PROTEIN; EXPRESSION; MEMBRANES	OX40 is a member of the TNF/NGF-receptor family expressed on activated T cells, whose ligand is found on activated T and a cells. in the present study, we show that cross-linking of OX40L on CD40L-stimulated B cells, alpha lgD dextran-stimulated B cells, or both results in a significantly enhanced proliferative response with no change in the cell survival rate. Furthermore, OX40 stimulation increases immunoglobulin heavy chain mRNA levels and immunoglobulin secretion, which could not be blocked by anti-cytokine antibodies. In additional molecular studies, we show that OX40L cross-linking results in the down-regulation of the transcription factor BSAP. This, in turn, leads to a change in the in vivo binding pattern of the immuno-globulin heavy chain gene 3' alpha enhancer, suggesting its activation. This effect may thus be one mechanism for OX40-induced increase in immunoglobulin secretion. in conclusion, our data suggest that the OX40-OX40L interaction is a novel pathway in T cell-dependent B cell proliferation and differentiation.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC IMMUNOL,SEATTLE,WA 98121	Bristol-Myers Squibb	STUBER, E (corresponding author), NIAID,CLIN INVEST LAB,MUCOSAL IMMUN SECT,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; COLCO, 1983, J IMMUNOL, V131, P2254; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; ECK MJ, 1992, J BIOL CHEM, V267, P2119; FINKELMAN FD, 1988, IMMUNOL REV, V102, P5; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P222, DOI 10.1016/0952-7915(94)90095-7; HARRIMAN GR, 1988, J IMMUNOL, V140, P3033; HODGKIN PD, 1991, J IMMUNOL, V147, P3696; JACOB J, 1992, IMMUNOL CELL BIOL, V70, P145, DOI 10.1038/icb.1992.19; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; KUNIMOTO DY, 1991, CYTOKINE, V3, P224, DOI 10.1016/1043-4666(91)90020-E; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LATZA U, 1994, EUR J IMMUNOL, V24, P677, DOI 10.1002/eji.1830240329; LYCKE N, 1986, SCAND J IMMUNOL, V24, P393, DOI 10.1111/j.1365-3083.1986.tb02127.x; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; MEIER T, 1992, ANAL BIOCHEM, V204, P220, DOI 10.1016/0003-2697(92)90165-4; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MIURA S, 1991, MOL CELL BIOL, V11, P1313, DOI 10.1128/MCB.11.3.1313; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; NEURATH MF, 1994, J IMMUNOL, V153, P730; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOELLE RJ, 1991, J IMMUNOL, V146, P1118; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; REBBE NF, 1993, MOL IMMUNOL, V30, P87, DOI 10.1016/0161-5890(93)90429-F; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STAVNEZERNORDGR.J, 1986, EMBO J, V5, P95; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; WAKATSUKI Y, 1994, J EXP MED, V179, P1099, DOI 10.1084/jem.179.4.1099	49	349	360	0	8	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					507	521		10.1016/1074-7613(95)90031-4	http://dx.doi.org/10.1016/1074-7613(95)90031-4			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749983	Bronze			2022-12-18	WOS:A1995QZ43000008
J	Kang, SJ; Tanaka, T; Narazaki, M; Kishimoto, T				Kang, Sujin; Tanaka, Toshio; Narazaki, Masashi; Kishimoto, Tadamitsu			Targeting Interleukin-6 Signaling in Clinic	IMMUNITY			English	Review							ACTIVE RHEUMATOID-ARTHRITIS; MODIFYING ANTIRHEUMATIC DRUGS; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; ENDOTHELIAL GROWTH-FACTOR; RANDOMIZED PHASE-II; SILTUXIMAB CNTO 328; DOUBLE-BLIND; INADEQUATE RESPONSE; T-CELLS; TOCILIZUMAB MONOTHERAPY	Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in immunity, tissue regeneration, and metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue injury, but excessive synthesis of IL-6 and dysregulation of IL-6 receptor signaling is involved in disease pathology. Therapeutic agents targeting the IL-6 axis are effective in rheumatoid arthritis, and applications are being extended to other settings of acute and chronic inflammation. Recent studies reveal that selective blockade of different modes of IL-6 receptor signaling has different outcomes on disease pathology, suggesting novel strategies for therapeutic intervention. However, some inflammatory diseases do not seem to respond to IL-6 blockade. Here, we review the current state of IL-6-targeting approaches in the clinic and discuss how to apply the growing understanding of the immunobiology of IL-6 to clinical decisions.	[Kang, Sujin; Kishimoto, Tadamitsu] Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, 3-1 Yamadaoka, Suita, Osaka, Japan; [Tanaka, Toshio] Osaka Habikino Med Ctr, Med Affairs Bur, 3-7-1 Habikino, Habikino, Osaka, Japan; [Narazaki, Masashi] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, 2-2 Yamadaoka, Suita, Osaka, Japan; [Narazaki, Masashi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, 3-1 Yamadaoka, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Kishimoto, T (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Immune Regulat, 3-1 Yamadaoka, Suita, Osaka, Japan.	kishimoto@ifrec.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Astellas Foundation for Research on Metabolic Disorders; Kishimoto Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Kishimoto Foundation	We thank T. Iizuka for secretarial support. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to S.K.) and by a research grant from the Astellas Foundation for Research on Metabolic Disorders (to S.K.). This study was supported by the Kishimoto Foundation.	AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Araki M, 2014, NEUROLOGY, V82, P1302, DOI 10.1212/WNL.0000000000000317; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Basu R, 2004, BIPOLAR DISORD, V6, P314, DOI 10.1111/j.1399-5618.2004.00126.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bijlsma JWJ, 2016, LANCET, V388, P343, DOI 10.1016/S0140-6736(16)30363-4; BRANDT SJ, 1990, J CLIN INVEST, V86, P592, DOI 10.1172/JCI114749; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Burmester GR, 2018, LANCET, V391, P2503, DOI 10.1016/S0140-6736(18)31115-2; Burmester GR, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210310; Burmester GR, 2016, ANN RHEUM DIS, V75, P1081, DOI 10.1136/annrheumdis-2015-207628; Burmester GR, 2014, ANN RHEUM DIS, V73, P69, DOI 10.1136/annrheumdis-2013-203523; Bykerk VP, 2012, ANN RHEUM DIS, V71, P1950, DOI 10.1136/annrheumdis-2011-201087; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chase KA, 2015, PSYCHIAT RES, V225, P208, DOI 10.1016/j.psychres.2014.11.007; Chen F, 2017, BIOCHEM BIOPH RES CO, V494, P534, DOI 10.1016/j.bbrc.2017.10.119; Chourbaji S, 2006, NEUROBIOL DIS, V23, P587, DOI 10.1016/j.nbd.2006.05.001; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; Denton CP, 2018, NAT REV RHEUMATOL, V14, P511, DOI 10.1038/s41584-018-0062-0; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P., 2018, RHEUMATOLOGY OXFORD; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Fizazi K, 2012, EUR J CANCER, V48, P85, DOI 10.1016/j.ejca.2011.10.014; Fleischmann R, 2017, ARTHRITIS RHEUMATOL, V69, P277, DOI 10.1002/art.39944; Gabay C, 2016, ANN RHEUM DIS, V75, P1806, DOI 10.1136/annrheumdis-2015-207872; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Genovese MC, 2018, LANCET, V391, P2513, DOI 10.1016/S0140-6736(18)31116-4; Genovese MC, 2015, ARTHRITIS RHEUMATOL, V67, P1424, DOI 10.1002/art.39093; Genovese MC, 2014, ANN RHEUM DIS, V73, P1607, DOI 10.1136/annrheumdis-2013-204760; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Higa M, 2018, P NATL ACAD SCI USA, V115, pE1214, DOI 10.1073/pnas.1719921115; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kaneko Y, 2016, ANN RHEUM DIS, V75, P1917, DOI 10.1136/annrheumdis-2015-208426; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Khanna D, 2016, LANCET, V387, P2630, DOI 10.1016/S0140-6736(16)00232-4; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Kivitz A, 2014, ARTHRIT CARE RES, V66, P1653, DOI 10.1002/acr.22384; Klemettila JP, 2014, PSYCHIAT RES, V218, P277, DOI 10.1016/j.psychres.2014.04.049; Koike T, 2014, J RHEUMATOL, V41, P15, DOI 10.3899/jrheum.130466; Kovacs E, 2001, BIOMED PHARMACOTHER, V55, P391, DOI 10.1016/S0753-3322(01)00079-8; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; Lamertz L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar7388; Le RQ, 2018, ONCOLOGIST, V23, P943, DOI 10.1634/theoncologist.2018-0028; Lee EE, 2017, AM J GERIAT PSYCHIAT, V25, P50, DOI 10.1016/j.jagp.2016.09.009; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Li Jie, 2005, Curr Opin Investig Drugs, V6, P639; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Masuda K, 2016, J EXP MED, V213, P605, DOI 10.1084/jem.20151289; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mease P, 2018, LANCET, V392, P2367, DOI 10.1016/S0140-6736(18)32483-8; Moots RJ, 2017, RHEUMATOLOGY, V56, P541, DOI 10.1093/rheumatology/kew370; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakagawa Hiroko, 2014, BMC Hematol, V14, P6, DOI 10.1186/2052-1839-14-6; Nakahara H, 2003, ARTHRITIS RHEUM-US, V48, P1521, DOI 10.1002/art.11143; Nakaoka Y, 2018, ANN RHEUM DIS, V77, P348, DOI 10.1136/annrheumdis-2017-211878; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Narazaki M, 2017, EXPERT REV CLIN IMMU, V13, P535, DOI 10.1080/1744666X.2017.1295850; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2010, MOD RHEUMATOL, V20, P222, DOI 10.1007/s10165-010-0279-5; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Nyati KK, 2017, NUCLEIC ACIDS RES, V45, P2687, DOI 10.1093/nar/gkx064; O'Shea JJ, 2019, NAT REV RHEUMATOL, V15, P74, DOI 10.1038/s41584-018-0155-9; O'Shea JJ, 2013, NAT REV RHEUMATOL, V9, P173, DOI 10.1038/nrrheum.2013.7; Ogata A, 2014, ARTHRIT CARE RES, V66, P344, DOI 10.1002/acr.22110; Ogata A, 2012, CLIN MED INSIGHTS-AR, V5, P27, DOI 10.4137/CMAMD.S7371; Okusaka T, 2015, HEPATOL RES, V45, P1283, DOI 10.1111/hepr.12504; Pardeo M, 2017, BEST PRACT RES CL RH, V31, P505, DOI 10.1016/j.berh.2018.02.002; Pawar A, 2019, ANN RHEUM DIS, V78, P456, DOI 10.1136/annrheumdis-2018-214367; Peters M, 2000, GASTROENTEROLOGY, V119, P1663, DOI 10.1053/gast.2000.20236; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Reilley MJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0436-5; Reinhardt A, 2016, ARTHRITIS RHEUMATOL, V68, P2476, DOI 10.1002/art.39732; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; Robak T, 1999, MEDIAT INFLAMM, V8, P277, DOI 10.1080/09629359990289; Rossi JF, 2010, BRIT J CANCER, V103, P1154, DOI 10.1038/sj.bjc.6605872; Rutherford AI, 2018, ANN RHEUM DIS, V77, P905, DOI 10.1136/annrheumdis-2017-212825; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; Sieper J, 2015, ANN RHEUM DIS, V74, P1051, DOI 10.1136/annrheumdis-2013-204963; Sieper J, 2014, ANN RHEUM DIS, V73, P95, DOI 10.1136/annrheumdis-2013-203559; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; Stenlof K, 2003, J CLIN ENDOCR METAB, V88, P4379, DOI 10.1210/jc.2002-021733; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Strangfeld A, 2017, ANN RHEUM DIS, V76, P504, DOI 10.1136/annrheumdis-2016-209773; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Suwa T, 2000, AM J PHYSIOL-HEART C, V279, pH2954, DOI 10.1152/ajpheart.2000.279.6.H2954; Takeuchi T, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1536-9; Takeuchi T, 2017, ANN RHEUM DIS, V76, P2001, DOI 10.1136/annrheumdis-2017-211328; Takeuchi T, 2016, MOD RHEUMATOL, V26, P15, DOI 10.3109/14397595.2015.1074648; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Taylor PC, 2018, ANN RHEUM DIS, V77, P658, DOI 10.1136/annrheumdis-2017-212496; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Teachey DT, 2013, BLOOD, V121, P5154, DOI 10.1182/blood-2013-02-485623; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Timper K, 2016, GASTROENTEROLOGY, V151, P165, DOI 10.1053/j.gastro.2016.03.003; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Turner M, 2018, NAT IMMUNOL, V19, P120, DOI 10.1038/s41590-017-0028-4; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; van Rhee F, 2014, LANCET ONCOL, V15, P966, DOI 10.1016/S1470-2045(14)70319-5; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010; Wong AL, 2015, ANN ONCOL, V26, P998, DOI 10.1093/annonc/mdv026; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xie FL, 2016, ARTHRITIS RHEUMATOL, V68, P2612, DOI 10.1002/art.39761; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xu E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14803; Yamamoto K, 2015, J RHEUMATOL, V42, P1368, DOI 10.3899/jrheum.141210; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Yun HF, 2016, ARTHRITIS RHEUMATOL, V68, P56, DOI 10.1002/art.39399; Zaman MMU, 2016, P NATL ACAD SCI USA, V113, P11543, DOI 10.1073/pnas.1613307113	149	348	368	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1007	1023		10.1016/j.immuni.2019.03.026	http://dx.doi.org/10.1016/j.immuni.2019.03.026			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995492	Bronze			2022-12-18	WOS:000464660800016
J	Wu, P; Wu, D; Ni, C; Ye, J; Chen, W; Hu, G; Wang, Z; Wang, C; Zhang, Z; Xia, W; Chen, Z; Wang, K; Zhang, T; Xu, J; Han, Y; Zhang, T; Wu, X; Wang, J; Gong, W; Zheng, S; Qiu, F; Yan, J; Huang, J				Wu, Pin; Wu, Dang; Ni, Chao; Ye, Jun; Chen, Wuzhen; Hu, Guoming; Wang, Zhen; Wang, Changrong; Zhang, Zhigang; Xia, Wenjie; Chen, Zhigang; Wang, Ke; Zhang, Tao; Xu, Jinghong; Han, Yuehua; Zhang, Ting; Wu, Xianguo; Wang, Jianwei; Gong, Weihua; Zheng, Shu; Qiu, Fuming; Yan, Jun; Huang, Jian			gamma delta T17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer	IMMUNITY			English	Article							DELTA-T-CELLS; PIVOTAL ROLE; GAMMA; INFLAMMATION; TUMOR; DIFFERENTIATION; MICE; ANGIOGENESIS; LYMPHOCYTES; PROGRESSION	Development of cancer has been linked to chronic inflammation, particularly via interleukin-23 (IL-23) and IL-17 signaling pathways. However, the cellular source of IL-17 and underlying mechanisms by which IL-17-producing cells promote human colorectal cancer (CRC) remain poorly defined. Here, we demonstrate that innate gamma delta T (gamma delta T17) cells are the major cellular source of IL-17 in human CRC. Microbial products elicited by tumorous epithelial barrier disruption correlated with inflammatory dendritic cell (inf-DC) accumulation and gamma delta T17 polarization in human tumors. Activated inf-DCs induced gamma delta T17 cells to secrete IL-8, tumor necrosis factor alpha, and GM-CSF with a concomitant accumulation of immunosuppressive PMN-MDSCs in the tumor. Importantly, gamma delta T17 cell infiltration positively correlated with tumor stages and other clinicopathological features. Our study uncovers an inf-DC-gamma delta T17-PMN-MDSC regulatory axis in human CRC that correlates MDSC-meditated immunosuppression with tumorelicited inflammation. These findings suggest that gamma delta T17 cells might be key players in human CRC progression and have the potential for treatment or prognosis prediction.	[Wu, Pin; Wu, Dang; Ni, Chao; Ye, Jun; Wang, Zhen; Chen, Zhigang; Zhang, Tao; Zheng, Shu; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Natl Minist Educ,Prov Key Lab Biol Med Sci,Canc I, Hangzhou 310009, Zhejiang, Peoples R China; [Wu, Pin; Wu, Dang; Ni, Chao; Chen, Wuzhen; Hu, Guoming; Zhang, Zhigang; Xia, Wenjie; Chen, Zhigang; Wang, Ke; Wang, Jianwei; Qiu, Fuming; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Changrong; Xu, Jinghong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310009, Zhejiang, Peoples R China; [Ye, Jun; Han, Yuehua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Ting] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiat Oncol, Hangzhou 310009, Zhejiang, Peoples R China; [Wu, Xianguo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Clin Lab, Hangzhou 310009, Zhejiang, Peoples R China; [Gong, Weihua] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gen Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Yan, Jun] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; University of Louisville	Huang, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Natl Minist Educ,Prov Key Lab Biol Med Sci,Canc I, Hangzhou 310009, Zhejiang, Peoples R China.	jun.yan@louisville.edu; drhuangjian@zju.edu.cn	Chen, Wuzhen/ABA-4680-2020; Yan, Jun/A-8988-2008	Chen, Wuzhen/0000-0003-0210-6645; Wu, Pin/0000-0002-0472-1425; Huang, Jian/0000-0003-3340-5007	Science and Technology Department of Zhejiang Province [2011c13034similar to1]; Ministry of Health of Zhejiang Province [2012ZDA021]; Natural Science Foundation of Zhejiang Province [Y2110034, Y2100414, Z2100366, Y2090386]; NIH [R01CA150947, P01CA163223]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Province Key Discipline of Traditional Chinese Medicine [2012-XK-A27]; Key Innovation Discipline of Medicine [2011-CX11]; NATIONAL CANCER INSTITUTE [R01CA150947, P01CA163223] Funding Source: NIH RePORTER	Science and Technology Department of Zhejiang Province; Ministry of Health of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Province Key Discipline of Traditional Chinese Medicine; Key Innovation Discipline of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Science and Technology Department of Zhejiang Province (2011c13034 similar to 1, J.H.), the Ministry of Health of Zhejiang Province (2012ZDA021, J.H.), Natural Science Foundation of Zhejiang Province (Y2110034, FMQ; Y2100414, ZT; Z2100366, J.H. and Y2090386, X. W.) and the NIH (R01CA150947 and P01CA163223, J.Y.). This work was also funded by the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (J.H.), the Zhejiang Province Key Discipline of Traditional Chinese Medicine (2012-XK-A27, J.H.) and Key Innovation Discipline of Medicine (2011-CX11, J.H.).	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Reichling T, 2005, CANCER RES, V65, P166; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Silva-Santos B, 2010, EUR J IMMUNOL, V40, P1873, DOI 10.1002/eji.201040707; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Wang XX, 2011, THESCIENTIFICWORLDJO, V11, P826, DOI 10.1100/tsw.2011.86; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	38	348	362	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					785	800		10.1016/j.immuni.2014.03.013	http://dx.doi.org/10.1016/j.immuni.2014.03.013			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24816404	Bronze, Green Accepted			2022-12-18	WOS:000336026100016
J	Ballesteros-Tato, A; Leon, B; Graf, BA; Moquin, A; Adams, PS; Lund, FE; Randall, TD				Ballesteros-Tato, Andre; Leon, Beatriz; Graf, Beth A.; Moquin, Amy; Adams, Pamela Scott; Lund, Frances E.; Randall, Troy D.			Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation	IMMUNITY			English	Article							RECOMBINANT INTERLEUKIN-2; REGULATORY CELLS; IN-VIVO; B-CELLS; IL-2; MICE; AUTOIMMUNITY; ACTIVATION; EXPRESSION; FOLLICLES	T follicular helper (Tfh) cells promote T cell-dependent humoral immune responses by providing T cell help to B cells and by promoting germinal center (GC) formation and long-lived antibody responses. However, the cellular and molecular mechanisms that control Tfh cell differentiation in vivo are incompletely understood. Here we show that interleukin-2 (IL-2) administration impaired influenza-specific GCs, long-lived IgG responses, and Tfh cells. IL-2 did not directly inhibit GC formation, but instead suppressed the differentiation of Tfh cells, thereby hindering the maintenance of influenza-specific GC B cells. Our data demonstrate that IL-2 is a critical factor that regulates successful Tfh and B cell responses in vivo and regulates Tfh cell development.	[Ballesteros-Tato, Andre; Leon, Beatriz; Graf, Beth A.; Lund, Frances E.; Randall, Troy D.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Moquin, Amy; Adams, Pamela Scott] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	University of Rochester; Trudeau Institute	Randall, TD (corresponding author), Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	randallt@uab.edu		Ballesteros-Tato, Andre/0000-0002-4833-593X	University of Rochester; NIH [HL069409, AI072689, AI061511, AI078907, AI068056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061511, R01AI068056, R01AI072689, P01AI078907] Funding Source: NIH RePORTER	University of Rochester; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank L. LaMere and A. Boucher for animal husbandry. This work was supported by the University of Rochester and by NIH grants HL069409, AI072689, and AI061511 to T.D.R. and NIH grants AI078907 and AI068056 to F.E.L.	Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; BACHMANN MF, 1995, J VIROL, V69, P4842, DOI 10.1128/JVI.69.8.4842-4846.1995; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chikuma S, 2009, J IMMUNOL, V182, P6682, DOI 10.4049/jimmunol.0900080; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Menezes DEL, 2007, J IMMUNOTHER, V30, P64, DOI 10.1097/01.cji.0000211315.21116.07; Deenick EK, 2011, CURR OPIN IMMUNOL, V23, P111, DOI 10.1016/j.coi.2010.10.007; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Friedberg JW, 2002, BRIT J HAEMATOL, V117, P828, DOI 10.1046/j.1365-2141.2002.03535.x; Gillies SD, 2005, BLOOD, V105, P3972, DOI 10.1182/blood-2004-09-3533; Gluck WL, 2004, CLIN CANCER RES, V10, P2253, DOI 10.1158/1078-0432.CCR-1087-3; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; HAN SH, 1995, J IMMUNOL, V155, P556; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Humrich JY, 2010, P NATL ACAD SCI USA, V107, P204, DOI 10.1073/pnas.0903158107; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King C, 2011, IMMUNITY, V34, P827, DOI 10.1016/j.immuni.2011.06.007; Kovacs JA, 2001, EUR J IMMUNOL, V31, P1351, DOI 10.1002/1521-4141(200105)31:5<1351::AID-IMMU1351>3.0.CO;2-9; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	65	348	357	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					847	856		10.1016/j.immuni.2012.02.012	http://dx.doi.org/10.1016/j.immuni.2012.02.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22464171	Green Accepted, Bronze			2022-12-18	WOS:000304976000017
J	Cornall, RJ; Cyster, JG; Hibbs, ML; Dunn, AR; Otipoby, KL; Clark, EA; Goodnow, CC				Cornall, RJ; Cyster, JG; Hibbs, ML; Dunn, AR; Otipoby, KL; Clark, EA; Goodnow, CC			Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; TYROSINE-PHOSPHATASE 1C; REACTIVE LYMPHOCYTES-B; TRANSGENIC MICE; DEFICIENT MICE; SRC-FAMILY; ASSOCIATION; DISEASE; KINASE; PROTOONCOGENE	A B lymphocyte hyperactivity syndrome resembling systemic lupus erythematosus characterizes mice lacking the src-family kinase Lyn, Lyn is not required to initiate a cell antigen receptor (BCR) signaling but is an essential inhibitory component. lyn(-/-) B cells have a delayed but increased calcium flux and exaggerated negative selection responses in the presence of antigen and spontaneous hyperactivity in the absence of antigen. As in invertebrates, genetic effects of loci with only one functional allele can be used to analyze signaling networks in mice, demonstrating that negative regulation of the BCR is a complex quantitative trait in which Lyn, the coreceptor CD22, and the tyrosine phosphatase SHP-1 are each limiting elements. The biochemical basis of this complex trait involves a pathway requiring Lyn to phosphorylate CD22 and recruit SHP-1 to the CD22/BCR complex.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Immunol & Microbiol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; Univ Washington, Dept Immunol & Microbiol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Washington; University of Washington Seattle	Cornall, RJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.		Goodnow, Christopher C/V-8108-2018; Clark, Edward/K-3462-2012; Hibbs, Margaret L/D-7013-2011	Goodnow, Christopher C/0000-0001-5296-6155; Hibbs, Margaret L/0000-0002-3751-6751; Clark, Edward A/0000-0001-8061-5475	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 42508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; BELL SE, 1994, EMBO J, V13, P816, DOI 10.1002/j.1460-2075.1994.tb06324.x; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x; FISHER CL, 1991, J IMMUNOL, V146, P1743; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Mohan C, 1997, J IMMUNOL, V159, P454; Morel L, 1997, J IMMUNOL, V158, P6019; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NISTSCHKE L, 1997, CURR BIOL, V7, P133; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P90, DOI 10.1016/0167-5699(95)80095-6; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; Verheyen EM, 1996, GENETICS, V144, P1127; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	49	348	351	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					497	508		10.1016/S1074-7613(00)80554-3	http://dx.doi.org/10.1016/S1074-7613(00)80554-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586639	Bronze			2022-12-18	WOS:000073348000011
J	Shu, HB; Halpin, DR; Goeddel, DV				Shu, HB; Halpin, DR; Goeddel, DV			Casper is a FADD- and caspase-related inducer of apoptosis	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1-BETA CONVERTING-ENZYME; DEATH GENE CED-3; CELL-DEATH; TNF RECEPTOR; C-ELEGANS; MOLECULAR-CLONING; MAMMALIAN HOMOLOG; FAS ANTIGEN; PROTEASE	Caspases are cysteine proteases that play a central role in apoptosis. Caspase-8 may be the first enzyme of the proteolytic cascade activated by the Fas ligand and tumor necrosis factor (TNF). Caspase-8 is recruited to Fas and TNF receptor-1 (TNF-R1) through interaction of its prodomain with the death effector domain (DED) of the receptor-associating FADD. Here we describe a novel 55 kDa protein, Gasper, that has sequence similarity to caspase-8 throughout its length. However, Gasper is not a caspase since it racks several conserved amino acids found in all caspases. Gasper interacts with FADD, caspase-8, caspase-3, TRAF1, and TRAF2 through distinct domains. When overexpressed in mammalian cells, Gasper potently induces apoptosis. A C-terminal deletion mutant of Gasper inhibits TNF- and Fas-induced cell death, suggesting that Gasper is involved in these apoptotic pathways.			Shu, HB (corresponding author), TULARIK INC,2 CORP DR,S SAN FRANCISCO,CA 94080, USA.							Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; GOEDDEL DV, 1986, COLD SPRING HARB SYM, V51, P597, DOI 10.1101/SQB.1986.051.01.072; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; ITOH N, 1993, J BIOL CHEM, V268, P10932; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1996, CURR BIOL, V6, P1241, DOI 10.1016/S0960-9822(02)70706-9; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sambrook J, 1989, MOL CLONING LAB MANU; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; SHU HB, 1995, J CELL SCI, V108, P2955; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; WONG GHW, 1994, J IMMUNOL, V152, P1751; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	50	348	360	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					751	763		10.1016/S1074-7613(00)80450-1	http://dx.doi.org/10.1016/S1074-7613(00)80450-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208847	Bronze			2022-12-18	WOS:A1997XG57900010
J	LABOW, MA; NORTON, CR; RUMBERGER, JM; LOMBARDGILLOOLY, KM; SHUSTER, DJ; HUBBARD, J; BERTKO, R; KNAACK, PA; TERRY, RW; HARBISON, ML; KONTGEN, F; STEWART, CL; MCINTYRE, KW; WILL, PC; BURNS, DK; WOLITZKY, BA				LABOW, MA; NORTON, CR; RUMBERGER, JM; LOMBARDGILLOOLY, KM; SHUSTER, DJ; HUBBARD, J; BERTKO, R; KNAACK, PA; TERRY, RW; HARBISON, ML; KONTGEN, F; STEWART, CL; MCINTYRE, KW; WILL, PC; BURNS, DK; WOLITZKY, BA			CHARACTERIZATION OF E-SELECTIN-DEFICIENT MICE - DEMONSTRATION OF OVERLAPPING FUNCTION OF THE ENDOTHELIAL SELECTINS	IMMUNITY			English	Article							LEUKOCYTE-ADHESION MOLECULE-1; CELL-ADHESION; P-SELECTIN; LUNG INJURY; STEM-CELLS; T-CELLS; NEUTROPHILS; RECEPTOR; EXPRESSION; RECOGNITION	The initial rolling interaction of leukocytes with the blood vessel wall during leukocyte trafficking has been postulated to rely on members of the selectin family of adhesion molecules. Two selectins, E-selectin and P-selectin, have been identified that are expressed on activated endothelial cells. Mice deficient in E-selectin expression have been produced in order to examine the role of this selectin in leukocyte trafficking. Mice homozygous for an E-selectin null mutation were viable and exhibited no obvious developmental alterations. E-selectin-deficient mice displayed no significant change in the trafficking of neutrophils in several models of inflammation. However, blocking both endothelial selectins by treatment of the E-selectin-deficient animals with an anti-murine P-selectin antibody, 5H1, significantly inhibited neutrophil emigration in two distinct models of inflammation. While neutrophil accumulation at early times during thioglycollate-induced peritonitis was dependent on P-selectin, neutrophil accumulation at later time points was blocked by 5H1 only in E-selectin-deficient mice but not in wild-type mice. Similarly, edema as well as leukocyte accumulation in a model of delayed-type hypersensitivity in the skin was almost completely prevented by blockade of P-selectin function with 5H1 in the E-selectin-deficient mice while the same treatment had no effect in wild-type mice. These data demonstrate that the majority of neutrophil migration in both models requires an endothelial selectin but that E-selectin and P-selectin are functionally redundant. These data have important implications in the use of selectin antagonists in the treatment of inflammatory disease.	GLAXO INC,RES INST,DEPT CELL PHYSIOL,RES TRIANGLE PK,NC 27709; ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,MELBOURNE,VIC 3050,AUSTRALIA; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	GlaxoSmithKline; Royal Melbourne Hospital; Walter & Eliza Hall Institute	LABOW, MA (corresponding author), HOFFMANN LA ROCHE INC,ROCHE RES CTR,340 KINGSLAND ST,NUTLEY,NJ 07110, USA.							ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; ALBELDA SM, 1990, J CELL BIOL, V110, P1227, DOI 10.1083/jcb.110.4.1227; ALLEN MD, 1993, CIRCULATION, V88, P243; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BECKERANDRE M, 1992, EUR J BIOCHEM, V206, P401, DOI 10.1111/j.1432-1033.1992.tb16940.x; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOCHNER BS, 1994, J IMMUNOL, V152, P774; BROCKMEYER C, 1993, TRANSPLANTATION, V55, P610; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CAMERINI D, 1989, NATURE, V342, P7882; CHAPMAN JR, 1986, AM J DERMATOPATH, V8, P130, DOI 10.1097/00000372-198604000-00007; COTRAN RS, 1986, J EXP MED, V164, P661, DOI 10.1084/jem.164.2.661; ERBE DV, 1992, J CELL BIOL, V119, P215, DOI 10.1083/jcb.119.1.215; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; GRIFFIN JD, 1990, J IMMUNOL, V145, P576; GUNDEL RH, 1991, J CLIN INVEST, V88, P1407, DOI 10.1172/JCI115447; JOHNSTON GI, 1989, J IMMUNOL, V143, P3318; KANSAS GS, 1991, J CELL BIOL, V114, P351, DOI 10.1083/jcb.114.2.351; KOCH AE, 1991, LAB INVEST, V64, P313; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1993, J IMMUNOL, V151, P6338; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; LEY K, 1991, BLOOD, V77, P2553; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MIYAKE K, 1991, J CELL BIOL, V114, P557, DOI 10.1083/jcb.114.3.557; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; MULLIGAN MS, 1991, J CLIN INVEST, V88, P1396, DOI 10.1172/JCI115446; MULLIGAN MS, 1992, J CLIN INVEST, V90, P1600, DOI 10.1172/JCI116029; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; NORTON CR, 1992, BIOCHEM BIOPH RES CO, V195, P250; PAULSON JC, 1992, ADHESION ITS ROLE IN, P19; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; SHIMIZU Y, 1991, NATURE, V349, P799, DOI 10.1038/349799a0; SILBER A, 1994, J CLIN INVEST, V93, P1554, DOI 10.1172/JCI117134; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SZABO P, 1994, DEVELOPMENT, V120, P1651; TAYLOR PM, 1992, TRANSPLANTATION, V54, P451, DOI 10.1097/00007890-199209000-00013; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; WALCHECK B, 1993, J EXP MED, V178, P853, DOI 10.1084/jem.178.3.853; WATSON SR, 1991, NATURE, V349, P164, DOI 10.1038/349164a0; WELLER A, 1992, J BIOL CHEM, V267, P15176	55	348	352	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					709	720		10.1016/1074-7613(94)90041-8	http://dx.doi.org/10.1016/1074-7613(94)90041-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7541306				2022-12-18	WOS:A1994PT93000008
J	Schulthess, J; Pandey, S; Capitani, M; Rue-Albrecht, KC; Arnold, I; Franchini, F; Chomka, A; Ilott, NE; Johnston, DGW; Pires, E; McCullagh, J; Sansom, SN; Arancibia-Carcamo, CV; Uhlig, HH; Powrie, F				Schulthess, Julie; Pandey, Sumeet; Capitani, Melania; Rue-Albrecht, Kevin C.; Arnold, Isabelle; Franchini, Fanny; Chomka, Agnieszka; Ilott, Nicholas E.; Johnston, Daniel G. W.; Pires, Elisabete; McCullagh, James; Sansom, Stephen N.; Arancibia-Carcamo, Carolina, V; Uhlig, Holm H.; Powrie, Fiona			The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages	IMMUNITY			English	Article							HISTONE DEACETYLASE 3; AUTOPHAGY; METABOLITES; ACTIVATION; CELLS; MICROBIOTA; MAINTAINS; INCREASE; NUTRIENT; DEFENSE	Host microbial cross-talk is essential to maintain intestinal homeostasis. However, maladaptation of this response through microbial dysbiosis or defective host defense toward invasive intestinal bacteria can result in chronic inflammation. We have shown that macrophages differentiated in the presence of the bacterial metabolite butyrate display enhanced antimicrobial activity. Butyrate-induced antimicrobial activity was associated with a shift in macrophage metabolism, a reduction in mTOR kinase activity, increased LC3-associated host defense and anti-microbial peptide production in the absence of an increased inflammatory cytokine response. Butyrate drove this monocyte to macrophage differentiation program through histone deacetylase 3 (HDAC3) inhibition. Administration of butyrate induced antimicrobial activity in intestinal macrophages in vivo and increased resistance to enteropathogens. Our data suggest that (1) increased intestinal butyrate might represent a strategy to bolster host defense without tissue damaging inflammation and (2) that pharmacological HDAC3 inhibition might drive selective macrophage functions toward antimicrobial host defense.	[Schulthess, Julie; Rue-Albrecht, Kevin C.; Franchini, Fanny; Chomka, Agnieszka; Ilott, Nicholas E.; Johnston, Daniel G. W.; Sansom, Stephen N.; Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England; [Schulthess, Julie; Pandey, Sumeet; Capitani, Melania; Arnold, Isabelle; Arancibia-Carcamo, Carolina, V; Uhlig, Holm H.; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Expt Med Div,Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Pires, Elisabete; McCullagh, James] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Uhlig, Holm H.] Univ Oxford, John Radcliffe Hosp, Dept Pediat, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Powrie, F (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Roosevelt Dr, Oxford OX3 7FY, England.; Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Expt Med Div,Translat Gastroenterol Unit, Oxford OX3 9DU, England.	fiona.powrie@kennedy.ox.ac.uk	McCullagh, James/AAD-2669-2022; Rue-Albrecht, Kevin/O-8151-2019	McCullagh, James/0000-0003-4733-1205; Rue-Albrecht, Kevin/0000-0003-3899-3872; Johnston, Daniel GW/0000-0002-1737-0046; Pires, Elisabete/0000-0001-8646-062X; Franchini, Fanny/0000-0002-4522-3385; Uhlig, Holm/0000-0002-6111-7355; Ilott, Nicholas/0000-0002-8432-8622	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) [11/YH/0020, 16/YH/0247]; Wellcome Trust UK [095688/Z/11/Z]; BBSRC [BB/I005609/1]; Leona M. and Harry B. Helmsley Charitable Trust; Kennedy Trust for Rheumatology Research; CRUK grant [OCRC-DPHIL13-FF: FF]; Crohn's & Colitis Foundation of America; BBSRC [BB/R013829/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Wellcome Trust UK(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leona M. and Harry B. Helmsley Charitable Trust; Kennedy Trust for Rheumatology Research; CRUK grant; Crohn's & Colitis Foundation of America; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all volunteers and blood donors for participation in this study. We thank Sebastian Rogatti for technical assistance, Helen Ferry and Jonathan Webber for flow cytometry cell sorting, and the staff of our animal houses. We acknowledge the contribution of the BRC Gastrointestinal biobank (11/YH/0020, 16/YH/0247), supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). This work was supported by the Wellcome Trust UK (095688/Z/11/Z: F.P., D.G.W.J., and A.C.), the BBSRC (BB/I005609/1: FP, CVA-C, JS), the Leona M. and Harry B. Helmsley Charitable Trust (FP, HHU, JS, MC), the Kennedy Trust for Rheumatology Research (SNS, K.C.R-A. and N.E.I.), CRUK grant (OCRC-DPHIL13-FF: FF) and the Crohn's & Colitis Foundation of America (HHU, FP and SP). Salmonella enterica serovar Typhimurium (S. Typhimurium)-expressing GFP was kindly provided by D. Holden (Imperial College, University of London, UK) and adherent-invasive E. coli reference strain LF82 (AIEC) by A. Darfeuille-Michaud. The graphical abstract was prepared including a graphic element from Les Laboratoires Servier. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Arnold IC, 2016, MUCOSAL IMMUNOL, V9, P352, DOI 10.1038/mi.2015.65; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baxt LA, 2015, GASTROENTEROLOGY, V149, P553, DOI 10.1053/j.gastro.2015.06.046; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bujko A, 2018, J EXP MED, V215, P441, DOI 10.1084/jem.20170057; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cadwell K, 2016, NAT REV IMMUNOL, V16, P661, DOI 10.1038/nri.2016.100; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cushing K, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.34; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; French KE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20091-z; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jia HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152498; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Leus NGJ, 2016, BIOCHEM PHARMACOL, V108, P58, DOI 10.1016/j.bcp.2016.03.010; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Peloquin JM, 2016, ANNU REV IMMUNOL, V34, P31, DOI 10.1146/annurev-immunol-032414-112151; Riffelmacher T, 2017, IMMUNITY, V47, P466, DOI 10.1016/j.immuni.2017.08.005; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Scott NA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4755; Shimobayashi M, 2016, CELL RES, V26, P7, DOI 10.1038/cr.2015.146; Sinha R., 2017, INDEX SWITCHING CAUS; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Uhlig HH, 2018, ANNU REV IMMUNOL, V36, P755, DOI 10.1146/annurev-immunol-042617-053055; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; van der Beek CM, 2015, J NUTR, V145, P2019, DOI 10.3945/jn.115.211193; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wang JL, 2015, J INFECTION, V70, P415, DOI 10.1016/j.jinf.2014.09.013; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Zaia AA, 2009, MUCOSAL IMMUNOL, V2, P43, DOI 10.1038/mi.2008.63	60	347	362	15	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					432	+		10.1016/j.immuni.2018.12.018	http://dx.doi.org/10.1016/j.immuni.2018.12.018			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30683619	Green Published, hybrid			2022-12-18	WOS:000459006700017
J	Jenks, SA; Cashman, KS; Zumaquero, E; Marigorta, UM; Patel, AV; Wang, XQ; Tomar, D; Woodruff, MC; Simon, Z; Bugrovsky, R; Blalock, EL; Scharer, CD; Tipton, CM; Wei, CW; Lim, SS; Petri, M; Niewold, TB; Anolik, JH; Gibson, G; Lee, FEH; Boss, JM; Lund, FE; Sanz, I				Jenks, Scott A.; Cashman, Kevin S.; Zumaquero, Esther; Marigorta, Urko M.; Patel, Aakash V.; Wang, Xiaoqian; Tomar, Deepak; Woodruff, Matthew C.; Simon, Zoe; Bugrovsky, Regina; Blalock, Emily L.; Scharer, Christopher D.; Tipton, Christopher M.; Wei, Chungwen; Lim, S. Sam; Petri, Michelle; Niewold, Timothy B.; Anolik, Jennifer H.; Gibson, Greg; Lee, F. Eun-Hyung; Boss, Jeremy M.; Lund, Frances E.; Sanz, Ignacio			Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus	IMMUNITY			English	Article							T-BET; TERMINAL DIFFERENTIATION; CD11C EXPRESSION; PLASMA-CELLS; IFN-GAMMA; POPULATION; TLR7; AUTOREACTIVITY; IDENTIFICATION; COMPARTMENT	Systemic Lupus Erythematosus (SLE) is characterized by B cells lacking IgD and CD27 (double negative; DN). We show that DN cell expansions reflected a subset of CXCR5(-) CD11c(+) cells (DN2) representing pre-plasma cells (PC). DN2 cells predominated in African-American patients with active disease and nephritis, anti-Smith and anti-RNA autoantibodies. They expressed a T-bet transcriptional network; increased Toll-like receptor-7 (TLR7); lacked the negative TLR regulator TRAF5; and were hyper-responsive to TLR7. DN2 cells shared with activated naive cells (aNAV), phenotypic and functional features, and similar transcriptomes. Their PC differentiation and autoantibody production was driven by TLR7 in an interleukin-21 (IL-21)-mediated fashion. An in vivo developmental link between aNAV, DN2 cells, and PC was demonstrated by clonal sharing. This study defines a distinct differentiation fate of autoreactive naive B cells into PC precursors with hyper-responsiveness to innate stimuli, as well as establishes prominence of extra-follicular B cell activation in SLE, and identifies therapeutic targets.	[Jenks, Scott A.; Cashman, Kevin S.; Patel, Aakash V.; Wang, Xiaoqian; Tomar, Deepak; Woodruff, Matthew C.; Simon, Zoe; Bugrovsky, Regina; Blalock, Emily L.; Tipton, Christopher M.; Wei, Chungwen; Lim, S. Sam; Sanz, Ignacio] Emory Univ, Dept Med, Div Rheumatol, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA; [Zumaquero, Esther; Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Marigorta, Urko M.; Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Petri, Michelle] Johns Hopkins Univ, Dept Med, Hopkins Lupus Ctr, Baltimore, MD USA; [Niewold, Timothy B.] NYU, Sch Med, Colton Ctr Autoimmun, New York, NY USA; [Anolik, Jennifer H.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Lee, F. Eun-Hyung] Emory Univ, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA; [Scharer, Christopher D.; Boss, Jeremy M.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; University of Alabama System; University of Alabama Birmingham; University System of Georgia; Georgia Institute of Technology; Johns Hopkins University; New York University; University of Rochester; Emory University; Emory University	Sanz, I (corresponding author), Emory Univ, Dept Med, Div Rheumatol, Lowance Ctr Human Immunol, Atlanta, GA 30322 USA.	ignacio.sanz@emory.edu	Tomar, Deepak/X-6124-2019; Marigorta, Urko M/L-9512-2014	Anolik, Jennifer/0000-0002-1450-1549; Scharer, Christopher/0000-0001-7716-8504; Blalock, Emily/0000-0001-9978-1000; Marigorta, Urko M/0000-0002-9087-6609; Woodruff, Matthew/0000-0002-5252-7539	CHOA; Emory Pediatrics; URMC Flow Cytometry Cores; National Institutes of Health [T32-DK007656, AR043737, AR069572, U19-A1110483, R37-A1049660, P01-A1125180, P01-A11078907, R01-A1110508, R01-A1121252, U19-A1109962]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121252, P01AI078907, R01AI110508, P01AI125180, R01AI123733, U19AI109962, R37AI049660, U19AI110483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007656] Funding Source: NIH RePORTER	CHOA; Emory Pediatrics; URMC Flow Cytometry Cores; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to our patients and healthy volunteers, clinical coordinators (Debbie Campbell, Jennifer Scantlin, Anna Stephens, and Frances Lee) and members of the Sanz and Lee laboratories for their valuable insights into this project. This work was supported by the CHOA and Emory Pediatrics (Kira Smith, Bridget Neary, and Aaron Rae), and the URMC Flow Cytometry Cores (Tim Bushnell). This work was also supported by National Institutes of Health grants: T32-DK007656 (M.C.W.), AR043737 (M.P.; The Hopkins Lupus Cohort), AR069572 (M.P.; The Hopkins Lupus Cohort), U19-A1110483 Autoimmunity Center of Excellence (I.S., J.M.B.), R37-A1049660 (LS.), P01-A1125180 (I.S., J.M.B., F.E.L., F.E-H.L), P01-A11078907 (F.E-H.L.), R01-A1110508 (F.E.L.), R01-A1121252 (F.E-H.L.), and U19-A1109962 (F.E.L., F.E-H.L.).	Akatsu C, 2016, J EXP MED, V213, P2691, DOI 10.1084/jem.20160560; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Barwick BG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04234-4; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Buchta CM, 2014, J IMMUNOL, V192, P145, DOI 10.4049/jimmunol.1301901; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR; Dement-Brown J, 2012, J LEUKOCYTE BIOL, V91, P59, DOI 10.1189/jlb.0211096; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kolhatkar NS, 2015, J EXP MED, V212, P1663, DOI 10.1084/jem.20150585; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Luo W, 2014, J IMMUNOL, V193, P909, DOI 10.4049/jimmunol.1400666; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2015, CELL IMMUNOL, V294, P80, DOI 10.1016/j.cellimm.2014.12.002; Russell L, 2015, J IMMUNOL, V195, P3574, DOI 10.4049/jimmunol.1500776; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Scharer CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27030; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287; Yeo L, 2015, ANN RHEUM DIS, V74, P928, DOI 10.1136/annrheumdis-2013-204116; Zickert A, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000170; Zuniga R, 2003, ARTHRITIS RHEUM, V48, P460, DOI 10.1002/art.10930	47	347	356	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					725	+		10.1016/j.immuni.2018.08.015	http://dx.doi.org/10.1016/j.immuni.2018.08.015			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30314758	Green Accepted, Bronze			2022-12-18	WOS:000447386700017
J	Zaidman-Remy, A; Herve, M; Poidevin, M; Pili-Floury, S; Kim, MS; Blanot, D; Oh, BH; Ueda, R; Mengin-Lecreulx, D; Lemaitre, B				Zaidman-Remy, A; Herve, M; Poidevin, M; Pili-Floury, S; Kim, MS; Blanot, D; Oh, BH; Ueda, R; Mengin-Lecreulx, D; Lemaitre, B			The Drosophila amidase PGRP-LB modulates the immune response to bacterial infection	IMMUNITY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; INDUCIBLE EXPRESSION; INNATE IMMUNITY; IMD-PATHWAY; MELANOGASTER; REVEALS; DEFENSE; SYSTEM; MICE	The Drosophila host defense against gram-negative bacteria is mediated by the Imd pathway upon sensing of peptidoglycan by the peptidoglycan recognition protein (PGRP)-LC. Here we report a functional analysis of PGRP-LB, a catalytic member of the PGRP family. We show that PGRP-LB is a secreted protein regulated by the Imd pathway. Biochemical studies demonstrate that PGRP-LB is an amidase that specifically degrades gram-negative bacteria peptidoglycan. In agreement with its amidase activity, PGRP-LB downregulates the Imd pathway. Hence, activation of PGRP-LB by the Imd pathway provides a negative feedback regulation to tightly adjust immune activation to infection. Our study also reveals that PGRP-LB controls the immune reactivity of flies to the presence of ingested bacteria in the gut. Our work highlights the key role of PGRPs that encode both sensors and scavengers of peptidoglycan, which modulate the level of the host immune response to the presence of infectious microorganisms.	CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; Pohang Univ Sci & Technol, Dept Life Sci, Ctr Biomol Recognit, Pohang 790784, Kyungbuk, South Korea; Natl Inst Genet, Shizuoka 4118540, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pohang University of Science & Technology (POSTECH); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Lemaitre, B (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	lemaitre@cgm.cnrs-gif.fr	Lemaitre, Bruno/T-8146-2019; Zaidman-Rémy, Anna/C-2481-2016; Oh, Byung-Ha/C-2061-2011	Lemaitre, Bruno/0000-0001-7970-1667; Zaidman-Remy, Anna/0000-0003-2550-1752; MENGIN-LECREULX, Dominique/0000-0003-3205-0275				Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Cho JH, 2005, BLOOD, V106, P2551, DOI 10.1182/blood-2005-02-0530; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Kaneko T, 2005, J ENDOTOXIN RES, V11, P383, DOI 10.1179/096805105X76823; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	26	347	369	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2006	24	4					463	473		10.1016/j.immuni.2006.02.012	http://dx.doi.org/10.1016/j.immuni.2006.02.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618604	Bronze, Green Submitted			2022-12-18	WOS:000237153000015
J	Angeli, V; Ginhoux, F; Llodra, J; Quemeneur, L; Frenette, PS; Skobe, M; Jessberger, R; Merad, M; Randolph, GJ				Angeli, V; Ginhoux, F; Llodra, J; Quemeneur, L; Frenette, PS; Skobe, M; Jessberger, R; Merad, M; Randolph, GJ			B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization	IMMUNITY			English	Article							THORACIC-DUCT LYMPH; LANGERHANS CELLS; MIGRATION; EXPRESSION; IMMUNE; TUMOR; MICROENVIRONMENTS; TRAFFICKING; VASCULATURE; ACTIVATION	Dendritic cell (DC) migration from the periphery to lymph nodes is regulated by the pattern of genes expressed by DCs themselves and by signals within the surrounding peripheral environment. Here, we report that DC mobilization can also be regulated by signals initiated within the downstream lymph nodes, particularly when lymph nodes enlarge as a consequence of immunization. Lymph node B lymphocytes orchestrate expansion of the lymphatic network within the immunized lymph node. This expanded network in turn supports increased DC migration from the periphery. These results reveal unique relationships between B cells, lymphatic vessels, and migratory DCs. Knowledge that DC migration from the periphery is augmented by B cell-dependent signals reveals new potential strategies to increase DC migration during vaccination.	CUNY Mt Sinai Sch Med, Dept Genet & Cell Medl, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; Tech Univ Dresden, Sch Med, Dept Physiol Chem, D-01307 Dresden, Germany	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden	Angeli, V (corresponding author), CUNY Mt Sinai Sch Med, Dept Genet & Cell Medl, New York, NY 10029 USA.	veronique.angeli@mssm.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NHLBI NIH HHS [HL69446] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069446] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alam A, 2004, BIOCHEM BIOPH RES CO, V324, P909, DOI 10.1016/j.bbrc.2004.08.237; ANDERSON AO, 1981, TRANSPL P, V13, P1460; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Angeli W, 2004, J IMMUNOL, V172, P3822, DOI 10.4049/jimmunol.172.6.3822; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BELL EB, 1979, IMMUNOLOGY, V38, P797; Berger TG, 2003, CURR TOP MICROBIOL, V276, P163; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Boardman KC, 2003, CIRC RES, V92, P801, DOI 10.1161/01.RES.0000065621.69843.49; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; DANDIE GW, 1994, IMMUNOL CELL BIOL, V72, P79, DOI 10.1038/icb.1994.12; Dikov MM, 2005, J IMMUNOL, V174, P215, DOI 10.4049/jimmunol.174.1.215; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; JALKANEN S, 1986, IMMUNOL REV, V91, P39, DOI 10.1111/j.1600-065X.1986.tb01483.x; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Morse MA, 1999, CANCER RES, V59, P56; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; SAINTEMARIE G, 1982, AM J ANAT, V164, P275, DOI 10.1002/aja.1001640402; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183	46	347	353	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					203	215		10.1016/j.immuni.2006.01.003	http://dx.doi.org/10.1016/j.immuni.2006.01.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473832	Bronze			2022-12-18	WOS:000235479000011
J	Gunzer, M; Schafer, A; Borgmann, S; Grabbe, S; Zanker, KS; Brocker, EB; Kampgen, E; Friedl, P				Gunzer, M; Schafer, A; Borgmann, S; Grabbe, S; Zanker, KS; Brocker, EB; Kampgen, E; Friedl, P			Antigen presentation in extracellular matrix: Interactions of T cells with dendritic cells are dynamic, short lived, and sequential	IMMUNITY			English	Article							3-DIMENSIONAL COLLAGEN LATTICES; PROTEIN-KINASE-C; LYMPH-NODE; B-CELLS; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; LYMPHOCYTES-T; HELPER-T; ACTIVATION; LOCOMOTION	Cognate interactions of naive T cells with antigen-presenting dendritic cells require physical cell-cell contacts leading to signal induction and T cell activation. Using a three-dimensional collagen matrix videomicroscopy model for ovalbumin peptide-specific activation of murine and oxidative mitogenesis of human T cells, we show that T cells maintain vigorous migration upon cognate interactions to DC (dendritic cell), continuously crawl across the DC surface, and rapidly detach (median within 6-12 min). These dynamic and short-lived encounters favor sequential contacts with the same or other DC and trigger calcium influx, upregulation of activation markers, T blast formation, and proliferation. We conclude that a tissue environment supports the accumulation of sequential signals, implicating a numeric or "digital" control mechanism for an ongoing primary immune response.	Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; Univ Witten Herdecke, Inst Immunol, Witten, Germany; Univ Munster, Dept Dermatol, D-4400 Munster, Germany	University of Wurzburg; Witten Herdecke University; University of Munster	Friedl, P (corresponding author), Univ Wurzburg, Dept Dermatol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.		Gunzer, Matthias/AAW-7026-2021; Friedl, Peter/A-8961-2010; Grabe, Stephan/AAJ-4578-2021	Gunzer, Matthias/0000-0002-5534-6055; Friedl, Peter/0000-0002-0119-4041; Grabe, Stephan/0000-0002-6863-8719				Abbas AK, 1999, NAT MED, V5, P1345, DOI 10.1038/70905; Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Entschladen F, 1997, J IMMUNOL, V159, P3203; FRIEDL P, 1994, IMMUNOLOGY, V82, P617; FRIEDL P, 1993, J IMMUNOL METHODS, V165, P157, DOI 10.1016/0022-1759(93)90341-4; FRIEDL P, 1995, J IMMUNOL, V154, P4973; Friedl P, 1997, CANCER RES, V57, P2061; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gretz JE, 1996, J IMMUNOL, V157, P495; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunzer M, 2000, J LEUKOCYTE BIOL, V67, P622, DOI 10.1002/jlb.67.5.622; Gunzer M, 1997, ADV EXP MED BIOL, V417, P97; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; INABA K, 1986, J EXP MED, V163, P247, DOI 10.1084/jem.163.2.247; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KING PD, 1989, EUR J IMMUNOL, V19, P581, DOI 10.1002/eji.1830190402; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Labeur MS, 1999, J IMMUNOL, V162, P168; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Neumann M, 2000, BLOOD, V95, P277; Nikolai G, 1998, IMMUNOLOGY, V95, P62; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Schaefer BC, 1999, IMMUNITY, V11, P411, DOI 10.1016/S1074-7613(00)80116-8; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; USHIKI T, 1995, ANAT REC, V241, P113, DOI 10.1002/ar.1092410115; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; VANVOORHIS WC, 1983, J EXP MED, V158, P174, DOI 10.1084/jem.158.1.174; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	53	347	362	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2000	13	3					323	332		10.1016/S1074-7613(00)00032-7	http://dx.doi.org/10.1016/S1074-7613(00)00032-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	359NF	11021530	Bronze			2022-12-18	WOS:000089616400005
J	HARTY, JT; BEVAN, MJ				HARTY, JT; BEVAN, MJ			SPECIFIC IMMUNITY TO LISTERIA-MONOCYTOGENES IN THE ABSENCE OF IFN-GAMMA	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; CELL-INDEPENDENT PATHWAY; NATURAL-KILLER-CELLS; TYPE-3 COMPLEMENT RECEPTOR; INTERFERON-GAMMA; T-CELLS; MACROPHAGE ACTIVATION; INTRACELLULAR BACTERIUM; MYELOMONOCYTIC CELLS; MURINE LISTERIOSIS	Cytokine and cytokine receptor gene knockout mice provide powerful experimental systems to characterize the functions of these molecules in resistance to infectious disease. Such mice may also provide unique models of immune deficiency to learn whether manipulation of the immune response can overcome the specific dysfunction. We demonstrate that resistance of IFN gamma gene knockout (GKO(-/-)) mice to the intracellular bacterium Listeria monocytogenes is severely impaired compared with wild-type mice. However, immunization of GKO(-/-) mice with an attenuated L. monocytogenes strain generates antigen-specific CD8 T cell responses that can transfer immunity to naive hosts. Furthermore, vaccinated GKO(-/-) mice themselves exhibit 20,000-fold increased resistance to challenge with virulent L. monocytogenes and this resistance appears to be CD8 T cell mediated. These studies demonstrate that vaccination-induced immunity can overcome the absence of a cytokine that is critical for resistance to acute infection.	UNIV WASHINGTON,HOWARD HUGHES MED INST,DEPT IMMUNOL,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	HARTY, JT (corresponding author), UNIV IOWA,DEPT MICROBIOL,IOWA CITY,IA 52242, USA.			Harty, John/0000-0001-7266-2802				APPLEBERG R, 1994, IMMUNOLOGY, V83, P302; BANCROFT GJ, 1989, J IMMUNOL, V143, P127; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BECKERMAN KP, 1993, J IMMUNOL, V150, P888; BISHOP DK, 1987, J IMMUNOL, V139, P2005; BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994; BRUNDAGE RA, 1993, P NATL ACAD SCI USA, V90, P11890, DOI 10.1073/pnas.90.24.11890; BRUNT LM, 1990, J IMMUNOL, V145, P3540; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; CONLAN JW, 1992, J LEUKOCYTE BIOL, V52, P130, DOI 10.1002/jlb.52.1.130; CONLAN JW, 1991, J EXP MED, V174, P741, DOI 10.1084/jem.174.3.741; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; COSSART P, 1989, MOL BIOL MED, V6, P463; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; DUNN PL, 1991, J INFECT DIS, V164, P878, DOI 10.1093/infdis/164.5.878; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; GAILLARD JL, 1986, INFECT IMMUN, V52, P50, DOI 10.1128/IAI.52.1.50-55.1986; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOOSSENS PL, 1992, INT IMMUNOL, V4, P1413, DOI 10.1093/intimm/4.12.1413; GREGORY SH, 1992, J LEUKOCYTE BIOL, V51, P421, DOI 10.1002/jlb.51.4.421; GREGORY SH, 1993, J IMMUNOL, V151, P1401; HARTY JT, 1992, J EXP MED, V175, P1531, DOI 10.1084/jem.175.6.1531; HARTY JT, 1992, P NATL ACAD SCI USA, V89, P11612, DOI 10.1073/pnas.89.23.11612; HARTY JT, 1995, J IMMUNOL, V154, P4642; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; LUKACS K, 1989, J IMMUNOL, V142, P2879; MIELKE MEA, 1989, J EXP MED, V170, P589, DOI 10.1084/jem.170.2.589; MIELKE MEA, 1988, INFECT IMMUN, V56, P1920, DOI 10.1128/IAI.56.8.1920-1925.1988; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; PAMER EG, 1994, J IMMUNOL, V152, P686; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; ROSEN H, 1989, J EXP MED, V170, P27, DOI 10.1084/jem.170.1.27; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; WHERRY JC, 1991, INFECT IMMUN, V59, P1709, DOI 10.1128/IAI.59.5.1709-1715.1991; WOOD S, 1993, INFECT IMMUN, V61, P3068, DOI 10.1128/IAI.61.7.3068-3072.1993	51	347	353	0	7	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					109	117		10.1016/1074-7613(95)90163-9	http://dx.doi.org/10.1016/1074-7613(95)90163-9			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621071	Bronze			2022-12-18	WOS:A1995RK86800012
J	Lee, J; Zhang, TX; Hwang, I; Kim, A; Nitschke, L; Kim, M; Scott, JM; Kamimura, Y; Lanier, LL; Kim, S				Lee, Jaewon; Zhang, Tianxiang; Hwang, Ilwoong; Kim, Ahrom; Nitschke, Larissa; Kim, MinJae; Scott, Jeannine M.; Kamimura, Yosuke; Lanier, Lewis L.; Kim, Sungjin			Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; UMBILICAL-CORD BLOOD; CD94/NKG2C RECEPTOR; ADAPTIVE IMMUNITY; TYROSINE KINASE; FCR-GAMMA; ACTIVATION; REPERTOIRE; CHILDREN; DIFFERENTIATION	Long-lived "memory-like'' NK cells have been identified in individuals infected by human cytomegalovirus (HCMV), but little is known about how the memory-like NK cell pool is formed. Here, we have shown that HCMV-infected individuals have several distinct subsets of memory-like NK cells that are often deficient for multiple transcription factors and signaling proteins, including tyrosine kinase SYK, for which the reduced expression was stable over time and correlated with epigenetic modification of the gene promoter. Deficient expression of these proteins was largely confined to the recently discovered FcRg-deficient NK cells that display enhanced antibody-dependent functional activity. Importantly, FcRg-deficient NK cells exhibited robust preferential expansion in response to virus-infected cells (both HCMV and influenza) in an antibody-dependent manner. These findings suggest that the memory-like NK cell pool is shaped and maintained by a mechanism that involves both epigenetic modification of gene expression and antibody-dependent expansion.	[Lee, Jaewon; Zhang, Tianxiang; Hwang, Ilwoong; Kim, Ahrom; Nitschke, Larissa; Kim, MinJae; Scott, Jeannine M.; Kim, Sungjin] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Kamimura, Yosuke; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Michigan State University; University of California System; University of California San Francisco	Kim, S (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	kimsj@msu.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Kim, Ahrom/0000-0003-2861-8366; Nitschke, Larissa/0000-0002-8040-2100	NIH [5R21CA149476]; Michigan State University; National Agenda Project grant from the Korea Research Council of Fundamental Science and Technology, Republic of Korea; NATIONAL CANCER INSTITUTE [R21CA149476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; National Agenda Project grant from the Korea Research Council of Fundamental Science and Technology, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Gardner (Michigan State University) for influenza virus stocks; S. Hong, D. Bieber, J. Conwell, S. Sheikh, and L. King for technical assistance; and W. Esselman for discussion and advice. Supported by the NIH (5R21CA149476), Michigan State University, and a National Agenda Project grant from the Korea Research Council of Fundamental Science and Technology, Republic of Korea.	Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Colucci F, 1999, J IMMUNOL, V163, P1769; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Della Chiesa M, 2014, J IMMUNOL, V192, P1471, DOI 10.4049/jimmunol.1302053; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Goodman PA, 2003, ONCOGENE, V22, P2504, DOI 10.1038/sj.onc.1206313; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hwang I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051858; Hwang I, 2012, INT IMMUNOL, V24, P793, DOI 10.1093/intimm/dxs080; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Mela CM, 2007, J INFECT DIS, V195, P158, DOI 10.1086/509811; Monsivais-Urenda A, 2010, EUR J IMMUNOL, V40, P1418, DOI 10.1002/eji.200939898; Muntasell A, 2013, EUR J IMMUNOL, V43, P3268, DOI 10.1002/eji.201343773; Noyola DE, 2012, EUR J IMMUNOL, V42, P3256, DOI 10.1002/eji.201242752; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Perez-Quintero LA, 2014, J EXP MED, V211, P727, DOI 10.1084/jem.20132038; Petersen L, 2010, HUM IMMUNOL, V71, P29, DOI 10.1016/j.humimm.2009.09.355; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Saghafian-Hedengren S, 2013, J VIROL, V87, P13446, DOI 10.1128/JVI.02382-13; Shapira KE, 2014, MOL BIOL CELL, V25, P1620, DOI 10.1091/mbc.E13-09-0537; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wu ZG, 2013, J VIROL, V87, P7717, DOI 10.1128/JVI.01096-13; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	42	346	352	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					431	442		10.1016/j.immuni.2015.02.013	http://dx.doi.org/10.1016/j.immuni.2015.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786175	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000351301900009
J	Shi, C; Jia, T; Mendez-Ferrer, S; Hohl, TM; Serbina, NV; Lipuma, L; Leiner, I; Li, MO; Frenette, PS; Pamer, EG				Shi, Chao; Jia, Ting; Mendez-Ferrer, Simon; Hohl, Tobias M.; Serbina, Natalya V.; Lipuma, Lauren; Leiner, Ingrid; Li, Ming O.; Frenette, Paul S.; Pamer, Eric G.			Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands	IMMUNITY			English	Article							NILE-VIRUS-INFECTION; CHEMOKINE RECEPTOR; INFLAMMATORY MONOCYTES; BACTERIAL-INFECTION; CHEMOATTRACTANT PROTEIN-1; MACROPHAGE RECRUITMENT; IMMUNE-RESPONSE; DENDRITIC CELLS; HOST-DEFENSE; MICE REVEALS	Inflammatory (Ly6C(hi) CCR2(+)) monocytes provide defense against infections but also contribute to autoimmune diseases and atherosclerosis. Monocytes originate from bone marrow and their entry into the bloodstream requires stimulation of CCR2 chemokine receptor by monocyte chemotactic protein-1 (MCP1). How monocyte emigration from bone marrow is triggered by remote infections remains unclear. We demonstrated that low concentrations of Toll-like receptor (TLR) ligands in the bloodstream drive CCR2-dependent emigration of monocytes from bone marrow. Bone marrow mesenchymal stem cells (MSCs) and their progeny, including CXC chemokine ligand (CXCL)12-abundant reticular (CAR) cells, rapidly expressed MCP1 in response to circulating TLR ligands or bacterial infection and induced monocyte trafficking into the bloodstream. Targeted deletion of MCP1 from MSCs impaired monocyte emigration from bone marrow. Our findings suggest that bone marrow MSCs and CAR cells respond to circulating microbial molecules and regulate bloodstream monocyte frequencies by secreting MCP1 in proximity to bone marrow vascular sinuses.	[Shi, Chao; Jia, Ting; Hohl, Tobias M.; Serbina, Natalya V.; Lipuma, Lauren; Leiner, Ingrid; Li, Ming O.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, New York, NY 10065 USA; [Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Shi, Chao] Weill Cornell Grad Sch Med Sci, Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Immunol Program,Sloan Kettering Inst, New York, NY 10065 USA.	pamere@mskcc.org	Frenette, Paul S/J-8272-2012; Méndez-Ferrer, Simón/ABG-8547-2020; Méndez-Ferrer, Simón/L-8088-2014; Shi, Chao/B-5455-2008	Frenette, Paul S/0000-0003-0862-9922; Méndez-Ferrer, Simón/0000-0002-9805-9988; Méndez-Ferrer, Simón/0000-0002-9805-9988; Hohl, Tobias/0000-0002-9097-5412; li, ming/0000-0002-1383-0535	NIH [5R37AI039031, 5P01CA023766-31, K08AI071998, R01DK056638, RO1HL097819]; American Society for Hematology; NATIONAL CANCER INSTITUTE [P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080619, K08AI071998, R37AI039031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 5R37AI039031 and 5P01CA023766-31 to E.G.P., K08AI071998 to T.M.H., and R01DK056638 and RO1HL097819 to P.S.F. and by a Scholar Award from the American Society for Hematology to S.M.-F.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Poon M, 1996, AM J PATHOL, V149, P307; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; TAVASSOLI M, 1979, BRIT J HAEMATOL, V41, P303, DOI 10.1111/j.1365-2141.1979.tb05863.x; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026	44	346	354	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					590	601		10.1016/j.immuni.2011.02.016	http://dx.doi.org/10.1016/j.immuni.2011.02.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21458307	Green Accepted, Bronze			2022-12-18	WOS:000290367300017
J	Lee, HK; Mattei, LM; Steinberg, BE; Alberts, P; Lee, YH; Chervonsky, A; Mizushima, N; Grinstein, S; Iwasaki, A				Lee, Heung Kyu; Mattei, Lisa M.; Steinberg, Benjamin E.; Alberts, Philipp; Lee, Yun Hee; Chervonsky, Alexander; Mizushima, Noboru; Grinstein, Sergio; Iwasaki, Akiko			In Vivo Requirement for Atg5 in Antigen Presentation by Dendritic Cells	IMMUNITY			English	Article							HERPES-SIMPLEX-VIRUS; CLASS-II MOLECULES; CD4(+) T-CELLS; RESTRICTED PRESENTATION; DIFFERENTIAL ROLES; CROSS-PRESENTATION; ADAPTIVE IMMUNITY; AUTOPHAGY PROTEIN; CYTOSOLIC ANTIGEN; TYPE-2 INFECTION	Autophagy is known to be important in presentation of cytosolic antigens on MHC class II (MHC II). However, the role of autophagic process in antigen presentation in vivo is unclear. Mice with dendritic cell (DC)-conditional deletion in Atg5, a key autophagy gene, showed impaired CD4(+) T cell priming after herpes simplex virus infection and succumbed to rapid disease. The most pronounced defect of Atg5(-/-) DCs was the processing and presentation of phagocytosed antigens containing Toll-like receptor stimuli for MHC class II. In contrast, cross-presentation of peptides on MHC I was intact in the absence of Atg5. Although induction of metabolic autophagy did not enhance MHC II presentation, autophagic machinery was required for optimal phagosome-to-lysosome fusion and subsequent processing of antigen for MHC II loading. Thus, our study revealed that DCs utilize autophagic machinery to optimally process and present extracellular microbial antigens for MHC II presentation.	[Lee, Heung Kyu; Mattei, Lisa M.; Alberts, Philipp; Lee, Yun Hee; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Steinberg, Benjamin E.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Steinberg, Benjamin E.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Chervonsky, Alexander] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan	Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Chicago; Tokyo Medical & Dental University (TMDU)	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Mizushima, Noboru/C-3635-2009; Lee, Heung Kyu/C-2073-2011; Iwasaki, Akiko/Z-1591-2019	Mizushima, Noboru/0000-0002-6258-6444; Lee, Heung Kyu/0000-0002-3977-1510; Iwasaki, Akiko/0000-0002-7824-9856; Mattei, Lisa/0000-0002-2238-0281; Chervonsky, Alexander/0000-0001-7547-871X	National Institute of Allergy and Immunology [AI054359, AI062428, AI064705, AI72627]; Anna Fuller cancer research; Richard K. Gershon predoctoral training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064705, R01AI072627, R01AI054359, R01AI081884, R56AI062428, R01AI062428] Funding Source: NIH RePORTER	National Institute of Allergy and Immunology; Anna Fuller cancer research; Richard K. Gershon predoctoral training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institute of Allergy and Immunology (AI054359, AI062428, and AI064705 to A.I. and AI72627 to A.C.). H.K.L. is a recipient of an Anna Fuller cancer research fellowship and Richard K. Gershon predoctoral training fellowship. A. I. is a recipient of the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease.	Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Chen M, 1998, J VIROL, V72, P8301, DOI 10.1128/JVI.72.10.8301-8308.1998; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dobbs ME, 2005, J VIROL, V79, P14546, DOI 10.1128/JVI.79.23.14546-14554.2005; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gueguen M, 1996, P NATL ACAD SCI USA, V93, P14692, DOI 10.1073/pnas.93.25.14692; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Jones LJ, 1997, ANAL BIOCHEM, V251, P144, DOI 10.1006/abio.1997.2259; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leib DA, 2009, J VIROL, V83, P12164, DOI 10.1128/JVI.01676-09; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mach N, 2000, CANCER RES, V60, P3239; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; MURPHY DB, 1992, J IMMUNOL, V148, P3483; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qi L, 2000, J IMMUNOL, V165, P5451, DOI 10.4049/jimmunol.165.10.5451; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	60	346	369	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					227	239		10.1016/j.immuni.2009.12.006	http://dx.doi.org/10.1016/j.immuni.2009.12.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20171125	Green Accepted, Bronze			2022-12-18	WOS:000275346000012
J	Das, H; Groh, V; Kuijl, C; Sugita, M; Morita, CT; Spies, T; Bukowski, JF				Das, H; Groh, V; Kuijl, C; Sugita, M; Morita, CT; Spies, T; Bukowski, JF			MICA engagement by human V gamma 2V delta 2 T cells enhances their antigen-dependent effector function	IMMUNITY			English	Article							PRENYL PYROPHOSPHATE ANTIGENS; DELTA LYMPHOCYTES-T; GAMMA-DELTA; NONPEPTIDE ANTIGENS; INNATE IMMUNITY; RECEPTOR; RECOGNITION; ACTIVATION; INFECTION; MOLECULES	V gamma 2V delta2 T cells comprise 2%-5% of human peripheral blood T cells, recognize ubiquitous nonpeptide antigens, and expand up to 50-fold during microbial infection. It is not clear why these V gamma 2V delta2 T cells expand only after microbial infection. We show here that the stress-inducible molecule, MICA, is induced on the surface of dendritic and epithelial cells by infection with M. tuberculosis in vitro and in vivo. MICA engagement by the activating receptor, NKG2D. present on V gamma 2V delta2 T cells, resulted in a substantial enhancement of the TCR-dependent V gamma 2V delta2 T cell response to nonpeptide antigens and protein superantigens alike. Thus, a MICA-NKG2D interaction may be necessary for an effective innate immune response to microbe-associated antigens that also are constitutively present in vivo.	Brigham & Womens Hosp, Lymphocyte Biol Sect, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Univ Iowa, Dept Internal Med, Div Rheumatol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grp Immunol, EMRB 340F, Iowa City, IA 52242 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; University of Iowa; University of Iowa	Bukowski, JF (corresponding author), Brigham & Womens Hosp, Lymphocyte Biol Sect, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Das, Hiranmoy/R-7452-2019; Morita, Craig T/C-1365-2011	Morita, Craig T/0000-0001-8496-8294; Kuijl, Coen/0000-0003-4378-1428; Sugita, Masahiko/0000-0001-5511-1304; Das, Hiranmoy/0000-0002-3343-0096				BALBI B, 1993, AM REV RESPIR DIS, V148, P1685, DOI 10.1164/ajrccm/148.6_Pt_1.1685; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Caldwell CW, 1996, AM J CLIN PATHOL, V105, P640; Carena I, 1997, J EXP MED, V186, P1769, DOI 10.1084/jem.186.10.1769; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; DAS H, 2001, IN PRESS BLOOD; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; DEMARIA A, 1992, J INFECT DIS, V165, P917, DOI 10.1093/infdis/165.5.917; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Garcia VE, 1997, J IMMUNOL, V159, P1328; GHENGHESH KS, 1989, BRAZ J MED BIOL RES, V22, P653; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2000, BLOOD, V96, P384; Lafont V, 2000, J BIOL CHEM, V275, P19282, DOI 10.1074/jbc.M910487199; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LICHTENBERGER LM, 1991, J PEDIATR GASTR NUTR, V13, P342, DOI 10.1097/00005176-199111000-00002; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Miyagawa F, 2001, J IMMUNOL, V166, P5508, DOI 10.4049/jimmunol.166.9.5508; MORITA CT, 1991, EUR J IMMUNOL, V21, P2999, DOI 10.1002/eji.1830211215; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 1999, MICROBES INFECT, V1, P175, DOI 10.1016/S1286-4579(99)80032-X; Morita CT, 1996, RES IMMUNOL, V147, P347, DOI 10.1016/0923-2494(96)89649-0; MUNK ME, 1990, J IMMUNOL, V145, P2434; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; RAZIUDDIN S, 1992, EUR J IMMUNOL, V22, P1143, DOI 10.1002/eji.1830220506; RUST CJJ, 1990, NATURE, V346, P572, DOI 10.1038/346572a0; SCALISE F, 1992, IMMUNOLOGY, V76, P668; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; SUMIDA T, 1992, INFECT IMMUN, V60, P2554, DOI 10.1128/IAI.60.6.2554-2558.1992; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	53	346	365	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					83	93		10.1016/S1074-7613(01)00168-6	http://dx.doi.org/10.1016/S1074-7613(01)00168-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485740	Bronze			2022-12-18	WOS:000170153300009
J	Babcock, GJ; Hochberg, D; Thorley-Lawson, DA				Babcock, GJ; Hochberg, D; Thorley-Lawson, DA			The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell	IMMUNITY			English	Article							IN-VIVO; PERIPHERAL-BLOOD; HODGKINS-DISEASE; EBNA-1 GENE; MEMORY; IDENTIFICATION; PROMOTER; EBV; PERSISTENCE; LYMPHOCYTES	Epstein-Barr virus-infected B cells in vivo demonstrate three distinct patterns of latent gene expression, depending on the differentiation stage of the cell. Tonsillar naive B cells express the EBNA2-dependent lymphoblastoid phenotype, characteristic of direct infection. Germinal center centroblasts and centrocytes as well as tonsillar memory B cells express a more restricted pattern of latent genes (EBNA1(Q-K)(+), LMP1(+), LMP2(+), EBNA2(-)) that has only been seen previously in EBV-positive tumors. Peripheral memory cells express an even more restricted pattern where no latent genes are expressed, with the possible exception of LMP2. These results are consistent with a model where EBV uses the normal biology of B lymphocytes to gain access to and persist within the long-lived memory B cell compartment.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02138 USA	Tufts University	Thorley-Lawson, DA (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02138 USA.	dlawson@opal.tufts.edu			NCI NIH HHS [CA 65883] Funding Source: Medline; NIAID NIH HHS [AI 18757] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; BOGEDAIN C, 1995, J VIROL, V69, P4872, DOI 10.1128/JVI.69.8.4872-4879.1995; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Decker LL, 1996, J VIROL, V70, P3286, DOI 10.1128/JVI.70.5.3286-3289.1996; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Gray D, 1996, IMMUNOL REV, V150, P45, DOI 10.1111/j.1600-065X.1996.tb00695.x; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; KHANNA R, 1995, MICROBIOL REV, V59, P387, DOI 10.1128/MMBR.59.3.387-405.1995; KHANNA R, 1992, J EXP MED, V176, P169, DOI 10.1084/jem.176.1.169; Kieff E., 1996, FIELDS VIROLOGY, P2343; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Masucci Maria G., 1994, Trends in Microbiology, V2, P125, DOI 10.1016/0966-842X(94)90599-1; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; Niedobitek G, 1997, BLOOD, V90, P1664, DOI 10.1182/blood.V90.4.1664.1664_1664_1672; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Oudejans JJ, 1996, J CLIN PATHOL, V49, P897, DOI 10.1136/jcp.49.11.897; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; SCHAEFER BC, 1995, P NATL ACAD SCI USA, V92, P10565, DOI 10.1073/pnas.92.23.10565; Thorley-Lawson DA, 1999, LIFE SCI, V65, P1433, DOI 10.1016/S0024-3205(99)00214-3; THORLEYLAWSON DA, 1982, J VIROL, V43, P730, DOI 10.1128/JVI.43.2.730-736.1982; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; TSAI CN, 1995, DNA CELL BIOL, V14, P767, DOI 10.1089/dna.1995.14.767; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300	33	346	354	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					497	506		10.1016/S1074-7613(00)00049-2	http://dx.doi.org/10.1016/S1074-7613(00)00049-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070168	Bronze			2022-12-18	WOS:000090079100009
J	Shirogane, T; Fukada, T; Muller, JMM; Shima, DT; Hibi, M; Hirano, T				Shirogane, T; Fukada, T; Muller, JMM; Shima, DT; Hibi, M; Hirano, T			Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis	IMMUNITY			English	Article							CYTOKINE RECEPTOR GP130; DNA-BINDING ACTIVITY; TRANSGENIC MICE; STAT3 ACTIVATION; GENE-EXPRESSION; MEDIATED APOPTOSIS; MYELOID CELLS; BONE-MARROW; PROTEIN; BCL-2	The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. We found that Pim-l and Pim-2 are targets for the gp130-mediated STAT3 signal. Expression of a kinase-defective Pim-1 mutant attenuated gp130-mediated cell proliferation. Constitutive expression of Pim-l together with c-myc, another STAT3 target, fully compensated for loss of the STAT3-mediated cell cycle progression, antiapoptosis, and bcl-2 expression. We also identified valosine-containing protein (VCP) as a target gene for the Pim-1-mediated signal. Expression of a mutant VCR led cells to undergo apoptosis. These results indicate that Rim-family proteins play crucial roles in gp130-mediated cell proliferation and explain the synergy between Rim and c-Myc proteins in cell proliferation and lymphomagenesis.	Osaka Univ, Grad Sch Med, Div Mol Oncol, Ctr Biomed Res, Suita, Osaka 5650871, Japan; Imperial Canc Res Fund, Cell Biol Lab, London WC2A 3PX, England	Osaka University; Cancer Research UK	Hirano, T (corresponding author), Osaka Univ, Grad Sch Med, Div Mol Oncol, Ctr Biomed Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Hirano, Toshio/C-8194-2009; Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444				Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; ASKEW DS, 1991, ONCOGENE, V6, P1915; Besser D, 1999, MOL CELL BIOL, V19, P1401; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BREUER M, 1989, NATURE, V340, P61, DOI 10.1038/340061a0; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CUYPERS HT, 1984, CELL, V37, P141; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DOMEN J, 1993, LEUKEMIA, V7, pS108; DOMEN J, 1993, BLOOD, V82, P1445; DOMEN J, 1993, J EXP MED, V178, P1665, DOI 10.1084/jem.178.5.1665; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Hilbert DM, 1996, IMMUNITY, V5, P81, DOI 10.1016/S1074-7613(00)80312-X; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Jaster R, 1999, CELL SIGNAL, V11, P331, DOI 10.1016/S0898-6568(98)00049-7; Kagaya S, 1997, MOL CELL BIOL, V17, P6736, DOI 10.1128/MCB.17.11.6736; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KEATH EJ, 1984, CELL, V37, P521, DOI 10.1016/0092-8674(84)90382-9; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Konietzko U, 1999, EMBO J, V18, P3359, DOI 10.1093/emboj/18.12.3359; Krumenacker JS, 1998, ENDOCRINE, V9, P163, DOI 10.1385/ENDO:9:2:163; Lilly M, 1997, CANCER RES, V57, P5348; LILLY M, 1992, ONCOGENE, V7, P727; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; MIGNONE TS, 1995, SCIENCE, V269, P79; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Muller JMM, 1999, J BIOL CHEM, V274, P10154, DOI 10.1074/jbc.274.15.10154; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Sakai I, 1997, J BIOL CHEM, V272, P12350, DOI 10.1074/jbc.272.19.12350; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; Shimizu S, 1996, CANCER RES, V56, P2161; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; WAGNER AJ, 1993, MOL CELL BIOL, V13, P2432, DOI 10.1128/MCB.13.4.2432; Wu DY, 1999, DEVELOPMENT, V126, P2021; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	66	346	368	1	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					709	719		10.1016/S1074-7613(00)80145-4	http://dx.doi.org/10.1016/S1074-7613(00)80145-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626893	Bronze			2022-12-18	WOS:000084612900007
J	Shaw, AS; Dustin, ML				Shaw, AS; Dustin, ML			Making the T cell receptor go the distance: A topological view of T cell activation	IMMUNITY			English	Review							MHC CLASS-II; FUNCTION-ASSOCIATED ANTIGEN-1; LEUKOCYTE-COMMON ANTIGEN; INTERCELLULAR-ADHESION; TYROSINE PHOSPHATASES; SIGNAL-TRANSDUCTION; DISSOCIATION RATE; PRESENTING CELL; MOLECULES; PROTEIN		WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63130	Washington University (WUSTL)	Shaw, AS (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63130, USA.		Dustin, Michael/AAM-4611-2020	Shaw, Andrey/0000-0001-5685-0272; Dustin, Michael/0000-0003-4983-6389				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DESPONT JP, 1975, CELL IMMUNOL, V17, P487, DOI 10.1016/S0008-8749(75)80052-9; Dustin ML, 1996, J IMMUNOL, V157, P2014; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; Ellies LG, 1996, BLOOD, V88, P1725, DOI 10.1182/blood.V88.5.1725.bloodjournal8851725; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; FISCHER EH, 1992, CIBA F SYMP, V164, P132; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GUTTINGER M, 1992, INT IMMUNOL, V4, P1325, DOI 10.1093/intimm/4.11.1325; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; KUBO RT, 1989, J IMMUNOL, V142, P2736; KUMAGAI N, 1987, J IMMUNOL, V139, P1393; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; MASON DW, 1980, BIOCHEM J, V187, P1; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MOINGEON PE, 1991, EUR J IMMUNOL, V21, P605, DOI 10.1002/eji.1830210311; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; OROURKE AM, 1991, J EXP MED, V173, P241, DOI 10.1084/jem.173.1.241; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; SAKIHAMA T, 1995, IMMUNOL TODAY, V16, P581, DOI 10.1016/0167-5699(95)80081-6; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; UNANUE ER, 1972, J EXP MED, V136, P885, DOI 10.1084/jem.136.4.885; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WEISS A, 1987, J IMMUNOL, V138, P2169	58	346	352	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					361	369		10.1016/S1074-7613(00)80279-4	http://dx.doi.org/10.1016/S1074-7613(00)80279-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133415	Bronze			2022-12-18	WOS:A1997XC61900001
J	Nakagawa, TY; Brissette, WH; Lira, PD; Griffiths, RJ; Petrushova, N; Stock, J; McNeish, JD; Eastman, SE; Howard, ED; Clarke, SRM; Rosloniec, EF; Elliott, EA; Rudensky, AY				Nakagawa, TY; Brissette, WH; Lira, PD; Griffiths, RJ; Petrushova, N; Stock, J; McNeish, JD; Eastman, SE; Howard, ED; Clarke, SRM; Rosloniec, EF; Elliott, EA; Rudensky, AY			Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice	IMMUNITY			English	Article							MHC CLASS-II; T-CELL DETERMINANTS; LIGAND-TREATED MICE; DENDRITIC CELLS; SURFACE EXPRESSION; IN-VIVO; MOLECULES; COMPLEX; TRANSPORT; BINDING	Cathepsins have been implicated in the degradation of proteins destined for the MHC class II processing pathway and in the proteolytic removal of invariant chain (Ii), a critical regulator of MHC class II function. Mice lacking the lysosomal cysteine proteinase cathepsin S (catS) demonstrated a profound inhibition of Ii degradation in professional APC in vivo. A marked variation in the generation of MHC class II-bound Ii fragments and presentation of exogenous proteins was observed between B cells, dendritic cells, and macrophages lacking catS. CatS-deficient mice showed diminished susceptibility to collagen-induced arthritis, suggesting a potential therapeutic target for regulation of immune responsiveness.	Pfizer Inc, Div Cent Res, Groton, CT 06340 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98115 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98115 USA; Univ Tennessee, Dept Med, Memphis, TN 38104 USA; Vet Adm Med Ctr, Memphis, TN 38104 USA	Pfizer; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Elliott, EA (corresponding author), Pfizer Inc, Div Cent Res, Groton, CT 06340 USA.							AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BARRETT AJ, 1987, TRENDS BIOCHEM SCI, V12, P193, DOI 10.1016/0968-0004(87)90092-2; Baumgart M, 1998, P NATL ACAD SCI USA, V95, P6936, DOI 10.1073/pnas.95.12.6936; BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; BRAND DD, 1994, J IMMUNOL, V152, P3088; BROMME D, 1991, BIOMED BIOCHIM ACTA, V50, P631; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Fineschi B, 1996, J IMMUNOL, V157, P3211; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Griffiths RJ, 1997, J EXP MED, V185, P1123, DOI 10.1084/jem.185.6.1123; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Guery JC, 1996, J EXP MED, V183, P751, DOI 10.1084/jem.183.3.751; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; LOSS GE, 1993, J IMMUNOL, V150, P3187; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MASON RW, 1989, BIOCHEM J, V257, P125, DOI 10.1042/bj2570125; Merz GS, 1997, J CELL PHYSIOL, V173, P423; MORENO J, 1991, J IMMUNOL, V147, P3306; Morkowski S, 1997, EUR J IMMUNOL, V27, P609, DOI 10.1002/eji.1830270306; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pulendran B, 1997, J IMMUNOL, V159, P2222; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; ROACH ML, 1995, EXP CELL RES, V221, P520, DOI 10.1006/excr.1995.1403; Robadey C, 1996, EUR J IMMUNOL, V26, P1656, DOI 10.1002/eji.1830260738; RODRIGUEZ GM, 1995, EUR J IMMUNOL, V25, P1823, DOI 10.1002/eji.1830250705; Rosloniec EF, 1996, CELL IMMUNOL, V172, P21, DOI 10.1006/cimm.1996.0210; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; Stebbins CC, 1996, J IMMUNOL, V157, P4892; VANNOORT JM, 1994, EUR J IMMUNOL, V24, P2175, DOI 10.1002/eji.1830240936; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821	45	345	377	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					207	217		10.1016/S1074-7613(00)80021-7	http://dx.doi.org/10.1016/S1074-7613(00)80021-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072073	Bronze			2022-12-18	WOS:000078972200008
J	Kalos, M; June, CH				Kalos, Michael; June, Carl H.			Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology	IMMUNITY			English	Review							PERIPHERAL-BLOOD LYMPHOCYTES; VERSUS-HOST-DISEASE; IN-VIVO PERSISTENCE; GENE-THERAPY; RETROVIRAL TRANSDUCTION; METASTATIC MELANOMA; IMMUNE-RESPONSES; RECEPTOR; MEMORY; EXPRESSION	Adoptive T cell transfer for cancer and chronic infection is an emerging field that shows promise in recent trials. Synthetic-biology-based engineering of T lymphocytes to express high-affinity antigen receptors can overcome immune tolerance, which has been a major limitation of immunotherapy-based strategies. Advances in cell engineering and culture approaches to enable efficient gene transfer and ex vivo cell expansion have facilitated broader evaluation of this technology, moving adoptive transfer from a "boutique'' application to the cusp of a mainstream technology. The major challenge currently facing the field is to increase the specificity of engineered T cells for tumors, because targeting shared antigens has the potential to lead to on-target off-tumor toxicities, as observed in recent trials. As the field of adoptive transfer technology matures, the major engineering challenge is the development of automated cell culture systems, so that the approach can extend beyond specialized academic centers and become widely available.	[Kalos, Michael; June, Carl H.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Kalos, Michael; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kalos, M (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	michael.kalos@uphs.upenn.edu; cjune@exchange.upenn.edu			NCI NIH HHS [R01 CA165206] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA165206] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Au P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004131; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Baker M, 2011, NAT MED, V17, P519, DOI 10.1038/nm0511-519; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brindley DA, 2012, REGEN MED, V7, P7, DOI [10.2217/rme.11.112, 10.2217/RME.11.112]; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Charo J, 2005, CANCER RES, V65, P2001, DOI 10.1158/0008-5472.CAN-04-2006; Cheever MA, 1997, IMMUNOL REV, V157, P177, DOI 10.1111/j.1600-065X.1997.tb00982.x; Chen YY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-240; Cheng LE, 2002, P NATL ACAD SCI USA, V99, P3001, DOI 10.1073/pnas.052676899; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dotti G, 2005, BLOOD, V105, P4677, DOI 10.1182/blood-2004-08-3337; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Eaton D, 2002, GENE THER, V9, P527, DOI 10.1038/sj.gt.3301685; Evans LS, 1999, HUM GENE THER, V10, P1941, DOI 10.1089/10430349950017301; Fisher DT, 2006, IMMUNOL INVEST, V35, P251, DOI 10.1080/08820130600745430; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Grupp SA, 2012, CLIN CANCER RES, V18, P6732, DOI 10.1158/1078-0432.CCR-12-1432; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hsu C, 2007, BLOOD, V109, P5168, DOI 10.1182/blood-2006-06-029173; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kircher MF, 2003, CANCER RES, V63, P6838; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Krause A, 1998, J EXP MED, V188, P619, DOI 10.1084/jem.188.4.619; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lamers CHJ, 2011, BLOOD, V117, P72, DOI 10.1182/blood-2010-07-294520; Laport GG, 2003, BLOOD, V102, P2004, DOI 10.1182/blood-2003-01-0095; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Linette GP, 2013, BLOOD; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Machiels JPH, 2001, CANCER RES, V61, P3689; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; MACY E, 1989, J ALLERGY CLIN IMMUN, V83, P871, DOI 10.1016/0091-6749(89)90099-7; Marktel S, 2003, BLOOD, V101, P1290, DOI 10.1182/blood-2002-08-2351; Mason C, 2010, REGEN MED, V5, P307, DOI [10.2217/rme.10.37, 10.2217/RME.10.37]; Maus M.V., 2013, IMMUNOL RES; Michalos G, 2010, CIRP J MANUF SCI TEC, V2, P81, DOI 10.1016/j.cirpj.2009.12.001; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mitchell DA, 2008, HUM GENE THER, V19, P511, DOI 10.1089/hum.2007.115; MITCHISON NA, 1955, J EXP MED, V102, P157, DOI 10.1084/jem.102.2.157; Mitsuyasu RT, 2000, BLOOD, V96, P785, DOI 10.1182/blood.V96.3.785.015k10_785_793; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2006, NAT CLIN PRACT ONCOL, V3, P668, DOI 10.1038/ncponc0666; Muul LM, 2003, BLOOD, V101, P2563, DOI 10.1182/blood-2002-09-2800; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nolz JC, 2011, IMMUNOTHERAPY-UK, V3, P1223, DOI [10.2217/IMT.11.100, 10.2217/imt.11.100]; O'Connor CM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00249; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Peggs KS, 2004, BLOOD, V103, P1548, DOI 10.1182/blood-2003-05-1513; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rapoport AP, 2009, CLIN CANCER RES, V15, P4499, DOI 10.1158/1078-0432.CCR-09-0418; Rapoport AP, 2005, NAT MED, V11, P1230, DOI 10.1038/nm1310; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rowley J, 2009, EUR J IMMUNOL, V39, P491, DOI 10.1002/eji.200838594; Rufer N, 2001, BLOOD, V98, P597, DOI 10.1182/blood.V98.3.597; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Scholler J., 2012, SCI TRANSL MED, V4; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tang YM, 2008, BRIT J HAEMATOL, V143, P84, DOI 10.1111/j.1365-2141.2008.07298.x; Topp MS, 2003, J EXP MED, V198, P947, DOI 10.1084/jem.20021288; Turtle CJ, 2011, CURR OPIN IMMUNOL, V23, P299, DOI 10.1016/j.coi.2010.12.012; Vitale M, 2005, CLIN CANCER RES, V11, P67; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Williams DA, 2008, MOL THER, V16, P635, DOI 10.1038/mt.2008.34; Wrzesinski C, 2005, CURR OPIN IMMUNOL, V17, P195, DOI 10.1016/j.coi.2005.02.002; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Yoon SH, 2009, CANCER GENE THER, V16, P489, DOI 10.1038/cgt.2008.98; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	114	344	404	5	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					49	60		10.1016/j.immuni.2013.07.002	http://dx.doi.org/10.1016/j.immuni.2013.07.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890063	Green Accepted, Bronze			2022-12-18	WOS:000330948300005
J	Tsuji, M; Suzuki, K; Kitamura, H; Maruya, M; Kinoshita, K; Ivanov, II; Itoh, K; Littman, DR; Fagarasan, S				Tsuji, Masayuki; Suzuki, Keiichiro; Kitamura, Hiroshi; Maruya, Mikako; Kinoshita, Kazuo; Ivanov, Ivaylo I.; Itoh, Kikuji; Littman, Dan R.; Fagarasan, Sidonia			Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin a generation in the gut	IMMUNITY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; INDUCED CYTIDINE DEAMINASE; MUCOSAL IMMUNE-SYSTEM; TUMOR-NECROSIS-FACTOR; LAMINA PROPRIA; B-CELLS; DENDRITIC CELLS; COMMENSAL BACTERIA; SMALL-INTESTINE; GERMINAL CENTER	Immunoglobulin A (IgA) is generated in the gut by both T cell-dependent and T cell-independent processes. The sites and the mechanisms for T cell-independent IgA synthesis remain elusive. Here we show that isolated lymphoid follicles (ILFs) were sites where induction of activation-induced cytidine deaminase (AID) and IgA class switching of B cells took place in the absence of T cells. We also show that formation of ILFs was regulated by interactions between lymphoid tissue-inducer cells expressing the nuclear receptor ROR gamma t (ROR gamma t(+)LTi cells) and stromal cells (SCs). Activation of SCs by ROR gamma t(+)LTi cells through lymphotoxin (LT)-beta receptor (LT beta R) and simultaneously by bacteria through TLRs induced recruitment of dendritic cells (DCs) and B cells and formation of ILFs. These findings provide insight into the crosstalk between bacteria, ROR gamma t(+)LTi cells, SCs, DCs, and B cells required for ILF formation an establish a critical role of ILFs in T cell-independent IgA synthesis in gut.	[Tsuji, Masayuki; Suzuki, Keiichiro; Maruya, Mikako; Fagarasan, Sidonia] RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Kitamura, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Yokohama, Kanagawa 2300045, Japan; [Kinoshita, Kazuo] Shiga Med Ctr, Res Inst, Moriyama Ku, Shiga 5248524, Japan; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Lab Vet Publ Hlth, Tokyo 1138657, Japan	RIKEN; RIKEN; Howard Hughes Medical Institute; New York University; University of Tokyo	Fagarasan, S (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama 1-7-22, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402	strategic research program for RD	strategic research program for RD	We thank Y. Doi and A. Yagisawa for technical assistance; H. Fujimoto and Y. Hachiman for cell sorting; H. Ishikawa, F. Sartori, and A. Sato for help with the techniques for gut fixation and staining; T. Honjo and O. Kanagawa for helpful discussion and for critically reading the manuscript; and T. Worbs for his help with the automated image analyses. This work is supported in part by strategic research program for R&D to S.F.	BEREK C, 1992, IMMUNOL REV, V126, P5, DOI 10.1111/j.1600-065X.1992.tb00628.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2006, CURR TOP MICROBIOL, V308, P137; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Heidinger M, 2006, BIOL CHEM, V387, P69, DOI 10.1515/BC.2006.010; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kim MY, 2003, IMMUNITY, V18, P643, DOI 10.1016/S1074-7613(03)00110-9; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; McDonald KG, 2005, J IMMUNOL, V174, P5720, DOI 10.4049/jimmunol.174.9.5720; MCWILLIAMS M, 1977, J EXP MED, V145, P866, DOI 10.1084/jem.145.4.866; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newberry RD, 2002, J IMMUNOL, V168, P4988, DOI 10.4049/jimmunol.168.10.4988; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Pabst O, 2006, J IMMUNOL, V177, P6824, DOI 10.4049/jimmunol.177.10.6824; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Taylor RT, 2004, J IMMUNOL, V173, P7183, DOI 10.4049/jimmunol.173.12.7183; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yu Q, 2000, GENE DEV, V14, P163	53	344	348	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					261	271		10.1016/j.immuni.2008.05.014	http://dx.doi.org/10.1016/j.immuni.2008.05.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18656387	Bronze			2022-12-18	WOS:000258610800014
J	OShea, JJ				OShea, JJ			Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?	IMMUNITY			English	Review							PROTEIN-TYROSINE KINASE; RECEPTOR-GAMMA-CHAIN; MUTANT-CELL LINE; INTERFERON-GAMMA; DNA-BINDING; LYMPHOID DEVELOPMENT; TRANSCRIPTION FACTOR; DEFICIENT MICE; IL-2 RECEPTOR; IFN-GAMMA				OShea, JJ (corresponding author), NIAMSD,LYMPHOCYTE CELL BIOL SECT,ARTHRIT & RHEUMATISM BRANCH,NIH,BETHESDA,MD 20892, USA.							Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adachi M, 1997, ONCOGENE, V14, P1629, DOI 10.1038/sj.onc.1200981; Adachi M, 1996, BLOOD, V88, P4118, DOI 10.1182/blood.V88.11.4118.bloodjournal88114118; Adler K, 1996, FEBS LETT, V395, P286, DOI 10.1016/0014-5793(96)01053-8; Ali S, 1996, EMBO J, V15, P135, DOI 10.1002/j.1460-2075.1996.tb00341.x; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Cao XM, 1996, MOL CELL BIOL, V16, P1595; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chen M, 1997, P NATL ACAD SCI USA, V94, P6910, DOI 10.1073/pnas.94.13.6910; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Cho SS, 1996, J IMMUNOL, V157, P4781; Conway G, 1997, P NATL ACAD SCI USA, V94, P3082, DOI 10.1073/pnas.94.7.3082; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; GouilleuxGruart V, 1996, BLOOD, V87, P1692; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Johnston JA, 1996, J LEUKOCYTE BIOL, V60, P441, DOI 10.1002/jlb.60.4.441; Kanwar VS, 1996, BLOOD, V87, P4911, DOI 10.1182/blood.V87.11.4911.bloodjournal87114911; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KAWAHARA A, 1995, P NATL ACAD SCI USA, V92, P8724, DOI 10.1073/pnas.92.19.8724; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; LAI KS, 1995, J BIOL CHEM, V270, P25028, DOI 10.1074/jbc.270.42.25028; Leonard WJ, 1996, ANNU REV MED, V47, P229; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Ohashi T, 1996, CURR TOP MICROBIOL, V211, P223; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Saijo K, 1997, J EXP MED, V185, P351, DOI 10.1084/jem.185.2.351; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER C, 1992, SCIENCE, V257, P807; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shuai K, 1996, ONCOGENE, V13, P247; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WeberNordt RM, 1996, BLOOD, V88, P809; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Yan H, 1996, MOL CELL BIOL, V16, P2074; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; ZHAO YM, 1995, J BIOL CHEM, V270, P13814, DOI 10.1074/jbc.270.23.13814	131	344	366	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					1	11		10.1016/S1074-7613(00)80505-1	http://dx.doi.org/10.1016/S1074-7613(00)80505-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252115	Bronze			2022-12-18	WOS:A1997XN69300001
J	Norbury, CC; Hewlett, LJ; Prescott, AR; Shastri, N; Watts, C				Norbury, CC; Hewlett, LJ; Prescott, AR; Shastri, N; Watts, C			Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages	IMMUNITY			English	Article							TOXIC LYMPHOCYTES-T; PRESENTING CELLS; PHORBOL ESTERS; PROTEIN; MOLECULES; INDUCTION; COSTIMULATION; PINOCYTOSIS; TOLERANCE; INFECTION	Extracellular proteins are not generally presented on class I MHC molecules in vitro, yet many studies show that a pathway exists in vivo for the presentation of extracellular material on class I molecules to prime CD8(+) T cell responses. Here, we provide morphological evidence that proteins taken up by macropinocytosis can gain access to the cytosol and therefore into the conventional class I MHC pathway. Class I presentation of soluble ovalbum in by mouse bone marrow macrophages was dramatically enhanced by MCSF or phorbol ester and blocked by amiloride, which stimulate and inhibit membrane ruffling and macropinocytosis, respectively. Brefeldin A, gelonin, and a peptide aldehyde inhibitor of proteasomal processing each blocked presentation of macropinocytosed antigen, demonstrating that unusual access to the conventional class I MHC pathway was occurring. This novel cell type-specific endocytic pathway may facilitate presentation of exogenous material on class I MHC molecules, allowing induction of CD8(+) T cell responses to soluble proteins, tumor cell fragments, and some pathogens.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	Norbury, CC (corresponding author), UNIV DUNDEE, INST MED SCI, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND.		Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Watts, Colin/0000-0001-6183-2087	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2228, DOI 10.1002/eji.1830240944; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; DEBRUIJN MLH, 1995, EUR J IMMUNOL, V25, P1274, DOI 10.1002/eji.1830250522; DODI AI, 1994, EUR J IMMUNOL, V24, P1632, DOI 10.1002/eji.1830240727; FINK PJ, 1983, J EXP MED, V157, P141, DOI 10.1084/jem.157.1.141; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GOODING LR, 1980, J IMMUNOL, V124, P1258; HARDING CV, 1994, J IMMUNOL, V153, P4925; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; HEWLETT LJ, 1995, THESIS U DUNDEE SCOT; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KE Y, 1995, EUR J IMMUNOL, V25, P549, DOI 10.1002/eji.1830250237; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; LIU TM, 1995, J IMMUNOL, V154, P3147; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROCK KL, 1993, J IMMUNOL, V150, P438; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; STAERZ UD, 1987, NATURE, V329, P449, DOI 10.1038/329449a0; STARNBACH MN, 1994, J IMMUNOL, V153, P1603; STIRPE F, 1980, J BIOL CHEM, V255, P6947; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; SWANSON JA, 1985, J CELL BIOL, V100, P851, DOI 10.1083/jcb.100.3.851; SWANSON JA, 1989, J CELL SCI, V94, P135; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; SZALAY G, 1994, EUR J IMMUNOL, V24, P1471, DOI 10.1002/eji.1830240703; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; VANDEURS B, 1989, INT REV CYTOL, V117, P131; WATTS C, 1992, J CELL SCI, V103, P1; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; WRAITH DC, 1987, J GEN VIROL, V68, P433, DOI 10.1099/0022-1317-68-2-433; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266	57	344	350	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					783	791		10.1016/1074-7613(95)90067-5	http://dx.doi.org/10.1016/1074-7613(95)90067-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777723	Bronze			2022-12-18	WOS:A1995TM02300012
J	Allen, IC; Wilson, JE; Schneider, M; Lich, JD; Roberts, RA; Arthur, JC; Woodford, RMT; Davis, BK; Uronis, JM; Herfarth, HH; Jobin, C; Rogers, AB; Ting, JPY				Allen, Irving C.; Wilson, Justin E.; Schneider, Monika; Lich, John D.; Roberts, Reid A.; Arthur, Janelle C.; Woodford, Rita-Marie T.; Davis, Beckley K.; Uronis, Joshua M.; Herfarth, Hans H.; Jobin, Christian; Rogers, Arlin B.; Ting, Jenny P. -Y.			NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-kappa B Signaling	IMMUNITY			English	Article							IKK-ALPHA; CUTTING EDGE; MOUSE MODEL; ACTIVATION; INNATE; PROTEIN; CELLS; CARCINOGENESIS; RECOGNITION; MUTATIONS	In vitro data suggest that a subgroup of NLR proteins, including NLRP12, inhibits the transcription factor NF-kappa B, although physiologic and disease-relevant evidence is largely missing. Dysregulated NF-kappa B activity is associated with colonic inflammation and cancer, and we found Nlrp12(-/-) mice were highly susceptible to colitis and colitis-associated colon cancer. Polyps isolated from Nlrp12(-/-) mice showed elevated noncanonical NF-kappa B activation and increased expression of target genes that were associated with cancer, including Cxcl13 and Cxcl12. NLRP12 negatively regulated ERK and AKT signaling pathways in affected tumor tissues. Both hematopoietic- and nonhematopoietic-derived NLRP12 contributed to inflammation, but the latter dominantly contributed to tumorigenesis. The noncanonical NF-kappa B pathway was regulated upon degradation of TRAF3 and activation of NIK. NLRP12 interacted with both NIK and TRAF3, and Nlrp12(-/-) cells have constitutively elevated NIK, p100 processing to p52 and reduced TRAF3. Thus, NLRP12 is a checkpoint of noncanonical NF-kappa B, inflammation, and tumorigenesis.	[Allen, Irving C.; Wilson, Justin E.; Lich, John D.; Davis, Beckley K.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Schneider, Monika; Roberts, Reid A.; Arthur, Janelle C.; Jobin, Christian; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Woodford, Rita-Marie T.; Ting, Jenny P. -Y.] Univ N Carolina, Sch Dent, Oral Biol Program, Chapel Hill, NC 27599 USA; [Uronis, Joshua M.; Herfarth, Hans H.; Jobin, Christian; Ting, Jenny P. -Y.] Univ N Carolina, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA; [Herfarth, Hans H.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA; [Jobin, Christian] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rogers, Arlin B.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	panyun@med.unc.edu	Herfarth, Hans/K-7547-2019	McFadden, Rita-Marie/0000-0002-2351-7198; Arthur, Janelle/0000-0002-4796-0207; Allen, Irving/0000-0001-9573-5250	CCFA; UNC-CH UCRF; American Cancer Society;  [R21CA131645];  [CA156330];  [AI077437];  [AI067798];  [AR007416];  [K01DK092355]; NATIONAL CANCER INSTITUTE [R21CA131645, R01CA156330, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, U19AI077437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092355, P30DK034987, F32DK088417, R01DK073338] Funding Source: NIH RePORTER	CCFA; UNC-CH UCRF; American Cancer Society(American Cancer Society); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Center for Gastrointestinal Biology and Disease (CGIBD) for providing core and technical support (P30DK34987). We also thank J. Berlin and Millenium Pharmaceuticals for providing the Nlrp12<SUP>-/-</SUP> mice. In addition, we would like to acknowledge E. Holl, K. Roney, M. Muhlbauer, and H. vanDeventer for technical assistance. This work is supported by: R21CA131645 and CCFA (B.K.D.); CA156330, AI077437, AI067798, and UNC-CH UCRF (J.P.Y.T.); and AR007416, the American Cancer Society, and K01DK092355 (I.C.A.).	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Del Grosso F, 2011, MOL CANCER RES, V9, P815, DOI 10.1158/1541-7786.MCR-10-0367; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Fushimi T, 2006, CANCER RES, V66, P3513, DOI 10.1158/0008-5472.CAN-05-1493; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Madge LA, 2010, J BIOL CHEM, V285, P38069, DOI 10.1074/jbc.M110.147207; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sollid LM, 2008, PLOS MED, V5, P1338, DOI 10.1371/journal.pmed.0050198; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Uronis JM, 2007, CANCER RES, V67, P11594, DOI 10.1158/0008-5472.CAN-07-3242; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	41	343	373	4	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					742	754		10.1016/j.immuni.2012.03.012	http://dx.doi.org/10.1016/j.immuni.2012.03.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22503542	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000304976000009
J	Jin, TC; Perry, A; Jiang, JS; Smith, P; Curry, JA; Unterholzner, L; Jiang, ZZ; Horvath, G; Rathinam, VA; Johnstone, RW; Hornung, V; Latz, E; Bowie, AG; Fitzgerald, KA; Xiao, TS				Jin, Tengchuan; Perry, Andrew; Jiang, Jiansheng; Smith, Patrick; Curry, James A.; Unterholzner, Leonie; Jiang, Zhaozhao; Horvath, Gabor; Rathinam, Vijay A.; Johnstone, Ricky W.; Hornung, Veit; Latz, Eicke; Bowie, Andrew G.; Fitzgerald, Katherine A.; Xiao, T. Sam			Structures of the HIN Domain: DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor	IMMUNITY			English	Article							INNATE IMMUNE SENSOR; X-RAY-DIFFRACTION; PATTERN-RECOGNITION; RNA RECOGNITION; I INTERFERON; RIG-I; MUTATIONS; PROCASPASE-9; INSIGHTS; FAMILY	Recognition of DNA by the innate immune system is central to antiviral and antibacterial defenses, as well as an important contributor to autoimmune diseases involving self DNA. AIM2 (absent in melanoma 2) and IFI16 (interferon-inducible protein 16) have been identified as DNA receptors that induce inflammasome formation and interferon production, respectively. Here we present the crystal structures of their HIN domains in complex with double-stranded (ds) DNA. Non-sequence-specific DNA recognition is accomplished through electrostatic attraction between the positively charged HIN domain residues and the dsDNA sugar-phosphate backbone. An intramolecular complex of the AIM2 Pyrin and HIN domains in an autoinhibited state is liberated by DNA binding, which may facilitate the assembly of inflammasomes along the DNA staircase. These findings provide mechanistic insights into dsDNA as the activation trigger and oligomerization platform for the assembly of large innate signaling complexes such as the inflammasomes.	[Jin, Tengchuan; Perry, Andrew; Jiang, Jiansheng; Smith, Patrick; Curry, James A.; Xiao, T. Sam] NIAID, Struct lmmunobiol Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Unterholzner, Leonie; Bowie, Andrew G.] Trinity Coll Dublin, Trin Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Jiang, Zhaozhao; Rathinam, Vijay A.; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Pharmacol, Unit Clin Biochem, D-53127 Bonn, Germany; [Johnstone, Ricky W.] Peter MacCallum Canc Inst, Canc Therapeut Program, Gene Regulat Lab, Melbourne, Vic 3002, Australia; [Johnstone, Ricky W.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3054, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Xiao, TS (corresponding author), NIAID, Struct lmmunobiol Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA.	xiaot@niaid.nih.gov	Hornung, Veit/C-3565-2012; Horvath, Gabor L/J-3917-2014; Latz, Eicke/H-3951-2014; Unterholzner, Leonie/ABG-4199-2020; Jin, Tengchuan/B-5883-2014; Xiao, Tsan Sam/A-8590-2010; Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020; Johnstone, Ricky w/H-3748-2014; Xiao, Tsan/I-7616-2013	Hornung, Veit/0000-0002-4150-194X; Horvath, Gabor L/0000-0003-0309-595X; Latz, Eicke/0000-0003-1488-5666; Unterholzner, Leonie/0000-0001-9824-692X; Jin, Tengchuan/0000-0002-1395-188X; Xiao, Tsan Sam/0000-0001-9688-475X; Rathinam, Vijay/0000-0002-8009-3977; Johnstone, Ricky w/0000-0001-7053-9237; Xiao, Tsan/0000-0001-9688-475X; Jiang, Jiansheng/0000-0003-0964-5481; Fitzgerald, Kate/0000-0003-3175-609X; Bowie, Andrew/0000-0001-5316-4373	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; Science Foundation Ireland [07/IN1/B934]; NIH [AI083713, AI067497]; European Research Council [ERC-2009-StG 243046]; DFG [SFB704, SFB670]; NHMRC; Susan G. Komen Breast Cancer Foundation; Prostate Cancer Foundation of Australia; Cancer Council Victoria; Leukemia Foundation of Australia; Victorian Breast Cancer Research Consortium; Victorian Cancer Agency; NERCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960, R37AI067497, R01AI083713, R01AI093752, R56AI067497, R01AI067497] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Prostate Cancer Foundation of Australia; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia; Victorian Breast Cancer Research Consortium; Victorian Cancer Agency; NERCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the beam line scientists at the Argonne National Laboratory GM/CA-CAT (Argonne, IL) and the Brookhaven National Laboratory (Upton, NY) for their support on data collection. The authors would like to thank A. Mian from LI, NIAID for technical support. We thank R. Schwartz, M. Lenardo, and D. Margulies for helpful discussions. We thank D.E. Anderson at the Mass Spectrometry facility of NIDDK for technical support. T.S.X. is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. A.G.B. and L.U. are supported by Science Foundation Ireland (07/IN1/B934). K.A.F. is supported by NIH grants AI083713 and AI067497. E.L. is supported by NIH grant AI067497. V.H. is supported by the European Research Council (ERC-2009-StG 243046) and the DFG (SFB704 and SFB670). R.W.J. is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and supported by NHMRC Program and Project Grants, the Susan G. Komen Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, Cancer Council Victoria, The Leukemia Foundation of Australia, Victorian Breast Cancer Research Consortium, and Victorian Cancer Agency. V.A.R. is supported by a NERCE Postdoctoral fellowship.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; BAROUDY BM, 1982, NUCLEIC ACIDS RES, V10, P5673, DOI 10.1093/nar/10.18.5673; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choubey D, 2008, FRONT BIOSCI-LANDMRK, V13, P598, DOI 10.2741/2705; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LAKSHMIN.AV, 1970, BIOCHIM BIOPHYS ACTA, V204, P49, DOI 10.1016/0005-2787(70)90489-2; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	64	343	365	4	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 20	2012	36	4					561	571		10.1016/j.immuni.2012.02.014	http://dx.doi.org/10.1016/j.immuni.2012.02.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22483801	Green Accepted, Bronze			2022-12-18	WOS:000303223900009
J	Reya, T; O'Riordan, M; Okamura, R; Devaney, E; Willert, K; Nusse, R; Grosschedl, R				Reya, T; O'Riordan, M; Okamura, R; Devaney, E; Willert, K; Nusse, R; Grosschedl, R			Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism	IMMUNITY			English	Article							TRANSCRIPTION FACTOR LEF-1; MAMMARY EPITHELIAL-CELLS; ALPHA ENHANCER FUNCTION; BETA-CATENIN; TRANSGENIC MICE; CYCLIN D1; C-MYC; COLON-CARCINOMA; DEFICIENT MICE; GENE FAMILY	Lymphocyte enhancer factor-1 (LEF-1) is a member of the LEF-1/TCF family of transcription factors, which have been implicated in Wnt signaling and tumorigenesis. LEF-1 was originally identified in pre-B and T cells, but its function in B lymphocyte development remains unknown. Here we report that LEF-1-deficient mice exhibit defects in pro-B cell proliferation and survival in vitro and in vivo. We further show that Lef1(-/-) pro-B cells display elevated levels of fas and c-myc transcription, providing a potential mechanism for their increased sensitivity to apoptosis. Finally, we establish a link between Wnt signaling and normal B cell development by demonstrating that Wnt proteins are mitogenic for pro-B cells and that this effect is mediated by LEF-1.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Stanford Univ, Dept Dev Biol, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Grosschedl, R (corresponding author), Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany.	rgross@lmb.uni-muenchen.de	O'Riordan, Mary/D-8227-2011	O'Riordan, Mary/0000-0001-6014-4637				Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Ceredig R, 1998, INT IMMUNOL, V10, P49, DOI 10.1093/intimm/10.1.49; DORSHKIND K, 1992, ADV EXP MED BIOL, V323, P119; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FISHER AG, 1995, INT IMMUNOL, V7, P415, DOI 10.1093/intimm/7.3.415; Galceran J, 2000, DEVELOPMENT, V127, P469; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; LeBein TW, 1998, CURR OPIN IMMUNOL, V10, P188, DOI 10.1016/S0952-7915(98)80248-3; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Lin Q, 1998, J IMMUNOL, V160, P4681; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; ONEL KB, 1995, EUR J IMMUNOL, V25, P2940, DOI 10.1002/eji.1830251034; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Reya T, 1998, CURR OPIN IMMUNOL, V10, P158, DOI 10.1016/S0952-7915(98)80244-6; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Sauter ER, 1999, CANCER RES, V59, P4876; Schilham MW, 1998, J IMMUNOL, V161, P3984; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; Shibamoto S, 1998, GENES CELLS, V3, P659; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang JY, 1996, EUR J IMMUNOL, V26, P92, DOI 10.1002/eji.1830260114; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	58	343	368	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2000	13	1					15	24		10.1016/S1074-7613(00)00004-2	http://dx.doi.org/10.1016/S1074-7613(00)00004-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933391	Bronze			2022-12-18	WOS:000088463600003
J	Yoshida, M; Claypool, SM; Wagner, JS; Mizoguchi, E; Mizoguchi, A; Roopenian, DC; Lencer, WI; Blumberg, RS				Yoshida, M; Claypool, SM; Wagner, JS; Mizoguchi, E; Mizoguchi, A; Roopenian, DC; Lencer, WI; Blumberg, RS			Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells	IMMUNITY			English	Article							INTESTINAL EPITHELIAL-CELLS; ALPHA-MUTANT MICE; CLASS-I ANTIGENS; IMMUNOGLOBULIN-G; CHRONIC COLITIS; RAT; EXPRESSION; CATABOLISM; IMMUNITY; GAMMA	Mucosal secretions of the human gastrointestinal, respiratory, and genital tracts contain significant quantities of IgG. The mechanism by which IgG reaches luminal secretions and the function of IgG in these locations are unknown. Here, we find that the human neonatal Fc receptor (FcRn) is the vehicle that transports IgG across the intestinal epithelial barrier into the lumen where the IgG can bind cognate antigen. The FcRn can then recycle the IgG/antigen complex back across the intestinal barrier into the lamina propria for processing by dendritic cells and presentation to CD4(+) T cells in regional organized lymphoid structures. These results explain how IgG is secreted onto mucosal surfaces and scavenges luminal antigens for recognition by the immune system.	Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Ctr Digest Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard University	Blumberg, RS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gastroenterol, 75 Francis St, Boston, MA 02115 USA.	rblumberg@partners.org		Claypool, Steven/0000-0001-5316-1623; Lencer, Wayne/0000-0001-7346-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R01DK044319, R56DK053056, R01DK056597, R01DK051362, R01DK053056] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44319, DK51362, DK56597, DK53056] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; ABRAHAMSON DR, 1979, SCIENCE, V206, P567, DOI 10.1126/science.493961; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; BERRYMAN M, 1995, J CELL SCI, V108, P2347; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; Christianson GJ, 1997, J IMMUNOL, V159, P4781; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Hayday A, 2000, SCIENCE, V290, P97, DOI 10.1126/science.290.5489.97; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Iwasaki A, 1999, AM J PHYSIOL-GASTR L, V276, pG1074, DOI 10.1152/ajpgi.1999.276.5.G1074; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; JONES EA, 1971, GUT, V12, P855; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KRIMPENFORT P, 1987, EMBO J, V6, P1673, DOI 10.1002/j.1460-2075.1987.tb02416.x; Leach JL, 1996, J IMMUNOL, V157, P3317; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; McCarthy KM, 2000, J CELL SCI, V113, P1277; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi E, 1997, LAB INVEST, V76, P385; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Praetor A, 1999, J CELL SCI, V112, P2291; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Robert-Guroff M, 2000, NAT MED, V6, P129, DOI 10.1038/72206; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Sehra S, 2003, J IMMUNOL, V171, P2080, DOI 10.4049/jimmunol.171.4.2080; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Telleman P, 2000, IMMUNOLOGY, V100, P245, DOI 10.1046/j.1365-2567.2000.00034.x; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Watanabe T, 2002, J IMMUNOL, V168, P2188, DOI 10.4049/jimmunol.168.5.2188; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200; Yamori M, 2004, BIOCHEM BIOPH RES CO, V316, P1015, DOI 10.1016/j.bbrc.2004.02.145; Yoshida M, 2002, GASTROENTEROLOGY, V123, P1949, DOI 10.1053/gast.2002.37049; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266; [No title captured]	49	342	383	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					769	783		10.1016/j.immuni.2004.05.007	http://dx.doi.org/10.1016/j.immuni.2004.05.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189741	Bronze			2022-12-18	WOS:000222205300012
J	de Bruijn, MFTR; Ma, XQ; Robin, C; Ottersbach, K; Sanchez, MJ; Dzierzak, E				de Bruijn, MFTR; Ma, XQ; Robin, C; Ottersbach, K; Sanchez, MJ; Dzierzak, E			Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta	IMMUNITY			English	Article							DEFINITIVE HEMATOPOIESIS; YOLK-SAC; MULTIGENE FAMILY; EMBRYO; EXPRESSION; GENE; REGION; SITES; SCA-1; IDENTIFICATION	The emergence of the first adult hematopoietic stem cells (HSCs) during mammalian ontogeny has been under intense investigation. It is as yet unresolved whether these first HSCs are derived from intraembryonic hemangioblasts, hemogenic endothelial cells, or other progenitors. Thus, to examine the spatial generation of functional HSCs within the mouse embryo, we used the well-known HSC marker, Sca-1, and a transgenic approach with an Ly-6A (Sca-1) GFP marker gene. Our results show that this transgene marker is expressed in all functional HSCs in the midgestation aorta. Immunohistology of aorta-gonads-mesonephros (AGM) regions show that GFP1 cells are specifically localized to the endothelial layer lining the wall of the dorsal aorta but not to the mesenchyme, strongly suggesting that HSC activity arises within a few cells within the endothelium of the major vasculature.	Erasmus Univ, Dept Cell Biol & Genet, Rotterdam, Netherlands; Univ Cambridge, Dept Hematol, CIMR Ctr, Cambridge, England	Erasmus University Rotterdam; University of Cambridge	Dzierzak, E (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, Rotterdam, Netherlands.	dzierzak@ch1.fgg.eur.nl	Sanchez, Maria Jose/P-4716-2016	Sanchez, Maria Jose/0000-0003-3464-6224; Ottersbach, Katrin/0000-0002-6880-4895	NIDDK NIH HHS [R01 DK51077] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernex F, 1996, DEVELOPMENT, V122, P3023; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; DZIERZAK E, 2002, METHODS MOL MED HEMA, P1; Garcia-Porrero JA, 1998, DEV COMP IMMUNOL, V22, P303, DOI 10.1016/S0145-305X(98)00006-8; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; KAMIURA S, 1992, GENOMICS, V12, P89, DOI 10.1016/0888-7543(92)90411-K; KHAN KD, 1990, MOL CELL BIOL, V10, P5150, DOI 10.1128/MCB.10.10.5150; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; KIMURA S, 1984, IMMUNOGENETICS, V20, P47, DOI 10.1007/BF00373446; LECLAIR KP, 1986, EMBO J, V5, P3227, DOI 10.1002/j.1460-2075.1986.tb04633.x; Lemischka I R, 1991, Semin Immunol, V3, P349; Ma XQ, 2002, BRIT J HAEMATOL, V116, P401, DOI 10.1046/j.1365-2141.2002.03250.x; Ma XQ, 2001, BRIT J HAEMATOL, V114, P724, DOI 10.1046/j.1365-2141.2001.02986.x; Marshall CJ, 2001, BRIT J HAEMATOL, V112, P838, DOI 10.1046/j.1365-2141.2001.02537.x; MCGREW JT, 1991, J IMMUNOL, V146, P3633; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Miles C, 1997, DEVELOPMENT, V124, P537; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; OKADA S, 1992, BLOOD, V80, P3044; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sinclair A, 1996, BLOOD, V87, P2750, DOI 10.1182/blood.V87.7.2750.bloodjournal8772750; SINCLAIR AM, 1993, BLOOD, V82, P3052; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; STANFORD JA, 1992, AQUAT CONSERV, V2, P35, DOI 10.1002/aqc.3270020104; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tavian M, 1999, DEVELOPMENT, V126, P793; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wood HB, 1997, BLOOD, V90, P2300; Wulf GG, 2001, EXP HEMATOL, V29, P1361, DOI 10.1016/S0301-472X(01)00752-4; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	45	342	347	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					673	683		10.1016/S1074-7613(02)00313-8	http://dx.doi.org/10.1016/S1074-7613(02)00313-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049719	Bronze			2022-12-18	WOS:000175820400006
J	Mrdjen, D; Pavlovic, A; Hartmann, FJ; Schreiner, B; Utz, SG; Leung, BP; Lelios, I; Heppner, FL; Kipnis, J; Merkler, D; Greter, M; Becher, B				Mrdjen, Dunja; Pavlovic, Anto; Hartmann, Felix J.; Schreiner, Bettina; Utz, Sebastian G.; Leung, Brian P.; Lelios, Iva; Heppner, Frank L.; Kipnis, Jonathan; Merkler, Doron; Greter, Melanie; Becher, Burkhard			High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; ALZHEIMERS-DISEASE; DENDRITIC CELLS; MASS CYTOMETRY; CHOROID-PLEXUS; GM-CSF; MULTIPLE-SCLEROSIS; STEM-CELLS; T-CELLS; MICROGLIA	Individual reports suggest that the central nervous system (CNS) contains multiple immune cell types with diverse roles in tissue homeostasis, immune defense, and neurological diseases. It has been challenging to map leukocytes across the entire brain, and in particular in pathology, where phenotypic changes and influx of blood-derived cells prevent a clear distinction between reactive leukocyte populations. Here, we applied high-dimensional single-cell mass and fluorescence cytometry, in parallel with genetic fate mapping systems, to identify, locate, and characterize multiple distinct immune populations within the mammalian CNS. Using this approach, we revealed that microglia, several subsets of border-associated macrophages and dendritic cells coexist in the CNS at steady state and exhibit disease-specific transformations in the immune microenvironment during aging and in models of Alzheimer's disease and multiple sclerosis. Together, these data and the described framework provide a resource for the study of disease mechanisms, potential biomarkers, and therapeutic targets in CNS disease.	[Mrdjen, Dunja; Pavlovic, Anto; Hartmann, Felix J.; Schreiner, Bettina; Utz, Sebastian G.; Leung, Brian P.; Lelios, Iva; Greter, Melanie; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Heppner, Frank L.] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Kipnis, Jonathan] Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA USA; [Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Merkler, Doron] Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland	University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Virginia; University of Geneva; University of Geneva	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Heppner, Frank/ABH-8393-2020; Becher, Burkhard/ABE-4225-2020; Kipnis, Jonathan/AGG-9735-2022; Merkler, Doron/N-9157-2016	Heppner, Frank/0000-0001-9816-8917; Becher, Burkhard/0000-0002-1541-7867; Kipnis, Jonathan/0000-0002-3714-517X; Hartmann, Felix/0000-0002-4174-2276; Greter, Melanie/0000-0002-7220-5369; Merkler, Doron/0000-0002-0247-2007; Mrdjen, Dunja/0000-0001-9269-2806	Swiss national science foundation [PP00P3_144781, 310030_146130, 316030_150768, 310030_170320]; European Union: FP7 ITN_NeuroKine; European Union: FP7 Project ATECT; University Priority Project Translational Cancer Research; National Science Foundation Graduate Research Fellowship Program [DGE1418060]; Forschungskredit - University of Zurich	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); European Union: FP7 ITN_NeuroKine; European Union: FP7 Project ATECT; University Priority Project Translational Cancer Research; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Forschungskredit - University of Zurich	We thank the Mass- and Flow Cytometry Facility (University of Zurich) and the Center for Microscopy and Image Analysis (University of Zurich) for technical assistance; Lucy Robinson of Insight Editing London for critical review and editing of the manuscript; Nathalie Krakoski for discussions about BAMs; Nikolaus Deigendesch for APP/PS1 mouse transfers; Nir Yogev and Andrea Cogurra for discussions about all things meningeal; Will Macnair for comparison of protein and RNA expression; and Sarah Mundt for critical review and editing of the manuscript. This work was supported by grants from the Swiss national science foundation (PP00P3_144781 to M.G., 310030_146130, 316030_150768, 310030_170320 to B.B.), from the European Union: FP7 ITN_NeuroKine (B.B.) and FP7 Project ATECT (B.B.), from the University Priority Project Translational Cancer Research (B.B.), from the National Science Foundation Graduate Research Fellowship Program (DGE1418060) (B.P.L.), and the Forschungskredit awarded by the University of Zurich to D. Mrdjen.	Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Clemente-Casares X, 2017, IMMUNITY, V47, P974, DOI 10.1016/j.immuni.2017.10.011; Codarri L, 2013, TRENDS IMMUNOL, V34, P114, DOI 10.1016/j.it.2012.09.007; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; David Della C., 2012, Frontiers in Genetics, V3, P247, DOI 10.3389/fgene.2012.00247; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Kalaria RN, 1996, MOL BRAIN RES, V35, P58, DOI 10.1016/0169-328X(95)00180-Z; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kotecha N., 2010, CURRENT PROTOCOLS CY; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mrdjen D, 2017, METHODS MOL BIOL, V1559, P321, DOI 10.1007/978-1-4939-6786-5_22; Murphy JB, 1923, J EXP MED, V38, P183, DOI 10.1084/jem.38.2.183; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prokop S, 2015, J EXP MED, V212, P1811, DOI 10.1084/jem.20150479; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schreiner B, 2009, SEMIN IMMUNOPATHOL, V31, P479, DOI 10.1007/s00281-009-0181-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shirai Y, 1921, JAPAN MED WORLD, V1921, P14; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	74	340	343	8	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					380	+		10.1016/j.immuni.2018.01.011	http://dx.doi.org/10.1016/j.immuni.2018.01.011			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29426702	Bronze, Green Accepted			2022-12-18	WOS:000425507800021
J	Plitas, G; Konopacki, C; Wu, KM; Bos, PD; Morrow, M; Putintseva, EV; Chudakov, DM; Rudensky, AY				Plitas, George; Konopacki, Catherine; Wu, Kenmin; Bos, Paula D.; Morrow, Monica; Putintseva, Ekaterina V.; Chudakov, Dmitriy M.; Rudensky, Alexander Y.			Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer	IMMUNITY			English	Article							INNATE IMMUNE CELLS; PROGNOSTIC-SIGNIFICANCE; DEPLETION; IDENTIFICATION; INFILTRATION; INFLAMMATION; RECRUITMENT; PROGRESSION; MIGRATION; ANTIBODY	Regulatory T (Treg) cells reside in lymphoid organs and barrier tissues where they control different types of inflammatory responses. Treg cells are also found in human cancers, and studies in animal models suggest that they contribute to cancer progression. However, properties of human intratumoral Treg cells and those present in corresponding normal tissue remain largely unknown. Here, we analyzed features of Treg cells in untreated human breast carcinomas, normal mammary gland, and peripheral blood. Tumor-resident Treg cells were potently suppressive and their gene-expression pattern resembled that of normal breast tissue, but not of activated peripheral blood Treg cells. Nevertheless, a number of cytokine and chemokine receptor genes, most notably CCR8, were upregulated in tumor-resident Treg cells in comparison to normal tissue-resident ones. Our studies suggest that targeting CCR8 for the depletion of tumor-resident Treg cells might represent a promising immunotherapeutic approach for the treatment of breast cancer.	[Plitas, George; Konopacki, Catherine; Wu, Kenmin; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Plitas, George; Konopacki, Catherine; Wu, Kenmin; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Plitas, George; Wu, Kenmin; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Plitas, George; Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA; [Bos, Paula D.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Chudakov, Dmitriy M.] Cent European Inst Technol, Brno 60177, Czech Republic; [Putintseva, Ekaterina V.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Putintseva, Ekaterina V.; Chudakov, Dmitriy M.] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Chudakov, Dmitriy M.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Virginia Commonwealth University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.	rudenska@mskcc.org	Chudakov, Dmitriy M/G-7741-2014	Chudakov, Dmitriy M/0000-0003-0430-790X	MSKCC Flow Cytometry Core, Tissue Procurement Service and Integrated Genomics Operation at MSKCC, NIH [R37 AI034206]; Cancer Center Support Grant [P30 CA008748]; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Russian Science Foundation [14-14-00533]; Breast Cancer Alliance Young Investigator Grant; Hutham S. Olayan Graduate Fellowship; NATIONAL CANCER INSTITUTE [U54CA209975, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	MSKCC Flow Cytometry Core, Tissue Procurement Service and Integrated Genomics Operation at MSKCC, NIH; Cancer Center Support Grant; Hilton-Ludwig Cancer Prevention Initiative - Conrad N. Hilton Foundation; Ludwig Cancer Research; Russian Science Foundation(Russian Science Foundation (RSF)); Breast Cancer Alliance Young Investigator Grant; Hutham S. Olayan Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Rachel Fromme and Emily Zabor for technical assistance and the specimen donors at MSKCC and the TCGA. The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This study was supported by MSKCC Flow Cytometry Core, Tissue Procurement Service and Integrated Genomics Operation at MSKCC, NIH grants R37 AI034206 (A.Y.R.), Cancer Center Support Grant P30 CA008748, the Hilton-Ludwig Cancer Prevention Initiative funded by the Conrad N. Hilton Foundation and Ludwig Cancer Research, and Russian Science Foundation project 14-14-00533 (D.M.C.). G.P. is the recipient of a Breast Cancer Alliance Young Investigator Grant. C.K. was a recipient of a Hutham S. Olayan Graduate Fellowship. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2015, J IMMUNOL, V195, P2507, DOI 10.4049/jimmunol.1500801; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Demir L, 2013, CLIN EXP METASTAS, V30, P1047, DOI 10.1007/s10585-013-9602-9; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Harner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015714; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim S, 2014, J BREAST CANCER, V17, P8, DOI 10.4048/jbc.2014.17.1.8; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu SZ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0432-8; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Roos RS, 1997, J BIOL CHEM, V272, P17251, DOI 10.1074/jbc.272.28.17251; Roychoudhuri R., 2015, CURR OPIN IMMUNOL, V33, P101; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Ueda R, 2015, ONCOLOGY-BASEL, V89, P16, DOI 10.1159/000431059; Xie Q, 2015, PROTEIN CELL, V6, P117, DOI 10.1007/s13238-014-0109-1	41	340	351	4	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1122	1134		10.1016/j.immuni.2016.10.032	http://dx.doi.org/10.1016/j.immuni.2016.10.032			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851913	Bronze, Green Accepted			2022-12-18	WOS:000389473500021
J	van de Laar, L; Saelens, W; De Prijck, S; Martens, L; Scott, CL; Van Isterdael, G; Hoffmann, E; Beyaert, R; Saeys, Y; Lambrecht, BN; Guilliams, M				van de laar, Lianne; Saelens, Wouter; De Prijck, Sofie; Martens, Liesbet; Scott, Charlotte L.; Van Isterdael, Gert; Hoffmann, Eik; Beyaert, Rudi; Saeys, Yvan; Lambrecht, Bart N.; Guilliams, Martin			Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages	IMMUNITY			English	Article							CYTOKINE GM-CSF; DENDRITIC CELLS; CARDIAC MACROPHAGES; STIMULATING FACTOR; STEADY-STATE; DIFFERENTIATION; PATHWAYS; RECEPTOR; REVEALS; ORIGINS	Tissue-resident macrophages can derive from yolk sac macrophages (YS-Macs), fetal liver monocytes (FL-MOs), or adult bone-marrow monocytes (BM-MOs). The relative capacity of these precursors to colonize a niche, self-maintain, and perform tissue-specific functions is unknown. We simultaneously transferred traceable YS-Macs, FL-MOs, and BM-MOs into the empty alveolar macrophage (AM) niche of neonatal Csf2rb(-/-) mice. All subsets produced AMs, but in competition preferential outgrowth of FL-MOs was observed, correlating with their superior granulocyte macrophage-colony stimulating factor (GM-CSF) reactivity and proliferation capacity. When transferred separately, however, all precursors efficiently colonized the alveolar niche and generated AMs that were transcriptionally almost identical, self-maintained, and durably prevented alveolar proteinosis. Mature liver, peritoneal, or colon macrophages could not efficiently colonize the empty AM niche, whereas mature AMs could. Thus, precursor origin does not affect the development of functional self-maintaining tissue-resident macrophages and the plasticity of the mononuclear phagocyte system is largest at the precursor stage.	[van de laar, Lianne; De Prijck, Sofie; Scott, Charlotte L.; Van Isterdael, Gert; Lambrecht, Bart N.; Guilliams, Martin] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [van de laar, Lianne; Saelens, Wouter; Martens, Liesbet; Van Isterdael, Gert; Saeys, Yvan; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Saelens, Wouter; Martens, Liesbet; Saeys, Yvan] VIB Inflammat Res Ctr, Data Min & Modeling Syst Immunol, B-9052 Ghent, Belgium; [De Prijck, Sofie; Scott, Charlotte L.; Hoffmann, Eik; Beyaert, Rudi; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Hoffmann, Eik; Beyaert, Rudi] VIB Inflammat Res Ctr, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium; [Lambrecht, Bart N.] Erasmus Univ, Pulm Med, Med Ctr, NL-3015 CE Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Erasmus University Rotterdam; Erasmus MC	Guilliams, M (corresponding author), VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	martin.guilliams@ugent.be	Beyaert, Rudi/B-2589-2009; Lambrecht, Bart N/K-2484-2014; Hoffmann, Eik/Y-2297-2019; Saelens, Wouter/I-6197-2019; Saeys, Yvan/C-1311-2009; Guilliams, Martin/N-7803-2013; Hoffmann, Eik/T-5428-2018; Scott, Charlotte/K-3563-2014	Lambrecht, Bart N/0000-0003-4376-6834; Hoffmann, Eik/0000-0003-4224-1091; Saelens, Wouter/0000-0002-7114-6248; Saeys, Yvan/0000-0002-0415-1506; Guilliams, Martin/0000-0003-3525-7570; Hoffmann, Eik/0000-0003-4224-1091; Martens, Liesbet/0000-0001-9180-7456; Scott, Charlotte/0000-0003-4914-6580; Van Isterdael, Gert/0000-0001-6626-1316; Beyaert, Rudi/0000-0002-5704-582X	EMBO; Marie Curie Intra-European Fellowship; Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; Marie Curie Reintegration grant; Odysseus grant; FWO grants of the Flemish Government	EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship(European Commission); Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University; Marie Curie Reintegration grant(European Commission); Odysseus grant; FWO grants of the Flemish Government(FWO)	The authors thank Manon Vanheerswynghels, Justine Van Moorleghem, Karl Vergote, other technicians of the B.N.L. lab, and Ellen Sanders (VIB-UGhent) for technical assistance, and Andrew Croxford and Burkhard Becher (University of Zurich) for help in setting up the pSTAT5 staining protocols. L.v.d.L. is supported by an EMBO long-term fellowship and a Marie Curie Intra-European Fellowship. W.S. is supported by a Bijzonder Onderzoeksfonds (BOF) Grant from Ghent University. M.G. is supported by a Marie Curie Reintegration grant, an Odysseus grant, and several FWO grants of the Flemish Government.	Bain CC, 2012, IMMUNOBIOLOGY, V217, P643, DOI 10.1016/j.imbio.2011.11.004; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Lambrecht B, 2014, J EXP MED, V211, P2136, DOI 10.1084/jem.21111insight1; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2014, IMMUNOL REV, V262, P9, DOI 10.1111/imr.12220; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tanaka T, 2011, J MED GENET, V48, P205, DOI 10.1136/jmg.2010.082586; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	36	340	342	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					755	768		10.1016/j.immuni.2016.02.017	http://dx.doi.org/10.1016/j.immuni.2016.02.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	26992565	Bronze			2022-12-18	WOS:000374444300009
J	Kallies, A; Xin, A; Belz, GT; Nutt, SL				Kallies, Axel; Xin, Annie; Belz, Gabrielle T.; Nutt, Stephen L.			Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8(+) T Cells and Memory Responses	IMMUNITY			English	Article							TERMINAL DIFFERENTIATION; LYMPHOCYTE DIVISION; REPRESSOR BLIMP-1; B-CELLS; EXPRESSION; INFLUENZA; BET; EOMESODERMIN; HOMEOSTASIS; ACTIVATION	In response to viral infection, naive CD8(+) T cells proliferate and differentiate into cytotoxic and cytokine-producing effector cells. Here we showed that the transcription factor Blimp-1, a crucial regulator of plasma cell differentiation, was required for CD8(+) T cells to differentiate into functional killer T cells in response to influenza virus. Blimp-1 was not essential for the generation of memory T cells but was crucial for their efficient recall response upon reinfection. Antigen-specific Blimp-1-deficient CD8(+) T cells failed to appropriately regulate the transcriptional program essential for killer T cell responses and showed impaired migration to the site of infection. This study identifies Blimp-1 as a master regulator of the terminal differentiation of CD8(+) effector T cells and uncovers a conservation of the pathways that regulate the terminal differentiation of T and B cells.	[Kallies, Axel; Xin, Annie; Belz, Gabrielle T.; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Xin, Annie] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au; nutt@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Belz, Gabrielle T/C-9350-2013	Nutt, Stephen L/0000-0002-0020-6637; Belz, Gabrielle T/0000-0002-9660-9587; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia (NHMRC); Leukemia & Lymphoma Society; Wellcome Trust Foundation; Howard Hughes Medical Institute; Viertel Foundation; Pfizer Australia Research Fellowship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Wellcome Trust Foundation(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Viertel Foundation; Pfizer Australia Research Fellowship(PfizerPfizer Australia)	We are grateful to N. Bernard, M. Camilleri, K. Elder, F. Masson, D. Tarlinton, and E. Cretney for technical assistance and discussions. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), the Leukemia & Lymphoma Society (A.K.), the Wellcome Trust Foundation, the Howard Hughes Medical Institute, the Viertel Foundation (G.T.B.), and the Pfizer Australia Research Fellowship (S.L.N.).	Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Santner-Nanan B, 2006, SIGNAL TRANSDUCT, V6, P268, DOI 10.1002/sita.200500062; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	44	340	350	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 21	2009	31	2					283	295		10.1016/j.immuni.2009.06.021	http://dx.doi.org/10.1016/j.immuni.2009.06.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19664942	Bronze			2022-12-18	WOS:000269338600014
J	CYSTER, JG; GOODNOW, CC				CYSTER, JG; GOODNOW, CC			PROTEIN-TYROSINE-PHOSPHATASE 1C NEGATIVELY REGULATES ANTIGEN RECEPTOR SIGNALING IN B-LYMPHOCYTES AND DETERMINES THRESHOLDS FOR NEGATIVE SELECTION	IMMUNITY			English	Article							HEMATOPOIETIC-CELL PHOSPHATASE; BONE-MARROW CELLS; MOTHEATEN ME ME; MOTH-EATEN MICE; CD8+ T-CELLS; VIABLE MOTHEATEN; TRANSGENIC MICE; DEFECTIVE LYMPHOPOIESIS; IMMUNOLOGICAL-TOLERANCE; IMMUNODEFICIENT MUTANT	Motheaten viable (me(v)) mice are deficient in the cytosolic protein tyrosine phosphatase, PTP1C, and exhibit severe B cell immunodeficiency and autoantibody production. The role of PTP1C in a cell selection and function was analyzed by breeding immunoglobulin transgenes specific for a defined antigen, hen egg lysozyme, into me(v) mice. Antigen triggered a greater and more rapid elevation of intracellular calcium in PTP1C-deficient B cells, indicating that this phosphatase negatively regulates immunoglobulin signaling. Elimination of self-reactive B cells carrying this signal-enhancing mutation was triggered during their development by binding a lower valency form of self-antigen than is normally required. These findings establish that activation of distinct repertoire-censoring mechanisms depends on quantitative differences in antigen receptor signaling, whose thresholds are determined by negative regulation through PTP1C.	STANFORD UNIV,SCH MED,BECKMAN CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	CYSTER, JG (corresponding author), STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305, USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BELL SE, 1994, EMBO J, V13, P816, DOI 10.1002/j.1460-2075.1994.tb06324.x; BRINK R, 1992, J EXP MED, V176, P91; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CHEN SZ, 1990, BIOTECHNIQUES, V8, P32; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DAVIDSON WF, 1979, J IMMUNOL, V122, P884; DINTZIS RZ, 1983, J IMMUNOL, V131, P2196; Dresser D W, 1968, Adv Immunol, V8, P129, DOI 10.1016/S0065-2776(08)60466-6; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOLD MR, 1994, ADV IMMUNOL, V55, P221; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; GREINER DL, 1986, J EXP MED, V164, P1129, DOI 10.1084/jem.164.4.1129; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAYASHI SI, 1988, J IMMUNOL, V140, P2139; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOWARD JG, 1975, PROG ALLERGY, V18, P43; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; June C H, 1990, Methods Cell Biol, V33, P37; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KATSURI KN, 1990, J IMMUNOL, V145, P2304; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KINOSHITA T, 1990, INT IMMUNOL, V2, P651, DOI 10.1093/intimm/2.7.651; KLAUS GGB, 1976, BRIT MED BULL, V32, P141, DOI 10.1093/oxfordjournals.bmb.a071346; KOO GC, 1993, J IMMUNOL, V151, P6733; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MCCOY KL, 1982, J IMMUNOL, V128, P1797; MCCOY KL, 1983, AM J PATHOL, V112, P18; MEDLOCK ES, 1987, J IMMUNOL, V138, P3590; METCALF ES, 1979, IMMUNOL REV, V43, P143; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; PAINTER CJ, 1908, J EXP MED, V167, P1137; PEI DH, 1993, P NATL ACAD SCI USA, V90, P1092, DOI 10.1073/pnas.90.3.1092; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; SIDMAN CL, 1978, J IMMUNOL, V121, P2392; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; SIDMAN CL, 1978, J IMMUNOL, V121, P2399; STRIEBICH CC, 1990, J IMMUNOL, V144, P1857; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VANZANT G, 1989, EXP HEMATOL, V17, P81; Weigle W O, 1973, Adv Immunol, V16, P61, DOI 10.1016/S0065-2776(08)60296-5; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	67	340	349	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					13	24		10.1016/1074-7613(95)90075-6	http://dx.doi.org/10.1016/1074-7613(95)90075-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600299	Bronze			2022-12-18	WOS:A1995QC59300002
J	Mangalmurti, N; Hunter, CA				Mangalmurti, Nilam; Hunter, Christopher A.			Cytokine Storms: Understanding COVID-19	IMMUNITY			English	Editorial Material							MACROPHAGE ACTIVATION SYNDROME	The elevated circulating levels of cytokines associated with a variety of infectious and immune-mediated conditions are frequently termed a cytokine storm. Here, we explain the protective functions of cytokines in "ideal" responses; the multi-factorial origins that can drive these responses to become pathological; and how this ultimately leads to vascular damage, immunopathology, and worsening clinical outcomes.	[Hunter, Christopher A.] Univ Penn, Sch Vet Med, 380 South Univ Ave, Philadelphia, PA 19104 USA; [Mangalmurti, Nilam] Univ Penn, Perelman Sch Med, Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, 380 South Univ Ave, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu						Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Al-Samkari H, 2018, ANNU REV PATHOL-MECH, V13, P27, DOI 10.1146/annurev-pathol-020117-043625; Ayres JS, 2020, CELL, V181, P250, DOI 10.1016/j.cell.2020.03.036; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Manjili RH, 2020, J IMMUNOL, V205, P12, DOI 10.4049/jimmunol.2000413; Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359; Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550; Shakoory B, 2016, CRIT CARE MED, V44, P275, DOI 10.1097/CCM.0000000000001402; Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004	15	339	350	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					19	25		10.1016/j.immuni.2020.06.017	http://dx.doi.org/10.1016/j.immuni.2020.06.017			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32610079	Green Published, Bronze			2022-12-18	WOS:000551116800007
J	Guo, CS; Xie, SJ; Chi, ZX; Zhang, JH; Liu, YY; Zhang, L; Zheng, MZ; Zhang, X; Xia, DJ; Ke, YH; Lu, LR; Wang, D				Guo, Chuansheng; Xie, Shujun; Chi, Zhexu; Zhang, Jinhua; Liu, Yangyang; Zhang, Li; Zheng, Mingzhu; Zhang, Xue; Xia, Dajing; Ke, Yuehai; Lu, Linrong; Wang, Di			Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome	IMMUNITY			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; HUMAN MACROPHAGES; CYCLIC-AMP; ACTIVATION; RECEPTOR; TGR5; MECHANISM; DISEASE; DEUBIQUITINATION	Reciprocal interactions between the metabolic system and immune cells play pivotal roles in diverse inflammatory diseases, but the underlying mechanisms remain elusive. The activation of bile acidmediated signaling has been linked to improvement in metabolic syndromes and enhanced control of inflammation. Here, we demonstrated that bile acids inhibited NLRP3 inflammasome activation via the TGR5-cAMP-PKA axis. TGR5 bile acid receptorinduced PKA kinase activation led to the ubiquitination of NLRP3, which was associated with the PKA-induced phosphorylation of NLRP3 on a single residue, Ser 291. Furthermore, this PKA-induced phosphorylation of NLRP3 served as a critical brake on NLRP3 inflammasome activation. In addition, in vivo results indicated that bile acids and TGR5 activation blocked NLRP3 inflammasome-dependent inflammation, including lipopolysaccharideinduced systemic inflammation, alum-induced peritoneal inflammation, and type-2 diabetes-related inflammation. Altogether, our study unveils the PKA-induced phosphorylation and ubiquitination of NLRP3 and suggests TGR5 as a potential target for the treatment of NLRP3 inflammasome-related diseases.	[Guo, Chuansheng; Xie, Shujun; Chi, Zhexu; Liu, Yangyang; Zhang, Li; Zheng, Mingzhu; Lu, Linrong; Wang, Di] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Chuansheng; Chi, Zhexu; Liu, Yangyang; Zhang, Li; Zheng, Mingzhu; Zhang, Xue; Ke, Yuehai; Lu, Linrong; Wang, Di] Zhejiang Univ, Sch Med, Program Mol & Cellular Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xue; Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Xie, Shujun; Xia, Dajing] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Jinhua] Zhejiang Prov Peoples Hosp, Dept Neurol, Hangzhou 310014, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Provincial People's Hospital	Wang, D (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, D (corresponding author), Zhejiang Univ, Sch Med, Program Mol & Cellular Biol, Hangzhou 310058, Zhejiang, Peoples R China.	diwang@zju.edu.cn	Zheng, Mingzhu/AAF-6010-2019; Xie, Shujun/HGU-6058-2022; Zheng, Mingzhu/AAC-7818-2022	Xie, Shujun/0000-0002-1582-9175; Zheng, Mingzhu/0000-0002-9399-9225; Lu, Linrong/0000-0002-0171-4115	National Key Research and Development Program of China [2016YFC1100204]; National Nature Science Foundation of China (NSFC) [31270017, 31522020, 31670926]; Zhejiang Provincial Natural Science Foundation of China (ZJNSF) [LR14H100001]; Fundamental Research Funds for the Central Universities [2015XZZX004-31]	National Key Research and Development Program of China; National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China (ZJNSF)(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Dr. Rongbin Zhou (University of Science and Technology of China) for providing plasmids of NLRP3 truncation mutants and his helpful discussion, Dr. Yongqun Zhu (Zhejiang University) for providing Salmonella, Dr. Zhong Chen (Zhejiang University) for support on animal studies, Drs. Hongbo Luo (Harvard Medical School), Hu Hu (Zhejiang University), and Zongping Xia (Zhejiang University) for their helpful discussion, Dr. Lain Bruce for his linguistic advices, and Jingjie PTM BioLab Co. Ltd. (Hangzhou, China) for the mass spectrometry analysis. This work was supported by National Key Research and Development Program of China (2016YFC1100204), National Nature Science Foundation of China (NSFC) (31270017, 31522020, 31670926), Zhejiang Provincial Natural Science Foundation of China (ZJNSF) (LR14H100001), and Fundamental Research Funds for the Central Universities (2015XZZX004-31).	Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Haselow K, 2013, J LEUKOCYTE BIOL, V94, P1253, DOI 10.1189/jlb.0812396; Hov JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012403; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Pellicciari R, 2009, J MED CHEM, V52, P7958, DOI 10.1021/jm901390p; Perino A, 2015, TRENDS PHARMACOL SCI, V36, P847, DOI 10.1016/j.tips.2015.08.002; Perino A, 2014, J CLIN INVEST, V124, P5424, DOI 10.1172/JCI76289; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	50	339	359	16	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					802	816		10.1016/j.immuni.2016.09.008	http://dx.doi.org/10.1016/j.immuni.2016.09.008			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27692610	Bronze			2022-12-18	WOS:000389473200013
J	Libby, P; Pober, JS				Libby, P; Pober, JS			Chronic rejection	IMMUNITY			English	Review							CORONARY-ARTERY DISEASE; CARDIAC ALLOGRAFT VASCULOPATHY; SERIAL INTRAVASCULAR ULTRASOUND; HEART-TRANSPLANT RECIPIENTS; VASCULAR ENDOTHELIAL-CELLS; GRAFT RECIPIENTS; T-CELLS; ARTERIOSCLEROSIS; ACTIVATION; COMPLEMENT		Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Yale Univ, Sch Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06520 USA	Harvard University; Brigham & Women's Hospital; Yale University	Libby, P (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.		Libby, Peter/AAY-6404-2021; Lemström, Karl B/J-8885-2016	Libby, Peter/0000-0002-1502-502X; Lemström, Karl B/0000-0001-6920-4093				Auchincloss Hugh Jr., 1993, P1099; Biedermann BC, 1999, J IMMUNOL, V162, P7022; Biedermann BC, 1998, J IMMUNOL, V161, P4679; Bigaud M, 1999, TRANSPLANTATION, V68, P1701, DOI 10.1097/00007890-199912150-00013; BILLINGHAM ME, 1994, CLIN TRANSPLANT, V8, P289; Black C A, 1999, Dermatol Online J, V5, P7; Cecka JM, 1999, CLIN TRANSPL, V13, P1; Cecka M, 1998, SURG CLIN N AM, V78, P133, DOI 10.1016/S0039-6109(05)70639-3; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Cosio FG, 1999, TRANSPLANTATION, V67, P690, DOI 10.1097/00007890-199903150-00008; Davis SF, 1996, CIRCULATION, V93, P457, DOI 10.1161/01.CIR.93.3.457; Denton M D, 2000, Pediatr Transplant, V4, P252, DOI 10.1034/j.1399-3046.2000.00031.x; EPLER GR, 1983, CHEST, V83, P161, DOI 10.1378/chest.83.2.161; Fredrich R, 1999, TRANSPLANTATION, V67, P385, DOI 10.1097/00007890-199902150-00008; Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Hornick PI, 2000, CIRCULATION, V101, P2405, DOI 10.1161/01.CIR.101.20.2405; Hosenpud JD, 1997, TRANSPLANTATION, V63, P1602, DOI 10.1097/00007890-199706150-00011; HRUBAN RH, 1990, AM J PATHOL, V137, P871; Julius BK, 2000, TRANSPLANTATION, V69, P847; Kapadia SR, 1999, CURR OPIN CARDIOL, V14, P140, DOI 10.1097/00001573-199903000-00011; KARMANN K, 1994, J IMMUNOL, V153, P3929; KATZNELSON S, 1995, KIDNEY INT S, V52, P112; Kaufmann Stefan H. E., 1993, P1251; KECK BM, 1999, CLIN TRANSPL, V13, P35; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Lakkis FG, 2000, NAT MED, V6, P686, DOI 10.1038/76267; Le Moine A, 1999, J CLIN INVEST, V103, P1659, DOI 10.1172/JCI5504; Lim TT, 1997, CIRCULATION, V95, P855; Lowry Robin P., 1996, P487; LYSON T, 1993, CIRC RES, V73, P596, DOI 10.1161/01.RES.73.3.596; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meehan SM, 1997, LAB INVEST, V76, P639; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Pethig K, 1998, AM HEART J, V135, P628, DOI 10.1016/S0002-8703(98)70278-9; Pober JS, 1996, TRANSPLANTATION, V61, P343, DOI 10.1097/00007890-199602150-00001; ROSE ML, 1994, TRANSPLANT REV, V8, P37; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; SALOMON RN, 1991, AM J PATHOL, V138, P791; SCHROEDER JS, 1993, NEW ENGL J MED, V328, P164, DOI 10.1056/NEJM199301213280303; Schwarzacher SP, 2000, CIRCULATION, V101, P1384, DOI 10.1161/01.CIR.101.12.1384; SHI CW, 1994, CIRC RES, V75, P199, DOI 10.1161/01.RES.75.2.199; Shi CW, 1996, P NATL ACAD SCI USA, V93, P4051, DOI 10.1073/pnas.93.9.4051; Shimizu K, 2000, J IMMUNOL, V165, P3506, DOI 10.4049/jimmunol.165.6.3506; SHIRWIN H, 1995, TRANSPLANTATION, V68, P715; Sirak J, 1997, TRANSPLANTATION, V63, P1300, DOI 10.1097/00007890-199705150-00018; SMITH CM, 1999, CLIN TRANSPLANT, V13, P23; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; TANAKA H, 1994, ARTERIOSCLER THROMB, V14, P734, DOI 10.1161/01.ATV.14.5.734; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; TUZCU EM, 1995, CIRCULATION, V91, P1706, DOI 10.1161/01.CIR.91.6.1706; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Wenke K, 1997, CIRCULATION, V96, P1398, DOI 10.1161/01.CIR.96.5.1398; WERSNER RH, 1999, LIVER TRANSPLANT SUR, V5, P388	60	339	355	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					387	397		10.1016/S1074-7613(01)00119-4	http://dx.doi.org/10.1016/S1074-7613(01)00119-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336684	Bronze			2022-12-18	WOS:000168246700006
J	Morel, S; Levy, F; Burlet-Schiltz, O; Brasseur, F; Probst-Kepper, M; Peitrequin, AL; Monsarrat, B; Van Velthoven, R; Cerottini, JC; Boon, T; Gairin, JE; Van den Eynde, BJ				Morel, S; Levy, F; Burlet-Schiltz, O; Brasseur, F; Probst-Kepper, M; Peitrequin, AL; Monsarrat, B; Van Velthoven, R; Cerottini, JC; Boon, T; Gairin, JE; Van den Eynde, BJ			Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOLYTIC T-LYMPHOCYTES; TUMOR-NECROSIS-FACTOR; CLASS-II REGION; INTERFERON-GAMMA; HUMAN-MELANOMA; IN-VIVO; MALIGNANT-MELANOMA; TISSUE EXPRESSION; HUMAN MHC	By stimulating human lymphocytes with an autologous renal carcinoma, we obtained CTL recognizing an antigen derived from a novel, ubiquitous protein. The CTL failed to lyse autologous EBV-transformed B cells, even though the latter express the protein. This is due to the presence in these cells of immunoproteasomes, which, unlike standard proteasomes, cannot produce the antigenic peptide. We show that dendritic cells also carry immunoproteasomes and fail to present this antigen. This may explain why the relevant CTL escape thymic deletion and are not regularly activated in the periphery. Lack of cleavage by the immunoproteasome was also observed for melanoma differentiation antigen Melan-A(26-35)/HLA-A2, currently used for antitumoral vaccination. For immunization with such antigens, proteins should be less suitable than peptides, which do not require proteasome digestion in dendritic cells.	Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; Inst Jules Bordet, Dept Urol, B-1000 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut Jules Bordet	Van den Eynde, BJ (corresponding author), Univ Catholique Louvain, Ludwig Inst Canc Res, Brussels Branch, Ave Hippocrate 74,UCL 7459, B-1200 Brussels, Belgium.			Schiltz, Odile/0000-0002-3606-2356				Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; Ayyoub M, 1998, RAPID COMMUN MASS SP, V12, P557, DOI 10.1002/(SICI)1097-0231(19980515)12:9<557::AID-RCM199>3.3.CO;2-4; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BOON T, 1980, J EXP MED, V152, P1184, DOI 10.1084/jem.152.5.1184; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; DePlaen E, 1997, METHODS, V12, P125, DOI 10.1006/meth.1997.0462; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; Frisan T, 1998, J IMMUNOL, V160, P3281; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Gaugler B, 1996, IMMUNOGENETICS, V44, P323, DOI 10.1007/s002510050133; GAZDAR AF, 1986, CANCER RES, V46, P6011; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Gueguen M, 1998, J IMMUNOL, V160, P6188; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Jager E, 1996, INT J CANCER, V67, P54, DOI 10.1002/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; KOWALZICK L, 1990, DERMATOLOGICA, V181, P298, DOI 10.1159/000247830; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MEYSKENS FL, 1990, J NATL CANCER I, V82, P1071, DOI 10.1093/jnci/82.12.1071-a; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Stohwasser R, 1997, EUR J IMMUNOL, V27, P1182, DOI 10.1002/eji.1830270520; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; Tanaka K, 1998, IMMUNOL REV, V163, P161; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; Valmori D, 1999, J EXP MED, V189, P895, DOI 10.1084/jem.189.6.895; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; YOSHIDA A, 1994, BIOCHEM BIOPH RES CO, V198, P857, DOI 10.1006/bbrc.1994.1122; ZANELLI E, 1993, IMMUNOGENETICS, V38, P400, DOI 10.1007/BF00184520	50	339	368	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					107	117		10.1016/S1074-7613(00)80163-6	http://dx.doi.org/10.1016/S1074-7613(00)80163-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661410	Bronze			2022-12-18	WOS:000085011900011
J	De Simone, M; Arrigoni, A; Rossetti, G; Gruarin, P; Ranzani, V; Politano, C; Bonnal, RJP; Provasi, E; Sarnicola, ML; Panzeri, I; Moro, M; Crosti, M; Mazzara, S; Vaira, V; Bosari, S; Palleschi, A; Santambrogio, L; Bovo, G; Zucchini, N; Totis, M; Gianotti, L; Cesana, G; Perego, RA; Maroni, N; Ceretti, AP; Opocher, E; De Francesco, R; Geginat, J; Stunnenberg, HG; Abrignani, S; Pagani, M				De Simone, Marco; Arrigoni, Alberto; Rossetti, Grazisa; Gruarin, Paola; Ranzani, Valeria; Politano, Claudia; Bonnal, Raoul J. P.; Provasi, Elena; Sarnicola, Maria Lucia; Panzeri, Ilaria; Moro, Monica; Crosti, Mariacristina; Mazzara, Saveria; Vaira, Valentina; Bosari, Silvano; Palleschi, Alessandro; Santambrogio, Luigi; Bovo, Giorgio; Zucchini, Nicola; Totis, Mauro; Gianotti, Luca; Cesana, Giancarlo; Perego, Roberto A.; Maroni, Nirvana; Ceretti, Andrea Pisani; Opocher, Enrico; De Francesco, Raffaele; Geginat, Jens; Stunnenberg, Hendrik G.; Abrignani, Sergio; Pagani, Massimiliano			Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells	IMMUNITY			English	Article							IMMUNE CHECKPOINTS; ANTITUMOR-ACTIVITY; TREG CELLS; CANCER; BLOCKADE; EFFECTOR; CCL18; DIFFERENTIATION; METASTASIS; MECHANISMS	Tumor-infiltrating regulatory T lymphocytes (Treg) can suppress effector T cells specific for tumor antigens. Deepermolecular definitions of tumor-infiltrating-lymphocytes could thus offer therapeutic opportunities. Transcriptomes of T helper 1 (Th1), Th17, and Treg cells infiltrating colorectal or non-small-cell lung cancers were compared to transcriptomes of the same subsets from normal tissues and validated at the single-cell level. We found that tumor-infiltrating Treg cells were highly suppressive, upregulated several immune-checkpoints, and expressed on the cell surfaces specific signature molecules such as interleukin-1 receptor 2 (IL1R2), programmed death (PD)-1 Ligand1, PD-1 Ligand2, and CCR8 chemokine, which were not previously described on Treg cells. Remarkably, high expression in whole-tumor samples of Treg cell signature genes, such as LAYN, MAGEH1, or CCR8, correlated with poor prognosis. Our findings provide insights into the molecular identity and functions of human tumor-infiltrating Treg cells and define potential targets for tumor immunotherapy.	[De Simone, Marco; Arrigoni, Alberto; Rossetti, Grazisa; Gruarin, Paola; Ranzani, Valeria; Politano, Claudia; Bonnal, Raoul J. P.; Provasi, Elena; Sarnicola, Maria Lucia; Panzeri, Ilaria; Moro, Monica; Crosti, Mariacristina; Mazzara, Saveria; Vaira, Valentina; De Francesco, Raffaele; Geginat, Jens; Abrignani, Sergio; Pagani, Massimiliano] Ist Nazl Genet Mol INGM Romeo & Enrica Invernizzi, I-20122 Milan, Italy; [Vaira, Valentina; Bosari, Silvano] IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, I-20122 Milan, Italy; [Palleschi, Alessandro; Santambrogio, Luigi] IRCCS Ca Granda Osped Maggiore Policlin, Div Thorac Surg, I-20122 Milan, Italy; [Vaira, Valentina; Bosari, Silvano; Santambrogio, Luigi] Univ Milan, Dept Pathophysiol & Organ Transplantat, I-20122 Milan, Italy; [Bovo, Giorgio; Zucchini, Nicola] San Gerardo Hosp, Dept Pathol, I-20900 Monza, Italy; [Totis, Mauro; Gianotti, Luca] San Gerardo Hosp, Dept Surg, I-20900 Monza, Italy; [Gianotti, Luca; Cesana, Giancarlo; Perego, Roberto A.] Milano Bicocca Univ, Sch Med & Surg, I-20900 Monza, Italy; [Maroni, Nirvana; Ceretti, Andrea Pisani; Opocher, Enrico] Osped San Paolo, UO Chirurg Epatobiliopancreat & Digest, I-20142 Milan, Italy; [Opocher, Enrico] Univ Milan, Dept Hlth Sci, I-20122 Milan, Italy; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Nijmegen, Netherlands; [Abrignani, Sergio] Univ Milan, Dept Clin Sci & Community Hlth, I-20122 Milan, Italy; [Pagani, Massimiliano] Univ Milan, Dept Med Biotechnol & Translat Med, I-20129 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; San Gerardo Hospital; San Gerardo Hospital; University of Milano-Bicocca; San Paolo-Polo Universitaria Hospital; University of Milan; Radboud University Nijmegen; University of Milan; University of Milan	Abrignani, S; Pagani, M (corresponding author), Ist Nazl Genet Mol INGM Romeo & Enrica Invernizzi, I-20122 Milan, Italy.; Abrignani, S (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, I-20122 Milan, Italy.; Pagani, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, I-20129 Milan, Italy.	abrignani@ingm.org; pagani@ingm.org	Santambrogio, Luigi/O-7335-2017; Ranzani, Valeria/AAB-8258-2019; Geginat, Jens/AAA-5818-2019; OPOCHER, ENRICO/H-9222-2012; Palleschi, Alessandro/J-6416-2015; rossetti, grazisa/C-3722-2015; De Francesco, Raffaele/J-6003-2012; Zucchini, Nicola/A-6916-2017; Vaira, Valentina/K-6499-2016; Bosari, Silvano/K-7744-2016	Santambrogio, Luigi/0000-0002-6192-8190; Geginat, Jens/0000-0003-4813-0384; OPOCHER, ENRICO/0000-0001-5668-3136; Palleschi, Alessandro/0000-0003-4510-5167; Abrignani, Sergio/0000-0002-0794-3285; rossetti, grazisa/0000-0001-6361-311X; De Francesco, Raffaele/0000-0001-8754-5123; Zucchini, Nicola/0000-0003-4997-2807; Pagani, Massimiliano/0000-0002-7017-9304; mazzara, saveria/0000-0003-1799-2360; Vaira, Valentina/0000-0003-4416-6216; Bonnal, Raoul/0000-0002-2123-6536; Bosari, Silvano/0000-0002-9744-6951; Panzeri, Ilaria/0000-0002-4139-8591	Italian Minister of Health [GR2011-02351626]; AIRC [IG2015-ID17448, IG2013-ID14596]; Italian Minister of University and Research Grant [CTN01_00177_817708]; ERC Advanced Grant [269022]; Flagship CNR-MIUR grant "EPIGEN," CARIPLO [2013-0955]; ERC Consolidator Grant [617978]; Fondazione Romeo ed Enrica Invernizzi; Research Grant "DNA on Disk" [CTN01_00177_817708]	Italian Minister of Health; AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Minister of University and Research Grant; ERC Advanced Grant(European Research Council (ERC)); Flagship CNR-MIUR grant "EPIGEN," CARIPLO; ERC Consolidator Grant(European Research Council (ERC)); Fondazione Romeo ed Enrica Invernizzi; Research Grant "DNA on Disk"	We would like to thank S. Biffo and P. Della Bona (San Raffaele Scientific Institute, Milan, Italy) for discussions and critical revision of the manuscript. This study was supported by: the Italian Minister of Health GR2011-02351626 to V.V.; AIRC grant no IG2015-ID17448 to J.G.; the Italian Minister of University and Research Grant CTN01_00177_817708 "DNA on Disk" to S.B.; the ERC Advanced Grant no 269022 to S.A.; the Flagship CNR-MIUR grant "EPIGEN," CARIPLO grant no 2013-0955, AIRC grant no IG2013-ID14596 and ERC Consolidator Grant no 617978 to M.P.; and by an unrestricted grant of the "Fondazione Romeo ed Enrica Invernizzi."	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Borowsky ML, 1998, J CELL BIOL, V143, P429, DOI 10.1083/jcb.143.2.429; Boussiotis VA, 2014, CANCER J, V20, P265, DOI 10.1097/PPO.0000000000000059; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gonzalez-Pons M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/149014; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Jacobs J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/158038; Jamal-Hanjani M, 2013, CURR OPIN PHARMACOL, V13, P497, DOI 10.1016/j.coph.2013.04.006; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kroemer G, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1058597; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lesterhuis WJ, 2011, MOL IMMUNOL, V49, P1, DOI 10.1016/j.molimm.2011.09.014; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Messal N, 2011, MOL IMMUNOL, V48, P2214, DOI 10.1016/j.molimm.2011.06.436; Munn DH, 2016, CURR OPIN IMMUNOL, V39, P1, DOI 10.1016/j.coi.2015.10.009; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Schoenbrunn A, 2012, J IMMUNOL, V189, P5985, DOI 10.4049/jimmunol.1201090; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sledzinska A, 2015, MOL ONCOL, V9, P1936, DOI 10.1016/j.molonc.2015.10.008; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; Voo KS, 2013, J IMMUNOL, V191, P3641, DOI 10.4049/jimmunol.1202752; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wirth H, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-18; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Yang JC, 2007, J IMMUNOTHER, V30, P825, DOI 10.1097/CJI.0b013e318156e47e; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	55	338	344	6	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1135	1147		10.1016/j.immuni.2016.10.021	http://dx.doi.org/10.1016/j.immuni.2016.10.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851914	Green Published, hybrid			2022-12-18	WOS:000389473500022
J	Lynch, L; Nowak, M; Varghese, B; Clark, J; Hogan, AE; Toxavidis, V; Balk, SP; O'Shea, D; O'Farrelly, C; Exley, MA				Lynch, Lydia; Nowak, Michael; Varghese, Bindu; Clark, Justice; Hogan, Andrew E.; Toxavidis, Vasillis; Balk, Steven P.; O'Shea, Donal; O'Farrelly, Cliona; Exley, Mark A.			Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production	IMMUNITY			English	Article							KILLER T-CELLS; INNATE IMMUNE-RESPONSE; INSULIN-RESISTANCE; MACROPHAGE POLARIZATION; ENDOPLASMIC-RETICULUM; GLUCOSE-INTOLERANCE; HUMAN-DISEASE; INKT CELLS; INFLAMMATION; ACTIVATION	Invariant natural killer T (iNKT) cells are evolutionarily conserved innate T cells that influence inflammatory responses. We have shown that iNKT cells, previously thought to be rare in humans, were highly enriched in human and murine adipose tissue, and that as adipose tissue expanded in obesity, iNKT cells were depleted, correlating with proinflammatory macrophage infiltration. iNKT cell numbers were restored in mice and humans after weight loss. Mice lacking iNKT cells had enhanced weight gain, larger adipocytes, fatty livers, and insulin resistance on a high-fat diet. Adoptive transfer of iNKT cells into obese mice or in vivo activation of iNKT cells via their lipid ligand, alpha-galactocylceramide, decreased body fat, triglyceride levels, leptin, and fatty liver and improved insulin sensitivity through anti-inflammatory cytokine production by adipose-derived iNKT cells. This finding highlights the potential of iNKT cell-targeted therapies, previously proven to be safe in humans, in the management of obesity and its consequences.	[Lynch, Lydia; Nowak, Michael; Varghese, Bindu; Clark, Justice; Toxavidis, Vasillis; Balk, Steven P.; Exley, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Lynch, Lydia; Hogan, Andrew E.] St Vincents Univ Hosp, Educ Res Ctr, Dublin 4, Ireland; [O'Shea, Donal] St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland; [O'Shea, Donal] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Hlth Sci, Dublin 2, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Trinity College Dublin; Trinity College Dublin	Lynch, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.	llynch1@bidmc.harvard.edu	Lynch, Lydia/ABD-5598-2021; Hogan, Andrew/K-1521-2013	Exley, Mark/0000-0002-5088-1032; O'Farrelly, Cliona/0000-0002-0616-2874; O'Shea, Donal/0000-0002-1408-5274; Hogan, Andrew/0000-0001-5875-230X; Lynch, Lydia/0000-0002-4273-4681	NIH [R21 CA143748, R01 DK066917, U19 AI066313]; US DOD [W81XWH-09-1-0156]; UNESCO L'Oreal; European Commission; Science Foundation Ireland; Health Research Board, Ireland; NATIONAL CANCER INSTITUTE [R21CA170194, R21CA143748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOD(United States Department of Defense); UNESCO L'Oreal; European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Ireland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to B. Kahn, O. Peroni, and the Metabolic Physiology Core, Boston for assistance with DEXA imaging and adipocyte measurement. We thank G. Hotamisligil of the Harvard School of Public Health and U. von Andrian of the Harvard Medical School for fruitful discussions, and M. Brenner for kind assistance and discussion of this manuscript. We gratefully acknowledge F. Scheuplein and S. Jordan for mouse care. We also thank the Beth Israel Deaconess Medical Center (BIDMC) Flow Cytometry Core, especially J. Tigges, and the BIDMC Histology Core, especially S. White and L.H. Ang. This study was supported by NIH R21 CA143748, NIH R01 DK066917, U19 AI066313 (M.A.E.), US DOD W81XWH-09-1-0156 (S.P.B.), the UNESCO L'Oreal Fellowship (L.L.), the European Commission Marie Curie Fellowship (L.L.), Science Foundation Ireland (C.O'F.), and the Health Research Board, Ireland (L.L., A.E.H., D.O.S.). S.P.B. and M.A.E. have consulting relationships with NKT Therapeutics. The other authors have no conflicting financial interests.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Exley MA, 2003, IMMUNOLOGY, V110, P519, DOI 10.1111/j.1365-2567.2003.01779.x; Exley MA, 2011, CLIN IMMUNOL, V140, P184, DOI 10.1016/j.clim.2011.04.017; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nowak M, 2010, EUR J IMMUNOL, V40, P682, DOI 10.1002/eji.200939897; O'Connell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009997; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Swann JB, 2007, CURR TOP MICROBIOL, V314, P293; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	55	338	346	4	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					574	587		10.1016/j.immuni.2012.06.016	http://dx.doi.org/10.1016/j.immuni.2012.06.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22981538	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000309199000020
J	Riley, JL; June, CH; Blazar, BR				Riley, James L.; June, Carl H.; Blazar, Bruce R.			Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning	IMMUNITY			English	Review							VERSUS-HOST-DISEASE; IN-VITRO; SUPPRESSIVE FUNCTION; CD28 SUPERAGONISTS; SELF-TOLERANCE; EXPANSION; INDUCTION; CTLA-4; VIVO; LINEAGE	Immune system regulation is of paramount importance to host survival. In settings of autoimmunity and alloimmunity, control is lost, resulting in injury to vital organs and tissues. Naturally occurring, thymic-derived T regulatory (Treg) cells that express CD4, CD25, and the forkhead box protein 3 (FoxP3) are potent suppressors of these adverse immune responses. Preclinical studies have shown that either freshly isolated or ex vivo expanded Treg cells can prevent both local and systemic organ and tissue destruction. Although promising, human Treg cell infusion therapy has heretofore been difficult to implement in the clinic, and relatively few clinical trials have been initiated. This review will focus on the preclinical models that provide the rationale for current trials and it will address both the challenges and opportunities in human Treg cell therapy.	[Riley, James L.; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Riley, James L.; June, Carl H.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Blazar, Bruce R.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Div Bone Marrow Transplantat, Dept Pediat, Minneapolis, MN 55455 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities	Riley, JL (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	rileyj@exchange.upenn.edu; blaza001@umn.edu		Riley, James/0000-0002-1057-576X; June, Carl/0000-0003-0241-3557	Becton and Dickinson Company [R01CA105216, R01AI057838, R37HL56067, P01CA670493]; Leukemia and Lymphoma Society [6220]; NATIONAL CANCER INSTITUTE [P01CA065493, R01CA105216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, R01AI057838] Funding Source: NIH RePORTER	Becton and Dickinson Company; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Carroll and K. Hippen for careful proofreading and helpful suggestions and members of the JDRF Collaborative Centers for Cell Therapy and the JDRF Center on Cord Blood Therapies for Type 1 Diabetes for insightful discussions. Work in our laboratories was supported by JDRF, a sponsored research grant from Becton and Dickinson & Company, R01CA105216, R01AI057838, R37HL56067, P01CA670493, and a translational grant (# 6220) from the Leukemia and Lymphoma Society. The authors declare a potential conflict of interest in the content of the manuscript because of the prior receipt of licensing fees and research support from BD Biosciences.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ansari AA, 2007, J AUTOIMMUN, V28, P152, DOI 10.1016/j.jaut.2007.02.014; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Christen U, 2004, CURR OPIN IMMUNOL, V16, P759, DOI 10.1016/j.coi.2004.09.002; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Davies JD, 1999, J IMMUNOL, V163, P5353; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; ERAN E, 2009, GASTROENTER IN PRESS; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gajewski TF, 2007, IMMUNITY, V27, P185, DOI 10.1016/j.immuni.2007.08.001; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Haanstra KG, 2006, TRANSPLANTATION, V82, P1194, DOI 10.1097/01.tp.0000235910.47214.67; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hanash AM, 2005, BLOOD, V105, P1828, DOI 10.1182/blood-2004-08-3213; Hippen KL, 2008, BLOOD, V112, P2847, DOI 10.1182/blood-2008-01-132951; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jarvinen LZ, 2003, TRANSPLANTATION, V76, P1375, DOI 10.1097/01.TP.0000093462.16309.73; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; June CH, 2006, SEMIN IMMUNOL, V18, P78, DOI 10.1016/j.smim.2006.01.006; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI200213605; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Li XM, 2007, J RHEUMATOL, V34, P2438; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mekala DJ, 2005, BLOOD, V105, P2090, DOI 10.1182/blood-2004-09-3579; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Nemunaitis J, 2006, CANCER GENE THER, V13, P555, DOI 10.1038/sj.cgt.7700922; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Radhakrishnan S, 2008, J IMMUNOL, V181, P3137, DOI 10.4049/jimmunol.181.5.3137; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; ROSENBERG AS, 1992, ANNU REV IMMUNOL, V10, P333, DOI 10.1146/annurev.immunol.10.1.333; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sanchez-Fueyo A, 2002, J IMMUNOL, V168, P2274, DOI 10.4049/jimmunol.168.5.2274; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Schraven B, 2008, IMMUNITY, V28, P591, DOI 10.1016/j.immuni.2008.04.003; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor PA, 2001, J EXP MED, V193, P1311, DOI 10.1084/jem.193.11.1311; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	100	338	375	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					656	665		10.1016/j.immuni.2009.04.006	http://dx.doi.org/10.1016/j.immuni.2009.04.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464988	Bronze, Green Accepted			2022-12-18	WOS:000266356900006
J	Mocsai, A; Zhou, MJ; Meng, FY; Tybulewicz, VL; Lowell, CA				Mocsai, A; Zhou, MJ; Meng, FY; Tybulewicz, VL; Lowell, CA			Syk is required for integrin signaling in neutrophils	IMMUNITY			English	Article							SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASE; ADHERENT HUMAN NEUTROPHILS; B-CELL DEVELOPMENT; INDUCED DEGRANULATION; MICE; ACTIVATION; ADHESION; ALPHA(IIB)BETA(3); MACROPHAGES	The Syk tyrosine kinase plays a critical role in the signaling machinery of various receptors of the adaptive immune system. Here we show that Syk is also an essential component of integrin signaling in neutrophils. syk(-/-) neutrophils failed to undergo respiratory burst, degranulation, or spreading in response to proinflammatory stimuli while adherent to immobilized integrin ligands or when stimulated by direct crosslinking of integrins. Signaling from the beta(1), beta(2), or beta(3) integrins was defective in syk(-/-) cells. Syk colocalized with CD18 during cell spreading and initiated downstream signaling events leading to actin polymerization. Surprisingly, these defects in integrin-mediated activation did not impair the integrin-dependent in vitro or in vivo migration of syk(-/-) neutrophils or of cells deficient in Src-family kinases. Thus, integrins use different signaling mechanisms to support migration and adherent activation.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Natl Inst Med Res, London, England	University of California System; University of California San Francisco; MRC National Institute for Medical Research	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.		Mocsai, Attila/B-2792-2008	Mocsai, Attila/0000-0002-0512-1157; Tybulewicz, Victor/0000-0003-2439-0798	NHLBI NIH HHS [HL-54476] Funding Source: Medline; NIDDK NIH HHS [DK-58066] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058066] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Colucci F, 2000, J IMMUNOL, V164, P5140, DOI 10.4049/jimmunol.164.10.5140; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Costello PS, 1996, ONCOGENE, V13, P2595; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Detmers PA, 1998, J IMMUNOL, V161, P1921; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Fernandez R, 1998, J IMMUNOL, V160, P5154; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; LIN TH, 1995, J BIOL CHEM, V270, P16189, DOI 10.1074/jbc.270.27.16189; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Miura K, 2001, CLIN EXP ALLERGY, V31, P1732, DOI 10.1046/j.1365-2222.2001.01236.x; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 1997, BIOCHEM PHARMACOL, V54, P781, DOI 10.1016/S0006-2952(97)00245-1; Mocsai A, 1999, J IMMUNOL, V162, P1120; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; OBERGFELL A, 2002, IN PRESS J CELL BIOL; Pereira S, 2001, J IMMUNOL, V166, P4115, DOI 10.4049/jimmunol.166.6.4115; PYSZNIAK AM, 1994, J IMMUNOL, V152, P5241; RICHTER J, 1990, P NATL ACAD SCI USA, V87, P9472, DOI 10.1073/pnas.87.23.9472; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Tsujimura T, 2001, FEBS LETT, V489, P129, DOI 10.1016/S0014-5793(01)02097-X; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; WILSON RW, 1993, J IMMUNOL, V151, P1571; Yan SR, 1997, J IMMUNOL, V158, P1902	42	338	359	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2002	16	4					547	558		10.1016/S1074-7613(02)00303-5	http://dx.doi.org/10.1016/S1074-7613(02)00303-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970878	Bronze			2022-12-18	WOS:000175109600006
J	Bachmann, MF; McKallFaienza, K; Schmits, R; Bouchard, D; Beach, J; Speiser, DE; Mak, TW; Ohashi, PS				Bachmann, MF; McKallFaienza, K; Schmits, R; Bouchard, D; Beach, J; Speiser, DE; Mak, TW; Ohashi, PS			Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation	IMMUNITY			English	Article							TOLERANCE INDUCTION; IMMUNE-SYSTEM; RECEPTOR; ANTIGEN; MICE; RESPONSES; VIRUS; CTLA4IG; INVIVO; REQUIREMENTS	Efficient T cell activation requires the engagement of a variety of ligand/receptor molecules in addition to T cell receptor (TCR)-major histocompatibility complex (MHC)/peptide interactions. The leukocyte function antigen 1 (LFA-1) and the CD28 glycoprotein have both been implicated in T cell activation. The present study dissects the roles of LFA-1 and CD28 in the activation of naive virus-specific CD8(+) T cells. We demonstrate that LFA-1 facilitates T cell activation by lowering the amounts of antigen necessary for T cell activation. In the absence of LFA-1, 100-fold more antigen was required for T cell-antigen-presenting cell (APC) conjugation and all subsequent events of T cell activation, including TCR down-regulation, Ca2+-flux, T cell proliferation, and lytic effector cell induction. Thus, LFA-1 facilitates the functional triggering of TCRs by promoting adhesion of T cells to APCs but does not affect T cell activation otherwise. In contrast, CD28 played an entirely different role during T cell activation. CD28 reduced the number of TCRs that had to be triggered for T cell activation and allowed activation of T cells by low affinity ligands. CD28 but not LFA-1 prevented induction of T cell unresponsiveness after stimulation of TCRs. These results demonstrate that LFA-1 and CD28 exhibit distinct, nonoverlapping ways to influence T cell activation and suggest that the terms costimulation and signal 2 should be revisited.	ONTARIO CANC INST,DEPT IMMUNOL,TORONTO,ON M5G 2M9,CANADA; AMGEN INST,TORONTO,ON M5G 2C1,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bachmann, MF (corresponding author), ONTARIO CANC INST,DEPT MED BIOPHYS,610 UNIV AVE,TORONTO,ON M5G 2M9,CANADA.		Speiser, Daniel E./F-2173-2013	Ohashi, Pamela S./0000-0003-2915-9317				Bachmann M.F., 1997, IMMUNOLOGY METHODS M, P1921; Bachmann MF, 1997, J VIROL, V71, P5764, DOI 10.1128/JVI.71.8.5764-5768.1997; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2017, DOI 10.1002/eji.1830260908; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Buckley CD, 1997, EUR J IMMUNOL, V27, P957, DOI 10.1002/eji.1830270423; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; DAVIGNON D, 1981, J IMMUNOL, V127, P590; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DeBenedette MA, 1997, J IMMUNOL, V158, P551; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; MEUER SC, 1984, P NATL ACAD SCI-BIOL, V81, P1509, DOI 10.1073/pnas.81.5.1509; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; PIRCHER H, 1993, EUR J IMMUNOL, V23, P669, DOI 10.1002/eji.1830230315; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SEVENTER GAV, 1990, J IMMUNOL, V144, P4579; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	43	338	364	2	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					549	557		10.1016/S1074-7613(00)80376-3	http://dx.doi.org/10.1016/S1074-7613(00)80376-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354475	Bronze			2022-12-18	WOS:A1997YD59300011
J	Schietinger, A; Philip, M; Krisnawan, VE; Chiu, EY; Delrow, JJ; Basom, RS; Lauer, P; Brockstedt, DG; Knoblaugh, SE; Hammerling, GJ; Schell, TD; Garbi, N; Greenberg, PD				Schietinger, Andrea; Philip, Mary; Krisnawan, Varintra E.; Chiu, Edison Y.; Delrow, Jeffrey J.; Basom, Ryan S.; Lauer, Peter; Brockstedt, Dirk G.; Knoblaugh, Sue E.; Haemmerling, Guenter J.; Schell, Todd D.; Garbi, Natalio; Greenberg, Philip D.			Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; CANCER-IMMUNOTHERAPY; HUMAN-MELANOMA; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY; EFFECTOR FUNCTION; TRANSGENIC MICE; EXHAUSTION; BLOCKADE; PD-1	CD8(+) T cells recognizing tumor-specific antigens are detected in cancer patients but are dysfunctional. Here we developed a tamoxifen-inducible liver cancer mouse model with a defined oncogenic driver antigen (SV40 large T-antigen) to follow the activation and differentiation of naive tumor-specific CD8(+) T (TST) cells after tumor initiation. Early during the pre-malignant phase of tumorigenesis, TST cells became dysfunctional, exhibiting phenotypic, functional, and transcriptional features similar to dysfunctional T cells isolated from late-stage human tumors. Thus, T cell dysfunction seen in advanced human cancers may already be established early during tumorigenesis. Although the TST cell dysfunctional state was initially therapeutically reversible, it ultimately evolved into a fixed state. Persistent antigen exposure rather than factors associated with the tumor microenvironment drove dysfunction. Moreover, the TST cell differentiation and dysfunction program exhibited features distinct from T cell exhaustion in chronic infections. Strategies to overcome this antigen-driven, cell-intrinsic dysfunction may be required to improve cancer immunotherapy.	[Schietinger, Andrea; Philip, Mary; Krisnawan, Varintra E.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Schietinger, Andrea; Krisnawan, Varintra E.; Chiu, Edison Y.; Greenberg, Philip D.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Schietinger, Andrea; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98109 USA; [Philip, Mary] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Delrow, Jeffrey J.; Basom, Ryan S.] Fred Hutchinson Canc Res Ctr, Genom & Bioinformat Shared Resources, Seattle, WA 98109 USA; [Lauer, Peter; Brockstedt, Dirk G.] Aduro BioTech Inc, Berkeley, CA 94710 USA; [Knoblaugh, Sue E.] Fred Hutchinson Canc Res Ctr, Comparat Med Shared Resource, Seattle, WA 98109 USA; [Haemmerling, Guenter J.; Garbi, Natalio] DKFZ, Div Cellular, D-69120 Heidelberg, Germany; [Haemmerling, Guenter J.; Garbi, Natalio] DKFZ, Div Mol Immunol, D-69120 Heidelberg, Germany; [Schell, Todd D.] Penn State Hershey Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Garbi, Natalio] Univ Bonn, Inst Mol Med, D-53127 Bonn, Germany; [Garbi, Natalio] Univ Bonn, Inst Expt Immunol, D-53127 Bonn, Germany; [Schietinger, Andrea; Philip, Mary] Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave,Box 512, New York, NY 10065 USA; [Knoblaugh, Sue E.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Bonn; University of Bonn; Memorial Sloan Kettering Cancer Center; University System of Ohio; Ohio State University	Schietinger, A (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.; Schietinger, A; Greenberg, PD (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98109 USA.; Schietinger, A; Greenberg, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, Seattle, WA 98109 USA.; Schietinger, A (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave,Box 512, New York, NY 10065 USA.	schietia@mskcc.org; pgreen@uw.edu	Schell, Todd/AAC-7261-2021	Lander, Varintra/0000-0001-8299-7104; Schell, Todd/0000-0002-6788-6518	Irvington Institute Fellowship Program of the Cancer Research Institute; NIH/NCI grant [K99/R00 CA172371]; V Foundation for Cancer Research; Josie Robertson Young Investigators Program; MSK Cancer Center Support Grant/Core Grant [P30 CA008748, R01 CA033084, R21 AI107776]; Korean Research Institute of Bioscience and Biotechnology [FND 7008-08]; NIH grant [P30 CA015704-39, K08CA158069]; NATIONAL CANCER INSTITUTE [P30CA015704, R00CA172371, K99CA172371, K08CA158069, R01CA033084, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107776] Funding Source: NIH RePORTER	Irvington Institute Fellowship Program of the Cancer Research Institute; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Josie Robertson Young Investigators Program; MSK Cancer Center Support Grant/Core Grant; Korean Research Institute of Bioscience and Biotechnology; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Tan, S. Funk, and I. Roberts for technical support, C. Chou and the other members of the Greenberg lab and the Program of Immunology (FHCRC) for helpful discussions, M. Black from the UW Flow Cytometry Core lab, J. Cao from the Immune Monitoring, C. Bennett from the Genomics Shared Resource (FHCRC), the MSKCC Flow Cytometry Core facility; and Bill Hanson from Aduro BioTech for technical help with the construction of the Listeria strains. This work was supported by the Irvington Institute Fellowship Program of the Cancer Research Institute (to A.S.), NIH/NCI grant K99/R00 CA172371 (to A.S.), the V Foundation for Cancer Research (to A.S.), the Josie Robertson Young Investigators Program (to A. S.), the MSK Cancer Center Support Grant/Core Grant P30 CA008748; R01 CA033084, R21 AI107776 (to P.D.G.), grant FND 7008-08 from the Korean Research Institute of Bioscience and Biotechnology (to P.D.G.), NIH grant P30 CA015704-39 (J.J.D. and R.S.B.), and NIH grant K08CA158069 (to M.P.). N.G. is a member of the DFG Cluster of Excellence Immunosensation.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Comerford SA, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.27; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; CULLEN JM, 1993, VET PATHOL, V30, P111, DOI 10.1177/030098589303000203; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Giordano M, 2015, EMBO J, V34, P2042, DOI 10.15252/embj.201490786; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; HELLSTROM I, 1968, NATURE, V220, P1352, DOI 10.1038/2201352a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kubuschok B, 2006, CLIN CANCER RES, V12, P1365, DOI 10.1158/1078-0432.CCR-05-1672; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Perez-Gracia JL, 2014, CURR OPIN IMMUNOL, V27, P89, DOI 10.1016/j.coi.2014.01.002; Mittrucker HW, 2001, J IMMUNOL, V167, P5620, DOI 10.4049/jimmunol.167.10.5620; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostrand-Rosenberg S, 2014, J IMMUNOL, V193, P3835, DOI 10.4049/jimmunol.1401572; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Philip M, 2010, IMMUNOLOGY, V130, P494, DOI 10.1111/j.1365-2567.2010.03258.x; Popovic J, 2011, BLOOD, V118, P946, DOI 10.1182/blood-2010-12-325035; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Savage PA, 2013, TRENDS IMMUNOL, V34, P33, DOI 10.1016/j.it.2012.08.005; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stahl S, 2009, IMMUNOL LETT, V123, P31, DOI 10.1016/j.imlet.2009.01.011; Staveley-O'Carroll K, 2003, J IMMUNOL, V171, P697, DOI 10.4049/jimmunol.171.2.697; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Wolchok JD, 2014, NATURE, V515, P496, DOI 10.1038/515496a; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	57	336	344	5	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					389	401		10.1016/j.immuni.2016.07.011	http://dx.doi.org/10.1016/j.immuni.2016.07.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27521269	Green Accepted, Bronze			2022-12-18	WOS:000382267300019
J	Oh, JZ; Ravindran, R; Chassaing, B; Carvalho, FA; Maddur, MS; Bower, M; Hakimpour, P; Gill, KP; Nakaya, HI; Yarovinsky, F; Sartor, RB; Gewirtz, AT; Pulendran, B				Oh, Jason Z.; Ravindran, Rajesh; Chassaing, Benoit; Carvalho, Frederic A.; Maddur, Mohan S.; Bower, Maureen; Hakimpour, Paul; Gill, Kiran P.; Nakaya, Helder I.; Yarovinsky, Felix; Sartor, R. Balfour; Gewirtz, Andrew T.; Pulendran, Bali			TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody Responses to Seasonal Influenza Vaccination	IMMUNITY			English	Article							BACTERIAL FLAGELLIN; SYSTEMS BIOLOGY; CELL RESPONSES; T-CELLS; RECOGNITION; DIFFERENTIATION; EXPRESSION; ADJUVANT; IMMUNITY; VIRUS	Systems biological analysis of immunity to the trivalent inactivated influenza vaccine (TIV) in humans revealed a correlation between early expression of TLR5 and the magnitude of the antibody response. Vaccination of Trl5(-/-) mice resulted in reduced antibody titers and lower frequencies of plasma cells, demonstrating a role for TLR5 in immunity to TIV. This was due to a failure to sense host microbiota. Thus, antibody responses in germ-free or antibiotic-treated mice were impaired, but restored by oral reconstitution with a flagellated, but not aflagellated, strain of E. coli. TLR5-mediated sensing of flagellin promoted plasma cell differentiation directly and by stimulating lymph node macrophages to produce plasma cell growth factors. Finally, TLR5-mediated sensing of the microbiota also impacted antibody responses to the inactivated polio vaccine, but not to adjuvanted vaccines or the live-attenuated yellow fever vaccine. These results reveal an unappreciated role for gut microbiota in promoting immunity to vaccination.	[Oh, Jason Z.; Ravindran, Rajesh; Maddur, Mohan S.; Gill, Kiran P.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Oh, Jason Z.; Ravindran, Rajesh; Maddur, Mohan S.; Hakimpour, Paul; Gill, Kiran P.; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30329 USA; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA; [Chassaing, Benoit; Carvalho, Frederic A.; Gewirtz, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30302 USA; [Carvalho, Frederic A.] Univ Auvergne, INSERM U1107, F-63001 Clermont Ferrand 1, France; [Bower, Maureen; Sartor, R. Balfour] Univ N Carolina, Natl Gnotobiot Rodent Resource Ctr, Chapel Hill, NC 27514 USA; [Nakaya, Helder I.] Univ Sao Paulo, Inst Pharmaceut Sci, Dept Clin & Toxicol Analyses, BR-05508000 Sao Paulo, Brazil; [Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75235 USA	Emory University; Emory University; Emory University; University System of Georgia; Georgia State University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of North Carolina; University of North Carolina Chapel Hill; Universidade de Sao Paulo; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@emory.edu	Carvalho, Frédéric/K-2204-2015; Nakaya, Helder/AAF-1738-2020; Maddur, Mohan/E-4763-2015; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010; Chassaing, Benoit/R-3819-2017	Carvalho, Frédéric/0000-0003-1592-2369; Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Hakimata, Paul/0000-0002-2526-6003; Chassaing, Benoit/0000-0002-4285-769X; Oh, Jason/0000-0001-5302-5971; Pulendran, Bali/0000-0001-6517-4333; Yarovinsky, Felix/0000-0001-5825-8002	NIH [HHSN272201400004C, U19AI090023, U54AI057157, R37AI48638, R37DK057665, U19AI057266, AI100663-02, DK099071, DK083890, AI085263, P40 OD010995, P30 DK34987]; Bill and Melinda Gates Foundation; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund; Influenza Pathogenesis and Immunology Research Center - CEIRS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048638, R01AI085263, R37AI048638, U19AI057266, U54AI057157, UM1AI100663, R56AI085263, U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R01DK083890, R01DK099071, R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, P40OD010995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Influenza Pathogenesis and Immunology Research Center - CEIRS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Darfeuille-Michaud for providing LF82 strains; R. L. Toennisson and M. Bower for technical assistance with gnotobiotic studies; and B. Cervasi for macrophage and B cell sorting. This work was supported by NIH grants HHSN272201400004C, U19AI090023, U54AI057157, R37AI48638, R37DK057665, U19AI057266, and AI100663-02 (to B. P.) and a grant from the Bill and Melinda Gates Foundation (to B. P.). Additional support was provided by grants from the NIH (DK099071 and DK083890) (A. T. G.), Research Fellowship award from the Crohn's and Colitis Foundation of America (B. C.), NIH (AI085263) and the Burroughs Wellcome Fund (F. Y.), NIH (P40 OD010995, P30 DK34987) and Crohn's and Colitis Foundation of America (R. B. S., NGRRC), and Research Fellowship award from the Influenza Pathogenesis and Immunology Research Center - CEIRS (J.Z.O.).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Letran SE, 2011, J IMMUNOL, V186, P5406, DOI 10.4049/jimmunol.1003576; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sirard JC, 2009, BBA-GENE REGUL MECH, V1789, P386, DOI 10.1016/j.bbagrm.2009.03.001; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721	36	336	346	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					478	492		10.1016/j.immuni.2014.08.009	http://dx.doi.org/10.1016/j.immuni.2014.08.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25220212	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000342626500017
J	Lin, L; Hron, JD; Peng, SL				Lin, L; Hron, JD; Peng, SL			Regulation of NF-kappa B, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a	IMMUNITY			English	Article							CELL-SURVIVAL; AUTOIMMUNITY; LYMPHOCYTES; EXPRESSION; P27(KIP1); MICE; BET; BIM; DIFFERENTIATION; IDENTIFICATION	Forkhead (Fox) transcription factors play key roles in immunoregulation. Members of the Foxo subfamily have been implicated in the regulation of the cell cycle and/or apoptosis, but their specific immunological contexts remain largely undefined. We demonstrate here that Foxo3a, the predominant Foxo member expressed in peripheral lymphoid organs, plays a critical role in lymphoid homeostasis. Foxo3a deficiency leads to spontaneous lymphoproliferation, associated with inflammation of several organs, in the absence of overt apoptotic defects. These findings correlated with the presence of hyperactivated helper T cells, which proliferated more vigorously and produced more Th1 and Th2 cytokines than their wild-type counterparts. Foxo3a inhibits NF-kappaB activation, whose overactivity was responsible for T cell hyperactivity in Foxo3a-deficient mice. Thus, Foxo3a regulates helper T cell activation and tolerance by inhibiting NF-kappaB activity, reinforcing a generalized role for the forkhead proteins in the maintenance of T cell tolerance through the inhibition of inflammatory transcriptional activities.	Washington Univ, Sch Med, Div Rheumatol, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Peng, SL (corresponding author), Washington Univ, Sch Med, Div Rheumatol, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	speng@wustl.edu	Peng, Stanford/S-6723-2019		NIAID NIH HHS [AI061478, AI057471I, AI01803] Funding Source: Medline; NIDDK NIH HHS [DK52574] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061478, K08AI001803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Coffer PJ, 2003, TRENDS IMMUNOL, V24, P470, DOI 10.1016/S1471-4906(03)00205-9; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gerth AJ, 2003, INT IMMUNOL, V15, P937, DOI 10.1093/intimm/dxg093; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Khaled AR, 1998, CLIN IMMUNOL IMMUNOP, V86, P170, DOI 10.1006/clin.1997.4486; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Onishi M, 1996, EXP HEMATOL, V24, P324; Peng SL, 2004, CLIN IMMUNOL, V110, P112, DOI 10.1016/j.clim.2003.10.008; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	43	336	354	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					203	213		10.1016/j.immuni.2004.06.016	http://dx.doi.org/10.1016/j.immuni.2004.06.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308101	Bronze			2022-12-18	WOS:000223441900009
J	Schildberg, FA; Klein, SR; Freeman, GJ; Sharpe, AH				Schildberg, Frank A.; Klein, Sarah R.; Freeman, Gordon J.; Sharpe, Arlene H.			Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family	IMMUNITY			English	Review							T-CELL-ACTIVATION; REGULATES PD-1 EXPRESSION; EMBRYONIC STEM-CELLS; CUTTING EDGE; CTLA-4 GENE; B7 FAMILY; PROGRAMMED DEATH-1; COSTIMULATORY MOLECULE; CLINICAL-SIGNIFICANCE; B7-H4 EXPRESSION	Immune responses need to be controlled for optimal protective immunity and tolerance. Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate immune homeostasis and defense and protect tissue integrity. These coinhibitory signals limit the strength and duration of immune responses, thereby curbing immune-mediated tissue damage, regulating resolution of inflammation, and maintaining tolerance to prevent autoimmunity. Tumors and microbes that cause chronic infections can exploit these coinhibitory pathways to establish an immunosuppressive microenvironment, hindering their eradication. Advances in understanding T cell coinhibitory pathways have stimulated a new era of immunotherapy with effective drugs to treat cancer, autoimmune and infectious diseases, and transplant rejection. In this review we discuss the current knowledge of the mechanisms underlying the coinhibitory functions of pathways in the B7-CD28 family, the diverse functional consequences of these inhibitory signals on immune responses, and the overlapping and unique functions of these key immunoregulatory pathways.	[Schildberg, Frank A.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Schildberg, Frank A.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Klein, Sarah R.; Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.	arlene_sharpe@hms.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616	NIH [P01AI056299, P50CA101942]; Novartis; Roche; NATIONAL CANCER INSTITUTE [P50CA101942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, R01AI040614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Roche(Roche Holding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank their colleagues for critical discussions. This work was supported by grants from NIH (P01AI056299 and P50CA101942 to A.H.S. and G.J.F.). G.J.F. has patents/pending royalties on the PD-1 pathway from Bristol-Myers-Squibb, Roche, Merck, EMD-Serono, Boehringer-Ingelheim, AstraZeneca, and Novartis. A.H.S. has received sponsored research support from Novartis and Roche. She has patents/pending royalties from Roche and Novartis. Because of space restrictions, we were able to cite only a fraction of the relevant literature and apologize to colleagues whose contributions might not be appropriately acknowledged in this review.	Abadi YM, 2013, J IMMUNOL, V190, P3806, DOI 10.4049/jimmunol.1202439; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Alegre ML, 1996, J IMMUNOL, V157, P4762; Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Araki M, 2009, J IMMUNOL, V183, P5146, DOI 10.4049/jimmunol.0802610; Arnett HA, 2007, J IMMUNOL, V178, P1523, DOI 10.4049/jimmunol.178.3.1523; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Bally APR, 2015, J IMMUNOL, V194, P4545, DOI 10.4049/jimmunol.1402550; Bour-Jordan H, 2003, NAT IMMUNOL, V4, P182, DOI 10.1038/ni884; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chattopadhyay G, 2013, J IMMUNOL, V191, P5875, DOI 10.4049/jimmunol.1301693; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chen XQ, 2009, J MOL NEUROSCI, V37, P86, DOI 10.1007/s12031-008-9133-z; Cheng L, 2009, INT J GYNECOL CANCER, V19, P1481, DOI 10.1111/IGC.0b013e3181ad0fa2; Cho HY, 2008, BBA-GENE REGUL MECH, V1779, P811, DOI 10.1016/j.bbagrm.2008.08.003; Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; CUNNINGHAM AJ, 1977, SCAND J IMMUNOL, V6, P1, DOI 10.1111/j.1365-3083.1977.tb00317.x; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; de Jong VM, 2013, GENES IMMUN, V14, P58, DOI 10.1038/gene.2012.38; Deichmann K, 1996, BIOCHEM BIOPH RES CO, V225, P817, DOI 10.1006/bbrc.1996.1256; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Esposito L, 2014, J IMMUNOL, V193, P889, DOI 10.4049/jimmunol.1303389; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Finn PW, 1997, J IMMUNOL, V158, P4074; Flies DB, 2014, J CLIN INVEST, V124, P1966, DOI 10.1172/JCI74589; Flies DB, 2011, J IMMUNOL, V187, P1537, DOI 10.4049/jimmunol.1100660; Ford ML, 2016, IMMUNITY, V44, P1020, DOI 10.1016/j.immuni.2016.04.012; Forni D, 2013, IMMUNITY, V38, P1129, DOI 10.1016/j.immuni.2013.04.008; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Gerold KD, 2011, DIABETES, V60, P1955, DOI 10.2337/db11-0130; Gibson HM, 2007, J IMMUNOL, V179, P3831, DOI 10.4049/jimmunol.179.6.3831; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Han YM, 2014, HEPATOLOGY, V59, P567, DOI 10.1002/hep.26694; HARPER K, 1991, J IMMUNOL, V147, P1037; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Janakiram M, 2015, CLIN CANCER RES, V21, P2359, DOI 10.1158/1078-0432.CCR-14-1495; Jones JC, 2013, IMMUNITY, V38, P1083, DOI 10.1016/j.immuni.2013.06.008; Kaku H, 2010, GENES IMMUN, V11, P55, DOI 10.1038/gene.2009.68; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kaufman KA, 1999, MOL HUM REPROD, V5, P84, DOI 10.1093/molehr/5.1.84; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kowalczyk A, 2014, EUR J IMMUNOL, V44, P1143, DOI 10.1002/eji.201343601; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Laurent S, 2010, HUM IMMUNOL, V71, P934, DOI 10.1016/j.humimm.2010.07.007; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Lines JL, 2014, CANCER RES, V74, P1924, DOI 10.1158/0008-5472.CAN-13-1504; Ling V, 1998, EXP CELL RES, V241, P55, DOI 10.1006/excr.1998.4055; LINSLEY PS, 1995, J BIOL CHEM, V270, P15417, DOI 10.1074/jbc.270.25.15417; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Liu J, 2015, P NATL ACAD SCI USA, V112, P6682, DOI 10.1073/pnas.1420370112; Liu SM, 2012, J IMMUNOL, V188, P155, DOI 10.4049/jimmunol.1102042; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu Y, 2009, CANCER IMMUNOL IMMUN, V58, P687, DOI 10.1007/s00262-008-0591-5; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Loos M, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/683875; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Mager DL, 1999, GENOMICS, V59, P255, DOI 10.1006/geno.1999.5877; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.3.CO;2-P; Malquori L, 2008, BBA-GENE REGUL MECH, V1779, P60, DOI 10.1016/j.bbagrm.2007.10.004; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Patsoukis N, 2013, MOL CELL BIOL, V33, P3091, DOI 10.1128/MCB.00319-13; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Perez-Garcia A, 2013, HUM IMMUNOL, V74, P1219, DOI 10.1016/j.humimm.2013.05.012; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pioli C, 2000, J IMMUNOL, V165, P5530, DOI 10.4049/jimmunol.165.10.5530; Pistillo MP, 2003, BLOOD, V101, P202, DOI 10.1182/blood-2002-06-1668; Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Schneider H, 1999, J IMMUNOL, V163, P1868; Schneider H, 2008, EUR J IMMUNOL, V38, P40, DOI 10.1002/eji.200737423; Sekulic A, 2015, MOL GENET GENOM MED, V3, P130, DOI 10.1002/mgg3.121; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Suh WK, 2006, MOL CELL BIOL, V26, P6403, DOI 10.1128/MCB.00755-06; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Swanson RM, 2013, J IMMUNOL, V190, P2027, DOI 10.4049/jimmunol.1201760; Tai XG, 2007, P NATL ACAD SCI USA, V104, P13756, DOI 10.1073/pnas.0706509104; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ungewickell A, 2015, NAT GENET, V47, P1056, DOI 10.1038/ng.3370; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; Wang HH, 2012, J NEUROIMMUNOL, V243, P52, DOI 10.1016/j.jneuroim.2011.11.010; Wang L, 2014, P NATL ACAD SCI USA, V111, P14846, DOI 10.1073/pnas.1407447111; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Wang XB, 2002, SCAND J IMMUNOL, V55, P53, DOI 10.1046/j.0300-9475.2001.01019.x; Wang XB, 2002, GENES IMMUN, V3, P233, DOI 10.1038/sj.gene.6363869; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Xiao YP, 2015, CLIN CANCER RES, V21, P2201, DOI 10.1158/1078-0432.CCR-14-2658; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yao Y, 2008, J NEURO-ONCOL, V89, P121, DOI 10.1007/s11060-008-9601-x; Ying HY, 2010, J IMMUNOL, V185, P1375, DOI 10.4049/jimmunol.0903369; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yoo HY, 2016, HAEMATOLOGICA; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhang GY, 2015, ONCOTARGET, V6, P18933, DOI 10.18632/oncotarget.3662; Zhang GY, 2010, HUM IMMUNOL, V71, P1209, DOI 10.1016/j.humimm.2010.08.014; Zhang L, 2013, ONCOGENE, V32, P5347, DOI 10.1038/onc.2012.600; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2; Zhao RH, 2013, P NATL ACAD SCI USA, V110, P9879, DOI 10.1073/pnas.1303524110; Zheng LH, 2010, J CLIN IMMUNOL, V30, P855, DOI 10.1007/s10875-010-9450-1; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhong XM, 2004, INT IMMUNOL, V16, P1181, DOI 10.1093/intimm/dxh121; Zhou JY, 2013, MOL THER, V21, P1445, DOI 10.1038/mt.2013.63; Zhou JY, 2013, J CLIN INVEST, V123, P2629, DOI 10.1172/JCI64704; Zhu GF, 2009, BLOOD, V113, P1759, DOI 10.1182/blood-2008-01-133223; Zhu YW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3043	202	335	366	5	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					955	972		10.1016/j.immuni.2016.05.002	http://dx.doi.org/10.1016/j.immuni.2016.05.002			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192563	Green Accepted, Bronze			2022-12-18	WOS:000376478500001
J	Lee, K; Gudapati, P; Dragovic, S; Spencer, C; Joyce, S; Killeen, N; Magnuson, MA; Boothby, M				Lee, Keunwook; Gudapati, Prathyusha; Dragovic, Srdjan; Spencer, Charles; Joyce, Sebastian; Killeen, Nigel; Magnuson, Mark A.; Boothby, Mark			Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways	IMMUNITY			English	Article							KINASE-C-THETA; KAPPA-B ACTIVATION; RICTOR-MTOR COMPLEX; T-CELLS; PKC-THETA; IMMUNOLOGICAL SYNAPSE; AKT PHOSPHORYLATION; LINEAGE COMMITMENT; MAF EXPRESSION; IFN-GAMMA	Many functions of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) have been defined, but relatively little is known about the biology of an alternative mTOR complex, mTORC2. We showed that conditional deletion of rictor, an essential subunit of mTORC2, impaired differentiation into T helper 1 (Th1) and Th2 cells without diversion into FoxP3(+) status or substantial effect on Th17 cell differentiation. mTORC2 promoted phosphorylation of protein kinase B (PKB, or Akt) and PKC, Akt activity, and nuclear NF-kappa B transcription factors in response to T cell activation. Complementation with active Akt restored only T-bet transcription factor expression and Th1 cell differentiation, whereas activated PKC-theta reverted only GATA3 transcription factor and the Th2 cell defect of mTORC2 mutant cells. Collectively, the data uncover vital mTOR-PKC and mTOR-Akt connections in T cell differentiation and reveal distinct pathways by which mTORC2 regulates development of Th1 and Th2 cell subsets.	[Lee, Keunwook; Gudapati, Prathyusha; Dragovic, Srdjan; Spencer, Charles; Joyce, Sebastian; Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Boothby, Mark] Vanderbilt Univ, Sch Med, Dept Med Rheumatol, Nashville, TN 37232 USA; [Killeen, Nigel] Univ Calif San Francisco, San Francisco, CA 94143 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco	Boothby, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu	Spencer, Charles/J-6489-2012; Gudapati, Prathyusha/AAV-7664-2020; Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009; spencer, charles/B-9411-2014	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499; Gudapati, Prathyusha/0000-0003-2545-5194; Lee, Keunwook/0000-0002-4713-8547; JOYCE, Sebastian/0000-0002-3183-1451	NIH [R01AI068149]; Vanderbilt Institutional Bridge Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068149, R01AI077528] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institutional Bridge Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01AI068149 and Vanderbilt Institutional Bridge Funds; additional acknowledgements are included in the Supplemental Information.	Andres PG, 2004, NAT IMMUNOL, V5, P435, DOI 10.1038/ni1044; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Blazar BR, 1998, J IMMUNOL, V160, P5355; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; CHAN TO, 2001, SCI STKE, pPE1; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Glimcher LH, 2000, GENE DEV, V14, P1693; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Konstandin MH, 2007, J IMMUNOL METHODS, V327, P30, DOI 10.1016/j.jim.2007.07.005; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lane P, 2000, J EXP MED, V191, P201, DOI 10.1084/jem.191.2.201; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Letschka T, 2008, BLOOD, V112, P4617, DOI 10.1182/blood-2007-11-121111; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu Y, 2001, J LEUKOCYTE BIOL, V69, P831; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Mora AL, 2003, J IMMUNOL, V171, P1891, DOI 10.4049/jimmunol.171.4.1891; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074; Valmori D, 2006, J IMMUNOL, V177, P944, DOI 10.4049/jimmunol.177.2.944; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DZ, 1997, J BIOL CHEM, V272, P25083, DOI 10.1074/jbc.272.40.25083; Wood JE, 2006, J BIOL CHEM, V281, P32385, DOI 10.1074/jbc.M604878200; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	57	335	349	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 25	2010	32	6					743	753		10.1016/j.immuni.2010.06.002	http://dx.doi.org/10.1016/j.immuni.2010.06.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620941	Bronze, Green Accepted			2022-12-18	WOS:000279365800006
J	Bunnell, SC; Kapoor, V; Trible, RP; Zhang, WG; Samelson, LE				Bunnell, SC; Kapoor, V; Trible, RP; Zhang, WG; Samelson, LE			Dynamic actin polymerization drives T cell receptor-induced spreading: A role for the signal transduction adaptor LAT	IMMUNITY			English	Article							WISKOTT-ALDRICH-SYNDROME; MICROTUBULE-ORGANIZING CENTER; CYTOSKELETAL REORGANIZATION; PHOSPHOLIPASE C-GAMMA-1; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASES; SYNDROME PROTEIN; B-CELLS; ACTIVATION; ANTIGEN	T cell activation induces functional changes in cell shape and cytoskeletal architecture. To facilitate the collection of dynamic, high-resolution images of activated T cells, we plated T cells on coverslips coated with antibodies to the T cell receptor (TCR). Using these images, we were able to quantitate the morphological responses of individual cells over time. Here, we show that TCR engagement triggers the formation and expansion of contacts bounded by continuously remodeled actin-rich rings, These processes are associated with the extension of lamellipodia and require actin polymerization, tyrosine kinase activation, cytoplasmic calcium increases, and LAT, an important hematopoietic adaptor. In addition, the maintenance of the resulting contact requires sustained calcium influxes, an intact microtubule cytoskeleton, and functional LAT.	NCI, Div Basic Sci, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University	Samelson, LE (corresponding author), NCI, Div Basic Sci, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA.	samelson@helix.nih.gov		Bunnell, Stephen/0000-0001-6887-0828				Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Cantrell D, 1998, CURR BIOL, V8, pR535, DOI 10.1016/S0960-9822(07)00341-7; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; KUPFER A, 1987, J EXP MED, V165, P1565, DOI 10.1084/jem.165.6.1565; KUPFER A, 1984, J IMMUNOL, V133, P2762; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; PARSEY MV, 1993, J IMMUNOL, V151, P1881; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Shan XC, 1999, J BIOL CHEM, V274, P29323, DOI 10.1074/jbc.274.41.29323; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zigmond SH, 2000, J CELL BIOL, V150, pF117, DOI 10.1083/jcb.150.6.F117	51	335	340	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					315	329		10.1016/S1074-7613(01)00112-1	http://dx.doi.org/10.1016/S1074-7613(01)00112-1			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290340	Bronze			2022-12-18	WOS:000167959500010
J	Matsumoto, M; Baba, A; Yokota, T; Nishikawa, H; Ohkawa, Y; Kayama, H; Kallies, A; Nutt, SL; Sakaguchi, S; Takeda, K; Kurosaki, T; Baba, Y				Matsumoto, Masanori; Baba, Akemi; Yokota, Takafumi; Nishikawa, Hiroyoshi; Ohkawa, Yasuyuki; Kayama, Hisako; Kallies, Axel; Nutt, Stephen L.; Sakaguchi, Shimon; Takeda, Kiyoshi; Kurosaki, Tomohiro; Baba, Yoshihiro			Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation	IMMUNITY			English	Article							B-CELLS; B10 CELLS; DIFFERENTIATION; TRANSCRIPTION; BLIMP-1; IL-10; ROLES; INTERFERON; ACTIVATION; INITIATION	B cells can suppress autoimmunity by secreting interleukin-10 (IL-10). Although subpopulations of splenic B lineage cells are reported to express IL-10 in vitro, the identity of IL-10-producing B cells with regulatory function in vivo remains unknown. By using IL-10 reporter mice, we found that plasmablasts in the draining lymph nodes (dLNs), but not splenic B lineage cells, predominantly expressed IL-10 during experimental autoimmune encephalomyelitis (EAE). These plasmablasts were generated only during EAE inflammation. Mice lacking plasmablasts by genetic ablation of the transcription factors Blimp1 or IRF4 in B lineage cells developed an exacerbated EAE. Furthermore, IRF4 positively regulated IL-10 production that can inhibit dendritic cell functions to generate pathogenic T cells. Our data demonstrate that plasmablasts in the dLNs serve as IL-10 producers to limit autoimmune inflammation and emphasize the importance of plasmablasts as IL-10-producing regulatory B cells.	[Matsumoto, Masanori; Baba, Akemi; Kurosaki, Tomohiro; Baba, Yoshihiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan; [Nishikawa, Hiroyoshi; Sakaguchi, Shimon] Osaka Univ, WPI Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka 5650871, Japan; [Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Matsumoto, Masanori; Kurosaki, Tomohiro; Baba, Yoshihiro] RIKEN, Ctr Integrat Med Sci IMS, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Yokota, Takafumi] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, JST CREST, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Kallies, Axel; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Kallies, Axel; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Osaka University; Osaka University; Osaka University; RIKEN; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Kyushu University; Walter & Eliza Hall Institute; University of Melbourne	Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kurosaki@ifrec.osaka-u.ac.jp; babay@ifrec.osaka-u.ac.jp	Kurosaki, Tomohiro/D-1306-2009; Nutt, Stephen L/C-9256-2013; Ohkawa, Yasuyuki/ABG-1839-2021; Sakaguchi, Shimon/C-9535-2009; Nishikawa, Hiroyoshi/AAI-7044-2020; Matsumoto, Masanori/N-9971-2018; Ohkawa, Yasuyuki/C-4087-2016; Takeda, Kiyoshi/C-9331-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Nutt, Stephen L/0000-0002-0020-6637; Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Takeda, Kiyoshi/0000-0002-1778-6332; Kallies, Axel/0000-0002-6312-6968	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Daiichi Sankyo Foundation of Life Science; National Health and Medical Research Council of Australia; Australia Research Council; Sylvia and Charles Viertel Foundation; Australian Government NHMRC IRIIS; Grants-in-Aid for Scientific Research [26860262] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Daiichi Sankyo Foundation of Life Science; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council(Australian Research Council); Sylvia and Charles Viertel Foundation; Australian Government NHMRC IRIIS(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Okada for Bcl6<SUP>yfp/yfp</SUP> mice; E. Hobeika and M. Reth for Mb1<SUP>Cre/+</SUP> mice; T. Matsuyama and K. Yui for Irf4<SUP>-/-</SUP> mice; Y. Nakatsuji and T. Okuno for discussion; and P.W. Kincade for critical reading and editing of the manuscript. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T.K., M.M., and Y.B.), Japan Science and Technology Agency and Core Research for Evolutional Science and Technology (T.K.), and Daiichi Sankyo Foundation of Life Science (Y.B.), and by grants and fellowships from the National Health and Medical Research Council of Australia (A.K. and S.L.N.), the Australia Research Council (A.K. and S.L.N.), and the Sylvia and Charles Viertel Foundation (A.K.) and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.	Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Giordani L, 2009, J LEUKOCYTE BIOL, V86, P261, DOI 10.1189/jlb.0908560; Gurcan HM, 2009, INT IMMUNOPHARMACOL, V9, P10, DOI 10.1016/j.intimp.2008.10.004; Hartung Hans-Peter, 2010, Ther Adv Neurol Disord, V3, P205, DOI 10.1177/1756285610371146; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; KIM T, 1987, CLIN EXP IMMUNOL, V70, P562; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Matsushita T, 2006, AM J PATHOL, V168, P812, DOI 10.2353/ajpath.2006.050923; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Ramgolam VS, 2011, J IMMUNOL, V186, P4518, DOI 10.4049/jimmunol.1000271; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Todd SK, 2014, RHEUMATOLOGY, V53, P1693, DOI 10.1093/rheumatology/keu136; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	44	334	357	6	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1040	1051		10.1016/j.immuni.2014.10.016	http://dx.doi.org/10.1016/j.immuni.2014.10.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25484301	Bronze			2022-12-18	WOS:000346654100020
J	Yoder, MC; Hiatt, K; Dutt, P; Mukherjee, P; Bodine, DM; Orlic, D				Yoder, MC; Hiatt, K; Dutt, P; Mukherjee, P; Bodine, DM; Orlic, D			Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac	IMMUNITY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; LONG-TERM REPOPULATION; COLONY-FORMING CELLS; IN-VIVO; MOUSE EMBRYO; C-KIT; SIALOMUCIN CD34; MESSENGER-RNA; EXPRESSION; VITRO	The site of origin of lymphohematopoietic stem cells (HSC) that initiate definitive blood cell production in the murine fetal liver is controversial. Contrary to reports that the preliver yolk sac does not contain definitive HSC, we observed that CD34(+) day 9 yolk sac cells repopulated multiple blood cell lineages in newborn hosts for at least 1 year. Furthermore, 100 CD34(+)cKit(+) day 9 yolk sac or para-aortic splanchnopleura (P-Sp) cells, known to give rise to embryonic HSC, similarly repopulated hematopoiesis in recipient hosts, Surprisingly, 37-fold more CD34(+)c-Kit(+) cells reside in the day 9 yolk sac than in the P-Sp. In sum, definitive HSC are coexistent, but not equal in number, in the murine yolk sac and P-Sp prior to fetal liver colonization.	INDIANA UNIV, SCH MED, DEPT PEDIAT, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOL BIOL, INDIANAPOLIS, IN 46202 USA; NIH, NATL CTR HUMAN GENOME RES, LAB GENE TRANSFER, BETHESDA, MD 20892 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yoder, MC (corresponding author), INDIANA UNIV, SCH MED, HERMAN B WELLS CTR PEDIAT RES, INDIANAPOLIS, IN 46202 USA.							Cheng J, 1996, BLOOD, V87, P479, DOI 10.1182/blood.V87.2.479.bloodjournal872479; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DieterlenLievre F, 1997, INT ARCH ALLERGY IMM, V112, P3, DOI 10.1159/000237423; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; FENNIE C, 1995, BLOOD, V86, P4454, DOI 10.1182/blood.V86.12.4454.bloodjournal86124454; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Krause DS, 1996, BLOOD, V87, P1; KRAUSE DS, 1994, BLOOD, V84, P691; Lu LS, 1996, P NATL ACAD SCI USA, V93, P14782, DOI 10.1073/pnas.93.25.14782; Marcos MAR, 1997, J IMMUNOL, V158, P2627; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MOORE MAS, 1967, LANCET, V2, P658, DOI 10.1016/S0140-6736(67)90693-9; MOORE T, 1994, J IMMUNOL, V153, P4978; Morel F, 1996, BLOOD, V88, P3774, DOI 10.1182/blood.V88.10.3774.bloodjournal88103774; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; OGATA H, 1995, P NATL ACAD SCI USA, V92, P5945, DOI 10.1073/pnas.92.13.5945; OGAWA M, 1993, DEVELOPMENT, V117, P1089; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; ORLIC D, 1994, BLOOD, V84, P3991, DOI 10.1182/blood.V84.12.3991.bloodjournal84123991; Orlic D, 1996, P NATL ACAD SCI USA, V93, P11097, DOI 10.1073/pnas.93.20.11097; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Palacios R, 1996, P NATL ACAD SCI USA, V93, P5247, DOI 10.1073/pnas.93.11.5247; Peault B, 1996, J Hematother, V5, P369, DOI 10.1089/scd.1.1996.5.369; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SPANGRUDE GJ, 1994, ANNU REV MED, V45, P93; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; TAVASSOLI M, 1991, BLOOD CELLS, V17, P269; Traycoff CM, 1996, EXP HEMATOL, V24, P299; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; Yoder M C, 1996, Biol Blood Marrow Transplant, V2, P59; Yoder MC, 1997, BLOOD, V89, P2176, DOI 10.1182/blood.V89.6.2176; YODER MC, 1993, BLOOD, V82, P385; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; YODER MC, 1995, BLOOD, V86, P1322, DOI 10.1182/blood.V86.4.1322.bloodjournal8641322; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; ZEIGLER FC, 1994, BLOOD, V84, P2422, DOI 10.1182/blood.V84.8.2422.bloodjournal8482422; Zhong RK, 1996, J IMMUNOL, V157, P138; ZON LI, 1995, BLOOD, V86, P2876	47	333	339	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1997	7	3					335	344		10.1016/S1074-7613(00)80355-6	http://dx.doi.org/10.1016/S1074-7613(00)80355-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324354	Bronze			2022-12-18	WOS:A1997XY83000003
J	Guilliams, M; Mildner, A; Yona, S				Guilliams, Martin; Mildner, Alexander; Yona, Simon			Developmental and Functional Heterogeneity of Monocytes	IMMUNITY			English	Review							TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; CENTRAL-NERVOUS-SYSTEM; CYTOKINE GM-CSF; ACUTE MYOCARDIAL-INFARCTION; INDUCED GRANULOMA-FORMATION; STEADY-STATE CONDITIONS; MOUSE BONE-MARROW	Novel experimental approaches such as fate-mapping and single-cell analysis have brought fresh insight into monocyte development and function over the past decade and helped redefine the monocyte field. Monocytes are now known to consist of multiple subsets generated through distinct developmental pathways with diverse functional specializations. Their fates under homeostatic conditions include the accumulation in peripheral reservoirs and the engraftment into certain resident macrophage pools. Under pathological conditions, monocytes acquire inflammatory effector functions, but can also develop regulatory properties essential for tissue repair. Importantly, monocytes recruited during inflammation are often functionally distinct from resident macrophages or conventional dendritic cells. Here we outline emerging concepts in monocyte heterogeneity, emergency monopoiesis, and trained immunity and discuss how these bring new perspectives to monocyte research.	[Guilliams, Martin] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Special, Technol Pk 927, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Mildner, Alexander] Max Delbruck Ctr Mol Med, Berlin, Germany; [Yona, Simon] UCL, Div Med, London, England	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of London; University College London	Guilliams, M (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Special, Technol Pk 927, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Mildner, A (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Yona, S (corresponding author), UCL, Div Med, London, England.	martin.guilliams@irc.vib-ugent.be; alexander.mildner@mdc-berlin.de; s.yona@ucl.ac.uk	Yona, Simon/ABE-6572-2020; mildner, alexander/GQA-3761-2022; Guilliams, Martin/N-7803-2013; mildner, alexander/AAF-9451-2022; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AFK-2161-2022	mildner, alexander/0000-0002-2019-8427; Guilliams, Martin/0000-0003-3525-7570; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Yona, Simon/0000-0002-3984-2008	DFG [MI1328]; ERC; FWO	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); FWO(FWO)	The authors contributed equally to this work and the authorship is in alphabetical order. This authorship can thus be cited in any order. We apologize to our colleagues whose work we have not cited, either due to space restriction or ignorance. We thank the Wellcome Trust Library staff for the reproduction of images in Figure 1 and access to their rare book collection. A.M. is a Heisenberg fellow supported by the DFG (MI1328). M.G. is supported by an ERC Consolidator grant and FWO funding.	AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Bonnardel J, 2018, CURR OPIN IMMUNOL, V50, P64, DOI 10.1016/j.coi.2017.12.001; Borst K., 2017, J HEPATOL, DOI [10.1016/j.jhep.2017.11.02, DOI 10.1016/J.JHEP.2017.11.02]; Bosschaerts T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001045; BOUWENS L, 1986, CELL TISSUE KINET, V19, P217, DOI 10.1111/j.1365-2184.1986.tb00732.x; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Buenrostro JD, 2018, CELL, V173, P1535, DOI 10.1016/j.cell.2018.03.074; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Devisscher L, 2017, CELL IMMUNOL, V322, P74, DOI 10.1016/j.cellimm.2017.10.006; DOCK W, 1958, ANN INTERN MED, V49, P699, DOI 10.7326/0003-4819-49-3-699; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Ebert RH, 1939, BRIT J EXP PATHOL, V20, P342; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Ehrlich P., 1880, Z KLIN MED, V1, P553; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Finsterbusch M, 2016, P NATL ACAD SCI USA, V113, pE5172, DOI 10.1073/pnas.1606253113; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; FORKNER CLAUDE E., 1930, JOUR EXP MED, V52, P385, DOI 10.1084/jem.52.3.385; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gamrekelashvili J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12597; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Graubardt N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00626; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guilliams M, 2009, J IMMUNOL, V182, P1107, DOI 10.4049/jimmunol.182.2.1107; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hibbs ML, 2007, J IMMUNOL, V178, P6435, DOI 10.4049/jimmunol.178.10.6435; Hilgendorf I, 2015, ARTERIOSCL THROM VAS, V35, P272, DOI 10.1161/ATVBAHA.114.303565; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hoeffel G, 2018, CELL IMMUNOL, V330, P5, DOI 10.1016/j.cellimm.2018.01.001; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hunter J., 1794, TREATISE BLOOD INFLA; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Izikson L, 2002, CLIN IMMUNOL, V103, P125, DOI 10.1006/clim.2001.5167; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kawamura S, 2017, IMMUNITY, V46, P835, DOI 10.1016/j.immuni.2017.04.019; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kiss M, 2018, CELL IMMUNOL, V330, P188, DOI 10.1016/j.cellimm.2018.02.008; Klein S., 1914, DIE MYELOGONIE; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurotaki D, 2018, CELL REP, V22, P2628, DOI 10.1016/j.celrep.2018.02.048; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LEDER LD, 1967, BLUT, V16, P86, DOI 10.1007/BF01632883; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lessard AJ, 2017, CELL REP, V20, P1830, DOI 10.1016/j.celrep.2017.08.009; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559; Maximow Alexander, 1907, Folia Haematologica Leipzig, V4; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Metchnikoff E, 1892, LECONS PATHOLOGIE CO; Metschnikoff E., 1887, ARCH PATHOL ANAT PHY, V107, P209, DOI DOI 10.1007/BF01926053; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; MIZOGUCHI S, 1992, J LEUKOCYTE BIOL, V52, P52, DOI 10.1002/jlb.52.1.52; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014; Naegeli O., 1908, BLUTKRANKHEITEN BLUT; Naegeli O., 1923, BLUTKRANKHEITEN BLUT; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; NAITO M, 1991, LAB INVEST, V64, P664; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; OGHISO Y, 1988, J RADIAT RES, V29, P189, DOI 10.1269/jrr.29.189; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pappenheim A., 1910, FOLIA HAEMATOL, V10, P72; Pasquevich KA, 2015, EUR J IMMUNOL, V45, P2821, DOI 10.1002/eji.201545530; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Patel A. A., 2018, PHAGOCYTE DEV, DOI [10.1002/9780470015902.a0001218.pub2, DOI 10.1002/9780470015902.A0001218.PUB2]; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Perie L, 2016, FEBS LETT, V590, P4068, DOI 10.1002/1873-3468.12299; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Plebanek MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01433-3; Polletti S, 2017, IMMUNITY, V46, P764, DOI 10.1016/j.immuni.2017.04.010; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quintar A, 2017, CIRC RES, V120, P1789, DOI 10.1161/CIRCRESAHA.117.310739; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sabin F., 1925, CARNEGIE I CONTRIB E, V16, P227; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez C, 1999, J IMMUNOL, V162, P5230; Sander J, 2017, IMMUNITY, V47, P1051, DOI 10.1016/j.immuni.2017.11.024; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; SAWYER RT, 1982, LAB INVEST, V46, P165; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Selimoglu-Buet D, 2015, BLOOD, V125, P3618, DOI 10.1182/blood-2015-01-620781; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; SOROKIN SP, 1992, ANAT REC, V232, P520, DOI 10.1002/ar.1092320409; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Sugimoto C, 2015, J IMMUNOL, V195, P1774, DOI 10.4049/jimmunol.1500522; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tak T, 2017, BLOOD, V130, P1474, DOI 10.1182/blood-2017-03-771261; Tak T, 2017, J INNATE IMMUN, V9, P464, DOI 10.1159/000475665; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tamura A., 2017, BLOOD; Thaler B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30162; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tusi BK, 2018, NATURE, V555, P54, DOI 10.1038/nature25741; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V47, P651; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol D, 2017, IMMUNITY, V46, P1030, DOI 10.1016/j.immuni.2017.05.003; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Verschoor CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104522; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Wolf Y, 2017, J EXP MED, V214, P905, DOI 10.1084/jem.20160499; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; YAMADA M, 1990, J LEUKOCYTE BIOL, V47, P195, DOI 10.1002/jlb.47.3.195; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yanez A, 2017, IMMUNITY, V47, P890, DOI 10.1016/j.immuni.2017.10.021; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V289, P135, DOI 10.1016/j.cellimm.2014.03.019; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	219	332	335	11	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					595	613		10.1016/j.immuni.2018.10.005	http://dx.doi.org/10.1016/j.immuni.2018.10.005			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332628	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000447386700008
J	Curtis, AM; Bellet, MM; Sassone-Corsi, P; O'Neill, LAJ				Curtis, Anne M.; Bellet, Marina M.; Sassone-Corsi, Paolo; O'Neill, Luke A. J.			Circadian Clock Proteins and Immunity	IMMUNITY			English	Review							REV-ERB-ALPHA; GENE-EXPRESSION; SHIFT-WORK; NEGATIVE REGULATOR; INNATE IMMUNITY; HOST RESPONSE; RECEPTOR; RHYTHMS; METABOLISM; SUSCEPTIBILITY	Immune parameters change with time of day and disruption of circadian rhythms has been linked to inflammatory pathologies. A circadian-clock-controlled immune system might allow an organism to anticipate daily changes in activity and feeding and the associated risk of infection or tissue damage to the host. Responses to bacteria have been shown to vary depending on time of infection, with mice being more at risk of sepsis when challenged ahead of their activity phase. Studies highlight the extent to which the molecular clock, most notably the core clock proteins BMAL1, CLOCK, and REV-ERB alpha, control fundamental aspects of the immune response. Examples include the BMAL1: CLOCK heterodimer regulating toll-like receptor 9 (TLR9) expression and repressing expression of the inflammatory monocyte chemokine ligand (CCL2) as well as REV-ERBa suppressing the induction of interleukin-6. Understanding the daily rhythm of the immune system could have implications for vaccinations and how we manage infectious and inflammatory diseases.	[Curtis, Anne M.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Bellet, Marina M.; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA	Trinity College Dublin; University of California System; University of California Irvine	Curtis, AM (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	acurtis@tcd.ie; laoneill@tcd.ie	Bellet, Marina Maria/K-7794-2016	Bellet, Marina Maria/0000-0001-7604-0189; Curtis, Annie/0000-0002-9601-9624; O'Neill, Luke/0000-0002-4333-2748	European Research Council (ERC) [268155_MicroInnateto]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by a grant from the European Research Council (ERC), number 268155_MicroInnateto, to L.A.J.O.	Aguilar-Arnal L, 2013, CURR OPIN CELL BIOL, V25, P170, DOI 10.1016/j.ceb.2013.01.003; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARNES P, 1980, NEW ENGL J MED, V303, P263, DOI 10.1056/NEJM198007313030506; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Bellet MM, 2012, CELL CYCLE, V11, P3304, DOI 10.4161/cc.21669; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carlson DE, 2008, SHOCK, V29, P127, DOI 10.1097/shk.0b013e318142c5a2; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Cutolo M, 2008, AUTOIMMUN REV, V7, P223, DOI 10.1016/j.autrev.2007.11.019; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dickmeis T, 2013, MOL CELL ENDOCRINOL, V380, P2, DOI 10.1016/j.mce.2013.05.012; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Froy O, 2007, MOL IMMUNOL, V44, P1954, DOI 10.1016/j.molimm.2006.09.026; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Haus E, 2012, BULL HOSP JT DIS, V70, pS3; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Herdegen JJ, 2002, CRIT CARE MED, V30, P709, DOI 10.1097/00003246-200203000-00040; Hrushesky WJM, 1997, J INFECT DIS, V175, P1283, DOI 10.1086/516457; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; Kraft M, 1996, AM J RESP CRIT CARE, V154, P1505, DOI 10.1164/ajrccm.154.5.8912772; Kwak Y, 2008, J BIOL RHYTHM, V23, P150, DOI 10.1177/0748730407313355; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039; Logan RW, 2011, BRAIN BEHAV IMMUN, V25, P101, DOI 10.1016/j.bbi.2010.08.007; Lundkvist GB, 2002, NEUROBIOL DIS, V11, P20, DOI 10.1006/nbdi.2002.0536; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Marpegan L, 2009, CHRONOBIOL INT, V26, P1430, DOI 10.3109/07420520903408358; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SHACKELFORD PG, 1973, SCIENCE, V182, P285, DOI 10.1126/science.182.4109.285; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Silver AC, 2012, BRAIN BEHAV IMMUN, V26, P407, DOI 10.1016/j.bbi.2011.10.001; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	67	332	343	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					178	186		10.1016/j.immuni.2014.02.002	http://dx.doi.org/10.1016/j.immuni.2014.02.002			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24560196	Bronze, Green Submitted			2022-12-18	WOS:000331637600006
J	den Braber, I; Mugwagwa, T; Vrisekoop, N; Westera, L; Mogling, R; de Boer, AB; Willems, N; Schrijver, EHR; Spierenburg, G; Gaiser, K; Mul, E; Otto, SA; Ruiter, AFC; Ackermans, MT; Miedema, F; Borghans, JAM; de Boer, RJ; Tesselaar, K				den Braber, Ineke; Mugwagwa, Tendai; Vrisekoop, Nienke; Westera, Liset; Mogling, Ramona; de Boer, Anne Bregje; Willems, Neeltje; Schrijver, Elise H. R.; Spierenburg, Gerrit; Gaiser, Koos; Mul, Erik; Otto, Sigrid A.; Ruiter, An F. C.; Ackermans, Mariette T.; Miedema, Frank; Borghans, Jose A. M.; de Boer, Rob J.; Tesselaar, Kiki			Maintenance of Peripheral Naive T Cells Is Sustained by Thymus Output in Mice but Not Humans	IMMUNITY			English	Article							EXCISION CIRCLE CONTENT; HIV-INFECTION; LIFE-SPAN; IN-VIVO; MARROW-TRANSPLANTATION; HUMAN ADULT; AGED MICE; LYMPHOCYTES; PROLIFERATION; REPERTOIRE	Parallels between T cell kinetics in mice and men have fueled the idea that a young mouse is a good model system for a young human, and an old mouse, for an elderly human. By combining in vivo kinetic labeling using deuterated water, thymectomy experiments, analysis of T cell receptor excision circles and CD31 expression, and mathematical modeling, we have quantified the contribution of thymus output and peripheral naive T cell division to the maintenance of T cells in mice and men. Aging affected naive T cell maintenance fundamentally differently in mice and men. Whereas the naive T cell pool in mice was almost exclusively sustained by thymus output throughout their lifetime, the maintenance of the adult human naive T cell pool occurred almost exclusively through peripheral T cell division. These findings put constraints on the extrapolation of insights into T cell dynamics from mouse to man and vice versa.	[den Braber, Ineke; Vrisekoop, Nienke; Westera, Liset; Mogling, Ramona; de Boer, Anne Bregje; Willems, Neeltje; Schrijver, Elise H. R.; Spierenburg, Gerrit; Gaiser, Koos; Otto, Sigrid A.; Miedema, Frank; Borghans, Jose A. M.; Tesselaar, Kiki] Univ Med Ctr Utrecht, Dept Immunol, NL-3584 EA Utrecht, Netherlands; [Mugwagwa, Tendai; Borghans, Jose A. M.; de Boer, Rob J.] Univ Utrecht, NL-3584 CA Utrecht, Netherlands; [Mul, Erik] Univ Amsterdam, Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Mul, Erik] Univ Amsterdam, Acad Med Ctr, NL-1066 CX Amsterdam, Netherlands; [Ruiter, An F. C.; Ackermans, Mariette T.] Univ Amsterdam, Acad Med Ctr, Lab Endocrinol & Radiochem, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tesselaar, K (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, NL-3584 EA Utrecht, Netherlands.	k.tesselaar@umcutrecht.nl	de Boer, Rob/B-6050-2011	de Boer, Rob/0000-0002-2130-691X; Tesselaar, Kiki/0000-0002-9847-0814; Mul, FPJ/0000-0002-8234-9972	Landsteiner Foundation for Blood Transfusion Research (LSBR) [0210]; Netherlands Organization for Scientific Research (NWO) [016.048.603, 917.96.350, 836.07.002]	Landsteiner Foundation for Blood Transfusion Research (LSBR); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors would like to thank V. Ganusov, M. Hazenberg, H. Starrevelt, S. Greeven, and L. Nijdam for technical assistance and theoretical input and L. Meyaard and G. van Bleek for critical comments on an earlier version of the manuscript. Thymic tissue for TREC analyses in thymocytes was kindly provided by K. Jansen. This research has been funded by the Landsteiner Foundation for Blood Transfusion Research (LSBR grant 0210) and the Netherlands Organization for Scientific Research (NWO, grants 016.048.603, 917.96.350 and 836.07.002).	Ahmed M, 2009, J IMMUNOL, V182, P784, DOI 10.4049/jimmunol.182.2.784; Asquith B, 2002, TRENDS IMMUNOL, V23, P596, DOI 10.1016/S1471-4906(02)02337-2; BAARS PA, 1995, J IMMUNOL, V154, P17; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; BINNS RM, 1988, IMMUNOLOGY, V63, P261; Borghans JAM, 2007, IMMUNOL REV, V216, P35; Broers AEC, 2002, EXP HEMATOL, V30, P745, DOI 10.1016/S0301-472X(02)00825-1; Crooks GM, 2006, BIOL BLOOD MARROW TR, V12, P42, DOI 10.1016/j.bbmt.2005.10.015; De Boer RJ, 2006, CURR OPIN HIV AIDS, V1, P16, DOI 10.1097/01.COH.0000194105.12816.6a; Di Rosa F, 1999, J IMMUNOL, V163, P1253; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Dutilh BE, 2003, J THEOR BIOL, V224, P351, DOI 10.1016/S0022-5193(03)00172-3; Efron B, 1986, STAT SCI, V1, P54, DOI 10.1214/ss/; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Halnon NJ, 2005, PEDIATR RES, V57, P42, DOI 10.1203/01.PDR.0000147735.19342.DE; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harris JM, 2005, CLIN IMMUNOL, V115, P138, DOI 10.1016/j.clim.2004.12.008; Hazenberg MD, 2004, BLOOD, V104, P3513, DOI 10.1182/blood-2004-03-0805; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Holder JE, 2006, EUR J IMMUNOL, V36, P2624, DOI 10.1002/eji.200636096; Jamieson BD, 1999, IMMUNITY, V10, P569, DOI 10.1016/S1074-7613(00)80056-4; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2005, EUR J IMMUNOL, V35, P1987, DOI 10.1002/eji.200526181; LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604; Mackall CL, 1997, IMMUNOL REV, V157, P61, DOI 10.1111/j.1600-065X.1997.tb00974.x; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Marusic M, 1998, CLIN EXP IMMUNOL, V111, P450; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Previs SF, 1996, J MASS SPECTROM, V31, P639, DOI 10.1002/(SICI)1096-9888(199606)31:6<639::AID-JMS336>3.0.CO;2-S; Ribeiro RM, 2008, JAIDS-J ACQ IMM DEF, V49, P1, DOI 10.1097/QAI.0b013e318184fb28; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Sempowski GD, 2001, J IMMUNOL, V166, P2808, DOI 10.4049/jimmunol.166.4.2808; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	51	332	340	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					288	297		10.1016/j.immuni.2012.02.006	http://dx.doi.org/10.1016/j.immuni.2012.02.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365666	Green Submitted, Bronze			2022-12-18	WOS:000300812400016
J	Kalesnikoff, J; Huber, M; Lam, V; Damen, JE; Zhang, J; Siraganian, RP; Krystal, G				Kalesnikoff, J; Huber, M; Lam, V; Damen, JE; Zhang, J; Siraganian, RP; Krystal, G			Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival	IMMUNITY			English	Article							FC-EPSILON-RI; PROTEIN-KINASE; IN-VIVO; STEEL FACTOR; LIPID RAFTS; GAMMA-RIII; RECEPTOR; ACTIVATION; EXPRESSION; BINDING	Although IgE binding to mast cells is thought to be a passive presensitization step, we demonstrate herein that monomeric IgE (mIgE) in the absence of antigen (Ag) stimulates multiple phosphorylation events in normal murine bone marrow-derived mast cells (BMMCs). While mIgE does not induce degranulation or leukotriene synthesis, it leads to a more potent production of cytokines than IgE + Ag. Moreover, mIgE prevents the apoptosis of cytokine-deprived BMMCs, likely by maintaining Bcl-X-L levels and producing autocrine-acting cytokines. The addition of Ag does not increase this IgE-induced survival. Since IgE concentrations as low as 0.1 mug/ml enhance BMMC survival, elevated plasma IgE levels in humans with atopic disorders may contribute to the elevated mast cell numbers seen in these individuals.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; NIDCR, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; Univ Freiburg, Dept Mol Immunol Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	British Columbia Cancer Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Freiburg; Max Planck Society	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Krystal, Gerald/0000-0002-1961-6281	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000696, ZIADE000696] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; BAUMGARTNER RA, 1994, J IMMUNOL, V153, P2609; BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; BENNICH H, 1970, VOX SANG, V19, P1, DOI 10.1111/j.1423-0410.1970.tb01490.x; Corry DB, 1999, NATURE, V402, pB18; DAERON M, 1980, CELL IMMUNOL, V49, P178, DOI 10.1016/0008-8749(80)90067-2; de Paulis A, 1999, J IMMUNOL, V163, P2799; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; FRIGERI LG, 1992, J IMMUNOL, V148, P861; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168; Gommerman JL, 1998, BLOOD, V91, P1891, DOI 10.1182/blood.V91.6.1891.1891_1891_1900; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Holowka D, 2000, J CELL SCI, V113, P1009; Hsu C, 1996, IMMUNOL LETT, V52, P129, DOI 10.1016/0165-2478(96)02599-0; Huber M, 1998, EMBO J, V17, P7311, DOI 10.1093/emboj/17.24.7311; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; INMAN JK, 1969, BIOCHEMISTRY-US, V8, P4074, DOI 10.1021/bi00838a026; KATZ HR, 1995, INT ARCH ALLERGY IMM, V107, P76, DOI 10.1159/000236936; KAWAKAMI T, 1992, J IMMUNOL, V148, P3513; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kozawa O, 1999, J CELL BIOCHEM, V74, P479, DOI 10.1002/(SICI)1097-4644(19990901)74:3<479::AID-JCB15>3.3.CO;2-0; KULCZYCK.A, 1974, J EXP MED, V140, P1676, DOI 10.1084/jem.140.6.1676; KUROSAKI T, 1992, J EXP MED, V175, P447, DOI 10.1084/jem.175.2.447; Lai YH, 1999, J IMMUNOL, V162, P78; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Lu-Kuo JM, 2000, J BIOL CHEM, V275, P6022, DOI 10.1074/jbc.275.8.6022; MacGlashan DW, 1997, INT ARCH ALLERGY IMM, V113, P45; MAO SY, 1993, J IMMUNOL, V151, P2760; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Ozes ON, 1999, NATURE, V401, P82; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; SULLIVAN JD, 1983, APPL ENVIRON MICROB, V45, P720, DOI 10.1128/AEM.45.2.720-722.1983; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; TRUFFABACHI P, 1970, P NATL ACAD SCI USA, V66, P685, DOI 10.1073/pnas.66.3.685; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; YANAGIDA M, 1995, BLOOD, V86, P3705, DOI 10.1182/blood.V86.10.3705.bloodjournal86103705	48	332	343	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					801	811		10.1016/S1074-7613(01)00159-5	http://dx.doi.org/10.1016/S1074-7613(01)00159-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420049	Bronze			2022-12-18	WOS:000169495100015
J	Lammas, DA; Stober, C; Harvey, CJ; Kendrick, N; Panchalingam, S; Kumararatne, DS				Lammas, DA; Stober, C; Harvey, CJ; Kendrick, N; Panchalingam, S; Kumararatne, DS			ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X(7)) receptors	IMMUNITY			English	Article							EXTRACELLULAR ATP; HUMAN-LYMPHOCYTES; CALMETTE-GUERIN; IFN-GAMMA; TUBERCULOSIS; INHIBITION; APOPTOSIS; LYSIS; CELLS; ACTIVATION	The death of BCG-infected human macrophages induced in vitro by ligation of surface CD95 (Fas), CD69, or complement-mediated lysis was shown not to result in the death of intracellular mycobacteria, whereas exposure to extracellular ATP initiated both macrophage death and killed the intracellular bacteria. ATP acted via P2Z receptors because these effects were mimicked by benzoylbenzoic ATP (a known agonist of P2Z receptors) and blocked by oxidized ATP, DIDS, suramin, amiloride, and KN62 (known inhibitors of P2Z-mediated responses). ATP-mediated bacterial killing was independent of reactive nitrogen and oxygen intermediates and of actinomycin D or cycloheximide inhibition. ATP-induced macrophage cell death, BCG killing, and lucifer yellow dye incorporation were minimal in 2 out of 19 healthy donors. The results suggest possible genetic heterogeneity of this mechanism of mycobacterial killing associated with P2Z-mediated pore formation.	UNIV BIRMINGHAM,SCH MED,DEPT INFECT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; CITY HOSP NHS TRUST,DEPT IMMUNOL,BIRMINGHAM B18 7QH,W MIDLANDS,ENGLAND	University of Birmingham	Lammas, DA (corresponding author), UNIV BIRMINGHAM,SCH MED,DEPT IMMUNOL,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND.		PANCHALINGAM, SANDRA/W-2663-2019	Panchalingam, Sandra/0000-0003-3526-1457				ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.iy.02.040184.001435; BARNES PF, 1996, CURR TOP MICROBIOL, P197; BLANCHARD DK, 1991, J IMMUNOL, V147, P2579; BLANCHARD DK, 1995, BLOOD, V85, P3173, DOI 10.1182/blood.V85.11.3173.bloodjournal85113173; BRONTE V, 1996, BIOCHEM BIOPH RES CO, V218, P314; BUELL G, 1997, IN PRESS RECEPTORS C; Dannenberg Arthur M. Jr., 1994, P459; DEMARIA R, 1994, J EXP MED, V180, P1999, DOI 10.1084/jem.180.5.1999; DIVIRGILIO F, 1990, IMMUNOL TODAY, V11, P274, DOI 10.1016/0167-5699(90)90111-L; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; ELMOATASSIM C, 1993, J BIOL CHEM, V268, P15571; FALAZONI S, 1995, J CLIN INVEST, V95, P1207; FAZAL N, 1995, CLIN EXP IMMUNOL, V99, P82; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; GONZALEZ FA, 1990, P NATL ACAD SCI USA, V67, P9717; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GORMAN A, 1996, APOPTOSIS, P1; Humphreys BD, 1996, J IMMUNOL, V157, P5627; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Laochumroonvorapong P, 1997, INFECT IMMUN, V65, P127, DOI 10.1128/IAI.65.1.127-132.1997; Laochumroonvorapong P, 1996, INFECT IMMUN, V64, P452, DOI 10.1128/IAI.64.2.452-459.1996; MALIN AS, 1995, THORAX S1, V1, P537; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MURGIA M, 1993, J BIOL CHEM, V268, P8199; NUTTLE LC, 1993, MOL PHARMACOL, V44, P93; OBRIEN L, 1996, CURR TOP MICROBIOL, P97; ORME IM, 1996, CURR TOP MICROBIOL, P181; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; REIF DW, 1995, ARCH BIOCHEM BIOPHYS, V320, P170, DOI 10.1006/abbi.1995.1356; RICHARDSON BC, 1994, EUR J IMMUNOL, V24, P2640, DOI 10.1002/eji.1830241111; SEGAL AW, 1974, LANCET, V2, P1248; SMITH RM, 1991, BLOOD, V77, P673; SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; STEINBERG TH, 1988, J CELL BIOL, V107, P887, DOI 10.1083/jcb.107.3.887; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; SUPRENANT A, 1996, SCIENCE, V272, P735; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tascon RE, 1996, NAT MED, V2, P888, DOI 10.1038/nm0896-888; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; WILEY JS, 1992, ARCH BIOCHEM BIOPHYS, V292, P411, DOI 10.1016/0003-9861(92)90010-T; WILEY JS, 1993, ARCH BIOCHEM BIOPHYS, V305, P54, DOI 10.1006/abbi.1993.1392	46	332	346	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					433	444		10.1016/S1074-7613(00)80364-7	http://dx.doi.org/10.1016/S1074-7613(00)80364-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830	9324363	Bronze			2022-12-18	WOS:A1997XY83000012
J	Ouyang, WJ; O'Garra, A				Ouyang, Wenjun; O'Garra, Anne			IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation	IMMUNITY			English	Review							ARYL-HYDROCARBON RECEPTOR; INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; FACTOR C-MAF; DENDRITIC CELLS; CUTTING EDGE; INDUCIBLE FACTOR; INTERLEUKIN-22 PROTECTS; IFN-GAMMA	Cytokines are among the most important effector and messenger molecules in the immune system. They profoundly participate in immune responses during infection and inflammation, protecting against or contributing to diseases such as allergy, autoimmunity, and cancer. Manipulating cytokine path Jays, therefore, is one of the most effective strategies to treat various diseases. IL-10 family cytokines exert essential functions to maintain tissue homeostasis during infection and inflammation through restriction of excessive inflammatory responses, upregulation of innate immunity, and promotion of tissue repairing mechanisms. Their important functions in diseases are supported by data from many preclinical models, human genetic studies, and clinical interventions. Despite significant efforts, however, there is still no clinically approved therapy through manipulating IL-10 family cytokines. Here, we summarize the recent progress in understanding the biology of this family of cytokines, suggesting more specific strategies to maneuver these cytokines for the effective treatment of inflammatory diseases and cancers.	[Ouyang, Wenjun] Amgen Inc, Dept Inflammat & Oncol Res, San Francisco, CA 94080 USA; [O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, 1 Midland Rd, London NW1 1AT, England	Amgen; Francis Crick Institute	Ouyang, WJ (corresponding author), Amgen Inc, Dept Inflammat & Oncol Res, San Francisco, CA 94080 USA.; O'Garra, A (corresponding author), Francis Crick Inst, Lab Immunoregulat & Infect, 1 Midland Rd, London NW1 1AT, England.	wouyang@amgen.com; anne.ogarra@crick.ac.uk	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864; O'Garra, Anne/0000-0001-9845-6134	MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5; Avitabile S, 2015, J INVEST DERMATOL, V135, P2862, DOI 10.1038/jid.2015.278; Balasa B, 2000, J IMMUNOL, V165, P2841, DOI 10.4049/jimmunol.165.5.2841; Balasa B, 2000, J IMMUNOL, V165, P7330, DOI 10.4049/jimmunol.165.12.7330; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bergmann H, 2017, EUR J IMMUNOL, V47, P1342, DOI 10.1002/eji.201646765; Berman RM, 1996, J IMMUNOL, V157, P231; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brucklacher-Waldert V, 2017, CELL REP, V19, P2357, DOI 10.1016/j.celrep.2017.05.052; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Caielli S, 2019, NAT MED, V25, P75, DOI 10.1038/s41591-018-0254-9; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; CHEN WF, 1991, J IMMUNOL, V147, P528; Cibrian D, 2016, NAT IMMUNOL, V17, P985, DOI 10.1038/ni.3504; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cochez PM, 2016, EUR J IMMUNOL, V46, P1449, DOI 10.1002/eji.201546070; Coomes S. M., 2017, J EXP MED, V174, P1209; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Danne C, 2018, MICROB CELL, V5, P208, DOI 10.15698/mic2018.04.626; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Dudakov JA, 2017, BLOOD, V130, P933, DOI 10.1182/blood-2017-01-762658; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Eberhardt MK, 2014, CURR TOP MICROBIOL, V380, P93, DOI 10.1007/978-3-662-43492-5_5; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Engelhardt KR, 2014, CURR TOP MICROBIOL, V380, P1, DOI 10.1007/978-3-662-43492-5_1; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fujii S, 2001, BLOOD, V98, P2143, DOI 10.1182/blood.V98.7.2143; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Gabrysova L., 2018, BIORXIV, DOI [10.1101/287920, DOI 10.1101/287920]; Gabrysova L, 2018, J EXP MED, V215, P1767, DOI 10.1084/jem.20180824; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Galeazzi M, 2014, ISR MED ASSOC J, V16, P666; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Giacomin PR, 2015, J EXP MED, V212, P1513, DOI 10.1084/jem.20141831; GIOVARELLI M, 1995, J IMMUNOL, V155, P3112; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gottlieb AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134703; Gray J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9412; Groux H, 1998, J IMMUNOL, V160, P3188; Gruarin P, 2019, EUR J IMMUNOL, V49, P96, DOI 10.1002/eji.201847722; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Guttman-Yassky E, 2018, J AM ACAD DERMATOL, V78, P872, DOI 10.1016/j.jaad.2018.01.016; Haining WN, 2018, NAT IMMUNOL, V19, P429, DOI 10.1038/s41590-018-0087-1; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Howes A, 2016, J IMMUNOL, V197, P2838, DOI 10.4049/jimmunol.1501923; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Hsu YH, 2010, ARTHRITIS RHEUM-US, V62, P3311, DOI 10.1002/art.27689; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jiang HP, 1995, ONCOGENE, V11, P2477; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Justa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093279; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kolumam G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170639; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Laurans L, 2018, NAT MED, V24, P1113, DOI 10.1038/s41591-018-0060-4; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Lee DW, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.434; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Leng RX, 2011, EXPERT OPIN THER TAR, V15, P119, DOI 10.1517/14728222.2011.534461; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Li W, 2014, INT IMMUNOL, V26, P269, DOI 10.1093/intimm/dxt065; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lino AC, 2018, IMMUNITY, V49, P120, DOI 10.1016/j.immuni.2018.06.007; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MacKenzie KF, 2014, CRIT REV IMMUNOL, V34, P315, DOI 10.1615/CritRevImmunol.2014010694; MALEFYT RD, 1991, J EXP MED, V174, P915; Malhotra N, 2016, J ALLERGY CLIN IMMUN, V138, P1098, DOI 10.1016/j.jaci.2016.07.001; Mannino MH, 2015, CANCER LETT, V367, P103, DOI 10.1016/j.canlet.2015.07.009; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martin JC, 2016, MUCOSAL IMMUNOL, V9, P539, DOI 10.1038/mi.2015.83; Martin JCJ, 2014, MUCOSAL IMMUNOL, V7, P101, DOI 10.1038/mi.2013.28; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Moreira-Teixeira L, 2017, J IMMUNOL, V199, P613, DOI 10.4049/jimmunol.1601340; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Naing A, 2016, J CLIN ONCOL, V34, P3562, DOI 10.1200/JCO.2016.68.1106; Neumann C, 2019, NAT IMMUNOL, V20, P471, DOI 10.1038/s41590-019-0316-2; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Ng CT, 2012, P NATL ACAD SCI USA, V109, P14116, DOI 10.1073/pnas.1211910109; Ngo VL, 2018, P NATL ACAD SCI USA, V115, pE5076, DOI 10.1073/pnas.1718902115; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oft M, 2014, CANCER IMMUNOL RES, V2, P194, DOI 10.1158/2326-6066.CIR-13-0214; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Oldstone MBA, 2015, J INFECT DIS, V212, pS31, DOI 10.1093/infdis/jiu501; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pelczar P, 2016, SCIENCE, V354, P358, DOI 10.1126/science.aah5903; Perucha E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08332-9; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Radaeva S., 2004, HEPATOLOGY, V39; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Redhu NS, 2017, ELIFE, V6, DOI 10.7554/eLife.27652; Ren XD, 2010, AM J PHYSIOL-GASTR L, V298, pG74, DOI 10.1152/ajpgi.00075.2009; RICHTER G, 1993, CANCER RES, V53, P4134; Robb CT, 2018, J ALLERGY CLIN IMMUN, V141, P152, DOI 10.1016/j.jaci.2017.04.045; Roncarolo MG, 2018, IMMUNITY, V49, P1004, DOI 10.1016/j.immuni.2018.12.001; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Rothenberg ME, 2019, CLIN PHARMACOL THER, V105, P177, DOI 10.1002/cpt.1164; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Rutz S, 2008, P NATL ACAD SCI USA, V105, P3497, DOI 10.1073/pnas.0712102105; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sakamoto K, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8371; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Senolt L, 2015, ARTHRITIS RHEUMATOL, V67, P1438, DOI 10.1002/art.39083; Sheikh F, 2004, J IMMUNOL, V172, P2006, DOI 10.4049/jimmunol.172.4.2006; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Smith CL, 2013, J IMMUNOL, V191, P1845, DOI 10.4049/jimmunol.1202716; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Stefanich EG, 2018, BIOCHEM PHARMACOL, V152, P224, DOI 10.1016/j.bcp.2018.03.031; Stewart CA, 2013, J CLIN INVEST, V123, P4859, DOI 10.1172/JCI65180; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tang KY, 2019, CELL MOL IMMUNOL, V16, P473, DOI 10.1038/s41423-018-0029-8; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Trevejo-Nunez G, 2016, J IMMUNOL, V197, P1877, DOI 10.4049/jimmunol.1600528; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tsai PY, 2017, CELL HOST MICROBE, V21, P671, DOI 10.1016/j.chom.2017.05.009; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Victor AR, 2017, J IMMUNOL, V199, P2333, DOI 10.4049/jimmunol.1601554; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; Vigne S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01184; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wang X., 2017, COLD SPRING HARB PER, V11; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Xue J, 2012, GASTROENTEROLOGY, V143, P1670, DOI 10.1053/j.gastro.2012.08.051; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang P, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7152; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	285	331	355	20	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					871	891		10.1016/j.immuni.2019.03.020	http://dx.doi.org/10.1016/j.immuni.2019.03.020			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995504	Bronze			2022-12-18	WOS:000464660800008
J	Posey, AD; Schwab, RD; Boesteanu, AC; Steentoft, C; Mandel, U; Engels, B; Stone, JD; Madsen, TD; Schreiber, K; Haines, KM; Cogdill, AP; Chen, TJ; Song, DC; Scholler, J; Kranz, DM; Feldman, MD; Young, R; Keith, B; Schreiber, H; Clausen, H; Johnson, LA; June, CH				Posey, Avery D., Jr.; Schwab, Robert D.; Boesteanu, Alina C.; Steentoft, Catharina; Mandel, Ulla; Engels, Boris; Stone, Jennifer D.; Madsen, Thomas D.; Schreiber, Karin; Haines, Kathleen M.; Cogdill, Alexandria P.; Chen, Taylor J.; Song, Decheng; Scholler, John; Kranz, David M.; Feldman, Michael D.; Young, Regina; Keith, Brian; Schreiber, Hans; Clausen, Henrik; Johnson, Laura A.; June, Carl H.			Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma	IMMUNITY			English	Article							O-GLYCOSYLATION; CHIMERIC RECEPTORS; MULTIPLE-MYELOMA; CHAPERONE COSMC; ANTIGEN; EXPRESSION; CARCINOMA; LEUKEMIA; DOMAINS; VACCINE	Genetically modified T cells expressing chimeric antigen receptors (CARs) demonstrate robust responses against lineage restricted, non-essential targets in hematologic cancers. However, in solid tumors, the full potential of CAR T cell therapy is limited by the availability of cell surface antigens with sufficient cancer-specific expression. The majority of CAR targets have been normal self-antigens on dispensable hematopoietic tissues or overexpressed shared antigens. Here, we established that abnormal self-antigens can serve as targets for tumor rejection. We developed a CAR that recognized cancer-associated Tn glycoform of MUC1, a neoantigen expressed in a variety of cancers. Anti-Tn-MUC1 CAR T cells demonstrated target-specific cytotoxicity and successfully controlled tumor growth in xenograft models of T cell leukemia and pancreatic cancer. These findings demonstrate the therapeutic efficacy of CAR T cells directed against Tn-MUC1 and present aberrantly glycosylated antigens as a novel class of targets for tumor therapy with engineered T cells.	[Posey, Avery D., Jr.; Schwab, Robert D.; Boesteanu, Alina C.; Haines, Kathleen M.; Cogdill, Alexandria P.; Chen, Taylor J.; Song, Decheng; Scholler, John; Young, Regina; Keith, Brian; Johnson, Laura A.; June, Carl H.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Posey, Avery D., Jr.; Schwab, Robert D.; Boesteanu, Alina C.; Haines, Kathleen M.; Cogdill, Alexandria P.; Chen, Taylor J.; Song, Decheng; Scholler, John; Young, Regina; Keith, Brian; Johnson, Laura A.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Steentoft, Catharina; Mandel, Ulla; Madsen, Thomas D.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Steentoft, Catharina; Mandel, Ulla; Madsen, Thomas D.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Odontol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Engels, Boris; Schreiber, Karin; Schreiber, Hans] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Stone, Jennifer D.; Kranz, David M.] Univ Illinois, Dept Biochem, Champaign, IL USA; [Feldman, Michael D.; Johnson, Laura A.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Engels, Boris] Novartis Inst BioMed Res, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Copenhagen; University of Copenhagen; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; Pennsylvania Medicine; Novartis	Posey, AD; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Posey, AD; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA.	aposey@mail.med.upenn.edu; cjune@exchange.upenn.edu	clausen, henrik/AAD-8016-2021; Posey, Avery D./P-4890-2019	Posey, Avery D./0000-0001-8711-629X; Madsen, Thomas Daugbjerg/0000-0002-7598-4636; Clausen, Henrik/0000-0002-0915-5055; Steentoft, Catharina/0000-0002-1424-6736; Schwab, Robert/0000-0001-8419-601X; Mandel, Ulla/0000-0001-7012-9836; Cogdill, Alexandria/0000-0001-8917-9462	Novartis; National Institutes of Health [5R01CA120409, 5R01CA037156, DP2 CA174502]; Danish Research Councils [DFF - 4004-00397B]; Danish National Research Foundation [DNRF107]; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [R01CA120409, R01CA022677, DP2CA174502, R01CA037156] Funding Source: NIH RePORTER	Novartis(Novartis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Councils(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for advice from Michael Milone and Robert Vonderheide, the Perelman School of Medicine Stem Cell & Xenograft Core, the Human Immunology Core, the Cancer Histology Core, and for staff in the animal facility for assistance with experiments. Supported in part by a grant from Novartis and National Institutes of Health (5R01CA120409, C.H.J.; 5R01CA037156, H.S. and H.C.; and DP2 CA174502, L.A.J.), The Danish Research Councils (DFF - 4004-00397B, C.S.), and The Danish National Research Foundation (DNRF107, H.C.). A.D.P. and C.H.J. are members of the Parker Institute for Cancer Immunotherapy, which supported the University of Pennsylvania Cancer Immunotherapy Program. The University of Copenhagen has patented the 5E5 antibody and antigen epitope. The University of Chicago has filed a patent on the 5E5 CAR and an invention disclosure has been filed on these studies. The University of Pennsylvania has entered into a strategic alliance with Novartis for the development of chimeric antigen receptors. This arrangement is managed in accordance with the University of Pennsylvania's Conflict of Interest Policy. The authors are in compliance with this policy.	Andrulis M, 2014, HISTOPATHOLOGY, V64, P799, DOI 10.1111/his.12330; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cloosen S, 2006, BRIT J HAEMATOL, V135, P513, DOI 10.1111/j.1365-2141.2006.06331.x; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Finn OJ, 2011, IMMUNOL RES, V50, P261, DOI 10.1007/s12026-011-8214-1; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Graham RA, 1996, CANCER IMMUNOL IMMUN, V42, P71, DOI 10.1007/s002620050254; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Itzkowitz S, 2003, J CLIN GASTROENTEROL, V36, pS70, DOI 10.1097/00004836-200305001-00012; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Katsuhara A, 2015, ANTICANCER RES, V35, P1251; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lin CY, 2014, HISTOPATHOLOGY, V64, P713, DOI 10.1111/his.12309; Madsen CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072413; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Ohno S, 2006, ANTICANCER RES, V26, P4047; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Ren DL, 2014, IUBMB LIFE, V66, P300, DOI 10.1002/iub.1268; Sabbatini PJ, 2007, CLIN CANCER RES, V13, P4170, DOI 10.1158/1078-0432.CCR-06-2949; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stone JD, 2012, ONCOIMMUNOLOGY, V1, P863, DOI 10.4161/onci.20592; Tamura F., 2014, GASTRIC CANC OFFICIA; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Van Elssen CHMJ, 2010, HISTOPATHOLOGY, V57, P597, DOI 10.1111/j.1365-2559.2010.03667.x; Victorzon M, 1996, INT J CANCER, V65, P295, DOI 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893	51	331	360	8	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1444	1454		10.1016/j.immuni.2016.05.014	http://dx.doi.org/10.1016/j.immuni.2016.05.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332733	Green Accepted, Bronze			2022-12-18	WOS:000378341200021
J	Doering, TA; Crawford, A; Angelosanto, JM; Paley, MA; Ziegler, CG; Wherry, EJ				Doering, Travis A.; Crawford, Alison; Angelosanto, Jill M.; Paley, Michael A.; Ziegler, Carly G.; Wherry, E. John			Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8(+) T Cell Exhaustion versus Memory	IMMUNITY			English	Article							QUIESCENCE; FRAMEWORK; RESPONSES; DIFFERENTIATION; EXPRESSION; ANTIBODY; GENOME; SAFETY; PD-1	Exhausted CD8(+) T cells function poorly and are negatively regulated by inhibitory receptors. Transcriptional profiling has identified gene expression changes associated with exhaustion. However, the transcriptional pathways critical to the differences between exhausted and functional memory CD8(+) T cells are unclear. We thus defined transcriptional coexpression networks to define pathways centrally involved in exhaustion versus memory. These studies revealed differences between exhausted and memory CD8(+) T cells including the following: lack of coordinated transcriptional modules of quiescence during exhaustion, centrally connected hub genes, pathways such as transcription factors, genes involved in regulation of immune responses, and DNA repair genes, as well as differential connectivity for genes including T-bet, Eomes, and other transcription factors. These data identify pathways involved in CD8(+) T cell exhaustion, and highlight the context-dependent nature of transcription factors in exhaustion versus memory.	[Doering, Travis A.; Crawford, Alison; Angelosanto, Jill M.; Paley, Michael A.; Ziegler, Carly G.; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Doering, Travis A.; Crawford, Alison; Angelosanto, Jill M.; Paley, Michael A.; Ziegler, Carly G.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	crawford, alison/AAS-3155-2020; Wherry, John/ABI-1280-2020; Crawford, Alison/N-3234-2014	Ziegler, Carly/0000-0002-8279-7150; Paley, Michael/0000-0001-8724-3176; Crawford, Alison/0000-0002-4591-6341	National Institutes of Health [A1082630, A1083022, A1078897, HHSN266200500030C]; Dana Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, U19AI082630, R01AI071309, U19AI083022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Wherry laboratory for helpful suggestions and feedback. We also thank Avinash Bhandoola, Mark Siracusa, and Michael Abt for comments and input. This work was supported by the National Institutes of Health (A1082630, A1083022, A1078897, and HHSN266200500030C to E.J.W.) and the Dana Foundation (E.J.W). E.J.W. has a patent licensing agreement on the PD-1 pathway.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Menendez D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001360; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	53	330	345	5	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1130	1144		10.1016/j.immuni.2012.08.021	http://dx.doi.org/10.1016/j.immuni.2012.08.021			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23159438	Green Accepted, Bronze			2022-12-18	WOS:000312575000019
J	Kerfoot, SM; Yaari, G; Patel, JR; Johnson, KL; Gonzalez, DG; Kleinstein, SH; Haberman, AM				Kerfoot, Steven M.; Yaari, Gur; Patel, Jaymin R.; Johnson, Kody L.; Gonzalez, David G.; Kleinstein, Steven H.; Haberman, Ann M.			Germinal Center B Cell and T Follicular Helper Cell Development Initiates in the Interfollicular Zone	IMMUNITY			English	Article							IN-VIVO; IMMUNE-RESPONSES; DENDRITIC CELLS; BCL6; DIFFERENTIATION; GENERATION; DYNAMICS; BLIMP-1; ANTIGEN; PHASES	We identify the interfollicular (IF) zone as the site where germinal center B cell and T follicular helper (Tfh) cell differentiation initiates. For the first 2 days postimmunization, antigen-specific T and B cells remained confined within the IF zone, formed long-lived interactions, and upregulated the transcriptional repressor BcI6. T cells also acquired the Tfh cell markers CXCR5, PD-1, and GL7. Responding B and T cells migrated to the follicle interior directly from the IF zone, T cell immigration preceding B cells by 1 day. Notably, in the absence of cognate B cells, Tfh cells still formed and migrated to the follicle. However, without such B cells, PD-1, ICOS, and GL7 were no longer expressed on follicular BcI6(hi) T cells that nevertheless persisted in the follicle. Thus, Ag-specific B cells are required for the maintenance of the PD-1(hi)ICOS(hi)GL7(hi) Tfh cell phenotype within the follicle, but not for their initial differentiation in the IF zone.	[Kerfoot, Steven M.; Patel, Jaymin R.; Johnson, Kody L.; Gonzalez, David G.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA; [Yaari, Gur; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06519 USA	Yale University; Yale University; Yale University	Haberman, AM (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06519 USA.	ann.haberman@yale.edu	Yaari, Gur/ABD-5122-2021; Kerfoot, Steven/C-1161-2015	Yaari, Gur/0000-0001-9311-9884; Kerfoot, Steven/0000-0002-5401-0373; Patel, Jaymin/0000-0002-4380-4805; Johnson, Kody/0000-0002-3335-3414	National Institutes of Health [R01AI080850, P30AR053495]; Canadian Institutes of Health Research; Gershon/Trudeau Fellowship; Multiple Sclerosis Society of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Gershon/Trudeau Fellowship; Multiple Sclerosis Society of Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to thank K. Good-Jacobson and A. Poholek for their constructive discussion and A. Hauser for her assistance in establishing the multiphoton facility. We thank M. Shlomchik for thoughtful input and critical reading of the manuscript. The excellent husbandry of A. Durso and the technicians of the Yale Animal Resources Center is also appreciated. This work was supported by National Institutes of Health grants R01AI080850 and P30AR053495. S.M.K. was supported by a fellowship from the Canadian Institutes of Health Research and the Gershon/Trudeau Fellowship, and is the current recipient of the Garrett Herman endMS Research and Training Network Career Development Award from the Multiple Sclerosis Society of Canada.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Hauser AE, 2010, SEMIN IMMUNOPATHOL, V32, P239, DOI 10.1007/s00281-010-0214-z; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Yu D, 2009, CURR OPIN IMMUNOL, V21, P619, DOI 10.1016/j.coi.2009.09.013; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505	31	330	340	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					947	960		10.1016/j.immuni.2011.03.024	http://dx.doi.org/10.1016/j.immuni.2011.03.024			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21636295	Green Accepted, Bronze			2022-12-18	WOS:000292349700014
J	Erickson, AL; Kimura, Y; Igarashi, S; Eichelberger, J; Houghton, M; Sidney, J; McKinney, D; Sette, A; Hughes, AL; Walker, CM				Erickson, AL; Kimura, Y; Igarashi, S; Eichelberger, J; Houghton, M; Sidney, J; McKinney, D; Sette, A; Hughes, AL; Walker, CM			The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes	IMMUNITY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; QUANTITATIVE-ANALYSIS; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; CELLS; VARIANT; LIVER; CTL; CHIMPANZEES; EVOLUTION	CD8(+) cytotoxic T lymphocytes (CTL) are thought to control hepatitis C virus (HCV) replication and so we investigated why this response fails in persistently infected individuals. The HCV quasispecies in three persistently infected chimpanzees acquired mutations in multiple epitopes that impaired class I MHC binding and/or CTL recognition. Most escape mutations appeared during acute infection and remained fixed in the quasispecies for years without further diversification. A statistically significant increase in the amino acid replacement rate was observed in epitopes versus adjacent regions of HCV proteins. In contrast, most epitopes were intact when hepatitis C resolved spontaneously. We conclude that CTIL exert positive selection pressure against the HCV quasispecies and the outcome of infection is predicted by mutations in class I MHC restricted epitopes.	Childrens Hosp W503, Childrens Res Inst, Columbus, OH 43205 USA; Chiron Corp, Emeryville, CA 94608 USA; Epimmune Corp, San Diego, CA 92121 USA; Univ S Carolina, Columbia, SC 29208 USA; Ohio State Univ, Dept Pediat & Mol Virol, Columbus, OH 43210 USA; Ohio State Univ, Dept Immunol, Columbus, OH 43210 USA; Ohio State Univ, Dept Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Novartis; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Walker, CM (corresponding author), Childrens Hosp W503, Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.		Sette, Alessandro/AFO-8916-2022; Yang, Chen/G-1379-2010	Houghton, Michael/0000-0003-3762-6771	NIAID NIH HHS [AI46766-01, AI38620-03, AI/DK48231, AI 95362, AI 47367] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047367, R44AI038620, N01AI095362, R43AI038620, U19AI048231, R43AI046766, R37AI047367] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 1998, J IMMUNOL, V160, P6062; BATTEGAY M, 1995, J VIROL, V69, P2462, DOI 10.1128/JVI.69.4.2462-2470.1995; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; CEMY A, 1995, J CLIN INVEST, V95, P521; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; CHOO QL, 1992, SEMIN LIVER DIS, V12, P279, DOI 10.1055/s-2007-1007399; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Eckels DD, 2000, IMMUNOL REV, V174, P90, DOI 10.1034/j.1600-0528.2002.017403.x; ERICKSON AL, 1993, J IMMUNOL, V151, P4189; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Grabowska AM, 2001, EUR J IMMUNOL, V31, P2388, DOI 10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO;2-L; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Hiroishi K, 1997, HEPATOLOGY, V25, P705, DOI 10.1002/hep.510250336; Kaneko T, 1997, EUR J IMMUNOL, V27, P1782, DOI 10.1002/eji.1830270728; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kowalski H, 1996, J EXP MED, V183, P1761, DOI 10.1084/jem.183.4.1761; KOZIEL MJ, 1992, J IMMUNOL, V149, P3339; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Manzin A, 2000, J VIROL, V74, P4327, DOI 10.1128/JVI.74.9.4327-4334.2000; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; SHIRAI M, 1994, J VIROL, V68, P3334, DOI 10.1128/JVI.68.5.3334-3342.1994; Sobao Y, 2001, HEPATOLOGY, V33, P287, DOI 10.1053/jhep.2001.21164; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tsai SL, 1998, GASTROENTEROLOGY, V115, P954, DOI 10.1016/S0016-5085(98)70268-9; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; Wong DKH, 1998, J IMMUNOL, V160, P1479; Wong DKH, 2001, J VIROL, V75, P1229, DOI 10.1128/JVI.75.3.1229-1235.2001; 1996, GUIDE CARE USE LAB A	35	330	338	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					883	895		10.1016/S1074-7613(01)00245-X	http://dx.doi.org/10.1016/S1074-7613(01)00245-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754811	Bronze			2022-12-18	WOS:000172961400004
J	Greenwald, RJ; Boussiotis, VA; Lorsbach, RB; Abbas, AK; Sharpe, AH				Greenwald, RJ; Boussiotis, VA; Lorsbach, RB; Abbas, AK; Sharpe, AH			CTLA-4 regulates induction of anergy in vivo	IMMUNITY			English	Article							CELL-CYCLE PROGRESSION; CD4(+) T-CELLS; IN-VIVO; TOLERANCE INDUCTION; PERIPHERAL TOLERANCE; CUTTING EDGE; ACTIVATION; ANTIGEN; CD28; COSTIMULATION	The requirement for CTLA-4 during the induction of peripheral T cell tolerance in vivo was investigated using naive TCR transgenic T cells lacking CTLA-4. CTLA-4(-/-) T cells are resistant to tolerance induction, as demonstrated by their proliferative responses, IL-2 production, and progression into the cell cycle. Following exposure to a tolerogenic stimulus in vivo and restimulation in vitro, wild-type T cells are blocked at the late G1 to S restriction point of the cell cycle. In contrast, CTLA-4(-/-) T cells enter into the S phase of the cell cycle, as shown by downregulation of p27(kip1), elevated cdk2 kinase activity, and Rb hyperphosphorylation. Thus, CTLA-4 has an essential role in determining the outcome of T cell encounter with a tolerogenic stimulus.	Harvard Univ, Sch Med, Div Immunol Res, Dept Pathol,Brigham & Womens Hosp, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; University of California System; University of California San Francisco	Sharpe, AH (corresponding author), Harvard Univ, Sch Med, Div Immunol Res, Dept Pathol,Brigham & Womens Hosp, Cambridge, MA 02138 USA.			Sharpe, Arlene/0000-0002-9736-2109	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041584, R21AI043552, R01AI043552, P01AI035297, R01AI040614, F32AI010415] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07627] Funding Source: Medline; NIAID NIH HHS [AI35297, AI41584, AI40614, F32AI10415, AI43552] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alegre ML, 1996, J IMMUNOL, V157, P4762; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Blair PJ, 1998, J IMMUNOL, V160, P12; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Brunner MC, 1999, J IMMUNOL, V162, P5813; Chai JG, 1997, INT IMMUNOL, V9, P935, DOI 10.1093/intimm/9.7.935; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Deeths MJ, 1999, J IMMUNOL, V163, P102; Fallarino F, 1998, J EXP MED, V188, P205, DOI 10.1084/jem.188.1.205; Frauwirth KA, 2000, J IMMUNOL, V164, P2987, DOI 10.4049/jimmunol.164.6.2987; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; GILBERT KM, 1992, CELL IMMUNOL, V141, P362, DOI 10.1016/0008-8749(92)90155-I; GILBERT KM, 1993, J IMMUNOL, V151, P1245; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Kato T, 2000, J IMMUNOL, V164, P3554, DOI 10.4049/jimmunol.164.7.3554; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Khattri R, 1999, J IMMUNOL, V162, P5784; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Oosterwegel MA, 1999, J IMMUNOL, V163, P2634; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perrin PJ, 1996, J IMMUNOL, V157, P1333; Powell JD, 1999, J IMMUNOL, V162, P2775; Scheipers P, 1998, IMMUNOL RES, V18, P103, DOI 10.1007/BF02788753; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Shrikant P, 1999, IMMUNITY, V11, P483, DOI 10.1016/S1074-7613(00)80123-5; Sotomayor EM, 1999, P NATL ACAD SCI USA, V96, P11476, DOI 10.1073/pnas.96.20.11476; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Van Parijs Luk, 1997, Journal of Experimental Medicine, V186, P1119; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; VIDARD L, 1995, P NATL ACAD SCI USA, V92, P2259, DOI 10.1073/pnas.92.6.2259; VIDARD L, 1994, P NATL ACAD SCI USA, V91, P5627, DOI 10.1073/pnas.91.12.5627; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Walunas TL, 1998, J IMMUNOL, V160, P3855; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang LM, 1997, PARASITE, V4, P94	46	329	343	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					145	155		10.1016/S1074-7613(01)00097-8	http://dx.doi.org/10.1016/S1074-7613(01)00097-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239447	Bronze			2022-12-18	WOS:000167092500005
J	Shouval, DS; Biswas, A; Goettel, JA; McCann, K; Conaway, E; Redhu, NS; Mascanfroni, ID; Al Adham, Z; Lavoie, S; Ibourk, M; Nguyen, DD; Samsom, JN; Escher, JC; Somech, R; Weiss, B; Beier, R; Conklin, LS; Ebens, CL; Santos, FGMS; Ferreira, AR; Sherlock, M; Bhan, AK; Muller, W; Mora, JR; Quintana, FJ; Klein, C; Muise, AM; Horwitz, BH; Snapper, SB				Shouval, Dror S.; Biswas, Amlan; Goettel, Jeremy A.; McCann, Katelyn; Conaway, Evan; Redhu, Naresh S.; Mascanfroni, Ivan D.; Al Adham, Ziad; Lavoie, Sydney; Ibourk, Mouna; Nguyen, Deanna D.; Samsom, Janneke N.; Escher, Johanna C.; Somech, Raz; Weiss, Batia; Beier, Rita; Conklin, Laurie S.; Ebens, Christen L.; Santos, Fernanda G. M. S.; Ferreira, Alexandre R.; Sherlock, Mary; Bhan, Atul K.; Mueller, Werner; Mora, J. Rodrigo; Quintana, Francisco J.; Klein, Christoph; Muise, Aleixo M.; Horwitz, Bruce H.; Snapper, Scott B.			Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; T-CELLS; LY6C(HI) MONOCYTES; IL-10; MICE; DIFFERENTIATION; COLITIS; SUPPRESSION; HOMEOSTASIS	Intact interleukin-10 receptor (IL-10R) signaling on effector and T regulatory (Treg) cells are each independently required to maintain immune tolerance. Here we show that IL-10 sensing by innate immune cells, independent of its effects on T cells, was critical for regulating mucosal homeostasis. Following wild-type (WT) CD4(+) T cell transfer, Rag2(-/-)Il10rb(-/-) mice developed severe colitis in association with profound defects in generation and function of Treg cells. Moreover, loss of IL-10R signaling impaired the generation and function of anti-inflammatory intestinal and bone-marrow-derived macrophages and their ability to secrete IL-10. Importantly, transfer of WT but not Il10rb(-/-) anti-inflammatory macrophages ameliorated colitis induction by WT CD4(+) T cells in Rag2(-/-) Il10rb(-/-) mice. Similar alterations in the generation and function of anti-inflammatory macrophages were observed in IL-10R-deficient patients with very early onset inflammatory bowel disease. Collectively, our studies define innate immune IL-10R signaling as a key factor regulating mucosal immune homeostasis in mice and humans.	[Shouval, Dror S.; Biswas, Amlan; Goettel, Jeremy A.; McCann, Katelyn; Redhu, Naresh S.; Lavoie, Sydney; Ibourk, Mouna; Snapper, Scott B.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA; [Shouval, Dror S.; Biswas, Amlan; Goettel, Jeremy A.; McCann, Katelyn; Redhu, Naresh S.; Horwitz, Bruce H.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Conaway, Evan; Horwitz, Bruce H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mascanfroni, Ivan D.; Quintana, Francisco J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Al Adham, Ziad; Muise, Aleixo M.] Hosp Sick Children, Dept Paediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Nguyen, Deanna D.; Mora, J. Rodrigo] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Nguyen, Deanna D.; Mora, J. Rodrigo; Snapper, Scott B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Samsom, Janneke N.] Sophia Childrens Univ Hosp, Lab Pediat Gastroenterol, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Escher, Johanna C.] Sophia Childrens Univ Hosp, Dept Pediat, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Somech, Raz] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Immunol Serv, IL-52661 Tel Hashomer, Israel; [Weiss, Batia] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Gastroenterol & Nutr, IL-52661 Tel Hashomer, Israel; [Somech, Raz; Weiss, Batia] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Beier, Rita] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Conklin, Laurie S.] Childrens Natl Med Ctr, Dept Gastroenterol, Washington, DC USA; [Ebens, Christen L.] Univ Michigan, Div Pediat Hematol & Oncol, Ann Arbor, MI 48109 USA; [Santos, Fernanda G. M. S.; Ferreira, Alexandre R.] Univ Fed Minas Gerais, Hosp Clin, BR-30130100 Belo Horizonte, MG, Brazil; [Sherlock, Mary] McMaster Childrens Hosp, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada; [Bhan, Atul K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bhan, Atul K.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, D-80337 Munich, Germany; [Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hannover Medical School; Children's National Health System; University of Michigan System; University of Michigan; Universidade Federal de Minas Gerais; McMaster University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Manchester; University of Munich; Harvard University; Brigham & Women's Hospital	Snapper, SB (corresponding author), Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA.	ssnapper@hms.harvard.edu	Muller, Werner/B-9044-2008; Quintana, Francisco Javier/AAB-6915-2020; Santos, Fernanda GMS/J-2163-2017; Ferreira, Alexandre Rodrigues/AAK-2601-2021	Muller, Werner/0000-0002-1297-9725; Santos, Fernanda GMS/0000-0002-0584-2640; Ferreira, Alexandre Rodrigues/0000-0001-6749-8980; Ebens, Christen/0000-0003-2430-911X	Crohn's and Colitis Foundation of America [RFA 3784]; NIH [HL59561, DK034854, AI50950]; Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100114, R56AI093903, R56AI050950, R01AI050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	D.S.S is a recipient of a Research Fellowship Award Grant from the Crohn's and Colitis Foundation of America (RFA 3784). S.B.S is supported by NIH Grants HL59561, DK034854, and AI50950, the Helmsley Charitable Trust, and the Wolpow Family Chair in IBD Treatment and Research. We would like to thank Thaddeus Stappenbeck for providing us Il10rb<SUP>-/-</SUP> mice on the C57BL/6 background.	Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Begue B, 2011, AM J GASTROENTEROL, V106, P1544, DOI 10.1038/ajg.2011.112; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Girard-Madoux MJH, 2012, J ALLERGY CLIN IMMUN, V129, P143, DOI 10.1016/j.jaci.2011.08.032; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hedl M, 2012, GASTROENTEROLOGY, V143, P1530, DOI 10.1053/j.gastro.2012.08.048; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; Liu B, 2011, GASTROENTEROLOGY, V141, P653, DOI 10.1053/j.gastro.2011.04.053; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nguyen DD, 2012, GASTROENTEROLOGY, V143, P719, DOI 10.1053/j.gastro.2012.06.008; Nguyen HH, 2012, J IMMUNOL, V189, P3112, DOI 10.4049/jimmunol.1200360; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	48	328	337	6	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					706	719		10.1016/j.immuni.2014.03.011	http://dx.doi.org/10.1016/j.immuni.2014.03.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24792912	Bronze, Green Accepted			2022-12-18	WOS:000336026100010
J	Shin, H; Blackburn, SD; Intlekofer, AM; Kao, C; Angelosanto, JM; Reiner, SL; Wherry, EJ				Shin, Haina; Blackburn, Shawn D.; Intlekofer, Andrew M.; Kao, Charlly; Angelosanto, Jill M.; Reiner, Steven L.; Wherry, E. John			A Role for the Transcriptional Repressor Blimp-1 in CD8(+) T Cell Exhaustion during Chronic Viral Infection	IMMUNITY			English	Article							IN-VIVO; MEMORY; EXPRESSION; EFFECTOR; BET; DIFFERENTIATION; HOMEOSTASIS; DEFINES; VIRUS; FATE	T cell exhaustion is common during chronic infections and can prevent optimal immunity. Although recent studies have demonstrated the importance of inhibitory receptors and other pathways in T cell exhaustion, the underlying transcriptional mechanisms are unknown. Here, we define a role for the transcription factor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Blimp-1 repressed key aspects of normal memory CD8(+) T cell differentiation and promoted high expression of inhibitory receptors during chronic infection. These cardinal features of CD8(+) T cell exhaustion were corrected by conditionally deleting Blimp-1. Although high expression of Blimp-1 fostered aspects of CD8(+) T cell exhaustion, haploinsufficiency indicated that moderate Blimp-1 expression sustained some effector function during chronic viral infection. Thus, we identify Blimp-1 as a transcriptional regulator of CD8(+) T cell exhaustion during chronic viral infection and propose that Blimp-1 acts as a transcriptional rheostat balancing effector function and T cell exhaustion.	[Shin, Haina; Blackburn, Shawn D.; Kao, Charlly; Angelosanto, Jill M.; Wherry, E. John] Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; [Shin, Haina; Blackburn, Shawn D.; Kao, Charlly; Angelosanto, Jill M.; Wherry, E. John] Wistar Inst Anat & Biol, Wistar Vaccine Ctr, Philadelphia, PA 19104 USA; [Intlekofer, Andrew M.; Reiner, Steven L.] Univ Penn, Dept Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA.	jwherry@wistar.org	Wherry, John/ABI-1280-2020	Intlekofer, Andrew/0000-0001-9046-6549; Shin, Haina/0000-0002-1014-1451	National Institutes of Health [A1071309, HHSN26620050030C]; Grand Challenges in Global Health Initiative; The Dana Foundation; The Ellison Medical Foundation; Cancer Center Core Grant [CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, R01AI076458, U19AI083022, R01AI042370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative; The Dana Foundation; The Ellison Medical Foundation(Lawrence Ellison Foundation); Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Wherry lab members for insightful comments and S. Kaech and R. Rutishauser for sharing unpublished data and helpful discussions. This work was supported by National Institutes of Health A1071309 and HHSN26620050030C), the Grand Challenges in Global Health Initiative, The Dana Foundation, The Ellison Medical Foundation, and the Cancer Center Core Grant (CA10815).	Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; de Souza FSJ, 1999, EMBO J, V18, P6062, DOI 10.1093/emboj/18.21.6062; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Heffner M, 2007, P NATL ACAD SCI USA, V104, P13414, DOI 10.1073/pnas.0706040104; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Trabattoni D, 2004, AIDS, V18, P859, DOI 10.1097/00002030-200404090-00003; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	57	328	346	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2009	31	2					309	320		10.1016/j.immuni.2009.06.019	http://dx.doi.org/10.1016/j.immuni.2009.06.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19664943	Green Accepted, Bronze			2022-12-18	WOS:000269338600016
J	LYNCH, DH; WATSON, ML; ALDERSON, MR; BAUM, PR; MILLER, RE; TOUGH, T; GIBSON, M; DAVISSMITH, T; SMITH, CA; HUNTER, K; BHAT, D; DIN, W; GOODWIN, RG; SELDIN, MF				LYNCH, DH; WATSON, ML; ALDERSON, MR; BAUM, PR; MILLER, RE; TOUGH, T; GIBSON, M; DAVISSMITH, T; SMITH, CA; HUNTER, K; BHAT, D; DIN, W; GOODWIN, RG; SELDIN, MF			THE MOUSE FAS-LIGAND GENE IS MUTATED IN GLD MICE AND IS PART OF A TNF FAMILY GENE-CLUSTER	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR RECEPTOR; MOLECULAR-CLONING; LINKAGE MAP; CELL-SURFACE; EXPRESSION; APOPTOSIS; ANTIGEN; MEMBER; LPR	The gene for the mouse Fas ligand was cloned and its chromosomal position determined. Fasl was tightly linked to gld (no crossovers in 567 meiotic events) on mouse chromosome 1 and closely linked with a novel member of the same TNF family of ligands, the Ox40 ligand (Ox40l, 1 crossover in 567 meiotic events). Southern blot analysis did not reveal any difference between the Fasl gene from gld and wild-type mice and levels of Fasl mRNA transcripts were similar in PMA and ionomycin induced wild-type and coisogenic gld T cells. Sequence analysis of the gld gene indicated a single amino acid change(Phe Leu) in the COOH terminal portion of this type II transmembrane protein, and COS cells transfected with Fasl cDNA from gld mice failed to induce apoptosis of pas-expressing target cells. Thus, the data demonstrate that the gld phenotype is the result of a point mutation in the Fasl gene and that Fasl is part of a complex of ligands structurally related to TNF mapping within a small region of mouse chromosome 1.	DUKE UNIV,CTR AUTOIMMUNE GENET,DEPT MICROBIOL,DIV RHEUMATOL,DURHAM,NC 27710; DUKE UNIV,DEPT MED,DURHAM,NC 27710; IMMUNEX RES & DEV CORP,DEPT CELLULAR IMMUNOL,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,DEPT MAMMALIAN CELL DEV,SEATTLE,WA 98101; IMMUNEX RES & DEV CORP,DEPT BIOCHEM,SEATTLE,WA 98101; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Duke University; Duke University; Massachusetts Institute of Technology (MIT)	LYNCH, DH (corresponding author), IMMUNEX RES & DEV CORP,DEPT IMMUNOBIOL,51 UNIV ST,SEATTLE,WA 98101, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-41053] Funding Source: Medline; NIGMS NIH HHS [T32-GM-07171] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; ALLEN RD, 1990, J EXP MED, V172, P1367, DOI 10.1084/jem.172.5.1367; BLANK RD, 1988, GENETICS, V120, P1073; BROWNING JL, 1991, J IMMUNOL, V147, P1230; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CAMERINI D, 1991, J IMMUNOL, V147, P3165; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ETTINGER R, 1993, J IMMUNOL, V152, P1557; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Green EL, 1981, GENETICS PROBABILITY, P77; HUNTER KW, 1993, GENOMICS, V18, P510, DOI 10.1016/S0888-7543(11)80007-8; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; MOHLER KM, 1993, J IMMUNOL, V151, P1548; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SOBEL ES, 1993, INT IMMUNOL, V5, P1275, DOI 10.1093/intimm/5.10.1275; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; WATANABE T, 1991, BIOCHEM GENET, V29, P325, DOI 10.1007/BF00554140; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, MAMM GENOME, V2, P158, DOI 10.1007/BF00302874; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645	31	328	335	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					131	136		10.1016/1074-7613(94)90106-6	http://dx.doi.org/10.1016/1074-7613(94)90106-6			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7889405				2022-12-18	WOS:A1994PK16200005
J	Freud, AG; Mundy-Bosse, BL; Yu, JH; Caligiuri, MA				Freud, Aharon G.; Mundy-Bosse, Bethany L.; Yu, Jianhua; Caligiuri, Michael A.			The Broad Spectrum of Human Natural Killer Cell Diversity	IMMUNITY			English	Review							HUMAN NK CELLS; HUMAN CYTOMEGALOVIRUS-INFECTION; INNATE LYMPHOID-CELLS; IG-LIKE RECEPTORS; INHIBITORY RECEPTORS; ADAPTIVE IMMUNITY; HUMAN LIVER; EXPRESSION; MEMORY; ACTIVATION	Natural killer (NK) cells provide protection against infectious pathogens and cancer. For decades it has been appreciated that two major NK cell subsets (CD56(bright) and CD56(dim)) exist in humans and have distinct anatomical localization patterns, phenotypes, and functions in immunity. In light of this traditional NK cell dichotomy, it is now clear that the spectrum of human NK cell diversity is much broader than originally appreciated as a result of variegated surface receptor, intracellular signaling molecule, and transcription factor expression; tissue-specific imprinting; and foreign antigen exposure. The recent discoveries of tissue-resident NK cell developmental intermediates, non-NK innate lymphoid cells, and the capacity for NK cells to adapt and differentiate into long-lived memory cells has added further complexity to this field. Here we review our current understanding of the breadth and generation of human NK cell diversity.	[Freud, Aharon G.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Mundy-Bosse, Bethany L.; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Freud, Aharon G.; Mundy-Bosse, Bethany L.; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Freud, Aharon G.; Mundy-Bosse, Bethany L.; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Freud, Aharon G.; Mundy-Bosse, Bethany L.; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Freud, AG (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.; Caligiuri, MA (corresponding author), Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA.; Freud, AG; Caligiuri, MA (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Freud, AG; Caligiuri, MA (corresponding author), Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA.; Freud, AG; Caligiuri, MA (corresponding author), Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA.	aharon.freud@osumc.edu; michael.caligiuri@osumc.edu			NIH/NCI [CA199447, CA208353, AI129582, CA185301, CA095426, CA163205, CA16058, CA068458]; Leukemia & Lymphoma Society [6503-17]; American Association of Cancer Research [17-20-46-MUND]; American Cancer Society Research [RSG-14-243-01-LIB]; Gabrielle's Angel Cancer Research Foundation [87]; NATIONAL CANCER INSTITUTE [R01CA185301, R37CA068458, P30CA016058, R01CA068458, R01CA208353, P01CA095426, P01CA163205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS106170] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Association of Cancer Research; American Cancer Society Research(American Cancer Society); Gabrielle's Angel Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to those researchers whose original work could not be cited due to space restrictions. We would also like to thank Ansel Nalin for his creative assistance with figure design. This review is supported by grants from the NIH/NCI (CA199447 and CA208353 to A.G.F., AI129582 to J.Y., CA185301 to J.Y. and M.A.C., and CA095426, CA163205, CA16058, and CA068458 to M.A.C.), the Leukemia & Lymphoma Society (6503-17), the American Association of Cancer Research (17-20-46-MUND to B.L.M.-B.), the American Cancer Society Research (RSG-14-243-01-LIB), and a grant from the Gabrielle's Angel Cancer Research Foundation (Foundation Reference Number 87 to J.Y.).	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Bjorkstrom NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027664; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bozzano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9109; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; CARSON WE, 1994, P NATL ACAD SCI USA, V91, P7553, DOI 10.1073/pnas.91.16.7553; Chen SS, 2016, IMMUNITY, V45, P292, DOI 10.1016/j.immuni.2016.07.013; Chen XL, 2016, ONCOTARGET, V7, P27764, DOI 10.18632/oncotarget.8526; Cichocki F, 2016, LEUKEMIA, V30, P456, DOI 10.1038/leu.2015.260; Cichocki F, 2016, CURR TOP MICROBIOL, V395, P63, DOI 10.1007/82_2015_487; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Collins A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90063; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Cooper MA, 2001, EUR J IMMUNOL, V31, P792, DOI 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Corat MAF, 2017, BLOOD, V129, P1940, DOI 10.1182/blood-2016-08-734285; Cortez VS, 2016, IMMUNOL LETT, V179, P19, DOI 10.1016/j.imlet.2016.07.005; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cuff AO, 2016, J IMMUNOL, V197, P4283, DOI 10.4049/jimmunol.1601424; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Das J, 2015, IMMUNOL REV, V267, P214, DOI 10.1111/imr.12315; Davis ZB, 2015, BIOL BLOOD MARROW TR, V21, P1653, DOI 10.1016/j.bbmt.2015.05.025; Deguine J, 2013, IMMUNOL REV, V251, P154, DOI 10.1111/imr.12015; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fehniger TA, 2016, TRENDS IMMUNOL, V37, P877, DOI 10.1016/j.it.2016.09.005; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; Freud AG, 2013, AM J CLIN PATHOL, V140, P853, DOI 10.1309/AJCPWGG69MCZOWMM; Garrido F, 2017, CANCER IMMUNOL IMMUN, V66, P259, DOI 10.1007/s00262-016-1947-x; Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467; Goodier MR, 2016, J IMMUNOL, V197, P313, DOI 10.4049/jimmunol.1502049; Griffin BD, 2010, VET MICROBIOL, V143, P89, DOI 10.1016/j.vetmic.2010.02.017; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002; Hammer Q, 2017, ADV IMMUNOL, V133, P171, DOI 10.1016/bs.ai.2016.10.001; Han JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11483; Harmon C, 2016, EUR J IMMUNOL, V46, P2111, DOI 10.1002/eji.201646559; Hatton O, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00607; He YK, 2017, CELL MOL IMMUNOL, V14, P321, DOI 10.1038/cmi.2016.26; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Horowitz A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag1672; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hudspeth K, 2016, J AUTOIMMUN, V66, P40, DOI 10.1016/j.jaut.2015.08.011; Hwang I, 2012, INT IMMUNOL, V24, P793, DOI 10.1093/intimm/dxs080; Jain A, 2017, J IMMUNOL, V198, P3791, DOI 10.4049/jimmunol.1602000; Kadri N, 2016, CURR TOP MICROBIOL, V395, P95, DOI 10.1007/82_2015_485; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; LANIER LL, 1983, J IMMUNOL, V131, P1789; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LANIER LL, 1986, J IMMUNOL, V136, P4480; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Lim AI, 2017, CURR OPIN IMMUNOL, V44, P61, DOI 10.1016/j.coi.2017.03.010; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Liu LL, 2016, CELL REP, V15, P1088, DOI 10.1016/j.celrep.2016.04.005; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Lunemann A, 2013, J IMMUNOL, V191, P4989, DOI 10.4049/jimmunol.1301046; Luetke-Eversloh M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00499; Lugthart G, 2016, J IMMUNOL, V197, P78, DOI 10.4049/jimmunol.1502603; Mace EM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00545; Mace EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12171; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; Marquardt N, 2015, J IMMUNOL, V194, P2467, DOI 10.4049/jimmunol.1402756; Meazza R, 2017, EUR J IMMUNOL, V47, P1051, DOI 10.1002/eji.201646885; Mehta RS, 2016, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00093; Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262; Michel T, 2016, J IMMUNOL, V196, P2923, DOI 10.4049/jimmunol.1502570; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Montaldo E, 2016, IMMUNOL LETT, V179, P2, DOI 10.1016/j.imlet.2016.01.007; Moretta L, 2014, INT ARCH ALLERGY IMM, V164, P253, DOI 10.1159/000365632; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Nabekura T, 2014, J EXP MED, V211, P2455, DOI 10.1084/jem.20140798; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2015, TRENDS IMMUNOL, V36, P293, DOI 10.1016/j.it.2015.03.006; Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; RITZ J, 1985, SCIENCE, V228, P1540, DOI 10.1126/science.2409597; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Schlums H, 2017, BLOOD, V129, P1927, DOI 10.1182/blood-2016-08-734236; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Siewiera J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10183; Simonetta F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00241; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stegmann KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26157; Strauss-Albee DM, 2017, CYTOM PART B-CLIN CY, V92, P33, DOI 10.1002/cyto.b.21485; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Strauss-Albee DM, 2014, J IMMUNOL, V193, P4871, DOI 10.4049/jimmunol.1401821; Sun C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002594; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Tesi B, 2016, TRENDS IMMUNOL, V37, P451, DOI 10.1016/j.it.2016.04.006; Tu MM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00166; Vasu S, 2016, BLOOD, V127, P2879, DOI 10.1182/blood-2015-11-680546; Vasu S, 2013, CURR OPIN HEMATOL, V20, P107, DOI 10.1097/MOH.0b013e32835d8101; Velardi A, 2012, CURR OPIN HEMATOL, V19, P421, DOI 10.1097/MOH.0b013e3283590395; Velardi A, 2012, CURR OPIN HEMATOL, V19, P319, DOI 10.1097/MOH.0b013e32835423c3; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wagner JA, 2017, BIOL BLOOD MARROW TR, V23, P398, DOI 10.1016/j.bbmt.2016.11.018; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Wu N, 2016, NAT IMMUNOL, V17, P387, DOI 10.1038/ni.3369; Yeang HXA, 2017, J IMMUNOL, V198, P1417, DOI 10.4049/jimmunol.1601818; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Zamora AE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87032; Zhang LH, 2016, J EXP MED, V213, P2249, DOI 10.1084/jem.20151998; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	144	327	333	6	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					820	833		10.1016/j.immuni.2017.10.008	http://dx.doi.org/10.1016/j.immuni.2017.10.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166586	Bronze, Green Accepted			2022-12-18	WOS:000416483700008
J	Dudeck, A; Dudeck, J; Scholten, J; Petzold, A; Surianarayanan, S; Kohler, A; Peschke, K; Vohringer, D; Waskow, C; Krieg, T; Muller, W; Waisman, A; Hartmann, K; Gunzer, M; Roers, A				Dudeck, Anne; Dudeck, Jan; Scholten, Julia; Petzold, Anke; Surianarayanan, Sangeetha; Koehler, Anja; Peschke, Katrin; Voehringer, David; Waskow, Claudia; Krieg, Thomas; Mueller, Werner; Waisman, Ari; Hartmann, Karin; Gunzer, Matthias; Roers, Axel			Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of Haptens	IMMUNITY			English	Article							TOLL-LIKE RECEPTOR; T-CELLS; SKIN CONTACT; CRUCIAL ROLE; MICE; HYPERSENSITIVITY; DEFICIENT; INTERLEUKIN-10; INFLAMMATION; ELICITATION	A prominent feature of sensitizing environmental compounds that cause allergic contact dermatitis is the rapid induction of an innate inflammatory response that seems to provide danger signals for efficient T cell priming. We generated mouse models of mast cell deficiency, mast cell-specific gene inactivation, and mast cell reporter mice for intravital imaging and showed that these adjuvant effects of contact allergens are mediated by mast cells and histamine. Mast cell deficiency resulted in impaired emigration of skin DCs to the lymph node and contact hypersensitivity was dramatically reduced in the absence of mast cells. In addition, mast cell-specific inactivation of the II10 gene did not reveal any role for mast cell-derived IL-10 in the regulation of contact allergy. Collectively, we demonstrate that mast cells are essential promoters of contact hypersensitivity, thereby highlighting their potential to promote immune responses to antigens entering via the skin.	[Koehler, Anja; Gunzer, Matthias] Univ Magdeburg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Dudeck, Anne; Dudeck, Jan; Petzold, Anke; Surianarayanan, Sangeetha; Peschke, Katrin; Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, D-01307 Dresden, Germany; [Scholten, Julia; Krieg, Thomas; Hartmann, Karin] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Voehringer, David] Univ Clin Erlangen, Dept Infect Biol, D-91054 Erlangen, Germany; [Waskow, Claudia] Tech Univ Dresden, CRTD DFG Ctr Regenerat Therapies, D-8027 Dresden, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany	Otto von Guericke University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cologne; University of Erlangen Nuremberg; Technische Universitat Dresden; University of Manchester; Johannes Gutenberg University of Mainz	Gunzer, M (corresponding author), Univ Magdeburg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany.	matthias.gunzer@med.ovgu.de; axel.roers@tu-dresden.de	Waskow, Claudia/F-8146-2010; Hartmann, Karin/N-4865-2015; Li, Yapeng/N-1042-2017; Dudeck, Anne/ABB-3498-2020; Müller, W. E. G./AAR-8651-2020; Waisman, Ari/C-7383-2015; Muller, Werner/B-9044-2008; Voehringer, David/K-2776-2019; Gunzer, Matthias/AAW-7026-2021	Waskow, Claudia/0000-0003-3261-0922; Hartmann, Karin/0000-0002-4595-8226; Li, Yapeng/0000-0002-5042-6881; Dudeck, Anne/0000-0002-1311-9620; Müller, W. E. G./0000-0002-8223-3689; Waisman, Ari/0000-0003-4304-8234; Muller, Werner/0000-0002-1297-9725; Gunzer, Matthias/0000-0002-5534-6055	German Research Council (DFG) [Ro2133/2, Ro2133/3, Ro2133/4, 1394, CRC/SFB832, A14, Du1172/1, Du1172/2, 1468]	German Research Council (DFG)(German Research Foundation (DFG))	We thank H.R. Rodewald for discussions and sharing of unpublished results, M. Hasenberg for help with generation of movies, and M. Maurer for providing Kit<SUP>W/W-v</SUP> mice. Expert technical assistance by L. Schulze, T. Haring, C. Hiller, and C. Berns is gratefully acknowledged. This work was supported by grants from the German Research Council (DFG; grants Ro2133/2 to A.R. and K.H., Ro2133/3 to A.R., Ro2133/4 (Priority Program 1394) to A.R, CRC/SFB832, project A14, to K.H., Du1172/1 and Du1172/2 (Priority Program 1468) to AD., SFB854 to M.G., and Gu769/4 (Priority Program 1468) to M.G. and A.W..	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; BELSITO DV, 1999, FITZPATRICKS DERMATO, P1447; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Bonneville M, 2007, J INVEST DERMATOL, V127, P1430, DOI 10.1038/sj.jid.5700726; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Garaczi E, 2004, INT IMMUNOL, V16, P1781, DOI 10.1093/intimm/dxh179; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Kobayashi M, 2010, J INVEST DERMATOL, V130, P725, DOI 10.1038/jid.2009.289; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; MEKORI YA, 1985, J IMMUNOL, V135, P879; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Saint-Mezard P, 2003, J INVEST DERMATOL, V120, P641, DOI 10.1046/j.1523-1747.2003.12093.x; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; VANLOVEREN H, 1983, J EXP MED, V157, P1604, DOI 10.1084/jem.157.5.1604; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	43	327	330	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					973	984		10.1016/j.immuni.2011.03.028	http://dx.doi.org/10.1016/j.immuni.2011.03.028			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703544	Bronze			2022-12-18	WOS:000292349700016
J	Chen, WJ; Frank, ME; Jin, WW; Wahl, SM				Chen, WJ; Frank, ME; Jin, WW; Wahl, SM			TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; MEDIATED ACTIVATION; TARGETED DISRUPTION; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; DEATH FACTOR; FAS; TOLERANCE; MICE	T cell apoptosis is critical to development and homeostasis of the immune system. The most salient feature of apoptosis is the lack of an attendant inflammatory response or tissue damage. Here, we present evidence that apoptotic T cells release TGF-beta, thereby contributing to an immunosuppressive milieu. Apoptotic T cells released not only latent but also bio-active TGF-beta. Nonetheless, TGF-beta transcription was not upregulated, suggesting release of existing rather than synthesis of new TGF-beta. Localized within the intracellular membrane-bound compartment, which includes mitochondria, TGF-beta was redistributed into the cytosol following loss of mitochondrial membrane potential. TGF-beta secreted from apoptotic T cells inhibited proinflammatory cytokine production by activated macrophages to foster immune suppression. These findings broaden the potential mechanisms whereby induction of immune tolerance or deficiency occurs through T cell deletion.	Natl Inst Dent & Craniofacial Res, Cellular Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, WJ (corresponding author), Natl Inst Dent & Craniofacial Res, Cellular Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA.			Frank, Mark/0000-0002-3529-2053	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000046] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bodey B, 1999, IN VIVO, V13, P357; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Chen WJ, 1999, MICROBES INFECT, V1, P1367, DOI 10.1016/S1286-4579(99)00249-X; Chen WJ, 1998, J IMMUNOL, V160, P1504; Chen WJ, 1998, J IMMUNOL, V161, P6297; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Ferguson TA, 1999, NAT MED, V5, P1231, DOI 10.1038/15180; Gao YK, 1998, J EXP MED, V188, P887, DOI 10.1084/jem.188.5.887; Gastman BR, 1999, CANCER RES, V59, P5356; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; HEINE UI, 1991, CELL REGUL, V2, P467, DOI 10.1091/mbc.2.6.467; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hu R, 1996, CLIN IMMUNOL IMMUNOP, V80, P283, DOI 10.1006/clin.1996.0125; KEKOW J, 1990, P NATL ACAD SCI USA, V87, P8321, DOI 10.1073/pnas.87.21.8321; KHALIL R, 1999, CANCER IMMUNOL IMMUN, V1, P1255; Kiessling R, 1999, CANCER IMMUNOL IMMUN, V48, P353, DOI 10.1007/s002620050586; Klebb G, 1996, CLIN IMMUNOL IMMUNOP, V81, P282, DOI 10.1006/clin.1996.0190; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kroemer G, 1998, CELL DEATH DIFFER, V5, P547, DOI 10.1038/sj.cdd.4400387; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCartneyFrancis NL, 1997, AM J PATHOL, V151, P1281; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; OGASAWARA J, 1993, NATURE, V364, P803; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SHER A, 1992, IMMUNOL REV, V127, P183, DOI 10.1111/j.1600-065X.1992.tb01414.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sporn MB, 1999, MICROBES INFECT, V1, P1251, DOI 10.1016/S1286-4579(99)00260-9; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; Van Parijs L, 1998, J IMMUNOL, V160, P2065; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zauli G, 1996, J EXP MED, V183, P99, DOI 10.1084/jem.183.1.99	51	327	349	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					715	725		10.1016/S1074-7613(01)00147-9	http://dx.doi.org/10.1016/S1074-7613(01)00147-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420042	Bronze			2022-12-18	WOS:000169495100008
J	SCOTT, B; LIBLAU, R; DEGERMANN, S; MARCONI, LA; OGATA, L; CATON, AJ; MCDEVITT, HO; LO, D				SCOTT, B; LIBLAU, R; DEGERMANN, S; MARCONI, LA; OGATA, L; CATON, AJ; MCDEVITT, HO; LO, D			A ROLE FOR NON-MHC GENETIC-POLYMORPHISM IN SUSCEPTIBILITY TO SPONTANEOUS AUTOIMMUNITY	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; MAJOR HISTOCOMPATIBILITY COMPLEX; GLUTAMIC-ACID DECARBOXYLASE; T-CELL REPERTOIRE; TRANSGENIC MICE; DIFFERENTIAL REGULATION; EXTRATHYMIC TOLERANCE; VIRUS-INFECTION; IMMUNE-RESPONSE; BB RAT	Peripheral immunological tolerance is traditionally explained by mechanisms for deletion or inactivation of autoreactive T cell clones. Using an autoimmune disease model combining transgenic mice expressing a well-defined antigen, influenza hemagglutinin (HA), on islet beta cells (Ins-HA), and a T cell receptor transgene (TCR-HNT) specific for a class II-restricted HA peptide, we demonstrate that the conventional assumptions do not apply to this in vivo situation. Double transgenic mice displayed either resistance or susceptibility to spontaneous autoimmune disease, depending on genetic contributions from either of two common inbred mouse strains, BALB/c or B10.D2. Functional studies on autoreactive CD4(+) T cells from resistant mice showed that, contrary to expectations, neither clonal anergy, clonal deletion, nor receptor desensitization was induced; rather, there was a non-MHC-encoded predisposition toward differentiation to a nonpathogenic effector (Th2 versus Th1) phenotype. T cells from resistant double transgenic mice showed evidence for prior activation by antigen, suggesting that disease may be actively suppressed by autoreactive Th2 cells. These findings shed light on functional aspects of genetically determined susceptibility to autoimmunity, and should lead to new therapeutic approaches aimed at controlling the differentiation of autoreactive CD4(+) effector T cells in vivo.	STANFORD UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA; WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA	Stanford University; The Wistar Institute	SCOTT, B (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.							BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; BLACKMAN MA, 1991, P NATL ACAD SCI USA, V88, P6682, DOI 10.1073/pnas.88.15.6682; BOITARD C, 1992, P NATL ACAD SCI USA, V89, P172, DOI 10.1073/pnas.89.1.172; BUTTERFIELD K, 1989, J EXP MED, V169, P1461, DOI 10.1084/jem.169.4.1461; CASTANO L, 1991, J CLIN ENDOCR METAB, V73, P1197, DOI 10.1210/jcem-73-6-1197; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GILBERT KM, 1990, J IMMUNOL, V144, P2063; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; HOBBS MV, 1993, J IMMUNOL, V150, P3602; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KAYE PM, 1992, EUR J IMMUNOL, V22, P357, DOI 10.1002/eji.1830220211; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; LAUFER TM, 1993, J EXP MED, V178, P589, DOI 10.1084/jem.178.2.589; LO D, 1993, EUR J IMMUNOL, V23, P1693, DOI 10.1002/eji.1830230744; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; MILLER BJ, 1988, J IMMUNOL, V140, P52; MORRIS L, 1993, INFECT IMMUN, V61, P3459, DOI 10.1128/IAI.61.8.3459-3465.1993; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NAKHOODA AF, 1978, DIABETOLOGIA, V14, P199, DOI 10.1007/BF00429781; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PARISH CR, 1972, TRANSPLANT REV-DENMA, V13, P35; PATTEN PA, 1993, J IMMUNOL, V150, P2281; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; SUTHERLAND RM, 1991, IMMUNOGENETICS, V34, P372, DOI 10.1007/BF01787487; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; SWAIN SL, 1988, J IMMUNOL, V141, P3445; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67	52	327	328	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1994	1	1					73	82		10.1016/1074-7613(94)90011-6	http://dx.doi.org/10.1016/1074-7613(94)90011-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889402				2022-12-18	WOS:A1994PK15400009
J	Biswas, SK				Biswas, Subhra K.			Metabolic Reprogramming of Immune Cells in Cancer Progression	IMMUNITY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; RECEPTOR TYROSINE KINASES; HYPOXIA-INDUCIBLE FACTORS; NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC CELLS; SUPPRESSOR-CELLS; REGULATORY T; MYELOID CELLS; LACTIC-ACID; TRANSCRIPTIONAL REGULATION	Immune cells play a key role in host defense against infection and cancer. Upon encountering danger signals, these cells undergo activation leading to a modulation in their immune functions. However, recent studies reveal that immune cells upon activation also show distinct metabolic changes that impact their immune functions. Such metabolic reprogramming and its functional effects are well known for cancer cells. Given that immune cells have emerged as crucial players in cancer progression, it is important to understand whether immune cells also undergo metabolic reprogramming in tumors and how this might affect their contribution in cancer progression. This emerging aspect of tumor-associated immune cells is reviewed here, discussing metabolic reprogramming of different immune cell types, the key pathways involved, and its impact on tumor progression.	ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Biswas, SK (corresponding author), ASTAR, Singapore Immunol Network SIgN, 04-06 Immunos,8A Biomed Grove, Singapore 138648, Singapore.	subhra_biswas@immunol.a-star.edu.sg			SIgN (A*STAR)	SIgN (A*STAR)	S.K.B. thanks SIgN (A*STAR) for the core funding and Dr. Irina N. Shalova for help with the figure preparation.	Ahmed MS, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984550; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cedervall J, 2015, CANCER RES, V75, P2653, DOI 10.1158/0008-5472.CAN-14-3299; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang CI, 2001, CANCER RES, V61, P1100; Chang M, 2009, J LEUKOCYTE BIOL, V85, P947, DOI 10.1189/jlb.0908522; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Deng R, 2012, ONCOL RES, V20, P473, DOI 10.3727/096504013X13715991125684; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dong H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00024; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Dumitriu IE, 2009, J IMMUNOL, V182, P2795, DOI 10.4049/jimmunol.0712671; Eikawa S, 2015, P NATL ACAD SCI USA, V112, P1809, DOI 10.1073/pnas.1417636112; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Hammami I, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-18; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Hossain F., 2015, CANCER IMMUNOL RES, P1; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jun HS, 2014, BLOOD, V123, P2843, DOI 10.1182/blood-2013-05-502435; Jung M, 2015, IMMUNOBIOLOGY, V220, P295, DOI 10.1016/j.imbio.2014.09.011; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Khan MW, 2013, CLIN CANCER RES, V19, P2342, DOI 10.1158/1078-0432.CCR-12-2623; Kim J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-170; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lewis C. E., 2007, CANCER RES, V67, P1; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028133; Li L, 2015, CELL DEATH DIFFER, V22, P1081, DOI 10.1038/cdd.2014.212; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liu GW, 2014, CANCER RES, V74, P727, DOI 10.1158/0008-5472.CAN-13-2584; Lochner M, 2015, TRENDS IMMUNOL, V36, P81, DOI 10.1016/j.it.2014.12.005; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Mancino A, 2008, BLOOD, V112, P3723, DOI 10.1182/blood-2008-02-142091; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mosca M, 2007, J LEUKOCYTE BIOL, V82, P320, DOI 10.1189/jlb.0906576; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okoye I, 2015, SCIENCE, V348, P995, DOI 10.1126/science.aaa7516; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Park J, 2015, CELL REP, V10, P1614, DOI 10.1016/j.celrep.2015.02.024; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pello OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045399; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Poczobutt JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079633; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rivera LB, 2015, CELL REP, V11, P577, DOI 10.1016/j.celrep.2015.03.055; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Ryu YK, 2015, J LEUKOCYTE BIOL, V97, P711, DOI 10.1189/jlb.3A0114-055R; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Siska PJ, 2015, TRENDS IMMUNOL, V36, P257, DOI 10.1016/j.it.2015.02.007; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Valencia T, 2014, CANCER CELL, V26, P121, DOI 10.1016/j.ccr.2014.05.004; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang MX, 2010, IMMUNOL CELL BIOL, V88, P165, DOI 10.1038/icb.2009.77; Zhang YW, 2014, CANCER RES, V74, P2986, DOI 10.1158/0008-5472.CAN-13-2689; Zhu YP, 2015, J IMMUNOL, V194, P584, DOI 10.4049/jimmunol.1401024	140	326	336	8	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					435	449		10.1016/j.immuni.2015.09.001	http://dx.doi.org/10.1016/j.immuni.2015.09.001			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377897	Bronze			2022-12-18	WOS:000361575300007
J	Hikosaka, Y; Nitta, T; Ohigashi, I; Yano, K; Ishimaru, N; Hayashi, Y; Matsumoto, M; Matsuo, K; Penninger, JM; Takayanagi, H; Yokota, Y; Yamada, H; Yoshikai, Y; Inoue, J; Akiyama, T; Takahama, Y				Hikosaka, Yu; Nitta, Takeshi; Ohigashi, Izumi; Yano, Kouta; Ishimaru, Naozumi; Hayashi, Yoshio; Matsumoto, Mitsuru; Matsuo, Koichi; Penninger, Josef M.; Takayanagi, Hiroshi; Yokota, Yoshifumi; Yamada, Hisakata; Yoshikai, Yasunobu; Inoue, Jun-ichiro; Akiyama, Taishin; Takahama, Yousuke			The cytokine RANKL produced by positively selected thymocytes Fosters medullary thymic epithelial cells that express autoimmune regulator	IMMUNITY			English	Article							CD4 T-CELLS; LYMPHOTOXIN PATHWAY; CENTRAL TOLERANCE; DENDRITIC CELLS; SELF-TOLERANCE; DEFICIENT MICE; INDUCER CELLS; ROR-GAMMA; LIGAND; TCR	The thymic medulla provides a microenvironment where medullary thymic epithelial cells (mTECs) express autoimmune regulator and diverse tissue-restricted genes, contributing to launching self-tolerance. Positive selection is essential for thymic medulla formation via a previously unknown mechanism. Here we show that the cytokine RANK ligand (RANKL) was produced by positively selected thymocytes and regulated the cellularity of mTEC by interacting with RANK and osteoprotegerin. Forced expression of RANKL restored thymic medulla in mice lacking positive selection, whereas RANKL perturbation impaired medulla formation. These results indicate that RANKL produced by positively selected thymocytes is responsible for fostering thymic medulla formation, thereby establishing central tolerance.	[Hikosaka, Yu; Nitta, Takeshi; Ohigashi, Izumi; Yano, Kouta; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; [Ishimaru, Naozumi; Hayashi, Yoshio] Univ Tokushima, Inst Hlth Biosci, Div Oral Mol Pathol, Tokushima 7708503, Japan; [Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Matsuo, Koichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Dept Cell Signaling, Tokyo 1138549, Japan; [Yokota, Yoshifumi] Univ Fukui, Fac Med Sci, Div Mol Genet, Fukui 9101193, Japan; [Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Div Host Def, Fukuoka 8128582, Japan; [Inoue, Jun-ichiro; Akiyama, Taishin] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo 1088639, Japan	Tokushima University; Tokushima University; Tokushima University; Keio University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Tokyo Medical & Dental University (TMDU); University of Fukui; Kyushu University; University of Tokyo	Takahama, Y (corresponding author), Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan.	takahama@genome.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010; Matsuo, Koichi/K-5695-2012; Penninger, Josef M/I-6860-2013	Takahama, Yousuke/0000-0002-4992-9174; Matsuo, Koichi/0000-0002-1490-8955; Penninger, Josef M/0000-0002-8194-3777; Akiyama, Taishin/0000-0002-0341-6154	MEXT; Mitsubishi Foundation	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	We thank H. Kikutani, T. Yasui, K. Sugamura, N. Ishii, D. Littman, S. Fagarasan, E. Podack, I. Negishi, S. Itohara, and M. Nanno for generously providing us the mice used in this study. We thank H. Nakase, T. Ueno, and Q. Cui for critically reading the manuscript. Technical support by S. Nitta is acknowledged. This study was supported by MEXT Grant-in-Aid for Scientific Research on Priority Areas "Immunological Self" and the Mitsubishi Foundation. Y.H. is a visiting graduate student from Nagoya City University Graduate School of Medical Sciences. T.N. is a JSPS Research Fellow.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Blazar BR, 2004, J IMMUNOL, V173, P2933, DOI 10.4049/jimmunol.173.5.2933; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dunn RJ, 1997, J HISTOCHEM CYTOCHEM, V45, P129, DOI 10.1177/002215549704500116; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Naspetti M, 1997, EUR J IMMUNOL, V27, P1392, DOI 10.1002/eji.1830270615; Nasreen M, 2003, J IMMUNOL, V171, P3394, DOI 10.4049/jimmunol.171.7.3394; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Takahama Y, 1996, J IMMUNOL, V157, P1508; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno Tomoo, 2005, Methods Mol Biol, V290, P117; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Venanzi ES, 2007, J IMMUNOL, V179, P5693, DOI 10.4049/jimmunol.179.9.5693; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347	54	326	333	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					438	450		10.1016/j.immuni.2008.06.018	http://dx.doi.org/10.1016/j.immuni.2008.06.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799150	Bronze			2022-12-18	WOS:000259708900014
J	Dunay, IR; DaMatta, RA; Fux, B; Presti, R; Greco, S; Colonna, M; Sibley, LD				Dunay, Ildiko R.; DaMatta, Renato A.; Fux, Blima; Presti, Rachel; Greco, Suellen; Colonna, Marco; Sibley, L. David			Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii	IMMUNITY			English	Article							DENDRITIC CELLS; INTRAEPITHELIAL LYMPHOCYTES; ORAL INFECTION; IL-12; MACROPHAGES; GAMMA; INTERLEUKIN-12; STIMULATION; RECRUITMENT; ACTIVATION	The enteric pathogen Toxoplasma gondii is controlled by a vigorous innate T helper 1 (Th1) cell response in the murine model. We demonstrated that after oral infection, the parasite rapidly recruited inflammatory monocytes [Gr1(+) (Ly6C(+), Ly6G(-)) F4/80(+)CD11b(+)CD11c(-)], which established a vital defensive perimeter within the villi of the ileum in the small intestine. Mice deficient of the chemokine receptor CCR2 or the ligand CCL2 failed to recruit Gr1(+) inflammatory monocytes, whereas dendritic cells and resident tissue macrophages remained unaltered. The selective lack of Gr1+ inflammatory monocytes resulted in an inability of mice to control replication of the parasite, high influx of neutrophils, extensive intestinal necrosis, and rapid death. Adoptive transfer of sorted Gr1+ inflammatory monocytes demonstrated their ability to home to the ileum in infected animals and protect Ccr2(-/-) mice, which were otherwise highly susceptible to oral toxoplasmosis. Collectively, these findings illustrate the critical importance of inflammatory monocytes as a first line of defense in controlling intestinal pathogens.	[Dunay, Ildiko R.; DaMatta, Renato A.; Fux, Blima; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Presti, Rachel; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Greco, Suellen] Washington Univ, Sch Med, Div Comparat Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@wustl.edu	Fux, Blima/AAO-2941-2020; DaMatta, Renato/G-8367-2015; Sibley, L. David/C-4616-2008	DaMatta, Renato/0000-0002-0108-9268; Fux, Blima/0000-0002-5038-3551; Colonna, Marco/0000-0001-5222-4987; Presti, Rachel/0000-0002-5469-0727	DFG Postdoctoral Fellowship Program, Germany; CNPq, Brazil; NIH [AI036629, AI071299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052293, R21AI071299, R56AI052293, R01AI036629] Funding Source: NIH RePORTER	DFG Postdoctoral Fellowship Program, Germany(German Research Foundation (DFG)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Hunter, E. Pamer, and O. Liesenfeld for helpful comments and J. Nawas, S. Schloemann, S. Hickerson, and W. Beatty for expert technical assistance. I.R.D. was supported by a fellowship from the DFG Postdoctoral Fellowship Program, Germany. R.A.D. was supported by a fellowship from CNPq, Brazil. This work was supported by grants from the NIH to L.D.S. (AI036629 and AI071299) and M.C. (AI071299).	Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Bliss SK, 1999, J IMMUNOL, V163, P2081; Bliss SK, 1999, J IMMUNOL, V162, P7369; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Buzoni-Gatel D., 2007, P593, DOI 10.1016/B978-012369542-0/50024-6; Buzoni-Gatel D, 1999, J IMMUNOL, V162, P5846; BuzoniGatel D, 1997, J IMMUNOL, V158, P5883; CHARDES T, 1994, J IMMUNOL, V153, P4596; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; Fux B, 2007, INFECT IMMUN, V75, P2580, DOI 10.1128/IAI.00085-07; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KHAN IA, 1994, INFECT IMMUN, V62, P1639, DOI 10.1128/IAI.62.5.1639-1642.1994; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; McKee AS, 2004, J IMMUNOL, V173, P2632, DOI 10.4049/jimmunol.173.4.2632; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Roberts C. W., 2007, P609, DOI 10.1016/B978-012369542-0/50025-8; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	46	326	333	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					306	317		10.1016/j.immuni.2008.05.019	http://dx.doi.org/10.1016/j.immuni.2008.05.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18691912	Green Accepted, Bronze			2022-12-18	WOS:000258610800018
J	Chu, WM; Ostertag, D; Li, ZW; Chang, LF; Chen, Y; Hu, YL; Williams, B; Perrault, J; Karin, M				Chu, WM; Ostertag, D; Li, ZW; Chang, LF; Chen, Y; Hu, YL; Williams, B; Perrault, J; Karin, M			JNK2 and IKK beta are required for activating the innate response to viral infection	IMMUNITY			English	Article							NF-KAPPA-B; DEPENDENT PROTEIN-KINASE; C-JUN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; IFN-BETA; GENE-EXPRESSION; HA-RAS; INTERFERON SYSTEM; VIRUS-INFECTION	Viral infection or double-stranded (ds) RNA induce interferons (IFN) and other cytokines. Transcription factors mediating IFN induction are known, but the signaling pathways that regulate them are less clear. We now describe two such pathways. The first pathway leading to NF-kappa B depends on the dsRNA-responsive protein kinase (PKR), which in turn activates I kappa B kinase (IKK) through the IKK beta subunit. The second viral- and dsRNA-responsive pathway is PKR independent and involves Jun kinase (JNK) activation leading to stimulation of AP-1. Both IKK beta and JNK2 are essential for efficient induction of type I IFN and other cytokines in response to viral infection or dsRNA. This study establishes a general role for these kinases in activation of innate immune responses.	Univ Calif San Diego, Dept Pharmacol, Lab Signal Transduct & Gene Regulat, La Jolla, CA 92093 USA; San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	University of California System; University of California San Diego; California State University System; San Diego State University; Cleveland Clinic Foundation	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Signal Transduct & Gene Regulat, La Jolla, CA 92093 USA.		Hu, Yinling/G-5682-2015; Williams, Bryan R. G./A-5021-2009	Hu, Yinling/0000-0002-4795-8537; Williams, Bryan R. G./0000-0002-4969-1151	NIAID NIH HHS [AI43477, AI21572] Funding Source: Medline; NIEHS NIH HHS [ES06376] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI021572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; Boulares AH, 1996, VIROLOGY, V218, P71, DOI 10.1006/viro.1996.0167; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DELHASE M, 1999, IN PRESS COLD SPRING, V64; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; GENDELMAN HE, 1990, J EXP MED, V172, P1433, DOI 10.1084/jem.172.5.1433; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KATZE MG, 1992, J INTERFERON RES, V12, P241, DOI 10.1089/jir.1992.12.241; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE SB, 1993, VIROLOGY, V193, P1037, DOI 10.1006/viro.1993.1223; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MEURS EF, 1992, J VIROL, V66, P5804; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Orange JS, 1996, J IMMUNOL, V156, P4746; PULLIAM L, 1995, J NEUROVIROL, V1, P219, DOI 10.3109/13550289509113968; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; SEN GC, 1992, J BIOL CHEM, V267, P5017; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Spadafora D, 1996, J VIROL, V70, P4538, DOI 10.1128/JVI.70.7.4538-4548.1996; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Verdijk RM, 1999, J IMMUNOL, V163, P57; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	69	326	338	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					721	731		10.1016/S1074-7613(00)80146-6	http://dx.doi.org/10.1016/S1074-7613(00)80146-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626894	Bronze			2022-12-18	WOS:000084612900008
J	Le Gall, S; Erdtmann, L; Benichou, S; Berlioz-Torrent, C; Liu, LX; Benarous, R; Heard, JM; Schwartz, O				Le Gall, S; Erdtmann, L; Benichou, S; Berlioz-Torrent, C; Liu, LX; Benarous, R; Heard, JM; Schwartz, O			Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; DOWN-REGULATION; VITRO BINDING; HEAVY-CHAINS; PROTEIN; ENDOCYTOSIS; PHOSPHORYLATION; CD4; ANTIGENS; DOMAIN	The surface expression of MHC I is reduced in HIV-infected cells. We show that the Nef protein affects the intracellular sorting of HLA-A and -B molecules. In the presence of Nef, these proteins accumulate in the Golgi and colocalize with clathrin-coated vesicles. MHC I modulation relies on a tyrosine-based sorting signal located in the cytoplasmic domain of HLA-A and -B heavy chains. This cryptic sorting signal becomes operative only in the presence of Nef. Nef interacts with the medium (mu) subunit of AP adaptor complexes involved in the recognition of tyrosine-based sorting signals, likely facilitating the connection between MHC I and the clathrin-dependent sorting machinery.	Inst Pasteur, Lab Retrovirus & Transfert Genet, URA CNRS 1157, F-75724 Paris 15, France; INSERM, CJF 9703, Inst Cochin Genet Mol, F-75014 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Schwartz, O (corresponding author), Inst Pasteur, Lab Retrovirus & Transfert Genet, URA CNRS 1157, 28 Rue Dr Roux, F-75724 Paris 15, France.		Schwartz, Olivier/AAZ-3765-2021; BERLIOZ-TORRENT, clarisse/F-2570-2013	Schwartz, Olivier/0000-0002-0729-1475; Le Gall, Sylvie/0000-0003-0385-926X; Benichou, Serge/0000-0003-3602-3530				AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; BACHELERIE F, 1990, J VIROL, V64, P3059, DOI 10.1128/JVI.64.6.3059-3062.1990; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; BIJIMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21; BODEUS M, 1995, J GEN VIROL, V76, P1337, DOI 10.1099/0022-1317-76-6-1337; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BRUTKIEWICZ RR, 1995, J VIROL, V69, P3967, DOI 10.1128/JVI.69.7.3967-3971.1995; CICCONE E, 1995, INT IMMUNOL, V7, P393, DOI 10.1093/intimm/7.3.393; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; FERRIER P, 1985, J IMMUNOL, V135, P1281; Foti M, 1997, J CELL BIOL, V139, P37, DOI 10.1083/jcb.139.1.37; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GUILD BC, 1984, J BIOL CHEM, V259, P9235; Harris M, 1996, J GEN VIROL, V77, P2379, DOI 10.1099/0022-1317-77-10-2379; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SCHWARTZ O, 1995, J VIROL, V69, P528, DOI 10.1128/JVI.69.1.528-533.1995; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SCHWARTZ O, 1993, J VIROL, V67, P3274, DOI 10.1128/JVI.67.6.3274-3280.1993; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635	40	326	328	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					483	495		10.1016/S1074-7613(00)80553-1	http://dx.doi.org/10.1016/S1074-7613(00)80553-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586638	Bronze			2022-12-18	WOS:000073348000010
J	Callahan, MK; Postow, MA; Wolchok, JD				Callahan, Margaret K.; Postow, Michael A.; Wolchok, Jedd D.			Targeting T Cell Co-receptors for Cancer Therapy	IMMUNITY			English	Review							LYMPHOCYTE-ASSOCIATED ANTIGEN-4; IPILIMUMAB PLUS DACARBAZINE; RESISTANT PROSTATE-CANCER; METASTATIC MELANOMA; UNTREATED MELANOMA; LUNG-CANCER; PD-1 BLOCKADE; PHASE-3 TRIAL; AUTOIMMUNE HYPOPHYSITIS; ANTI-PD-L1 ANTIBODY	Checkpoint-blocking antibodies can generate potent anti-tumor responses by encouraging the immune system to seek and destroy cancer cells. At this time, the United States Food and Drug Administration has approved three checkpoint-blocking antibodies in three disease indications, and additional approvals are expected to broaden the clinical scope of immunotherapy. Herein, we review the clinical development of CTLA-4-, PD-1-, and PD-L1-blocking antibodies across tumor types and briefly discuss areas of active investigation of potential biomarkers.	[Callahan, Margaret K.; Postow, Michael A.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Immunotherapeut Serv, New York, NY 10065 USA; [Callahan, Margaret K.; Postow, Michael A.; Wolchok, Jedd D.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Callahan, MK (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma & Immunotherapeut Serv, New York, NY 10065 USA.; Callahan, MK (corresponding author), Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA.	callaham@mskcc.org			Bristol-Myers Squibb; Merck; Medimmune; Genentech; Novartis; Array; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Medimmune(AstraZenecaMedimmune); Genentech(Roche HoldingGenentech); Novartis(Novartis); Array; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.D.W. receives research support from and is a consultant for Bristol-Myers Squibb, Merck, Medimmune, and Genentech. M.A.P. receives research support from Bristol-Myers Squibb, Novartis, and Array. M.A.P. has received honoraria from Bristol-Myers Squibb and Merck and serves as an advisor to Bristol-Myers Squibb. M.K.C. receives research support from Bristol-Myers Squibb.	Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andrews Stephanie, 2012, Cancer Manag Res, V4, P299, DOI 10.2147/CMAR.S31873; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Bashey A, 2009, BLOOD, V113, P1581, DOI 10.1182/blood-2008-07-168468; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Camacho LH, 2009, J CLIN ONCOL, V27, P1075, DOI 10.1200/JCO.2008.19.2435; Di Giacomo AM, 2010, SEMIN ONCOL, V37, P499, DOI 10.1053/j.seminoncol.2010.09.007; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; Drake CG, 2014, ONCOLOGY-NY, V28, P974; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Fecher LA, 2013, ONCOLOGIST, V18, P733, DOI 10.1634/theoncologist.2012-0483; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Forde PM, 2012, ANTICANCER RES, V32, P4607; Gandini S, 2016, CRIT REV ONCOL HEMAT, V100, P88, DOI 10.1016/j.critrevonc.2016.02.001; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Horvat TZ, 2015, J CLIN ONCOL, V33, P3193, DOI 10.1200/JCO.2015.60.8448; Hwu W. J., 2010, HEMONC TODAY; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Juszczak A, 2012, EUR J ENDOCRINOL, V167, P1, DOI 10.1530/EJE-12-0167; Kaehler KC, 2009, MELANOMA RES, V19, P333, DOI 10.1097/CMR.0b013e32832e0bff; Kirkwood JM, 2010, CLIN CANCER RES, V16, P1042, DOI 10.1158/1078-0432.CCR-09-2033; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lo JA, 2015, JAMA ONCOL, V1, P1340, DOI 10.1001/jamaoncol.2015.2274; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Maur M, 2012, J CLIN ONCOL, V30, pE76, DOI 10.1200/JCO.2011.38.7886; Melero I, 2014, CANCER DISCOV, V4, P522, DOI 10.1158/2159-8290.CD-13-0985; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Naidoo J., 2016, ANN ONCOL; Nghiem P. T., 2016, N ENGL J MED; Nishino M, 2015, NEW ENGL J MED, V373, P288, DOI 10.1056/NEJMc1505197; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Reuben JM, 2006, CANCER, V106, P2437, DOI 10.1002/cncr.21854; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snyder A, 2015, SCIENCE, V350, P1031, DOI 10.1126/science.aad7706; Tavare R, 2016, CANCER RES, V76, P73, DOI 10.1158/0008-5472.CAN-15-1707; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Weber J, 2009, CANCER IMMUNOL IMMUN, V58, P823, DOI 10.1007/s00262-008-0653-8; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Wolchok J, 2012, ANN ONCOL, V23, P15, DOI 10.1093/annonc/mds258; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	71	325	357	2	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1069	1078		10.1016/j.immuni.2016.04.023	http://dx.doi.org/10.1016/j.immuni.2016.04.023			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192570	Bronze			2022-12-18	WOS:000376478500008
J	Baumjohann, D; Preite, S; Reboldi, A; Ronchi, F; Ansel, KM; Lanzavecchia, A; Sallusto, F				Baumjohann, Dirk; Preite, Silvia; Reboldi, Andrea; Ronchi, Francesca; Ansel, K. Mark; Lanzavecchia, Antonio; Sallusto, Federica			Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; IN-VIVO DEPLETION; DENDRITIC CELLS; IMMUNE-RESPONSES; DIFFERENTIATION; EXPRESSION; BCL6; GENERATION; DYNAMICS; MICE	T follicular helper (Tfh) cells provide help to B cells and are crucial for establishment of germinal center (GC) reactions, including production of high-affinity antibodies and generation of memory B cells and long-lived plasma cells. Here we report that the magnitude of the Tfh cell response was dictated by the amount of antigen and directly correlated with the magnitude of the GC B cell response. In addition, maintenance of the Tfh cell phenotype required sustained antigenic stimulation by GC B cells. In lymphopenic conditions, a strong and prolonged Tfh cell response led to bystander B cell activation, hyper-gammaglobulinemia, and production of poly-and self-reactive antibodies. These data demonstrate that antigen dose determines the size and duration of the Tfh cell response and GC reaction, highlight the transient nature of the Tfh cell phenotype, and suggest a link between overstimulation of Tfh cells and the development of dysregulated humoral immune responses.	[Baumjohann, Dirk; Preite, Silvia; Reboldi, Andrea; Ronchi, Francesca; Lanzavecchia, Antonio; Sallusto, Federica] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Baumjohann, Dirk; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Baumjohann, Dirk; Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA	Universita della Svizzera Italiana; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baumjohann, D (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	dirk.baumjohann@ucsf.edu; federica.sallusto@irb.usi.ch	Baumjohann, Dirk/C-9047-2009	Baumjohann, Dirk/0000-0001-8385-8288; Ronchi, Francesca/0000-0002-2035-6528	Boehringer Ingelheim Fonds PhD Scholarship; Swiss National Science Foundation Postdoctoral Fellowship; Swiss National Science Foundation [N. 116440, 131092, 126027]; Helmut Horten Foundation	Boehringer Ingelheim Fonds PhD Scholarship(Boehringer Ingelheim); Swiss National Science Foundation Postdoctoral Fellowship(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	The authors would like to thank Takaharu Okada (RIKEN) for YFP-BCL6 mice; Robert Brink (Garvan Institute) for providing SW<INF>HEL</INF> mice through Antonio Freitas (Institut Pasteur); Hideo Yagita for the anti-iCOS-L antibodies; Robert Dunn (Biogen Idec) for the anti-CD20 antibodies; Mehrdad Matloubian (UCSF) for LCMV; David Jarrossay for cell sorting; Luana Perlini, Enrica Mira Cato, Andrea D'Ercole, and Emanuele Cavadini for technical support and animal care; and Dior Baumjohann, Afonso Almeida, and Chris Allen for insightful discussions. D. B. designed and performed experiments, analyzed and interpreted data, and wrote the manuscript; S. P. performed and analyzed experiments; A. R. and F. R. performed some of the experiments; K. M. A. provided vital reagents and intellectual input; A. L. conceived of the project and wrote the manuscript; F. S. conceived of the project, wrote the manuscript, and provided overall direction of the study. S. P. conducted this study as partial fulfillment of her PhD in Molecular Medicine, Program in Basic and Applied Immunology, San Raffaele University, Milan, Italy. This work was supported by a Boehringer Ingelheim Fonds PhD Scholarship and a Swiss National Science Foundation Postdoctoral Fellowship (to D. B.), and by grants from the Swiss National Science Foundation (N. 116440 and 131092 to F. S. and 126027 to A. L.). The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation.	Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Langenkamp A, 2003, EUR J IMMUNOL, V33, P474, DOI 10.1002/immu.200310023; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Murphy KM, 2011, SCIENCE, V333, DOI 10.1126/science.1198277; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	66	325	331	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					596	605		10.1016/j.immuni.2012.11.020	http://dx.doi.org/10.1016/j.immuni.2012.11.020			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23499493	Bronze			2022-12-18	WOS:000330941500022
J	McKenzie, GJ; Emson, CL; Bell, SE; Anderson, S; Fallon, P; Zurawski, G; Murray, R; Grencis, R; McKenzie, ANJ				McKenzie, GJ; Emson, CL; Bell, SE; Anderson, S; Fallon, P; Zurawski, G; Murray, R; Grencis, R; McKenzie, ANJ			Impaired development of Th2 cells in IL-13-deficient mice	IMMUNITY			English	Article							RECEPTOR-ALPHA CHAIN; HUMAN B-CELLS; INTERLEUKIN-13 RECEPTOR; T-CELLS; IN-VIVO; CYTOKINE PRODUCTION; BINDING SUBUNIT; HUMAN-MONOCYTES; IFN-GAMMA; IL-4	We report that Th2 cell cultures generated using T cells or splenocytes from IL-13-deficient mice produce significantly reduced levels of IL-4, IL-5, and IL-10 compared with wild-type. In contrast, IL-4 and IL-5 production by mast cells stimulated in vitro with PMA, ionomycin, or IgE cross-linking are unaffected. In vitro Th2 cell differentiation cannot be rescued by the addition of exogenous factors, but in vivo antigen challenge and administration of IL-13 can increase Th2-like cytokine responses as can infection with the parasitic nematode Nippostrongylus brasiliensis. IL-13-deficient mice also have lower basal levels of serum IgE and biased antigen-specific immunoglobulin responses. Thus, IL-13 is an important regulator of Th2 commitment and may therefore play a central role in atopy and infectious diseases.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	MRC Laboratory Molecular Biology; University of Cambridge; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of Cambridge; University of Manchester	McKenzie, GJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Bancroft AJ, 1998, J IMMUNOL, V160, P3453; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Bost KL, 1996, IMMUNOLOGY, V87, P633, DOI 10.1046/j.1365-2567.1996.502574.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BROWN KD, 1989, J IMMUNOL, V142, P679; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Curiel RE, 1997, EUR J IMMUNOL, V27, P1982, DOI 10.1002/eji.1830270823; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; HE YW, 1995, J IMMUNOL, V155, P9; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; HJULSTROM S, 1995, EUR J IMMUNOL, V25, P1469, DOI 10.1002/eji.1830250552; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JANKOVIC D, 1998, 2 WOODS HOL IMM M SU; Jinquan Tan, 1995, Journal of Immunology, V154, P3742; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kotanides H, 1996, J BIOL CHEM, V271, P25555, DOI 10.1074/jbc.271.41.25555; Kraan TCTMV, 1996, J IMMUNOL, V156, P1818; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Morawetz RA, 1996, J EXP MED, V184, P1651, DOI 10.1084/jem.184.5.1651; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muchamuel T, 1997, J IMMUNOL, V158, P2898; MURPHY E, 1993, J IMMUNOL METHODS, V162, P211, DOI 10.1016/0022-1759(93)90386-L; Nicoletti F, 1997, EUR J IMMUNOL, V27, P1580, DOI 10.1002/eji.1830270639; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SMERZBERTLING C, 1995, J BIOL CHEM, V270, P966, DOI 10.1074/jbc.270.2.966; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VANDERWELD T, 1994, EUR J IMMUNOL, V24, P2285; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869; ZURAWSKI SM, 1993, EMBO J, V12, P3899	58	325	336	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	1998	9	3					423	432		10.1016/S1074-7613(00)80625-1	http://dx.doi.org/10.1016/S1074-7613(00)80625-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768762	Bronze, Green Published			2022-12-18	WOS:000076202300015
J	Healy, JI; Dolmetsch, RE; Timmerman, LA; Cyster, JG; Thomas, ML; Crabtree, GR; Lewis, RS; Goodnow, CC				Healy, JI; Dolmetsch, RE; Timmerman, LA; Cyster, JG; Thomas, ML; Crabtree, GR; Lewis, RS; Goodnow, CC			Different nuclear signals are activated by the B cell receptor during positive versus negative signaling	IMMUNITY			English	Article							LYN-DEFICIENT MICE; NF-KAPPA-B; ANTIGEN RECEPTOR; PROTEIN-KINASE; T-LYMPHOCYTES; AUTOIMMUNE-DISEASE; TRANSGENIC MICE; CYCLOSPORINE-A; SELF-TOLERANCE; IMMUNE-SYSTEM	It is not known how immunogenic versus tolerogenic cellular responses are signaled by receptors such as the B cell antigen receptor (BCR). Here we compare BCR signaling in naive cells that respond positively to foreign antigen and self-tolerant cells that respond negatively to self-antigen. In naive cells, foreign antigen triggered a Targe biphasic calcium response and activated nuclear signals through NF-AT, NF-kappa B, JNK, and ERK/pp90rsk. In tolerant B cells, self-antigen stimulated low calcium oscillations and activated NF-AT and ERK/pp90rsk but not NF-kappa B or JNK. Self-reactive B cells lacking the phosphatase CD45 did not exhibit calcium oscillations or ERK/pp90rsk activation, nor did they repond negatively to self-antigen. These data reveal striking biochemical differences in BCR signaling to the nucleus during positive selection by foreign antigens and negative selection by self-antigens.	STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,PROGRAM IMMUNOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT MOL & CELLULAR PHYSIOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; WASHINGTON UNIV,SCH MED,DEPT PATHOL,HOWARD HUGHES MED INST,ST LOUIS,MO 63110	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Washington University (WUSTL)			Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155	NIGMS NIH HHS [R01 GM045374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Benatar T, 1996, J EXP MED, V183, P329, DOI 10.1084/jem.183.1.329; CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; CHUI D, 1994, EMBO J, V13, P798, DOI 10.1002/j.1460-2075.1994.tb06322.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1994, ANNU REV BIOCHEM, V63, P1045; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DOLMETSCH RE, 1994, J GEN PHYSIOL, V103, P365, DOI 10.1085/jgp.103.3.365; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOLD MR, 1994, ADV IMMUNOL, V55, P221; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MCMAHON SB, 1995, J EXP MED, V181, P417, DOI 10.1084/jem.181.1.417; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; SAMUELS ML, 1994, MOL CELL BIOL, V14, P7855, DOI 10.1128/MCB.14.12.7855; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SCOTT DW, 1993, ADV IMMUNOL, V54, P393, DOI 10.1016/S0065-2776(08)60539-8; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; YAN MH, 1994, NATURE, V372, P798	69	325	327	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					419	428		10.1016/S1074-7613(00)80285-X	http://dx.doi.org/10.1016/S1074-7613(00)80285-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133421	Bronze			2022-12-18	WOS:A1997XC61900007
J	Tabas, I; Lichtman, AH				Tabas, Ira; Lichtman, Andrew H.			Monocyte-Macrophages and T Cells in Atherosclerosis	IMMUNITY			English	Review							STRESS PROMOTES ATHEROSCLEROSIS; BINDING CASSETTE TRANSPORTERS; RECEPTOR TYROSINE KINASE; ACUTE CORONARY SYNDROMES; CLONAL HEMATOPOIESIS; NECROTIC CORE; LY-6C(HIGH) MONOCYTES; VASCULAR INFLAMMATION; INSULIN-RESISTANCE; MERTK RECEPTOR	Atherosclerosis is an arterial disease process characterized by the focal subendothelial accumulation of apolipoprotein-B-containing lipoproteins, immune and vascular wall cells, and extracellular matrix. The lipoproteins acquire features of damage-associated molecular patterns and trigger first an innate immune response, dominated by monocyte-macrophages, and then an adaptive immune response. These inflammatory responses often become chronic and non-resolving and can lead to arterial damage and thrombosis-induced organ infarction. The innate immune response is regulated at various stages, from hematopoiesis to monocyte changes and macrophage activation. The adaptive immune response is regulated primarily by mechanisms that affect the balance between regulatory and effector T cells. Mechanisms related to cellular cholesterol, phenotypic plasticity, metabolism, and aging play key roles in affecting these responses. Herein, we review select topics that shed light on these processes and suggest new treatment strategies.	[Tabas, Ira] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Med Ctr, Dept Physiol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Lichtman, Andrew H.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lichtman, Andrew H.] Harvard Med Sch, Boston, MA 02115 USA	Columbia University; Columbia University; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Tabas, I (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Med Ctr, Dept Physiol, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.; Lichtman, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.; Lichtman, AH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	iat1@columbia.edu; alichtman@bwh.harvard.edu			NIH [R01 HL132412, HL127464, HL075662, P01 HL087123, R01 HL087282, HL131862]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087282, R01HL075662, R01HL132412, P01HL087123, R01HL140554, R01HL081181, R01HL127464, R01HL131862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH (R01 HL132412, HL127464, HL075662, and P01 HL087123 to I.T.; R01 HL087282 and HL131862 to A.H.L.).	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; American Heart Association, 2017, CARD DIS COSTL BURD; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Angelin A, 2017, CELL METAB, V25, P1282, DOI 10.1016/j.cmet.2016.12.018; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Aryal B, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0407-3; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Behn A, 2006, CURR OPIN CARDIOL, V21, P353, DOI 10.1097/01.hco.0000231406.84554.96; Bekkering S, 2016, ATHEROSCLEROSIS, V254, P228, DOI 10.1016/j.atherosclerosis.2016.10.019; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Boren J, 2016, CURR OPIN LIPIDOL, V27, P473, DOI 10.1097/MOL.0000000000000330; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Burkett PR, 2015, J CLIN INVEST, V125, P2211, DOI 10.1172/JCI78085; Butcher MJ, 2016, CIRC RES, V119, P1190, DOI 10.1161/CIRCRESAHA.116.309764; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chaudhari SM, 2015, ARTERIOSCL THROM VAS, V35, P2316, DOI 10.1161/ATVBAHA.115.306171; Chen HH, 2015, CIRC RES, V117, P671, DOI 10.1161/CIRCRESAHA.114.305777; Cheng HY, 2016, J CLIN INVEST, V126, P3236, DOI 10.1172/JCI83136; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dullaart RPF, 2017, NEW ENGL J MED, V376, P1790, DOI 10.1056/NEJMe1703138; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Erbilgin A, 2013, J LIPID RES, V54, P1894, DOI 10.1194/jlr.M037085; Fogelstrand P, 2012, NUTR METAB CARDIOVAS, V22, P1, DOI 10.1016/j.numecd.2011.09.007; Franck G, 2017, CIRC RES, V121, P31, DOI 10.1161/CIRCRESAHA.117.310694; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Garbin U, 2013, CARDIOVASC RES, V97, P125, DOI 10.1093/cvr/cvs301; Gautier EL, 2013, J EXP MED, V210, P339, DOI 10.1084/jem.20121357; GENG YJ, 1995, AM J PATHOL, V147, P251; Gimbrone MA, 2013, CARDIOVASC PATHOL, V22, P9, DOI 10.1016/j.carpath.2012.06.006; Gistera A, 2017, J INTERN MED, V281, P383, DOI 10.1111/joim.12589; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hilgendorf I, 2012, CURR ATHEROSCLER REP, V14, P450, DOI 10.1007/s11883-012-0274-8; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; Hoseini Z, 2018, J CELL PHYSIOL, V233, P2116, DOI 10.1002/jcp.25930; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Jahagirdar R, 2014, ATHEROSCLEROSIS, V236, P91, DOI 10.1016/j.atherosclerosis.2014.06.008; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kimura T, 2017, AM J PHYSIOL-HEART C, V312, pH781, DOI 10.1152/ajpheart.00798.2016; Kojima Y, 2016, NATURE, V536, P86, DOI 10.1038/nature18935; Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Li J, 2016, CIRC RES, V118, P1540, DOI 10.1161/CIRCRESAHA.116.308648; Libby P, 2017, EUR HEART J, V38, P801, DOI 10.1093/eurheartj/ehw599; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lichtman AH, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00018; Linton MF, 2016, CIRC J, V80, P2259, DOI 10.1253/circj.CJ-16-0924; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Mailer RKW, 2017, CIRC RES, V120, P1740, DOI 10.1161/CIRCRESAHA.116.310054; Marsch E, 2014, ARTERIOSCL THROM VAS, V34, P2545, DOI 10.1161/ATVBAHA.114.304023; Marsch E, 2013, CURR OPIN LIPIDOL, V24, P393, DOI 10.1097/MOL.0b013e32836484a4; McMullin MF, 2011, AM J HEMATOL, V86, P962, DOI 10.1002/ajh.22154; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nus M., 2016, CARDIOVASC RES, V23, P610; Nus M, 2017, NAT MED, V23, P601, DOI 10.1038/nm.4315; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; Otsuka F, 2015, ATHEROSCLEROSIS, V241, P772, DOI 10.1016/j.atherosclerosis.2015.05.011; Ouimet M, 2015, J CLIN INVEST, V125, P4334, DOI 10.1172/JCI81676; Packard RRS, 2008, CIRC RES, V103, P965, DOI 10.1161/CIRCRESAHA.108.185793; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petri MH, 2017, BRIT J PHARMACOL, V174, P4043, DOI 10.1111/bph.13707; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Razani B, 2008, ENDOCRIN METAB CLIN, V37, P603, DOI 10.1016/j.ecl.2008.05.001; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Sakai M, 2000, CURR OPIN LIPIDOL, V11, P503, DOI 10.1097/00041433-200010000-00008; Sakai M, 1996, J BIOL CHEM, V271, P27346, DOI 10.1074/jbc.271.44.27346; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Sayin VI, 2014, CIRC RES, V115, P781, DOI 10.1161/CIRCRESAHA.115.304992; Schierwagen R, 2017, AM J PHYSIOL-GASTR L, V312, pG407, DOI 10.1152/ajpgi.00441.2016; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2016, TRENDS IMMUNOL, V37, P32, DOI 10.1016/j.it.2015.11.004; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tang J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400223; Tao H, 2015, J LIPID RES, V56, P1449, DOI 10.1194/jlr.M056689; Tawakol A, 2015, ARTERIOSCL THROM VAS, V35, P1463, DOI 10.1161/ATVBAHA.115.305551; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Viny AD, 2014, CANCER J, V20, P61, DOI 10.1097/PPO.0000000000000013; Viola J, 2015, SEMIN IMMUNOL, V27, P184, DOI 10.1016/j.smim.2015.03.013; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Wang W, 2016, CIRC RES, V119, pE91, DOI 10.1161/CIRCRESAHA.116.308955; Wang Y, 2017, ARTERIOSCL THROM VAS, V37, pE99, DOI 10.1161/ATVBAHA.117.309580; Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watanabe R, 2017, J CLIN INVEST, V127, P2725, DOI 10.1172/JCI92167; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Westerterp M, 2017, CELL METAB, V25, P1294, DOI 10.1016/j.cmet.2017.04.005; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Willecke F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128996; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Wu XQ, 2016, IMMUNOLOGY, V148, P237, DOI 10.1111/imm.12608; Xu Y, 2016, J CLIN INVEST, V126, P2678, DOI 10.1172/JCI85834; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	151	324	337	7	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					621	634		10.1016/j.immuni.2017.09.008	http://dx.doi.org/10.1016/j.immuni.2017.09.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045897	Green Accepted, Bronze			2022-12-18	WOS:000413091600009
J	Sette, A; Rappuoli, R				Sette, Alessandro; Rappuoli, Rino			Reverse Vaccinology: Developing Vaccines in the Era of Genomics	IMMUNITY			English	Review							T-CELL RESPONSES; HUMAN DENDRITIC CELLS; PLASMODIUM-FALCIPARUM; PEPTIDE BINDING; LYMPHOCYTE RESPONSES; ANTIBODY-RESPONSES; DIFFERENT EPITOPES; IMMUNE-RESPONSES; PD-1 EXPRESSION; MHC SUPERTYPES	The sequence of microbial genomes made all potential antigens of each pathogen available for vaccine development This increased by orders of magnitude potential vaccine targets in bacteria, parasites, and large viruses and revealed virtually all their CD4(+) and CD8(+) T cell epitopes The genomic information was first used for the development of a vaccine against serogroup B meningococcus, and it is now being used for several other bacterial vaccines In this review, we will first summarize the impact that genome sequencing has had on vaccine development, and then we will analyze how the genomic information can help further our understanding of immunity to infection or vaccination and lead to the design of better vaccines by diving into the world of T cell immunity	[Rappuoli, Rino] Novartis Vaccines, I-53100 Siena, Italy; [Sette, Alessandro] La Jolla Inst Allergy & Immunol, San Diego, CA 92130 USA	Novartis; La Jolla Institute for Immunology	Rappuoli, R (corresponding author), Novartis Vaccines, I-53100 Siena, Italy.		Sette, Alessandro/AFO-8916-2022		NIH NIAID [HHSN272200700048C, 900042C, 900044C]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank M Kotturi J Sidney M Moutaftsi and B Mothe for their comments and critical reading of the manuscript The authors are also grateful to C Mallia for editorial assistance and G Corsi for the artwork This work is supported by funding from NIH NIAID contracts HHSN272200700048C 900042C 900044C (to AS)	Alexander J, 2000, J IMMUNOL, V164, P1625, DOI 10.4049/jimmunol.164.3.1625; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Bakker AH, 2005, CURR OPIN IMMUNOL, V17, P428, DOI 10.1016/j.coi.2005.06.008; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Berlanda S.F., 2008, MOL CELL PROTEOMICS, V7, P473, DOI DOI 10.1074/MCP.M700295-MCP200; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Bocchia M, 2005, LANCET, V365, P657; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buus S, 1999, CURR OPIN IMMUNOL, V11, P209, DOI 10.1016/S0952-7915(99)80035-1; BUYNAK EB, 1976, JAMA-J AM MED ASSOC, V235, P2832, DOI 10.1001/jama.235.26.2832; CALVO CJM, 2007, PLOS PATHOG, V3, P1511; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; De Groot AS, 2005, VACCINE, V23, P2136, DOI 10.1016/j.vaccine.2005.01.097; DEGROOT ASM, 2009, CLIN APPL IMMUNOMICS; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Doytchinova IA, 2004, J IMMUNOL, V172, P4314, DOI 10.4049/jimmunol.172.7.4314; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; ELAD B, 1990, J INFECT DIS, V161, P446, DOI 10.1093/infdis/161.3.446; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Falugi F, 2001, EUR J IMMUNOL, V31, P3816, DOI 10.1002/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fenner F, 1988, SMALLPOX ITS ERADICA; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Freeman ML, 2010, J VIROL, V84, P2881, DOI 10.1128/JVI.02229-09; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Glenny AT, 1923, BRIT J EXP PATHOL, V4, P283; Graham BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011995; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hertz T, 2007, BIOINFORMATICS, V23, pE148, DOI 10.1093/Bioinformatics/btl324; Ingram RJ, 2010, INFECT IMMUN, V78, P2353, DOI 10.1128/IAI.00072-10; Ingram RJ, 2010, J IMMUNOL, V184, P3814, DOI 10.4049/jimmunol.0901581; Jenne L, 2000, GENE THER, V7, P1575, DOI 10.1038/sj.gt.3301287; Jenner E., 1959, CLASSICS MED SURG, P213; JENNER E, 1801, ORIGIN VACCINES INOC; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Jing L, 2008, J VIROL, V82, P7120, DOI 10.1128/JVI.00453-08; Jing L, 2007, J IMMUNOL, V178, P6374, DOI 10.4049/jimmunol.178.10.6374; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kangueane P, 2005, FRONT BIOSCI-LANDMRK, V10, P879, DOI 10.2741/1582; Karpenko O, 2008, IMMUNOGENETICS, V60, P25, DOI 10.1007/s00251-007-0266-y; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klade CS, 2008, GASTROENTEROLOGY, V134, P1385, DOI 10.1053/j.gastro.2008.02.058; Koelle DM, 2003, P NATL ACAD SCI USA, V100, P12899, DOI 10.1073/pnas.2131705100; Koelle DM, 2001, J IMMUNOL, V166, P4049, DOI 10.4049/jimmunol.166.6.4049; Koita OA, 2006, HUM VACCINES, V2, P119, DOI 10.4161/hv.2869; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Lauemoller S L, 2000, Rev Immunogenet, V2, P477; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; Leisner C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001678; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Levine MM, 2009, NEW GENERATION VACCI, P1, DOI [10.3109/9781420060744, DOI 10.3109/9781420060744]; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Liu LZ, 2005, J VIROL, V79, P7363, DOI 10.1128/JVI.79.12.7363-7370.2005; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mallios RR, 2003, HUM IMMUNOL, V64, P852, DOI 10.1016/S0198-8859(03)00142-3; Manuel ER, 2009, J VIROL, V83, P10028, DOI 10.1128/JVI.01015-09; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; McHeyzerWilliams MG, 1996, IMMUNOL REV, V150, P5, DOI 10.1111/j.1600-065X.1996.tb00693.x; McMurry J, 2005, TUBERCULOSIS, V85, P95, DOI 10.1016/j.tube.2004.09.005; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; Moise L, 2009, VACCINE, V27, P6471, DOI 10.1016/j.vaccine.2009.06.018; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Moutaftsi M, 2010, FUTURE MICROBIOL, V5, P221, DOI [10.2217/fmb.09.110, 10.2217/FMB.09.110]; Moutaftsi M, 2009, EUR J IMMUNOL, V39, P717, DOI 10.1002/eji.200838815; Moynihan JS, 2001, INTERVIROLOGY, V44, P65, DOI 10.1159/000050034; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; OFFIT PAUL.A, 2007, VACCINATED ONE MANS; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Ou DW, 1998, HUM IMMUNOL, V59, P665, DOI 10.1016/S0198-8859(98)00067-6; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Pasteur L., 1880, CR HEBD ACAD SCI, V91, P673; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Provenzano M, 2007, CANCER IMMUNOL IMMUN, V56, P1047, DOI 10.1007/s00262-006-0246-3; Putz MM, 2005, J GEN VIROL, V86, P2955, DOI 10.1099/vir.0.81265-0; Ramon G, 1924, ANN I PASTEUR PARIS, V38, P1; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Reche PA, 2004, LECT NOTES COMPUT SC, V3239, P189; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Sester U, 2008, AM J TRANSPLANT, V8, P1486, DOI 10.1111/j.1600-6143.2008.02279.x; Sette A, 1998, CURR OPIN IMMUNOL, V10, P478, DOI 10.1016/S0952-7915(98)80124-6; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Southwood S, 1998, J IMMUNOL, V160, P3363; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thorpe C, 2007, VACCINE, V25, P2252, DOI 10.1016/j.vaccine.2006.12.003; Tobery TW, 2001, J IMMUNOL METHODS, V254, P59, DOI 10.1016/S0022-1759(01)00397-0; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Tong JC, 2007, BIOINFORMATICS, V23, P177, DOI 10.1093/bioinformatics/btl563; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; Walsh SR, 2009, VACCINE, V27, P4990, DOI 10.1016/j.vaccine.2009.05.077; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	142	324	336	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					530	541		10.1016/j.immuni.2010.09.017	http://dx.doi.org/10.1016/j.immuni.2010.09.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029963	Green Accepted, Bronze			2022-12-18	WOS:000284300200009
J	Shaked, I; Meerson, A; Wolf, Y; Avni, R; Greenberg, D; Gilboa-Geffen, A; Soreq, H				Shaked, Iftach; Meerson, Ari; Wolf, Yochai; Avni, Ran; Greenberg, David; Gilboa-Geffen, Adi; Soreq, Hermona			MicroRNA-132 Potentiates Cholinergic Anti-inflammatory Signaling by Targeting Acetylcholinesterase	IMMUNITY			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; SPLICE VARIANTS; HEART-FAILURE; HOST RESPONSE; VAGUS NERVE; PATHWAY; ACTIVATION; BRAIN; INFLAMMATION	MicroRNAs (miRNAs) contribute to both neuronal and immune cell fate, but their involvement in intertissue communication remained unexplored. The brain, via vagal secretion of acetylcholine (ACh), suppresses peripheral inflammation by intercepting cytokine production; therefore, we predicted that microRNAs targeting acetylcholinesterase (AChE) can attenuate inflammation. Here, we report that inflammatory stimuli induced leukocyte overexpression of the AChE-targeting miR-132. Injected locked nucleic acid (LNA)-modified anti-miR-132 oligonucleotide depleted miR-132 amounts while elevating AChE in mouse circulation and tissues. In transfected cells, a mutated 3'UTR miR-132 binding site increased AChE mRNA expression, whereas cells infected with a lentivirus expressing pre-miR-132 showed suppressed AChE. Transgenic mice overexpressing 3'UTR null AChE showed excessive inflammatory mediators and impaired cholinergic anti-inflammatory regulation, in spite of substantial miR-132 upregulation in brain and bone marrow. Our findings identify the AChE mRNA-targeting miR-132 as a functional regulator of the brain-to-body resolution of inflammation, opening avenues for study and therapeutic manipulations of the neuro-immune dialog.	[Shaked, Iftach; Meerson, Ari; Wolf, Yochai; Avni, Ran; Greenberg, David; Gilboa-Geffen, Adi; Soreq, Hermona] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.		Shaked, Iftach/GNM-9959-2022; Shaked, Iftach/AAS-9961-2020; Meerson, Ari/N-2338-2019; gilboa-geffen, adi/E-3028-2013	Meerson, Ari/0000-0002-5811-7952; gilboa-geffen, adi/0000-0001-9549-4194; Wolf, Yochai/0000-0003-0270-2025; Greenberg, David/0000-0001-8959-8640; Soreq, Hermona/0000-0002-0955-526X	European Communities' Specific Targeted Research [LSHG-CT-2006-037277]; German Ministry of Science [DIP-G 3 2]; US-Israel Binational Science Fund [2003028-01]; The Hebrew University of Jerusalem's Johnson's and Johnson Fund for Innovative Science; The Lady Davis; Israel Psychobiology Foundations	European Communities' Specific Targeted Research; German Ministry of Science; US-Israel Binational Science Fund(US-Israel Binational Science Foundation); The Hebrew University of Jerusalem's Johnson's and Johnson Fund for Innovative Science; The Lady Davis; Israel Psychobiology Foundations	The authors are grateful to F. Eckstein, Gottingen for critical evaluation of this manuscript and to Eyal Soreq, Jerusalem, for the cover picture This study was supported by European Communities' Specific Targeted Research (LSHG-CT-2006-037277), the German Ministry of Science DIP-G 3 2, the US-Israel Binational Science Fund (2003028-01), and The Hebrew University of Jerusalem's Johnson's and Johnson Fund for Innovative Science. I.S. was the incumbent of postdoctoral fellowships from The Lady Davis and the Israel Psychobiology Foundations.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; ALOYA RB, 1993, P NATL ACAD SCI USA, V90, P2471; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Ben-Ari S, 2006, J NEUROCHEM, V97, P24, DOI 10.1111/j.1471-4159.2006.03725.x; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blatteis CM, 2007, PROG BRAIN RES, V162, P3, DOI 10.1016/S0079-6123(06)62001-3; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Davies John Q, 2005, Methods Mol Biol, V290, P105; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dombkowski AA, 2004, FEBS LETT, V560, P120, DOI 10.1016/S0014-5793(04)00083-3; Dunlap ME, 2003, AM J PHYSIOL-HEART C, V285, pH1632, DOI 10.1152/ajpheart.01051.2002; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Evron T, 2007, TOXICOLOGY, V233, P97, DOI 10.1016/j.tox.2006.08.018; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Giacobini E, 2003, INT J GERIATR PSYCH, V18, pS1, DOI 10.1002/gps.935; Gilboa-Geffen A, 2007, BLOOD, V109, P4383, DOI 10.1182/blood-2006-07-033373; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guimaraes-Sternberg C, 2006, LEUKEMIA RES, V30, P583, DOI 10.1016/j.leukres.2005.09.005; HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kang YJ, 2007, NAT IMMUNOL, V8, P601, DOI 10.1038/ni1471; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pick M, 2006, BLOOD, V107, P3397, DOI 10.1182/blood-2005-08-3240; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Pollak Y, 2005, ANN NEUROL, V57, P741, DOI 10.1002/ana.20454; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; SCHIEBELER H, 1974, International Journal of Chronobiology, V2, P281; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; SPLAWINSKI JA, 1977, PFLUG ARCH EUR J PHY, V368, P125, DOI 10.1007/BF01063464; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710; WOLFE AD, 1987, FUND APPL TOXICOL, V9, P266, DOI 10.1016/0272-0590(87)90048-0	75	324	349	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					965	973		10.1016/j.immuni.2009.09.019	http://dx.doi.org/10.1016/j.immuni.2009.09.019			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20005135	Bronze			2022-12-18	WOS:000273616400016
J	ZHENG, H; FLETCHER, D; KOZAK, W; JIANG, MH; HOFMANN, KJ; CONN, CA; SOSZYNSKI, D; GRABIEC, C; TRUMBAUER, ME; SHAW, A; KOSTURA, MJ; STEVENS, K; ROSEN, H; NORTH, RJ; CHEN, HY; TOCCI, MJ; KLUGER, MJ; VANDERPLOEG, LHT				ZHENG, H; FLETCHER, D; KOZAK, W; JIANG, MH; HOFMANN, KJ; CONN, CA; SOSZYNSKI, D; GRABIEC, C; TRUMBAUER, ME; SHAW, A; KOSTURA, MJ; STEVENS, K; ROSEN, H; NORTH, RJ; CHEN, HY; TOCCI, MJ; KLUGER, MJ; VANDERPLOEG, LHT			RESISTANCE TO FEVER INDUCTION AND IMPAIRED ACUTE-PHASE RESPONSE IN INTERLEUKIN-1-BETA-DEFICIENT MICE	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR; CONVERTING ENZYME; IL-1 RECEPTOR; MURINE LISTERIOSIS; MOLECULAR-CLONING; IMMUNE-RESPONSES; GENE-EXPRESSION; INFECTION; CELLS	We used gene targeting in embryonic stem cells to introduce an IL-1 beta null allele in mice. The IL-1 beta-deficient mice develop normally and are apparently healthy and fertile. The IL-1 beta null mice responded normally in models of contact and delayed-type hypersensitivity or following bacterial endotoxin LPS-induced inflammation. The IL-1 beta-deficient mice showed equivalent resistance to Listeria monocytogenes compared with wild-type controls. In contrast, when challenged with turpentine, which causes localized inflammation and tissue injury, the IL-1 beta mutant mice exhibited an impaired acute-phase inflammatory response and were completely resistant to fever development and anorexia. These results highlight a central role for IL-1 beta as a pyrogen and a mediator of the acute-phase response in a subset of inflammatory disease models, and support the notion that blocking the action of a single key cytokine can alter the course of specific immune and inflammatory responses.	MERCK RES LABS,DEPT IMMUNOL & INFLAMMAT,RAHWAY,NJ 07065; MERCK RES LABS,LAB ANIM RESOURCES,RAHWAY,NJ 07065; LOVELACE INST,INST BASIC & APPL MED RES,ALBUQUERQUE,NM 87108; MERCK RES LABS,DEPT VIRUS & CELL BIOL,W POINT,PA 19486; TRUDEAU INST INC,SARANAC LAKE,NY 12983	Merck & Company; Merck & Company; Lovelace Respiratory Research Institute; Merck & Company; Trudeau Institute	ZHENG, H (corresponding author), MERCK RES LABS,DEPT GENET & MOLEC BIOL,126 E LINCOLN AVE,RAHWAY,NJ 07065, USA.		Soszyński, Dariusz DS/H-4150-2014; Kozak, Wieslaw E/L-5976-2014		NIAID NIH HHS [AI 27756] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; ASHERSON GL, 1968, IMMUNOLOGY, V15, P405; BAUMANN H, 1986, J CELL BIOL, V102, P370, DOI 10.1083/jcb.102.2.370; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BRODY DT, 1989, J IMMUNOL, V143, P1183; CAMERON PM, 1986, J EXP MED, V164, P237, DOI 10.1084/jem.164.1.237; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHIZZONITE R, 1989, P NATL ACAD SCI USA, V86, P8029, DOI 10.1073/pnas.86.20.8029; CHU CQ, 1992, CLIN EXP IMMUNOL, V90, P522; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; COOPER AL, 1991, AM J PHYSIOL, V261, pE698, DOI 10.1152/ajpendo.1991.261.6.E698; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DENCZUK S, 1987, J MOL CELL IMMUNOL, V5, P255; DIGIOVINE FS, 1990, IMMUNOL TODAY, V11, P13; DINARELLO CA, 1992, INT J TISSUE REACT, V14, P65; DOWER SK, 1987, IMMUNOL TODAY, V8, P46, DOI 10.1016/0167-5699(87)90238-6; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; ENK AH, 1993, J IMMUNOL, V150, P3698; ENK AH, 1909, P NATL ACAD SCI USA, V89, P1398; FAHERTY DA, 1992, J IMMUNOL, V148, P766; FANSLOW WC, 1990, SCIENCE, P739; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; FENTON MJ, 1992, INT J IMMUNOPHARMACO, V14, P401, DOI 10.1016/0192-0561(92)90170-P; FERRERI NR, 1991, CELL IMMUNOL, V137, P389, DOI 10.1016/0008-8749(91)90088-S; GEIGER T, 1993, CLIN EXP RHEUMATOL, V11, P515; GERSHENWALD JE, 1990, P NATL ACAD SCI USA, V87, P4966, DOI 10.1073/pnas.87.13.4966; HARBRECHT BG, 1994, HEPATOLOGY, V20, P1055, DOI 10.1002/hep.1840200439; HAVELL EA, 1992, J IMMUNOL, V148, P1486; KLIR JJ, 1994, AM J PHYSIOL, V266, pR1845, DOI 10.1152/ajpregu.1994.266.6.R1845; KLIR JJ, 1909, AM J PHYSIOL, V265, pR512; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KOZAK W, 1994, AM J PHYSIOL, V266, pR125, DOI 10.1152/ajpregu.1994.266.1.R125; KOZAK W, 1995, IN PRESS AM J PHYSL; KUSHNER I, 1993, ACUTE PHASE PROTEINS, P255; LEMAY L G, 1990, Cytokine, V2, P199, DOI 10.1016/1043-4666(90)90016-M; LI P, 1905, CELL, V80, P401; LONG NC, 1990, AM J PHYSIOL, V259, pR724, DOI 10.1152/ajpregu.1990.259.4.R724; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MCMASTER MT, 1992, J IMMUNOL, V148, P1699; MOLINEAUX SM, 1993, P NATL ACAD SCI USA, V90, P1809, DOI 10.1073/pnas.90.5.1809; NORTHEMANN W, 1985, J BIOL CHEM, V260, P6200; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; ROSEN H, 1989, J EXP MED, V170, P27, DOI 10.1084/jem.170.1.27; ROTHSTEIN JL, 1992, GENE DEV, V6, P1190, DOI 10.1101/gad.6.7.1190; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Sipe J.D, 1993, ACUTE PHASE PROTEINS, P511; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; TELFORD JL, 1986, NUCLEIC ACIDS RES, V14, P9955, DOI 10.1093/nar/14.24.9955; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	63	324	332	0	12	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1995	3	1					9	19		10.1016/1074-7613(95)90154-X	http://dx.doi.org/10.1016/1074-7613(95)90154-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621081	Bronze			2022-12-18	WOS:A1995RK86800003
J	Abelin, JG; Keskin, DB; Sarkizova, S; Hartigan, CR; Zhang, WD; Sidney, J; Stevens, J; Lane, W; Zhang, GL; Eisenhaure, TM; Clauser, KR; Hacohen, N; Rooney, MS; Carr, SA; Wu, CJ				Abelin, Jennifer G.; Keskin, Derin B.; Sarkizova, Siranush; Hartigan, Christina R.; Zhang, Wandi; Sidney, John; Stevens, Jonathan; Lane, William; Zhang, Guang Lan; Eisenhaure, Thomas M.; Clauser, Karl R.; Hacohen, Nir; Rooney, Michael S.; Carr, Steven A.; Wu, Catherine J.			Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction	IMMUNITY			English	Article							HIGH-RESPONDING PEPTIDES; PROTEOMICS EXPERIMENTS; PROTEASOMAL CLEAVAGE; ANTIGEN PRESENTATION; NEURAL-NETWORKS; PROTEIN; BINDING; MOTIFS; UBIQUITINATION; QUANTIFICATION	Identification of human leukocyte antigen (HLA)-bound peptides by liquid chromatography-tandem mass spectrometry (LC-MS/MS) is poised to provide a deep understanding of rules underlying antigen presentation. However, a key obstacle is the ambiguity that arises from the co-expression of multiple HLA alleles. Here, we have implemented a scalable monoallelic strategy for profiling the HLA peptidome. By using cell lines expressing a single HLA allele, optimizing immunopurifications, and developing an application-specific spectral search algorithm, we identified thousands of peptides bound to 16 different HLA class I alleles. These data enabled the discovery of subdominant binding motifs and an integrative analysis quantifying the contribution of factors critical to epitope presentation, such as protein cleavage and gene expression. We trained neural-network prediction algorithms with our large dataset (>24,000 peptides) and outperformed algorithms trained on datasets of peptides with measured affinities. We thus demonstrate a strategy for systematically learning the rules of endogenous antigen presentation.	[Abelin, Jennifer G.; Keskin, Derin B.; Sarkizova, Siranush; Hartigan, Christina R.; Eisenhaure, Thomas M.; Clauser, Karl R.; Hacohen, Nir; Rooney, Michael S.; Carr, Steven A.; Wu, Catherine J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sarkizova, Siranush] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02142 USA; [Keskin, Derin B.; Zhang, Wandi; Zhang, Guang Lan; Hacohen, Nir; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Sarkizova, Siranush; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Stevens, Jonathan; Lane, William] Brigham & Womens Hosp, Tissue Typing Lab, Boston, MA 02115 USA; [Keskin, Derin B.; Zhang, Guang Lan; Wu, Catherine J.] Harvard Med Sch, Boston, MA 02115 USA; [Sidney, John] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Rooney, Michael S.] Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Rooney, Michael S.] Neon Therapeut, Cambridge, MA 02139 USA; [Keskin, Derin B.; Zhang, Guang Lan] Boston Univ, Metropolitan Coll, Dept Comp Sci, Boston, MA 02215 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Immunol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; La Jolla Institute for Immunology; Harvard University; Boston University; Harvard University; Massachusetts General Hospital	Hacohen, N; Rooney, MS; Carr, SA; Wu, CJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Hacohen, N; Wu, CJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Wu, CJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Rooney, MS (corresponding author), Harvard MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Rooney, MS (corresponding author), Neon Therapeut, Cambridge, MA 02139 USA.; Hacohen, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc Immunol, Boston, MA 02114 USA.	nhacohen@mgh.harvard.edu; mrooney@neontherapeutics.com; scarr@broad.mit.edu; cwu@partners.org	Carr, Steven A./AAH-8366-2019	Clauser, Karl/0000-0002-1052-9456; Abelin, Jennifer/0000-0001-5262-7241	Blavatnik Family Foundation; National Cancer Institute (NCI) [R01 CA155010]; NCI CPTAC [U24 CA160034]; NHGRI [T32 HG002295]; Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE [2P50CA101942-11A1]; NATIONAL CANCER INSTITUTE [P50CA101942, U24CA160034, R01CA155010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	Blavatnik Family Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI CPTAC; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by the Blavatnik Family Foundation (N.H. and C.W.), National Cancer Institute (NCI) R01 CA155010 (C.W.), NCI CPTAC U24 CA160034 (S.A.C, and K.C.), NHGRI T32 HG002295 (S.S.), and Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE 2P50CA101942-11A1 (D.B.K.). C.W. is a Scholar of the Leukemia and Lymphoma Society. J.G.A. and M.S.R. are employees and shareholders of Neon Therapeutics; N.H. and C.J.W. are founders of Neon Therapeutics and members of its scientific advisory board.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Bassani-Sternberet M, 2016, J IMMUNOL, V197, P2492, DOI 10.4049/jimmunol.1600808; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berg M, 2006, RAPID COMMUN MASS SP, V20, P1558, DOI 10.1002/rcm.2476; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Bremel Robert D, 2010, Immunome Res, V6, P7, DOI 10.1186/1745-7580-6-7; Burgevin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002402; Caron E, 2015, ELIFE, V4, DOI 10.7554/eLife.07661; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Eichmann M, 2014, TISSUE ANTIGENS, V84, P378, DOI 10.1111/tan.12413; Evnouchidou I, 2014, J IMMUNOL, V193, P901, DOI 10.4049/jimmunol.1302855; Eyers C. E., 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.M110.003384; Fusaro VA, 2009, NAT BIOTECHNOL, V27, P190, DOI 10.1038/nbt.1524; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hawkins OE, 2008, J PROTEOME RES, V7, P1445, DOI 10.1021/pr700761w; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Juncker AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007448; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kim Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002884; Kim Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-394; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Llano A, 2013, HIV MOL IMMUNOLOGY 2, P3; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Mommen GPM, 2016, MOL CELL PROTEOMICS, V15, P1412, DOI 10.1074/mcp.M115.055780; Muntel J, 2015, MOL CELL PROTEOMICS, V14, P430, DOI 10.1074/mcp.M114.044321; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Osorio D., 2014, PEPTIDES CALCULATE I; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reche Pedro A, 2006, Med Immunol, V5, P1, DOI 10.1186/1476-9433-5-1; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Saxova P, 2003, INT IMMUNOL, V15, P781, DOI 10.1093/intimm/dxg084; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Searle BC, 2015, MOL CELL PROTEOMICS, V14, P2331, DOI 10.1074/mcp.M115.051300; Sidney J., 2001, CURR PROTOC IMMUNOL, P3; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Theano Development Team, 2016, THEAN PYTH FRAM FAST; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Trolle T, 2016, J IMMUNOL, V196, P1480, DOI 10.4049/jimmunol.1501721; Trolle T, 2015, BIOINFORMATICS, V31, P2174, DOI 10.1093/bioinformatics/btv123; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	58	323	330	6	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					315	326		10.1016/j.immuni.2017.02.007	http://dx.doi.org/10.1016/j.immuni.2017.02.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228285	Green Accepted, Bronze			2022-12-18	WOS:000396410900018
J	Porritt, HE; Rumfelt, LL; Tabrizifard, S; Schmitt, TM; Carlos, J; Zuniga-Pflucker, JC; Petrie, HT				Porritt, HE; Rumfelt, LL; Tabrizifard, S; Schmitt, TM; Carlos, J; Zuniga-Pflucker, JC; Petrie, HT			Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages	IMMUNITY			English	Article							MOUSE BONE-MARROW; COMMON LYMPHOID PROGENITORS; FETAL THYMUS; C-KIT; STEM-CELLS; IN-VITRO; EXPRESSION; THYMOCYTES; MICE; PRECURSORS	The nature of early T lineage progenitors in the thymus or bone marrow remains controversial. Here we assess lineage capacity and proliferative potential among five distinct components of the earliest intrathymic stage (DN1, CD25(-)44(+)). All of these express one or more hemato-lymphoid lineage markers. All can produce T lineage cells, but only two of them display kinetics of differentiation, proliferative capacity, and other traits consistent with being canonical T progenitors. The latter also appeared limited to producing cells of the T or NK lineages, while B lineage potential derived mainly from the other, less typical T progenitors. In addition to precisely defining canonical early progenitors in the thymus, this work reconciles conflicting results from numerous groups by showing that multiple progenitors with a DN1 phenotype home to the thymus and make T cells, but possess different proliferative potentials and lineage capacities.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA; Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Miami; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Petrie, HT (corresponding author), Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA.	hpetrie@med.miami.edu	Schmitt, Tom/AAG-9941-2020; Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Schmitt, Thomas/0000-0002-0736-4195	NIAID NIH HHS [AI33940, AI53739] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053739, R56AI033940, R29AI033940, R01AI033940, R21AI033940] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Gordon KM, 2003, J IMMUNOL METHODS, V275, P113, DOI 10.1016/S0022-1759(03)00009-7; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Hare KJ, 1999, SEMIN IMMUNOL, V11, P3, DOI 10.1006/smim.1998.0151; HOZUMI K, 1994, EUR J IMMUNOL, V24, P1339, DOI 10.1002/eji.1830240615; Igarashi H, 2001, BLOOD, V97, P2680, DOI 10.1182/blood.V97.9.2680; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; KADISH JL, 1976, J EXP MED, V143, P1082, DOI 10.1084/jem.143.5.1082; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lind EF, 1999, J IMMUNOL, V162, P5374; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Michie AM, 2000, J IMMUNOL, V164, P1730, DOI 10.4049/jimmunol.164.4.1730; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; Pear WS, 2004, CURR OPIN IMMUNOL, V16, P167, DOI 10.1016/j.coi.2004.01.011; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PENIT C, 1995, J IMMUNOL, V154, P5103; Perry SS, 2003, J IMMUNOL, V170, P1877, DOI 10.4049/jimmunol.170.4.1877; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SHORTMAN K, 1988, IMMUNOL CELL BIOL, V66, P423, DOI 10.1038/icb.1988.54; Shortman K, 1990, Semin Immunol, V2, P3; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Tourigny MR, 1997, J EXP MED, V185, P1549, DOI 10.1084/jem.185.9.1549; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; WILSON A, 1988, J IMMUNOL, V140, P1461; WILSON A, 1995, INT IMMUNOL, V7, P1659, DOI 10.1093/intimm/7.10.1659; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	49	323	326	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2004	20	6					735	745		10.1016/j.immuni.2004.05.004	http://dx.doi.org/10.1016/j.immuni.2004.05.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189738	Bronze			2022-12-18	WOS:000222205300009
J	Seshasayee, D; Valdez, P; Yan, MH; Dixit, VM; Tumas, D; Grewal, IS				Seshasayee, D; Valdez, P; Yan, MH; Dixit, VM; Tumas, D; Grewal, IS			Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor	IMMUNITY			English	Article							NECROSIS-FACTOR FAMILY; B-CELL MATURATION; NF-KAPPA-B; LYMPHOTOXIN-BETA-RECEPTOR; TNF RECEPTOR; MOLECULAR SWITCH; BAFF; APRIL; BCMA; IDENTIFICATION	BLyS, a key cytokine that sustains B cell maturation and tolerance, binds three receptors: BR3, BCMA, and TACI. Results from knockout mice implicate a major functional role for BR3 and a redundant one for BCMA in B cell function. TACI's role is controversial based on defects in TI antibody responses accompanied by B cell hyperplasia in knockout mice. We have presently characterized a precise role for TACI in vivo. TACI(-/-) mice develop fatal autoimmune glomerulonephritis, proteinurea, and elevated levels of circulating autoantibodies. Treatment of B cells with TACI agonistic antibodies inhibits proliferation in vitro and activation of a chimeric receptor containing the TACI intracellular domain induces apoptosis. These results demonstrate the critical requirement for TACI in regulating B cell homeostasis.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Grewal, IS (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	iqbal@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Grewal, Iqbal S/0000-0002-4775-055X				Amanna IJ, 2001, J IMMUNOL, V167, P6069, DOI 10.4049/jimmunol.167.11.6069; Browning JL, 1996, J EXP MED, V183, P867, DOI 10.1084/jem.183.3.867; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; GROSS JA, 1992, J IMMUNOL, V149, P380; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	39	323	340	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					279	288		10.1016/S1074-7613(03)00025-6	http://dx.doi.org/10.1016/S1074-7613(03)00025-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594954	Bronze			2022-12-18	WOS:000181138100011
J	Bolland, S; Pearse, RN; Kurosaki, T; Ravetch, JV				Bolland, S; Pearse, RN; Kurosaki, T; Ravetch, JV			SHIP modulates immune receptor responses by regulating membrane association of Btk	IMMUNITY			English	Article							BRUTONS TYROSINE KINASE; X-LINKED AGAMMAGLOBULINEMIA; IMMUNODEFICIENT XID MICE; NATURAL-KILLER-CELLS; FC-GAMMA-RIIB; PHOSPHATIDYLINOSITOL 3-KINASE; B-CELLS; CROSS-LINKING; PHOSPHOLIPASE C-GAMMA-2; SIGNAL-TRANSDUCTION	Membrane recruitment of SHIP is responsible for the inhibitory signal generated by Fc gamma RIIB coligation to the BCR. By reducing the level of PIP3, SHIP regulates the association of the tyrosine kinase Btk with the membrane through PH domain-phosphoinositol lipid interactions. Inhibition of BCR signaling by either Fc gamma RIIB coligation, membrane expression of SHIP, or inhibition of PI3K, conditions which result in decreased levels of PIP3, is suppressed by the expression of Btk as a membrane-associated chimera. Conversely, increasing PIP3 levels by deletion of SHIP results in increased Btk association with the membrane and hyperresponsive BCR signaling. These results suggest a central role for PIP3 in regulating the B cell stimulatory state by modulating Btk localization and thereby calcium fluxes.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Kansai Med Univ, Dept Mol Genet, Moriguchi, Osaka 570, Japan	Rockefeller University; Memorial Sloan Kettering Cancer Center; Kansai Medical University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA.		Ravetch, Jeffrey/Z-1596-2019; Kurosaki, Tomohiro/D-1306-2009	Ravetch, Jeffrey/0000-0003-2024-9041; Kurosaki, Tomohiro/0000-0002-6352-304X				BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; CHOQUET D, 1993, J CELL BIOL, V121, P355, DOI 10.1083/jcb.121.2.355; Cornall RJ, 1995, CURR OPIN IMMUNOL, V7, P804, DOI 10.1016/0952-7915(95)80052-2; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; Geier SJ, 1997, BLOOD, V89, P1876, DOI 10.1182/blood.V89.6.1876; GOLD MR, 1994, J IMMUNOL, V152, P42; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; KAUFMAN DS, 1995, P NATL ACAD SCI USA, V92, P6484, DOI 10.1073/pnas.92.14.6484; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Li TJ, 1997, ONCOGENE, V15, P1375, DOI 10.1038/sj.onc.1201308; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RIGLEY KP, 1989, EUR J IMMUNOL, V19, P2081, DOI 10.1002/eji.1830191117; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Vely F, 1997, J IMMUNOL, V159, P2075; VONWILLEBRAND M, 1994, EUR J IMMUNOL, V24, P234, DOI 10.1002/eji.1830240137; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; YANO H, 1993, J BIOL CHEM, V268, P25846	49	322	335	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					509	516		10.1016/S1074-7613(00)80555-5	http://dx.doi.org/10.1016/S1074-7613(00)80555-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586640	Bronze			2022-12-18	WOS:000073348000012
J	Mackay, LK; Wynne-Jones, E; Freestone, D; Pellicci, DG; Mielke, LA; Newman, DM; Braun, A; Masson, F; Kallies, A; Belz, GT; Carbone, FR				Mackay, Laura K.; Wynne-Jones, Erica; Freestone, David; Pellicci, Daniel G.; Mielke, Lisa A.; Newman, Dane M.; Braun, Asolina; Masson, Frederick; Kallies, Axel; Belz, Gabrielle T.; Carbone, Francis R.			T-box Transcription Factors Combine with the Cytokines TGF-beta and IL-15 to Control Tissue-Resident Memory T Cell Fate	IMMUNITY			English	Article							CUTTING EDGE; RM CELLS; EFFECTOR; INFECTION; DIFFERENTIATION; MAINTENANCE; MIGRATION; COMPARTMENTALIZATION; EXPRESSION; SKIN	Tissue-resident memory T (Trm) cells contribute to local immune protection in non-lymphoid tissues such as skin and mucosa, but little is known about their transcriptional regulation. Here we showed that CD8(+)CD103(+) Trm cells, independent of circulating memory T cells, were sufficient for protection against infection and described molecular elements that were crucial for their development in skin and lung. We demonstrated that the T-box transcription factors (TFs) Eomes and T-bet combined to control CD8(+)CD103(+) Trm cell formation, such that their coordinate downregulation was crucial for TGF-beta cytokine signaling. TGF-beta signaling, in turn, resulted in reciprocal T-box TF downregulation. However, whereas extinguishment of Eomes was necessary for CD8(+)CD103(+) Trm cell development, residual T-bet expression maintained cell surface interleukin-15 (IL-15) receptor beta-chain (CD122) expression and thus IL-15 responsiveness. These findings indicate that the T-box TFs control the two cytokines, TGF-b and IL-15, which are pivotal for CD8(+)CD103(+) Trm cell development and survival.	[Mackay, Laura K.; Wynne-Jones, Erica; Freestone, David; Pellicci, Daniel G.; Newman, Dane M.; Braun, Asolina; Carbone, Francis R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pellicci, Daniel G.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia; [Mielke, Lisa A.; Masson, Frederick; Kallies, Axel; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Masson, Frederick] Olivia Newton John Canc Res Inst, Heidelberg, Vic 3084, Australia; [Masson, Frederick] La Trobe Univ, Sch Canc Med, Melbourne, Vic 3086, Australia	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University	Mackay, LK (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	lkmackay@unimelb.edu.au	Carbone, Francis/ABF-2141-2020; Belz, Gabrielle T/C-9350-2013; Mackay, Laura K/HGC-6580-2022; Pellicci, Daniel/AAX-8539-2020	Belz, Gabrielle T/0000-0002-9660-9587; Mackay, Laura K/0000-0002-8496-6632; Mielke, Lisa/0000-0002-9522-9320; Kallies, Axel/0000-0002-6312-6968; Wynne-Jones, Erica/0000-0003-2661-6981; Braun, Asolina/0000-0002-2646-5362; Pellicci, Daniel/0000-0001-5305-2398; Masson, Frederic/0000-0001-9909-2985	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank members of the Carbone and Heath laboratories for helpful discussions. We also thank J.M. Schenkel (University of Minnesota) for advice on Thy1.1 depletion and IL-15 blocking studies and S. Turner (University of Melbourne) for the influenza virus X31-OVA. This work was supported by National Health and Medical Research Council of Australia (L.K.M. and F.R.C.) and Australian Research Council (L.K.M. and F.R.C.).	Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Hofmann M, 2013, EUR J IMMUNOL, V43, P2295, DOI 10.1002/eji.201343519; Hu YH, 2015, J IMMUNOL, V194, P2407, DOI 10.4049/jimmunol.1402369; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Klose CSN, 2014, IMMUNITY, V41, P230, DOI 10.1016/j.immuni.2014.06.018; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	36	321	328	5	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1101	1111		10.1016/j.immuni.2015.11.008	http://dx.doi.org/10.1016/j.immuni.2015.11.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682984	Bronze			2022-12-18	WOS:000366846600014
J	Kawamoto, S; Maruya, M; Kato, LM; Suda, W; Atarashi, K; Doi, Y; Tsutsui, Y; Qin, HY; Honda, K; Okada, T; Hattori, M; Fagarasan, S				Kawamoto, Shimpei; Maruya, Mikako; Kato, Lucia M.; Suda, Wataru; Atarashi, Koji; Doi, Yasuko; Tsutsui, Yumi; Qin, Hongyan; Honda, Kenya; Okada, Takaharu; Hattori, Masahira; Fagarasan, Sidonia			Foxp3(+) T Cells Regulate Immunoglobulin A Selection and Facilitate Diversification of Bacterial Species Responsible for Immune Homeostasis	IMMUNITY			English	Article							GUT MICROBIOTA; IGA RESPONSE; TGF-BETA; DIVERSITY; MUTATION; MICE; DIFFERENTIATION; METABOLITES; ACTIVATION; METAGENOME	Foxp3(+) T cells play a critical role for the maintenance of immune tolerance. Here we show that in mice, Foxp3(+) T cells contributed to diversification of gut microbiota, particularly of species belonging to Firmicutes. The control of indigenous bacteria by Foxp3(+) T cells involved regulatory functions both outside and inside germinal centers (GCs), consisting of suppression of inflammation and regulation of immunoglobulin A (IgA) selection in Peyer's patches, respectively. Diversified and selected IgAs contributed to maintenance of diversified and balanced microbiota, which in turn facilitated the expansion of Foxp3(+) T cells, induction of GCs, and IgA responses in the gut through a symbiotic regulatory loop. Thus, the adaptive immune system, through cellular and molecular components that are required for immune tolerance and through the diversification as well as selection of antibody repertoire, mediates host-microbial symbiosis by controlling the richness and balance of bacterial communities required for homeostasis.	[Kawamoto, Shimpei; Maruya, Mikako; Kato, Lucia M.; Doi, Yasuko; Tsutsui, Yumi; Qin, Hongyan; Fagarasan, Sidonia] RIKEN, Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Honda, Kenya] RIKEN, Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Gut Homeostasis, Yokohama, Kanagawa 2300045, Japan; [Okada, Takaharu] RIKEN, Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Tissue Dynam, Yokohama, Kanagawa 2300045, Japan; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Ctr Omics & Bioinformat, Kashiwa, Chiba 2778561, Japan; [Qin, Hongyan] 4th Mil Med Univ, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China	RIKEN; RIKEN; RIKEN; University of Tokyo; Air Force Military Medical University	Fagarasan, S (corresponding author), RIKEN, Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Okada, Takaharu/N-7931-2015; Hattori, Masahira/AAD-3785-2019; Suda, Wataru/AAF-4469-2019; Fagarasan, Sidonia/A-5258-2016; Atarashi, Koji/I-5363-2014; Honda, Kenya/N-5297-2015	Fagarasan, Sidonia/0000-0003-2086-6402; Atarashi, Koji/0000-0001-5422-0736; Qin, Hongyan/0000-0003-1038-7037	Naito Foundation, RIKEN special Postdoctoral Researchers Program; MEXT of Japan; JSPS Postdoctoral Fellowship;  [25293118];  [25860375]	Naito Foundation, RIKEN special Postdoctoral Researchers Program; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	We thank T. Honjo, O. Kanagawa, I. Taniuchi, and D. Littman for inspiring discussions, suggestions, and critical comments and M. Miyajima, K. Suzuki, K. Moro, A. Hijikata, H. Fujimoto, Y. Hachiman, Y. Murahashi, C. Shindo, K. Komiya, H. Kuroyanagi, E. Iioka, Y. Takayama, E. Ohmori, M. Kiuchi, and Y. Hattori for technical assistance. The data reported in this paper are tabulated in the main paper and the Supplemental Data. This work was supported in part by Grants-in-Aid for Scientific Research (25293118) (S.F.) and for Young Scientist (25860375), the Naito Foundation, RIKEN special Postdoctoral Researchers Program (S.K.), the global COE project "Genome Information Big Bang" from the MEXT of Japan (M.H.), and JSPS Postdoctoral Fellowship for Foreign Researchers (L.M.K.).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.1038/s41577-019-0268-7, 10.4161/gmic.20228]; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Sutherland DB, 2012, CURR OPIN IMMUNOL, V24, P261, DOI 10.1016/j.coi.2012.03.005; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Vinuesa CG, 2013, IMMUNITY, V39, P417, DOI 10.1016/j.immuni.2013.09.001; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	52	321	330	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					152	165		10.1016/j.immuni.2014.05.016	http://dx.doi.org/10.1016/j.immuni.2014.05.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25017466	Bronze			2022-12-18	WOS:000341444200018
J	Eisele, E; Siliciano, RF				Eisele, Evelyn; Siliciano, Robert F.			Redefining the Viral Reservoirs that Prevent HIV-1 Eradication	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COMBINATION ANTIRETROVIRAL THERAPY; LOW-LEVEL VIREMIA; IN-VIVO; LATENT RESERVOIR; RESIDUAL HIV-1; INTRINSIC STABILITY; ONGOING REPLICATION; CHEMOKINE RECEPTOR	This Perspective proposes definitions for key terms in the field of HIV-1 latency and eradication. In the context of eradication, a reservoir is a cell type that allows persistence of replication-competent HIV-1 on a timescale of years in patients on optimal antiretroviral therapy. Reservoirs act as a barrier to eradication in the patient population in which cure attempts will likely be made. Halting viral replication is essential to eradication, and definitions and criteria for assessing whether this goal has been achieved are proposed. The cell types that may serve as reservoirs for HIV-1 are discussed. Currently, only latently infected resting CD4(+) T cells fit the proposed definition of a reservoir, and more evidence is necessary to demonstrate that other cell types, including hematopoietic stem cells and macrophages, fit this definition. Further research is urgently required on potential reservoirs in the gut-associated lymphoid tissue and the central nervous system.	[Eisele, Evelyn; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Eisele, Evelyn; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu			National Institutes of Health [AI43222]; Martin Delaney CARE Collaboratory; Martin Delaney DARE Collaboratory; Foundation for AIDS Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, U19AI096113, R37AI051178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Delaney CARE Collaboratory; Martin Delaney DARE Collaboratory; Foundation for AIDS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (RO1 grant AI43222), the Martin Delaney CARE and DARE Collaboratories, an ARCHE grant from the Foundation for AIDS Research, and the Howard Hughes Medical Institute. We thank J. Siliciano for a critical reading of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; [Anonymous], 2011, CSH PERSPECT MED, DOI DOI 10.1101/cshperspect.a007096; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Avery LB, 2011, CLIN PHARMACOL THER, V90, P151, DOI 10.1038/clpt.2011.99; Babas T, 2003, J VIROL, V77, P208, DOI 10.1128/JVI.77.1.208-216.2003; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; BUKRINSKY M, 1993, J VIROL, V67, P6863, DOI 10.1128/JVI.67.11.6863-6865.1993; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Durand C.M., 2012, TRENDS IMMU IN PRESS; Durand CM, 2012, J INFECT DIS, V205, P1014, DOI 10.1093/infdis/jir884; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; HUFERT FT, 1993, J ACQ IMMUN DEF SYND, V6, P772; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; MARTIN BK, 1965, NATURE, V207, P274, DOI 10.1038/207274a0; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McIlroy D, 1996, RES VIROLOGY, V147, P115, DOI 10.1016/0923-2516(96)80225-1; McNamara LA, 2011, CURR OPIN HIV AIDS, V6, P43, DOI 10.1097/COH.0b013e32834086b3; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Perng Guey-Chuen, 2010, Interdiscip Perspect Infect Dis, V2010, P262415, DOI 10.1155/2010/262415; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Sahu GK, 2010, J VIROL, V84, P8348, DOI 10.1128/JVI.00362-10; Sahu GK, 2009, J MED VIROL, V81, P9, DOI 10.1002/jmv.21366; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Sharkey M, 2005, J VIROL, V79, P5203, DOI 10.1128/JVI.79.8.5203-5210.2005; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Varatharajan L, 2009, ANTIVIR RES, V82, pA99, DOI 10.1016/j.antiviral.2008.12.013; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	139	321	331	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					377	388		10.1016/j.immuni.2012.08.010	http://dx.doi.org/10.1016/j.immuni.2012.08.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999944	Green Accepted, Bronze			2022-12-18	WOS:000309199000001
J	Karaghiosoff, M; Neubauer, H; Lassnig, C; Kovarik, P; Schindler, H; Pircher, H; McCoy, B; Bogdan, C; Decker, T; Brem, G; Pfeffer, K; Muller, M				Karaghiosoff, M; Neubauer, H; Lassnig, C; Kovarik, P; Schindler, H; Pircher, H; McCoy, B; Bogdan, C; Decker, T; Brem, G; Pfeffer, K; Muller, M			Partial impairment of cytokine responses in Tyk2-deficient mice	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; NITRIC-OXIDE SYNTHASE; SIGNAL-TRANSDUCTION PATHWAY; T-CELL PROLIFERATION; IFN-GAMMA PRODUCTION; INTERFERON-GAMMA; COMPLEMENTS DEFECTS; ANTIVIRAL DEFENSE; JANUS KINASES; LACKING JAK3	To assess the role of the Janus kinase (Jak) family member Tyk2, we have generated Tyk2(-/-) mice. In contrast to other Jaks, where inactivation leads to a complete loss of the respective cytokine receptor signal, Tyk2(-/-) mice display reduced responses to IFN alpha/beta and IL-12 and a selective deficiency in Stat3 activation in these pathways. Unexpectedly, lFN gamma signaling is also impaired in Tyk2(-/-) mice. Tyk2(-/-) macrophages fail to produce nitric oxide upon lipopolysaccharide induction. Tyk2(-/-) mice are unable to clear vaccinia virus and show a reduced T cell response after LCMV challenge. These data imply a selective contribution of Tyk2 to the signals triggered by various biological stimuli and cytokine receptors.	Vet Univ Vienna, Inst Genet & Anim Breeding, A-1210 Vienna, Austria; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; IFA Tulln, Dept Biotechnol Anim Prod, A-3430 Tulln, Austria; Vienna Bioctr, Inst Microbiol & Genet, A-1030 Vienna, Austria; Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; Ludwig Boltzman Inst Immuno Cyto & Mol Genet, A-1210 Vienna, Austria	University of Veterinary Medicine Vienna; Technical University of Munich; University of Natural Resources & Life Sciences, Vienna; Vienna Biocenter (VBC); University of Erlangen Nuremberg; University of Freiburg; Ludwig Boltzmann Institute	Muller, M (corresponding author), Vet Univ Vienna, Inst Genet & Anim Breeding, Vet Pl 1, A-1210 Vienna, Austria.		Kovarik, Pavel/D-1184-2014; Neubauer, Hans/C-4467-2016	Kovarik, Pavel/0000-0003-2956-0944; Neubauer, Hans/0000-0002-3467-4105; Bogdan, Christian/0000-0002-2300-0631; Muller, Mathias/0000-0002-7879-3552; LASSNIG, Caroline/0000-0001-7905-3620; Pfeffer, Klaus/0000-0002-5652-6330				Ahn HJ, 1998, J IMMUNOL, V161, P5893; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Bartholdy C, 1999, J GEN VIROL, V80, P2997, DOI 10.1099/0022-1317-80-11-2997; BINDER D, 1991, J IMMUNOL, V146, P4301; Bogdan C, 1997, J IMMUNOL, V159, P4506; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bright JJ, 1999, J IMMUNOL, V162, P6255; Briscoe J, 1996, TRENDS CELL BIOL, V6, P336, DOI 10.1016/0962-8924(96)10028-3; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; DING AH, 1988, J IMMUNOL, V141, P2407; Drachman JG, 1999, J BIOL CHEM, V274, P13480, DOI 10.1074/jbc.274.19.13480; Eilers A, 1996, CELL GROWTH DIFFER, V7, P833; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kitamura Y, 1996, EUR J PHARMACOL, V306, P297, DOI 10.1016/0014-2999(96)00212-9; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagata Y, 1996, BIOCHEM BIOPH RES CO, V221, P785, DOI 10.1006/bbrc.1996.0674; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; Pestka Sidney, 1997, Cytokine and Growth Factor Reviews, V8, P189, DOI 10.1016/S1359-6101(97)00009-9; Pien GC, 2000, J IMMUNOL, V164, P994, DOI 10.4049/jimmunol.164.2.994; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rolph MS, 1996, VIROLOGY, V217, P470, DOI 10.1006/viro.1996.0141; SATTLER M, 1995, EXP HEMATOL, V23, P1040; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; van den Broek M, 2000, J IMMUNOL, V164, P371, DOI 10.4049/jimmunol.164.1.371; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	64	321	345	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					549	560		10.1016/S1074-7613(00)00054-6	http://dx.doi.org/10.1016/S1074-7613(00)00054-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070173	Bronze			2022-12-18	WOS:000090079100014
J	POWRIE, F				POWRIE, F			T-CELLS IN INFLAMMATORY BOWEL-DISEASE - PROTECTIVE AND PATHOGENIC ROLES	IMMUNITY			English	Article							CHRONIC INTESTINAL INFLAMMATION; MICE; GENE; DISRUPTION; RESPONSES; CYTOKINES; SUBSETS; INDUCE				POWRIE, F (corresponding author), DNAX RES INST MOLEC & CELLULAR IMMUNOL INC,901 CALIF AVE,PALO ALTO,CA 93404, USA.							BRAEGGER CP, 1994, ANN ALLERGY, V72, P135; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; MA A, 1995, IN PRESS J EXP MED; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; MORRISSEY PJ, 1994, RES IMMUNOL, V145, P357, DOI 10.1016/S0923-2494(94)80200-9; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; PENHALE WJ, 1976, CLIN EXP IMMUNOL, V25, P6; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; POWRIE F, 1995, J CELL BIOCHEM, V21, P152; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAKAGUCHI S, 1989, J IMMUNOL, V142, P471; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SHER A, 1992, IMMUNOL REV, V127, P183, DOI 10.1111/j.1600-065X.1992.tb01414.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; TARGAN SR, 1991, IMMUNOL RES, V10, P472, DOI 10.1007/BF02919744; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; WEINER HL, 1994, P NATL ACAD SCI USA, V91, P10762, DOI 10.1073/pnas.91.23.10762	34	321	333	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					171	174		10.1016/1074-7613(95)90086-1	http://dx.doi.org/10.1016/1074-7613(95)90086-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648390	Bronze			2022-12-18	WOS:A1995RR33900002
J	GREEN, JM; NOEL, PJ; SPERLING, AI; WALUNAS, TL; GRAY, GS; BLUESTONE, JA; THOMPSON, CB				GREEN, JM; NOEL, PJ; SPERLING, AI; WALUNAS, TL; GRAY, GS; BLUESTONE, JA; THOMPSON, CB			ABSENCE OF B7-DEPENDENT RESPONSES IN CD28-DEFICIENT MICE	IMMUNITY			English	Article							T-CELL ACTIVATION; HUMAN LYMPHOCYTES-T; B-CELLS; CD28; CTLA-4; EXPRESSION; ANTIGEN; INDUCTION; PROLIFERATION; ANTIBODY	Costimulation of T cell proliferation can occur through the CD28 signal transduction pathway. In addition, other cell surface receptors, including the CD28 homolog CTLA-4, have been proposed to be capable of providing costimulatory signals. We have examined the response of CD28-deficient T cells to activation by a variety of agonists. We demonstrate that proliferation of CD28-deficient T cells in the presence of antigen-presenting cells or B7-1 transfectants is markedly reduced. Although CTLA-4 can be expressed on CD28-deficient T cells, we observed no B7-dependent costimulation in the absence of CD28. This data demonstrates that CD28 is the major B7-binding costimulatory ligand on T cells. Furthermore, our data suggest that CD28 is the primary, and perhaps exclusive, costimulatory receptor used by traditional antigen-presenting cells to augment the proliferation of antigen-activated T cells.	UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637; REPLIGEN CORP,CAMBRIDGE,MA 02139; UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	GREEN, JM (corresponding author), UNIV CHICAGO,DEPT MED,5841 S MARYLAND AVE,CHICAGO,IL 60637, USA.		Sperling, Anne/ACZ-2351-2022	Green, Jonathan/0000-0002-7449-4387; Sperling, Anne I./0000-0002-4265-9212; Walunas, Theresa/0000-0002-7653-3650				AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; DAMLE NK, 1994, J IMMUNOL, V152, P2686; DAMLE NK, 1988, J IMMUNOL, V140, P1753; FREEDMAN AS, 1987, J IMMUNOL, V139, P3260; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; GIMMI CD, 1991, P NATL ACAD SCI USA, V88, P6575, DOI 10.1073/pnas.88.15.6575; GREEN JM, 1994, EUR J IMMUNOL, V24, P265, DOI 10.1002/eji.1830240141; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARPER K, 1991, J IMMUNOL, V147, P1037; JENKINS MK, 1990, J IMMUNOL, V144, P16; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SYMINGTON FW, 1993, J IMMUNOL, V150, P1286; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; TURKA LA, 1992, P NATL ACAD SCI USA, V89, P11102, DOI 10.1073/pnas.89.22.11102; VANGOOL SW, 1994, BLOOD, V83, P176, DOI 10.1182/blood.V83.1.176.bloodjournal831176; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X	27	321	328	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1994	1	6					501	508		10.1016/1074-7613(94)90092-2	http://dx.doi.org/10.1016/1074-7613(94)90092-2			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7534617				2022-12-18	WOS:A1994PK17100007
J	Huang, SCC; Smith, AM; Everts, B; Colonna, M; Pearce, EL; Schilling, JD; Pearce, EJ				Huang, Stanley Ching-Cheng; Smith, Amber M.; Everts, Bart; Colonna, Marco; Pearce, Erika L.; Schilling, Joel D.; Pearce, Edward J.			Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation	IMMUNITY			English	Article							T-CELLS; MAMMALIAN TARGET; COMPLEX 2; MTOR; POLARIZATION; KINASE; CANCER; DIFFERENTIATION; AKT; PHOSPHORYLATION	Macrophage activation status is intrinsically linked to metabolic remodeling. Macrophages stimulated by interleukin 4 (IL-4) to become alternatively (or, M2) activated increase fatty acid oxidation and oxidative phosphorylation; these metabolic changes are critical for M2 activation. Enhanced glucose utilization is also characteristic of the M2 metabolic signature. Here, we found that increased glucose utilization is essential for M2 activation. Increased glucose metabolism in IL-4-stimulated macrophages required the activation of the mTORC2 pathway, and loss of mTORC2 in macrophages suppressed tumor growth and decreased immunity to a parasitic nematode. Macrophage colony stimulating factor (M-CSF) was implicated as a contributing upstream activator of mTORC2 in a pathway that involved PI3K and AKT. mTORC2 operated in parallel with the IL-4R alpha-Stat6 pathway to facilitate increased glycolysis during M2 activation via the induction of the transcription factor IRF4. IRF4 expression required both mTORC2 and Stat6 pathways, providing an underlying mechanism to explain how glucose utilization is increased to support M2 activation.	[Huang, Stanley Ching-Cheng; Smith, Amber M.; Colonna, Marco; Schilling, Joel D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Everts, Bart] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 AA Leiden, Netherlands; [Pearce, Erika L.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany; [Pearce, Edward J.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; University of Freiburg	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Huang, Stanley Ching-Cheng/AAE-7866-2019; Everts, Bart/H-6986-2016	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Everts, Bart/0000-0002-3764-5131	NIH [AI110481, CA164062, CA18112502, P30 DK020579]; NWO [VENI-91614087]; Marie Curie [CIG-631585]; American Heart Association [14POST20480221]; NATIONAL CANCER INSTITUTE [R01CA181125, R01CA164062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341, R01DK110034] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO(Netherlands Organization for Scientific Research (NWO)); Marie Curie(European Commission); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Ramon Klein Geltink for careful reading of the manuscript and helpful discussions, Drs. Ken Murphy, Skip Virgin, Chih-Hao Chang, and Joe Urban for generously providing mice, reagents, or parasites, and Erica Lantelme and Dorjan Brinja for expert FACS assistance. The work was supported by NIH grants to E.J.P. (AI110481 and CA164062), E.L.P. (CA18112502), and J.D.S. (P30 DK020579), NWO VENI-91614087 and Marie Curie CIG-631585 to B.E., and an American Heart Association 14POST20480221 Postdoctoral Fellowship to S.C.-C.H.	Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Festuccia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095432; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Masui K, 2015, BRAIN PATHOL, V25, P755, DOI 10.1111/bpa.12307; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Masui K, 2014, CELL CYCLE, V13, P1053, DOI 10.4161/cc.28377; Munugalavadla V, 2005, BLOOD, V106, P103, DOI 10.1182/blood-2004-10-4041; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Ries CH, 2015, CURR OPIN PHARMACOL, V23, P45, DOI 10.1016/j.coph.2015.05.008; Ruckerl D, 2012, BLOOD, V120, P2307, DOI 10.1182/blood-2012-02-408252; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	46	320	331	13	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					817	830		10.1016/j.immuni.2016.09.016	http://dx.doi.org/10.1016/j.immuni.2016.09.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760338	Green Accepted, Bronze			2022-12-18	WOS:000389473200014
J	Bar, JJ; Khanna, KM; Lefrancois, L				Bar, Joshua J.; Khanna, Kamal M.; Lefrancois, Leo			Endogenous naive CD8(+) T cell precursor frequency regulates primary and memory responses to infection	IMMUNITY			English	Article							NEGATIVE SELECTION; IN-VIVO; MURINE CYTOMEGALOVIRUS; REPERTOIRE DIVERSITY; TOLERANCE INDUCTION; VIRAL-INFECTIONS; VIRUS-INFECTIONS; ANALYSIS REVEALS; TRANSGENIC MICE; CUTTING EDGE	Through genetic recombination, the adaptive immune system generates a diverse T cell repertoire allowing recognition of avast spectrum of foreign antigens. Any given CD8(+) T cell specificity is thought to be rare, but none have been directly quantified. Here, major histocompatibility complex tetramer and magnetic-bead technology were coupled to quantitate naive antigen-specific CD8(+) T cells and the early response to infection. Among six specificities measured, the number of naive antigen-specific precursors ranged from similar to 80 to 1200 cells/mouse. After vesicular stomatitis virus infection, the antigen-specific CD8(+) T cell response occurred in discrete phases: prolonged activation of a subset of cells over the first 72 hr followed by a rapid proliferative burst. Naive precursor frequency altered response kinetics and regulated immunodominance, as well as the time required for the responding population to shift toward CD62L(hi) memory cells. Thus, initial endogenous precursor frequencies were surprisingly diverse and not only regulated initial immune response characteristics but also controlled memory CD8(+) T cell lineage decisions.	[Bar, Joshua J.; Khanna, Kamal M.; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, 263 Farmington Ave, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu		Obar, Joshua/0000-0003-4068-7911	NIAID NIH HHS [R01 AI041576, F32AI074277, F32 AI074277-01A1, AI41576, F32 AI074277] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI074277, R01AI041576] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bahl K, 2006, J IMMUNOL, V176, P4284, DOI 10.4049/jimmunol.176.7.4284; Barnes E, 2004, EUR J IMMUNOL, V34, P1570, DOI 10.1002/eji.200424898; BERG LJ, 1988, MOL CELL BIOL, V8, P5459, DOI 10.1128/MCB.8.12.5459; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; CEBRIAN M, 1989, EUR J IMMUNOL, V19, P809, DOI 10.1002/eji.1830190505; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jabbari A, 2006, J IMMUNOL, V177, P3012, DOI 10.4049/jimmunol.177.5.3012; Jung T M, 1988, Adv Exp Med Biol, V237, P519; JUNG TM, 1988, J IMMUNOL, V141, P4110; Kalergis AM, 1999, J IMMUNOL, V162, P7263; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lefrancois L, 2000, J IMMUNOL, V164, P725, DOI 10.4049/jimmunol.164.2.725; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Maxwell JR, 2004, J IMMUNOL, V172, P248, DOI 10.4049/jimmunol.172.1.248; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Obar JJ, 2004, J IMMUNOL, V173, P2705, DOI 10.4049/jimmunol.173.4.2705; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Rothoeft T, 2006, EUR J IMMUNOL, V36, P3105, DOI 10.1002/eji.200636145; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Stock AT, 2007, IMMUNOL CELL BIOL, V85, P394, DOI 10.1038/sj.icb.7100076; TRIPP RA, 1995, J IMMUNOL, V154, P5870; VANBLEEK GM, 1990, NATURE, V348, P213; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Welsh RM, 2000, VIROLOGY, V270, P4, DOI 10.1006/viro.2000.0278; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	59	320	322	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					859	869		10.1016/j.immuni.2008.04.010	http://dx.doi.org/10.1016/j.immuni.2008.04.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18499487	Green Accepted, Bronze			2022-12-18	WOS:000256760200016
J	Cazac, BB; Roes, J				Cazac, BB; Roes, J			TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; CD4(+) T-CELLS; IMMUNE-RESPONSES; TRANSFORMING GROWTH-FACTOR-BETA-1; SWITCH RECOMBINATION; CD22-DEFICIENT MICE; NEGATIVE REGULATOR; DNA RECOMBINATION; MAMMALIAN-CELLS; DEFICIENT MICE	To determine the role of the pleiotropic cytokine TGF-beta in B cells, we generated mice lacking the TGF-beta receptor (TPR) type II selectively in this cell type through conditional mutagenesis (Cre/loxP). The absence of T beta RII in B cells leads to a reduced life span of conventional B cells, expansion of peritoneal B-1 cells, B cell hyperplasia in Peyer's patches, elevated serum immunoglobulin, and substantial IgG3 responses to a normally weak immunogen. This B cell hyperresponsiveness is associated with a virtually complete serum IgA deficiency. The data reveal differential roles of TPR in homeostasis and antigen responsiveness of a cell subpopulations and establish a critical function of the TGF-beta receptor ligand pair in the induction of IgA responses in vivo.	UCL, Windeyer Inst Med Sci, Dept Med, London W1P 6DB, England	University of London; University College London	Roes, J (corresponding author), UCL, Windeyer Inst Med Sci, Dept Med, 46 Cleveland St, London W1P 6DB, England.	j.roes@ucl.ac.uk		Roes, Jurgen/0000-0003-3235-2345				Bouchard C, 1997, J IMMUNOL, V159, P4155; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; FEARSON TF, 2000, ANNU REV IMMUNOL, V18, P393; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Gonnella PA, 1998, J IMMUNOL, V160, P4708; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOLDER MJ, 1992, EUR J IMMUNOL, V22, P2725, DOI 10.1002/eji.1830221037; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; LAWLER S, 1994, DEVELOPMENT, V120, P165; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; LOMO J, 1995, J IMMUNOL, V154, P1634; Lorenz MGO, 1997, RES IMMUNOL, V148, P460, DOI 10.1016/S0923-2494(97)82671-5; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PERKINS DL, 1990, J IMMUNOL, V145, P549; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SHER A, 1992, IMMUNOL REV, V127, P183, DOI 10.1111/j.1600-065X.1992.tb01414.x; Shi MJ, 1998, J IMMUNOL, V161, P6751; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; SNAPPER CM, 1993, J IMMUNOL, V151, P4625; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; SOBEL ES, 1991, J EXP MED, V173, P1441, DOI 10.1084/jem.173.6.1441; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Takenoshita S, 1996, GENOMICS, V36, P341, DOI 10.1006/geno.1996.0471; TAKI S, 1992, ANN NY ACAD SCI, V651, P328; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; WELLS SM, 1994, J IMMUNOL, V153, P5503; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439; Zan H, 1998, J IMMUNOL, V161, P5217	65	320	332	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					443	451		10.1016/S1074-7613(00)00044-3	http://dx.doi.org/10.1016/S1074-7613(00)00044-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070163	Bronze			2022-12-18	WOS:000090079100004
J	Gilboa, E				Gilboa, E			The makings of a tumor rejection antigen	IMMUNITY			English	Review							CYTOTOXIC T-LYMPHOCYTE; IN-VIVO; TRANSGENIC MICE; CELL RESPONSES; HUMAN-MELANOMA; INFILTRATING LYMPHOCYTES; WILD-TYPE; INDUCTION; CANCER; CTL	The demonstration that naturally induced tumors in rodents were largely nonimmunogenic and disappointing results from clinical studies were responsible for the notion that tumors are not sufficiently distinct from normal tissue to activate the immune system and led to the inevitable conclusion that immunological intervention in cancer is futile (Hewitt et al., 1976). In a seminal work, van Pel and Boon have shown that a protective immune response can be generated against a "nonimmunogenic" murine tumor, providing the first experimental evidence that lack of immunogenicity could be due to the tumor's inability to activate the immune system rather then the absence of tumor antigens (van Pel and Boon, 1982). This observation, subsequently confirmed and extended to other rodent nonimmunogenic tumor models, has shown that by proper manipulation-otherwise called vaccination-the tumor antigens present in nonimmunogenic tumors can be "exposed" to the immune system to generate an immune response capable of eradicating the tumor. If this conclusion can be extrapolated to human cancer-and I see no reason why it cannot-all forms of cancer should be susceptible to immunological intervention; namely, all forms of cancer contain tumor antigens that can be targeted for immunotherapy. The recognition that tumors could after all be sufficiently "foreign" to be recognized by the immune system has reinvigorated the efforts to identify and isolate tumor antigens (Boon and van der Bruggen, 1996; Rosenberg, 1999). This review will focus on what makes a tumor antigen a good or not-so-good target for immunotherapy.	Duke Univ, Med Ctr, Dept Surg, Ctr Genet & Cellular Therapies, Durham, NC 27710 USA	Duke University	Gilboa, E (corresponding author), Duke Univ, Med Ctr, Dept Surg, Ctr Genet & Cellular Therapies, Durham, NC 27710 USA.	e.gilboa@cgct.duke.edu						AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Anichini A, 1996, J IMMUNOL, V156, P208; Ashley DM, 1997, J EXP MED, V186, P1177, DOI 10.1084/jem.186.7.1177; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Brandle D, 1998, EUR J IMMUNOL, V28, P4010, DOI 10.1002/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5; Busch DH, 1998, J IMMUNOL, V160, P4441; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; Coggin J H Jr, 1989, Mol Biother, V1, P223; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cormier JN, 1997, CANCER J, V3, P37; Coulie PG, 1999, ADV CANCER RES, V76, P213, DOI 10.1016/S0065-230X(08)60778-2; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; Disis ML, 1996, CURR OPIN IMMUNOL, V8, P637, DOI 10.1016/S0952-7915(96)80079-3; Dudley ME, 1996, J EXP MED, V184, P441, DOI 10.1084/jem.184.2.441; Fong L, 1997, J IMMUNOL, V159, P3113; Frasca L, 1998, CRIT REV IMMUNOL, V18, P569, DOI 10.1615/CritRevImmunol.v18.i6.50; Gallimore A, 1998, J EXP MED, V187, P1647; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Gilboa E, 1998, CANCER IMMUNOL IMMUN, V46, P82, DOI 10.1007/s002620050465; GILBOA E, 1994, BIOL THERAPY CANC UP, P1; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; HERIYN D, 1999, ANN MED, V31, P66; HEWITT H, 1976, CANCER, V32, P241; HICKLIN DJ, 1999, IN PRESS MOL MED TOD; HU J, 1993, J EXP MED, V177, P1681, DOI 10.1084/jem.177.6.1681; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Imro MA, 1999, CANCER RES, V59, P2287; Jaeger E, 1996, INT J CANCER, V66, P162; Johnston JV, 1996, J EXP MED, V183, P791, DOI 10.1084/jem.183.3.791; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; KLEIN G, 1960, CANCER RES, V20, P1561; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; MANDELBOIM O, 1995, NAT MED, V1, P1179, DOI 10.1038/nm1195-1179; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; Mayordomo JI, 1996, J EXP MED, V183, P1357, DOI 10.1084/jem.183.4.1357; Melero I, 1997, J VIROL, V71, P3998, DOI 10.1128/JVI.71.5.3998-4004.1997; Morgan DJ, 1998, J IMMUNOL, V160, P643; Naftzger C, 1996, P NATL ACAD SCI USA, V93, P14809, DOI 10.1073/pnas.93.25.14809; Nair SK, 1998, NAT BIOTECHNOL, V16, P364, DOI 10.1038/nbt0498-364; NAIR SK, 1999, IN PRESS INT J CANC; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OLD LJ, 1981, CANCER RES, V41, P361; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; POINDEXTER NJ, 1992, J IMMUNOL, V149, P38; Poplonski L, 1996, EUR J IMMUNOL, V26, P601, DOI 10.1002/eji.1830260315; PREHN RT, 1957, J NATL CANCER I, V18, P769; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; RAMARATHINAM L, 1995, J IMMUNOL, V155, P5323; Rosato A, 1997, HUM GENE THER, V8, P1451, DOI 10.1089/hum.1997.8.12-1451; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rosenberg SA, 1999, IMMUNITY, V10, P281, DOI 10.1016/S1074-7613(00)80028-X; Roth J, 1996, P NATL ACAD SCI USA, V93, P4781, DOI 10.1073/pnas.93.10.4781; ROWLEY DA, 1993, J EXP MED, V178, P835, DOI 10.1084/jem.178.3.835; Sahin U, 1997, CURR OPIN IMMUNOL, V9, P709, DOI 10.1016/S0952-7915(97)80053-2; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Syrengelas AD, 1999, J IMMUNOL, V162, P4790; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; VANPEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4718; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Whiteside TL, 1998, ADV EXP MED BIOL, V451, P167; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zajac AJ, 1998, CURR OPIN IMMUNOL, V10, P444, DOI 10.1016/S0952-7915(98)80119-2; Zeh HJ, 1999, J IMMUNOL, V162, P989; ZOM E, 1999, EUR J IMMUNOL, V29, P592; ZOM E, 1999, EUR J IMMUNOL, V29, P602; 1992, J IMMUNOL, V149, P972	81	320	343	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1999	11	3					263	270		10.1016/S1074-7613(00)80101-6	http://dx.doi.org/10.1016/S1074-7613(00)80101-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	242BN	10514004	Bronze			2022-12-18	WOS:000082918500001
J	Ding, YH; Baker, BM; Garboczi, DN; Biddison, WE; Wiley, DC				Ding, YH; Baker, BM; Garboczi, DN; Biddison, WE; Wiley, DC			Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical	IMMUNITY			English	Article							PEPTIDE-MHC COMPLEXES; ALPHA-BETA; LIGAND INTERACTIONS; MAXIMUM-LIKELIHOOD; VIRUS TYPE-1; RECEPTOR; ACTIVATION; ANTIGEN; PROTEIN; CRYSTALLIZATION	The interactions of three singly substituted peptide variants of the HTLV-1 Tax peptide bound to HLA-A2 with the A6 T cell receptor have been studied using T cell assays, kinetic and thermodynamic measurements, and X-ray crystallography. The three peptide/MHC ligands include weak agonists and antagonists with different affinities for TCR. The three-dimensional structures of the three A6-TCR/peptide/HLA-A2 complexes are remarkably similar to each other and to the wild-type agonist complex, with minor adjustments at the interface to accommodate the peptide substitutions (P6A, V7R, and Y8A). The lack of correlation between structural changes and the type of T cell signals induced provides direct evidence that different signals are not generated by different ligand-induced conformational changes in the alpha beta TCR.	Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; NIAID, Struct Biol Sect, NIH, Rockville, MD 20852 USA; NINDS, Mol Immunol Sect, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wiley, DC (corresponding author), Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA.		Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039619] Funding Source: NIH RePORTER; NIAID NIH HHS [AI39619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Ausubel LJ, 1996, P NATL ACAD SCI USA, V93, P15317, DOI 10.1073/pnas.93.26.15317; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GUO HC, 1993, P NATL ACAD SCI USA, V90, P8053, DOI 10.1073/pnas.90.17.8053; Hausmann S, 1999, J IMMUNOL, V162, P5389; Hemmer B, 1998, J IMMUNOL, V160, P5807; JANEWAY CA, 1989, COLD SH Q B, V54, P657; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; QUIOCHO FA, 1987, NATURE, V329, P561, DOI 10.1038/329561a0; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; ROMAN GC, 1988, LANCET, V1, P651; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Utz U, 1996, J VIROL, V70, P843, DOI 10.1128/JVI.70.2.843-851.1996; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	46	320	331	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1999	11	1					45	56		10.1016/S1074-7613(00)80080-1	http://dx.doi.org/10.1016/S1074-7613(00)80080-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435578	Bronze			2022-12-18	WOS:000081671300005
J	Li, X; Shu, C; Yi, GH; Chaton, CT; Shelton, CL; Diao, JS; Zuo, XB; Kao, CC; Herr, AB; Li, PW				Li, Xin; Shu, Chang; Yi, Guanghui; Chaton, Catherine T.; Shelton, Catherine L.; Diao, Jiasheng; Zuo, Xiaobing; Kao, C. Cheng; Herr, Andrew B.; Li, Pingwei			Cyclic GMP-AMP Synthase Is Activated by Double-Stranded DNA-Induced Oligomerization	IMMUNITY			English	Article							DI-GMP; STRUCTURAL BASIS; RECOGNITION; 2ND-MESSENGER; DINUCLEOTIDE; SENSOR; MECHANISM; REVEALS; ADAPTER; TBK1	Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor mediating innate antimicrobial immunity. It catalyzes the synthesis of a noncanonical cyclic dinucleotide, 20,50 cGAMP, that binds to STING and mediates the activation of TBK1 and IRF-3. Activated IRF-3 translocates to the nucleus and initiates the transcription of the IFN-beta gene. The structure of mouse cGAS bound to an 18 bp dsDNA revealed that cGAS interacts with dsDNA through two binding sites, forming a 2: 2 complex. Enzyme assays and IFN-beta reporter assays of cGAS mutants demonstrated that interactions at both DNA binding sites are essential for cGAS activation. Mutagenesis and DNA binding studies showed that the two sites bind dsDNA cooperatively and that site B plays a critical role in DNA binding. The structure of mouse cGAS bound to dsDNA and 20,50 cGAMP provided insight into the catalytic mechanism of cGAS. These results demonstrated that cGAS is activated by dsDNA-induced oligomerization.	[Li, Xin; Shu, Chang; Diao, Jiasheng; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Yi, Guanghui; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Chaton, Catherine T.; Shelton, Catherine L.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Zuo, Xiaobing] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati; United States Department of Energy (DOE); Argonne National Laboratory	Li, PW (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pingwei@tamu.edu	Herr, Andrew/R-3049-2019; shu, chang/H-4452-2015	Herr, Andrew/0000-0002-3598-3399; shu, chang/0000-0002-6738-8973; Shelton, Catherine/0000-0002-6155-4600	National Institutes of Health [AI 087741]; Welch Foundation [A-1816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The diffraction data of the hcGAS crystals were collected the Stanford Synchrotron Radiation Lightsource (SSRL). The SAXS studies of cGAS were conducted at the Advanced Photon Source (APS). We thank L. Tong from Columbia University for suggestions on structural determination and J.-Y. Ji from Texas A&M University for critical reading of the manuscript and valuable discussions. This research was supported by the National Institutes of Health (grant AI 087741 to P. L.) and the Welch Foundation (grant A-1816 to P. L.). This work is dedicated to the memory of Y.-X. Wang (1914-2008) of Peking University.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barber GN, 2011, NAT IMMUNOL, V12, P929, DOI 10.1038/ni.2118; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	41	319	354	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1019	1031		10.1016/j.immuni.2013.10.019	http://dx.doi.org/10.1016/j.immuni.2013.10.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332030	Bronze, Green Accepted			2022-12-18	WOS:000330951000009
J	Takeda, S; Rodewald, HR; Arakawa, H; Bluethmann, H; Shimizu, T				Takeda, S; Rodewald, HR; Arakawa, H; Bluethmann, H; Shimizu, T			MHC class II molecules are not required for survival of newly generated CD4(+) T cells, but affect their long-term life span	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; MONOCLONAL-ANTIBODY; LYMPHOCYTES-T; SCID MICE; THYMUS; THYMOCYTES; MEMORY; DELETION; MODEL	We grafted fetal thymi from wild-type mice into immunodeficient RAG-2(-/-) or class II(-/-)RAG-2(-/-) (class II MHC(-)) recipients and followed the fate of naive CD4(+) T cells derived from the grafts. In both types of recipients, newly generated CD4(+) T cells proliferated to the same extent in the periphery and rapidly filled the empty T cell compartment. However, CD4(+) T cells in class II- recipients gradually decreased in number over 6 months. These results show that interactions between the TCR and class II molecules are not required for newly generated CD4(+) T cells to survive and proliferate, but are necessary to maintain the size of the peripheral T cell pool for extended periods.	BASEL INST IMMUNOL, CH-4005 BASEL, SWITZERLAND; F HOFFMANN LA ROCHE & CO LTD, CH-4070 BASEL, SWITZERLAND	Roche Holding				Takeda, Shunichi/0000-0002-7924-7991				AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BRADLEY LM, 1993, IMMUNOL TODAY, V14, P197, DOI 10.1016/0167-5699(93)90161-D; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; BUDD RC, 1987, J IMMUNOL, V138, P3120; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; FINK PJ, 1985, NATURE, V313, P233, DOI 10.1038/313233a0; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; FREY JR, 1992, J EXP MED, V175, P1067, DOI 10.1084/jem.175.4.1067; GEO E, 1989, J EXP MED, V170, P1947; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOGAN B, 1986, MANIPULATING MOUSE E, P271; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JANEWAY CA, 1991, ADV IMMUNOL, V50, P1; KANAGAWA O, 1988, J IMMUNOL METHODS, V110, P169; KIRBERG J, 1993, EUR J IMMUNOL, V23, P1963, DOI 10.1002/eji.1830230835; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; PIRCHER H, 1992, EUR J IMMUNOL, V22, P399, DOI 10.1002/eji.1830220217; PIRCHER H, 1994, EUR J IMMUNOL, V24, P1982, DOI 10.1002/eji.1830240907; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1990, Semin Immunol, V2, P3; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	48	319	334	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1996	5	3					217	228		10.1016/S1074-7613(00)80317-9	http://dx.doi.org/10.1016/S1074-7613(00)80317-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808677	Bronze			2022-12-18	WOS:A1996VJ79700004
J	Lewis, KL; Caton, ML; Bogunovic, M; Greter, M; Grajkowska, LT; Ng, D; Klinakis, A; Charo, IF; Jung, S; Gommerman, JL; Ivanov, II; Liu, K; Merad, M; Reizis, B				Lewis, Kanako L.; Caton, Michele L.; Bogunovic, Milena; Greter, Melanie; Grajkowska, Lucja T.; Ng, Dennis; Klinakis, Apostolos; Charo, Israel F.; Jung, Steffen; Gommerman, Jennifer L.; Ivanov, Ivaylo I.; Liu, Kang; Merad, Miriam; Reizis, Boris			Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine	IMMUNITY			English	Article							MOUSE; HOMEOSTASIS; GENERATION; EXPRESSION; REGULATOR; RESPONSES; SUBSETS; PATHWAY; MICE	Dendritic cells (DCs) in tissues and lymphoid organs comprise distinct functional subsets that differentiate in situ from circulating progenitors. Tissue-specific signals that regulate DC subset differentiation are poorly understood. We report that DC-specific deletion of the Notch2 receptor caused a reduction of DC populations in the spleen. Within the splenic CD11b(+) DC subset, Notch signaling blockade ablated a distinct population marked by high expression of the adhesion molecule Esam. The Notch-dependent Esamh DC subset required lymphotoxin beta receptor signaling, proliferated in situ, and facilitated CD4(+) T cell priming. The Notch-independent Esam(lo) DCs expressed monocyte-related genes and showed superior cytokine responses. In addition, Notch2 deletion led to the loss of CD11b(+)CD103(+) DCs in the intestinal lamina propria and to a corresponding decrease of IL-17-producing CD4(+) T cells in the intestine. Thus, Notch2 is a common differentiation signal for T cell-priming CD11b(+) DC subsets in the spleen and intestine.	[Lewis, Kanako L.; Caton, Michele L.; Grajkowska, Lucja T.; Ivanov, Ivaylo I.; Liu, Kang; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Bogunovic, Milena; Greter, Melanie; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Ng, Dennis; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Klinakis, Apostolos] Acad Athens, Biomed Res Fdn, Athens 11527, Greece; [Charo, Israel F.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Columbia University; Icahn School of Medicine at Mount Sinai; University of Toronto; Academy of Athens; University of California System; University of California San Francisco; The J David Gladstone Institutes; Weizmann Institute of Science	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	bvr2101@columbia.edu	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Gommerman, Jennifer/0000-0003-4576-6168; Reizis, Boris/0000-0003-1140-7853; Greter, Melanie/0000-0002-7220-5369	American Asthma Foundation; NIH [AI072571, DK085329, AI007161, HD055165]; CIHR/IRSC [67157]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571, R21AI067804, T32AI007161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/IRSC(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank U. Klein, A. Efstratiadis, F. Radtke, T. Gridley, and W. Pear for mouse strains; A. Capobianco, D. Lin, and A. Ferrante for animal donations; M. Lahoud for antibodies; and J. Ericson for Immgen data. Supported by the American Asthma Foundation (B.R.), NIH grants AI072571 (B.R.) and DK085329 (I.I.I.), NIH training grants AI007161 (K.L.L.) and HD055165 (M.L.C.), and CIHR/IRSC award MOP #67157 (J.L.G.).	Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng PY, 2003, BLOOD, V102, P3980, DOI 10.1182/blood-2003-04-1034; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; Deluca LS, 2011, P NATL ACAD SCI USA, V108, P2046, DOI 10.1073/pnas.1014188108; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Feng F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-90; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yashiro-Ohtani Y, 2010, SEMIN IMMUNOL, V22, P261, DOI 10.1016/j.smim.2010.04.015; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	49	318	329	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					780	791		10.1016/j.immuni.2011.08.013	http://dx.doi.org/10.1016/j.immuni.2011.08.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22018469	Bronze, Green Accepted			2022-12-18	WOS:000297390800017
J	Alugupalli, KR; Leong, JM; Woodland, RT; Muramatsu, M; Honjo, T; Gerstein, RM				Alugupalli, KR; Leong, JM; Woodland, RT; Muramatsu, M; Honjo, T; Gerstein, RM			B1b lymphocytes confer T cell-independent long-lasting immunity	IMMUNITY			English	Article							RELAPSING FEVER BORRELIOSIS; B-CELLS; IN-VIVO; ANTIBODY-RESPONSES; MARGINAL ZONE; B-1 CELLS; ANTIGENS; MEMORY; MICE; DIFFERENTIATION	Many microbial pathogens employ antigenic variation as a strategy to evade the immune system, posing a challenge in vaccine development. To understand the requirements for immunity against such pathogens, we studied Borrelia hermsii, a relapsing fever bacterium. We found that mice deficient in T, follicular B, marginal zone B, or B1 a lymphocytes resolved B. hermsii bacteremia and became resistant to reinfection. The resolution of bacteremia coincided with an expansion and persistence of B1b lymphocytes, and purified B1b lymphocytes from convalescent wild-type or TCR-betaxdelta(-/-) mice conferred immunity to Rag1(-/-) mice. The B1b lymphocytes in the reconstituted Rag1(-/-) mice provided long-lasting immunity by rapidly generating B. hermsii-specific IgM but not IgG upon bacterial challenge. Unmutated IgM is sufficient to eliminate B. hermsii, because AID(-/-) mice deficient in somatic hypermutation and class switch recombination efficiently resolved all bacteremic episodes. These data demonstrate that B1b lymphocytes can provide long-lasting T cell-independent IgM memory.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	University of Massachusetts System; University of Massachusetts Worcester; Kyoto University	Alugupalli, KR (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	kishore.alugupalli@umassmed.edu	Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041054, R01AI043534, R01AI037601] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI 43534, R01-AI 41054, R01-AI 37601] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Alugupalli KR, 2003, BLOOD, V102, P2843, DOI 10.1182/blood-2003-02-0426; Alugupalli KR, 2001, MOL MICROBIOL, V39, P330, DOI 10.1046/j.1365-2958.2001.02201.x; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; BARBOUR AG, 1990, ANNU REV MICROBIOL, V44, P155, DOI 10.1146/annurev.mi.44.100190.001103; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Burgdorfer W., 1976, The biology of parasitic spirochetes., P191; BURLEN O, 1988, EUR J IMMUNOL, V18, P1433, DOI 10.1002/eji.1830180920; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Chelvarajan RL, 1998, J IMMUNOL, V161, P3315; COLLE JH, 1988, EUR J IMMUNOL, V18, P1307, DOI 10.1002/eji.1830180902; Connolly SE, 2004, J IMMUNOL, V172, P1191, DOI 10.4049/jimmunol.172.2.1191; Connolly SE, 2001, J IMMUNOL, V167, P3029, DOI 10.4049/jimmunol.167.6.3029; COUDERC J, 1987, IMMUNOLOGY, V61, P71; KANTOR AB, 1995, INT IMMUNOL, V7, P55, DOI 10.1093/intimm/7.1.55; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; MacLennan ICM, 2000, PHILOS T R SOC B, V355, P345, DOI 10.1098/rstb.2000.0571; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; McHeyzer-Williams MG, 2003, CURR OPIN IMMUNOL, V15, P354, DOI 10.1016/S0952-7915(03)00046-3; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NEWMAN K, 1984, INFECT IMMUN, V45, P572, DOI 10.1128/IAI.45.3.572-576.1984; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Vink A, 1999, J EXP MED, V189, P1413, DOI 10.1084/jem.189.9.1413; Vinuesa CG, 2001, EUR J IMMUNOL, V31, P1340, DOI 10.1002/1521-4141(200105)31:5<1340::AID-IMMU1340>3.0.CO;2-H; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vos Q, 2000, IMMUNOL REV, V176, P154; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577; Yokota M, 1997, J MED MICROBIOL, V46, P675, DOI 10.1099/00222615-46-8-675; ZHANG J, 1988, EUR J IMMUNOL, V18, P1417, DOI 10.1002/eji.1830180918	41	318	322	2	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2004	21	3					379	390		10.1016/j.immuni.2004.06.019	http://dx.doi.org/10.1016/j.immuni.2004.06.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357949	Bronze			2022-12-18	WOS:000224034900009
J	Wright, GJ; Puklavec, MJ; Willis, AC; Hoek, RM; Sedgwick, JD; Brown, MH; Barclay, AN				Wright, GJ; Puklavec, MJ; Willis, AC; Hoek, RM; Sedgwick, JD; Brown, MH; Barclay, AN			Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function	IMMUNITY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; OX-2 MEMBRANE GLYCOPROTEIN; SIGNAL-REGULATORY PROTEIN; MRC OX-2; IMMUNOGLOBULIN SUPERFAMILY; NUCLEOTIDE-SEQUENCE; ADHESION MOLECULE; NERVOUS-SYSTEM; LOW-AFFINITY; RAT CD2	The OX2 membrane glycoprotein (CD200) is expressed on a broad range of tissues including lymphoid cells, neurons, and endothelium. We report the characterization of an OX2 receptor (OX2R) that is a novel protein restricted to cells of the myeloid lineage. OX2 and its receptor are both cell surface glycoproteins containing two immunoglobulin-like domains and interact with a dissociation constant of 2.5 mu M and k(off) 0.8 s(-1), typical of many leukocyte protein membrane interactions. Pervanandate treatment of macrophages showed that OX2R could be phosphorylated on tyrosine residues. Blockade of the OX2-OX2R interaction with an OX2R mAb exacerbated the disease model experimental allergic encephalomyelitis. These data, together with data from an OX2-deficient mouse (R.M. Hoek et al., submitted), suggest that myeloid function can be controlled in a tissue-specific manner by the OX2-OX2R interaction.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA	University of Oxford; University of Oxford; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Barclay, AN (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.			Wright, Gavin/0000-0003-0537-0863				Adams S, 1998, J IMMUNOL, V161, P1853; BARCLAY AN, 1981, IMMUNOLOGY, V44, P727; Barclay AN, 1997, LEUCOCYTE ANTIGENS F; Borriello F, 1998, MAMM GENOME, V9, P114, DOI 10.1007/s003359900700; Borriello F, 1997, J IMMUNOL, V158, P4548; Brown MH, 1995, EUR J IMMUNOL, V25, P3222, DOI 10.1002/eji.1830251204; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; BUKOVSKY A, 1983, IMMUNOLOGY, V48, P587; CLARK MJ, 1985, EMBO J, V4, P113, DOI 10.1002/j.1460-2075.1985.tb02324.x; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Gorczynski L, 1999, J IMMUNOL, V162, P774; Gorczynski RM, 1999, TRANSPLANT P, V31, P577, DOI 10.1016/S0041-1345(98)01563-2; Gorczynski RM, 1998, TRANSPLANTATION, V65, P1106, DOI 10.1097/00007890-199804270-00016; Gorczynski RM, 1999, J IMMUNOL, V163, P1654; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GUM JR, 1992, AM J RESP CELL MOL, V7, P557, DOI 10.1165/ajrcmb/7.6.557; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Heijnen I A, 1997, Int Rev Immunol, V16, P29, DOI 10.3109/08830189709045702; Howell BW, 1999, MOL CELL BIOL, V19, P5179; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; MACPHEE IAM, 1989, J EXP MED, V169, P431, DOI 10.1084/jem.169.2.431; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Martiney JA, 1998, J IMMUNOL, V160, P5588; MCCAUGHAN GW, 1987, IMMUNOGENETICS, V25, P329, DOI 10.1007/BF00404426; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Nicholas J, 1996, J VIROL, V70, P5975, DOI 10.1128/JVI.70.9.5975-5989.1996; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; PERRY VH, 1991, INT REV CYTOL, V125, P203, DOI 10.1016/S0074-7696(08)61220-6; Preston S, 1997, EUR J IMMUNOL, V27, P1911, DOI 10.1002/eji.1830270814; PUGH CW, 1983, J EXP MED, V157, P1758, DOI 10.1084/jem.157.6.1758; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; SUNDERLAND CA, 1979, EUR J IMMUNOL, V9, P155, DOI 10.1002/eji.1830090212; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tivol EA, 1996, CURR OPIN IMMUNOL, V8, P822, DOI 10.1016/S0952-7915(96)80011-2; VANDERMERWE PA, 1993, EUR J IMMUNOL, V23, P1373, DOI 10.1002/eji.1830230628; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	54	318	351	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					233	242		10.1016/S1074-7613(00)00023-6	http://dx.doi.org/10.1016/S1074-7613(00)00023-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981966	Bronze			2022-12-18	WOS:000089132100008
J	Kang, TB; Yang, SH; Toth, B; Kovalenko, A; Wallach, D				Kang, Tae-Bong; Yang, Seung-Hoon; Toth, Beata; Kovalenko, Andrew; Wallach, David			Caspase-8 Blocks Kinase RIPK3-Mediated Activation of the NLRP3 Inflammasome	IMMUNITY			English	Article							MIXED LINEAGE KINASE; CELL-DEATH; MOLECULAR-MECHANISMS; PROGRAMMED NECROSIS; DEPENDENT NECROSIS; DENDRITIC CELLS; DOMAIN-LIKE; RECEPTORS; INDUCTION; RIP3	Caspase-8 deficiency in certain cells prompts chronic inflammation. One mechanism suggested to account for this inflammation is enhanced signaling for necrotic cell death, mediated by the protein kinases RIPK1 and RIPK3 that caspase-8 can cleave. We describe an activity of caspase-8 in dendritic cells that controls the initiation of inflammation in another way. Caspase-8 deficiency in these cells facilitated lipopolysaccharide-induced assembly and function of the NLRP3 inflammasome. This effect depended on the functions of RIPK1 and RIPK3, as well as of MLKL and PGAM5, two signaling proteins recently shown to contribute to RIPK3-mediated induction of necrosis. However, although enhancement of inflammasome assembly in the caspase-8-deficient cells shares proximal signaling events with the induction of necrosis, it occurred independently of cell death. These findings provide new insight into potentially pathological inflammatory processes to which RIPK1- and RIPK3-mediated signaling contributes.	[Kang, Tae-Bong; Yang, Seung-Hoon; Toth, Beata; Kovalenko, Andrew; Wallach, David] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kang, Tae-Bong] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju 380701, South Korea	Weizmann Institute of Science; Konkuk University	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470; Yang, Seung-Hoon/0000-0002-6880-8861	Ares Trading SA, Switzerland; A Center of Excellence Grant from the Flight Attendant Medical Research Institute (FAMRI); Kekst Family Center for Medical Genetics; Shapell Family Center for Genetic Disorders Research at The Weizmann Institute of Science	Ares Trading SA, Switzerland; A Center of Excellence Grant from the Flight Attendant Medical Research Institute (FAMRI); Kekst Family Center for Medical Genetics; Shapell Family Center for Genetic Disorders Research at The Weizmann Institute of Science	We thank Vitaly Konstantinov, Inna Kolesnik, and Tatiana Shalevich for assistance, Shoshana Grossfeld for animal maintenance, On Brenner for advice on histological analysis, and Steffen Jung for comments on the manuscript. Special thanks to Israel Vlodavsky, Soo-Hyun Kim, and Kwang-Ho Lee for assistance. This study was supported in part by grants from Ares Trading SA, Switzerland, A Center of Excellence Grant from the Flight Attendant Medical Research Institute (FAMRI), the Kekst Family Center for Medical Genetics, and the Shapell Family Center for Genetic Disorders Research at The Weizmann Institute of Science. D.W. is the incumbent of the Joseph and Bessie Feinberg Professorial Chair at The Weizmann Institute of Science.	[Anonymous], CARDIOVASCULAR DRUGS, V21, P227; Ben Moshe T, 2008, CYTOKINE GROWTH F R, V19, P209, DOI 10.1016/j.cytogfr.2008.04.012; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mankan AK, 2012, CLIN EXP IMMUNOL, V167, P369, DOI 10.1111/j.1365-2249.2011.04534.x; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Ravi R, 1998, CANCER RES, V58, P882; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; van Raam BJ, 2012, BBA-PROTEINS PROTEOM, V1824, P113, DOI 10.1016/j.bbapap.2011.06.005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Wallach D, 2010, ANN NY ACAD SCI, V1209, P17, DOI 10.1111/j.1749-6632.2010.05742.x; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	48	317	323	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					27	40		10.1016/j.immuni.2012.09.015	http://dx.doi.org/10.1016/j.immuni.2012.09.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23260196	Bronze			2022-12-18	WOS:000314195500007
J	Pham, THM; Okada, T; Matioubian, M; Lo, CG; Cyster, JG				Pham, Trung H. M.; Okada, Takaharu; Matioubian, Mehrdad; Lo, Charles G.; Cyster, Jason G.			S1P(1) receptor signaling overrides retention mediated by G alpha(i)-coupled receptors to promote T cell egress	IMMUNITY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; SECONDARY LYMPHOID ORGANS; IN-VIVO; DEEP CORTEX; MIGRATION; NODE; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; CCR7; TRAFFICKING	The mechanism by which sphingosine-1-phosphate receptor-1 (S1P(1)) acts to promote lymphocyte egress from lymphoid organs is not defined. Here, we showed that CCR7-deficient T cells left lymph nodes more rapidly than wild-type cells did, whereas CCR7-overexpressing cells were retained for longer. After treatment with FTY720, an agonist that causes down-modulation of lymphocyte S1P(1), CCR7-deficient T cells were less effectively retained than wild-type T cells. Moreover, treatment with pertussis toxin to inactivate signaling via G alpha(i)-protein-coupled receptors restored egress competence to S1P(1)-deficient lymphocytes. We also found that T cell accumulation in lymph node cortical sinusoids required intrinsic S1P(1) expression and was antagonized by CCR7. These findings suggest a model where S1P(1) acts in the lymphocyte to promote lymph node egress by overcoming retention signals mediated by CCR7 and additional G alpha(i)-coupled receptors. Furthermore, by simultaneously upregulating S1P(1) and downregulating CCR7, T cells that have divided multiple times switch to a state favoring egress over retention.	[Pham, Trung H. M.; Okada, Takaharu; Matioubian, Mehrdad; Lo, Charles G.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Okada, Takaharu] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu	Okada, Takaharu/N-7931-2015	Pham, Trung/0000-0003-2724-2547	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Arnold CN, 2004, J IMMUNOL, V173, P866, DOI 10.4049/jimmunol.173.2.866; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BELISLE C, 1981, ANAT REC, V199, P213, DOI 10.1002/ar.1091990206; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; COMPTON CC, 1985, ANAT RECORD, V212, P408, DOI 10.1002/ar.1092120412; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; HE Y, 1985, ARCH HISTOL JAPON, V48, P1, DOI 10.1679/aohc.48.1; HEATH TJ, 1987, J ANAT, V155, P177; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; KELLY RH, 1975, INT ARCH ALLER A IMM, V48, P836, DOI 10.1159/000231371; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; KOWALA MC, 1986, J ANAT, V148, P25; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NICANDER L, 1991, J ANAT, V178, P203; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SODERSTROM N, 1969, SCAND J HAEMATOL, V6, P186; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	44	317	325	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					122	133		10.1016/j.immuni.2007.11.017	http://dx.doi.org/10.1016/j.immuni.2007.11.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18164221	Green Accepted, Bronze			2022-12-18	WOS:000252627300016
J	Wiley, SR; Cassiano, L; Lofton, T; Davis-Smith, T; Winkles, JA; Lindner, V; Liu, H; Daniel, TO; Smith, CA; Fanslow, WC				Wiley, SR; Cassiano, L; Lofton, T; Davis-Smith, T; Winkles, JA; Lindner, V; Liu, H; Daniel, TO; Smith, CA; Fanslow, WC			A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; LIGAND; GENE; DEFINES; DEATH; IDENTIFICATION; STIMULATION; INVOLVEMENT; SUPERFAMILY	TWEAK is a member of the TNF ligand family that induces angiogenesis in vivo. We report cloning of a receptor for TWEAK (TweakR) from a human umbilical vein endothelial cell (HUVEC) library. The mature form of TweakR has only one hundred and two amino acids and six cysteine residues in its extracellular region. Five different assays demonstrate TWEAK-TweakR binding, and the interaction affinity constant (Kd) is within a physiologically relevant range of 2.3 +/- 0.1 nM. The TweakR cytoplasmic domain binds TRAFs 1, 2, and 3. Cross-linking of TweakR induces HUVEC growth, and mRNA levels are upregulated in vitro by a variety of agents and in vivo following arterial injury. Soluble TweakR inhibits endothelial cell migration in vitro and corneal angiogenesis in vivo.	Immunex Res & Dev Corp, Seattle, WA 98101 USA; Amer Red Cross, Dept Vasc Biol, Holland Lab, Rockville, MD 20855 USA; Maine Med Ctr, Inst Res, Ctr Mol Med, Scarborough, ME 04106 USA	American Red Cross; Maine Medical Center	Wiley, SR (corresponding author), Immunex Res & Dev Corp, 51 Univ St, Seattle, WA 98101 USA.				NHLBI NIH HHS [HL-39727] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039727, R29HL039727] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biancone L, 1997, J EXP MED, V186, P147, DOI 10.1084/jem.186.1.147; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chicheportiche Y, 2000, BIOCHEM BIOPH RES CO, V279, P162, DOI 10.1006/bbrc.2000.3913; Daniel TO, 1999, CANCER RES, V59, P4574; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; Kaptein A, 2000, FEBS LETT, V485, P135, DOI 10.1016/S0014-5793(00)02219-5; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Martin M, 1997, IN VITRO CELL DEV-AN, V33, P261, DOI 10.1007/s11626-997-0045-y; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Saas P, 2000, GLIA, V32, P102, DOI 10.1002/1098-1136(200010)32:1<102::AID-GLIA100>3.3.CO;2-L; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Silverman ES, 1999, AM J PATHOL, V155, P1311, DOI 10.1016/S0002-9440(10)65233-9; Smith CA, 1996, VIROLOGY, V223, P132, DOI 10.1006/viro.1996.0462; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467	25	317	342	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					837	846		10.1016/S1074-7613(01)00232-1	http://dx.doi.org/10.1016/S1074-7613(01)00232-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728344	Bronze			2022-12-18	WOS:000172528200015
J	Kim, JI; Ho, IC; Grusby, MJ; Glimcher, LH				Kim, JI; Ho, IC; Grusby, MJ; Glimcher, LH			The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines	IMMUNITY			English	Article							IMMUNOGLOBULIN-E PRODUCTION; T-CELLS; MURINE LEISHMANIASIS; IMMUNE-RESPONSES; INTERFERON-GAMMA; DEFICIENT MICE; IGE SYNTHESIS; FACTOR GATA-3; IL-4; EXPRESSION	IL-4 promotes the differentiation of naive CD4(+) T cells into IL-4-producing T helper 2 (Th2) cells. Previous work provided suggestive but not conclusive evidence that the transcription factor c-Maf directed the tissue-specific expression of IL-4. It was not known whether c-Maf controlled the transcription of other Th2 cytokine genes. To elucidate the role of c-Maf in vivo, we examined cytokine production in mice lacking c-Maf (c-maf(-/-)). CD4(+) T cells and NK T cells from c-maf(-/-) mice were markedly deficient in IL-4 production. However, the mice produced normal levels of IL-13 and IgE, and, when differentiated in the presence of exogenous IL-4, c-maf(-/-) T cells produced approximately normal levels of other Th2 cytokines. We conclude that c-Maf has a critical and selective function in IL-4 gene transcription in vivo.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NIAID NIH HHS [AI/AG 37833] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037833] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Bost KL, 1996, IMMUNOLOGY, V87, P633, DOI 10.1046/j.1365-2567.1996.502574.x; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; BROWN KD, 1989, J IMMUNOL, V142, P679; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Cohn L, 1998, J IMMUNOL, V161, P3813; Csonga R, 1998, J IMMUNOL, V160, P273; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan SP, 1998, J IMMUNOL, V161, P1501; Hoshino T, 1999, J IMMUNOL, V162, P5070; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KIM JL, 1999, KOPF, V96, P3781; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEE HJ, 1993, J IMMUNOL, V151, P6135; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; vonderWeid T, 1996, J IMMUNOL, V157, P4421; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yamagata T, 1997, MOL CELL BIOL, V17, P4272, DOI 10.1128/MCB.17.8.4272; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	50	317	325	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1999	10	6					745	751		10.1016/S1074-7613(00)80073-4	http://dx.doi.org/10.1016/S1074-7613(00)80073-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403649	Bronze			2022-12-18	WOS:000081209600012
J	Patel, DD; Kuchroo, VK				Patel, Dhavalkumar D.; Kuchroo, Vijay K.			Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions	IMMUNITY			English	Review							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; INFLAMMATORY-BOWEL-DISEASE; HYPER-IGE SYNDROME; IL-17-PRODUCING T-CELLS; PATHOGENIC T(H)17 CELLS; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; PLAQUE PSORIASIS	The T helper 17 (Th17) cell pathway has been linked by genome-wide association studies to multiple autoimmune diseases. Identification of the genetic causes of primary immunodeficiency diseases revealed that Th17 cells are also critical in host immunity to mucocutaneous candida infections and Staphylococcus aureus. Therapeutic interventions with inhibitors of the different components of the pathway such as interleukin-12 (IL-12), IL-23, IL-17A, and IL-17RA have variably beneficial effects in psoriasis, Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-infectious uveitis, and multiple sclerosis. Thus, whereas Th17 cells are protective against Candida albicans and to a lesser degree Staphylococcus aureus, they are pathogenic in many autoimmune diseases. Here, we compare and contrast the effects of human genetic mutations of and therapeutic interventions targeted at Th17 cell molecules. We discuss that although there are similarities when Th17 cell pathway molecules are modulated, each molecule has unique non-Th17 cell features that lead to different functional outcomes.	[Patel, Dhavalkumar D.] Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat Dis Area, CH-4002 Basel, Switzerland; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Novartis; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Patel, DD (corresponding author), Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat Dis Area, CH-4002 Basel, Switzerland.	dhavalkumar.patel@novartis.com						Al Khatib S, 2009, J ALLERGY CLIN IMMUN, V124, P342, DOI 10.1016/j.jaci.2009.05.004; Baeten DLP, 2013, NAT MED, V19, P824, DOI 10.1038/nm.3268; Bettelli E, 2005, J EXP MED, V201, P169, DOI 10.1084/jem.20042279; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Farago B, 2008, ANN RHEUM DIS, V67, P248, DOI 10.1136/ard.2007.072819; Felson DT, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4428; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon KB, 2015, NEW ENGL J MED, V373, P136, DOI 10.1056/NEJMoa1501646; Gordon KB, 2012, J INVEST DERMATOL, V132, P304, DOI 10.1038/jid.2011.304; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Huppler AR, 2015, PATHOGENS, V4, P559, DOI 10.3390/pathogens4030559; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Krueger J.G., 2015, J ALLERGY CLIN IMMUN, V136, P116; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Letko E, 2015, OPHTHALMOLOGY, V122, P939, DOI 10.1016/j.ophtha.2014.12.033; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Mease PJ, 2014, NEW ENGL J MED, V370, P2295, DOI 10.1056/NEJMoa1315231; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mozaffari S, 2015, EXPERT OPIN INV DRUG, V24, P949, DOI 10.1517/13543784.2015.1035432; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouederni M, 2014, CLIN INFECT DIS, V58, P204, DOI 10.1093/cid/cit722; Papp K, 2015, J DRUGS DERMATOL, V14, P58; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Pavelka K, 2015, J RHEUMATOL, V42, P912, DOI 10.3899/jrheum.141271; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Poddubnyy D, 2014, ANN RHEUM DIS, V73, P817, DOI 10.1136/annrheumdis-2013-204248; Prando C, 2013, MEDICINE, V92, P109, DOI 10.1097/MD.0b013e31828a01f9; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Ritchlin C, 2014, ANN RHEUM DIS, V73, P990, DOI 10.1136/annrheumdis-2013-204655; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Thaci D, 2015, J AM ACAD DERMATOL, V73, P400, DOI 10.1016/j.jaad.2015.05.013; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479; Wang R, 2015, INFLAMM BOWEL DIS, V21, P973, DOI 10.1097/MIB.0000000000000353; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	88	316	328	4	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1040	1051		10.1016/j.immuni.2015.12.003	http://dx.doi.org/10.1016/j.immuni.2015.12.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682981	Bronze			2022-12-18	WOS:000366846600009
J	Scheiermann, C; Kunisaki, Y; Lucas, D; Chow, A; Jang, JE; Zhang, D; Hashimoto, D; Merad, M; Frenette, PS				Scheiermann, Christoph; Kunisaki, Yuya; Lucas, Daniel; Chow, Andrew; Jang, Jung-Eun; Zhang, Dachuan; Hashimoto, Daigo; Merad, Miriam; Frenette, Paul S.			Adrenergic Nerves Govern Circadian Leukocyte Recruitment to Tissues	IMMUNITY			English	Article							BONE-MARROW; P-SELECTIN; PNEUMOCOCCAL INFECTION; NEUTROPHIL ADHESION; GENITOFEMORAL NERVE; IMMUNE-RESPONSES; VASCULAR-DISEASE; SEPTIC SHOCK; MICE; SUSCEPTIBILITY	The multistep sequence leading to leukocyte migration is thought to be locally regulated at the inflammatory site. Here, we show that broad systemic programs involving long-range signals from the sympathetic nervous system (SNS) delivered by adrenergic nerves regulate rhythmic recruitment of leukocytes in tissues. Constitutive leukocyte adhesion and migration in murine bone marrow (BM) and skeletal-muscle microvasculature fluctuated with circadian peak values at night. Migratory oscillations, altered by experimental jet lag, were implemented by perivascular SNS fibers acting on beta-adrenoreceptors expressed on nonhematopoietic cells and leading to tissue-specific, differential circadian oscillations in the expression of endothelial cell adhesion molecules and chemokines. We showed that these rhythms have physiological consequences through alteration of hematopoietic cell recruitment and overall survival in models of septic shock, sickle cell vaso-occlusion, and BM transplantation. These data provide unique insights in the leukocyte adhesion cascade and the potential for time-based therapeutics for transplantation and inflammatory diseases.	[Scheiermann, Christoph; Kunisaki, Yuya; Lucas, Daniel; Chow, Andrew; Jang, Jung-Eun; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Biol &, Bronx, NY 10461 USA; [Chow, Andrew; Jang, Jung-Eun; Hashimoto, Daigo; Merad, Miriam; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Biol &, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Scheiermann, Christoph/B-8261-2014; Hashimoto, Daigo/O-1013-2013; Lucas, Daniel/ABB-6893-2021; Zhang, Dachuan/GZA-8781-2022; Frenette, Paul S/J-8272-2012	Scheiermann, Christoph/0000-0002-9212-0995; Hashimoto, Daigo/0000-0001-9489-9704; Lucas, Daniel/0000-0002-0147-5425; Frenette, Paul S/0000-0003-0862-9922; Chow, Andrew/0000-0003-1151-2450; Zhang, Dachuan/0000-0002-1746-275X	National Institutes of Health (NIH) [HL097700, HL069438, DK056638]; German Academic Exchange Service (DAAD); Japan Society for the Promotion of Science; Fundacion Ramon Areces; National Heart, Lung, and Blood Institute (NHLBI) [F30HL099028]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099028, R01HL069438, R01HL097700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fundacion Ramon Areces; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Sellers for histopathological examinations, L. Tesfa for cell-sorting experiments, and C. Prophete, M. Huggins, and N. Dholakia for technical assistance. This work was supported by the National Institutes of Health (NIH) (R01 grants HL097700; HL069438; DK056638) to P.S.F. We are grateful for fellowship support from the German Academic Exchange Service (DAAD) to C.S., the Japan Society for the Promotion of Science to Y.K., the Fundacion Ramon Areces to D.L., a Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute (NHLBI) (F30HL099028) to A.C., and a Founders Affiliate Predoctoral Fellowship from the American Heart Association to J.-E.J.	ALITO AE, 1987, ACTA PHYSIOL PHARM L, V37, P305; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chang JS, 2008, BLOOD, V111, P915, DOI 10.1182/blood-2007-04-084061; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; FEIGIN RD, 1969, NATURE, V224, P379, DOI 10.1038/224379a0; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Forlow SB, 2002, FASEB J, V16, P1488, DOI 10.1096/fj.02-0230com; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Haus E, 2007, ADV DRUG DELIVER REV, V59, P985, DOI 10.1016/j.addr.2007.01.001; HEWETT JA, 1992, LAB INVEST, V66, P347; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; House SD, 1997, LIFE SCI, V60, P2023, DOI 10.1016/S0024-3205(97)00167-7; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Lucio RA, 2001, PHYSIOL BEHAV, V73, P487, DOI 10.1016/S0031-9384(01)00437-1; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; SHACKELFORD PG, 1973, SCIENCE, V182, P285, DOI 10.1126/science.182.4109.285; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinle JJ, 2003, J BIOL CHEM, V278, P20681, DOI 10.1074/jbc.M300368200; THOMAS JR, 1992, J APPL PHYSIOL, V73, P1510, DOI 10.1152/jappl.1992.73.4.1510; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Walton Kelly A, 2003, Curr Opin Ophthalmol, V14, P357, DOI 10.1097/00055735-200312000-00007; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Zempoalteca R, 2002, J ANAT, V201, P493, DOI 10.1046/j.1469-7580.2002.00112.x; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	60	316	324	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					290	301		10.1016/j.immuni.2012.05.021	http://dx.doi.org/10.1016/j.immuni.2012.05.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22863835	Green Accepted, Bronze			2022-12-18	WOS:000308261800013
J	Peters, A; Pitcher, LA; Sullivan, JM; Mitsdoerffer, M; Acton, SE; Franz, B; Wucherpfennig, K; Turley, S; Carroll, MC; Sobel, RA; Bettelli, E; Kuchroo, VK				Peters, Anneli; Pitcher, Lisa A.; Sullivan, Jenna M.; Mitsdoerffer, Meike; Acton, Sophie E.; Franz, Bettina; Wucherpfennig, Kai; Turley, Shannon; Carroll, Michael C.; Sobel, Raymond A.; Bettelli, Estelle; Kuchroo, Vijay K.			Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation	IMMUNITY			English	Article							PLATELET ACTIVATION; RECEPTOR; PODOPLANIN; BLOOD; DIFFERENTIATION; INTERLEUKIN-21; GLYCOPROTEIN; SUPPRESSION; BIOLOGY; CLEC-2	Ectopic lymphoid follicles are hallmarks of chronic autoimmune inflammatory diseases such as multiple sclerosis (MS), rheumatoid arthritis, Sjogren's syndrome, and myasthenia gravis. However, the effector cells and mechanisms that induce their development are unknown. Here we showed that in experimental autoimmune encephalomyelitis (EAE), the animal model of MS, Th17 cells specifically induced ectopic lymphoid follicles in the central nervous system (CNS). Development of ectopic lymphoid follicles was partly dependent on the cytokine interleukin 17 (IL-17) and on the cell surface molecule Podoplanin (Pdp), which was expressed on Th17 cells, but not on other effector T cell subsets. Pdp was also crucial for the development of secondary lymphoid structures: Pdp-deficient mice lacked peripheral lymph nodes and had a defect in forming normal lymphoid follicles and germinal centers in spleen and lymph node remnants. Thus, Th17 cells are uniquely endowed to induce tissue inflammation, characterized by ectopic lymphoid follicles within the target organ.	[Peters, Anneli; Sullivan, Jenna M.; Mitsdoerffer, Meike; Bettelli, Estelle; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Pitcher, Lisa A.; Carroll, Michael C.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Pitcher, Lisa A.; Carroll, Michael C.] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp,Dept Pediat, Boston, MA 02115 USA; [Pitcher, Lisa A.; Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Acton, Sophie E.; Franz, Bettina; Wucherpfennig, Kai; Turley, Shannon] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Sobel, Raymond A.] Stanford Univ, Sch Med, Palto Vet Adm Hlth Care Syst, Stanford, CA 94305 USA; [Bettelli, Estelle] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Stanford University; Stanford University	Bettelli, E (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	ebettelli@benaroyaresearch.org; vkuchroo@rics.bwh.harvard.edu	Acton, Sophie/G-9784-2012	Acton, Sophie/0000-0003-2704-716X; Sobel, Raymond/0000-0002-0477-9002	NIH [1R01NS059996, 5T32HL066987-09, R01NS045937, R01NS035685, R37NS030843, R01A1044880, P01A1039671, P01NS038037]; Javits Neuroscience Investigator Award; National Multiple Sclerosis Society (NMSS) [TA3014A1/1, RG-2571]; Boehringer Ingelheim Fonds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030843, R01NS059996, R01NS045937, R01NS035685, P01NS038037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Javits Neuroscience Investigator Award; National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ramirez (Boston University, Boston, MA) for generously sharing Pdpn<SUP>-/-</SUP> mice with us. We thank D. Kozoriz for cell sorting. A.P. is a graduate student jointly supervised by R. Heumann (Ruhr-University Bochum, Germany) and V.K.K. This work was supported by grants from the NIH (1R01NS059996 to E.B., 5T32HL066987-09 to LAP., and R01NS045937, R01NS035685, R37NS030843, R01A1044880, P01A1039671, P01NS038037, and a Javits Neuroscience Investigator Award to V.K.K.) and the National Multiple Sclerosis Society (NMSS Transition Award TA3014A1/1 to E.B. and RG-2571 to V.K.K.). A.P. is the recipient of a Ph.D. scholarship by the Boehringer Ingelheim Fonds.	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Columba-Cabezas S, 2006, J NEUROIMMUNOL, V179, P76, DOI 10.1016/j.jneuroim.2006.06.015; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	30	316	336	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					986	996		10.1016/j.immuni.2011.10.015	http://dx.doi.org/10.1016/j.immuni.2011.10.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22177922	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000298777300016
J	Mocikat, R; Braumuller, H; Gumy, A; Egeter, O; Ziegler, H; Reusch, U; Bubeck, A; Louis, J; Mailhammer, R; Riethmuller, G; Koszinowski, U; Rocken, M				Mocikat, R; Braumuller, H; Gumy, A; Egeter, O; Ziegler, H; Reusch, U; Bubeck, A; Louis, J; Mailhammer, R; Riethmuller, G; Koszinowski, U; Rocken, M			Natural killer cells activated by MHC class I-low targets prime dendritic cells to induce protective CD8 T cell responses	IMMUNITY			English	Article							TUMOR-IMMUNITY; INHIBITORY RECEPTORS; IFN-GAMMA; NK CELLS; VIVO; RESISTANCE; REJECTION; VIRUS; MOUSE; MECHANISMS	Conserved molecular patterns derived from pathogenic microorganisms prime antigen-presenting dendritic cells (DC) to induce adaptive T cell responses. In contrast, virus-infected or tumor cells that express low levels of major histocompatibility complex (MHC) class I activate natural killer(NK) cells for direct killing. It is unknown whether NK cell recognition of MHC class I-low targets can also induce adaptive T cell responses. Here, we show that MHC class I-low targets initiate a cascade of immune responses, starting with the immediate activation of NK cells. The activated NK cells then prime DC to produce IL-12 and to induce highly protective CD8 T cell memory responses. Therefore, sensing of MHC class I-low targets by NK cells can link innate and adaptive immunity to induce protective T cell responses and may alarm the immune system during early infection with noncytopathic viruses.	GSF, Inst Mol Immunol, D-81377 Munich, Germany; Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; Univ Munich, Dept Dermatol & Allergol, D-80336 Munich, Germany; Univ Lausanne, Inst Biochem, WHO, Immunol Res & Training Ctr, CH-1015 Lausanne, Switzerland; Univ Munich, Max von Pettenkofer Inst, D-80337 Munich, Germany; GSF, Inst Klin Mol Biol & Tumorgenet, D-81377 Munich, Germany; Univ Munich, Inst Immunol, D-80337 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Lausanne; World Health Organization; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Mocikat, R (corresponding author), GSF, Inst Mol Immunol, D-81377 Munich, Germany.			Rocken, Martin/0000-0003-3795-7001				Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Egeter O, 2000, CANCER RES, V60, P1515; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kelly JM, 2002, J IMMUNOL, V168, P4472, DOI 10.4049/jimmunol.168.9.4472; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mocikat R, 1997, CANCER RES, V57, P2346; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Selmayr M, 1999, GENE THER, V6, P778, DOI 10.1038/sj.gt.3300875; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Xu XN, 2001, IMMUNITY, V15, P867, DOI 10.1016/S1074-7613(01)00255-2; Ziegler H, 1997, IMMUNITY, V6, P57, DOI 10.1016/S1074-7613(00)80242-3; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	34	316	335	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					561	569		10.1016/S1074-7613(03)00264-4	http://dx.doi.org/10.1016/S1074-7613(03)00264-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563320	Bronze			2022-12-18	WOS:000186051900012
J	Kaneko, T; Goldman, WE; Mellroth, P; Steiner, H; Fukase, K; Kusumoto, S; Harley, W; Fox, A; Golenbock, D; Silverman, N				Kaneko, T; Goldman, WE; Mellroth, P; Steiner, H; Fukase, K; Kusumoto, S; Harley, W; Fox, A; Golenbock, D; Silverman, N			Monomeric and polymeric gram-negative peptidoglycan but not purified LPS stimulate the Drosophila IMD pathway	IMMUNITY			English	Article							TRACHEAL CYTO-TOXIN; L-ALANINE AMIDASE; RECOGNITION PROTEIN; INNATE IMMUNITY; STRUCTURAL REQUIREMENTS; BORDETELLA-PERTUSSIS; SIGNAL-TRANSDUCTION; HOST RECOGNITION; FACTOR-C; LIPOPOLYSACCHARIDE	Insects depend solely upon innate immune responses to survive infection. These responses include the activation of extracellular protease cascades, leading to melanization and clotting, and intracellular signal transduction pathways inducing antimicrobial peptide gene expression. In Drosophila, the IMD pathway is required for antimicrobial gene expression in response to gram-negative bacteria. The exact molecular component(s) from these bacteria that activate the IMD pathway remain controversial. We found that highly purified LPS did not stimulate the IMD pathway. However, lipid A, the active portion of LPS in mammals, activated melanization in the silkworm Bombyx morii. On the other hand, the IMD pathway was remarkably sensitive to polymeric and monomeric gram-negative peptidoglycan. Recognition of peptidoglycan required the stem-peptide sequence specific to gram-negative peptidoglycan and the receptor PGRP-LC. Recognition of monomeric and polymeric peptidoglycan required different PGRP-LC splice isoforms, while lipid A recognition required an unidentified soluble factor in the hemolymph of Bombyx morii.	Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA; Univ S Carolina, Sch Med, Dept Pathol & Microbiol, Columbia, SC 29208 USA; Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; Univ Stockholm, Dept Microbiol, S-10691 Stockholm, Sweden; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Nagasaki Univ, Sch Med, Dept Periodontol, Nagasaki 8528588, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Osaka University; Stockholm University; Washington University (WUSTL); Nagasaki University	Silverman, N (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA.	neal.silverman@umassmed.edu	Steiner, Håkan/E-6415-2019; Mellroth, Peter/F-8214-2013	Kaneko, Takashi/0000-0001-9276-5550; Mellroth, Peter/0000-0002-3518-1054; Silverman, Neal/0000-0002-4259-456X; Goldman, William/0000-0002-1551-6718	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060025, R01AI052455, R56AI060025, R56AI052455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060025, AI52455] Funding Source: Medline; NIDDK NIH HHS [DK50305] Funding Source: Medline; NIGMS NIH HHS [GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; COOKSON BT, 1989, INFECT IMMUN, V57, P2223, DOI 10.1128/IAI.57.7.2223-2229.1989; COOKSON BT, 1989, BIOCHEMISTRY-US, V28, P1744, DOI 10.1021/bi00430a048; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dimarcq JL, 1997, INSECT BIOCHEM MOLEC, V27, P877, DOI 10.1016/S0965-1748(97)00072-6; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kozar MP, 2002, INFECT IMMUN, V70, P741, DOI 10.1128/IAI.70.2.741-748.2002; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; LUKER KE, 1995, MOL MICROBIOL, V16, P733, DOI 10.1111/j.1365-2958.1995.tb02434.x; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; MUTA T, 1993, METHOD ENZYMOL, V223, P336; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tan NS, 2000, FASEB J, V14, P859, DOI 10.1096/fasebj.14.7.859; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1111/j.1574-695X.1996.tb00063.x; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; VUKAJLOVICH SW, 1987, MOL IMMUNOL, V24, P319, DOI 10.1016/0161-5890(87)90173-8; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu LP, 2001, GENETICS, V159, P189; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	40	315	326	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					637	649		10.1016/S1074-7613(04)00104-9	http://dx.doi.org/10.1016/S1074-7613(04)00104-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142531	Bronze			2022-12-18	WOS:000221631900013
J	Diehl, S; Anguita, J; Hoffmeyer, A; Zapton, T; Ihle, JN; Fikrig, E; Rincon, M				Diehl, S; Anguita, J; Hoffmeyer, A; Zapton, T; Ihle, JN; Fikrig, E; Rincon, M			Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1	IMMUNITY			English	Article							CD4+ T-CELLS; INTERFERON-GAMMA PRODUCTION; INDUCED STAT INHIBITOR; IFN-GAMMA; TRANSGENIC MICE; INTERLEUKIN-6-DEFICIENT MICE; AUTOIMMUNE ENCEPHALOMYELITIS; SIGNAL-TRANSDUCTION; DEFICIENT MICE; CUTTING EDGE	Interleukin 6 (IL-6) is a cytokine produced by immune and nonimmune cells and exhibits functional pleiotropy and redundancy. IL-6 plays an important role in the differentiation of several cell types. Here, we describe a novel function of IL-6: the negative regulation of CD4(+) Th1 cell differentiation. While IL-6-directed CD4(+) Th2 differentiation is mediated by IL-4, inhibition of Th1 differentiation by IL-6 is independent of IL-4. IL-6 upregulates suppressor of cytokine signaling 1 (SOCS1) expression in activated CD4(+) T cells, thereby interfering with signal transducer and activator of transcription 1 (STAT1) phosphorylation induced by interferon gamma (IFN gamma). Inhibition of IFN gamma receptor-mediated signals by IL-6 prevents autoregulation of IFN I gene expression by IFN gamma during CD4(+) T cell activation, thereby preventing Th1 differentiation. Thus, IL-6 promotes CD4(+) Th2 differentiation and inhibits Th1 differentiation by two independent molecular mechanisms.	Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Biochem, Memphis, TN USA	University of Vermont; Yale University; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Rincon, M (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Given Med Bldg, Burlington, VT 05405 USA.		Diehl, Sean/C-7166-2008; Anguita, Juan/D-5432-2011; Diehl, Sean/AAE-2779-2020	Diehl, Sean/0000-0001-9700-235X; Anguita, Juan/0000-0003-2061-7182; Diehl, Sean/0000-0001-9700-235X	NIAID NIH HHS [P01 AI045666] Funding Source: Medline; NIEHS NIH HHS [T32ES07122] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007122] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander WS, 1999, J LEUKOCYTE BIOL, V66, P588, DOI 10.1002/jlb.66.4.588; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Anguita J, 1996, J CLIN INVEST, V97, P1028, DOI 10.1172/JCI118494; Anguita J, 1998, J INFECT DIS, V178, P1512, DOI 10.1086/314448; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bradley LM, 1996, J IMMUNOL, V157, P1350; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fallarino F, 1999, J IMMUNOL, V163, P4109; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Joseph SB, 1998, EUR J IMMUNOL, V28, P277, DOI 10.1002/(SICI)1521-4141(199801)28:01<277::AID-IMMU277>3.0.CO;2-8; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEANEMYERS A, 1995, J IMMUNOL, V155, P2020; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; La Flamme AC, 2000, J IMMUNOL, V164, P2419, DOI 10.4049/jimmunol.164.5.2419; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Losman JA, 1999, J IMMUNOL, V162, P3770; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; MATYNIAK JE, 1995, J EXP MED, V181, P1251, DOI 10.1084/jem.181.3.1251; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MULLER MM, 1989, NUCLEIC ACIDS RES, V17, P6420, DOI 10.1093/nar/17.15.6420; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Murphy KM, 1998, CURR OPIN IMMUNOL, V10, P226, DOI 10.1016/S0952-7915(98)80253-7; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; RODRIGUEZ M, 1994, J IMMUNOL, V153, P3811; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SCHIJNS VECJ, 1994, J IMMUNOL, V153, P2029; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SWAIN SL, 1995, CURR BIOL, V5, P849, DOI 10.1016/S0960-9822(95)00170-9; SWIHART K, 1995, J EXP MED, V181, P961, DOI 10.1084/jem.181.3.961; Teague TK, 1997, J IMMUNOL, V158, P5791; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; TUGORES A, 1992, J IMMUNOL, V148, P2300; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Wenner CA, 1996, J IMMUNOL, V156, P1442; WILLENBORG DO, 1995, SCAND J IMMUNOL, V41, P31, DOI 10.1111/j.1365-3083.1995.tb03530.x; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z	56	315	332	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					805	815		10.1016/S1074-7613(00)00078-9	http://dx.doi.org/10.1016/S1074-7613(00)00078-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163196	Bronze			2022-12-18	WOS:000166142300006
J	Lenschow, DJ; Herold, KC; Rhee, L; Patel, B; Koons, A; Qin, HY; Fuchs, E; Singh, B; Thompson, CB; Bluestone, JA				Lenschow, DJ; Herold, KC; Rhee, L; Patel, B; Koons, A; Qin, HY; Fuchs, E; Singh, B; Thompson, CB; Bluestone, JA			CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes	IMMUNITY			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CD4(+) T-CELLS; NOD MICE; CD28-DEFICIENT MICE; IMMUNE-RESPONSE; TRANSGENIC MICE; MURINE LUPUS; IN-VIVO; CTLA-4; COSTIMULATION	CD28 ligation delivers a costimulatory signal important in T cell activation. This study demonstrates that the disruption of the CD28/B7 pathway early in the nonobese diabetic mouse strain, using CD28(-/-) and CTLA4Ig transgenic mice, promoted the development and progression of spontaneous autoimmune diabetes. Functional analyses of T cells isolated from CD28-deficient mice demonstrated that the GAD-specific T cells produced enhanced Th1-type cytokines (IL-2 and IFN gamma) and diminished Th2-type cytokine, IL-4. Moreover, there was a significant decrease in serum levels of anti-GAD antibodies of the IgG1 isotype consistent with a profound suppression of The-type responses in these animals. Thus, the early differentiation of naive diabetogenic T cells into the Th2 subset is dependent upon CD28 signaling and extends our understanding of the importance of Th1/Th2 balance in the regulation of this spontaneous autoimmune disease.	UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,COMM IMMUNOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MOL GENET & CELL BIOL,CHICAGO,IL 60637; UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON,ON N6A 5C1,CANADA	Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Western University (University of Western Ontario)	Lenschow, DJ (corresponding author), UNIV CHICAGO,BEN MAY INST CANC RES,DEPT PATHOL,CHICAGO,IL 60637, USA.		Singh, Bhagirath/C-4010-2013	Singh, Bhagirath/0000-0002-9792-8694	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK49799] Funding Source: Medline; NIGMS NIH HHS [GM07183-19] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE R, 1995, J IMMUNOL, V154, P985; CORRY DB, 1994, J IMMUNOL, V153, P4142; CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; ELLIOTT JF, 1994, DIABETES, V43, P1494, DOI 10.2337/diabetes.43.12.1494; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kawai K, 1996, TRANSPLANTATION, V61, P352, DOI 10.1097/00007890-199602150-00003; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; KUMMEL MF, 1995, J EXP MED, V182, P459; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; NAKAJIMA A, 1995, EUR J IMMUNOL, V25, P3060, DOI 10.1002/eji.1830251112; NISHIKAWA K, 1994, EUR J IMMUNOL, V24, P1249, DOI 10.1002/eji.1830240602; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHEHADEH NN, 1993, J AUTOIMMUN, V6, P291, DOI 10.1006/jaut.1993.1025; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; SPERLING AI, 1995, J EXP MED, V182, P139, DOI 10.1084/jem.182.1.139; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; VANDERPOUWKRAAN T, 1993, EUR J IMMUNOL, V23, P1, DOI 10.1002/eji.1830230102; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEBB LMC, 1995, BLOOD, V86, P3479, DOI 10.1182/blood.V86.9.3479.bloodjournal8693479; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143	42	315	327	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1996	5	3					285	293		10.1016/S1074-7613(00)80323-4	http://dx.doi.org/10.1016/S1074-7613(00)80323-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808683	Bronze			2022-12-18	WOS:A1996VJ79700010
J	Gosmann, C; Anahtar, MN; Handley, SA; Farcasanu, M; Abu-Ali, G; Bowman, BA; Padavattan, N; Desai, C; Droit, L; Moodley, A; Dong, M; Chen, YZ; Ismail, N; Ndung'u, T; Ghebremichael, MS; Wesemann, DR; Mitchell, C; Dong, KL; Huttenhower, C; Walker, BD; Virgin, HW; Kwon, DS				Gosmann, Christina; Anahtar, Melis N.; Handley, Scott A.; Farcasanu, Mara; Abu-Ali, Galeb; Bowman, Brittany A.; Padavattan, Nikita; Desai, Chandni; Droit, Lindsay; Moodley, Amber; Dong, Mary; Chen, Yuezhou; Ismail, Nasreen; Ndung'u, Thumbi; Ghebremichael, Musie S.; Wesemann, Duane R.; Mitchell, Caroline; Dong, Krista L.; Huttenhower, Curtis; Walker, Bruce D.; Virgin, Herbert W.; Kwon, Douglas S.			Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women	IMMUNITY			English	Article							T-CELL-ACTIVATION; SEXUAL TRANSMISSION; GENITAL-TRACT; TH17 CELLS; MICROBIOME; IMMUNODEFICIENCY; SUSCEPTIBILITY; INFECTION; SIV; VAGINOSIS	Elevated inflammation in the female genital tract is associated with increased HIV risk. Cervicovaginal bacteria modulate genital inflammation; however, their role in HIV susceptibility has not been elucidated. In a prospective cohort of young, healthy South African women, we found that individuals with diverse genital bacterial communities dominated by anaerobes other than Gardnerella were at over 4-fold higher risk of acquiring HIV and had increased numbers of activated mucosal CD4(+) T cells compared to those with Lactobacillus crispatus- dominant communities. We identified specific bacterial taxa linked with reduced (L. crispatus) or elevated (Prevotella, Sneathia, and other anaerobes) inflammation and HIV infection and found that high-risk bacteria increased numbers of activated genital CD4(+) T cells in a murine model. Our results suggest that highly prevalent genital bacteria increase HIV risk by inducing mucosal HIV target cells. These findings might be leveraged to reduce HIV acquisition in women living in sub-Saharan Africa.	[Gosmann, Christina; Anahtar, Melis N.; Farcasanu, Mara; Bowman, Brittany A.; Dong, Mary; Ndung'u, Thumbi; Ghebremichael, Musie S.; Dong, Krista L.; Walker, Bruce D.; Kwon, Douglas S.] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Gosmann, Christina; Anahtar, Melis N.; Chen, Yuezhou; Ghebremichael, Musie S.; Wesemann, Duane R.; Kwon, Douglas S.] Harvard Med Sch, Boston, MA 02115 USA; [Handley, Scott A.; Desai, Chandni; Droit, Lindsay; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Abu-Ali, Galeb; Huttenhower, Curtis] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Padavattan, Nikita; Ismail, Nasreen; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, HIV Pathogenesis Programme, ZA-4001 Durban, Kwazulu Natal, South Africa; [Moodley, Amber; Dong, Mary; Dong, Krista L.] Females Rising Educ Support & Hlth, ZA-4066 Durban, Kwazulu Natal, South Africa; [Chen, Yuezhou; Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Mitchell, Caroline] Massachusetts Gen Hosp, Vincent Obstet & Gynecol, Boston, MA 02115 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Walker, Bruce D.; Kwon, Douglas S.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walker, Bruce D.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Kwon, DS (corresponding author), Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Kwon, DS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kwon, DS (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA.	dkwon@mgh.harvard.edu	Desai, Chandni/AAA-5477-2020; Abu-Ali, Galeb/AAE-9742-2020; Anahtar, Melis/AAT-6231-2020	Desai, Chandni/0000-0002-3708-3634; Abu-Ali, Galeb/0000-0002-2599-2937; Ndung'u, Thumbi/0000-0003-2962-3992; Wesemann, Duane/0000-0002-6690-944X; Bowman, Brittany/0000-0003-1101-163X; Virgin, Herbert/0000-0001-8580-7628	Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI) [UKZNRSA1001]; NIAID [1R01AI111918, R01AI067073]; Harvard Center for AIDS Research; Burroughs Wellcome Fund; National Institute of General Medical Sciences [T32GM007753]; NIH [AI1113217]; Doris Duke Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111918, R01AI113217, R01AI067073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Center for AIDS Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the FRESH participants; T. Cele for performing the pelvic exams; T. Sikhakhane, S. Ngcobo, and S. Zungu for clinical support; H. Shen for flow cytometry assistance; M. Karpel for performing the IL-8 ELISA. This work was supported by the Collaboration for AIDS Vaccine Discovery of the Bill and Melinda Gates Foundation, the International AIDS Vaccine Initiative (IAVI) (UKZNRSA1001), the NIAID (1R01AI111918 and R01AI067073), and the Harvard Center for AIDS Research. D. S. K. and D. R. W. received additional support from the Burroughs Wellcome Fund, M.N.A. from the National Institute of General Medical Sciences (award number T32GM007753), D. R. W. from the NIH (AI1113217) and C. M. from a Doris Duke Clinical Scientist Development Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the NIH.	Anahtar M. N., 2016, JOVE-J VIS EXP, V110, P53939; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Bradshaw CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034540; Byrne EH, 2016, LANCET INFECT DIS, V16, P441, DOI 10.1016/S1473-3099(15)00429-6; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Christensen-Quick A, 2016, J VIROL, V90, P7833, DOI 10.1128/JVI.02869-15; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Gorgos LM, 2015, SEX TRANSM DIS, V42, P475, DOI 10.1097/OLQ.0000000000000318; Gosmann C, 2014, J IMMUNOL, V193, P2248, DOI 10.4049/jimmunol.1400216; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Handley SA, 2016, CELL HOST MICROBE, V19, P323, DOI 10.1016/j.chom.2016.02.010; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; Lango D., 2014, DIGITAL LITERACY CAM; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McKinnon LR, 2016, CURR HIV-AIDS REP, V13, P158, DOI 10.1007/s11904-016-0314-z; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rodriguez-Garcia M, 2014, MUCOSAL IMMUNOL, V7, P1375, DOI 10.1038/mi.2014.26; Spurbeck RR, 2011, FUTURE MICROBIOL, V6, P567, DOI [10.2217/FMB.11.36, 10.2217/fmb.11.36]; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Stieh DJ, 2016, CELL HOST MICROBE, V19, P529, DOI 10.1016/j.chom.2016.03.005; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Woodman Z, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0132-6	34	314	330	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					29	37		10.1016/j.immuni.2016.12.013	http://dx.doi.org/10.1016/j.immuni.2016.12.013			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28087240	Green Accepted, Bronze			2022-12-18	WOS:000392918300008
J	Sandstrom, A; Peigne, CM; Leger, A; Crooks, JE; Konczak, F; Gesnel, MC; Breathnach, R; Bonneville, M; Scotet, E; Adams, EJ				Sandstrom, Andrew; Peigne, Cassie-Marie; Leger, Alexandra; Crooks, James E.; Konczak, Fabienne; Gesnel, Marie-Claude; Breathnach, Richard; Bonneville, Marc; Scotet, Emmanuel; Adams, Erin J.			The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human V gamma 9V delta 2 T Cells	IMMUNITY			English	Article							NONPEPTIDE ANTIGENS; (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE; BIOLOGICAL-ACTIVITY; PROTEIN CRYSTALS; CROSS-LINKING; RECOGNITION; STIMULATION; RECEPTOR; RESPONSES; DAUDI	In humans, V gamma 9V delta 2 T cells detect tumor cells and microbial infections, including Mycobacterium tuberculosis, through recognition of small pyrophosphate containing organic molecules known as phosphoantigens (pAgs). Key to pAg-mediated activation of V gamma 9V delta 2 T cells is the butyrophilin 3A1 (BTN3A1) protein that contains an intracellular B30.2 domain critical to pAg reactivity. Here, we have demonstrated through structural, biophysical, and functional approaches that the intracellular B30.2 domain of BTN3A1 directly binds pAg through a positively charged surface pocket. Charge reversal of pocket residues abrogates binding and V gamma 9V delta 2 T cell activation. We have also identified a gain-of-function mutation within this pocket that, when introduced into the B30.2 domain of the nonstimulatory BTN3A3 isoform, transfers pAg binding ability and V gamma 9V delta 2 T cell activation. These studies demonstrate that internal sensing of changes in pAg metabolite concentrations by BTN3A1 molecules is a critical step in V gamma 9V delta 2 T cell detection of infection and tumorigenesis.	[Sandstrom, Andrew; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Peigne, Cassie-Marie; Leger, Alexandra; Konczak, Fabienne; Gesnel, Marie-Claude; Breathnach, Richard; Bonneville, Marc; Scotet, Emmanuel] INSERM, Ctr Rech Cancerol Nantes Angers, Unite Mixte Rech 892, F-44000 Nantes, France; [Peigne, Cassie-Marie; Leger, Alexandra; Konczak, Fabienne; Gesnel, Marie-Claude; Breathnach, Richard; Bonneville, Marc; Scotet, Emmanuel] Univ Nantes, F-44000 Nantes, France; [Peigne, Cassie-Marie; Leger, Alexandra; Konczak, Fabienne; Gesnel, Marie-Claude; Breathnach, Richard; Bonneville, Marc; Scotet, Emmanuel] CNRS, Unite Mixte Rech 6299, F-44000 Nantes, France; [Crooks, James E.] Univ Chicago, Program Biophys Sci, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); University of Chicago; University of Chicago	Scotet, E (corresponding author), INSERM, Ctr Rech Cancerol Nantes Angers, Unite Mixte Rech 892, F-44000 Nantes, France.	emmanuel.scotet@univ-nantes.fr; ejadams@uchicago.edu	Breathnach, Richard/K-7599-2015; SCOTET, Emmanuel/L-2576-2015; SCOTET, Emmanuel/AAC-9971-2019; Del Gatto-Konczak, Fabienne/L-1506-2015	SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Sandstrom, Andrew/0000-0002-8629-9087	NIH [R56_AI097386, R01_AI073922]; INSERM; Universite de Nantes; Association pour la Recherche contre le Cancer [R10139NN]; Institut National du Cancer [V9V2THER]; Agence Nationale de la Recherche [GDSTRESS]; Ligue Nationale contre le Cancer; Investissements d'Avenir (Agence Nationale de la Recherche-Programme Laboratoires d'Excellence Immunotherapy Graft Oncology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922, R56AI097386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Nantes; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Investissements d'Avenir (Agence Nationale de la Recherche-Programme Laboratoires d'Excellence Immunotherapy Graft Oncology)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the Advanced Proton Source at GM/CA-CAT 23-ID) and NE-CAT 24-ID) for their use and assistance with X-ray beamlines and R. Sanishvili, C. Ogata, and K. Perry in particular for help and advice during data collection. We thank M. S. Gu, A. Luoma, and C. Palka for advice and helpful discussions. A. S. designed and performed ITC experiments, mutagenesis, and protein crystallization and structure determination and handled manuscript preparation. We thank the staff of the Cytometry Facility Cytocell) and Cellular and Tissular Imaging Core Facility MicroPICell) of Nantes University for technical assistance, and Q. Amosse and S. Nedellec in particular for microscopy data collection and expert advice. We also thank C. Belmant Innate Pharma) for kindly providing reagents. R. B., M.-C. G., F. K., C.-M. P., and A. L. designed and performed experiments involving mutagenesis and functional assays. E.J.A., M. B., and E. S. led the investigation and contributed to experiment design, data interpretation, and manuscript preparation. This work was supported by NIH grants R56_AI097386 and R01_AI073922 to E.J.A.; INSERM, Universite de Nantes, Association pour la Recherche contre le Cancer (#R10139NN), Institut National du Cancer (#V9V2THER), Agence Nationale de la Recherche (#GDSTRESS), and Ligue Nationale contre le Cancer and Investissements d'Avenir (Agence Nationale de la Recherche-Programme Laboratoires d'Excellence Immunotherapy Graft Oncology). M. B. is a founding scientist of the company Innate Pharma SA and was a consultant for this company until October 2013. He is currently vice president of the Institut Merieux in charge of scientific and medical affairs.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OA, 2009, ACTA CRYSTALLOGR D, V65, P872, DOI 10.1107/S0907444909017855; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boedec A, 2008, J MED CHEM, V51, P1747, DOI 10.1021/jm701101g; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P58, DOI 10.1038/cmi.2012.46; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Espinosa E, 2001, J BIOL CHEM, V276, P18337, DOI 10.1074/jbc.M100495200; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Julian RR, 2001, INT J MASS SPECTROM, V210, P613, DOI 10.1016/S1387-3806(01)00431-6; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kotlyar SA, 2005, ACTA CRYSTALLOGR E, V61, pM293, DOI 10.1107/S1600536805000085; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2000, BLOOD, V96, P384; LANG F, 1995, J IMMUNOL, V154, P5986; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; McClanahan J, 1999, CYTOMETRY, V38, P280, DOI 10.1002/(SICI)1097-0320(19991215)38:6<280::AID-CYTO4>3.3.CO;2-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Puan KJ, 2007, INT IMMUNOL, V19, P657, DOI 10.1093/intimm/dxm031; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang H, 2013, J IMMUNOL, V191, P1029, DOI 10.4049/jimmunol.1300658; Wang H, 2010, J IMMUNOL, V184, P6209, DOI 10.4049/jimmunol.1000231; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Zhang YH, 2006, CHEM BIOL, V13, P985, DOI 10.1016/j.chembiol.2006.08.007	41	314	320	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					490	500		10.1016/j.immuni.2014.03.003	http://dx.doi.org/10.1016/j.immuni.2014.03.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24703779	Bronze, Green Accepted			2022-12-18	WOS:000334849400008
J	Haribhai, D; Williams, JB; Jia, S; Nickerson, D; Schmitt, EG; Edwards, B; Ziegelbauer, J; Yassai, M; Li, SH; Relland, LM; Wise, PM; Chen, A; Zheng, YQ; Simpson, PM; Gorski, J; Salzman, NH; Hessner, MJ; Chatila, TA; Williams, CB				Haribhai, Dipica; Williams, Jason B.; Jia, Shuang; Nickerson, Derek; Schmitt, Erica G.; Edwards, Brandon; Ziegelbauer, Jennifer; Yassai, Maryam; Li, Shun-Hwa; Relland, Lance M.; Wise, Petra M.; Chen, Andrew; Zheng, Yu-Qian; Simpson, Pippa M.; Gorski, Jack; Salzman, Nita H.; Hessner, Martin J.; Chatila, Talal A.; Williams, Calvin B.			A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity	IMMUNITY			English	Article							RECALL RESPONSES; CUTTING EDGE; INDUCTION; SELF; REPERTOIRES; PROTEIN; ABSENCE	Although both natural and induced regulatory T (nTreg and iTreg) cells can enforce tolerance, the mechanisms underlying their synergistic actions have not been established. We examined the functions of nTreg and iTreg cells by adoptive transfer immunotherapy of newborn Foxp3-deficient mice. As monotherapy, only nTreg cells prevented disease lethality, but did not suppress chronic inflammation and autoimmunity. Provision of Foxp3-sufficient conventional T cells with nTreg cells reconstituted the iTreg pool and established tolerance. In turn, acute depletion of iTreg cells in rescued mice resulted in weight loss and inflammation. Whereas the transcriptional signatures of nTreg and in vivo-derived iTreg cells were closely matched, there was minimal overlap in their T cell receptor (TCR) repertoires. Thus, iTreg cells are an essential nonredundant regulatory subset that supplements nTreg cells, in part by expanding TCR diversity within regulatory responses.	[Nickerson, Derek; Wise, Petra M.; Chen, Andrew; Zheng, Yu-Qian; Chatila, Talal A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Immunol Allergy & Rheumatol, Dept Pediat, Los Angeles, CA 90095 USA; [Haribhai, Dipica; Williams, Jason B.; Schmitt, Erica G.; Edwards, Brandon; Ziegelbauer, Jennifer; Relland, Lance M.; Williams, Calvin B.] Med Coll Wisconsin, Rheumatol Sect, Dept Pediat, Milwaukee, WI 53226 USA; [Jia, Shuang; Hessner, Martin J.] Med Coll Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Dept Pediat, Milwaukee, WI 53226 USA; [Li, Shun-Hwa; Simpson, Pippa M.] Med Coll Wisconsin, Sect Quantitat Hlth Sci, Dept Pediat, Milwaukee, WI 53226 USA; [Salzman, Nita H.] Med Coll Wisconsin, Gastroenterol Sect, Dept Pediat, Milwaukee, WI 53226 USA; [Yassai, Maryam; Gorski, Jack] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin	Chatila, TA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Immunol Allergy & Rheumatol, Dept Pediat, Los Angeles, CA 90095 USA.	tchatila@mednet.ucla.edu; cwilliam@mcw.edu	simpson, pippa/AAI-8172-2020; Chen, Andrew/AAT-6318-2021	simpson, pippa/0000-0003-1458-3748; Chen, Andrew/0000-0002-6688-7674; Williams, Calvin/0000-0002-5492-8475; Chatila, Talal/0000-0001-7439-2762; Salzman, Nita/0000-0003-0939-6139	National Institutes of Health [R01 AI073731, R01 AI085090, N01 50032, R01 AI065617, R01 AI078713]; D.B. and Marjorie Reinhart Foundation; Montgomery Family Foundation; Advancing a Healthier Wisconsin-Research for a Healthier Tomorrow Initiative; Crohn's and Colitis Foundation of America; Children's Hospital of Wisconsin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065617, R21AI080002, R01AI078713, R01AI085090, R01AI073731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.B. and Marjorie Reinhart Foundation; Montgomery Family Foundation; Advancing a Healthier Wisconsin-Research for a Healthier Tomorrow Initiative; Crohn's and Colitis Foundation of America; Children's Hospital of Wisconsin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Ebert for technical support, and R. Lang for providing Simian DTR cDNA. This work was supported by National Institutes of Health grants R01 AI073731 and R01 AI085090 (C.B.W. and T.A.C), N01 50032 (C.B.W.), R01 AI065617 (T.A.C.), R01 AI078713 (M.J.H.), the D.B. and Marjorie Reinhart, and the Montgomery Family Foundations (C.B.W.), the Advancing a Healthier Wisconsin-Research for a Healthier Tomorrow Initiative (C.B.W.), the Crohn's and Colitis Foundation of America (C.B.W), and the Children's Hospital of Wisconsin (C.B.W.).	Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Naumov YN, 2006, J IMMUNOL, V177, P2006, DOI 10.4049/jimmunol.177.3.2006; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Relland LM, 2009, J IMMUNOL, V182, P1341, DOI 10.4049/jimmunol.182.3.1341; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Schmitz-Winnenthal H, 2010, GASTROENTEROLOGY, V138, P1178, DOI 10.1053/j.gastro.2009.11.011; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	42	314	324	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					109	122		10.1016/j.immuni.2011.03.029	http://dx.doi.org/10.1016/j.immuni.2011.03.029			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21723159	Green Accepted, Bronze			2022-12-18	WOS:000293107300014
J	Coelho, MA; Trecesson, SD; Rana, S; Zecchin, D; Moore, C; Molina-Arcas, M; East, P; Spencer-Dene, B; Nye, E; Barnouin, K; Snijders, AP; Lai, WS; Blackshear, PJ; Downward, J				Coelho, Matthew A.; Trecesson, Sophie de Carne; Rana, Sareena; Zecchin, Davide; Moore, Christopher; Molina-Arcas, Miriam; East, Philip; Spencer-Dene, Bradley; Nye, Emma; Barnouin, Karin; Snijders, Ambrosius P.; Lai, Wi S.; Blackshear, Perry J.; Downward, Julian			Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA	IMMUNITY			English	Article							CELL LUNG-CANCER; ACTIVATED PROTEIN-KINASE; CHECKPOINT BLOCKADE; EPITHELIAL-CELLS; MELANOMA-CELLS; TNF-ALPHA; TRISTETRAPROLIN; EXPRESSION; KRAS; TTP	The immunosuppressive protein PD-L1 is upregulated in many cancers and contributes to evasion of the host immune system. The relative importance of the tumor microenvironment and cancer cell-intrinsic signaling in the regulation of PD-L1 expression remains unclear. We report that oncogenic RAS signaling can upregulate tumor cell PD-L1 expression through a mechanism involving increases in PD-L1 mRNA stability via modulation of the AU-rich element-binding protein tristetraprolin (TTP). TTP negatively regulates PD-L1 expression through AU-rich elements in the 3' UTR of PD-L1 mRNA. MEK signaling downstream of RAS leads to phosphorylation and inhibition of TTP by the kinase MK2. In human lung and colorectal tumors, RAS pathway activation is associated with elevated PD-L1 expression. In vivo, restoration of TTP expression enhances anti-tumor immunity dependent on degradation of PD-L1 mRNA. We demonstrate that RAS can drive cell-intrinsic PD-L1 expression, thus presenting therapeutic opportunities to reverse the innately immunoresistant phenotype of RAS mutant cancers.	[Coelho, Matthew A.; Trecesson, Sophie de Carne; Zecchin, Davide; Moore, Christopher; Molina-Arcas, Miriam; Downward, Julian] Francis Crick Inst, Oncogene Biol, 1 Midland Rd, London NW1 1AT, England; [East, Philip] Francis Crick Inst, Computat Biol, 1 Midland Rd, London NW1 1AT, England; [Spencer-Dene, Bradley; Nye, Emma] Francis Crick Inst, Expt Histopathol, 1 Midland Rd, London NW1 1AT, England; [Barnouin, Karin; Snijders, Ambrosius P.] Francis Crick Inst, Prot Anal & Prote Labs, 1 Midland Rd, London NW1 1AT, England; [Lai, Wi S.; Blackshear, Perry J.] NIEHS, Signal Transduct Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27703 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27703 USA; [Rana, Sareena; Downward, Julian] Inst Canc Res, Div Mol Pathol, Lung Canc Grp, 237 Fulham Rd, London SW3 6JB, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Downward, J (corresponding author), Francis Crick Inst, Oncogene Biol, 1 Midland Rd, London NW1 1AT, England.; Downward, J (corresponding author), Inst Canc Res, Div Mol Pathol, Lung Canc Grp, 237 Fulham Rd, London SW3 6JB, England.	julian.downward@crick.ac.uk	Blackshear, Perry J./C-6206-2019; Molina-Arcas, Miriam/R-4908-2019	Blackshear, Perry J./0000-0002-9561-8529; Molina-Arcas, Miriam/0000-0002-8176-8948; East, Philip/0000-0001-5801-5713; moore, christopher/0000-0002-4653-1427; Coelho, Matthew/0000-0003-3737-2468; Snijders, Bram/0000-0002-5416-8592; Downward, Julian/0000-0002-2331-4729	Francis Crick Institute - Cancer Research UK [FC001070]; UK Medical Research Council [FC001070]; Wellcome Trust [FC001070, 103799/Z/14/Z]; European Research Council; National Institute of Environmental Health Sciences, NIH; European Commission Marie Sklodowska-Curie Actions programme, iGEMMdev; Cancer Research UK [15680] Funding Source: researchfish; Versus Arthritis [20265] Funding Source: researchfish; Wellcome Trust [103799/A/14/Z] Funding Source: researchfish; The Francis Crick Institute [10009, 10070, 10011, 10074, 703228-IGEMMdev, 10071, 10002] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Commission Marie Sklodowska-Curie Actions programme, iGEMMdev; Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Charles Swanton and Caetano Reis e Sousa for helpful discussion, David Hancock and Febe Van Maldegem for critical reading of the manuscript, and science technology platforms at the Francis Crick Institute including Biological Resources, FACS, Equipment Park, Experimental Histopathology, and Cell Services. We thank Lynn McGregor and Kevan Shokat for providing ARS853. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001070), the UK Medical Research Council (FC001070), and the Wellcome Trust (FC001070), and by funding to J.D. from the European Research Council Advanced Grant RASTARGET and a Wellcome Trust Senior Investigator Award (103799/Z/14/Z). This work was also supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (W.S.L. and P.J.B.). S.C.T. was supported by a fellowship from the European Commission Marie Sklodowska-Curie Actions programme, iGEMMdev.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Berthon C, 2010, CANCER IMMUNOL IMMUN, V59, P1839, DOI 10.1007/s00262-010-0909-y; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bourcier C, 2011, AM J PHYSIOL-CELL PH, V301, pC609, DOI 10.1152/ajpcell.00506.2010; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Dong ZY, 2017, CLIN CANCER RES, V23, P3012, DOI 10.1158/1078-0432.CCR-16-2554; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; El-Jawhari J, 2014, MOL IMMUNOL, V58, P160, DOI 10.1016/j.molimm.2013.11.020; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Giannou AD, 2017, EMBO MOL MED, V9, P672, DOI 10.15252/emmm.201606978; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hardle L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15112; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Kemp SJ, 2008, AM J RESP CELL MOL, V39, P591, DOI 10.1165/rcmb.2007-0334OC; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li D, 2017, EJSO-EUR J SURG ONC, V43, P1372, DOI 10.1016/j.ejso.2017.02.008; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; RAJAGOPALAN LE, 1995, BLOOD, V86, P2551; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sumimoto H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166626; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Yang HT, 2017, ONCOTARGET, V8, P23517, DOI 10.18632/oncotarget.15627; Yang NS, 2004, GENE THER, V11, P100, DOI 10.1038/sj.gt.3302137; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	58	313	321	8	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1083	+		10.1016/j.immuni.2017.11.016	http://dx.doi.org/10.1016/j.immuni.2017.11.016			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29246442	Green Published, hybrid			2022-12-18	WOS:000418486500013
J	Bunker, JJ; Flynn, TM; Koval, JC; Shaw, DG; Meisel, M; McDonald, BD; Ishizuka, IE; Dent, AL; Wilson, PC; Jabri, B; Antonopoulos, DA; Bendelac, A				Bunker, Jeffrey J.; Flynn, Theodore M.; Koval, Jason C.; Shaw, Dustin G.; Meisel, Marlies; McDonald, Benjamin D.; Ishizuka, Isabel E.; Dent, Alexander L.; Wilson, Patrick C.; Jabri, Bana; Antonopoulos, Dionysios A.; Bendelac, Albert			Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A	IMMUNITY			English	Article							INTESTINAL IGA; CELLS; GUT; GENERATION; IMMUNITY; ROLES	Immunoglobulin A (IgA) is prominently secreted at mucosal surfaces and coats a fraction of the intestinal microbiota. However, the commensal bacteria bound by IgA are poorly characterized and the type of humoral immunity they elicit remains elusive. We used bacterial flow cytometry coupled with 16S rRNA gene sequencing (IgA-Seq) in murine models of immunodeficiency to identify IgA-bound bacteria and elucidate mechanisms of commensal IgA targeting. We found that residence in the small intestine, rather than bacterial identity, dictated induction of specific IgA. Most commensals elicited strong T-independent (TI) responses that originated from the orphan B1b lineage and from B2 cells, but excluded natural antibacterial B1a specificities. Atypical commensals including segmented filamentous bacteria and Mucispirillum evaded TI responses but elicited T-dependent IgA. These data demonstrate exquisite targeting of distinct commensal bacteria by multiple layers of humoral immunity and reveal a specialized function of the B1b lineage in TI mucosal IgA responses.	[Bunker, Jeffrey J.; Meisel, Marlies; McDonald, Benjamin D.; Ishizuka, Isabel E.; Wilson, Patrick C.; Jabri, Bana; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bunker, Jeffrey J.; McDonald, Benjamin D.; Ishizuka, Isabel E.; Bendelac, Albert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Flynn, Theodore M.; Koval, Jason C.; Antonopoulos, Dionysios A.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Flynn, Theodore M.; Antonopoulos, Dionysios A.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Shaw, Dustin G.; Meisel, Marlies; Wilson, Patrick C.; Jabri, Bana; Antonopoulos, Dionysios A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Antonopoulos, Dionysios A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago; Indiana University System; Indiana University Bloomington; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu	Wilson, Patrick/HGC-3157-2022; Flynn, Theodore/C-1221-2008; Antonopoulos, Dionysios/ABE-6212-2020	Flynn, Theodore/0000-0002-1838-8942; Antonopoulos, Dionysios/0000-0002-2238-5031; Bunker, Jeffrey/0000-0002-9351-7003; Shaw, Dustin/0000-0003-3961-7588	NIH Medical Scientist Training Program [T32GM007281]; FWF Austrian Science Fund [J3418-B19]; NIH [R01AI038339, R01AI108643, R01GM106173, R01HL118092, 1R21AI099825, R01DK067180, R01DK098435]; University of Chicago DDRCC, NIDDK [P30DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339, R01AI108643, F30AI124476, U19AI082724, R21AI099825, P01AI097092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098435, P30DK042086, R01DK067180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106173, T32GM007281] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3418] Funding Source: researchfish	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWF Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago DDRCC, NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the University of Chicago Flow Cytometry Core for assistance with cell sorting, S. Owens and S. Greenwald in the Next Generation Sequencing Core at Argonne National Laboratory for assistance with amplicon sequencing, and B. Casterline for providing B. fragilis cultures. J.J.B and B.D.M. were supported by an NIH Medical Scientist Training Program grant T32GM007281 and M.M. by FWF Austrian Science Fund grant J3418-B19. This work was supported by NIH grants R01AI038339, R01AI108643, R01GM106173, and R01HL118092 to A.B., NIH grant 1R21AI099825 to A.L.D., NIH grants to R01DK067180 and R01DK098435 to B.J., and support to D.A.A. from the University of Chicago DDRCC, NIDDK P30DK42086.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kroese F G, 1996, Semin Immunol, V8, P11, DOI 10.1006/smim.1996.0003; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mathew R, 2014, J EXP MED, V211, P1137, DOI 10.1084/jem.20132267; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Slack E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00100; Stephens WZ, 2014, CELL HOST MICROBE, V16, P265, DOI 10.1016/j.chom.2014.08.012; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Thurnheer MC, 2003, J IMMUNOL, V170, P4564, DOI 10.4049/jimmunol.170.9.4564; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuruta T, 2010, BIOSCI BIOTECH BIOCH, V74, P968, DOI 10.1271/bbb.90801; Tsuruta T, 2009, FEMS IMMUNOL MED MIC, V56, P185, DOI 10.1111/j.1574-695X.2009.00568.x; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348	35	312	323	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					541	553		10.1016/j.immuni.2015.08.007	http://dx.doi.org/10.1016/j.immuni.2015.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26320660	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000370965900006
J	Su, LF; Kidd, BA; Han, A; Kotzin, JJ; Davis, MM				Su, Laura F.; Kidd, Brian A.; Han, Arnold; Kotzin, Jonathan J.; Davis, Mark M.			Virus-Specific CD4(+) Memory-Phenotype T Cells Are Abundant in Unexposed Adults	IMMUNITY			English	Article							MHC CLASS-II; ROUTINE VACCINATIONS; GENE-EXPRESSION; MEASLES-VACCINE; MALE MORTALITY; GUINEA-BISSAU; PEPTIDE; REPERTOIRE; DIVERSITY; COMPLEX	Although T cell memory is generally thought to require direct antigen exposure, we found an abundance of memory-phenotype cells (20%-90%, averaging over 50%) of CD4(+) T cells specific to viral antigens in adults who had never been infected. These cells express the appropriate memory markers and genes, rapidly produce cytokines, and have clonally expanded. In contrast, the same T cell receptor (TCR) specificities in newborns are almost entirely naive, which might explain the vulnerability of young children to infections. One mechanism for this phenomenon is TCR cross-reactivity to environmental antigens, and in support of this, we found extensive cross-recognition by HIV-1 and influenza-reactive T lymphocytes to other microbial peptides and expansion of one of these after influenza vaccination. Thus, the presence of these memory-phenotype T cells has significant implications for immunity to novel pathogens, child and adult health, and the influence of pathogen-rich versus hygienic environments.	[Su, Laura F.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94304 USA; [Kidd, Brian A.; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94304 USA; [Han, Arnold] Stanford Univ, Sch Med, Div Gastroenterol, Stanford, CA 94304 USA; [Kotzin, Jonathan J.] Stanford Univ, Sch Med, Dept Biol Sci, Stanford, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94304 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X; Kidd, Brian/0000-0003-2110-1145	Daland fellowship from the American Philosophical Foundation; ACR REF Rheumatology Scientist Development Award; K08 award from National Institutes of Health (NIH) [K08 AR059760]; NIH training grant [5 T32 DK007056-36]; NIH [U19 AI057229, U19AI090019]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090019, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007056] Funding Source: NIH RePORTER	Daland fellowship from the American Philosophical Foundation; ACR REF Rheumatology Scientist Development Award; K08 award from National Institutes of Health (NIH); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Kai Wucherpfennig for providing the HLA-DR4 stable transfectant cell line for the production of HLA-DR monomers. Thanks also go to Yuehhsiu Chien, John Imboden, Jonathan Graf, Elizabeth Mellins, Peter Ebert, Marc Jenkins, and Wong Yu for helpful discussions. We thank Bithi Chatterjee for helpful advice on deriving dendritic cells, Andrew Prentice for helpful suggestions, and Cristina Tato for manuscript edits. L. F. S was supported by a Daland fellowship from the American Philosophical Foundation and an ACR REF Rheumatology Scientist Development Award and is currently supported by a K08 award from National Institutes of Health (NIH) grant K08 AR059760. A. H. is supported by NIH training grant 5 T32 DK007056-36. Other research support came from grants from the NIH (U19 AI057229 and U19AI090019) and the Howard Hughes Medical Institute to M. M. D. L. F. S. and M. M. D. were responsible for design of the research. L. F. S performed experiments and analyzed data. A. H. designed the TCR sequencing primers and protocol. B. A. K. provided statistical expertise and analyzed gene expression data. J.J.K. assisted with HA epitope identification and performed the HAI assays. L. F. S wrote the paper. M. M. D, A. H., B. A. K, and J.J.K edited the manuscript.	Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Alexander J, 2010, VACCINE, V28, P664, DOI 10.1016/j.vaccine.2009.10.103; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Auger I, 2005, ARTHRITIS RHEUM-US, V52, P3424, DOI 10.1002/ART.21391; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Bronke C, 2005, HUM IMMUNOL, V66, P950, DOI 10.1016/j.humimm.2005.06.011; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Chu HH, 2010, J IMMUNOL, V185, P4705, DOI 10.4049/jimmunol.1002276; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Decman V, 2012, J IMMUNOL, V188, P1933, DOI 10.4049/jimmunol.1101098; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Levy PY, 2009, CLIN INFECT DIS, V49, P1244, DOI 10.1086/605672; Mascher B, 1999, J IMMUNOL METHODS, V223, P115, DOI 10.1016/S0022-1759(98)00200-2; Min B, 2004, P NATL ACAD SCI USA, V101, P3874, DOI 10.1073/pnas.0400606101; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Nielen MMJ, 2005, ANN RHEUM DIS, V64, P1199, DOI 10.1136/ard.2004.029389; Norris PJ, 2004, AIDS RES HUM RETROV, V20, P315, DOI 10.1089/088922204322996554; Novak EJ, 2001, J IMMUNOL, V166, P6665, DOI 10.4049/jimmunol.166.11.6665; Phan GQ, 2003, J IMMUNOTHER, V26, P349, DOI 10.1097/00002371-200307000-00007; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108; SETTE A, 1993, J IMMUNOL, V151, P3163; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; Southwood S, 1998, J IMMUNOL, V160, P3363; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Veirum JE, 2005, VACCINE, V23, P1197, DOI 10.1016/j.vaccine.2004.02.053; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Yuan Jianda, 2009, Cancer Immun, V9, P5; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	51	312	314	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					373	383		10.1016/j.immuni.2012.10.021	http://dx.doi.org/10.1016/j.immuni.2012.10.021			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23395677	Green Accepted, Bronze			2022-12-18	WOS:000330940800018
J	Muranski, P; Borman, ZA; Kerkar, SP; Klebanoff, CA; Ji, Y; Sanchez-Perez, L; Sukumar, M; Reger, RN; Yu, ZY; Kern, SJ; Roychoudhuri, R; Ferreyra, GA; Shen, W; Durum, SK; Feigenbaum, L; Palmer, DC; Antony, PA; Chan, CC; Laurence, A; Danner, RL; Gattinoni, L; Restifo, NP				Muranski, Pawel; Borman, Zachary A.; Kerkar, Sid P.; Klebanoff, Christopher A.; Ji, Yun; Sanchez-Perez, Luis; Sukumar, Madhusudhanan; Reger, Robert N.; Yu, Zhiya; Kern, Steven J.; Roychoudhuri, Rahul; Ferreyra, Gabriela A.; Shen, Wei; Durum, Scott K.; Feigenbaum, Lionel; Palmer, Douglas C.; Antony, Paul A.; Chan, Chi-Chao; Laurence, Arian; Danner, Robert L.; Gattinoni, Luca; Restifo, Nicholas P.			Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature	IMMUNITY			English	Article							CD8(+) T-CELLS; ADOPTIVE IMMUNOTHERAPY; TRANSCRIPTION FACTOR; EFFECTOR FUNCTION; TUMOR-REGRESSION; T(H)17 CELLS; IN-VITRO; MEMORY; DIFFERENTIATION; EXPRESSION	Th17 cells have been described as short lived, but this view is at odds with their capacity to trigger protracted damage to normal and transformed tissues. We report that Th17 cells, despite displaying low expression of CD27 and other phenotypic markers of terminal differentiation, efficiently eradicated tumors and caused autoimmunity, were long lived, and maintained a core molecular signature resembling early memory CD8(+) cells with stem cell-like properties. In addition, we found that Th17 cells had high expression of Tcf7, a direct target of the Wnt and beta-catenin signaling axis, and accumulated beta-catenin, a feature observed in stem cells. In vivo, Th17 cells gave rise to Th1-like effector cell progeny and also self-renewed and persisted as IL-17A-secreting cells. Multipotency was required for Th17 cell-mediated tumor eradication because effector cells deficient in IFN-gamma or IL-17A had impaired activity. Thus, Th17 cells are not always short lived and are a less-differentiated subset capable of superior persistence and functionality.	[Muranski, Pawel; Borman, Zachary A.; Kerkar, Sid P.; Klebanoff, Christopher A.; Ji, Yun; Sanchez-Perez, Luis; Sukumar, Madhusudhanan; Reger, Robert N.; Yu, Zhiya; Roychoudhuri, Rahul; Palmer, Douglas C.; Gattinoni, Luca; Restifo, Nicholas P.] NCI, Bethesda, MD 20892 USA; [Kern, Steven J.; Ferreyra, Gabriela A.; Danner, Robert L.] NIH, Ctr Clin, Dept Crit Care Med, Funct Genom & Prote Facil, Bethesda, MD 20892 USA; [Shen, Wei; Durum, Scott K.] NCI, Mol Immunoregulat Lab, Frederick, MD 21702 USA; [Feigenbaum, Lionel] Sci Applicat Int Corp SAIC, NCI, Frederick, MD 21702 USA; [Antony, Paul A.] Univ Maryland, Sch Med, Dept Pathol, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Antony, Paul A.] Univ Maryland, Sch Med, Tumor Immunol & lmmunotherapy Program, Baltimore, MD 21201 USA; [Chan, Chi-Chao] NEI, NIH, Bethesda, MD 20892 USA; [Laurence, Arian] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Restifo, NP (corresponding author), NCI, CRC10 Room 3W5816, Bethesda, MD 20892 USA.	restifon@mail.nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas P/A-5713-2008; Restifo, Nicholas Phillip/Z-1614-2019; Gattinoni, Luca/A-2281-2008; Waldmann, Thomas/AAT-5972-2021; Laurence, Arian/A-8770-2009; Palmer, Douglas/B-9454-2008; Ji, Yun/B-7245-2009; Roychoudhuri, Rahul/A-7442-2010	Gattinoni, Luca/0000-0003-2239-3282; Waldmann, Thomas/0000-0003-4500-6660; Laurence, Arian/0000-0003-0942-8292; Palmer, Douglas/0000-0001-5018-5734; Ji, Yun/0000-0001-6340-7009; Roychoudhuri, Rahul/0000-0002-5392-1853; durum, scott/0000-0003-1307-9582; Restifo, Nicholas P./0000-0003-4229-4580; Klebanoff, Christopher/0000-0001-9645-3896	NATIONAL CANCER INSTITUTE [ZIABC011150] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000222] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL001164] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999, ZIA BC010763-05, ZIA BC011037-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ballesteros-Tato A, 2011, IMMUNITY, V35, P496, DOI 10.1016/j.immuni.2011.10.001; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kerkar SP, 2011, J IMMUNOTHER, V34, P343, DOI 10.1097/CJI.0b013e3182187600; Kim JW, 2006, GENE DEV, V20, P2833, DOI 10.1101/gad.1462706; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; McKinstry KK, 2010, IMMUNOL REV, V236, P110, DOI 10.1111/j.1600-065X.2010.00921.x; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2006, NAT CLIN PRACT ONCOL, V3, P668, DOI 10.1038/ncponc0666; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Palmer DC, 2008, P NATL ACAD SCI USA, V105, P8061, DOI 10.1073/pnas.0710929105; Palmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Railo A, 2009, EXP CELL RES, V315, P2690, DOI 10.1016/j.yexcr.2009.06.021; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Shen XL, 2007, J IMMUNOTHER, V30, P123, DOI 10.1097/01.cji.0000211321.07654.b8; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 2006, J CELL PHYSIOL, V206, P103, DOI 10.1002/jcp.20433; Surh CD, 2010, NAT IMMUNOL, V11, P47, DOI 10.1038/ni0110-47; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Waddington C.H., 2014, STRATEGY GENES; Wahren-Herlenius M, 2011, SEMIN IMMUNOL, V23, P65, DOI 10.1016/j.smim.2011.02.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	82	312	322	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					972	985		10.1016/j.immuni.2011.09.019	http://dx.doi.org/10.1016/j.immuni.2011.09.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22177921	Bronze, Green Accepted			2022-12-18	WOS:000298777300015
J	Hu, XY; Paik, PK; Chen, J; Yarilina, A; Kockeritz, L; Lu, TT; Woodgett, JR; Ivashkiv, LB				Hu, Xiaoyu; Paik, Paul K.; Chen, Janice; Yarilina, Anna; Kockeritz, Lisa; Lu, Theresa T.; Woodgett, James R.; Ivashkiv, Lionel B.			IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins	IMMUNITY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; DNA-BINDING ACTIVITY; RESPONSES IN-VIVO; GENE-EXPRESSION; DENDRITIC CELLS; INTACT-CELLS; C-FOS; MACROPHAGE ACTIVATION	The control of IL-10 production and mechanisms that mediate synergy between IFN-gamma and TLR ligands are not well understood. We report that IFN-gamma augments induction of TNF alpha by TLR ligands, immune complexes, and zymosan by suppressing IL-10 production and thereby interrupting Stat3-mediated feedback inhibition. IFN-gamma altered TLR2-induced signal transduction by increasing GSK3 activity and suppressing MAPK activation, leading to diminished IL-10 production. Inhibition of GSK3 or ablation of the GSK3 beta gene ameliorated TLR2-induced peritonitis and arthritis. IFN-gamma suppressed the activity of CREB and AP-1, transcription factors that induce IL-10 expression and are regulated in part by MAPKs and GSK3. These results yield insight into mechanisms by which IFN-gamma regulates IL-10 production and TLR2-mediated inflammatory responses and identify inhibition of CREB and AP-1 as part of the macrophage response to IFN-gamma. GSK3 and CREB/AP-1 are key players in integrating IFN-gamma and TLR2 responses in innate immunity and inflammation.	Cornell Univ, Weill Grad Sch Med Sci, Arthritis & Tissue Degenerat Program, Hosp Special Surg, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Cornell University; Cornell University; Cornell University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Ivashkiv, LB (corresponding author), Cornell Univ, Weill Grad Sch Med Sci, Arthritis & Tissue Degenerat Program, Hosp Special Surg, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998; Woodgett, James/0000-0003-3731-5797; Yarilina, Anna/0000-0002-7925-856X	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012538] Funding Source: NIH RePORTER; NCRR NIH HHS [C06-RR12538-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.iy.02.040184.001435; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DEGROOT RP, 1993, ONCOGENE, V8, P841; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Foey AD, 1998, J IMMUNOL, V160, P920; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu XY, 2005, J IMMUNOL, V175, P131, DOI 10.4049/jimmunol.175.1.131; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NAGARAJAN S, 1995, J BIOL CHEM, V270, P25762, DOI 10.1074/jbc.270.43.25762; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Smith DG, 2001, BIOORG MED CHEM LETT, V11, P635, DOI 10.1016/S0960-894X(00)00721-6; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; TERATO K, 1992, J IMMUNOL, V148, P2103; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	64	312	320	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					563	574		10.1016/j.immuni.2006.02.014	http://dx.doi.org/10.1016/j.immuni.2006.02.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713974	Bronze			2022-12-18	WOS:000237970100013
J	Cheuk, S; Schlums, H; Serezal, IG; Martini, E; Chiang, SC; Marquardt, N; Gibbs, A; Detlofsson, E; Introini, A; Forkel, M; Hoog, C; Tjernlund, A; Michaelsson, J; Folkersen, L; Mjosberg, J; Blomqvist, L; Ehrstrom, M; Stahle, M; Bryceson, YT; Eidsmo, L				Cheuk, Stanley; Schlums, Heinrich; Serezal, Irene Gallais; Martini, Elisa; Chiang, Samuel C.; Marquardt, Nicole; Gibbs, Anna; Detlofsson, Ebba; Introini, Andrea; Forkel, Marianne; Hoog, Charlotte; Tjernlund, Annelie; Michaelsson, Jakob; Folkersen, Lasse; Mjosberg, Jenny; Blomqvist, Lennart; Ehrstrom, Marcus; Stahle, Mona; Bryceson, Yenan T.; Eidsmo, Liv			CD49a Expression Defines Tissue-Resident CD8(+) T Cells Poised for Cytotoxic Function in Human Skin	IMMUNITY			English	Article							MEMORY; IMMUNITY; INFECTION; VITILIGO; MAINTENANCE; PROTECTION; PATHWAY; TRIGGER; GAMMA; RNA	Tissue-resident memory T (Trm) cells form a heterogeneous population that provides localized protection against pathogens. Here, we identify CD49a as a marker that differentiates CD8(+) Trm cells on a compartmental and functional basis. In human skin epithelia, CD8(+)CD49a(+) Trm cells produced interferon-g, whereas CD8(+)CD49a(-) Trm cells produced interleukin-17 (IL-17). In addition, CD8(+)CD49a(+) Trm cells from healthy skin rapidly induced the expression of the effector molecules perforin and granzyme B when stimulated with IL-15, thereby promoting a strong cytotoxic response. In skin from patients with vitiligo, where melanocytes are eradicated locally, CD8(+)CD49a(+) Trm cells that constitutively expressed perforin and granzyme B accumulated both in the epidermis and dermis. Conversely, CD8(+)CD49a(-) Trm cells from psoriasis lesions predominantly generated IL-17 responses that promote local inflammation in this skin disease. Overall, CD49a expression delineates CD8(+) Trm cell specialization in human epithelial barriers and correlates with the effector cell balance found in distinct inflammatory skin diseases.	[Cheuk, Stanley; Serezal, Irene Gallais; Martini, Elisa; Gibbs, Anna; Detlofsson, Ebba; Introini, Andrea; Tjernlund, Annelie; Stahle, Mona; Eidsmo, Liv] Karolinska Inst, Dept Med Solna, S-17177 Stockholm, Sweden; [Schlums, Heinrich; Chiang, Samuel C.; Bryceson, Yenan T.] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med Huddinge, S-17177 Stockholm, Sweden; [Serezal, Irene Gallais; Marquardt, Nicole; Forkel, Marianne; Michaelsson, Jakob; Mjosberg, Jenny; Stahle, Mona; Eidsmo, Liv] Karolinska Univ Hosp, Dept Dermatol, S-14186 Stockholm, Sweden; [Hoog, Charlotte] Karolinska Inst, Unit Inflammat Gastroenterol & Rheumatol, Dept Med, Huddinge, S-17177 Stockholm, Sweden; [Folkersen, Lasse] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, Bldg 208, DK-2800 Lyngby, Denmark; [Blomqvist, Lennart] Karolinska Inst, Dept Med, Unit Endocrinol & Diabet, Huddinge, S-17177 Stockholm, Sweden; [Ehrstrom, Marcus] Karolinska Univ, Hosp Solna, Dept Reconstruct Plast Surg, S-17176 Stockholm, Sweden; [Bryceson, Yenan T.] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, N-5021 Bergen, Norway	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Technical University of Denmark; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Bergen	Eidsmo, L (corresponding author), Karolinska Inst, Dept Med Solna, S-17177 Stockholm, Sweden.; Bryceson, YT (corresponding author), Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med Huddinge, S-17177 Stockholm, Sweden.; Eidsmo, L (corresponding author), Karolinska Univ Hosp, Dept Dermatol, S-14186 Stockholm, Sweden.; Bryceson, YT (corresponding author), Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, N-5021 Bergen, Norway.	yenan.bryceson@ki.se; liv.eidsmo@ki.se	/K-2942-2013; Chiang, Samuel CC/O-5960-2019; CHeuk, Stanley Sing Hoi/S-5871-2018; Cheuk, Stanley/P-1235-2019; Bryceson, Yenan T/D-2121-2018; Introini, Andrea/ABC-9951-2020	/0000-0003-3186-4752; Chiang, Samuel CC/0000-0001-6597-6117; CHeuk, Stanley Sing Hoi/0000-0002-2759-3884; Cheuk, Stanley/0000-0002-2759-3884; Bryceson, Yenan T/0000-0002-7783-9934; Introini, Andrea/0000-0002-9929-8964; Schlums, Heinrich/0000-0002-2895-7766; Eidsmo, Liv/0000-0001-9237-8374; Mjosberg, Jenny/0000-0002-1119-0976; Gallais Serezal, Irene/0000-0002-7301-9699; Folkersen, Lasse/0000-0003-0708-9530	Novartis; Swedish Research Council; Ragnar Soderberg Stiftelse; Svenska Lakaresallskapet; Stockholm County Council; Psoriasisfonden; Hudfonden; European Research Council under the European Union [311335]; Swedish Cancer Foundation; Swedish Foundation for Strategic Research; Stockholm City Council; Karolinska Institutet Center for Innovative Medicine; Wallenberg Foundation	Novartis(Novartis); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Stiftelse; Svenska Lakaresallskapet; Stockholm County Council(Stockholm County Council); Psoriasisfonden; Hudfonden; European Research Council under the European Union(European Research Council (ERC)); Swedish Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Stockholm City Council; Karolinska Institutet Center for Innovative Medicine; Wallenberg Foundation(European Commission)	We would like to thank Emma Wadman and Kerstin Bergh for excellent help in recruitment of patients and technical assistance and Frank Carbone for scientific advice and for critically reading the manuscript. This work was supported in part by funds from Novartis. We acknowledge funding from the Swedish Research Council (Y.T.B. and L.E.), Ragnar Soderberg Stiftelse, Svenska Lakaresallskapet, Stockholm County Council (ALF and Clinical Research Appointment), Psoriasisfonden, Hudfonden (L.E.), European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 311335 (Y.T.B.), Swedish Cancer Foundation (Y.T.B.), Swedish Foundation for Strategic Research (Y.T.B.), and Stockholm City Council and Karolinska Institutet Center for Innovative Medicine (Y.T.B.), and Wallenberg Foundation (KAW for Y.T.B. and MMW for L.E.).	Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cheuk S, 2014, J IMMUNOL, V192, P3111, DOI 10.4049/jimmunol.1302313; Chiang SCC, 2013, BLOOD, V121, P1345, DOI 10.1182/blood-2012-07-442558; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Craiglow BG, 2015, JAMA DERMATOL, V151, P1110, DOI 10.1001/jamadermatol.2015.1520; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Ezzedine K, 2015, LANCET, V386, P74, DOI 10.1016/S0140-6736(14)60763-7; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Harden Jamie L, 2015, F1000Res, V4, P460, DOI 10.12688/f1000research.6756.1; Harris JE, 2012, J INVEST DERMATOL, V132, P1869, DOI 10.1038/jid.2011.463; Hondowicz BD, 2016, IMMUNITY, V44, P155, DOI 10.1016/j.immuni.2015.11.004; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Loser K, 2004, EUR J IMMUNOL, V34, P2022, DOI 10.1002/eji.200324785; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2898, DOI 10.1038/jid.2014.261; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	50	311	324	6	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					287	300		10.1016/j.immuni.2017.01.009	http://dx.doi.org/10.1016/j.immuni.2017.01.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28214226	Green Published, hybrid			2022-12-18	WOS:000396410900016
J	Liao, HX; Bonsignori, M; Alam, SM; McLellan, JS; Tomaras, GD; Moody, MA; Kozink, DM; Hwang, KK; Chen, X; Tsao, CY; Liu, PH; Lu, XZ; Parks, RJ; Montefiori, DC; Ferrari, G; Pollara, J; Rao, M; Peachman, KK; Santra, S; Letvin, NL; Karasavvas, N; Yang, ZY; Dai, KF; Pancera, M; Gorman, J; Wiehe, K; Nicely, NI; Rerks-Ngarm, S; Nitayaphan, S; Kaewkungwal, J; Pitisuttithum, P; Tartaglia, J; Sinangil, F; Kim, JH; Michael, NL; Kepler, TB; Kwong, PD; Mascola, JR; Nabel, GJ; Pinter, A; Zolla-Pazner, S; Haynes, BF				Liao, Hua-Xin; Bonsignori, Mattia; Alam, S. Munir; McLellan, Jason S.; Tomaras, Georgia D.; Moody, M. Anthony; Kozink, Daniel M.; Hwang, Kwan-Ki; Chen, Xi; Tsao, Chun-Yen; Liu, Pinghuang; Lu, Xiaozhi; Parks, Robert J.; Montefiori, David C.; Ferrari, Guido; Pollara, Justin; Rao, Mangala; Peachman, Kristina K.; Santra, Sampa; Letvin, Norman L.; Karasavvas, Nicos; Yang, Zhi-Yong; Dai, Kaifan; Pancera, Marie; Gorman, Jason; Wiehe, Kevin; Nicely, Nathan I.; Rerks-Ngarm, Supachai; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Pitisuttithum, Punnee; Tartaglia, James; Sinangil, Faruk; Kim, Jerome H.; Michael, Nelson L.; Kepler, Thomas B.; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.; Pinter, Abraham; Zolla-Pazner, Susan; Haynes, Barton F.			Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2	IMMUNITY			English	Article							NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; V1/V2 DOMAIN; EFFICACY; REACTIVITY; EPITOPES; BINDING; GP41; SOFTWARE; LINEAGE	The RV144 HIV-1 trial of the canary pox vector (ALVAC-HIV) plus the gp120 AIDSVAX B/E vaccine demonstrated an estimated efficacy of 31%, which correlated directly with antibodies to HIV-1 envelope variable regions 1 and 2 (V1-V2). Genetic analysis of trial viruses revealed increased vaccine efficacy against viruses matching the vaccine strain at V2 residue 169. Here, we isolated four V2 monoclonal antibodies from RV144 vaccinees that recognize residue 169, neutralize laboratory-adapted HIV-1, and mediate killing of field-isolate HIV-1-infected CD4(+) T cells. Crystal structures of two of the V2 antibodies demonstrated that residue 169 can exist within divergent helical and loop conformations, which contrasted dramatically with the 13 strand conformation previously observed with a broadly neutralizing antibody PG9. Thus, RV144 vaccine-induced immune pressure appears to target a region that may be both sequence variable and structurally polymorphic. Variation may signal sites of HIV-1 envelope vulnerability, providing vaccine designers with new options.	[Liao, Hua-Xin; Bonsignori, Mattia; Alam, S. Munir; Tomaras, Georgia D.; Moody, M. Anthony; Kozink, Daniel M.; Hwang, Kwan-Ki; Chen, Xi; Tsao, Chun-Yen; Liu, Pinghuang; Lu, Xiaozhi; Parks, Robert J.; Montefiori, David C.; Ferrari, Guido; Pollara, Justin; Wiehe, Kevin; Nicely, Nathan I.; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA; [McLellan, Jason S.; Yang, Zhi-Yong; Dai, Kaifan; Pancera, Marie; Gorman, Jason; Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Rao, Mangala; Peachman, Kristina K.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Santra, Sampa; Letvin, Norman L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Karasavvas, Nicos; Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, US Army Med Component, Dept Retrovirol, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi 11000, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat BIOPHI, Bangkok 10400, Thailand; [Tartaglia, James] Sanofi Pasteur, Swiftwater, PA 18370 USA; [Sinangil, Faruk] Global Solut Infect Dis, San Francisco, CA 94080 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Pinter, Abraham] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA; [Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA; [Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Duke University; National Institutes of Health (NIH) - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Mahidol University; Sanofi-Aventis; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University	Liao, HX (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA.	hliao@duke.edu; hayne002@mc.duke.edu	, PEP-MX Core/AGV-4051-2022; Mascola, John/AAI-7193-2021; Ferrari, Guido/A-6088-2015; Zolla-Pazner, Susan/S-1864-2019; Bonsignori, Mattia/AAE-7678-2019; Ferrari, Guido/Z-2137-2019; Gorman, Jason/AGG-9417-2022; Alam, S. Munir/AAC-6711-2019; Tomaras, Georgia/J-5041-2016; Moody, M/AAB-6947-2020	Ferrari, Guido/0000-0001-7747-3349; Zolla-Pazner, Susan/0000-0002-0750-2666; Bonsignori, Mattia/0000-0003-2973-2101; Moody, M/0000-0002-3890-5855; Kepler, Thomas/0000-0002-1383-6865; Kaewkungwal, Jaranit/0000-0001-7916-8460; McLellan, Jason/0000-0003-3991-542X; Gorman, Jason/0000-0002-3775-6560	Bill & Melinda Gates Foundation; NIH/NIAID [AI067854, AI100645]; Department of Veterans Affairs [Y1-AI-2642-12]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; NIH; NIH grants [S10RR019145, UC6 AI058607, AI64518, P30 AI051445]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392, U19AI067854, U01AI067854, UC6AI058607, ZIAAI005023, UM1AI100645, R01AI046283, P30AI051445] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Collaboration for AIDS Vaccine Discovery grants from Bill & Melinda Gates Foundation, by grants from NIH/NIAID (AI067854, the Center for HIV/AIDS Vaccine Immunology, and AI100645, the Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery), by research funds from the Department of Veterans Affairs, by an Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Material Command (USAMRMC), by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DOD), and by intramural NIH support for the NIAID Vaccine Research Center. The authors thank A. Foulger, H. Chen, M. Cooper, S. Crawford, J. Holland, R. De, R. Scearce, L. Jeffries, Jr., A. Hogan, J. Pritchett, D. Pause, E. Solomon, L Sutherland, J. Blinn, and K. Lloyd for expert technical assistance in antibody and HIV-1 Env protein production; D. Marshall and J. Whitesides for expert technical assistance in flow cytometry; and K. Soderberg, J. Kircherr, and C. Andrews for project management. Flow cytometry supported by NIH grants S10RR019145, UC6 AI058607, AI64518, and P30 AI051445. The opinions herein are those of the authors and should not be construed as official or representing the views of the U.S. Department of Health and Human Services, National Institute for Allergy and Infectious Diseases, the Department of Defense, the Department of the Army, or the Department of Veteran Affairs. Materials from the RV144 clinical trial were provided by the Ministry of Public Health, Thailand, the Thai AIDS Vaccine Evaluation Group, and the USMHRP through the Henry M. Jackson Foundation for the Advancement of Military Medicine. H.-X.L., M.B., S.M.A., J.H.K., N.L.M., T.B.K., S.Z.-P., and B.F.H. have filed partent applications on the RV144 V2 mAbs and related antigens used in this study.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Alam SM, 2012, J VIROL; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Burrer R, 2005, VIROLOGY, V333, P102, DOI 10.1016/j.virol.2004.12.034; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/B978-0-12-381270-4.00019-6, 10.1016/S0076-6879(11)87019-9]; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Liu PH, 2011, J VIROL, V85, P11196, DOI 10.1128/JVI.05601-11; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori D.C., 2005, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1211S64; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	45	311	317	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					176	186		10.1016/j.immuni.2012.11.011	http://dx.doi.org/10.1016/j.immuni.2012.11.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23313589	Green Accepted, Bronze			2022-12-18	WOS:000314195500019
J	Tsuchida, T; Zou, JA; Saitoh, T; Kumar, H; Abe, T; Matsuura, Y; Kawai, T; Akira, S				Tsuchida, Tetsuo; Zou, Jian; Saitoh, Tatsuya; Kumar, Himanshu; Abe, Takayuki; Matsuura, Yoshiharu; Kawai, Taro; Akira, Shizuo			The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNA	IMMUNITY			English	Article							RIG-I PATHWAY; CYTOSOLIC DNA; ANTIVIRAL RESPONSE; CYTOPLASMIC DNA; FAMILY PROTEINS; RECOGNITION; ACTIVATION; RECEPTORS; INDUCTION; ADAPTER	The innate immune system detects pathogen- and host-derived double-stranded DNA exposed to the cytosol and induces type I interferon (IFN) and other cytokines. Here, we identified interferon-inducible tripartite-motif (TRIM) 56 as a regulator of double-stranded DNA-mediated type I interferon induction. TRIM56 overexpression enhanced IFN-beta promoter activation after double-stranded DNA stimulation whereas TRIM56 knockdown abrogated it. TRIM56 interacted with STING and targeted it for lysine 63-linked ubiquitination. This modification induced STING dimerization, which was a prerequisite for recruitment of the antiviral kinase TBK1 and subsequent induction of IFN-beta. Taken together, these results indicate that TRIM56 is an interferon-inducible E3 ubiquitin ligase that modulates STING to confer double-stranded DNA-mediated innate immune responses.	[Tsuchida, Tetsuo; Zou, Jian; Saitoh, Tatsuya; Kumar, Himanshu; Kawai, Taro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Abe, Takayuki; Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Tsuchida, Tetsuo] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 9909585, Japan; [Saitoh, Tatsuya] Indian Inst Sci Educ & Res, Dept Biol Sci, Immunol Lab, Bhopal 460023, India	Osaka University; Osaka University; Yamagata University; Indian Institute of Science Education & Research (IISER) - Bhopal	Kawai, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tkawai@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Kumar, Himanshu/J-4494-2012; Akira, Shizuo/C-3134-2009	Kumar, Himanshu/0000-0001-5246-2694; Kawai, Taro/0000-0001-7510-4662	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Center of Excellence Program of Japan; National Institutes of Health [AI070167]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Center of Excellence Program of Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Funamoto for technical assistance; O. Takeuchi, Y. Kumagai, and S. Matsuzawa for discussions; and E. Kamada for secretarial assistance. This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Ministry of Health, Labor, and Welfare of Japan, the 21st Century Center of Excellence Program of Japan, and the National Institutes of Health (No. AI070167).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	42	311	336	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					765	776		10.1016/j.immuni.2010.10.013	http://dx.doi.org/10.1016/j.immuni.2010.10.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21074459	Bronze			2022-12-18	WOS:000286082600014
J	de Lafaille, MAC; Kutchukhidze, N; Shen, S; Ding, Y; Yee, H; Lafaille, JJ				de Lafaille, Maria A. Curotto; Kutchukhidze, Nino; Shen, Shiqian; Ding, Yi; Yee, Herman; Lafaille, Juan J.			Adaptive Foxp3(+) regulatory T cell-dependent and -independent control of allergic inflammation	IMMUNITY			English	Article							SPONTANEOUS AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR FOXP3; RECEPTOR TRANSGENIC MICE; MYELIN BASIC-PROTEIN; TGF-BETA; DENDRITIC CELLS; RETINOIC-ACID; IN-VIVO; AIRWAY HYPERRESPONSIVENESS; INDUCTION	Adaptive Foxp3(+) regulatory T (Treg) cells develop during induction of mucosal tolerance and after immunization. Large numbers of Foxp3(+) T cells have been found in inflamed tissues. We investigated the role of adaptive Foxp3(+) Treg cells in mucosal tolerance and in chronic allergic lung inflammation. We used two strains of mice that are devoid of naturally occurring Treg cells; one is capable of generating adaptive Foxp3+ Treg cells upon exposure to antigen, whereas the other is deficient in both naturally occurring and adaptive Foxp3(+) Treg cells. We found that adaptive Foxp3(+) Treg cells were essential for establishing mucosal tolerance and for suppressing IL-4 production and lymphoid neogenesis in chronic inflammation, whereas IL-5 production and eosinophilia. could be controlled by Foxp3-independent IFN-gamma-dependent mechanisms. Thus, whereas adaptive Foxp3(+) Treg cells regulate sensitization to allergens and the severity of chronic inflammation, IFN-gamma-producing cells can play a beneficial role in inflammatory conditions involving eosinophils.	[de Lafaille, Maria A. Curotto; Kutchukhidze, Nino; Shen, Shiqian; Ding, Yi; Lafaille, Juan J.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Program Mol Pathogenesis, New York, NY 10016 USA; [Ding, Yi] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; [de Lafaille, Maria A. Curotto; Yee, Herman; Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University	de Lafaille, MAC (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Program Mol Pathogenesis, New York, NY 10016 USA.	curotto@saturn.med.nyu.edu; lafaille@saturn.med.nyu.edu		Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777				Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Erazo A, 2007, IMMUNITY, V26, P191, DOI 10.1016/j.immuni.2006.12.006; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Iweala OI, 2006, IMMUNOL REV, V213, P82, DOI 10.1111/j.1600-065X.2006.00431.x; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Levings MK, 2005, BLOOD, V105, P1162, DOI 10.1182/blood-2004-03-1211; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Moyron-Quiroz J, 2007, ADV EXP MED BIOL, V590, P55; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Sasaki M, 2007, J CLIN PATHOL, V60, P1102, DOI 10.1136/jcp.2006.044776; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shen SQ, 2005, J CLIN INVEST, V115, P3517, DOI 10.1172/JCI25463; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wensky A, 2001, J IMMUNOL, V167, P3074, DOI 10.4049/jimmunol.167.6.3074; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	51	311	314	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					114	126		10.1016/j.immuni.2008.05.010	http://dx.doi.org/10.1016/j.immuni.2008.05.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18617425	Bronze			2022-12-18	WOS:000257905400015
J	Burchill, MA; Yang, JY; Vang, KB; Moon, JJ; Chu, HH; Lio, CWJ; Vegoe, AL; Hsieh, CS; Jenkins, MK; Farrar, MA				Burchill, Matthew A.; Yang, Jianying; Vang, Kieng B.; Moon, James J.; Chu, H. Hamlet; Lio, Chan-Wang J.; Vegoe, Amanda L.; Hsieh, Chyi-Song; Jenkins, Marc K.; Farrar, Michael A.			Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire	IMMUNITY			English	Article							FOXP3 EXPRESSION; LETHAL AUTOIMMUNITY; STAT5 ACTIVATION; CUTTING EDGE; IN-VIVO; SELF; TRANSCRIPTION; SELECTION; CD4(+); INTERLEUKIN-2	Appropriate development of regulatory T (Treg) cells is necessary to prevent autoimmunity. Neonatal mice, unlike adults, lack factors required for Treg cell development. It is unclear what these missing factors are. However, signals emanating from the T cell receptor (TCR), the costimulatory receptor CD28, and the family of gamma c-dependent cytokine receptors are required for Treg cell development. Herein we demonstrate that expression of a constitutively active Stat5b transgene (Stat5b-CA) allowed for Treg cell development in neonatal mice and restored Treg cell numbers in Cd28(-/-) mice. Sequence analysis of TCR genes in Stat5b-CA Treg cells indicated that ectopic STAT5 activation resulted in a TCR repertoire that more closely resembled that of naive T cells. Using MHCII tetramers to identify antigen-specific T cells, we showed that STAT5 signals diverted thymocytes normally destined to become naive T cells into the Treg cell lineage. Our data support a two-step model of Treg cell differentiation in which TCR and CD28 signals induce cytokine responsiveness and STAT5-inducing cytokines then complete the program of Treg cell differentiation.	[Burchill, Matthew A.; Yang, Jianying; Vang, Kieng B.; Vegoe, Amanda L.; Farrar, Michael A.] Univ Minnesota, Ctr Canc, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Moon, James J.; Chu, H. Hamlet; Jenkins, Marc K.] Univ Minnesota, Ctr Immunol, Dept Microbiol, Ctr Canc, Minneapolis, MN 55455 USA; [Lio, Chan-Wang J.; Hsieh, Chyi-Song] Washington Univ, Dept Med, St Louis, MO 63110 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL)	Farrar, MA (corresponding author), Univ Minnesota, Ctr Canc, Dept Lab Med & Pathol, 312 Church St SE,6-116 Nils Hasselmo Hall, Minneapolis, MN 55455 USA.	farra005@tc.umn.edu	Jenkins, Marc K/G-1063-2012; Farrar, Michael A/M-7802-2013; Dings, Kieng Vang/AAW-3189-2021; moon, james/F-1031-2014	Jenkins, Marc K/0000-0001-8009-7655; Farrar, Michael/0000-0002-5569-0366; Lio, Jerry/0000-0003-3876-6741; moon, james/0000-0001-8071-1491; Vang Dings, Kieng/0000-0002-2892-1114	NIAID NIH HHS [R01 AI061165-01A1, R01 AI061165-02S1, R01 AI061165, R56 AI061165, F32 AI063793, R01 AI061165-03, R01 AI061165-02, AI061165, R01 AI061165-04] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061165, R56AI061165, F32AI063793] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Bassiri H, 2001, J IMMUNOL, V166, P5945, DOI 10.4049/jimmunol.166.10.5945; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2000, J IMMUNOL, V164, P2905, DOI 10.4049/jimmunol.164.6.2905; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; Nakajima H, 2001, EMBO J, V20, P6836, DOI 10.1093/emboj/20.23.6836; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Will WM, 2006, J IMMUNOL, V176, P3350, DOI 10.4049/jimmunol.176.6.3350; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yang-Snyder J A, 1998, Dev Immunol, V5, P223, DOI 10.1155/1998/12421; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	50	311	322	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2008	28	1					112	121		10.1016/j.immuni.2007.11.022	http://dx.doi.org/10.1016/j.immuni.2007.11.022			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199418	Green Accepted, Bronze			2022-12-18	WOS:000252627300015
J	Amsen, D; Antov, A; Jankovic, D; Sher, A; Radtke, F; Souabni, A; Busslinger, M; McCright, B; Gridley, T; Flavell, RA				Amsen, Derk; Antov, Andrey; Jankovic, Dragana; Sher, Alan; Radtke, Freddy; Souabni, Abdallah; Busslinger, Meinrad; McCright, Brent; Gridley, Thomas; Flavell, Richard A.			Direct regulation of Gata3 expression determines the T helper differentiation potential of notch	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; NF-KAPPA-B; GENE-EXPRESSION; LINEAGE COMMITMENT; IN-VIVO; RBP-J; SCHISTOSOMA-MANSONI; HEMATOPOIETIC-CELLS; TH2 DEVELOPMENT; OX40 LIGAND	CD4(+) T helper cells differentiate into T helper 1 (Th1) or Th2 effector lineages, which orchestrate immunity to different types of microbes. Both Th1 and Th2 differentiation can be induced by Notch, but what dictates which of these programs is activated in response to Notch is not known. By using T cell-specific gene ablation of the Notch effector RBP-J or the Notch1 and 2 receptors, we showed here that Notch was required on CD4+ T cells for physiological Th2 responses to parasite antigens. GATA-3 was necessary for Notch-induced Th2 differentiation, and we identified an upstream Gata3 promoter as a direct target for Notch signaling. Moreover, absence of GATA-3 turned Notch from a Th2 inducer into a powerful inducer of Th1 differentiation. Therefore, GaW is a critical element determining inductive Th2 differentiation and limiting Th1 differentiation by Notch.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Res Inst Mol Pathol, A-1030 Vienna, Austria; Jackson Lab, Bar Harbor, ME 04609 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Swiss Institute Experimental Cancer Research; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Jackson Laboratory; Yale University	Amsen, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.amsen@amc.uva.nl	Radtke, Freddy/Q-3198-2017; Busslinger, Meinrad J./J-1249-2016	Radtke, Freddy/0000-0003-4315-4045; Busslinger, Meinrad J./0000-0002-9111-9351	NINDS NIH HHS [R01 NS036437-12, NS036437, R01 NS036437] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036437] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; de Pooter RF, 2006, J IMMUNOL, V176, P5267, DOI 10.4049/jimmunol.176.9.5267; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Katada T, 2006, MECH DEVELOP, V123, P851, DOI 10.1016/j.mod.2006.08.001; Kato H, 1997, DEVELOPMENT, V124, P4133; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; OKA C, 1995, DEVELOPMENT, V121, P3291; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; So T, 2006, P NATL ACAD SCI USA, V103, P3740, DOI 10.1073/pnas.0600205103; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	69	311	330	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					89	99		10.1016/j.immuni.2007.05.021	http://dx.doi.org/10.1016/j.immuni.2007.05.021			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658279	Bronze, Green Accepted			2022-12-18	WOS:000248398100011
J	Ouaaz, F; Arron, J; Zheng, Y; Choi, YW; Beg, AA				Ouaaz, F; Arron, J; Zheng, Y; Choi, YW; Beg, AA			Dendritic cell development and survival require distinct NF-kappa B subunits	IMMUNITY			English	Article							MOUSE BONE-MARROW; TNF FAMILY MEMBER; IMMUNE-RESPONSES; TARGETED DISRUPTION; T-CELLS; HEMATOPOIETIC ABNORMALITIES; SPLENIC MICROARCHITECTURE; INDUCED APOPTOSIS; MICE LACKING; IN-VIVO	Despite the established role of dendritic cells (DCs) in regulating T lymphocyte activation, intracellular mechanisms responsible for controlling DC function are largely undefined. Here, we have studied DCs from mice deficient in the p50, RelA, and cRel subunits of the immunomodulatory NF-kappaB transcription factor. Although DO development and function was normal in mice lacking individual NF-kappaB subunits, development of doubly deficient p50(-/-)RelA(-/-) DCs was significantly impaired. In contrast, DCs from p50(-/-)cRel(-/-) mice developed normally, but CD40L- and TRANCE-induced survival and IL-12 production was abolished. Surprisingly, no significant impairment in MHC and costimulatory molecule expression was seen, despite significantly reduced kappaB site binding activity. These results therefore indicate essential, subunit-specific functions for NF-kappaB proteins in regulating DO development, survival, and cytokine production.	Columbia Univ, Fairchild Ctr 1110, Dept Biol Sci, New York, NY 10027 USA; Univ Penn, Sch Med, Abramson Family Canc Ctr Inst, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania	Beg, AA (corresponding author), Columbia Univ, Fairchild Ctr 1110, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.		Ouaaz, Fatah/M-4242-2017; Zheng, Ye/G-4866-2015	Zheng, Ye/0000-0001-5012-4309	NATIONAL CANCER INSTITUTE [R01CA074892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044264] Funding Source: NIH RePORTER; NCI NIH HHS [CA074892] Funding Source: Medline; NIAID NIH HHS [AI44264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GRANELLIPIPERNO A, 1995, P NATL ACAD SCI USA, V92, P10944, DOI 10.1073/pnas.92.24.10944; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Pirtskhalaishvili G, 2000, J IMMUNOL, V165, P1956, DOI 10.4049/jimmunol.165.4.1956; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Sousa CRE, 2001, IMMUNITY, V14, P495; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Verhasselt V, 1999, J IMMUNOL, V162, P2569; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 2001, Int Rev Immunol, V20, P117, DOI 10.3109/08830180109056726; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yoshimoto T, 1997, EUR J IMMUNOL, V27, P3461, DOI 10.1002/eji.1830271247; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	49	311	336	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					257	270		10.1016/S1074-7613(02)00272-8	http://dx.doi.org/10.1016/S1074-7613(02)00272-8			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869686	Bronze			2022-12-18	WOS:000174039600009
J	Chang, CH; Guerder, S; Hong, SC; vanEwijk, W; Flavell, RA				Chang, CH; Guerder, S; Hong, SC; vanEwijk, W; Flavell, RA			Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; BARE LYMPHOCYTE SYNDROME; INTERFERON-GAMMA; GENE-EXPRESSION; TRANSGENIC MICE; WILD-TYPE; CELLS; PROMOTER; INVIVO; MOUSE	CIITA activates the expression of multiple genes involved in antigen presentation and it is believed to be required for both constitutive and IFN gamma-inducible expression of these genes. To understand the role of CIITA in vivo, we have used gene targeting to generate mice that lack CIITA. CIITA-deficient (-/-) mice do not express conventional MHC class II molecules on the surface of splenic B cells and dendritic cells. In addition, macrophages resident in the peritoneal cavity do not express MHC class II molecules upon IFN gamma stimulation nor do somatic tissues of mice injected with IFN gamma, in contrast with wild-type mice. The levels of ii and H-2M gene transcripts are substantially decreased but not absent in CIITA (-/-) mice. The transcription of nonconventional MHC class II genes is, however, not affected by CIITA deficiency. A subset of thymic epithelial cells express MHC class II molecules. Nonetheless, very few mature CD4 T cells are present in the periphery of CIITA (-/-) mice despite MHC class II expression in the thymus. Consequently, CIITA (-/-) mice are impaired in T-dependent antigen responses and MHC class II-mediated allogeneic reponses.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; ERASMUS UNIV ROTTERDAM,DEPT IMMUNOL,3000 DR ROTTERDAM,NETHERLANDS	Howard Hughes Medical Institute; Yale University; Erasmus University Rotterdam	Chang, CH (corresponding author), YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.		Guerder, sylvie/L-6548-2014		PHS HHS [P01A136529-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BASTA PV, 1988, P NATL ACAD SCI USA, V85, P8618, DOI 10.1073/pnas.85.22.8618; BOSS JM, 1986, P NATL ACAD SCI USA, V83, P9139, DOI 10.1073/pnas.83.23.9139; BURKLY LC, 1990, IMMUNOL RES, V9, P34, DOI 10.1007/BF02918477; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHIN KC, 1992, IMMUNITY, V2, P533; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COGSWELL JP, 1991, J IMMUNOL, V146, P1361; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DENNING SM, 1988, P NATL ACAD SCI USA, V85, P3125, DOI 10.1073/pnas.85.9.3125; ELLIOTT EA, 1994, INVARIANT CHAIN REQU, V179, P681; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Griscelli C, 1989, Immunodefic Rev, V1, P135; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KARLSSON L, 1992, J EXP MED, V176, P477, DOI 10.1084/jem.176.2.477; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295; Lambert M, 1992, Dev Immunol, V2, P227, DOI 10.1155/1992/29814; LAMBERT M, 1991, RES IMMUNOL, V142, P789, DOI 10.1016/0923-2494(91)90124-2; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; MOMBURG F, 1986, J IMMUNOL, V136, P940; MOMBURG F, 1986, EUR J IMMUNOL, V16, P551, DOI 10.1002/eji.1830160516; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; ROUSE RV, 1979, J IMMUNOL, V122, P2508; Sambrook J., 1989, MOL CLONING LAB MANU; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; SLOAN JH, 1988, P NATL ACAD SCI USA, V85, P8186, DOI 10.1073/pnas.85.21.8186; SLOAN JH, 1992, J IMMUNOL, V148, P2591; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; TSANG SY, 1988, P NATL ACAD SCI USA, V85, P8598, DOI 10.1073/pnas.85.22.8598; VANEWIJK W, 1988, CELL, V53, P357, DOI 10.1016/0092-8674(88)90156-0; VANEWIJK W, 1980, J HISTOCHEM CYTOCHEM, V28, P1089, DOI 10.1177/28.10.6999083; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; WAKE CT, 1985, CELL, V42, P623, DOI 10.1016/0092-8674(85)90119-9; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	51	311	322	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					167	178		10.1016/S1074-7613(00)80681-0	http://dx.doi.org/10.1016/S1074-7613(00)80681-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624807	Green Published, hybrid			2022-12-18	WOS:A1996TX22500007
J	Pepper, M; Pagan, AJ; Igyarto, BZ; Taylor, JJ; Jenkins, MK				Pepper, Marion; Pagan, Antonio J.; Igyarto, Botond Z.; Taylor, Justin J.; Jenkins, Marc K.			Opposing Signals from the Bcl6 Transcription Factor and the Interleukin-2 Receptor Generate T Helper 1 Central and Effector Memory Cells	IMMUNITY			English	Article							CD4 T-CELLS; LISTERIA-MONOCYTOGENES INFECTION; FOLLICULAR HELPER-CELL; IN-VIVO; B-CELLS; IMMUNE-RESPONSES; STAT PROTEINS; LYMPH-NODES; DIFFERENTIATION; EXPRESSION	Listeria monocyto genes infection generates T helper 1 (Th1) effector memory cells and CC chemokine receptor 7 (CCR7)(+) cells resembling central memory cells. We tracked endogenous L. monocytogenes-specific CD4(+) T cells to determine how these memory cells are formed. Two effector cell populations were already present several days after infection. One highly expressed the T-bet transcription factor and produced Th1 memory cells in an interleukin-2 (IL-2) receptor-dependent fashion. The other resided in the T cell areas, expressed CCR7 and CXC chemokine receptor 5 (CXCR5), and like follicular helper cells depended on the Bcl6 transcription factor and inducible costimulator ligand on B cells. The CCR7(+)CXCR5(+) effector cells produced similar memory cells that generated diverse effector cell populations in a secondary response. Thus, Th1 effector memory and follicular helper-like central memory cells are produced from early effector cell populations that diverge in response to signals from the IL-2 receptor, Bcl6, and B cells.	[Pepper, Marion; Pagan, Antonio J.; Taylor, Justin J.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Igyarto, Botond Z.] Univ Minnesota, Sch Med, Dept Dermatol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Pagan, Antonio/AAB-1604-2019; Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Igyarto, Botond/0000-0002-9770-800X	NIH [R01-AI39614, R37-AI27998, R01-AI66018, T32-AI07313, R01-AR056632]; Kunze Fellowship; Dermatology Foundation Fellowship; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027998, T32AI007313, R01AI066018, R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kunze Fellowship; Dermatology Foundation Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank J. Walter and R. Speier for technical help, T. Martin and the CFI core flow cytometry facility for assistance with sorting and flow cytometry experiments, and K. Pape for assistance with immunohistology. This work was supported by grants to M.K.J. (NIH R01-AI39614, R37-AI27998, R01-AI66018), A.J.P. (NIH T32-AI07313 and a Kunze Fellowship), and B.Z.I. (NIH R01-AR056632 and Dermatology Foundation Fellowship).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; MacLeod MKL, 2011, J IMMUNOL, V186, P2889, DOI 10.4049/jimmunol.1002955; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	52	310	312	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					583	595		10.1016/j.immuni.2011.09.009	http://dx.doi.org/10.1016/j.immuni.2011.09.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22018468	Bronze, Green Accepted			2022-12-18	WOS:000296657700017
J	Roozendaal, R; Mempel, TR; Pitcher, LA; Gonzalez, SF; Verschoor, A; Mebius, RE; von Andrian, UH; Carroll, MC				Roozendaal, Ramon; Mempel, Thorsten R.; Pitcher, Lisa A.; Gonzalez, Santiago F.; Verschoor, Admar; Mebius, Reina E.; von Andrian, Ulrich H.; Carroll, Michael C.			Conduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node Follicles	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; HUMORAL IMMUNE-RESPONSE; ZONE B-CELLS; COMPLEMENT RECEPTORS 1; IN-VIVO; ANTIBODY-RESPONSES; SUBCAPSULAR SINUS; GERMINAL-CENTERS; MARGINAL ZONE; NETWORKS	To track drainage of lymph-borne small and large antigens (Ags) into the peripheral lymph nodes and subsequent encounter by B cells and follicular dendritic cells, we used the approach of multiphoton intravital microscopy. We find a system of conduits that extend into the follicles and mediate delivery of small antigens to cognate B cells and follicular dendritic cells. The follicular conduits provide an efficient and rapid mechanism for delivery of small antigens and chemokines such as CXCL13 to B cells that directly contact the conduits. By contrast, large antigens were bound by subcapsular sinus macrophages and subsequently transferred to follicular B cells as previously reported. In summary, the findings identify a unique pathway for the channeling of small lymph-borne antigens and chemoattractants from the subcapsular sinus directly to the B cell follicles. This pathway could be used for enhancing delivery of vaccines or small molecules for improvement of humoral immunity.	[Roozendaal, Ramon; Pitcher, Lisa A.; Gonzalez, Santiago F.; Verschoor, Admar; Carroll, Michael C.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Roozendaal, Ramon; Pitcher, Lisa A.; Gonzalez, Santiago F.; Verschoor, Admar; Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Roozendaal, Ramon; Mempel, Thorsten R.; Pitcher, Lisa A.; Gonzalez, Santiago F.; Verschoor, Admar; von Andrian, Ulrich H.; Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Roozendaal, Ramon; Mebius, Reina E.] VU Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Carroll, MC (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 800 Huntington Ave, Boston, MA 02115 USA.	carroll@idi.harvard.edu	von Andrian, Ulrich H/A-5775-2008	F. Gonzalez, Santiago/0000-0003-4166-7664; Mebius, Reina/0000-0003-0451-7464	Marie Curie Fellowship [008873]; National Institutes of Health [Al 039246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039246] Funding Source: NIH RePORTER	Marie Curie Fellowship(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank D. Vargas for exceptional animal care, R. Yeamans for technical assistance, and N. Barteneva at the IDI Flow and Imaging Cytometry Core facility and M. Ericsson at the Harvard Medical School EM Facility for technical assistance. R.R. is supported by a Marie Curie Fellowship (008873). M.C.C. is supported by a grant from the National Institutes of Health (Al 039246).	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cyster JG, 2000, IMMUNOL REV, V176, P181; Fang YF, 1998, J IMMUNOL, V160, P5273; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hauser AE, 2007, NAT REV IMMUNOL, V7, P499, DOI 10.1038/nri2120; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kelsoe G, 2000, IMMUNOL RES, V22, P199, DOI 10.1385/IR:22:2-3:199; KELSOE G, 1995, IMMUNOL TODAY, V16, P324, DOI 10.1016/0167-5699(95)80146-4; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KOSCO MH, 1992, IMMUNOL REV, V126, P63, DOI 10.1111/j.1600-065X.1992.tb00631.x; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; PRAGER EM, 1971, J BIOL CHEM, V246, P5978; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; Verschoor A, 2001, J IMMUNOL, V167, P2446, DOI 10.4049/jimmunol.167.5.2446; Victoratos P, 2006, IMMUNITY, V24, P65, DOI 10.1016/j.immuni.2005.11.013; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Youd ME, 2002, EUR J IMMUNOL, V32, P2328, DOI 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T	55	310	313	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					264	276		10.1016/j.immuni.2008.12.014	http://dx.doi.org/10.1016/j.immuni.2008.12.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19185517	Green Accepted, Bronze			2022-12-18	WOS:000263710500013
J	Badovinac, VP; Haring, JS; Harty, JT				Badovinac, Vladimir P.; Haring, Jodie S.; Harty, John T.			Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection	IMMUNITY			English	Article							IN-VIVO; SELECTIVE EXPRESSION; VIRAL-INFECTION; IL-7 RECEPTOR; CUTTING EDGE; MEMORY CELLS; EFFECTOR; NAIVE; DIFFERENTIATION; GENERATION	Adoptive-transfer experiments with relatively large input numbers (similar to 10(6)) of T cell receptor-transgenic (TCR-tg) T cells are widely used to model endogenous T cell responses to infection or immunization. We show that input numbers of naive TCR-tg T cells sufficient to squelch the endogenous response to the same epitope substantially alter the kinetics, proliferative expansion, phenotype, and efficiency of memory generation by the TCR-tg T cells in response to infection. Thus, responses from nonphysiologic input numbers of TCR-tg T cells fail to accurately mimic the endogenous T cell response. Importantly, seeding as few as similar to 10-50 TCR-tg T cells, which constitute a fraction of the endogenous repertoire, allowed vigorous proliferation and analysis of TCR-tg cells after infection in a scenario representing normal physiology for any individual TCR. These data strongly suggest that modeling the endogenous T cell response with TCR-tg cells will require every effort to approximate the endogenous precursor frequency.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu	badovinac, Vladimir/O-7760-2015	Badovinac, Vladimir/0000-0003-3180-2439; Harty, John/0000-0001-7266-2802	NIAID NIH HHS [R01 AI059752-03, R01 AI042767-09, R01 AI046653, R01 AI046653-07, R01 AI050073-06, R01 AI059752, R01 AI042767, R01 AI050073] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046653, R01AI042767, R01AI059752, R01AI050073] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kedzierska K, 2006, J IMMUNOL, V177, P6705, DOI 10.4049/jimmunol.177.10.6705; Kemp RA, 2004, J IMMUNOL, V173, P2923, DOI 10.4049/jimmunol.173.5.2923; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wong P, 2004, J IMMUNOL, V172, P7239, DOI 10.4049/jimmunol.172.12.7239	40	310	314	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					827	841		10.1016/j.immuni.2007.04.013	http://dx.doi.org/10.1016/j.immuni.2007.04.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17555991	Green Accepted, Bronze			2022-12-18	WOS:000247646900017
J	Dong, HD; Zhu, GF; Tamada, K; Flies, DB; van Deursen, JMA; Chen, LP				Dong, HD; Zhu, GF; Tamada, K; Flies, DB; van Deursen, JMA; Chen, LP			B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes	IMMUNITY			English	Article							DEATH-1 PD-1 PATHWAY; CELL-DEATH; B7 FAMILY; PERIPHERAL DELETION; DENDRITIC CELLS; FAS LIGAND; LIVER; ACTIVATION; APOPTOSIS; MEMBER	Upon systemic activation by antigens, CD8(+), but not CD4(+), T cells selectively accumulate and undergo apoptosis in the liver, a mechanism associated with the induction of hepatic tolerance and chronic infection. The molecular basis for CD8(+) T cell preference in this process is unknown. We prepared B7-H1-deficient mice by gene targeting and found spontaneous accumulation of CD8(+) T cells in the liver while CD4(+) T cell levels remained normal. Moreover, antigen-driven CD8(+) T cells proliferated normally while apoptotic levels during the contraction phase was selectively impaired in the liver, leading to accelerated hepatocyte damage in experimental autoimmune hepatitis. Therefore, B7-H1 is a key protein selectively regulating the accumulation and deletion of intrahepatic CD8(+) T cells and may also contribute to inflammation, autoimmune diseases, and tolerance in the liver.	Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Chen, LP (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	chen.lieping@mayo.edu		Dong, Haidong/0000-0002-5782-2983	NCI NIH HHS [CA98721, CA85721, CA97085] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085721, R01CA097085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Dao T, 2001, J IMMUNOL, V166, P3090, DOI 10.4049/jimmunol.166.5.3090; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; Dini L, 2000, EUR J HISTOCHEM, V44, P217; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ehl S, 1996, J IMMUNOL, V156, P2357; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liu XL, 2003, J EXP MED, V197, P1721, DOI 10.1084/jem.20022089; Liu ZX, 2001, J IMMUNOL, V166, P3035, DOI 10.4049/jimmunol.166.5.3035; Luettig B, 1999, J IMMUNOL, V163, P4300; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Mehal WZ, 1998, J IMMUNOL, V161, P1686; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki I, 2000, P NATL ACAD SCI USA, V97, P1707, DOI 10.1073/pnas.97.4.1707; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tamura H, 2001, BLOOD, V97, P1809, DOI 10.1182/blood.V97.6.1809; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Wick MJ, 2002, CRIT REV IMMUNOL, V22, P47; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k	46	310	346	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					327	336		10.1016/S1074-7613(04)00050-0	http://dx.doi.org/10.1016/S1074-7613(04)00050-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030776	Bronze			2022-12-18	WOS:000221442600010
J	Dessen, A; Lawrence, CM; Cupo, S; Zaller, DM; Wiley, DC				Dessen, A; Lawrence, CM; Cupo, S; Zaller, DM; Wiley, DC			X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II	IMMUNITY			English	Article							T-CELL RECOGNITION; MHC CLASS-II; DR-BETA-CHAIN; RHEUMATOID-ARTHRITIS; ALPHA-BETA; 3-DIMENSIONAL STRUCTURE; BINDING-SPECIFICITY; IMMUNE-RESPONSE; MOLECULES; ASSOCIATION	Genetic predisposition to rheumatoid arthritis (RA) is linked to the MHC class II allele HLA-DR4. The charge of the amino acid at DR beta 71 in the peptide-binding site appears to be critical in discriminating DR molecules linked to increased disease susceptibility. We have determined the 2.5 Angstrom x-ray structure of the DR4 molecule with the strongest linkage to RA (DRB1*0401) complexed with a human collagen II peptide. Details of a predicted salt bridge between lysine DR beta 71 and aspartic acid at the P4 peptide position suggest how it may participate in both antigen binding and TCR activation. A model is proposed for the DR4 recognition of collagen II (261-273), an antigen immunodominant in human-transgenic mouse models of RA.	CHILDRENS HOSP,MOL MED LAB,BOSTON,MA 02115; CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,DEPT MOL & CELLULAR BIOL,CAMBRIDGE,MA 02138; MERCK RES LABS,MOL IMMUNOL,RAHWAY,NJ 07065	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Merck & Company			Lawrence, C. Martin/AAH-3420-2020	Lawrence, C. Martin/0000-0002-5398-466X; Dessen, Andrea/0000-0001-6487-4020				BANERJEE S, 1988, CLIN EXP RHEUMATOL, V6, P373; BARBER LD, 1991, HUM IMMUNOL, V32, P110, DOI 10.1016/0198-8859(91)90107-K; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; BUSCH R, 1991, J IMMUNOL, V147, P1292; DEMOTZ S, 1993, EUR J IMMUNOL, V23, P425, DOI 10.1002/eji.1830230219; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FU XT, 1995, J EXP MED, V181, P915, DOI 10.1084/jem.181.3.915; Fugger L, 1996, EUR J IMMUNOL, V26, P928, DOI 10.1002/eji.1830260431; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GORGA JC, 1991, RES IMMUNOL, V142, P401, DOI 10.1016/0923-2494(91)90038-K; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; HIRAIWA A, 1990, P NATL ACAD SCI USA, V87, P8051, DOI 10.1073/pnas.87.20.8051; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JASIN HE, 1985, ARTHRITIS RHEUM, V28, P241, DOI 10.1002/art.1780280302; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KHARE SD, 1995, J IMMUNOL, V155, P3653; LANCHBURY JSS, 1991, HUM IMMUNOL, V32, P56, DOI 10.1016/0198-8859(91)90117-R; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; NEWTONNASH DK, 1993, J IMMUNOL, V150, P1813; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; SIGNORELLI KL, 1995, CELL IMMUNOL, V162, P217, DOI 10.1006/cimm.1995.1072; SILVER J, 1985, EPITOPES FUNCTIONAL; STEERE AC, 1990, NEW ENGL J MED, V323, P219, DOI 10.1056/NEJM199007263230402; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STUART JM, 1983, ARTHRITIS RHEUM, V26, P832, DOI 10.1002/art.1780260703; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; TERATO K, 1990, ARTHRITIS RHEUM, V33, P1493, DOI 10.1002/art.1780331006; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; TODD JA, 1988, SCIENCE, V241, P888; VERRECK FAW, 1993, EUR J IMMUNOL, V23, P1346, DOI 10.1002/eji.1830230624; WATSON WC, 1986, ARTHRITIS RHEUM, V29, P1316, DOI 10.1002/art.1780291103; Woulfe SL, 1995, ARTHRITIS RHEUM, V38, P1744, DOI 10.1002/art.1780381207; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; Zanelli E, 1996, P NATL ACAD SCI USA, V93, P1814, DOI 10.1073/pnas.93.5.1814; ZANELLI E, 1995, IMMUNOL TODAY, V16, P274, DOI 10.1016/0167-5699(95)80181-2	55	310	336	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					473	481		10.1016/S1074-7613(00)80369-6	http://dx.doi.org/10.1016/S1074-7613(00)80369-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354468	Bronze			2022-12-18	WOS:A1997YD59300004
J	SHERMAN, MA; WEBER, DA; JENSEN, PE				SHERMAN, MA; WEBER, DA; JENSEN, PE			DM ENHANCES PEPTIDE BINDING TO CLASS-II MHC BY RELEASE OF INVARIANT CHAIN-DERIVED PEPTIDE	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-DR MOLECULES; ANTIGEN PRESENTATION; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; ACIDIC PH; CELL LINE; T-CELLS; ABSENCE; GENES	Major histocompatibility complex (MHC) class II molecules bind antigenic peptides rapidly after biosynthesis in antigen-presenting cells (APCs). By contrast, the rate of peptide binding to purified class II molecules is remarkably slow. We find that purified HLA-DR molecules bind peptides rapidly in the presence but not the absence of HLA-DM, a recently identified heterodimer required for efficient antigen processing. The same effect is seen with immunoprecipitated DM, suggesting that DM interacts directly with DR. Class II-associated invariant chain peptides (CLIP) are selectively and rapidly released from DR during incubation with DM at pH 5. We conclude that DM is a cofactor that enhances peptide binding to DR molecules through a mechanism involving peptide exchange.			SHERMAN, MA (corresponding author), EMORY UNIV,SCH MED,DEPT PATHOL,ATLANTA,GA 30322, USA.							AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CEMAN S, 1992, J IMMUNOL, V149, P754; CEPPELLINI R, 1989, NATURE, V339, P392, DOI 10.1038/339392a0; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; ERLICH H, 1986, HUM IMMUNOL, V16, P205, DOI 10.1016/0198-8859(86)90049-2; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; JENSEN PE, 1993, J IMMUNOL, V150, P3347; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARSH EW, 1992, J EXP MED, V175, P425, DOI 10.1084/jem.175.2.425; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROOSNEK E, 1988, J IMMUNOL, V140, P4079; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1994, J EXP MED, V179, P229, DOI 10.1084/jem.179.1.229; SINIGAGLIA F, 1995, J EXP MED, V181, P449, DOI 10.1084/jem.181.2.449; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	58	310	312	0	4	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					197	205		10.1016/1074-7613(95)90089-6	http://dx.doi.org/10.1016/1074-7613(95)90089-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648393	Bronze			2022-12-18	WOS:A1995RR33900005
J	READ, MA; NEISH, AS; LUSCINSKAS, FW; PALOMBELLA, VJ; MANIATIS, T; COLLINS, T				READ, MA; NEISH, AS; LUSCINSKAS, FW; PALOMBELLA, VJ; MANIATIS, T; COLLINS, T			THE PROTEASOME PATHWAY IS REQUIRED FOR CYTOKINE-INDUCED ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULE EXPRESSION	IMMUNITY			English	Article							NF-KAPPA-B; HUMAN VASCULAR ENDOTHELIUM; TRANSENDOTHELIAL MIGRATION; CHROMOSOMAL LOCATION; NEUTROPHIL MIGRATION; DISTINCT MECHANISMS; E-SELECTIN; CELLS; GENE; ALPHA	Multiple cell adhesion protei ns are up-regulated in vascular endothelial cells in response to TNF alpha and other inflammatory cytokines. This increase in cell adhesion gene expression is thought to require the transcription factor NF-KB. Here, we show that peptide aldehyde inhibitors of the proteasome, a multicatalytic protease recently shown to be required for the activation of NF-kappa B, block TNF alpha induction of the leukocyte adhesion molecules E-selectin, VCAM-1, and ICAM-1. Striking functional consequences of this inhibition were observed in analyses of leukocyte-endothelial interactions under defined flow conditions. Lymphocyte attachment to TNF alpha-treated endothelial monolayers was totally blocked, while neutrophil attachment was partially reduced but transmigration was essentially prevented.	MYOGEN INC, CAMBRIDGE, MA 02139 USA; HARVARD UNIV, DEPT MOLEC & CELLULAR BIOL, CAMBRIDGE, MA 02138 USA	Harvard University	READ, MA (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT PATHOL, DIV VASC RES, BOSTON, MA 02115 USA.		Neish, Andrew/B-3895-2009		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL047646] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03011-01, HL47646] Funding Source: Medline; NIAID NIH HHS [AI2064] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BRISCOE DM, 1991, TRANSPLANTATION, V51, P537; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; CARLOS TM, 1994, BLOOD, V84, P2068; CHAN BMC, 1992, J BIOL CHEM, V267, P8366; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; COLLINS T, 1991, J BIOL CHEM, V266, P2466; COLLINS T, 1993, TRENDS CARDIOVAS MED, V3, P92, DOI 10.1016/1050-1738(93)90030-A; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; CYBULSKY MI, 1991, P NATL ACAD SCI USA, V88, P7859, DOI 10.1073/pnas.88.17.7859; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DONALD R, 1995, J BIOL CHEM, V270, P9, DOI 10.1074/jbc.270.1.9; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FREEDMAN AS, 1990, SCIENCE, V249, P1030, DOI 10.1126/science.1697696; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; GIMBRONE MA, 1995, IN PRESS MOL CARDIOV; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Grilli Mariagrazia, 1993, V143, P1; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; KUIJPERS TW, 1992, J CELL BIOL, V117, P565, DOI 10.1083/jcb.117.3.565; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LAWRENCE MB, 1993, J IMMUNOL, V151, P6338; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; LUSCINSKAS FW, 1989, J IMMUNOL, V142, P2257; LUSCINSKAS FW, 1995, J EXP MED, V181, P1179, DOI 10.1084/jem.181.3.1179; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; NELSH A, 1992, J EXP MED, V176, P1583; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; PTASHNE M, 1909, GENETIC SWITCH GENE; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosen S D, 1993, Semin Immunol, V5, P237, DOI 10.1006/smim.1993.1028; Sambrook J., 1989, MOL CLONING LAB MANU; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; VORABERGER G, 1991, J IMMUNOL, V147, P2777; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; WESTLIN WF, 1993, AM J PATHOL, V142, P117; WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464	71	310	322	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1995	2	5					493	506		10.1016/1074-7613(95)90030-6	http://dx.doi.org/10.1016/1074-7613(95)90030-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7538441	Bronze			2022-12-18	WOS:A1995QZ43000007
J	Corthay, A; Skovseth, DK; Lundin, KU; Rosjo, E; Omholt, H; Hofgaard, PO; Haraldsen, G; Bogen, B				Corthay, A; Skovseth, DK; Lundin, KU; Rosjo, E; Omholt, H; Hofgaard, PO; Haraldsen, G; Bogen, B			Primary antitumor immune response mediated by CD4(+) T cells	IMMUNITY			English	Article							COMPLEX CLASS-II; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; DENDRITIC CELLS; IN-VIVO; INTERFERON-GAMMA; SURVEILLANCE; MACROPHAGES; IDIOTYPE; RECEPTOR	Gene-targeted mice have recently revealed a role for lymphocytes and interferon-gamma (IFN-gamma) in conferring protection against cancer, but the mechanisms remain unclear. Here, we have characterized a successful primary antitumor immune response initiated by naive CD4(+) T cells. Major histocompatibility complex class II (MHC-II)-negative myeloma cells injected subcutaneously into syngeneic mice were surrounded within 3 days by macrophages that captured tumor antigens. Within 6 days, naive myeloma-specific CD4(+) T cells became activated in draining lymph nodes and subsequently migrated to the incipient tumor site. Upon recognition of tumor-derived antigenic peptides presented on MHC-II by macrophages, the myeloma-specific CD4(+) T cells were reactivated and started to secrete cytokines. T cell-derived IFN gamma activated macrophages in close proximity to the tumor cells. Tumor cell growth was completely inhibited by such locally activated macrophages. These data indicate a mechanism for immunosurveillance of MHC-II-negative cancer cells by tumor-specific CD4(+) T cells through collaboration with macrophages.	Univ Oslo, Rikshosp, Dept Immunol, N-0027 Oslo, Norway; Univ Oslo, Rikshosp, Inst Pathol, N-0027 Oslo, Norway; Univ Oslo, Rikshosp, Dept Pathol, N-0027 Oslo, Norway; Rikshosp Univ Hosp, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Corthay, A (corresponding author), Univ Oslo, Rikshosp, Dept Immunol, N-0027 Oslo, Norway.	alexandre.corthay@medisin.uio.no; bjarne.bogen@medisin.uio.no	Haraldsen, Guttorm/W-4359-2019; Haraldsen, Guttorm/I-2680-2013; Corthay, Alexandre/M-5289-2013; Corthay, Alexandre/M-5289-2013	Corthay, Alexandre/0000-0003-1152-0549; Corthay, Alexandre/0000-0001-9519-5725; Haraldsen, Guttorm/0000-0002-0064-9665				Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; BOGEN B, 1995, EUR J IMMUNOL, V25, P3079, DOI 10.1002/eji.1830251114; BOGEN B, 1992, EUR J IMMUNOL, V22, P703, DOI 10.1002/eji.1830220313; BOGEN B, 1986, EUR J IMMUNOL, V16, P1373, DOI 10.1002/eji.1830161110; BOTTAZZI B, 1983, SCIENCE, V220, P210, DOI 10.1126/science.6828888; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dembic Z, 2004, SCAND J IMMUNOL, V60, P143, DOI 10.1111/j.0300-9475.2004.01435.x; Dembic Z, 2000, P NATL ACAD SCI USA, V97, P2697, DOI 10.1073/pnas.050579897; Dembic Z, 2001, BLOOD, V97, P2808, DOI 10.1182/blood.V97.9.2808; EVANS R, 1970, NATURE, V228, P620, DOI 10.1038/228620a0; FUJIWARA H, 1984, J IMMUNOL, V133, P1671; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gross L, 1943, CANCER RES, V3, P326; HORI K, 1987, CANCER RES, V47, P5868; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; LYNCH RG, 1972, P NATL ACAD SCI USA, V69, P1540, DOI 10.1073/pnas.69.6.1540; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Munthe LA, 1999, EUR J IMMUNOL, V29, P4043, DOI 10.1002/(SICI)1521-4141(199912)29:12<4043::AID-IMMU4043>3.0.CO;2-E; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; SCHREIBER RD, 1983, J IMMUNOL, V131, P826; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; STEEG PS, 1982, J EXP MED, V156, P1780, DOI 10.1084/jem.156.6.1780; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171	40	309	320	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					371	383		10.1016/j.immuni.2005.02.003	http://dx.doi.org/10.1016/j.immuni.2005.02.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780993	Bronze			2022-12-18	WOS:000228105700011
J	Sansonetti, PJ; Phalipon, A; Arondel, J; Thirumalai, K; Banerjee, S; Akira, S; Takeda, K; Zychlinsky, A				Sansonetti, PJ; Phalipon, A; Arondel, J; Thirumalai, K; Banerjee, S; Akira, S; Takeda, K; Zychlinsky, A			Caspase-1 activation of IL-1 beta and IL-18 are essential for Shigella flexneri-induced inflammation	IMMUNITY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; IFN-GAMMA PRODUCTION; IL-1-BETA-CONVERTING ENZYME; MACROPHAGE APOPTOSIS; IL-18-DEFICIENT MICE; ULCERATIVE-COLITIS; CROHNS-DISEASE; HELA-CELLS; INFECTION; INTERFERON	Caspases are intracellular proteases that mediate mammalian cell apoptosis. Caspase-1 (Casp-1) is a unique caspase because it activates the proinflammatory cytokines interleukin (Il)-1 beta and IL-18. Shigella flexneri, the etiological agent of bacillary dysentery, induces macrophage apoptosis, which requires Casp-1 and results in the release of mature IL-1 beta and IL-18. Here we show that casp-1(-/-) mice infected with S. flexneri do not develop the acute inflammation characteristic of shigellosis and are unable to resolve the bacterial infection. Using casp-1(-/-) mice supplemented with recombinant cytokines and experiments with IL-1 beta(-/-) and IL-18(-/-) mice, we show that IL-1 beta and IL-18 are both required to mediate inflammation in S. flexneri infections. Together, these data demonstrate the importance of Casp-1 in acute inflammation and show the different roles of its substrates, IL-1 beta and IL-18, in this response.	NYU, Sch Med, Skirball Inst, Dept Microbiol, New York, NY 10016 USA; NYU, Kaplan Canc Ctr, Sch Med, New York, NY 10016 USA; BASF Biores Corp, Worcester, MA 01605 USA; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U389, F-75724 Paris 15, France	New York University; New York University; BASF; Osaka University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zychlinsky, A (corresponding author), NYU, Sch Med, Skirball Inst, Dept Microbiol, 550 1St Ave, New York, NY 10016 USA.		Akira, Shizuo/C-3134-2009; Takeda, Kiyoshi/C-9331-2009		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037720] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37720] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAM T, 1995, J CELL BIOL, V129, P367, DOI 10.1083/jcb.129.2.367; Arondel J, 1999, INFECT IMMUN, V67, P6056, DOI 10.1128/IAI.67.11.6056-6066.1999; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bohn E, 1998, J IMMUNOL, V160, P299; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cirulli F, 1998, BRAIN RES, V791, P308, DOI 10.1016/S0006-8993(98)00137-1; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Kawakami K, 1997, J IMMUNOL, V159, P5528; Kohka H, 1998, J LEUKOCYTE BIOL, V64, P519, DOI 10.1002/jlb.64.4.519; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LINDBERG AA, 1993, VACCINE, V11, P168, DOI 10.1016/0264-410X(93)90014-O; MACDERMOTT RP, 1994, MED CLIN N AM, V78, P1207, DOI 10.1016/S0025-7125(16)30096-7; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MATHAN MM, 1991, REV INFECT DIS, V13, pS314; MAURELLI AT, 1988, ANNU REV MICROBIOL, V42, P127, DOI 10.1146/annurev.micro.42.1.127; MENARD R, 1993, J BACTERIOL, V175, P5899; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Neveu PJ, 1998, PHYSIOL BEHAV, V63, P587, DOI 10.1016/S0031-9384(97)00495-2; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75, DOI 10.1128/IAI.34.1.75-83.1981; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Shapiro GG, 1998, IMMUNOL ALLERGY CLIN, V18, P1, DOI 10.1016/S0889-8561(05)70343-X; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Thirumalai K, 1997, INFECT IMMUN, V65, P787, DOI 10.1128/IAI.65.2.787-793.1997; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; VOINOYASENETSKY MV, 1961, ACT MORPHOL, V10, P440; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998; Wei XQ, 1999, J IMMUNOL, V163, P2821; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X; Zychlinsky A, 1996, INFECT IMMUN, V64, P5357, DOI 10.1128/IAI.64.12.5357-5365.1996; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	45	309	317	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2000	12	5					581	590		10.1016/S1074-7613(00)80209-5	http://dx.doi.org/10.1016/S1074-7613(00)80209-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843390	Bronze			2022-12-18	WOS:000087356400013
J	Liszewski, MK; Kolev, M; Le Friec, G; Leung, M; Bertram, PG; Fara, AF; Subias, M; Pickering, MC; Drouet, C; Meri, S; Arstila, TP; Pekkarinen, PT; Ma, M; Cope, A; Reinheckel, T; de Cordoba, SR; Afzali, B; Atkinson, JP; Kemper, C				Liszewski, M. Kathryn; Kolev, Martin; Le Friec, Gaelle; Leung, Marilyn; Bertram, Paula G.; Fara, Antonella F.; Subias, Marta; Pickering, Matthew C.; Drouet, Christian; Meri, Seppo; Arstila, T. Petteri; Pekkarinen, Pirkka T.; Ma, Margaret; Cope, Andrew; Reinheckel, Thomas; de Cordoba, Santiago Rodriguez; Afzali, Behdad; Atkinson, John P.; Kemper, Claudia			Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation	IMMUNITY			English	Article							C3 DEFICIENCY; IMMUNE-RESPONSE; 2 PARTS; CD46; PROTEIN; EXPRESSION; DISEASE; ROLES; C5A; IMMUNOLOGY	Complement is viewed as a critical serum-operative component of innate immunity, with processing of its key component, C3, into activation fragments C3a and C3b confined to the extracellular space. We report here that C3 activation also occurred intracellularly. We found that the T cell-expressed protease cathepsin L (CTSL) processed C3 into biologically active C3a and C3b. Resting T cells contained stores of endosomal and lysosomal C3 and CTSL and substantial amounts of CTSL-generated C3a. While "tonic" intracellular C3a generation was required for homeostatic T cell survival, shuttling of this intracellular C3-activation-system to the cell surface upon T cell stimulation induced autocrine proinflammatory cytokine production. Furthermore, T cells from patients with autoimmune arthritis demonstrated hyperactive intracellular complement activation and interferon-g production and CTSL inhibition corrected this deregulated phenotype. Importantly, intracellular C3a was observed in all examined cell populations, suggesting that intracellular complement activation might be of broad physiological significance.	[Liszewski, M. Kathryn; Leung, Marilyn; Bertram, Paula G.; Atkinson, John P.] Washington Univ, Sch Med, Div Rheumatol, Dept Med, St Louis, MO 63110 USA; [Kolev, Martin; Le Friec, Gaelle; Fara, Antonella F.; Afzali, Behdad; Kemper, Claudia] Guys Hosp, Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England; [Subias, Marta] CSIC, Ctr Invest Biol, Dept Immunol, E-28006 Madrid, Spain; [Pickering, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London SW7 2AZ, England; [Drouet, Christian] Univ Grenoble 1, GREPI AGIM CNRS FRE3405, F-38041 Grenoble, France; [Meri, Seppo; Arstila, T. Petteri; Pekkarinen, Pirkka T.] Univ Helsinki, Haartman Inst, FI-00014 Helsinki, Finland; [Meri, Seppo; Arstila, T. Petteri; Pekkarinen, Pirkka T.] Univ Helsinki, Res Programs Unit, FI-00014 Helsinki, Finland; [Ma, Margaret; Cope, Andrew; Afzali, Behdad] Guys Hosp, Kings Hlth Partners, Ctr Biomed Res, London SE1 9RT, England; [Ma, Margaret; Cope, Andrew] Kings Coll London, Acad Dept Rheumatol, London SE1 9RT, England; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Imperial College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Helsinki; University of Helsinki; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Freiburg; University of Freiburg	Kemper, C (corresponding author), Guys Hosp, Kings Coll London, Div Transplant Immunol & Mucosal Biol, MRC Ctr Transplantat, London SE1 9RT, England.	claudia.kemper@kcl.ac.uk	de Cordoba, Santiago Rodriguez/K-6727-2014; DROUET, Christian/J-8775-2019; DROUET, Christian/AAE-5682-2020; Reinheckel, Thomas/AAL-9761-2021; Afzali, Behdad/H-8565-2013; kolev, mihail/D-1476-2015; Kemper, Claudia/B-1502-2015	de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; DROUET, Christian/0000-0003-1318-4278; DROUET, Christian/0000-0003-1318-4278; Reinheckel, Thomas/0000-0001-9866-9105; Afzali, Behdad/0000-0003-2968-1156; kolev, mihail/0000-0002-5226-4759; Meri, Seppo/0000-0001-9142-501X; Kemper, Claudia/0000-0003-4196-1417; Le Friec, Gaelle/0000-0002-2051-3829; Kolev, Martin/0000-0002-7208-3875; Pickering, Matthew/0000-0002-1153-0192; Cope, Andrew/0000-0001-6735-5496; Atkinson, John/0000-0002-2514-3441; Pekkarinen, Pirkka/0000-0002-8203-3409	MRC [G1002165]; EU; Wellcome Trust Intermediate Research Fellowship; Sigrid Juselius Foundation, Helsinki, Finland; Spanish MICINN project [SAF2011-265835, S2010/BMD-2316]; Spanish CM project [SAF2011-265835, S2010/BMD-2316]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; MRC Centre for Transplantation; National Institutes of Health [GM0099111]; Antibody Production Facility of the Rheumatic Diseases Core Center at Washington University in Saint Louis; National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health [P30AR048335]; Medical Research Council [G1002165, MR/J006742/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099111] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); Sigrid Juselius Foundation, Helsinki, Finland(Sigrid Juselius Foundation); Spanish MICINN project(Spanish Government); Spanish CM project; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); MRC Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antibody Production Facility of the Rheumatic Diseases Core Center at Washington University in Saint Louis; National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Marina Botto (Imperial College London, UK) and Adrian Hayday (King's College London, UK) for critical discussions on manuscript composition. We thank Jorg Kohl (University of Lubeck, Germany) for the anti-C3a neo-epitope antibody and Margaret So (University of Arizona, USA) for the anti-CD46 CYT-1 antibody. This work was supported by an MRC Research Grant G1002165 (C. K.), an EU-funded Innovative Medicines Initiative BTCURE (A. C., M. M., and C. K.), a Wellcome Trust Intermediate Research Fellowship (B. A.), and the Sigrid Juselius Foundation, Helsinki, Finland, and the Spanish MICINN and CM projects SAF2011-265835 and S2010/BMD-2316' (S.R.d.C.). The research was also funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The authors acknowledge the support of the MRC Centre for Transplantation. Support was also provided by the National Institutes of Health (R01 grant GM0099111 to J.P.A.) and the Antibody Production Facility of the Rheumatic Diseases Core Center at Washington University in Saint Louis. Research reported in this publication is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number P30AR048335.	Andre C, 2012, P NUTR SOC, V71, P502, DOI 10.1017/S0029665112000754; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Choileain SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016287; Couzi L, 2008, AM J KIDNEY DIS, V52, pE5, DOI 10.1053/j.ajkd.2008.02.359; Dehrmann FM, 1995, ARCH BIOCHEM BIOPHYS, V324, P93, DOI 10.1006/abbi.1995.9924; Fernandez-Centeno E, 2000, J IMMUNOL, V164, P4533, DOI 10.4049/jimmunol.164.9.4533; Frade R, 1998, CANCER RES, V58, P2733; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; KATZ Y, 1994, EUR J IMMUNOL, V24, P1517, DOI 10.1002/eji.1830240709; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kitagawa Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00106; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Le Friec G, 2009, ARCH IMMUNOL THER EX, V57, P393, DOI 10.1007/s00005-009-0047-4; Liszewski MK, 2005, SPRINGER SEMIN IMMUN, V27, P345, DOI 10.1007/s00281-005-0002-3; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Miller EC, 2012, CLIN IMMUNOL, V145, P241, DOI 10.1016/j.clim.2012.09.007; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Pekkarinen PT, 2013, J ALLERGY CLIN IMMUN, V131, P1167, DOI 10.1016/j.jaci.2012.09.004; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SINGER L, 1994, J BIOL CHEM, V269, P28494; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; Verbist KC, 2012, SEMIN IMMUNOL, V24, P399, DOI 10.1016/j.smim.2012.12.006; Volanakis JE., 1998, CRC PRESS, P9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Yang K, 2012, SEMIN IMMUNOL, V24, P421, DOI 10.1016/j.smim.2012.12.004	44	308	316	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1143	1157		10.1016/j.immuni.2013.10.018	http://dx.doi.org/10.1016/j.immuni.2013.10.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24315997	Green Published, hybrid			2022-12-18	WOS:000330951000019
J	Phalipon, A; Cardona, A; Kraehenbuhl, JP; Edelman, L; Sansonetti, PJ; Corthesy, B				Phalipon, A; Cardona, A; Kraehenbuhl, JP; Edelman, L; Sansonetti, PJ; Corthesy, B			Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo	IMMUNITY			English	Article							IMMUNOGLOBULIN-A; PROTEOLYTIC DEGRADATION; RESPIRATORY-TRACT; HUMAN EOSINOPHILS; ESCHERICHIA-COLI; MUCOSAL DEFENSE; IN-VIVO; ANTIBODY; BINDING; PROTECTS	Secretory immunoglobulin (Ig) A (SIgA) is essential in protecting mucosal surfaces. It is composed of at least two monomeric IgA molecules, covalently linked through the J chain, and secretory component (SC). We show here that a dimeric/polymeric IgA (IgA(d/p)) is more efficient when bound to SC in protecting mice against bacterial infection of the respiratory tract. We demonstrate that SC ensures, through its carbohydrate residues, the appropriate tissue localization of SIgA by anchoring the antibody to mucus lining the epithelial surface. This in turn impacts the localization and the subsequent clearance of bacteria. Thus, SC is directly involved in the SIgA function in vivo. Therefore, binding of IgA(d/p) to SC during the course of SIgA-mediated mucosal response constitutes a crucial step in achieving efficient protection of the epithelial barrier by immune exclusion.	INSERM, U389, Unite Pathogenie Microbienne Mol, F-75015 Paris, France; Inst Pasteur, Lab Technol Cellulaire, F-75015 Paris, France; Inst Biochim, ISREC, CH-1066 Epalinges, Switzerland; CHUV Lausanne, Div Immunol & Allergie, Hop Orthoped, CH-1005 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Phalipon, A (corresponding author), INSERM, U389, Unite Pathogenie Microbienne Mol, 28 Rue Dr Roux, F-75015 Paris, France.							BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Brandtzaeg P, 1996, ANN NY ACAD SCI, V778, P1, DOI 10.1111/j.1749-6632.1996.tb21110.x; BROWN WR, 1970, J CLIN INVEST, V49, P1374, DOI 10.1172/JCI106354; Corthesy B, 1999, CURR TOP MICROBIOL, V236, P93; Crottet P, 1998, J IMMUNOL, V161, P5445; Dallas SD, 1998, J MED MICROBIOL, V47, P879, DOI 10.1099/00222615-47-10-879; Dixon D, 1999, PATHOLOGY MOUSE, P293; Fujioka H, 1998, J EXP MED, V188, P1223, DOI 10.1084/jem.188.7.1223; Giraudi V, 1997, INT J PEDIATR OTORHI, V39, P103, DOI 10.1016/S0165-5876(96)01472-3; GIUGLIANO LG, 1995, J MED MICROBIOL, V42, P3, DOI 10.1099/00222615-42-1-3; Herbert R. A, 1999, PATHOLOGY MOUSE REFE, P259; Hughes GJ, 1999, BBA-PROTEIN STRUCT M, V1434, P86, DOI 10.1016/S0167-4838(99)00168-5; Iikura M, 1998, J IMMUNOL, V161, P1510; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; LAMKHIOUED B, 1995, EUR J IMMUNOL, V25, P117, DOI 10.1002/eji.1830250121; Laniece P, 1998, J NEUROSCI METH, V86, P1, DOI 10.1016/S0165-0270(98)00128-9; LINDH E, 1975, J IMMUNOL, V114, P284; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; MATHAN MM, 1991, REV INFECT DIS S4, V13, P314; MAZANEC MB, 1993, IMMUNOL TODAY, V14, P430, DOI 10.1016/0167-5699(93)90245-G; MERRILL WW, 1980, AM REV RESPIR DIS, V122, P156; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Motegi Y, 1998, J IMMUNOL, V161, P4340; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Philpott DJ, 2000, PHILOS T R SOC B, V355, P575, DOI 10.1098/rstb.2000.0599; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Renegar KB, 1998, J IMMUNOL, V160, P1219; REYNOLDS HY, 1991, PHYSIOL REV, V71, P1117, DOI 10.1152/physrev.1991.71.4.1117; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Rougeot C, 1997, AM J PHYSIOL-REG I, V273, pR1309, DOI 10.1152/ajpregu.1997.273.4.R1309; RUSSELL MW, 1999, MUCOSAL IMMUNOLOGY, P225; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Schroten H, 1998, INFECT IMMUN, V66, P3971, DOI 10.1128/IAI.66.8.3971-3973.1998; UNDERDOWN BJ, 1974, J IMMUNOL, V112, P949; Weltzin R, 1999, CLIN MICROBIOL REV, V12, P383, DOI 10.1128/CMR.12.3.383; Weltzin R, 1996, J INFECT DIS, V174, P256, DOI 10.1093/infdis/174.2.256; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; Zeitlin L, 1999, EMERG INFECT DIS, V5, P54, DOI 10.3201/eid0501.990107	43	308	336	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					107	115		10.1016/S1074-7613(02)00341-2	http://dx.doi.org/10.1016/S1074-7613(02)00341-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150896	Bronze			2022-12-18	WOS:000177187500011
J	Deftos, ML; He, YW; Ojala, EW; Bevan, MJ				Deftos, ML; He, YW; Ojala, EW; Bevan, MJ			Correlating notch signaling with thymocyte maturation	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; INHIBITS MULTIPLE FORMS; T-CELLS; DROSOPHILA NOTCH; TRANSGENIC MICE; EXPRESSION; BCL-2; DIFFERENTIATION; SELECTION; DEATH	The Notch receptor and its ligands are involved in many developmental processes. They are highly expressed in the thymus and have been implicated in the CD4 versus CD8 lineage decision. We identified the constitutively active intracellular fragment of murine Notch-1 as capable of rendering thymomas resistant to glucocorticoid-induced apoptosis. This effect was confirmed in other T cell lines and in CD4(+)CD8(+) DP thymocytes. Activation of the Notch signaling pathway also upregulated a number of other markers that, like steroid resistance, correlate with DP maturation into both the CD4 and CD8 lineages. These results suggest that Notch signaling is critically involved in the maturation of DP thymocytes into both CD4(+) and CD8(+) SP thymocytes.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.				NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA09537, T32 CA009537, T32 CA009537-13] Funding Source: Medline; NIAID NIH HHS [R01 AI029802-11, R01 AI029802, AI29802] Funding Source: Medline; NIGMS NIH HHS [T32 GM007266, GM07266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cohen J J, 1992, Semin Immunol, V4, P363; COHEN JJ, 1984, J IMMUNOL, V132, P38; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; KEARSE KP, 1995, BIOESSAYS, V17, P1049, DOI 10.1002/bies.950171209; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; MIYASHITA T, 1992, CANCER RES, V52, P5407; Onishi M, 1996, EXP HEMATOL, V24, P324; Pampeno CL, 1996, CELL GROWTH DIFFER, V7, P1113; PEAR W, 1996, CURRENT PROTOCOLS MO, P9; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RICHIE ER, 1988, P NATL ACAD SCI USA, V85, P1174, DOI 10.1073/pnas.85.4.1174; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Sambrook J, 1989, MOL CLONING LAB MANU; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SCREPANTI I, 1989, J IMMUNOL, V142, P3378; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shawber C, 1996, DEVELOPMENT, V122, P3765; SIEGEL RM, 1992, P NATL ACAD SCI USA, V89, P7003, DOI 10.1073/pnas.89.15.7003; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Vacchio MS, 1998, ANN NY ACAD SCI, V840, P317, DOI 10.1111/j.1749-6632.1998.tb09571.x; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; XU T, 1990, GENETICS, V126, P665; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037	55	308	322	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					777	786		10.1016/S1074-7613(00)80643-3	http://dx.doi.org/10.1016/S1074-7613(00)80643-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881968	Bronze, Green Accepted			2022-12-18	WOS:000077836600003
J	Griffith, TS; Yu, XH; Herndon, JM; Green, DR; Ferguson, TA				Griffith, TS; Yu, XH; Herndon, JM; Green, DR; Ferguson, TA			CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance	IMMUNITY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GROWTH-FACTOR-BETA; ANTERIOR-CHAMBER; DEVIATION ACAID; FAS LIGAND; T-CELLS; EYE; INDUCTION; ANTIGEN; MICE	We examined the relationship between cell death and tolerance induction following antigen injection into the anterior chamber of the eye. Our data show that when inflammatory cells undergo apoptosis following infection with HSV-1, tolerance to the virus was observed. In contrast, when cell death was absent due to defects in Fas or FasL, immune tolerance was not observed. Further studies revealed that cell death and tolerance required that the lymphoid cells be Fas(+) and the eye be FasL(+). Additionally, we show that while Fas/FasL-mediated apoptosis occurred in the eye, it was apoptotic cell death that was critical for tolerance induction. Our results further demonstrate immune privilege is not a passive process involving physical barriers, but is an active process that employs an important natural mechanism to induce cell death and immune tolerance.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; LA JOLLA INST ALLERGY & IMMUNOL,DIV CELLULAR IMMUNOL,LA JOLLA,CA 92037	Washington University (WUSTL); La Jolla Institute for Immunology	Griffith, TS (corresponding author), WASHINGTON UNIV,SCH MED,DEPT OPHTHALMOL & VISUAL SCI,ST LOUIS,MO 63110, USA.		Green, Douglas R/N-8083-2018; Griffith, Thomas/ABF-8225-2020	Green, Douglas R/0000-0002-7332-1417; Herndon, John/0000-0002-8378-9654	NEI NIH HHS [EY06374, EY06765] Funding Source: Medline; NIGMS NIH HHS [GM52735] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052735, R01GM052735] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; FERGUSON TA, 1995, J IMMUNOL, V155, P1746; FERGUSON TA, 1989, J IMMUNOL, V143, P821; FERGUSON TA, 1994, INVEST OPHTH VIS SCI, V35, P2643; FERGUSON TA, 1987, J IMMUNOL, V139, P352; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; GRIFFITH TS, 1995, INT IMMUNOL, V7, P1617, DOI 10.1093/intimm/7.10.1617; HOOPER P, 1991, CURR EYE RES, V10, P363, DOI 10.3109/02713689108996342; HORI S, 1989, J IMMUNOL, V143, P1447; IWAI K, 1994, BLOOD, V84, P1201; JOHNSTON JA, 1994, J IMMUNOL, V153, P1762; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; KINESELY T, 1991, OPHTHAL VIS SCI, V32, P2423; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; RAMSDELL F, 1994, INT IMMUNOL, V6, P1545, DOI 10.1093/intimm/6.10.1545; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SEDER RA, 1995, J EXP MED, V181, P5, DOI 10.1084/jem.181.1.5; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SONODA Y, 1993, J IMMUNOL, V150, P1727; STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058; STREILEIN JW, 1987, CURR EYE RES, V6, P127, DOI 10.3109/02713688709020079; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TAYLOR AW, 1994, J IMMUNOL, V153, P1080; THOMPSON CB, 1995, CELL, V81, P979, DOI 10.1016/S0092-8674(05)80001-7; van Dooremaal J. C., 1873, A VONGRAEFES ARCH OP, V19, P359; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WETZIG RP, 1982, J IMMUNOL, V128, P1753; WHITTUMHUDSON J, 1985, INVEST OPHTH VIS SCI, V26, P1524; WILBANKS G A, 1989, Regional Immunology, V2, P390; WILBANKS GA, 1990, IMMUNOLOGY, V71, P383; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILBANKS GA, 1991, J IMMUNOL, V146, P3018	39	308	322	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					7	16		10.1016/S1074-7613(00)80305-2	http://dx.doi.org/10.1016/S1074-7613(00)80305-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758890	Bronze			2022-12-18	WOS:A1996UZ45400002
J	Ganal, SC; Sanos, SL; Kallfass, C; Oberle, K; Johner, C; Kirschning, C; Lienenklaus, S; Weiss, S; Staeheli, P; Aichele, P; Diefenbach, A				Ganal, Stephanie C.; Sanos, Stephanie L.; Kallfass, Carsten; Oberle, Karin; Johner, Caroline; Kirschning, Carsten; Lienenklaus, Stefan; Weiss, Siegfried; Staeheli, Peter; Aichele, Peter; Diefenbach, Andreas			Priming of Natural Killer Cells by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal Microbiota	IMMUNITY			English	Article							DENDRITIC CELLS; NK-CELLS; INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; VIRAL-INFECTION; INNATE IMMUNITY; GERMFREE MICE; IN-VIVO; RECEPTOR; RECOGNITION	Mononuclear phagocytes are an important component of an innate immune system perceived as a system ready to react upon encounter of pathogens. Here, we show that in response to microbial stimulation, mononuclear phagocytes residing in nonmucosal lymphoid organs of germ-free mice failed to induce expression of a set of inflammatory response genes, including those encoding the various type I interferons (IFN-I). Consequently, NK cell priming and antiviral immunity were severely compromised. Whereas pattern recognition receptor signaling and nuclear translocation of the transcription factors NF-kappa B and IRF3 were normal in mononuclear phagocytes of germ-free mice, binding to their respective cytokine promoters was impaired, which correlated with the absence of activating histone marks. Our data reveal a previously unrecognized role for postnatally colonizing microbiota in the introduction of chromatin level changes in the mononuclear phagocyte system, thereby poising expression of central inflammatory genes to initiate a powerful systemic immune response during viral infection.	[Ganal, Stephanie C.; Sanos, Stephanie L.; Kallfass, Carsten; Oberle, Karin; Staeheli, Peter; Aichele, Peter; Diefenbach, Andreas] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Ganal, Stephanie C.; Diefenbach, Andreas] Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Johner, Caroline] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Kirschning, Carsten] Univ Essen Gesamthsch, Inst Med Microbiol, D-45147 Essen, Germany; [Lienenklaus, Stefan; Weiss, Siegfried] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Diefenbach, Andreas] Ctr Biol Signaling Studies, BIOSS, D-79104 Freiburg, Germany	University of Freiburg; Max Planck Society; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research	Diefenbach, A (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Diefenbach, Andreas/T-2589-2018; Ganal-Vonarburg, Stephanie C./AAE-5705-2019	Diefenbach, Andreas/0000-0002-9176-9530; Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Lienenklaus, Stefan/0000-0003-4790-3445	Deutsche Forschungsgemeinschaft (SGBM); Deutsche Forschungsgemeinschaft [SFB992]; Bundesministerium fur Bildung und Forschung; Centrum fur Chronische Immundefizienz; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft (SGBM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Centrum fur Chronische Immundefizienz; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank G. Hacker for support and for critically reading the manuscript; the members of the A.D. laboratory for valuable discussions; M. Reddehase, S. Saccani, and D. van Essen for advice and discussions; C. Bogdan, C. Connor, E. Kiss, H. Pircher, Y. Tanriver, and C. Vonarbourg for comments on the manuscript; and N. Goppert and I. Cao for technical assistance. We are grateful to K. McCoy and J. Kirundi for providing access to germ-free mice and to J. Wersing for cell sorting. The work was supported by the Deutsche Forschungsgemeinschaft (SGBM to S.C.G. and SFB992 to A.D.), the Bundesministerium fur Bildung und Forschung, Centrum fur Chronische Immundefizienz (to A.D.), and the Boehringer Ingelheim Fonds (to S.C.G.).	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Arneson LN, 2008, J IMMUNOL, V181, P6995, DOI 10.4049/jimmunol.181.10.6995; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BAUER H, 1963, AM J PATHOL, V42, P471; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; DESOMER P, 1966, ARCH GES VIRUSFORSCH, V19, P143; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; ITO Y, 1976, INFECT IMMUN, V13, P332, DOI 10.1128/IAI.13.2.332-336.1976; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; MITSUYAMA M, 1986, INFECT IMMUN, V52, P236, DOI 10.1128/IAI.52.1.236-239.1986; MORLAND B, 1979, INFECT IMMUN, V26, P1129; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Ovchinnikov DA, 2008, GENESIS, V46, P447, DOI 10.1002/dvg.20417; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCALZO AA, 1992, J IMMUNOL, V149, P581; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; SHELTON E, 1970, SCIENCE, V168, P1232, DOI 10.1126/science.168.3936.1232; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walton KLW, 2006, IMMUNOL LETT, V102, P16, DOI 10.1016/j.imlet.2005.07.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125	57	307	321	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					171	186		10.1016/j.immuni.2012.05.020	http://dx.doi.org/10.1016/j.immuni.2012.05.020			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22749822	Green Submitted, Bronze			2022-12-18	WOS:000307133200019
J	Chae, JJ; Cho, YH; Lee, GS; Cheng, J; Liu, PP; Feigenbaum, L; Katz, SI; Kastner, DL				Chae, Jae Jin; Cho, Young-Hun; Lee, Geun-Shik; Cheng, Jun; Liu, P. Paul; Feigenbaum, Lionel; Katz, Stephen I.; Kastner, Daniel L.			Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1 beta Activation and Severe Autoinflammation in Mice	IMMUNITY			English	Article							FAMILIAL MEDITERRANEAN FEVER; NF-KAPPA-B; MEFV; CASPASE-1; DISEASE; INFLAMMASOME; EXPRESSION; INTERACTS; CRYOPYRIN; ANAKINRA	Missense mutations in the C-terminal B30.2 domain of pyrin cause familial Mediterranean fever (FMF), the most common Mendelian autoinflammatory disease. However, it remains controversial as to whether FMF is due to the loss of an inhibitor of inflammation or to the activity of a proinflammatory molecule. We generated both pyrin-deficient mice and "knockin" mice harboring mutant human B30.2 domains. Homozygous knockin, but not pyrin-deficient, mice exhibited spontaneous bone marrow-dependent inflammation similar to but more severe than human FMF. Caspase-1 was constitutively activated in knockin macrophages and active IL-1 beta was secreted when stimulated with lipopolysaccharide alone, which is also observed in FMF patients. The inflammatory phenotype of knockin mice was completely ablated by crossing with IL-1 receptor-deficient or adaptor molecule ASC-deficient mice, but not NLRP3-deficient mice. Thus, our data provide evidence for an ASC-dependent NLRP3-independent inflammasome in which gain-of-function pyrin mutations cause autoinflammatory disease.	[Chae, Jae Jin; Lee, Geun-Shik; Kastner, Daniel L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Cho, Young-Hun; Katz, Stephen I.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cheng, Jun; Liu, P. Paul] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Sci Applicat Int Corp Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Chae, JJ (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	chaej@mail.nih.gov; kastnerd@mail.nih.gov	Liu, Paul/A-7976-2012	Liu, Paul/0000-0002-6779-025X; Chae, Jae Jin/0000-0003-0719-4349	NIAMS, NCI; NHGRI, NIH; NATIONAL CANCER INSTITUTE [ZIASC003657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200349, ZIAHG000030, ZIAHG200372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041083] Funding Source: NIH RePORTER	NIAMS, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Intramural Research Program of NIAMS, NCI, and NHGRI, NIH.	Aksentijevich I, 1997, CELL, V90, P797; Belkhir R, 2007, ANN INTERN MED, V146, P825, DOI 10.7326/0003-4819-146-11-200706050-00023; Bernot A, 1997, NAT GENET, V17, P25; Bilginer Y, 2010, CLIN RHEUMATOL, V29, P209, DOI 10.1007/s10067-009-1279-8; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Calligaris L, 2008, EUR J PEDIATR, V167, P695, DOI 10.1007/s00431-007-0547-3; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chae JJ, 2008, BLOOD, V112, P1794, DOI 10.1182/blood-2008-01-134932; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2000, MAMM GENOME, V11, P428, DOI 10.1007/s003350010082; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kuijk LM, 2007, ANN RHEUM DIS, V66, P1545, DOI 10.1136/ard.2007.071498; Lachmann HJ, 2006, RHEUMATOLOGY, V45, P746, DOI 10.1093/rheumatology/kei279; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Milledge J, 2002, BLOOD, V100, P774, DOI 10.1182/blood-2002-02-0651; Moser C, 2009, NEPHROL DIAL TRANSPL, V24, P676, DOI 10.1093/ndt/gfn646; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Schaner P, 2001, NAT GENET, V27, P318, DOI 10.1038/85893; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	30	307	320	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					755	768		10.1016/j.immuni.2011.02.020	http://dx.doi.org/10.1016/j.immuni.2011.02.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21600797	Green Accepted, Bronze			2022-12-18	WOS:000291456500014
J	Dahl, MR; Thiel, S; Matsushita, M; Fujita, T; Willis, AC; Christensen, T; Vorup-Jensen, T; Jensenius, JC				Dahl, MR; Thiel, S; Matsushita, M; Fujita, T; Willis, AC; Christensen, T; Vorup-Jensen, T; Jensenius, JC			MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway	IMMUNITY			English	Article							SERINE-PROTEASE MASP; CLASSICAL PATHWAY; INNATE IMMUNITY; STRUCTURAL GENE; SERUM; RESPONSES; MUTATIONS; COMPONENT; ANTIGENS; FORMS	The mannan-binding lectin (MBL) pathway of complement activation is part of the innate immune defense. The binding of MBL to microbial carbohydrates activates the MBL-associated serine proteases (MASPs) which recruit the complement factors, C4 and C2, to generate the C3 convertase or directly activate C3. We present a phylogenetically highly conserved member of the MBL complex, MASP-3, which is generated through alternative splicing of the MASP-1/3 gene. The designation of MASP-3 as a protease is based on homology to known MASPs. Different MBL oligomers were found to have distinct MASP composition and biological activities. MASP-1, MAp19, and direct C3-cleaving activity are associated with smaller oligomers whereas MASP-3 is found together with MASP-2 on larger oligomers. MASP-3 downregulate the C4 and C2 cleaving activity of MASP-2.	Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; Fukushima Med Univ, Dept Biochem, Fukushima 9601295, Japan; Univ Oxford, MRC, Immunochem Unit, Oxford OX1 3QU, England	Aarhus University; Fukushima Medical University; University of Oxford	Thiel, S (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark.		Vorup-Jensen, Thomas/N-9082-2016	Vorup-Jensen, Thomas/0000-0002-4140-6563; Thiel, Steffen/0000-0002-4817-155X; Christensen, Tove/0000-0003-3977-6677				Carroll M C, 2000, Adv Immunol, V74, P61; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Endo Y, 1998, J IMMUNOL, V161, P4924; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fischer MB, 1996, J IMMUNOL, V157, P549; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JI YH, 1993, J IMMUNOL, V150, P571; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Law S.K.A., 1995, COMPLEMENT; Lipscombe RJ, 1996, EUR J HUM GENET, V4, P13; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; LU J, 1990, J IMMUNOL, V144, P2287; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; MATSUSHITA M, 1995, BIOCHEM J, V311, P1021, DOI 10.1042/bj3111021; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Selander B, 1999, SCAND J IMMUNOL, V50, P555; Stover CM, 1999, J IMMUNOL, V162, P3481; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Thiel S, 2000, J IMMUNOL, V165, P878, DOI 10.4049/jimmunol.165.2.878; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Turner M W, 2000, Rev Immunogenet, V2, P305; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; YOKOTA Y, 1995, J BIOCHEM-TOKYO, V117, P414, DOI 10.1093/jb/117.2.414	41	307	335	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					127	135		10.1016/S1074-7613(01)00161-3	http://dx.doi.org/10.1016/S1074-7613(01)00161-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485744	Bronze			2022-12-18	WOS:000170153300013
J	Boniface, JJ; Rabinowitz, JD; Wulfing, C; Hampl, J; Reich, Z; Altman, JD; Kantor, RM; Beeson, C; McConnell, HM; Davis, MM				Boniface, JJ; Rabinowitz, JD; Wulfing, C; Hampl, J; Reich, Z; Altman, JD; Kantor, RM; Beeson, C; McConnell, HM; Davis, MM			Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands	IMMUNITY			English	Article							ANTIGEN RECEPTOR; CYTOPLASMIC DOMAINS; ANTAGONIST LIGANDS; CRYSTAL-STRUCTURE; TYROSINE KINASE; LOW-AFFINITY; ACTIVATION; RECOGNITION; COMPLEXES; SPECIFICITY	While much is known about intracellular signaling events in T cells when T cell receptors (TCRs) are engaged, the mechanism by which signaling is initiated is unclear. We have constructed defined oligomers of soluble antigen-major histocompatibility complex (MHC) molecules, the natural ligands for the TCR. Using these to stimulate specific T cells in vitro, we find that agonist peptide/MHC ligands are nonstimulatory as monomers and minimally stimulatory as dimers. Similarly, a partial-agonist ligand is very weakly active as a tetramer. In contrast, trimeric or tetrameric agonist ligands that engage multiple TCRs for a sustained duration are potent stimuli. Ligand-driven formation of TCR clusters seems required for effective activation and helps to explain the specificity and sensitivity of T cells.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@cmgm.stanford.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Davis, Mark/0000-0001-6868-657X				ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BECKER DM, 1985, NATURE, V317, P430, DOI 10.1038/317430a0; Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9; KARJALAINEN K, 1994, CURR OPIN IMMUNOL, V6, P9, DOI 10.1016/0952-7915(94)90027-2; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MASON DW, 1986, HDB EXPT IMMUNOLOGY, V1, pCH38; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; ORTEGA E, 1995, MOL IMMUNOL, V32, P941, DOI 10.1016/0161-5890(95)00070-U; PAHLER A, 1987, J BIOL CHEM, V262, P13933; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; REAY PA, 1994, J IMMUNOL, V152, P3946; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rotzschke O, 1997, P NATL ACAD SCI USA, V94, P14642, DOI 10.1073/pnas.94.26.14642; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; Torigoe C, 1997, P NATL ACAD SCI USA, V94, P1372, DOI 10.1073/pnas.94.4.1372; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; WATTS TH, 1988, J IMMUNOL, V141, P3708; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302	59	307	318	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					459	466		10.1016/S1074-7613(00)80629-9	http://dx.doi.org/10.1016/S1074-7613(00)80629-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806632	Bronze			2022-12-18	WOS:000076680700004
J	Long, MX; Park, SG; Strickland, I; Hayden, MS; Ghosh, S				Long, Meixiao; Park, Sung-Gyoo; Strickland, Ian; Hayden, Mafthew S.; Ghosh, Sankar			Nuclear Factor-kappa B Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; DIFFERENTIAL REQUIREMENT; RECEPTOR; INTERLEUKIN-2; ACTIVATION; INDUCTION; SELECTION; SURVIVAL; ANTIGEN; CARMA1	Naturally derived regulatory T (Treg) cells are characterized by stable expression of the transcription factor Foxp3 and characteristic epigenetic imprinting at the Foxp3 gene locus. Here, we found that enhancing nuclear factor (NF)-kappa B activity via a constitutive active inhibitor of kappa B kinase beta (IKK beta) transgene in T cells led to increased number of Foxp3(+) cells in the thymus and can rescue Foxp3 expression in thymocytes deficient in other pleiotropic signaling molecules. Enhancing the signal strength of the NF-kappa B pathway also induced Foxp3 expression in otherwise conventionally selected T cells. NF-kappa B directly promoted the transcription of Foxp3, and upon T cell receptor (TCR) stimulation, c-Rel, a NF-kappa B family member, bound to Foxp3 enhancer region, which is specifically demethylated in natural Treg cells. Hence, NF-kappa B signaling pathway is a key regulator of Foxp3 expression during natural Treg cell development.	[Long, Meixiao; Park, Sung-Gyoo; Strickland, Ian; Hayden, Mafthew S.; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol & Mol Biophys & Biochem, New Haven, CT 06520 USA; [Long, Meixiao; Park, Sung-Gyoo; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Yale University; Columbia University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol & Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.		Hayden, Matthew/C-1263-2008; Park, Sung-Gyoo/H-8652-2019	Park, Sung-Gyoo/0000-0003-3702-5765; Hayden, Matthew/0000-0003-1670-6430	NIH [R37 AI33443, R01 AI068977, T32AI007019-33]; NIH/NIGMS MSTP [GM07205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, T32AI007019, R01AI068977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank R Flavell and A Rudensky for providing the Foxp3 RFP and GFP reporter mice The TAK1-floxed mice were obtained from the laboratory of M. Schneider The CARMA1-deficient mice were obtained from the laboratory of D Littman The Foxp3 reporter constructs were kindly provided by W.J Leonard The work reported in this manuscript was supported by NIH R37 AI33443 and R01 AI068977 M L was supported by NIH T32AI007019-33 M S H was also supported by NIH/NIGMS MSTP grant GM07205	Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Long MX, 2006, J IMMUNOL, V177, P4257, DOI 10.4049/jimmunol.177.7.4257; Long MX, 2006, J IMMUNOL, V176, P1036, DOI 10.4049/jimmunol.176.2.1036; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; MOORE NC, 1995, J IMMUNOL, V155, P4653; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Vallabhapurapu S, 2008, EUR J IMMUNOL, V38, P3508, DOI 10.1002/eji.200737830; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	46	306	323	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					921	931		10.1016/j.immuni.2009.09.022	http://dx.doi.org/10.1016/j.immuni.2009.09.022			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064449	Bronze			2022-12-18	WOS:000273616400012
J	Sykes, M				Sykes, M			Mixed chimerism and transplant tolerance	IMMUNITY			English	Review							BONE-MARROW CHIMERAS; NATURAL-KILLER-CELLS; NONLETHAL PREPARATIVE REGIMEN; HEMATOPOIETIC STEM-CELLS; LONG-TERM SURVIVAL; LARGE-ANIMAL-MODEL; CLASS II+ CELLS; T-CELLS; COSTIMULATION BLOCKADE; ALLOGRAFT TOLERANCE		Harvard Univ, Massachusetts Gen Hosp, Bone Marrow Transplantat Sect, Transplantat Biol Res Ctr,Sch Med, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sykes, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Bone Marrow Transplantat Sect, Transplantat Biol Res Ctr,Sch Med, Boston, MA 02129 USA.	megan.sykes@tbrc.mgh.harvard.edu						Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; Chen AM, 2000, TRANSPLANTATION, V69, P2484, DOI 10.1097/00007890-200006270-00005; COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0; Dey B, 1998, MEDICINE, V77, P355, DOI 10.1097/00005792-199809000-00005; Durham MM, 2000, J IMMUNOL, V165, P1, DOI 10.4049/jimmunol.165.1.1; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Gritsch HA, 1996, XENOTRANSPLANTATION, V3, P312, DOI 10.1111/j.1399-3089.1996.tb00153.x; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Huang CA, 2000, J CLIN INVEST, V105, P173, DOI 10.1172/JCI7913; Idris AH, 1998, J EXP MED, V188, P2243, DOI 10.1084/jem.188.12.2243; ILDSTAD ST, 1984, NATURE, V307, P168, DOI 10.1038/307168a0; ITO H, 2001, IN PRESS J IMMUNOL; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kenyon NS, 1999, P NATL ACAD SCI USA, V96, P8132, DOI 10.1073/pnas.96.14.8132; Khan A, 1996, TRANSPLANTATION, V62, P380, DOI 10.1097/00007890-199608150-00014; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Kung SKP, 1997, J IMMUNOL, V158, P2616; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lee LA, 1996, TRANSPLANTATION, V61, P125, DOI 10.1097/00007890-199601150-00024; Lehnert AM, 2000, TRANSPLANTATION, V69, P1176, DOI 10.1097/00007890-200003270-00024; Li YS, 1998, TRANSPLANTATION, V66, P1387, DOI 10.1097/00007890-199811270-00021; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; Manilay JO, 1998, INT IMMUNOL, V10, P1943, DOI 10.1093/intimm/10.12.1943; Manilay JO, 1999, J IMMUNOL, V163, P2628; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; Nakamura MC, 1999, J IMMUNOL, V163, P4694; Nikolic B, 2001, J IMMUNOL, V166, P1398, DOI 10.4049/jimmunol.166.2.1398; Nikolic B, 1998, TRANSPLANTATION, V65, P1216, DOI 10.1097/00007890-199805150-00013; Nikolic B, 2000, BLOOD, V96, P1166, DOI 10.1182/blood.V96.3.1166.015k41_1166_1172; NIKOLIC B, 2001, IN PRESS BIOL BLOOD; Ohdan H, 1999, J CLIN INVEST, V104, P281, DOI 10.1172/JCI6656; OHDAN H, 2001, IN PRESS TRANSPLANTA; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; RUEDI E, 1989, CELL IMMUNOL, V121, P185, DOI 10.1016/0008-8749(89)90016-6; Rugeles MT, 1997, TRANSPLANTATION, V64, P735, DOI 10.1097/00007890-199709150-00013; SCHLITT HJ, 1994, NEW ENGL J MED, V330, P646, DOI 10.1056/NEJM199403033300919; Seebach JD, 1997, XENOTRANSPLANTATION, V4, P201, DOI 10.1111/j.1399-3089.1997.tb00184.x; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; SHARABI Y, 1990, J EXP MED, V172, P195, DOI 10.1084/jem.172.1.195; Simon AR, 1999, IMMUNOL TODAY, V20, P323, DOI 10.1016/S0167-5699(99)01485-1; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; Spitzer TR, 2000, BIOL BLOOD MARROW TR, V6, P309, DOI 10.1016/S1083-8791(00)70056-5; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STEWART FM, 1993, BLOOD, V81, P2566; Storb R, 1997, BLOOD, V89, P3048, DOI 10.1182/blood.V89.8.3048; Sykes M, 1998, EXP HEMATOL, V26, P457; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; SYKES M, 1988, J EXP MED, V168, P2391, DOI 10.1084/jem.168.6.2391; Tomita N, 1996, GENE THER, V3, P477; TOMITA Y, 1994, BLOOD, V83, P939; TOMITA Y, 1994, J IMMUNOL, V153, P1087; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Tran HM, 1997, J IMMUNOL, V159, P2232; Wekerle T, 1998, J EXP MED, V187, P2037, DOI 10.1084/jem.187.12.2037; Wekerle T, 1999, TRANSPLANTATION, V68, P459, DOI 10.1097/00007890-199908270-00001; Wekerle T, 1999, TRANSPLANT P, V31, P680, DOI 10.1016/S0041-1345(98)01605-4; Wekerle T, 2001, J IMMUNOL, V166, P2311, DOI 10.4049/jimmunol.166.4.2311; Wekerle T, 1999, TRANSPLANTATION, V68, P1348, DOI 10.1097/00007890-199911150-00022; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Wu MF, 1997, J IMMUNOL, V158, P1628; Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335; YOSHIKAI Y, 1990, J IMMUNOL, V145, P505; Zinkernagel RM, 1999, P NATL ACAD SCI USA, V96, P8092, DOI 10.1073/pnas.96.14.8092	68	306	320	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2001	14	4					417	424		10.1016/S1074-7613(01)00122-4	http://dx.doi.org/10.1016/S1074-7613(01)00122-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336687	Bronze			2022-12-18	WOS:000168246700009
J	Bukowski, JF; Morita, CT; Brenner, MB				Bukowski, JF; Morita, CT; Brenner, MB			Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES; LIQUID-CHROMATOGRAPHY; NONPEPTIDE ANTIGENS; PROTECTIVE ROLE; ORAL TOLERANCE; LYMPHOCYTES-T; IN-VITRO; RECEPTOR; INFECTION; MICE	Approximately 4% of peripheral blood T cells in humans express a T cell receptor with markedly restricted germline gene segment usage (V gamma 2V delta 2). Remarkably, these T cells expand 2- to 10-fold (8%-60% of all circulating T cells) during many microbial infections. We show here that these T cells recognize a family of naturally occurring primary alkylamines in a TCR-dependent manner. These antigenic alkylamines are secreted to millimolar concentrations in bacterial supernatants and are found in certain edible plants. Given the large numbers of memory V gamma 2V delta 2 T cells in adult humans, recognition of alkylamine antigens offers the immune system a response of the magnitude of major superantigens for trp T cells and may bridge the gap between innate and adaptive immunity.	Brigham & Womens Hosp, Lymphocyte Biol Sect, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Iowa, Dept Internal Med, Div Rheumatol, Iowa City, IA 52242 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Iowa	Bukowski, JF (corresponding author), Brigham & Womens Hosp, Lymphocyte Biol Sect, Dept Med, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.		Morita, Craig T/C-1365-2011	Morita, Craig T/0000-0001-8496-8294				ALLISON C, 1989, APPL ENVIRON MICROB, V55, P2894, DOI 10.1128/AEM.55.11.2894-2898.1989; ASATOOR AM, 1966, NATURE, V210, P1358, DOI 10.1038/2101358b0; BALBI B, 1993, AM REV RESPIR DIS, V148, P1685, DOI 10.1164/ajrccm/148.6_Pt_1.1685; BAND H, 1987, SCIENCE, V238, P682, DOI 10.1126/science.3672118; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; BURK MR, 1995, EUR J IMMUNOL, V25, P2052, DOI 10.1002/eji.1830250737; Caldwell CW, 1996, AM J CLIN PATHOL, V105, P640; CARTWRIGHT RA, 1954, J SCI FOOD AGR, V5, P597, DOI 10.1002/jsfa.2740051208; DANESHVAR MI, 1989, CAN J MICROBIOL, V35, P786, DOI 10.1139/m89-131; DAVODEAU F, 1993, EUR J IMMUNOL, V23, P804, DOI 10.1002/eji.1830230405; DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311; DEMARIA A, 1992, J INFECT DIS, V165, P917, DOI 10.1093/infdis/165.5.917; ESCHENBACH DA, 1993, AM J OBSTET GYNECOL, V169, P441, DOI 10.1016/0002-9378(93)90337-I; GHENGHESH KS, 1989, BRAZ J MED BIOL RES, V22, P653; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Hara T, 1996, P NATL ACAD SCI USA, V93, P5136, DOI 10.1073/pnas.93.10.5136; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; HARTMANN T, 1967, EXPERIENTIA, V23, P680, DOI 10.1007/BF02144201; HERMANN E, 1992, CLIN EXP IMMUNOL, V89, P427; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; IBE A, 1991, J ASSOC OFF ANA CHEM, V74, P695; JONES BM, 1994, INT J STD AIDS, V5, P52, DOI 10.1177/095646249400500112; JouenBeades F, 1997, INFECT IMMUN, V65, P4267, DOI 10.1128/IAI.65.10.4267-4272.1997; Ke Y, 1997, J IMMUNOL, V158, P3610; LADEL CH, 1995, EUR J IMMUNOL, V25, P2877, DOI 10.1002/eji.1830251025; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LICHTENBERGER LM, 1991, J PEDIATR GASTR NUTR, V13, P342, DOI 10.1097/00005176-199111000-00002; LUNDQVIST C, 1993, IMMUNOLOGY, V79, P38; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mengel J, 1995, IMMUNOL LETT, V48, P97, DOI 10.1016/0165-2478(95)02451-4; MINCHEVANILSSON L, 1992, J IMMUNOL, V149, P2203; MORITA CT, 1991, EUR J IMMUNOL, V21, P2999, DOI 10.1002/eji.1830211215; MUNK ME, 1990, J IMMUNOL, V145, P2434; PADLAN EA, 1976, IMMUNOCHEMISTRY, V13, P945, DOI 10.1016/0019-2791(76)90239-1; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; PAWELEC G, 1995, CELL IMMUNOL, V162, P8, DOI 10.1006/cimm.1995.1045; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; PERRY TL, 1962, PEDIATRICS, V30, P576; PETERMAN GM, 1993, J IMMUNOL, V151, P6546; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; RAZIUDDIN S, 1992, EUR J IMMUNOL, V22, P1143, DOI 10.1002/eji.1830220506; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; Sakato Y., 1949, NIPPON NOGEIKAGAKU K, V23, P262, DOI DOI 10.1271/NOGEIKAGAKU1924.23.262; SCALISE F, 1992, IMMUNOLOGY, V76, P668; SCHILD H, 1994, CELL, V76, P29, DOI 10.1016/0092-8674(94)90170-8; SCHOEL B, 1994, EUR J IMMUNOL, V24, P1886, DOI 10.1002/eji.1830240826; Sciammas R, 1997, J EXP MED, V185, P1969, DOI 10.1084/jem.185.11.1969; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; SUMIDA T, 1992, INFECT IMMUN, V60, P2554, DOI 10.1128/IAI.60.6.2554-2558.1992; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; TANNER A, 1993, CLIN INFECT DIS, V4, pS304; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; ZENKA J, 1989, FOLIA PARASIT, V36, P177	59	306	315	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1999	11	1					57	65		10.1016/S1074-7613(00)80081-3	http://dx.doi.org/10.1016/S1074-7613(00)80081-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435579	Bronze			2022-12-18	WOS:000081671300006
J	Chambers, CA; Sullivan, TJ; Allison, JP				Chambers, CA; Sullivan, TJ; Allison, JP			Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4(+) T cells	IMMUNITY			English	Article							MONOCLONAL-ANTIBODY; NEGATIVE REGULATOR; CTLA-4 EXPRESSION; LIFE-SPAN; IN-VIVO; RESPONSES; CD28; ANTIGEN; ENGAGEMENT; INDUCTION	CTLA-4-deficient animals develop a fatal lymphoproliferative disorder. The cellular mechanism(s) responsible for this phenotype have not been determined. Here, we show that there is a preferential expansion of CD4(+) T cells in CTLA-4(-/-) mice, which results in a skewing of the CD4/CD8 T cell ratio. In vivo antibody depletion of CD8(+) T cells from birth does not alter the onset or the severity of the CD28-dependent lymphoproliferative disorder. In contrast, CD4(+) T cell depletion completely prevents all features characteristic of the lymphoproliferation observed in CTLA-4-deficient mice. These results demonstrate that CD4(+) T cells initiate the phenotype in the CTLA-4(-/-) mice. Further, these results suggest that the role of CTLA-4 in peripheral CD4(+) versus CD8(+) T cell homeostasis is distinct.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Canc Res Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Allison, JP (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Canc Res Lab, Berkeley, CA 94720 USA.	jallison@uclink4.berkeley.edu		Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [R37CA040041, R01CA040041] Funding Source: NIH RePORTER; NCI NIH HHS [CA40041] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alegre ML, 1996, J IMMUNOL, V157, P4762; Allison J.P., 1987, T CELL RECEPTOR, P33; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; CAMPBELL KS, 1995, EUR J IMMUNOL, V25, P2408, DOI 10.1002/eji.1830250842; CHACE JH, 1994, J IMMUNOL, V152, P405; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Chambers CA, 1997, P NATL ACAD SCI USA, V94, P9296, DOI 10.1073/pnas.94.17.9296; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Chuang E, 1997, J IMMUNOL, V159, P144; DEETHS MJ, 1997, EUR J IMMUNOL, V27, P597; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; Finn PW, 1997, J IMMUNOL, V158, P4074; Fournier S, 1997, IMMUNITY, V6, P327, DOI 10.1016/S1074-7613(00)80335-0; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; Hurwitz AA, 1997, J NEUROIMMUNOL, V73, P57, DOI 10.1016/S0165-5728(96)00168-3; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; Kronin V, 1996, J IMMUNOL, V157, P3819; Krummel MF, 1996, INT IMMUNOL, V8, P519, DOI 10.1093/intimm/8.4.519; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; KUBO RT, 1989, J IMMUNOL, V142, P2736; KUIPER HM, 1995, J IMMUNOL, V155, P1776; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LEUNG HT, 1995, J BIOL CHEM, V270, P1; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MAROUN CR, 1994, EUR J IMMUNOL, V24, P967, DOI 10.1002/eji.1830240428; Perkins D, 1996, J IMMUNOL, V156, P4154; Perrin PJ, 1996, J IMMUNOL, V157, P1333; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Tivol EA, 1997, J IMMUNOL, V158, P5091; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TOWNSEND SE, 1994, CANCER RES, V54, P6477; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Waterhouse P, 1996, IMMUNOL REV, V153, P183, DOI 10.1111/j.1600-065X.1996.tb00925.x; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	63	306	340	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					885	895		10.1016/S1074-7613(00)80406-9	http://dx.doi.org/10.1016/S1074-7613(00)80406-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430233	Bronze			2022-12-18	WOS:000071351300015
J	Morrison, SJ; Prowse, KR; Ho, P; Weissman, IL				Morrison, SJ; Prowse, KR; Ho, P; Weissman, IL			Telomerase activity in hematopoietic cells is associated with self-renewal potential	IMMUNITY			English	Article							STEM-CELLS; HUMAN FIBROBLASTS; HUMAN-LYMPHOCYTES; IMMORTAL CELLS; BONE-MARROW; SCID MICE; B-CELL; MOUSE; DIFFERENTIATION; KINETICS	It has been proposed that the biological clock underlying the limited division potential of eukaryotic cells is telomere length. We assayed telomerase activity in single cells of the hematopoietic and immune systems. We examined hematopoietic stem cells at four stages of differentiation, lineage-committed progenitors, and mature myeloid and lymphoid cells. The frequency of telomerase-expressing cells within each population was proportional to the frequency of cells thought to have self-renewal potential. Among bone marrow hematopoietic stem cells, 70% exhibited detectable telomerase activity. The telomerase-expressing somatic cells observed in this study are not thought to be immortal, and expression was not correlated with cell cycle distribution or differentiation state. This study demonstrates that the developmental characteristic most consistently associated with telomerase expression is self-renewal potential.	STANFORD UNIV, SCH MED, DEPT PATHOL, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA; GERON CORP, MENLO PK, CA 94025 USA	Stanford University; Stanford University; Geron Corporation			Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	NCI NIH HHS [CA42551] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; BLACK SJ, 1980, EUR J IMMUNOL, V10, P846, DOI 10.1002/eji.1830101109; CAMPBELL RC, 1989, STATISTICS BIOL; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DOHERTY DE, 1988, LAB INVEST, V59, P200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HARRISON DE, 1979, MECH AGEING DEV, V9, P409, DOI 10.1016/0047-6374(79)90082-4; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HEIMFELD S, 1991, P NATL ACAD SCI USA, V88, P9902, DOI 10.1073/pnas.88.21.9902; HILBERT DM, 1994, TRANSPLANTATION, V58, P466, DOI 10.1097/00007890-199408270-00013; HIYAMA K, 1995, J IMMUNOL, V155, P3711; ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; KRAFT DL, 1993, J EXP MED, V178, P265, DOI 10.1084/jem.178.1.265; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; LOWENTHAL JW, 1988, J IMMUNOL, V140, P474; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MORRISON J, 1994, BLOOD, V83, P3480; MORRISON SJ, 1995, P ASSOC AM PHYSICIAN, V107, P187; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; NAITO M, 1993, ARCH HISTOL CYTOL, V56, P331, DOI 10.1679/aohc.56.331; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; OHGAMI M, 1991, J APPL PHYSIOL, V70, P152, DOI 10.1152/jappl.1991.70.1.152; Osmond D G, 1990, Semin Immunol, V2, P173; PARKS DR, 1984, METHOD ENZYMOL, V108, P197; PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; REINCKE U, 1982, SCIENCE, V215, P1619, DOI 10.1126/science.7071580; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343; SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; VANFURTH R, 1970, J EXP MED, V132, P813, DOI 10.1084/jem.132.4.813; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; VOLKMAN A, 1983, LAB INVEST, V49, P291; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; WIJFFELS JFAM, 1994, IMMUNOBIOLOGY, V191, P52, DOI 10.1016/S0171-2985(11)80267-6; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	69	306	330	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1996	5	3					207	216		10.1016/S1074-7613(00)80316-7	http://dx.doi.org/10.1016/S1074-7613(00)80316-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808676	Bronze			2022-12-18	WOS:A1996VJ79700003
J	Carroll, EC; Jin, L; Mori, A; Munoz-Wolf, N; Oleszycka, E; Moran, HBT; Mansouri, S; McEntee, CP; Lambe, E; Agger, EM; Andersen, P; Cunningham, C; Hertzog, P; Fitzgerald, KA; Bowie, AG; Lavelle, EC				Carroll, Elizabeth. C.; Jin, Lei; Mori, Andres; Munoz-Wolf, Natalia; Oleszycka, Ewa; Moran, Hannah B. T.; Mansouri, Samira; McEntee, Craig P.; Lambe, Eimear; Agger, Else Marie; Andersen, Peter; Cunningham, Colm; Hertzog, Paul; Fitzgerald, Katherine A.; Bowie, Andrew G.; Lavelle, Ed C.			The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; MURINE B-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; IFN-GAMMA; INFLAMMASOME; TUBERCULOSIS; RESPONSES; MODULATION; ACTIVATION	The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent cell-mediated immunity, but the mechanism by which it acts is not clear. We show that chitosan promotes dendritic cell maturation by inducing type I interferons (IFNs) and enhances antigen-specific T helper 1 (Th1) responses in a type I IFN receptor-dependent manner. The induction of type I IFNs, IFN-stimulated genes and dendritic cell maturation by chitosan required the cytoplasmic DNA sensor cGAS and STING, implicating this pathway in dendritic cell activation. Additionally, this process was dependent on mitochondrial reactive oxygen species and the presence of cytoplasmic DNA. Chitosan-mediated enhancement of antigen specific Th1 and immunoglobulin G2c responses following vaccination was dependent on both cGAS and STING. These findings demonstrate that a cationic polymer can engage the STING-cGAS pathway to trigger innate and adaptive immune responses.	[Carroll, Elizabeth. C.; Mori, Andres; Munoz-Wolf, Natalia; Oleszycka, Ewa; Moran, Hannah B. T.; McEntee, Craig P.; Lambe, Eimear; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin D02 PN40 2, Ireland; [Jin, Lei; Mansouri, Samira] Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA; [Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Hertzog, Paul] Monash Univ, MIMR PHI, Ctr Innate Immun & Infect Dis, Clayton, Vic 3068, Australia; [Hertzog, Paul] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3068, Australia; [Cunningham, Colm] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin D02 PN40 2, Ireland; [Cunningham, Colm] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin D02 PN40 2, Ireland; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Fitzgerald, Katherine A.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Viral Immune Evas Grp, Dublin D02 PN40 2, Ireland; [Lavelle, Ed C.] Trinity Coll Dublin, CRANN, Dublin D02 PN40 2, Ireland; [Lavelle, Ed C.] Trinity Coll Dublin, Adv Mat Bioengn Res Ctr AMBER, Dublin D02 PN40 2, Ireland	Trinity College Dublin; Albany Medical College; Statens Serum Institut; Monash University; Prince Henry's Institute of Medical Research; Monash University; Trinity College Dublin; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Lavelle, EC (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin D02 PN40 2, Ireland.; Lavelle, EC (corresponding author), Trinity Coll Dublin, CRANN, Dublin D02 PN40 2, Ireland.; Lavelle, EC (corresponding author), Trinity Coll Dublin, Adv Mat Bioengn Res Ctr AMBER, Dublin D02 PN40 2, Ireland.	lavellee@tcd.ie	Hertzog, Paul J/I-7053-2013; Fitzgerald, Katherine/ABE-6317-2020; Oleszycka, Ewa/AAW-1322-2020; Lavelle, Ed/A-1716-2008; Muñoz-Wolf, Natalia/AAQ-1677-2021; Cunningham, Colm/A-1743-2010	Hertzog, Paul J/0000-0002-1373-8472; Oleszycka, Ewa/0000-0002-8351-9224; Lavelle, Ed/0000-0002-3167-1080; Muñoz-Wolf, Natalia/0000-0002-5173-4026; Andersen, Peter/0000-0002-5869-2551; McEntee, Craig/0000-0002-4762-7607; Cunningham, Colm/0000-0003-1423-5209; Bowie, Andrew/0000-0001-5316-4373; Fitzgerald, Kate/0000-0003-3175-609X; jin, lei/0000-0001-6836-1142	Science Foundation Ireland [12/1A/1421]; EMBARK postgraduate scholarship - Irish Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110606] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EMBARK postgraduate scholarship - Irish Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Gavin McManus for experimental advice with the confocal microscopy and Barry Moran M.Sc. for technical assistance with flow cytometry experiments. This work was funded by a Science Foundation Ireland Investigator Award 12/1A/1421 (E.C.L.) and an EMBARK postgraduate scholarship awarded by the Irish Research Council (E.C.C.).	Agger EM, 2008, IMMUNOLOGY, V124, P175, DOI 10.1111/j.1365-2567.2007.02751.x; Blaauboer SM, 2015, ELIFE, V4, DOI 10.7554/eLife.06670; BOSSIE A, 1991, CELL IMMUNOL, V135, P95, DOI 10.1016/0008-8749(91)90257-C; Brewer JM, 1999, J IMMUNOL, V163, P6448; Bueter CL, 2014, J IMMUNOL, V192, P5943, DOI 10.4049/jimmunol.1301695; Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Garcia N, 2005, LIFE SCI, V76, P2873, DOI 10.1016/j.lfs.2004.12.012; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lin YC, 2014, BIOMATERIALS, V35, P8867, DOI 10.1016/j.biomaterials.2014.07.014; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Mori A, 2012, EUR J IMMUNOL, V42, P2709, DOI 10.1002/eji.201242372; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; van Dissel JT, 2014, VACCINE, V32, P7098, DOI 10.1016/j.vaccine.2014.10.036; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Vasiliev YM, 2015, EXPERT REV VACCINES, V14, P37, DOI 10.1586/14760584.2015.956729; Villiers C, 2009, MOL CELL PROTEOMICS, V8, P1252, DOI 10.1074/mcp.M800589-MCP200; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	45	305	319	21	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					597	608		10.1016/j.immuni.2016.02.004	http://dx.doi.org/10.1016/j.immuni.2016.02.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26944200	Green Accepted, Bronze			2022-12-18	WOS:000372784200017
J	Crawford, A; Angelosanto, JM; Kao, C; Doering, TA; Odorizzi, PM; Barnett, BE; Wherry, EJ				Crawford, Alison; Angelosanto, Jill M.; Kao, Charlly; Doering, Travis A.; Odorizzi, Pamela M.; Barnett, Burton E.; Wherry, E. John			Molecular and Transcriptional Basis of CD4(+) T Cell Dysfunction during Chronic Infection	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PERSISTENT LCMV INFECTION; INTERFERON-PRODUCTION; INHIBITORY RECEPTORS; RESPONSES; EXHAUSTION; BLOCKADE; CD8; DIFFERENTIATION	T cell exhaustion is common during chronic infections. Although CD4(+) T cells are critical for controlling viral load during chronic viral infections, less is known about their differentiation and transcriptional program. We defined the phenotypic, functional, and molecular profiles of exhausted CD4(+) T cells. Global transcriptional analysis demonstrated a molecular profile distinct from effector and memory CD4(+) T cells and also from exhausted CD8(+) T cells, though some common features of CD4(+) and CD8(+) T cell exhaustion were revealed. We have demonstrated unappreciated roles for transcription factors (TFs) including Helios, type I interferon (IFN-I) signaling, and a diverse set of coinhibitory and costimulatory molecules during CD4(+) T cell exhaustion. Moreover, the signature of CD4(+) T cell exhaustion was found to be distinct from that of other CD4(+) T cell lineage subsets and was associated with TF heterogeneity. This study provides a framework for therapeutic interventions targeting exhausted CD4(+) T cells.	[Crawford, Alison; Angelosanto, Jill M.; Kao, Charlly; Doering, Travis A.; Odorizzi, Pamela M.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Crawford, Alison; Angelosanto, Jill M.; Kao, Charlly; Doering, Travis A.; Odorizzi, Pamela M.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; crawford, alison/AAS-3155-2020; Crawford, Alison/N-3234-2014	Crawford, Alison/0000-0002-4591-6341	NIH [AI071309, AI083022, AI082630, AI095608, AI078897, HHSN266200500030C]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U01AI095608, R01AI071309, P01AI078897, U19AI083022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Faust, D. J. Hussey, and D. E. Ambrose for FACS sorting. Thanks to members of the E. J. W. lab, G. Perona-Wright, and I. Stylianou for reading of the manuscript. This work was supported by grants from the NIH (AI071309, AI083022, AI082630, AI095608, AI078897, and HHSN266200500030C) to E. J. W. and the American Heart Association postdoctoral fellowship (to A.C.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Agnellini P, 2007, P NATL ACAD SCI USA, V104, P4565, DOI 10.1073/pnas.0610335104; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor JJ, 2009, J CLIN INVEST, V119, P1019, DOI 10.1172/JCI36534; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	43	305	319	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					289	302		10.1016/j.immuni.2014.01.005	http://dx.doi.org/10.1016/j.immuni.2014.01.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24530057	Green Accepted, Bronze			2022-12-18	WOS:000331637600015
J	Nakayamada, S; Kanno, Y; Takahashi, H; Jankovic, D; Lu, KT; Johnson, TA; Sun, HW; Vahedi, G; Hakim, O; Handon, R; Schwartzberg, PL; Hager, GL; O'Shea, JJ				Nakayamada, Shingo; Kanno, Yuka; Takahashi, Hayato; Jankovic, Dragana; Lu, Kristina T.; Johnson, Thomas A.; Sun, Hong-wei; Vahedi, Golnaz; Hakim, Ofir; Handon, Robin; Schwartzberg, Pamela L.; Hager, Gordon L.; O'Shea, John J.			Early Th1 Cell Differentiation Is Marked by a Tfh Cell-like Transition	IMMUNITY			English	Article							CD4(+) T-CELLS; FOLLICULAR HELPER-CELLS; INTERFERON-GAMMA; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; LINEAGE; EXPRESSION; PLASTICITY; BET; COMMITMENT	Follicular helper T (Tfh) cells comprise an important subset of helper T cells; however, their relationship with other helper lineages is incompletely understood. Herein, we showed interleukin-12 acting via the transcription factor STAT4 induced both 1121 and BcI6 genes, generating cells with features of both Tfh and Th1 cells. However, STAT4 also induced the transcription factor T-bet. With ChIP-seq, we defined the genome-wide targets of T-bet and found that it repressed BcI6 and other markers of Tfh cells, thereby attenuating the nascent Tfh cell-like phenotype in the late phase of Th1 cell specification. Tfh-like cells were rapidly generated after Toxoplasma gondii infection in mice, but T-bet constrained Tfh cell expansion and consequent germinal center formation and antibody production. Our data argue that Tfh and Th1 cells share a transitional stage through the signal mediated by STAT4, which promotes both phenotypes. However, T-bet represses Tfh cell functionalities, promoting full Th1 cell differentiation.	[Nakayamada, Shingo; Kanno, Yuka; Takahashi, Hayato; Vahedi, Golnaz; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Jankovic, Dragana] NIAID, Immunobiol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Lu, Kristina T.; Handon, Robin; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Johnson, Thomas A.; Hakim, Ofir; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA; [Sun, Hong-wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Nakayamada, S (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA.	nakayamadas@mail.nih.gov	Kanno, Yuka/B-5802-2013; Takahashi, Hayato/AAV-7707-2021	Kanno, Yuka/0000-0001-5668-9319; Takahashi, Hayato/0000-0001-6768-8821; Hakim, Ofir/0000-0003-0063-2721	NIAMS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Simone and J. Lay for technical help with cell sorting and A.C. Poholek for critical review of the manuscript. This research was supported by the Intramural Research Programs of NIAMS.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Aune TM, 2009, IMMUNOLOGY, V126, P299, DOI 10.1111/j.1365-2567.2008.03026.x; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Daha NA, 2009, ARTHRITIS RHEUM-US, V60, P1255, DOI 10.1002/art.24503; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Lund R, 2005, EUR J IMMUNOL, V35, P3307, DOI 10.1002/eji.200526079; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	41	305	313	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					919	931		10.1016/j.immuni.2011.11.012	http://dx.doi.org/10.1016/j.immuni.2011.11.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195747	Green Accepted, Bronze			2022-12-18	WOS:000298777300011
J	Kerdiles, YM; Stone, EL; Beisner, DL; McGargill, MA; Ch'en, IL; Stockmann, C; Katayama, CD; Hedrick, SM				Kerdiles, Yann M.; Stone, Erica L.; Beisner, Daniel L.; McGargill, Maureen A.; Ch'en, Irene L.; Stockmann, Christian; Katayama, Carol D.; Hedrick, Stephen M.			Foxo Transcription Factors Control Regulatory T Cell Development and Function	IMMUNITY			English	Article							L-SELECTIN; EXPRESSION; MICE; AKT; CTLA-4; DIFFERENTIATION; AUTOIMMUNITY; DOWNSTREAM; DISRUPTION; ACTIVATION	Foxo transcription factors integrate extrinsic signals to regulate cell division, differentiation and survival, and specific functions of lymphoid and myeloid cells. Here, we showed the absence of Foxo1 severely curtailed the development of Foxp3(+) regulatory T (Treg) cells and those that developed were nonfunctional in vivo. The loss of function included diminished CTLA-4 receptor expression as the Ctla4 gene was a direct target of Foxo1 T cell-specific loss of Foxo1 resulted in exocrine pancreatitis, hind limb paralysis, multiorgan lymphocyte infiltration, antinuclear antibodies and expanded germinal centers. Foxo-mediated control over Treg cell specification was further revealed by the inability of TGF-beta cytokine to suppress T-bet transcription factor in the absence of Foxo1, resulting in IFN-gamma secretion. In addition, the absence of Foxo3 exacerbated the effects of the loss of Foxo1. Thus, Foxo transcription factors guide the contingencies of T cell differentiation and the specific functions of effector cell populations.	[Kerdiles, Yann M.; Stone, Erica L.; Beisner, Daniel L.; Ch'en, Irene L.; Stockmann, Christian; Katayama, Carol D.; Hedrick, Stephen M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Kerdiles, Yann M.; Stone, Erica L.; Beisner, Daniel L.; Ch'en, Irene L.; Stockmann, Christian; Katayama, Carol D.; Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [McGargill, Maureen A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital	Hedrick, SM (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	kerdiles, yann/U-2190-2018; Hedrick, Stephen M/E-9171-2010; Stockmann, Christian/L-6956-2017; McGargill, Maureen/N-8131-2018; Ramaraj, Ravi Dr/U-7781-2018; Stockmann, Christian/Q-1615-2017	kerdiles, yann/0000-0002-8605-1073; McGargill, Maureen/0000-0002-0916-0372; Ramaraj, Ravi Dr/0000-0002-6288-808X; Hedrick, Stephen/0000-0002-6345-8751; Stockmann, Christian/0000-0002-9726-6838	PHS [R01 AI073885]; Juvenile Diabetes Research Foundation [2-2007-105]; Institutional Research and Academic Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073885] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Institutional Research and Academic Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Singer, NCI, Bethesda, MD, for providing Cd2-ll7Ra transgenic mice and D. Vignali (St. Jude's, TN) and A. Rudensky (Sloan-Kettering Memorial Hospital, New York, NY) for bone marrow from male Foxp3<SUP>-</SUP> mice. We thank Y. Lin (UC San Diego) for help with chromatin immunoprecipitation, I. Adams for expert mouse typing and technical support, and A. Morales and L. Lefler for mouse line maintenance. We especially thank P. Vogel, DVM, PhD, for the histological analysis and scoring of pancreata and the Veterinary Pathology Core at St. Jude for preparing, cutting, and staining tissue sections. This work was supported by PHS grant R01 AI073885 to S.M.H. and Juvenile Diabetes Research Foundation grant #2-2007-105 to M.A.M. E.L.S. is supported by an (K12) Institutional Research and Academic Career Development Award (L. Brunton, Director).	Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; D'Souza WN, 2008, J IMMUNOL, V181, P7617, DOI 10.4049/jimmunol.181.11.7617; Dejean A.S., 2010, ANTIOXID RE IN PRESS; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Drennan MB, 2009, EUR J IMMUNOL, V39, P925, DOI 10.1002/eji.200838912; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Mabrouk I, 2008, IMMUNITY, V29, P922, DOI 10.1016/j.immuni.2008.10.007; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ouyang W., 2010, TRENDS IMMU IN PRESS; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perkins D, 1996, J IMMUNOL, V156, P4154; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Torres-Borrego J, 2008, ALLERGOL IMMUNOPATH, V36, P90, DOI 10.1157/13120394; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wan YY, 2009, J MOL CELL BIOL, V1, P20, DOI 10.1093/jmcb/mjp001; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; WOODLAND DL, 1991, NATURE, V349, P529, DOI 10.1038/349529a0; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	67	305	321	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					890	904		10.1016/j.immuni.2010.12.002	http://dx.doi.org/10.1016/j.immuni.2010.12.002			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21167754	Bronze, Green Accepted			2022-12-18	WOS:000286293900010
J	Zhang, N; Schroppel, B; Lal, G; Jakubzick, C; Mao, X; Chen, D; Yin, N; Jessberger, R; Ochando, JC; Ding, YZ; Bromberg, JS				Zhang, Nan; Schroeppel, Bernd; Lal, Girdhari; Jakubzick, Claudia; Mao, Xia; Chen, Dan; Yin, Na; Jessberger, Rolf; Ochando, Jordi C.; Ding, Yaozhong; Bromberg, Jonathan S.			Regulatory T Cells Sequentially Migrate from Inflamed Tissues to Draining Lymph Nodes to Suppress the Alloimmune Response	IMMUNITY			English	Article							DENDRITIC CELLS; L-SELECTIN; CHEMOKINE RECEPTOR; IMMUNE-RESPONSE; NAIVE-LIKE; FUC-TVII; IN-VIVO; CCR7; INHIBIT; MICE	To determine the site and mechanism of suppression by regulatory T (Treg) cells, we investigated their migration and function in an islet allograft model. Treg cells first migrated from blood to the inflamed allograft where they were essential for the suppression of alloimmunity. This process was dependent on the chemokine receptors CCR2, CCR4, and CCR5 and P- and E-selectin ligands. In the allograft, Treg cells were activated and subsequently migrated to the draining lymph nodes (dLNs) in a CCR2, CCR5, and CCR7 fashion; this movement was essential for optimal suppression. Treg cells inhibited dendritic cell migration in a TGF-beta and IL-10 dependent fashion and suppressed antigen-specific T effector cell migration, accumulation, and proliferation in dLNs and allografts. These results showed that sequential migration from blood to the target tissue and to dLNs is required for Treg cells to differentiate and execute fully their suppressive function.	[Zhang, Nan; Lal, Girdhari; Jakubzick, Claudia; Mao, Xia; Chen, Dan; Yin, Na; Jessberger, Rolf; Ochando, Jordi C.; Ding, Yaozhong; Bromberg, Jonathan S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Zhang, Nan; Schroeppel, Bernd; Ochando, Jordi C.; Ding, Yaozhong; Bromberg, Jonathan S.] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA; [Schroeppel, Bernd] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Ding, Yaozhong; Bromberg, Jonathan S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Jessberger, Rolf] Tech Univ Dresden, Dept Physiol Chem, D-01307 Dresden, Germany; [Ochando, Jordi C.] Inst Salud Carlos III, Unidad Immunol Trasplantes, Ctr Nacl Microbiol, Madrid 28220, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Bromberg, JS (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.	jon.bromberg@mountsinai.org	Lal, Girdhari/AAU-8179-2021; Ochando, Jordi/B-6219-2008; Ochando, jordi/ABE-2358-2020; Lal, Girdhari/C-1752-2012	Lal, Girdhari/0000-0002-3799-3603; Ochando, Jordi/0000-0001-7037-1681; Ochando, jordi/0000-0001-7037-1681; Lal, Girdhari/0000-0002-3799-3603	NIH [R01 Al-44929, R01 Al-62765, JDRF 1-2005-1, K08 A1071038]; Emerald Foundation; Ministerio de Educacion y Ciencia, Spain [SAF2007-63579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI071038, R01AI041428, R01AI044929, R01AI062765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Ministerio de Educacion y Ciencia, Spain(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 Al-44929, NIH R01 Al-62765, JDRF 1-2005-16, and the Emerald Foundation (all to J.S.B.); NIH K08 A1071038 (to B.S.); and the Ministerio de Educacion y Ciencia, Spain SAF2007-63579 (to J.C.O.).	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Chen DM, 2006, DIABETES, V55, P1011, DOI 10.2337/diabetes.55.04.06.db05-1048; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Huang MC, 2000, J BIOL CHEM, V275, P31353, DOI 10.1074/jbc.M005449200; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Schuh JM, 2002, FASEB J, V16, P1313, DOI 10.1096/fj.02-0193fje; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Wagers AJ, 2000, J IMMUNOL, V165, P5011, DOI 10.4049/jimmunol.165.9.5011; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963	37	305	315	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					458	469		10.1016/j.immuni.2008.12.022	http://dx.doi.org/10.1016/j.immuni.2008.12.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303390	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000264405500017
J	de Alboran, IM; O'Hagan, RC; Gartner, F; Malynn, B; Davidson, L; Rickert, R; Rajewsky, K; DePinho, RA; Alt, FW				de Alboran, IM; O'Hagan, RC; Gartner, F; Malynn, B; Davidson, L; Rickert, R; Rajewsky, K; DePinho, RA; Alt, FW			Analysis of C-MYC function in normal cells via conditional gene-targeted mutation	IMMUNITY			English	Article							EXPRESSION INDUCES APOPTOSIS; GROWTH ARREST; CYCLE PROGRESSION; PROTEIN-SYNTHESIS; TRANSGENIC MICE; IN-VIVO; B-CELLS; IDENTIFICATION; FIBROBLASTS; ACTIVATION	Germline inactivation of c-myc in mice causes embryonic lethality. Therefore, we developed a LoxP/Cre-based conditional mutation approach to test the role of c-myc in mouse embryonic fibroblasts (MEFs) and mature B lymphocytes. Cre expression resulted in reduced proliferation of wild-type MEFs, but c-Myc-deficient MEFs showed a further reduction. In contrast to fibroblasts, Cre expression had no apparent affect on wild-type B cell proliferation. Deletion of both c-Myc genes in B cells led to severely impaired proliferation in response to anti-CD40 plus IL-4. However, treated cells did upregulate several early activation markers but not CD95 or CD95 ligand. We discuss these findings with respect to potential c-Myc functions in proliferation and apoptosis and also discuss potential limitations in the Cre-mediated gene inactivation approach.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu	Moreno de Alboran, Ignacio/K-1044-2017; de Fátima Gärtner, Maria/A-3530-2010	de Fátima Gärtner, Maria/0000-0002-5302-0086; Rajewsky, Klaus/0000-0002-6633-6370; DePinho, Ronald/0000-0002-5625-577X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028317] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R29CA061009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009300] Funding Source: NIH RePORTER; NCI NIH HHS [CA61009] Funding Source: Medline; NEI NIH HHS [EY09300] Funding Source: Medline; NICHD NIH HHS [HD28317] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ASKEW DS, 1991, ONCOGENE, V6, P1915; BELANI CP, 1994, CANCER CHEMOTH PHARM, V34, pS118, DOI 10.1007/BF00684875; Berns K, 1997, ONCOGENE, V15, P1347, DOI 10.1038/sj.onc.1201280; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; DAKSIS JI, 1994, ONCOGENE, V9, P3635; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ezhevsky SA, 1996, MOL BIOL CELL, V7, P553, DOI 10.1091/mbc.7.4.553; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; FISCHER G, 1994, J EXP MED, V179, P221, DOI 10.1084/jem.179.1.221; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kaptein JS, 1996, J BIOL CHEM, V271, P18875, DOI 10.1074/jbc.271.31.18875; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAHOZ EG, 1994, P NATL ACAD SCI USA, V91, P5503, DOI 10.1073/pnas.91.12.5503; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MORGENBESSER SD, 1994, SEMIN CANCER BIOL, V5, P21; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; PALMIERI S, 1983, EMBO J, V2, P2385, DOI 10.1002/j.1460-2075.1983.tb01750.x; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Rudolph B, 1996, EMBO J, V15, P3065, DOI 10.1002/j.1460-2075.1996.tb00669.x; SHEINESS D, 1978, J VIROL, V28, P600, DOI 10.1128/JVI.28.2.600-610.1978; Sonenshein GE, 1997, J IMMUNOL, V158, P1994; SPANOPOULOU E, 1989, NATURE, V342, P185, DOI 10.1038/342185a0; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; STERN DF, 1986, MOL CELL BIOL, V6, P870, DOI 10.1128/MCB.6.3.870; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; WATERS CM, 1991, ONCOGENE, V6, P797; Wu M, 1999, J IMMUNOL, V163, P6530; Wu M, 1996, MOL CELL BIOL, V16, P5015; ZIMMERMAN K, 1990, Critical Reviews in Oncogenesis, V2, P75; Zornig M, 1996, CURR BIOL, V6, P1553, DOI 10.1016/S0960-9822(02)70769-0	60	305	314	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2001	14	1					45	55		10.1016/S1074-7613(01)00088-7	http://dx.doi.org/10.1016/S1074-7613(01)00088-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163229	Bronze			2022-12-18	WOS:000166513800005
J	Zaiss, DMW; Gause, WC; Osborne, LC; Artis, D				Zaiss, Dietmar M. W.; Gause, William C.; Osborne, Lisa C.; Artis, David			Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair	IMMUNITY			English	Review							GROWTH-FACTOR RECEPTOR; INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; HUMAN MAST-CELLS; HEPARAN-SULFATE; GENE-EXPRESSION; TGF-BETA; AIRWAY HYPERREACTIVITY; SUSTAINED ACTIVATION; DENDRITIC CELLS	Type 2 inflammatory responses can be elicited by diverse stimuli, including toxins, venoms, allergens, and infectious agents, and play critical roles in resistance and tolerance associated with infection, wound healing, tissue repair, and tumor development. Emerging data suggest that in addition to characteristic type 2-associated cytokines, the epidermal growth factor (EGF)-like molecule Amphiregulin (AREG) might be a critical component of type 2-mediated resistance and tolerance. Notably, numerous studies demonstrate that in addition to the established role of epithelial- and mesenchymal-derived AREG, multiple leukocyte populations including mast cells, basophils, group 2 innate lymphoid cells (ILC2s), and a subset of tissue-resident regulatory CD4(+) T cells can express AREG. In this review, we discuss recent advances in our understanding of the AREG-EGF receptor pathway and its involvement in infection and inflammation and propose a model for the function of this pathway in the context of resistance and tissue tolerance.	[Zaiss, Dietmar M. W.] Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh EH9 3FL, Midlothian, Scotland; [Gause, William C.] Rutgers State Univ, New Jersey Med Sch, Ctr Immun & Inflammat, Dept Med, Newark, NJ 07101 USA; [Osborne, Lisa C.; Artis, David] Cornell Univ, Jill Roberts Inst Res IBD, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med Coll, New York, NY 10021 USA	University of Edinburgh; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University	Zaiss, DMW (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh EH9 3FL, Midlothian, Scotland.	dietmar.zaiss@ed.ac.uk; gausewc@njms.rutgers.edu; dartis@med.cornell.edu	Osborne, Lisa/K-3027-2015	Osborne, Lisa/0000-0002-7170-3235; Zaiss, Dietmar M.W./0000-0003-3596-7062; Artis, David/0000-0002-1753-4100	European Union; Medical Research Council [MR/M011755/1]; Asthma UK; National Institutes of Health [AI107588, AI031678, AI061570, AI095608, AI074878, AI095466, AI106697, AI102942, AI097333]; Crohns and Colitis Foundation of America; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031678, R01AI107588, R01AI074878, U01AI095608, R01AI095466, R01AI061570, P01AI106697, R01AI097333, R01AI102942] Funding Source: NIH RePORTER; MRC [MR/M011755/1] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma UK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Alice Sijts, as well as members of the Zaiss and of the Artis laboratories, for critical appraisal of the manuscript. Research in the Zaiss laboratory is supported by the European Union (CIG: "EGFR for Immunity''), the Medical Research Council (MR/M011755/1), and Asthma UK. D.M.W.Z. is a member of The Wellcome Trust supported Center for Immunity, Infection and Evolution (CIIE). The Gause laboratory is supported by the National Institutes of Health (AI107588, AI031678). The Artis laboratory is supported by the National Institutes of Health (AI061570, AI095608, AI074878, AI095466, AI106697, AI102942, AI097333), the Crohns and Colitis Foundation of America, and the Burroughs Wellcome Fund. The Gause laboratory is supported by the National Institutes of Health (AI107588, AI031678).	ADAM R, 1995, BBA-MOL CELL RES, V1266, P83, DOI 10.1016/0167-4889(94)00224-3; Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bennett KL, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046925; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Bles N, 2010, BLOOD, V116, P3219, DOI 10.1182/blood-2010-01-265611; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brunner SM, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-16; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Chung EK, 2005, EXP CELL RES, V309, P149, DOI 10.1016/j.yexcr.2005.05.012; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; Dai K., 2014, IMMUNOLOGY; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; de Vries VC, 2010, CURR OPIN IMMUNOL, V22, P643, DOI 10.1016/j.coi.2010.08.015; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Halabi-Tawil M, 2009, BRIT J DERMATOL, V160, P645, DOI 10.1111/j.1365-2133.2008.08835.x; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbst RS, 2001, EXPERT OPIN BIOL TH, V1, P719, DOI 10.1517/14712598.1.4.719; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Johansson CC, 2004, ENDOCRINOLOGY, V145, P5177, DOI 10.1210/en.2004-0232; JOHNSON GR, 1994, J BIOL CHEM, V269, P27149; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jovanovic K, 2014, CLIN EXP IMMUNOL, V178, P201, DOI 10.1111/cei.12409; Kajiwara Naoki, 2010, Allergology International, V59, P207, DOI 10.2332/allergolint.09-OA-0144; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kim S, 2008, HEAD NECK-J SCI SPEC, V30, P667, DOI 10.1002/hed.20859; KIMURA H, 1992, J CELL BIOL, V116, P777, DOI 10.1083/jcb.116.3.777; Krishnamoorthy N., 2014, J IMMUNOLOGY; Kwong BY, 2010, J INVEST DERMATOL, V130, P1726, DOI 10.1038/jid.2009.362; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Leveson-Gower DB, 2013, BLOOD, V122, P3659, DOI 10.1182/blood-2013-08-519157; LI SW, 1992, J CELL PHYSIOL, V153, P103, DOI 10.1002/jcp.1041530114; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Mascia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005773; Matsumoto K, 2009, INT ARCH ALLERGY IMM, V149, P39, DOI 10.1159/000210652; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meulenbroeks C, 2015, J INVEST DERMATOL, V135, P222, DOI 10.1038/jid.2014.329; Yamada M, 2008, CLIN CANCER RES, V14, P2351, DOI 10.1158/1078-0432.CCR-07-4499; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Mukhopadhyay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075907; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palucka K, 2013, CANCER J, V19, P511, DOI 10.1097/PPO.0000000000000007; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Qi YL, 2010, J ALLERGY CLIN IMMUN, V126, P1260, DOI 10.1016/j.jaci.2010.08.040; Rodland KD, 2008, J BIOL CHEM, V283, P31477, DOI 10.1074/jbc.M800456200; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schuger L, 1996, DEVELOPMENT, V122, P1759; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Shao JY, 2003, CANCER RES, V63, P5218; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Suga H, 2014, STEM CELLS, V32, P1347, DOI 10.1002/stem.1648; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; VARDY DA, 1995, J CELL PHYSIOL, V163, P257, DOI 10.1002/jcp.1041630206; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Yagami Akiko, 2010, Allergol Int, V59, P277, DOI 10.2332/allergolint.09-OA-0149; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zheng T, 2008, J IMMUNOL, V180, P522, DOI 10.4049/jimmunol.180.1.522; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	112	304	314	8	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					216	226		10.1016/j.immuni.2015.01.020	http://dx.doi.org/10.1016/j.immuni.2015.01.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692699	Green Accepted, Bronze			2022-12-18	WOS:000349916400007
J	Fehniger, TA; Cai, SF; Cao, X; Bredemeyer, AJ; Presti, RI; French, AR; Ley, TJ				Fehniger, Todd A.; Cai, Sheng F.; Cao, Xuefan; Bredemeyer, Andrew J.; Presti, Rachel Im.; French, Anthony R.; Ley, Timothy J.			Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HERPES-SIMPLEX-VIRUS; T-CELLS; CYTOMEGALOVIRUS-INFECTION; DIFFERENTIAL EXPRESSION; GAMMA-INTERFERON; RAPID INDUCTION; DENDRITIC CELLS; DISTINCT ROLES; ACTIVATION	Although activated murine NK cells can use the granule exocytosis pathway to kill target cells immediately upon recognition, resting murine NK cells are minimally cytotoxic for unknown reasons. Here, we showed that resting NK cells contained abundant granzyme A, but little granzyme B or perforin; in contrast, the mRNAs for all three genes were abundant. Cytokine-induced in vitro activation of NK cells resulted in potent cytotoxicity associated with a dramatic increase in granzyme B and perforin, but only minimal changes in mRNA abundance for these genes. The same pattern of regulation was found in vivo with murine cytomegalovirus infection as a physiologic model of NK cell activation. These data suggest that resting murine NK cells are minimally cytotoxic because of a block in perforin and granzyme B mRNA translation that is released by NK cell activation.	Washington Univ, Sch Med, Siteman Canc Ctr, Dept Pediat,Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, Dept Internal Med,Div Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Siteman Canc Ctr, Dept Internal Med,Div Infect Dis, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	French, AR (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, Dept Pediat,Div Rheumatol, St Louis, MO 63110 USA.	french_a@kids.wusti.edu; tley@im.wustl.edu		Presti, Rachel/0000-0002-5469-0727; Fehniger, Todd/0000-0002-8705-2887; Cai, Sheng/0000-0002-2708-887X	NIAID NIH HHS [AI059083] Funding Source: Medline; NIAMS NIH HHS [P30 AR048335] Funding Source: Medline; NIDDK NIH HHS [DK49786] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI059083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Babichuk CK, 1997, J BIOL CHEM, V272, P18564, DOI 10.1074/jbc.272.30.18564; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Cheeran MCJ, 2005, J NEUROVIROL, V11, P274, DOI 10.1080/13550280590952808; Chen G, 2001, BLOOD, V98, P156, DOI 10.1182/blood.V98.1.156; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dix RD, 2003, J VIROL, V77, P3402, DOI 10.1128/JVI.77.6.3402-3408.2003; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; EBNET K, 1995, J EXP MED, V181, P755, DOI 10.1084/jem.181.2.755; GARCIASANZ JA, 1990, J IMMUNOL, V145, P3111; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; GRUNDY MA, 2006, IN PRESS IN VIV 1208, DOI DOI 10.1007/S00262-006-0264-1; HANSON RD, 1990, MOL CELL BIOL, V10, P5655, DOI 10.1128/MCB.10.11.5655; HEISE MT, 1995, J VIROL, V69, P904, DOI 10.1128/JVI.69.2.904-909.1995; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Maclvor DM, 1999, BLOOD, V93, P963, DOI 10.1182/blood.V93.3.963.403k18_963_973; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Shresta S, 1997, J BIOL CHEM, V272, P20236, DOI 10.1074/jbc.272.32.20236; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; SMYTH MJ, 1995, J LEUKOCYTE BIOL, V57, P88, DOI 10.1002/jlb.57.1.88; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yuan W, 2007, BLOOD, V109, P961, DOI 10.1182/blood-2006-07-036640	60	304	312	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					798	811		10.1016/j.immuni.2007.04.010	http://dx.doi.org/10.1016/j.immuni.2007.04.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17540585	Bronze			2022-12-18	WOS:000247646900015
J	Bergtold, A; Desai, DD; Gavhane, A; Clyne, R				Bergtold, A; Desai, DD; Gavhane, A; Clyne, R			Cell surface recycling of internalized antigen permits dendritic cell priming of B cells	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; IN-VITRO; ANTIBODY-RESPONSES; IMMUNOGLOBULIN-G; III RECEPTORS; FC-RECEPTORS; LYMPH-NODES; IGG; DIFFERENTIATION; COMPLEMENT	Dendritic cells process internalized antigens to present degradative products on MHC for TCR recognition. Because antigen-exposed DCs also induce humoral immunity, DCs must also retain antigen in its native state for the engagement of BCR on B cells. Here, we demonstrate that antigen endocytosed by the inhibitory Fc receptor, Fc gamma RIIB, accesses a nondegradative intracellular vesicular compartment that recycles to the cell surface, enabling interaction of native antigen with BCR on B cells. Immunization with IgG-opsonized, T independent antigens leads to enhanced humoral responses in a FcyRIIB and complement dependent manner. IC-loaded DCs trafficking to the splenic marginal zone can prime a T independent response in an Fc gamma RIIB-dependent manner. Thus dendritic cells are equipped with both nondegradative and degradative antigen uptake pathways to facilitate antigen presentation to both B and T cells.	Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med & Microbiol, New York, NY 10032 USA	Columbia University; Columbia University	Clyne, R (corresponding author), Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA.	rc645@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007525] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI 07525, P01AI150514] Funding Source: Medline; NCPDCID CDC HHS [R01 NCI CA94037] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS		Amigorena S, 1998, J EXP MED, V187, P505, DOI 10.1084/jem.187.4.505; AMIGORENA S, 1992, NATURE, V358, P337, DOI 10.1038/358337a0; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Dubois B, 1998, J IMMUNOL, V161, P2223; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Fang YF, 1998, J IMMUNOL, V160, P5273; Getahun A, 2004, J IMMUNOL, V172, P5269, DOI 10.4049/jimmunol.172.9.5269; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kushnir N, 1998, J IMMUNOL, V160, P1774; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Malarkannan S, 2000, METH MOL B, V156, P265; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; Minskoff SA, 1998, J IMMUNOL, V161, P2079; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Saeki H, 2000, EUR J IMMUNOL, V30, P2808, DOI 10.1002/1521-4141(200010)30:10<2808::AID-IMMU2808>3.0.CO;2-K; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; STUART SG, 1989, EMBO J, V8, P3657, DOI 10.1002/j.1460-2075.1989.tb08540.x; Tan PS, 2003, J IMMUNOL, V170, P2549, DOI 10.4049/jimmunol.170.5.2549; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; UKKONEN P, 1986, J EXP MED, V163, P952, DOI 10.1084/jem.163.4.952; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Wernersson S, 1999, J IMMUNOL, V163, P618; Wu MT, 2002, J IMMUNOL, V168, P5096, DOI 10.4049/jimmunol.168.10.5096; Wykes M, 1998, J IMMUNOL, V161, P1313; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	57	304	315	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					503	514		10.1016/j.immuni.2005.09.013	http://dx.doi.org/10.1016/j.immuni.2005.09.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286018	Bronze			2022-12-18	WOS:000233660700007
J	Pentcheva-Hoang, T; Egen, JG; Wojnoonski, K; Allison, JP				Pentcheva-Hoang, T; Egen, JG; Wojnoonski, K; Allison, JP			B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse	IMMUNITY			English	Article							CD4(+) T-CELLS; COSTIMULATORY MOLECULE; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; SPLICE VARIANT; BINDING DOMAIN; CO-STIMULATION; CD86; EXPRESSION; ACTIVATION	The reported affinity differences between CD28 and CTLA-4 binding to B7-1 and B7-2 may serve to selectively regulate CD28 and CTLA-4 function by differentially recruiting and/or stabilizing these molecules at the immunological synapse. Here we show that ligand binding is important for the accumulation of both CD28 and CTLA-4 at the synapse. While CD28 is recruited to the synapse in the absence of B7-1 and B7-2 binding, it is not effectively stabilized there, as its localization can be disrupted by CTLA-4. In the case of CTLA-4 ligand binding is critical for its concentration at the synapse. We also demonstrate that the affinity and avidity differences in ligand binding translate into selective recruitment of CD28 or CTLA-4 to the immunological synapse-B7-1 is the major ligand mediating CTLA-4 localization, while B7-2 is the main ligand for CD28 concentration at the synapse.	Univ Calif Berkeley, Howard Hughes Med Inst, Canc Res Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Allison, JP (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA.	allisonj@mskcc.org		Egen, Jackson/0000-0003-2053-0837; Allison, James/0000-0001-8980-5697	NATIONAL CANCER INSTITUTE [R01CA040041, R37CA040041] Funding Source: NIH RePORTER; NCI NIH HHS [CA40041] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; ARNOLD LW, 1983, J IMMUNOL, V131, P2064; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Hanawa H, 2002, BLOOD, V99, P2138, DOI 10.1182/blood.V99.6.2138; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HAWLEY RG, 1994, GENE THER, V1, P136; Judge TA, 1999, J IMMUNOL, V162, P1947; Kariv I, 1996, J IMMUNOL, V157, P29; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Kuhns MS, 2000, P NATL ACAD SCI USA, V97, P12711, DOI 10.1073/pnas.220423597; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; Li S, 2000, EUR J IMMUNOL, V30, P1394, DOI 10.1002/(SICI)1521-4141(200005)30:5<1394::AID-IMMU1394>3.0.CO;2-O; Liang BL, 1999, J IMMUNOL, V163, P2322; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Miller SD, 1995, IMMUNITY, V3, P739, DOI 10.1016/1074-7613(95)90063-2; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morton PA, 1996, J IMMUNOL, V156, P1047; NAKAJIMA A, 1995, EUR J IMMUNOL, V25, P3060, DOI 10.1002/eji.1830251112; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; Peterson KE, 1999, J IMMUNOL, V162, P1859; Saegusa K, 2000, CLIN EXP IMMUNOL, V119, P354; Salomon B, 2001, ANNU REV IMMUNOL, V19, P225, DOI 10.1146/annurev.immunol.19.1.225; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Silver PB, 2000, J IMMUNOL, V165, P5041, DOI 10.4049/jimmunol.165.9.5041; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Zang XX, 2003, P NATL ACAD SCI USA, V100, P10388, DOI 10.1073/pnas.1434299100; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	47	304	331	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					401	413		10.1016/j.immuni.2004.06.017	http://dx.doi.org/10.1016/j.immuni.2004.06.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357951	Bronze			2022-12-18	WOS:000224034900011
J	Klonowski, KD; Williams, KJ; Marzo, AL; Blair, DA; Lingenheld, EG; Lefrancois, L				Klonowski, KD; Williams, KJ; Marzo, AL; Blair, DA; Lingenheld, EG; Lefrancois, L			Dynamics of blood-borne CD8 memory T cell migration in vivo	IMMUNITY			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; CUTTING EDGE; PROTECTIVE IMMUNITY; PHENOTYPIC ANALYSIS; DENDRITIC CELLS; GUT; EFFECTOR; TISSUE; EXPRESSION; TRAFFICKING	Memory T cells are distributed throughout the body following infection, but the migratory dynamics of the memory pool in vivo is unknown. The ability of circulating microbe-specific memory T cells to populate lymphoid and nonlymphoid tissues was examined using adoptive transfer and parabiosis systems. While migration of memory CD8 T cells to lymph nodes and peritoneal cavity required G(i)-coupled receptor signaling, migration to the spleen, bone marrow, lung, and liver was independent of this pathway. Following parabiosis, memory T cells rapidly equilibrated into the lymphoid tissues, lung, and liver of each parabiont, implying most memory cells were not obligately tissue resident. Equilibration of memory cell populations was delayed in the brain, peritoneal cavity, and intestinal lamina propria, indicating controlled gating for entry into these tissues. In addition, memory cell migration to the lamina propria required beta7 integrins. Thus, the blood-borne T cell pool serves to maintain the homeostasis of tissue-based memory populations.	Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Div Immunol, 263 Farmington Ave, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu		Marzo, amanda/0000-0002-5839-0430	NIAID NIH HHS [AI41576, AI053970] Funding Source: Medline; NIDDK NIH HHS [DK45260] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, F32AI053970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045260] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abitorabi MA, 1996, J IMMUNOL, V156, P3111; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; DEMARIA R, 1993, EUR J IMMUNOL, V23, P3104, DOI 10.1002/eji.1830231209; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Haddad W, 2003, J EXP MED, V198, P369, DOI 10.1084/jem.20020691; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; HULEATT JW, 1995, J IMMUNOL, V154, P5684; JAMES SP, 1986, GASTROENTEROLOGY, V91, P1483, DOI 10.1016/0016-5085(86)90205-2; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kim SK, 1999, J IMMUNOL, V163, P4125; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Laky K, 1997, J IMMUNOL, V158, P1417; Lefrancois L, 1999, J EXP MED, V190, P1275, DOI 10.1084/jem.190.9.1275; Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631; Lefrancois L, 2003, J IMMUNOL, V171, P2832, DOI 10.4049/jimmunol.171.6.2832; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Marzo AL, 2002, J IMMUNOL, V168, P4504, DOI 10.4049/jimmunol.168.9.4504; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; POUSSIER P, 1993, J EXP MED, V178, P1947, DOI 10.1084/jem.178.6.1947; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang HC, 2002, J IMMUNOL, V169, P4717, DOI 10.4049/jimmunol.169.9.4717; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Westermann J, 1999, IMMUNOL TODAY, V20, P302, DOI 10.1016/S0167-5699(99)01474-7; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241	64	304	305	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					551	562		10.1016/S1074-7613(04)00103-7	http://dx.doi.org/10.1016/S1074-7613(04)00103-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142524	Bronze			2022-12-18	WOS:000221631900006
J	Liu, XQ; Dai, SD; Zhu, YN; Marrack, P; Kappler, JW				Liu, XQ; Dai, SD; Zhu, YN; Marrack, P; Kappler, JW			The structure of a Bcl-x(L)/Bim fragment complex: implications for bim function	IMMUNITY			English	Article							BCL-2 FAMILY PROTEINS; CYTOCHROME-C RELEASE; CELL-DEATH; BAX OLIGOMERIZATION; BH3 DOMAIN; MEMBER BIM; T-CELLS; X-RAY; CHANNEL; MITOCHONDRIA	After antigen-driven expansion, the majority of T cells involved in an immune response die rapidly by apoptosis dependent on the Bcl-2 related proteins, Bim and Bax or Bak. The details of how these proteins are activated and interact are still unclear. The crystal structure of mouse Bcl-x(L) bound to a long helical fragment of Bim indicates that the structure of Bim is very different from proteins with a Bcl-2-like fold and may leave the BH3 region of Bim constitutively exposed. Based on the structural homology between BcI-x(L) and Bax, we predicted that binding of Bim to Bax would require displacement of the Bax penultimate alpha helix. Consistent with this prediction, truncation of this short helix was required for Bim/Bax interaction and led to spontaneous activation of Bax. Our results suggest a way in which both Bim and Bax/Bak might be required for activated T cell apoptosis.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, 1400 Jackson St, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Biomol Struct, Denver, CO 80262 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kappler, JW (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, 1400 Jackson St, Denver, CO 80206 USA.	kapplerj@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI017134, R56AI018785, R01AI017134, R01AI018785, R37AI017134, R37AI018785, P01AI022295] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22295, AI-18785, AI-17134] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKBAR AN, 1993, IMMUNOL TODAY, V14, P526, DOI 10.1016/0167-5699(93)90181-J; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belzacq AS, 2003, CANCER RES, V63, P541; Bouillet P, 2002, NAT IMMUNOL, V3, P893, DOI 10.1038/ni1002-893; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; MARTZ E, 2001, PROTEIN EXPLORER SOF; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Noel PJ, 1996, J IMMUNOL, V157, P636; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Ruffolo SC, 2000, CELL DEATH DIFFER, V7, P1101, DOI 10.1038/sj.cdd.4400739; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Webb S R, 1992, Semin Immunol, V4, P329; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	63	304	322	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					341	352		10.1016/S1074-7613(03)00234-6	http://dx.doi.org/10.1016/S1074-7613(03)00234-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499110	Bronze			2022-12-18	WOS:000185499800006
J	Rada, C; Ehrenstein, MR; Neuberger, MS; Milstein, C				Rada, C; Ehrenstein, MR; Neuberger, MS; Milstein, C			Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting	IMMUNITY			English	Article							IMMUNOGLOBULIN GENES; B-CELLS; PASSENGER TRANSGENES; REPERTOIRE; MATURATION; SEQUENCES; PATCHES; KAPPA	Likely creation of mismatches during somatic hypermutation has stimulated interest in the effect of mismatch repair deficiency on the process. Analysis of unselected mutations in the 3' Rank of VH rearrangements in germinal center B cells revealed that MSH2 deficiency caused a B-fold reduced mutation accumulation. This might reflect ectopic effects of the Msh2 disruption; indeed, the mice exhibit other perturbations within the B cell compartment. However, that MSH2 (or factors dependent upon it) plays a role in the mechanism of mutation fixation is indicated by a strikingly increased focusing of the mutations on intrinsic hot spots. We propose two phases to hypermutation targeting. The first is hot spot focused and MSH2 independent; the second, MSH2-dependent phase yields a more even spread of mutation fixation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Neuberger, MS (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Ehrenstein, Michael/0000-0003-1673-743X				BEREK C, 1987, IMMUNOL REV, V96, P23, DOI 10.1111/j.1600-065X.1987.tb00507.x; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Dorner T, 1998, IMMUNOL REV, V162, P161, DOI 10.1111/j.1600-065X.1998.tb01439.x; GONZALEZFERNANDEZ A, 1993, P NATL ACAD SCI USA, V90, P9862, DOI 10.1073/pnas.90.21.9862; GONZALEZFERNANDEZ A, 1994, EUR J IMMUNOL, V24, P2918, DOI 10.1002/eji.1830241151; GONZALEZFERNANDEZ A, 1994, P NATL ACAD SCI USA, V91, P12614, DOI 10.1073/pnas.91.26.12614; Goyenechea B, 1996, P NATL ACAD SCI USA, V93, P13979, DOI 10.1073/pnas.93.24.13979; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Klix N, 1998, EUR J IMMUNOL, V28, P317, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;317::AID-IMMU317&gt;3.0.CO;2-S; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; MILSTEIN C, 1998, IN PRESS P NATL ACAD; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; PARHAM P, 1998, IMMUNOLOGICAL REV, V162; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; SHARPE MJ, 1991, EMBO J, V10, P2139, DOI 10.1002/j.1460-2075.1991.tb07748.x; Storb U, 1996, CURR OPIN IMMUNOL, V8, P206, DOI 10.1016/S0952-7915(96)80059-8; WEILL JC, 1996, SEMIN IMMUNOL, V8; Winter DB, 1998, P NATL ACAD SCI USA, V95, P6953, DOI 10.1073/pnas.95.12.6953	26	304	307	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					135	141		10.1016/S1074-7613(00)80595-6	http://dx.doi.org/10.1016/S1074-7613(00)80595-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697843	Bronze			2022-12-18	WOS:000075066600013
J	Weng, NP				Weng, NP			Aging of the immune system: How much can the adaptive immune system adapt?	IMMUNITY			English	Editorial Material							T-CELL REPERTOIRE; B-CELL; TELOMERASE EXPRESSION; AGE; LYMPHOCYTES; NAIVE; DIFFERENTIATION; ACTIVATION; SENESCENCE; PHENOTYPE	The competency of the adaptive immune function decreases with age, primarily because of the decline in production of naive lymphocytes in the bone marrow and thymus as well as the expansion of incompetent memory lymphocytes. Here I discuss the recent progress on age-associated changes in lymphocytes and their effect on the adaptive immune system.	NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Weng, NP (corresponding author), NIA, Immunol Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	wengn@mail.nih.gov	Weng, Nan-ping/AAC-5037-2020		Intramural NIH HHS [Z01 AG000756-10] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000756] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akha AAS, 2005, CURR OPIN IMMUNOL, V17, P486, DOI 10.1016/j.coi.2005.07.004; Allman D, 2005, CURR OPIN IMMUNOL, V17, P463, DOI 10.1016/j.coi.2005.07.002; Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; AZUMA M, 1993, J IMMUNOL, V150, P1147; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Fann M, 2005, IMMUNOL REV, V205, P190, DOI 10.1111/j.0105-2896.2005.00262.x; Franceschi C, 1995, Int Rev Immunol, V12, P1, DOI 10.3109/08830189509056697; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Hooijberg E, 2000, J IMMUNOL, V165, P4239, DOI 10.4049/jimmunol.165.8.4239; Johnson SA, 2004, ARTHRITIS RES THER, V6, P131, DOI 10.1186/ar1180; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Kovaiou RD, 2005, INT IMMUNOL, V17, P1359, DOI 10.1093/intimm/dxh314; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mo R, 2003, J IMMUNOL, V170, P895, DOI 10.4049/jimmunol.170.2.895; Monteiro J, 1996, J IMMUNOL, V156, P3587; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Reed JR, 2004, J EXP MED, V199, P1433, DOI 10.1084/jem.20040178; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Son NH, 2003, MECH AGEING DEV, V124, P427, DOI 10.1016/S0047-6374(03)00018-6; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091	31	303	328	2	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					495	499		10.1016/j.immuni.2006.05.001	http://dx.doi.org/10.1016/j.immuni.2006.05.001			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713964	Green Accepted, Bronze			2022-12-18	WOS:000237970100003
J	de Saint-Vis, B; Vincent, J; Vandenabeele, S; Vanbervliet, B; Pin, JJ; Ait-Yahia, S; Patel, S; Mattei, MG; Banchereau, J; Zurawski, S; Davoust, J; Caux, C; Lebecque, S				de Saint-Vis, B; Vincent, J; Vandenabeele, S; Vanbervliet, B; Pin, JJ; Ait-Yahia, S; Patel, S; Mattei, MG; Banchereau, J; Zurawski, S; Davoust, J; Caux, C; Lebecque, S			A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment	IMMUNITY			English	Article; Proceedings Paper	Keystone Symposia on Cellular and Molecular Biology of Dendritic Cells	MAR 03-09, 1998	SANTA FE, NM				CELL-SURFACE EXPRESSION; HUMAN DENDRITIC CELLS; LANGERHANS CELLS; B-CELLS; INFLAMMATORY STIMULI; ANTIGEN PRESENTATION; INVARIANT CHAIN; PLASMA-MEMBRANE; TRANSPORT; ACCUMULATION	We have identified a novel lysosome-associated membrane glycoprotein localized on chromosome 3q26.3-q27, DC-LAMP, which is homologous to CD68. DC-LAMP mRNA is present only in lymphoid organs and DC. A specific MAb detects the protein exclusively in interdigitating dendritic cells. Expression of DC-LAMP increases progressively during in vitro DC differentiation, but sharply upon activation with LPS, TNF alpha, or CD40L. Confocal microscopy confirmed the lysosomal distribution of the protein. Furthermore, DC-LAMP was found in the MHC class II compartment immediately before the translocation of MHC class II molecules to the cell surface, after which it concentrates into perinuclear lysosomes. This suggests that DC-LAMP might change the lysosome function after the transfer of peptide-MHC class II molecules to the surface of DC.	Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France; CNRS, INSERM, Ctr Immunol, F-13288 Marseille, France; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Fac Med Timone, INSERM, U491, F-13385 Marseille, France; Baylor Inst Immunol Res, Dallas, TX 75246 USA	Merck & Company; Schering Plough Corporation; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Baylor Scott & White Health	Lebecque, S (corresponding author), Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France.	serge.lebecque@sch-plough.fr		Caux, Christophe/0000-0003-2438-833X; Davoust, Jean/0000-0002-3098-7665; lebecque, serge/0000-0003-4006-8061				AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bjorck P, 1997, EUR J IMMUNOL, V27, P1266, DOI 10.1002/eji.1830270531; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cresswell P, 1998, SCIENCE, V280, P394, DOI 10.1126/science.280.5362.394; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; FITHIAN E, 1981, P NATL ACAD SCI-BIOL, V78, P2541, DOI 10.1073/pnas.78.4.2541; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GARRIGUES J, 1994, J CELL BIOL, V125, P129, DOI 10.1083/jcb.125.1.129; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HOLNESS CL, 1993, BLOOD, V81, P1607; INABA K, 1985, SCIENCE, V229, P475, DOI 10.1126/science.3160115; INABA K, 1983, P NATL ACAD SCI-BIOL, V80, P6041, DOI 10.1073/pnas.80.19.6041; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KASHIHARA M, 1986, J INVEST DERMATOL, V87, P602, DOI 10.1111/1523-1747.ep12455849; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MATTEI MG, 1990, J BIOL CHEM, V265, P7548; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mosialos G, 1996, AM J PATHOL, V148, P593; NIJMAN HW, 1995, J EXP MED, V182, P163, DOI 10.1084/jem.182.1.163; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Rovere P, 1998, P NATL ACAD SCI USA, V95, P1067, DOI 10.1073/pnas.95.3.1067; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; SAITOH O, 1992, J BIOL CHEM, V267, P5700; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; ZHOU LJ, 1992, J IMMUNOL, V149, P735	46	303	313	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					325	336		10.1016/S1074-7613(00)80615-9	http://dx.doi.org/10.1016/S1074-7613(00)80615-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology	124VA	9768752	Bronze			2022-12-18	WOS:000076202300005
J	Taki, S; Sato, T; Ogasawara, K; Fukuda, T; Sato, M; Hida, S; Suzuki, G; Mitsuyama, M; Shin, EH; Kojima, S; Taniguchi, T; Asano, Y				Taki, S; Sato, T; Ogasawara, K; Fukuda, T; Sato, M; Hida, S; Suzuki, G; Mitsuyama, M; Shin, EH; Kojima, S; Taniguchi, T; Asano, Y			Multistage regulation of Th1-type immune responses by the transcription factor IRF-1	IMMUNITY			English	Article							HELPER PHENOTYPE DEVELOPMENT; NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; CD4+ T-CELLS; NF-KAPPA-B; INTERFERON-GAMMA; TRANSGENIC MICE; NUCLEAR FACTOR; FACTOR-I; INTERLEUKIN-12	Eradication of a given pathogen is dependent on the selective differentiation of T helper (Th) cells into Th1 or Th2 types. We show here that T cells from mice lacking the transcription factor IRF-1 fail to mount Th1 responses and instead exclusively undergo Th2 differentiation in vitro. Compromised Th1 differentiation is found to be associated with defects in multiple cell types, namely impaired production of interleukin-12 by macrophages, hyporesponsiveness of CD4(+) T cells to interleukin-12, and defective development of natural killer cells. These results indicate the involvement of IRF-1 in multiple stages of the Th1 limb of the immune response.	NATL INST RADIOL SCI,CHIBA 263,JAPAN; NIIGATA UNIV,SCH MED,DEPT MICROBIOL,NIIGATA 951,JAPAN; UNIV TOKYO,INST MED SCI,DEPT PARASITOL,TOKYO 108,JAPAN	National Institutes for Quantum Science & Technology; Niigata University; University of Tokyo	Taki, S (corresponding author), UNIV TOKYO,FAC MED,DEPT IMMUNOL,TOKYO 113,JAPAN.		Ogasawara, Kouetsu/G-9892-2011	Taki, Shinsuke/0000-0001-5143-3496				ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401; AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; CHUA AO, 1995, J IMMUNOL, V155, P4286; Coffman RL, 1997, J EXP MED, V185, P373, DOI 10.1084/jem.185.3.373; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY KM, 1989, P NATL ACAD SCI USA, V86, P10034, DOI 10.1073/pnas.86.24.10034; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Takahashi M, 1996, J IMMUNOL, V156, P2436; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; URBAN JF, 1993, J IMMUNOL, V151, P7086; URBAN JF, 1995, J IMMUNOL, V154, P4675; WATANABE Y, 1986, INFECT IMMUN, V52, P730, DOI 10.1128/IAI.52.3.730-735.1986; WOLF SF, 1991, J IMMUNOL, V146, P3074; Yoshimoto T, 1996, J IMMUNOL, V156, P1082	56	303	305	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					673	679		10.1016/S1074-7613(00)80443-4	http://dx.doi.org/10.1016/S1074-7613(00)80443-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208840	Bronze			2022-12-18	WOS:A1997XG57900003
J	Tedder, TF; Inaoki, M; Sato, S				Tedder, TF; Inaoki, M; Sato, S			The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity	IMMUNITY			English	Review							HUMAN LYMPHOCYTES-B; SYSTEMIC LUPUS-ERYTHEMATOSUS; BARR VIRUS RECEPTOR; TRANSGENIC MICE; B-1 CELLS; T-CELL; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIPROLIFERATIVE ANTIBODY; MONOCLONAL-ANTIBODIES; CYTOPLASMIC DOMAIN				Tedder, TF (corresponding author), DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27710 USA.				NATIONAL CANCER INSTITUTE [R01CA054464, R55CA054464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL050985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026872] Funding Source: NIH RePORTER; NCI NIH HHS [CA-54464] Funding Source: Medline; NHLBI NIH HHS [HL-50985] Funding Source: Medline; NIAID NIH HHS [AI-26872] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ATKINSON JP, 1992, SYSTEMIC LUPUS ERYTH, P87; BITTERSUERMANN D, 1990, CURR TOP MICROBIOL, V153, P222; BOTTGER EC, 1985, J IMMUNOL, V135, P4100; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; BRADBURY LE, 1993, J IMMUNOL, V151, P2915; CAHENKRAMER Y, 1994, J EXP MED, V180, P2079, DOI 10.1084/jem.180.6.2079; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CHALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978, DOI 10.1002/eji.1830251040; Cook L., 1992, SYSTEMIC LUPUS ERYTH, P569; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; COOPER MD, 1980, IMMUNOL REV, V52, P29, DOI 10.1111/j.1600-065X.1980.tb00329.x; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DUKOR P, 1973, CELL IMMUNOL, V7, P349, DOI 10.1016/0008-8749(73)90199-8; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; ENGEL P, 1994, LEUKOCYTE TYPING, V5, P684; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; FINCO O, 1992, J EXP MED, V175, P537, DOI 10.1084/jem.175.2.537; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Fischer MB, 1996, J IMMUNOL, V157, P549; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GUILBERT B, 1982, J IMMUNOL, V128, P2779; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; JACKSON CG, 1979, NEW ENGL J MED, V300, P1124, DOI 10.1056/NEJM197905173002002; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; Kearney J F, 1992, Int Rev Immunol, V8, P247, DOI 10.3109/08830189209055577; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KLAUS GGB, 1977, IMMUNOLOGY, V33, P31; KLINMAN DM, 1988, J CLIN INVEST, V82, P652, DOI 10.1172/JCI113644; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; KOZONO Y, 1995, EUR J IMMUNOL, V25, P1013, DOI 10.1002/eji.1830250423; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; LACHMANN PJ, 1987, CIBA F SYMP, V129, P149; LEVY S, 1991, J BIOL CHEM, V266, P14597; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; MATSUMOTO AK, 1991, J EXP MED, V173, P55, DOI 10.1084/jem.173.1.55; MELCHERS F, 1985, NATURE, V317, P264, DOI 10.1038/317264a0; MELCHERS F, 1986, MOL IMMUNOL, V23, P1173, DOI 10.1016/0161-5890(86)90148-3; MOLINA H, 1990, J IMMUNOL, V145, P2974; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; MURAKAMI M, 1995, IMMUNOL TODAY, V16, P534, DOI 10.1016/0167-5699(95)80047-6; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; OCHS HD, 1983, CLIN EXP IMMUNOL, V53, P208; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; ONEIL KM, 1988, J IMMUNOL, V140, P1939; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; PEPYS MB, 1976, TRANSPLANT REV-DENMA, V32, P93; PEPYS MB, 1972, NATURE-NEW BIOL, V237, P157, DOI 10.1038/newbio237157a0; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; PETRI M, 1993, MEDICINE, V72, P236, DOI 10.1097/00005792-199307000-00003; REAP EA, 1993, J EXP MED, V177, P69, DOI 10.1084/jem.177.1.69; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; RIGLEY KP, 1991, EUR J IMMUNOL, V21, P535, DOI 10.1002/eji.1830210302; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1996, J IMMUNOL, V157, P4371; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SATO S, 1997, IN PRESS J IMMUNOL, V158; SHIRAI T, 1991, CLIN IMMUNOL IMMUNOP, V59, P173, DOI 10.1016/0090-1229(91)90016-4; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STRIEBICH CC, 1990, J IMMUNOL, V144, P1857; TAKAHASHI S, 1990, J IMMUNOL, V145, P2207; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; TEDDER TF, 1984, J IMMUNOL, V133, P678; TEDDER TF, 1989, J IMMUNOL, V143, P712; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; TEDDER TF, 1983, J IMMUNOL, V130, P1668; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; UCKUN FM, 1993, J BIOL CHEM, V268, P21172; VANNOESEL CJM, 1993, IMMUNOL TODAY, V14, P8, DOI 10.1016/0167-5699(93)90316-D; VANNOESEL CJM, 1993, INT IMMUNOL, V5, P699; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WEIS JJ, 1986, P NATL ACAD SCI USA, V83, P5639, DOI 10.1073/pnas.83.15.5639; WENG WK, 1994, J BIOL CHEM, V269, P32514; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WIERSMA EJ, 1991, EUR J IMMUNOL, V21, P2501, DOI 10.1002/eji.1830211029; WILSON JG, 1983, J IMMUNOL, V131, P684; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHOU LJ, 1991, J IMMUNOL, V147, P1424; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	101	303	312	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1997	6	2					107	118		10.1016/S1074-7613(00)80418-5	http://dx.doi.org/10.1016/S1074-7613(00)80418-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047233	Bronze			2022-12-18	WOS:A1997XC61600001
J	Asano, K; Nabeyama, A; Miyake, Y; Qiu, CH; Kurita, A; Tomura, M; Kanagawa, O; Fujii, S; Tanaka, M				Asano, Kenichi; Nabeyama, Ami; Miyake, Yasunobu; Qiu, Chun-Hong; Kurita, Ai; Tomura, Michio; Kanagawa, Osami; Fujii, Shin-ichiro; Tanaka, Masato			CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens	IMMUNITY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; TRANSFECTED DENDRITIC CELLS; LYMPH-NODE; APOPTOTIC CELLS; T-CELLS; B-CELLS; CANCER-IMMUNOTHERAPY; LANGERHANS CELLS; MARGINAL ZONE; IN-VIVO	The generation of tumor-directed cytotoxic T lymphocytes is considered crucial for the induction of antitumor immunity. To activate these CD8(+) T cells, antigen-presenting cells (APCs) must initially acquire tumor cell-associated antigens. The major source of tumor antigens is dead tumor cells, but little is known about how APCs in draining lymph nodes acquire and crosspresent these antigens. Here we show that CD169(+) macrophages phagocytose dead tumor cells transported via lymphatic flow and subsequently crosspresent tumor antigens to CD8(+) T cells. Subcutaneous immunization with irradiated tumor cells protects mice from syngenic tumor. However, tumor antigen-specific CD8(+) T cell activation and subsequent antitumor immunity are severely impaired in mice depleted with CD169(+) macrophages. Neither migratory dendritic cells (DCs) nor lymph node-resident conventional DCs are essential for the crosspresentation of tumor antigens. Thus, we have identified CD169(+) macrophages as lymph node-resident APCs dominating early activation of tumor antigen-specific CD8(+) T cells.	[Asano, Kenichi; Nabeyama, Ami; Miyake, Yasunobu; Qiu, Chun-Hong; Kurita, Ai; Tanaka, Masato] RIKEN Res Ctr Allergy & Immunol, Lab Innate Cellular Immun, Kanagawa 2300045, Japan; [Tomura, Michio; Kanagawa, Osami] RIKEN Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Kanagawa 2300045, Japan; [Fujii, Shin-ichiro] RIKEN Res Ctr Allergy & Immunol, Res Unit Cellular Immunotherapy, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN	Tanaka, M (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Innate Cellular Immun, Kanagawa 2300045, Japan.	mtanaka@rcai.riken.jp	Fujii, Shin-ichiro/O-6218-2015	Qiu, Chunhong/0000-0001-7514-5093; Fujii, Shin-ichiro/0000-0003-3586-3976	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; Grants-in-Aid for Scientific Research [21590546, 23390095] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. Malissen for Langerin-DTR mice, W.R. Heath for OT-I mice, S. Nagata for W3 cells, P.D. Burrows for critical reading of the manuscript, A. Tesniere for advice regarding anticancer chemotherapy, H. Fujimoto and Y. Hachiman for cell sorting, and M. Shimura for secretarial assistance. This work was supported in a part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Angeli V, 2001, J EXP MED, V193, P1135, DOI 10.1084/jem.193.10.1135; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535	44	302	310	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					85	95		10.1016/j.immuni.2010.12.011	http://dx.doi.org/10.1016/j.immuni.2010.12.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21194983	Bronze			2022-12-18	WOS:000287336600012
J	George, S; Miao, D; Demetri, GD; Adeegbe, D; Rodig, SJ; Shukla, S; Lipschitz, M; Amin-Mansour, A; Raut, CP; Carter, SL; Hammerman, P; Freeman, GJ; Wu, CJ; Ott, PA; Wong, KK; Van Allen, EM				George, Suzanne; Miao, Diana; Demetri, George D.; Adeegbe, Dennis; Rodig, Scott J.; Shukla, Sachet; Lipschitz, Mikel; Amin-Mansour, Ali; Raut, Chandrajit P.; Carter, Scott L.; Hammerman, Peter; Freeman, Gordon J.; Wu, Catherine J.; Ott, Patrick A.; Wong, Kwok-Kin; Van Allen, Eliezer M.			Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma	IMMUNITY			English	Article							SOMATIC MUTATIONS; CTLA-4 BLOCKADE; EXOME ANALYSIS; PD-1 BLOCKADE; GENOMICS DATA; HUMAN CANCER; T-CELLS; MELANOMA; BINDING; LANDSCAPE	Response to immune checkpoint blockade in mesenchymal tumors is poorly characterized, but immunogenomic dissection of these cancers could inform immunotherapy mediators. We identified a treatment- naive patient who has metastatic uterine leiomyosarcoma and has experienced complete tumor remission for >2 years on anti-PD-1 (pembrolizumab) monotherapy. We analyzed the primary tumor, the sole treatment-resistant metastasis, and germline tissue to explore mechanisms of immunotherapy sensitivity and resistance. Both tumors stained diffusely for PD-L2 and showed sparse PD-L1 staining. PD-1(+) cell infiltration significantly decreased in the resistant tumor (p = 0.039). Genomically, the treatment-resistant tumor uniquely harbored biallelic PTEN loss and had reduced expression of two neoantigens that demonstrated strong immunoreactivity with patient T cells in vitro, suggesting long-lasting immunological memory. In this near-complete response to PD-1 blockade in a mesenchymal tumor, we identified PTEN mutations and reduced expression of genes encoding neoantigens as potential mediators of resistance to immune checkpoint therapy.	[George, Suzanne; Miao, Diana; Demetri, George D.; Adeegbe, Dennis; Shukla, Sachet; Carter, Scott L.; Hammerman, Peter; Freeman, Gordon J.; Wu, Catherine J.; Ott, Patrick A.; Wong, Kwok-Kin; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Miao, Diana; Amin-Mansour, Ali; Carter, Scott L.; Hammerman, Peter; Wu, Catherine J.; Van Allen, Eliezer M.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Demetri, George D.] Ludwig Ctr Harvard, Boston, MA 02215 USA; [Rodig, Scott J.; Lipschitz, Mikel] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Rodig, Scott J.; Freeman, Gordon J.; Wu, Catherine J.] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA 02215 USA; [Raut, Chandrajit P.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02215 USA; [Adeegbe, Dennis; Carter, Scott L.; Van Allen, Eliezer M.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Van Allen, EM (corresponding author), Broad Inst & Harvard, Cambridge, MA 02142 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA.	eliezerm_vanallen@dfci.harvard.edu	Freeman, Gordon/AAC-5380-2019; Rodig, Scott/Y-3889-2019	Freeman, Gordon/0000-0002-7210-5616; Adeegbe, Dennis/0000-0001-9233-3328	BroadIgnite; BroadNext10; Catherine England Leiomyosarcoma Research Fund; Ludwig Center at Harvard; Erica Kaitz LMS RESEARCH NOW Fund; NIH [K08CA188615, P50CA101942]; Alexandra J. Miliotis Pediatric Oncology Research Fund; Howard Hughes Medical Institute Medical Research Fellowship; NATIONAL CANCER INSTITUTE [P50CA101942, R50CA211482, R01CA155010, K08CA188615, R01CA140594] Funding Source: NIH RePORTER	BroadIgnite; BroadNext10; Catherine England Leiomyosarcoma Research Fund; Ludwig Center at Harvard; Erica Kaitz LMS RESEARCH NOW Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexandra J. Miliotis Pediatric Oncology Research Fund; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by BroadIgnite (E.M.V.A.), BroadNext10 (E.M.V.A., D.M., and P.H.), the Catherine England Leiomyosarcoma Research Fund (S.G.), the Ludwig Center at Harvard (G.D.D.), the Erica Kaitz LMS RESEARCH NOW Fund (G.D.D.), NIH K08CA188615 (E.M.V.A.), NIH P50CA101942 (G.J.F.), the Alexandra J. Miliotis Pediatric Oncology Research Fund (D.M.), and the Howard Hughes Medical Institute Medical Research Fellowship (D.M.). The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Anagnostou V., 2016, CANC DISCOV; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0393-x; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin Y, 2009, CYTOTHERAPY, V11, P912, DOI 10.3109/14653240903136987; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Maki Robert G., 2013, Sarcoma, V2013, P168145, DOI 10.1155/2013/168145; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Philips GK, 2015, INT IMMUNOL, V27, P39, DOI 10.1093/intimm/dxu095; Rizvi NA, 2016, CANCER DISCOV, V6, P128, DOI 10.1158/2159-8290.CD-15-1501; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stachler MD, 2015, NAT GENET, V47, P1047, DOI 10.1038/ng.3343; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	39	301	318	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					197	204		10.1016/j.immuni.2017.02.001	http://dx.doi.org/10.1016/j.immuni.2017.02.001			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228279	Green Accepted, Bronze			2022-12-18	WOS:000396410900009
J	Scharschmidt, TC; Vasquez, KS; Truong, HA; Gearty, SV; Pauli, ML; Nosbaum, A; Gratz, IK; Otto, M; Moon, JJ; Liese, J; Abbas, AK; Fischbach, MA; Rosenblum, MD				Scharschmidt, Tiffany C.; Vasquez, Kimberly S.; Truong, Hong-An; Gearty, Sofia V.; Pauli, Mariela L.; Nosbaum, Audrey; Gratz, Iris K.; Otto, Michael; Moon, James J.; Liese, Jan; Abbas, Abul K.; Fischbach, Michael A.; Rosenblum, Michael D.			A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes	IMMUNITY			English	Article							INTESTINAL MICROBIOTA; HAIR-FOLLICLES; IMMUNITY; DISEASE; INFLAMMATION; DIVERSITY; INFECTION; RESIDENT; BACTERIA; HOST	The skin is a site of constant dialog between the immune system and commensal bacteria. However, the molecular mechanisms that allow us to tolerate the presence of skin commensals without eliciting destructive inflammation are unknown. Using a model system to study the antigen-specific response to S. epidermidis, we demonstrated that skin colonization during a defined period of neonatal life was required for establishing immune tolerance to commensal microbes. This crucial window was characterized by an abrupt influx of highly activated regulatory T (Treg) cells into neonatal skin. Selective inhibition of this Treg cell wave completely abrogated tolerance. Thus, the host-commensal relationship in the skin relied on a unique Treg cell population that mediated tolerance to bacterial antigens during a defined developmental window. This suggests that the cutaneous microbiome composition in neonatal life is crucial in shaping adaptive immune responses to commensals, and disrupting these interactions might have enduring health implications.	[Scharschmidt, Tiffany C.; Vasquez, Kimberly S.; Truong, Hong-An; Gearty, Sofia V.; Pauli, Mariela L.; Nosbaum, Audrey; Rosenblum, Michael D.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Gratz, Iris K.] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Otto, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Pulm & Crit Care Med, Boston, MA 02129 USA; [Moon, James J.] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Liese, Jan] Univ Tubingen Hosp, Inst Med Microbiol & Hyg, D-72076 Tubingen, Germany; [Abbas, Abul K.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Salzburg University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosenblum, MD (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.	michael.rosenblum@ucsf.edu	Gratz, Iris K/L-6267-2015; Nosbaum, Audrey/AAC-9329-2020; moon, james/F-1031-2014	Gratz, Iris K/0000-0001-7470-7277; Nosbaum, Audrey/0000-0003-2281-9052; Fischbach, Michael/0000-0003-3079-8247; Gearty, Sofia/0000-0001-8633-3663; moon, james/0000-0001-8071-1491; Scharschmidt, Tiffany/0000-0001-5517-089X; Moon, James/0000-0001-8246-931X; Otto, Michael/0000-0002-2222-4115	Diabetes Research Center [NIH P30 DK063720]; NIH [5P30CA082103-15, K08-AR062064, R21-AR066821, DP2-AR068130]; Dermatology Foundation Career Development Award; UCSF Department of Dermatology; Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases; Burroughs Wellcome Fund [CAMS-1010934]; Scleroderma Research Foundation grant; National Psoriasis Foundation Translational Grant; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001080, ZIAAI000904, U19AI095261, R01AI107020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR062064, R21AR066821, DP2AR068130, K08AR068409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Diabetes Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation Career Development Award; UCSF Department of Dermatology; Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Scleroderma Research Foundation grant; National Psoriasis Foundation Translational Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Benetiz for assistance with animal husbandry and Creative Commons author Seans Potato Business for use of the mouse image in Figures S2 and S4 under the Attribution-ShareAlike license (https://creativecommons.org/licenses/by-sa/3.0/legalcode). Flow-cytometry data were generated in the UCSF Parnassus Flow Cytometry Core, which is supported by the Diabetes Research Center grant NIH P30 DK063720. Histology was performed with assistance from the UCSF Mouse Pathology Core, which is supported by NIH 5P30CA082103-15. T.C.S. is supported by a Dermatology Foundation Career Development Award and the UCSF Department of Dermatology. M.O. is supported by the Intramural Research Program of the NIH National Institute of Allergy and Infectious Diseases. This work was primarily funded by grants to M.D.R.: NIH K08-AR062064, Burroughs Wellcome Fund CAMS-1010934, NIH R21-AR066821, NIH DP2-AR068130, a Scleroderma Research Foundation grant, and a National Psoriasis Foundation Translational Grant.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; ALLGAIER H, 1986, EUR J BIOCHEM, V160, P9, DOI 10.1111/j.1432-1033.1986.tb09933.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002883; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Garcia-Garcera M, 2012, ENVIRON MICROBIOL, V14, P2087, DOI 10.1111/j.1462-2920.2012.02756.x; Gauger T, 2012, MICROB BIOTECHNOL, V5, P129, DOI 10.1111/j.1751-7915.2011.00304.x; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gratz IK, 2014, J IMMUNOL, V192, P1351, DOI 10.4049/jimmunol.1301777; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lange-Asschenfeldt B, 2011, SKIN PHARMACOL PHYS, V24, P305, DOI 10.1159/000328728; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LEEMING JP, 1984, J GEN MICROBIOL, V130, P803; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nazary M, 2011, EUR J PHARMACOL, V672, P1, DOI 10.1016/j.ejphar.2011.08.047; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	54	301	313	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					1011	1021		10.1016/j.immuni.2015.10.016	http://dx.doi.org/10.1016/j.immuni.2015.10.016			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588783	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000366846000020
J	Molofsky, AB; Van Gool, F; Liang, HE; Van Dyken, SJ; Nussbaum, JC; Lee, J; Bluestone, JA; Locksley, RM				Molofsky, Ari B.; Van Gool, Frederic; Liang, Hong-Erh; Van Dyken, Steven J.; Nussbaum, Jesse C.; Lee, Jinwoo; Bluestone, Jeffrey A.; Locksley, Richard M.			Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation	IMMUNITY			English	Article							ADIPOSE-TISSUE INFLAMMATION; T-CELLS; INSULIN-RESISTANCE; TYPE-2 IMMUNITY; ALLOGRAFT SURVIVAL; PPAR-GAMMA; BEIGE FAT; IL-33; OBESITY; MACROPHAGES	Group 2 innate lymphoid cells (ILC2s) and regulatory T (Treg) cells are systemically induced by helminth infection but also sustain metabolic homeostasis in adipose tissue and contribute to tissue repair during injury. Here we show that interleukin-33 (IL-33) mediates activation of ILC2s and Treg cells in resting adipose tissue, but also after helminth infection or treatment with IL-2. Unexpectedly, ILC2-intrinsic IL-33 activation was required for Treg cell accumulation in vivo and was independent of ILC2 type 2 cytokines but partially dependent on direct co-stimulatory interactions via ICOSL-ICOS. IFN-gamma inhibited ILC2 activation and Treg cell accumulation by IL-33 in infected tissue, as well as adipose tissue, where repression increased with aging and high-fat diet-induced obesity. IL-33 and ILC2s are central mediators of type 2 immune responses that promote tissue and metabolic homeostasis, and IFN-gamma suppresses this pathway, likely to promote inflammatory responses and divert metabolic resources necessary to protect the host.	[Liang, Hong-Erh; Van Dyken, Steven J.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Van Gool, Frederic; Bluestone, Jeffrey A.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Nussbaum, Jesse C.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Molofsky, Ari B.; Van Dyken, Steven J.; Nussbaum, Jesse C.; Lee, Jinwoo; Bluestone, Jeffrey A.; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Lee, Jinwoo/AAA-9510-2020; Van Gool, Frederic/V-4638-2019	Lee, Jinwoo/0000-0003-2991-4183; Molofsky, Ari/0000-0003-0764-3175; Van Dyken, Steven/0000-0002-9787-0883	NIH [AI026918, AI030663, AI078869, HL107202, K08DK101604]; UCSF Diabetes Family Fund; UCSF REAC Pilot Grant; Sandler Asthma Basic Research Center at UCSF; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, T32AI007334, K08AI113143, P01AI078869, R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, K08DK101604] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes Family Fund; UCSF REAC Pilot Grant; Sandler Asthma Basic Research Center at UCSF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Akira, J.-P. Girard, A. DeFranco, and A. Rudensky for mice; Drs. A. DeFranco, A. Abbas, and C. Lowell for comments on the manuscript; Z.-E. Wang for technical assistance; and G. Rizzuto and J.D. Sauer for assistance with Listeria infections. This work was supported by AI026918, AI030663, AI078869, HL107202, and K08DK101604 (A.B.M.) from the NIH, the UCSF Diabetes Family Fund (A.B.M.), the UCSF REAC Pilot Grant (A.B.M.), the Sandler Asthma Basic Research Center at UCSF, and the Howard Hughes Medical Institute.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Brestoff J. R., 2014, NATURE, V519, P1; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Coyle AJ, 1996, J IMMUNOL, V156, P2680; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hussaarts L., 2015, FASEB J; Johnston CJ, 2014, TRANSPLANTATION, V97, P127, DOI 10.1097/TP.0b013e3182a53f59; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liang YJ, 2013, J IMMUNOL, V190, P5666, DOI 10.4049/jimmunol.1300117; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Reinhardt R. L., 2015, NOVEL MODEL IFN MEDI; REINHOLD U, 1993, J AM ACAD DERMATOL, V29, P58, DOI 10.1016/0190-9622(93)70152-J; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Sim GC, 2014, J CLIN INVEST, V124, P99, DOI 10.1172/JCI46266; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Van Gool F, 2014, BLOOD, V124, P3572, DOI 10.1182/blood-2014-07-587493; Vasanthakumar A, 2015, NAT IMMUNOL; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Wood PMD, 2005, EUR J PEDIATR, V164, P741, DOI 10.1007/s00431-005-1745-5; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Zeyda M., 2012, INT J OBES LONDON; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	60	301	311	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					161	174		10.1016/j.immuni.2015.05.019	http://dx.doi.org/10.1016/j.immuni.2015.05.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26092469	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000360101100018
J	Mazzini, E; Massimiliano, L; Penna, G; Rescigno, M				Mazzini, Elisa; Massimiliano, Lucia; Penna, Giuseppe; Rescigno, Maria			Oral Tolerance Can Be Established via Gap Junction Transfer of Fed Antigens from CX3CR1(+) Macrophages to CD103(+) Dendritic Cells	IMMUNITY			English	Article							MEDIATED INTERCELLULAR COMMUNICATION; REGULATORY T-CELLS; LY6C(HI) MONOCYTES; CROSS-PRESENTATION; MUCOSAL; DIFFERENTIATION; ACTIVATION; GENERATION; IMMUNITY; BACTERIA	Antigen-presenting cells (APCs) in the gut are apt at oral tolerance establishment at steady state and immunity after infection; complex tasks in an environment exposed to the inflammatory burden of the microbiota. Here we show an unanticipated division of labor among APCs for the establishment of oral tolerance. Chemokine receptor CX3CR1(+) macrophages were found to take up soluble fed antigens and quickly transfer them to CD103(+) dendritic cells (DCs). Antigen transfer occurred via a mechanism that was Connexin 43-dependent and required membrane transfer, indicating a physiological role of gap junctions in antigen presentation. Deletion of Connexin 43 in APCs affected antigen transfer and resulted in the inability of CD103(+) DCs to acquire and present antigens in vivo, to drive T regulatory cell differentiation and to induce tolerance to food antigens. This functional cooperation between intestinal phagocytes might be a mechanism to avoid the exposure of tolerogenic DCs to the intestinal microbiota.	[Mazzini, Elisa; Massimiliano, Lucia; Penna, Giuseppe; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.	maria.rescigno@ieo.eu	Massimiliano, Lucia/AAP-5179-2020; Rescigno, Maria/J-9704-2012; Penna, Giuseppe/AAB-8784-2019; Penna, Giuseppe/B-3359-2015	Rescigno, Maria/0000-0002-6464-509X; Penna, Giuseppe/0000-0003-3534-7090; Massimiliano, Lucia/0000-0001-9128-4317	European Commission (ERC Dendroworld); Italian Foundation for Cancer Research (AIRC); International Association for Cancer Research (AICR); Italian Ministry of Health (Ricerca Finalizzata)	European Commission (ERC Dendroworld); Italian Foundation for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research (AICR); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy)	M.R. is supported by grants of the European Commission (ERC Dendroworld), the Italian Foundation for Cancer Research (AIRC), the International Association for Cancer Research (AICR), and the Italian Ministry of Health (Ricerca Finalizzata).	Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Falk MM, 2012, J MEMBRANE BIOL, V245, P465, DOI 10.1007/s00232-012-9464-0; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Luckey U, 2012, J ALLERGY CLIN IMMUN, V130, P781, DOI 10.1016/j.jaci.2012.06.022; Matsue H, 2006, J IMMUNOL, V176, P181, DOI 10.4049/jimmunol.176.1.181; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Montecino-Rodriguez E, 2000, BLOOD, V96, P917, DOI 10.1182/blood.V96.3.917.015k45_917_924; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Pabst O, 2010, EUR J IMMUNOL, V40, P2107, DOI 10.1002/eji.201040557; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Saccheri F, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000739; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Smyth LA, 2012, J IMMUNOL, V189, P2274, DOI 10.4049/jimmunol.1200664; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Zeng R, 2013, MUCOSAL IMMUNOL, V6, P847, DOI 10.1038/mi.2012.123; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	44	301	308	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					248	261		10.1016/j.immuni.2013.12.012	http://dx.doi.org/10.1016/j.immuni.2013.12.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24462723	Bronze			2022-12-18	WOS:000331637600012
J	Igyarto, BZ; Haley, K; Ortner, D; Bobr, A; Gerami-Nejad, M; Edelson, BT; Zurawski, SM; Malissen, B; Zurawski, G; Berman, J; Kaplan, DH				Igyarto, Botond Z.; Haley, Krystal; Ortner, Daniela; Bobr, Aleh; Gerami-Nejad, Maryam; Edelson, Brian T.; Zurawski, Sandra M.; Malissen, Bernard; Zurawski, Gerard; Berman, Judith; Kaplan, Daniel H.			Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses	IMMUNITY			English	Article							EPIDERMAL LANGERHANS CELLS; CANDIDA-ALBICANS; IN-VIVO; CONTACT HYPERSENSITIVITY; IMMUNE-RESPONSES; TH17 CELLS; POSITIVE SELECTION; SELF-ANTIGENS; HOST-DEFENSE; INFECTIONS	Skin-resident dendritic cells (DCs) are well positioned to encounter cutaneous pathogens and are required for the initiation of adaptive immune responses. There are at least three subsets of skin DC-Langerhans cells (LC), Langerin(+) dermal DCs (dDCs), and classic dDCs. Whether these subsets have distinct or redundant function in vivo is poorly understood. Using a Candida albicans skin infection model, we have shown that direct presentation of antigen by LC is necessary and sufficient for the generation of antigen-specific T helper-17 (Th17) cells but not for the generation of cytotoxic lymphocytes (CTLs). In contrast, Langerin(+) dDCs are required for the generation of antigen specific CTL and Th1 cells. Langerin(+) dDCs also inhibited the ability of LCs and classic DCs to promote Th17 cell responses. This work demonstrates that skin-resident DC subsets promote distinct and opposing antigen-specific responses.	[Igyarto, Botond Z.; Haley, Krystal; Ortner, Daniela; Bobr, Aleh; Kaplan, Daniel H.] Univ Minnesota, Ctr Immunol, Dept Dermatol, Minneapolis, MN 55455 USA; [Gerami-Nejad, Maryam; Berman, Judith] Univ Minnesota, Ctr Immunol, Dept Mol & Cellular Biol, Minneapolis, MN 55455 USA; [Zurawski, Sandra M.; Zurawski, Gerard] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Zurawski, Sandra M.; Zurawski, Gerard] ANRS Ctr Human Vaccines, INSERM U899, Dallas, TX 75204 USA; [Malissen, Bernard] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, F-13288 Marseille 9, France; [Edelson, Brian T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Washington University (WUSTL)	Kaplan, DH (corresponding author), Univ Minnesota, Ctr Immunol, Dept Dermatol, Minneapolis, MN 55455 USA.	dankaplan@umn.edu	Berman, Judith/AAS-5115-2021; Kaplan, Daniel H/N-2779-2013; Berman, Judith/ABA-8528-2021; Malissen, Bernard/AAK-4659-2020	Kaplan, Daniel H/0000-0002-7851-7320; Berman, Judith/0000-0002-8577-0084; Bobr, Aleh/0000-0003-1597-8071; Ortner-Tobider, Daniela Anna/0000-0002-9433-5367; Edelson, Brian/0000-0003-2856-7650; Malissen, Bernard/0000-0003-1340-9342; Igyarto, Botond/0000-0002-9770-800X	National Institutes of Health (NIH) [R01-AR056632, U19 AI057234]; Dermatology Foundation; American Skin Association; Baylor Health Care System Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, R01AI062427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056632] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; American Skin Association; Baylor Health Care System Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	S.Z. and G.Z. are inventors on patent applications for LC-targeting vaccines. We would like to acknowledge K. Hogquist and M. Jenkins for their insightful input and critique of the manuscript. We thank the University of Minnesota Research Animal Resources staff for animal care. P. Champoux and the Flow Cytometry Core Facility at the Center for Immunology (University of Minnesota) assisted with sorting and flow-cytometry experiments. This work was supported by a grant from the National Institutes of Health (NIH) (R01-AR056632) to D.H.K., a Dermatology Foundation research award (BZI), and an American Skin Association research award (BZI). D.H.K. is also supported by the Al Zelickson endowed professorship. The 2G3 antibody reagents were developed with the support of NIH grant U19 AI057234 and the Baylor Health Care System Foundation. B.T.E. is the recipient of a Burroughs Wellcome Fund Career Award for Medical Scientists.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Bursch LS, 2009, J IMMUNOL, V182, P4657, DOI 10.4049/jimmunol.0803656; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cunningham AL, 2010, IMMUNOL CELL BIOL, V88, P416, DOI 10.1038/icb.2010.42; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Flacher V, 2010, J INVEST DERMATOL, V130, P755, DOI 10.1038/jid.2009.343; FONZI WA, 1993, GENETICS, V134, P717; Gaspari AA, 1998, INFECT IMMUN, V66, P4440; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Ni L, 2010, J IMMUNOL, V185, P3504, DOI 10.4049/jimmunol.1000999; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	58	301	311	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					260	272		10.1016/j.immuni.2011.06.005	http://dx.doi.org/10.1016/j.immuni.2011.06.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21782478	Bronze, Green Accepted			2022-12-18	WOS:000294387900015
J	Tsuda, Y; Takahashi, H; Kobayashi, M; Hanafusa, T; Herndon, DN; Suzuki, F				Tsuda, Y; Takahashi, H; Kobayashi, M; Hanafusa, T; Herndon, DN; Suzuki, F			Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus	IMMUNITY			English	Article							ALTERNATIVE ACTIVATION; IMMUNE DYSFUNCTION; MYELOID CELLS; MACROPHAGES; EXPRESSION; IL-10; HETEROGENEITY; POLARIZATION; INHIBIT; MCP-1	Neutrophils (PMN) have been described as critical effector cells in the host's antibacterial innate immunities. However, the classification of murine PMNs remains unclear. Here, we show that in addition to normal PMN (PMN-N), there are at least two distinct subsets of PMNs (PMN-I and PMN-II) distinguished as follows: (1) cytokine and chemokine production (PMN-I, IL-12/CCL3; PMN-II, IL-10/CCL2; PMN-N, no cytokine/chemokine production), (2) macrophage activation (PMN-I, classically activated macrophages; PMN-II, alternatively activated macrophages; PMN-N, no effect on macrophage activation), (3) Toll-like receptor (TLR) expression (PMN-I, TLR2/TLR4/TLR5/ TLR8; PMN-II, TLR2/TLR4/TLR7/TLR9; PMN-N, TLR2/ TLR4/TLR9), and (4) surface antigen expression (PMN-I, CD49d(+)CD11b(-); PMN-II, CD49d(-)CD11b(+); PMN-N, CD49d(-)CD11b(-)). PMN-I was obtained from MRSA (methicillin-resistant Staphylococcus aureus)-resistant hosts, while MRSA-sensitive hosts were a source of PMN-II. PMN-N was obtained from naive mice. Anti-MRSA innate immunities might be influenced differently by these biochemically and physically distinguished PMNs. PMN-N may convert to PMN-I or PMN-II in response to host circumstance.	Univ Texas, Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA; Shriners Hosp Children, Galveston, TX 77550 USA; Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan	University of Texas System; University of Texas Medical Branch Galveston; Osaka Medical College	Suzuki, F (corresponding author), Univ Texas, Med Branch, Dept Internal Med, Div Infect Dis, 301 Univ Blvd, Galveston, TX 77555 USA.	fsuzuki@utmb.edu			NIAID NIH HHS [AI44218] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044218] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Brandt E, 2000, J LEUKOCYTE BIOL, V68, P125; BROWN CC, 1991, CELL IMMUNOL, V132, P102, DOI 10.1016/0008-8749(91)90010-9; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Davey V, 2002, EMERGING INFECTIOUS DISEASES: TRENDS AND ISSUES, P303; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Furukawa K, 2002, ANN SURG, V236, P112, DOI 10.1097/00000658-200207000-00017; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; GALLIN JI, 1984, BLOOD, V63, P977; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385; HIBBS JB, 1975, TRANSPLANTATION, V19, P77, DOI 10.1097/00007890-197501000-00015; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; KRAUSE PJ, 1986, BLOOD, V68, P200; Kristian SA, 2003, INFECT IMMUN, V71, P546, DOI 10.1128/IAI.71.1.546-549.2003; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Malawista SE, 1996, J LEUKOCYTE BIOL, V60, P753, DOI 10.1002/jlb.60.6.753; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mencacci A, 2002, J IMMUNOL, V169, P3180, DOI 10.4049/jimmunol.169.6.3180; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Romani L, 1997, J IMMUNOL, V158, P5349; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sester DP, 1999, J LEUKOCYTE BIOL, V66, P542, DOI 10.1002/jlb.66.4.542; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinstraesser L, 2001, SHOCK, V15, P272, DOI 10.1097/00024382-200115040-00004; Takahashi H, 2002, J LEUKOCYTE BIOL, V72, P1190; Taub DD, 1996, J IMMUNOL, V156, P2095; Ulevitch RJ, 1999, NATURE, V401, P755, DOI 10.1038/44490; VERHOEF J, 1997, STAPHYLOCOCCI HUMAN, P213; Yamashiro S, 1999, J LEUKOCYTE BIOL, V65, P671, DOI 10.1002/jlb.65.5.671; Yoshitake H, 2002, J LEUKOCYTE BIOL, V71, P205; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	41	301	308	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					215	226		10.1016/j.immuni.2004.07.006	http://dx.doi.org/10.1016/j.immuni.2004.07.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308102	Bronze			2022-12-18	WOS:000223441900010
J	Peng, SL; Gerth, AJ; Ranger, AM; Glimcher, LH				Peng, SL; Gerth, AJ; Ranger, AM; Glimcher, LH			NFATc1 and NFATc2 together control both T and B cell activation and differentiation	IMMUNITY			English	Article							ATP-DEFICIENT MICE; TRANSCRIPTION FACTOR; NF-ATC; CYCLOSPORINE-A; SYNTHASE KINASE-3; ANTIGEN RECEPTOR; TH2 DEVELOPMENT; LACKING JAK3; INDUCTION; DEFECTS	NFAT transcription factors play critical roles in gene transcription during immune responses. To investigate further the two most prominent NFAT family members, NFATc1 and NFATc2, we generated mice bearing lymphoid systems devoid of both. Doubly deficient T cells displayed cell surface markers of activation yet were significantly deficient in the development of multiple effector functions, including Th cytokine production, surface effector molecule expression, and cytolytic activity. Nevertheless, doubly deficient B cells were hyperactivated, as evidenced by extremely elevated serum IgG1 and IgE, as well as plasma cell expansion and infiltration of end organs. Thus, in T cells, NFATc1 and NFATc2 are dispensable for inflammatory reactivity but are required for effector differentiation, while in B cells, NFATs regulate both normal homeostasis and differentiation.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.		Peng, Stanford/S-6723-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541, K08AI001803] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31541, AI01803] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Chow CW, 1999, MOL CELL BIOL, V19, P2300; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Gold MR, 1999, J IMMUNOL, V163, P1894; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RUSSEL AJF, 1995, EUROPEAN FINE FIBRE, V3, P3; Schuh K, 1997, IMMUNOL LETT, V57, P171, DOI 10.1016/S0165-2478(97)00068-0; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; Thomis DC, 1999, J IMMUNOL, V163, P5411; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yankee TM, 1999, J IMMUNOL, V163, P5827; Yoshida T, 1998, Ann Nucl Med, V12, P35	36	301	312	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2001	14	1					13	20		10.1016/S1074-7613(01)00085-1	http://dx.doi.org/10.1016/S1074-7613(01)00085-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	394FQ	11163226	Bronze			2022-12-18	WOS:000166513800002
J	Saitoh, S; Arudchandran, R; Manetz, TS; Zhang, WG; Sommers, CL; Love, PE; Rivera, J; Samelson, LE				Saitoh, S; Arudchandran, R; Manetz, TS; Zhang, WG; Sommers, CL; Love, PE; Rivera, J; Samelson, LE			LAT is essential for Fc epsilon RI-mediated mast cell activation	IMMUNITY			English	Article							AFFINITY IGE RECEPTOR; VAV PROTOONCOGENE PRODUCT; BASOPHILIC LEUKEMIA-CELLS; PROTEIN-TYROSINE KINASE; GRB2 ADAPTER PROTEIN; T-CELLS; PHOSPHOLIPASE C-GAMMA-1; SIGNAL TRANSDUCTION; ALLERGIC MEDIATORS; MOLECULAR-CLONING	The linker molecule LAT is a substrate of the tyrosine kinases activated following TCR engagement of T cells. LAT is also expressed in platelets, NK, and mast cells. Although LAT-deficient mice contain normal numbers of mast cells, we found that LAT-deficient mice were resistant to IgE-mediated passive systemic anaphylaxis. LAT-deficient bone marrow-derived mast cells (BMMC) showed normal growth and development. Whereas tyrosine phosphorylation of Fc epsilon RI, Syk, and Vav was intact in LAT-deficient BMMCs following Fc epsilon RI engagement, tyrosine phosphorylation of SLP-76, PLC-gamma 1, and PLC-gamma 2 and calcium mobilization were dramatically reduced. LAT-deficient BMMCs also exhibited profound defects in activation of MAPK, degranulation, and cytokine production after Fc epsilon RI cross-linking. These results show that LAT plays a critical role in Fc epsilon RI-mediated signaling in mast cells.	NCI, Cellular & Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA; NIAMSD, Sect Chem Immunol, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Samelson, LE (corresponding author), NCI, Cellular & Mol Biol Lab, Div Basic Sci, NIH, Bldg 37, Bethesda, MD 20892 USA.	samelson@helix.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001803] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001803] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010304, ZIABC010304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041101, Z01AR041101] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBER G, 1991, J BIOL CHEM, V266, P22613; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Barker SA, 1998, MOL BIOL CELL, V9, P483, DOI 10.1091/mbc.9.2.483; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Bourette RP, 1998, EMBO J, V17, P7273, DOI 10.1093/emboj/17.24.7273; BUDAY L, 1994, J BIOL CHEM, V269, P9019; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Costello PS, 1996, ONCOGENE, V13, P2595; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; EISEMAN E, 1992, NATURE, V355, P78; Facchetti F, 1999, AM J PATHOL, V154, P1037, DOI 10.1016/S0002-9440(10)65356-4; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; Jevremovic D, 1999, J IMMUNOL, V162, P2453; Kawakami Y, 1998, J IMMUNOL, V161, P1795; LIU FT, 1980, J IMMUNOL, V124, P2728; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moriya K, 1997, P NATL ACAD SCI USA, V94, P12539, DOI 10.1073/pnas.94.23.12539; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PARK DJ, 1991, J BIOL CHEM, V266, P24237; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Qiu MS, 1998, BIOCHEM BIOPH RES CO, V253, P443, DOI 10.1006/bbrc.1998.9795; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RIVERA VM, 1995, MOL CELL BIOL, V15, P1582; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; Song JS, 1999, J IMMUNOL, V163, P802; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; TURNER H, 1995, J BIOL CHEM, V270, P9500, DOI 10.1074/jbc.270.16.9500; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang YQ, 1998, IEEE T NEURAL NETWOR, V9, P83, DOI 10.1109/72.655032	53	301	304	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					525	535		10.1016/S1074-7613(00)80204-6	http://dx.doi.org/10.1016/S1074-7613(00)80204-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843385	Bronze			2022-12-18	WOS:000087356400008
J	Diefenbach, A; Schindler, H; Donhauser, N; Lorenz, E; Laskay, T; MacMicking, J; Rollinghoff, M; Gresser, I; Bogdan, C				Diefenbach, A; Schindler, H; Donhauser, N; Lorenz, E; Laskay, T; MacMicking, J; Rollinghoff, M; Gresser, I; Bogdan, C			Type 1 interferon (IFN alpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; GROWTH-FACTOR-BETA; LEISHMANIA-MAJOR INFECTION; IN-VIVO; LISTERIA-MONOCYTOGENES; TRANSCRIPTION FACTOR; REACTIVE OXYGEN; BALB/C MICE; RESISTANCE; MACROPHAGES	Type 2 nitric oxide synthase (NOS2) is required for the Th1-dependent healing of infections with intracellular microbes, including Leishmania major. Here, we demonstrate the expression and define the function of NOS2 during the innate response to L. major. At day 1 of infection, genetic deletion or functional inactivation of NOS2 abolished the IFN gamma and natural killer cell response, increased the expression of TGF beta, and caused parasite spreading from the skin and lymph node to the spleen, liver, bone marrow, and lung. Induction of NOS2 was dependent on IFN alpha/beta. Neutralization of IFN alpha/beta mimicked the phenotype of NOS2(-/-) mice. Thus, IFN alpha/beta and NOS2 are critical regulators of the innate response to L. major.	Univ Erlangen Nurnberg, Inst Clin Microbiol & Immunol, D-91054 Erlangen, Germany; Cornell Univ Med Coll, Beatrice & Samuel A Seaver Lab, New York, NY 10021 USA; CNRS, Lab Viral Oncol, F-94801 Villejuif, France	University of Erlangen Nuremberg; Cornell University; Centre National de la Recherche Scientifique (CNRS)	Bogdan, C (corresponding author), Univ Erlangen Nurnberg, Inst Clin Microbiol & Immunol, Wassertumstr 3, D-91054 Erlangen, Germany.	bogdan@mikrobio.med.uni-erlangen.de	Laskay, Tamás/E-9190-2013; Diefenbach, Andreas/T-2589-2018	Laskay, Tamás/0000-0002-4212-8366; Diefenbach, Andreas/0000-0002-9176-9530; Bogdan, Christian/0000-0002-2300-0631				BECKERMAN KP, 1993, J IMMUNOL, V150, P888; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; BIRON CA, 1995, CURR OPIN IMMUNOL, V7, P485, DOI 10.1016/0952-7915(95)80093-X; Bogdan C, 1997, Behring Inst Mitt, P58; BOGDAN C, 1991, EUR J IMMUNOL, V21, P327, DOI 10.1002/eji.1830210213; CIFONE MG, 1994, CELL IMMUNOL, V157, P181, DOI 10.1006/cimm.1994.1215; DANIELPOUR D, 1993, J IMMUNOL METHODS, V158, P17, DOI 10.1016/0022-1759(93)90254-5; DEMAEYERGUIGNARD J, 1986, J VIROL, V58, P743, DOI 10.1128/JVI.58.3.743-747.1986; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DING AH, 1988, J IMMUNOL, V141, P2407; Duncan GS, 1996, J EXP MED, V184, P2043, DOI 10.1084/jem.184.5.2043; EVANS TG, 1993, J IMMUNOL, V151, P907; FORSTER E, 1994, BIOTECHNIQUES, V16, P18; GRESSER I, 1988, J EXP MED, V168, P1271, DOI 10.1084/jem.168.4.1271; HAVELL EA, 1993, J INFECT DIS, V167, P1364, DOI 10.1093/infdis/167.6.1364; JURETIC A, 1994, CELL IMMUNOL, V157, P462, DOI 10.1006/cimm.1994.1242; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; LANDER HM, 1993, J IMMUNOL, V151, P7182; LASKAY T, 1993, EUR J IMMUNOL, V23, P2237, DOI 10.1002/eji.1830230928; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MAGRINAT G, 1992, BLOOD 1992, P1880; MARCINKIEWICZ J, 1995, EUR J IMMUNOL, V25, P947, DOI 10.1002/eji.1830250414; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; NAKANE A, 1985, INFECT IMMUN, V50, P877, DOI 10.1128/IAI.50.3.877-880.1985; NOBLE PW, 1993, J IMMUNOL, V151, P979; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; PLATZER C, 1992, EUR J IMMUNOL, V22, P1179, DOI 10.1002/eji.1830220511; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Remick DG, 1996, J LEUKOCYTE BIOL, V59, P471, DOI 10.1002/jlb.59.4.471; ROOK AH, 1986, J IMMUNOL, V136, P3916; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; SchartonKersten TM, 1997, CURR OPIN IMMUNOL, V9, P44, DOI 10.1016/S0952-7915(97)80157-4; Shankar AH, 1996, EXP PARASITOL, V84, P136, DOI 10.1006/expr.1996.0099; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Stenger S, 1995, EUR J PHARMACOL, V294, P703, DOI 10.1016/0014-2999(95)00618-4; Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0	47	301	304	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					77	87		10.1016/S1074-7613(00)80460-4	http://dx.doi.org/10.1016/S1074-7613(00)80460-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462513	Bronze			2022-12-18	WOS:000071765700008
J	Kundig, TM; Shahinian, A; Kawai, K; Mittrucker, HW; Sebzda, E; Bachmann, MF; Mak, TW; Ohashi, PS				Kundig, TM; Shahinian, A; Kawai, K; Mittrucker, HW; Sebzda, E; Bachmann, MF; Mak, TW; Ohashi, PS			Duration of TCR stimulation determines costimulatory requirement of T cells	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VESICULAR STOMATITIS-VIRUS; MHC CLASS-I; CLONAL ANERGY; TUMOR-CELLS; INTERLEUKIN-2 PRODUCTION; CD28-B7 INTERACTIONS; CD28-DEFICIENT MICE; TOLERANCE INDUCTION; SYNTHETIC PEPTIDES	Current models suggest that T cells that receive only signal-1 through antigenic stimulation of the T cell receptor (TCR) become anergic, but will mount an immune response when a costimulatory signal-2 is provided. Using mice deficient for an important costimulatory molecule, CD28, we show that a transient signal-1 alone, either through infection with an abortively replicating virus, or through injection of viral peptide, anergizes CD8(+) T cells, demonstrating the biological relevance of T cell anergy in vivo. However, in the absence of CD28, continued presence of signal-1 alone, either through prolonged viral replication or repeated injection of peptide, prevents the induction of anergy and generates a functional T cell response in vivo.	ONTARIO CANC INST, DEPT IMMUNOL, TORONTO, ON M5G 2M9, CANADA; AMGEN INST, TORONTO, ON M5G 2C1, CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kundig, TM (corresponding author), ONTARIO CANC INST, DEPT MED BIOPHYS, 610 UNIV AVE, TORONTO, ON M5G 2M9, CANADA.		Kawai, Kazuhiro/D-4998-2011	Kawai, Kazuhiro/0000-0001-9375-0713; Ohashi, Pamela S./0000-0003-2915-9317				AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; ANDO K, 1994, J IMMUNOL, V153, P482; BACHMANN MF, 1994, CURR OPIN IMMUNOL, V6, P320, DOI 10.1016/0952-7915(94)90108-2; BASKAR S, 1993, P NATL ACAD SCI USA, V90, P5687, DOI 10.1073/pnas.90.12.5687; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BINDER D, 1991, J IMMUNOL, V146, P4301; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; BOHME J, 1989, SCIENCE, V244, P1179, DOI 10.1126/science.2499048; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CIAVARRA RP, 1990, CELL IMMUNOL, V125, P363, DOI 10.1016/0008-8749(90)90091-5; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; GANSBACHER B, 1990, J EXP MED, V172, P1217, DOI 10.1084/jem.172.4.1217; GREEN JM, 1994, IMMUNITY, V1, P501, DOI 10.1016/1074-7613(94)90092-2; GUERDER S, 1994, IMMUNITY, V1, P155; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HANY M, 1989, EUR J IMMUNOL, V19, P417, DOI 10.1002/eji.1830190302; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KARUPIAH G, 1990, J IMMUNOL, V144, P290; Kawai K, 1996, TRANSPLANTATION, V61, P352, DOI 10.1097/00007890-199602150-00003; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KISIELOW P, 1991, IMMUNOL REV, V122, P69, DOI 10.1111/j.1600-065X.1991.tb00597.x; KUNDIG TM, 1993, J VIROL, V67, P3680; KUNDIG TM, 1992, P NATL ACAD SCI USA, V89, P7757, DOI 10.1073/pnas.89.16.7757; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; KUNDIG TM, 1993, J IMMUNOL, V150, P4450; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LAFFERTY KJ, 1977, IMMUNOL REV, V35, P231, DOI 10.1111/j.1600-065X.1977.tb00241.x; LEHMANNGRUBE F, 1971, VIROL MONOGR, V10, P1; LEIST TP, 1987, J IMMUNOL, V138, P2278; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; MACDONALD HR, 1993, IMMUNOL REV, V133, P105, DOI 10.1111/j.1600-065X.1993.tb01512.x; MACKETT M, 1985, SCIENCE, V227, P433, DOI 10.1126/science.2981435; MARRACK P, 1993, IMMUNOL REV, V133, P119, DOI 10.1111/j.1600-065X.1993.tb01513.x; MIGITA K, 1993, J IMMUNOL, V150, P763; MOSKOPHIDIS D, 1987, EUR J IMMUNOL, V17, P937, DOI 10.1002/eji.1830170707; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OHASHI PS, 1993, J IMMUNOL, V150, P5185; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PUDDINGTON L, 1986, J VIROL, V60, P708, DOI 10.1128/JVI.60.2.708-717.1986; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; SPRENT J, 1993, IMMUNOL REV, V133, P151, DOI 10.1111/j.1600-065X.1993.tb01515.x; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; WAGNER RR, 1987, RHABDOVIRUSES; WIDMANN C, 1991, J IMMUNOL, V147, P3745; ZINKERNAGEL RM, 1993, IMMUNOL REV, V133, P199, DOI 10.1111/j.1600-065X.1993.tb01517.x	68	301	305	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1996	5	1					41	52		10.1016/S1074-7613(00)80308-8	http://dx.doi.org/10.1016/S1074-7613(00)80308-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758893	Bronze			2022-12-18	WOS:A1996UZ45400005
J	Patel, SA; Minn, AJ				Patel, Shetal A.; Minn, Andy J.			Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies	IMMUNITY			English	Review							T-CELL EXHAUSTION; EPITHELIAL-MESENCHYMAL TRANSITION; I INTERFERON RESPONSES; PD-1 BLOCKADE; TGF-BETA; ANTITUMOR IMMUNITY; TUMOR-CELLS; ANTIVIRAL DEFENSE; RADIATION-THERAPY; CTLA-4 BLOCKADE	The success of immune checkpoint blockade in patients with a wide variety of malignancies has changed the treatment paradigm in oncology. However, combination therapies with immune checkpoint blockade will be needed to overcome resistance and broaden the clinical utility of immunotherapy. Here we discuss a framework for rationally designing combination therapy strategies based on enhancing major discriminatory functions of the immune system that are corrupted by cancer-namely, antigenicity, adjuvanticity, and homeostatic feedback inhibition. We review recent advances on how conventional genotoxic cancer therapies, molecularly targeted therapies, epigenetic agents, and immune checkpoint inhibitors can restore these discriminatory functions. Potential barriers that can impede response despite combination therapy are also discussed.	[Patel, Shetal A.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Patel, Shetal A.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Basser Ctr BRCA, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Basser Ctr BRCA, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	andyminn@upenn.edu		Minn, Andy/0000-0003-1418-0906	Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Melanoma Research Alliance; Basser Center for BRCA; NIH/NCI [R01CA172651, 1P01CA210944]; Department of Defense;  [TL1TR001880]; NATIONAL CANCER INSTITUTE [P01CA210944, R01CA172651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001880] Funding Source: NIH RePORTER	Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Melanoma Research Alliance; Basser Center for BRCA; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	A.J.M. and S.A.P. are supported by the Parker Institute for Cancer Immunotherapy, S.A.P. is supported by TL1TR001880 and A.J.M. is supported by the Breast Cancer Research Foundation, Melanoma Research Alliance, and the Basser Center for BRCA. A.J.M. is also supported by funding from the NIH/NCI (R01CA172651, 1P01CA210944) and the Department of Defense.	Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bonam SR, 2017, TRENDS PHARMACOL SCI, V38, P771, DOI 10.1016/j.tips.2017.06.002; Byrne KT, 2016, CELL REP, V15, P2719, DOI 10.1016/j.celrep.2016.05.058; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Charlebois R, 2017, CANCER RES, V77, P312, DOI 10.1158/0008-5472.CAN-16-1873; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2015, JAMA ONCOL, V1, P1325, DOI 10.1001/jamaoncol.2015.2756; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dongre A, 2017, CANCER RES, V77, P3982, DOI 10.1158/0008-5472.CAN-16-3292; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Enyedi B, 2015, TRENDS CELL BIOL, V25, P398, DOI 10.1016/j.tcb.2015.02.007; Fu G, 2014, TRENDS IMMUNOL, V35, P311, DOI 10.1016/j.it.2014.05.003; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Gamrekelashvili J, 2012, ONCOIMMUNOLOGY, V1, P1017, DOI 10.4161/onci.21098; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Garg AD, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1386829; Gerner MY, 2013, J IMMUNOL, V191, P1011, DOI 10.4049/jimmunol.1300652; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Hamilton DH, 2014, CANCER RES, V74, P2510, DOI 10.1158/0008-5472.CAN-13-1894; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hochheiser K, 2016, J IMMUNOL, V196, P2439, DOI 10.4049/jimmunol.1501958; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Kohlhapp FJ, 2016, CLIN CANCER RES, V22, P1048, DOI 10.1158/1078-0432.CCR-15-2667; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Liu J, 2015, P NATL ACAD SCI USA, V112, P6682, DOI 10.1073/pnas.1420370112; Lou YY, 2016, CLIN CANCER RES, V22, P3630, DOI 10.1158/1078-0432.CCR-15-1434; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Marcucci F, 2016, NAT REV DRUG DISCOV, V15, P311, DOI 10.1038/nrd.2015.13; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Minn AJ, 2016, CELL, V165, P272, DOI 10.1016/j.cell.2016.03.031; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; MURARO E, 2017, FRONT IMMUNOL, V8; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Portou MJ, 2015, VASC PHARMACOL, V71, P31, DOI 10.1016/j.vph.2015.02.007; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Prendergast GC, 2017, CANCER RES, V77, P6795, DOI 10.1158/0008-5472.CAN-17-2285; Purbey PK, 2017, IMMUNITY, V47, P421, DOI 10.1016/j.immuni.2017.08.017; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sanmamed MF, 2015, SEMIN ONCOL, V42, P640, DOI 10.1053/j.seminoncol.2015.05.014; Sato T, 2010, WOUND REPAIR REGEN, V18, P586, DOI 10.1111/j.1524-475X.2010.00632.x; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shabason JE, 2017, SEMIN RADIAT ONCOL, V27, P289, DOI 10.1016/j.semradonc.2017.03.002; Shekarian T, 2017, ANN ONCOL, V28, P1756, DOI 10.1093/annonc/mdx179; Singer M, 2017, CELL, V171, P1221, DOI 10.1016/j.cell.2017.11.006; Sistigu A, 2017, CYTOKINE GROWTH F R, V36, P67, DOI 10.1016/j.cytogfr.2017.05.008; Snell LM, 2015, CURR OPIN IMMUNOL, V34, P91, DOI 10.1016/j.coi.2015.03.002; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Stelekati E, 2014, IMMUNITY, V40, P801, DOI 10.1016/j.immuni.2014.04.010; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Trahtemberg U, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01356; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Urban SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004357; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vanpouille-Box C, 2015, CANCER RES, V75, P2232, DOI 10.1158/0008-5472.CAN-14-3511; Vargas FA, 2017, IMMUNITY, V46, P577, DOI 10.1016/j.immuni.2017.03.013; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015; Zhang T., 2017, SCI REP, V7; Zhu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00784-1; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723; Zuniga EI, 2012, EUR J IMMUNOL, V42, P2285, DOI 10.1002/eji.201242852	164	300	308	10	153	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					417	433		10.1016/j.immuni.2018.03.007	http://dx.doi.org/10.1016/j.immuni.2018.03.007			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562193	Bronze, Green Accepted			2022-12-18	WOS:000427916900002
J	Goto, Y; Panea, C; Nakato, G; Cebula, A; Lee, C; Diez, MG; Laufer, TM; Ignatowicz, L; Ivanov, II				Goto, Yoshiyuki; Panea, Casandra; Nakato, Gaku; Cebula, Anna; Lee, Carolyn; Diez, Marta Galan; Laufer, Terri M.; Ignatowicz, Leszek; Ivanov, Ivaylo I.			Segmented Filamentous Bacteria Antigens Presented by Intestinal Dendritic Cells Drive Mucosal Th17 Cell Differentiation	IMMUNITY			English	Article							REGULATORY T-CELLS; CLASS-II MOLECULES; COMMENSAL BACTERIA; EPITHELIAL-CELLS; LAMINA PROPRIA; DEFICIENT MICE; IMMUNE-SYSTEM; CHAIN GENE; HOMEOSTASIS; MICROBIOTA	How commensal microbiota contributes to immune cell homeostasis at barrier surfaces is poorly understood. Lamina propria (LP) T helper 17 (Th17) cells participate in mucosal protection and are induced by commensal segmented filamentous bacteria (SFB). Here we show that MHCII-dependent antigen presentation of SFB antigens by intestinal dendritic cells (DCs) is crucial for Th17 cell induction. Expression of MHCII on CD11c(+) cells was necessary and sufficient for SFB-induced Th17 cell differentiation. Most SFB-induced Th17 cells recognized SFB in an MHCII-dependent manner. SFB primed and induced Th17 cells locally in the LP and Th17 cell induction occurred normally in mice lacking secondary lymphoid organs. The importance of other innate cells was unveiled by the finding that MHCII deficiency in group 3 innate lymphoid cells (ILCs) resulted in an increase in SFB-independent Th17 cell differentiation. Our results outline the complex role of DCs and ILCs in the regulation of intestinal Th17 cell homeostasis.	[Goto, Yoshiyuki; Panea, Casandra; Nakato, Gaku; Lee, Carolyn; Diez, Marta Galan; Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Cebula, Anna; Ignatowicz, Leszek] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Laufer, Terri M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	Columbia University; University System of Georgia; Augusta University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Ivanov, II (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	ii2137@columbia.edu	Goto, Yoshiyuki/H-9860-2017; Galan-Diez, Marta/A-7037-2019	Goto, Yoshiyuki/0000-0001-8552-4839; Galan-Diez, Marta/0000-0002-2092-3414	National Institute of Health [1R01DK098378]; Crohn's and Colitis Foundation of America SRA [259540]; Toyobo Biofoundation; Pew Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098378] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America SRA; Toyobo Biofoundation; Pew Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the I. I. I. laboratory for their help in all aspects of the project. We thank Yoshinori Umesaki at the Yakult Central Institute for providing feces from SFB-monocolonized mice. We thank Kenya Honda and Seiko Narushima for developing and sharing the SFB sorting protocol. We thank Steve Reiner and Boris Reizis for reading the manuscript and for invaluable scientific discussions. We thank Siu-Hong Ho at the Columbia Center for Translational Immunology Flow Cytometry Core and Amir Figueroa at the Department of Microbiology and Immunology Flow Cytometry Core for help with sorting. This work was supported by the National Institute of Health 1R01DK098378 to I. I. I. and by the Crohn's and Colitis Foundation of America SRA#259540 to I. I. I. G.N. was supported by a long-term research grant from Toyobo Biofoundation. I. I. I. is a Pew Scholar in the Biomedical Sciences, supported by the Pew Charitable Trust.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hershberg RM, 2000, IMMUNOL TODAY, V21, P123, DOI 10.1016/S0167-5699(99)01575-3; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lemos MP, 2003, J IMMUNOL, V171, P5077, DOI 10.4049/jimmunol.171.10.5077; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Newberry RD, 2002, J IMMUNOL, V168, P4988, DOI 10.4049/jimmunol.168.10.4988; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shima T, 2008, FEMS IMMUNOL MED MIC, V52, P69, DOI 10.1111/j.1574-695X.2007.00344.x; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; WHITE J, 1989, J IMMUNOL, V143, P1822; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	49	300	322	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					594	607		10.1016/j.immuni.2014.03.005	http://dx.doi.org/10.1016/j.immuni.2014.03.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24684957	Green Accepted, Bronze			2022-12-18	WOS:000334849400016
J	Gao, Y; Nish, SA; Jiang, RY; Hou, L; Licona-Limon, P; Weinstein, JS; Zhao, HY; Medzhitov, R				Gao, Yan; Nish, Simone A.; Jiang, Ruoyi; Hou, Lin; Licona-Limon, Paula; Weinstein, Jason S.; Zhao, Hongyu; Medzhitov, Ruslan			Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells	IMMUNITY			English	Article							INTERFERON REGULATORY FACTOR-4; CONTACT HYPERSENSITIVITY; TYPE-2 IMMUNITY; DIFFERENTIATION; POLARIZATION; HOMEOSTASIS; DISRUPTION; SUFFICIENT; EXPRESSION; PLASTICITY	CD4(+) T cell differentiation is regulated by specialized antigen-presenting cells. Dendritic cells (DCs) produce cytokines that promote naive CD4(+) T cell differentiation into T helper 1 (Th1), Th17, and inducible T regulatory (iTreg) cells. However, the initiation of Th2 cell responses remains poorly understood, although it is likely that more than one mechanism might be involved. Here we have defined a specific DC subset that is involved in Th2 cell differentiation in vivo in response to a protease allergen, as well as infection with Nippostrongylus brasiliensis. We have demonstrated that this subset is controlled by the transcription factor interferon regulatory factor 4 (IRF4), which is required for their differentiation and Th2 cell-inducing function. IRF4 is known to control Th2 cell differentiation and Th2 cell-associated suppressing function in Treg cells. Our finding suggests that IRF4 also plays a role in DCs where it controls the initiation of Th2 cell responses.	[Gao, Yan; Nish, Simone A.; Licona-Limon, Paula; Weinstein, Jason S.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Gao, Yan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Jiang, Ruoyi] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Hou, Lin] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Jiang, Ruoyi/0000-0002-8494-082X	National Institutes of Health [RO1 AI08977, 5RO1 AI055502, R37 AI046688]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI055502, R37AI046688, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank A. Iwasaki, Y. Kumamoto, U. Klein, B. Reizis, L. Chen, and A. Pernis for providing reagents. This study was supported by a grant from the National Institutes of Health (RO1 AI08977, 5RO1 AI055502, and R37 AI046688) and the Howard Hughes Medical Institute.	Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Bell BD, 2013, NAT IMMUNOL, V14, P364, DOI 10.1038/ni.2541; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Haley K, 2012, J IMMUNOL, V188, P4334, DOI 10.4049/jimmunol.1102759; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishiwata K, 2010, J IMMUNOL, V184, P2086, DOI 10.4049/jimmunol.0804051; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nguyen LT, 2002, J EXP MED, V196, P1393, DOI 10.1084/jem.20021466; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	43	300	306	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					722	732		10.1016/j.immuni.2013.08.028	http://dx.doi.org/10.1016/j.immuni.2013.08.028			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24076050	Bronze, Green Accepted			2022-12-18	WOS:000330950000013
J	Kowal, C; DeGiorgio, LA; Nakaoka, T; Hetherington, H; Huerta, PT; Diamond, B; Volpe, BT				Kowal, C; DeGiorgio, LA; Nakaoka, T; Hetherington, H; Huerta, PT; Diamond, B; Volpe, BT			Cognition and immunity: Antibody impairs memory	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; DEPENDENT SYNAPTIC PLASTICITY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; RECEPTOR ANTAGONIST; N-ACETYLASPARTATE; DNA ANTIBODIES; CELL-DEATH	Patients with lupus (SLE) experience progressive cognitive loss without evidence of CNS vascular disease or inflammation. SLE patients produce anti-DNA antibodies that crossreact with NMDA receptors and are capable of mediating excitotoxic death. We now show that mice induced by antigen to express these antibodies have no neuronal damage until breakdown of the blood-brain barrier occurs. Following administration of lipopolysaccharide (LPS) to immunized mice, antibodies gain access to the brain. They bind preferentially to hippocampal neurons and cause neuronal death with resulting cognitive dysfunction and altered hippocampal metabolism on magnetic resonance spectroscopy. Memantine, an NMDA receptor antagonist, given prior to LIPS administration, prevents neuronal damage. Thus, systemic immune responses can cause cognitive impairment in the absence of an inflammatory cascade, implicating the immune system in yet another arena of human pathobiology. Furthermore, NMDA receptor antagonists prevent antibody-mediated damage and may constitute a new approach to therapy in SLE.	Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Dept Radiol, Bronx, NY 10461 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Cornell University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Volpe, BT (corresponding author), Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	bvolpe@burke.org	volpe, b/U-8409-2019	Huerta, Patricio/0000-0003-0270-2308; Volpe, Bruce/0000-0002-1098-1848	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057084, R01AR049126] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR057084, R01 AR049126, AR R01 49126] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abdel-Rahman A, 2002, NEUROBIOL DIS, V10, P306, DOI 10.1006/nbdi.2002.0524; Avenet P, 1997, NEUROSCI LETT, V223, P133, DOI 10.1016/S0304-3940(97)13422-X; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cho S, 1997, BRAIN RES, V755, P335, DOI 10.1016/S0006-8993(97)00188-1; Chu WJ, 2000, MAGNET RESON MED, V43, P359, DOI 10.1002/(SICI)1522-2594(200003)43:3<359::AID-MRM7>3.0.CO;2-C; Chung YL, 2003, NEUROPATH APPL NEURO, V29, P445, DOI 10.1046/j.1365-2990.2003.00438.x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Crawley J.N., 2007, WHATS WRONG MY MOUSE, P226; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DENBURG SD, 1999, SYSTEMIC LUPUS ERYTH, P611; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; HAHN BH, 2002, DUBOIS LUPUS ERYTHEM, pCH21; HANLY JG, 1992, J RHEUMATOL, V19, P562; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HAY EM, 1992, ARTHRITIS RHEUM, V35, P411, DOI 10.1002/art.1780350409; HETHERINGTON H, 1995, ANN NEUROL, V38, P396, DOI 10.1002/ana.410380309; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; HUGG JW, 1993, ANN NEUROL, V34, P788, DOI 10.1002/ana.410340606; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; KIER AB, 1990, J COMP PATHOL, V102, P165, DOI 10.1016/S0021-9975(08)80122-3; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Kuzniecky R, 1997, NEUROLOGY, V48, P1018, DOI 10.1212/WNL.48.4.1018; Leritz E, 2000, J INT NEUROPSYCH SOC, V6, P821, DOI 10.1017/S1355617700677093; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Putterman C, 1998, J EXP MED, V188, P29, DOI 10.1084/jem.188.1.29; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; RempelClower NL, 1996, J NEUROSCI, V16, P5233; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schlachetzki F, 2002, J NEUROCHEM, V81, P203, DOI 10.1046/j.1471-4159.2002.00840.x; Sharma A, 2003, RHEUMATOLOGY, V42, P453, DOI 10.1093/rheumatology/keg161; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; Volpe BT, 1998, NEUROSCIENCE, V83, P741, DOI 10.1016/S0306-4522(97)00424-7; VOLPE BT, 1992, BEHAV NEUROSCI, V106, P457, DOI 10.1037/0735-7044.106.3.457; VOLPE BT, 1985, NEUROLOGY, V35, P1793, DOI 10.1212/WNL.35.12.1793; VOLPE BT, 1983, ARCH NEUROL-CHICAGO, V40, P436, DOI 10.1001/archneur.1983.04050070066017; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9	57	300	310	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					179	188		10.1016/j.immuni.2004.07.011	http://dx.doi.org/10.1016/j.immuni.2004.07.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308099	Bronze			2022-12-18	WOS:000223441900007
J	Franc, NC; Dimarcq, JL; Lagueux, M; Hoffmann, J; Ezekowitz, RAB				Franc, NC; Dimarcq, JL; Lagueux, M; Hoffmann, J; Ezekowitz, RAB			Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells	IMMUNITY			English	Article							SCAVENGER RECEPTOR; MOLECULAR FLYPAPER; ANIMAL LECTINS; MACROPHAGES; DEATH; CD36; ATHEROSCLEROSIS; ENDOCYTOSIS; F4/80; EYE	Programmed cell death is first observed at stage 11 of embryogenesis in Drosophila. The systematic removal of apoptotic cells is mediated by cells that are derived from the procephalic mesoderm and differentiate into macrophages. We describe a macrophage receptor for apoptotic cells. This receptor, croquemort (catcher of death), is a member of the CD36 superfamily. Croquemort-mediated phagocytosis represents the concept that phagocytosis evolved primarily as a cellular process for the removal of effete cells. Our findings support the idea that the primordial function of macrophages may have been in tissue modeling and that their adapted role is in host defense.	HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV INFECT DIS, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, MASSACHUSETTS GEN HOSP, DEPT PEDIAT, BOSTON, MA 02115 USA; INST BIOL MOLEC & CELLULAIRE, CNRS, UNITE PROPRE RECH, F-67084 STRASBOURG, FRANCE	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Franc, NC (corresponding author), HARVARD UNIV, CHILDRENS HOSP, SCH MED, DIV HEMATOL, BOSTON, MA 02115 USA.		Franc, Nathalie/C-2208-2009	Franc, Nathalie/0000-0002-1617-385X				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; ACTON SL, 1994, J BIOL CHEM, V269, P21003; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; EZEKOWITZ RAB, 1988, J CELL SCI, P121; EZEKOWITZ RAB, 1989, NAT IMMUN, P15; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gateff E., 1980, INVERTEBRATE SYSTEMS, P517; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GREENWALT DE, 1993, PROTEIN EXPRES PURIF, V4, P72, DOI 10.1006/prep.1993.1011; GREENWALT DE, 1992, BLOOD, V80, P1105; GUAN E, 1991, J BIOL CHEM, V266, P20345; Harlow E LD, 1988, ANTIBODIES LAB MANUA; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; KRIEGER M, 1992, TRENDS BIOCHEM SCI, V17, P141, DOI 10.1016/0968-0004(92)90322-Z; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LIM K, 1989, BIOTECHNIQUES, V7, P576; Metchnikoff E., 1905, IMMUNITY INFECTIVE D; MORRIS L, 1991, DEVELOPMENT, V112, P517; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; PEARCE SFA, 1994, BLOOD, V84, P384; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; STAHL PD, 1990, AM J RESP CELL MOL, V2, P317, DOI 10.1165/ajrcmb/2.4.317; STELLER H, 1994, NEURON, V13, P1269, DOI 10.1016/0896-6273(94)90413-8; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tauber AI, 1991, METCHNIKOFF ORIGINS; TEPASS U, 1994, DEVELOPMENT, V120, P1829; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	44	300	310	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1996	4	5					431	443		10.1016/S1074-7613(00)80410-0	http://dx.doi.org/10.1016/S1074-7613(00)80410-0			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630729	Bronze			2022-12-18	WOS:A1996UM67800003
J	Wen, HT; Miao, EA; Ting, JPY				Wen, Haitao; Miao, Edward A.; Ting, Jenny P. -Y.			Mechanisms of NOD-like Receptor-Associated Inflammasome Activation	IMMUNITY			English	Review							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; THIOREDOXIN-INTERACTING PROTEIN; INNATE IMMUNE DETECTION; LINKS OXIDATIVE STRESS; NLRP3 INFLAMMASOME; CUTTING EDGE; HOST-DEFENSE; IL-1-BETA SECRETION; COLON INFLAMMATION	A major function of a subfamily of NLR (nucleotide-binding domain, leucine-rich repeat containing, or NOD-like receptor) proteins is in inflammasome activation, which has been implicated in a multitude of disease models and human diseases. This work will highlight key progress in understanding the mechanisms that activate the best-studied NLRs (NLRP3, NLRC4, NAIP, and NLRP1) and in uncovering inflammasome NLRs.	[Wen, Haitao; Miao, Edward A.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA; [Miao, Edward A.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Miao, EA (corresponding author), Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu; jenny_ting@med.unc.edu	Wen, Haitao/AAJ-7621-2020	Miao, Edward/0000-0001-7295-3490	National Institutes of Health [R37-AI029564, U54-AI057157, U19AI077437, U19AI067798, CA156330]; NIH [AI097518, AI057141, K01DK098307]; American Heart Association; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564, R01AI029564, U54AI057141, R01AI097518, U19AI067798, U19AI077437, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R37-AI029564, U54-AI057157 (SERCEB), U19AI077437, U19AI067798, and CA156330 awarded to J.P.-Y.T., NIH grants AI097518 and AI057141 awarded to E. A. M., and NIH grant K01DK098307 awarded to H. W. H. W. is a recipient of Postdoctoral Fellowship of the American Heart Association (Mid-Atlantic Affiliate) and Postdoctoral Fellowship of Cancer Research Institute. We thank M. Moayeri for helpful discussions.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Averette KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007913; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Gerlic M, 2013, P NATL ACAD SCI USA, V110, P7808, DOI 10.1073/pnas.1215995110; Gregory SM, 2011, SCIENCE, V331, P330, DOI 10.1126/science.1199478; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jin TC, 2013, PROTEINS, V81, P1266, DOI 10.1002/prot.24287; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Messaed C, 2011, J BIOL CHEM, V286, P43313, DOI 10.1074/jbc.M111.306191; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Moayeri M, 2012, MICROBES INFECT, V14, P392, DOI 10.1016/j.micinf.2011.12.005; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Triantafilou K, 2013, AM J RESP CELL MOL, V49, P923, DOI 10.1165/rcmb.2013-0032OC; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	111	299	319	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					432	441		10.1016/j.immuni.2013.08.037	http://dx.doi.org/10.1016/j.immuni.2013.08.037			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054327	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000330949600008
J	Zhong, B; Zhang, L; Lei, CQ; Li, Y; Mao, AP; Yang, Y; Wang, YY; Zhang, XL; Shu, HB				Zhong, Bo; Zhang, Lu; Lei, Caoqi; Li, Ying; Mao, Ai-Ping; Yang, Yan; Wang, Yan-Yi; Zhang, Xiao-Lian; Shu, Hong-Bing			The Ubiquitin Ligase RNF5 Regulates Antiviral Responses by Mediating Degradation of the Adaptor Protein MITA	IMMUNITY			English	Article							KAPPA-B KINASE; RING FINGER PROTEIN; HEPATITIS-C VIRUS; RIG-I; NEGATIVE REGULATION; PATHOGEN RECOGNITION; SIGNALING PATHWAY; INNATE; IRF3; RNA	Viral infection activates transcription factors NF-kappa B and IRF3, which collaborate to induce type I interferons (IFNs) and elicit innate antiviral response. MITA (also known as STING) has recently been identified as an adaptor that links virus-sensing receptors to IRF3 activation. Here, we showed that the E3 ubiquitin ligase RNF5 interacted with MITA in a viral-infection-dependent manner. Overexpression of RNF5 inhibited virus-triggered IRF3 activation, IFNB1 expression, and cellular antiviral response, whereas knockdown of RNF5 had opposite effects. RNF5 targeted MITA at Lysl 50 for ubiquitination and degradation after viral infection. Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER) and viral infection caused their redistribution to the ER and mitochondria, respectively. We further found that virus-induced ubiquitination and degradation of MITA by RNF5 occurred at the mitochondria. These findings suggest that RNF5 negatively regulates virus-triggered signaling by targeting MITA for ubiquitination and degradation at the mitochondria.	[Zhong, Bo; Zhang, Lu; Lei, Caoqi; Li, Ying; Mao, Ai-Ping; Yang, Yan; Wang, Yan-Yi; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Zhang, Xiao-Lian] Wuhan Univ, Sch Med, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Zhang, Lu/P-6929-2015		Chinese 973 program [2006CB504301]; National Natural Science Foundation of China [30630019]; Chinese 863 program [2006AA02A306]; Chinese Science and Technology Key Project [2008ZX1 0002-014]	Chinese 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Chinese Science and Technology Key Project	We thank D. Cyr for reagents, Y.-F. Me for technical help with the preparation of human monocytes, and members of our laboratory for discussion and technique help. This work was supported by grants from the Chinese 973 program (#2006CB504301), the National Natural Science Foundation of China (#30630019), the Chinese 863 program (#2006AA02A306), and the Chinese Science and Technology Key Project (2008ZX1 0002-014).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kyushiki H, 1997, CYTOGENET CELL GENET, V79, P114, DOI 10.1159/000134695; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Matsuda N, 2001, J CELL SCI, V114, P1949; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang Y, 2005, J BIOL CHEM, V280, P38682, DOI 10.1074/jbc.M506309200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	47	299	331	0	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					397	407		10.1016/j.immuni.2009.01.008	http://dx.doi.org/10.1016/j.immuni.2009.01.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19285439	Bronze			2022-12-18	WOS:000264405500012
J	Peng, G; Wang, HY; Peng, W; Kiniwa, Y; Seo, KH; Wang, RF				Peng, Guangyong; Wang, Helen Y.; Peng, Weiyi; Kiniwa, Yukiko; Seo, Kook Heon; Wang, Rong-Fu			Tumor-infiltrating gamma delta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway	IMMUNITY			English	Article							IMMUNE-RESPONSES; PERIPHERAL-BLOOD; REGULATORY-CELLS; INNATE IMMUNITY; LUNG-CANCER; KINASE TAK1; RECOGNITION; ANTIGEN; IMMUNOTHERAPY; LYMPHOCYTES	gamma delta T cells are important contributors to innate immunity against cancer, but their regulatory role in controlling immune responses remains largely unknown. Here we report that a dominant gamma delta 1 T cell population among lymphocytes infiltrating breast tumors possessed a potent ability to suppress naive and effector T cell responses and to block the maturation and function of dendritic cells. Adoptive cotransfer experiments demonstrated their in vivo suppressive activity. However, their immunosuppressive activity could be reversed by human Toll-like receptor (TLR) 8 ligands both in vitro and in vivo. siRNA-mediated knockdown experiments revealed that MyD88, TRAF6, IKK alpha IKK beta, and p38 alpha molecules in gamma delta 1 cells were required for these cells to respond to TLR8 ligands, whereas TAK1, JNK, and ERK molecules did not appear to be involved in functional regulation. These results provide new insights into the regulatory mechanisms of tumor-specific gamma delta T cells and identify a unique TLR8 signaling pathway linking to their functional regulation.	Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rongfuw@bcm.tmc.edu						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; CHOUDHARY A, 1995, J IMMUNOL, V154, P3932; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eberl M, 2004, IMMUNOLOGY, V112, P364, DOI 10.1111/j.1365-2567.2004.01921.x; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Havran WL, 2000, IMMUNOL RES, V21, P63, DOI 10.1385/IR:21:2-3:63; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jameson J, 2003, CURR OPIN IMMUNOL, V15, P349, DOI 10.1016/S0952-7915(03)00045-1; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kabelitz D, 2005, INT ARCH ALLERGY IMM, V137, P73, DOI 10.1159/000085107; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; Okita R, 2005, ONCOL REP, V14, P1269; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang HY, 2005, MICROBES INFECT, V7, P1056, DOI 10.1016/j.micinf.2005.03.028; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wang J, 1999, ELECTROANAL, V11, P284; Wang YJ, 2004, PROTEOMICS, V4, P20, DOI 10.1002/pmic.200300549; Woo EY, 2001, CANCER RES, V61, P4766	47	299	319	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					334	348		10.1016/j.immuni.2007.05.020	http://dx.doi.org/10.1016/j.immuni.2007.05.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17656116	Bronze			2022-12-18	WOS:000249056300018
J	Winau, F; Hegasy, G; Weiskirchen, R; Weber, S; Cassan, C; Sieling, PA; Modlin, RL; Liblau, RS; Gressner, AM; Kaufmann, SHE				Winau, Florian; Hegasy, Guido; Weiskirchen, Ralf; Weber, Stephan; Cassan, Cecile; Sieling, Peter A.; Modlin, Robert L.; Liblau, Roland S.; Gressner, Axel M.; Kaufmann, Stefan H. E.			Ito cells are liver-resident antigen-presenting cells for activating T cell responses	IMMUNITY			English	Article							HEPATIC STELLATE CELLS; V(ALPHA)14 NKT CELLS; ENDOTHELIAL-CELLS; VITAMIN-A; MECHANISM; DIFFERENTIATION; RECOGNITION; HOMEOSTASIS; APOPTOSIS; BIOLOGY	Here we identified Ito cells (hepatic stellate cells, HSC), known for storage of vitamin A and participation in hepatic fibrosis, as professional liver-resident antigen-presenting cells (APC). Ito cells efficiently presented antigens to CD1-, major histocompatibility complex (MHC)-I-, and MHC-II-restricted T cells. Ito cells presented lipid antigens to CD1-restricted T lymphocytes such as natural killer T (NKT) cells and promoted homeostatic proliferation of liver NKT cells through interieukin-15. Moreover, Ito cells presented antigenic peptides to CD8(+) and CD4(+) T cells and mediated crosspriming of CD8(+) T cells. Peptide-specific T cells were activated by transgenic Ito cells presenting endogenous neoantigen. Upon bacterial infection, Ito cells elicited antigen-specific T cells and mediated protection. In contrast to other liver cell types that have been implicated in induction of immunological tolerance, our data identify Ito cells as professional intrahepatic APCs activating T cells and eliciting a multitude of T cell responses specific for protein and lipid antigens.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; RWTH Univ Hosp, Inst Clin Chem & Pathobiochem, D-52074 Aachen, Germany; Purpan Univ Hosp, INSERM U563, F-31000 Toulouse, France; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA	Max Planck Society; RWTH Aachen University; RWTH Aachen University Hospital; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Winau, F (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Schumann Str 21-22, D-10117 Berlin, Germany.	winau@mpiib-berlin.mpg.de	Weiskirchen, Ralf/O-1734-2018; Modlin, Robert L/M-7941-2014; Liblau, Roland/J-3530-2014; Kaufmann, Stefan HE/I-5454-2014	Weiskirchen, Ralf/0000-0003-3888-0931; Modlin, Robert L/0000-0003-4720-031X; Cassan, Cecile/0000-0003-2205-8222; Kaufmann, Stefan HE/0000-0001-9866-8268; LIBLAU, Roland/0000-0001-5477-5475				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bertolino P, 1999, INT IMMUNOL, V11, P1225, DOI 10.1093/intimm/11.8.1225; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Cornet A, 2001, P NATL ACAD SCI USA, V98, P13306, DOI 10.1073/pnas.231474098; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Geerts A, 2004, J HEPATOL, V40, P331, DOI 10.1016/j.jhep.2003.12.006; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jomantaite L, 2004, EUR J IMMUNOL, V34, P355, DOI 10.1002/eji.200324336; Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kennedy P, 2000, LAT TRADE, V8, P15; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Morgan DJ, 1996, J IMMUNOL, V157, P978; Nagy NE, 1997, J LIPID RES, V38, P645; Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; ROLAND CR, 1994, J IMMUNOL, V153, P5453; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6; Winau F, 2005, EUR J IMMUNOL, V35, P1046, DOI 10.1002/eji.200425603; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	51	299	321	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					117	129		10.1016/j.immuni.2006.11.011	http://dx.doi.org/10.1016/j.immuni.2006.11.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17239632	Green Submitted, Bronze			2022-12-18	WOS:000243959000014
J	Wu, J; Motto, DG; Koretzky, GA; Weiss, A				Wu, J; Motto, DG; Koretzky, GA; Weiss, A			Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; TYROSINE KINASE; ZETA-CHAIN; PROTOONCOGENE PRODUCT; PHOSPHORYLATION; PROTEINS; ZAP-70; DOMAIN; SH2	T cell antigen receptor (TCR) stimulation induces tyrosine phosphorylation of many intracellular proteins, including the proto-oncogene Vav, which is expressed exclusively in hematopoietic and trophoblast cells. Vav is critical for lymphocyte development and activation. Overexpression of Vav in Jurkat T cells leads to potentiation of TCR-mediated IL-2 gene activation. However, the biochemical function of Vav is unknown. Here, we demonstrate that the major induced tyrosine phosphoprotein associated with Vav is the hematopoietic cell-specific SLP-76. The Vav SH2 domain is required for this interaction and for TCR-mediated Vav tyrosine phosphorylation. Similar to Vav, overexpression of SLP-76 markedly potentiates TCR-mediated NF-AT and IL-2 gene activation. Furthermore, overexpression of both Vav and SLP-76 synergistically induces basal and TCR-stimulated NF-AT activation. These results suggest that a signaling complex containing Vav and SLP-76 plays an important role in lymphocyte activation.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV IOWA, DEPT PHYSIOL & BIOPHYS, COLL MED, IOWA CITY, IA 52242 USA; UNIV IOWA, DEPT INTERNAL MED, COLL MED, IOWA CITY, IA 52242 USA; UNIV IOWA, GRAD PROGRAM IMMUNOL, COLL MED, IOWA CITY, IA 52242 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Iowa; University of Iowa; University of Iowa	Wu, J (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA.		Koretzky, Gary/AAU-5381-2021		NATIONAL CANCER INSTITUTE [R01CA056050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044493, R01GM053256] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA56050] Funding Source: Medline; NIGMS NIH HHS [R01GM53256, GM 44493] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1992, ONCOGENE, V7, P611; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOGUSKI MS, 1992, NATURE, V358, P113, DOI 10.1038/358113a0; BUDAY L, 1994, J BIOL CHEM, V269, P9019; BUSTELO XR, 1994, ONCOGENE, V9, P2405; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; EVANS GA, 1993, BIOCHEM J, V294, P339, DOI 10.1042/bj2940339; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GALLAND F, 1992, ONCOGENE, V7, P585; GOUY H, 1995, EUR J IMMUNOL, V25, P3030, DOI 10.1002/eji.1830251107; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; GUPTA S, 1994, J BIOL CHEM, V269, P17349; HOBERT O, 1994, J BIOL CHEM, V269, P20225; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Huby RDJ, 1995, J BIOL CHEM, V270, P30241, DOI 10.1074/jbc.270.51.30241; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1994, J BIOL CHEM, V269, P32579; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Romero F, 1996, MOL CELL BIOL, V16, P37; SIEH M, 1994, MOL CELL BIOL, V14, P4435, DOI 10.1128/MCB.14.7.4435; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WU J, 1995, MOL CELL BIOL, V15, P4337; YE ZS, 1994, P NATL ACAD SCI USA, V91, P12629, DOI 10.1073/pnas.91.26.12629; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZMUIDZINAS A, 1995, EMBO J, V14, P1	45	299	306	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1996	4	6					593	602		10.1016/S1074-7613(00)80485-9	http://dx.doi.org/10.1016/S1074-7613(00)80485-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673706	Bronze			2022-12-18	WOS:A1996UU44300008
J	Wagtmann, N; Rajagopalan, S; Winter, CC; Peruzzi, M; Long, EO				Wagtmann, N; Rajagopalan, S; Winter, CC; Peruzzi, M; Long, EO			Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer	IMMUNITY			English	Article							NK CLONES; T-CELL; I ALLELES; RECOGNITION; EXPRESSION; LYSIS; MOLECULES; SUSCEPTIBILITY; PROTECTION; RESISTANCE	An inhibitory signal is delivered to natural killer (NK) cells and a subset of cytotoxic T cells upon recognition of HLA class I molecules on target cells. We demonstrate that soluble forms of killer cell inhibitory receptors (KIR) bind directly and specifically to HLA-C alleles on transfected cells. Furthermore, transfer of individual KIR into NK clones reconstituted recognition of HLA-C on target cells, leading to inhibition of lysis. Using such functional reconstitution, a related KIR that confers specificity for some HLA-B alleles was also identified. These KIR share conserved tyrosine phosphorylation motifs in their cytoplasmic tails. Thus, a single receptor in NK cells provides both specificity for HLA class I on target cells and the inhibitory signal that prevents lysis.			Wagtmann, N (corresponding author), NIAID,IMMUNOGENET LAB,12441 PARKLAWN DR,ROCKVILLE,MD 20852, USA.		Long, Eric O/G-5475-2011	Long, Eric O/0000-0002-7793-3728				ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BRUTKIEWICZ RR, 1995, J VIROL, V69, P3967, DOI 10.1128/JVI.69.7.3967-3971.1995; CALVO V, 1990, J IMMUNOL, V144, P4038; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; CICCONE E, 1994, EUR J IMMUNOL, V24, P1003, DOI 10.1002/eji.1830240434; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; CORREA I, 1994, EUR J IMMUNOL, V24, P1323, DOI 10.1002/eji.1830240613; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANDREA A, 1995, J IMMUNOL, V155, P2306; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; EARL PL, 1988, CURRENT PROTOCOLS MO; FERRINI S, 1994, EUR J IMMUNOL, V24, P2294, DOI 10.1002/eji.1830241005; GUEGUEN M, 1994, J EXP MED, V180, P1989, DOI 10.1084/jem.180.5.1989; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KAUFMAN DS, 1995, P NATL ACAD SCI USA, V92, P6484, DOI 10.1073/pnas.92.14.6484; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Lanier L L, 1995, Semin Immunol, V7, P75, DOI 10.1006/smim.1995.0011; LANIER LL, 1995, J IMMUNOL, V154, P3320; LEIBSON PJ, 1995, IMMUNITY, V3, P5, DOI 10.1016/1074-7613(95)90153-1; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1989, J IMMUNOL, V142, P2911; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MALNATI MS, 1993, J EXP MED, V178, P961, DOI 10.1084/jem.178.3.961; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; MINGARI MC, 1995, INT IMMUNOL, V7, P697, DOI 10.1093/intimm/7.4.697; MIZUNO S, 1989, IMMUNOGENETICS, V29, P323, DOI 10.1007/BF00352842; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; MURPHY WJ, 1993, JNCI-J NATL CANCER I, V85, P1475, DOI 10.1093/jnci/85.18.1475; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; STORKUS WJ, 1991, P NATL ACAD SCI USA, V88, P5989, DOI 10.1073/pnas.88.14.5989; VITALE M, 1995, P NATL ACAD SCI USA, V92, P3536, DOI 10.1073/pnas.92.8.3536; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	54	299	312	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					801	809		10.1016/1074-7613(95)90069-1	http://dx.doi.org/10.1016/1074-7613(95)90069-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777725	Bronze			2022-12-18	WOS:A1995TM02300014
J	LIU, YJ; BARTHELEMY, C; DEBOUTEILLER, O; ARPIN, C; DURAND, I; BANCHEREAU, J				LIU, YJ; BARTHELEMY, C; DEBOUTEILLER, O; ARPIN, C; DURAND, I; BANCHEREAU, J			MEMORY B-CELLS FROM HUMAN TONSILS COLONIZE MUCOSAL EPITHELIUM AND DIRECTLY PRESENT ANTIGEN TO T-CELLS BY RAPID UP-REGULATION OF B7-1 AND B7-2	IMMUNITY			English	Article							GERMINAL-CENTERS; COSTIMULATORY ACTIVITY; PROTEIN ANTIGENS; ANTIBODY MUTANTS; DRIVEN SELECTION; ACTIVATION; INDUCTION; LIGAND; LYMPHOCYTES; APOPTOSIS	Human memory B cells that carry mutated IgV region genes were isolated from tonsils by negative selection of IgD(+) naive a cells and CD38(+) germinal center B cells and plasma cells. They were mainly found within the intraepithelial areas, but not in the B cell follicles of human tonsils. Memory a cells but not naive B cells have the capacity to present antigen directly to T cells, owing to the constitutive expression of the accessory molecules B7-1/CD80 and B7-2/CD86. Signals through antigen receptors and CD40 antigen result in these two molecules being further up-regulated more rapidly and strongly on memory a cells than on naive B cells. The unique anatomical localization of memory B cells beneath the surface of mucosa, together with their strong APC capacity, may explain the well-known prompt and robust secondary antibody responses.			LIU, YJ (corresponding author), SCHERING PLOUGH CORP, IMMUNOL RES LAB, 27 CHEM PEUPLIERS, BP 11, F-69571 DARDILLY, FRANCE.		Arpin, Christophe/M-3862-2014	Arpin, Christophe/0000-0003-0915-5554				ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; ALLISON JP, 1994, CURR OPIN IMMUNOL, V6, P414, DOI 10.1016/0952-7915(94)90120-1; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; AZUMA M, 1993, J IMMUNOL, V150, P2091; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEVERLEY PCL, 1990, CURR TOP MICROBIOL, V159, P111; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; CASSELL DJ, 1994, J EXP MED, V180, P1829, DOI 10.1084/jem.180.5.1829; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; CHIODETTI L, 1992, J IMMUNOL, V149, P901; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; FLUCKIGER AC, 1993, J EXP MED, V178, P1473, DOI 10.1084/jem.178.5.1473; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; GIMMI CD, 1993, P NATL ACAD SCI USA, V90, P6586, DOI 10.1073/pnas.90.14.6586; GOWANS JL, 1966, J EXP MED, V124, P1017, DOI 10.1084/jem.124.5.1017; GRAY D, 1990, CURR TOP MICROBIOL, V159, P1; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; IRSCH J, 1994, P NATL ACAD SCI USA, V91, P1323, DOI 10.1073/pnas.91.4.1323; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JENKINS MK, 1988, J IMMUNOL, V140, P3324; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KORSMEYER SJ, 1992, BLOOD, V80, P879; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LAGRESLE C, 1993, INT IMMUNOL, V5, P1259, DOI 10.1093/intimm/5.10.1259; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LING NR, 1987, LEUCOCYTE TYPING, V3, P302; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LIU Y, 1992, P NATL ACAD SCI USA, V89, P3845, DOI 10.1073/pnas.89.9.3845; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; LIU YJ, 1994, 5 HUMAN MATURE B CEL; MACKAY CR, 1993, ADV IMMUNOL, V53, P217, DOI 10.1016/S0065-2776(08)60501-5; MACLENNAN ICM, 1991, RES IMMUNOL, V142, P346, DOI 10.1016/0923-2494(91)90089-2; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MAMULA MJ, 1993, IMMUNOL TODAY, V14, P151, DOI 10.1016/0167-5699(93)90274-O; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; MOLLER P, 1989, LEUCOCYTE TYPING, V4, P175; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; RAJEWSKY K, 1989, PROGR IMMUNOLOGY, V7, P397; RON Y, 1987, J IMMUNOL, V138, P2848; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; VITETTA ES, 1991, ANNU REV IMMUNOL, V9, P193, DOI 10.1146/annurev.iy.09.040191.001205; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; YELLIN MJ, 1994, J IMMUNOL, V153, P666	61	299	301	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1995	2	3					239	248		10.1016/1074-7613(95)90048-9	http://dx.doi.org/10.1016/1074-7613(95)90048-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7535180	Bronze			2022-12-18	WOS:A1995QP27600003
J	Farache, J; Koren, I; Milo, I; Gurevich, I; Kim, KW; Zigmond, E; Furtado, GC; Lira, SA; Shakhar, G				Farache, Julia; Koren, Idan; Milo, Idan; Gurevich, Irina; Kim, Ki-Wook; Zigmond, Ehud; Furtado, Glaucia C.; Lira, Sergio A.; Shakhar, Guy			Luminal Bacteria Recruit CD103(+) Dendritic Cells into the Intestinal Epithelium to Sample Bacterial Antigens for Presentation	IMMUNITY			English	Article							IN-VIVO; LAMINA PROPRIA; T-CELLS; SALMONELLA-TYPHIMURIUM; TARGETED DISRUPTION; SEROVAR TYPHIMURIUM; LY6C(HI) MONOCYTES; IMMUNE-RESPONSES; DIFFERENTIATION; MOBILIZATION	CD103(+) dendritic cells (DCs) carry bacteria from the small intestine and can present antigens to T cells. Yet they have not been recorded sampling luminal bacteria or presenting bacterial antigens in mesentery lymph nodes. We used 2-photon microscopy in live Cx3cr1(+/gfp) 3 Cd11c-YFP mice to study these processes. At steady state, sparse CD103(+) DCs occupied the epithelium. They patrolled among enterocytes while extending dendrites toward the lumen, likely using tight-junction proteins to penetrate the epithelium. Challenge with Salmonella triggered chemokine-and toll-like receptor (TLR)-dependent recruitment of additional DCs from the lamina propria (LP). The DCs efficiently phagocytosed the bacteria using intraepithelial dendrites. Noninvasive bacteria were similarly sampled. In contrast, CD103(+) DCs sampled soluble luminal antigen inefficiently. In mice harboring CD103(+) DCs, antigen-specific CD8 T cells were subsequently activated in MLNs. Intestinal CD103(+) DCs are therefore equipped with unique mechanisms to independently complete the processes of uptake, transportation, and presentation of bacterial antigens.	[Farache, Julia; Koren, Idan; Milo, Idan; Gurevich, Irina; Kim, Ki-Wook; Zigmond, Ehud; Shakhar, Guy] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Furtado, Glaucia C.; Lira, Sergio A.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Weizmann Institute of Science; Icahn School of Medicine at Mount Sinai	Shakhar, G (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	shakhar@weizmann.ac.il		/0000-0002-7207-4389	Leona M. and Harry B. Helmsley Charitable Trust; European Union [NMP4-LA-2009-229289]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067381, P01DK072201] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; European Union(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Oliver Pabst and Steffen Jung for critical discussion, Mary Jo Wick and Wolf-Dietrich Hardt for providing Salmonella strains, and Olga Schultz for technical advice. This work was supported by the Leona M. and Harry B. Helmsley Charitable Trust and by the "NanoII'' grant (#NMP4-LA-2009-229289) from the European Union FP7 program.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Arques JL, 2009, GASTROENTEROLOGY, V137, P579, DOI 10.1053/j.gastro.2009.04.010; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BOWE F, 1994, METHOD ENZYMOL, V236, P509; Brokaw JJ, 1998, AM J RESP CELL MOL, V19, P598, DOI 10.1165/ajrcmb.19.4.2870; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cruickshank SA, 2009, J IMMUNOL, V182, P3055, DOI 10.4049/jimmunol.0802749; Diehl G.E., 2013, NATURE; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Mach N, 2000, CANCER RES, V60, P3239; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Maric I, 1996, J IMMUNOL, V156, P1408; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McDonald KG, 2012, AM J PATHOL, V180, P984, DOI 10.1016/j.ajpath.2011.11.009; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PARKER CM, 1992, P NATL ACAD SCI USA, V89, P1924, DOI 10.1073/pnas.89.5.1924; Persson EK, 2010, IMMUNOBIOLOGY, V215, P692, DOI 10.1016/j.imbio.2010.05.013; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Schlickum S, 2008, BLOOD, V112, P619, DOI 10.1182/blood-2008-01-134833; SCHODEL F, 1994, INFECT IMMUN, V62, P1669; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Semmrich M, 2012, MUCOSAL IMMUNOL, V5, P150, DOI 10.1038/mi.2011.61; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takahashi-Iwanaga H, 1999, ARCH HISTOL CYTOL, V62, P471, DOI 10.1679/aohc.62.471; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yrlid U, 2001, INFECT IMMUN, V69, P5726, DOI 10.1128/IAI.69.9.5726-5735.2001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; Zimmerli SC, 2007, J INVEST DERMATOL, V127, P2381, DOI 10.1038/sj.jid.5700882	68	298	307	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					581	595		10.1016/j.immuni.2013.01.009	http://dx.doi.org/10.1016/j.immuni.2013.01.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23395676	Green Accepted, Bronze			2022-12-18	WOS:000330941500021
J	Greter, M; Helft, J; Chow, A; Hashimoto, D; Mortha, A; Agudo-Cantero, J; Bogunovic, M; Gautier, EL; Miller, J; Leboeuf, M; Lu, GM; Aloman, C; Brown, BD; Pollard, JW; Xiong, HB; Randolph, GJ; Chipuk, JE; Frenette, PS; Merad, M				Greter, Melanie; Helft, Julie; Chow, Andrew; Hashimoto, Daigo; Mortha, Arthur; Agudo-Cantero, Judith; Bogunovic, Milena; Gautier, Emmanuel L.; Miller, Jennifer; Leboeuf, Marylene; Lu, Geming; Aloman, Costica; Brown, Brian D.; Pollard, Jeffrey W.; Xiong, Huabao; Randolph, Gwendalyn J.; Chipuk, Jerry E.; Frenette, Paul S.; Merad, Miriam			GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic Cells	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; ANTIGEN CROSS-PRESENTATION; STEADY-STATE; MITOCHONDRIAL FISSION; MONOCYTE MIGRATION; DEFICIENT MICE; LYMPH-NODES; C-FMS; MACROPHAGE; REVEALS	GM-CSF (Csf-2) is a critical cytokine for the in vitro generation of dendritic cells (DCs) and is thought to control the development of inflammatory DCs and resident CD103(+) DCs in some tissues. Here we showed that in contrast to the current understanding, Csf-2 receptor acts in the steady state to promote the survival and homeostasis of nonlymphoid tissue-resident CD103(+) and CD11b(+) DCs. Absence of Csf-2 receptor on lung DCs abrogated the induction of CD8(+) T cell immunity after immunization with particulate antigens. In contrast, Csf-2 receptor was dispensable for the differentiation and innate function of inflammatory DCs during acute injuries. Instead, inflammatory DCs required Csf-1 receptor for their development. Thus, Csf-2 is important in vaccine-induced CD8(+) T cell immunity through the regulation of nonlymphoid tissue DC homeostasis rather than control of inflammatory DCs in vivo.	[Greter, Melanie; Helft, Julie; Chow, Andrew; Hashimoto, Daigo; Mortha, Arthur; Bogunovic, Milena; Miller, Jennifer; Leboeuf, Marylene; Chipuk, Jerry E.; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Greter, Melanie; Helft, Julie; Chow, Andrew; Hashimoto, Daigo; Mortha, Arthur; Agudo-Cantero, Judith; Bogunovic, Milena; Gautier, Emmanuel L.; Miller, Jennifer; Leboeuf, Marylene; Lu, Geming; Brown, Brian D.; Xiong, Huabao; Randolph, Gwendalyn J.; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Agudo-Cantero, Judith; Brown, Brian D.] Mt Sinai Sch Med, Genom Inst, New York, NY 10029 USA; [Gautier, Emmanuel L.; Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lu, Geming; Aloman, Costica; Xiong, Huabao] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Brown, Brian D.; Xiong, Huabao; Chipuk, Jerry E.; Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Pollard, Jeffrey W.; Frenette, Paul S.] Albert Einstein Coll Med, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu	Mortha, Arthur/ABE-6250-2020; Gautier, Emmanuel L./E-2259-2017; Frenette, Paul S/J-8272-2012; Hashimoto, Daigo/O-1013-2013; Helft, Julie/ABE-6179-2020	Gautier, Emmanuel L./0000-0003-2976-7566; Frenette, Paul S/0000-0003-0862-9922; Hashimoto, Daigo/0000-0001-9489-9704; Helft, Julie/0000-0002-2733-1972; Chow, Andrew/0000-0003-1151-2450; Lu, Geming/0000-0002-1322-3997; Greter, Melanie/0000-0002-7220-5369; Mortha, Arthur/0000-0003-2673-0485; Chipuk, Jerry Edward/0000-0002-1337-842X	NIH from the March of Dimes Foundation [CA157740, 5-FY11-74]; American Heart Association; NIH [R56AI091871]; Eli and Edythe L. Broad Foundation; Crohn's and Colitis Foundation of America; National Science Foundation of Switzerland; National Institutes of Health [HL086899, AI095611, CA154947];  [JDRF172010770];  [DP2DK083052-01];  [AI049653];  [R01 CA131270];  [P01 CA100324];  [HL69438];  [DK056638];  [HL097819];  [HL097700]; Medical Research Council [G1002033] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA173861, R01CA157740, R01CA131270, P01CA100324, R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899, R01HL069438, R01HL097700, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091871, R01AI049653, U01AI095611, R37AI049653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083052, K08DK088954, R01DK056638] Funding Source: NIH RePORTER	NIH from the March of Dimes Foundation; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe L. Broad Foundation; Crohn's and Colitis Foundation of America; National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank B. Becher for critical discussions. B.D.B. is supported by JDRF172010770 and DP2DK083052-01. J.E.C. is supported by NIH CA157740 and 5-FY11-74 grant from the March of Dimes Foundation. E.L.G. is supported by American Heart Association Postdoctoral Fellowship (Founder's Affiliate). H.X. is supported by NIH R56AI091871 and the Eli and Edythe L. Broad Foundation. G.J.R. is supported by AI049653. J.W.P. is supported by R01 CA131270 and P01 CA100324. M.B. is supported by a career development award from the Crohn's and Colitis Foundation of America and a primary caregiver technical assistance supplement from the National Institute of Allergy and Infectious Diseases. M.G. is supported by the National Science Foundation of Switzerland. M.M. is supported by the National Institutes of Health grants HL086899, AI095611, and CA154947. P.S.F. is supported by HL69438, DK056638, HL097819, and HL097700.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Guleria I, 2001, INFECT IMMUN, V69, P1795, DOI 10.1128/IAI.69.3.1795-1807.2001; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Li J, 2006, GENESIS, V44, P328, DOI 10.1002/dvg.20219; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sathe P, 2011, J IMMUNOL, V186, P5184, DOI 10.4049/jimmunol.1002683; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Sudo T, 1995, ONCOGENE, V11, P2469; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540	62	298	307	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					1031	1046		10.1016/j.immuni.2012.03.027	http://dx.doi.org/10.1016/j.immuni.2012.03.027			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749353	Green Accepted, Bronze			2022-12-18	WOS:000306097100019
J	Khanna, KM; Bonneau, RH; Kinchington, PR; Hendricks, RL				Khanna, KM; Bonneau, RH; Kinchington, PR; Hendricks, RL			Herpes simplex virus-specific memory CD8(+) T cells are selectively activated and retained in latently infected sensory ganglia	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; DRAINING LYMPH-NODES; IN-VIVO; ANTIGEN PRESENTATION; TRIGEMINAL GANGLION; GAMMA-INTERFERON; GENE-EXPRESSION; TYPE-1; REACTIVATION; TRANSCRIPTS	This study challenges the concept that herpes simplex virus type 1 (HSV-1) latency represents a silent infection that is ignored by the host immune system, and suggests antigen-directed retention of memory CD8(+) T cells. CD8(+) T cells specific for the immunodominant gB(498-505) HSV-1 epitope are selectively retained in the ophthalmic branch of the latently infected trigeminal ganglion, where they acquire and maintain an activation phenotype and the capacity to produce IFN-gamma. Some CD8(+) T cells showed TCR polarization to junctions with neurons. A gB(498-505) peptide-specific CD8(+) T cell clone can block HSV-1 reactivation from latency in ex vivo trigeminal ganglion cultures. We conclude that CD8+ T cells provide active surveillance of HSV-1 gene expression in latently infected sensory neurons.	Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Ophthalmol & Mol Genet, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Biochem, Pittsburgh, PA 15213 USA; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, 203 Lothrop St, Pittsburgh, PA 15213 USA.				NATIONAL EYE INSTITUTE [P30EY008098, R01EY005945, R01EY007397, P30EY001792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049719] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY001792-209002, P30 EY001792, P30 EY001792-209001, P30 EY08098, R01 EY005945-15, P30 EY008098-10, P30 EY008098, EY05945, P30 EY008098-11, P30 EY008098-119003, R01 EY005945-14, R01 EY005945-13, P30 EY008098-12, R01 EY005945, P30 EY008098-129003, EY07397] Funding Source: Medline; NIAID NIH HHS [AI49719, R01 AI049719] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bergmann CC, 1999, J IMMUNOL, V163, P3379; Brehm M, 1999, VIROLOGY, V256, P258, DOI 10.1006/viro.1999.9653; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; Chen SH, 1997, J VIROL, V71, P5878, DOI 10.1128/JVI.71.8.5878-5884.1997; Chen SH, 2000, VIROLOGY, V278, P207, DOI 10.1006/viro.2000.0643; Favoreel HW, 2000, ARCH VIROL, V145, P1269, DOI 10.1007/s007050070090; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; FU TM, 1993, J VIROL, V67, P6866, DOI 10.1128/JVI.67.11.6866-6871.1993; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Halford WP, 1996, J IMMUNOL, V157, P3542; Hawke S, 1998, J EXP MED, V187, P1575, DOI 10.1084/jem.187.10.1575; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jones CM, 2000, J GEN VIROL, V81, P407, DOI 10.1099/0022-1317-81-2-407; KRAMER MF, 1995, J VIROL, V69, P1389, DOI 10.1128/JVI.69.3.1389-1399.1995; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; PEREIRA RA, 1994, J EXP MED, V180, P841, DOI 10.1084/jem.180.3.841; Pereira RA, 1999, J VIROL, V73, P6484, DOI 10.1128/JVI.73.8.6484-6489.1999; SALVUCCI LA, 1995, J VIROL, V69, P1122, DOI 10.1128/JVI.69.2.1122-1131.1995; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; TalSinger R, 1997, J VIROL, V71, P5268, DOI 10.1128/JVI.71.7.5268-5276.1997; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	37	298	308	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					593	603		10.1016/S1074-7613(03)00112-2	http://dx.doi.org/10.1016/S1074-7613(03)00112-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753737	Green Accepted			2022-12-18	WOS:000182962200005
J	GRAWUNDER, U; LEU, TMJ; SCHATZ, DG; WERNER, A; ROLINK, AG; MELCHERS, F; WINKLER, TH				GRAWUNDER, U; LEU, TMJ; SCHATZ, DG; WERNER, A; ROLINK, AG; MELCHERS, F; WINKLER, TH			DOWN-REGULATION OF RAG1 AND RAG2 GENE-EXPRESSION IN PREB CELLS AFTER FUNCTIONAL IMMUNOGLOBULIN HEAVY-CHAIN REARRANGEMENT	IMMUNITY			English	Article							V(D)J RECOMBINATION; BONE-MARROW; LYMPHOCYTES-B; LIGHT-CHAIN; FETAL LIVER; SURFACE; ANTIBODIES; LAMBDA-5; MOUSE; LOCUS	Two waves of immunoglobulin gene rearrangements, first of the heavy, then of the light chain gene loci form functional immunoglobulin genes during B cell development. In mouse bone marrow the differential surface expression of B220 (CD45R), c-kit, CD25, and surrogate light chain as well as the cell cycle status allows FACS separation of the cells in which these two waves of rearrangements occur. The gene products of two recombination activating genes, RAG1 and RAG2 are crucial for this rearrangement process, Here, we show that the expression of the RAG genes is twice up- and down-regulated, at the transcriptional level for RAG1 and RAG2, and at the postranscriptional level for RAG2 protein. Expression levels are high in D --> J(H) and V-H --> DJ(H) rearranging proB and preB-I cells, low in preB cells expressing the preB cell receptor on the cell surface, and high again in V-L --> J(L) rearranging small preB-II cells, In immature B cells expressing on the cell surface RAG1 and RAG2 mRNA is down-regulated, whereas RAG2 protein levels are maintained. Downregulation of RAG1 and RAG2 gene expression after productive rearrangement at one heavy chain allele might be part of the mechanisms that prevent further rearrangements at the other allele.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06520	Howard Hughes Medical Institute; Yale University	GRAWUNDER, U (corresponding author), BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032524, R37AI032524] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; BRUGGEMANN EP, 1991, BIOTECHNIQUES, V10, P202; CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; GRAWUNDER U, 1993, INT IMMUNOL, V5, P1609, DOI 10.1093/intimm/5.12.1609; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1991, CELL, V69, P823; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; LENNON GG, 1990, J IMMUNOL, V144, P1983; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MELCHERS F, 1994, ANNU REV IMMUNOL, V12, P209, DOI 10.1146/annurev.immunol.12.1.209; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PARKHOUSE RME, 1992, IMMUNOLOGY, V76, P535; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; WEAVER D, 1985, CELL, V42, P117, DOI 10.1016/S0092-8674(85)80107-0; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221	36	298	301	0	5	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					601	608		10.1016/1074-7613(95)90131-0	http://dx.doi.org/10.1016/1074-7613(95)90131-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584150	Bronze			2022-12-18	WOS:A1995TG28100008
J	Wellenstein, MD; de Visser, KE				Wellenstein, Max D.; de Visser, Karin E.			Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape	IMMUNITY			English	Review							NF-KAPPA-B; BREAST-CANCER; TRANSGENIC MICE; LUNG-CANCER; METASTATIC MELANOMA; SECRETORY PHENOTYPE; ANTITUMOR IMMUNITY; PD-1 BLOCKADE; MOUSE MODEL; INFILTRATING LYMPHOCYTES	Owing to their tremendous diversity and plasticity, immune cells exert multifaceted functions in tumor-bearing hosts, ranging from anti-tumor to pro-tumor activities. Tumor immune landscapes differ greatly between and within cancer types. Emerging evidence suggests that genetic aberrations in cancer cells dictate the immune contexture of tumors. Here, we review the current understanding of the mechanisms whereby common drivers of tumorigenesis modulate the tumor immune milieu. We discuss these findings in the context of clinical observations and examine how cancer-cell-intrinsic properties can be exploited to maximize the benefit of immunomodulatory therapies. Understanding the relationship between cancer cell-intrinsic genetic events and the immune response may enable personalized immune intervention strategies for cancer patients.	[Wellenstein, Max D.; de Visser, Karin E.] Netherlands Canc Inst, Oncode Inst, Div Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	de Visser, KE (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl		de Visser, Karin/0000-0002-0293-868X	European Research Council Consolidator award [InflaMet 615300]; Dutch Cancer Society [KWF10083, KWF10623]; Beug Foundation for Metastasis Research	European Research Council Consolidator award(European Research Council (ERC)); Dutch Cancer Society(KWF Kankerbestrijding); Beug Foundation for Metastasis Research	We apologize to those researchers whose original work could not be cited due to space restrictions. We would like to thank Hannah Garner for insightful input during the writing process. Research in the De Visser laboratory is funded by European Research Council Consolidator award (InflaMet 615300), the Dutch Cancer Society (KWF10083; KWF10623), and the Beug Foundation for Metastasis Research. K.E.d.V. is an EMBO Young Investigator.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balli D, 2017, CLIN CANCER RES, V23, P3129, DOI 10.1158/1078-0432.CCR-16-2128; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bezzi M, 2018, NAT MED, V24, P165, DOI 10.1038/nm.4463; Blaisdell A, 2015, CANCER CELL, V28, P785, DOI 10.1016/j.ccell.2015.11.005; Borre PV, 2014, ONCOTARGET, V5, P3996, DOI 10.18632/oncotarget.2130; Boveri T., 1914, FRAGE ENTSTEHUNG MAL, V1, P1; Brandetti E, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1316439; Busch SE, 2016, J IMMUNOL, V197, P4493, DOI 10.4049/jimmunol.1600576; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cha YJ, 2016, LUNG CANCER, V97, P73, DOI 10.1016/j.lungcan.2016.05.001; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen CF, 2017, CELL REP, V18, P2331, DOI 10.1016/j.celrep.2017.02.040; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095475; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coley WB, 1893, AM J MED SCI, V105, P487, DOI [DOI 10.1097/00000441-189305000-00001, 10.1097/00000441-189305000-00001]; Cooks T, 2014, CARCINOGENESIS, V35, P1680, DOI 10.1093/carcin/bgu134; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Debebe A, 2017, ONCOGENE, V36, P6020, DOI 10.1038/onc.2017.207; Decker T, 2012, J CANCER RES CLIN, V138, P1945, DOI 10.1007/s00432-012-1258-3; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Doucette T, 2013, CANCER IMMUNOL RES, V1, P112, DOI 10.1158/2326-6066.CIR-13-0028; DUESBERG PH, 1970, P NATL ACAD SCI USA, V67, P1673, DOI 10.1073/pnas.67.4.1673; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Groenendijk FH, 2014, MOL ONCOL, V8, P1067, DOI 10.1016/j.molonc.2014.05.004; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Huijbers IJ, 2017, METHODS MOL BIOL, V1642, P1, DOI 10.1007/978-1-4939-7169-5_1; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Jiang DQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1742-7; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Keck MK, 2015, CLIN CANCER RES, V21, P870, DOI 10.1158/1078-0432.CCR-14-2481; Kersten K, 2017, EMBO MOL MED, V9, P137, DOI 10.15252/emmm.201606857; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Layer JP, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1320626; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lesina M, 2016, J CLIN INVEST, V126, P2919, DOI 10.1172/JCI86477; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99; Ock CY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01018-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Quigley D, 2015, MOL CANCER RES, V13, P493, DOI 10.1158/1541-7786.MCR-14-0387; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Sarkar S, 2017, GENE DEV, V31, P1109, DOI 10.1101/gad.296640.117; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schuster C, 2011, BLOOD, V118, P4635, DOI 10.1182/blood-2010-10-313098; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shen Q, 2017, CANCER DISCOV, V7, P1320, DOI 10.1158/2159-8290.CD-17-0037; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Stanton SE, 2016, JAMA ONCOL, V2, P1354, DOI 10.1001/jamaoncol.2016.1061; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Stiff A, 2016, CANCER RES, V76, P2125, DOI 10.1158/0008-5472.CAN-15-1490; Stodden GR, 2015, ONCOGENE, V34, P2471, DOI 10.1038/onc.2014.193; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; von Hansemann D, 1890, VIRCHOWS ARCH PATHOL, V119, P299, DOI [DOI 10.1007/BF01882039, 10.1007/BF01882039, DOI 10.1515/9783112369746-021]; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Welte T, 2016, NAT CELL BIOL, V18, P632, DOI 10.1038/ncb3355; Wislez M, 2006, CANCER RES, V66, P4198, DOI 10.1158/0008-5472.CAN-05-3842; Wormann SM, 2016, GASTROENTEROLOGY, V151, P180, DOI 10.1053/j.gastro.2016.03.010; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871; Yetil A, 2015, ONCOTARGET, V6, P3563, DOI 10.18632/oncotarget.2969; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031	117	297	302	12	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					399	416		10.1016/j.immuni.2018.03.004	http://dx.doi.org/10.1016/j.immuni.2018.03.004			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562192	Bronze			2022-12-18	WOS:000427916900001
J	Chavan, SS; Pavlov, VA; Tracey, KJ				Chavan, Sangeeta S.; Pavlov, Valentin A.; Tracey, Kevin J.			Mechanisms and Therapeutic Relevance of Neuro-immune Communication	IMMUNITY			English	Review							VAGUS NERVE-STIMULATION; SPINAL-CORD-INJURY; SYSTEMIC INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION INJURY; RESOLVING LIPID MEDIATORS; PRIMARY AFFERENT NEURONS; SENSORY NEURONS; T-CELLS; IMPROVES SURVIVAL; INNATE IMMUNITY	Active research at the frontiers of immunology and neuroscience has identified multiple points of interaction and communication between the immune system and the nervous system. Immune cell activation stimulates neuronal circuits that regulate innate and adaptive immunity. Molecular mechanistic insights into the inflammatory reflex and other neuro-immune interactions have greatly advanced our understanding of immunity and identified new therapeutic possibilities in inflammatory and autoimmune diseases. Recent successful clinical trials using bioelectronic devices that modulate the inflammatory reflex to significantly ameliorate rheumatoid arthritis and inflammatory bowel disease provide a path for using electrons as a therapeutic modality for targeting molecular mechanisms of immunity. Here, we review mechanisms of peripheral sensory neuronal function in response to immune challenges, the neural regulation of immunity and inflammation, and the therapeutic implications of those mechanistic insights.	[Chavan, Sangeeta S.; Pavlov, Valentin A.; Tracey, Kevin J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA; [Chavan, Sangeeta S.; Pavlov, Valentin A.; Tracey, Kevin J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Chavan, SS; Pavlov, VA; Tracey, KJ (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA.; Chavan, SS; Pavlov, VA; Tracey, KJ (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY 11030 USA.	schavan@northwell.edu		Pavlov, Valentin/0000-0002-1994-2853; Chavan, Sangeeta S./0000-0002-4822-3356; Tracey, Kevin J/0000-0003-1884-6314	NIH National Institute of General Medical Sciences [R01GM089807, 1 R35 GM118182-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089807, R35GM118182] Funding Source: NIH RePORTER	NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the NIH National Institute of General Medical Sciences: R01GM089807 (to V.A.P. and K.J.T.) and 1 R35 GM118182-01 (to K.J.T.).	Abe C, 2017, NAT NEUROSCI, V20, P700, DOI 10.1038/nn.4526; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; [Anonymous], 2011, COMPR PHYSIOL; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; BARNES PJ, 1986, LANCET, V1, P242; BELLINGER D L, 1989, Brain Behavior and Immunity, V3, P291, DOI 10.1016/0889-1591(89)90029-9; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Browning KN, 2017, GASTROENTEROLOGY, V152, P730, DOI 10.1053/j.gastro.2016.10.046; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Carnevale D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13035; CAYGILL CPJ, 1987, GUT, V28, P924, DOI 10.1136/gut.28.8.924; Chavan SS, 2017, J IMMUNOL, V198, P3389, DOI 10.4049/jimmunol.1601613; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cole SW, 2015, NAT REV CANCER, V15, P563, DOI 10.1038/nrc3978; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; Dampney RAL, 2016, ADV PHYSIOL EDUC, V40, P283, DOI 10.1152/advan.00027.2016; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; de Lartigue G, 2011, AM J PHYSIOL-ENDOC M, V301, pE187, DOI 10.1152/ajpendo.00056.2011; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ek M, 1998, J NEUROSCI, V18, P9471; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Erin N, 2013, ANTICANCER RES, V33, P3675; Erin N, 2008, REGUL PEPTIDES, V151, P35, DOI 10.1016/j.regpep.2008.03.012; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gallowitsch-Puerta M, 2007, LIFE SCI, V80, P2325, DOI 10.1016/j.lfs.2007.01.002; Gaykema RPA, 1998, NEUROIMMUNOMODULAT, V5, P234, DOI 10.1159/000026343; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Gidron Y, 2005, LANCET ONCOL, V6, P245, DOI 10.1016/S1470-2045(05)70096-6; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Goehler LE, 1999, J NEUROSCI, V19, P2799; Goehler LE, 1998, BRAIN RES, V804, P306, DOI 10.1016/S0006-8993(98)00685-4; Grisanti LA, 2011, J PHARMACOL EXP THER, V338, P648, DOI 10.1124/jpet.110.178012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guarini S, 2004, CARDIOVASC RES, V63, P357, DOI 10.1016/j.cardiores.2004.03.029; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hanes William M, 2016, Bioelectron Med, V3, P18, DOI 10.15424/bioelectronmed.2016.00001; Hanes WM, 2015, MOL MED; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Herrity AN, 2015, AM J PHYSIOL-REG I, V308, pR1021, DOI 10.1152/ajpregu.00445.2014; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012; Houghton BL, 2006, J PHYSIOL-LONDON, V572, P811, DOI 10.1113/jphysiol.2005.104067; HOUGHTON PWJ, 1987, POSTGRAD MED J, V63, P47, DOI 10.1136/pgmj.63.735.47; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Janig W, 2014, AUTON NEUROSCI-BASIC, V182, P4, DOI 10.1016/j.autneu.2014.01.004; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kimura K, 2016, CELL REP, V14, P2362, DOI 10.1016/j.celrep.2016.02.032; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Kollarik M, 2010, AUTON NEUROSCI-BASIC, V153, P12, DOI 10.1016/j.autneu.2009.08.001; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Lai N.Y., 2017, J INTERN MED; Lee ST, 2010, BRAIN RES, V1309, P164, DOI 10.1016/j.brainres.2009.10.076; Li M, 2005, ACTA PHARMACOL SIN, V26, P192, DOI 10.1111/j.1745-7254.2005.00522.x; Li M, 2010, AUTON NEUROSCI-BASIC, V154, P66, DOI 10.1016/j.autneu.2009.11.009; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Lu B, 2014, MOL MED, V20, P350, DOI 10.2119/molmed.2013.00117; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Marino F, 2013, AMINO ACIDS, V45, P55, DOI 10.1007/s00726-011-1186-6; Marvel FA, 2004, BRAIN BEHAV IMMUN, V18, P123, DOI 10.1016/j.bbi.2003.09.004; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Mina-Osorio P, 2012, MOL MED, V18, P618, DOI 10.2119/molmed.2012.00027; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Munyaka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109272; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; NANCE D M, 1989, Brain Behavior and Immunity, V3, P281, DOI 10.1016/0889-1591(89)90028-7; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nicol GD, 1997, J NEUROSCI, V17, P975; Nieuwenhoff MD, 2016, MICROVASC RES, V106, P1, DOI 10.1016/j.mvr.2016.03.001; Niijima A, 1996, J AUTONOM NERV SYST, V61, P287, DOI 10.1016/S0165-1838(96)00098-7; OGAWA T, 1991, CARCINOGENESIS, V12, P1227, DOI 10.1093/carcin/12.7.1227; Olofsson P., 2015, BIOELECTRON MED, V2, P37, DOI [10.15424/bioelectronmed.2015., DOI 10.15424/BIOELECTRONMED.2015]; Olofsson PS, 2016, NAT BIOTECHNOL, V34, P1066, DOI 10.1038/nbt.3663; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Ondicova K, 2010, LANCET ONCOL, V11, P596, DOI 10.1016/S1470-2045(09)70337-7; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Partecke LI, 2017, ONCOTARGET, V8, P22501, DOI 10.18632/oncotarget.15019; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pinho-Ribeiro FA, 2017, TRENDS IMMUNOL, V38, P5, DOI 10.1016/j.it.2016.10.001; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2015, BRAIN BEHAV IMMUN, V44, P19, DOI 10.1016/j.bbi.2014.07.010; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sabharwal L, 2014, J BIOCHEM, V156, P299, DOI 10.1093/jb/mvu057; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schaible HG, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0470-8; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; SHIPLEY MT, 1982, BRAIN RES BULL, V8, P139, DOI 10.1016/0361-9230(82)90040-5; Song JG, 2012, ANESTHESIOLOGY, V116, P406, DOI 10.1097/ALN.0b013e3182426ebd; Steinberg Benjamin E, 2016, Bioelectron Med, V3, P7; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talbot S, 2016, ANNU REV IMMUNOL, V34, P421, DOI 10.1146/annurev-immunol-041015-055340; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; TATSUTA M, 1985, CANCER RES, V45, P194; TATSUTA M, 1988, INT J CANCER, V42, P414, DOI 10.1002/ijc.2910420318; Terrando N, 2014, MOL MED, V20, P667, DOI 10.2119/molmed.2014.00143; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2015, SCI AM, V312, P28, DOI 10.1038/scientificamerican0315-28; Tracey Kevin J, 2014, J Exp Med, V211, P2483, DOI 10.1084/jem.21113insight3; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Ueno M, 2016, NAT NEUROSCI, V19, P784, DOI 10.1038/nn.4289; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward NL, 2012, J INVEST DERMATOL, V132, P1927, DOI 10.1038/jid.2012.60; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Yaprak M., 2008, NEUROANATOMY, V7, P17; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	165	297	305	12	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					927	942		10.1016/j.immuni.2017.06.008	http://dx.doi.org/10.1016/j.immuni.2017.06.008			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636960	Bronze, Green Accepted			2022-12-18	WOS:000403665900003
J	Ishiai, M; Kurosaki, M; Pappu, R; Okawa, K; Ronko, I; Fu, C; Shibata, M; Iwamatsu, A; Chan, AC; Kurosaki, T				Ishiai, M; Kurosaki, M; Pappu, R; Okawa, K; Ronko, I; Fu, C; Shibata, M; Iwamatsu, A; Chan, AC; Kurosaki, T			BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR STIMULATION; PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHOLIPASE C-GAMMA-2; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT; DEPENDENT ACTIVATION; MOLECULAR-CLONING; DISTINCT PATHWAYS; LYMPHOCYTES-B	Signaling through the B cell receptor (BCR) is essential for B cell function and development. Despite the key role of Syk in BCR signaling, little is known about the mechanism by which Syk transmits downstream effecters. BLNK (B cell LiNKer protein), a substrate for Syk, is now shown to be essential in activating phospholipase C (PLC)gamma 2 and JNK. The BCR-induced PLC gamma S activation, but not the JNK activation, was restored by introduction of PLC gamma 2 membrane-associated form into BLNK-deficient B cells. As JNK activation requires both Rad and PLC gamma 2, our results suggest that BLNK regulates the Rac1-JNK pathway, in addition to modulating PLC gamma 2 localization.	Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med,Ctr Immunol,Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol,Div Rheumatol,Ctr Immunol, St Louis, MO 63110 USA; Kirin Brewery Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa 2360004, Japan; Ina Lab, Med Biol Labs, Nagano 3960002, Japan	Kansai Medical University; Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Kirin Brewery Company Limited	Kurosaki, T (corresponding author), Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X	NATIONAL CANCER INSTITUTE [R01CA071516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042787] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA71516] Funding Source: Medline; NIAID NIH HHS [R01AI42787] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; CHEN CLH, 1982, J IMMUNOL, V129, P2580; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; EMORI Y, 1989, J BIOL CHEM, V264, P21885; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fu C, 1997, J BIOL CHEM, V272, P27362, DOI 10.1074/jbc.272.43.27362; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harmer SL, 1997, MOL CELL BIOL, V17, P4087, DOI 10.1128/MCB.17.7.4087; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; HEMPEL WM, 1991, J IMMUNOL, V146, P3713; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; KOST TA, 1983, NUCLEIC ACIDS RES, V11, P8287, DOI 10.1093/nar/11.23.8287; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Law CL, 1996, MOL CELL BIOL, V16, P1305; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Richards JD, 1996, J BIOL CHEM, V271, P6458, DOI 10.1074/jbc.271.11.6458; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SAXTON TM, 1994, J IMMUNOL, V153, P623; SMIT L, 1994, J BIOL CHEM, V269, P20209; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	49	297	300	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1999	10	1					117	125		10.1016/S1074-7613(00)80012-6	http://dx.doi.org/10.1016/S1074-7613(00)80012-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023776	Bronze			2022-12-18	WOS:000078428700012
J	Kobayashi, T; Glatz, M; Horiuchi, K; Kawasaki, H; Akiyama, H; Kaplan, DH; Kong, HH; Amagai, M; Nagao, K				Kobayashi, Tetsuro; Glatz, Martin; Horiuchi, Keisuke; Kawasaki, Hiroshi; Akiyama, Haruhiko; Kaplan, Daniel H.; Kong, Heidi H.; Amagai, Masayuki; Nagao, Keisuke			Dysbiosis and Staphyloccus aureus Colonization Drives Inflammation in Atopic Dermatitis	IMMUNITY			English	Article							LANGERHANS CELLS; HUMAN SKIN; EGFR; BARRIER; ACTIVATION; MANAGEMENT; MICROBIOME; MUTATIONS; FILAGGRIN; IMMUNITY	Staphyloccus aureus skin colonization is universal in atopic dermatitis and common in cancer patients treated with epidermal growth factor receptor inhibitors. However, the causal relationship of dysbiosis and eczema has yet to be clarified. Herein, we demonstrate that Adam17(fl/fl) Sox9-Cre mice, generated to model ADAM17-deficiency in human, developed eczematous dermatitis with naturally occurring dysbiosis, similar to that observed in atopic dermatitis. Corynebacterium mastitidis, S. aureus, and Corynebacterium bovis sequentially emerged during the onset of eczematous dermatitis, and antibiotics specific for these bacterial species almost completely reversed dysbiosis and eliminated skin inflammation. Whereas S. aureus prominently drove eczema formation, C. bovis induced robust T helper 2 cell responses. Langerhans cells were required for eliciting immune responses against S. aureus inoculation. These results characterize differential contributions of dysbiotic flora during eczema formation, and highlight the microbiota-host immunity axis as a possible target for future therapeutics in eczematous dermatitis.	[Kobayashi, Tetsuro; Kawasaki, Hiroshi; Amagai, Masayuki; Nagao, Keisuke] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Kobayashi, Tetsuro; Glatz, Martin; Kong, Heidi H.; Nagao, Keisuke] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan; [Akiyama, Haruhiko] Gifu Univ, Dept Orthoped, Gifu 5011194, Japan; [Kaplan, Daniel H.] Univ Minnesota, Ctr Immunol, Dept Dermatol, Minneapolis, MN 55414 USA	Keio University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Keio University; Gifu University; University of Minnesota System; University of Minnesota Twin Cities	Nagao, K (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan.	keisuke.nagao@nih.gov	Nagao, Keisuke/P-3837-2018; Kaplan, Daniel H/N-2779-2013; Horiuchi, Keisuke/L-2277-2013; Amagai, Masayuki/K-5325-2013; Kong, Heidi H/L-4856-2018; Nagao, Keisuke/J-5116-2013	Nagao, Keisuke/0000-0002-7005-3138; Kaplan, Daniel H/0000-0002-7851-7320; Horiuchi, Keisuke/0000-0001-7063-9609; Amagai, Masayuki/0000-0003-3314-7052; Kong, Heidi H/0000-0003-4424-064X; Nagao, Keisuke/0000-0002-7005-3138; Kobayashi, Tetsuro/0000-0003-2316-4748	Ministry of Health, Labor and Welfare of Japan; NATIONAL CANCER INSTITUTE [ZIABC011561, ZIABC010938, ZIABC011558] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Research for Prevention and Treatment of Immune/Allergic Diseases from the Ministry of Health, Labor and Welfare of Japan, Grant-in-Aid for JSPS Fellows and the US National Institutes of Health (NIH) NCI Intramural Research Programs. We thank Julie A. Segre and Mark C. Udey for helpful discussions and Cynthia Ng, Morgan Park, and Sean Conlan for underlying efforts.	Bath-Hextall FJ, 2010, BRIT J DERMATOL, V163, P12, DOI 10.1111/j.1365-2133.2010.09743.x; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Leung TH, 2013, J CLIN INVEST, V123, P5361, DOI 10.1172/JCI70895; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Mascia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005773; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nagao K, 2012, STEM CELLS, V30, P1781, DOI 10.1002/stem.1153; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Plant JD, 2012, VET DERMATOL, V23, DOI 10.1111/j.1365-3164.2012.01113.x; Saaf A, 2012, ARCH DERMATOL RES, V304, P773, DOI 10.1007/s00403-012-1242-4; Schneider L, 2013, J ALLERGY CLIN IMMUN, V131, P295, DOI 10.1016/j.jaci.2012.12.672; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zhang ZH, 2014, J IMMUNOL, V192, P859, DOI 10.4049/jimmunol.1301062	51	296	311	5	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					756	766		10.1016/j.immuni.2015.03.014	http://dx.doi.org/10.1016/j.immuni.2015.03.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902485	Green Accepted, Bronze			2022-12-18	WOS:000353347500020
J	Campbell, EL; Bruyninckx, WJ; Kelly, CJ; Glover, LE; McNamee, EN; Bowers, BE; Bayless, AJ; Scully, M; Saeedi, BJ; Golden-Mason, L; Ehrentraut, SF; Curtis, VF; Burgess, A; Garvey, JF; Sorensen, A; Nemenoff, R; Jedlicka, P; Taylor, CT; Kominsky, DJ; Colgan, SP				Campbell, Eric L.; Bruyninckx, Walter J.; Kelly, Caleb J.; Glover, Louise E.; McNamee, Eoin N.; Bowers, Brittelle E.; Bayless, Amanda J.; Scully, Melanie; Saeedi, Bejan J.; Golden-Mason, Lucy; Ehrentraut, Stefan F.; Curtis, Valerie F.; Burgess, Adrianne; Garvey, John F.; Sorensen, Amber; Nemenoff, Raphael; Jedlicka, Paul; Taylor, Cormac T.; Kominsky, Douglas J.; Colgan, Sean P.			Transmigrating Neutrophils Shape the Mucosal Microenvironment through Localized Oxygen Depletion to Influence Resolution of Inflammation	IMMUNITY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; INTESTINAL TREFOIL FACTOR; INDUCIBLE FACTOR-I; EXPERIMENTAL COLITIS; BARRIER FUNCTION; BOWEL-DISEASE; NADPH OXIDASE; HYPOXIA; MACROPHAGES; SUPEROXIDE	Acute intestinal inflammation involves early accumulation of neutrophils (PMNs) followed by either resolution or progression to chronic inflammation. Based on recent evidence that mucosal metabolism influences disease outcomes, we hypothesized that transmigrating PMNs influence the transcriptional profile of the surrounding mucosa. Microarray studies revealed a cohort of hypoxia-responsive genes regulated by PMN-epithelial crosstalk. Transmigrating PMNs rapidly depleted microenvironmental O-2 sufficiently to stabilize intestinal epithelial cell hypoxia-inducible factor (HIF). By utilizing HIF reporter mice in an acute colitis model, we investigated the relative contribution of PMNs and the respiratory burst to "inflammatory hypoxia" in vivo. CGD mice, lacking a respiratory burst, developed accentuated colitis compared to control, with exaggerated PMN infiltration and diminished inflammatory hypoxia. Finally, pharmacological HIF stabilization within the mucosa protected CGD mice from severe colitis. In conclusion, transcriptional imprinting by infiltrating neutrophils modulates the host response to inflammation, via localized O-2 depletion, resulting in microenvironmental hypoxia and effective inflammatory resolution.	[Campbell, Eric L.; Kelly, Caleb J.; Glover, Louise E.; McNamee, Eoin N.; Bowers, Brittelle E.; Bayless, Amanda J.; Scully, Melanie; Saeedi, Bejan J.; Ehrentraut, Stefan F.; Curtis, Valerie F.; Burgess, Adrianne; Kominsky, Douglas J.; Colgan, Sean P.] Univ Colorado, Mucosal Inflammat Program, Aurora, CO 80045 USA; [Bruyninckx, Walter J.] Hanover Coll, Dept Biol, Hanover, IN 47243 USA; [Golden-Mason, Lucy; Sorensen, Amber; Nemenoff, Raphael; Jedlicka, Paul] Univ Colorado, Aurora, CO 80045 USA; [Garvey, John F.; Taylor, Cormac T.] Natl Univ Ireland Univ Coll Dublin, Dublin 4, Ireland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University College Dublin	Campbell, EL (corresponding author), Univ Colorado, Mucosal Inflammat Program, Anschutz Med Campus, Aurora, CO 80045 USA.	eric.campbell@ucdenver.edu	Campbell, Eric/N-5357-2015	Campbell, Eric/0000-0003-0744-6577; Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192; Saeedi, Bejan/0000-0001-8356-5960; Ehrentraut, Stefan/0000-0001-5747-6737; McNamee, Eoin/0000-0002-3331-3148; Kelly, Caleb/0000-0003-4861-1479; Glover, Louise/0000-0001-9056-1810; Taylor, Cormac/0000-0002-0946-1247	NIH [DK050189, DK095491, HL60569, DK088663]; CCFA Career Development Award; NATIONAL CANCER INSTITUTE [P50CA058187, R01CA162226, R01CA108610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088663, R01DK099452, R01DK050189, R29DK050189, R37DK050189, R01DK095491, R01DK103639] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Reisdorph for technical assistance and C. Wilson and E. Lee for procurement of tissues for histological analysis. Work was supported by NIH grants DK050189, DK095491, HL60569, and DK088663 and by a CCFA Career Development Award (to E.L.C.).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Beck PL, 2010, AM J PHYSIOL-GASTR L, V299, pG43, DOI 10.1152/ajpgi.00228.2009; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Colgan SP, 2013, INFLAMM BOWEL DIS, V19, P2238, DOI 10.1097/MIB.0b013e31828dcaaf; Colgan SP, 2013, IMMUNOL RES, V55, P75, DOI 10.1007/s12026-012-8350-2; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; COX G, 1995, AM J RESP CELL MOL, V12, P232, DOI 10.1165/ajrcmb.12.2.7865221; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; Ehrentraut SF, 2013, J IMMUNOL, V190, P392, DOI 10.4049/jimmunol.1202041; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Huang JS, 2004, CLIN GASTROENTEROL H, V2, P690, DOI 10.1016/S1542-3565(04)00292-7; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Lim Kihong, 2013, Immune Netw, V13, P102, DOI 10.4110/in.2013.13.3.102; Louis NA, 2006, J CELL BIOCHEM, V99, P1616, DOI 10.1002/jcb.20947; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Okumura CYM, 2012, J MOL MED, V90, P1079, DOI 10.1007/s00109-012-0882-3; Polosukhin VV, 2011, J PATHOL, V224, P203, DOI 10.1002/path.2863; RADI R, 1991, J BIOL CHEM, V266, P4244; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Stie J, 2007, J LEUKOCYTE BIOL, V81, P672, DOI 10.1189/jlb.0806513; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; vanRees EP, 1997, MEDIAT INFLAMM, V6, P85, DOI 10.1080/09629359791776; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0	42	296	303	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					66	77		10.1016/j.immuni.2013.11.020	http://dx.doi.org/10.1016/j.immuni.2013.11.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412613	Green Accepted, Bronze			2022-12-18	WOS:000331476900010
J	Qiu, J; Guo, XH; Chen, ZME; He, L; Sonnenberg, GF; Artis, D; Fu, YX; Zhou, L				Qiu, Ju; Guo, Xiaohuan; Chen, Zong-ming E.; He, Lei; Sonnenberg, Gregory F.; Artis, David; Fu, Yang-Xin; Zhou, Liang			Group 3 Innate Lymphoid Cells Inhibit T-Cell-Mediated Intestinal Inflammation through Aryl Hydrocarbon Receptor Signaling and Regulation of Microflora	IMMUNITY			English	Article							ROR-GAMMA-T; SEGMENTED FILAMENTOUS BACTERIA; TRANSCRIPTION FACTOR GATA3; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; T(H)17 CELLS; TH17 CELLS; GASTROINTESTINAL-TRACT; NKP46(+) CELLS; BOWEL-DISEASE	Aryl hydrocarbon receptor (Ahr) is crucial for the maintenance and function of group 3 innate lymphoid cells (ILCs), which are important in gut immunity. Because Ahr promotes T helper 17 (Th17) cell differentiation in vitro, it is reasonable to expect that Ahr would enhance Th17 cells in vivo. Instead, we show that Ahr deficiency caused increased intestinal Th17 cells, raising the possibility that group 3 ILCs could negatively regulate Th17 cells. Reduced innate interleukin-22 (IL-22) in Ahr-deficient mice allowed expansion of commensal segmented filamentous bacteria (SFB), known to promote Th17 cells. Compared to Rorc(+/+) Ahr(-/-) mice, Rorc(gfp/+) Ahr(-/-) mice had further reduced group 3 ILCs and were prone to spontaneous colitis with increased SFB and Th17 cells. Innate expression of Ahr played a protective role in T-cell-mediated experimental colitis by suppressing pathogenic Th17 cells. Our data reveal an intricate balance between ILCs and Th17 cells regulated by Ahr and commensal flora.	[Qiu, Ju; Chen, Zong-ming E.; He, Lei; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Qiu, Ju; He, Lei; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Guo, Xiaohuan; Fu, Yang-Xin] Univ Chicago, Comm Immunol, Dept Pathol, Chicago, IL 60637 USA; [Sonnenberg, Gregory F.] Univ Penn, Div Gastroenterol, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Zhou, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.	l-zhou@northwestern.edu	Qiu, Ju/AAW-7301-2021; He, Lei/L-4726-2019; Guo, Xiaohuan/I-3710-2017	Guo, Xiaohuan/0000-0001-5152-3010; He, Lei/0000-0002-3821-2047; Artis, David/0000-0002-1753-4100; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [AI089954, AI091962, CA141975, CA134563]; Cancer Research Institute Investigator Award; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R01CA141975, R01CA134563, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, R21AI091962, R01AI102942, R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Investigator Award; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the entire L.Z. laboratory for their help and suggestions. We thank S. Swaminathan and C. Goolsby at Flow Cytometry Facility (Northwestern University) for cell-sorting support. We thank the Mouse Histology and Phenotyping Laboratory (Northwestern University) for their services and assistance. We also thank D. Scholtens for the statistical analysis. The work was supported by the National Institutes of Health (AI089954 and AI091962 to L.Z. and CA141975 and CA134563 to Y.-X.F.) and by a Cancer Research Institute Investigator Award (to L.Z.). L.Z. is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pavlick KP, 2006, INT IMMUNOL, V18, P389, DOI 10.1093/intimm/dxh378; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2012, IMMUNITY, V37, P589, DOI 10.1016/j.immuni.2012.10.002; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	70	296	311	4	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					386	399		10.1016/j.immuni.2013.08.002	http://dx.doi.org/10.1016/j.immuni.2013.08.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23954130	Bronze, Green Accepted			2022-12-18	WOS:000330948800019
J	Ruan, QG; Kameswaran, V; Tone, Y; Li, L; Liou, HC; Greene, MI; Tone, M; Chen, YHH				Ruan, Qingguo; Kameswaran, Vasumathi; Tone, Yukiko; Li, Li; Liou, Hsiou-Chi; Greene, Mark I.; Tone, Masahide; Chen, Youhai H.			Development of Foxp3(+) Regulatory T Cells Is Driven by the c-Rel Enhanceosome	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; FACTOR-KAPPA-B; DNA METHYLATION; LYMPHOCYTE-ACTIVATION; GENE-EXPRESSION; TOLERANCE; CD4(+)CD25(+); MECHANISMS; DISEASE; MATURE	Regulatory T (Treg) cells are essential for maintaining immune homeostasis. Although Foxp3 expression marks the commitment of progenitors to Treg cell lineage, how Treg cells are generated during lymphocyte development remains enigmatic. We report here that the c-Rel transcription factor controlled development of Treg cells by promoting the formation of a Foxp3-specific enhanceosome. This enhanceosome contained c-Rel, p65, NFAT, Smad, and CREB. Although Smad and CREB first bound to Foxp3 enhancers, they later moved to the promoter to form the c-Rel enhanceosome. c-Rel-deficient mice had up to 90% reductions of Treg cells compared to wild-type mice, and c-Rel-deficient T cells were compromised in Treg cell differentiation. Thus, Treg cell development is controlled by a c-Rel enhanceosome, and strategies targeting Rel-NF-kappa B can be effective for manipulating Treg cell function.	[Ruan, Qingguo; Kameswaran, Vasumathi; Tone, Yukiko; Li, Li; Greene, Mark I.; Tone, Masahide; Chen, Youhai H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Liou, Hsiou-Chi] Cornell Univ, Coll Med, Dept Med, New York, NY 10021 USA	University of Pennsylvania; Cornell University	Chen, YHH (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.		Kameswaran, Vasumathi/AAJ-8771-2020; Chen, Youhai/AAJ-4031-2021	Kameswaran, Vasumathi/0000-0003-2552-6183; 	National Institutes of Health [AI50059, DK070691, AI069289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050059, R01AI069289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R Carmody, W Chen, and S Gong for valuable discussions and J DeVirgilus for technical support supported by grants from the National Institutes of Health (AI50059, DK070691, and AI069289)	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Bondarenko VA, 2003, BIOCHEM CELL BIOL, V81, P241, DOI 10.1139/o03-051; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; BROWNELL E, 1987, MOL CELL BIOL, V7, P1304, DOI 10.1128/MCB.7.3.1304; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Huguet C, 1998, Dev Immunol, V5, P247, DOI 10.1155/1998/58608; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim CH, 2006, EXP HEMATOL, V34, P1033, DOI 10.1016/j.exphem.2006.03.014; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; MENKA M, 2001, CURR OPIN GENE DEV, V11, P205; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; SIMEK S, 1988, ONCOGENE RES, V2, P103; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tommasini A, 2002, CLIN EXP IMMUNOL, V130, P127, DOI 10.1046/j.1365-2249.2002.01940.x; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	46	296	308	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 18	2009	31	6					932	940		10.1016/j.immuni.2009.10.006	http://dx.doi.org/10.1016/j.immuni.2009.10.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064450	Green Accepted, Bronze			2022-12-18	WOS:000273616400013
J	Chtanova, T; Schaeffer, M; Han, SJ; van Dooren, GG; Nollmann, M; Herzmark, P; Chan, SW; Satija, H; Camfield, K; Aaron, H; Striepen, B; Robey, EA				Chtanova, Tatyana; Schaeffer, Marie; Han, Seong-Ji; van Dooren, Giel G.; Nollmann, Marcelo; Herzmark, Paul; Chan, Shiao Wei; Satija, Harshita; Camfield, Kristin; Aaron, Holly; Striepen, Boris; Robey, Ellen A.			Dynamics of neutrophil migration in lymph nodes during infection	IMMUNITY			English	Article							TOXOPLASMA-GONDII; DENDRITIC CELLS; T-CELLS; B-CELLS; 2-PHOTON MICROSCOPY; FLUORESCENT PROTEIN; SUBCAPSULAR SINUS; ADENYLYL-CYCLASE; IMMUNE-SYSTEM; ACTIVATION	Although the signals that control neutrophil migration from the blood to sites of infection have been well characterized, little is known about their migration patterns within lymph nodes or the strategies that neutrophils use to find their local sites of action. To address these questions, we used two-photon scanning-laser microscopy to examine neutrophil migration in intact lymph nodes during infection with an intracellular parasite, Toxoplasma gondii. We found that neutrophils formed both small, transient and large, persistent swarms via a coordinated migration pattern. We provided evidence that cooperative action of neutrophils and parasite egress from host cells could trigger swarm formation. Neutrophil swarm formation coincided in space and time with the removal of macrophages that line the subcapsular sinus of the lymph node. Our data provide insights into the cellular mechanisms underlying neutrophil swarming and suggest new roles for neutrophils in shaping immune responses.	[Chtanova, Tatyana; Schaeffer, Marie; Han, Seong-Ji; Nollmann, Marcelo; Herzmark, Paul; Chan, Shiao Wei; Satija, Harshita; Camfield, Kristin; Aaron, Holly; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Paul Coverdell Ctr, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [van Dooren, Giel G.; Striepen, Boris] Univ Georgia, Paul Coverdell Ctr, Dept Cellular Biol, Athens, GA 30602 USA	University of California System; University of California Berkeley; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Robey, EA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	erobey@berkeley.edu	van Dooren, Giel G/A-8896-2012; Schaeffer, Marie/C-9815-2019	van Dooren, Giel G/0000-0003-2455-9821; Schaeffer, Marie/0000-0002-2063-5324; Striepen, Boris/0000-0002-7426-432X; Chtanova, Tatyana/0000-0003-3419-4483; Nollmann, Marcelo/0000-0003-3339-2349	NIH; Human Frontier Science Program Fellowship; C.J. Martin Overseas Fellowship [400489]; Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065831, R01AI065537, R01AI093132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Fellowship(Human Frontier Science Program); C.J. Martin Overseas Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Nolla (LICB) and J. Nelson (CTEGD) for assistance with flow cytometry, M. Rivera for flow-cytometry analysis, T. Graf for providing lysMGFP reporter mice, Y.F. Liao for tracking neutrophils, E. Ladi for assistance with quantitating neutrophil motility, the CHPS mouse/virus core for providing mouse strains, and D. Portnoy, M. Welsh, and members of the Robey lab for comments on the manuscript. This work was funded by the NIH (B.S. and E.R.), Human Frontier Science Program Fellowship (T.C.), and C.J. Martin Overseas Fellowship (400489) from the Australian National Health and Medical Research Council (G.v.D.).	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; DEBRU C, 1993, BLOOD CELLS, V19, P5; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Faust N, 2000, BLOOD, V96, P719; FUHRMAN SA, 1989, J IMMUNOL, V142, P940; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; NAKAO M, 1991, PARASITOLOGY, V103, P29, DOI 10.1017/S0031182000059254; NAKAO M, 1991, PARASITOLOGY, V103, P23, DOI 10.1017/S0031182000059242; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pesce JT, 2008, J IMMUNOL, V180, P464, DOI 10.4049/jimmunol.180.1.464; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Sayles PC, 1997, NAT IMMUN, V15, P249; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zinselmeyer BH, 2008, INFLAMM RES, V57, P93, DOI 10.1007/s00011-007-7195-y	44	296	298	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					487	496		10.1016/j.immuni.2008.07.012	http://dx.doi.org/10.1016/j.immuni.2008.07.012			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18718768	Green Accepted, Bronze			2022-12-18	WOS:000259708900018
J	Prinz, M; Schmidt, H; Mildner, A; Knobeloch, KP; Hanisch, UK; Raasch, J; Merkler, D; Detje, C; Gutcher, I; Mages, J; Lang, R; Martin, R; Gold, R; Becher, B; Bruck, W; Kalinke, U				Prinz, Marco; Schmidt, Hauke; Mildner, Alexander; Knobeloch, Klaus-Peter; Hanisch, Uwe-Karsten; Raasch, Jenni; Merkler, Doron; Detje, Claudia; Gutcher, Ilona; Mages, Joerg; Lang, Roland; Martin, Roland; Gold, Ralf; Becher, Burkhard; Bruck, Wolfgang; Kalinke, Ulrich			Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system	IMMUNITY			English	Article							INTERFERON-BETA; MULTIPLE-SCLEROSIS; ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; T-CELLS; B-CELLS; ENCEPHALOMYELITIS; GENE; MICROGLIA; MACROPHAGES	The action of type I interferons in the central nervous system (CNS) during autoimmunity is largely unknown. Here, we demonstrate elevated interferon beta concentrations in the CNS, but not blood, of mice with experimental autoimmune encephalomyelitis (EAE), a model for CNS autoimmunity. Furthermore, mice devoid of the broadly expressed type I IFN receptor (IFNAR) developed exacerbated clinical disease accompanied by a markedly higher inflammation, demyelination, and lethality without shifting the T helper 17 (Th17) or Th1 cell immune response. Whereas adoptive transfer of encephalitogenic T cells led to enhanced disease in Ifnar1(-/-) mice, newly created conditional mice with B or T lymphocyte-specific IFNAR ablation showed normal EAE. The engagement of IFNAR on neuroectodermal CNS cells had no protective effect. In contrast, absence of IFNAR on myeloid cells led to severe disease with an enhanced effector phase and increased lethality, indicating a distinct protective function of type I IFNs during autoimmune inflammation of the CNS.	[Prinz, Marco; Mildner, Alexander; Knobeloch, Klaus-Peter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Prinz, Marco; Schmidt, Hauke; Mildner, Alexander; Hanisch, Uwe-Karsten; Raasch, Jenni; Merkler, Doron; Bruck, Wolfgang] Univ Gottingen, Inst Neuropathol, D-37099 Gottingen, Germany; [Knobeloch, Klaus-Peter] Inst Mol Pharmacol, Dept Mol Genet, D-12207 Berlin, Germany; [Detje, Claudia; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Gutcher, Ilona; Becher, Burkhard] Univ Hosp, Dept Neurol, Neuroimmunol Unit, CH-8091 Zurich, Switzerland; [Martin, Roland] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Martin, Roland] Univ, Inst Neuroimmunol, D-20251 Hamburg, Germany; [Gold, Ralf; Bruck, Wolfgang] Univ Gottingen, Inst Multiple Sclerosis Res, D-37099 Gottingen, Germany	University of Freiburg; University of Gottingen; Paul Ehrlich Institute; University of Zurich; University Zurich Hospital; Technical University of Munich; University of Gottingen	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de; kalul@pei.de	Mildner, Alexander/ABG-6122-2020; Becher, Burkhard/ABE-4225-2020; Horstmann, Britta/C-2154-2008; mildner, alexander/AFK-2161-2022; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022; Merkler, Doron/N-9157-2016; Lang, Roland/C-3287-2011	Becher, Burkhard/0000-0002-1541-7867; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Merkler, Doron/0000-0002-0247-2007; Kalinke, Ulrich/0000-0003-0503-9564; Lang, Roland/0000-0003-0502-3677				Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROD SA, 1994, NEUROLOGY, V44, P1144, DOI 10.1212/WNL.44.6.1144; Brod SA, 1996, J AUTOIMMUN, V9, P11, DOI 10.1006/jaut.1996.0003; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Floris S, 2002, J NEUROIMMUNOL, V127, P69, DOI 10.1016/S0165-5728(02)00098-X; FORD AL, 1995, J IMMUNOL, V154, P4309; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heine S, 2006, J NEUROIMMUNOL, V177, P173, DOI 10.1016/j.jneuroim.2006.04.016; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Jin S, 2007, BRAIN RES, V1179, P140, DOI 10.1016/j.brainres.2007.08.055; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; KATO T, 1992, J INTERFERON RES, P29; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Li QD, 1998, IMMUNOPHARM IMMUNOT, V20, P39, DOI 10.3109/08923979809034808; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; McRae BL, 1998, J IMMUNOL, V160, P4298; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miller SD, 2007, ANN NY ACAD SCI, V1103, P179, DOI 10.1196/annals.1394.023; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Neilley LK, 1996, NEUROLOGY, V46, P552, DOI 10.1212/WNL.46.2.552; Okada K, 2005, J NEUROIMMUNOL, V159, P48, DOI 10.1016/j.jneuroim.2004.09.013; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; PASSAQUIN AC, 1989, NEUROCHEM RES, V14, P987, DOI 10.1007/BF00965933; Pogue SL, 2004, J INTERF CYTOK RES, V24, P131, DOI 10.1089/107999004322813372; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; SATOH J, 1995, NEUROLOGY, V45, P367, DOI 10.1212/WNL.45.2.367; Satoh J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-18; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; STONE LA, 1995, ANN NEUROL, V37, P611, DOI 10.1002/ana.410370511; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; WALKER EB, 1985, J LEUKOCYTE BIOL, V37, P121, DOI 10.1002/jlb.37.2.121; Wandinger KP, 2001, ANN NEUROL, V50, P349, DOI 10.1002/ana.1096; Waubant E, 2003, NEUROLOGY, V61, P184, DOI 10.1212/01.WNL.0000078888.07196.0B; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Zehntner SP, 2005, J IMMUNOL, V174, P5124, DOI 10.4049/jimmunol.174.8.5124	55	296	304	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					675	686		10.1016/j.immuni.2008.03.011	http://dx.doi.org/10.1016/j.immuni.2008.03.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18424188	Bronze			2022-12-18	WOS:000256003900014
J	Cheng, FD; Wang, HW; Cuenca, A; Huang, M; Ghansah, T; Brayer, J; Kerr, WG; Takeda, K; Akira, S; Schoenberger, SP; Yu, H; Jove, R; Sotomayor, EM				Cheng, FD; Wang, HW; Cuenca, A; Huang, M; Ghansah, T; Brayer, J; Kerr, WG; Takeda, K; Akira, S; Schoenberger, SP; Yu, H; Jove, R; Sotomayor, EM			A critical role for stat3 signaling in immune tolerance	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; MHC CLASS-I; DENDRITIC CELLS; T-CELLS; CROSS-PRESENTATION; INNATE IMMUNITY; GENE-EXPRESSION; TUMOR-ANTIGENS; MICE; INDUCTION	Antigen-presenting cells (APCs) can induce T cell activation as well as T cell tolerance. The molecular mechanisms by which APCs regulate this critical decision of the immune system are not well understood. Here we show that Stat3 signaling plays a critical role in the induction of antigen-specific T cell tolerance. Targeted disruption of Stat3 signaling in APCs resulted in priming of antigen-specific CD4(+) T cells in response to an otherwise tolerogenic stimulus in vivo. Furthermore, APCs devoid of Stat3 effectively break antigen-specific T cell anergy in vitro. Conversely, increased Stat3 activity in APCs led to impaired antigen-specific T cell responses. Stat3 signaling provides, therefore, a novel molecular target for manipulation of immune activation/tolerance, a central decision with profound implications in autoimmunity, transplantation, and cancer immunotherapy.	Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Biochem, Tampa, FL 33612 USA; Osaka Univ, Dept Host Def, Osaka 5650871, Japan; La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA 92121 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Osaka University; La Jolla Institute for Immunology	Sotomayor, EM (corresponding author), Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA.		Ghansah, Tomar/H-4566-2011; Akira, Shizuo/C-3134-2009; Kerr, William G/B-8616-2015; Takeda, Kiyoshi/C-9331-2009	Kerr, William G/0000-0002-4720-7135; YU, Hua/0000-0003-0931-1000	NATIONAL CANCER INSTITUTE [R01CA087583, K08CA078656, R01CA100850] Funding Source: NIH RePORTER; NCI NIH HHS [CA100850, CA78656, CA87583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DING L, 1993, J IMMUNOL, V151, P1224; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hackenmiller R, 2000, IMMUNITY, V13, P397, DOI 10.1016/S1074-7613(00)00039-X; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; JENKINS MK, 1990, J IMMUNOL, V144, P16; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Pardoll D, 2001, NATURE, V411, P1010, DOI 10.1038/35082676; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Shen ZH, 1997, J IMMUNOL, V158, P2723; Soltys J, 2002, J IMMUNOL, V168, P1903, DOI 10.4049/jimmunol.168.4.1903; Sotomayor EM, 2001, BLOOD, V98, P1070, DOI 10.1182/blood.V98.4.1070; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100	35	296	320	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					425	436		10.1016/S1074-7613(03)00232-2	http://dx.doi.org/10.1016/S1074-7613(03)00232-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499117	Bronze			2022-12-18	WOS:000185499800013
J	Muhlethaler-Mottet, A; Di Berardino, W; Otten, LA; Mach, B				Muhlethaler-Mottet, A; Di Berardino, W; Otten, LA; Mach, B			Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1	IMMUNITY			English	Article							HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR USF; BARE LYMPHOCYTE SYNDROME; GENE-EXPRESSION; REGULATORY FACTOR-1; BINDING PROTEINS; DNA; COMPLEX; DEFICIENCY; INDUCTION	CIITA is the mediator of MHC class II gene induction by interferon-gamma (IFN gamma). The CIITA gene is itself selectively activated via one of its four promoters (PIV). We show here that three cis-acting elements, the GAS, the E box, and the IRF-1-binding site, as well as the transacting factors Stat1 and IRF-1, are essential for activation of CIITA promoter IV by IFN gamma. Stat1 binds to the GAS site only in the presence of the ubiquitous factor USF-1, which binds to the adjacent E box. Indeed, Stat1 and USF-1 bind to the GAS/E box motif in a cooperative manner. The specificity for CIITA activation by IFN gamma is thus dictated by the GAS/E box motif and by the selective interaction of IFN gamma-activated Stat1 and USF-1. This clarifies the missing link in the overall pathway of IFN gamma activation of MHC-II expression.	Univ Geneva, Sch Med, Louis Jeantet Lab Mol Genet, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	University of Geneva	Mach, B (corresponding author), Univ Geneva, Sch Med, Louis Jeantet Lab Mol Genet, Dept Genet & Microbiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.		, Mühlethaler-Mottet/H-2848-2019	, Mühlethaler-Mottet/0000-0001-8274-0907				AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHANG LA, 1992, NUCLEIC ACIDS RES, V20, P287, DOI 10.1093/nar/20.2.287; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Griscelli C, 1989, Immunodefic Rev, V1, P135; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; Hobart M, 1997, J IMMUNOL, V158, P4260; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KOBR M, 1990, MOL CELL BIOL, V10, P965, DOI 10.1128/MCB.10.3.965; Lee YJ, 1996, J IMMUNOL, V157, P1559; LITTLEWOOD TD, 1992, ONCOGENE, V7, P1783; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; MACH B, 1994, IMMUNOL REV, V138, P207, DOI 10.1111/j.1600-065X.1994.tb00853.x; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E; PERITZ LN, 1988, J BIOL CHEM, V263, P5005; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; RICCIO A, 1992, MOL CELL BIOL, V12, P1846, DOI 10.1128/MCB.12.4.1846; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sperisen P, 1992, PCR Methods Appl, V1, P164; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	49	296	304	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					157	166		10.1016/S1074-7613(00)80468-9	http://dx.doi.org/10.1016/S1074-7613(00)80468-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9491997	Bronze			2022-12-18	WOS:000072201800003
J	Sheng, JP; Ruedl, C; Karjalainen, K				Sheng, Jianpeng; Ruedl, Christiane; Karjalainen, Klaus			Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells	IMMUNITY			English	Article							YOLK-SAC; DENDRITIC CELLS; MONOCYTES; REVEALS; PATHWAYS; IDENTITY; ORIGINS; RUNX1; LIFE	Macrophages are one of the most diverse cell populations in terms of their anatomical location and functional specialization during both homeostasis and disease. Although it has been shown in different fate mapping models that some macrophages present in adult tissues are already established during fetal development, their exact origins are still under debate. In the current study, we developed a fate mapping strain, based on the Kit locus, which allowed us to readdress "the origins'' question. Different types of macrophages from various adult tissues were traced to their fetal or adult sources by inducing labeling in precursors at several time points either during fetal development or in adult mice. We show that all adult macrophages, resident or infiltrating, are progenies of classical hematopoietic stem cells (HSC) with the exception of microglia and, partially epidermal Langerhans cells, which are yolk sac (YS)-derived.	[Sheng, Jianpeng; Ruedl, Christiane; Karjalainen, Klaus] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ruedl, C (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ruedl@ntu.edu.sg; klaus@ntu.edu.sg	Karjalainen, Klaus/A-2206-2011; Ruedl, christiane/A-2219-2011	Ruedl, christiane/0000-0002-5599-6541	MOE Tier [1 RG49/13]	MOE Tier	We thank Dr. Florent Ginhoux for CX<INF>3</INF>CR1-GFP and Rosa26<SUP>LSL-eYFP</SUP> transgenic mice and discussions and Dr. Michael Reth for the MercreMer DNA construct. The authors would like also to thank Kerry McLaughlin of Insight Editing London for editing this manuscript. This work was supported by MOE Tier 1 RG49/13 to K.K.	Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; HOGG JC, 1995, ANNU REV PHYSIOL, V57, P97, DOI 10.1146/annurev.ph.57.030195.000525; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Palis J, 1999, DEVELOPMENT, V126, P5073; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Purnama C, 2014, EUR J IMMUNOL, V44, P2003, DOI 10.1002/eji.201344359; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	34	295	304	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					382	393		10.1016/j.immuni.2015.07.016	http://dx.doi.org/10.1016/j.immuni.2015.07.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287683	Bronze			2022-12-18	WOS:000360101200019
J	Sato, S; Li, K; Kameyama, T; Hayashi, T; Ishida, Y; Murakami, S; Watanabe, T; Iijima, S; Sakurai, Y; Watashi, K; Tsutsumi, S; Sato, Y; Akita, H; Wakita, T; Rice, CM; Harashima, H; Kohara, M; Tanaka, Y; Takaoka, A				Sato, Seiichi; Li, Kai; Kameyama, Takeshi; Hayashi, Takaya; Ishida, Yuji; Murakami, Shuko; Watanabe, Tsunamasa; Iijima, Sayuki; Sakurai, Yu; Watashi, Koichi; Tsutsumi, Susumu; Sato, Yusuke; Akita, Hidetaka; Wakita, Takaji; Rice, Charles M.; Harashima, Hideyoshi; Kohara, Michinori; Tanaka, Yasuhito; Takaoka, Akinori			The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus	IMMUNITY			English	Article							STEM-LOOP STRUCTURE; IFN-LAMBDA-S; CYTOSOLIC DNA; ENCAPSIDATION SIGNAL; INFECTION; REPLICATION; RESPONSES; IMMUNITY; PATHWAY; BINDING	Host innate recognition triggers key immune responses for viral elimination. The sensing mechanism of hepatitis B virus (HBV), a DNA virus, and the subsequent downstream signaling events remain to be fully clarified. Here we found that type III but not type I interferons are predominantly induced in human primary hepatocytes in response to HBV infection, through retinoic acid-inducible gene-I (RIG-I)-mediated sensing of the 5'-epsilon region of HBV pregenomic RNA. In addition, RIG-I could also counteract the interaction of HBV polymerase (P protein) with the 5'-epsilon region in an RNA-binding dependent manner, which consistently suppressed viral replication. Liposome-mediated delivery and vector-based expression of this e region-derived RNA in liver abolished the HBV replication in human hepatocyte-chimeric mice. These findings identify an innate-recognition mechanism by which RIG-I dually functions as an HBV sensor activating innate signaling and to counteract viral polymerase in human hepatocytes.	[Sato, Seiichi; Li, Kai; Kameyama, Takeshi; Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido 0600815, Japan; [Sato, Seiichi; Li, Kai; Kameyama, Takeshi; Takaoka, Akinori] Hokkaido Univ, Grad Sch Chem Sci & Engn, Mol Med Biochem Unit, Biol Chem & Engn Course, Sapporo, Hokkaido 0600815, Japan; [Hayashi, Takaya] Hokkaido Univ, Res Ctr Infect Associated Canc, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Ishida, Yuji] PhoenixBio Co Ltd, Higashihiroshima, Hiroshima 7390046, Japan; [Murakami, Shuko; Watanabe, Tsunamasa; Iijima, Sayuki; Tsutsumi, Susumu; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi 4678601, Japan; [Murakami, Shuko; Watanabe, Tsunamasa; Iijima, Sayuki; Tsutsumi, Susumu; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi 4678601, Japan; [Sakurai, Yu; Sato, Yusuke; Akita, Hidetaka; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Innovat Nanomed, Sapporo, Hokkaido 0600812, Japan; [Watashi, Koichi; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan; [Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan	Hokkaido University; Hokkaido University; Hokkaido University; PHOENIXBIO CO. LTD.; Nagoya City University; Nagoya City University; Hokkaido University; National Institute of Infectious Diseases (NIID); Rockefeller University; Tokyo Metropolitan Institute of Medical Science	Takaoka, A (corresponding author), Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Sapporo, Hokkaido 0600815, Japan.	takaoka@igm.hokudai.ac.jp	Sakurai, Yu/AAV-1243-2021; Jin, Zhi/O-3281-2015	Sakurai, Yu/0000-0001-6584-8350; Tanaka, Yasuhito/0000-0002-2473-6966; Li, Kai/0000-0002-3062-3618	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25253030, 25115502, 23112701, 25870015]; Kato Memorial Bioscience Foundation; Yasuda Medical Foundation; Takeda Science Foundation; Waksman Foundation of Japan; IRYO HOJIN SHADAN JIKOKAI; Grants-in-Aid for Scientific Research [25253030] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Yasuda Medical Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); IRYO HOJIN SHADAN JIKOKAI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Hijikata and K. Shimotohno for HuS-E/2 cell line, N. Sakamoto for Huh-7.5.1/Rep-Feo-1b cells, J. Miyazaki for pCAGGS vector, A. Miyawaki for pCAGGS-YFP vector, T. Fujita for the luciferase reporter plasmid p-55C1BLuc, A. Takada for VSV, H. Kida for NDV, H. Ishizu and T. Hirose for technical advice on RIP assay, and A. Bergthaler, A. Shlomai, T. Saito, and M. Yasuda for critical reading of the manuscript and helpful advice. The authors are grateful for financial supports from the Ministry of Health, Labour and Welfare of Japan (Grant-in-Aid to A. T. and Y. T.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research [A] [25253030] to A. T., Grant-in-Aid for Scientific Research on Innovative Areas [25115502, 23112701] to A. T., Grant-in-Aid for Young Scientists [B] [25870015] to S. S.), IRYO HOJIN SHADAN JIKOKAI (H. Tanaka and N. Takayanagi) to A. T., the Kato Memorial Bioscience Foundation to A. T., the Yasuda Medical Foundation to A. T., the Takeda Science Foundation to A. T., and The Waksman Foundation of Japan to A. T. Y. I. is an employee of PhoenixBio.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Fujiwara K, 2005, J VIROL, V79, P14404, DOI 10.1128/JVI.79.22.14404-14410.2005; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Jeong JK, 2000, J VIROL, V74, P5502, DOI 10.1128/JVI.74.12.5502-5508.2000; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; Kato H, 2002, J VIROL, V76, P6131, DOI 10.1128/JVI.76.12.6131-6137.2002; KNAUS T, 1993, NUCLEIC ACIDS RES, V21, P3967, DOI 10.1093/nar/21.17.3967; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lu HL, 2013, J IMMUNOL, V191, P3264, DOI 10.4049/jimmunol.1300512; Marzio DHD, 2014, WORLD J GASTROENTERO, V20, P401, DOI 10.3748/wjg.v20.i2.401; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Revill P, 2013, ANTIVIR THER, V18, P1, DOI 10.3851/IMP2542; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Song ZL, 2012, WORLD J GASTROENTERO, V18, P7149, DOI 10.3748/wjg.v18.i48.7149; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You S, 2008, J VIROL, V82, P184, DOI 10.1128/JVI.01796-07; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0	47	295	313	4	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					123	132		10.1016/j.immuni.2014.12.016	http://dx.doi.org/10.1016/j.immuni.2014.12.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25557055	Green Published, Bronze			2022-12-18	WOS:000348197500016
J	Ma, YT; Galluzzi, L; Zitvogel, L; Kroemer, G				Ma, Yuting; Galluzzi, Lorenzo; Zitvogel, Laurence; Kroemer, Guido			Autophagy and Cellular Immune Responses	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; WIDE ASSOCIATION SCAN; CLASS-II PRESENTATION; FIND-ME SIGNAL; MHC CLASS-II; APOPTOTIC CELLS; CYSTIC-FIBROSIS; MOLECULAR-MECHANISMS; CANONICAL AUTOPHAGY; SELECTIVE AUTOPHAGY	Autophagy constitutes a mechanism for the sequestration and lysosomal degradation of various cytoplasmic structures, including damaged organelles and invading microorganisms. Autophagy not only represents an essential cell-intrinsic mechanism to protect against internal and external stress conditions but also shapes cellular immunity. Recent evidence indicates that autophagic responses in antigen-donor cells affect the release of several cytokines and "danger signals." Thus, especially when it precedes cell death, autophagy alerts innate immune effectors to elicit cognate immune responses. Autophagy is also important for the differentiation, survival, and activation of myeloid and lymphoid cells. Accordingly, inherited mutations in autophagy-relevant genes are associated with immune diseases, whereas oncogenesis-associated autophagic defects promote the escape of developing tumors from immunosurveillance. Here, we discuss the regulation of autophagy in the course of cellular immune responses and emphasize its impact on the immunogenicity of antigen-donor cells and on the activity of antigen-presenting cells and T lymphocytes.	[Ma, Yuting; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Ma, Yuting; Galluzzi, Lorenzo; Zitvogel, Laurence; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Ma, Yuting; Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellise Ligue Natl Canc 11, F-75006 Paris, France; [Zitvogel, Laurence] INSERM, U1015, F-94805 Villejuif, France; [Zitvogel, Laurence] Inst Gustave Roussy, Ctr Clin Invest CBT507, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Metabol Platform, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Cell Biol Platform, F-94805 Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, AP HP, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), INSERM, U848, F-94805 Villejuif, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998	Ligue contre le Cancer (equipe labellisee); Agence Nationale de la Recherche; AXA Chair for Longevity Research; Association pour la Recherche sur le Cancer; Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale; European Commission (ArtForce); European Research Council; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate); Cancer Research and Personalized Medicine (CARPEM) consortium; Paris Alliance of Cancer Research Institutes (PACRI)	Ligue contre le Cancer (equipe labellisee); Agence Nationale de la Recherche(French National Research Agency (ANR)); AXA Chair for Longevity Research(AXA Research Fund); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate); Cancer Research and Personalized Medicine (CARPEM) consortium; Paris Alliance of Cancer Research Institutes (PACRI)	We are indebted to Vojo Deretic (Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, USA) and Oliver Kepp (INSERM, U848; Villejuif, France) for help with the preparation of the manuscript and figures, respectively. The authors are supported by the Ligue contre le Cancer (equipe labellisee), Agence Nationale de la Recherche, AXA Chair for Longevity Research, Association pour la Recherche sur le Cancer, Canceropole Ile-de-France, Institut National du Cancer (INCa), Fondation Bettencourt-Schueller, Fondation de France, Fondation pour la Recherche Medicale, the European Commission (ArtForce), the European Research Council, the LabEx Immuno-Oncology, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (Socrate), the Cancer Research and Personalized Medicine (CARPEM) consortium, and the Paris Alliance of Cancer Research Institutes (PACRI).	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Admon A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011833; Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Altman BJ, 2012, FEBS J, V279, P2598, DOI 10.1111/j.1742-4658.2012.08651.x; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Brazil MI, 1997, EUR J IMMUNOL, V27, P1506, DOI 10.1002/eji.1830270629; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Conway KL, 2013, AUTOPHAGY, V9, P528, DOI 10.4161/auto.23484; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Criollo A, 2011, EMBO J, V30, P4908, DOI 10.1038/emboj.2011.413; Dai JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061026; Demachi-Okamura A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047126; Dengiel J, 2008, AUTOPHAGY, V4, P1057, DOI 10.4161/auto.6824; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Doherty TM, 2012, IMMUNOTHERAPY-UK, V4, P629, DOI [10.2217/IMT.12.52, 10.2217/imt.12.52]; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fiegl D, 2013, J IMMUNOL, V190, P2791, DOI 10.4049/jimmunol.1202741; Fimia GM, 2013, CELL DEATH DIFFER, V20, P1, DOI 10.1038/cdd.2012.97; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Galluzzi L, 2008, CURR MOL MED, V8, P78; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gros F, 2012, AUTOPHAGY, V8, P1113, DOI 10.4161/auto.20275; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Ishibashi K, 2012, MOL BIOL CELL, V23, P3193, DOI 10.1091/mbc.E12-01-0010; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jacquel A, 2012, BLOOD, V119, P4527, DOI 10.1182/blood-2011-11-392167; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Jiang S., 2013, J INNATE IM IN PRESS; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; King KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016317; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kondylis V, 2013, AUTOPHAGY, V9, P861, DOI 10.4161/auto.24111; Konishi A, 2012, J BIOL CHEM, V287, P13919, DOI 10.1074/jbc.M112.348375; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Lapaquette P, 2012, CELL MICROBIOL, V14, P791, DOI 10.1111/j.1462-5822.2012.01768.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053564; Li YH, 2012, CANCER RES, V72, P3535, DOI 10.1158/0008-5472.CAN-11-3103; Li YH, 2011, CLIN CANCER RES, V17, P7047, DOI 10.1158/1078-0432.CCR-11-0951; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033454; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Martins I., 2013, CELL DEATH DIFFER; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Molejon MI, 2013, AUTOPHAGY, V9, P933, DOI 10.4161/auto.24390; Morris S, 2011, J IMMUNOL, V187, P3953, DOI 10.4049/jimmunol.1100524; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Patel KK, 2013, ANNU REV PHYSIOL, V75, P241, DOI 10.1146/annurev-physiol-030212-183658; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pengo N, 2013, NAT IMMUNOL, V14, P298, DOI 10.1038/ni.2524; Phadwal K, 2012, AUTOPHAGY, V8, P677, DOI 10.4161/auto.18935; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2006, J CELL SCI, V119, P2903, DOI 10.1242/jcs.03047; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmeisser H, 2013, AUTOPHAGY, V9, P683, DOI 10.4161/auto.23921; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Smyth LA, 2012, J IMMUNOL, V189, P2274, DOI 10.4049/jimmunol.1200664; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Su CW, 2012, J IMMUNOL, V189, P1459, DOI 10.4049/jimmunol.1200484; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Thakor N, 2012, NUCLEIC ACIDS RES, V40, P541, DOI 10.1093/nar/gkr701; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Twitty CG, 2011, CLIN CANCER RES, V17, P6467, DOI 10.1158/1078-0432.CCR-11-0812; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; VAN DER LUGT L, 1958, Acta Derm Venereol, V38, P264; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Villella VR, 2013, CELL DEATH DIFFER, V20, P1101, DOI 10.1038/cdd.2013.46; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Wenger T, 2012, AUTOPHAGY, V8, P350, DOI [10.4161/auto.8.3.18806, 10.4161/auto.18806]; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wildenberg ME, 2012, GASTROENTEROLOGY, V142, P1493, DOI 10.1053/j.gastro.2012.02.034; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Xu T, 2011, AUTOPHAGY, V7, P1316, DOI 10.4161/auto.7.11.17785; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	173	295	312	4	401	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					211	227		10.1016/j.immuni.2013.07.017	http://dx.doi.org/10.1016/j.immuni.2013.07.017			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973220	Bronze			2022-12-18	WOS:000330948800006
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Toll-dependent control mechanisms of CD4 T cell activation	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; DENDRITIC CELLS; IN-VIVO; SIGNALING PATHWAY; IMMUNE-RESPONSES; CUTTING EDGE; MEMORY CELLS; COSTIMULATION; RECEPTORS; INFECTION	Toll-like receptors (TLRs) detect microbial infection and play an essential role in the induction of innate and adaptive immune responses. The mechanisms of TLR-mediated control of adaptive immunity are not yet fully understood. Induction of dendritic cell (DC) maturation is essential for activation of naive T cells. Here, we demonstrate that TLR-induced DC maturation and migration to the lymph nodes, in the absence of TLR-induced inflammatory cytokines, are not sufficient for T cell activation in vivo. We show that transient depletion of regulatory T (Tr) cells recovers the primary CD4 T cells response in MyD88-deficient mice, demonstrating that a major mechanism of TLR-mediated activation of T cell responses is the blocking of suppression by regulatory T cells. In addition we show that a TLR-induced signal(s) is required for memory CD4 T cell differentiation, but not for activation of memory T cells.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			NIAID NIH HHS [AI 05502] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; CROFT M, 1994, J IMMUNOL, V152, P2675; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Onizuka S, 1999, CANCER RES, V59, P3128; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Swain SL, 2003, MICROBES INFECT, V5, P213, DOI 10.1016/S1286-4579(03)00013-3; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059	39	295	317	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					733	741		10.1016/j.immuni.2004.10.006	http://dx.doi.org/10.1016/j.immuni.2004.10.006			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539158	Bronze			2022-12-18	WOS:000225365000013
J	Rozzo, SJ; Allard, JD; Choubey, D; Vyse, TJ; Izui, S; Peltz, G; Kotzin, BL				Rozzo, SJ; Allard, JD; Choubey, D; Vyse, TJ; Izui, S; Peltz, G; Kotzin, BL			Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus	IMMUNITY			English	Article							ZEALAND BLACK MICE; MURINE LUPUS; 200 CLUSTER; P202; ERYTHEMATOSUS; TRANSCRIPTION; PROTEIN; INHIBITION; ACTIVATORS; NEPHRITIS	The Nba2 locus is a major genetic contribution to disease susceptibility in the (NZB X NZW)F-1 mouse model of systemic lupus. We generated C57BL/6 mice congenic for this NZB locus, and these mice produced antinuclear autoantibodies characteristic of lupus. F-1 offspring of congenic and NZW mice developed high autoantibody levels and severe lupus nephritis similar to (NZB X NZW)F1 mice. Expression profiling with oligonucleotide microarrays revealed only two differentially expressed genes, interferon-inducible genes Ifi202 and Ifi203, in congenic versus control mice, and both were within the Nba2 interval. Quantitative PCR localized increased Ifi202 expression to splenic B cells and non-T/non-B cells. These results, together with analyses of promoter region polymorphisms, strain distribution of expression, and effects on cell proliferation and apoptosis, implicate Ifi202 as a candidate gene for lupus.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Roche Biosci, Palo Alto, CA 94304 USA; Loyola Univ, Stritch Sch Med, Dept Radiat Oncol, Maywood, IL 60153 USA; Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roche Holding; Loyola University Chicago; University of Geneva; National Jewish Health	Kotzin, BL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA.		Vyse, Tim J/G-3887-2011; Choubey, Divaker/A-4771-2008		NCI NIH HHS [CA 69031] Funding Source: Medline; NIAMS NIH HHS [AR 37070] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037070] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 1997, ONCOGENE, V15, P291, DOI 10.1038/sj.onc.1201184; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Choubey D, 2000, J BIOL REG HOMEOS AG, V14, P187; D'Souza S, 2001, J BIOL CHEM, V276, P298, DOI 10.1074/jbc.M007155200; Datta B, 1996, J BIOL CHEM, V271, P27544, DOI 10.1074/jbc.271.44.27544; DRAKE CG, 1995, J IMMUNOL, V154, P2441; Germer S, 1999, GENOME RES, V9, P72; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Gribaudo G, 1999, J INTERF CYTOK RES, V19, P129, DOI 10.1089/107999099314270; GRIBAUDO G, 1987, J BIOL CHEM, V262, P11878; Gutterman JU, 1999, CELL GROWTH DIFFER, V10, P93; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Kozono Y, 1996, J IMMUNOL, V156, P4498; Landolfo S, 1998, BIOCHIMIE, V80, P721, DOI 10.1016/S0300-9084(99)80025-X; Lawson BR, 2000, J CLIN INVEST, V106, P207, DOI 10.1172/JCI10167; LINCOLN S, 1992, MAPPING GENES CONTRO; Min W, 1996, MOL CELL BIOL, V16, P359; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Rozzo SJ, 1996, P NATL ACAD SCI USA, V93, P15164, DOI 10.1073/pnas.93.26.15164; Rozzo SJ, 2000, J IMMUNOL, V164, P5515, DOI 10.4049/jimmunol.164.10.5515; SAMANTA H, 1986, J BIOL CHEM, V261, P1849; SOBEL ES, 1991, J EXP MED, V173, P1441, DOI 10.1084/jem.173.6.1441; Theofilopoulos AN, 1999, P ASSOC AM PHYSICIAN, V111, P228, DOI 10.1046/j.1525-1381.1999.99244.x; Tucker RM, 2000, J IMMUNOL, V165, P1665, DOI 10.4049/jimmunol.165.3.1665; Vyse TJ, 1999, P NATL ACAD SCI USA, V96, P8098, DOI 10.1073/pnas.96.14.8098; Vyse TJ, 1997, J IMMUNOL, V158, P5566; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Vyse TJ, 1998, J IMMUNOL, V160, P2757; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; Wang H, 2000, J BIOL CHEM, V275, P27377; Wang H, 1999, GENOMICS, V60, P281, DOI 10.1006/geno.1999.5923	42	295	315	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		435	443		10.1016/S1074-7613(01)00196-0	http://dx.doi.org/10.1016/S1074-7613(01)00196-0			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567633	Bronze			2022-12-18	WOS:000171211800010
J	Liu, J; Qian, C; Cao, XT				Liu, Juan; Qian, Cheng; Cao, Xuetao			Post-Translational Modification Control of Innate Immunity	IMMUNITY			English	Review							NF-KAPPA-B; TOLL-LIKE RECEPTORS; E3 UBIQUITIN LIGASE; NLRP3 INFLAMMASOME ACTIVATION; MEDIATED ANTIVIRAL RESPONSE; I INTERFERON-PRODUCTION; RIG-I; NEGATIVE REGULATOR; DENDRITIC CELLS; PATTERN-RECOGNITION	A coordinated balance between the positive and negative regulation of pattern-recognition receptor (PRR)-initiated innate inflammatory responses is required to ensure the most favorable outcome for the host. Posttranslational modifications (PTMs) of innate sensors and downstream signaling molecules influence their activity and function by inducing their covalent linkage to new functional groups. PTMs including phosphorylation and polyubiquitination have been shown to potently regulate innate inflammatory responses through the activation, cellular translocation, and interaction of innate receptors, adaptors, and downstream signaling molecules in response to infectious and dangerous signals. Other PTMs such as methylation, acetylation, SUMOylation, and succinylation are increasingly implicated in the regulation of innate immunity and inflammation. In this review, we focus on the roles of PTMs in controlling PRR-triggered innate immunity and inflammatory responses. The emerging roles of PTMs in the pathogenesis and potential treatment of infectious and inflammatory immune diseases are also discussed.	[Liu, Juan; Qian, Cheng; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Liu, Juan; Qian, Cheng; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.	caoxt@immunol.org			National Key Basic Research Program of China [2013CB530502]; National Natural Science Foundation of China [31400777, 31390431]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2013CB530502) and National Natural Science Foundation of China (31400777, 31390431).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Decque A, 2016, NAT IMMUNOL, V17, P140, DOI 10.1038/ni.3342; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Fu JH, 2011, MOL IMMUNOL, V48, P415, DOI 10.1016/j.molimm.2010.09.003; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Heaton SM, 2016, J EXP MED, V213, P1, DOI 10.1084/jem.20151531; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Le HT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00275; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lin AE, 2013, NAT IMMUNOL, V14, P27, DOI 10.1038/ni.2478; Liu J, 2015, J AUTOIMMUN, V63, P1, DOI 10.1016/j.jaut.2015.07.011; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480; Liu YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037636; Llona-Minguez S, 2013, PHARM PAT ANAL, V2, P481, DOI [10.4155/PPA.13.31, 10.4155/ppa.13.31]; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McInnes IB, 2016, NAT REV RHEUMATOL, V12, P63, DOI 10.1038/nrrheum.2015.171; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qin Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004358; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tempe D, 2014, ONCOGENE, V33, P921, DOI 10.1038/onc.2013.4; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wen MY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8167; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhang Y., 2015, CELL MOL IMMUNOL, V2015, P17; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhao K, 2016, J IMMUNOL, V196, P1209, DOI 10.4049/jimmunol.1501224; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	159	294	313	13	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					15	30		10.1016/j.immuni.2016.06.020	http://dx.doi.org/10.1016/j.immuni.2016.06.020			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438764	Bronze			2022-12-18	WOS:000380749000007
J	Basu, R; O'Quinn, DB; Silberger, DJ; Schoeb, TR; Fouser, L; Ouyang, WJ; Hatton, RD; Weaver, CT				Basu, Rajatava; O'Quinn, Darrell B.; Silberger, Daniel J.; Schoeb, Trenton R.; Fouser, Lynette; Ouyang, Wenjun; Hatton, Robin D.; Weaver, Casey T.			Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria	IMMUNITY			English	Article							CHRONIC VIRAL-INFECTION; INNATE LYMPHOID-CELLS; INDUCER-LIKE CELLS; CITROBACTER-RODENTIUM; T-CELLS; MUCOSAL IMMUNITY; T(H)17 DIFFERENTIATION; INTESTINAL PATHOLOGY; INTERLEUKIN 22; POTENTIAL ROLE	Interleukin-22 (IL-22) is central to host protection against bacterial infections at barrier sites. Both innate lymphoid cells (ILCs) and T cells produce IL-22. However, the specific contributions of CD4(+) T cells and their developmental origins are unclear. We found that the enteric pathogen Citrobacter rodentium induced sequential waves of IL-22-producing ILCs and CD4(+) T cells that were each critical to host defense during a primary infection. Whereas IL-22 production by ILCs was strictly IL-23 dependent, development of IL-22-producing CD4(+) T cells occurred via an IL-6-dependent mechanism that was augmented by, but not dependent on, IL-23 and was dependent on both transcription factors T-bet and AhR. Transfer of CD4(+) T cells differentiated with IL-6 in the absence of TGF-beta ("Th22" cells) conferred complete protection of infected IL-22-deficient mice whereas transferred Th17 cells did not. These findings establish Th22 cells as an important component of mucosal antimicrobial host defense.	[Basu, Rajatava; O'Quinn, Darrell B.; Silberger, Daniel J.; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Schoeb, Trenton R.] Univ Alabama Birmingham, Dept Genet & Genom, Birmingham, AL 35294 USA; [Fouser, Lynette] Pfizer, Inflammat & Immunol, Biotherapeut Res & Dev, Cambridge, MA 02140 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pfizer; Roche Holding; Genentech	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864; Hatton, Robin/0000-0002-4797-9899; Weaver, Casey/0000-0002-2180-1793; BASU, RAJATAVA/0000-0003-4029-8043	NIH; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176, R24DK064400, R01DK093015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to D. Randolph and members of the C.T.W. laboratory for their helpful comments and suggestions. We thank J. Mezrich and C. Bradfield (University of Wisconsin) for provision of AhR-deficient mice and D. Grossman for assistance with analysis of gene expression data. We also thank the UAB Digestive Diseases Research Developmental Center (DDRDC), the UAB Small Animal Imaging Facility, UAB Genomics Core, UAB Center for AIDS Research Flow Cytometry Core, and UAB Epitope Recognition and Immunoreagent Core Facility for genotyping of gene-targeted mice, imaging studies, gene expression studies, flow cytometric sorting, and antibody preparations, respectively. This work was supported by grants from the NIH (C.T.W. and R.D.H.) and the Crohn's and Colitis Foundation of America (R.B. and D.B.O.).	Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Ertelt JM, 2010, IMMUNOLOGY, V131, P183, DOI 10.1111/j.1365-2567.2010.03287.x; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	294	302	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					1061	1075		10.1016/j.immuni.2012.08.024	http://dx.doi.org/10.1016/j.immuni.2012.08.024			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23200827	Green Accepted, Bronze			2022-12-18	WOS:000312575000014
J	Seneschal, J; Clark, RA; Gehad, A; Baecher-Allan, CM; Kupper, TS				Seneschal, Julien; Clark, Rachael A.; Gehad, Ahmed; Baecher-Allan, Clare M.; Kupper, Thomas S.			Human Epidermal Langerhans Cells Maintain Immune Homeostasis in Skin by Activating Skin Resident Regulatory T Cells	IMMUNITY			English	Article							TOLEROGENIC DENDRITIC CELLS; ANTIGEN UPTAKE; MEMORY; SUBSETS; INFECTION; INTERLEUKIN-15; PROLIFERATION; EFFICIENT; RESPONSES; RECEPTOR	Recent studies have demonstrated that the skin of a normal adult human contains 10-20 billion resident memory T cells, including various helper, cytotoxic, and regulatory T cell subsets, that are poised to respond to environmental antigens. Using only autologous human tissues, we report that both in vitro and in vivo, resting epidermal Langerhan cells (LCs) selectively and specifically induced the activation and proliferation of skin resident regulatory T (Treg) cells, a minor subset of skin resident memory T cells. In the presence of foreign pathogen, however, the same LCs activated and induced proliferation of effector memory T (Tem) cells and limited Treg cells' activation. These underappreciated properties of LCs, namely maintenance of tolerance in normal skin, and activation of protective skin resident memory T cells upon infectious challenge, help clarify the role of LCs in skin.	[Seneschal, Julien; Clark, Rachael A.; Gehad, Ahmed; Baecher-Allan, Clare M.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Seneschal, Julien] Univ Bordeaux, Dept Dermatol & Pediat Dermatol, INSERM, U1035, Bordeaux, France; [Seneschal, Julien] CIRID UMR 5164, Bordeaux, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Kupper, TS (corresponding author), Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, 75 Francis St, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019	Seneschal, Julien/0000-0003-1139-0908; Baecher-Allan, Clare/0000-0003-2405-8525	NIH/NIAID/NIAMS [R01AI041707, R01AI097218, R01 AR056720]; NIH/NIMH [R03 MH095529]; Damon Runyon Cancer Research Foundation; Fondation Rene Touraine; Ministere Francais des Affaires Etrangeres; Centre Hospitalier Universitaire de Bordeaux, France; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218, K08AI060890, R01AI041707, R01AI025082, R01AI097128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098, P30AR042689, R01AR065807, R01AR056720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH095529] Funding Source: NIH RePORTER	NIH/NIAID/NIAMS; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Damon Runyon Cancer Research Foundation; Fondation Rene Touraine; Ministere Francais des Affaires Etrangeres; Centre Hospitalier Universitaire de Bordeaux, France; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Normal skin was kindly provided by B. Pomahoc, S. Talbot, and E. Eriksson of BWH and T. Cochran of the Boston Center for Plastic Surgery. We thank G.F. Murphy and Q. Zhan of Brigham and Women's Hospital for technical advice on immunofluorescence assay. We thank A. Taeib, P. Blanco, and J.-F. Moreau from the University of Bordeaux for helpful discussions. This work was supported by the following grants from the NIH/NIAID/NIAMS: R01AI041707, R01AI097218 (to T.S.K.), R01 AR056720 (to R.A.C.), and NIH/NIMH R03 MH095529 (to R.A.C.). R.A.C. was also supported by a Damon Runyon Cancer Research Foundation Clinical Investigator Award. J.S. was support by grants from Fondation Rene Touraine (European Fellowships 2008), Ministere Francais des Affaires Etrangeres, and Centre Hospitalier Universitaire de Bordeaux, France. J.S. designed the experiments, analyzed and interpreted the data, and drafted the paper; R.A.C. provided intellectual input and technical advice and helped edit the manuscript. A.G. performed experiments in Figure 7. C.M.B.-A. provided intellectual input and technical advice. T.S.K. conceived the project, helped plan and design the experiments, analyzed and interpreted the data, and contributed to drafting and editing the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Baecher-Allan CM, 2006, CURR PROTOC IMMUNOL; Banchereau J, 2009, ANN NY ACAD SCI, V1174, P24, DOI 10.1111/j.1749-6632.2009.04999.x; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Bond E, 2009, J IMMUNOL METHODS, V348, P42, DOI 10.1016/j.jim.2009.06.012; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Clark RA, 2008, J EXP MED, V205, P2221, DOI 10.1084/jem.20071190; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Davis M.M., 2012, J INFECT DIS, V4, p[fs2, 981]; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; ESCH RE, 1988, J BIOL STAND, V16, P33, DOI 10.1016/0092-1157(88)90027-3; Fujita H, 2009, P NATL ACAD SCI USA, V106, P21795, DOI 10.1073/pnas.0911472106; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lutz MB, 2010, IMMUNOL CELL BIOL, V88, P381, DOI 10.1038/icb.2010.17; Mathers AR, 2009, J IMMUNOL, V182, P921, DOI 10.4049/jimmunol.182.2.921; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2001, SEMIN IMMUNOL, V13, P323, DOI 10.1006/smim.2001.0328; Munz C, 2005, BLOOD, V105, P266, DOI 10.1182/blood-2004-06-2492; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Rappl G, 2001, J INVEST DERMATOL, V116, P102, DOI 10.1046/j.1523-1747.2001.00239.x; Ratzinger G, 2004, J IMMUNOL, V173, P2780, DOI 10.4049/jimmunol.173.4.2780; Romani L, 2000, J LEUKOCYTE BIOL, V68, P175; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stary G, 2011, J IMMUNOL, V186, P103, DOI 10.4049/jimmunol.1002485; Stoitzner P, 2010, IMMUNOL CELL BIOL, V88, P348, DOI 10.1038/icb.2010.46; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walsh P, 1996, J DERMATOL SCI, V12, P140, DOI 10.1016/0923-1811(95)00473-4; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	53	294	305	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 25	2012	36	5					873	884		10.1016/j.immuni.2012.03.018	http://dx.doi.org/10.1016/j.immuni.2012.03.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22560445	Bronze, Green Accepted			2022-12-18	WOS:000304976000019
J	Kitano, M; Moriyama, S; Ando, Y; Hikida, M; Mori, Y; Kurosaki, T; Okada, T				Kitano, Masahiro; Moriyama, Saya; Ando, Yoshikazu; Hikida, Masaki; Mori, Yasuo; Kurosaki, Tomohiro; Okada, Takaharu			BcI6 Protein Expression Shapes Pre-Germinal Center B Cell Dynamics and Follicular Helper T Cell Heterogeneity	IMMUNITY			English	Article							IN-VIVO; ANTIBODY-RESPONSES; BCL6; AFFINITY; DIFFERENTIATION; ORGANIZATION; INFLAMMATION; MIGRATION; SELECTION; SURVIVAL	The transcription factor BcI6 is essential for the development of germinal center (GC) B cells and follicular helper T (Tfh) cells. However, little is known about in vivo dynamics of BcI6 protein expression during and after development of these cells. By using a BcI6 reporter mouse strain, we found that antigen-engaged B cells upregulated BcI6 before clustering in GCs. Two-photon microscopic analysis indicated that BcI6 upregulation in pre-GC B cells contributed to sustaining their interactions with helper T cells and was required for their entry to GC clusters. Our data also suggested that Tfh cells gradually downmodulated BcI6 protein over weeks after development. The BcI6-low Tfh cells rapidly terminated proliferation and upregulated IL-7 receptor. These results clarify the role of BcI6 in pre-GC B cell dynamics and highlight the modulation of BcI6 expression in Tfh cells that persist in the late phase of the antibody response.	[Kitano, Masahiro; Ando, Yoshikazu; Okada, Takaharu] RIKEN, Res Ctr Allergy & Immunol, Res Unit Immunodynam, Yokohama, Kanagawa 2300045, Japan; [Moriyama, Saya; Hikida, Masaki; Kurosaki, Tomohiro] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Moriyama, Saya; Kurosaki, Tomohiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Mori, Yasuo; Okada, Takaharu] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Innovat Technohub Integrated Med Bioimaging, Kyoto 6158530, Japan; [Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	RIKEN; RIKEN; Osaka University; Kyoto University; Osaka University	Okada, T (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Res Unit Immunodynam, Yokohama, Kanagawa 2300045, Japan.	tokada@rcai.riken.jp	Okada, Takaharu/N-7931-2015; Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	We thank J. Cyster, Y. Aiba, K. Kometani, D. Baumjohann, M. Ansel, and S. Fagarasan for discussion, N. Takahashi, E. Mori, M. Kurosaki, and the core facilities at RIKEN, RCAI for the technical assistance, M. Matsuda, S. Kiyonaka, Y. Wakabayashi, and T. Saito for help on setting up the microscopes. M.K. is a RIKEN Special Postdoctoral Researcher, and S.M. is a RIKEN Junior Research Associate. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.K., Y.M., T.K., and T.O.), the Uehara Memorial Foundation (T.O.), the Sumitomo Foundation (T.O.), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.O.).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kurosaki T, 2010, IMMUNOL REV, V237, P104, DOI 10.1111/j.1600-065X.2010.00939.x; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Nutt SL, 2007, NAT REV IMMUNOL, V7, P923, DOI 10.1038/nri2204; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	41	293	301	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					961	972		10.1016/j.immuni.2011.03.025	http://dx.doi.org/10.1016/j.immuni.2011.03.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21636294	Bronze			2022-12-18	WOS:000292349700015
J	Kamanaka, M; Kim, ST; Wan, YY; Sutterwala, FS; Lara-Tejero, M; Galan, JE; Harhaj, E; Flavell, RA				Kamanaka, Masahito; Kim, Sean T.; Wan, Yisong Y.; Sutterwala, Fayyaz S.; Lara-Tejero, Maria; Galan, Jorge E.; Harhaj, Ed; Flavell, Richard A.			Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELLS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; IN-VIVO; MICE; TOLERANCE; RECEPTOR; IL-10; RECOGNITION	To identify interleukin-10 (IL-10)-producing cells in vivo, we generated a knockin mouse where an internal ribosome entry site (IRES) green fluorescence protein (GFP) element was inserted immediately before the polyadenylation site of the IL-10 gene. GFP fluorescence in cells from these mice was found to correlate positively with IL-10 protein expression. With this model, we found that after multiple T cell receptor (TCR) stimulations, strong expression of IL-10 was produced specifically by intraepithelial lymphocytes (IEL) in the small intestine and colonic lamina propria lymphocytes (cLPL). We found that anti-CD3 treatment induces T regulatory cell 1 (Tr1)-like cells in small intestinal IEL (sIEL) and led to the accumulation of naturally occurring regulatory T (nTreg) cells in colonic LPL (cLPL). These findings highlight the intestine as a unique site for induction of IL-10-producing T cells, which play a critical role in the regulation of inflammation in the gut.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Wan, Yisong/ABE-1200-2021; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Wan, Yisong/0000-0003-4346-9717; Cassel, Suzanne/0000-0003-2492-1923				Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; ALEGRE ML, 1995, J IMMUNOL, V155, P1544; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6; Bachmair L., 2001, HDB AUTOMATED REASON, P19, DOI DOI 10.1016/B978-044450813-3/50004-7; Braunstein J, 1997, GUT, V41, P215, DOI 10.1136/gut.41.2.215; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kambayashi T, 1996, CELL IMMUNOL, V171, P153, DOI 10.1006/cimm.1996.0186; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Miller C, 1999, J EXP MED, V190, P53, DOI 10.1084/jem.190.1.53; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NICOLLS MR, 1993, TRANSPLANTATION, V55, P459, DOI 10.1097/00007890-199303000-00001; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sundstedt A, 1997, J IMMUNOL, V158, P180; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102	22	293	307	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2006	25	6					941	952		10.1016/j.immuni.2006.09.013	http://dx.doi.org/10.1016/j.immuni.2006.09.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17137799	Bronze			2022-12-18	WOS:000243087500013
J	Winau, F; Weber, S; Sad, S; de Diego, J; Hoops, SL; Breiden, B; Sandhoff, K; Brinkmann, V; Kaufmann, SHE; Schaible, UE				Winau, F; Weber, S; Sad, S; de Diego, J; Hoops, SL; Breiden, B; Sandhoff, K; Brinkmann, V; Kaufmann, SHE; Schaible, UE			Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis	IMMUNITY			English	Article							MHC CLASS-I; SPHINGOLIPID ACTIVATOR PROTEINS; DENDRITIC CELLS; ANTIGEN PRESENTATION; EXOGENOUS ANTIGENS; LYMPH-NODE; VIVO; MECHANISMS; INDUCTION; DEGRADATION	CD8 T lymphocytes are important effectors in protective immunity against Mycobacterium tuberculosis. We recently characterized the detour pathway of CD8 T cell activation in tuberculosis mediated by apoptotic vesicles from infected cells that transport mycobacterial antigens to dendritic cells (DCs). Here we demonstrate that apoptotic vesicles from mycobacteria-infected macrophages stimulate CD8 T cells in vivo. Homing of DCs to draining lymph nodes was critically required for effective crosspriming. Subsequent fate of vesicle-associated antigens in recipient DCs was characterized by endosomal mechanisms predominating over proteasomal processing. In addition, vesicle processing depended on the presence of saposins to disintegrate apoptotic membranes. Apoptotic vesicles displayed potent adjuvant activity by stimulating through Toll-like receptors (TLR). Ultimately, vaccination with vesicles from infected cells induced protection against M. tuberculosis infection. Taken together, we propose the detour pathway to represent a genuine immunological mechanism mediating crosspriming of CD8 T cells in vivo and protection against tuberculosis.	Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Cent Core Facil Microscopy, D-10117 Berlin, Germany; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany	Max Planck Society; Max Planck Society; Max Planck Society; National Research Council Canada; University of Bonn	Winau, F (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Schumannstr 21-22, D-10117 Berlin, Germany.	winau@mpiib-berlin.mpg.de	Breiden, Bernadette/S-3005-2019; Schaible, Ulrich/C-7837-2011; Brinkmann, Volker/A-6015-2009; Breiden, Bernadette/F-2422-2014; Kaufmann, Stefan HE/I-5454-2014	Breiden, Bernadette/0000-0002-4838-4109; Schaible, Ulrich/0000-0002-6638-7282; Breiden, Bernadette/0000-0002-4838-4109; Kaufmann, Stefan HE/0000-0001-9866-8268; Sad, Subash/0000-0002-2462-7137				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Ciaramella A, 2004, J INFECT DIS, V190, P1167, DOI 10.1086/423850; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Storni T, 2004, J IMMUNOL, V172, P6129, DOI 10.4049/jimmunol.172.10.6129; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	53	293	304	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2006	24	1					105	117		10.1016/j.immuni.2005.12.001	http://dx.doi.org/10.1016/j.immuni.2005.12.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413927	Bronze			2022-12-18	WOS:000234850200014
J	Li, YS; Wasserman, R; Hayakawa, K; Hardy, RR				Li, YS; Wasserman, R; Hayakawa, K; Hardy, RR			Identification of the earliest B lineage stage in mouse bone marrow	IMMUNITY			English	Article							SURROGATE LIGHT-CHAIN; HEMATOPOIETIC PRECURSOR CELLS; TRANSCRIPTION FACTOR BSAP; IMMUNOGLOBULIN HEAVY; DNA-BINDING; LYMPHOCYTES-B; FETAL LIVER; RAG-1-DEFICIENT MICE; V(D)J RECOMBINATION; GENE-TRANSCRIPTION	We have identified a very early stage of B lineage cells in the CD45R (B220)(+)CD24 (HSA)(-) pre-pro-B fraction of mouse bone marrow delineated by expression of AA4.1, a molecule found on stem cells and early B lineage cells. These cells are B lineage precursors based on their capacity to generate B lineage cells rapidly in stromal-dependent culture and their expression of high levels of germline IgH transcripts in the absence of Rag-1/2. Half of these AA4.1(+) precursors express low levels of CD4, characteristic of lymphoid progenitors, but few if any have up-regulated CD19, a molecule expressed very early in the B lineage. Furthermore, expression of genes encoding pre-B and B cell receptor components (mb-1, B29, and lambda 5) and transcription factors necessary for B lineage differentiation (BSAP, E12, E47, and Id) provide further support for designating these cells as the earliest B cell precursors.	FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111; CHILDRENS HOSP,DIV ONCOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104	Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania					NCI NIH HHS [CA-06927] Funding Source: Medline; NIAID NIH HHS [AI-26782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI126782, R01AI026782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ALESSANDRINI A, 1991, MOL CELL BIOL, V11, P2096, DOI 10.1128/MCB.11.4.2096; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; CHERVENAK R, 1993, J IMMUNOL, V151, P4486; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FAUST EA, 1993, J EXP MED, V177, P915, DOI 10.1084/jem.177.4.915; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FREDRICKSON GG, 1989, J EXP MED, V169, P1473, DOI 10.1084/jem.169.4.1473; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Hardy R. R., 1986, HDB EXPT IMMUNOLOGY; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; KRIP I, 1996, EUR J IMMUNOL, V26, P238; LEE G, 1989, J IMMUNOL, V142, P3875; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LOKEN MR, 1988, PATHOL IMMUNOPATH R, V7, P357, DOI 10.1159/000157129; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OKABE T, 1992, EUR J IMMUNOL, V22, P37, DOI 10.1002/eji.1830220107; Osmond D G, 1990, Semin Immunol, V2, P173; RETH M, 1993, ANNU REV IMMUNOL, V10, P98; ROLINK A, 1993, ADV IMMUNOL, V53, P123, DOI 10.1016/S0065-2776(08)60499-X; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROSNET O, 1991, ONCOGENE, V6, P1641; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SYKES M, 1990, J IMMUNOL, V145, P3209; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WATERS SH, 1989, MOL CELL BIOL, V9, P5594, DOI 10.1128/MCB.9.12.5594; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; XU LZ, 1992, INT IMMUNOL, V4, P875, DOI 10.1093/intimm/4.8.875; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	65	293	297	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					527	535		10.1016/S1074-7613(00)80268-X	http://dx.doi.org/10.1016/S1074-7613(00)80268-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986713	hybrid			2022-12-18	WOS:A1996WA65100004
J	Yang, DH; He, Y; Munoz-Planillo, R; Liu, Q; Nunez, G				Yang, Dahai; He, Yuan; Munoz-Planillo, Raul; Liu, Qin; Nunez, Gabriel			Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock	IMMUNITY			English	Article							NLRP3 INFLAMMASOME ACTIVATION; CUTTING EDGE; ATP RELEASE; RECEPTOR; RECOGNITION; APOPTOSIS; ABSENCE; SILICA; TOXINS	The noncanonical inflammasome induced by intracellular lipopolysaccharide (LPS) leads to caspase-11-dependent pyroptosis, which is critical for induction of endotoxic shock in mice. However, the signaling pathway downstream of caspase-11 is unknown. We found that cytosolic LPS stimulation induced caspase-11-dependent cleavage of the pannexin-1 channel followed up by ATP release, which in turn activated the purinergic P2X7 receptor to mediate cytotoxicity. In the absence of P2X7 or pannexin-1, pyroptosis induced by cytosolic LPS was abrogated. Cleavage of pannexin-1 required the catalytic activity of caspase-11 and was essential for ATP release and P2X7-mediated pyroptosis. Priming the caspase-11 pathway in vivo with LPS or Toll-like receptor-3 (TLR3) agonist resulted in high mortality in wild-type mice after secondary LPS challenge, but not in Casp11(-/-), Panx1(-/-), or P2x7(-/)-mice. These results reveal a critical role for pannexin-1 and P2X7 downstream of caspase-11 for pyroptosis and susceptibility to sepsis induced by the noncanonical inflammasome.	[Yang, Dahai; He, Yuan; Munoz-Planillo, Raul; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Yang, Dahai; He, Yuan; Munoz-Planillo, Raul; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Yang, Dahai; Liu, Qin] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; East China University of Science & Technology	Liu, Q (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	qinliu@ecust.edu.cn; gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014		China Scholarship Council [201306740018]; National Institutes of Health [R01AI063331, R01DK091191]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI063331, R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Junying Yuan for sharing Casp11<SUP>-/-</SUP> mice, Vishva Dixit (Genentech) for sharing Panx1<SUP>-/-</SUP> and Aim2<SUP>-/-</SUP> mice, Amal Amer for providing caspase-11 plasmids, and Melody Zeng, Grace Chen, and Jessica Werner for critical reading of the manuscript. We also thank members of the Nunez laboratory for discussions and technical assistance, Lisa Burmeister for mouse husbandry, and Joel Whitfield from the University of Michigan Immunology Core for performing ELISA assays. D.Y. was supported by the State Scholarship Fund from China Scholarship Council (No. 201306740018). This work was supported by grants R01AI063331 and R01DK091191 from the National Institutes of Health to G.N.	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sakaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059778; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Santana PT, 2015, J INNATE IMMUN, V7, P417, DOI 10.1159/000371388; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	41	292	329	17	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					923	932		10.1016/j.immuni.2015.10.009	http://dx.doi.org/10.1016/j.immuni.2015.10.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26572062	Green Accepted, Bronze			2022-12-18	WOS:000366846000013
J	Ruland, J; Duncan, GS; Wakeham, A; Mak, TW				Ruland, J; Duncan, GS; Wakeham, A; Mak, TW			Differential requirement for Malt1 in T and B cell antigen receptor signaling	IMMUNITY			English	Article							NF-KAPPA-B; HELICOBACTER-PYLORI ERADICATION; LYMPHOID-TISSUE; MARGINAL ZONE; B1B CELLS; ACTIVATION; REGULATOR; RESPONSES; GENE; LYMPHOCYTES	The translocation t(11;18)(q21;q21) involving MALT1 is the most common chromosomal abnormality in lymphomas of mucosa-associated lymphoid tissue. Although the paracaspase MALT1 can bind to BCL10, the physiological function of MALT1 is unknown. Using mouse models, we show that Malt1 is essential for T cell activation, proliferation, and IL-2 production in response to TCR ligation and strictly required for signal-specific NF-kappaB activation induced by the TCR but not TNF-alpha. or IL-1 signaling. Malt1 operates downstream of Bcl10, controls the catalytic activity of the canonical IKK complex, and regulates the signaling of Jnk and p38 MAP kinases. In contrast to Bcl10 disruption, however, inactivation of Malt1 has only mild effects on B cell activation and does not cause defects during neurodevelopment. Thus, Malt1 is an essential regulator of Bcl10 signaling that is differentially required depending on cellular context.	Univ Toronto, Ontario Canc Inst, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Tech Univ Munich, Dept Med 3, Klinikum Rechts Isar, D-81675 Munich, Germany	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Technical University of Munich	Ruland, J (corresponding author), Univ Toronto, Ontario Canc Inst, Adv Med Discovery Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597				Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu HX, 2002, GASTROENTEROLOGY, V122, P1286, DOI 10.1053/gast.2002.33047; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Morgan JA, 1999, CANCER RES, V59, P6205; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SEDWICK CE, 2002, SCI STKE; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sugiyama T, 2001, GASTROENTEROLOGY, V120, P1884, DOI 10.1053/gast.2001.25305; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tarakhovsky A, 1997, J EXP MED, V185, P981, DOI 10.1084/jem.185.6.981; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wotherspoon AC, 2002, CURR OPIN HEMATOL, V9, P50, DOI 10.1097/00062752-200201000-00009; Zucca E, 2000, BLOOD, V96, P410	31	292	306	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					749	758		10.1016/S1074-7613(03)00293-0	http://dx.doi.org/10.1016/S1074-7613(03)00293-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614861	Bronze			2022-12-18	WOS:000186672200014
J	Semerad, CL; Liu, FL; Gregory, AD; Stumpf, K; Link, DC				Semerad, CL; Liu, FL; Gregory, AD; Stumpf, K; Link, DC			G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; NEUTROPENIA/ACUTE MYELOID-LEUKEMIA; SEVERE CONGENITAL NEUTROPENIA; FACTOR-RECEPTOR; PROGENITOR CELLS; PERIPHERAL-BLOOD; STEM-CELLS; HEMATOPOIETIC PROGENITOR; DEFICIENT MICE; STROMAL CELLS	Neutrophils are released from the bone marrow in a regulated fashion to maintain homeostatic levels in the blood and to respond to physiological stresses, including infection. We show that under basal conditions granulocyte colony-stimulating factor (G-CSF) is an essential regulator of neutrophil release from the bone marrow. Nonredundant signals generated by the membrane-proximal 87 amino acids of the G-CSF receptor (G-CSFR) are sufficient to mediate this response. Surprisingly, G-CSFR expression on neutrophils is neither necessary nor sufficient for their mobilization from the bone marrow, suggesting that G-CSF induces neutrophil mobilization indirectly through the generation of trans-acting signals. Evidence is provided suggesting that downregulation of stromal cell-derived factor 1 expression in the bone marrow may represent such a signal.	Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060772, T32HL007088] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 07088-23, R01HL60772-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; Basu S, 2000, BLOOD, V95, P3725; BOCCHIETTO E, 1993, J CELL PHYSIOL, V155, P89, DOI 10.1002/jcp.1041550112; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Bruhl H, 2001, CLIN EXP IMMUNOL, V126, P551, DOI 10.1046/j.1365-2249.2001.01679.x; CAMPBELL FR, 1972, AM J ANAT, V135, P521, DOI 10.1002/aja.1001350406; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; COHEN AM, 1987, P NATL ACAD SCI USA, V84, P2484, DOI 10.1073/pnas.84.8.2484; DEMETRI GD, 1991, BLOOD, V78, P2791; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; GRZEGORZEWSKI K, 1994, BLOOD, V83, P377; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Iizuka K, 1997, BLOOD, V89, P1446, DOI 10.1182/blood.V89.4.1446; Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166; INUKAI T, 1995, BRIT J HAEMATOL, V89, P623, DOI 10.1111/j.1365-2141.1995.tb08373.x; JAGELS MA, 1994, IMMUNOPHARMACOLOGY, V28, P1, DOI 10.1016/0162-3109(94)90034-5; JAGELS MA, 1992, J IMMUNOL, V148, P1119; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; KAWAKAMI M, 1990, BLOOD, V76, P1962; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; LENNON JE, 1986, EXP HEMATOL, V14, P287; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; LORD BI, 1991, BLOOD, V77, P2154; LORD BI, 1992, BAILLIERE CLIN HAEM, V5, P533, DOI 10.1016/S0950-3536(11)80006-5; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Molineux G, 1997, BLOOD, V89, P3998, DOI 10.1182/blood.V89.11.3998; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagase H, 2002, J LEUKOCYTE BIOL, V71, P711; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; PETRIDES PE, 1990, BLUT, V61, P3, DOI 10.1007/BF01739426; Rausch O, 1997, MOL CELL BIOL, V17, P1170, DOI 10.1128/MCB.17.3.1170; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; ULICH TR, 1988, AM J PATHOL, V133, P630	47	292	296	2	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					413	423		10.1016/S1074-7613(02)00424-7	http://dx.doi.org/10.1016/S1074-7613(02)00424-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387736	Bronze			2022-12-18	WOS:000178667100003
J	Prigozy, TI; Sieling, PA; Clemens, D; Stewart, PL; Behar, SM; Porcelli, SA; Brenner, MB; Modlin, RL; Kronenberg, M				Prigozy, TI; Sieling, PA; Clemens, D; Stewart, PL; Behar, SM; Porcelli, SA; Brenner, MB; Modlin, RL; Kronenberg, M			The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules	IMMUNITY			English	Article							CLASS-II COMPARTMENTS; CLATHRIN-COATED VESICLES; B-LYMPHOBLASTOID-CELLS; MYCOBACTERIUM-TUBERCULOSIS; HUMAN MACROPHAGES; DENDRITIC CELLS; MHC MOLECULES; LIPOARABINOMANNAN; RECOGNITION; COMPLEX	We have characterized the CD1b-mediated presentation pathway for the mycobacterial lipoglycan lipoarabinomannan (LAM) in monocyte-derived antigen-presenting cells. The macrophage mannose receptor (MR) was responsible for uptake of LAM. Antagonism of MR function inhibited both the internalization of LAM and the presentation of this antigen to LAM-reactive T cells. Intracellular MRs were most abundant in early endosomes, but they also were located in the compartment for MHC class II antigen loading (MIIC). Internalized LAM was transported to late endosomes, lysosomes, and MIICs. MRs colocalized with CD1b molecules, suggesting that the MR could deliver LAM to late endosomes for loading onto CD1b. LAM acid CD1b colocalized in organelles that may be sites of lipoglycan antigen loading. This pathway links recognition of microbial antigens by a receptor of the innate immune system to the induction of adaptive T cell responses.	UNIV CALIF LOS ANGELES,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,DEPT MED,DIV DERMATOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,DEPT MED,DIV INFECT DIS,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,DEPT MED,DIV DIGEST DIS,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,DEPT MOL & MED PHARMACOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,CRUMP INST BIOL IMAGING,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,INST MOL BIOL,LOS ANGELES,CA 90095; BRIGHAM & WOMENS HOSP,DEPT MED,DIV RHEUMATOL & IMMUNOL,BOSTON,MA 02115	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital			Behar, Samuel M/C-3541-2009; Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Behar, Samuel/0000-0002-3374-6699	NCI NIH HHS [CA52511] Funding Source: Medline; NIAID NIH HHS [AI 35275] Funding Source: Medline; NIAMS NIH HHS [AR 40312] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; CALABI F, 1991, TISSUE ANTIGENS, V37, P1, DOI 10.1111/j.1399-0039.1991.tb01836.x; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; CROSS CE, 1995, INFECT IMMUN, V63, P2604, DOI 10.1128/IAI.63.7.2604-2611.1995; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; DIAZ R, 1989, BIOCHEM J, V260, P127, DOI 10.1042/bj2600127; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KLEIJMEER MJ, 1995, J IMMUNOL, V154, P5715; ORIORDAN DM, 1995, INFECT IMMUN, V63, P779, DOI 10.1128/IAI.63.3.779-784.1995; PETERS PJ, 1995, J EXP MED, V182, P325, DOI 10.1084/jem.182.2.325; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; PORCELLI SA, 1995, J IMMUNOL, V155, P3709; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VENISSE A, 1995, EUR J BIOCHEM, V231, P440, DOI 10.1111/j.1432-1033.1995.tb20717.x; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; XU SM, 1994, J IMMUNOL, V153, P2568	33	292	300	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					187	197		10.1016/S1074-7613(00)80425-2	http://dx.doi.org/10.1016/S1074-7613(00)80425-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047240	Bronze			2022-12-18	WOS:A1997XC61600008
J	Zhu, Y; Herndon, JM; Sojka, DK; Kim, KW; Knolhoff, BL; Zuo, C; Cullinan, DR; Luo, JQ; Bearden, AR; Lavine, KJ; Yokoyama, WM; Hawkins, WG; Fields, RC; Randolph, GJ; DeNardo, DG				Zhu, Yu; Herndon, John M.; Sojka, Dorothy K.; Kim, Ki-Wook; Knolhoff, Brett L.; Zuo, Chong; Cullinan, Darren R.; Luo, Jingqin; Bearden, Audrey R.; Lavine, Kory J.; Yokoyama, Wayne M.; Hawkins, William G.; Fields, Ryan C.; Randolph, Gwendalyn J.; DeNardo, David G.			Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression	IMMUNITY			English	Article							BONE-MARROW; CHECKPOINT IMMUNOTHERAPY; INFILTRATING MACROPHAGES; FUNCTIONALLY DISTINCT; CARDIAC MACROPHAGES; T-CELLS; MONOCYTES; CANCER; MICE; INFLAMMATION	Tumor-associated macrophages (TAMs) are essential components of the cancer microenvironment and play critical roles in the regulation of tumor progression. Optimal therapeutic intervention requires in-depth understanding of the sources that sustain macrophages in malignant tissues. In this study, we investigated the ontogeny of TAMs in murine pancreatic ductal adenocarcinoma (PDAC) models. We identified both inflammatory monocytes and tissue-resident macrophages as sources of TAMs. Unexpectedly, significant portions of pancreas-resident macrophages originated from embryonic development and expanded through in situ proliferation during tumor progression. Whereas monocyte-derived TAMs played more potent roles in antigen presentation, embryonically derived TAMs exhibited a profibrotic transcriptional profile, indicative of their role in producing and remodeling molecules in the extracellular matrix. Collectively, these findings uncover the heterogeneity of TAM origin and functions and could provide therapeutic insight for PDAC-treatment.	[Zhu, Yu; Herndon, John M.; Sojka, Dorothy K.; Kim, Ki-Wook; Knolhoff, Brett L.; Zuo, Chong; Cullinan, Darren R.; Luo, Jingqin; Bearden, Audrey R.; Lavine, Kory J.; Hawkins, William G.; Fields, Ryan C.; Randolph, Gwendalyn J.; DeNardo, David G.] Washington Univ St Louis, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	DeNardo, DG (corresponding author), Washington Univ St Louis, Sch Med, St Louis, MO 63110 USA.	ddenardo@wustl.edu		DeNardo, David/0000-0002-3655-5783; Herndon, John/0000-0002-8378-9654; luo, jingqin/0000-0003-2759-3072; /0000-0002-7207-4389; Zhu, Yu/0000-0002-3250-6546	American Association for Cancer Research and Pancreatic Cancer Action Network; National Cancer Institute (NCI) [R01-CA177670, R01-CA203890, P50-CA196510, T32CA009621, UL1TR000448, P30-CA91842]; BJC Institute of Health and Siteman Cancer Center Cancer Frontier Fund; NCI [P30-CA91842 NCRR UL1RR024992]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA196510, R01CA177670, R01CA203890, T32CA009621] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL123519, R01HL138466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK109668] Funding Source: NIH RePORTER	American Association for Cancer Research and Pancreatic Cancer Action Network; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BJC Institute of Health and Siteman Cancer Center Cancer Frontier Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge support from an award from the American Association for Cancer Research and Pancreatic Cancer Action Network, National Cancer Institute (NCI) awards R01-CA177670, R01-CA203890, P50-CA196510, T32CA009621, UL1TR000448, and P30-CA91842, and the BJC Institute of Health and Siteman Cancer Center Cancer Frontier Fund. Microarray analyses were performed by the Genome Technology Access Center at Washington University and were partially funded by NCI award P30-CA91842 NCRR UL1RR024992. The authors also acknowledge Grant Gould and Hans Challen for help on irradiation experiments, Liping Yang for help on parabiosis, and Daniel C. Link, Jason C. Mills, Boris Calderon, and Jesse W. Williams for advice.	Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Beatty GL, 2015, GASTROENTEROLOGY, V149, P201, DOI 10.1053/j.gastro.2015.04.010; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Calderon B, 2015, J EXP MED, V212, P1497, DOI 10.1084/jem.20150496; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sanford DE, 2013, CLIN CANCER RES, V19, P3404, DOI 10.1158/1078-0432.CCR-13-0525; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	37	291	300	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					323	+		10.1016/j.immuni.2017.07.014	http://dx.doi.org/10.1016/j.immuni.2017.07.014			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813661	Bronze, Green Accepted			2022-12-18	WOS:000407788300017
J	Izcue, A; Hue, S; Buonocore, S; Arancibia-Carcamo, CV; Ahern, PP; Iwakura, Y; Maloy, KJ; Powrie, F				Izcue, Ana; Hue, Sophie; Buonocore, Sofia; Arancibia-Carcamo, Carolina V.; Ahern, Philip P.; Iwakura, Yoichiro; Maloy, Kevin J.; Powrie, Fiona			Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; INTESTINAL INFLAMMATION; MEDIATED COLITIS; DENDRITIC CELLS; IL-23; DISTINCT; MUCOSAL; T(H)17	Interleukin-23 (IL-23) is an inflammatory cytokine that plays a key role in the pathogenesis of several autoimmune and inflammatory diseases. It orchestrates innate and T cell-mediated inflammatory pathways and can promote T helper 17 (Th17) cell responses. Utilizing a T cell transfer model, we showed that IL-23-dependent colitis did not require IL-17 secretion by T cells. Furthermore, IL-23-independent intestinal inflammation could develop if immunosuppressive pathways were reduced. The frequency of naive T cell-derived Foxp3(+) cells in the colon increased in the absence of IL-23, indicating a role for IL-23 in controlling regulatory T cell induction. Foxp3-deficient T cells induced colitis when transferred into recipients lacking IL-23p19, showing that IL-23 was not essential for intestinal inflammation in the absence of Foxp3. Taken together, our data indicate that overriding immunosuppressive pathways is an important function of IL-23 in the intestine and could influence not only Th17 cell activity but also other types of immune responses.	[Izcue, Ana; Hue, Sophie; Buonocore, Sofia; Arancibia-Carcamo, Carolina V.; Ahern, Philip P.; Maloy, Kevin J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan	University of Oxford; University of Tokyo	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	fiona.powrie@path.ox.ac.uk	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Izcue, Ana/0000-0002-7974-7451; Maloy, Kevin/0000-0001-5795-7688; HUE, Sophie/0000-0002-2530-7346				Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DASCH JR, 1989, J IMMUNOL, V142, P1536; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kim HR, 2007, RHEUMATOLOGY, V46, P57, DOI 10.1093/rheumatology/kel159; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Noguchi D, 2007, INT IMMUNOL, V19, P1431, DOI 10.1093/intimm/dxm114; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wang W, 2007, J IMMUNOL, V178, P7072, DOI 10.4049/jimmunol.178.11.7072; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	55	291	315	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					559	570		10.1016/j.immuni.2008.02.019	http://dx.doi.org/10.1016/j.immuni.2008.02.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400195	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-18	WOS:000254939400016
J	Deftos, ML; Huang, E; Ojala, EW; Forbush, KA; Bevan, MJ				Deftos, ML; Huang, E; Ojala, EW; Forbush, KA; Bevan, MJ			Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes	IMMUNITY			English	Article							T-CELL-RECEPTOR; DROSOPHILA NOTCH; ANKYRIN REPEATS; MELTRIN-BETA; ALPHA-BETA; EXPRESSION; GENE; LINEAGE; MICE; THYMUS	Notch proteins regulate many developmental processes. Notch1 is highly expressed on thymocytes, but its role in regulating their development is not known. We show that activation of Notch1 signaling in CD4(+)CD8(+) double positive thymocytes promotes the maturation of both CD4(+) and CD8(+) single positive thymocytes and that this occurs in the absence of interactions between the T cell receptor and MHC molecules expressed on thymic epithelial cells. We have also identified several genes that are transcriptionally regulated by Notch1 in T cells and show that they are upregulated during maturation into both single positive lineages. These observations suggest that Notch1 signaling plays a role in promoting maturation into both the CD4 and CD8 T cell lineages.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.				Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009537-13, CA09537, T32 CA009537] Funding Source: Medline; NIAID NIH HHS [R01 AI029802-11, R01 AI029802, AI29802] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029802] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bruno L, 1999, CURR BIOL, V9, P559, DOI 10.1016/S0960-9822(99)80259-0; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; HYMAN R, 1980, IMMUNOGENETICS, V10, P261, DOI 10.1007/BF01561574; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Itoh M, 1999, J IMMUNOL, V162, P5317; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Johnstone RW, 1999, MOL CELL BIOL, V19, P5833; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Osborne B, 1999, IMMUNITY, V11, P653, DOI 10.1016/S1074-7613(00)80140-5; Pampeno CL, 1996, CELL GROWTH DIFFER, V7, P1113; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TANNENBAUM CS, 1993, J LEUKOCYTE BIOL, V53, P563, DOI 10.1002/jlb.53.5.563; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7	43	291	297	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					73	84		10.1016/S1074-7613(00)00009-1	http://dx.doi.org/10.1016/S1074-7613(00)00009-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933396	Green Accepted, Bronze			2022-12-18	WOS:000088463600008
J	VanParijs, L; Ibraghimov, A; Abbas, AK				VanParijs, L; Ibraghimov, A; Abbas, AK			The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance	IMMUNITY			English	Article							LYMPHOCYTES-T; ANERGY; ANTIGEN	Using cells from TCR transgenic mice that do or do not express Fas, we show that there are two mechanistically distinct forms of apoptosis in CD4(+) T cells. Naive T cells undergo apoptosis if cultured in the absence of antigen or costimulation. This form of programmed cell death (PCD) is not dependent on Fas, and is prevented by CD28-mediated signals, which lead to the secretion of growth factors and the expression of survival genes, such as bcl-x(L). Recently activated T cells undergo apoptotic death upon repeated stimulation. This activation-induced cell death (AICD) is mediated by Fas, but is independent of costimulation and is not prevented by IL-2 or bcl-x(L). Finally, we show that peripheral tolerance may be induced in vivo independent of Fas-mediated cell death.	BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV IMMUNOL RES,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NHLBI NIH HHS [HL07627] Funding Source: Medline; NIAID NIH HHS [P01AI35297, R01AI32531] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032531, P01AI035297] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; BURSTEIN HJ, 1993, J EXP MED, V177, P457, DOI 10.1084/jem.177.2.457; BURSTEIN HJ, 1992, J IMMUNOL, V148, P3687; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; DASPRABHU MR, 1995, EUR J IMMUNOL, V25, P207; DEWIT D, 1992, J EXP MED, V175, P9, DOI 10.1084/jem.175.1.9; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; FANG W, 1994, J IMMUNOL, V153, P4388; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GREEN DR, 1994, CURR OPIN IMMUNOL, V6, P476, DOI 10.1016/0952-7915(94)90130-9; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; JU ST, 1995, NATURE, V373, P441; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P5220; MEMON SA, 1995, J IMMUNOL, V155, P4644; MILLER JFAP, 1994, CURR OPIN IMMUNOL, V6, P892, DOI 10.1016/0952-7915(94)90010-8; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NUNEZ G, 1994, IMMUNOL TODAY, V15, P582, DOI 10.1016/0167-5699(94)90221-6; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; RUSSELL JH, 1995, CURR OPIN IMMUNOL, V7, P382, DOI 10.1016/0952-7915(95)80114-6; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; STRASSER A, 1996, IN PRESS EMBO J; VIDARD L, 1994, P NATL ACAD SCI USA, V91, P5627, DOI 10.1073/pnas.91.12.5627; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; YUH K, 1993, INT IMMUNOL, V5, P1375, DOI 10.1093/intimm/5.11.1375	36	291	294	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					321	328		10.1016/S1074-7613(00)80440-9	http://dx.doi.org/10.1016/S1074-7613(00)80440-9			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624822	Bronze			2022-12-18	WOS:A1996UC01800013
J	Gough, DJ; Messina, NL; Clarke, CJP; Johnstone, RW; Levy, DE				Gough, Daniel J.; Messina, Nicole L.; Clarke, Christopher J. P.; Johnstone, Ricky W.; Levy, David E.			Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic Signaling	IMMUNITY			English	Review							NF-KAPPA-B; HEMATOPOIETIC STEM-CELLS; IFN-ALPHA-BETA; DENDRITIC CELLS; DOWN-REGULATION; NATURAL-KILLER; EXPRESSION INFLUENCES; POSITIVE FEEDBACK; ISGF3 COMPONENTS; MELANOMA-CELLS	Interferons (IFNs) were discovered as cytokines induced during and protecting from viral infection. They have been documented to play essential roles in numerous physiological processes beyond antiviral and antimicrobial defense, including immunomodulation, cell cycle regulation, cell survival, and cell differentiation. Recent data have also uncovered a potentially darker side to IFN, including roles in inflammatory diseases, such as autoimmunity and diabetes. IFN can have effects in the absence of acute infection, highlighting a physiologic role for constitutive IFN. Type I IFNs are constitutively produced at vanishingly low quantities and yet exert profound effects, mediated in part through modulation of signaling intermediates required for responses to diverse cytokines. We review evidence for a yin-yang of IFN function through its role in modulating crosstalk between multiple cytokines by both feedforward and feedback regulation of common signaling intermediates and postulate a homeostatic role for IFN through tonic signaling in the absence of acute infection.	[Messina, Nicole L.; Clarke, Christopher J. P.; Johnstone, Ricky W.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Gough, Daniel J.; Levy, David E.] NYU, Med Ctr, New York, NY 10016 USA; [Messina, Nicole L.; Johnstone, Ricky W.] Univ Melbourne, Parkville, Vic 3054, Australia	Peter Maccallum Cancer Center; New York University; University of Melbourne	Johnstone, RW (corresponding author), Peter MacCallum Canc Ctr, St Andrews Pl, Melbourne, Vic 3002, Australia.	ricky.johnstone@petermac.org; david.levy@nyumc.org	Johnstone, Ricky w/H-3748-2014; Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Johnstone, Ricky w/0000-0001-7053-9237; Levy, David/0000-0002-7320-7788; Gough, Daniel/0000-0001-6479-1735; Messina, Nicole/0000-0001-8404-4462; Gough, Daniel/0000-0001-5725-8668	Leukemia and Lymphoma society; Cancer Research Institute Predoctoral Emphasis in Tumor Immunology Scholarship; NHMRC; Susan G. Komen Breast Cancer Foundation; Prostate Cancer Foundation of Australia, Cancer Council Victoria; Leukemia Foundation of Australia, Victorian Breast Cancer Research Consortium, Victorian Cancer Agency; Australian Rotary Health Foundation; National Institutes of Health [R01Al28900, U54AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900, U54AI057158] Funding Source: NIH RePORTER	Leukemia and Lymphoma society(Leukemia and Lymphoma Society); Cancer Research Institute Predoctoral Emphasis in Tumor Immunology Scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Prostate Cancer Foundation of Australia, Cancer Council Victoria; Leukemia Foundation of Australia, Victorian Breast Cancer Research Consortium, Victorian Cancer Agency; Australian Rotary Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.J.G. is supported by a Special Fellow award from the Leukemia and Lymphoma society. N.L.M. is supported by a Cancer Research Institute Predoctoral Emphasis in Tumor Immunology Scholarship. R.W.J. is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC) and is supported by NHMRC Program and Project Grants, the Susan G. Komen Breast Cancer Foundation, the Prostate Cancer Foundation of Australia, Cancer Council Victoria, The Leukemia Foundation of Australia, Victorian Breast Cancer Research Consortium, Victorian Cancer Agency, and the Australian Rotary Health Foundation. D.E.L. acknowledges funding from the National Institutes of Health (R01Al28900, U54AI057158).	Arakura F, 2007, J IMMUNOL, V179, P3249, DOI 10.4049/jimmunol.179.5.3249; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; BILLARD C, 1986, BLOOD, V67, P821; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; BOCCI V, 1980, MED HYPOTHESES, V6, P735, DOI 10.1016/0306-9877(80)90091-2; Buttmann Mathias, 2007, Expert Rev Neurother, V7, P227, DOI 10.1586/14737175.7.3.227; Chen HM, 2009, CANCER SCI, V100, P449, DOI 10.1111/j.1349-7006.2008.01051.x; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; COLAMONICI OR, 1992, BLOOD, V80, P744; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; de Souza EP, 2001, CLIN RHEUMATOL, V20, P297, DOI 10.1007/PL00011206; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dikopoulos N, 2005, J IMMUNOL, V174, P99, DOI 10.4049/jimmunol.174.1.99; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; GRESSER I, 1990, J INVEST DERMATOL, V95, pS66, DOI 10.1111/1523-1747.ep12874776; Hamilton JA, 1996, J IMMUNOL, V156, P2553; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; HEYMAN M, 1994, LEUKEMIA, V8, P425; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lesinski GB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-142; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Li Z, 2004, J INVEST DERMATOL, V123, P737, DOI 10.1111/j.0022-202X.2004.23408.x; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lu Q, 2007, GENES IMMUN, V8, P590, DOI 10.1038/sj.gene.6364421; Mack EA, 2011, MBIO, V2, DOI 10.1128/mBio.00169-11; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nacionales DC, 2007, ARTHRITIS RHEUM, V56, P3770, DOI 10.1002/art.23023; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; PFEFFER LM, 1990, CANCER RES, V50, P2654; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Tak PP, 2004, FRONT BIOSCI-LANDMRK, V9, P3242, DOI 10.2741/1475; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; TOVEY MG, 1987, P NATL ACAD SCI USA, V84, P5038, DOI 10.1073/pnas.84.14.5038; van der Fits L, 2003, J PATHOL, V199, P107, DOI 10.1002/path.1263; VITI A, 1985, J APPL PHYSIOL, V59, P426, DOI 10.1152/jappl.1985.59.2.426; VOGEL SN, 1984, INFECT IMMUN, V45, P417, DOI 10.1128/IAI.45.2.417-423.1984; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Wong LH, 1998, J IMMUNOL, V160, P5475; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Xiao WH, 2000, BBA-GENE STRUCT EXPR, V1492, P163, DOI 10.1016/S0167-4781(00)00111-1; YAAR M, 1986, J CELL BIOL, V103, P1349, DOI 10.1083/jcb.103.4.1349; Yamazaki M, 2010, INTERNAL MED, V49, P403, DOI 10.2169/internalmedicine.49.2656; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	99	290	295	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 24	2012	36	2					166	174		10.1016/j.immuni.2012.01.011	http://dx.doi.org/10.1016/j.immuni.2012.01.011			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365663	Green Accepted, Bronze			2022-12-18	WOS:000300812400006
J	Barton, K; Muthusamy, N; Fischer, C; Ting, CN; Walunas, TL; Lanier, LL; Leiden, JM				Barton, K; Muthusamy, N; Fischer, C; Ting, CN; Walunas, TL; Lanier, LL; Leiden, JM			The Ets-1 transcription factor is required for the development of natural killer cells in mice	IMMUNITY			English	Article							MARROW GRAFT-REJECTION; SIGNAL-TRANSDUCTION; DIFFERENTIATION; IDENTIFICATION; LYMPHOCYTES; ACTIVATION; PROGENITOR; THYMOCYTES; PRECURSORS; RESPONSES	In this report we have investigated the role of the Ets-1 transcription factor in the differentiation of the NK cell lineage in mice. Splenic NK cells express high levels of Ets-1. Ets-1-deficient mice produced by gene targeting developed mature erythrocytes, monocytes, neutrophils, and T and B lymphocytes. However, spleens from the Ets-1-deficient mice contained significantly reduced numbers of natural killer (NK) cells, and splenocytes from these mice lacked detectable cytolytic activity against NK cell targets in vitro. Moreover, unlike wild-type animals, Ets-1-deficient mice developed tumors following subcutaneous injection of NK susceptible RMA-S cells. These NK cell defects could not be correlated with defects in the expression of IL-12, IL-15, and IL-18 or the IL-2 or IL-15 receptors. Thus, Ets-1 defines a novel transcriptional pathway that is required for the development of the NK cell lineage in mice.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA	University of Chicago; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Leiden, JM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jleiden@medicine.bsd.uchicago.edu	Lanier, Lewis L/E-2139-2014; Muthusamy, Natarajan/A-6915-2009	Lanier, Lewis L/0000-0003-1308-3952; Walunas, Theresa/0000-0002-7653-3650				BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CHAN SH, 1992, J IMMUNOL, V148, P92; CREPIEUX P, 1994, CRIT REV ONCOGENESIS, V5, P615; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; KALLAND T, 1986, IMMUNOLOGY, V57, P493; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Lanier LL, 1998, CELL, V92, P705, DOI 10.1016/S0092-8674(00)81398-7; Lanier LL, 1997, IMMUNITY, V6, P371, DOI 10.1016/S1074-7613(00)80280-0; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Moore TA, 1996, IMMUNOL RES, V15, P151, DOI 10.1007/BF02918504; MURPHY WJ, 1993, JNCI-J NATL CANCER I, V85, P1475, DOI 10.1093/jnci/85.18.1475; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Ogasawara K, 1998, NATURE, V391, P700, DOI 10.1038/35636; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Puzanov IJ, 1996, J IMMUNOL, V157, P4282; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	36	290	300	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					555	563		10.1016/S1074-7613(00)80638-X	http://dx.doi.org/10.1016/S1074-7613(00)80638-X			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806641	Bronze			2022-12-18	WOS:000076680700013
J	KOJIMA, H; SHINOHARA, N; HANAOKA, S; SOMEYASHIROTA, Y; TAKAGAKI, Y; OHNO, H; SAITO, T; KATAYAMA, T; YAGITA, H; OKUMURA, K; SHINKAI, Y; ALT, FW; MATSUZAWA, A; YONEHARA, S; TAKAYAMA, H				KOJIMA, H; SHINOHARA, N; HANAOKA, S; SOMEYASHIROTA, Y; TAKAGAKI, Y; OHNO, H; SAITO, T; KATAYAMA, T; YAGITA, H; OKUMURA, K; SHINKAI, Y; ALT, FW; MATSUZAWA, A; YONEHARA, S; TAKAYAMA, H			2 DISTINCT PATHWAYS OF SPECIFIC KILLING REVEALED BY PERFORIN MUTANT CYTOTOXIC T-LYMPHOCYTES	IMMUNITY			English	Article							TARGET-CELL LYSIS; TUMOR-NECROSIS-FACTOR; CYTOLYTIC LYMPHOCYTES; MONOCLONAL-ANTIBODY; MEDIATED CYTOLYSIS; CLASS-I; GENE; ANTIGEN; EXPRESSION; CLONES	To study the contribution of putative perforin-independent mechanism in the antigen-specific target destruction by cytotoxic T lymphocytes, CD8(+) CTL lines were established from spleen cells of chimeric mice produced by injecting perforin (-/-) embryonic stem cells into blastocysts of RAG-2(-/-) mice. When tested on normal concanavalin A blasts, these perforin-deficient cytotoxic T lymphocyte lines were found to be capable of inducing antigen-specific target cell lysis accompanied by DNA degradation. In contrast, with target cells carrying a mutation in Fas molecule, perforin-independent cytotoxicity was not detectable. These data not only confirmed the primary role of perforin but simultaneously revealed a major contribution of a perforin-independent Fas-mediated pathway in antigen-specific cytolysis.	SCI UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PATHOPHYSIOL,SHINJUKU KU,TOKYO 162,JAPAN; MITSUBISHI KASEI INST LIFE SCI,MOLEC IMMUNOL LAB,MACHIDA,TOKYO 194,JAPAN; CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC GENET,CHUO KU,CHIBA 260,JAPAN; JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN; CHILDRENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; UNIV TOKYO,INST MED SCI,LAB ANIM RES CTR,MINATO KU,TOKYO 108,JAPAN; JT INC,PHARMACEUT BASIC RES LABS,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN	Tokyo University of Science; Chiba University; Juntendo University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Tokyo	KOJIMA, H (corresponding author), MITSUBISHI KASEI INST LIFE SCI,CELLULAR IMMUNOL LAB,11 MINAMIOOYA,MACHIDA,TOKYO 194,JAPAN.		Ohno, Hiroshi/L-7899-2014; Shinkai, Yoichi/N-3909-2014; Saito, Takashi/C-9684-2009	Ohno, Hiroshi/0000-0001-8776-9661; Shinkai, Yoichi/0000-0002-6051-2484; Saito, Takashi/0000-0001-9495-3547	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI020047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BEER JZ, 1983, CANCER RES, V43, P4736; BERKE G, 1993, IMMUNOLOGY, V78, P105; BERKE G, 1989, FUNDAMENTAL IMMUNOLO, P735; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; GRUSBY MJ, 1990, CELL, V60, P451, DOI 10.1016/0092-8674(90)90596-7; HANABUCHI S, 1994, P NATL ACAD SCI USA, V91, P4930, DOI 10.1073/pnas.91.11.4930; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; LANCKI DW, 1991, J IMMUNOL, V146, P3242; LICHTENHELD MG, 1992, J IMMUNOL, V149, P2619; LIU CC, 1987, CELL, V51, P393, DOI 10.1016/0092-8674(87)90635-0; MAIMONE MM, 1986, J IMMUNOL, V137, P3639; MATSUZAWA A, 1990, J EXP MED, V171, P519, DOI 10.1084/jem.171.2.519; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; OJCIUS DM, 1991, P NATL ACAD SCI USA, V88, P4621, DOI 10.1073/pnas.88.11.4621; OSTERGAARD HL, 1987, NATURE, V330, P71, DOI 10.1038/330071a0; OSTERGAARD HL, 1989, J IMMUNOL, V143, P2120; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; RUSSELL JH, 1980, J IMMUNOL, V125, P1256; SHINKAI Y, 1988, EUR J IMMUNOL, V18, P29, DOI 10.1002/eji.1830180106; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SHINOHARA N, 1991, EUR J IMMUNOL, V21, P23, DOI 10.1002/eji.1830210105; SHINOHARA N, 1988, NATURE, V336, P481, DOI 10.1038/336481a0; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; STRACK P, 1990, EUR J IMMUNOL, V20, P179, DOI 10.1002/eji.1830200126; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAYAMA H, 1991, INT IMMUNOL, V3, P1149, DOI 10.1093/intimm/3.11.1149; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; TRENN G, 1987, NATURE, V330, P72, DOI 10.1038/330072a0; TSCHOPP J, 1990, ANNU REV IMMUNOL, V8, P279, DOI 10.1146/annurev.immunol.8.1.279; VERRET CR, 1987, J EXP MED, V166, P1536, DOI 10.1084/jem.166.5.1536; VIRGILIO FD, 1989, J IMMUNOL, V143, P1955; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEI WZ, 1981, J IMMUNOL, V126, P513; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; YOUN BS, 1991, J EXP MED, V173, P813, DOI 10.1084/jem.173.4.813; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	44	290	294	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					357	364		10.1016/1074-7613(94)90066-3	http://dx.doi.org/10.1016/1074-7613(94)90066-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7533644				2022-12-18	WOS:A1994PK16800004
J	Yoshida, H; Nishina, H; Takimoto, H; Marengere, LEM; Wakeham, AC; Bouchard, D; Kong, YY; Ohteki, T; Shahinian, A; Bachmann, M; Ohashi, PS; Penninger, JM; Crabtree, GR; Mak, TW				Yoshida, H; Nishina, H; Takimoto, H; Marengere, LEM; Wakeham, AC; Bouchard, D; Kong, YY; Ohteki, T; Shahinian, A; Bachmann, M; Ohashi, PS; Penninger, JM; Crabtree, GR; Mak, TW			The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production	IMMUNITY			English	Article							T-CELL DEVELOPMENT; NF-AT; CYCLOSPORINE-A; NUCLEAR FACTOR; GENE-EXPRESSION; MICE LACKING; ACTIVATION; FAMILY; IL-4; INTERLEUKIN-4	NF-ATc1 is a member of a family of genes that encodes the cytoplasmic component of the nuclear factor of activated T cells (NF-AT). In activated T cells, nuclear NF-AT binds to the promoter regions of multiple cytokine genes and induces their transcription. The role of NF-ATc1 was investigated in recombination activating gene-1 (RAG-1)-deficient blastocyst complementation assays using homozygous NF-ATc1(-/-) mutant ES cell lines. NF-ATc1(-/-)/RAG-1(-/-) chimeric mice showed reduced numbers of thymocytes and impaired proliferation of peripheral lymphocytes, but normal production of IL-2. Induction in vitro of Th2 responses, as demonstrated by a decrease in IL-4 and IL-6 production, was impaired in mutant T cells. These data indicate that NF-ATc1 plays roles in the development of T lymphocytes and in the differentiation of the Th2 response.	Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2C1, Canada; Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Dev Biol,Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Stanford University; Howard Hughes Medical Institute; Stanford University	Mak, TW (corresponding author), Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Ohashi, Pamela S./0000-0003-2915-9317				Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; CARDING SR, 1991, IMMUNOL TODAY, V12, P239, DOI 10.1016/0167-5699(91)90037-T; CHEN JZ, 1994, CURR OPIN IMMUNOL, V6, P313, DOI 10.1016/0952-7915(94)90107-4; CHEN JZ, 1994, IMMUNITY, V1, P65, DOI 10.1016/1074-7613(94)90010-8; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Clevers HC, 1996, IMMUNOL TODAY, V17, P336, DOI 10.1016/0167-5699(96)10019-0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Galandrini R, 1997, IMMUNITY, V7, P163, DOI 10.1016/S1074-7613(00)80519-1; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Liu J, 1997, MOL BIOL CELL, V8, P157, DOI 10.1091/mbc.8.1.157; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Paul WE, 1997, CIBA F SYMP, V204, P208; PENIT C, 1995, J IMMUNOL, V154, P5103; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rincon M, 1997, BIOCHEM SOC T, V25, P347, DOI 10.1042/bst0250347; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SEN J, 1994, J EXP MED, V180, P2321, DOI 10.1084/jem.180.6.2321; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; ZLOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206, DOI 10.1016/0952-7915(95)80005-0; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	62	289	292	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	1998	8	1					115	124		10.1016/S1074-7613(00)80464-1	http://dx.doi.org/10.1016/S1074-7613(00)80464-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462517	Bronze			2022-12-18	WOS:000071765700012
J	Croxford, AL; Lanzinger, M; Hartmann, FJ; Schreiner, B; Mair, F; Pelczar, P; Clausen, BE; Jung, S; Greter, M; Becher, B				Croxford, Andrew L.; Lanzinger, Margit; Hartmann, Felix J.; Schreiner, Bettina; Mair, Florian; Pelczar, Pawel; Clausen, Bjoern E.; Jung, Steffen; Greter, Melanie; Becher, Burkhard			The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2(+) Monocytes and Licenses Autoimmunity	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; T-CELLS; MULTIPLE-SCLEROSIS; EFFECTOR PHASE; MACROPHAGES; CNS; ENCEPHALOMYELITIS; IMMUNE; DIFFERENTIATION	Granulocyte-macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine produced by auto-reactive T helper (Th) cells that initiate tissue inflammation. Multiple cell types can sense GM-CSF, but the identity of the pathogenic GM-CSF-responsive cells is unclear. By using conditional gene targeting, we systematically deleted the GM-CSF receptor (Csf2rb) in specific subpopulations throughout the myeloid lineages. Experimental autoimmune encephalomyelitis (EAE) progressed normally when either classical dendritic cells (cDCs) or neutrophils lacked GM-CSF responsiveness. The development of tissue-invading monocyte-derived dendritic cells (moDCs) was also unperturbed upon Csf2rb deletion. Instead, deletion of Csf2rb in CCR2(+) Ly6C(hi) monocytes phenocopied the EAE resistance seen in complete Csf2rb-deficient mice. High-dimensional analysis of tissue-infiltrating moDCs revealed that GM-CSF initiates a combination of inflammatory mechanisms. These results indicate that GM-CSF signaling controls a pathogenic expression signature in CCR2(+)Ly6C(hi) monocytes and their progeny, which was essential for tissue damage.	[Croxford, Andrew L.; Lanzinger, Margit; Hartmann, Felix J.; Schreiner, Bettina; Mair, Florian; Pelczar, Pawel; Greter, Melanie; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Clausen, Bjoern E.] Johannes Gutenberg Univ Mainz, Inst Mol Med, D-55131 Mainz, Germany; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	University of Zurich; Johannes Gutenberg University of Mainz; Weizmann Institute of Science	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; CLAUSEN, Björn Erik/A-8229-2010; Jung, Steffen/K-1409-2012	Becher, Burkhard/0000-0002-1541-7867; CLAUSEN, Björn Erik/0000-0002-2484-7842; Jung, Steffen/0000-0003-4290-5716; Greter, Melanie/0000-0002-7220-5369; Hartmann, Felix/0000-0002-4174-2276; Mair, Florian/0000-0001-6732-5449	Swiss national science foundation [PP00P3_144781, 310030_146130, 316030_150768]; European Union, FP7 ITN_NeuroKine; European Union FP7 project TargetBraIn [279017]; Swiss Multiple Sclerosis Society; University Priority Project Translational Cancer Research; EMBO Long term Fellowship [ALTF 508-2011]; Forschungskredit - University of Zurich	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); European Union, FP7 ITN_NeuroKine; European Union FP7 project TargetBraIn; Swiss Multiple Sclerosis Society; University Priority Project Translational Cancer Research; EMBO Long term Fellowship(European Molecular Biology Organization (EMBO)); Forschungskredit - University of Zurich	This work was supported by grants from the Swiss national science foundation (PP00P3_144781 to M.G., 310030_146130 and 316030_150768 to B.B.), the European Union, FP7 ITN_NeuroKine and the European Union FP7 project TargetBraIn (279017) (B.B.), the Swiss Multiple Sclerosis Society (B. B. and M.G.), and the University Priority Project Translational Cancer Research (B. B.). A.L.C. holds an EMBO Long term Fellowship (ALTF 508-2011) and was further supported by the Forschungskredit awarded by the University of Zurich. We thank Adriano Flora at TaconicArtemis for generating the Ccr2-creER<SUP>T2</SUP> mKate2 strain, Lennart Opitz and Anna Bratus for performing the NGS analysis at the Functional Genomics Centre Zurich (FGCZ), Carsten Krieg for the labeling of antibodies used in CyTOF analyses, and Jennifer Jaberg, Jan Candreia, and Sabrina Nemetz for technical support.	Amir A.D., 2013, NAT BIOTECHNOL, V31, P545; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Asensio VC, 1999, AM J PATHOL, V154, P1181, DOI 10.1016/S0002-9440(10)65370-9; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becher B, 2012, EUR J IMMUNOL, V42, P2551, DOI 10.1002/eji.201242928; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bordon Y, 2012, NAT REV IMMUNOL, V12, P477, DOI 10.1038/nri3248; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cotsapas C, 2013, TRENDS IMMUNOL, V34, P22, DOI 10.1016/j.it.2012.09.001; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Forde EA, 2011, J NEUROIMMUNOL, V236, P17, DOI 10.1016/j.jneuroim.2011.04.008; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gomez JMM, 2012, J NEUROSCI, V32, P18246, DOI 10.1523/JNEUROSCI.2473-12.2012; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gyulveszi G, 2009, EUR J IMMUNOL, V39, P1864, DOI 10.1002/eji.200939305; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kroenke MA, 2010, EUR J IMMUNOL, V40, P2340, DOI 10.1002/eji.201040489; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Rottman JB, 2000, EUR J IMMUNOL, V30, P2372, DOI 10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wumesh KC, 2014, NATURE, V507, P243, DOI 10.1038/nature12967; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880	56	288	293	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					502	514		10.1016/j.immuni.2015.08.010	http://dx.doi.org/10.1016/j.immuni.2015.08.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26341401	Bronze			2022-12-18	WOS:000370965900003
J	Cui, TX; Kryczek, I; Zhao, LL; Zhao, ED; Kuick, R; Roh, MH; Vatan, L; Szeliga, W; Mao, YJ; Thomas, DG; Kotarski, J; Tarkowski, R; Wicha, M; Cho, K; Giordano, T; Liu, R; Zou, WP				Cui, Tracy X.; Kryczek, Ilona; Zhao, Lili; Zhao, Ende; Kuick, Rork; Roh, Michael H.; Vatan, Linda; Szeliga, Wojciech; Mao, Yujun; Thomas, Dafydd G.; Kotarski, Jan; Tarkowski, Rafal; Wicha, Max; Cho, Kathleen; Giordano, Thomas; Liu, Rebecca; Zou, Weiping			Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2	IMMUNITY			English	Article							BREAST-CANCER; T-CELLS; OVARIAN-CARCINOMA; PROSTATE-CANCER; IMMUNE-SYSTEM; METASTASIS; EXPRESSION; SURVIVAL; PROGENITORS; PRINCIPLES	Myeloid-derived suppressor cells (MDSCs) and cancer stem cells (CSCs) are important cellular components in the cancer microenvironment and may affect cancer phenotype and patient outcome. The nature of MDSCs and their interaction with CSCs in ovarian carcinoma are unclear. We examined the interaction between MDSCs and CSCs in patients with ovarian carcinoma and showed that MDSCs inhibited T cell activation and enhanced CSC gene expression, sphere formation, and cancer metastasis. MDSCs triggered miRNA101 expression in cancer cells. miRNA101 subsequently repressesed the corepressor gene C-terminal binding protein-2 (CtBP2), and CtBP2 directly targeted stem cell core genes resulting in increased cancer cell stemness and increasing metastatic and tumorigenic potential. Increased MDSC density and tumor microRNA101 expression predict poor survival, as does decreased tumor CtBP2 expression, independent of each other. Collectively, our work identifies an immune-associated cellular, molecular, and clinical network involving MDSCs-microRNA101-CtBP2-stem cell core genes, which extrinsically controls cancer stemness and impacts patient outcome.	[Cui, Tracy X.; Kryczek, Ilona; Zhao, Ende; Vatan, Linda; Szeliga, Wojciech; Mao, Yujun; Zou, Weiping] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Zhao, Lili] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Roh, Michael H.; Thomas, Dafydd G.; Cho, Kathleen; Giordano, Thomas] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Wicha, Max] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; [Liu, Rebecca] Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Kuick, Rork] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Zou, Weiping] Univ Michigan, Grad Program Tumor Biol, Ann Arbor, MI 48109 USA; [Kotarski, Jan; Tarkowski, Rafal] Med Univ Lublin, Dept Gynecol Oncol & Gynecol 1, PL-20081 Lublin, Poland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical University of Lublin	Zou, WP (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	wzou@med.umich.edu	Wicha, Max/AAE-7268-2019; Zhao, Ende/B-9851-2013; Tarkowski, Rafał/GQQ-9740-2022	Zhao, Ende/0000-0002-1355-6919; Giordano, Thomas/0000-0003-0641-8873; Cho, Kathleen/0000-0003-0500-9998	National Institutes of Health [CA123088, CA099985, CA156685, CA171306, 5P30CA46592]; Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA156685, R01CA171306, R01CA099985, R01CA123088, R01CA152470, R01CA193136, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported (in part) by the National Institutes of Health grants (CA123088, CA099985, CA156685, CA171306, 5P30CA46592), the Ovarian Cancer Research Fund, and Marsha Rivkin Center for Ovarian Cancer Research. We thank D. Postiff, M. Vinco, R. Craig, and J. Barikdar in the tissue procurement core for their technical assistance.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cui TX, 2008, J ENDOCRINOL, V196, P89, DOI 10.1677/JOE-07-0169; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kryczek I, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002949; Kryczek I, 2012, INT J CANCER, V130, P29, DOI 10.1002/ijc.25967; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.1093/biomet/80.3.557; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tarleton HP, 2010, MECH DEVELOP, V127, P107, DOI 10.1016/j.mod.2009.10.002; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	44	288	296	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					611	U222		10.1016/j.immuni.2013.08.025	http://dx.doi.org/10.1016/j.immuni.2013.08.025			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012420	Green Accepted, Bronze			2022-12-18	WOS:000330949600022
J	Jiang, XM; Kinch, LN; Brautigam, CA; Chen, X; Du, FH; Grishin, NV; Chen, ZJJ				Jiang, Xiaomo; Kinch, Lisa N.; Brautigam, Chad A.; Chen, Xiang; Du, Fenghe; Grishin, Nick V.; Chen, Zhijian J.			Ubiquitin-Induced Oligomerization of the RNA Sensors RIG-I and MDA5 Activates Antiviral Innate Immune Response	IMMUNITY			English	Article							RECOGNITION; BINDING; COMPLEXES; REVEALS; PATHWAY	RIG-I and MDA5 detect viral RNA in the cytoplasm and activate signaling cascades leading to the production of type-I interferons. RIG-I is activated through sequential binding of viral RNA and unanchored lysine-63 (K63) polyubiquitin chains, but how polyubiquitin activates RIG-I and whether MDA5 is activated through a similar mechanism remain unresolved. Here, we showed that the CARD domains of MDA5 bound to K63 polyubiquitin and that this binding was essential for MDA5 to activate the transcription factor IRF3. Mutations of conserved residues in MDA5 and RIG-I that disrupt their ubiquitin binding also abrogated their ability to activate IRF3. Polyubiquitin binding induced the formation of a large complex consisting of four RIG-I and four ubiquitin chains. This hetero-tetrameric complex was highly potent in activating the antiviral signaling cascades. These results suggest a unified mechanism of RIG-I and MDA5 activation and reveal a unique mechanism by which ubiquitin regulates cell signaling and immune response.	[Jiang, Xiaomo; Chen, Xiang; Du, Fenghe; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Xiang; Du, Fenghe; Grishin, Nick V.; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa N.; Brautigam, Chad A.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Brautigam, Chad/0000-0001-6563-1338; Kinch, Lisa/0000-0003-3041-2615	NIH [RO1-GM063692, RO1-AI093967]; Cancer Prevention and Research Institute of Texas [RP110430]; Welch Foundation [I-1389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM063692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jung (University of Southern California) for providing some of the RIG-I mutant plasmids and Trim 25-deficient MEFs, and S. Akira (Osaka University) for the Ubc13<SUP>fI/fI</SUP> mice. This work was supported by grants from NIH (RO1-GM063692 and RO1-AI093967), Cancer Prevention and Research Institute of Texas (RP110430) and the Welch Foundation (I-1389).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	23	288	293	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					959	973		10.1016/j.immuni.2012.03.022	http://dx.doi.org/10.1016/j.immuni.2012.03.022			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22705106	Green Accepted, Bronze			2022-12-18	WOS:000306097100014
J	Szanto, A; Balint, BL; Nagy, ZS; Barta, E; Balazs, D; Pap, A; Szeles, L; Poliska, S; Oros, M; Evans, RM; Barak, Y; Schwabe, J; Nagy, L				Szanto, Attila; Balint, Balint L.; Nagy, Zsuzsanna S.; Barta, Endre; Balazs Dezso; Pap, Attila; Szeles, Lajos; Poliska, Szilard; Oros, Melinda; Evans, Ronald M.; Barak, Yaacov; Schwabe, John; Nagy, Laszlo			STAT6 Transcription Factor Is a Facilitator of the Nuclear Receptor PPAR gamma-Regulated Gene Expression in Macrophages and Dendritic Cells	IMMUNITY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MYELOID CELLS; FATTY-ACIDS; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; OXIDIZED LDL; DIFFERENTIATION; REVEALS; ALPHA; TRANSREPRESSION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a lipid-activated transcription factor regulating lipid metabolism and inflammatory response in macrophages and dendritic cells (DCs). These immune cells exposed to distinct inflammatory milieu show cell type specification as a result of altered gene expression. We demonstrate here a mechanism how inflammatory molecules modulate PPAR gamma signaling in distinct subsets of cells. Proinflammatory molecules inhibited whereas interleukin-4 (IL-4) stimulated PPAR gamma activity in macrophages and DCs. Furthermore, IL-4 signaling augmented PPAR gamma activity through an interaction between PPAR gamma and signal transducer and activators of transcription 6 (STAT6) on promoters of PPAR gamma target genes, including FABP4. Thus, STAT6 acts as a facilitating factor for PPAR gamma by promoting DNA binding and consequently increasing the number of regulated genes and the magnitude of responses. This interaction, underpinning cell type-specific responses, represents a unique way of controlling nuclear receptor signaling by inflammatory molecules in immune cells.	[Szanto, Attila; Balint, Balint L.; Nagy, Zsuzsanna S.; Barta, Endre; Pap, Attila; Szeles, Lajos; Poliska, Szilard; Oros, Melinda; Nagy, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Dept Biochem Mol Biol, H-4010 Debrecen, Hungary; [Nagy, Zsuzsanna S.; Barta, Endre; Szeles, Lajos; Nagy, Laszlo] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Apoptosis & Genom Res Grp,Hungarian Acad Sci, H-4010 Debrecen, Hungary; [Balazs Dezso] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pathol, H-4028 Debrecen, Hungary; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92093 USA; [Barak, Yaacov] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Barak, Yaacov] Univ Pittsburgh, Dept OBGYN & Reprod Sci, Pittsburgh, PA 15213 USA; [Schwabe, John] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; Howard Hughes Medical Institute; Salk Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Leicester	Nagy, L (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Dept Biochem Mol Biol, Egyetem Ter 1, H-4010 Debrecen, Hungary.	nagyl@med.unideb.hu	Evans, Ronald/AAF-4001-2019; Nagy, Laszlo/A-3814-2008; Schwabe, John WR/A-9132-2008; Szanto, Attila/B-2198-2012; Széles, Lajos/B-4165-2012; Barta, Endre/B-1166-2008	Evans, Ronald/0000-0002-9986-5965; Nagy, Laszlo/0000-0001-6653-2155; Schwabe, John WR/0000-0003-2865-4383; Barta, Endre/0000-0002-6753-0714; Balint, Balint/0000-0002-6163-7190; Szeles, Lajos/0000-0003-1206-8515; Dezso, Balazs/0000-0002-7871-0219	Wellcome Trust; Hungarian Science Research Fund OTKA [NK72730, OTKA/61814, OTKA F-68254]; Hungarian Academy of Sciences Bolyai Scholarships; University of Debrecen; NKTH-Baross [EA KFI EPIGEN08];  [TAMOP-4.2.2/08/1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, R24DK090962] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Science Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences Bolyai Scholarships; University of Debrecen; NKTH-Baross; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to L. Fariall (Univ. of Leicester, UK) for her help in EMSA experiments; M. Demeny for help with immunoprecipitation; and members of the L.N. laboratory for comments on the manuscript. We thank I. Furtos, M. Balogh, B. Menyhart, and A. Farkas for technical assistance. LW. is an International Scholar of HHMI and holds a Wellcome Trust Senior Research Fellowship in Biomedical Sciences. This work was supported by grants from the Hungarian Science Research Fund OTKA NK72730 to L.N., OTKA/61814 to A.S., and OTKA F-68254 to B.L.B.; Hungarian Academy of Sciences Bolyai Scholarships to A.S., E.B., and B.L.B.; from the University of Debrecen (Mecenatura) to A.S.; TAMOP-4.2.2/08/1 to L.N.; and NKTH-Baross EA KFI EPIGEN08 to L.N. and B.L.B.	Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cua DJ, 1997, J IMMUNOL, V159, P5834; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Guo XM, 2000, GENE, V251, P45, DOI 10.1016/S0378-1119(00)00192-X; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; Matsukura S, 1999, J IMMUNOL, V163, P6876; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; Szanto A, 2005, MOL PHARMACOL, V67, P1935, DOI 10.1124/mol.104.006445; Szatmari I, 2004, IMMUNITY, V21, P95, DOI 10.1016/j.immuni.2004.06.003; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0	43	288	309	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					699	712		10.1016/j.immuni.2010.11.009	http://dx.doi.org/10.1016/j.immuni.2010.11.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21093321	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000286082600009
J	Wang, LS; Li, L; Shojaei, F; Levac, K; Cerdan, C; Menendez, P; Martin, T; Rouleau, A; Bhatia, M				Wang, LS; Li, L; Shojaei, F; Levac, K; Cerdan, C; Menendez, P; Martin, T; Rouleau, A; Bhatia, M			Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties	IMMUNITY			English	Article							CORD BLOOD; DIFFERENTIATION; EXPRESSION; ERYTHROPOIESIS; PRECURSORS; RECEPTOR; PROTEIN; CULTURE; GROWTH; MOUSE	The cellular organization and relationships among precursors that initiate embryonic angiogenesis and hematopoiesis in the human have yet to be characterized. Here, we identify a subpopulation of primitive endothelial-like cells derived from human embryonic stem cells (hESCs) that express PECAM-1, Flk-1, and VE-cadherin, but not CD45 (CD45(neg)PFV cells), and that are uniquely responsible for endothelial and hematopoietic development. Molecular profiling of CD45(neg)PFV cells is consistent with endothelial and hematopoietic competency. Clonal isolation demonstrates that the CD45(neg)PFV population includes bipotent cells with endothelial and hematopoietic capacity. We suggest that human hematopoiesis and endothelial maturation originate exclusively from a subset of embryonic endothelium that possesses hemangioblastic properties and offers a model system to study these lineage relationships in the human.	John P Robarts Res Inst, Krembil Ctr Stem Cell Biol & Regenerat Med, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Bhatia, M (corresponding author), John P Robarts Res Inst, Krembil Ctr Stem Cell Biol & Regenerat Med, 100 Perth Dr, London, ON N6A 5K8, Canada.	mbhatia@robarts.ca	Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007				Bailey AS, 2003, EXP HEMATOL, V31, P987, DOI 10.1016/j.exphem.2003.07.001; Bhatia M, 1997, J EXP MED, V186, P619, DOI 10.1084/jem.186.4.619; Boldicke T, 2001, STEM CELLS, V19, P24, DOI 10.1634/stemcells.19-1-24; Breier G, 2000, ADV EXP MED BIOL, V476, P57; Casella I, 2003, BLOOD, V101, P1316, DOI 10.1182/blood-2002-07-2184; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi K, 1998, DEVELOPMENT, V125, P725; Eaves C, 1999, ANN NY ACAD SCI, V872, P1, DOI 10.1111/j.1749-6632.1999.tb08447.x; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fielder W, 1997, LEUKEMIA, V11, P1234, DOI 10.1038/sj.leu.2400722; Guo H, 2003, EXP HEMATOL, V31, P650, DOI 10.1016/S0301-472X(03)00087-0; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; Katz SG, 2003, P NATL ACAD SCI USA, V100, P14030, DOI 10.1073/pnas.1936250100; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Neumuller J, 1997, Methods Mol Biol, V75, P399; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RAGHAVACHARI NBP, 2002, AMBION TECHNOTES, V9, P13; Schulze D, 2000, IMECHE CONF TRANS, V2000, P97; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Wood HB, 1997, BLOOD, V90, P2300; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	31	288	319	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					31	41		10.1016/j.immuni.2004.06.006	http://dx.doi.org/10.1016/j.immuni.2004.06.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345218	Bronze			2022-12-18	WOS:000222975500006
J	Duerkop, BA; Vaishnava, S; Hooper, LV				Duerkop, Breck A.; Vaishnava, Shipra; Hooper, Lora V.			Immune Responses to the Microbiota at the Intestinal Mucosal Surface	IMMUNITY			English	Review							NF-KAPPA-B; SYMBIOTIC BACTERIA; ALKALINE-PHOSPHATASE; ALPHA-DEFENSINS; CROHNS-DISEASE; PANETH CELLS; PPAR-GAMMA; GERM-FREE; INFLAMMATION; IGA	The mammalian intestinal mucosal surface is continuously exposed to a complex and dynamic community of microorganisms. These microbes establish symbiotic relationships with their hosts, making important contributions to metabolism and digestive efficiency. The intestinal epithelial surface is the primary interface between the vast microbiota and internal host tissues. Given the enormous numbers of enteric bacteria and the persistent threat of opportunistic invasion, it is crucial that mammalian hosts monitor and regulate microbial interactions with intestinal epithelial surfaces. Here we discuss recent insights into how the innate and adaptive arms of the immune system collaborate to maintain homeostasis at the luminal surface of the intestinal host-microbial interface. These findings are also yielding a better understanding of how symbiotic host-microbial relationships can break down in inflammatory bowel disease.	[Duerkop, Breck A.; Vaishnava, Shipra; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Duerkop, Breck/I-2460-2019	Duerkop, Breck/0000-0003-4030-9822	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; ANDOH A, 1993, J IMMUNOL, V151, P4239; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Avall-Jaaskelainen S, 2003, APPL ENVIRON MICROB, V69, P2230, DOI 10.1128/AEM.69.4.2230-2236.2003; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; HESPELL RB, 1990, J DAIRY SCI, V73, P3013, DOI 10.3168/jds.S0022-0302(90)78988-6; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Ladero V, 2009, CAN J MICROBIOL, V55, P215, DOI [10.1139/W08-133, 10.1139/w08-133]; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Liu CH, 2008, P NATL ACAD SCI USA, V105, P3951, DOI 10.1073/pnas.0709266105; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petrof EO, 2009, INFLAMM BOWEL DIS, V15, P1537, DOI 10.1002/ibd.20930; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vaughan EE, 2002, ANTON LEEUW INT J G, V82, P341, DOI 10.1023/A:1020672724450; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	78	287	304	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					368	376		10.1016/j.immuni.2009.08.009	http://dx.doi.org/10.1016/j.immuni.2009.08.009			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766080	Bronze			2022-12-18	WOS:000270525900003
J	Goubier, A; Dubois, B; Gheit, H; Joubert, G; Villard-Truc, F; Asselin-Paturel, C; Trinchieri, G; Kaiserlian, D				Goubier, Anne; Dubois, Bertrand; Gheit, Hanane; Joubert, Grgoire; Villard-Truc, Florence; Asselin-Paturel, Carine; Trinchieri, Giorgio; Kaiserlian, Dominique			Plasmacytoid dendritic cells mediate oral tolerance	IMMUNITY			English	Article							REGULATORY T-CELLS; DRAINING LYMPH-NODES; IIFN-PRODUCING CELLS; IN-VIVO; INDOLEAMINE 2,3-DIOXYGENASE; PERIPHERAL TOLERANCE; IMMUNE-RESPONSES; PEYERS-PATCHES; RETINOIC-ACID; TGF-BETA	Oral tolerance prevents oral sensitization to dietary antigens (Ags), including proteins and haptens, and development of delayed-type hypersensitivity (DTH) responses. We showed here that plasmacytoid dendritic cells (pDCs) prevented oral T cell priming and were responsible for systemic tolerance to CD4(+) and CD8(+) T cell-mediated DTH responses induced by Ag feeding. Systemic depletion of pDCs prevented induction of tolerance by antigen feeding. Transfer of oral Ag-loaded liver pDCs to naive recipient mice induced Ag-specific suppression of CD4(+) and CD8(+) T cell responses to protein and hapten, respectively. Liver is a site of oral Ag presentation, and pDCs appeared to induce anergy or deletion of Ag-specific T cells in the liver relatively rapidly via a CD4(+) T cell-independent mechanism. These data demonstrate that oral tolerance relies on Ag presentation by pDC to T cells and suggest that pDC could represent a key therapeutic target for intestinal and systemic inflammatory diseases.	[Goubier, Anne; Dubois, Bertrand; Gheit, Hanane; Joubert, Grgoire; Kaiserlian, Dominique] INSERM, U851, F-69007 Lyon, France; [Goubier, Anne; Dubois, Bertrand; Gheit, Hanane; Joubert, Grgoire; Kaiserlian, Dominique] Univ Lyon 1, IFR128, F-69622 Villeurbanne, France; [Villard-Truc, Florence] Hop Edouard Herriot, Hosp Civils Lyon, Serv Gastroenterol Pediat, F-69003 Lyon, France; [Asselin-Paturel, Carine; Trinchieri, Giorgio] Schering Plough Lab Immunol Res, F-69570 Dardilly, France; [Trinchieri, Giorgio] NCI, Ctr Canc Res, Canc & Inflammat Program, Frederick, MD 21702 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kaiserlian, D (corresponding author), INSERM, U851, 21 Ave Tony Garnier, F-69007 Lyon, France.	kaiserlian@cervi-lyon.inserm.fr	Trinchieri, Giorgio/F-9369-2015; Dubois, Bertrand/D-4446-2013; KAISERLIAN, Dominique/G-3325-2013	Trinchieri, Giorgio/0000-0001-5892-7464; Dubois, Bertrand/0000-0002-7859-4975; KAISERLIAN, Dominique/0000-0001-6252-4916	INSERM (poste d'accueil); Fondation pour la Recherche Medicale; Academie de Medecine; NATIONAL CANCER INSTITUTE [ZIABC010793] Funding Source: NIH RePORTER	INSERM (poste d'accueil)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Academie de Medecine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr. Amine Boulheddi and Pr. Thierry Roger from Ecole Nationale Veterinaire de Lyon, Unite d'Anatomie, Marcy l'Etoile, for their expertise and skilful assistance in performing portocaval injections. We thank Pierre-Yves Durand and Jean-Benoit Le Luduec for their expert technical assistance. We would also like to thank the staff of the Plateau de Biologie Experimentale de la Souris (PBES) of Ecole Normale Superieure de Lyon for breeding and maintaining mouse strains and Chantal Bella from the flow cytometry facility of IFR-128 Biosciences Gerland-Lyon Sud for cell sorting. Anne Goubier was supported by grants from INSERM (poste d'accueil), Fondation pour la Recherche Medicale, and Academie de Medecine.	Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; CANTOR HM, 1967, NATURE, V215, P744, DOI 10.1038/215744a0; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Desvignes C, 2000, J IMMUNOL, V164, P2515, DOI 10.4049/jimmunol.164.5.2515; Dubois B, 2005, CELL MOL LIFE SCI, V62, P1322, DOI 10.1007/s00018-005-5036-0; Dubois B, 2003, BLOOD, V102, P3295, DOI 10.1182/blood-2003-03-0727; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; HUSBY S, 1994, J IMMUNOL, V152, P4663; Ju C, 2001, CHEM RES TOXICOL, V14, P1209, DOI 10.1021/tx0100587; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kingham TP, 2007, HEPATOLOGY, V45, P445, DOI 10.1002/hep.21457; Krasteva M, 1998, J IMMUNOL, V160, P1181; Kunkel D, 2003, EUR J IMMUNOL, V33, P1292, DOI 10.1002/eji.200323383; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Li W, 2004, AM J TRANSPLANT, V4, P1574, DOI 10.1111/j.1600-6143.2004.00551.x; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Lu LN, 2001, J IMMUNOL, V166, P7042, DOI 10.4049/jimmunol.166.12.7042; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nancey S, 2006, GASTROENTEROLOGY, V131, P485, DOI 10.1053/j.gastro.2006.05.018; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; SWARBRICK ET, 1979, GUT, V20, P121, DOI 10.1136/gut.20.2.121; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Viney JL, 1998, J IMMUNOL, V160, P5815; Watanabe T, 2003, HEPATOLOGY, V38, P403, DOI 10.1053/jhep.2003.50343; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; YANG R, 1994, J PEDIATR SURG, V29, P1145, DOI 10.1016/0022-3468(94)90297-6; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	44	287	293	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 19	2008	29	3					464	475		10.1016/j.immuni.2008.06.017	http://dx.doi.org/10.1016/j.immuni.2008.06.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18789731	Green Accepted, Bronze			2022-12-18	WOS:000259708900016
J	Fang, TC; Yashiro-Ohtani, Y; Del Bianco, C; Knoblock, DM; Blacklow, SC; Pear, WS				Fang, Terry C.; Yashiro-Ohtani, Yumi; Del Bianco, Cristina; Knoblock, Dawson M.; Blacklow, Stephen C.; Pear, Warren S.			Notch directly regulates Gata3 expression during T helper 2 cell differentiation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; CYTOKINE GENE-EXPRESSION; CD4 T-CELLS; CUTTING EDGE; IL-4 GENE; IN-VITRO; TH2 DIFFERENTIATION; LINEAGE COMMITMENT; RESPONSES; INACTIVATION	Notch signaling plays multiple roles to direct diverse decisions regarding cell fate during T cell development. During helper T (Th) cell differentiation, Notch is involved in generating optimal Th2 cell responses. Here, we present data investigating how Notch mediates Th2 cell differentiation. Notch showed a CD4+ T cell intrinsic role in promoting IL-4 expression that required GATA-3. In the absence of Notch signals, Gata3 expression was markedly diminished. Introduction of an activated allele of Notchl into CD4+ T cells led to the specific and direct upregulation of a developmentally regulated Gata3 transcript that included the exon 1a sequences. Furthermore, Notch acted in parallel with GATA-3 to synergistically activate IL-4 expression. Together, these data implicate Gata3 as a direct transcriptional Notch target that acts in concert with Notch signaling to generate optimal Th2 cell responses.	Univ Penn, Inst Med & Engn, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pear, WS (corresponding author), Univ Penn, Inst Med & Engn, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu	Del Bianco, Cristina/J-4665-2012		NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA119070-01A19001, R01 CA092433, P01 CA119070-020003, R01 CA092433-05, P01 CA119070] Funding Source: Medline; NIAID NIH HHS [R01 AI047833-09, R01 AI047833] Funding Source: Medline; NIGMS NIH HHS [T32GM007229, T32 GM007229] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lieuw KH, 1997, DEV BIOL, V188, P1, DOI 10.1006/dbio.1997.8575; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Martins GA, 2005, J IMMUNOL, V175, P5981, DOI 10.4049/jimmunol.175.9.5981; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	51	287	304	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					100	110		10.1016/j.immuni.2007.04.018	http://dx.doi.org/10.1016/j.immuni.2007.04.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17658278	Bronze, Green Accepted			2022-12-18	WOS:000248398100012
J	Hart, A; Melet, F; Grossfeld, P; Chien, K; Jones, C; Tunnacliffe, A; Favier, R; Bernstein, A				Hart, A; Melet, F; Grossfeld, P; Chien, K; Jones, C; Tunnacliffe, A; Favier, R; Bernstein, A			Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia	IMMUNITY			English	Article							ETS TRANSCRIPTION FACTORS; RECEPTOR TYROSINE KINASE; FRIEND-ERYTHROLEUKEMIA CELLS; GLYCOPROTEIN-IX PROMOTER; DNA-BINDING; EWINGS-SARCOMA; MICE LACKING; MOUSE TIE; GENE; EXPRESSION	The ETS gene Fli-1 is involved in the induction of erythroleukemia in mice by Friend murine leukemia virus and Ewings sarcoma in children. Mice with a targeted null mutation in the Fli-1 locus die at day 11.5 of embryogenesis with loss of vascular integrity leading to bleeding within the vascular plexus of the cerebral meninges and specific downregulation of Tek/Tie-2, the receptor for angiopoietin-1. We also show that dysmegakaryopoiesis in Fli-1 null embryos resembles that frequently seen in patients with terminal deletions of 11q (Jacobsen or Paris-Trousseau Syndrome). We map the megakaryocytic defects in 14 Jacobsen patients to a minimal region on 11q that includes the Fli-1 gene and suggest that dysmegakaryopoiesis in these patients may be caused by hemizygous loss of Fli-1.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Ottawa, ON K1A 0W9, Canada; Univ Calif San Diego, Sch Med, Salk Program Mol Med, La Jolla, CA 92093 USA; St Bartholomews & Royal London Med & Dent Sch, Dept Expt Hematol, London E1 2AD, England; Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England; Hop Enfants Armand Trousseau, INSERM, U91, F-75571 Paris, France	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Institute for Work & Health; University of California System; University of California San Diego; University of London; Queen Mary University London; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Hart, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	hart@mshri.on.ca	Jones, Christopher/C-1900-2008; Hart, Adam/C-1196-2011	Hart, Adam/0000-0001-8129-3877; Tunnacliffe, Alan/0000-0001-8570-125X				Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Bastian LS, 1996, J BIOL CHEM, V271, P18554, DOI 10.1074/jbc.271.31.18554; Bastian LS, 1999, BLOOD, V93, P2637, DOI 10.1182/blood.V93.8.2637.408k20_2637_2644; BEN DY, 1991, GENE DEV, V5, P908; BRETONGORIUS J, 1995, BLOOD, V85, P1805, DOI 10.1182/blood.V85.7.1805.bloodjournal8571805; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLEMAN MP, 1994, GENOMICS, V21, P337, DOI 10.1006/geno.1994.1274; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deveaux S, 1996, BLOOD, V87, P4678, DOI 10.1182/blood.V87.11.4678.bloodjournal87114678; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Feng S, 1999, BLOOD, V93, P4256, DOI 10.1182/blood.V93.12.4256.412k33_4256_4263; Grossfeld P, 1999, MOL BASIS CARDIOVASC, P135; IDA K, 1995, INT J CANCER, V63, P500, DOI 10.1002/ijc.2910630407; Iljin K, 1999, FASEB J, V13, P377, DOI 10.1096/fasebj.13.2.377; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jones C, 2000, HUM MOL GENET, V9, P1201, DOI 10.1093/hmg/9.8.1201; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; Mager AM, 1998, INT J DEV BIOL, V42, P561; Melet F, 1996, MOL CELL BIOL, V16, P2708; Meyer D, 1995, INT J DEV BIOL, V39, P909; MIGNOTTE V, 1994, GENOMICS, V20, P5, DOI 10.1006/geno.1994.1120; Minami T, 1998, EUR J BIOCHEM, V258, P879, DOI 10.1046/j.1432-1327.1998.2580879.x; Nagy A, 1993, GENE TARGETING PRACT; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; PAOLETTI F, 1995, BLOOD, V86, P2624; PENNY LA, 1995, AM J HUM GENET, V56, P676; Puri MC, 1999, DEVELOPMENT, V126, P4569; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Ratajczak MZ, 1998, BLOOD, V91, P1934, DOI 10.1182/blood.V91.6.1934.1934_1934_1946; Remy P, 1996, INT J DEV BIOL, V40, P577; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Risau W, 1998, KIDNEY INT, V54, pS3, DOI 10.1046/j.1523-1755.1998.06701.x; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sambrook J., 1989, MOL CLONING; Schwachtgen JL, 1997, ONCOGENE, V15, P3091, DOI 10.1038/sj.onc.1201502; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Tamir A, 1999, MOL CELL BIOL, V19, P4452; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tunnacliffe A, 1999, GENOME RES, V9, P44; Vannucchi AM, 1997, BRIT J HAEMATOL, V99, P500, DOI 10.1046/j.1365-2141.1997.4273230.x; Vyas P, 1999, BLOOD, V93, P2867; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; ZHANG LQ, 1993, ONCOGENE, V8, P1621; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961	54	287	296	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2000	13	2					167	177		10.1016/S1074-7613(00)00017-0	http://dx.doi.org/10.1016/S1074-7613(00)00017-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981960	Bronze			2022-12-18	WOS:000089132100002
J	Prodeus, AP; Goerg, S; Shen, LM; Pozdnyakova, OO; Chu, L; Alicot, EM; Goodnow, CC; Carroll, MC				Prodeus, AP; Goerg, S; Shen, LM; Pozdnyakova, OO; Chu, L; Alicot, EM; Goodnow, CC; Carroll, MC			A critical role for complement in maintenance of self-tolerance	IMMUNITY			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; REACTIVE B-CELLS; T-DEPENDENT ANTIGEN; LYMPHOCYTE; MICE; KERATINOCYTES; EXPRESSION; THRESHOLDS; SELECTION; INDUCTION	The role of complement in the maintenance of self-tolerance has been examined in two models: an immunoglobulin transgenic model of peripheral tolerance and a lupus-like murine model of CD95 (Fas) deficiency. We find that self-reactive B lymphocytes deficient in complement receptors CD21/CD35 or transferred into mice deficient in the complement protein C4 are not anergized by soluble self-antigen. In the second model, deficiency in CD21/CD35 or C4 combined with CD95 deficiency results in high titers of anti-nuclear antibodies leading to severe lupus-like disease. These findings suggest a novel role for the complement system in B cell tolerance and provide insight into the genetic association of complement deficiency with susceptibility to systemic lupus erythematosus.	Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Australian National University; John Curtin School of Medical Research	Carroll, MC (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA.	mcarroll@rics.bwh.harvard.edu	Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				AGNELLO V, 1978, ARTHRITIS RHEUM, V21, P146; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ALLMAN DM, 1992, J IMMUNOL, V151, P431; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545; Carroll MC, 1998, NAT GENET, V19, P3, DOI 10.1038/ng0598-3; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chan O, 1998, J IMMUNOL, V160, P51; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; COTRAN RS, 1994, PATHOLOGIC BASIS DIS; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; EMLEN W, 1990, J IMMUNOL METHODS, V132, P91, DOI 10.1016/0022-1759(90)90402-H; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fischer MB, 1998, J IMMUNOL, V160, P2619; Fischer MB, 1996, J IMMUNOL, V157, P549; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Greimers R, 1996, CYTOMETRY, V23, P205, DOI 10.1002/(SICI)1097-0320(19960301)23:3<205::AID-CYTO4>3.0.CO;2-H; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; Korb LC, 1997, J IMMUNOL, V158, P4525; MICHET CJ, 1985, MAYO CLIN PROC, V60, P105, DOI 10.1016/S0025-6196(12)60294-8; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; PEPYS MB, 1972, NATURE-NEW BIOL, V237, P157, DOI 10.1038/newbio237157a0; Qin DH, 1998, J IMMUNOL, V161, P4549; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9	37	287	296	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					721	731		10.1016/S1074-7613(00)80669-X	http://dx.doi.org/10.1016/S1074-7613(00)80669-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846493	Bronze			2022-12-18	WOS:000077298300014
J	Nishikawa, S; Nishikawa, S; Kawamoto, H; Yoshida, H; Kizumoto, M; Kataoka, H; Katsura, Y				Nishikawa, S; Nishikawa, S; Kawamoto, H; Yoshida, H; Kizumoto, M; Kataoka, H; Katsura, Y			In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos	IMMUNITY			English	Article							C-KIT; STEM-CELLS; EXPRESSION; MOUSE; JUNCTIONS; CADHERIN; RECEPTOR; CULTURE; SYSTEM; AORTA	We have investigated the lymphohematopoietic potentials of endothelial cells (EC) and hematopoietic cells (HPC) sorted from embryos. Expression of VE-cadherin, CD45, and Ter119 was used to distinguish EC (VE-cadherin(+)CD45(-)Ter119(-)) from HPC (VE-cadherin(-)CD45(+)). Thus defined, EC population takes up acetylated LDL and coexpresses CD31, Flk1,and CD34. In E9.5 embryos, EC from yolk sac (YS) and the embryo proper generate blood cells, including lymphocytes. Thus, lymphohematopoietic EC do exist in the embryo, and they are generated both in YS and the embryo proper. On the other hand, HPC with lymphopoietic potency appear first in the embryo proper. These findings implicate involvement of multiple environmental cues for acquiring lymphopoietic competency during differentiation of HPC.	Kyoto Univ, Fac Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Chest Dis Res Inst, Dept Immunol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Nishikawa, S (corresponding author), Kyoto Univ, Fac Med, Dept Mol Genet, Sakyo Ku, Shogoin Kawaharacho 53, Kyoto 6068507, Japan.	snishika@virus.kyoto-u.ac.jp		Yoshida, Hisahiro/0000-0001-6360-5988				AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DieterlenLievre F, 1997, INT ARCH ALLERGY IMM, V112, P3, DOI 10.1159/000237423; DOU YM, 1995, THYMUS, V23, P195; DZIERZAK E, 1995, TRENDS GENET, V11, P356; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; KANATSU M, 1996, DEVELOPMENT, V122, P831; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; KODAMA H, 1994, EXP HEMATOL, V22, P979; LAMPUGNANI MG, 1993, BAILLIERE CLIN HAEM, V6, P539, DOI 10.1016/S0950-3536(05)80187-8; LAMPUGNANI MG, 1995, J CELL BIOL, V126, P247; Matsuyoshi N, 1997, P ASSOC AM PHYSICIAN, V109, P362; MEDVINSKY A, 1996, CELL, V86, P896; MOORE M, 1967, LANCET, V11, P658; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; SMITH RA, 1982, DEV COMP IMMUNOL, V6, P359, DOI 10.1016/S0145-305X(82)80019-0; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; WEISSMANN I, 1978, COLD SPRING HARB SYM, V5, P33; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	33	287	296	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1998	8	6					761	769		10.1016/S1074-7613(00)80581-6	http://dx.doi.org/10.1016/S1074-7613(00)80581-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655490	Bronze			2022-12-18	WOS:000074396300012
J	Kelsoe, G				Kelsoe, G			Life and death in germinal centers (redux)	IMMUNITY			English	Article							IMMUNOGLOBULIN VARIABLE GENES; FOLLICULAR DENDRITIC CELLS; SOMATIC MUTATION; IMMUNE-RESPONSE; IMMUNOLOGICAL MEMORY; CHAIN DIVERSITY; REGION GENES; LIGHT-CHAINS; FAS ANTIGEN; V-GENES				Kelsoe, G (corresponding author), UNIV MARYLAND,SCH MED,DEPT MICROBIOL & IMMUNOL,BALTIMORE,MD 21201, USA.				NIAID NIH HHS [AI24335] Funding Source: Medline; NIA NIH HHS [AG10207] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010207] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; AZUMA T, 1993, INT IMMUNOL, V5, P121, DOI 10.1093/intimm/5.2.121; BACHL J, 1995, NATURE, V375, P285, DOI 10.1038/375285c0; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; COICO RF, 1983, J IMMUNOL, V131, P2254; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; FULLER KA, 1993, J IMMUNOL, V151, P4505; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOLDING GB, 1987, GENETICS, V115, P169; GORSKI J, 1983, SCIENCE, V220, P1179, DOI 10.1126/science.6857243; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; HARRIMAN GR, 1990, J IMMUNOL, V145, P2406; HINDSFREY KR, 1993, J EXP MED, V178, P815, DOI 10.1084/jem.178.3.815; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P675; JACOB J, 1991, J EXP MED, V173, P165; JU ST, 1994, P NATL ACAD SCI USA, V91, P4185, DOI 10.1073/pnas.91.10.4185; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; KELSOE G, 1995, NATURE, V375, P286, DOI 10.1038/375286a0; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KROESE FGM, 1985, DEV COMP IMMUNOL, V9, P641, DOI 10.1016/0145-305X(85)90029-1; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MATHER EL, 1981, NUCLEIC ACIDS RES, V9, P6855, DOI 10.1093/nar/9.24.6855; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MILLER C, 1995, J IMMUNOL, V155, P3377; MILLER C, 1994, AGING IMMUNOL INFECT, V5, P556; MOTOYAMA N, 1991, P NATL ACAD SCI USA, V88, P7933, DOI 10.1073/pnas.88.18.7933; NOSSAL GJV, 1964, AUST J EXP BIOL MED, V42, P311, DOI 10.1038/icb.1964.32; NOSSAL GJV, 1993, P NATL ACAD SCI USA, V90, P3088, DOI 10.1073/pnas.90.7.3088; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; PICARD D, 1984, EMBO J, V3, P3031, DOI 10.1002/j.1460-2075.1984.tb02250.x; PULENDRAN B, 1994, P NATL ACAD SCI USA, V91, P2639, DOI 10.1073/pnas.91.7.2639; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; RADA C, 1994, EUR J IMMUNOL, V24, P1453, DOI 10.1002/eji.1830240632; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; ROGERSON BJ, 1994, MOL IMMUNOL, V31, P83, DOI 10.1016/0161-5890(94)90081-7; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; SCHRIEVER F, 1992, ADV IMMUNOL, V51, P243, DOI 10.1016/S0065-2776(08)60489-7; SELSING E, 1981, CELL, V25, P47, DOI 10.1016/0092-8674(81)90230-0; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; STORB U, 1996, IN PRESS CURR OPIN I; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; VORA KA, 1995, J EXP MED, V181, P271, DOI 10.1084/jem.181.1.271; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBER JS, 1991, J IMMUNOL, V146, P3218; WEINSTEIN PD, 1994, IMMUNITY, V1, P647, DOI 10.1016/1074-7613(94)90036-1; WEISS S, 1987, EMBO J, V6, P927, DOI 10.1002/j.1460-2075.1987.tb04840.x; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233; WILSON M, 1992, EMBO J, V11, P4337, DOI 10.1002/j.1460-2075.1992.tb05533.x; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; YELAMOS J, 1995, NATURE, V376, P225; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0	72	287	293	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					107	111		10.1016/S1074-7613(00)80675-5	http://dx.doi.org/10.1016/S1074-7613(00)80675-5			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624801	Bronze			2022-12-18	WOS:A1996TX22500001
J	Roers, A; Hiller, B; Hornung, V				Roers, Axel; Hiller, Bjoern; Hornung, Veit			Recognition of Endogenous Nucleic Acids by the Innate Immune System	IMMUNITY			English	Review							AICARDI-GOUTIERES-SYNDROME; CYCLIC GMP-AMP; DOUBLE-STRANDED-RNA; PLASMACYTOID DENDRITIC CELLS; DNA EXONUCLEASE TREX1; AUTOREACTIVE B-CELLS; TOLL-LIKE RECEPTOR-3; I-LIKE RECEPTORS; RIG-I; SELF-DNA	Recognition of DNA and RNA by endosomal and cytosolic sensors constitutes a central element in the detection of microbial invaders by the innate immune system. However, the capacity of these sensors to discriminate between microbial and endogenous nucleic acids is limited. Over the past few years, evidence has accumulated to suggest that endogenous DNA or RNA species can engage nucleic-acid-sensing pattern-recognition receptors that can trigger or sustain detrimental pathology. Here, we review principles of how the activation of innate sensors by host nucleic acids is prevented in the steady state and discuss four important determinants of whether a nucleic-acid-driven innate response is mounted. These include structural features of the ligand being sensed, the subcellular location and quantity of pathogen-derived or endogenous nucleic acids, and the regulation of sensor-activation thresholds. Furthermore, we emphasize disease mechanisms initiated by failure to discriminate self from non-self in nucleic acid detection.	[Roers, Axel] Tech Univ Dresden, Inst Immunol, Med Fak Carl Gustav Carus, D-01069 Dresden, Germany; [Hiller, Bjoern; Hornung, Veit] Univ Hosp Bonn, Inst Mol Med, D-53127 Bonn, Germany; [Hornung, Veit] Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany; [Hornung, Veit] Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany; [Hornung, Veit] Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bonn; University of Munich; University of Munich; University of Munich	Hornung, V (corresponding author), Univ Hosp Bonn, Inst Mol Med, D-53127 Bonn, Germany.; Hornung, V (corresponding author), Univ Munich, Gene Ctr, Marchioninistr 15, D-81377 Munich, Germany.; Hornung, V (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.; Hornung, V (corresponding author), Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany.	hornung@genzentrum.lmu.de	Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Ahn J, 2014, J IMMUNOL, V193, P4634, DOI 10.4049/jimmunol.1401337; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bauer S, 2013, IMMUNOL LETT, V149, P85, DOI 10.1016/j.imlet.2012.11.003; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Calvani N, 2005, J IMMUNOL, V175, P4777, DOI 10.4049/jimmunol.175.7.4777; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Duany YD, 2015, CURR OPIN VIROL, V12, P20, DOI 10.1016/j.coviro.2015.01.011; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Geyer M, 2015, NAT STRUCT MOL BIOL, V22, P99, DOI 10.1038/nsmb.2967; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Guiducci C, 2013, J EXP MED, V210, P2903, DOI 10.1084/jem.20131044; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Herzner AM, 2015, NAT IMMUNOL, V16, P1025, DOI 10.1038/ni.3267; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Karayel E, 2009, EUR J IMMUNOL, V39, P1929, DOI 10.1002/eji.200939344; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kato H, 2015, CURR OPIN IMMUNOL, V37, P40, DOI 10.1016/j.coi.2015.10.002; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lencer WI, 2015, TRENDS IMMUNOL, V36, P401, DOI 10.1016/j.it.2015.05.006; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; Lu A., 2015, CELL DISCOV, V1, P15013; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mackenzie K. J., 2016, EMBO J; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pawaria S, 2015, J IMMUNOL, V194, P1403, DOI 10.4049/jimmunol.1402893; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Pelka K, 2016, IMMUNOL REV, V269, P60, DOI 10.1111/imr.12375; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Ravenscroft JC, 2011, AM J MED GENET A, V155A, P235, DOI 10.1002/ajmg.a.33778; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Sharma S, 2015, J IMMUNOL, V195, P3507, DOI 10.4049/jimmunol.1500964; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Shibata T., 2015, INT IMMUNOL; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; THOMPSON RA, 1980, NEW ENGL J MED, V303, P22, DOI 10.1056/NEJM198007033030107; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wegmann F, 2012, NAT BIOTECHNOL, V30, P883, DOI 10.1038/nbt.2344; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu B, 2015, CURR OPIN VIROL, V12, P91, DOI 10.1016/j.coviro.2015.04.004; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	161	286	296	9	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					739	754		10.1016/j.immuni.2016.04.002	http://dx.doi.org/10.1016/j.immuni.2016.04.002			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096317	Bronze			2022-12-18	WOS:000374444300008
J	Wolfer, A; Wilson, A; Nemir, M; MacDonald, HR; Radtke, F				Wolfer, A; Wilson, A; Nemir, M; MacDonald, HR; Radtke, F			Inactivation of Notch2 impairs VDJ beta rearrangement and allows pre-TCR-independent survival of early alpha beta lineage thymocytes	IMMUNITY			English	Article							T-CELL DEVELOPMENT; GAMMA-DELTA; CD4(+)8(+) THYMOCYTES; GENE ENHANCER; RECEPTOR; EXPRESSION; MICE; RECOMBINATION; FATE; THYMUS	Notch proteins influence cell fate decisions in many developmental systems. During lymphoid development, Notch1 signaling is essential to direct a bipotent T/B precursor toward the T cell fate, but the role of Notch1 at later stages of T cell development remains controversial. We have recently reported that tissue-specific inactivation of Notch1 in immature (CD44(-)CD25(+)) thymocytes does not affect subsequent T cell development. Here, we demonstrate that loss of Notch1 signaling at an earlier (CD44(+)CD25(+)) developmental stage results in severe perturbation of up but not gammadelta lineage development. Immature Notch1(-/-) thymocytes show impaired VDJbeta rearrangement and aberrant pre-TCR-independent survival. Collectively, our data demonstrate that Notch1 controls several nonredundant functions necessary for alphabeta lineage development.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne	Radtke, F (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.		Wolfer, Anita/AAK-1720-2021; Radtke, Freddy/Q-3198-2017; Wilson, Anne/A-7131-2011	Radtke, Freddy/0000-0003-4315-4045; 				Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; BORN W, 1988, J IMMUNOL, V140, P3228; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jehn BM, 1999, J IMMUNOL, V162, P635; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; MCDOUGALL S, 1988, SCIENCE, V241, P205, DOI 10.1126/science.2968651; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; OKADA A, 1994, J EXP MED, V180, P261, DOI 10.1084/jem.180.1.261; PENIT C, 1995, J IMMUNOL, V154, P5103; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Senoo M, 2001, INT IMMUNOL, V13, P1405, DOI 10.1093/intimm/13.11.1405; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; VITELLI L, 1988, DEV BIOL, V127, P54, DOI 10.1016/0012-1606(88)90188-1; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	51	286	295	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					869	879		10.1016/S1074-7613(02)00330-8	http://dx.doi.org/10.1016/S1074-7613(02)00330-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121668	Bronze			2022-12-18	WOS:000176534000012
J	Williams, AP; Peh, CA; Purcell, AW; McCluskey, J; Elliott, T				Williams, AP; Peh, CA; Purcell, AW; McCluskey, J; Elliott, T			Optimization of the MHC class I peptide cargo is dependent on tapasin	IMMUNITY			English	Article							SURFACE EXPRESSION; ER CHAPERONE; INTACT-CELLS; MOLECULES; BINDING; TAP; DISSOCIATION; STABILITY; TRANSPORTERS; REPERTOIRE	The loading of MHC class I molecules with their peptide cargo is undertaken by a multimolecular peptide loading complex within the endoplasmic reticulum. We show that MHC class I molecules can optimize their peptide repertoire over time and that this process is dependent on tapasin. Optimization of the peptide repertoire is both quantitatively and qualitatively improved by tapasin. The extent of optimization is maximal when MHC class I molecules are allowed to load within the fully assembled peptide loading complex. Finally, we identify a single natural polymorphism (116D>Y) in HLA-B*4402 that permits tapasin-independent loading of HLA-B*4405 (116Y). In the presence of tapasin, the tapasin-independent allele B*4405 (116Y) acquires a repertoire of peptides that is less optimal than the tapasin-dependent allele B*4402 (116D).	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; Univ Southampton, Sch Med, Canc Sci Div, Southhampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic, Australia	University of Oxford; University of Southampton; University of Melbourne	Elliott, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England.	tje@soton.ac.uk	Purcell, Anthony/AAH-1942-2019; McCluskey, James/A-1291-2007	Purcell, Anthony/0000-0003-0532-8331; McCluskey, James/0000-0002-8597-815X; Elliott, Tim/0000-0003-1097-0222; Peh, Chen Au/0000-0002-9712-0396				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Brouwenstijn N, 2001, IMMUNITY, V15, P95, DOI 10.1016/S1074-7613(01)00174-1; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dedier S, 2000, J BIOL CHEM, V275, P27055; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fruh K, 1999, IMMUNOL REV, V168, P157, DOI 10.1111/j.1600-065X.1999.tb01290.x; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li SL, 2000, J BIOL CHEM, V275, P1581, DOI 10.1074/jbc.275.3.1581; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; Neisig A, 1996, J IMMUNOL, V156, P3196; Neisig A, 1998, J IMMUNOL, V160, P171; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	39	286	287	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					509	520		10.1016/S1074-7613(02)00304-7	http://dx.doi.org/10.1016/S1074-7613(02)00304-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970875	Bronze			2022-12-18	WOS:000175109600003
J	Cannons, JL; Qi, H; Lu, KT; Dutta, M; Gomez-Rodriguez, J; Cheng, J; Wakeland, EK; Germain, RN; Schwartzberg, PL				Cannons, Jennifer L.; Qi, Hai; Lu, Kristina T.; Dutta, Mala; Gomez-Rodriguez, Julio; Cheng, Jun; Wakeland, Edward K.; Germain, Ronald N.; Schwartzberg, Pamela L.			Optimal Germinal Center Responses Require a Multistage T Cell:B Cell Adhesion Process Involving Integrins, SLAM-Associated Protein, and CD84	IMMUNITY			English	Article							FOLLICULAR-HELPER-CELLS; RESTING NK CELLS; HUMORAL IMMUNITY; MOLECULAR DISSECTION; CUTTING EDGE; B-CELLS; SAP; FAMILY; AUTOIMMUNITY; RECEPTORS	CD4(+) T cells deficient in signaling lymphocyte activation molecule (SLAM)-associated protein (SAP) exhibit a selective impairment in adhesion to antigen-presenting B cells but not dendritic cells (DCs), resulting in defective germinal center formation. However, the nature of this selective adhesion defect remained unclear. We found that whereas T cell:DC interactions were primarily integrin dependent, T cell:B cell interactions had both an early integrin-dependent phase and a sustained phase that also required SAP. We further found that the SLAM family member CD84 was required for prolonged T cell:B cell contact, optimal T follicular helper function, and germinal center formation in vivo. Moreover, both CD84 and another SLAM member, Ly108, mediated T cell adhesion and participated in stable T cell:B cell interactions in vitro. Our results reveal insight into the dynamic regulation of T cell:B cell interactions and identify SLAM family members as critical components of sustained T cell:B cell adhesion required for productive humoral immunity.	[Cannons, Jennifer L.; Lu, Kristina T.; Dutta, Mala; Gomez-Rodriguez, Julio; Cheng, Jun; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Qi, Hai; Germain, Ronald N.] NIAID, NIH, Bethesda, MD 20892 USA; [Dutta, Mala] George Washington Univ, Inst Biomed Sci, Washington, DC 20052 USA; [Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75235 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	pams@nhgri.nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019		NHGRI; MAID; NIH, USA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000403, ZIAAI000545] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MAID; NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Handon and A. Venegas for invaluable technical assistance; M. Kirby and S. Anderson for cell sorting; J. Fekecs for graphics assistance; and K. Nichols and S.-H. Hwang for mouse reagents. This work was funded by the intramural research programs of the NHGRI and MAID, NIH, USA.	Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Alleyne A, 2007, IEEE CONTR SYST MAG, V27, P19, DOI 10.1109/MCS.2007.909486; Barber DF, 2003, J IMMUNOL, V170, P294, DOI 10.4049/jimmunol.170.1.294; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chan AY, 2006, CURR OPIN IMMUNOL, V18, P656, DOI 10.1016/j.coi.2006.09.010; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Li CJ, 2003, BIOCHEMISTRY-US, V42, P14885, DOI 10.1021/bi034798l; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tangye SG, 2003, J IMMUNOL, V171, P2485, DOI 10.4049/jimmunol.171.5.2485; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	41	285	303	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					253	265		10.1016/j.immuni.2010.01.010	http://dx.doi.org/10.1016/j.immuni.2010.01.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20153220	Bronze, Green Accepted			2022-12-18	WOS:000275346000014
J	Rakoff-Nahoum, S; Hao, LM; Medzhitov, R				Rakoff-Nahoum, Seth; Hao, Liming; Medzhitov, Ruslan			Role of Toll-like receptors in spontaneous commensal-dependent colitis	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; INTERLEUKIN-10-DEFICIENT MICE; CROHNS-DISEASE; INTESTINAL INFLAMMATION; CHRONIC ENTEROCOLITIS; ULCERATIVE-COLITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; CELIAC-DISEASE	Inflammatory bowel disease (IBD) is thought to result from a dysregulated interaction between the host immune system and its commensal microflora. Heterogeneity of disease susceptibility in humans and rodents suggest that multiple mechanisms are responsible for the etiology of IBD. In particular, deficiencies in anti-inflammatory and immune-suppressive mechanisms play an important role in the development of IBD. However, it is unknown how the indigenous microflora stimulates the immune system and how this response is regulated. To address these questions, we investigated the role of Toll-like receptor (TLR) signaling in the development of spontaneous, commensal-dependent colitis in interleukin (IL)-2- and IL-10-deficient mice. We report that colitis was dependent on TLR signaling in II10(-/-) mice. In contrast, II2(-/-) mice developed intestinal inflammation in the absence of TLR signaling pathways. These results demonstrate a differential role of innate immune recognition by TLRs in the development of commensal-dependent colitis.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu			NIAID NIH HHS [AI46688] Funding Source: Medline; NIGMS NIH HHS [GM07205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Becker C, 2005, INFLAMM BOWEL DIS, V11, P755, DOI 10.1097/01.MIB.0000172808.03877.4d; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Laky K, 1997, J IMMUNOL, V158, P1417; MA A, 1995, J EXP MED, V182, P1567, DOI 10.1084/jem.182.5.1567; Madara J, 2004, NEW ENGL J MED, V351, P1685, DOI 10.1056/NEJMcibr042621; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; McDonald SAC, 1997, IMMUNOLOGY, V91, P73, DOI 10.1046/j.1365-2567.1997.00217.x; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Monteleone I, 2004, GUT, V53, P1090, DOI 10.1136/gut.2003.030551; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	55	285	305	2	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					319	329		10.1016/j.immuni.2006.06.010	http://dx.doi.org/10.1016/j.immuni.2006.06.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16879997	Bronze			2022-12-18	WOS:000240047500017
J	van Anken, E; Romijn, EP; Maggioni, C; Mezghrani, A; Sitia, R; Braakman, I; Heck, AJR				van Anken, E; Romijn, EP; Maggioni, C; Mezghrani, A; Sitia, R; Braakman, I; Heck, AJR			Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion	IMMUNITY			English	Article							GLUCOSE-REGULATED PROTEINS; TRANSCRIPTION FACTOR XBP-1; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; PROTEOME ANALYSIS; QUALITY-CONTROL; IGM SECRETION; PLASMA-CELLS; IMMUNOGLOBULIN; DIFFERENTIATION	Upon encounter with antigen, B lymphocytes differentiate into Ig-secreting plasma cells. This step involves a massive development of secretory organelles, most notably the endoplasmic reticulum. To analyze the relationship between organelle reshaping and Ig secretion, we performed a dynamic proteomics study of B lymphoma cells undergoing in vitro terminal differentiation. By clustering proteins according to temporal expression patterns, it appeared that B cells anticipate their secretory role in a multistep process. Metabolic capacity and secretory machinery expand first to accommodate the mass production of IgM that follows.	Univ Utrecht, Bijvoet Ctr, Dept Bioorgan Chem 1, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Bijvoet Ctr, Dept Biomol Mass Spectrometry, NL-3584 CA Utrecht, Netherlands; Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; Univ Vita Salute San Raffaele, I-20132 Milan, Italy; DiBiT, HSR, I-20132 Milan, Italy	Utrecht University; Utrecht University; Utrecht University; Vita-Salute San Raffaele University	Braakman, I (corresponding author), Univ Utrecht, Bijvoet Ctr, Dept Bioorgan Chem 1, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		Heck, Albert/D-7098-2011; Romijn, Edwin/B-5129-2010; van Anken, Eelco/AAN-9015-2020; Sitia, Roberto/AAB-5005-2019	Heck, Albert/0000-0002-2405-4404; Sitia, Roberto/0000-0001-7086-4152; Braakman, Ineke/0000-0003-1592-4364; van Anken, Eelco/0000-0001-9529-2701; Maggioni, cristina/0000-0002-3522-9847	Telethon [GP0117Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		ALBERINI C, 1987, EUR J IMMUNOL, V17, P555, DOI 10.1002/eji.1830170419; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; BREWER JW, 1994, IMMUNOL TODAY, V15, P165, DOI 10.1016/0167-5699(94)90313-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chilosi M, 1999, MODERN PATHOL, V12, P1101; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Frey JR, 2000, ELECTROPHORESIS, V21, P3730, DOI 10.1002/1522-2683(200011)21:17<3730::AID-ELPS3730>3.0.CO;2-5; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P525, DOI 10.1073/pnas.79.2.525; KETTMAN J, 1984, EUR J IMMUNOL, V14, P778, DOI 10.1002/eji.1830140903; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Lucero HA, 1998, J BIOL CHEM, V273, P9857, DOI 10.1074/jbc.273.16.9857; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; Reddy PS, 1999, IMMUNOL TODAY, V20, P582, DOI 10.1016/S0167-5699(99)01542-X; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Sealy L, 1996, EUR J IMMUNOL, V26, P1838, DOI 10.1002/eji.1830260826; SHACHAR I, 1992, J BIOL CHEM, V267, P24241; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; SITIA R, 1987, EMBO J, V6, P3969, DOI 10.1002/j.1460-2075.1987.tb02739.x; SITIA R, 1985, EUR J IMMUNOL, V15, P570, DOI 10.1002/eji.1830150608; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; STAVNEZER J, 1985, J EXP MED, V161, P577, DOI 10.1084/jem.161.3.577; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wang WW, 2000, AQUAT GEOCHEM, V6, P275, DOI 10.1023/A:1009679730079; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	48	285	290	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					243	253		10.1016/S1074-7613(03)00024-4	http://dx.doi.org/10.1016/S1074-7613(03)00024-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594951	Green Published, Bronze			2022-12-18	WOS:000181138100008
J	Halary, F; Amara, A; Lortat-Jacob, H; Messerle, M; Delaunay, T; Houles, C; Fieschi, F; Arenzana-Seisdedos, F; Moreau, JF; Dechanet-Merville, J				Halary, F; Amara, A; Lortat-Jacob, H; Messerle, M; Delaunay, T; Houles, C; Fieschi, F; Arenzana-Seisdedos, F; Moreau, JF; Dechanet-Merville, J			Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection	IMMUNITY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUSES; C-TYPE LECTIN; GLYCOPROTEIN-B; ENDOTHELIAL-CELLS; EXPRESSION; PROTEIN; FUSION; RECEPTOR; ENVELOPE; PURIFICATION	Cytomegalovirus (CMV) infection is characterized by host immunosuppression and multiorganic involvement. CMV-infected dendritic cells (DC) were recently shown to display reduced immune functions, but their role in virus dissemination is not clear. In this report, we demonstrated that CMV could be captured by DC through binding on DC-SIGN and subsequently transmitted to permissive cells. Moreover, blocking DC-SIGN by specific antibodies inhibited DC infection by primary CMV isolates and expression of DC-SIGN or its homolog DC-SIGNR rendered susceptible cells permissive to CMV infection. We demonstrated that CMV envelope glycoprotein B is a viral ligand for DC-SIGN and DC-SIGNR. These results provide new insights into the molecular interactions contributing to cell infection by CMV and extend DC-SIGN implication in virus propagation.	Univ Bordeaux 2, CNRS, UMR 5540, Immunol Lab, F-33000 Bordeaux, France; Inst Pasteur, Unite Immunol Virale, Dept Mol Med, F-75015 Paris, France; Univ Grenoble 1, CNRS,CEA, UMR 5075, Inst Biol Struct, F-38027 Grenoble, France; Univ Halle Wittenberg, Fac Med, Virus Cell Interact Grp, D-06120 Halle Saale, Germany; INRA, Dept Pathol Vegetale, F-33883 Villenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Martin Luther University Halle Wittenberg; INRAE	Dechanet-Merville, J (corresponding author), Univ Bordeaux 2, CNRS, UMR 5540, Immunol Lab, F-33000 Bordeaux, France.		AMARA, Ali/ABX-9903-2022; halary, franck/AAR-9437-2020; Arenzana-Seisdedos, Fernando/E-5835-2016; Fieschi, Franck/W-2748-2019; Halary, Franck/B-3782-2017	halary, franck/0000-0003-0336-9615; Halary, Franck/0000-0003-0336-9615; Messerle, Martin/0000-0002-1227-3933; FIESCHI, Franck/0000-0003-1194-8107; SANCHEZ, Corinne/0000-0003-3895-0194; AMARA, Ali/0000-0002-0283-1815				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Baldwin BR, 2000, J GEN VIROL, V81, P27, DOI 10.1099/0022-1317-81-1-27; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bodaghi B, 1999, INVEST OPHTH VIS SCI, V40, P2598; Borst EM, 2001, J VIROL, V75, P1450, DOI 10.1128/JVI.75.3.1450-1458.2001; Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; EINHORN L, 1982, J MED VIROL, V10, P225, DOI 10.1002/jmv.1890100402; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; GIBSON W, 1983, VIROLOGY, V128, P391, DOI 10.1016/0042-6822(83)90265-9; JACQUET A, 1995, PROTEIN EXPRES PURIF, V6, P91, DOI 10.1006/prep.1995.1012; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Kahl M, 2000, J VIROL, V74, P7628, DOI 10.1128/JVI.74.16.7628-7635.2000; KARI B, 1992, J VIROL, V66, P1761, DOI 10.1128/JVI.66.3.1761-1764.1992; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lashmit PE, 1998, J VIROL, V72, P9575, DOI 10.1128/JVI.72.12.9575-9584.1998; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Milne RSB, 1998, J GEN VIROL, V79, P855, DOI 10.1099/0022-1317-79-4-855; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; NAVARRO D, 1993, VIROLOGY, V197, P143, DOI 10.1006/viro.1993.1575; Norais N, 1996, J VIROL, V70, P5716, DOI 10.1128/JVI.70.8.5716-5719.1996; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Plachter B, 1996, ADV VIRUS RES, V46, P195, DOI 10.1016/S0065-3527(08)60073-1; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Scheffczik H, 2001, FEBS LETT, V506, P113, DOI 10.1016/S0014-5793(01)02891-5; SISK WP, 1994, J VIROL, V68, P766, DOI 10.1128/JVI.68.2.766-775.1994; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026; TAUPIN JL, 1993, SCAND J IMMUNOL, V38, P293, DOI 10.1111/j.1365-3083.1993.tb01728.x; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625	44	285	317	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2002	17	5					653	664		10.1016/S1074-7613(02)00447-8	http://dx.doi.org/10.1016/S1074-7613(02)00447-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	616ZX	12433371	Bronze			2022-12-18	WOS:000179335100011
J	Kumanogoh, A; Watanabe, C; Lee, I; Wang, XS; Shi, W; Araki, H; Hirata, H; Iwahori, K; Uchida, J; Yasui, T; Matsumoto, M; Yoshida, K; Yakura, H; Pan, C; Parnes, JR; Kikutani, H				Kumanogoh, A; Watanabe, C; Lee, I; Wang, XS; Shi, W; Araki, H; Hirata, H; Iwahori, K; Uchida, J; Yasui, T; Matsumoto, M; Yoshida, K; Yakura, H; Pan, C; Parnes, JR; Kikutani, H			Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: A novel mechanism for regulating B cell signaling	IMMUNITY			English	Article							TYROSINE-PHOSPHATASE SHP-1; SURFACE PROTEIN CD72; GROWTH CONE GUIDANCE; DIFFERENTIATION ANTIGEN; T-CELLS; LEUKOCYTE SEMAPHORIN; MOLECULAR-CLONING; ACTIVATION; TRANSMEMBRANE; LIGAND	We have identified the lymphocyte semaphorin CD100/Sema4D as a CD40-inducible molecule by subtractive cDNA cloning. CD100 stimulation significantly enhanced the effects of CD40 on B cell responses. Administration of soluble CD100 markedly accelerated in vivo antigen-specific antibody responses. CD100 receptors with different binding affinities were detected on renal tubular cells (K-d = similar to1 X 10(-9) M) and lymphocytes (K-d = similar to3 x 10(-7) M) Expression cloning revealed that the CD100 receptor on lymphocytes is CD72, a negative regulator of B cell responsiveness. CD72 thus represents a novel class of semaphorin receptors. CD100 stimulation induced tyrosine dephosphorylation of CD72 and dissociation of SHP-1 from CD72. Our findings indicate that CD100 plays a critical role in immune responses by the novel mechanism of turning off negative signaling by CD72.	Osaka Univ, Res Inst Microbiol Dis, Dept Mol Immunol, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Neurosci, Dept Microbiol & Immunol, Tokyo 1838526, Japan; Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Osaka University; Osaka University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Stanford University	Kikutani, H (corresponding author), Osaka Univ, Res Inst Microbiol Dis, Dept Mol Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kikutani@ragtime.biken.osaka-u.ac.jp	Kikutani, Hitoshi/C-9525-2009; Kumanogoh, Atsushi/C-7354-2009	Iwahori, Kota/0000-0002-9891-6003	NCI NIH HHS [CA68675] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi T, 1998, J IMMUNOL, V160, P4662; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Biancone L, 1996, J EXP MED, V184, P811, DOI 10.1084/jem.184.3.811; Bikah G, 1998, INT IMMUNOL, V10, P1185, DOI 10.1093/intimm/10.8.1185; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; GORDON J, 1994, IMMUNOL TODAY, V15, P411, DOI 10.1016/0167-5699(94)90270-4; GORDON J, 1991, EUR J IMMUNOL, V21, P1917, DOI 10.1002/eji.1830210821; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEROLD C, 1995, INT IMMUNOL, V7, P1, DOI 10.1093/intimm/7.1.1; Herold C, 1996, J IMMUNOL, V157, P5262; KATIRA A, 1992, IMMUNOLOGY, V76, P422; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LANDOLFI MT, 1997, LEUKOCYTE TYPING, V6, P162; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; NAKAYAMA E, 1989, P NATL ACAD SCI USA, V86, P1352, DOI 10.1073/pnas.86.4.1352; Nomura T, 1996, INT IMMUNOL, V8, P867, DOI 10.1093/intimm/8.6.867; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; ROBINSON WH, 1992, J IMMUNOL, V149, P880; Robinson WH, 1997, IMMUNOGENETICS, V45, P195, DOI 10.1007/s002510050189; SATO H, 1976, IMMUNOGENETICS, V3, P565, DOI 10.1007/BF01576986; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; SUBBARAO B, 1984, J EXP MED, V159, P1796, DOI 10.1084/jem.159.6.1796; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; VAN DE VELDE H, 1991, NATURE, V351, P662; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Venkataraman C, 1998, EUR J IMMUNOL, V28, P3003; Venkataraman C, 1998, J IMMUNOL, V160, P3322; VONHOEGEN I, 1990, J IMMUNOL, V144, P4870; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; YAKURA H, 1986, J IMMUNOL, V137, P1475; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8	54	285	317	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					621	631		10.1016/S1074-7613(00)00062-5	http://dx.doi.org/10.1016/S1074-7613(00)00062-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114375	Bronze			2022-12-18	WOS:000165598500005
J	Hanson, HL; Donermeyer, DL; Ikeda, H; White, JM; Shankaran, V; Old, LJ; Shiku, H; Schreiber, RD; Allen, PM				Hanson, HL; Donermeyer, DL; Ikeda, H; White, JM; Shankaran, V; Old, LJ; Shiku, H; Schreiber, RD; Allen, PM			Eradication of established tumors by CD8(+) T cell adoptive immunotherapy	IMMUNITY			English	Article							CHEMICALLY-INDUCED SARCOMAS; ANTITUMOR IMMUNITY; REJECTION ANTIGEN; IN-VIVO; INFILTRATING LYMPHOCYTES; PROTECTIVE IMMUNITY; PEPTIDE VACCINATION; TRANSGENIC MICE; DENDRITIC CELLS; HUMAN-MELANOMA	We generated the DUC18 T cell receptor transgenic mouse expressing an H-2K(d)-restricted transgenic T cell receptor specific for the syngeneic CMS5 fibrosarcoma rejection antigen mutated ERK2(136-144). DUC18 mice were capable of specifically eliminating lethal CMS5 tumor challenges, and transfer of DUC18 splenocytes to naive nontransgenic recipients conferred protection from subsequent and established CMS5 tumor burdens. Eradication of established tumor burdens by adoptive transfer of DUC18 splenocytes was dose and time dependent. Transferred tumor-specific T cells remained functional in vivo and capable of rejecting small tumors even in the presence of large, established tumor burdens. These findings highlight the kinetic battle between tumor growth and the production of a tumor-specific response and have critical implications for effective adoptive immunotherapy.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Ludwig Inst Canc Res, New York, NY 10158 USA; Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 514, Japan	Washington University (WUSTL); Washington University (WUSTL); Ludwig Institute for Cancer Research; Mie University	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.		Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Shiku, Hiroshi/0000-0002-0362-755X; Schreiber, Robert/0000-0003-1590-2341; White, James Michael/0000-0001-5110-6567	NCI NIH HHS [P01 CA76464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA076464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; BANNERJI R, 1994, J IMMUNOL, V152, P2324; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Cordaro TA, 2000, EUR J IMMUNOL, V30, P1297, DOI 10.1002/(SICI)1521-4141(200005)30:5<1297::AID-IMMU1297>3.0.CO;2-C; CUSTER RP, 1985, AM J PATHOL, V120, P464; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637; GANSBACHER B, 1990, J EXP MED, V172, P1217, DOI 10.1084/jem.172.4.1217; Granziero L, 1999, EUR J IMMUNOL, V29, P1127, DOI 10.1002/(SICI)1521-4141(199904)29:04<1127::AID-IMMU1127>3.0.CO;2-X; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; Hogan B., 1986, MANIPULATING MOUSE E; Hsu BL, 1996, J IMMUNOL, V157, P2291; HU J, 1993, J EXP MED, V177, P1681, DOI 10.1084/jem.177.6.1681; Ikeda H, 1997, P NATL ACAD SCI USA, V94, P6375, DOI 10.1073/pnas.94.12.6375; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kersh GJ, 1998, J IMMUNOL, V161, P585; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; Linehan DC, 1999, SEMIN SURG ONCOL, V17, P72, DOI 10.1002/(SICI)1098-2388(199907/08)17:1<72::AID-SSU9>3.0.CO;2-A; Liu B, 1996, J IMMUNOL, V156, P1117; Marzo AL, 1999, CANCER RES, V59, P1071; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; MINEV BR, 1994, CANCER RES, V54, P4155; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; NAKAGOMI H, 1993, CANCER RES, V53, P5610; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P2233, DOI 10.1073/pnas.96.5.2233; OLD LJ, 1962, ANN NY ACAD SCI, V101, P80, DOI 10.1111/j.1749-6632.1962.tb26446.x; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pardoll DM, 1998, NAT MED, V4, P525, DOI 10.1038/nm0598supp-525; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENSTEIN M, 1984, J IMMUNOL, V132, P2117; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Salvadori S, 1996, J IMMUNOL, V156, P2927; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Shrikant P, 1999, J IMMUNOL, V162, P2858; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Toes REM, 1998, J IMMUNOL, V160, P4449; Toes REM, 1996, J IMMUNOL, V156, P3911; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Wick M, 1997, J EXP MED, V186, P229, DOI 10.1084/jem.186.2.229; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	48	285	291	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					265	276		10.1016/S1074-7613(00)00026-1	http://dx.doi.org/10.1016/S1074-7613(00)00026-1			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981969	Bronze			2022-12-18	WOS:000089132100011
J	Hashimoto, D; Miller, J; Merad, M				Hashimoto, Daigo; Miller, Jennifer; Merad, Miriam			Dendritic Cell and Macrophage Heterogeneity In Vivo	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; PERIPHERAL LYMPHOID ORGANS; SUBCAPSULAR SINUS MACROPHAGES; STEADY-STATE CONDITIONS; MOUSE BONE-MARROW; LANGERHANS CELLS; FUNCTIONAL-PROPERTIES; ANTIGEN-PRESENTATION; CROSS-PRESENTATION; RETINOIC-ACID	Macrophage and dendritic cell (DC) are hematopoietic cells found in all tissues in the steady state that share the ability to sample the environment but have distinct function in tissue immunity. Controversies remain on the best way to distinguish macrophages from DCs in vivo. In this Perspective, we discuss how recent discoveries in the origin of the DC and macrophage lineage help establish key functional differences between tissue DC and macrophage subsets. We also emphasize the need to further understand the functional heterogeneity of the tissue DC and macrophage lineages to better comprehend the complex role of these cells in tissue homeostasis and immunity.	[Hashimoto, Daigo; Miller, Jennifer; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Hashimoto, Daigo; Miller, Jennifer; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Merad, Miriam] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Merad, M (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	miriam.merad@mssm.edu	Hashimoto, Daigo/O-1013-2013	Hashimoto, Daigo/0000-0001-9489-9704	National Institutes of Health [HL086899, AI095611, CA154947]; NATIONAL CANCER INSTITUTE [R01CA154947] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884, U01AI095611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.M. is supported by the National Institutes of Health grants HL086899, AI095611, and CA154947.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Chang-Rodriguez S, 2005, J LEUKOCYTE BIOL, V77, P352, DOI 10.1189/jlb.1004584; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Ducreux J, 2009, IMMUNOL LETT, V124, P77, DOI 10.1016/j.imlet.2009.04.006; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; FLOTTE TJ, 1983, AM J PATHOL, V111, P112; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon SM, 2008, EUR J IMMUNOL, V38, P3257, DOI 10.1002/eji.200838855; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Hemmi H, 2001, INT IMMUNOL, V13, P695, DOI 10.1093/intimm/13.5.695; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; KORN A P, 1973, Experimental Hematology (Charlottesville), V1, P362; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; PUGH CW, 1983, J EXP MED, V157, P1758, DOI 10.1084/jem.157.6.1758; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Randolph GJ, 2011, SCIENCE, V332, P1268, DOI 10.1126/science.1208480; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Soga H, 1997, ARCH HISTOL CYTOL, V60, P53, DOI 10.1679/aohc.60.53; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stoitzner P, 2008, J IMMUNOL, V180, P1991, DOI 10.4049/jimmunol.180.3.1991; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V47, P651; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; You Y, 2011, J IMMUNOL, V186, P2172, DOI 10.4049/jimmunol.1002106	146	284	299	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					323	335		10.1016/j.immuni.2011.09.007	http://dx.doi.org/10.1016/j.immuni.2011.09.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943488	Bronze, Green Accepted			2022-12-18	WOS:000295748100005
J	Wang, YQ; Su, MA; Wan, YSY				Wang, Yunqi; Su, Maureen A.; Wan, Yisong Y.			An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T Cells	IMMUNITY			English	Article							TGF-BETA; EXPRESSION; DIFFERENTIATION; LINEAGE; FOXP3; DISRUPTION; DISTINCT; GENE; INFLAMMATION; PROMOTES	Forkhead Box P3 (Foxp3)-expressing regulatory T (Treg) cells are central to maintaining self-tolerance and immune homeostasis. How Treg cell function and Foxp3 expression are regulated is an important question under intensive investigation. Here, we have demonstrated an essential role for the transcription factor GATA-3, a previously recognized Th2 cell master regulator, in controlling Treg cell function. Treg cell-specific GATA-3 deletion led to a spontaneous inflammatory disorder in mice. GATA-3-null Treg cells were defective in peripheral homeostasis and suppressive function, gained Th17 cell phenotypes, and expressed reduced amounts of Foxp3. In addition, GATA-3 controlled Foxp3 expression by binding to and promoting the activity of cis-acting elements of Foxp3. Furthermore, the combined function of GATA-3 and Foxp3 was essential for Foxp3 expression. These findings provide insights into immune regulatory mechanisms and uncover a critical function of GATA-3 in Treg cells and immune tolerance.	[Wang, Yunqi; Wan, Yisong Y.] Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Su, Maureen A.] Univ N Carolina, Inflammatory Dis Inst, Dept Pediat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wan, YSY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, 221 Med Sch Wing E, Chapel Hill, NC 27599 USA.	wany@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; WANG, YUNQI/F-4668-2014; Wan, Yisong/ABE-1200-2021	Wan, Yisong/0000-0003-4346-9717; Su, Maureen/0000-0002-3680-9982	NIH [R00AI072956]; Lupus Research Institute; University Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072956, K08AI076429, R01AI097392, K99AI072956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; University Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Ghosh (Columbia University) for Foxp3 luciferase reporter constructs; J. Engel (University of Michigan) for GATA-3 cDNA constructs; Y. Zheng (Salk Institute) for suggestions on ChIP assays; R. Haven (Yale University) for FIR and FILIG mice; M. Busslinger and A. Souabni (Research Institute of Molecular Pathology) for Gata3<SUP>fl/fl</SUP> mice, N. Fisher and J. Kalnitsky (University of North Carolina Flow-cytometry facility) for cell sorting; J. Ting and G. Matsushima (University of North Carolina) for helpful discussions. This study is supported by the NIH (R00AI072956), the Lupus Research Institute, and the University Cancer Research Fund (Y.Y.W.).	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Yue-Hien, 2010, V22, P84; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	46	284	292	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 23	2011	35	3					337	348		10.1016/j.immuni.2011.08.012	http://dx.doi.org/10.1016/j.immuni.2011.08.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21924928	Green Submitted, Green Accepted, Bronze			2022-12-18	WOS:000295748100006
J	Watkins, SC; Salter, RD				Watkins, SC; Salter, RD			Functional connectivity between immune cells mediated by tunneling nanotubules	IMMUNITY			English	Article							DENDRITIC CELLS; CUTTING EDGE; RECEPTOR; ACTIVATION; RECOGNITION; MACROPHAGES; DYNAMICS	Intercellular signals can be transmitted through neuronal synapses or through gap junctions, with the latter mediating transmission of calcium fluxes and small molecules between cells. We show here that a third form of communication between cells can be mediated by tunneling nanotubules (TNT). When myeloid-lineage dendritic cells and monocytes are triggered to flux calcium by chemical or mechanical stimulation, the signal can be propagated within seconds to other cells at distances hundreds of microns away via TNT. A complex and transient network of TNT is seen in live cells, with individual tubules exhibiting substantial variation in length and diameter. In addition to calcium fluxes, microinjected dye tracers can be transferred through these connections. Following TNT-mediated stimulation, spreading of lamellipodia occurs in dendritic cells characteristic of that seen during the phagocytic response to bacteria. These results demonstrate that nonneuronal cells can transmit signals to distant cells through a physically connected network.	Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Salter, RD (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.	rds@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Salter, Russell/0000-0003-4553-2986	NATIONAL CANCER INSTITUTE [P01CA073743] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ballarin L, 2002, DEV COMP IMMUNOL, V26, P345, DOI 10.1016/S0145-305X(01)00082-9; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Boitano S, 2000, AM J PHYSIOL-LUNG C, V279, pL623, DOI 10.1152/ajplung.2000.279.4.L623; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dong X, 1999, J IMMUNOL, V163, P5427; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Galkina SI, 2001, EXP CELL RES, V266, P222, DOI 10.1006/excr.2001.5227; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Kornberg T, 1999, Trends Cell Biol, V9, P434, DOI 10.1016/S0962-8924(99)01653-0; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salter RD, 2004, J LEUKOCYTE BIOL, V75, P240, DOI 10.1189/jlb.0703339; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	24	284	296	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					309	318		10.1016/j.immuni.2005.08.009	http://dx.doi.org/10.1016/j.immuni.2005.08.009			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169503	Bronze			2022-12-18	WOS:000232382500009
J	Hock, H; Hamblen, MJ; Rooke, HM; Traver, D; Bronson, RT; Cameron, S; Orkin, SH				Hock, H; Hamblen, MJ; Rooke, HM; Traver, D; Bronson, RT; Cameron, S; Orkin, SH			Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation	IMMUNITY			English	Article							BINDING PROTEIN-ALPHA; C/EBP-ALPHA; PU.1; GRANULOCYTE; EPSILON; IDENTIFICATION; DEFICIENT; MICE; MUTATIONS; CELLS	We report essential roles of zinc finger transcription factor Gfi-1 in myeloid development. Gene-targeted Gfi-1(-/-) mice lack normal neutrophils and are highly susceptible to abscess formation by gram-positive bacteria. Arrested, morphologically atypical, Gr1(+)Mac1(+) myeloid cells expand with age in the bone marrow. RNAs encoding primary but not secondary or tertiary neutrophil (granulocyte) granule proteins are expressed. The atypical Gr1(+)Mac1(+) cell population shares characteristics of both the neutrophil and macrophage lineages and exhibits phagocytosis and respiratory burst activity. Reexpression of Gfi-1 in sorted Gfi-1(-/-) progenitors ex vivo rescues neutrophil differentiation in response to G-CSF. Thus, Gfi-1 not only promotes differentiation of neutrophils but also antagonizes traits of the alternate monocyte/macrophage program.	Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Tufts Univ, Sch Med & Vet Med, Dept Pathol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Grieshaber-Bouyer, Ricardo/R-7512-2016	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Borregaard N, 2001, CURR OPIN HEMATOL, V8, P23, DOI 10.1097/00062752-200101000-00005; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; FREITAS AA, 1986, IMMUNOL REV, V91, P5, DOI 10.1111/j.1600-065X.1986.tb01482.x; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HESTDAL K, 1991, J IMMUNOL, V147, P22; HO MK, 1983, J BIOL CHEM, V258, P636; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Lekstrom-Himes JA, 2001, STEM CELLS, V19, P125, DOI 10.1634/stemcells.19-2-125; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Nakajima H, 2001, BLOOD, V98, P897, DOI 10.1182/blood.V98.4.897; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; ROTHWELL VM, 1987, ONCOGENE RES, V1, P311; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schmidt T, 1998, EMBO J, V17, P5349, DOI 10.1093/emboj/17.18.5349; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 1998, J EXP MED, V188, P1173, DOI 10.1084/jem.188.6.1173; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	38	284	289	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					109	120		10.1016/S1074-7613(02)00501-0	http://dx.doi.org/10.1016/S1074-7613(02)00501-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530980	Bronze			2022-12-18	WOS:000180860600011
J	Mayer-Barber, KD; Andrade, BB; Barber, DL; Hieny, S; Feng, CG; Caspar, P; Oland, S; Gordon, S; Sher, A				Mayer-Barber, Katrin D.; Andrade, Bruno B.; Barber, Daniel L.; Hieny, Sara; Feng, Carl G.; Caspar, Patricia; Oland, Sandy; Gordon, Siamon; Sher, Alan			Innate and Adaptive Interferons Suppress IL-1 alpha and IL-1 beta Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection	IMMUNITY			English	Article							DENDRITIC CELLS; IL-10 PRODUCTION; IFN-GAMMA; IN-VIVO; INTERLEUKIN-1-BETA; MONOCYTES; INFLAMMATION; ACTIVATION; INDUCTION; IMMUNITY	Interleukin-1 (IL-1) receptor signaling is necessary for control of Mycobacterium tuberculosis (Mtb) infection, yet the role of its two ligands, IL-1 alpha and IL-1 beta, and their regulation in vivo are poorly understood. Here, we showed that both IL-1 alpha and IL-1 beta are critically required for host resistance and identified two multifunctional inflammatory monocyte-macrophage and DC populations that coexpressed both IL-1 species at the single-cell level in lungs of Mtb-infected mice. Moreover, we demonstrated that interferons (IFNs) played important roles in regulating IL-1 production by these cells in vivo. Type I interferons inhibited IL-1 production by both subsets whereas CD4(+) T cell-derived IFN-gamma selectively suppressed monocyte-macrophages. These data provide a cellular basis for both the anti-inflammatory effects of IFNs and probacterial functions of type I IFNs during Mtb infection and reveal differential regulation of IL-1 production by distinct cell populations as an additional layer of complexity in the activity of IL-1 in vivo.	[Mayer-Barber, Katrin D.; Andrade, Bruno B.; Barber, Daniel L.; Hieny, Sara; Feng, Carl G.; Caspar, Patricia; Oland, Sandy; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Gordon, Siamon] Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford	Mayer-Barber, KD (corresponding author), NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	mayerk@niaid.nih.gov; asher@niaid.nih.gov	Andrade, Bruno/J-9111-2012; Andrade, Bruno/AAI-2248-2020	Andrade, Bruno/0000-0001-6833-3811; feng, carl/0000-0003-4301-4640	NIAID, NIH; NIAID; NCI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001044] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the NIAD flow cytometry core facility and in particular B. Hague for assistance with the BSL3 FACS sorting and to the staff of the NIAID animal BSL3 facility for excellent technical help. We thank K. Shenderov, G. Trinchieri, Y. Belkaid, and R. Goldzmid for valuable discussion. This research was supported by the Intramural Research Program of the NIAID, NIH. S.G.'s contributions occurred during a sabbatical supported by a stipend from the NIAID and NCI intramural programs.	Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Dinarello CA, 2010, ARTHRITIS RHEUM-US, V62, P3140, DOI 10.1002/art.27663; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu XY, 2005, J IMMUNOL, V175, P131, DOI 10.4049/jimmunol.175.1.131; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Saunders BM, 2004, CLIN EXP IMMUNOL, V137, P279, DOI 10.1111/j.1365-2249.2004.02518.x; SCHINDLER R, 1989, LYMPHOKINE RES, V8, P275; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Thacker SG, 2010, J IMMUNOL, V185, P4457, DOI 10.4049/jimmunol.1001782; TILG H, 1993, J IMMUNOL, V150, P4687; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Walter K, 2010, IMMUNOBIOLOGY, V215, P804, DOI 10.1016/j.imbio.2010.05.015; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	46	283	292	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					1023	1034		10.1016/j.immuni.2011.12.002	http://dx.doi.org/10.1016/j.immuni.2011.12.002			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195750	Bronze, Green Accepted			2022-12-18	WOS:000298777300019
J	Gri, G; Piconese, S; Frossi, B; Manfroi, V; Merluzzi, S; Tripodo, C; Viola, A; Odom, S; Rivera, J; Colombo, MP; Pucillo, CE				Gri, Giorgia; Piconese, Silvia; Frossi, Barbara; Manfroi, Vanessa; Merluzzi, Sonia; Tripodo, Claudio; Viola, Antonella; Odom, Sandra; Rivera, Juan; Colombo, Mario P.; Pucillo, Carlo E.			CD4(+)CD25(+) Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction	IMMUNITY			English	Article							OX40 LIGAND; MONOCLONAL-ANTIBODY; CUTTING EDGE; MURINE MODEL; B-CELLS; ACTIVATION; EXPRESSION; ASTHMA; ROLES; CD134	T regulatory (Treg) cells play a role in the suppression of immune responses, thus serving to induce tolerance and control autoimmunity. Here, we explored whether Treg cells influence the immediate hypersensitivity response of mast cells (MCs). Treg cells directly inhibited the Fc epsilon RI-dependent MC degranulation through cell-cell contact involving OX40-OX40L interactions between Treg cells and MCs, respectively. When activated in the presence of Treg cells, MCs showed increased cyclic adenosine monophosphate (cAMP) concentrations and reduced Ca2+ influx, independently of phospholipase C (PLC)-gamma 2 or Ca2+ release from intracellular stores. Antagonism of cAMP in MCs reversed the inhibitory effects of Treg cells, restoring normal Ca2+ responses and degranulation. Importantly, the in vivo depletion or inactivation of Treg cells caused enhancement of the anaphylactic response. The demonstrated crosstalk between Treg cells and MCs defines a previously unrecognized mechanism controlling MC degranulation. Loss of this interaction may contribute to the severity of allergic responses.	[Piconese, Silvia; Colombo, Mario P.] Fdn IRCCS, Ist Nazl Tumori, Dept Expt Oncol, Immunotherapy & Gene Therapy Unit, I-20133 Milan, Italy; [Gri, Giorgia; Frossi, Barbara; Manfroi, Vanessa; Merluzzi, Sonia; Pucillo, Carlo E.] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Gri, Giorgia; Frossi, Barbara; Manfroi, Vanessa; Merluzzi, Sonia; Pucillo, Carlo E.] Univ Udine, MATI Ctr Excellence, I-33100 Udine, Italy; [Tripodo, Claudio] Univ Palermo, Dept Human Pathol, I-90127 Palermo, Italy; [Viola, Antonella] Univ Padua, Dept Biomed Sci, I-35129 Padua, Italy; [Viola, Antonella] Venetian Inst Mol Med, I-35129 Padua, Italy; [Odom, Sandra; Rivera, Juan] Natl Inst Arthrit Musculoskeletal & Skin Dis, Lab Immune Cell Signaling, NIH, Bethesda, MD 20892 USA	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Udine; University of Udine; University of Palermo; University of Padua; Veneto Institute Molecular Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Colombo, MP (corresponding author), Fdn IRCCS, Ist Nazl Tumori, Dept Expt Oncol, Immunotherapy & Gene Therapy Unit, I-20133 Milan, Italy.	mario.colombo@istitutotumori.mi.it	Tripodo, Claudio/O-4536-2016; Colombo, Mario P./V-7166-2017; Frossi, Barbara/AFL-0800-2022; Pucillo, Carlo/A-5515-2008; Tripodo, Claudio/AAB-6004-2022; Agatea, Lisa/L-8267-2016; Viola, Antonella/A-4321-2015	Tripodo, Claudio/0000-0002-0821-6231; Colombo, Mario P./0000-0003-0042-7955; Frossi, Barbara/0000-0001-9855-2396; Pucillo, Carlo/0000-0002-4872-6156; Tripodo, Claudio/0000-0002-0821-6231; Piconese, Silvia/0000-0002-9685-5227; Viola, Antonella/0000-0002-0125-9271; GRI, Giorgia/0000-0002-2826-0459	Ministero dell'lstruzione Universita e Ricerca; Agenzia Spaziale Italiana (Progetto OSMA); Associazione Italana Ricerca sul Cancro; LR.11 del Friuli Venezia Giulia; Fondazione Italiana Ricerca sul Cancro; National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041155, ZIAAR041156] Funding Source: NIH RePORTER	Ministero dell'lstruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana (Progetto OSMA)(Agenzia Spaziale Italiana (ASI)); Associazione Italana Ricerca sul Cancro; LR.11 del Friuli Venezia Giulia; Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Ministero dell'lstruzione Universita e Ricerca (PRIN 2005), Agenzia Spaziale Italiana (Progetto OSMA), Associazione Italana Ricerca sul Cancro, and LR.11 del Friuli Venezia Giulia. S.P. is supported by a fellowship from Fondazione Italiana Ricerca sul Cancro. The work of J.R. and S.O. was supported by the National Institute of Arthritis, Musculoskeletal and Skin Diseases of the National Institutes of Health. We thank A.H. Sharpe (Harvard University) for providing Tnfsf4<SUP>-/-</SUP> bone marrow and I. Arioli for technical assistance. We also thank D. Cesselli and E. Puppato for cell sorting.	Akdis M, 2006, CURR OPIN IMMUNOL, V18, P738, DOI 10.1016/j.coi.2006.06.003; Arestides RSS, 2002, EUR J IMMUNOL, V32, P2874, DOI 10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4; Bhattacharyya SP, 1998, J LEUKOCYTE BIOL, V63, P337, DOI 10.1002/jlb.63.3.337; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bradding P, 2005, CHEM IMMUNOL ALLERGY, V87, P163, DOI 10.1159/000087643; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P683, DOI 10.1016/j.jaci.2003.12.311; Christy AL, 2007, J IMMUNOL, V179, P2673, DOI 10.4049/jimmunol.179.5.2673; Fonseca PC, 2006, CYTOM PART A, V69A, P487, DOI 10.1002/cyto.a.20255; Frossi B, 2007, J IMMUNOL, V178, P2549, DOI 10.4049/jimmunol.178.4.2549; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Hua XY, 2007, J EXP MED, V204, P117, DOI 10.1084/jem.20061372; Inamura N, 1998, J IMMUNOL, V160, P4026; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; LIU FT, 1980, J IMMUNOL, V124, P2728; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Lorentz A, 2005, J IMMUNOL, V174, P6751, DOI 10.4049/jimmunol.174.11.6751; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Merluzzi S, 2008, MOL IMMUNOL, V45, P76, DOI 10.1016/j.molimm.2007.05.010; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Patel DD, 2001, J CLIN INVEST, V107, P155, DOI 10.1172/JCI11966; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; Pippig SD, 1999, J IMMUNOL, V163, P6520; Ring J, 2001, CURR OPIN IMMUNOL, V13, P701, DOI 10.1016/S0952-7915(01)00282-5; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sayed BA, 2007, IMMUNOL REV, V217, P53, DOI 10.1111/j.1600-065X.2007.00524.x; Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x; Simon AK, 2007, EUR J IMMUNOL, V37, P758, DOI 10.1002/eji.200636593; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Treter S, 2000, CELL IMMUNOL, V206, P116, DOI 10.1006/cimm.2000.1739; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Vliagoftis H, 1999, J ALLERGY CLIN IMMUN, V103, P656, DOI 10.1016/S0091-6749(99)70239-3; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Wing K, 2006, CURR OPIN ALLERGY CL, V6, P482, DOI 10.1097/01.all.0000246625.79988.12; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740	51	283	298	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2008	29	5					771	781		10.1016/j.immuni.2008.08.018	http://dx.doi.org/10.1016/j.immuni.2008.08.018			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18993084	Green Accepted, Bronze			2022-12-18	WOS:000261036000014
J	Kjer-Nielsen, L; Clements, CS; Purcell, AW; Brooks, AG; Whisstock, JC; Burrows, SR; McCluskey, J; Rossjohn, J				Kjer-Nielsen, L; Clements, CS; Purcell, AW; Brooks, AG; Whisstock, JC; Burrows, SR; McCluskey, J; Rossjohn, J			A structural basis for the selection of dominant alpha beta T cell receptors in antiviral immunity	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; CRYSTAL-STRUCTURE; ANTIGEN RECEPTOR; AMINO-ACIDS; HYPERVARIABLE REGIONS; CANONICAL STRUCTURES; MHC RESTRICTION; COMPLEX; PEPTIDE; RECOGNITION	We have examined the basis for immunodominant or "public" TCR usage in an antiviral CTL response. Residues encoded by each of the highly selected genetic elements of an immunodominant clonotype recognizing Epstein-Barr virus were critical to the antigen specificity of the receptor. Upon recognizing antigen the immunodominant TCR undergoes extensive conformational changes in the complementarity determining regions (CDRs), including the disruption of the canonical structures of the germline-encoded CDR1alpha and CDR2alpha loops to produce an enhanced fit with the HLA-peptide complex. TCR ligation induces conformational changes in the TCRalpha constant domain thought to form part of the docking site for CD3epsilon. These findings indicate that TCR immunodominance is associated with structural properties conferring receptor specificity and suggest a novel structural link between TCR ligation and intracellular signaling.	Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3168, Australia; Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3168, Australia; Queensland Inst Med Res, Bancroft Ctr, Herston, Qld, Australia	University of Melbourne; Monash University; Monash University; QIMR Berghofer Medical Research Institute	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.		Burrows, Scott/G-2050-2011; McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; Rossjohn, Jamie/F-9032-2013	Burrows, Scott/0000-0002-1430-0472; McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Rossjohn, Jamie/0000-0002-2020-7522; Whisstock, James/0000-0003-4200-5611; Brooks, Andrew/0000-0002-4085-9683				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bourcier KD, 2001, J VIROL, V75, P9836, DOI 10.1128/JVI.75.20.9836-9843.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CALLAN MFC, 1995, EUR J IMMUNOL, V25, P1529, DOI 10.1002/eji.1830250609; Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.3.CO;2-Q; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Correia-Neves M, 1999, J IMMUNOL, V163, P5471; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garboczi DN, 1999, IMMUNITY, V10, P1, DOI 10.1016/S1074-7613(00)80001-1; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Karaivanova V, 1999, HYBRIDOMA, V18, P497; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; LESK AM, 1986, BIOSEQUENCES PERSPEC, P23; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Machius M, 2001, J MOL BIOL, V310, P689, DOI 10.1006/jmbi.2001.4794; Moss DJ, 2001, PHILOS T ROY SOC B, V356, P475, DOI 10.1098/rstb.2000.0784; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TOMONARI K, 1992, INT IMMUNOL, V4, P1195, DOI 10.1093/intimm/4.10.1195; TorresNagel N, 1997, INT IMMUNOL, V9, P1441, DOI 10.1093/intimm/9.10.1441; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	54	283	289	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					53	64		10.1016/S1074-7613(02)00513-7	http://dx.doi.org/10.1016/S1074-7613(02)00513-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530975	Bronze			2022-12-18	WOS:000180860600006
J	Campbell, KA; Ovendale, PJ; Kennedy, MK; Fanslow, WC; Reed, SG; Maliszewski, CR				Campbell, KA; Ovendale, PJ; Kennedy, MK; Fanslow, WC; Reed, SG; Maliszewski, CR			CD40 ligand is required for protective cell-mediated immunity to Leishmania major	IMMUNITY			English	Article							MURINE CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; T-CELLS; MICE; INTERLEUKIN-12; RESISTANCE; MACROPHAGES; SUBSETS; PARASITE; ANTIGENS	The CD40-CD40 ligand (CD40L) signaling process is a pivotal component of multiple immunoregulatory pathways. Although the role that CD40L plays in humoral immune responses is fairly well defined, its function(s) in cell-mediated responses in vivo has not been established. We investigated this issue by assessing the course of Leishmania major infection in CD40L knockout (CD40LKO) mice that were generated on a resistant background. In response to parasite challenge, CD40LKO mice developed ulcerating cutaneous lesions and failed to mount a vigorous Th1-like response. The impaired Th1-like response appears to be related to a defect in the ability of CD40LKO T cells to induce the production of IL-12 from macrophages. Treatment with exogenous IL-12 prevented disease progression in CD40LKO mice, and administration of recombinant CD40L provided partial protection against infection. Thus, a protective cell-mediated immune response to L. major appears to be dependent upon CD40L-induced IL-12 secretion by antigen-presenting cells.	INFECT DIS RES INST,SEATTLE,WA 98104; IMMUNEX CORP,DEPT IMMUNOBIOL,SEATTLE,WA 98101	Immunex Corporation	Campbell, KA (corresponding author), IMMUNEX CORP,DEPT CELLULAR IMMUNOL,51 UNIV ST,SEATTLE,WA 98101, USA.							ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARMITAGE RJ, 1993, EUR J IMMUNOL, V23, P2326, DOI 10.1002/eji.1830230941; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; BUHLMANN JE, 1995, IMMUNITY, V2, P645; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; DING AH, 1988, J IMMUNOL, V141, P2407; DURIE FH, 1994, J CLIN INVEST, V94, P1333, DOI 10.1172/JCI117453; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; FLESCH IEA, 1995, J EXP MED, V181, P1615, DOI 10.1084/jem.181.5.1615; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; HAYES MP, 1995, BLOOD, V86, P646, DOI 10.1182/blood.V86.2.646.bloodjournal862646; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1995, J IMMUNOL, V155, P730; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P2271, DOI 10.1002/eji.1830241002; KENNEDY MK, 1996, IN PRESS EUR J IMMUN; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; LOCKSLEY RM, 1993, P NATL ACAD SCI USA, V90, P5879, DOI 10.1073/pnas.90.13.5879; MACATONIA SE, 1993, INT IMMUNOL, V5, P1119, DOI 10.1093/intimm/5.9.1119; MORRIS L, 1993, INFECT IMMUN, V61, P3459, DOI 10.1128/IAI.61.8.3459-3465.1993; MURPHY EE, 1994, J EXP MED, V180, P223, DOI 10.1084/jem.180.1.223; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SADICK MD, 1986, J IMMUNOL, V136, P655; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SCHARTONKERSTEN T, 1995, J LEUKOCYTE BIOL, V57, P515, DOI 10.1002/jlb.57.4.515; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Stout RD, 1996, J IMMUNOL, V156, P8; TIAN LC, 1995, EUR J IMMUNOL, V25, P306, DOI 10.1002/eji.1830250152; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; WILEY JA, 1995, J IMMUNOL, V155, P3525; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	48	283	287	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1996	4	3					283	289		10.1016/S1074-7613(00)80436-7	http://dx.doi.org/10.1016/S1074-7613(00)80436-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624818	Bronze			2022-12-18	WOS:A1996UC01800009
J	Simoni, Y; Fehlings, M; Kloverpris, HN; McGovern, N; Koo, SL; Loh, CY; Lim, S; Kurioka, A; Fergusson, JR; Tang, CL; Kam, MH; Dennis, K; Lim, TKH; Fui, ACY; Hoong, CW; Chan, JKY; de Lafaille, MC; Narayanan, S; Baig, S; Shabeer, M; Toh, SAES; Tan, HKK; Anicete, R; Tan, EH; Takano, A; Klenerman, P; Leslie, A; Tan, DSW; Tan, IB; Ginhoux, F; Newell, EW				Simoni, Yannick; Fehlings, Michael; Kloverpris, Henrik N.; McGovern, Naomi; Koo, Si-Lin; Loh, Chiew Yee; Lim, Shawn; Kurioka, Ayako; Fergusson, Joannah R.; Tang, Choong-Leong; Kam, Ming Hian; Dennis, Koh; Lim, Tony Kiat Hon; Fui, Alexander Chung Yaw; Hoong, Chan Weng; Chan, Jerry Kok Yen; de Lafaille, Maria Curotto; Narayanan, Sriram; Baig, Sonia; Shabeer, Muhammad; Toh, Sue-Anne Ee Shiow; Tan, Henry Kun Kiaang; Anicete, Rosslyn; Tan, Eng-Huat; Takano, Angela; Klenerman, Paul; Leslie, Alasdair; Tan, Daniel S. W.; Tan, Iain Beehuat; Ginhoux, Florent; Newell, Evan W.			Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency	IMMUNITY			English	Article							INFLAMMATION; EXPRESSION; INTERLEUKIN-2; HOMEOSTASIS; ACTIVATION; DISEASE; UNIQUE; IL-18; FATE	Animal models have highlighted the importance of innate lymphoid cells (ILCs) in multiple immune responses. However, technical limitations have hampered adequate characterization of ILCs in humans. Here, we used mass cytometry including a broad range of surface markers and transcription factors to accurately identify and profile ILCs across healthy and inflamed tissue types. High dimensional analysis allowed for clear phenotypic delineation of ILC2 and ILC3 subsets. We were not able to detect ILC1 cells in any of the tissues assessed, however, we identified intra-epithelial (ie) ILC1-like cells that represent a broader category of NK cells in mucosal and non-mucosal pathological tissues. In addition, we have revealed the expression of phenotypic molecules that have not been previously described for ILCs. Our analysis shows that human ILCs are highly heterogeneous cell types between individuals and tissues. It also provides a global, comprehensive, and detailed description of ILC heterogeneity in humans across patients and tissues.	[Simoni, Yannick; Fehlings, Michael; McGovern, Naomi; Loh, Chiew Yee; Lim, Shawn; de Lafaille, Maria Curotto; Ginhoux, Florent; Newell, Evan W.] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Kloverpris, Henrik N.; Leslie, Alasdair] Africa Hlth Res Inst, ZA-4001 Durban, South Africa; [Kloverpris, Henrik N.] Univ Copenhagen, Dept Immunol & Microbiol, DK-1165 Copenhagen, Denmark; [Koo, Si-Lin; Tan, Eng-Huat; Tan, Daniel S. W.; Tan, Iain Beehuat] Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore; [Kurioka, Ayako; Fergusson, Joannah R.; Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England; [Tang, Choong-Leong; Kam, Ming Hian; Dennis, Koh] Singapore Gen Hosp, Dept Colorectal Surg, Singapore 169856, Singapore; [Dennis, Koh] Mt Elizabeth Med Ctr, Colorectal Practice, Singapore 228510, Singapore; [Lim, Tony Kiat Hon; Takano, Angela] Singapore Gen Hosp, Dept Anat Pathol, Singapore 169608, Singapore; [Fui, Alexander Chung Yaw] Singapore Gen Hosp, Dept Hepatopancreatobiliary Transplant Surg, Singapore 169608, Singapore; [Hoong, Chan Weng] Singapore Gen Hosp, Dept Upper GI Bariatr Surg, Singapore 169608, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Chan, Jerry Kok Yen; Toh, Sue-Anne Ee Shiow; Tan, Iain Beehuat] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Narayanan, Sriram] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Baig, Sonia; Toh, Sue-Anne Ee Shiow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore; [de Lafaille, Maria Curotto] NYU, Sch Med, 550 1st Ave, New York, NY 10012 USA; [Toh, Sue-Anne Ee Shiow] Natl Univ Hlth Syst, Dept Med, Singapore 119228, Singapore; [Toh, Sue-Anne Ee Shiow] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tan, Henry Kun Kiaang; Anicete, Rosslyn] KK Womens & Childrens Hosp, Dept Otolaryngol, Singapore 229899, Singapore; [Tan, Daniel S. W.; Tan, Iain Beehuat] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Africa Health Research Institute; University of Copenhagen; National Cancer Centre Singapore (NCCS); University of Oxford; Singapore General Hospital; Mount Elizabeth Medical Centre; Singapore General Hospital; Singapore General Hospital; Singapore General Hospital; KK Women's & Children's Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; New York University; National University of Singapore; University of Pennsylvania; Pennsylvania Medicine; KK Women's & Children's Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Simoni, Y (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	yannick_simoni@immunol.a-star.edu.sg; evan_newell@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012	Newell, Evan W/0000-0002-2889-243X; SIMONI, Yannick/0000-0002-9086-3680; leslie, alasdair/0000-0003-2538-6467; klenerman, paul/0000-0003-4307-9161; Koo, Si-Lin/0000-0002-8217-3321; McGovern, Naomi/0000-0001-5200-2698; Kloverpris, Henrik/0000-0002-2165-3313	A-STAR/SIgN core funding; A-STAR/SIgN immunomonitoring platform funding; Translational & Clinical Research grand from the National Medical Research Council, Singapore [NMRC/TCR/007-NCC/2013]; National Cancer Center Singapore [CG/007/2013-SD2 (NCCSPG-YR2015-JUL-13)]; NIHR Biomedical Research Centre, Oxford; NIHR Senior Fellowship;  [WT109965MA]; Lundbeck Foundation [R151-2013-14624] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10005] Funding Source: researchfish	A-STAR/SIgN core funding; A-STAR/SIgN immunomonitoring platform funding; Translational & Clinical Research grand from the National Medical Research Council, Singapore; National Cancer Center Singapore; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIHR Senior Fellowship; ; Lundbeck Foundation(Lundbeckfonden); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank all members of E.N. and F.G. laboratory, Etienne Becht, Harsimran Singh, the SIgN community, and the SIgN flow cytometry and luminex facilities. This study was funded by A-STAR/SIgN core funding, A-STAR/SIgN immunomonitoring platform funding, a Translational & Clinical Research grand from the National Medical Research Council, Singapore (NMRC/TCR/007-NCC/2013) and the National Cancer Center Singapore CG/007/2013-SD2 (NCCSPG-YR2015-JUL-13). P.K. is supported by NIHR Biomedical Research Centre, Oxford, an NIHR Senior Fellowship and WT109965MA.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hazenberg MD, 2014, BLOOD, V124, P700, DOI 10.1182/blood-2013-11-427781; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Morandi B, 2005, J IMMUNOL, V175, P3690, DOI 10.4049/jimmunol.175.6.3690; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Newell EW, 2016, NAT IMMUNOL, V17, P890, DOI 10.1038/ni.3485; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Robinette ML, 2016, HLA, V87, P5, DOI 10.1111/tan.12723; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Vonarbourg C, 2012, SEMIN IMMUNOL, V24, P165, DOI 10.1016/j.smim.2012.03.002; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318	34	282	287	3	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					148	161		10.1016/j.immuni.2016.11.005	http://dx.doi.org/10.1016/j.immuni.2016.11.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	27986455	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000392918300017
J	Lazear, HM; Nice, TJ; Diamond, MS				Lazear, Helen M.; Nice, Timothy J.; Diamond, Michael S.			Interferon-lambda: Immune Functions at Barrier Surfaces and Beyond	IMMUNITY			English	Review							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-C; III INTERFERON; IFN-LAMBDA; ANTIVIRAL ACTIVITY; STIMULATED GENES; DIFFERENTIAL EXPRESSION; NOROVIRUS INFECTION; SIGNAL-TRANSDUCTION; SUSCEPTIBILITY LOCI	When type III interferon (IFN-lambda; also known as interleukin-28 [IL-28] and IL-29) was discovered in 2003, its antiviral function was expected to be analogous to that of type I IFNs (IFN-alpha and IFN-beta) via the induction of IFN-stimulated genes (ISGs). Although IFN-lambda stimulates expression of antiviral ISGs preferentially in cells of epithelial origin, recent studies have defined additional antiviral mechanisms in other cell types and tissues. Viral infection models using mice lacking IFN-lambda signaling and SNP associations with human disease have expanded our understanding of the contribution of IFN-lambda to the antiviral response at anatomic barriers and the immune response beyond these barriers. In this review, we highlight recent insights into IFN-lambda functions, including its ability to restrict virus spread into the brain and to clear chronic viral infections in the gastrointestinal tract. We also discuss how IFN-lambda modulates innate and adaptive immunity, autoimmunity, and tumor progression and its possible therapeutic applications in human disease.	[Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Nice, Timothy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Diamond, Michael/AAH-1733-2019; Nice, Timothy/X-9114-2019	Diamond, Michael/0000-0002-8791-3165; Nice, Timothy/0000-0002-4471-7666; Lazear, Helen/0000-0002-8649-4579	NIH [U19 AI083019, R01 AI074973, 5T32A100716334]; Cancer Research Institute; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI074973, R01AI104972, R01AI104002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants U19 AI083019 and R01 AI074973 (M.S.D). T.J.N. was supported by NIH training grant 5T32A100716334 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society.	Alexopoulou A, 2015, ANN GASTROENTEROL, V28, P55; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Bandi P, 2010, J INTERF CYTOK RES, V30, P123, DOI 10.1089/jir.2009.0049; Banos-Lara MD, 2015, J VIROL, V89, P730, DOI 10.1128/JVI.02897-14; Bibert S, 2014, AIDS, V28, P1885, DOI 10.1097/QAD.0000000000000379; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Booy S, 2015, J INTERF CYTOK RES, V35, P327, DOI 10.1089/jir.2014.0157; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Cannella F, 2014, MED MICROBIOL IMMUN, V203, P177, DOI 10.1007/s00430-014-0330-9; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Clark RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007504; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773; Crow YJ, 2015, CURR OPIN IMMUNOL, V32, P7, DOI 10.1016/j.coi.2014.10.005; Dai JH, 2009, BLOOD, V113, P5829, DOI 10.1182/blood-2008-09-179507; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Di Trolio R, 2015, CYTOKINE GROWTH F R, V26, P203, DOI 10.1016/j.cytogfr.2014.11.008; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Egli A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004556; Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Epperson ML, 2012, IMMUNOL REV, V250, P199, DOI 10.1111/imr.12009; Forrest JC, 2003, J VIROL, V77, P9109, DOI 10.1128/JVI.77.17.9109-9115.2003; Fox J. M., 2015, J INTERFERON CYTOKIN; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Galmozzi E, 2014, ALIMENT PHARM THER, V39, P569, DOI 10.1111/apt.12631; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Grayfer L, 2015, J VIROL, V89, P5072, DOI 10.1128/JVI.00051-15; Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Hermant P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087906; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Huang JY, 2007, P NATL ACAD SCI USA, V104, P9822, DOI 10.1073/pnas.0610352104; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382; Jordan WJ, 2007, GENES IMMUN, V8, P13, DOI 10.1038/sj.gene.6364348; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kim HJ, 2013, AM J RESP CELL MOL, V49, P855, DOI 10.1165/rcmb.2013-0003OC; Koch S, 2015, J INNATE IMMUN, V7, P224, DOI 10.1159/000369459; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Li Y, 2013, J MED GENET, V50, P812, DOI 10.1136/jmedgenet-2013-101787; de Lapuente AL, 2012, J NEUROIMMUNOL, V245, P98, DOI 10.1016/j.jneuroim.2012.02.005; Lopez S, 2006, CURR TOP MICROBIOL, V309, P39; Love AC, 2014, INFECT IMMUN, V82, P2405, DOI 10.1128/IAI.01617-14; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Mahlakoiv T, 2012, J GEN VIROL, V93, P2601, DOI 10.1099/vir.0.046284-0; Malhotra S, 2011, J NEUROIMMUNOL, V239, P101, DOI 10.1016/j.jneuroim.2011.08.004; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068; Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Muir AJ, 2014, J HEPATOL, V61, P1238, DOI 10.1016/j.jhep.2014.07.022; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pagliaccetti NE, 2010, VIRUSES-BASEL, V2, P1589, DOI 10.3390/v2081589; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pietila TE, 2010, J LEUKOCYTE BIOL, V88, P665, DOI 10.1189/jlb.1009651; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Reuter A, 2014, J VIROL, V88, P2835, DOI 10.1128/JVI.02764-13; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Russell CD, 2014, DNA CELL BIOL, V33, P60, DOI 10.1089/dna.2013.2261; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Siegel R, 2011, J IMMUNOL, V187, P5636, DOI 10.4049/jimmunol.1003988; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Sorgeloos F, 2013, VIRUSES-BASEL, V5, P834, DOI 10.3390/v5030834; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Srinivas S, 2008, IMMUNOLOGY, V125, P492, DOI 10.1111/j.1365-2567.2008.02862.x; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Swider A, 2014, CYTOKINE, V65, P17, DOI 10.1016/j.cyto.2013.09.020; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Travar M, 2014, SCAND J IMMUNOL, V80, P43, DOI 10.1111/sji.12178; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1016/j.jaci.2003.07.001; Wongthida P, 2010, CANCER RES, V70, P4539, DOI 10.1158/0008-5472.CAN-09-4658; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025385; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	150	282	306	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					15	28		10.1016/j.immuni.2015.07.001	http://dx.doi.org/10.1016/j.immuni.2015.07.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200010	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000360101100007
J	Jameson, SC; Masopust, D				Jameson, Stephen C.; Masopust, David			Diversity in T Cell Memory: An Embarrassment of Riches	IMMUNITY			English	Review							IL-7 RECEPTOR-ALPHA; CUTTING EDGE; HOMEOSTATIC PROLIFERATION; CLONAL EXPANSIONS; CD8(+) MEMORY; PROMOTES DIFFERENTIATION; SECONDARY EXPANSION; DENDRITIC CELLS; LUNG AIRWAYS; BONE-MARROW	The adaptive immune response meets the needs of the organism to generate effector cells capable of controlling pathogens but also leads to production of memory cells, which mediate more effective protection during rechallenge. In this review, we focus on the generation, maintenance, and function of memory T cells, with a special emphasis on the increasing evidence for great diversity among functional memory T cell subsets.	[Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Masopust, David] Univ Minnesota, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	masopust@umn.edu	Jameson, Stephen C/D-9892-2013; masopust, david/B-5027-2008	Jameson, Stephen C/0000-0001-9137-1146; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075168] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075168, R01 AI075168-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Buentke E, 2006, BLOOD, V108, P1949, DOI 10.1182/blood-2006-04-016857; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Clamby ET, 2008, P NATL ACAD SCI USA, V105, P12997, DOI 10.1073/pnas.0805465105; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Riva A, 2007, J IMMUNOL, V178, P5488, DOI 10.4049/jimmunol.178.9.5488; Dudani R, 2008, J IMMUNOL, V181, P1700, DOI 10.4049/jimmunol.181.3.1700; Ely KH, 2007, J IMMUNOL, V179, P3535, DOI 10.4049/jimmunol.179.6.3535; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V171, P3338, DOI 10.4049/jimmunol.171.7.3338; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Huang T, 2005, CLIN IMMUNOL, V117, P221, DOI 10.1016/j.clim.2005.09.012; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; KALLIES A, 2009, IMMUNITY IN PRESS; Kassiotis G, 2004, J IMMUNOL, V173, P7292, DOI 10.4049/jimmunol.173.12.7292; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Leignadier J, 2008, P NATL ACAD SCI USA, V105, P20440, DOI 10.1073/pnas.0806289106; LIANG SH, 1994, J IMMUNOL, V152, P1653; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; MANS CH, 2003, J IMMUNOL, V171, P2393; Marzo AL, 2007, J IMMUNOL, V179, P36, DOI 10.4049/jimmunol.179.1.36; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; Masopust D, 2001, J IMMUNOL, V166, P2348, DOI 10.4049/jimmunol.166.4.2348; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Messaoudi I, 2006, J IMMUNOL, V177, P2784, DOI 10.4049/jimmunol.177.5.2784; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nanan R, 2000, J GEN VIROL, V81, P1313, DOI 10.1099/0022-1317-81-5-1313; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; RUTISHAUSER RL, 2009, IMMUNITY IN PRESS; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Schuler T, 2004, J IMMUNOL, V172, P15, DOI 10.4049/jimmunol.172.1.15; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Shaulov A, 2008, J IMMUNOL, V180, P1131, DOI 10.4049/jimmunol.180.2.1131; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; van der Most RG, 2003, INT IMMUNOL, V15, P119, DOI 10.1093/intimm/dxg009; Van Epps HL, 2002, J EXP MED, V196, P579, DOI 10.1084/jem.20011255; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Leeuwen EMM, 2006, J IMMUNOL, V177, P4998, DOI 10.4049/jimmunol.177.8.4998; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2008, J IMMUNOL, V180, P6777, DOI 10.4049/jimmunol.180.10.6777; Whitmire JK, 2007, J IMMUNOL, V179, P1190, DOI 10.4049/jimmunol.179.2.1190; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Xiao ZG, 2009, J IMMUNOL, V182, P2786, DOI 10.4049/jimmunol.0803484; Zhou H, 2009, J IMMUNOL, V182	140	282	295	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					859	871		10.1016/j.immuni.2009.11.007	http://dx.doi.org/10.1016/j.immuni.2009.11.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064446	Bronze, Green Accepted			2022-12-18	WOS:000273616400007
J	Silver, AC; Arjona, A; Walker, WE; Fikrig, E				Silver, Adam C.; Arjona, Alvaro; Walker, Wendy E.; Fikrig, Erol			The Circadian Clock Controls Toll-like Receptor 9-Mediated Innate and Adaptive Immunity	IMMUNITY			English	Article							CPG OLIGODEOXYNUCLEOTIDES; GENE-EXPRESSION; IFN-GAMMA; RHYTHMS; CELLS; RESPONSES; SEPSIS; SYSTEM; SLEEP; MACROPHAGES	Circadian rhythms refer to biologic processes that oscillate with a period of similar to 24 hr. These rhythms are sustained by a molecular clock and provide a temporal matrix that ensures the coordination of homeostatic processes with the periodicity of environmental challenges. We demonstrate the circadian molecular clock controls the expression and function of Toll-like receptor 9 (TLR9). In a vaccination model using TLR9 ligand as adjuvant, mice immunized at the time of enhanced TLR9 responsiveness presented weeks later with an improved adaptive immune response. In a TLR9-dependent mouse model of sepsis, we found that disease severity was dependent on the timing of sepsis induction, coinciding with the daily changes in TLR9 expression and function. These findings unveil a direct molecular link between the circadian and innate immune systems with important implications for immunoprophylaxis and immunotherapy.	[Silver, Adam C.; Arjona, Alvaro; Walker, Wendy E.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA; [Walker, Wendy E.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	erol.fikrig@yale.edu	Walker, Wendy/GQB-0819-2022; Arjona, PhD, Alvaro/AAX-8914-2021		National Institutes of Health [AI079360, AI50031, T32 AI07019, N01 HHSN272201100019C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079360, N01AI050031, T32AI007019, R01AI041440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Chen for technical assistance with the qPCR and immunoblot analysis, K. DePonte and D. Beck for assistance with the animal work, and A. Bozzi for help with the sepsis model. This work was supported by National Institutes of Health grants AI079360 and AI50031 (to E.F.), and NIH Training Grant, T32 AI07019 (to A.S.) and in part by N01 HHSN272201100019C. EF is an Investigator with the Howard Hughes Medical Institute.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bovbjerg DH, 2003, BRAIN BEHAV IMMUN, V17, pS48; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Esquifino AI, 1996, BRAIN BEHAV IMMUN, V10, P92, DOI 10.1006/brbi.1996.0010; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Holzheimer RG, 2002, SHOCK, V17, P527, DOI 10.1097/00024382-200206000-00015; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hrushesky WJM, 1997, J INFECT DIS, V175, P1283, DOI 10.1086/516457; Huang CF, 2008, SCAND J IMMUNOL, V68, P502, DOI 10.1111/j.1365-3083.2008.02172.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kline JN, 2007, IMMUNOL RES, V39, P279, DOI 10.1007/s12026-007-0083-2; KOWANKO IC, 1982, ANN RHEUM DIS, V41, P453, DOI 10.1136/ard.41.5.453; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1999, COLD SPRING HARB SYM, V64, P429, DOI 10.1101/sqb.1999.64.429; Petrovsky N, 1998, Int Rev Immunol, V16, P635, DOI 10.3109/08830189809043012; Petrovsky N, 2001, IMMUNOL CELL BIOL, V79, P350, DOI 10.1046/j.1440-1711.2001.01029.x; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Redwine L, 2004, BRAIN BEHAV IMMUN, V18, P333, DOI 10.1016/j.bbi.2004.01.001; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roberts JE, 2000, ANN NY ACAD SCI, V917, P435; Scheff JD, 2010, J THEOR BIOL, V264, P1068, DOI 10.1016/j.jtbi.2010.03.026; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	39	281	287	2	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					251	261		10.1016/j.immuni.2011.12.017	http://dx.doi.org/10.1016/j.immuni.2011.12.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22342842	Bronze, Green Accepted			2022-12-18	WOS:000300812400013
J	Swiecki, M; Gilfillan, S; Vermi, W; Wang, YM; Colonna, M				Swiecki, Melissa; Gilfillan, Susan; Vermi, William; Wang, Yaming; Colonna, Marco			Plasmacytoid Dendritic Cell Ablation Impacts Early Interferon Responses and Antiviral NK and CD8(+) T Cell Accrual	IMMUNITY			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELLS; RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTOR-9; IIFN-PRODUCING CELLS; I INTERFERON; VIRAL-INFECTION; CUTTING EDGE; IFN-ALPHA; AUTOIMMUNE-DISEASES	Plasmacytoid dendritic cells (pDCs) mediate type 1 interferon (IFN-I) responses to viruses that are recognized through the Toll-like receptor 7 (TLR7) or TLR9 signaling pathway. However, it is unclear how pDCs regulate the antiviral responses via innate and adaptive immune cells. We generated diphtheria toxin receptor transgenic mice to selectively deplete pDCs by administration of diphtheria toxin. pDC-depleted mice were challenged with viruses known to activate pDCs. In murine cytomegalovirus (MCMV) infection, pDC depletion reduced early IFN-I production and augmented viral burden facilitating the expansion of natural killer (NK) cells expressing the MCMV-specific receptor Ly49H. During vesicular stomatitis virus (VSV) infection, pDC depletion enhanced early viral replication and impaired the survival and accumulation of virus-specific cytotoxic T lymphocytes. We conclude that pDCs mediate early antiviral IFN-I responses and influence the accrual of virus-specific NK or CD8(+) T cells in a virus-dependent manner.	[Swiecki, Melissa; Gilfillan, Susan; Wang, Yaming; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Vermi, William] Univ Brescia, Dept Pathol, I-25123 Brescia, Italy	Washington University (WUSTL); University of Brescia	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 425 S Euclid, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987; VERMI, WILLIAM/0000-0002-2291-2997	NRSA [5T32DK007296-30]; National Heart, Lung, and Blood Institute [2T32HL007317-31]; Juvenile Diabetes Research Foundation [24-2007-420]; National Institutes of Health [CA109673]; NATIONAL CANCER INSTITUTE [R01CA109673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007296] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank W. Yokoyama, T. Cheng, A. French, R. Presti (Washington University, St. Louis, MO), L. Lefrancois (University Of Connecticut, Farmington, CT), and M. Brown (University of Virginia, Charlottesville, VA) for reagents and advice on virus infections; S. Jung for the DTR plasmid (Weizmann Institute of Science, Rehovot, Israel); S. McCartney and K. Otero (VVashington University) for helping with injections; S. Schloemann and O. Malkova for cell sorting; M. White for injection of the BDCA2-DTR transgene and the SiglecH-eGFP ES cells; and M. Cella, M. Diamond, A. French, T. Hannan, and P. Allen for helpful discussions and critically reading the manuscript. M.S. is supported by the NRSA training grant 5T32DK007296-30. Y.W. is supported by the Pulmonary and Critical Care training grant 2T32HL007317-31 from the National Heart, Lung, and Blood Institute. This project was supported by Juvenile Diabetes Research Foundation grant 24-2007-420 and National Institutes of Health grant CA109673 to M.C.	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Borrow P, 2008, CURR OPIN HIV AIDS, V3, P36, DOI 10.1097/COH.0b013e3282f2bce7; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geurs TL, 2009, J IMMUNOL, V183, P5830, DOI 10.4049/jimmunol.0901520; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Steinberg C, 2009, EUR J IMMUNOL, V39, P1007, DOI 10.1002/eji.200838814; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Szomolanyi-Tsuda E, 2006, J VIROL, V80, P4286, DOI 10.1128/JVI.80.9.4286-4291.2006; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Thompson JM, 2008, ADV DRUG DELIVER REV, V60, P786, DOI 10.1016/j.addr.2007.11.003; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263; Wang JP, 2007, J IMMUNOL, V178, P3363, DOI 10.4049/jimmunol.178.6.3363; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; Wrammert J, 2002, EUR J IMMUNOL, V32, P97, DOI 10.1002/1521-4141(200201)32:1<97::AID-IMMU97>3.0.CO;2-Y; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	59	281	283	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					955	966		10.1016/j.immuni.2010.11.020	http://dx.doi.org/10.1016/j.immuni.2010.11.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21130004	Green Accepted, Bronze			2022-12-18	WOS:000286293900015
J	Elzey, BD; Tian, J; Jensen, RJ; Swanson, KA; Lees, JR; Lentz, SR; Stein, CS; Nieswandt, B; Wang, YQ; Davidson, BL; Ratliff, TL				Elzey, BD; Tian, J; Jensen, RJ; Swanson, KA; Lees, JR; Lentz, SR; Stein, CS; Nieswandt, B; Wang, YQ; Davidson, BL; Ratliff, TL			Platelet-mediated modulation of adaptive immunity: A communication link between innate and adaptive immune compartments	IMMUNITY			English	Article							CYTOTOXIC T-LYMPHOCYTES; CD40 LIGAND; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; DENDRITIC CELLS; MICE; DEFICIENT; RESPONSES; ADENOVIRUS; INTEGRIN	Platelets are highly reactive components of the circulatory system with well-documented hemostatic function. Recent studies extend platelet function to modulation of local inflammatory events through the release of chemokines, cytokines, and a number of immunomodulatory ligands, including CD154. We hypothesized that platelet-derived CD154 modulates adaptive immunity. The data reported herein demonstrate that platelets, via CD154, induce dendritic cell maturation, B cell isotype switching, and augment CD8(+) T cell responses both in vitro and in vivo. Platelet transfusion studies demonstrate that platelet-derived CD154 alone is sufficient to induce isotype switching and augment T lymphocyte function during viral infection, leading to enhanced protection against viral rechallenge. Additionally, depletion of platelets in normal mice results in decreased antigen-specific antibody production.	Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; Univ Iowa, Prostate Canc Res Grp, Iowa City, IA 52242 USA; Univ Iowa, Program Immunol, Iowa City, IA 52242 USA; Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa; University of Wurzburg	Ratliff, TL (corresponding author), Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.	tim-ratliff@uiowa.edu		Lees, Jason/0000-0002-9965-1414; Lentz, Steven/0000-0002-8885-4718	NATIONAL CANCER INSTITUTE [R01CA096691] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054014] Funding Source: NIH RePORTER; NCI NIH HHS [CA096691] Funding Source: Medline; NHLBI NIH HHS [HL63943, HL63017] Funding Source: Medline; NIDDK NIH HHS [DK54014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad R, 2001, J LEUKOCYTE BIOL, V69, P123; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x; Bombeli T, 1998, J EXP MED, V187, P329, DOI 10.1084/jem.187.3.329; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; COLLINS CE, 1994, GASTROENTEROLOGY, V106, P840, DOI 10.1016/0016-5085(94)90741-2; Diacovo TG, 1998, J EXP MED, V187, P197, DOI 10.1084/jem.187.2.197; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Gawaz M, 2000, ATHEROSCLEROSIS, V148, P75, DOI 10.1016/S0021-9150(99)00241-5; Geba GP, 1996, J IMMUNOL, V157, P557; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075; Kurts C, 1998, J EXP MED, V188, P415, DOI 10.1084/jem.188.2.415; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; Piguet PF, 2001, EUR J CELL BIOL, V80, P171, DOI 10.1078/0171-9335-00147; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rudin CM, 1998, SEMIN ONCOL, V25, P435; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Siemens DR, 2001, J IMMUNOL, V166, P731, DOI 10.4049/jimmunol.166.2.731; SZAKAL AK, 1990, ANAT REC, V227, P475, DOI 10.1002/ar.1092270411; Warren TL, 2000, J IMMUNOL, V165, P6244, DOI 10.4049/jimmunol.165.11.6244; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yang YP, 1996, J VIROL, V70, P6370, DOI 10.1128/JVI.70.9.6370-6377.1996; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; Yeaman MR, 1997, CLIN INFECT DIS, V25, P951, DOI 10.1086/516120; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	41	281	301	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2003	19	1					9	19		10.1016/S1074-7613(03)00177-8	http://dx.doi.org/10.1016/S1074-7613(03)00177-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871635	Bronze			2022-12-18	WOS:000184260400004
J	Meyaard, L; Adema, GJ; Chang, CW; Woollatt, E; Sutherland, GR; Lanier, LL; Phillips, JH				Meyaard, L; Adema, GJ; Chang, CW; Woollatt, E; Sutherland, GR; Lanier, LL; Phillips, JH			LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; TYROSINE-PHOSPHATASE 1C; HLA-B; MOLECULAR-CLONING; ANTIGEN RECEPTOR; IMMUNOGLOBULIN-SUPERFAMILY; MONOCLONAL-ANTIBODIES; CYTOLYTIC FUNCTION; T-LYMPHOCYTES; NK CELLS	In the present study, we describe a novel inhibitory receptor, leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), that is constitutively expressed on the majority of human peripheral blood mononuclear leukocytes. LAIR-1 is a 32 kDa transmembrane glycoprotein with a single immunoglobulin-like domain and a cytoplasmic tail containing two immune receptor tyrosine-based inhibitory motifs. LAIR-1 recruits SHP-1 and SHP-2 phosphatases upon activation, and crosslinking of the LAIR-1 antigen on natural killer (NK) cells results in strong inhibition of NK cell-mediated cytotoxicity. Although it is structurally related to human killer cell inhibitory receptors, LAIR-1 does not appear to recognize human leukocyte antigen (HLA) class I molecules and thus represents a novel HLA class I-independent mechanism of NK cell regulation.	DNAX RES INST MOL & CELLULAR BIOL INC, DEPT MOL BIOL, PALO ALTO, CA 94304 USA; WOMENS & CHILDRENS HOSP, CTR MED GENET, DEPT CYTOGENET & MOL GENET, ADELAIDE, SA 5006, AUSTRALIA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Womens & Childrens Hospital Australia	Meyaard, L (corresponding author), DNAX RES INST MOL & CELLULAR BIOL INC, DEPT IMMUNOBIOL, 901 CALIF AVE, PALO ALTO, CA 94304 USA.		Lanier, Lewis L/E-2139-2014; Sutherland, Grant Robert/D-2606-2012; Adema, G.J./H-8007-2014	Lanier, Lewis L/0000-0003-1308-3952; Meyaard, Linde/0000-0003-0707-4793				ARM JP, 1991, J BIOL CHEM, V266, P15966; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DANDREA A, 1995, J IMMUNOL, V155, P2306; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; GONG JH, 1994, LEUKEMIA, V8, P652; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; LANIER LL, 1988, J IMMUNOL, V141, P3478; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; LANIER LL, 1983, J IMMUNOL, V131, P1789; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lazetic S, 1996, J IMMUNOL, V157, P4741; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Olcese L, 1996, J IMMUNOL, V156, P4531; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; PHILLIPS JH, 1991, J EXP MED, V174, P1571, DOI 10.1084/jem.174.6.1571; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rojo S, 1997, J IMMUNOL, V158, P9; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; TESTI R, 1989, J IMMUNOL, V142, P1854; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; YODOI J, 1985, J IMMUNOL, V134, P1623; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; ZHANG GP, 1995, J IMMUNOL, V155, P1534	45	281	371	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1997	7	2					283	290		10.1016/S1074-7613(00)80530-0	http://dx.doi.org/10.1016/S1074-7613(00)80530-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285412	Bronze, Green Published			2022-12-18	WOS:A1997XT49200011
J	Trompette, A; Gollwitzer, ES; Pattaroni, C; Lopez-Mejia, IC; Riva, E; Pernot, J; Ubags, N; Fajas, L; Nicod, LP; Marsland, BJ				Trompette, Aurelien; Gollwitzer, Eva S.; Pattaroni, Celine; Lopez-Mejia, Isabel C.; Riva, Erika; Pernot, Julie; Ubags, Niki; Fajas, Lluis; Nicod, Laurent P.; Marsland, Benjamin J.			Dietary Fiber Confers Protection against Flu by Shaping Ly6c(-) Patrolling Monocyte Hematopoiesis and CD8(+) T Cell Metabolism	IMMUNITY			English	Article							CHAIN FATTY-ACIDS; INFLUENZA-VIRUS INFECTION; DENDRITIC CELLS; GUT MICROBIOTA; ENERGY-METABOLISM; BLOOD MONOCYTES; GENE-EXPRESSION; BONE-MARROW; MACROPHAGES; LUNG	Dietary fiber protects against chronic inflammatory diseases by dampening immune responses through short-chain fatty acids (SCFAs). Here we examined the effect of dietary fiber in viral infection, where the anti-inflammatory properties of SCFAs in principle could prevent protective immunity. Instead, we found that fermentable dietary fiber increased survival of influenza-infected mice through two complementary mechanisms. High-fiber diet (HFD)-fed mice exhibited altered bone marrow hematopoiesis, characterized by enhanced generation of Ly6c(-) patrolling monocytes, which led to increased numbers of alternatively activated macrophages with a limited capacity to produce the chemokine CXCL1 in the airways. Blunted CXCL1 production reduced neutrophil recruitment to the airways, thus limiting tissue immunopathology during infection. In parallel, diet-derived SCFAs boosted CD8(+) T cell effector function by enhancing cellular metabolism. Hence, dietary fermentable fiber and SCFAs set an immune equilibrium, balancing innate and adaptive immunity so as to promote the resolution of influenza infection while preventing immune-associated pathology.	[Trompette, Aurelien; Gollwitzer, Eva S.; Pattaroni, Celine; Riva, Erika; Pernot, Julie; Ubags, Niki; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, Serv Pneumol, CHUV, Fac Biol & Med, CLED 02-206,Chemin Boveresses 155, CH-1066 Epalinges, Switzerland; [Lopez-Mejia, Isabel C.] Univ Lausanne, Dept Physiol, CH-1011 Lausanne, Switzerland; [Lopez-Mejia, Isabel C.; Fajas, Lluis] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland; [Gollwitzer, Eva S.] Ecole Polytech Fed Lausanne, EPFL SV GHI Stn 19, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Pattaroni, Celine; Marsland, Benjamin J.] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Monash University	Marsland, BJ (corresponding author), Univ Lausanne, Serv Pneumol, CHUV, Fac Biol & Med, CLED 02-206,Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.; Marsland, BJ (corresponding author), Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia.	benjamin.marsland@monash.edu	Coll, Lluis Fajas/C-8567-2014; Nicod, Laurent/ABD-3360-2020	Fajas, Lluis/0000-0002-1283-9503; Lopez-Mejia, Isabel C./0000-0001-5918-0227; Pattaroni, Celine/0000-0002-9920-1181	SNF grant [310030_166210]	SNF grant	We are grateful to Norbert Sprenger, Christine Martin-Paschoud, and Catherine Murset-Mounoud for assistance with the SCFA quantification and to Alexis Rapin for sequencing support. This work was supported by an SNF grant 310030_166210 awarded to B.J.M.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Holscher HD, 2015, AM J CLIN NUTR, V101, P55, DOI 10.3945/ajcn.114.092064; Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Millard AL, 2002, CLIN EXP IMMUNOL, V130, P245; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nsiah-Sefaa A., 2016, BIOSCIENCE REP, V36, P36; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Roy M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-18; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vinolo MAR, 2009, CELL BIOCHEM FUNCT, V27, P48, DOI 10.1002/cbf.1533; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; WHO, 2016, INFLUENZA; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593	55	280	295	16	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					992	+		10.1016/j.immuni.2018.04.022	http://dx.doi.org/10.1016/j.immuni.2018.04.022			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768180	Bronze			2022-12-18	WOS:000432488600018
J	Halim, TYF; MacLaren, A; Romanish, MT; Gold, MJ; McNagny, KM; Takei, F				Halim, Timotheus Y. F.; MacLaren, Aric; Romanish, Mark T.; Gold, Matthew J.; McNagny, Kelly M.; Takei, Fumio			Retinoic-Acid-Receptor-Related Orphan Nuclear Receptor Alpha Is Required for Natural Helper Cell Development and Allergic Inflammation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; BONE-MARROW; TYPE-2 IMMUNITY; PROGENITORS; DIFFERENTIATION; EXPRESSION; CYTOKINES; MICE	Natural helper (NH) cells are innate lymphoid cells (ILCs) that produce T helper-2 (Th2)-cell-type cytokines in the lung- and gut-associated lymphoid tissues. Currently, the lineage relationship between NH cells in different tissues and between NH cells and interleukin-22 (IL-22)-producing retinoic-acid-receptor-related orphan receptor (ROR)gamma t-positive ILCs is unclear. Here, we report that NH cells express ROR alpha, but not ROR gamma t. ROR alpha-deficient, but not ROR gamma t-deficient, mice lacked NH cells in all tissues, whereas all other lymphocytes, including ROR gamma t(+) ILCs, were unaffected. NH-cell-deficient mice generated by ROR alpha-deficient bone-marrow transplantation had normal Th2 cell responses but failed to develop acute lung inflammation in response to protease allergen, thus confirming the essential role of NH cells in allergic lung inflammation. We have also identified ROR alpha-dependent NH cell progenitors in the bone marrow. Thus, all NH cells belong to a unique ROR alpha-dependent cell lineage separate from other lymphoid cell lineages.	[Halim, Timotheus Y. F.; MacLaren, Aric; Romanish, Mark T.; Takei, Fumio] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Halim, Timotheus Y. F.; Takei, Fumio] Univ British Columbia, Coll Interdisciplinary Studies, Genet Grad Program, Vancouver, BC V6T 1Z2, Canada; [Gold, Matthew J.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Takei, Fumio] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Takei, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ftakei@bccrc.ca	McNagny, Kelly/P-5239-2014; Halim, Timotheus/B-3117-2018	McNagny, Kelly/0000-0003-4737-3499; Halim, Timotheus/0000-0001-9773-0023; Takei, Fumio/0000-0002-3620-5046	Canadian Cancer Society Research Institute; Canadian Institute for Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	We thank David Ko for help with flow cytometry. This work was supported by the Canadian Cancer Society Research Institute. T.Y.F.H. was supported by a Canadian Institute for Health Research studentship. T.Y.F.H. designed and did experiments and analyzed the data. A.M., M.T.R., and M.G. did experiments. F.T. designed experiments and analyzed the data. T.Y.F.H., K.M.M. and F.T. prepared the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; BAKALIAN A, 1992, RES IMMUNOL, V143, P129, DOI 10.1016/0923-2494(92)80090-8; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jaradat M, 2006, AM J RESP CRIT CARE, V174, P1299, DOI 10.1164/rccm.200510-1672OC; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Veinotte LL, 2008, BLOOD, V111, P4201, DOI 10.1182/blood-2007-04-087577; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	28	280	290	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					463	474		10.1016/j.immuni.2012.06.012	http://dx.doi.org/10.1016/j.immuni.2012.06.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22981535	Bronze			2022-12-18	WOS:000309199000011
J	Kumagai, Y; Takeuchi, O; Kato, H; Kumar, H; Matsui, K; Morii, E; Aozasa, K; Kawai, T; Akira, S				Kumagai, Yutaro; Takeuchi, Osamu; Kato, Hiroki; Kumar, Himanshu; Matsui, Kosuke; Morii, Eiichi; Aozasa, Katsuyuki; Kawai, Taro; Akira, Shizuo			Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNE-RESPONSES; KAPPA-B KINASE; I INTERFERON; RIG-I; ANTIVIRAL RESPONSES; VIRAL-INFECTION; ADAPTER PROTEIN; LYMPH-NODES; INDUCTION	Type I interferons (IFNs) are critical for antiviral responses. Here we generated a knockin mouse in which green fluorescence protein (GFP) was expressed under the control of the Ifna6 promoter. Virus-induced expression of GFP recapitulated various IFN-alpha subtypes. Systemic infection of the mice with Newcastle disease virus (NDV) increased GFP(+) plasmacytoid dendritic cells (pDCs) via the Toll-like receptor system, and GFP+ conventional dendritic cells (cDCs) and macrophages via the RIG-I-like helicase system. By contrast, lung infection with NDV led to IFN-alpha production in alveolar macrophages (AMs) and cDCs, but not in pDCs. Specific depletion of AMs caused a marked defect in the initial viral elimination in the lung. pDCs produced IFN-alpha in the absence of AM-mediated viral recognition, suggesting that pDCs function when the first defense line is broken. Thus, AMs act as a type I IFN producer that is important for the initial responses to viral infection in the lung.	Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, ERATO, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019; Kumagai, Yutaro/L-7732-2018; Kumar, Himanshu/A-8070-2010; Kumar, Himanshu/J-4494-2012; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Kumar, Himanshu/0000-0001-5246-2694; Kawai, Taro/0000-0001-7510-4662				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; HOMUNG V, 1960, SCIENCE, V314, P994; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Louten J, 2006, J IMMUNOL, V177, P3266, DOI 10.4049/jimmunol.177.5.3266; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Peters-Golden M, 2004, AM J RESP CELL MOL, V31, P3, DOI 10.1165/rcmb.f279; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	44	280	292	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					240	252		10.1016/j.immuni.2007.07.013	http://dx.doi.org/10.1016/j.immuni.2007.07.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723216	Bronze			2022-12-18	WOS:000249056300011
J	Tkalcevic, J; Novelli, M; Phylactides, M; Iredale, JP; Segal, AW; Roes, J				Tkalcevic, J; Novelli, M; Phylactides, M; Iredale, JP; Segal, AW; Roes, J			Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; CHRONIC GRANULOMATOUS-DISEASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ASPERGILLUS-FUMIGATUS; GRANULOCYTE ELASTASE; RESPIRATORY BURST; DEFICIENT MICE; TISSUE-INJURY; HOST-DEFENSE; SEPTIC SHOCK	While the critical role of reactive oxygen intermediates (ROI) in the microbicidal activity of polymorphonuclear granulocytes is well established, the function of the nonoxidative effector mechanisms in vivo remains unclear. Here we show that mice deficient in the neutrophil granule serine proteases elastase and/or cathepsin G are susceptible to fungal infections, despite normal neutrophil development and recruitment. The protease deficiencies but not the absence of ROI leads to enhanced resistance to the lethal effects of endotoxin LPS, although normal levels of TNF alpha are produced. The data demonstrate a critical role of the nonoxidative effector mechanisms of neutrophils in host immunity and immunopathology and identify elastase and cathepsin G as effecters in the endotoxic shock cascade downstream of TNF alpha.	UCL, Windeyer Inst Med Sci, Dept Med, London W1P 6DB, England; Rayne Inst, London WC1E 6JJ, England; Dept Histopathol, London WC1E 6JJ, England	University of London; University College London; University of London; King's College London	Roes, J (corresponding author), UCL, Windeyer Inst Med Sci, Dept Med, 46 Cleveland St, London W1P 6DB, England.	j.roes@ucl.ac.uk		Iredale, John/0000-0003-2174-5127; Roes, Jurgen/0000-0003-3235-2345; Segal, Anthony/0000-0001-7602-9043				BANCROFT JD, 1998, MANUAL BIOL TECHNIQU; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj K, 1997, MAMM GENOME, V8, P5, DOI 10.1007/s003359900337; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; CAUGHEY GH, 1993, GENOMICS, V15, P614, DOI 10.1006/geno.1993.1115; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DIAMOND RD, 1982, INFECT IMMUN, V38, P487, DOI 10.1128/IAI.38.2.487-495.1982; EMMENDORFFER A, 1990, J IMMUNOL METHODS, V131, P269, DOI 10.1016/0022-1759(90)90198-5; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Garcia R, 1998, INFECT IMMUN, V66, P1408, DOI 10.1128/IAI.66.4.1408-1412.1998; GRAY PW, 1989, J BIOL CHEM, V264, P9505; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HASLETT C, 1996, INTEGRATED IMMUNE SY; HEUSEL JW, 1993, BLOOD, V81, P1614; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; KAW S, 1992, P NATL ACAD SCI USA, V89, P6886, DOI 10.1073/pnas.89.15.6886; KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220; LEFF JA, 1993, NEUTROPHIL, P229; LEHRER RI, 1990, BLOOD, V76, P2169; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mills E. L., 1993, NEUTROPHIL, P183; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; NEEMAN N, 1974, P SOC EXP BIOL MED, V146, P1137; Nicholson SC, 1999, SHOCK, V11, P253, DOI 10.1097/00024382-199904000-00005; ODEBERG H, 1976, INFECT IMMUN, V14, P1276; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PATRIGNANI P, 1991, BLOOD, V78, P2715; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; REST RF, 1988, METHOD ENZYMOL, V163, P309; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROOS D, 1994, IMMUNOL REV, V138, P121, DOI 10.1111/j.1600-065X.1994.tb00850.x; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; SHAPIRO SD, 1991, J RHEUMATOL, V18, P95; SMEDLY LA, 1986, J CLIN INVEST, V77, P1233, DOI 10.1172/JCI112426; Sturrock A, 1998, CYTOGENET CELL GENET, V83, P104, DOI 10.1159/000015144; TANAKA H, 1991, ANN SURG, V213, P81, DOI 10.1097/00000658-199101000-00014; THORNE KJI, 1976, INFECT IMMUN, V14, P555, DOI 10.1128/IAI.14.2.555-563.1976; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	57	280	291	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2000	12	2					201	210		10.1016/S1074-7613(00)80173-9	http://dx.doi.org/10.1016/S1074-7613(00)80173-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714686	Bronze			2022-12-18	WOS:000085621400010
J	Martin, F; Kearney, JF				Martin, F; Kearney, JF			Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk	IMMUNITY			English	Article							TRANSGENIC MICE; LYMPHOCYTES-B; B-1 CELLS; GENE-EXPRESSION; SELF-TOLERANCE; IMMUNOGLOBULIN; ACTIVATION; RESPONSES; MOUSE; DELETION	Using immunoglobulin heavy chain transgenic mice, we show that B cell clones reaching the long-lived pool are heterogeneous: some are enriched in the CD21(high) compartment (mostly marginal zone [MZ]), others reside primarily in the follicles (FO). Altering the composition of the B cell receptor through N region additions decreases the rate of clonal production and the MZ enrichment. This process can be recapitulated by purified CD21(low) B cells and is due to a preferential clonal survival that requires a functional btk tyrosine kinase, We also show that generation of the MZ population is dependent on CD19. These findings suggest that the MZ B cell repertoire is positively selected and have functional implications for antigenic responses effected by B cells from this microenvironment.	Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kearney, JF (corresponding author), Univ Alabama, Dept Microbiol, Div Dev & Clin Immunol, Birmingham, AL 35294 USA.		Kearney, John/GOV-3123-2022		NCI NIH HHS [CA13148] Funding Source: Medline; NIAID NIH HHS [AI 14782, R01 AI014782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014782, R21AI014782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; BHAT NM, 1992, INT IMMUNOL, V4, P243, DOI 10.1093/intimm/4.2.243; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1997, ANN NY ACAD SCI, V815, P55, DOI 10.1111/j.1749-6632.1997.tb52044.x; GRAY D, 1982, EUR J IMMUNOL, V12, P564, DOI 10.1002/eji.1830120707; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HachemiRachedi S, 1997, EUR J IMMUNOL, V27, P1069, DOI 10.1002/eji.1830270505; HARDY RR, 1983, NATURE, V306, P270, DOI 10.1038/306270a0; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayakawa K, 1997, ANN NY ACAD SCI, V815, P15, DOI 10.1111/j.1749-6632.1997.tb52041.x; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; Kenny JJ, 1996, J IMMUNOL, V157, P1054; Klaus GGB, 1997, EUR J IMMUNOL, V27, P2749, DOI 10.1002/eji.1830271102; KUMARARATNE DS, 1982, ADV EXP MED BIOL, V149, P83; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liu Y J, 1988, Adv Exp Med Biol, V237, P105; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Martin F, 1997, INT IMMUNOL, V9, P493, DOI 10.1093/intimm/9.4.493; Martin F, 1998, J IMMUNOL, V160, P3748; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Murakami M, 1997, J EXP MED, V185, P791, DOI 10.1084/jem.185.4.791; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink A, 1996, IMMUNOL LETT, V54, P157, DOI 10.1016/S0165-2478(96)02666-1; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Stall A M, 1996, Semin Immunol, V8, P45, DOI 10.1006/smim.1996.0007; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; Takahashi K, 1997, J IMMUNOL, V159, P1557; Tanguay DA, 1999, J EXP MED, V189, P1685, DOI 10.1084/jem.189.11.1685; Tarakhovsky A, 1997, J EXP MED, V185, P981, DOI 10.1084/jem.185.6.981; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Zimecki Michal, 1994, Archivum Immunologiae et Therapiae Experimentalis, V42, P115; Zinkernagel RM, 1997, IMMUNOL REV, V156, P199, DOI 10.1111/j.1600-065X.1997.tb00969.x	51	280	285	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					39	49		10.1016/S1074-7613(00)80157-0	http://dx.doi.org/10.1016/S1074-7613(00)80157-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661404	Bronze			2022-12-18	WOS:000085011900005
J	Viret, C; Wong, FS; Janeway, CA				Viret, C; Wong, FS; Janeway, CA			Designing and maintaining the mature TCR repertoire: the continuum of self-peptide : self-MHC complex recognition	IMMUNITY			English	Article							CLASS-II MOLECULES; T-CELL REPERTOIRE; SINGLE MHC/PEPTIDE LIGAND; POSITIVE SELECTION; THYMIC SELECTION; DENDRITIC CELLS; DEFICIENT MICE; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; BINDING PEPTIDES	Peripheral T cell maintenance requires a survival signal delivered upon T cell receptor (TCR)-major histocompatibility complex (MHC) molecule interaction. Since self-peptides play a critical role in the intrathymic positive selection of the mature TCR repertoire, we hypothesized an equally important role in T cell persistence. We used mice with a normal expression of MHC class II molecules but a restricted self-peptide complexity (H-2M alpha(-/-)) to show that an MHC class II-restricted T cell specificity that displays a deficient positive selection in the H-2M alpha(-/-) thymus shows an impaired persistence after adoptive transfer in H-2M alpha(-/-) recipients. Finally, a wild-type CD4(+) TCR repertoire is incompletely maintained in H-2M alpha(-/-) recipients. These observations suggest that, similar to intrathymic positive selection, the maintenance of the mature TCR repertoire relies on the recognition of self-peptide:self-MHC complexes.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Janeway, CA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.		VIRET, Christophe/M-4590-2014	VIRET, CHRISTOPHE/0000-0003-1874-3489; Wong, F. Susan/0000-0002-2812-8845	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-14579] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; Bevan MJ, 1997, IMMUNITY, V7, P175, DOI 10.1016/S1074-7613(00)80520-8; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chervonsky AV, 1998, P NATL ACAD SCI USA, V95, P10094, DOI 10.1073/pnas.95.17.10094; DeKoning J, 1997, J IMMUNOL, V158, P2558; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Janeway CA, 1998, IMMUNOLOGIST, V6, P5; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MURPHY DB, 1992, J IMMUNOL, V148, P3483; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; OZATO K, 1980, J IMMUNOL, V124, P533; Penit C, 1997, J IMMUNOL, V159, P4848; RIBERDY JM, 1992, NATURE, V353, P660; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHA WC, 1990, P NATL ACAD SCI USA, V87, P6186, DOI 10.1073/pnas.87.16.6186; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; TANCHOT C, 1995, EUR J IMMUNOL, V25, P2127, DOI 10.1002/eji.1830250802; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; VIRET C, 1999, IN PRESS REV IMMUNOG, V1; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	54	280	285	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					559	568		10.1016/S1074-7613(00)80055-2	http://dx.doi.org/10.1016/S1074-7613(00)80055-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367901	Bronze			2022-12-18	WOS:000080709400007
J	Zhao, JC; Zhao, JX; Mangalam, AK; Channappanavar, R; Fett, C; Meyerholz, DK; Agnihothram, S; Baric, RS; David, CS; Perlman, S				Zhao, Jincun; Zhao, Jingxian; Mangalam, Ashutosh K.; Channappanavar, Rudragouda; Fett, Craig; Meyerholz, David K.; Agnihothram, Sudhakar; Baric, Ralph S.; David, Chella S.; Perlman, Stanley			Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses	IMMUNITY			English	Article							VIRUS-INFECTION; RECOVERED PATIENTS; BALB/C MICE; RESPONSES; INFLUENZA; RECEPTOR; VACCINE; PROTEIN; GENERATION; DISEASE	Two zoonotic coronaviruses (CoVs)-SARS-CoV and MERS-CoV-have crossed species to cause severe human respiratory disease. Here, we showed that induction of airway memory CD4(+) T cells specific for a conserved epitope shared by SARS-CoV and MERS-CoV is a potential strategy for developing pan-coronavirus vaccines. Airway memory CD4(+) T cells differed phenotypically and functionally from lung-derived cells and were crucial for protection against both CoVs in mice. Protection was dependent on interferon-gamma and required early induction of robust innate and virus-specific CD8(+) T cell responses. The conserved epitope was also recognized in SARS-CoV- and MERS-CoV-infected human leukocyte antigen DR2 and DR3 transgenic mice, indicating potential relevance in human populations. Additionally, this epitope was cross-protective between human and bat CoVs, the progenitors for many human CoVs. Vaccine strategies that induce airway memory CD4(+) T cells targeting conserved epitopes might have broad applicability in the context of new CoVs and other respiratory virus outbreaks.	[Zhao, Jincun] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China; [Zhao, Jincun; Zhao, Jingxian; Channappanavar, Rudragouda; Fett, Craig; Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Mangalam, Ashutosh K.; Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Agnihothram, Sudhakar; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Agnihothram, Sudhakar; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [David, Chella S.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Agnihothram, Sudhakar] Natl Ctr Toxicol Res, US FDA, Jefferson, AR 72079 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Iowa; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; US Food & Drug Administration (FDA)	Zhao, JC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China.; Zhao, JC; Perlman, S (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	zhaojincun@gird.cn; stanley-perlman@uiowa.edu	Meyerholz, David/J-8131-2019; Mangalam, Ashutosh/I-8565-2017; Zhao, Jincun/ABD-8679-2021	Meyerholz, David/0000-0003-1552-3253; Mangalam, Ashutosh/0000-0002-9926-2531; Zhao, Jincun/0000-0003-2515-5589; Perlman, Stanley/0000-0003-4213-2354	NIH [RO1 AI091322, PO1 AI060699, U19 AI100625]; Thousand Talents Plan Award of China; Municipal Healthcare Joint-Innovation Major Project of Guangzhou (Jincun Zhao); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060699, R01AI091322, U19AI100625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thousand Talents Plan Award of China; Municipal Healthcare Joint-Innovation Major Project of Guangzhou (Jincun Zhao); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Wethank Drs. John Harty and Kevin Legge for critical review of the manuscript. This research was supported in part by grants from the NIH (RO1 AI091322 and PO1 AI060699 to S.P. and U19 AI100625 R.S.B.), the Thousand Talents Plan Award of China 2015, and the Municipal Healthcare Joint-Innovation Major Project of Guangzhou (Jincun Zhao).	Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609; Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z; CHINESE SME, 2004, SCIENCE, V303, P1666, DOI DOI 10.1126/SCIENCE.1092002; Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Harcourt GC, 1998, J EXP MED, V188, P1785, DOI 10.1084/jem.188.10.1785; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Iwata-Yoshikawa N, 2014, J VIROL, V88, P8597, DOI 10.1128/JVI.00983-14; Lees JR, 2010, IMMUNOLOGY, V130, P463, DOI 10.1111/j.1365-2567.2010.03288.x; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Ma CQ, 2014, VACCINE, V32, P6170, DOI 10.1016/j.vaccine.2014.08.086; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Moran TP, 2005, J IMMUNOL, V175, P3431, DOI 10.4049/jimmunol.175.5.3431; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Oh HLJ, 2011, J VIROL, V85, P10464, DOI 10.1128/JVI.05039-11; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peng H, 2006, VIROLOGY, V351, P466, DOI 10.1016/j.virol.2006.03.036; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Sui JH, 2014, J VIROL, V88, P13769, DOI 10.1128/JVI.02232-14; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tang F, 2011, J IMMUNOL, V186, P7264, DOI 10.4049/jimmunol.0903490; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Tonkin DR, 2012, VACCINE, V30, P4532, DOI 10.1016/j.vaccine.2012.04.030; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Woo PCY, 2004, J CLIN MICROBIOL, V42, P5885, DOI 10.1128/JCM.42.12.5885-5888.2004; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011	41	279	289	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1379	1391		10.1016/j.immuni.2016.05.006	http://dx.doi.org/10.1016/j.immuni.2016.05.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27287409	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-18	WOS:000378341200016
J	Weisel, FJ; Zuccarino-Catania, GV; Chikina, M; Shlomchik, MJ				Weisel, Florian J.; Zuccarino-Catania, Griselda V.; Chikina, Maria; Shlomchik, Mark J.			A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells	IMMUNITY			English	Article							SOMATIC HYPERMUTATION; TRANSCRIPTION FACTORS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; CENTER SELECTION; CUTTING EDGE; AFFINITY; GENERATION; EXPRESSION; SURVIVAL	There is little insight into or agreement about the signals that control differentiation of memory B cells (MBCs) and long-lived plasma cells (LLPCs). By performing BrdU pulse-labeling studies, we found that MBC formation preceded the formation of LLPCs in an adoptive transfer immunization system, which allowed for a synchronized Ag-specific response with homogeneous Ag-receptor, yet at natural precursor frequencies. We confirmed these observations in wild-type (WT) mice and extended them with germinal center (GC) disruption experiments and variable region gene sequencing. We thus show that the GC response undergoes a temporal switch in its output as it matures, revealing that the reaction engenders both MBC subsets with different immune effector function and, ultimately, LLPCs at largely separate points in time. These data demonstrate the kinetics of the formation of the cells that provide stable humoral immunity and therefore have implications for autoimmunity, for vaccine development, and for understanding long-term pathogen resistance.	[Weisel, Florian J.; Zuccarino-Catania, Griselda V.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Weisel, Florian J.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Chikina, Maria] Univ Pittsburgh, Dept Computat & Syst Biol, Sch Med, Pittsburgh, PA 15260 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	NIH [R01-AI46303]; DFG Research Fellowship [WE 4752/1-1]; NSF Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603, R01AI105018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG Research Fellowship(German Research Foundation (DFG)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tomayko, T. Winkler, and M. Cancro for critical reading the manuscript and discussions; the Yale Cell Sorter Facility for expert cell sorting; the Yale Animal Resource Center and the Division of Laboratory Animal Resources of the University of Pittsburgh, in particular A. Durso and K. Faidley, for expert animal care; the Keck Facility at Yale University for DNA sequencing; L. Conter and P. Baevova for supporting experimental procedures; and W. Humphries IV for help with imaging and analysis. Supported by the NIH (R01-AI46303 to M.J.S.), DFG Research Fellowship (WE 4752/1-1 to F.J.W.), and NSF Graduate Research Fellowship (G.V.Z.-C).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2006, J IMMUNOL, V176, P4515, DOI 10.4049/jimmunol.176.8.4515; Barnett BE, 2012, SCIENCE, V335, P342, DOI 10.1126/science.1213495; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chevrier S, 2014, IMMUNOL CELL BIOL, V92, P481, DOI 10.1038/icb.2014.20; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Gatto D, 2005, J EXP MED, V201, P993, DOI 10.1084/jem.20042239; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Granum S, 2008, J BIOL CHEM, V283, P21909, DOI 10.1074/jbc.M800871200; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rao SP, 2002, J IMMUNOL, V169, P1859, DOI 10.4049/jimmunol.169.4.1859; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yoon J, 2014, J BIOL CHEM, V289, P34250, DOI 10.1074/jbc.M114.571182; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	61	279	280	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					116	130		10.1016/j.immuni.2015.12.004	http://dx.doi.org/10.1016/j.immuni.2015.12.004			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795247	Green Accepted, Bronze			2022-12-18	WOS:000368347000017
J	Afonina, IS; Muller, C; Martin, SJ; Beyaert, R				Afonina, Inna S.; Muller, Christina; Martin, Seamus J.; Beyaert, Rudi			Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme	IMMUNITY			English	Review							MAST-CELL CHYMASE; GENERALIZED PUSTULAR PSORIASIS; ALLERGIC AIRWAY INFLAMMATION; GAMMA-INDUCING FACTOR; GRANZYME-B; CONVERTING-ENZYME; STERILE INFLAMMATION; HUMAN KERATINOCYTES; MICE DEFICIENT; IN-VIVO	Members of the extended interleukin-1 (IL-1) cytokine family, such as IL-1, IL-18, IL-33, and IL-36, play a pivotal role in the initiation and amplification of immune responses. However, deregulated production and/or activation of these cytokines can lead to the development of multiple inflammatory disorders. IL-1 family members share a broadly similar domain organization and receptor signaling pathways. Another striking similarity between IL-1 family members is the requirement for proteolytic processing in order to unlock their full biological potential. Although much emphasis has been put on the role of caspase-1, another emerging theme is the involvement of neutrophil-and mast cell-derived proteases in IL-1 family cytokine processing. Elucidating the regulation of IL-1 family members by proteolytic processing is of great interest for understanding inflammation and immunity. Here, we review the identity of the proteases involved in the proteolytic processing of IL-1 family cytokines and the therapeutic implications in inflammatory disease.	[Afonina, Inna S.; Muller, Christina; Beyaert, Rudi] VIB, Inflammat Res Ctr, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium; [Afonina, Inna S.; Muller, Christina; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland	Flanders Institute for Biotechnology (VIB); Ghent University; Trinity College Dublin	Beyaert, R (corresponding author), VIB, Inflammat Res Ctr, Unit Mol Signal Transduct Inflammat, Technol Pk 927, B-9052 Ghent, Belgium.	rudi.beyaert@irc.vib-ugent.be	Afonina, Inna/AAM-8978-2020; Beyaert, Rudi/B-2589-2009	Afonina, Inna/0000-0001-8894-5305; Beyaert, Rudi/0000-0002-5704-582X; Martin, Seamus/0000-0002-8539-3143	Fund for Scientific Research Flanders (FWO) [G028712N, G046612N, G016413N, G027413N, G090914N]; Belgian Foundation Against Cancer; Agency for Innovation by Science and Technology; Interuniversity Attraction Poles [P7/32]; Belgian Science Policy (Belgian Coordinated Collections of Microorganisms [BCCM]/LMBP); Ghent University [BOF13-GOA-005]; FWO; IWT	Fund for Scientific Research Flanders (FWO)(FWO); Belgian Foundation Against Cancer; Agency for Innovation by Science and Technology; Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Belgian Science Policy (Belgian Coordinated Collections of Microorganisms [BCCM]/LMBP); Ghent University(Ghent University); FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Research in the lab of R.B. is supported by grants from the following sources: Fund for Scientific Research Flanders (FWO) (grant numbers G028712N, G046612N, G016413N, G027413N, G090914N), Belgian Foundation Against Cancer, Agency for Innovation by Science and Technology, Interuniversity Attraction Poles (grant number P7/32), Belgian Science Policy (Belgian Coordinated Collections of Microorganisms [BCCM]/LMBP), and Ghent University (Hercules, Concerted Research Actions [GOA] [grant number BOF13-GOA-005], Group-ID Multidisciplinary research partnership). I.S.A. is supported by a postdoctoral fellowship and a research grant from FWO. C.M. is supported by a doctoral fellowship from the IWT.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akeda T, 2014, ARCH DERMATOL RES, V306, P125, DOI 10.1007/s00403-013-1382-1; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Ali S, 2010, BIOCHEM BIOPH RES CO, V391, P1512, DOI 10.1016/j.bbrc.2009.12.107; Andersson CK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-139; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; Bae S, 2012, J BIOL CHEM, V287, P8205, DOI 10.1074/jbc.M111.295055; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Clavel G, 2013, JOINT BONE SPINE, V80, P449, DOI 10.1016/j.jbspin.2013.04.014; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Companjen AR, 2000, EUR CYTOKINE NETW, V11, P383; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Dinarello CA, 2003, BLOOD PURIFICAT, V21, P258, DOI 10.1159/000070699; Dinarello CA, 2012, BLOOD, V120, P2538, DOI 10.1182/blood-2012-08-445254; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fabbi M, 2015, J LEUKOCYTE BIOL, V97, P665, DOI 10.1189/jlb.5RU0714-360RR; Gabay E, 2011, EUR J PAIN, V15, P242, DOI 10.1016/j.ejpain.2010.07.012; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Grimsby S, 2004, FEBS LETT, V577, P93, DOI 10.1016/j.febslet.2004.09.069; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hayes E, 2011, ARCH IMMUNOL THER EX, V59, P97, DOI 10.1007/s00005-011-0113-6; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; HOWARD AD, 1991, AGENT ACTION SUPPL, V35, P77; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kumar S, 2002, COMPUT SCI ENG, V4, P18, DOI 10.1109/MCISE.2002.976433; KURTJONES EA, 1987, J IMMUNOL, V139, P2317; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Lunding L, 2015, ALLERGY, V70, P366, DOI 10.1111/all.12566; MacKenzie SH, 2010, CURR OPIN DRUG DISC, V13, P568; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; MOSLEY B, 1987, P NATL ACAD SCI USA, V84, P4572, DOI 10.1073/pnas.84.13.4572; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Niki Y, 2004, J IMMUNOL, V172, P577, DOI 10.4049/jimmunol.172.1.577; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315; Omoto Y, 2010, J DERMATOL SCI, V59, P129, DOI 10.1016/j.jdermsci.2010.05.004; Overed-Sayer C, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00174; Pan GH, 2001, CYTOKINE, V13, P1, DOI 10.1006/cyto.2000.0799; Pei C, 2014, IMMUNOLOGY, V141, P9, DOI 10.1111/imm.12174; Petrella BL, 2012, CANCER LETT, V325, P220, DOI 10.1016/j.canlet.2012.07.009; PRIESTLE JP, 1988, EMBO J, V7, P339, DOI 10.1002/j.1460-2075.1988.tb02818.x; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Rudolphi K, 2003, OSTEOARTHR CARTILAGE, V11, P738, DOI 10.1016/S1063-4584(03)00153-5; Sasu S, 2001, AM J PHYSIOL-HEART C, V280, pH1615, DOI 10.1152/ajpheart.2001.280.4.H1615; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sugiura K, 2014, J INVEST DERMATOL, V134, P578, DOI 10.1038/jid.2013.354; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Ushio S, 1996, J IMMUNOL, V156, P4274; van Raam BJ, 2012, BBA-PROTEINS PROTEOM, V1824, P113, DOI 10.1016/j.bbapap.2011.06.005; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Yoshifuji H, 2005, INT IMMUNOL, V17, P1327, DOI 10.1093/intimm/dxh311; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	118	279	289	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					991	1004		10.1016/j.immuni.2015.06.003	http://dx.doi.org/10.1016/j.immuni.2015.06.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084020	Bronze			2022-12-18	WOS:000356362800007
J	Taganov, KD; Boldin, MP; Baltimore, D				Taganov, Konstantin D.; Boldin, Mark P.; Baltimore, David			MicroRNAs and immunity: Tiny players in a big field	IMMUNITY			English	Article							POSTTRANSCRIPTIONAL REGULATION; DICER; DIFFERENTIATION; IDENTIFICATION; VIRUSES; TARGETS; ABSENCE; GENES; CELLS	MicroRNAs (miRNAs) are found in most metazoan organisms as well as in viruses and are implicated in an increasingly wide variety of biological processes in animals. Here, Taganov et al. discuss the role of miRNAs in the innate immune response to microbial infection.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Boldin, MP (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	baltimo@caltech.edu		Boldin, Mark/0000-0003-4593-0669				Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Siedlar M, 2004, J IMMUNOL, V173, P2736, DOI 10.4049/jimmunol.173.4.2736; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102	29	279	312	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					133	137		10.1016/j.immuni.2007.02.005	http://dx.doi.org/10.1016/j.immuni.2007.02.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307699	Bronze			2022-12-18	WOS:000244628600002
J	Jamieson, BD; Douek, DC; Killian, S; Hultin, LE; Scripture-Adams, DD; Giorgi, JV; Marelli, D; Koup, RA; Zack, JA				Jamieson, BD; Douek, DC; Killian, S; Hultin, LE; Scripture-Adams, DD; Giorgi, JV; Marelli, D; Koup, RA; Zack, JA			Generation of functional thymocytes in the human adult	IMMUNITY			English	Article							THYMIC ORGAN-CULTURE; HIV-1 INFECTION; IN-VIVO; INVOLUTION; DEPLETION; THERAPY; MODEL	Reconstituting the immune response will be critical for the survival of HIV-infected individuals once viral load is brought under control. While the adult thymus was previously thought to be relatively inactive, new data suggest it may play a role in T cell reconstitution. We examined thymopoiesis in adults up to 56 years of age and found active T cell receptor (TCR) rearrangement, generating a diverse TCR VP repertoire. The resulting thymocytes are functional and are capable of responding to costimulatory signals. These data demonstrate that the adult thymus remains active late in life and contributes functional T cells to the peripheral lymphoid pool.	Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75235 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Surg, Div Cardiol Thorac, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Jamieson, BD (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.			Scripture-Adams, Deirdre/0000-0002-3676-1771; Killian, Scott/0000-0002-2012-3732	NIAID NIH HHS [AI36554, AI36059] Funding Source: Medline; NIA NIH HHS [AG16825] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036059, R01AI036554, R01AI036059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG016825] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bertho JM, 1997, CELL IMMUNOL, V179, P30, DOI 10.1006/cimm.1997.1148; BONYHADI ML, 1995, AIDS RES HUM RETROV, V11, P1073, DOI 10.1089/aid.1995.11.1073; CALABRO ML, 1995, AIDS RES HUM RETROV, V11, P11, DOI 10.1089/aid.1995.11.11; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3; Haynes BF, 1999, J CLIN INVEST, V103, P453, DOI 10.1172/JCI5201; Haynes BF, 1998, IMMUNOL RES, V18, P175, DOI 10.1007/BF02788778; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jamieson BD, 1997, J VIROL, V71, P8245, DOI 10.1128/JVI.71.11.8245-8253.1997; JOSHI VV, 1986, ARCH PATHOL LAB MED, V110, P837; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Marusic M, 1998, CLIN EXP IMMUNOL, V111, P450; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; ROSENZWEIG M, 1994, PATHOBIOLOGY, V62, P245, DOI 10.1159/000163917; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; SIMPSON JG, 1975, CLIN EXP IMMUNOL, V19, P261; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Vanhecke D, 1997, J IMMUNOL, V159, P5973; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WithersWard ES, 1997, NAT MED, V3, P1102, DOI 10.1038/nm1097-1102	22	279	286	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					569	575		10.1016/S1074-7613(00)80056-4	http://dx.doi.org/10.1016/S1074-7613(00)80056-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367902	Bronze			2022-12-18	WOS:000080709400008
J	Ranger, AM; Oukka, M; Rengarajan, J; Glimcher, LH				Ranger, AM; Oukka, M; Rengarajan, J; Glimcher, LH			Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development	IMMUNITY			English	Article							T-CELL ACTIVATION; CYTOKINE GENE-EXPRESSION; NUCLEAR FACTOR; CYCLOSPORINE-A; LYMPHOPROLIFERATIVE DISEASE; TRANSCRIPTION FACTORS; CD40 LIGAND; FAS LIGAND; PROMOTER; MICE	Nuclear factor of activated T cells (NFAT) is a critical regulator of early gene transcription in response to TCR-mediated signals. Here, we show that mice lacking both NFATp and NFAT4 develop a profound lymphoproliferative disorder likely due to a lowered threshold for TCR signaling coupled with increased resistance to apoptosis secondary to defective Fast expression. NFAT mutant mice also have allergic blepharitis, interstitial pneumonitis, and a 10(3) to 10(4) fold increase in serum IgG1 and IgE levels, secondary to a dramatic and selective increase in Th2 cytokines. This phenotype may be ascribed to unopposed occupancy of the IL-4 promoter by NFATc. Our data demonstrate that lymphoid homeostasis and Th2 activation require a critical balance among NFAT family members.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	Iglimohe@hsph.harvard.edu			NIAID NIH HHS [AI 35833] Funding Source: Medline; NIA NIH HHS [AG 35833] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Latinis KM, 1997, J IMMUNOL, V158, P4602; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MIYATAKE S, 1991, MOL CELL BIOL, V11, P5894, DOI 10.1128/MCB.11.12.5894; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Timmerman LA, 1997, J IMMUNOL, V159, P2735; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TSITSIKOV EN, 1994, MOL IMMUNOL, V31, P895, DOI 10.1016/0161-5890(94)90009-4; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WYNN TA, 1995, CURR OPIN IMMUNOL, V7, P505, DOI 10.1016/0952-7915(95)80095-6; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; [No title captured]	49	279	289	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					627	635		10.1016/S1074-7613(00)80660-3	http://dx.doi.org/10.1016/S1074-7613(00)80660-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846484	Bronze			2022-12-18	WOS:000077298300005
J	Andrade, F; Roy, S; Nicholson, D; Thornberry, N; Rosen, A; Casciola-Rosen, L				Andrade, F; Roy, S; Nicholson, D; Thornberry, N; Rosen, A; Casciola-Rosen, L			Granzyme B directly and efficiently cleaves several downstream caspase substrates: Implications for CTL-induced apoptosis	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; BACULOVIRUS P35 PROTEIN; TARGET-CELLS; MEDIATED APOPTOSIS; SERINE PROTEASES; JURKAT CELLS; DEATH; INHIBITION; AUTOANTIGENS; ACTIVATION	Caspase-mediated proteolysis of downstream substrates is a critical element of the execution pathway common to all forms of apoptosis studied to date. While this caspase-dependent pathway is activated during cytotoxic lymphocyte granule-induced cell death, recent studies have also provided evidence for caspase-independent pathways. However, the mechanisms mediating these additional pathways have not been defined. The current study demonstrates that DNA-PKcs, and NuMA are directly and efficiently cleaved by granzyme B in vitro and in vivo, generating unique substrate fragments not observed during other forms of apoptosis. This direct, caspase-independent ability of granzyme B to cleave downstream death substrates constitutes an apoptotic effector mechanism that is insensitive to inhibitors of the signaling or execution components of the endogenous apoptotic cascade.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anat & Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada; Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Merck & Company; Merck & Company	Rosen, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	arosen@welchlink.welch.jhu.edu; lcasciol@welchlink.welch.jhu.edu			NIAMS NIH HHS [R01 AR044684, AR44684] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044684] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V227, P658, DOI 10.1006/bbrc.1996.1565; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Greidinger EL, 1996, FEBS LETT, V390, P299, DOI 10.1016/0014-5793(96)00678-3; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; Krajewska M, 1997, CANCER RES, V57, P1605; Krajewski S, 1997, BLOOD, V89, P3817, DOI 10.1182/blood.V89.10.3817.3817_3817_3825; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MCGAHON AJ, 1995, J BIOL CHEM, V270, P22625, DOI 10.1074/jbc.270.38.22625; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; PEITSCH MC, 1994, METHOD ENZYMOL, V244, P80; Pinkoski MJ, 1996, J BIOL CHEM, V271, P10225, DOI 10.1074/jbc.271.17.10225; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; POE M, 1991, J BIOL CHEM, V266, P266; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Song QZ, 1996, J EXP MED, V184, P619, DOI 10.1084/jem.184.2.619; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TOPALIAN SL, 1989, J IMMUNOL, V142, P3714; Trapani JA, 1996, J BIOL CHEM, V271, P4127; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0	42	279	302	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1998	8	4					451	460		10.1016/S1074-7613(00)80550-6	http://dx.doi.org/10.1016/S1074-7613(00)80550-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586635	hybrid			2022-12-18	WOS:000073348000007
J	Miller, SD; Vanderlugt, CL; Lenschow, DJ; Pope, JG; Karandikar, NJ; DalCanto, MC; Bluestone, JA				Miller, SD; Vanderlugt, CL; Lenschow, DJ; Pope, JG; Karandikar, NJ; DalCanto, MC; Bluestone, JA			Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN PROTEOLIPID PROTEIN; T-CELL ACTIVATION; ENCEPHALITOGENIC DETERMINANT; ANTIGEN PRESENTATION; SJL MICE; IDENTIFICATION; CTLA-4; DEMYELINATION; EXPRESSION	Relapsing experimental autoimmune encephalomyelitis (R-EAE) induced with the immunodominant epitope from proteolipid protein, PLP(139-151), is characterized by the development of recurrent relapses with recruitment of T cells reactive to additional myelin peptides, including PLP(178-191) (epitope spreading). In this study, we have determined that the CD28/B7 costimulatory pathway is involved in this process. We found preferential up-regulation of B7-1 during the course of R-EAE and a selective increase in its functional costimulatory activity, relative to B7-2. Anti B7-1 F(ab) fragment therapy, but not anti B7-2 MAb therapy, blocked clinical relapses, ameliorated CNS pathology, and blocked epitope spreading. These results suggest that the maintenance of autoimmune reactivity in EAE depends on CD28/B7-1-dependent costimulation of newly recruited T cells responsible for epitope spreading. These studies have important implications for the role of epitope spreading in disease progression and the clinical application of costimulatory antagonists in autoimmune diseases.	NORTHWESTERN UNIV,SCH MED,CTR INTERDEPARTMENTAL IMMUNOBIOL,DEPT PATHOL,CHICAGO,IL 60611; UNIV CHICAGO,BEN MAY INST,CHICAGO,IL 60637; UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637	Northwestern University; University of Chicago; University of Chicago	Miller, SD (corresponding author), NORTHWESTERN UNIV,SCH MED,CTR INTERDEPARTMENTAL IMMUNOBIOL,DEPT MICROBIOL IMMUNOL,CHICAGO,IL 60611, USA.			Karandikar, Nitin/0000-0002-6867-6950	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030871, R01NS026543] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35294] Funding Source: Medline; NINDS NIH HHS [NS26543, NS30871] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; DALCANTO MC, 1975, LAB INVEST, V33, P626; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; GONATAS NK, 1986, IMMUNOL TODAY, V7, P121, DOI 10.1016/0167-5699(86)90072-1; GREER JM, 1992, J IMMUNOL, V149, P783; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1994, J IMMUNOL, V153, P1990; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LENSCHOW DJ, 1995, IN PRESS TRANSPLANTA, V60; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1990, P NATL ACAD SCI USA, V87, P5031, DOI 10.1073/pnas.87.13.5031; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; MCRAE BL, 1992, J NEUROIMMUNOL, V38, P229, DOI 10.1016/0165-5728(92)90016-E; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; MILLER SD, 1995, IMMUNOL REV, V144, P225, DOI 10.1111/j.1600-065X.1995.tb00071.x; MILLER SD, 1994, IMMUNOL TODAY, V15, P356, DOI 10.1016/0167-5699(94)90173-2; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; PERRIN PJ, 1995, J IMMUNOL, V154, P1481; PERRY LL, 1987, J IMMUNOL, V138, P1434; TAN LJ, 1991, J IMMUNOL, V147, P1797; TUOHY VK, 1989, J IMMUNOL, V142, P1523; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wekerle H, 1991, Acta Neurol (Napoli), V13, P197	31	279	282	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1995	3	6					739	745		10.1016/1074-7613(95)90063-2	http://dx.doi.org/10.1016/1074-7613(95)90063-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777719	Bronze			2022-12-18	WOS:A1995TM02300008
J	LEE, N; MALACKO, AR; ISHITANI, A; CHEN, MC; BAJORATH, J; MARQUARDT, H; GERAGHTY, DE				LEE, N; MALACKO, AR; ISHITANI, A; CHEN, MC; BAJORATH, J; MARQUARDT, H; GERAGHTY, DE			THE MEMBRANE-BOUND AND SOLUBLE FORMS OF HLA-G BIND IDENTICAL SETS OF ENDOGENOUS PEPTIDES BUT DIFFER WITH RESPECT TO TAP ASSOCIATION	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; CELL-LINE; RMA-S; ANTIGEN PRESENTATION; LYMPHOCYTES-T; GENE-TRANSFER; TRANSPORTER; EXPRESSION; RECOGNITION	The class Ib antigen HLA-G is expressed as a membrane-bound protein like classical class Ia molecules (M . HLA-G) but, unlike typical class I, is also expressed as a soluble protein (S . HLA-G) with a unique C terminus. Our results show that, similar to classical class I proteins, the membrane-bound form of HLA-G associated with TAP, as evidenced by the ability to immunoprecipitate HLA-G class I heavy chain with TAP antisera. In contrast, the soluble G protein did not appear to associate with TAP in the same manner, since similar immunoprecipitation experiments failed to detect soluble G complex. A detailed analysis of peptides bound to the soluble and membrane HLA-G proteins expressed in the B lymphoblastoid cell line 721.221 showed that, like class Ia complexes, both HLA-G protei ns consist of heavy and light chains complexed with nonameric peptides in a 1:1:1 ratio. The two proteins bind essentially the same set of peptides, which are derived from a variety of intracellular proteins and define a peptide motif for HLA-G. The peptides contain Leu at the C terminus and Pro or small hydrophobic amino acids in position 3 followed by Pro or Gly in position 4. The complexity of the bound peptides is lower than that found for some class Ia complexes, but is more similar to class Ia than to the limited repertoire of some murine class Ib molecules.	NARA MED UNIV, NARA 634, JAPAN; BRISTOL MYERS SQUIBB CO, PHARMACEUT RES INST, SEATTLE, WA 98121 USA	Nara Medical University; Bristol-Myers Squibb	LEE, N (corresponding author), FRED HUTCHINSON CANC RES CTR, DIV CLIN RES, 1124 COLUMBIA ST, M374, SEATTLE, WA 98104 USA.		Bajorath, Jürgen/F-7493-2014		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008911, R01AI038508] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38508, AI08911] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; CHUMBLEY G, 1994, CELL IMMUNOL, V155, P312, DOI 10.1006/cimm.1994.1125; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; DENIZ G, 1994, J IMMUNOL, V152, P4255; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIBRINO M, 1994, J BIOL CHEM, V269, P32426; ELLIS SA, 1986, IMMUNOLOGY, V59, P595; Engelhard V H, 1993, Chem Immunol, V57, P39; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; FUJII T, 1994, J IMMUNOL, V153, P5516; GERAGHTY DE, 1992, J IMMUNOL, V149, P1934; GERAGHTY DE, 1993, CURR OPIN IMMUNOL, V5, P3, DOI 10.1016/0952-7915(93)90073-2; GRANDEA AG, 1995, IN PRESS SCIENCE; GUENGUEN M, 1994, J EXP MED, V180, P1989; HAMMOND SA, 1993, NATURE, V364, P158, DOI 10.1038/364158a0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOSKEN NA, 1992, J EXP MED, V175, P719, DOI 10.1084/jem.175.3.719; HSI BL, 1984, IMMUNOLOGY, V52, P621; HUCZKO EL, 1993, J IMMUNOL, V151, P2572; HUNT JS, 1992, CURR OPIN IMMUNOL, V4, P591, DOI 10.1016/0952-7915(92)90032-A; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; JOYCE S, 1994, CURR OPIN IMMUNOL, V6, P24, DOI 10.1016/0952-7915(94)90029-9; JOYCE S, 1994, J EXP MED, V179, P579, DOI 10.1084/jem.179.2.579; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KOLLER BH, 1987, IMMUNOL RES, V6, P1, DOI 10.1007/BF02918100; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LINDAHL KF, 1991, ANNU REV IMMUNOL, V9, P351, DOI 10.1146/annurev.iy.09.040191.002031; LOKE YW, 1991, CURR OPIN IMMUNOL, V3, P762, DOI 10.1016/0952-7915(91)90110-M; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; REDDEHASE MJ, 1987, J VIROL, V61, P3102, DOI 10.1128/JVI.61.10.3102-3108.1987; REDMAN CWG, 1984, IMMUNOLOGY, V52, P457; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; ROTZSCHKE O, 1993, NATURE, V361, P642, DOI 10.1038/361642a0; SANDERS SK, 1991, J EXP MED, V174, P737, DOI 10.1084/jem.174.3.737; SARGENT IL, 1993, EXP CLIN IMMUNOGENET, V10, P85; SCHIRMBECK R, 1994, EUR J IMMUNOL, V24, P1478, DOI 10.1002/eji.1830240704; SCHMIDT CM, 1993, CRIT REV IMMUNOL, V13, P207; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; SIJTS AJAM, 1992, EUR J IMMUNOL, V22, P1639, DOI 10.1002/eji.1830220644; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; STROYNOWSKI I, 1990, ANNU REV IMMUNOL, V8, P501, DOI 10.1146/annurev.iy.08.040190.002441; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TABACZEWSKI P, 1994, J IMMUNOL, V152, P5268; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VANDERVEN K, 1994, J IMMUNOL, V153, P5628; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YELAVARTHI KK, 1991, J IMMUNOL, V146, P2847; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756	58	279	290	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1995	3	5					591	600		10.1016/1074-7613(95)90130-2	http://dx.doi.org/10.1016/1074-7613(95)90130-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584149	Bronze			2022-12-18	WOS:A1995TG28100007
J	Walther, M; Tongren, JE; Andrews, L; Korbel, D; King, E; Fletcher, H; Andersen, RF; Bejon, P; Thompson, F; Dunachie, SJ; Edele, F; de Souza, JB; Sinden, RE; Gilbert, SC; Riley, EM; Hill, AVS				Walther, M; Tongren, JE; Andrews, L; Korbel, D; King, E; Fletcher, H; Andersen, RF; Bejon, P; Thompson, F; Dunachie, SJ; Edele, F; de Souza, JB; Sinden, RE; Gilbert, SC; Riley, EM; Hill, AVS			Upregulation of TGF-beta, FOXP3, and CD4(+)CD25(+) regulatory T cells correlates with more rapid parasite growth in human malaria infection	IMMUNITY			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TRANSCRIPTION FACTOR FOXP3; POLYMERASE-CHAIN-REACTION; IN-VITRO; CYTOKINE PRODUCTION; SUPPRESSIVE ACTIVITY; PERIPHERAL-BLOOD; CUTTING EDGE; EX-VIVO; CD4(+)	Understanding the regulation of immune responses is central for control of autoimmune and infectious disease. In murine models of autoimmunity and chronic inflammatory disease, potent regulatory T lymphocytes have recently been characterized. Despite an explosion of interest in these cells, their relevance to human disease has been uncertain. In a longitudinal study of malaria sporozoite infection via the natural route, we provide evidence that regulatory T cells have modifying effects on blood-stage infection in vivo in humans. Cells with the characteristics of regulatory T cells are rapidly induced following blood-stage infection and are associated with a burst of TGF-beta production, decreased proinflammatory cytokine production, and decreased antigen-specific immune responses. Both the production of TGF-beta and the presence of CD4(+)CD25(+)FOXP3(+) regulatory T cells are associated with higher rates of parasite growth in vivo. P. falciparum-mediated induction of regulatory T cells may represent a parasite-specific virulence factor.	Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Clin Med, Churchill Hosp, Oxford OX3 7LJ, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Royal Free & UCL Med Sch, Dept Immunol & Mol Pathol, London W1T 4JF, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Imperial College London	Riley, EM (corresponding author), Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Clin Med, Churchill Hosp, S Parks Rd, Oxford OX3 7LJ, England.	eleanor.riley@lshtm.ac.uk	de Souza, Joseph B/D-4979-2009; Riley, Eleanor M/C-8960-2013; Fletcher, Helen/D-1470-2011; HILL, Adrian V>S>/C-1306-2008; Riley, Eleanor/AAL-1382-2020; Gilbert, Sarah C./H-2857-2019	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Gilbert, Sarah C./0000-0002-6823-9750; Andersen, Rikke Fredslund/0000-0002-5894-7745; Korbel, Daniel/0000-0002-4682-9928; Fletcher, Helen/0000-0002-0435-1006; Dunachie, Susanna/0000-0001-5665-6293	MRC [G84/6323] Funding Source: UKRI; Medical Research Council [G84/6323] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Baecher-Allan C, 2005, CLIN IMMUNOL, V115, P10, DOI 10.1016/j.clim.2005.02.018; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Chaiyaroj SC, 2004, ACTA TROP, V89, P319, DOI 10.1016/j.actatropica.2003.10.010; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Omer FM, 2003, J EXP MED, V198, P1817, DOI 10.1084/jem.20030713; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; Rhee MSM, 2001, CLIN EXP IMMUNOL, V126, P503, DOI 10.1046/j.1365-2249.2001.01681.x; Rouse BT, 2004, J IMMUNOL, V173, P2211, DOI 10.4049/jimmunol.173.4.2211; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tsutsui N, 1999, INFECT IMMUN, V67, P2306, DOI 10.1128/IAI.67.5.2306-2311.1999; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; VanWaarde MAWH, 1997, ANAL BIOCHEM, V247, P45, DOI 10.1006/abio.1997.2026; WENISCH C, 1995, J CLIN IMMUNOL, V15, P69, DOI 10.1007/BF01541734; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	58	278	292	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					287	296		10.1016/j.immuni.2005.08.006	http://dx.doi.org/10.1016/j.immuni.2005.08.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169501	Bronze			2022-12-18	WOS:000232382500007
J	Legge, KL; Braciale, TJ				Legge, KL; Braciale, TJ			Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection	IMMUNITY			English	Article							CYTOLYTIC LYMPHOCYTES-T; IN-VIVO; INFLUENZA HEMAGGLUTININ; INFLAMMATORY RESPONSE; AIRWAY EPITHELIUM; SENDAI VIRUS; ANTIGEN; RECOGNITION; MATURATION; GENERATION	Respiratory dendritic cells (RDC) are believed to play a central role in the induction of adaptive immune responses to pulmonary infection. Herein we examine the basal migration of RDC from the lungs to secondary lymphoid tissues and their enhanced maturation/migration after pulmonary infection/inflammation. We demonstrate that the accelerated migration of RDC to the draining peribronchial lymph nodes occurs only during the first 24 hr after pulmonary virus infection. RDC are refractory to further migration thereafter in spite of ongoing virus replication and pulmonary inflammation. We further demonstrate that induction of this RDC refractory state suppresses additional RDC mobilization to subsequent pulmonary virus infection and results in concomitant suppression of an antiviral pulmonary CD8(+) T cell response.	Univ Virginia, Hlth Sci Ctr, Carter Immunol Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Hlth Sci Ctr, Carter Immunol Ctr, Charlottesville, VA 22908 USA.		Legge, Kevin/B-1610-2009	Legge, Kevin/0000-0001-9800-6854	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015608, R37AI015608, T32AI007496] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33391] Funding Source: Medline; NIAID NIH HHS [AI15608, AI07496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; BODMER HC, 1988, CELL, V52, P253, DOI 10.1016/0092-8674(88)90514-4; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; BRACIALE TJ, 1977, CELL IMMUNOL, V33, P423, DOI 10.1016/0008-8749(77)90170-8; BRACIALE TJ, 1989, P NATL ACAD SCI USA, V86, P277, DOI 10.1073/pnas.86.1.277; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; HAVENITH CEG, 1993, AM J RESP CELL MOL, V9, P484, DOI 10.1165/ajrcmb/9.5.484; HOLT PG, 1994, J IMMUNOL, V153, P256; Holt PG, 2000, J AEROSOL MED, V13, P361, DOI 10.1089/jam.2000.13.361; Holt PG, 2000, J ALLERGY CLIN IMMUN, V105, P421, DOI 10.1067/mai.2000.105010; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Larsson M, 2000, J IMMUNOL, V165, P1182, DOI 10.4049/jimmunol.165.3.1182; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; NONACS R, 1992, J EXP MED, V176, P519, DOI 10.1084/jem.176.2.519; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Sparwasser T, 2000, EUR J IMMUNOL, V30, P3591, DOI 10.1002/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J; SWEETSER MT, 1989, J EXP MED, V170, P1357, DOI 10.1084/jem.170.4.1357; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275	35	278	286	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2003	18	2					265	277		10.1016/S1074-7613(03)00023-2	http://dx.doi.org/10.1016/S1074-7613(03)00023-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594953	Bronze			2022-12-18	WOS:000181138100010
J	Potocnik, AJ; Brakebusch, C; Fassler, R				Potocnik, AJ; Brakebusch, C; Fassler, R			Fetal and adult hematopoietic stem cells require beta 1 integrin function for colonizing fetal liver, spleen, and bone marrow	IMMUNITY			English	Article							ADHESION MOLECULE-1; IN-VITRO; ENDOTHELIAL SELECTINS; GENE-EXPRESSION; MOUSE EMBRYO; THYMUS; PROGENITORS; DIFFERENTIATION; MIGRATION; MICE	Homing of hematopoietic stem cells (HSCs) into hematopoietic organs is a prerequisite for the establishment of hematopoiesis during embryogenesis and after bone marrow transplantation. We show that beta 1 integrin-deficient HSCs from the para-aortic splanchnopleura and the fetal blood had hematolymphoid differentiation potential in vitro and in fetal organ cultures but were unable to seed fetal and adult hematopoietic tissues. Adult beta 1 integrin null HSCs isolated from mice carrying loxP-tagged beta 1 integrin alleles and ablated for beta 1 integrin expression by retroviral cre transduction failed to engraft irradiated recipient mice. Moreover, absence of beta 1 integrin resulted in sequestration of HSCs in the circulation and their reduced adhesion to endothelioma cells. These findings define beta 1 integrin as an essential adhesion receptor for the homing of HSCs.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Lund, Dept Expt Pathol, S-22185 Lund, Sweden	Max Planck Society; Lund University	Potocnik, AJ (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Brakebusch, Cord/0000-0002-9342-1634; Potocnik, Alexandre/0000-0002-4730-8593				ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; ARROYO AG, 1999, NATURE, V11, P555; Baudoin C, 1996, CELL ADHES COMMUN, V4, P1, DOI 10.3109/15419069609010759; COOPER D, 1995, P NATL ACAD SCI USA, V92, P3978, DOI 10.1073/pnas.92.9.3978; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Friedrich C, 1996, EUR J IMMUNOL, V26, P2773, DOI 10.1002/eji.1830261133; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; HAWLEY RG, 1994, GENE THER, V1, P136; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; Kawakami N, 1999, J IMMUNOL, V163, P3211; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Marcos MAR, 1997, J IMMUNOL, V158, P2627; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; MCKEARN JP, 1984, J IMMUNOL, V132, P332; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MULLER WA, 1995, J LEUKOCYTE BIOL, V57, P523, DOI 10.1002/jlb.57.4.523; OWEN JJT, 1977, COLD SPRING HARB SYM, V41, P129; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Rohnelt RK, 1997, INT IMMUNOL, V9, P435, DOI 10.1093/intimm/9.3.435; RUIZ P, 1995, EUR J IMMUNOL, V25, P2034, DOI 10.1002/eji.1830250735; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Schmitz H, 1997, PHILOS RUNDSCH, V44, P90; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Voura EB, 1997, EXP HEMATOL, V25, P1172; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0	45	278	287	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2000	12	6					653	663		10.1016/S1074-7613(00)80216-2	http://dx.doi.org/10.1016/S1074-7613(00)80216-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894165	Bronze			2022-12-18	WOS:000087937300007
J	Yewdell, JW				Yewdell, Jonathan W.			Confronting complexity: Real-world immunodominance in antiviral CD8(+) T cell responses	IMMUNITY			English	Review							INFLUENZA-A VIRUS; HEPATITIS-C-VIRUS; HUMAN CYTOMEGALOVIRUS; CROSS-REACTIVITY; IN-VIVO; DENDRITIC CELLS; VACCINIA VIRUS; PRIVATE SPECIFICITIES; EPITOPE EXPRESSION; DNA IMMUNIZATION	Antiviral CD8(+) T cells respond to only a minute fraction of the potential peptide determinants encoded by viral genomes. Immunogenic determinants can be ordered into highly reproducible hierarchies based on the magnitude of cognate CD8(+) T cell responses. Until recently, this phenomenon, termed immunodominance, was largely defined and characterized in model systems utilizing a few strains of inbred mice infected with a handful of viruses with limited coding capacity. Here, I review work that has extended immunodominance studies to viruses of greater complexity and to the real world of human antiviral immunity.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000814, Z01AI000814] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali A, 2004, J VIROL, V78, P561, DOI 10.1128/JVI.78.2.561-567.2004; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; Belz GT, 2000, J IMMUNOL, V165, P2404, DOI 10.4049/jimmunol.165.5.2404; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Boon ACM, 2004, J IMMUNOL, V172, P4435, DOI 10.4049/jimmunol.172.7.4435; Borghans JAM, 1998, IMMUNOL TODAY, V19, P428, DOI 10.1016/S0167-5699(98)01317-6; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Bronte V, 1997, P NATL ACAD SCI USA, V94, P3183, DOI 10.1073/pnas.94.7.3183; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Chen WS, 2002, J VIROL, V76, P10332, DOI 10.1128/JVI.76.20.10332-10337.2002; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Choi EY, 2002, IMMUNITY, V17, P593, DOI 10.1016/S1074-7613(02)00428-4; Crotzer VL, 2000, J IMMUNOL, V164, P6120, DOI 10.4049/jimmunol.164.12.6120; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; CROWE SR, 2006, IMMUNODOMINANCE CHOI, P189; Davis MM, 2003, NAT IMMUNOL, V4, P649, DOI 10.1038/ni0703-649; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Fu TM, 1998, J VIROL, V72, P1469, DOI 10.1128/JVI.72.2.1469-1481.1998; GADDIS DE, 2006, IMMUNODOMINANCE CHOI; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; Istrail S, 2004, P NATL ACAD SCI USA, V101, P13268, DOI 10.1073/pnas.0404740101; Ito Y, 2006, J VIROL, V80, P883, DOI 10.1128/JVI.80.2.883-890.2006; JAMIESON BD, 1989, J EXP MED, V169, P1993, DOI 10.1084/jem.169.6.1993; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Landais E, 2005, INT J DEV BIOL, V49, P285, DOI 10.1387/ijdb.041947el; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Liu F, 2004, J IMMUNOL, V173, P456, DOI 10.4049/jimmunol.173.1.456; Lu XJ, 2006, J VIROL, V80, P4200, DOI 10.1128/JVI.80.8.4200-4202.2006; MAINI M, 2006, IMMUNODOMINANCE CHOI; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; MUNKS MW, 2006, IMMUNODOMINANCE CHOI, P255; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rodriguez F, 2001, J VIROL, V75, P7399, DOI 10.1128/JVI.75.16.7399-7409.2001; ROSENTHAL KL, 1981, J IMMUNOL, V126, P446; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; Saveanu L, 2005, IMMUNOL REV, V207, P42, DOI 10.1111/j.0105-2896.2005.00313.x; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; SETTE A, 2006, IMMUNODOMINANCE CHOI, P57; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Slev PR, 2006, CURR OPIN IMMUNOL, V18, P608, DOI 10.1016/j.coi.2006.07.012; Snyder-Cappione JE, 2006, J IMMUNOL, V176, P2662, DOI 10.4049/jimmunol.176.4.2662; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, EXPERT OPIN BIOL TH, V5, P263, DOI 10.1517/14712598.5.2.263; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058; van der Most RG, 2003, VIROLOGY, V315, P93, DOI 10.1016/j.virol.2003.07.001; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2006, CURR OPIN IMMUNOL, V18, P331, DOI 10.1016/j.coi.2006.03.002; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Whitton JL, 2004, ADV VIRUS RES, V63, P181, DOI 10.1016/S0065-3527(04)63003-X; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Yang OO, 2005, J VIROL, V79, P15368, DOI 10.1128/JVI.79.24.15368-15375.2005; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yewdell JW, 2004, IMMUNITY, V21, P149, DOI 10.1016/j.immuni.2004.06.015; Yewdell JW, 2005, IMMUNOL REV, V207, P8; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	101	277	281	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					533	543		10.1016/j.immuni.2006.09.005	http://dx.doi.org/10.1016/j.immuni.2006.09.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17046682	Bronze			2022-12-18	WOS:000241481500006
J	Youngblood, B; Oestreich, KJ; Ha, SJ; Duraiswamy, J; Akondy, RS; West, EE; Wei, ZY; Lu, PY; Austin, JW; Riley, JL; Boss, JM; Ahmed, R				Youngblood, Ben; Oestreich, Kenneth J.; Ha, Sang-Jun; Duraiswamy, Jaikumar; Akondy, Rama S.; West, Erin E.; Wei, Zhengyu; Lu, Peiyuan; Austin, James W.; Riley, James L.; Boss, Jeremy M.; Ahmed, Rafi			Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8(+) T Cells	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; DNA METHYLTRANSFERASE EXPRESSION; CHRONIC VIRAL-INFECTION; EPIGENETIC CONTROL; IN-VIVO; MEMORY; METHYLATION; EFFECTOR; DIFFERENTIATION; PERSISTENCE	Functionally exhausted T cells have high expression of the PD-1 inhibitory receptor, and therapies that block PD-1 signaling show promise for resolving chronic viral infections and cancer. By using human and murine systems of acute and chronic viral infections, we analyzed epigenetic regulation of PD-1 expression during CD8(+) T cell differentiation. During acute infection, naive to effector CD8(+) T cell differentiation was accompanied by a transient loss of DNA methylation of the Pdcd1 locus that was directly coupled to the duration and strength of T cell receptor signaling. Further differentiation into functional memory cells coincided with Pdcd1 remethylation, providing an adapted program for regulation of PD-1 expression. In contrast, the Pdcd1 regulatory region was completely demethylated in exhausted CD8(+) T cells and remained unmethylated even when virus titers decreased. This lack of DNA remethylation leaves the Pdcd1 locus poised for rapid expression, potentially providing a signal for premature termination of antiviral functions.	[Youngblood, Ben; Oestreich, Kenneth J.; Ha, Sang-Jun; Duraiswamy, Jaikumar; Akondy, Rama S.; West, Erin E.; Lu, Peiyuan; Austin, James W.; Boss, Jeremy M.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Youngblood, Ben; Ha, Sang-Jun; Duraiswamy, Jaikumar; Akondy, Rama S.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Oestreich, Kenneth J.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Ha, Sang-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Wei, Zhengyu; Riley, James L.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wei, Zhengyu; Riley, James L.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Emory University; Emory University; University of Washington; University of Washington Seattle; Yonsei University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	jmboss@emory.edu; rahmed@emory.edu	Youngblood, Benjamin/N-2508-2018; Akondy, Rama/AAC-4656-2020	Youngblood, Benjamin/0000-0002-1261-9957; Ha, Sang-Jun/0000-0002-1192-6031; Riley, James/0000-0002-1057-576X; Akondy, Rama/0000-0003-4737-5240	National Institutes of Health (NIH) [1 P01 AI080192-01, 2 R37 AI30048-17, AHMED05GCGH0]; American Cancer Society (ACS) [PF-09-134-01-MPC]; Korea Research Foundation (KRF); Korea government (MEST) [2010-0004892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI080192, R37AI030048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); Korea Research Foundation (KRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Karaffa and S. Durham for FACS sorting at the Emory University School of Medicine Flow Cytometry Core Facility. This work was supported by the National Institutes of Health (NIH) grant 1 P01 AI080192-01 (to R.A. and J.M.B.), grant 2 R37 AI30048-17 (to R.A.), and grant AHMED05GCGH0 (to R.A.), the American Cancer Society (ACS) postdoctoral fellowship PF-09-134-01-MPC (to B.Y.), and the Korea Research Foundation (KRF) grant funded by the Korea government (MEST) No. 2010-0004892 (to S.-J.H.). R.A. and S.-J.H. have patents and receive patent royalties related to the PD-1 pathway.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bevan MJ, 2000, CURR BIOL, V10, pR338, DOI 10.1016/S0960-9822(00)00461-9; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Johnson TB, 1925, J AM CHEM SOC, V47, P2838, DOI 10.1021/ja01688a030; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lu Qianjin, 2004, Biol Proced Online, V6, P189, DOI 10.1251/bpo89; Lucifero D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-36; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Reiner SL, 2005, HUM MOL GENET, V14, pR41, DOI 10.1093/hmg/ddi115; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Youngblood B, 2010, INT IMMUNOL, V22, P797, DOI 10.1093/intimm/dxq437; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang Z, 2009, J HEPATOL, V50, P1163, DOI 10.1016/j.jhep.2009.01.026	64	276	291	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 23	2011	35	3					400	412		10.1016/j.immuni.2011.06.015	http://dx.doi.org/10.1016/j.immuni.2011.06.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943489	Bronze, Green Accepted			2022-12-18	WOS:000295748100011
J	Tsujimura, Y; Obata, K; Mukai, K; Shindou, H; Yoshida, M; Nishikado, H; Kawano, Y; Minegishi, Y; Shimizu, T; Karasuyama, H				Tsujimura, Yusuke; Obata, Kazushige; Mukai, Kaori; Shindou, Hideo; Yoshida, Masayuki; Nishikado, Hideto; Kawano, Yohei; Minegishi, Yoshiyuki; Shimizu, Takao; Karasuyama, Hajime			Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis	IMMUNITY			English	Article							PLATELET-ACTIVATING-FACTOR; FC-GAMMA-RIII; MAST-CELL DEGRANULATION; IN-VIVO; IGE; ANTIBODIES; MOUSE; IL-4; MICE; LIPOPOLYSACCHARIDE	Anaphylaxis is an acute, severe, and potentially fatal systemic allergic reaction. Immunoglobulin E (IgE), mast cells, and histamine have long been associated with anaphylaxis, but an alternative pathway mediated by IgG has been suggested to be more important in the elicitation of anaphylaxis. Here, we showed that basophils, the least common blood cells, were dispensable for IgE-mediated anaphylaxis but played a critical role in IgG-mediated, passive and active systemic anaphylaxis in mice. In vivo depletion of basophils but not macrophages, neutrophils, or NK cells ameliorated IgG-mediated passive anaphylaxis and rescued mice from death in active anaphylaxis. Upon capture of IgG-allergen complexes, basophils released platelet-activating factor (PAF), leading to increased vascular permeability. These results highlight a pivotal role for basophils in vivo and contrast two major, distinct pathways leading to allergen-induced systemic anaphylaxis: one mediated by basophils, IgG, and PAF and the other "classical" pathway mediated by mast cells, IgE, and histamine.	[Tsujimura, Yusuke; Obata, Kazushige; Mukai, Kaori; Nishikado, Hideto; Kawano, Yohei; Minegishi, Yoshiyuki; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo 1138519, Japan; [Yoshida, Masayuki] Tokyo Med & Dent Univ, Grad Sch, Life Sci & Bioeth Res Ctr, Tokyo 1138519, Japan; [Shindou, Hideo; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo	Karasuyama, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo 1138519, Japan.	karasuyama.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011; Kawano, Yohei/V-1335-2018; Shimizu, Takao/AAV-7052-2021	Karasuyama, Hajime/0000-0003-0689-0836; Kawano, Yohei/0000-0001-7181-2282				ADOURIAN U, 1993, ANESTHESIOLOGY, V78, P368, DOI 10.1097/00000542-199302000-00024; ARIMURA A, 1990, IMMUNOL INVEST, V19, P227, DOI 10.3109/08820139009041837; BENVENISTE J, 1974, NATURE, V249, P581, DOI 10.1038/249581a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCHNER BS, 1991, NEW ENGL J MED, V324, P1785, DOI 10.1056/NEJM199106203242506; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Choi IH, 1998, J EXP MED, V188, P1587, DOI 10.1084/jem.188.9.1587; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Dybendal T, 2003, ACTA ANAESTH SCAND, V47, P1211, DOI 10.1046/j.1399-6576.2003.00237.x; ENDO Y, 1995, BRIT J PHARMACOL, V114, P187, DOI 10.1111/j.1476-5381.1995.tb14924.x; Falcone FH, 2000, BLOOD, V96, P4028; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2005, J ALLERGY CLIN IMMUN, V115, P571, DOI 10.1016/j.jaci.2004.12.1133; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; HIRAYAMA N, 1982, P NATL ACAD SCI-BIOL, V79, P613, DOI 10.1073/pnas.79.2.613; HUMPHREY DM, 1982, LAB INVEST, V46, P422; JACOBY W, 1984, J INVEST DERMATOL, V83, P302, DOI 10.1111/1523-1747.ep12340431; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; KITAMURA Y, 1978, BLOOD, V52, P447; Kojima T, 2007, J IMMUNOL, V179, P7093, DOI 10.4049/jimmunol.179.10.7093; KRAFT D, 1982, ALLERGY, V37, P481, DOI 10.1111/j.1398-9995.1982.tb02331.x; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lie WJ, 2003, CLIN EXP ALLERGY, V33, P1125, DOI 10.1046/j.1365-2222.2003.01726.x; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; MULKAI K, 2005, IMMUNITY, V23, P191; Nishioka T, 2007, J LEUKOCYTE BIOL, V82, P327, DOI 10.1189/jlb.1006598; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Park JS, 1997, J IMMUNOL, V158, P5002; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; WEISS ME, 1989, NEW ENGL J MED, V320, P886, DOI 10.1056/NEJM198904063201402; Winbery Stephen L, 2002, Clin Allergy Immunol, V17, P287	48	276	288	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					581	589		10.1016/j.immuni.2008.02.008	http://dx.doi.org/10.1016/j.immuni.2008.02.008			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18342553	Bronze			2022-12-18	WOS:000254939400018
J	Otsuka, M; Jing, Q; Georgel, P; New, L; Chen, JM; Mols, J; Kang, YJ; Jiang, ZF; Du, X; Cook, R; Das, SC; Pattnaik, AK; Beutler, B; Han, JH				Otsuka, Motoyuki; Jing, Qing; Georgel, Philippe; New, Liguo; Chen, Jianming; Mols, Johann; Kang, Young Jun; Jiang, Zhengfan; Du, Xin; Cook, Ryan; Das, Subash C.; Pattnaik, Asit K.; Beutler, Bruce; Han, Jiahuai			Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression	IMMUNITY			English	Article							RNA INTERFERENCE; CAENORHABDITIS-ELEGANS; ANTIVIRAL DEFENSE; ENZYME DICER; ARABIDOPSIS-THALIANA; MOUSE DEVELOPMENT; PHOSPHOPROTEIN-P; MICRORNA; MORPHOGENESIS; INHIBITION	Dicer is essential for plant, Caenorhabditis elegans, and Drosophila antiviral responses because of its role in generating small interfering RNA (siRNA) from viral genomes. We show that because of impaired miRNA production, mice with a variant Dicer1 allele (Dicer1(d/d)) were more susceptible to vesicular stomatitis virus (VSV) infection. We did not detect VSV genome-derived siRNA in wild-type cells or any alteration of interferon-mediated antiviral responses by Dicer1 deficiency. Rather, we found that host miR24 and miR93 could target viral large protein (L protein) and phosphoprotein (P protein) genes, and a lack of miR24 and miR93 was responsible for increased VSV replication in Dicer1(d/d) cells. Our data suggest that host miRNA can play a role in host interactions with viruses.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China; Chinese Acad Prevent Med, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68588 USA; Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA	Scripps Research Institute; Xiamen University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Center for Disease Control & Prevention; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	jhan@scripps.edu	Pattnaik, Asit K./X-1531-2019; Jing, Qing/F-6752-2016; georgel, philippe/P-5676-2016; Otsuka, Motoyuki/H-9067-2019; Han, J/G-4671-2010	Pattnaik, Asit K./0000-0002-9581-6787; Jing, Qing/0000-0001-9834-1214; georgel, philippe/0000-0001-6853-7080; Otsuka, Motoyuki/0000-0003-2869-2881; Kang, Young Jun/0000-0001-9778-1963	NIAAA NIH HHS [AA02Z164] Funding Source: Medline; NIAID NIH HHS [AI41637, AI54696] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basler Christopher F, 2002, Int Rev Immunol, V21, P305; BELKOWSKI LS, 1987, J VIROL, V61, P653, DOI 10.1128/JVI.61.3.653-660.1987; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Das SC, 2005, J VIROL, V79, P8101, DOI 10.1128/JVI.79.13.8101-8112.2005; Das SC, 2004, J VIROL, V78, P6420, DOI 10.1128/JVI.78.12.6420-6430.2004; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ono K, 2001, MOL CELL BIOL, V21, P8276, DOI 10.1128/MCB.21.24.8276-8288.2001; Otsuka M, 2000, J BIOL CHEM, V275, P34122, DOI 10.1074/jbc.M000578200; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200	47	276	307	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					123	134		10.1016/j.immuni.2007.05.014	http://dx.doi.org/10.1016/j.immuni.2007.05.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17613256	Bronze			2022-12-18	WOS:000248398100014
J	Le Borgne, M; Etchart, N; Goubier, A; Lira, SA; Sirard, JC; van Rooijen, N; Caux, C; Ait-Yahia, S; Vicari, A; Kaiserlian, D; Dubois, B				Le Borgne, M; Etchart, N; Goubier, A; Lira, SA; Sirard, JC; van Rooijen, N; Caux, C; Ait-Yahia, S; Vicari, A; Kaiserlian, D; Dubois, B			Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8(+) T cell crosspriming in vivo	IMMUNITY			English	Article							SKEWS MONOCYTE DIFFERENTIATION; INFLAMMATORY PROTEIN 3-ALPHA; LANGERHANS CELLS; CONTACT HYPERSENSITIVITY; LYMPH-NODE; ANTIGEN PRESENTATION; BUCCAL MUCOSA; LIFE-SPAN; IMMUNITY; DISTINCT	The nature of dendritic cell(s) (DC[s]) that conditions efficient in vivo priming of CD8(+) CTL after immunization via epithelial tissues remains largely unknown. Here, we show that myeloid DCs rapidly recruited by adjuvants into the buccal mucosa or skin are essential for CD8(+) T cell crosspriming. Recruitment of circulating DC precursors, including Gr1(+) monocytes, precedes the sequential accumulation of CD11c(+) MHC class II+ DCs in dermis and epithelium via a CCR6/CCL20-dependent mechanism. Remarkably, a defect in CCR6, local neutralization of CCL20, or depletion of monocytes prevents in vivo priming of CD8(+) CTL against an innocuous protein antigen administered with adjuvant. In addition, transfer of CCR6-sufficient Gr1(+) monocytes restores CD8(+) T cell priming in CCRo/o mice via a direct Ag presentation mechanism. Thus, newly recruited DCs likely derived from circulating monocytes are responsible for efficient crosspriming of CD8(+) CTL after mucosal or skin immunization.	INSERM, U404 Immunite & Vaccinat, IFR128 Biosci Lyon Gerland, F-69365 Lyon, France; Univ Lyon 1, IFR128 Biosci Lyon Gerland, F-69365 Lyon, France; CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Univ Lille 2, INSERM, E0364, F-59021 Lille, France; Univ Lille 2, Inst Biol, F-59021 Lille, France; Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; Schering Plough Lab Immunol Res, F-69570 Dardilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Vrije Universiteit Amsterdam; Merck & Company	Le Borgne, M (corresponding author), INSERM, U404 Immunite & Vaccinat, IFR128 Biosci Lyon Gerland, F-69365 Lyon, France.	kaiserlian@cervi-lyon.inserm.fr; dubois@cervi-lyon.inserm.fr	Le Borgne, Marie/P-2313-2015; Caux, Christophe/G-2851-2013; KAISERLIAN, Dominique/G-3325-2013; Van Rooijen, Nico/Z-1578-2019; Sirard, Jean-Claude/B-5932-2011; Dubois, Bertrand/D-4446-2013	Le Borgne, Marie/0000-0002-3439-4867; Caux, Christophe/0000-0003-2438-833X; KAISERLIAN, Dominique/0000-0001-6252-4916; Sirard, Jean-Claude/0000-0001-9854-4652; Dubois, Bertrand/0000-0002-7859-4975				Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Desvignes C, 1998, CLIN EXP IMMUNOL, V113, P386; DIDUIEFAURENT A, 2004, J IMMUNOL, V172, P6922; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Etchart N, 2001, J IMMUNOL, V167, P384, DOI 10.4049/jimmunol.167.1.384; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Merad M, 2004, NAT MED, V10, P510, DOI 10.1038/nm1038; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Ritter U, 2004, EUR J IMMUNOL, V34, P1542, DOI 10.1002/eji.200324586; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shah JA, 2003, J EXP MED, V198, P281, DOI 10.1084/jem.20030645; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yang D, 1999, J IMMUNOL, V163, P1737; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	46	276	289	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					191	201		10.1016/j.immuni.2006.01.005	http://dx.doi.org/10.1016/j.immuni.2006.01.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473831	Bronze			2022-12-18	WOS:000235479000010
J	Pasquier, B; Launay, P; Kanamaru, Y; Moura, IC; Pfirsch, S; Ruffie, C; Henin, D; Benhamou, M; Pretolani, M; Blank, U; Monteiro, RC				Pasquier, B; Launay, P; Kanamaru, Y; Moura, IC; Pfirsch, S; Ruffie, C; Henin, D; Benhamou, M; Pretolani, M; Blank, U; Monteiro, RC			Identification of Fc alpha RI as an inhibitory receptor that controls inflammation: Dual role of FcR gamma ITAM	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; AFFINITY IGE RECEPTOR; MAST-CELL SURVIVAL; HUMAN SERUM IGA; EPSILON-RI; TYROSINE PHOSPHORYLATION; FUNCTIONAL ASSOCIATION; MEDIATED PHAGOCYTOSIS; AIRWAY INFLAMMATION; MONOCLONAL-ANTIBODY	Serum IgA is considered a discrete housekeeper of the immune system with multiple anti-inflammatory functions, whereas IgA-immune complexes mediate inflammatory responses. Here, we identify FcalphaRI as a molecular device that determines the nature of IgA responses. In the absence of sustained aggregation, receptor targeting by serum IgA or anti-FalphaRI Fab inhibits activating responses of heterologous FcgammaR or FcepsilonRI. The inhibitory mechanism involves recruitment of tyrosine phosphatase SHP-1 to FcalphaRI and impairment of Syk, LAT, and ERK phosphorylation induced by FcepsilonRI engagement. SHP-1 recruitment is dependent on ERK. Conversely, sustained aggregation of FcalphaRI by multimeric ligands stimulates cell activation by recruiting high amounts of Syk and aborting SHP-1 binding. Both types of signals require the FcRgamma-ITAM motif. Anti-FcalphaRI Fab treatment suppresses manifestations of allergic asthma in FcalphaRI transgenic mice. These findings redefine FcalphaRI as a bifunctional inhibitory/activating receptor of the immune system that mediates both anti- and proinflammatory functions of IgA.	Bichat Med Sch, INSERM, U699, F-75870 Paris 18, France; Bichat Med Sch, INSERM, U700, F-75870 Paris 18, France; Hop Bichat, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Monteiro, RC (corresponding author), Bichat Med Sch, INSERM, U699, 16 Rue Henri Huchard, F-75870 Paris 18, France.	monteiro@bichat.inserm.fr	Launay, Pierre/AAH-7076-2019; Pretolani, Marina/G-6643-2017; Monteiro, Renato C/U-8633-2017; Moura, Ivan C/A-9510-2013; Cruz Moura, Ivan/A-9510-2013	Monteiro, Renato C/0000-0001-5202-5646; Moura, Ivan C/0000-0002-2977-0354; Cruz Moura, Ivan/0000-0002-8418-2803; Blank, Ulrich/0000-0002-2661-2983; Benhamou, Marc/0000-0001-7763-3795				Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BONNEROT C, 1992, EMBO J, V11, P1747; Coggeshall KM, 2002, MOL IMMUNOL, V39, P521, DOI 10.1016/S0161-5890(02)00209-2; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Gulle H, 1998, BLOOD, V91, P383, DOI 10.1182/blood.V91.2.383.383_383_391; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kimura T, 1997, J IMMUNOL, V159, P4426; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Launay P, 2000, J EXP MED, V191, P1999, DOI 10.1084/jem.191.11.1999; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Launay P, 1999, J BIOL CHEM, V274, P7216, DOI 10.1074/jbc.274.11.7216; LIU FT, 1980, J IMMUNOL, V124, P2728; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; MONTEIRO RC, 1993, J CLIN INVEST, V92, P1681, DOI 10.1172/JCI116754; MONTEIRO RC, 1992, J IMMUNOL, V148, P1764; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Morton HC, 1999, J EXP MED, V189, P1715; MORTON HC, 1995, J BIOL CHEM, V270, P29781; Nakamura K, 2002, BLOOD, V100, P3374, DOI 10.1182/blood-2002-03-0787; NIKOLOVA EB, 1995, J LEUKOCYTE BIOL, V57, P875, DOI 10.1002/jlb.57.6.875; Park RK, 1999, BLOOD, V94, P2112; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Roa M, 1997, J IMMUNOL, V159, P2815; Russell MW, 1997, BIOCHEM SOC T, V25, P466, DOI 10.1042/bst0250466; SCHAFFER F M, 1991, Immunodeficiency Reviews, V3, P15; SCHUPPEL R, 1987, EUR J IMMUNOL, V17, P739, DOI 10.1002/eji.1830170527; Shen L, 2001, BLOOD, V97, P205, DOI 10.1182/blood.V97.1.205; SHEN L, 1989, J IMMUNOL, V143, P4117; SILVAIN C, 1995, J IMMUNOL, V155, P1606; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; VANEPPS DE, 1981, INFECT IMMUN, V34, P864, DOI 10.1128/IAI.34.3.864-870.1981; VANEPPS DE, 1978, CELL IMMUNOL, V36, P363, DOI 10.1016/0008-8749(78)90280-0; VANEPPS DE, 1976, J EXP MED, V144, P1227, DOI 10.1084/jem.144.5.1227; WILTON JMA, 1978, CLIN EXP IMMUNOL, V34, P423; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Wolf HM, 1996, CLIN EXP IMMUNOL, V105, P537, DOI 10.1046/j.1365-2249.1996.d01-793.x; WOLF HM, 1994, BLOOD, V83, P1278; Xu R, 1999, J IMMUNOL, V163, P1110; Zhang C, 1997, J BIOL CHEM, V272, P13397, DOI 10.1074/jbc.272.20.13397; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265; Zuberi RI, 2000, J IMMUNOL, V164, P2667, DOI 10.4049/jimmunol.164.5.2667	53	276	294	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					31	42		10.1016/j.immuni.2004.11.017	http://dx.doi.org/10.1016/j.immuni.2004.11.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664157	Bronze			2022-12-18	WOS:000226682900005
J	Holler, PD; Kranz, DM				Holler, PD; Kranz, DM			Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation	IMMUNITY			English	Article							MHC CLASS-I; RECEPTOR-BINDING; PEPTIDE-MHC; CD8-ALPHA-BETA CORECEPTOR; LIGAND-BINDING; TCR; ANTIGEN; RECOGNITION; COMPLEX; KINETICS	The relative roles of CD8, TCR:pepMHC affinity, and TCR:pepMHC dissociation rate in T cell activation have remained controversial. To determine the relationships among these factors, we used T cells transfected with normal and in vitro engineered alphabeta TCRs, in the presence or absence of CD8. The TCRs exhibited a wide range of affinities (K-D values of 80 muM to 5 nM). T cells with the highest affinity TCRs were efficiently stimulated by peptide, with or without CD8. In contrast, CD8 was required for T cells that expressed TCRs with affinities typical of syngeneic reactions (K-D values above similar to3 muM). The results suggest that virtually all normal syngeneic interactions require CD8, which enhances peptide sensitivity by one million-fold or more.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM55767] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Baker BM, 2001, IMMUNITY, V14, P681, DOI 10.1016/S1074-7613(01)00160-1; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Cai ZL, 1996, J EXP MED, V183, P2247, DOI 10.1084/jem.183.5.2247; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; CAI ZL, 1994, J EXP MED, V179, P2005, DOI 10.1084/jem.179.6.2005; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Devine L, 1999, J IMMUNOL, V162, P846; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Gao GF, 2002, TRENDS IMMUNOL, V23, P408, DOI 10.1016/S1471-4906(02)02282-2; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; GASCOIGNE NRJ, 2001, EXP REV MOL MED 0212; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hansen T, 2000, IMMUNOL TODAY, V21, P83, DOI 10.1016/S0167-5699(98)01426-1; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Holler PD, 2001, J EXP MED, V194, P1043, DOI 10.1084/jem.194.8.1043; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Lee SJE, 2002, TRENDS IMMUNOL, V23, P500, DOI 10.1016/S1471-4906(02)02325-6; Manning TC, 1999, J EXP MED, V189, P461, DOI 10.1084/jem.189.3.461; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; PARNES JR, 1989, ADV IMMUNOL, V44, P265; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Schodin BA, 1996, MOL IMMUNOL, V33, P819, DOI 10.1016/0161-5890(96)00038-7; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Tallquist MD, 1998, J IMMUNOL, V160, P802; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9	61	276	284	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2003	18	2					255	264		10.1016/S1074-7613(03)00019-0	http://dx.doi.org/10.1016/S1074-7613(03)00019-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	648FC	12594952	Bronze			2022-12-18	WOS:000181138100009
J	Smyth, MJ; Takeda, K; Hayakawa, Y; Peschon, JJ; van den Brink, MRM; Yagita, H				Smyth, MJ; Takeda, K; Hayakawa, Y; Peschon, JJ; van den Brink, MRM; Yagita, H			Nature's TRAIL - On a path to cancer immunotherapy	IMMUNITY			English	Article							APOPTOSIS-INDUCING LIGAND; CELL-MEDIATED CYTOTOXICITY; TUMORICIDAL ACTIVITY; TUMOR-METASTASIS; DIFFERENTIAL USE; RECEPTOR GENE; KILLER-CELLS; FAS LIGAND; NK CELLS; T-CELLS	The TNF-related apoptosis-inducing ligand (TRAIL) offers great promise as a cancer therapeutic. Initially, soluble recombinant versions of the TRAIL molecule have exhibited specific tumoricidal activity against a variety of tumors alone, or in combination with other cancer treatments, and much anticipation awaits the outcomes from early clinical trials. More recently, the natural role of TRAIL has been explored in tumor and allogeneic bone marrow transplantation models in the mouse. Strikingly, the TRAIL effector pathway appears a vital component of immunosurveillance of spontaneous or resident tumor cells by both T cells and NK cells, stimulating more hope that manipulating TRAIL activity is a natural path to improved cancer immunotherapy.	Peter MacCallum Canc Inst, Canc Immunol Program, Sir Donald & Lady Trescowthick Labs, Melbourne, Vic 3002, Australia; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Immunex Corp, Seattle, WA 98101 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Peter Maccallum Cancer Center; Juntendo University; Immunex Corporation; Memorial Sloan Kettering Cancer Center	Smyth, MJ (corresponding author), Peter MacCallum Canc Inst, Canc Immunol Program, Sir Donald & Lady Trescowthick Labs, Melbourne, Vic 3002, Australia.		Smyth, Mark J/H-8709-2014; van den Brink, Marcel R. M./HGB-9434-2022	Smyth, Mark J/0000-0001-7098-7240; van den Brink, Marcel/0000-0003-0696-4401	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL072412] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 72412, HL 69929] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Burns TF, 2001, J BIOL CHEM, V276, P37879; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Degli-Esposti M, 1999, J LEUKOCYTE BIOL, V65, P535, DOI 10.1002/jlb.65.5.535; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Hilliard B, 2001, J IMMUNOL, V166, P1314, DOI 10.4049/jimmunol.166.2.1314; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kayagaki N, 1999, J IMMUNOL, V162, P2639; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Nagane M, 2001, APOPTOSIS, V6, P191, DOI 10.1023/A:1011336726649; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Plasilova M, 2002, LEUKEMIA, V16, P67, DOI 10.1038/sj.leu.2402338; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Schmaltz C, 2001, BLOOD, V97, P2886, DOI 10.1182/blood.V97.9.2886; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 2000, ADV EXP MED BIOL, V465, P143; Wuchter C, 2001, LEUKEMIA, V15, P921, DOI 10.1038/sj.leu.2402131; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	36	276	297	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					1	6		10.1016/S1074-7613(02)00502-2	http://dx.doi.org/10.1016/S1074-7613(02)00502-2			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530970	Bronze			2022-12-18	WOS:000180860600001
J	Bouneaud, C; Kourilsky, P; Bousso, P				Bouneaud, C; Kourilsky, P; Bousso, P			Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion	IMMUNITY			English	Article							TRANSGENIC MICE; ANTIGEN RECEPTOR; ALPHA-CHAINS; BETA-CHAINS; TCR LEVELS; TOLERANCE; EXPRESSION; INDUCTION; MODEL; RECOGNITION	How negative selection shapes a polyclonal population of self-reactive T cells has been difficult to address directly because of the lack of means to isolate T cells reactive to a particular self-peptide. Here, using mice transgenic for the TCR-P chain of a CTL clone directed against a mate-specific peptide, we compared the preimmune repertoire reactive to this peptide in male and female animals. Surprisingly, in the presence of the deleting ligand, as many as 25%-40% of reactive T cells escaped clonal deletion. A correlation was found between T cell avidity, TCR alpha structures, and susceptibility to negative selection. These results suggest that numerous low-affinity self-specific T cells persist in the periphery and show that a deleting ligand can specifically narrow the structural diversity of the TCR repertoire.	Inst Pasteur, INSERM, U277, Unite Biol Mol Gene, F-75724 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bousso, P (corresponding author), Inst Pasteur, INSERM, U277, Unite Biol Mol Gene, 25 Rue Dr Roux, F-75724 Paris 15, France.		BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Apostolou I, 2000, J IMMUNOL, V165, P2481, DOI 10.4049/jimmunol.165.5.2481; Apostolou I, 1999, P NATL ACAD SCI USA, V96, P5141, DOI 10.1073/pnas.96.9.5141; Arden Bernhard, 1995, Immunogenetics, V42, P501; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; AUPHAN N, 1992, INT IMMUNOL, V4, P541, DOI 10.1093/intimm/4.4.541; Baldwin KK, 1999, J IMMUNOL, V163, P689; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; de Visser KE, 2000, EUR J IMMUNOL, V30, P1458, DOI 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2; DILLON SR, 1994, J IMMUNOL, V152, P1790; Fukui Y, 1998, J EXP MED, V188, P897, DOI 10.1084/jem.188.5.897; Girgis L, 1999, J EXP MED, V189, P265, DOI 10.1084/jem.189.2.265; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; HOMER RJ, 1993, INT IMMUNOL, V5, P1495, DOI 10.1093/intimm/5.12.1495; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Kruisbeek AM, 1996, CURR OPIN IMMUNOL, V8, P233, DOI 10.1016/S0952-7915(96)80062-8; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TESTI R, 1989, J IMMUNOL, V142, P1854; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; UEMATSU Y, 1992, EUR J IMMUNOL, V22, P603, DOI 10.1002/eji.1830220247; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; VASQUEZ NJ, 1994, IMMUNITY, V1, P45, DOI 10.1016/1074-7613(94)90008-6; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Yee C, 1999, J IMMUNOL, V162, P2227; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102	42	276	287	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					829	840		10.1016/S1074-7613(00)00080-7	http://dx.doi.org/10.1016/S1074-7613(00)00080-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163198	Bronze			2022-12-18	WOS:000166142300008
J	Rutschmann, S; Jung, AC; Hetru, C; Reichhart, JM; Hoffmann, JA; Ferrandon, D				Rutschmann, S; Jung, AC; Hetru, C; Reichhart, JM; Hoffmann, JA; Ferrandon, D			The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila	IMMUNITY			English	Article							NF-KAPPA-B; ANTIMICROBIAL PEPTIDE GENES; IMMUNE-RESPONSE; TRANSCRIPTION FACTORS; INNATE IMMUNITY; NUCLEAR IMPORT; FAT-BODY; DORSAL; TOLL; SPECIFICITY	We have isolated two Drosophila lines that carry point mutations in the gene coding for the NF-kappa B-like factor DIF. Like mutants of the Toll pathway, Dif mutant flies are susceptible to fungal but not to bacterial infections. Genetic epistasis experiments demonstrate that Dif mediates the Toll-dependent control of the inducibility of the antifungal peptide gene Drosomycin. Strikingly, DIF alone is required for the antifungal response in adults, but is redundant in larvae with Dorsal, another Rel family member. In Drosophila, Dif appears to be dedicated to the antifungal defense elicited by fungi and gram-positive bacteria. We discuss in this light the possibility that NF-kappa B1/p50 might be required more specifically in the innate immune response against gram-positive bacteria in mammals.	Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ferrandon, D (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Jung, Alain/X-5384-2019; Jung, Alain/AAC-6598-2019	Jung, Alain/0000-0002-4049-4151; Rutschmann, Sophie/0000-0003-3932-1162; FERRANDON, Dominique/0000-0001-7680-7773				Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Cramer P, 1999, STRUCT FOLD DES, V7, pR1, DOI 10.1016/S0969-2126(99)80002-1; Cramer P, 1999, STRUCTURE, V7, P841, DOI 10.1016/S0969-2126(99)80107-5; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; LEHMING N, 1995, P NATL ACAD SCI USA, V92, P10242, DOI 10.1073/pnas.92.22.10242; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lowenberger C, 1999, J BIOL CHEM, V274, P20092, DOI 10.1074/jbc.274.29.20092; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; NUSSLEINVOLHARD C, 1980, NATURE, V283, P474, DOI 10.1038/283474a0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Stein D, 1998, DEVELOPMENT, V125, P2159; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TATEI K, 1995, MOL CELL BIOL, V15, P3627; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195	45	276	286	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2000	12	5					569	580		10.1016/S1074-7613(00)80208-3	http://dx.doi.org/10.1016/S1074-7613(00)80208-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	319RT	10843389	Bronze			2022-12-18	WOS:000087356400012
J	Becher, B; Tugues, S; Greter, M				Becher, Burkhard; Tugues, Sonia; Greter, Melanie			GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; REMITTING MULTIPLE-SCLEROSIS; COLLAGEN-INDUCED ARTHRITIS; CENTRAL-NERVOUS-SYSTEM; HOUSE-DUST MITE; T-CELLS; DENDRITIC CELLS; TUMOR-CELLS; FETAL MONOCYTES; EFFECTOR PHASE	The granulocyte-macrophage colony-stimulating factor (GM-CSF) was initially classified as a hematopoietic growth factor. However, unlike its close relatives macrophage CSF (M-CSF) and granulocyte CSF (G-CSF), the majority of myeloid cells do not require GM-CSF for steady-state myelopoiesis. Instead, in inflammation, GM-CSF serves as a communication conduit between tissue-invading lymphocytes and myeloid cells. Even though lymphocytes are in all likelihood the instigators of chronic inflammatory disease, GM-CSF-activated phagocytes are well equipped to cause tissue damage. The pivotal role of GM-CSF at the T cell:myeloid cell interface might shift our attention toward studying the function of the myeloid compartment in immunopathology. Targeting specifically the crosstalk between T cells and myeloid cells through GM-CSF holds promise for the development of therapeutics to combat chronic tissue inflammation. Here, we will review some of the major discoveries of the recent past, which indicate that GM-CSF is so much more than its name suggests.	[Becher, Burkhard; Tugues, Sonia; Greter, Melanie] Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Greter, Melanie/0000-0002-7220-5369				Adorini L, 1996, AUTOIMMUNITY, V23, P53, DOI 10.3109/08916939608995329; AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; BERDEL WE, 1989, BLOOD, V73, P80; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; Burga RA, 2015, CANCER IMMUNOL IMMUN, V64, P817, DOI 10.1007/s00262-015-1692-6; BURGESS AW, 1980, BLOOD, V56, P947; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; Campbell IK, 1998, J IMMUNOL, V161, P3639; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Cook AD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4037; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Darrieutort-Laffite C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/241840; DEDHAR S, 1988, P NATL ACAD SCI USA, V85, P9253, DOI 10.1073/pnas.85.23.9253; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GIANNI AM, 1990, J CLIN ONCOL, V8, P768, DOI 10.1200/JCO.1990.8.5.768; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; HAMILTON JA, 1992, BLOOD, V79, P1413; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Herndler-Brandstetter D, 2014, CELL RES, V24, P1379, DOI 10.1038/cr.2014.155; Hirata Y, 2010, CELL HOST MICROBE, V7, P151, DOI 10.1016/j.chom.2010.01.006; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hodi FS, 2014, JAMA-J AM MED ASSOC, V312, P1744, DOI 10.1001/jama.2014.13943; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Kohanbash G, 2013, CANCER RES, V73, P6413, DOI 10.1158/0008-5472.CAN-12-4124; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lawson DH, 2015, J CLIN ONCOL, V33, P4066, DOI 10.1200/JCO.2015.62.0500; Li R, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00626; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LIESCHKE GJ, 1989, ANN INTERN MED, V110, P357, DOI 10.7326/0003-4819-110-5-357; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Luiten RM, 2005, J CLIN ONCOL, V23, P8978, DOI 10.1200/JCO.2005.01.6816; Luu C., 2016, EXPERT OPIN BIOL THE; Mair F, 2016, EUR J IMMUNOL, V46, P34, DOI 10.1002/eji.201545774; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; NEMUNAITIS J, 1990, BLOOD, V76, P245; Newell EW, 2016, NAT IMMUNOL, V17, P890, DOI 10.1038/ni.3485; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; O'Day SJ, 2009, J CLIN ONCOL, V27, P6207, DOI 10.1200/JCO.2008.20.3075; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Parronchi P, 1997, AM J PATHOL, V150, P823; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; RENNO T, 1995, J IMMUNOL, V154, P944; Renwick W, 2009, BIODRUGS, V23, P175, DOI 10.2165/00063030-200923030-00004; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schreiner B, 2009, SEMIN IMMUNOPATHOL, V31, P479, DOI 10.1007/s00281-009-0181-4; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shaw OM, 2014, ARTHRITIS RHEUMATOL, V66, P2423, DOI 10.1002/art.38730; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; SHERIDAN JW, 1972, J CELL PHYSIOL, V80, P129, DOI 10.1002/jcp.1040800114; Shieh A., 2016, MUCOSAL IMMUNOL; Shiomi A, 2014, J IMMUNOL, V193, P849, DOI 10.4049/jimmunol.1303255; Simons JW, 1997, CANCER RES, V57, P1537; Simons JW, 1999, CANCER RES, V59, P5160; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Sorensen PS, 2014, NEUROLOGY, V82, P573, DOI 10.1212/WNL.0000000000000125; Stanley ER, 2014, COLD SPRING HARB PER, V6; Steinwede K, 2011, J IMMUNOL, V187, P5346, DOI 10.4049/jimmunol.1101413; Stock AT, 2016, J EXP MED, V213, P1983, DOI 10.1084/jem.20151853; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Subramaniam R, 2014, J INFECT DIS, V209, P1827, DOI 10.1093/infdis/jit830; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; Ushach I, 2016, J LEUKOCYTE BIOL, V100, P481, DOI 10.1189/jlb.3RU0316-144R; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; van Nieuwenhuijze AE, 2014, AM J PATHOL, V184, P184, DOI 10.1016/j.ajpath.2013.09.014; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vlahos R, 2006, PHARMACOL THERAPEUT, V112, P106, DOI 10.1016/j.pharmthera.2006.03.007; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Willebrand R., 2016, CURR OPIN HEMATOL; WILLIAMSON DJ, 1988, CLIN EXP IMMUNOL, V72, P67; Wimmers F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00165; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhou Q, 2014, J IMMUNOL, V193, P496, DOI 10.4049/jimmunol.1303138	135	275	290	8	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					963	973		10.1016/j.immuni.2016.10.026	http://dx.doi.org/10.1016/j.immuni.2016.10.026			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851925	Bronze			2022-12-18	WOS:000389473500009
J	Mashayekhi, M; Sandau, MM; Dunay, IR; Frickel, EM; Khan, A; Goldszmid, RS; Sher, A; Ploegh, HL; Murphy, TL; Sibley, LD; Murphy, KM				Mashayekhi, Mona; Sandau, Michelle M.; Dunay, Ildiko R.; Frickel, Eva M.; Khan, Asis; Goldszmid, Romina S.; Sher, Alan; Ploegh, Hidde L.; Murphy, Theresa L.; Sibley, L. David; Murphy, Kenneth M.			CD8 alpha(+) Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii Tachyzoites	IMMUNITY			English	Article							CUTTING EDGE; IFN-GAMMA; INFLAMMATORY MONOCYTES; IL-12 PRODUCTION; RESISTANCE; MICE; PARASITE; IMMUNITY; STIMULATION; NEUTROPHILS	CD8 alpha(+) dendritic cells (DCs) are important in vivo for cross-presentation of antigens derived from intracellular pathogens and tumors. Additionally, secretion of interleukin-12 (IL-12) by CD8 alpha(+) DCs suggests a role for these cells in response to Toxoplasma gondii antigens, although it remains unclear whether these cells are required for protection against T. gondii infection. Toward this goal, we examined T. gondii infection of Batf3(-/-) mice, which selectively lack only lymphoid-resident CD8 alpha(+) DCs and related peripheral CD103(+) DCs. Batf3(-/-) mice were extremely susceptible to T. gondii infection, with decreased production of IL-12 and interferon-gamma. IL-12 administration restored resistance in Batf3(-/-) mice, and mice in which IL-12 production was ablated only from CD8 alpha(+) DCs failed to control infection. These results reveal that the function of CD8 alpha(+) DCs extends beyond a role in cross-presentation and includes a critical role for activation of innate immunity through IL-12 production during T. gondii infection.	[Mashayekhi, Mona; Sandau, Michelle M.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dunay, Ildiko R.; Khan, Asis; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Frickel, Eva M.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Goldszmid, Romina S.; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Goldszmid, Romina S.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu		Mashayekhi, Mona/0000-0003-0331-2395	Howard Hughes Medical Institute; American Heart Association;  [AI059176]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036629, R01AI059176, ZIAAI000579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute (K.M.M.), the American Heart Association Midwest Affiliate Predoctoral Fellowship Program (M.M.), and AI059176 (L.D.S.).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bliss SK, 1999, J IMMUNOL, V163, P2081; Bliss SK, 2000, J IMMUNOL, V165, P4515, DOI 10.4049/jimmunol.165.8.4515; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sayles PC, 1997, NAT IMMUN, V15, P249; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	31	275	281	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					249	259		10.1016/j.immuni.2011.08.008	http://dx.doi.org/10.1016/j.immuni.2011.08.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867928	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000294387900014
J	Tokoyoda, K; Zehentmeier, S; Hegazy, AN; Albrecht, I; Grun, JR; Lohning, M; Radbruch, A				Tokoyoda, Koji; Zehentmeier, Sandra; Hegazy, Ahmed N.; Albrecht, Inka; Gruen, Joachim R.; Loehning, Max; Radbruch, Andreas			Professional Memory CD4(+) T Lymphocytes Preferentially Reside and Rest in the Bone Marrow	IMMUNITY			English	Article							HOMEOSTATIC PROLIFERATION; CELLS; CD8(+); EXPRESSION; NAIVE; GENERATION; SURVIVAL; SITE; IL-7; INTERLEUKIN-15	CD4(+) T lymphocytes are key to immunological memory. Here we show that in the memory phase of specific immune responses, most of the memory CD4(+) T lymphocytes had relocated into the bone marrow (BM) within 3-8 weeks after their generation-a process involving integrin alpha 2. Antigen-specific memory CD4(+) T lymphocytes highly expressed Ly-6C, unlike most splenic CD44(hi)CD62L(-)CD4(+) T lymphocytes. In adult mice, more than 80% of Ly-6C(hi)CD44(hi)CD62L(-) memory CD4(+) T lymphocytes were in the BM. In the BM, they associated to IL-7-expressing VCAM-1(+) stroma. cells. Gene expression and proliferation were downregulated, indicating a resting state. Upon challenge with antigen, they rapidly expressed cytokines and CD154 and efficiently induced the production of high-affinity antibodies by B lymphocytes. Thus, in the memory phase of immunity, memory helper T cells are maintained in BM as resting but highly reactive cells in survival niches defined by IL-7-expressing stroma cells.	[Tokoyoda, Koji; Zehentmeier, Sandra; Hegazy, Ahmed N.; Albrecht, Inka; Gruen, Joachim R.; Loehning, Max; Radbruch, Andreas] DRFZ, D-10117 Berlin, Germany; [Hegazy, Ahmed N.; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Tokoyoda, K (corresponding author), DRFZ, Charitepl 1, D-10117 Berlin, Germany.	tokoyoda@drfz.de	Zehentmeier, Sandra/AAL-1682-2020; Löhning, Max/AAL-2967-2021	Zehentmeier, Sandra/0000-0001-6263-1535; Löhning, Max/0000-0001-6382-7281; Tokoyoda, Koji/0000-0001-6101-4826; Hegazy, Ahmed N./0000-0002-2946-8251; Radbruch, Andreas/0000-0001-5753-0000; Grun, Joachim R./0000-0002-2875-3691	Deutsche Forschungsgemeinschaft [SFB 421, SFB 633, Exc 257]; Research Fellow of the Alexander von Humboldt Foundation; German Research Foundation [GRK1121]; EU IP AutoCure [LSHB-CT-2006018661]; Volkswagen Foundation; EU NoE MUGEN.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Fellow of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); EU IP AutoCure; Volkswagen Foundation(Volkswagen); EU NoE MUGEN.	We thank T. Geske, H. Hecker-Kia, H. Schliemann, and A. Grutzkau for expert technical help. This work was supported by Deutsche Forschungsgemeinschaft through SFB 421, SFB 633, and Exc 257. K.T. was a Research Fellow of the Alexander von Humboldt Foundation. S.Z. is a member of International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI). A.N.H. was a fellow of GRK1121 of the German Research Foundation. J.R.G. and A.R. are supported by the EU IP AutoCure (LSHB-CT-2006018661). M.L. is a Lichtenberg fellow funded by the Volkswagen Foundation. A.R. is supported by and a member of the EU NoE MUGEN.	Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; FRANCUS T, 1991, CELL IMMUNOL, V134, P520, DOI 10.1016/0008-8749(91)90323-4; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; GERSHON RK, 1971, J IMMUNOL, V106, P872; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kassiotis G, 2006, J IMMUNOL, V177, P968, DOI 10.4049/jimmunol.177.2.968; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lohning M, 2003, P NATL ACAD SCI USA, V100, P12307, DOI 10.1073/pnas.2035254100; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MacLeod M, 2006, J EXP MED, V203, P897, DOI 10.1084/jem.20050711; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Menssen A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-98; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Robertson JM, 2006, IMMUNOL REV, V211, P49, DOI 10.1111/j.0105-2896.2006.00383.x; SANDER B, 1993, J IMMUNOL METHODS, V166, P201, DOI 10.1016/0022-1759(93)90361-A; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Taylor PC, 2003, CURR OPIN PHARMACOL, V3, P323, DOI 10.1016/S1471-4892(03)00032-8; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; WALUNAS TL, 1995, J IMMUNOL, V155, P1873	47	275	279	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					721	730		10.1016/j.immuni.2009.03.015	http://dx.doi.org/10.1016/j.immuni.2009.03.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19427242	Bronze			2022-12-18	WOS:000266356900014
J	Mazo, IB; Honczarenko, M; Leung, H; Cavanagh, LL; Bonasio, R; Weninger, W; Engelke, K; Xia, LJ; McEver, RP; Koni, PA; Silberstein, LE; von Andrian, UH				Mazo, IB; Honczarenko, M; Leung, H; Cavanagh, LL; Bonasio, R; Weninger, W; Engelke, K; Xia, LJ; McEver, RP; Koni, PA; Silberstein, LE; von Andrian, UH			Bone marrow is a major reservoir and site of recruitment for central memory CD8(+) T cells	IMMUNITY			English	Article							L-SELECTIN; LEUKOCYTE ACCUMULATION; VASCULAR ENDOTHELIUM; LYMPHOCYTE MIGRATION; HEMATOPOIETIC STEM; B-LYMPHOCYTE; BETA-CHAIN; IN-VIVO; EFFECTOR; EXPRESSION	Normal bone marrow (BM) contains T cells whose function and origin are poorly understood. We observed that CD8(+) T cells in BM consist chiefly of CCR7(+) L-selectin(+) central memory cells (T(CM)s). Adoptively transferred T(CM)s accumulated more efficiently in the BM than naive and effector T cells. Intravital microscopy (IVM) showed that T(CM)s roll efficiently in BM microvessels via L-, P-, and E-selectin, whereas firm arrest required the VCAM-1/alpha4beta1 pathway. alpha4beta1 integrin activation did not depend on pertussis toxin (PTX)-sensitive Galphai proteins but was reduced by anti-CXCL12. In contrast, T-CM diapedesis did not require CXCL12 but was blocked by PTX. After extravasation, T(CM)s displayed agile movement within BM cavities, remained viable, and mounted potent antigen-specific recall responses for at least two months. Thus, the BM functions as a major reservoir for T(CM)s by providing specific recruitment signals that act in sequence to mediate the constitutive recruitment of T(CM)s from the blood.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Childrens Hosp, Joint Program Transfus Med, Boston, MA 02215 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; University System of Georgia; Augusta University	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, Boston, MA 02215 USA.	uva@cbr.med.harvard.edu	Bonasio, Roberto/P-1356-2014; Koni, Pandelakis/A-3349-2008; von Andrian, Ulrich H/A-5775-2008	Bonasio, Roberto/0000-0002-0767-0889; Koni, Pandelakis/0000-0002-0892-4764; Weninger, Wolfgang/0000-0003-3133-8699	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, R01HL062524, R01HL054936, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047379, R01AI061663] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56949, HL54936, HL62524, T32 HL66987] Funding Source: Medline; NIAID NIH HHS [AI061663, R01 AI047379] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams GB, 2003, BLOOD, V101, P45, DOI 10.1182/blood-2002-02-0486; AMAN MJ, 1993, BLOOD, V82, P2371, DOI 10.1182/blood.V82.8.2371.bloodjournal8282371; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Beider K, 2003, BLOOD, V102, P1951, DOI 10.1182/blood-2002-10-3293; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Di Rosa F, 2003, IMMUNOLOGY, V108, P296, DOI 10.1046/j.1365-2567.2003.01593.x; Di Rosa F, 2002, EUR J IMMUNOL, V32, P1873; Eriksson EE, 2001, J EXP MED, V194, P205, DOI 10.1084/jem.194.2.205; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Feuerer M, 2001, NAT MED, V7, P452, DOI 10.1038/86523; Feuerer M, 2001, INT J CANCER, V92, P96, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q; Fuhlbrigge RC, 1996, J CELL BIOL, V135, P837, DOI 10.1083/jcb.135.3.837; Gandy KL, 1999, IMMUNITY, V11, P579, DOI 10.1016/S1074-7613(00)80133-8; Garcia-Ojeda ME, 1998, J EXP MED, V187, P1813, DOI 10.1084/jem.187.11.1813; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hasegawa H, 2000, BLOOD, V95, P30; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kuroda MJ, 2000, BLOOD, V96, P1474, DOI 10.1182/blood.V96.4.1474.h8001474_1474_1479; LEUNG H, 2002, B MICROS SOC CANADA, V30, P25; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Martinez C, 1999, EXP HEMATOL, V27, P561, DOI 10.1016/S0301-472X(98)00029-0; Matzer SP, 2001, J IMMUNOL, V167, P4635, DOI 10.4049/jimmunol.167.8.4635; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Price PW, 1999, EUR J IMMUNOL, V29, P1051, DOI 10.1002/(SICI)1521-4141(199903)29:03<1051::AID-IMMU1051>3.0.CO;2-Y; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schirrmacher V, 2003, TRENDS MOL MED, V9, P526, DOI 10.1016/j.molmed.2003.10.001; Schuchert MJ, 2000, NAT MED, V6, P904, DOI 10.1038/78667; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; Sierra MD, 2004, BLOOD, V103, P2452; Slifka MK, 1997, BLOOD, V90, P2103, DOI 10.1182/blood.V90.5.2103; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Sperandio M, 2001, J IMMUNOL, V167, P2268, DOI 10.4049/jimmunol.167.4.2268; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tang MLK, 1998, J IMMUNOL, V160, P5113; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tripp RA, 1997, J IMMUNOL, V158, P3716; Tsark EC, 2001, J IMMUNOL, V166, P170, DOI 10.4049/jimmunol.166.1.170; Tsujimoto T, 1996, BLOOD, V87, P3375, DOI 10.1182/blood.V87.8.3375.bloodjournal8783375; Vanderkerken K, 2002, CLIN EXP METASTAS, V19, P87, DOI 10.1023/A:1013891205989; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wan J, 2003, IMMUNOLOGY, V110, P10, DOI 10.1046/j.1365-2567.2003.01710.x; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Weninger W, 2002, IMMUNOL REV, V186, P221, DOI 10.1034/j.1600-065X.2002.18618.x; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright N, 2002, J IMMUNOL, V168, P5268, DOI 10.4049/jimmunol.168.10.5268; Zeng DF, 2002, BLOOD, V99, P1449, DOI 10.1182/blood.V99.4.1449	69	275	285	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					259	270		10.1016/j.immuni.2005.01.008	http://dx.doi.org/10.1016/j.immuni.2005.01.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723813	Bronze			2022-12-18	WOS:000227509600011
J	Jeon, MS; Atfield, A; Venuprasad, K; Krawczyk, C; Sarao, R; Elly, C; Yang, C; Arya, S; Bachmaier, K; Su, L; Bouchard, D; Jones, R; Gronski, M; Ohashi, P; Wada, T; Bloom, D; Fathman, CG; Liu, YC; Penninger, JM				Jeon, MS; Atfield, A; Venuprasad, K; Krawczyk, C; Sarao, R; Elly, C; Yang, C; Arya, S; Bachmaier, K; Su, L; Bouchard, D; Jones, R; Gronski, M; Ohashi, P; Wada, T; Bloom, D; Fathman, CG; Liu, YC; Penninger, JM			Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction	IMMUNITY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; C-CBL; TOLERANCE INDUCTION; NEGATIVE REGULATOR; ACTIVATION; AUTOIMMUNITY; PROTEOLYSIS; MECHANISMS; IMMUNITY; GENE	Antigen-specific immunotolerance limits the expansion of self-reactive T cells involved in autoimmune diseases. Here, we show that the E3 ubiquitin ligase CbI-b is upregulated in T cells after tolerizing signals. Loss of CbI-b in mice results in impaired induction of T cell tolerance both in vitro and in vivo. Importantly, rechallenge of CbI-b mutant mice with the tolerizing antigen results in massive lethality. Moreover, ablation of CbI-b resulted in exacerbated autoimmunity. Mechanistically, loss of CbI-b rescues reduced calcium mobilization of anergic T cells, which was attributed to CbI-b-mediated regulation of PLCgamma-1 phosphorylation. Our results show a critical role for CbI-b in the regulation of peripheral tolerance and anergy of T cells.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Stanford Univ, Sch Med, Div Immunol & Rheumatol, Dept Med, Stanford, CA 94305 USA	La Jolla Institute for Immunology; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University of Toronto; Stanford University	Penninger, JM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA.	josef.penninger@imba.oeaw.ac.at	Penninger, Josef M/I-6860-2013; Bachmaier, Kurt/B-6331-2014; Bachmaier, Kurt/AHC-5491-2022	Penninger, Josef M/0000-0002-8194-3777; Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; poojary, venuprasd/0000-0001-8986-9092; Ohashi, Pamela S./0000-0003-2915-9317; Gronski, Matthew/0000-0003-4779-5720; LIU, YUN-CAI/0000-0002-0996-7109	NIAID NIH HHS [R01AI50280] Funding Source: Medline; PHS HHS [R0156558] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050280] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bansal-Pakala P, 2001, NAT MED, V7, P907, DOI 10.1038/90942; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BHANDOOLA A, 1993, J IMMUNOL, V151, P2355; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CHO EA, 1993, J IMMUNOL, V151, P20; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; GAJEWSKI TF, 1994, P NATL ACAD SCI USA, V91, P38, DOI 10.1073/pnas.91.1.38; GERMANN T, 1995, P NATL ACAD SCI USA, V92, P4823, DOI 10.1073/pnas.92.11.4823; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KEANE MM, 1995, ONCOGENE, V10, P2367; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Wells AD, 2003, J IMMUNOL, V170, P4127, DOI 10.4049/jimmunol.170.8.4127; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	33	275	295	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					167	177		10.1016/j.immuni.2004.07.013	http://dx.doi.org/10.1016/j.immuni.2004.07.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308098	Bronze			2022-12-18	WOS:000223441900006
J	Chapman, TL; Heikema, AP; Bjorkman, PJ				Chapman, TL; Heikema, AP; Bjorkman, PJ			The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SURFACE-PLASMON RESONANCE; HUMAN CYTOMEGALOVIRUS; ENDOGENOUS PEPTIDES; VIRUS; CELLS; CRYSTALLIZATION; GLYCOSYLATION; ANTIGENS; FORMS	LIR-1 is a class I MHC receptor related to natural killer inhibitory receptors (KIRs). Binding of LIR-1 or KIRs to class I molecules results in inhibitory signals. Unlike individual KIRs, LIR-1 recognizes many class I alleles and also binds UL18, a human cytomegalovirus class I MHC homolog. Here, we show that LIR-1 interacts with the relatively nonpolymorphic alpha 3 domain of class I proteins and the analogous region of UL18 using its N-terminal immunoglobulin-like domain. The >1000-fold higher affinity of LIR-1 for UL18 than for class I illustrates how a viral protein competes with host proteins to subvert the host immune response. LIR-1 recognition of class I molecules resembles the CD4-class II MHC interaction more than the KIR-class I interaction, implying a functional distinction between LIR-1 and KIRs.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Grad Opt Biochem, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.							Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; BECK S, 1988, NATURE, V331, P269, DOI 10.1038/331269a0; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; Borges L, 1997, J IMMUNOL, V159, P5192; BRAUD VM, 1997, CURR BIOL, V8, P1; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Chapman TL, 1998, J VIROL, V72, P460, DOI 10.1128/JVI.72.1.460-466.1998; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Garboczi DN, 1996, J IMMUNOL, V157, P5403; HANSEN JC, 1994, BIOCHEMISTRY-US, V33, P13155, DOI 10.1021/bi00249a001; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kim J, 1997, J IMMUNOL, V159, P3875; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lanier LL, 1997, IMMUNOL REV, V155, P145, DOI 10.1111/j.1600-065X.1997.tb00947.x; LEAHY DJ, 1995, FASEB J, V9, P17, DOI 10.1096/fasebj.9.1.7821755; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; PARHAM P, 1983, J BIOL CHEM, V258, P6179; PARHAM P, 1979, J IMMUNOL, V123, P342; Raghavan M, 1996, PROTEIN SCI, V5, P2080, DOI 10.1002/pro.5560051014; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; SIDNEY J, 1995, J IMMUNOL, V154, P247; VALESGOMEZ M, 1998, IMMUNITY, V9, pU9; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; WENTWORTH BB, 1971, AM J EPIDEMIOL, V94, P496, DOI 10.1093/oxfordjournals.aje.a121347; Wiertz E, 1997, IMMUNOL LETT, V57, P213, DOI 10.1016/S0165-2478(97)00073-4; WILEY D, 1988, NATURE, V331, P209, DOI 10.1038/331209a0	36	275	289	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					603	613		10.1016/S1074-7613(00)80135-1	http://dx.doi.org/10.1016/S1074-7613(00)80135-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591185	Bronze			2022-12-18	WOS:000083952200012
J	Sytwu, HK; Liblau, RS; McDevitt, HO				Sytwu, HK; Liblau, RS; McDevitt, HO			The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; LUPUS-PRONE MICE; FAS ANTIGEN; LPR/LPR MICE; FACTOR-ALPHA; LPR MICE; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL-ANTIBODIES; INDUCED APOPTOSIS; MRL-LPR/LPR	The possible involvement of Fas/APO-1 (CD95) and TNF in antigen-specific AICD of thymocytes and mature T cells has been investigated. Antigenic stimulation in vivo of influenza hemagglutinin (HA)-specific TCRtg mice was used to demonstrate that the kinetics of thymocyte and peripheral CD4(+) T cell deletion are similar in mice with normal (+/+) or defective Fas (lpr/lpr) background, indicating that a Fas-independent pathway(s) is responsible for the deletion of activated T cells. TCRtg-+/+ or TCRtg-lpr/lpr mice injected with murine TNF-blocking MAb (TN3) showed rapid apoptosis of thymocytes after HA stimulation, indicating that death signaling through Fas and TNF receptors is not essential for HA-induced thymocyte deletion. CD4(+) peripheral T cells in TCRtg-lpr/lpr mice did not undergo apoptosis following injection with HA and TN3, indicating that TNF-mediated apoptosis is involved in the deletion of mature T cells after antigenic stimulation. However, apoptosis still occurred in TCRtg-+/+ mice injected with TN3, indicating that both Fas- and TNF-mediated cell death can contribute to the deletion of activated peripheral T cells.	STANFORD UNIV,SCH MED,DEPT IMMUNOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT MED,STANFORD,CA 94305	Stanford University; Stanford University	Sytwu, HK (corresponding author), STANFORD UNIV,SCH MED,DEPT MICROBIOL,STANFORD,CA 94305, USA.		Liblau, Roland/J-3530-2014	LIBLAU, Roland/0000-0001-5477-5475	NCI NIH HHS [CA49734] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA049734] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CRISPE IN, 1994, IMMUNITY, V1, P347; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DAVIDSON WF, 1991, J IMMUNOL, V146, P4138; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; FIELDS LE, 1992, P NATL ACAD SCI USA, V89, P5730, DOI 10.1073/pnas.89.13.5730; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GIESE T, 1992, J IMMUNOL, V149, P3097; GIESE T, 1995, INT IMMUNOL, V7, P1213, DOI 10.1093/intimm/7.8.1213; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; HAMMERLING GJ, 1993, IMMUNOL REV, V133, P93, DOI 10.1111/j.1600-065X.1993.tb01511.x; HANG LM, 1984, J IMMUNOL, V132, P1809; HERNANDEZCASELLES T, 1993, J IMMUNOL, V151, P3999; HERRON LR, 1993, J IMMUNOL, V151, P3450; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mountz J D, 1994, Semin Immunol, V6, P27, DOI 10.1006/smim.1994.1005; MOUNTZ JD, 1990, J EXP MED, V172, P1805, DOI 10.1084/jem.172.6.1805; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; ORANGE JS, 1995, J EXP MED, V181, P901, DOI 10.1084/jem.181.3.901; OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; RUSSELL JH, 1993, EUR J IMMUNOL, V23, P2379, DOI 10.1002/eji.1830230951; SARIN A, 1995, J IMMUNOL, V155, P3716; SCOTT B, 1994, IMMUNITY, V1, P72; SCOTT DE, 1993, J IMMUNOL, V150, P664; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; SHI YF, 1991, J IMMUNOL, V146, P3340; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; TSAI CY, 1995, SCAND J IMMUNOL, V41, P157, DOI 10.1111/j.1365-3083.1995.tb03548.x; TucekSzabo CL, 1996, J IMMUNOL, V156, P192; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WILT SG, 1995, ANN NEUROL, V37, P381, DOI 10.1002/ana.410370315; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	70	275	280	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1996	5	1					17	30		10.1016/S1074-7613(00)80306-4	http://dx.doi.org/10.1016/S1074-7613(00)80306-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ454	8758891	Bronze			2022-12-18	WOS:A1996UZ45400003
J	VONHERRATH, MG; DOCKTER, J; OLDSTONE, MBA				VONHERRATH, MG; DOCKTER, J; OLDSTONE, MBA			HOW VIRUS INDUCES A RAPID OR SLOW ONSET INSULIN-DEPENDENT DIABETES-MELLITUS IN A TRANSGENIC MODEL	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CROSS-REACTIVITY; CLASS-II; MOLECULAR CHARACTERIZATION; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSE; CLONAL DELETION; DEFICIENT MICE; BETA-CELL; T-CELLS	We developed two distinct transgenic mouse models in which virus induced insulin-dependent (type 1) diabetes mellitus (IDDM). In one of these lines, the unique viral transgene was expressed in the islets of Langerhans and also in the thymus, but in the other line, expression was only in the islets. Insertion and expression of the viral (self) gene, per se, did not lead to IDDM, (incidence <5%). By contrast, induction of an anti-self (anti-viral) CD8(+) CTL response to the same virus later in life caused IDDM (incidence <90%) in both transgenic lines, although the kinetics and requirements for CD4 help, the affinity and avidity of CD8(+) CTL differed in each line. Mice not expressing the viral (self) gene in the thymus developed IDDM 10-14 days after infection. CD4(+) T cells played no detectable role, since their depletion failed to alter either the kinetics or incidence of IDDM. By contrast, mice that expressed the viral gene in the thymus required significantly more time to develop IDDM. Their anti-self (viral) CD8(+) CTL were of lower affinity and avidity than CD8(+) CTL generated by nontransgenic controls. Disease was dependent on T cell help, since deletion of CD4(+) cells completely circumvented the IDDM.			VONHERRATH, MG (corresponding author), SCRIPPS RES INST, DEPT NEUROPHARMACOL, DIV VIROL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NIAID NIH HHS [AI09484] Funding Source: Medline; NIA NIH HHS [AG04232] Funding Source: Medline; NINDS NIH HHS [NS12428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009484, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS012428] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED R, 1984, J VIROL, V51, P34, DOI 10.1128/JVI.51.1.34-41.1984; ALLOUCHE M, 1982, J IMMUNOL, V129, P689; BORROW P, 1991, J EXP MED, V174, P203, DOI 10.1084/jem.174.1.203; BUCHMEIER MJ, 1981, VIROLOGY, V113, P73, DOI 10.1016/0042-6822(81)90137-9; COOKE A, 1990, CURR TOP MICROBIOL, V164, P125; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P9939, DOI 10.1073/pnas.89.20.9939; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; DYRBERG T, 1990, CURR TOP MICROBIOL, V156, P1; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HEATH WR, 1993, J IMMUNOL, V151, P5993; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; Hogan B., 1986, MANIPULATING MOUSE E; JENSON AB, 1984, PROG MED VIROL, V29, P197; KLAVINSKIS LS, 1989, J VIROL, V63, P4311, DOI 10.1128/JVI.63.10.4311-4316.1989; KOSAKA H, 1993, J EXP MED, V177, P367, DOI 10.1084/jem.177.2.367; LAUFER TM, 1993, J EXP MED, V178, P589, DOI 10.1084/jem.178.2.589; LEWICKI H, 1990, ANIMAL VIRUS PATHOGE, P99; Maniatis T., 1982, MOL CLONING; MILLINI R, 1993, MICROPOROUS MATER, V1, P9, DOI 10.1016/0927-6513(93)80004-E; MULLER D, 1992, SCIENCE, V255, P1576, DOI 10.1126/science.1347959; NOTKINS AL, 1984, CONCEPTS VIRAL PATHO, P241; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1982, NATURE, V300, P360, DOI 10.1038/300360a0; OLDSTONE MBA, 1988, J EXP MED, V168, P559, DOI 10.1084/jem.168.2.559; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SIGURDSSON E, 1990, CURR TOP MICROBIOL, V164, P143; SOUTHERN PJ, 1987, VIROLOGY, V157, P145, DOI 10.1016/0042-6822(87)90323-0; SPRENT J, 1990, SCIENCE, V248, P1357, DOI 10.1126/science.1694041; TISHON A, 1988, J IMMUNOL, V140, P1280; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; UNGER R H, 1985, P1018; WHITTON JL, 1988, VIROLOGY, V162, P321, DOI 10.1016/0042-6822(88)90471-0; WHITTON JL, 1989, J VIROL, V63, P4303, DOI 10.1128/JVI.63.10.4303-4310.1989; WHITTON JL, 1988, J VIROL, V62, P687, DOI 10.1128/JVI.62.3.687-695.1988; YANAGI Y, 1992, J VIROL, V66, P2527, DOI 10.1128/JVI.66.4.2527-2531.1992	42	275	278	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1994	1	3					231	242		10.1016/1074-7613(94)90101-5	http://dx.doi.org/10.1016/1074-7613(94)90101-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK165	7889411				2022-12-18	WOS:A1994PK16500007
J	Jiang, A; Bloom, O; Ono, S; Cui, WG; Unternaehrer, J; Jiang, S; Whitney, JA; Connolly, J; Banchereau, J; Mellman, I				Jiang, Aimin; Bloom, Ona; Ono, Satoru; Cui, Weiguo; Unternaehrer, Juli; Jiang, Shan; Whitney, J. Andrew; Connolly, John; Banchereau, Jacques; Mellman, Ira			Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation	IMMUNITY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CC-CHEMOKINE RECEPTOR-7; STEADY-STATE CONDITIONS; REGULATORY T-CELLS; CLASS-II TRANSPORT; LANGERHANS CELLS; BETA-CATENIN; IN-VIVO; SIGNALING PATHWAYS; INFLAMMATORY MEDIATORS	The maturation of dendritic cells (DCs) after exposureto microbial products or inflammatory mediators plays a critical role in initiating the immune response. We found that maturation can also occur under steady-state conditions triggered by alterations in E-cadherin-mediate DC-DC adhesion. Selective disruption of these interactions induced the typical features of DC maturation including the upregulation of costimulatory molecules, MHC class 11, and chemokine receptors. These events were triggered at least in part by activation of the P-catenin pathway. However, unlike maturation induced by microbial products, E-cadherin-stimulated DCs failed to release immunostimulatory cytokines, exhibiting an entirely different transcriptional profile. As a result, E-cadherin-stimulated DCs elicited an entirely different T cell response in vivo, generating T cells with a regulatory as opposed to an effector phenotype. These I)Cs induced tolerance in vivo and may thus contribute to the elusive steady-state "tolerogenic DCs."	Genentech Inc, San Francisco, CA 94080 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA; CGI Pharmaceut Inc, Branford, CT 06405 USA; Baylor Inst Immunol Res, Dallas, TX 75204 USA	Roche Holding; Genentech; Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University; Baylor Scott & White Health	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Connolly, John/B-8099-2014; Mellman, Ira/ABG-5896-2020	BLOOM, ONA/0000-0002-8340-2392; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NIAID NIH HHS [R37 AI034098-07, R37AI34098, R37 AI034098, U19 AI057234, U19AI057234, U19 AI057234-05] Funding Source: Medline; NIAMS NIH HHS [AR46032, P30 AR046032] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, R37AI034098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Jakob T, 1999, J INVEST DERMATOL, V112, P102, DOI 10.1046/j.1523-1747.1999.00475.x; Jakob T, 1998, J IMMUNOL, V160, P4067; Jakob T, 2001, J ALLERGY CLIN IMMUN, V108, P688, DOI 10.1067/mai.2001.118797; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Riedl E, 2000, BLOOD, V96, P4276; Riedl E, 2000, J IMMUNOL, V165, P1381, DOI 10.4049/jimmunol.165.3.1381; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886	52	274	295	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					610	624		10.1016/j.immuni.2007.08.015	http://dx.doi.org/10.1016/j.immuni.2007.08.015			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17936032	Green Accepted, Bronze			2022-12-18	WOS:000250490700012
J	Freud, AG; Becknell, B; Roychowdhury, S; Mao, HC; Ferketich, AK; Nuovo, GJ; Hughes, TL; Marburger, TB; Sung, J; Baiocchi, RA; Guimond, M; Caligiuri, MA				Freud, AG; Becknell, B; Roychowdhury, S; Mao, HC; Ferketich, AK; Nuovo, GJ; Hughes, TL; Marburger, TB; Sung, J; Baiocchi, RA; Guimond, M; Caligiuri, MA			A human CD34(+) subset resides in lymph nodes and differentiates into CD56(bright) natural killer cells	IMMUNITY			English	Article							NK CELLS; ABNORMAL-DEVELOPMENT; MARROW PROGENITORS; HEMATOPOIETIC STEM; DENDRITIC CELLS; FLT3 LIGAND; HUMAN T; IDENTIFICATION; EXPRESSION; GENERATION	In humans, T cells differentiate in thymus and B cells develop in bone marrow (BM), but the natural killer (NK) precursor cell(s) and site(s) of NK development are unclear. The CD56(bright) NK subset predominates in lymph nodes (LN) and produces abundant cytokines compared to the cytolytic CD56(dim) NK cell that predominates in blood. Here, we identify a novel CD34(dim) CD45RA(+) hematopoietic precursor cell (HPC) that is integrin alpha(4)beta(bright)(7). CD34(dim)CD45RA(+)beta(bright)(7) HPCs constitute < 1% of BM CD34(+) HPCs and 6% of blood CD34(+) HPCs, but > 95% of LN CD34(+) HPCs. They reside in the parafollicular T cell regions of LN with CD56(bright) NK cells, and when stimulated by IL-15, IL-2, or activated LN T cells, they become CD56(bright) NK cells. The data identify a new NK precursor and support a model of human NK development in which BM-derived CD341(dim)CD45RA(+)beta(bright)(7) HPCs reside in LN where endogenous cytokines drive their differentiation to CD56 (bright) NK cells in vivo.	Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Epidemiol & Biometr, Columbus, OH 43210 USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Coll Med & Publ Hlth, Columbus, OH 43210 USA; Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Caligiuri, MA (corresponding author), Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA.	caligiuri-1@medctr.osu.edu			NCI NIH HHS [CA95426, CA68458] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA068458, P01CA095426, R01CA068458] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Barao I, 2003, J IMMUNOL, V171, P683, DOI 10.4049/jimmunol.171.2.683; Bendelac A, 1997, CURR OPIN IMMUNOL, V9, P1, DOI 10.1016/S0952-7915(97)80151-3; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; CARSON WE, 1994, P NATL ACAD SCI USA, V91, P7553, DOI 10.1073/pnas.91.16.7553; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Fehniger TA, 2000, J CLIN INVEST, V106, P117, DOI 10.1172/JCI6218; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; HACKETT J, 1985, J IMMUNOL, V134, P3731; Iizuka K, 1999, P NATL ACAD SCI USA, V96, P6336, DOI 10.1073/pnas.96.11.6336; LANIER LL, 1992, IMMUNOL TODAY, V13, P392, DOI 10.1016/0167-5699(92)90087-N; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MILLER JS, 1994, BLOOD, V83, P2594; Miller JS, 1999, BLOOD, V93, P96, DOI 10.1182/blood.V93.1.96.401k13_96_106; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; NAGLER A, 1990, J EXP MED, V171, P1527, DOI 10.1084/jem.171.5.1527; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; SHIBUYA A, 1993, BLOOD, V81, P1819; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Wodnar-Filipowicz A, 2003, NEWS PHYSIOL SCI, V18, P247, DOI 10.1152/nips.01452.2003; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657	42	274	290	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					295	304		10.1016/j.immuni.2005.01.013	http://dx.doi.org/10.1016/j.immuni.2005.01.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780987	Bronze			2022-12-18	WOS:000228105700005
J	HUANG, L; SOLDEVILA, G; LEEKER, M; FLAVELL, R; CRISPE, IN				HUANG, L; SOLDEVILA, G; LEEKER, M; FLAVELL, R; CRISPE, IN			THE LIVER ELIMINATES T-CELLS UNDERGOING ANTIGEN-TRIGGERED APOPTOSIS IN-VIVO	IMMUNITY			English	Article							MONOCLONAL-ANTIBODY; FAS ANTIGEN; LPR MICE; LYMPHOCYTES; RECEPTOR; TOLERANCE; DELETION; EXPRESSION; DEATH; PROLIFERATION	Deletion of mature peripheral T cells may result from TCR ligation by bacterial enterotoxins, endogenous provirus-encoded superantigens, and peptide antigens. But the ultimate fate of deleted T cells is not clear. Using a line of T cell receptor transgenic mice injected with antigenic peptide, we have documented that peripheral deletion is accompanied by the induction of abortive T cell activation followed by the disappearance of transgene-positive T cells. As these T cells disappear from the lymph nodes and spleen, they accumulate in the liver, where they undergo apoptosis. This is likely to be a general clearance pathway for T cells that are programmed to undergo apoptosis in vivo, and it may further explain the expansion of the intrahepatic T cell pool in mice with genetic defects in the T cell apoptosis mechanism, such as the for mutant.			HUANG, L (corresponding author), YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.			Soldevila, Gloria/0000-0003-1539-2548	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030561] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 30561] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEHLKE MA, 1987, J EXP MED, V165, P257, DOI 10.1084/jem.165.1.257; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; BOSSU P, 1993, J IMMUNOL, V151, P7233; CARLOW DA, 1992, INT IMMUNOL, V4, P599, DOI 10.1093/intimm/4.5.599; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; Crispe I N, 1994, Semin Immunol, V6, P39, DOI 10.1006/smim.1994.1006; CRISPE IN, 1994, IMMUNITY, V1, P347; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; GEIGER T, 1992, P NATL ACAD SCI USA, V89, P2985, DOI 10.1073/pnas.89.7.2985; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HUANG L, 1994, INT IMMUNOL, V6, P533, DOI 10.1093/intimm/6.4.533; HUANG L, 1993, J IMMUNOL, V151, P1844; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; MARSHAKROTHSTEI.A, 1978, J IMMUNOL, V122, P2491; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; NEWELL MK, 1990, NATURE, V347, P286, DOI 10.1038/347286a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIOKA WK, 1994, J EXP MED, V179, P769, DOI 10.1084/jem.179.2.769; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; ROCHA B, 1992, SCIENCE, V251, P1225; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SCOTT DE, 1993, J IMMUNOL, V150, P664; SEKI S, 1991, J IMMUNOL, V147, P1214; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; Wyllie A H, 1980, Int Rev Cytol, V68, P251	37	274	288	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					741	749		10.1016/S1074-7613(94)80016-2	http://dx.doi.org/10.1016/S1074-7613(94)80016-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895163				2022-12-18	WOS:A1994PX64800004
J	Gerner, MY; Kastenmuller, W; Ifrim, I; Kabat, J; Germain, RN				Gerner, Michael Y.; Kastenmuller, Wolfgang; Ifrim, Ina; Kabat, Juraj; Germain, Ronald N.			Histo-Cytometry: A Method for Highly Multiplex Quantitative Tissue Imaging Analysis Applied to Dendritic Cell Subset Microanatomy in Lymph Nodes	IMMUNITY			English	Article							T-CELLS; TRANSGENIC MICE; AFFERENT LYMPH; MARGINAL ZONE; RECEPTOR; IMMUNE; EXPRESSION; RESPONSES; DISTINCT; SYSTEM	Flow cytometry allows highly quantitative analysis of complex dissociated populations at the cost of neglecting their tissue localization. In contrast, conventional microscopy methods provide spatial information, but visualization and quantification of cellular subsets defined by complex phenotypic marker combinations is challenging. Here, we describe an analytical microscopy method, "histo-cytometry," for visualizing and quantifying phenotypically complex cell populations directly in tissue sections. This technology is based on multiplexed antibody staining, tiled high-resolution confocal microscopy, voxel gating, volumetric cell rendering, and quantitative analysis. We have tested this technology on various innate and adaptive immune populations in murine lymph nodes (LNs) and were able to identify complex cellular subsets and phenotypes, achieving quantitatively similar results to flow cytometry, while also gathering cellular positional information. Here, we employ histo-cytometry to describe the spatial segregation of resident and migratory dendritic cell subsets into specialized microanatomical domains, suggesting an unexpected LN demarcation into discrete functional compartments.	[Gerner, Michael Y.; Kastenmuller, Wolfgang; Ifrim, Ina; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Kabat, Juraj] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gerner, MY (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	gernermy@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Gerner, Michael/0000-0001-5406-8308	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Several individuals contributed to the development of this work. O.M. Schwartz and S. Becker provided training and expertise for confocal imaging. M. Roederer provided essential expertise in spillover correction and data transformation for FlowJo-based analysis. D.H. Kaplan and B.Z. Igyarto provided the (human-promoter)Langerin-Cre x eYFP-flox mice and advice in migratory DC visualization. J. Schenkel provided advice with antibody clone selection. T. Laemmerman and K.A. Casey provided critical manuscript reviews and general project advice. This work was supported by the Intramural Research Program of NIAID, NIH.	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Eckert RC, 2004, CYTOM PART A, V59A, P182, DOI 10.1002/cyto.a.20052; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; Hattori T, 2011, INVEST OPHTH VIS SCI, V52, P4598, DOI 10.1167/iovs.10-6741; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Jabbari A, 2006, J IMMUNOL, V177, P3012, DOI 10.4049/jimmunol.177.5.3012; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kastenmuller W., 2012, CELL, V151; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Petrovas C., 2012, J CLIN INVEST; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Roederer Mario, 2002, Curr Protoc Cytom, VChapter 1, DOI 10.1002/0471142956.cy0114s22; Rothfuchs AG, 2009, J IMMUNOL, V182, P6915, DOI 10.4049/jimmunol.0900074; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Scriven DRL, 2008, AM J PHYSIOL-CELL PH, V294, pC1119, DOI 10.1152/ajpcell.00133.2008; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47	51	273	276	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					364	376		10.1016/j.immuni.2012.07.011	http://dx.doi.org/10.1016/j.immuni.2012.07.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22863836	Green Accepted, Bronze			2022-12-18	WOS:000308261800019
J	Park, C; Li, S; Cha, E; Schindler, C				Park, C; Li, S; Cha, E; Schindler, C			Immune response in stat2 knockout mice	IMMUNITY			English	Article							INTERFERON-GAMMA; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; SIGNALING PATHWAY; POSITIVE FEEDBACK; ALPHA-INTERFERON; VIRUS-INFECTION; I INTERFERON; IFN-BETA; T-CELLS	Type I IFNs induce gene expression through Stat1 and Stat2, which can in turn associate either to form Stat1 homodimers or the transcription factor ISGF-3 Stat1 homodimers also transduce signals for IFN-gamma. To explore the unique properties of Stat2 and ISGF-3 in type I IFN signaling, its gene was targeted for deletion. Stat2 null mice exhibit a number of defects in immune response. This includes an increased susceptibility to viral infection and the loss of a type I IFN autocrine/paracrine loop, which in turn regulates several aspects of immune response. Intriguingly, Stat2-deficient fibroblasts exhibit a more significant defect in their response to type I IFNs than macrophages, highlighting tissue-specific differences in the response to this family of ligands.	Columbia Univ, Dept Microbiol, New York, NY 10021 USA; Columbia Univ, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Inst, Dept Cell Biol, New York, NY 10021 USA	Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Schindler, C (corresponding author), Columbia Univ, Dept Microbiol, New York, NY 10021 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054686] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56984] Funding Source: Medline; NIGMS NIH HHS [GM54686] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; BOTHWELL A, 1988, J IMMUNOL, V140, P2815; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; JOHNSON DR, 1994, MOL CELL BIOL, V14, P1322, DOI 10.1128/MCB.14.2.1322; Kawabata K, 1997, CANCER LETT, V113, P159, DOI 10.1016/S0304-3835(96)04594-6; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Lu BF, 1998, P NATL ACAD SCI USA, V95, P8233, DOI 10.1073/pnas.95.14.8233; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; MATTEI S, 1994, INT J CANCER, V56, P853, DOI 10.1002/ijc.2910560617; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 1998, METHODS, V15, P175, DOI 10.1006/meth.1998.0622; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; RESNITZKY D, 1986, CELL, V46, P31, DOI 10.1016/0092-8674(86)90857-3; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SCHINDLER C, 2000, CYTOKINES STAT SIGNA, V47; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; WANG JY, 1995, IMMUNITY, V3, P475, DOI 10.1016/1074-7613(95)90176-0; Wang W, 1999, J IMMUNOL, V162, P314; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wurst W., 1993, Gene targeting: a practical approach., P33	48	273	279	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6					795	804		10.1016/S1074-7613(00)00077-7	http://dx.doi.org/10.1016/S1074-7613(00)00077-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ	11163195	Bronze			2022-12-18	WOS:000166142300005
J	Liu, HY; Rhodes, M; Wiest, DL; Vignali, DAA				Liu, HY; Rhodes, M; Wiest, DL; Vignali, DAA			On the dynamics of TCR : CD3 complex cell surface expression and downmodulation	IMMUNITY			English	Article							RECEPTOR DOWN-REGULATION; ENDOPLASMIC-RETICULUM ER; TRANS-GOLGI NETWORK; CLASS-II MOLECULE; T-CELLS; ANTIGEN RECEPTOR; PROTEIN-DEGRADATION; MEDIATED ENDOCYTOSIS; CYTOPLASMIC DOMAINS; IMMATURE THYMOCYTES	TCR downmodulation following ligation by MHC:peptide complexes is considered to be a pivotal event in T cell activation. Here, we analyzed the dynamics of TCR:CD3 cell surface expression on resting and antigen-activated T cells. We show that the TCR:CD3 complex is very stable and is rapidly internalized and recycled in resting T cells. Surprisingly, the internalization rate is not increased following TCR ligation by MHC:peptide complexes, despite significant TCR downmodulation, suggesting that constitutive internalization rather than ligation-induced downmodulation serves as the force that drives serial ligation. Furthermore, TCR downmodulation is mediated by the intracellular retention of ligated complexes and degradation by lysosomes and proteasomes. Thus, our data demonstrate that ligation induces TCR downmodulation by preventing recycling rather than inducing internalization.	St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38101 USA; Univ Tennessee, Med Ctr, Dept Pathol, Memphis, TN 38163 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Fox Chase Cancer Center	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38101 USA.	dario.vignali@stjude.org	Liu, Haiyan/ABD-8689-2021	Liu, Haiyan/0000-0002-4652-469X; Wiest, David/0000-0002-0792-3188	NCI NIH HHS [5 P30 CA21765-17] Funding Source: Medline; NIAID NIH HHS [AI-39480] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039480, R01AI039480] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN PM, 1985, J EXP MED, V162, P1264, DOI 10.1084/jem.162.4.1264; Bachmann MF, 1997, EUR J IMMUNOL, V27, P2195, DOI 10.1002/eji.1830270912; Blichfeldt E, 1996, EUR J IMMUNOL, V26, P2876, DOI 10.1002/eji.1830261211; Borroto A, 1999, J IMMUNOL, V163, P25; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; CANTRELL D, 1987, NATURE, V325, P540, DOI 10.1038/325540a0; Carson RT, 1997, IMMUNITY, V7, P387, DOI 10.1016/S1074-7613(00)80360-X; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Cormont M, 1996, ENDOCRINOLOGY, V137, P3408, DOI 10.1210/en.137.8.3408; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Dietrich J, 1998, J BIOL CHEM, V273, P26281, DOI 10.1074/jbc.273.41.26281; Dietrich J, 1999, EUR J IMMUNOL, V29, P1719, DOI 10.1002/(SICI)1521-4141(199905)29:05<1719::AID-IMMU1719>3.3.CO;2-D; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; GLIMCHER LH, 1985, J IMMUNOL, V135, P3542; Hemmer B, 1998, J IMMUNOL, V160, P5807; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; HOU D, 1994, J BIOL CHEM, V269, P14244; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Itoh Y, 1999, J IMMUNOL, V162, P2073; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Jose ES, 2000, IMMUNITY, V12, P161, DOI 10.1016/S1074-7613(00)80169-7; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KRANGEL MS, 1987, J EXP MED, V165, P1141, DOI 10.1084/jem.165.4.1141; Lauritsen JPH, 1998, J IMMUNOL, V161, P260; Legendre V, 1999, INT IMMUNOL, V11, P1731, DOI 10.1093/intimm/11.11.1731; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Liu HY, 1999, J IMMUNOL, V163, P599; Lord JM, 1996, CURR BIOL, V6, P1067, DOI 10.1016/S0960-9822(02)70666-0; Luton F, 1997, J IMMUNOL, V158, P3140; Luton F, 1997, J IMMUNOL, V158, P4162; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; RETH M, 1987, NATURE, V38, P383; Rottier RJ, 1998, HUM MOL GENET, V7, P1787, DOI 10.1093/hmg/7.11.1787; Salio M, 1997, EUR J IMMUNOL, V27, P1769, DOI 10.1002/eji.1830270726; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; TAX WJM, 1987, TRANSPLANT P, V19, P273; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VIGNALI DAA, 1993, EUR J IMMUNOL, V23, P1602, DOI 10.1002/eji.1830230731; VIGNALI DAA, 1994, J EXP MED, V179, P1945, DOI 10.1084/jem.179.6.1945; Vignali DAA, 1999, J IMMUNOL, V162, P1431; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; ZANDERS ED, 1983, NATURE, V303, P625, DOI 10.1038/303625a0	65	273	277	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					665	675		10.1016/S1074-7613(00)00066-2	http://dx.doi.org/10.1016/S1074-7613(00)00066-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114379	Bronze			2022-12-18	WOS:000165598500009
J	VANKAER, L; ASHTONRICKARDT, PG; EICHELBERGER, M; GACZYNSKA, M; NAGASHIMA, K; ROCK, KL; GOLDBERG, AL; DOHERTY, PC; TONEGAWA, S				VANKAER, L; ASHTONRICKARDT, PG; EICHELBERGER, M; GACZYNSKA, M; NAGASHIMA, K; ROCK, KL; GOLDBERG, AL; DOHERTY, PC; TONEGAWA, S			ALTERED PEPTIDASE AND VIRAL-SPECIFIC T-CELL RESPONSE IN LMP2 MUTANT MICE	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; MULTICATALYTIC PROTEINASE COMPLEXES; PROTEASOME-RELATED GENE; MHC-LINKED LMP; ANTIGEN PRESENTATION; POSITIVE SELECTION; LYMPHOCYTES-T; LYMPH-NODE; SUBUNITS	MHC class I molecules present peptides generated by processing of endogenously synthesized proteins to CD8(+) T lymphocytes. Recently, large proteolytic complexes, termed proteasomes, were implicated in antigen processing.Two proteasomal subunits, LMP2 and LMP7, are encoded within the MHC class II region, but their precise role in antigen processing is unknown. We have generated mice that harbor a disruption in their LMP2 gene. Proteasomes purified from spleen and liver of these mutant mice exhibit altered peptidase activities, and antigen-presenting cells showed reduced capacity to stimulate a T cell hybridoma specific for H-2D(b) plus a nucleoprotein epitope of an influenza A virus. The mutant mice have reduced (60%-70% of wild type) levels of CD8(+) T lymphocytes and generate 5- to B-fold fewer influenza nucleoprotein-specific cytotoxic T lymphocyte precursors. These findings indicate that LMPS influences antigen processing.	MIT, HOWARD HUGHES MED INST, CTR CANC RES, CAMBRIDGE, MA 02139 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; ST JUDE CHILDRENS RES HOSP, DEPT IMMUNOL, MEMPHIS, TN 38105 USA; HARVARD UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Van Kaer, Luc/H-1033-2015; Doherty, Peter Charles/C-4185-2013	Van Kaer, Luc/0000-0001-5275-2309; Doherty, Peter Charles/0000-0002-5028-3489				AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; ALLAN W, 1990, J IMMUNOL, V144, P3980; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BATAILLON G, 1975, INT J CANCER, V16, P255, DOI 10.1002/ijc.2910160208; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BROWN MG, 1993, J IMMUNOL, V151, P1193; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Celis J, 1984, 2 DIMENSIONAL GEL EL; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; DICK LR, 1994, J IMMUNOL, V152, P3884; DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GACZYNSKA M, 1994, IN PRESS P NATL ACAD; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HOU S, 1993, J IMMUNOL, V150, P5494; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; MONACO JJ, 1982, P NATL ACAD SCI-BIOL, V79, P3001, DOI 10.1073/pnas.79.9.3001; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; ORTIZNAVARRETE V, 1991, NATURE, V353, P662, DOI 10.1038/353662a0; RIVETT AJ, 1993, BIOCHEM J, V291, P1; ROCK KL, 1990, J IMMUNOL, V145, P804; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; ROCK KL, 1991, P NATL ACAD SCI USA, V88, P301, DOI 10.1073/pnas.88.1.301; ROCK KL, 1994, IN PRESS CELL; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WALDEN PR, 1990, P NATL ACAD SCI USA, V87, P9015, DOI 10.1073/pnas.87.22.9015; Waldmann H., 1979, LIMITING DILUTION AN; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; YEWDELL J, 1994, J IMMUNOL, V152, P1163; ZHOU P, 1993, P NATL ACAD SCI USA, V90, P2681, DOI 10.1073/pnas.90.7.2681; ZHOU XZ, 1994, EUR J IMMUNOL, V24, P1863, DOI 10.1002/eji.1830240822	52	273	279	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					533	541		10.1016/1074-7613(94)90043-4	http://dx.doi.org/10.1016/1074-7613(94)90043-4			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600282				2022-12-18	WOS:A1994PN12700002
J	Cariappa, A; Tang, M; Parng, C; Nebelitskiy, E; Carroll, M; Georgopoulos, K; Pillai, S				Cariappa, A; Tang, M; Parng, C; Nebelitskiy, E; Carroll, M; Georgopoulos, K; Pillai, S			The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21	IMMUNITY			English	Article							POSITIVE SELECTION; ANTI-IG; EXPRESSION; MICE; IMMUNOGLOBULIN; ACTIVATION; PROTEIN; MOUSE; CD19; CR-2	Most splenic B cells in mice that lack Aiolos are mature IgD(hi)IgM(lo) follicular lymphocytes, suggesting that maturation signals delivered via the BCR are enhanced in the absence of Aiolos. The enhanced maturation of follicular B cells is accompanied by the absence of MZ B lymphocytes and the downregulation of CD21 expression in follicular B cells, all of which depend on the generation of signals via Btk, which is in epistasis to Aiolos. The inverse relationship between the strength of BCR signaling and MZ B cell development is supported by an examination of MZ B cells in CD21 null mice. These data support the view that antigens tin contrast to "tonic" signals) drive the development of naive B cells.	Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02129 USA; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Pillai, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02129 USA.	pillai@helix.mgh.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA069618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254, R56AI042254, R01AI033507] Funding Source: NIH RePORTER; NCI NIH HHS [CA69618] Funding Source: Medline; NIAID NIH HHS [AI33507, AI42254] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Amano M, 1998, J IMMUNOL, V161, P1710; BOYD AW, 1985, J IMMUNOL, V134, P1516; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 1999, J IMMUNOL, V162, P4417; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HARDY RR, 1982, NATURE, V297, P589, DOI 10.1038/297589a0; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; KRAAL G, 1988, AM J ANAT, V182, P148, DOI 10.1002/aja.1001820205; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Liu Y J, 1988, Adv Exp Med Biol, V237, P105; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Roark JH, 1998, J IMMUNOL, V160, P3121; Takahashi K, 1997, J IMMUNOL, V159, P1557; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WILSON HA, 1987, J IMMUNOL, V138, P1712; WILSON JG, 1986, ARTHRITIS RHEUM, V29, P739, DOI 10.1002/art.1780290606	43	272	275	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					603	615		10.1016/S1074-7613(01)00135-2	http://dx.doi.org/10.1016/S1074-7613(01)00135-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371362	Bronze			2022-12-18	WOS:000168880900012
J	Launois, P; Maillard, I; Pingel, S; Swihart, KG; Xenarios, I; AchaOrbea, H; Diggelmann, H; Locksley, RM; MacDonald, HR; Louis, JA				Launois, P; Maillard, I; Pingel, S; Swihart, KG; Xenarios, I; AchaOrbea, H; Diggelmann, H; Locksley, RM; MacDonald, HR; Louis, JA			IL-4 rapidly produced by V beta 4 V alpha 8 CD4(+) T cells instructs the development and susceptibility to Leishmania major in BALB/c mice	IMMUNITY			English	Article							HELPER PHENOTYPE DEVELOPMENT; TH2 CYTOKINE RESPONSES; CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; MURINE LEISHMANIASIS; INFECTED MICE; IN-VIVO; INTERLEUKIN-4; CD4+; EXPRESSION	BALB/c mice develop aberrant T helper 2 (Th2) responses and suffer progressive disease after infection with Leishmania major. These outcomes depend on the production of interleukin-4 (IL-4) early after infection. Here we demonstrate that the burst of IL-4 mRNA, peaking in draining lymph nodes of BALB/c mice 16 hr after infection, occurs within CD4(+) T cells that express V beta 4 V alpha 8 T cell receptors. In contrast to control and V beta 6-deficient BALB/c mice, V beta 4-deficient BALB/c mice were resistant to infection, demonstrating the role of these cells in Th2 development. The early IL-4 response was absent in these mice, and T helper 1 responses occurred following infection. Recombinant LACK antigen from L. major induced comparable IL-4 production in V beta 4 V alpha 8 CD4(+) cells. Thus, the IL-4 required for Th2 development and susceptibility to L. major is produced by a restricted population of V beta 4 V alpha 8 CD4(+) T cells after cognate interaction with a single antigen from this complex organism.	WHO,IMMUNOL RES & TRAINING CTR,EPALINGES,SWITZERLAND; UNIV LAUSANNE,INST BIOCHEM,CH-1066 EPALINGES,SWITZERLAND; UNIV LAUSANNE,LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND; UNIV LAUSANNE,INST MICROBIOL,LAUSANNE,SWITZERLAND; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT IMMUNOL MICROBIOL,SAN FRANCISCO,CA 94143	World Health Organization; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Xenarios, Ioannis/ABD-5045-2021	Xenarios, Ioannis/0000-0002-3413-6841; Maillard, Ivan/0000-0003-1312-6748	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; FAVRE N, 1993, J IMMUNOL METHODS, V164, P213, DOI 10.1016/0022-1759(93)90314-W; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HEINZEL FP, 1995, J IMMUNOL, V155, P730; HELD W, 1992, J EXP MED, V175, P1623, DOI 10.1084/jem.175.6.1623; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Launois P, 1997, J IMMUNOL, V158, P3317; Launois P, 1995, EUR J IMMUNOL, V25, P3298, DOI 10.1002/eji.1830251215; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; LOULS JA, 1979, EUR J IMMUNOL, V9, P841; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Maillard I, 1996, EUR J IMMUNOL, V26, P1000, DOI 10.1002/eji.1830260507; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; MILON G, 1986, J IMMUNOL, V136, P1467; MORRIS L, 1992, J IMMUNOL, V149, P2715; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; PAUL WE, 1993, ADV IMMUNOL, V53, P1, DOI 10.1016/S0065-2776(08)60496-4; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; SABIN EA, 1995, J IMMUNOL, V155, P4844; SADICK MD, 1991, INFECT IMMUN, V59, P4710, DOI 10.1128/IAI.59.12.4710-4714.1991; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SCHMITZ J, 1994, J EXP MED, V179, P1349, DOI 10.1084/jem.179.4.1349; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SLADE SJ, 1989, IMMUNOBIOLOGY, V179, P353, DOI 10.1016/S0171-2985(89)80041-5; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; vonderWeid T, 1996, J IMMUNOL, V157, P4421; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845	49	272	277	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					541	549		10.1016/S1074-7613(00)80342-8	http://dx.doi.org/10.1016/S1074-7613(00)80342-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175832	Bronze			2022-12-18	WOS:A1997XB81900005
J	JAMESON, SC; BEVAN, MJ				JAMESON, SC; BEVAN, MJ			T-CELL RECEPTOR ANTAGONISTS AND PARTIAL AGONISTS	IMMUNITY			English	Review							ANTIGEN-PRESENTING CELLS; GROWTH-HORMONE RECEPTOR; PHYSICAL ASSOCIATION; TYROSINE KINASES; ACTIVATION; ANTIBODIES; BINDING; LIGAND; PROLIFERATION; SEPARATION				JAMESON, SC (corresponding author), UNIV WASHINGTON,HOWARD HUGHES MED INST,DEPT IMMUNOL,SEATTLE,WA 98195, USA.		Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146				ALEXANDER J, 1993, J IMMUNOL, V150, P1; BARNDEN MJ, 1994, EUR J IMMUNOL, V24, P2452, DOI 10.1002/eji.1830241029; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BOURNE HR, 1987, BASIC CLIN PHARM, P9; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEKROON AIPM, 1994, J IMMUNOL, V152, P609; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DIAMOND DJ, 1991, J EXP MED, V174, P229, DOI 10.1084/jem.174.1.229; DILLON SR, 1994, J IMMUNOL, V152, P1790; EVAVOLD BD, 1994, P NATL ACAD SCI USA, V91, P2300, DOI 10.1073/pnas.91.6.2300; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; FRANCO A, 1994, EUR J IMMUNOL, V24, P40; FUH G, 1993, J BIOL CHEM, V268, P5376; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; HOGQUIST KA, 1994, CURR OPIN IMMUNOL, V6, P273, DOI 10.1016/0952-7915(94)90101-5; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; HOYER D, 1993, TRENDS PHARMACOL SCI, V14, P270, DOI 10.1016/0165-6147(93)90129-8; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JANEWAY CA, 1989, COLD SH Q B, V54, P657; JANEWAY CA, 1993, CURR BIOL, V2, P591; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KENAKIN T, 1987, TRENDS PHARMACOL SCI, V8, P423, DOI 10.1016/0165-6147(87)90229-X; KENAKIN TP, 1989, TRENDS PHARMACOL SCI, V10, P18, DOI 10.1016/0165-6147(89)90102-8; Kenakin TP., 1993, PHARM ANAL DRUG RECE, V2; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEBRUN C, 1993, J BIOL CHEM, V268, P11272; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; MANNIE MD, 1991, J THEOR BIOL, V151, P169, DOI 10.1016/S0022-5193(05)80360-1; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; OROURKE AM, 1994, J IMMUNOL, V152, P4358; OROURKE AM, 1992, NATURE, V258, P253; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PALLOTTA BS, 1991, FASEB J, V5, P2035, DOI 10.1096/fasebj.5.7.1707020; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; RAO A, 1984, CELL, V36, P889, DOI 10.1016/0092-8674(84)90038-2; RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROJO JM, 1988, J IMMUNOL, V140, P1081; ROJO JM, 1989, P NATL ACAD SCI USA, V86, P3311, DOI 10.1073/pnas.86.9.3311; RUPPERT J, 1993, P NATL ACAD SCI USA, V90, P2671, DOI 10.1073/pnas.90.7.2671; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SCHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376, DOI 10.1016/0165-6147(92)90116-N; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SLOANLANCASTER J, 1994, J EXP MED, V180, P1195, DOI 10.1084/jem.180.4.1195; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SLOANLANCASTER J, 1994, CELL, V79, P931; SPAIN LM, 1994, J IMMUNOL, V152, P1709; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WELLS JA, 1994, CURR OPIN CELL BIOL, V6, P163, DOI 10.1016/0955-0674(94)90132-5; YOON ST, 1994, IMMUNITY, V1, P563	70	272	274	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					1	11		10.1016/1074-7613(95)90074-8	http://dx.doi.org/10.1016/1074-7613(95)90074-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600296	Bronze			2022-12-18	WOS:A1995QC59300001
J	Wing, JB; Tanaka, A; Sakaguchi, S				Wing, James B.; Tanaka, Atsushi; Sakaguchi, Shimon			Human FOXP3(+) Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer	IMMUNITY			English	Review							TUMOR-INFILTRATING LYMPHOCYTES; IMMUNE DYSREGULATION; SELF-TOLERANCE; SUPPRESSIVE FUNCTION; EPIGENETIC CHANGES; FAMILY-MEMBER; CIS-ELEMENT; TREG CELLS; EXPRESSION; RECEPTOR	Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in single cell analyses have revealed a range of Treg cell activation and differentiation states in different human pathologies. Here we review recent progress in the understanding of human Treg cell heterogeneity and function. We discuss these findings within the context of concepts in Treg cell development and function derived from preclinical models and insight from approaches targeting Treg cells in clinical settings. Distinguishing functional Treg cells from other T cells and understanding the context-dependent function(s) of different Treg subsets will be crucial to the development of strategies toward the selective therapeutic manipulation of Treg cells in autoimmunity and cancer.	[Wing, James B.; Tanaka, Atsushi; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Lab Expt Immunol, Suita, Osaka 5650871, Japan; [Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Osaka University; Kyoto University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Expt Immunol, Suita, Osaka 5650871, Japan.; Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@ifrec.osaka-u.ac.jp	Wing, James Badger/H-6256-2019; Tanaka, Atsushi/U-6761-2019; Sakaguchi, Shimon/C-9535-2009	Wing, James Badger/0000-0002-3462-1003; Tanaka, Atsushi/0000-0003-1660-9892; 	Japan Society for Promotion of Science (JSPS) [16H06295, 18K07175]; JSPS [16H06295, 17K15723]; Project for Cancer Research and Therapeutic Evolution by Japan Agency for Medical Research and Development [P-CREATE: JP18cm0106303]; Leading Advanced Projects for medical innovation by Japan Agency for Medical Research and Development [LEAP: JP18gm0010005]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project for Cancer Research and Therapeutic Evolution by Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Leading Advanced Projects for medical innovation by Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors thank all members of the Sakaguchi lab for helpful discussion. J.B.W. is supported by Japan Society for Promotion of Science (JSPS) grant in aid for Specially Promoted Research (16H06295) and Scientific Research (C) (18K07175); S.S. is supported by JSPS Grants-in-Aid for Specially Promoted Research (16H06295), Project for Cancer Research and Therapeutic Evolution (P-CREATE: JP18cm0106303), and Leading Advanced Projects for medical innovation (LEAP: JP18gm0010005) by Japan Agency for Medical Research and Development.; A.T. is supported by JSPS Grants-in-Aid for Young Scientists (B) (17K15723).	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Bin Dhuban K, 2015, J IMMUNOL, V194, P3687, DOI 10.4049/jimmunol.1401803; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunstein CG, 2016, BLOOD, V127, P1044, DOI 10.1182/blood-2015-06-653667; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Champiat S, 2017, CLIN CANCER RES, V23, P1920, DOI 10.1158/1078-0432.CCR-16-1741; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cuadrado E, 2018, IMMUNITY, V48, P1046, DOI 10.1016/j.immuni.2018.04.008; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dhaeze T, 2015, J IMMUNOL, V195, P832, DOI 10.4049/jimmunol.1500759; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dong S, 2013, BLOOD, V122, P1802, DOI 10.1182/blood-2013-02-482539; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Ferreira RC, 2017, J AUTOIMMUN, V84, P75, DOI 10.1016/j.jaut.2017.07.009; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fonseca V. R., 2017, SCI IMMUNOL, P2, DOI DOI 10.1126/SCIIMMUN0L.AAN1487; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fransen MF, 2013, CLIN CANCER RES, V19, P5381, DOI 10.1158/1078-0432.CCR-12-0781; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fuhrman CA, 2015, J IMMUNOL, V195, P145, DOI 10.4049/jimmunol.1402381; Gautron AS, 2014, EUR J IMMUNOL, V44, P2703, DOI 10.1002/eji.201344392; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Golding A, 2013, ARTHRITIS RHEUM-US, V65, P2898, DOI 10.1002/art.38119; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Grant CR, 2015, AUTOIMMUN REV, V14, P105, DOI 10.1016/j.autrev.2014.10.012; Green JA, 2017, J EXP MED, V214, P3565, DOI 10.1084/jem.20170356; Ha D, 2019, P NATL ACAD SCI USA, V116, P609, DOI 10.1073/pnas.1812186116; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Halim L, 2017, CELL REP, V20, P757, DOI 10.1016/j.celrep.2017.06.079; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2014, IMMUNOL REV, V259, P159, DOI 10.1111/imr.12175; Hornero RA, 2017, TRANSPLANTATION, V101, P302, DOI 10.1097/TP.0000000000001278; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Itoh M, 1999, J IMMUNOL, V162, P5317; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kitagawa Y, 2017, CURR OPIN IMMUNOL, V49, P64, DOI 10.1016/j.coi.2017.10.002; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Klocke K, 2016, P NATL ACAD SCI USA, V113, pE2383, DOI 10.1073/pnas.1603892113; Kluger MA, 2016, KIDNEY INT, V89, P158, DOI 10.1038/ki.2015.296; Kluger MA, 2014, J AM SOC NEPHROL, V25, P1291, DOI 10.1681/ASN.2013080904; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu C, 2018, ARTHRITIS RHEUMATOL, V70, P711, DOI 10.1002/art.40430; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Mason GM, 2015, J IMMUNOL, V195, P2030, DOI 10.4049/jimmunol.1500703; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Miyara M, 2015, P NATL ACAD SCI USA, V112, P7225, DOI 10.1073/pnas.1508224112; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Morita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162306; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Ogawa C, 2018, CELL REP, V25, P19, DOI 10.1016/j.celrep.2018.09.016; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Perdigoto AL, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00654; Pesenacker AM, 2013, BLOOD, V121, P2647, DOI 10.1182/blood-2012-08-443473; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sato K, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6843; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Shabaneh TB, 2018, CANCER RES, V78, P5038, DOI 10.1158/0008-5472.CAN-18-0365; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Shimizu J, 1999, J IMMUNOL, V163, P5211; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Spence A, 2015, CURR OPIN IMMUNOL, V37, P11, DOI 10.1016/j.coi.2015.09.002; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Szurek E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141161; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trotta E, 2018, NAT MED, V24, P1005, DOI 10.1038/s41591-018-0070-2; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vargas FA, 2018, CANCER CELL, V33, P649, DOI 10.1016/j.ccell.2018.02.010; Vargas FA, 2017, IMMUNITY, V46, P577, DOI 10.1016/j.immuni.2017.03.013; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P544, DOI 10.1038/ni0515-544d; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Villarreal DO, 2018, CANCER RES, V78, P5340, DOI 10.1158/0008-5472.CAN-18-1119; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wirth TC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01848; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yamaguchi T, 2013, P NATL ACAD SCI USA, V110, pE2116, DOI 10.1073/pnas.1307185110; Yamaguchi T, 2011, SEMIN IMMUNOL, V23, P424, DOI 10.1016/j.smim.2011.10.002; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	176	271	282	16	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					302	316		10.1016/j.immuni.2019.01.020	http://dx.doi.org/10.1016/j.immuni.2019.01.020			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784578	Bronze			2022-12-18	WOS:000459006700008
J	Hall, JA; Cannons, JL; Grainger, JR; Dos Santos, LM; Hand, TW; Naik, S; Wohlfert, EA; Chou, DB; Oldenhove, G; Robinson, M; Grigg, ME; Kastenmayer, R; Schwartzberg, PL; Belkaid, Y				Hall, Jason A.; Cannons, Jennifer L.; Grainger, John R.; Dos Santos, Liliane M.; Hand, Timothy W.; Naik, Shruti; Wohlfert, Elizabeth A.; Chou, David B.; Oldenhove, Guillaume; Robinson, Melody; Grigg, Michael E.; Kastenmayer, Robin; Schwartzberg, Pamela L.; Belkaid, Yasmine			Essential Role for Retinoic Acid in the Promotion of CD4(+) T Cell Effector Responses via Retinoic Acid Receptor Alpha	IMMUNITY			English	Article							VITAMIN-A-DEFICIENCY; DENDRITIC CELLS; TOXOPLASMA-GONDII; SIGNALING PATHWAY; SMALL-INTESTINE; TH17 CELLS; FOXP3; DIFFERENTIATION; MICE; METABOLISM	Vitamin A and its metabolite, retinoic acid (RA) are implicated in the regulation of immune homeostasis via the peripheral induction of regulatory T cells. Here we showed RA was also required to elicit proinflammatory CD4(+) helper T cell responses to infection and mucosal vaccination. Retinoic acid receptor alpha (RAR alpha) was the critical mediator of these effects. Antagonism of RAR signaling and deficiency in RAR alpha (Rara(-/-)) resulted in a cell-autonomous CD4(+) T cell activation defect, which impaired intermediate signaling events, including calcium mobilization. Altogether, these findings reveal a fundamental role for the RA-RAR alpha axis in the development of both regulatory and inflammatory arms of adaptive immunity and establish nutritional status as a broad regulator of adaptive T cell responses.	[Hall, Jason A.; Grainger, John R.; Dos Santos, Liliane M.; Hand, Timothy W.; Naik, Shruti; Wohlfert, Elizabeth A.; Chou, David B.; Oldenhove, Guillaume; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Robinson, Melody; Kastenmayer, Robin] NIAID, Comparat Med Branch, NIH, Bethesda, MD 20892 USA; [Grigg, Michael E.] NIAID, Mol Parasitol Unit, NIH, Bethesda, MD 20892 USA; [Hall, Jason A.; Naik, Shruti] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Santos, Liliane Martins dos/AAR-9220-2020; Hand, Timothy W/AAH-1216-2021; wohlfert, beth/ABA-2255-2020	Santos, Liliane Martins dos/0000-0002-4466-8868; Hand, Timothy W/0000-0002-2684-9462; Chou, David/0000-0002-1659-9308; Belkaid, Yasmine/0000-0001-9962-3571; Grainger, John/0000-0002-4052-5923	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Office of Dietary Supplements; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001017, ZIGAI001047] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health and the Office of Dietary Supplements. We thank K. Holmes, D. Stephany, and the NIAID sorting facility. We thank K. Beacht and the Comparative Medicine Branch animal for animal handling and technical assistance. We thank J. Clements for providing LT(R129G). We thank R. Schwartz, S.-Y. Choi, K. Laky, and D. Hildeman for experimental advice. Finally, we thank R. Bosselut and A. Sher for critical reading of the manuscript.	Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Biesalski HK, 2004, J NUTR, V134, p3453S, DOI 10.1093/jn/134.12.3453S; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; CARMAN JA, 1992, J EXP MED, V175, P111, DOI 10.1084/jem.175.1.111; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, GENESIS, V32, P87, DOI 10.1002/gene.10071; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cui DM, 2000, J NUTR, V130, P1132, DOI 10.1093/jn/130.5.1132; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; DEPAOLO RW, NATURE IN PRESS, DOI DOI 10.1038/NATURE09849; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Geissmann F, 2003, J EXP MED, V198, P623, DOI 10.1084/jem.20030390; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; Lawson ND, 1999, EXP HEMATOL, V27, P1355, DOI 10.1016/S0301-472X(99)00085-5; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	54	271	279	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					435	447		10.1016/j.immuni.2011.03.003	http://dx.doi.org/10.1016/j.immuni.2011.03.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21419664	Green Accepted, Bronze			2022-12-18	WOS:000289014500018
J	Ransohoff, RM				Ransohoff, Richard M.			Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology	IMMUNITY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; BLOOD-BRAIN-BARRIER; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; MULTIPLE-SCLEROSIS; CXC CHEMOKINES; MICE LACKING; LYMPHOCYTE MIGRATION	There are several molecular entities common to the immune and nervous systems. Salient among them are the chemokines and their receptors, which play remarkably varied and potent roles in immunobiology and neurobioloogy. This review limns several illustrative examples and presents general principles of c action that are manifest in both systems. These include the following: (1) chemokines tend equally to arrest cells and to make them move, in the process of positioning target cells with spatiotemporal precision; (2) signaling and nonsignaling receptors collaborate to adjust the chemokine environment for maxima and (3) expression of a single chemokine receptor on circulating blood cells and parenchymal cells is often used to coordinate complex tissue responses. The challenge is to integrate knowledge of the roles of key receptors (as well as their ligands) into a coherent account of events during pathologic processes, in order to guide therapeutic development.	[Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; [Ransohoff, Richard M.] Cleveland Clin, Inst Neurol, Mellen Ctr MS Treatment & Res, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Mail Code NC30,9500 Euclid Ave, Cleveland, OH 44195 USA.	ransohr@ccf.org			National Institutes of Health; National Multiple Sclerosis Society; Charles A. Dana Foundation; Robert Packard Center; Nancy Davis Center Without Walls; Williams Family Fund; FOGARTY INTERNATIONAL CENTER [R03TW000784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041972, K24NS051400, P50NS038667, R01NS032151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Charles A. Dana Foundation; Robert Packard Center; Nancy Davis Center Without Walls; Williams Family Fund; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I thank past and recent members of the Ransohoff lab for their dedication and hard work, J. Ma (University of California, Davis) for critical review of the manuscript, and S. Hardy (Cleveland Clinic Lerner College of Medicine of CWRU) for renderings of draft figures. Research in my laboratory has received support from the National Institutes of Health, the National Multiple Sclerosis Society, the Charles A. Dana Foundation, the Robert Packard Center for ALS Research at Johns Hopkins, the Nancy Davis Center Without Walls, and the Williams Family Fund for MS Research.	Abbadie C, 2005, TRENDS IMMUNOL, V26, P529, DOI 10.1016/j.it.2005.08.001; Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Allen NJ, 2001, NAT NEUROSCI, V4, P676, DOI 10.1038/89443; Alon R, 2003, MICROCIRCULATION, V10, P297, DOI 10.1038/sj.mn.7800195; Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; BELL MD, 1995, J NEUROCYTOL, V24, P695, DOI 10.1007/BF01179819; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Borroni EM, 2009, METHOD ENZYMOL, V460, P231, DOI 10.1016/S0076-6879(09)05211-2; Borroni EM, 2008, IMMUNOL INVEST, V37, P483, DOI 10.1080/08820130802191318; BROSNAN CF, 1981, J IMMUNOL, V126, P614; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Cali C, 2008, J NEUROIMMUNOL, V198, P82, DOI 10.1016/j.jneuroim.2008.04.015; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; CHARO IF, 2001, BLOOD, V97, P1905; Chen XK, 2006, NEUROSCIENTIST, V12, P375, DOI 10.1177/1073858406291588; Cinamon G, 2004, J IMMUNOL, V173, P7282, DOI 10.4049/jimmunol.173.12.7282; Cinamon G, 2001, J LEUKOCYTE BIOL, V69, P860; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; Colobran R, 2007, CLIN EXP IMMUNOL, V148, P208, DOI 10.1111/j.1365-2249.2007.03344.x; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dogan RNE, 2004, FRONT BIOSCI-LANDMRK, V9, P1500, DOI 10.2741/1284; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Glabinski AR, 1997, AM J PATHOL, V150, P617; Gorbachev AV, 2007, J IMMUNOL, V178, P2278, DOI 10.4049/jimmunol.178.4.2278; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Gu L, 1999, Chem Immunol, V72, P7, DOI 10.1159/000058723; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Huising MO, 2003, TRENDS IMMUNOL, V24, P307, DOI 10.1016/S1471-4906(03)00120-0; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Infante-Duarte C, 2005, FASEB J, V19, P1902, DOI 10.1096/fj.05-3832fje; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jung H, 2008, J NEUROCHEM, V104, P254, DOI 10.1111/j.1471-4159.2007.04969.x; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lipp M, 2003, Verh Dtsch Ges Pathol, V87, P90; Liu LP, 2006, J IMMUNOL, V176, P4399, DOI 10.4049/jimmunol.176.7.4399; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Liu LP, 2005, CURR TOP DEV BIOL, V68, P149, DOI 10.1016/S0070-2153(05)68006-4; Locati M, 2005, CYTOKINE GROWTH F R, V16, P679, DOI 10.1016/j.cytogfr.2005.05.003; LORD G, 2005, BLOOD, V85, P3412; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Mantovani A, 2008, BLOOD, V112, P215, DOI 10.1182/blood-2008-04-149237; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Martins-Green M., 1997, Cytokine and Growth Factor Reviews, V8, P221, DOI 10.1016/S1359-6101(97)00016-6; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; McColl SR, 1998, J IMMUNOL, V161, P6421; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Menetski J, 2007, NEUROSCIENCE, V149, P706, DOI 10.1016/j.neuroscience.2007.08.014; Mihara K, 2005, EUR J IMMUNOL, V35, P2573, DOI 10.1002/eji.200526021; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Proudfoot AEI, 2008, J NEUROIMMUNOL, V198, P27, DOI 10.1016/j.jneuroim.2008.04.007; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Ransohoff RM, 2007, BLOOD, V109, P1342, DOI 10.1182/blood-2006-11-059600; Ransohoff RM, 2005, J IMMUNOL, V175, P5567, DOI 10.4049/jimmunol.175.9.5567; Ransohoff RM, 2003, NAT NEUROSCI, V6, P1009, DOI 10.1038/nn1003-1009; Reutershan J, 2006, DRUG NEWS PERSPECT, V19, P615, DOI 10.1358/dnp.2006.19.10.1068009; Robinson S, 1998, J NEUROSCI, V18, P10457; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Schall T, 1997, IMMUNOL TODAY, V18, P147, DOI 10.1016/S0167-5699(97)84655-5; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Sunnemark D, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-17; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Trettel F, 2008, J NEUROIMMUNOL, V198, P1, DOI 10.1016/j.jneuroim.2008.04.006; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Ward SG, 2009, IMMUNITY, V30, P315, DOI 10.1016/j.immuni.2009.03.002; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; White FA, 2008, CURR OPIN ANESTHESIO, V21, P580, DOI 10.1097/ACO.0b013e32830eb69d; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	140	271	279	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					711	721		10.1016/j.immuni.2009.09.010	http://dx.doi.org/10.1016/j.immuni.2009.09.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19836265	Green Accepted, Bronze			2022-12-18	WOS:000272097900007
J	Hanke, T; Takizawa, H; McMahon, CW; Busch, DH; Pamer, EG; Miller, JD; Altman, JD; Liu, Y; Cado, D; Lemonnier, FA; Bjorkman, PJ; Raulet, DH				Hanke, T; Takizawa, H; McMahon, CW; Busch, DH; Pamer, EG; Miller, JD; Altman, JD; Liu, Y; Cado, D; Lemonnier, FA; Bjorkman, PJ; Raulet, DH			Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HISTOCOMPATIBILITY COMPLEX-MOLECULES; BONE-MARROW ALLOGRAFTS; LY-49 MULTIGENE FAMILY; CARBOHYDRATE-RECOGNITION; MISSING SELF; T-CELLS; EXPRESSION; REJECTION; MICE	Mouse NK cells express at least seven inhibitory Ly49 receptors. Here we employ a semiquantitative cell-cell adhesion assay as well as class I/peptide tetramers to provide a comprehensive analysis of specificities of Ly49 receptors for class I MHC molecules in eight MHC haplotypes. Different Ly49 receptors exhibited diverse binding properties. The degree of class I binding was related to the extent of functional inhibition. The tetramer studies demonstrated that neither glycosylation nor coreceptors were necessary for class I binding to Ly49 receptors and uncovered peptide-specific recognition by a Ly49 receptor. The results provide a foundation for interpreting and integrating many existing functional studies as well as for designing tests of NK cell development and self-tolerance.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Inst Pasteur, SIDA Retrovirus, Unite Immunite Cellulaire Antivirale Dept, F-75724 Paris 15, France	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Yale University; Yale University; Emory University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035021] Funding Source: NIH RePORTER; NIAID NIH HHS [R0-1AI35021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; BRENNAN J, 1995, J BIOL CHEM, V270, P9691, DOI 10.1074/jbc.270.17.9691; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; CORRAL L, 1999, IN PRESS HYBRIDOMA; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; George T, 1997, IMMUNOL REV, V155, P29, DOI 10.1111/j.1600-065X.1997.tb00937.x; George TC, 1999, J IMMUNOL, V162, P2035; Held W, 1997, J EXP MED, V185, P2079, DOI 10.1084/jem.185.12.2079; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; HOGLUND P, 1997, IMMUNOL REV, V155, P1; Johansson MH, 1998, EUR J IMMUNOL, V28, P4198, DOI 10.1002/(SICI)1521-4141(199812)28:12<4198::AID-IMMU4198>3.0.CO;2-9; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1994, J IMMUNOL, V153, P2407; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Lian RH, 1998, J IMMUNOL, V161, P2301; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Matsumoto N, 1998, IMMUNITY, V8, P245, DOI 10.1016/S1074-7613(00)80476-8; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; MURPHY WJ, 1990, J IMMUNOL, V144, P3305; NAGASAWA R, 1987, J IMMUNOL, V138, P815; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; Ortaldo JR, 1998, J IMMUNOL, V160, P1158; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Raziuddin A, 1996, INT IMMUNOL, V8, P1833, DOI 10.1093/intimm/8.12.1833; SMITH HRC, 1994, J IMMUNOL, V153, P1068; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; Summers MD, 1987, MANUAL METHODS BACUL; Sundback J, 1998, J IMMUNOL, V160, P5971; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Vance RE, 1998, CURR TOP MICROBIOL, V230, P135; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; WONG S, 1991, J IMMUNOL, V147, P1417; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	46	271	275	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1999	11	1					67	77		10.1016/S1074-7613(00)80082-5	http://dx.doi.org/10.1016/S1074-7613(00)80082-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435580	Bronze			2022-12-18	WOS:000081671300007
J	Okamura, RM; Sigvardsson, M; Galceran, J; Verbeek, S; Clevers, H; Grosschedl, R				Okamura, RM; Sigvardsson, M; Galceran, J; Verbeek, S; Clevers, H; Grosschedl, R			Redundant regulation of T cell differentiation and TCR alpha gene expression by the transcription factors LEF-1 and TCF-1	IMMUNITY			English	Article							THYMOCYTE DIFFERENTIATION; HMG DOMAIN; NUCLEOPROTEIN STRUCTURES; FUNCTIONAL-ANALYSIS; ACTIVATION DOMAIN; RECEPTOR GENES; SCID MICE; ENHANCER; BETA; PROTEIN	Lymphoid enhancer factor 1 (LEF-1) and T cell factor 1 (TCF-1) are closely related transcription factors that are both expressed during murine T cell differentiation and that regulate the T cell receptor alpha (TCR alpha) enhancer in transfection assays. Targeted gene disruption of either the Tcf1 or Lef1 gene in mice did not affect TCR alpha gene expression and resulted in an incomplete defect or no defect in thymocyte differentiation. Here, we examine a potential redundancy of these transcription factors by analyzing double-mutant mice. In fetal thymic organ cultures from Lef1(-/-)Tcf1(-/-)mice, alpha/beta T cell differentiation is completely arrested at the immature CD8(+) single-positive (CD8(+) ISP) stage and is markedly impaired at an earlier stage. In addition, we find that sorted CD8(+) ISP cells from Lef1(-/-)Tcf1(-/-) mice express TCR beta but show a severely reduced level of TCR alpha gene transcription. Together, these data show that LEF-1 and TCF-1 are redundant in the regulation of T cell differentiation and gene expression.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Utrecht Hosp, Dept Immunol, NL-3508 GA Utrecht, Netherlands	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center	Grosschedl, R (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol, San Francisco, CA 94143 USA.	rgross@itsa.ucsf.edu	Galceran, Juan/K-6744-2014	Galceran, Juan/0000-0002-5247-2726				ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Brickner AG, 1995, GENE, V167, P261, DOI 10.1016/0378-1119(95)00673-7; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; CARROLL AM, 1991, GENE DEV, V5, P1357, DOI 10.1101/gad.5.8.1357; Clevers HC, 1996, IMMUNOL TODAY, V17, P336, DOI 10.1016/0167-5699(96)10019-0; CLEVERS HC, 1993, IMMUNOL TODAY, V14, P591, DOI 10.1016/0167-5699(93)90198-T; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FULOP GM, 1986, J IMMUNOL, V136, P4438; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Haynes TL, 1996, NUCLEIC ACIDS RES, V24, P5034, DOI 10.1093/nar/24.24.5034; HO IC, 1990, MOL CELL BIOL, V10, P4720, DOI 10.1128/MCB.10.9.4720; KRIMPENFORT P, 1988, EMBO J, V7, P745, DOI 10.1002/j.1460-2075.1988.tb02871.x; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Ohteki T, 1996, EUR J IMMUNOL, V26, P351, DOI 10.1002/eji.1830260213; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; RAMSDELL F, 1992, CURRENT PROTOCOLS IM; RAULET DH, 1991, IMMUNOL REV, V120, P185, DOI 10.1111/j.1600-065X.1991.tb00592.x; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; TAKEDA J, 1990, MOL CELL BIOL, V10, P5027, DOI 10.1128/MCB.10.10.5027; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0	49	271	290	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1998	8	1					11	20		10.1016/S1074-7613(00)80454-9	http://dx.doi.org/10.1016/S1074-7613(00)80454-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YU884	9462507	Bronze			2022-12-18	WOS:000071765700002
J	Shiratori, T; Miyatake, S; Ohno, H; Nakaseko, C; Isono, K; Bonifacino, JS; Saito, T				Shiratori, T; Miyatake, S; Ohno, H; Nakaseko, C; Isono, K; Bonifacino, JS; Saito, T			Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2	IMMUNITY			English	Article							CYTOPLASMIC TAIL; CD28 RECEPTOR; T-CELLS; SIGNAL	CTLA-4 is a costimulation receptor that binds to the same ligands, CD80 and CD86, as CD28 with high affinity and is transiently expressed on the cell surface of activated T cells. CTLA-4 delivers an inhibitory signal through association of a phosphotyrosine-containing motif in the cytoplasmic domain with Syp tyrosine phosphatase. We now demonstrate that CTLA-4 interacts with the mu(2) subunit of the plasma membrane-associated adaptor complex, AP-2, through the same motif involved in the interaction with Syp, except that the interaction with mu(2) requires unphosphorylated tyrosine. The interaction with mu(2) likely induces rapid internalization of CTLA-4 from the cell surface. Our results suggest that the phosphorylation state of a single tyrosine residue determines whether CTLA-4 delivers a negative signal or is internalized.	CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOL GENET,CHUO KU,CHIBA 280,JAPAN; CHIBA UNIV,SCH MED,DEPT SURG 2,CHUO KU,CHIBA 280,JAPAN; NICHHD,CELL BIOL & METAB BRANCH,NIH,BETHESDA,MD 20892	Chiba University; Chiba University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)			Saito, Takashi/C-9684-2009; Ohno, Hiroshi/L-7899-2014	Saito, Takashi/0000-0001-9495-3547; Ohno, Hiroshi/0000-0001-8776-9661; Bonifacino, Juan S./0000-0002-5673-6370				BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; HARPER K, 1991, J IMMUNOL, V147, P1037; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cellbio.6.1.151; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129; WALNUS TL, 1994, IMMUNITY, V1, P405; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	20	271	277	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					583	589		10.1016/S1074-7613(00)80346-5	http://dx.doi.org/10.1016/S1074-7613(00)80346-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175836	Bronze			2022-12-18	WOS:A1997XB81900009
J	KERNER, JD; APPLEBY, MW; MOHR, RN; CHIEN, S; RAWLINGS, DJ; MALISZEWSKI, CR; WITTE, ON; PERLMUTTER, RM				KERNER, JD; APPLEBY, MW; MOHR, RN; CHIEN, S; RAWLINGS, DJ; MALISZEWSKI, CR; WITTE, ON; PERLMUTTER, RM			IMPAIRED EXPANSION OF MOUSE B-CELL PROGENITORS LACKING BTK	IMMUNITY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PROTEIN-TYROSINE KINASES; BONE-MARROW; LYMPHOCYTES-B; IMMUNE-DEFICIENCY; HEMATOPOIETIC-CELLS; SIGNALING PROTEINS; SH3 DOMAINS; FETAL LIVER; SRC FAMILY	Mutations in the gene encoding the protein tyrosine kinase Btk are associated with the human B cell immunodeficiency X-linked agammaglobulinemia (XLA). In the mouse, a point mutation in the Btk pleckstrin homology domain segregates with a milder X-linked immunodeficiency (rid). To assess the importance of Btk function in murine lymphopoiesis, we generated multiple embryonic stem cell clones bearing a targeted disruption of the btk gene and examined their potential to produce lymphocytes in both C57BL/6 and RAG2(-/-) host chimeric animals. These mice provide a complementary set of in vivo competition assays that formally establish the genetic basis for the rid phenotype. Although the null mutation yields a phenotype quite similar to that of rid, it also compromises expansion of B cell precursors. Our results suggest that the murine and human consequences of Btk deficiency differ only quantitatively, and represent the same disease process.	UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED MED GENET, SEATTLE, WA 98195 USA; UNIV CALIF LOS ANGELES, DEPT MICROBIOL & MOLEC GENET, LOS ANGELES, CA 90024 USA; IMMUNEX RES & DEV CORP, DEPT IMMUNOL, SEATTLE, WA 98101 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	KERNER, JD (corresponding author), UNIV WASHINGTON, DEPT IMMUNOL, SEATTLE, WA 98195 USA.		Rawlings, David/CAI-4751-2022		NCI NIH HHS [CA45682, CA12800] Funding Source: Medline; NIAMS NIH HHS [AR36834] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045682, P01CA012800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036834] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMSBAUGH DF, 1972, J EXP MED, V136, P931, DOI 10.1084/jem.136.4.931; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; APPLEBY MW, 1995, IN PRESS J EXP MED; BOLEN JB, 1993, ONCOGENE, V8, P2025; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; BRANDON EP, 1995, RECENT PROG HORM RES, V50, P4003; BRUTON OC, 1952, PEDIATRICS, V9, P722; CAMPANA D, 1990, J IMMUNOL, V145, P1675; CHEN JZ, 1994, IMMUNITY, V1, P65, DOI 10.1016/1074-7613(94)90010-8; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHERAYIL BJ, 1991, J EXP MED, V173, P111, DOI 10.1084/jem.173.1.111; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; CONLEY ME, 1985, J IMMUNOL, V134, P3070; CONLEY ME, 1994, IMMUNOL REV, V138, P5, DOI 10.1111/j.1600-065X.1994.tb00844.x; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; COOPER MD, 1971, LANCET, V2, P791; CROCKARD AD, 1992, CLIN EXP IMMUNOL, V88, P29; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; DEWEERS M, 1993, EUR J IMMUNOL, V23, P3109, DOI 10.1002/eji.1830231210; DURIEZ B, 1994, FEBS LETT, V346, P165, DOI 10.1016/0014-5793(94)00457-9; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FORRESTER LM, 1987, J EXP MED, V165, P949, DOI 10.1084/jem.165.4.949; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; GREGORY RJ, 1987, MOL CELL BIOL, V7, P2119, DOI 10.1128/MCB.7.6.2119; GROSS JA, 1995, J EXP MED, V181, P463, DOI 10.1084/jem.181.2.463; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; HARADA N, 1993, J IMMUNOL, V151, P3111; HARDY RR, 1989, CURR TOP MICROBIOL, V152, P19; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASBOLD J, 1994, EUR J IMMUNOL, V24, P152, DOI 10.1002/eji.1830240123; HITOSHI Y, 1993, INT IMMUNOL, V5, P1183, DOI 10.1093/intimm/5.9.1183; KARAGOGEOS D, 1986, EUR J IMMUNOL, V16, P1125, DOI 10.1002/eji.1830160916; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KAUFMAN RJ, 1987, EMBO J, V6, P187, DOI 10.1002/j.1460-2075.1987.tb04737.x; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; KINCADE PW, 1982, IMMUNOL REV, V64, P81, DOI 10.1111/j.1600-065X.1982.tb00419.x; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KORNFELD SJ, 1994, NEW ENGL J MED, V331, P949; LANIER LL, 1981, J IMMUNOL, V127, P1691; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MALEK SN, 1993, J BIOL CHEM, V268, P22557; MANO H, 1993, ONCOGENE, V8, P417; MATHIESON BJ, 1980, J IMMUNOL, V125, P2127; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; MELCHERS F, 1994, ANNU REV IMMUNOL, V12, P209, DOI 10.1146/annurev.immunol.12.1.209; MOND JJ, 1982, J EXP MED, V155, P924, DOI 10.1084/jem.155.3.924; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NAHM MH, 1983, J EXP MED, V158, P920, DOI 10.1084/jem.158.3.920; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OHTA Y, 1994, P NATL ACAD SCI USA, V91, P9062, DOI 10.1073/pnas.91.19.9062; OSMAN GE, 1992, J IMMUNOL, V148, P1928; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PEARL ER, 1978, J IMMUNOL, V120, P1169; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; PERLMUTTER RM, 1979, J EXP MED, V149, P993, DOI 10.1084/jem.149.4.993; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REID GK, 1985, J IMMUNOL, V135, P2299; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; RICHARDS SJ, 1992, BRIT J HAEMATOL, V81, P160, DOI 10.1111/j.1365-2141.1992.tb08201.x; ROBERTSON EJ, 1987, TERATOCARINOMAS EMBR; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOSARGUMEDO L, 1995, INT IMMUNOL, V7, P163, DOI 10.1093/intimm/7.2.163; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHER I, 1973, J IMMUNOL, V110, P1396; SCHER I, 1982, ADV IMMUNOL, V33, P1, DOI 10.1016/S0065-2776(08)60834-2; SCHER I, 1975, J EXP MED, V141, P788; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIDERAS P, 1994, J IMMUNOL, V153, P5607; SIECKMANN DG, 1978, J EXP MED, V148, P1628, DOI 10.1084/jem.148.6.1628; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; SMITH CIE, 1994, J IMMUNOL, V152, P557; SPRENT J, 1985, J IMMUNOL, V134, P1442; SPRENT J, 1984, J EXP MED, V160, P711, DOI 10.1084/jem.160.3.711; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEDDER TF, 1985, J IMMUNOL, V135, P1786; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WICKER LS, 1986, CURR TOP MICROBIOL, V124, P87; WORTIS HH, 1982, J EXP MED, V155, P903, DOI 10.1084/jem.155.3.903; YAMADA N, 1993, BIOCHEM BIOPH RES CO, V192, P231, DOI 10.1006/bbrc.1993.1404; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	100	271	273	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1995	3	3					301	312		10.1016/1074-7613(95)90115-9	http://dx.doi.org/10.1016/1074-7613(95)90115-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552995	Bronze			2022-12-18	WOS:A1995RX64500005
J	Steiner, DF; Thomas, MF; Hu, JK; Yang, ZY; Babiarz, JE; Allen, CDC; Matloubian, M; Blelloch, R; Ansel, KM				Steiner, David F.; Thomas, Molly F.; Hu, Joyce K.; Yang, Zhiyong; Babiarz, Joshua E.; Allen, Christopher D. C.; Matloubian, Mehrdad; Blelloch, Robert; Ansel, K. Mark			MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-gamma Production in Helper T Cells	IMMUNITY			English	Article							EXPRESSION; DICER; BET; EFFECTOR; DIFFERENTIATION; ACTIVATION; MIR-17-92; SURVIVAL; LINEAGE; CANCER	MicroRNA (miRNA)-deficient helper T cells exhibit abnormal IFN-gamma production and decreased proliferation. However, the contributions of individual miRNAs to this phenotype remain poorly understood. We conducted a screen for miRNA function in primary T cells and identified individual miRNAs that rescue the defects associated with miRNA deficiency. Multiple members of the miR-17 and miR-92 families enhanced miRNA-deficient T cell proliferation whereas miR-29 largely corrected their aberrant interferon-gamma (IFN-gamma) expression. Repression of IFN-gamma production by miR-29 involved direct targeting of both T-bet and Eomes, two transcription factors known to induce IFN-gamma production. Although not usually expressed at functionally relevant amounts in helper T cells, Eomes was abundant in miRNA-deficient cells and was upregulated after miR-29 inhibition in wild-type cells. These results demonstrate that miR-29 regulates helper T cell differentiation by repressing multiple target genes, including at least two that are independently capable of inducing the T helper 1 (Th1) cell gene expression program.	[Steiner, David F.; Thomas, Molly F.; Yang, Zhiyong; Allen, Christopher D. C.; Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Steiner, David F.; Thomas, Molly F.; Yang, Zhiyong; Allen, Christopher D. C.; Ansel, K. Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Hu, Joyce K.; Matloubian, Mehrdad] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Hu, Joyce K.; Matloubian, Mehrdad] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Babiarz, Joshua E.; Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Babiarz, Joshua E.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ansel, KM (corresponding author), Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	mark.ansel@ucsf.edu		Yang, Zhiyong/0000-0003-0589-6224; Allen, Christopher/0000-0002-1879-9047	Dana Foundation; Burroughs Wellcome Fund [CABS 1006173]; UCSF; UCSF/NIH; Susan G. Komen Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109102] Funding Source: NIH RePORTER	Dana Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); UCSF; UCSF/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank S. Abdul-Wajid and M. Panduro-Sicheva for technical assistance; H.J. Fehling (Institute for Immunology, University Clinics Ulm) for providing R26-tdRFP reporter mice; R. Barbeau, J. Pollack, A. Barczak, and D. Erie for advice and expert assistance with microarray experiments; O. Solberg and P. Woodruff for help with bioinformatic analysis; E. Fink for advice on the use of statistics; A. Weiss and L. Jeker for critical reading of the manuscript; and members of the UCSF miRNA in lymphocytes interest group for helpful discussions. This work was supported by the Dana Foundation, the Burroughs Wellcome Fund (CABS 1006173), the UCSF Program for Breakthrough Biomedical Research, the UCSF/NIH Medical Scientist Training Program (D.F.S. and M.F.T.), and the Susan G. Komen Foundation.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kim JA, 2008, BIOSENS BIOELECTRON, V23, P1353, DOI 10.1016/j.bios.2007.12.009; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	270	288	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					169	181		10.1016/j.immuni.2011.07.009	http://dx.doi.org/10.1016/j.immuni.2011.07.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21820330	Bronze, Green Accepted			2022-12-18	WOS:000294387900008
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			Biology of Lung Dendritic Cells at the Origin of Asthma	IMMUNITY			English	Review							HOUSE-DUST MITE; ALLERGIC AIRWAY INFLAMMATION; CD4(+) T-CELLS; RESPIRATORY SYNCYTIAL VIRUS; ANTIGEN-PRESENTING CELLS; BLOOD MONOCYTE SUBSETS; EPITHELIAL-CELLS; IMMUNE-RESPONSES; INHALED ANTIGEN; TH2 RESPONSES	Dendritic cells (DCs) initiate and maintain adaptive T helper 2 (Th2) cell responses to inhaled allergens in asthma. Various functions like antigen uptake, migration to the draining LNs, and induction of tolerance and adaptive immunity are not equally shared by all subsets of DCs, adding considerable complexity to understanding the immunology of allergic sensitization. Whereas the epithelium was initially considered solely as a physical barrier, it is now seen as a central player in controlling the function of lung DCs through release of Th2 cell-promoting cytokines. Although DCs are sufficient and necessary for induction of Th2 cell responses to many antigens, some allergens might require antigen presentation by basophils. Clinically relevant allergens, as well as environmental and genetic risk factors for allergy and asthma, often interfere directly or indirectly with the innate immune functions of airway epithelial cells, basophils, and DCs. This review summarizes the recent progress on our understanding how DCs control Th2 cell immunity in the lung.	[Lambrecht, Bart N.; Hammad, Hamida] Ghent Univ Hosp, Dept Resp Dis, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium; [Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulm Med, NL-3015 GE Rotterdam, Netherlands	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Ghent Univ Hosp, Dept Resp Dis, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium.	bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603				Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Charbonnier AS, 2003, J LEUKOCYTE BIOL, V73, P91, DOI 10.1189/jlb.0602289; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Hammad H, 2003, EUR CYTOKINE NETW, V14, P219; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; Hammad H, 2003, J IMMUNOL, V171, P3936, DOI 10.4049/jimmunol.171.8.3936; Hammad H, 2002, J IMMUNOL, V169, P1524, DOI 10.4049/jimmunol.169.3.1524; Hammad H, 2001, BLOOD, V98, P1135, DOI 10.1182/blood.V98.4.1135; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Hammad H, 2006, J ALLERGY CLIN IMMUN, V118, P331, DOI 10.1016/j.jaci.2006.03.041; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Headley MB, 2009, J IMMUNOL, V182, P1641, DOI 10.4049/jimmunol.182.3.1641; HOLT PG, 1994, J IMMUNOL, V153, P256; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Idzko M, 2007, J CLIN INVEST, V117, P464, DOI 10.1172/JCI28949; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Kuipers H, 2009, J LEUKOCYTE BIOL, V85, P64, DOI 10.1189/jlb.0807519; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li Q, 2008, EUR J IMMUNOL, V38, P2751, DOI 10.1002/eji.200838542; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Matsubara S, 2006, AM J RESP CELL MOL, V34, P426, DOI 10.1165/rcmb.2005-0298OC; Maurer D, 1998, J IMMUNOL, V161, P2731; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Naito T, 2008, AM J RESP CELL MOL, V38, P161, DOI 10.1165/rcmb.2007-0237OC; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nolte MA, 2007, J EXP MED, V204, P1487, DOI 10.1084/jem.20070325; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; RAYMOND M, 2009, J ALLERGY C IN PRESS; Robays LJ, 2009, MUCOSAL IMMUNOL, V2, P206, DOI 10.1038/mi.2009.7; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SERTL K, 1986, J EXP MED, V163, P436, DOI 10.1084/jem.163.2.436; Shao ZF, 2009, J ALLERGY CLIN IMMUN, V123, P917, DOI 10.1016/j.jaci.2009.01.052; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Traves SL, 2008, CURR MOL MED, V8, P416, DOI 10.2174/156652408785160998; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van Rift LS, 2004, J ALLERGY CLIN IMMUN, V114, P166, DOI 10.1016/j.jaci.2004.03.044; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Veres TZ, 2009, AM J PATHOL, V174, P808, DOI 10.2353/ajpath.2009.080800; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; von Garnier C, 2005, J IMMUNOL, V175, P1609, DOI 10.4049/jimmunol.175.3.1609; Walzer T, 2005, J ALLERGY CLIN IMMUN, V115, P192, DOI 10.1016/j.jaci.2004.08.046; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Webb DC, 2007, J IMMUNOL, V178, P219, DOI 10.4049/jimmunol.178.1.219; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wikstrom ME, 2007, IMMUNOL CELL BIOL, V85, P182, DOI 10.1038/sj.icb.7100039; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702	121	270	275	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					412	424		10.1016/j.immuni.2009.08.008	http://dx.doi.org/10.1016/j.immuni.2009.08.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766084	Bronze			2022-12-18	WOS:000270525900007
J	Schmitt, N; Morita, R; Bourdery, L; Bentebibel, SE; Zurawski, SM; Banchereau, J; Ueno, H				Schmitt, Nathalie; Morita, Rimpei; Bourdery, Laure; Bentebibel, Salah Eddine; Zurawski, Sandra M.; Banchereau, Jacques; Ueno, Hideki			Human Dendritic Cells Induce the Differentiation of Interleukin-21-Producing T Follicular Helper-like Cells through Interleukin-12	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; AUTOCRINE REGULATION; IMMUNE-RESPONSES; B-CELLS; IL-21; IL-12; GENERATION; ACTIVATION; ICOS; EXPRESSION	T follicular helper (Tfh) cells help development of antibody responses via interleukin-21 (IL-21). Here we show that activated human dendritic cells (DCs) induced naive CD4(+) T cells to become IL-21-producing Tfh-like cells through IL-12. CD4(+) T cells primed with IL-12 induced B cells to produce immunoglobulins in a fashion dependent on IL-21 and inducible costimulator (ICOS), thus sharing fundamental characteristics with Tfh cells. The induction of Tfh-like cells by activated DCs was inhibited by neutralizing IL-12. IL-12 induced two different IL-21-producers: IL-21(+)IFN-gamma T+-bet(+) Th1 cells and IL-21(+)IFN-gamma T+-bet(-) non-Th1 cells, in a manner dependent on signal transducer and activator of transcription 4 (STAT4). IL-12 also regulated IL-21 secretion by memory CD4(+) T cells. Thus, IL-12 produced by activated DCs regulates antibody responses via developing IL-21-producing Tflh-like cells and inducing IL-21 secretion from memory CD4(+) T cells. These data suggest that the developmental pathway of Tfh cells differs between mice and humans, which have considerable implications for vaccine development.	[Schmitt, Nathalie; Morita, Rimpei; Bourdery, Laure; Bentebibel, Salah Eddine; Zurawski, Sandra M.; Banchereau, Jacques; Ueno, Hideki] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Zurawski, Sandra M.; Banchereau, Jacques; Ueno, Hideki] INSERM, U899, Dallas, TX 75204 USA; [Banchereau, Jacques] Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA; [Banchereau, Jacques] Mt Sinai Sch Med, Dept Gene & Cell Med, Inst Immunol, New York, NY 10029 USA	Baylor Scott & White Health; Baylor University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Banchereau, J (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	jacquesb@baylorhealth.edu; hidekiu@baylorhealth.edu	Bentebibel, Salah-Eddine/AAS-9766-2021; Ueno, Hideki/L-1237-2016	Ueno, Hideki/0000-0001-7747-0738; Schmitt, Nathalie/0000-0001-9993-2788	Baylor Health Care Foundation;  [U19-AI057234];  [R01-CA84512];  [R01-CA078846]; NATIONAL CANCER INSTITUTE [P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Baylor Health Care Foundation; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Kowalski and S. Coquery for cell sorting; L. Walters for cell processing from apheresis blood; G. Zurawski for IL-21 generation; and G. Xia and J. Connolly for technical discussion. This study was supported by U19-AI057234, R01-CA84512, R01-CA078846 (J.B.), and Baylor Health Care Foundation (H.U. and J.B.). J.B. holds the W.W. Caruth, Jr., Chair for Transplantation Immunology Research.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Caprioli F, 2008, J IMMUNOL, V180, P1800, DOI 10.4049/jimmunol.180.3.1800; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cyster JG, 2000, IMMUNOL REV, V176, P181; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Dubois B, 1998, J IMMUNOL, V161, P2223; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hirao LA, 2008, VACCINE, V26, P3112, DOI 10.1016/j.vaccine.2008.02.036; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; van der Meide PH, 2002, VACCINE, V20, P2296, DOI 10.1016/S0264-410X(02)00101-9; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	53	270	279	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					158	169		10.1016/j.immuni.2009.04.016	http://dx.doi.org/10.1016/j.immuni.2009.04.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592276	Bronze, Green Accepted			2022-12-18	WOS:000268219900020
J	Dittmer, U; He, H; Messer, RJ; Schimmer, S; Olbrich, ARM; Ohlen, C; Greenberg, PD; Stromnes, IM; Iwashiro, M; Sakaguchi, S; Evans, LH; Peterson, KE; Yang, GJ; Hasenkrug, KJ				Dittmer, U; He, H; Messer, RJ; Schimmer, S; Olbrich, ARM; Ohlen, C; Greenberg, PD; Stromnes, IM; Iwashiro, M; Sakaguchi, S; Evans, LH; Peterson, KE; Yang, GJ; Hasenkrug, KJ			Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; GAMMA-INTERFERON; FRIEND-VIRUS; PERFORIN EXPRESSION; DISEASE PROGRESSION; EFFECTOR FUNCTION; LEISHMANIA-MAJOR; HIV-1 INFECTION; HELPER TYPE-1	The establishment of viral persistence generally requires evasion of the host CD8(+) T cell response. Here we describe a form of evasion wherein the CD8(+) T cells are fully capable of recognizing their cognate antigen but their effector functions are suppressed by regulatory T cells. Virus-specific CD8(+) T cells adoptively transferred into mice persistently infected with Friend virus proliferated and appeared activated, but failed to produce IFNgamma or reduce virus loads. Cotransfer experiments revealed that a subpopulation of CD4(+) T cells from persistently infected mice suppressed IFNgamma production by the CD8(+) T cells. Treatment of persistently infected mice with anti-GITR antibody to ameliorate suppression by regulatory T cells significantly improved IFNgamma production by transferred CD8(+) T cells and allowed a significant reduction in viral loads. The results indicate that CD4(+) regulatory T cells contribute to viral persistence and demonstrate an immunotherapy for treating chronic retroviral infections.	NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Natl Inst Hlth, Hamilton, MT 59840 USA; Univ Klinikum Essen, Inst Virol, D-45122 Essen, Germany; Univ Washington, Dept Med & Immunol, Seattle, WA 98195 USA; Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Duisburg Essen; University of Washington; University of Washington Seattle; Kyoto University	Hasenkrug, KJ (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Natl Inst Hlth, Hamilton, MT 59840 USA.	khasenkrug@nih.gov	Sakaguchi, Shimon/C-9535-2009; Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, Z01AI000753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Andersson J, 2002, J INFECT DIS, V185, P1355, DOI 10.1086/340124; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; CHEN AB, 1996, J BIOTECHNOL HEALTHC, V3, P70; Dittmer U, 1998, J VIROL, V72, P6554, DOI 10.1128/JVI.72.8.6554-6558.1998; Dittmer U, 2002, J VIROL, V76, P450, DOI 10.1128/JVI.76.1.450-454.2002; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Geertsma MF, 1999, J INFECT DIS, V180, P649, DOI 10.1086/314941; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hasenkrug KJ, 1999, J VIROL, V73, P6468, DOI 10.1128/JVI.73.8.6468-6473.1999; HASENKRUG KJ, 1995, P NATL ACAD SCI USA, V92, P10492, DOI 10.1073/pnas.92.23.10492; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Iwashiro M, 2001, J VIROL, V75, P52, DOI 10.1128/JVI.75.1.52-60.2001; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; LILLY F, 1973, VIROLOGY, V55, P363, DOI 10.1016/0042-6822(73)90176-1; Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Oldstone MBA, 1997, VIROLOGY, V234, P179, DOI 10.1006/viro.1997.8674; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Rich RF, 2000, VIROLOGY, V272, P237, DOI 10.1006/viro.2000.0388; ROBERTSON MN, 1992, J VIROL, V66, P3271, DOI 10.1128/JVI.66.6.3271-3277.1992; Sakaguchi S, 2003, NAT IMMUNOL, V4, P10, DOI 10.1038/ni0103-10; Schepers K, 2002, J IMMUNOL, V169, P3191, DOI 10.4049/jimmunol.169.6.3191; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stromnes IM, 2002, J VIROL, V76, P2225, DOI 10.1128/JVI.76.5.2225-2232.2002; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Trimble LA, 1998, BLOOD, V91, P585, DOI 10.1182/blood.V91.2.585.585_585_594; Uraushihara K, 2003, J IMMUNOL, V171, P708, DOI 10.4049/jimmunol.171.2.708; Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Xu XN, 2001, IMMUNITY, V15, P867, DOI 10.1016/S1074-7613(01)00255-2	52	270	293	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2004	20	3					293	303		10.1016/S1074-7613(04)00054-8	http://dx.doi.org/10.1016/S1074-7613(04)00054-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030773	Bronze			2022-12-18	WOS:000221442600007
J	Zhang, XW; Schwartz, JCD; Guo, XL; Bhatia, S; Cao, EH; Chen, LP; Zhang, ZY; Edidin, MA; Nathenson, SG; Almo, SC				Zhang, XW; Schwartz, JCD; Guo, XL; Bhatia, S; Cao, EH; Chen, LP; Zhang, ZY; Edidin, MA; Nathenson, SG; Almo, SC			Structural and functional analysis of the costimulatory receptor programmed death-1	IMMUNITY			English	Article							B7 FAMILY; BINDING; PROTEIN; EXPRESSION; CTLA-4; B7-H1; MOLECULES; ADHESION; COMPLEX; SURFACE	PD-1, a member of the CD28/CTLA-4/ICOS costimulatory receptor family, delivers negative signals that have profound effects on T and B cell immunity. The 2.0 A crystal structure of the extracellular domain of murine PD-1 reveals an Ig V-type topology with overall similarity to the CTLA-4 monomer; however, there are notable differences in regions relevant to function. Our structural and biophysical data show that PD-1 is monomeric both in solution as well as on cell surface, in contrast to CTLA-4 and other family members that are all disulfide-linked homodimers. Furthermore, our structure-based mutagenesis studies identify the ligand binding surface of PD-1, which displays significant differences compared to those present in the other members of the family.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Synchrotron Biosci, Bronx, NY 10461 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; Johns Hopkins University	Nathenson, SG (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu; almo@aecom.yu.edu	cao, erhu/A-7204-2011; Schwartz, Jean-Claude/U-3163-2019	Cammer, Michael/0000-0003-4930-1739				Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Morton PA, 1996, J IMMUNOL, V156, P1047; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Reyes-Moreno C, 2004, J BIOL CHEM, V279, P7799, DOI 10.1074/jbc.M313168200; Schwartz JCD, 2002, NAT IMMUNOL, V3, P427, DOI 10.1038/ni0502-427; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Wang SD, 2002, J EXP MED, V195, P1033, DOI 10.1084/jem.20011607; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616	38	270	355	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					337	347		10.1016/S1074-7613(04)00051-2	http://dx.doi.org/10.1016/S1074-7613(04)00051-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030777	Bronze			2022-12-18	WOS:000221442600011
J	Willcox, BE; Gao, GF; Wyer, JR; Ladbury, JE; Bell, JI; Jakobsen, BK; van der Merwe, PA				Willcox, BE; Gao, GF; Wyer, JR; Ladbury, JE; Bell, JI; Jakobsen, BK; van der Merwe, PA			TCR binding to peptide-MHC stabilizes a flexible recognition interface	IMMUNITY			English	Article							PROTEIN-PROTEIN INTERACTIONS; T-CELL RECOGNITION; SURFACE-PLASMON RESONANCE; HISTOCOMPATIBILITY COMPLEX MHC; MYELIN BASIC-PROTEIN; LIPID-LINKED FORM; INFLUENZA-A; RECEPTOR; ANTIGEN; ADHESION	The binding of TCRs to their peptide-MHC ligands is characterized by a low affinity, slow kinetics, and a high degree of cross-reactivity, Here, we report the results of a kinetic and thermodynamic analysis of two TCRs binding to their peptide-MHC ligands, which reveal two striking features. First, significant activation energy barriers must be overcome during both association and dissociation, suggesting that conformational adjustments are required. Second, the low affinity of binding is a consequence of highly unfavorable entropic effects, indicative of a substantial reduction in disorder upon binding. This is evidence that the TCR and/or peptide-MHC have flexible binding surfaces that are stabilized upon binding. Such conformational flexibility, which may also be a feature of primary antibodies, is likely to contribute to cross-reactivity in antigen recognition.	John Radcliffe Hosp, Inst Mol Med, Nuffield Dept Clin Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of London; University College London; University of Oxford	Jakobsen, BK (corresponding author), John Radcliffe Hosp, Inst Mol Med, Nuffield Dept Clin Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England.	jakobsen@pinnacle.jr2.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Gao, George Fu/ABD-5229-2021	Ladbury, John/0000-0002-6328-7200				BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BHARDWAJ V, 1993, J IMMUNOL, V151, P5000; Braden BC, 1996, J MOL BIOL, V257, P889, DOI 10.1006/jmbi.1996.0209; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; DAY LA, 1963, ANN NY ACAD SCI, V103, P611, DOI 10.1111/j.1749-6632.1963.tb53721.x; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hodgkin PD, 1998, IMMUNOLOGIST, V6, P223; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaliyaperumal A, 1996, J EXP MED, V183, P2459, DOI 10.1084/jem.183.6.2459; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.immunol.13.1.587; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MASON DW, 1986, HDB EXPT IMMUNOLOGY; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Ono T, 1998, J IMMUNOL, V161, P5454; PALMER MS, 1989, NUCLEIC ACIDS RES, V17, P2353, DOI 10.1093/nar/17.6.2353; Plaksin D, 1997, J IMMUNOL, V158, P2218; REAY PA, 1994, J IMMUNOL, V152, P3946; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wedemayer GJ, 1997, SCIENCE, V277, P1423; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	50	270	279	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					357	365		10.1016/S1074-7613(00)80035-7	http://dx.doi.org/10.1016/S1074-7613(00)80035-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204491	Bronze			2022-12-18	WOS:000079455700008
J	Soong, L; Xu, JC; Grewal, IS; Kima, P; Sun, JR; Longley, BJ; Ruddle, NH; McMahonPratt, D; Flavell, RA				Soong, L; Xu, JC; Grewal, IS; Kima, P; Sun, JR; Longley, BJ; Ruddle, NH; McMahonPratt, D; Flavell, RA			Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection	IMMUNITY			English	Article							TRANSFORMING GROWTH FACTOR-BETA-1; L-ARGININE; MICE; AMASTIGOTES; EXPRESSION; ACTIVATION; MECHANISM; INDUCTION; ANTIBODY; MOUSE	To study the role of CD40 ligand (CD40L) in the host immune responses against intracellular pathogens, we infected CD40L knockout (CD40L(-/-)) mice with Leishmania amazonensis. Although wild-type mice were susceptible to infection and developed progressive ulcerative lesions, tissue parasite burdens in CD40L(-/-) mice were significantly higher. This heightened susceptibility to infection was associated with an impaired T cell and macrophage activation and altered inflammatory response, as reflected by low levels of IFN gamma, lymphotoxin-tumor necrosis factor (LT-TNF), and nitric oxide (NO) production. Furthermore, CD40L(-/-) mice failed to generate a protective immune response after immunization. These results indicate an essential role of cognate CD40-CD40L interactions in the generation of cellular immune responses against an intracellular parasite.	YALE UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, IMMUNOBIOL SECT, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, DEPT DERMATOL, NEW HAVEN, CT 06520 USA	Yale University; Yale University; Yale University				Grewal, Iqbal S/0000-0002-4775-055X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027811, R01AI023004, R21AI027811] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23004, AI27811] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; ARREDONDO B, 1979, INFECT IMMUN, V25, P16, DOI 10.1128/IAI.25.1.16-22.1979; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARRAL A, 1983, AM J TROP MED HYG, V32, P277, DOI 10.4269/ajtmh.1983.32.277; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; BARTEN DM, 1994, J NEUROIMMUNOL, V51, P123, DOI 10.1016/0165-5728(94)90074-4; BERMAN JD, 1988, REV INFECT DIS, V10, P560; CALABRESE KD, 1992, MEM I OSWALDO CRUZ, V87, P49, DOI 10.1590/S0074-02761992000500010; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; CHATELAIN R, 1992, J IMMUNOL, V148, P1182; DING A, 1990, J IMMUNOL, V145, P940; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; FINKELMAN FD, 1987, J IMMUNOL, V138, P2826; GREEN SJ, 1990, J IMMUNOL, V144, P278; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; HEINZEL FP, 1994, INFECT IMMUN, V62, P4244, DOI 10.1128/IAI.62.10.4244-4249.1994; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HOLLENBAUGH D, 1994, IMMUNOL REV, V138, P23, DOI 10.1111/j.1600-065X.1994.tb00845.x; HOWARD JG, 1980, J EXP MED, V152, P594, DOI 10.1084/jem.152.3.594; LAMAN JD, 1994, CURR OPIN IMMUNOL, V6, P636, DOI 10.1016/0952-7915(94)90153-8; LIEW FY, 1990, J IMMUNOL, V144, P4794; LOCKSLEY RM, 1991, IMMUNOPARASITOL TOD, pA58, DOI 10.1016/S0167-5699(05)80017-9; MOLL H, 1995, EUR J IMMUNOL, V25, P693, DOI 10.1002/eji.1830250310; MOORE KJ, 1993, J IMMUNOL, V150, P4457; MURRAY HW, 1995, J EXP MED, V181, P387, DOI 10.1084/jem.181.1.387; NELSON BJ, 1991, J IMMUNOL, V146, P1849; Ochs H D, 1994, Semin Immunol, V6, P337, DOI 10.1006/smim.1994.1042; PAN AA, 1988, J IMMUNOL, V140, P2406; PRESTON PM, 1979, T ROY SOC TROP MED H, V73, P212, DOI 10.1016/0035-9203(79)90215-3; PRINA E, 1993, J IMMUNOL, V151, P2050; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; SHU U, 1995, EUR J IMMUNOL, V25, P1125, DOI 10.1002/eji.1830250442; SOONG L, 1995, INFECT IMMUN, V63, P3559, DOI 10.1128/IAI.63.9.3559-3566.1995; Stout RD, 1996, J IMMUNOL, V156, P8; SUNDERKOTTER C, 1993, J IMMUNOL, V151, P4891; TASWELL C, 1981, J IMMUNOL, V126, P1614; TIAN LC, 1995, EUR J IMMUNOL, V25, P306, DOI 10.1002/eji.1830250152; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VIEIRA LQ, 1994, IMMUNOL LETT, V40, P157, DOI 10.1016/0165-2478(94)90187-2; WAGNER DH, 1994, EUR J IMMUNOL, V24, P3148, DOI 10.1002/eji.1830241235; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; WU Y, 1995, CURR BIOL, V5, P1303, DOI 10.1016/S0960-9822(95)00257-0; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	48	270	276	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1996	4	3					263	273		10.1016/S1074-7613(00)80434-3	http://dx.doi.org/10.1016/S1074-7613(00)80434-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624816	hybrid			2022-12-18	WOS:A1996UC01800007
J	Mansson, R; Hultquist, A; Luc, S; Yang, L; Anderson, K; Kharazi, S; Al-Hashmi, S; Liuba, K; Thoren, L; Adolfsson, J; Buza-Vidas, N; Qian, H; Soneji, S; Enver, T; Sigvardsson, M; Jacobsen, SEW				Mansson, Robert; Hultquist, Anne; Luc, Sidinh; Yang, Liping; Anderson, Kristina; Kharazi, Shabnam; Al-Hashmi, Suleiman; Liuba, Karina; Thoren, Lina; Adolfsson, Jorgen; Buza-Vidas, Natalija; Qian, Hong; Soneji, Shamit; Enver, Tariq; Sigvardsson, Mikael; Jacobsen, Sten Eirik W.			Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors	IMMUNITY			English	Article							LONG-TERM; B-CELL; HEMATOPOIETIC PROGENITORS; LYMPHOID PROGENITORS; IN-VITRO; DIFFERENTIATION; IDENTIFICATION; COMMITMENT; THROMBOPOIETIN; PRECURSORS	Recent studies implicated the existence of adult lymphoid-primed multipotent progenitors (LMPPs) with little or no megakaryocyte-erythroid potential, questioning common myeloid and lymphoid progenitors as obligate intermediates in hematopoietic stem cell (HSC) lineage commitment. However, the existence of LMPPs remains contentious. Herein, global and single-cell analyses revealed a hierarchical organization of transcriptional lineage programs, with downregulation of megakaryocyte-erythroid genes from HSCs to LMPPs, sustained granulocyte-monocyte priming, and upregulation of common lymphoid (but not B and T cell-specific) genes. These biological and molecular relationships, implicating almost mutual exclusion of megakaryocyte-erythroid and lymphoid pathways, are established already in fetal hematopoiesis, as evidenced by existence of LMPPs in fetal liver. The identification of LMPPs and hierarchically ordered transcriptional activation and downregulation of distinct lineage programs is compatible with a model for HSC lineage commitment in which the probability for undergoing different lineage commitment fates changes gradually when progressing from HSCs to LMPPs.	Lund Univ, Lund Strateg Res Ctr Stem Cell Biol, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England	Lund University; University of Oxford	Jacobsen, SEW (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Qian, Hong/D-5588-2014; Mansson, Robert/D-4372-2014; Jacobsen, Sten Eirik W/D-3974-2018	Qian, Hong/0000-0002-2512-9199; Mansson, Robert/0000-0003-0738-0328; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Luc, Sidinh/0000-0001-7006-6169; Sigvardsson, Mikael/0000-0001-8527-7276; Hultquist, Anne/0000-0003-4355-230X	Medical Research Council [MC_U137973817, G0501838] Funding Source: Medline; MRC [G0501838, MC_U137973817] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KAIHO SI, 1985, ANAL BIOCHEM, V149, P117, DOI 10.1016/0003-2697(85)90483-X; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Ogawa M, 2002, EXP HEMATOL, V30, P3, DOI 10.1016/S0301-472X(01)00770-6; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Tsapogas P, 2003, J LEUKOCYTE BIOL, V74, P102, DOI 10.1189/jlb.0103008; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	33	269	272	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					407	419		10.1016/j.immuni.2007.02.013	http://dx.doi.org/10.1016/j.immuni.2007.02.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17433729	Bronze			2022-12-18	WOS:000246126400007
J	Wu, BB; Crampton, SP; Hughes, CCW				Wu, Beibei; Crampton, Steve P.; Hughes, Christopher C. W.			Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BETA-CATENIN; ENDOTHELIAL-CELLS; TRANSENDOTHELIAL MIGRATION; EXTRACELLULAR-MATRIX; LYMPHOCYTE MIGRATION; FIBRILLAR COLLAGEN; EPITHELIAL-CELLS; GENE-EXPRESSION; BLOOD-VESSELS	Wnts are a family of secreted glycoproteins with diverse developmental roles, including regulation of cell migration; however, little is known about wnt signaling in mature T cells. We find that endothelial-cell-derived wnts, acting through Frizzled receptors, induce matrix metalloproteinase (MMP) 2 and MMP9 expression in effector T cells. Blocking wnt signaling, or MMP activity, reduces T cell migration through the basement membrane in vitro and into inflamed skin in vivo. Wnt signaling stabilizes beta-catenin protein in T cells and directly targets the MMP promoters through tandem TCF sites. Thus, our data support a necessary and previously unexpected role for wnt signaling in T cell extravasation.	Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Hughes, CCW (corresponding author), Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA.	cchughes@uci.edu	Wu, Beibei/B-7463-2011; Hughes, Christopher/F-7510-2010; Wu, Beibei/B-5169-2010		NIAID NIH HHS [R01 AI 40710, T32 AI 60573, R01 AI040710, T32 AI060573] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040710, T32AI060573] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Barker N, 2000, ADV CANCER RES, V77, P1; Cai Y, 2003, J PHARM PHARMACOL, V55, P691, DOI 10.1211/002235703765344612; Chenga CW, 2003, EXP CELL RES, V291, P415, DOI 10.1016/S0014-4827(03)00411-7; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Graesser D, 1998, LAB INVEST, V78, P1445; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Helary C, 2006, BIOMATERIALS, V27, P4443, DOI 10.1016/j.biomaterials.2006.04.005; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang ZF, 2006, J IMMUNOL, V176, P4880, DOI 10.4049/jimmunol.176.8.4880; HUGHES CCW, 1990, J EXP MED, V171, P1453, DOI 10.1084/jem.171.5.1453; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jolivet G, 2005, J CELL BIOCHEM, V95, P313, DOI 10.1002/jcb.20397; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kulidjian AA, 2002, INT IMMUNOL, V14, P751, DOI 10.1093/intimm/dxf045; Kumagai K, 1999, J IMMUNOL, V162, P4212; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Madri J A, 2000, Dev Immunol, V7, P103, DOI 10.1155/2000/79045; Madri JA, 1996, BIOCHEM CELL BIOL, V74, P749, DOI 10.1139/o96-082; Marchenko GN, 2002, BIOCHEM J, V363, P253, DOI 10.1042/0264-6021:3630253; Marchenko ND, 2004, INT J BIOCHEM CELL B, V36, P942, DOI 10.1016/j.biocel.2003.12.007; Marracci GH, 2002, J NEUROIMMUNOL, V131, P104, DOI 10.1016/S0165-5728(02)00269-2; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOON RT, 2002, CONNECTIONS MAP PATH; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; NUSSE R, 2002, WNT HOMEPAGE; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Pongracz JE, 2006, EUR J IMMUNOL, V36, P2376, DOI 10.1002/eji.200535721; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Romanic AM, 1997, LAB INVEST, V76, P11; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Steeber DA, 2000, IMMUNOL RES, V22, P299, DOI 10.1385/IR:22:2-3:299; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; TANAKA R, 1975, AM J PATHOL, V81, P467; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008	62	269	287	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					227	239		10.1016/j.immuni.2006.12.007	http://dx.doi.org/10.1016/j.immuni.2006.12.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17306568	Bronze, Green Accepted			2022-12-18	WOS:000244628600013
J	Shaffer, AL; Rosenwald, A; Hurt, EM; Giltnane, JM; Lam, LT; Pickeral, OK; Staudt, LM				Shaffer, AL; Rosenwald, A; Hurt, EM; Giltnane, JM; Lam, LT; Pickeral, OK; Staudt, LM			Signatures of the immune response	IMMUNITY			English	Review							NF-KAPPA-B; GERMINAL-CENTER FORMATION; GENE-EXPRESSION PATTERNS; DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTORS; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; PHOSPHORYLATION; DIFFERENTIATION; DISRUPTION	A compendium of global gene expression measurements from DNA microarray analysis of immune cells identifies gene expression signatures defining various lineages, differentiation stages, and signaling pathways. Germinal center (GC) B cells represent a discrete stage of differentiation with a unique gene expression signature. This includes genes involved in proliferation, as evidenced by high expression of G2/M phase regulators and low expression of ribosomal and metabolic genes that are transcriptional targets of c-myc. GC B cells also lack expression of the NF-kappaB signature genes, which may favor apoptosis. Finally, the transcriptional repression signature of BCL-6 reveals how this factor can prevent terminal differentiation of B cells and cause B cell lymphomas.	NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, NIH, 9000 Rockville Pike Blvd 10,Room 4N114, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Giltnane, Jennifer/D-2584-2013; Staudt, Louis/AAC-5324-2019					Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; Bauch A, 2000, ADV IMMUNOL, V75, P89, DOI 10.1016/S0065-2776(00)75002-4; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dimberg A, 2000, BLOOD, V96, P2870; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Guo QM, 2000, CANCER RES, V60, P5922; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; LAM LT, 2001, IN PRESS GENOME BIOL; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Ma C, 2001, PHILOS T ROY SOC B, V356, P83, DOI 10.1098/rstb.2000.0752; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Nyman TA, 2000, EUR J BIOCHEM, V267, P4011, DOI 10.1046/j.1432-1327.2000.01433.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Seebach FA, 2001, EXP MOL PATHOL, V70, P265, DOI 10.1006/exmp.2001.2361; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sherlock G, 2000, CURR OPIN IMMUNOL, V12, P201, DOI 10.1016/S0952-7915(99)00074-6; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stark G R, 1997, Harvey Lect, V93, P1; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Staudt LM, 2001, TRENDS IMMUNOL, V22, P35, DOI 10.1016/S1471-4906(00)01792-0; Taniguchi M, 2001, GENOMICS, V71, P34, DOI 10.1006/geno.2000.6427; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wong M, 2001, J BIOL CHEM, V276, P11427, DOI 10.1074/jbc.M010750200; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	57	269	277	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		375	385		10.1016/S1074-7613(01)00194-7	http://dx.doi.org/10.1016/S1074-7613(01)00194-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567628	Bronze			2022-12-18	WOS:000171211800005
J	Coughlin, CM; Salhany, KE; Gee, MS; LaTemple, DC; Kotenko, S; Ma, XJ; Gri, G; Wysocka, M; Kim, JE; Liu, L; Liao, F; Farber, JM; Pestka, S; Trinchieri, G; Lee, WMF				Coughlin, CM; Salhany, KE; Gee, MS; LaTemple, DC; Kotenko, S; Ma, XJ; Gri, G; Wysocka, M; Kim, JE; Liu, L; Liao, F; Farber, JM; Pestka, S; Trinchieri, G; Lee, WMF			Tumor cell responses to IFN gamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis	IMMUNITY			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; ANGIOGENESIS IN-VIVO; MESSENGER-RNA; INTERLEUKIN-12; ANTITUMOR; RECEPTOR; IDENTIFICATION; INHIBITION; EXPRESSION; LYMPHOCYTES	Expression of a dominant negative mutant IFN gamma R1 in murine SCK and K1735 tumor cells rendered them relatively unresponsive to IFN gamma in vitro and more tumorigenic and less responsive to IL-12 therapy in vivo. IL-12 induced histologic evidence of ischemic damage only in IFN gamma-responsive tumors, and in vivo Matrigel vascularization assays revealed that while IFN gamma-responsive and -unresponsive tumor cells induced angiogenesis equally well, IL-12 and its downstream mediator IFN gamma only inhibited angiogenesis induced by the responsive cells. IL-12 induced angiogenesis inhibitory activity in the responsive cells, which may be attributable to production of the chemokine IP-10. Thus, IL-12 and IFN gamma inhibit tumor growth by inducing tumor cells to generate antiangiogenic activity.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Biomed Grad Program, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA; Wistar Inst, Philadelphia, PA 19104 USA; PharMingen, San Diego, CA 92121 USA; NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lee, WMF (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.		Liao, Fang/S-7021-2018	GRI, Giorgia/0000-0002-2826-0459	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09140] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COUGHLIN CM, 1995, CANCER RES, V55, P4980; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; DAMELL JE, 1994, SCIENCE, V264, P1415; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; GATELY MK, 1992, CELL IMMUNOL, V143, P127, DOI 10.1016/0008-8749(92)90011-D; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; GRAY PW, 1989, P NATL ACAD SCI USA, V86, P8497, DOI 10.1073/pnas.86.21.8497; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kotenko SV, 1996, J BIOL CHEM, V271, P17174, DOI 10.1074/jbc.271.29.17174; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; KRIPKE ML, 1979, JNCI-J NATL CANCER I, V63, P541, DOI 10.1093/jnci/63.3.541; Kurzawa H, 1998, CANCER RES, V58, P491; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEHROTRA PT, 1993, J IMMUNOL, V151, P2444; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NASTALA CL, 1994, J IMMUNOL, V153, P1697; PASSANITI A, 1992, LAB INVEST, V67, P519; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; Schmitt M, 1997, INT J CANCER, V72, P505, DOI 10.1002/(SICI)1097-0215(19970729)72:3<505::AID-IJC20>3.0.CO;2-9; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Sgadari C, 1997, BLOOD, V89, P2635, DOI 10.1182/blood.V89.8.2635; SONG CW, 1994, BRIT J CANCER, V41, P309; STREITER RM, 1995, SHOCK, V4, P155; Tan J, 1996, CANCER RES, V56, P3399; TOWNSEND SE, 1994, CANCER RES, V54, P6477; VANGURI P, 1990, J BIOL CHEM, V265, P15049; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511	37	269	273	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	1998	9	1					25	34		10.1016/S1074-7613(00)80585-3	http://dx.doi.org/10.1016/S1074-7613(00)80585-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105HL	9697833	hybrid			2022-12-18	WOS:000075066600003
J	BAUR, AS; SAWAI, ET; DAZIN, P; FANTL, WJ; CHENGMAYER, C; PETERLIN, BM				BAUR, AS; SAWAI, ET; DAZIN, P; FANTL, WJ; CHENGMAYER, C; PETERLIN, BM			HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; RECEPTOR TYROSINE KINASES; OPEN READING FRAME; ANTIGEN RECEPTOR; SIGNAL TRANSDUCTION; TYPE-1 NEF; GENE-PRODUCTS; MUTATIONAL ANALYSIS; PROTEIN	Nef of primate lentiviruses is required for viremia and progression to AIDS in monkeys. Negative, positive, and no effects of Nef have also been reported on viral replication in cells. To reconcile these observations, we expressed a hybrid CD8-Nef protein in Jurkat cells. Two opposite phenotypes were found, which depended on the intracellular localization of Nef. Expressed in the cytoplasm or on the cell surface, the chimera inhibited or activated early signaling events from the T cell antigen receptor. Activated Jurkat cells died by apoptosis, and only cells with mutated nef genes expressing truncated Nefs survived, which rendered Nef nonfunctional. These mutations paralleled those in other viral strains passaged in vitro. Not only do these positional effects of Nef reconcile diverse phenotypes of Nef and suggest a role for its N-terminal myristylation, but they also explain effects of Nef in HIV infection and progression to AIDS.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT MICROBIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	BAUR, AS (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT MED,SAN FRANCISCO,CA 94143, USA.				PHS HHS [25284] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHAM RT, 1992, TRENDS BIOCHEM SCI, V17, P434, DOI 10.1016/0968-0004(92)90015-2; AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ALLAN JS, 1985, SCIENCE, V230, P810, DOI 10.1126/science.2997921; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; CHAN AC, 1992, CURR OPIN IMMUNOL, V4, P246, DOI 10.1016/0952-7915(92)90072-M; CHENGMAYER C, 1989, SCIENCE, V246, P1629, DOI 10.1126/science.2531920; Clark S J, 1993, Semin Immunol, V5, P149, DOI 10.1006/smim.1993.1018; CROMPTON T, 1992, BIOCHEM BIOPH RES CO, V183, P532, DOI 10.1016/0006-291X(92)90514-L; CULLEN BR, 1990, VIROLOGY, V178, P1, DOI 10.1016/0042-6822(90)90373-Y; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DE SK, 1994, J BIOL CHEM, V269, P6656; DELASSUS S, 1991, J VIROL, V65, P225, DOI 10.1128/JVI.65.1.225-231.1991; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; Green D R, 1992, Semin Immunol, V4, P379; GUY B, 1990, VIROLOGY, V176, P413, DOI 10.1016/0042-6822(90)90011-F; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HAMMES SR, 1989, P NATL ACAD SCI USA, V86, P9549, DOI 10.1073/pnas.86.23.9549; HANAFUSA H, 1989, RETROVIRUSES DISEASE, P40; HARDIN JA, 1992, J IMMUNOL METHODS, V154, P99, DOI 10.1016/0022-1759(92)90217-H; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JUNE CH, 1990, J IMMUNOL, V144, P1591; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; KAMPS MP, 1986, CELL, V45, P105, DOI 10.1016/0092-8674(86)90542-8; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIENZLE N, 1993, EUR J BIOCHEM, V214, P451, DOI 10.1111/j.1432-1033.1993.tb17941.x; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LUCIW PA, 1987, P NATL ACAD SCI USA, V84, P1434, DOI 10.1073/pnas.84.5.1434; LURIA S, 1991, P NATL ACAD SCI USA, V88, P5326, DOI 10.1073/pnas.88.12.5326; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; MUNIS JR, 1992, J GEN VIROL, V73, P1899, DOI 10.1099/0022-1317-73-8-1899; MURPHY KM, 1993, J VIROL, V67, P6956, DOI 10.1128/JVI.67.12.6956-6964.1993; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; MYERS G, 1993, HUMAN RETROVIRUSES A; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; NIEDERMAN TMJ, 1993, VIROLOGY, V197, P420, DOI 10.1006/viro.1993.1605; NIEDERMAN TMJ, 1992, J VIROL, V66, P6213, DOI 10.1128/JVI.66.10.6213-6219.1992; NIEDERMAN TMJ, 1993, VIROLOGY, V194, P338, DOI 10.1006/viro.1993.1264; OHMICHI M, 1992, J BIOL CHEM, V267, P21601; ORMEROD MG, 1992, J IMMUNOL METHODS, V153, P57, DOI 10.1016/0022-1759(92)90305-D; PARKIN NT, 1993, GENE DEV, V7, P2181, DOI 10.1101/gad.7.11.2181; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; RATNER L, 1985, NUCLEIC ACIDS RES, V13, P8219, DOI 10.1093/nar/13.22.8219; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SAWAI ET, 1994, P NATL ACAD SCI USA, V91, P1539, DOI 10.1073/pnas.91.4.1539; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; TERWILLIGER E, 1986, J VIROL, V60, P754, DOI 10.1128/JVI.60.2.754-760.1986; TERWILLIGER EF, 1991, P NATL ACAD SCI USA, V88, P10971, DOI 10.1073/pnas.88.23.10971; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; YU G, 1992, VIROLOGY, V187, P46, DOI 10.1016/0042-6822(92)90293-X; ZAZOPOULOS E, 1993, VIROLOGY, V194, P20, DOI 10.1006/viro.1993.1230	73	269	271	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					373	384		10.1016/1074-7613(94)90068-X	http://dx.doi.org/10.1016/1074-7613(94)90068-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882168				2022-12-18	WOS:A1994PK16800006
J	Kurtulus, S; Madi, A; Escobar, G; Klapholz, M; Nyman, J; Christian, E; Pawlak, M; Dionne, D; Xia, JR; Rozenblatt-Rosen, O; Kuchroo, VK; Regev, A; Anderson, AC				Kurtulus, Sema; Madi, Asaf; Escobar, Giulia; Klapholz, Max; Nyman, Jackson; Christian, Elena; Pawlak, Mathias; Dionne, Danielle; Xia, Junrong; Rozenblatt-Rosen, Orit; Kuchroo, Vijay K.; Regev, Aviv; Anderson, Ana C.			Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1(-)CD8(+) Tumor-Infiltrating T Cells	IMMUNITY			English	Article							SET ENRICHMENT ANALYSIS; DIFFERENTIAL EXPRESSION; BIOCONDUCTOR PACKAGE; METASTATIC MELANOMA; PD-1 EXPRESSION; CD8; TIM-3; EXHAUSTION; RESPONSES; THERAPY	An improved understanding of the anti-tumor CD8(+) T cell response after checkpoint blockade would enable more informed and effective therapeutic strategies. Here we examined the dynamics of the effector response of CD8(+) tumor-infiltrating lymphocytes (TILs) after checkpoint blockade therapy. Bulk and single-cell RNA profiles of CD8(+) TILs after combined Tim-3+PD-1 blockade in preclinical models revealed significant changes in the transcriptional profile of PD-1(-)TILs. These cells could be divided into subsets bearing characterstics of naive-, effector-, and memory-precursor-like cells. Effector- and memory-precursor-like TILs contained tumor-antigen-specific cells, exhibited proliferative and effector capacity, and expanded in response to different checkpoint blockade therapies across different tumor models. The memory-precursor-like subset shared features with CD8(+) T cells associated with response to checkpoint blockade in patients and was compromised in the absence of Tcf7. Expression of Tcf7/Tcf1 was requisite for the efficacy of diverse immunotherapies, highlighting the importance of this transcriptional regulator in the development of effective CD8(+) T cell responses upon immunotherapy.	[Kurtulus, Sema; Madi, Asaf; Escobar, Giulia; Klapholz, Max; Pawlak, Mathias; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Kurtulus, Sema; Madi, Asaf; Escobar, Giulia; Klapholz, Max; Pawlak, Mathias; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Kurtulus, Sema; Madi, Asaf; Escobar, Giulia; Klapholz, Max; Pawlak, Mathias; Xia, Junrong; Kuchroo, Vijay K.; Anderson, Ana C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Madi, Asaf] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Tel Aviv, Israel; [Nyman, Jackson; Christian, Elena; Dionne, Danielle; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Koch Inst, Dept Biol, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Ludwig Ctr, Cambridge, MA 02142 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Kuchroo, VK; Anderson, AC (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK; Anderson, AC (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Kuchroo, VK; Anderson, AC (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Koch Inst, Dept Biol, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Ludwig Ctr, Cambridge, MA 02142 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	vkuchroo@evergrande.hms.harvard.edu; aregev@broadinstitute.org; acanderson@bwh.harvard.edu	Anderson, Ana C/ABD-6829-2021; Escobar, Giulia/AFD-7497-2022; Rozenblatt-Rosen, Orit/HDN-4182-2022	Anderson, Ana C/0000-0002-0877-2932; Madi, Asaf/0000-0003-3441-3228; Escobar, Giulia/0000-0001-9177-0251; Christian, Elena/0000-0002-5593-0155; Klapholz, Max/0000-0001-6527-8722; Nyman, Jackson/0000-0001-6151-6930; Dionne, Danielle/0000-0002-8338-4323; Pawlak, Mathias/0000-0002-4533-398X	National Institutes of Health [R01NS045937, P01AI073748, R01CA187975]; American Cancer Society [RSG-11-057-01-LIB]; Klarman Cell Observatory at the Broad Institute; Klarman Cell Observatory at the HHMI; EMBO long-term fellowship; NATIONAL CANCER INSTITUTE [R01CA187975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Klarman Cell Observatory at the Broad Institute; Klarman Cell Observatory at the HHMI; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Mary Collins for comments on this manuscript, Deneen Kozoriz for cell sorting, Samantha Riesenfeld for computational advice, and Sigrid Knemeyer and Leslie Gaffney for help in figure preparation. IM0-2125 was obtained from Idera Pharmaceuticals under an MTA. This work was supported by grants from the National Institutes of Health (R01NS045937 to V.K.K., P01AI073748 to V.K.K. and A.C.A., R01CA187975 to A.C.A.), the American Cancer Society (RSG-11-057-01-LIB to A.C.A.), by the Klarman Cell Observatory at the Broad Institute and HHMI, and by an EMBO long-term fellowship (to G.E.). A.R. is an Investigator of the Howard Hughes Medical Institute.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahn E, 2016, J VIROL, V90, P8934, DOI 10.1128/JVI.00798-16; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; da Silva IP, 2014, CANCER IMMUNOL RES, V2, P410, DOI 10.1158/2326-6066.CIR-13-0171; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Haymaker CL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014246; Hervas-Stubbs S, 2010, EUR J IMMUNOL, V40, P3389, DOI 10.1002/eji.201040664; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jiang XW, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1211219; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kolde Raivo, 2015, F1000Res, V4, P574, DOI 10.12688/f1000research.6925.1; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YF, 2010, J IMMUNOL, V184, P452, DOI 10.4049/jimmunol.0901101; Lim TS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1085146; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Makowska Z, 2013, J HEPATOL, V58, P743, DOI 10.1016/j.jhep.2012.11.038; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishino M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0193-2; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Der Maaten Laurens, 2009, ARTIF INTELL, P384; Wang X, 2014, BIOINFORMATICS, V30, P1777, DOI 10.1093/bioinformatics/btu090; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xu BL, 2015, ONCOTARGET, V6, P20592, DOI 10.18632/oncotarget.4112; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	68	268	275	5	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					181	+		10.1016/j.immuni.2018.11.014	http://dx.doi.org/10.1016/j.immuni.2018.11.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30635236	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000455661600019
J	Falkowska, E; Le, KM; Ramos, A; Doores, KJ; Lee, JH; Blattner, C; Ramirez, A; Derking, R; van Gils, MJ; Liang, CH; Mcbride, R; von Bredow, B; Shivatare, SS; Wu, CY; Chan-Hui, PY; Liu, Y; Feizi, T; Zwick, MB; Koff, WC; Seaman, MS; Swiderek, K; Moore, JP; Evans, D; Paulson, JC; Wong, CH; Ward, AB; Wilson, IA; Sanders, RW; Poignard, P; Burton, DR				Falkowska, Emilia; Le, Khoa M.; Ramos, Alejandra; Doores, Katie J.; Lee, Jeong Hyun; Blattner, Claudia; Ramirez, Alejandro; Derking, Ronald; van Gils, Marit J.; Liang, Chi-Hui; Mcbride, Ryan; von Bredow, Benjamin; Shivatare, Sachin S.; Wu, Chung-Yi; Chan-Hui, Po-Ying; Liu, Yan; Feizi, Ten; Zwick, Michael B.; Koff, Wayne C.; Seaman, Michael S.; Swiderek, Kristine; Moore, John P.; Evans, David; Paulson, James C.; Wong, Chi-Huey; Ward, Andrew B.; Wilson, Ian A.; Sanders, Rogier W.; Poignard, Pascal; Burton, Dennis R.			Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; SITE-SPECIFIC ANALYSIS; CD4 BINDING-SITE; POTENT NEUTRALIZATION; GLYCOPROTEIN; GP120; VACCINE; DESIGN; COMBINATION; RECOGNITION	Broadly neutralizing HIV antibodies are much sought after (a) to guide vaccine design, both as templates and as indicators of the authenticity of vaccine candidates, (b) to assist in structural studies, and (c) to serve as potential therapeutics. However, the number of targets on the viral envelope spike for such antibodies has been limited. Here, we describe a set of human monoclonal antibodies that define what is, to the best of our knowledge, a previously undefined target on HIV Env. The antibodies recognize a glycan-dependent epitope on the prefusion conformation of gp41 and unambiguously distinguish cleaved from uncleaved Env trimers, an important property given increasing evidence that cleavage is required for vaccine candidates that seek to mimic the functional HIV envelope spike. The availability of this set of antibodies expands the number of vaccine targets on HIV and provides reagents to characterize the native envelope spike.	[Falkowska, Emilia; Le, Khoa M.; Ramos, Alejandra; Doores, Katie J.; Ramirez, Alejandro; Liang, Chi-Hui; Zwick, Michael B.; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Falkowska, Emilia; Le, Khoa M.; Ramos, Alejandra; Doores, Katie J.; Lee, Jeong Hyun; Blattner, Claudia; Liang, Chi-Hui; Ward, Andrew B.; Wilson, Ian A.; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat, La Jolla, CA 92037 USA; [Falkowska, Emilia; Le, Khoa M.; Lee, Jeong Hyun; Blattner, Claudia; Liang, Chi-Hui; Ward, Andrew B.; Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Lee, Jeong Hyun; Blattner, Claudia; Paulson, James C.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mcbride, Ryan] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Mcbride, Ryan] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Falkowska, Emilia; Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Falkowska, Emilia; Burton, Dennis R.] Harvard, Boston, MA 02114 USA; [Doores, Katie J.] Kings Coll London, Guys Hosp, Sch Med, Dept Infect Dis, London SE1 9RT, England; [Derking, Ronald; van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [von Bredow, Benjamin] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA; [Shivatare, Sachin S.; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chan-Hui, Po-Ying; Swiderek, Kristine] Theraclone Sci Inc, Seattle, WA 98104 USA; [Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 ONN, England; [Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, New York, NY 10004 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Wisconsin System; University of Wisconsin Madison; Academia Sinica - Taiwan; Imperial College London; International AIDS Vaccine Initiative; Harvard University; Beth Israel Deaconess Medical Center; Cornell University	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA.	burton@scripps.edu	Ward, Andrew B/F-9203-2014; Shivatare, Sachin S/G-7264-2017; poignard, pascal/N-6678-2013; van Gils, Marit J./H-4791-2019; McBride, Ryan/E-6812-2011; poignard, pascal/AAB-4613-2020; Ward, Andrew/ABD-7728-2021; Paulson, James/AAG-3565-2019; Wu, Chung-Yi/K-8334-2018; Liu, Yan/D-9117-2013	Ward, Andrew B/0000-0001-7153-3769; Shivatare, Sachin S/0000-0002-7512-752X; van Gils, Marit J./0000-0003-3422-8161; Ward, Andrew/0000-0001-7153-3769; Doores, Katie/0000-0002-5507-1725; Feizi, Ten/0000-0001-6495-0329; Liu, Yan/0000-0002-2566-6867; Lee, Jeong Hyun/0000-0001-7371-845X; Poignard, Pascal/0000-0002-0021-7192; von Bredow, Benjamin/0000-0001-8924-2193	IAVI through the NAC; NIH [AI33232, AI098484, AI095098]; CHAVI-ID [UM1AI100663]; Ragon Institute; AIDS fonds Netherlands [2011032, 2012041]; HIVRAD [P01 AI82362]; DAAD; CA HIV/AIDS Research Program; Vidi grant NWO [ERC-StG-2011-280829-SHEV]; NSC [101-CDA-L07, 101-2321-B-001-024, 102-2321-B-001-017]; CFG glycan microarrays [GM62116, GM098791]; Bill & Melinda Gates Foundation; United States Agency for International Development (USAID);  [AI69993];  [AI98602];  [T32 AI007244];  [GRS/79268];  [EP/G037604/1];  [WT093378MA];  [WT099197MA];  [U01 CA128416]; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA128416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI098484, R01AI033292, R01AI095098, R37AI095098, UM1AI100663, R01AI114401, P01AI082362, R01AI098602, T32AI007244, R01AI069993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791, U54GM062116] Funding Source: NIH RePORTER	IAVI through the NAC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHAVI-ID; Ragon Institute; AIDS fonds Netherlands; HIVRAD; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); CA HIV/AIDS Research Program; Vidi grant NWO; NSC(Ministry of Science and Technology, Taiwan); CFG glycan microarrays; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); ; ; ; ; ; ; ; ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by IAVI through the NAC (D.R.B., P.P., I.A.W., A.B.W., and J.P.M.), NIH grant AI33232 (D.R.B.), the CHAVI-ID UM1AI100663 (D.R.B., I.A.W., A.B.W.), and The Ragon Institute (D.R.B. and E.F.); the AIDS fonds Netherlands, grants 2011032 (R.D.) and 2012041 (M.J.v.G.); HIVRAD, grant P01 AI82362 (J.P.M.); NIH R01 numbers AI098484 and AI095098 (D.E.); a DAAD Research fellowship (C.B.); a Dissertation Fellowship from the CA HIV/AIDS Research Program (J.H.L); a Vidi grant NWO and ERC-StG-2011-280829-SHEV (R.W.S.); grant numbers 101-CDA-L07 (CYW), NSC 101-2321-B-001-024, and NSC 102-2321-B-001-017 (C.H.W. and C.Y.W.); AI69993 and AI98602 (M.B.Z.) and T32 AI007244 (A. Ramirez); and GRS/79268, EP/G037604/1, WT093378MA, WT099197MA, and U01 CA128416 (T.F.). GM62116 and GM098791 supported the CFG glycan microarrays. The work of the International AIDS Vaccine Initiative is made possible by generous support from many donors, including the Bill & Melinda Gates Foundation and the United States Agency for International Development (USAID). We thank A. Cuevas, D. Parton, J. Russell, A. Cupo, J. Korzun, and P.J. Klasse for technical assistance and/or advice and C. Corbaci for her help in figure preparation.	Alpert M. D., 2012, J VIROL, V86, P11955; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; BUCHACHER A, 1992, VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P191; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI [10.1089/aid.2010.0281, 10.1089/AID.2010.0281]; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Ferguson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080562; Go EP, 2008, J PROTEOME RES, V7, P1660, DOI 10.1021/pr7006957; Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kulp DW, 2013, CURR OPIN VIROL, V3, P322, DOI 10.1016/j.coviro.2013.05.010; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liang CH, 2011, ANGEW CHEM INT EDIT, V50, P1608, DOI 10.1002/anie.201003482; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shiyatare SS, 2013, J AM CHEM SOC, V135, P15382, DOI 10.1021/ja409097c; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	60	268	309	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					657	668		10.1016/j.immuni.2014.04.009	http://dx.doi.org/10.1016/j.immuni.2014.04.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24768347	Green Accepted, Bronze			2022-12-18	WOS:000336026100006
J	Groom, JR; Richmond, J; Murooka, TT; Sorensen, EW; Sung, JH; Bankert, K; von Andrian, UH; Moon, JJ; Mempel, TR; Luster, AD				Groom, Joanna R.; Richmond, Jillian; Murooka, Thomas T.; Sorensen, Elizabeth W.; Sung, Jung Hwan; Bankert, Katherine; von Andrian, Ulrich H.; Moon, James J.; Mempel, Thorsten R.; Luster, Andrew D.			CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4(+) T Helper 1 Cell Differentiation	IMMUNITY			English	Article							T-CELLS; DENDRITIC CELLS; IFN-GAMMA; CLASS-II; EXPRESSION; EFFECTOR; ANTIGEN; LYMPHOCYTES; RECRUITMENT; FREQUENCY	Differentiation of naive CD4(+) T cells into T helper (Th) cells is a defining event in adaptive immunity. The cytokines and transcription factors that control Th cell differentiation are understood, but it is not known how this process is orchestrated within lymph nodes (LNs). Here we have shown that the CXCR3 chemokine receptor was required for optimal generation of interferon-gamma (IFN-gamma)-secreting Th1 cells in vivo. By using a CXCR3 ligand reporter mouse, we found that stromal cells predominately expressed the chemokine ligand CXCL9 whereas hematopoietic cells expressed CXCL10 in LNs. Dendritic cell (DC)derived CXCL10 facilitated T cell-DC interactions in LNs during T cell priming while both chemokines guided intranodal positioning of CD4(+) T cells to interfollicular and medullary zones. Thus, different chemokines acting on the same receptor can function locally to facilitate DC-T cell interactions and globally to influence intranodal positioning, and both functions contribute to Th1 cell differentiation.	[Groom, Joanna R.; Richmond, Jillian; Murooka, Thomas T.; Sorensen, Elizabeth W.; Bankert, Katherine; Moon, James J.; Mempel, Thorsten R.; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02114 USA; [Sung, Jung Hwan; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Sung, Jung Hwan; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Luster, AD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02114 USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Richmond, Jillian/AFO-1248-2022; von Andrian, Ulrich H/A-5775-2008; moon, james/F-1031-2014	Luster, Andrew/0000-0001-9679-7912; Richmond, Jillian/0000-0003-1589-6770; Sorensen, Elizabeth/0000-0001-8632-6658; Groom, Joanna/0000-0001-5251-7835; Murooka, Thomas/0000-0002-3030-2726; moon, james/0000-0001-8071-1491	NIH [CA069212, A1078897]; NHMRC, Australia [516791]; Samsung Scholarship; NATIONAL CANCER INSTITUTE [R01CA150975, R01CA069212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI069259, P01AI078897, T32AI007387, U19AI095261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); Samsung Scholarship(Samsung); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was supported by the NIH grants CA069212 (to A.D.L.) and A1078897 (to U.H.v.A.). J.R.G. was supported by the NH&MRC, Australia (Fellowship 516791). J.H.S. was supported by a Samsung Scholarship. We thank D. Alvarez for assistance with LCMV infections, J. Farber for the Cxcl9<SUP>-/-</SUP> breeding breeding pair, and C. Gerard for the Cxcr3<SUP>-/-</SUP> breeding pair.	Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; GATTASS CR, 1994, J EXP MED, V179, P1373, DOI 10.1084/jem.179.4.1373; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Hugues S, 2010, SEMIN IMMUNOPATHOL, V32, P227, DOI 10.1007/s00281-010-0211-2; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rabin RL, 1999, J IMMUNOL, V162, P3840; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Varga SM, 2000, J VIROL, V74, P4429, DOI 10.1128/JVI.74.9.4429-4432.2000; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	268	274	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1091	1103		10.1016/j.immuni.2012.08.016	http://dx.doi.org/10.1016/j.immuni.2012.08.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23123063	Bronze, Green Accepted			2022-12-18	WOS:000312575000016
J	Ahrens, S; Zelenay, S; Sancho, D; Hanc, P; Kjaer, S; Feest, C; Fletcher, G; Durkin, C; Postigo, A; Skehel, M; Batista, F; Thompson, B; Way, M; Sousa, CRE; Schulz, O				Ahrens, Susan; Zelenay, Santiago; Sancho, David; Hanc, Pavel; Kjaer, Svend; Feest, Christoph; Fletcher, Georgina; Durkin, Charlotte; Postigo, Antonio; Skehel, Mark; Batista, Facundo; Thompson, Barry; Way, Michael; Sousa, Caetano Reis e; Schulz, Oliver			F-Actin Is an Evolutionarily Conserved Damage-Associated Molecular Pattern Recognized by DNGR-1, a Receptor for Dead Cells	IMMUNITY			English	Article							C-TYPE LECTIN; INFLAMMATORY RESPONSE; DENDRITIC CELLS; IMMUNE-SYSTEM; DANGER; MOVEMENT; CLEC9A	Sterile inflammation can be initiated by innate immune recognition of markers of tissue injury termed damage-associated molecular patterns (DAMPs). DAMP recognition by dendritic cells (DCs) has also been postulated to lead to T cell responses to foreign antigens in tumors or allografts. Many DAMPs represent intracellular contents that are released upon cell damage, notably after necrosis. In this regard, we have previously described DNGR-1 (CLEC9A) as a DC-restricted receptor specific for an unidentified DAMP that is exposed by necrotic cells and is necessary for efficient priming of cytotoxic T cells against dead cell-associated antigens. Here, we have shown that the DNGR-1 ligand is preserved from yeast to man and corresponds to the F-actin component of the cellular cytoskeleton. The identification of F-actin as a DNGR-1 ligand suggests that cytoskeletal exposure is a universal sign of cell damage that can be targeted by the innate immune system to initiate immunity.	[Ahrens, Susan; Zelenay, Santiago; Hanc, Pavel; Sousa, Caetano Reis e; Schulz, Oliver] Lincolns Inn Fields Labs, London Res Inst, Immunobiol Lab, London WC2A 3LY, England; [Feest, Christoph; Batista, Facundo] Lincolns Inn Fields Labs, London Res Inst, Lymphocyte Interact Lab, London WC2A 3LY, England; [Fletcher, Georgina; Thompson, Barry] Lincolns Inn Fields Labs, London Res Inst, Epithelial Biol Lab, London WC2A 3LY, England; [Durkin, Charlotte; Postigo, Antonio; Way, Michael] Lincolns Inn Fields Labs, London Res Inst, Cell Motil Lab, London WC2A 3LY, England; [Skehel, Mark] Lincolns Inn Fields Labs, London Res Inst, Protein Anal & Prote Lab, London WC2A 3LY, England; [Sancho, David] CNIC Ctr Nacl lnvest Cardiovasc Carlos III, Dept Vasc Biol & Inflammat, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Sousa, CRE (corresponding author), Lincolns Inn Fields Labs, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/O-1657-2014; Sancho, David/D-3433-2009; Feest, Christoph/C-7874-2013; Reis e Sousa, Caetano/ABD-7322-2021	Reis e Sousa, Caetano/0000-0001-7392-2119; Sancho, David/0000-0003-2890-3984; Feest, Christoph/0000-0002-0772-7267; Reis e Sousa, Caetano/0000-0001-7392-2119; Zelenay, Santiago/0000-0002-6865-3978; Way, Michael/0000-0001-7207-2722; Thompson, Barry/0000-0002-0103-040X; Schulz, Oliver/0000-0002-1493-3341; Hanc, Pavel/0000-0002-0511-5566	Cancer Research UK; Fondation Bettencourt-Schueller; European Research Council (ERG) [AdG-2010-268670]; Cancer Research UK [15689, 15155] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fondation Bettencourt-Schueller; European Research Council (ERG)(European Research Council (ERC)); Cancer Research UK(Cancer Research UK)	We thank R. Karlsson for providing yeast actin. We are grateful to L. Collinson, H. Armer, M. Howell, R. Mori, L. Lopez-Serra, A. Fennell, and I. Jourdain for assistance with experiments. We thank R. Treisman, G. Superti-Furga, A. Pichlmair, K. Bennett, and members of the Immunobiology Laboratory for helpful discussions and suggestions. Work at the London Research Institute is funded by Cancer Research UK. C.R.S. acknowledges additional support in the form of a prize from Fondation Bettencourt-Schueller and a grant from the European Research Council (ERG Advanced Researcher Grant AdG-2010-268670).	Alberts B., 2002, MOL BIOL CELL, V4th edition; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dahl B, 2003, CRIT CARE MED, V31, P152, DOI 10.1097/00003246-200301000-00024; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LEE WM, 1992, NEW ENGL J MED, V326, P1335; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Zelenay S., 2012, J CLIN INVE IN PRESS	23	268	281	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					635	645		10.1016/j.immuni.2012.03.008	http://dx.doi.org/10.1016/j.immuni.2012.03.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22483800	Bronze			2022-12-18	WOS:000303223900015
J	Pulendran, B; Li, SZ; Nakaya, HI				Pulendran, Bali; Li, Shuzhao; Nakaya, Helder I.			Systems Vaccinology	IMMUNITY			English	Review							YELLOW-FEVER VIRUS; GENE-EXPRESSION PATTERNS; VARICELLA-ZOSTER-VIRUS; INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; CD8(+) T-CELLS; DENDRITIC CELLS; NALP3 INFLAMMASOME; IN-VIVO; B-CELLS	Vaccination is one of the greatest triumphs of modern medicine, yet we remain largely ignorant of the mechanisms by which successful vaccines stimulate protective immunity Two recent advances are beginning to illuminate such mechanisms realization of the pivotal role of the innate immune system in sensing microbes and stimulating adaptive immunity, and advances in systems biology Recent studies have used systems biology approaches to obtain a global picture of the immune responses to vaccination in humans This has enabled the identification of early innate signatures that predict the immunogenicity of vaccines, and identification of potentially novel mechanisms of immune regulation Here, we review these advances and critically examine the potential opportunities and challenges posed by systems biology in vaccine development	[Pulendran, Bali; Li, Shuzhao; Nakaya, Helder I.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Emory University	Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.		Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020	Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Li, Shuzhao/0000-0002-7386-2539; Pulendran, Bali/0000-0001-6517-4333	NIAID NIH HHS [R38 AI140299, U19 AI090023] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2001, NAT IMMUNOL, V2, P373, DOI 10.1038/87665; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ANDREONI J, 1993, J INFECT DIS, V168, P227, DOI 10.1093/infdis/168.1.227; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Brenner S, 1997, CURR BIOL, V7, pR58, DOI 10.1016/S0960-9822(06)00031-5; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; DAVIES K, 2008, BIO IT WORLD MAG MAY; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; DOWDLE WR, 1973, POSTGRAD MED J, V49, P159, DOI 10.1136/pgmj.49.569.159; EIN DL, 2006, P NATL ACAD SCI USA, V103, P5923; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; IPSEN J, 1946, J IMMUNOL, V54, P325; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; LOONEY JM, 1956, NEW ENGL J MED, V254, P6, DOI 10.1056/NEJM195601052540102; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; MOSTOW SR, 1973, POSTGRAD MED J, V49, P152, DOI 10.1136/pgmj.49.569.152; Nagarajan T, 2008, CURR TOP MICROBIOL, V317, P67; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; *NAT I ALL INF DIS, 2010, NIH LAUNCH EFF DEF M; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; OUEREC T, 2006, J EXP MED, V203, P413; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; REYES SA, 2009, CURR OPIN MOL THER, V11, P72; Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; SHEN OSS, 2010, NAT METHODS, V7, P287; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Tong JC, 2009, DRUG DISCOV TODAY, V14, P684, DOI 10.1016/j.drudis.2009.04.001; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; Van Damme Pierre, 2007, Travel Med Infect Dis, V5, P79, DOI 10.1016/j.tmaid.2006.04.004; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; WHEELOCK EF, 1965, NEW ENGL J MED, V273, P194, DOI 10.1056/NEJM196507222730404; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	99	268	274	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					516	529		10.1016/j.immuni.2010.10.006	http://dx.doi.org/10.1016/j.immuni.2010.10.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029962	Green Accepted, Bronze			2022-12-18	WOS:000284300200008
J	Meng, GX; Zhang, FP; Fuss, I; Kitani, A; Strober, W				Meng, Guangxun; Zhang, Fuping; Fuss, Ivan; Kitani, Atsushi; Strober, Warren			A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses	IMMUNITY			English	Article							IL-17-PRODUCING T-CELLS; NEUTROPHIL RECRUITMENT; CIAS1 MUTATIONS; INTERLEUKIN-1-BETA SECRETION; CASPASE-1 INFLAMMASOME; RHEUMATOID-ARTHRITIS; NALP3 INFLAMMASOME; CYTOKINE MILIEU; T(H)17 CELLS; TGF-BETA	Missense mutations of the gene encoding NLRP3 are associated with autoinflammatory disorders characterized with excessive production of interleukin-1 beta (IL-1 beta). Here we analyzed the immune responses of gene-targeted mice carrying a mutation in the Nlrp3 gene equivalent to the human mutation associated with Muckle-Wells Syndrome. We found that antigen-presenting cells (APCs) from such mice produced massive amounts of IL-1 beta upon stimulation with microbial stimuli in the absence of ATP. This was likely due to a diminished inflammasome activation threshold that allowed a response to the small amount of agonist. Moreover, the Nlrp3 gene-targeted mice exhibited skin inflammation characterized by neutrophil infiltration and a Th17 cytokine-dominant response, which originated from hematopoietic cells. The inflammation of Nlrp3 gene-targeted mice resulted from excess IL-1 beta production from APCs, which augmented Th17 cell differentitation. These results demonstrate that the NLRP3 mutation leads to inflammasome hyperactivation and consequently Th17 cell-dominant immunopathology in autoinflammation.	[Meng, Guangxun; Zhang, Fuping; Fuss, Ivan; Kitani, Atsushi; Strober, Warren] NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bldg 10-CRC,Room 5W3890,10 Ctr Dr, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov		孟, 广勋/0000-0002-4253-9675	Intramural NIH HHS [NIH0011985623] Funding Source: Medline; PHS HHS [NIH0011985623] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000354, ZIAAI000354] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Chabaud M, 1998, J IMMUNOL, V161, P409; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Granet C, 2004, ARTHRITIS RES THER, V6, pR190, DOI 10.1186/ar1159; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shen XI, 2000, BIOCHEM J, V352, P913, DOI 10.1042/0264-6021:3520913; Spiller S, 2007, J BIOL CHEM, V282, P13190, DOI 10.1074/jbc.M610340200; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	49	268	275	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					860	874		10.1016/j.immuni.2009.04.012	http://dx.doi.org/10.1016/j.immuni.2009.04.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19501001	Green Accepted, Bronze			2022-12-18	WOS:000267270700013
J	Iwasaki, H; Akashi, K				Iwasaki, Hirorni; Akashi, Koichi			Myeloid lineage commitment from the hematopoietic stem cell	IMMUNITY			English	Review							TRANSCRIPTION FACTOR GATA-1; COLONY-STIMULATING FACTOR; RECEPTOR-DEFICIENT MICE; COMMON LYMPHOID PROGENITORS; GREEN FLUORESCENT PROTEIN; SELF-RENEWAL CAPACITY; NATURAL-KILLER-CELLS; DENDRITIC CELLS; BONE-MARROW; LONG-TERM	Prospective isolation of hematopoietic stem and progenitor cells has identified the lineal relationships among all blood-cell types and has allowed their developmental mechanisms to be assayed at the single-cell level. These isolated cell populations are used to elucidate the molecular mechanism of lineage fate decision and of its plasticity directly by stage-specific enforcement or repression of lineage-instructive signaling in purified cells. With an emphasis on the myeloid lineage, this review summarizes current concepts and controversies regarding adult murine hematopoietic development and discusses the potential mechanisms, operated by single or by multiple transcription factors, of myeloid lineage fate decision.	Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Akashi, K (corresponding author), Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan.	koichi_akashi@dfci.harvard.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Berger Shelley L., 2001, Molecular Cell, V8, P263, DOI 10.1016/S1097-2765(01)00330-6; BHATIA SK, 1995, J EXP MED, V181, P1399, DOI 10.1084/jem.181.4.1399; Bonifer C, 2005, CELL CYCLE, V4, P211; Borge OJ, 1999, BLOOD, V94, P3781, DOI 10.1182/blood.V94.11.3781.423k04_3781_3790; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; CHEN HM, 1995, ONCOGENE, V11, P1549; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Faust N, 2000, BLOOD, V96, P719; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; GRAF T, 1992, CELL, V70, P201, DOI 10.1016/0092-8674(92)90096-U; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2001, BLOOD, V97, P2680, DOI 10.1182/blood.V97.9.2680; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kaufmann C, 2003, EMBO J, V22, P2211, DOI 10.1093/emboj/cdg186; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kontaraki J, 2000, GENE DEV, V14, P2106; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Moritz DR, 1998, J IMMUNOL, V161, P4866; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Nakao M, 1996, LEUKEMIA, V10, P1911; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Ogawa M, 1999, INT J HEMATOL, V69, P2; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Singh H, 2006, CURR OPIN IMMUNOL, V18, P116, DOI 10.1016/j.coi.2006.01.014; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Spain LM, 1999, J IMMUNOL, V163, P2681; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; SUDA T, 1983, P NATL ACAD SCI-BIOL, V80, P6689, DOI 10.1073/pnas.80.21.6689; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Traver D, 2004, ADV IMMUNOL, V83, P1; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	122	268	279	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					726	740		10.1016/j.immuni.2007.06.004	http://dx.doi.org/10.1016/j.immuni.2007.06.004			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582345	Bronze			2022-12-18	WOS:000247646900007
J	Sommer, K; Guo, BC; Pomerantz, JL; Bandaranayake, AD; Moreno-Garcia, ME; Ovechkina, YL; Rawlings, DJ				Sommer, K; Guo, BC; Pomerantz, JL; Bandaranayake, AD; Moreno-Garcia, ME; Ovechkina, YL; Rawlings, DJ			Phosphorylation of the CARMA1 linker controls NF-kappa B activation	IMMUNITY			English	Article							KINASE-C-THETA; T-CELL-RECEPTOR; LIPID RAFT RECRUITMENT; MAGUK FAMILY; LYMPHOCYTE-ACTIVATION; BCL10; COMPLEX; BETA; TCR; COSTIMULATION	PKC isoforms and CARMA1 play crucial roles in immunoreceptor-dependent NF-KB activation. We tested whether PKC-dependent phosphorylation of CARMA1 directly regulates this signaling cascade. B cell antigen receptor (BCR) engagement led to the progressive recruitment of CARMA1 into lipid rafts and to the association of CARMA1 with, and phosphorylation by, PKC beta. Furthermore, PKC beta interacted with the serinerich CARMA1 linker, and both PKC beta and PKC0 phosphorylated identical serine residues (S564, S649, and S657) within this linker. Mutation of two of these sites ablated the functional activity of CARMA1. In contrast, deletion of the linker resulted in constitutive, receptor and PKC-independent NF-KB activation. Together, our data support a model whereby CARMA1 phosphorylation controls NF-KB activation by triggering a shift from an inactive to an active CARMA1 conformer. This PKC-dependent switch regulates accessibility of the CARD and CC domains and controls assembly and full activation of the membrane-associated licS kinase (IKK) signalosome.	Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Inst Cell Engn, Baltimore, MD 21205 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University	Rawlings, DJ (corresponding author), Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.	drawling@u.washington.edu	Rawlings, David/CAI-4751-2022	Pomerantz, Joel L./0000-0002-5030-1018	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA081140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075453] Funding Source: NIH RePORTER; NCI NIH HHS [CA81140] Funding Source: Medline; NHLBI NIH HHS [HL075453] Funding Source: Medline; NICHD NIH HHS [HD37091] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sebald A, 2005, EUR J IMMUNOL, V35, P318, DOI 10.1002/eji.200425024; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	32	268	282	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					561	574		10.1016/j.immuni.2005.09.014	http://dx.doi.org/10.1016/j.immuni.2005.09.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356855	Bronze			2022-12-18	WOS:000234316900004
J	Zhang, ZQ; Kim, T; Bao, MS; Facchinetti, V; Jung, SY; Ghaffari, AA; Qin, J; Cheng, GH; Liu, YJ				Zhang, Zhiqiang; Kim, Taeil; Bao, Musheng; Facchinetti, Valeria; Jung, Sung Yun; Ghaffari, Amir Ali; Qin, Jun; Cheng, Genhong; Liu, Yong-Jun			DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; DEPENDENT PROTEIN-KINASE; INDUCIBLE GENE-I; RIG-I; INNATE IMMUNITY; VIRAL-INFECTION; VIRUS-INFECTION; CUTTING EDGE	The innate immune system detects viral infection predominantly by sensing viral nucleic acids. We report the identification of a viral sensor, consisting of RNA helicases DDX1, DDX21, and DHX36, and the adaptor molecule TRIF, by isolation and sequencing of poly I:C-binding proteins in myeloid dendritic cells (mDCs). Knockdown of each helicase or TRIF by shRNA blocked the ability of mDCs to mount type I interferon (IFN) and cytokine responses to poly I:C, influenza A virus, and reovirus. Although DDX1 bound poly I:C via its Helicase A domain, DHX36 and DDX21 bound the TIR domain of TRIF via their HA2-DUF and PRK domains, respectively. This sensor was localized within the cytosol, independent of the endosomes. Thus, the DDX1-DDX21-DHX36 complex represents a dsRNA sensor that uses the TRIF pathway to activate type I IFN responses in the cytosol of mDCs.	[Zhang, Zhiqiang; Kim, Taeil; Bao, Musheng; Facchinetti, Valeria; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Immunol, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Ghaffari, Amir Ali; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of California System; University of California Los Angeles	Liu, YJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org		Jung, Sung Yun/0000-0003-1521-7977	NIAID NIH HHS [R01 AI069120, R01 AI056154] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069120, R01AI056154] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Ueta M, 2011, BIOCHEM BIOPH RES CO, V404, P419, DOI 10.1016/j.bbrc.2010.11.136; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	49	267	284	3	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					866	878		10.1016/j.immuni.2011.03.027	http://dx.doi.org/10.1016/j.immuni.2011.03.027			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703541	Green Accepted, Bronze			2022-12-18	WOS:000292349700008
J	Wu, L; Liu, YJ				Wu, Li; Liu, Yong-Jun			Development of dendritic-cell lineages	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; INTERFERON-PRODUCING CELLS; REGULATORY T-CELLS; MOUSE PLASMACYTOID CELLS; TUMOR-NECROSIS-FACTOR; IFN-ALPHA; STEADY-STATE; FLT3 LIGAND; HEMATOPOIETIC PRECURSORS; PREDENDRITIC CELLS	Dendritic cells (DCs) are a heterogenous population of bone-marrow-derived immune cells. Although all DCs share a common ability to process and present antigen to naive T cells for the initiation of an immune response, they differ in surface markers, migratory patterns, localization, and cytokine production. DCs were originally considered to be myeloid cells, but recent findings have demonstrated that DCs can develop not only from myeloid- but also from lymphoid-committed progenitors. The common feature of the progenitors capable of developing into DCs is the surface expression of Flt3 receptor. The development of different populations of DCs is differentially regulated by various transcription factors and cytokines. This review summarizes the recent advances made in the field of DC development.	Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA	Walter & Eliza Hall Institute; University of Texas System; UTMD Anderson Cancer Center	Wu, L (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, 1G Royal Parade, Parkville, Vic 3050, Australia.	wu@wehi.edu.au; yjliu@mdanderson.org						Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Austyn J M, 1988, Adv Exp Med Biol, V237, P583; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Blom B, 2000, J EXP MED, V192, P1785, DOI 10.1084/jem.192.12.1785; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Borkowski TA, 1997, J CLIN INVEST, V100, P575, DOI 10.1172/JCI119567; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Caux C, 1999, J LEUKOCYTE BIOL, V66, P781, DOI 10.1002/jlb.66.5.781; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Chicha L, 2004, J EXP MED, V200, P1519, DOI 10.1084/jem.20040809; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Dakic A, 2003, LEUKEMIA LYMPHOMA, V44, P1469, DOI 10.1080/1042819031000083370; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Goldschneider I, 2003, TRENDS IMMUNOL, V24, P77, DOI 10.1016/S1471-4906(02)00038-8; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Gurney KB, 2004, J IMMUNOL, V173, P7269, DOI 10.4049/jimmunol.173.12.7269; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; HOFMAN FM, 1984, TRANSPLANTATION, V37, P590, DOI 10.1097/00007890-198406000-00013; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; ITO T, 1999, P INT C STAINL STEEL, V1, P1; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; JANOSSY G, 1986, J IMMUNOL, V136, P4354; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Keir ME, 2002, J IMMUNOL, V168, P325, DOI 10.4049/jimmunol.168.1.325; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Krug A, 2003, J EXP MED, V197, P899, DOI 10.1084/jem.20021091; KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Manz MG, 2001, ANN NY ACAD SCI, V938, P167; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; MCIIROY D, 2001, BLOOD, V97, P3470; Mende I, 2006, BLOOD, V107, P1383, DOI 10.1182/blood-2005-05-1878; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; Naik SH, 2005, IMMUNOL CELL BIOL, V83, P563, DOI 10.1111/j.1440-1711.2005.01390.x; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2003, BLOOD, V101, P1453, DOI 10.1182/blood-2002-03-0974; O'Keeffe M, 2002, BLOOD, V99, P2122, DOI 10.1182/blood.V99.6.2122; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pulendran B, 2001, TRENDS IMMUNOL, V22, P41, DOI 10.1016/S1471-4906(00)01794-4; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; REID CDL, 1992, J IMMUNOL, V149, P2681; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schiavoni G, 2004, BLOOD, V103, P2221, DOI 10.1182/blood-2003-09-3007; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Strunk D, 1997, J EXP MED, V185, P1131, DOI 10.1084/jem.185.6.1131; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Szabolcs P, 1996, BLOOD, V87, P4520, DOI 10.1182/blood.V87.11.4520.bloodjournal87114520; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tilloy F, 1999, EUR J IMMUNOL, V29, P3313, DOI 10.1002/(SICI)1521-4141(199910)29:10<3313::AID-IMMU3313>3.0.CO;2-8; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vandenabeele S, 2001, BLOOD, V97, P1733, DOI 10.1182/blood.V97.6.1733; Vollstedt S, 2003, J EXP MED, V197, P575, DOI 10.1084/jem.20021900; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; WEIL F, 1995, CELL, V80, P331; Welner RS, 2007, BLOOD, V109, P4825, DOI 10.1182/blood-2006-08-043810; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	123	267	293	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2007	26	6					741	750		10.1016/j.immuni.2007.06.006	http://dx.doi.org/10.1016/j.immuni.2007.06.006			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582346	Bronze			2022-12-18	WOS:000247646900008
J	Shen, LJ; Sigal, LJ; Boes, M; Rock, KL				Shen, LJ; Sigal, LJ; Boes, M; Rock, KL			Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; CD8(-) DENDRITIC CELLS; CROSS-PRESENTATION; INVARIANT CHAIN; CUTTING EDGE; EXOGENOUS ANTIGENS; T-CELLS; DEGRADATION; VIRUS; PROTEINS	The immune system detects viral infections and mutations in parenchymal cells when antigens from these cells are crosspresented on MHC class I molecules of professional antigen-presenting cells (APC). Exogenous antigens are crosspresented through TAP-dependent (cytosolic) or poorly understood TAP-independent (vacuolar) pathways. The TAP-independent pathway is blocked by the cysteine protease inhibitor, leupeptin, but not by proteasome inhibitors, which is opposite to the effects of these agents on the TAP-dependent pathway. Dendritic cells lacking the cysteine protease cathepsin S lack the TAP-independent pathway. Mice whose APC lack cathepsin S have reduced crosspriming to particulate and cell-associated antigens, as well as to influenza virus. Cathepsin S-deficient phagosomes generate a class I-presented peptide poorly. In contrast, cathepsin S-sufficient phagosomes and recombinant cathepsin S produce the mature epitope. Therefore, cathepsin S plays a major role in generating presented peptides for the vacuolar pathway of cross-presentation, and this mechanism is active in vivo.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Fox Chase Cancer Center; Harvard University; Harvard Medical School	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	kenneth.rock@umassmed.edu	Sigal, Luis/AAL-1849-2021	Sigal, Luis/0000-0001-6642-5472; Boes, Marianne/0000-0003-2590-1692				Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Cervi L, 2004, J IMMUNOL, V172, P2016, DOI 10.4049/jimmunol.172.4.2016; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Fonteneau JF, 2003, BLOOD, V102, P4448, DOI 10.1182/blood-2003-06-1801; Freigang S, 2003, P NATL ACAD SCI USA, V100, P13477, DOI 10.1073/pnas.1835685100; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kleindienst P, 2003, J IMMUNOL, V170, P2817, DOI 10.4049/jimmunol.170.6.2817; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Oh YK, 1996, J CELL BIOL, V132, P585, DOI 10.1083/jcb.132.4.585; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; ROCK KL, 1990, J IMMUNOL, V145, P804; Rock KL, 1996, J IMMUNOL, V156, P3721; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Ruedl C, 2002, EUR J IMMUNOL, V32, P818, DOI 10.1002/1521-4141(200203)32:3<818::AID-IMMU818>3.0.CO;2-U; Serna A, 2003, J IMMUNOL, V171, P5668, DOI 10.4049/jimmunol.171.11.5668; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Shen ZH, 1997, J IMMUNOL, V158, P2723; SHI GP, 1992, J BIOL CHEM, V267, P7258; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Song R, 1996, J IMMUNOL, V156, P4182; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Vigna JL, 1996, J IMMUNOL, V157, P4503; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wick MJ, 1996, EUR J IMMUNOL, V26, P2790, DOI 10.1002/eji.1830261135	58	267	277	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					155	165		10.1016/j.immuni.2004.07.004	http://dx.doi.org/10.1016/j.immuni.2004.07.004			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308097	Bronze			2022-12-18	WOS:000223441900005
J	Hara, H; Wada, T; Bakal, C; Kozieradzki, I; Suzuki, S; Suzuki, N; Nghiem, M; Griffiths, EK; Krawczyk, C; Bauer, B; D'Acquisto, F; Ghosh, S; Yeh, WC; Baier, G; Rottapel, R; Penninger, JM				Hara, H; Wada, T; Bakal, C; Kozieradzki, I; Suzuki, S; Suzuki, N; Nghiem, M; Griffiths, EK; Krawczyk, C; Bauer, B; D'Acquisto, F; Ghosh, S; Yeh, WC; Baier, G; Rottapel, R; Penninger, JM			The MAGUK family protein CARD11 is essential for lymphocyte activation	IMMUNITY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; SIGNALING PATHWAY; PKC-THETA; RECRUITMENT; BCL10; MICE	Members of the MAGUK family proteins cluster receptors and intracellular signaling molecules at the neuronal synapse. We report that genetic inactivation of the MAGUK family protein CARD11/Carmal/Bimp3 results in a complete block in T and B cell immunity. CARD11 is essential for antigen receptor- and PKC-mediated proliferation and cytokine production in T and B cells due to a selective defect in JNK and NFkappaB activation. Moreover, B cell proliferation and JNK activation were impaired upon stimulation of TLR4 with lipopolysaccharide, indicating that CARD11 is involved in both the innate and adaptive immune systems. Our results show that the same family of molecules are critical regulators of neuronal synapses and immune receptor signaling.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Ontario Canc Inst, Hlth Network, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Innsbruck; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	josef.penninger@oeaw.ac.at	Baier, Gottfried/E-8755-2012; D'Acquisto, Fulvio/E-7204-2018; Penninger, Josef M/I-6860-2013	D'Acquisto, Fulvio/0000-0002-4513-1608; Penninger, Josef M/0000-0002-8194-3777; Bakal, Chris/0000-0002-0413-6744; Baier, Gottfried/0000-0002-2085-8325; Rottapel, Robert/0000-0002-6024-5558				Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Caruana G, 2002, INT J DEV BIOL, V46, P511; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Damiano JS, 2001, GENOMICS, V75, P77, DOI 10.1006/geno.2001.6579; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Donnadieu E, 2001, IMMUNOLOGY, V103, P417, DOI 10.1046/j.1365-2567.2001.01268.x; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Procyk KJ, 2000, BLOOD, V96, P2592; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414	45	267	277	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN	2003	18	6					763	775		10.1016/S1074-7613(03)00148-1	http://dx.doi.org/10.1016/S1074-7613(03)00148-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818158	Bronze			2022-12-18	WOS:000183767700007
J	Kinoshita, S; Su, LS; Amano, M; Timmerman, LA; Kaneshima, H; Nolan, GP				Kinoshita, S; Su, LS; Amano, M; Timmerman, LA; Kaneshima, H; Nolan, GP			The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENHANCER-BINDING-PROTEIN; KAPPA-B; NUCLEAR FACTOR; CYCLOSPORINE-A; HTLV-III; CYCLOPHILIN-A; IL-4 GENE; TRANSCRIPTION; TYPE-1	Clinical deterioration in human immunodeficiency virus type 1 (HIV-1) infection is associated with increased levels of viral replication and burden in the peripheral blood and lymphoid organs. T cell activation and ensuing cellular gene activation can be critical for HIV-1 replication. The hypothesis that the nuclear factor of activated T cells (NF-AT) may influence HIV-1 replication is therefore compelling given the tight correlation of HIV-1 transcriptional induction to T cell activation. We report that certain NF-AT(Rel) family members productively bind the KB regulatory elements, synergize with NF-KB and Tat in transcriptional activation of HIV-1, and enhance HIV-1 replication in T cells. These results link regulatory factors critical to T cell commitment directly to HIV-1 replication.	STANFORD UNIV,SCH MED,DEPT MOL PHARMACOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; SYSTEMIX INC,PALO ALTO,CA 94303	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Novartis			Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	NCI NIH HHS [CA39612] Funding Source: Medline; NIAID NIH HHS [AI27666, AI35304] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039612, R37CA039612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027666, R01AI035304] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BAGNARELLI P, 1992, J VIROL, V66, P7328, DOI 10.1128/JVI.66.12.7328-7335.1992; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; FRANZA BR, 1987, NATURE, V330, P391, DOI 10.1038/330391a0; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GREENE WC, 1986, PROG HEMATOL, V14, P283; GREENE WC, 1990, ANNU REV IMMUNOL, V8, P453, DOI 10.1146/annurev.iy.08.040190.002321; GRUTERS RA, 1991, EUR J IMMUNOL, V21, P167, DOI 10.1002/eji.1830210125; HASELTINE WA, 1991, FASEB J, V5, P2349, DOI 10.1096/fasebj.5.10.1829694; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HODGE MR, 1995, J IMMUNOL, V154, P6397; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JAIN J, 1980, J IMMUNOL, V151, P837; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Jellinger RM, 1997, J INFECT DIS, V175, P561, DOI 10.1093/infdis/175.3.561; KARPAS A, 1992, P NATL ACAD SCI USA, V89, P8351, DOI 10.1073/pnas.89.17.8351; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; LU YC, 1990, J VIROL, V64, P5226, DOI 10.1128/JVI.64.10.5226-5229.1990; LU YC, 1991, J ACQ IMMUN DEF SYND, V4, P173; Luo C, 1996, MOL CELL BIOL, V16, P3955; MARKOVITZ DM, 1990, P NATL ACAD SCI USA, V87, P9098, DOI 10.1073/pnas.87.23.9098; MARKOVITZ DM, 1992, J VIROL, V66, P3961, DOI 10.1128/JVI.66.6.3961-3965.1992; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PAUL WE, 1995, CELL, V82, P177, DOI 10.1016/0092-8674(95)90304-6; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERKINS ND, 1994, J VIROL, V68, P6820, DOI 10.1128/JVI.68.10.6820-6823.1994; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; SCHMIDT A, 1990, J VIROL, V64, P4037, DOI 10.1128/JVI.64.8.4037-4041.1990; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIEKEVITZ M, 1988, SCIENCE, V239, P451; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; TONGSTARKSEN SE, 1990, J IMMUNOL, V145, P4348; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502	60	267	271	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					235	244		10.1016/S1074-7613(00)80326-X	http://dx.doi.org/10.1016/S1074-7613(00)80326-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075924	Bronze			2022-12-18	WOS:A1997XC61800003
J	Gerlach, C; Moseman, EA; Loughhead, SM; Alvarez, D; Zwijnenburg, AJ; Waanders, L; Garg, R; de la Torre, JC; von Andrian, UH				Gerlach, Carmen; Moseman, E. Ashley; Loughhead, Scott M.; Alvarez, David; Zwijnenburg, Anthonie J.; Waanders, Lisette; Garg, Rohit; de la Torre, Juan C.; von Andrian, Ulrich H.			The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis	IMMUNITY			English	Article							RESIDENT MEMORY; EFFECTOR; LYMPH; MIGRATION; EXPRESSION; LYMPHOCYTES; GENERATION; PRECURSOR; BLOOD; NAIVE	Infections induce pathogen-specific T cell differentiation into diverse effectors (Teff) that give rise to memory (Tmem) subsets. The cell-fate decisions and lineage relationships that underlie these transitions are poorly understood. Here, we found that the chemokine receptor CX3CR1 identifies three distinct CD8(+) Teff and Tmem subsets. Classical central (Tcm) and effector memory (Tem) cells and their corresponding Teff precursors were CX3CR1(-) and CX3CR1(high), respectively. Viral infection also induced a numerically stable CX3CR1(int) subset that represented similar to 15% of blood-borne Tmem cells. CX3CR1(int) Tmem cells underwent more frequent homeostatic divisions than other Tmem subsets and not only self-renewed, but also contributed to the expanding CX3CR1-Tcm pool. Both Tcm and CX3CR1(int) cells homed to lymph nodes, but CX3CR1(int) cells, and not Tem cells, predominantly surveyed peripheral tissues. As CX3CR1(int) Tmem cells present unique phenotypic, homeostatic, and migratory properties, we designate this subset peripheral memory (tpm) cells and propose that tpm cells are chiefly responsible for the global surveillance of non-lymphoid tissues.	[Gerlach, Carmen; Moseman, E. Ashley; Loughhead, Scott M.; Alvarez, David; Zwijnenburg, Anthonie J.; Waanders, Lisette; Garg, Rohit; von Andrian, Ulrich H.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Gerlach, Carmen; Moseman, E. Ashley; Loughhead, Scott M.; Alvarez, David; Zwijnenburg, Anthonie J.; Waanders, Lisette; Garg, Rohit; von Andrian, Ulrich H.] Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [von Andrian, Ulrich H.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Moseman, E. Ashley] NINDS, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	von Andrian, UH (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; von Andrian, UH (corresponding author), Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA.; von Andrian, UH (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.	uva@hms.harvard.edu		Gerlach, Carmen/0000-0001-7889-2393; Zwijnenburg, Anthonie/0000-0003-3150-0190	Rubicon fellowship (Netherlands Organization for Scientific Research, NWO); Cancer Research Institute Irvington Fellowship Program; NIH T32 Training Grant in Hematology [HL07623-20]; NIH F31 grant [CA171339]; NIH T32 grant [HL066987]; Ragon Institute of MGH, MIT, and Harvard; NIH/NIAID [RO1 AI069259, PO1 AI078897, PO1 AI112521]; HMS Center for Immune Imaging; NATIONAL CANCER INSTITUTE [F31CA171339] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, T32HL066987] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, R01AI069259, P01AI112521, R01AI111595] Funding Source: NIH RePORTER	Rubicon fellowship (Netherlands Organization for Scientific Research, NWO); Cancer Research Institute Irvington Fellowship Program; NIH T32 Training Grant in Hematology; NIH F31 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT, and Harvard; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HMS Center for Immune Imaging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank N.H. Ruddle for Lta<SUP>-/-</SUP> mice, D. Higgins for LM-ova, I. B. Mazo, R.J. Gonzales, and M. Perro for technical assistance, and A.K. Chakraborty, A. Thiriot, and Y. Nemoto for fruitful discussions. This study was supported by a Rubicon fellowship (Netherlands Organization for Scientific Research, NWO) and a postdoctoral fellowship of the Cancer Research Institute Irvington Fellowship Program to C.G., NIH T32 Training Grant in Hematology HL07623-20 to E.A.M., NIH F31 grant CA171339 to S.M.L., NIH T32 grant HL066987 to D.A., the Ragon Institute of MGH, MIT, and Harvard, the HMS Center for Immune Imaging, and NIH/NIAID RO1 AI069259, PO1 AI078897 and PO1 AI112521 to U.H.v.A.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GERDES J, 1984, J IMMUNOL, V133, P1710; Gerlach C, 2011, ANN NY ACAD SCI, V1217, P139, DOI 10.1111/j.1749-6632.2010.05830.x; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; HINTZEN RQ, 1993, J IMMUNOL, V151, P2426; Hunger RE, 1999, BRIT J DERMATOL, V141, P565; Ionac M, 1997, J IMMUNOL METHODS, V202, P35, DOI 10.1016/S0022-1759(96)00226-8; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	44	266	267	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1270	1284		10.1016/j.immuni.2016.10.018	http://dx.doi.org/10.1016/j.immuni.2016.10.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27939671	Bronze, Green Accepted			2022-12-18	WOS:000392918100013
J	Yagi, RJ; Zhong, C; Northrup, DL; Yu, F; Bouladoux, N; Spencer, S; Hu, GQ; Barron, L; Sharma, S; Nakayama, T; Belkaid, Y; Zhao, KJ; Zhu, JF				Yagi, Ryoji; Zhong, Chao; Northrup, Daniel L.; Yu, Fang; Bouladoux, Nicolas; Spencer, Sean; Hu, Gangqing; Barron, Luke; Sharma, Suveena; Nakayama, Toshinori; Belkaid, Yasmine; Zhao, Keji; Zhu, Jinfang			The Transcription Factor GATA3 Is Critical for the Development of All IL-7R alpha-Expressing Innate Lymphoid Cells	IMMUNITY			English	Article							ROR-GAMMA-T; EXPRESSION; FETAL; BET; GENERATION; POPULATION; CYTOKINES; ELICITS; DRIVES; ALPHA	Innate lymphoid cells (ILCs) are critical in innate immune responses to pathogens and lymphoid organ development. Similar to CD4(+) T helper (Th) cell subsets, ILC subsets positive for interleukin-7 receptor alpha (IL-7R alpha) produce distinct sets of effector cytokines. However, the molecular control of IL-7R alpha(+) ILC development and maintenance is unclear. Here, we report that GATA3 was indispensable for the development of all IL-7R alpha(+) ILC subsets and T cells but was not required for the development of classical natural killer cells. Conditionally Gata3-deficient mice had no lymph nodes and were susceptible to Citrobactor rodentium infection. After the ILCs had fully developed, GATA3 remained important for the maintenance and functions of ILC2s. Genome-wide gene expression analyses indicated that GATA3 regulated a similar set of cytokines and receptors in Th2 cells and ILC2s, but not in ILC3s. Thus, GATA3 plays parallel roles in regulating the development and functions of CD4(+) T cells and IL-7R alpha(+) ILCs.	[Yagi, Ryoji; Zhong, Chao; Yu, Fang; Sharma, Suveena; Zhu, Jinfang] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Northrup, Daniel L.; Hu, Gangqing; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Spencer, Sean; Barron, Luke; Belkaid, Yasmine] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chiba University	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov	Zhu, Jinfang/B-7574-2012; HU, GANGQING/K-5849-2012; Nakayama, Toshinori/E-1067-2017; Hu, Gangqing/ABA-3507-2020	Zhu, Jinfang/0000-0002-0117-4745; HU, GANGQING/0000-0001-5453-6888; Nakayama, Toshinori/0000-0002-1434-2007; Bouladoux, Nicolas/0000-0003-1593-671X; Northrup, Daniel/0000-0002-2665-2686; Belkaid, Yasmine/0000-0001-9962-3571; Spencer, Sean/0000-0002-7328-5399	NIH NIAID Division of Intramural Research (DIR); NHLBI DIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL006030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	NIH NIAID Division of Intramural Research (DIR); NHLBI DIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ronald Germain, Dragana Jankovic, William Paul, and John O'Shea for their critical reading of our manuscript; Julie Edwards for her excellent assistance in cell sorting; the NHLBI DNA Sequencing and Computational Biology Core for sequencing the RNA-seq libraries; and Naofumi Takemoto, Hidehiro Yamane, George Punkosdy, Michelle Crank, Amina Metidji, Liying Guo, and Giuseppe Sciume for their helpful discussions. The work was supported by the NIH NIAID Division of Intramural Research (DIR) and NHLBI DIR.	Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	266	275	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					378	388		10.1016/j.immuni.2014.01.012	http://dx.doi.org/10.1016/j.immuni.2014.01.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24631153	Green Accepted, Bronze			2022-12-18	WOS:000333422300011
J	O'Neill, LAJ				O'Neill, Luke A. J.			When signaling pathways collide: Positive and negative regulation of Toll-like receptor signal transduction	IMMUNITY			English	Review							BRUTONS TYROSINE KINASE; NF-KAPPA-B; MYD88 ADAPTER-LIKE; HOST-DEFENSE; CYTOKINE PRODUCTION; NALP3 INFLAMMASOME; MURAMYL DIPEPTIDE; IMMUNE-RESPONSES; DENDRITIC CELLS; VACCINIA VIRUS	Toll-like receptor (TLR) signaling is subjected to crosstalk from other signals, with a resulting positive or negative effect. There is complex crosstalk between the NLR family of immune-regulatory molecules and TLRs, and C-type lectin receptors such as Dectin-1 synergize with TLR2 via the tyrosine kinase Syk. Bruton's tyrosine kinase plays an important positive role in TLR signaling, whereas the TAM family of receptor tyrosine kinases is inhibitory. The tyrosine phosphatase SHP1 has been shown to positively regulate induction of interferon-beta, whereas SHP2 inhibits the kinase TBK1, limiting this response. K63-linked polyubiquination has also been shown to be critical for the initiation of TLR signaling. Finally, glucocorticoids affect TLR signaling by inducing the phosphatase MKP1 and inhibiting TBK1 activation. These recent findings emphasize the importance of considering TLR signaling in the context of other signaling pathways, as is likely to occur in vivo during infection and inflammation.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; NETEA MG, 2008, MONCYTES ARE NOT MAC; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Palmer CD, 2008, BIOCHEM BIOPH RES CO, V370, P599, DOI 10.1016/j.bbrc.2008.03.142; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Schmidt NW, 2006, J IMMUNOL, V177, P7203, DOI 10.4049/jimmunol.177.10.7203; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Taneichi H, 2008, CLIN IMMUNOL, V126, P148, DOI 10.1016/j.clim.2007.10.005; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	84	266	278	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					12	20		10.1016/j.immuni.2008.06.004	http://dx.doi.org/10.1016/j.immuni.2008.06.004			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631453	Bronze			2022-12-18	WOS:000257905400006
J	Grivennikov, SI; Tumanov, AV; Liepinsh, DJ; Kruglov, AA; Marakusha, BI; Shakhov, AN; Murakami, T; Drutskaya, LN; Forster, I; Clausen, BE; Tessarollo, L; Ryffel, B; Kuprash, DV; Nedospasov, SA				Grivennikov, SI; Tumanov, AV; Liepinsh, DJ; Kruglov, AA; Marakusha, BI; Shakhov, AN; Murakami, T; Drutskaya, LN; Forster, I; Clausen, BE; Tessarollo, L; Ryffel, B; Kuprash, DV; Nedospasov, SA			Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: Protective and deleterious effects	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; LIVER-INJURY; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; FACTOR RECEPTOR; SECRETED TNF; HOST-DEFENSE; MICE LACKING; B-CELLS; LYMPHOTOXIN	Tumor necrosis factor (TNF, TNFalpha) is implicated in various pathophysiological processes and can be either protective, as in host defense, or deleterious, as in autoimmunity or toxic shock. To uncover the in vivo functions of TNF produced by different cell types, we generated mice with TNF ablation targeted to various leukocyte subsets. Systemic TNF in response to lipopolysaccharide was produced mainly by macrophages and neutrophils. This source of TNF was indispensable for resistance to an intracellular pathogen, Listeria, whereas T-cell-derived TNF was important for protection against high bacterial load. Additionally, both T-cell-derived TNF and macrophage-derived TNF had critical and nonredundant functions in the promotion of autoimmune hepatitis. Our data suggest that T-cell-specific TNF ablation may provide a therapeutic advantage over systemic blockade.	Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Mol Immunol, Moscow 119991, Russia; Belozersky Inst Physicochem Biol, Moscow 119991, Russia; NCI, Canc Res Ctr, Mol Immunoregulat Lab, Frederick, MD 21702 USA; NCI, Canc Res Ctr, Mouse Genet Program, Frederick, MD 21702 USA; SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA; Russian Acad Med Sci, Gamaleya Inst Epidemiol & Microbiol, Moscow 123098, Russia; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; CNRS, Inst Transgenose, IEM, F-45071 Orleans, France	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Technical University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS)	Nedospasov, SA (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Lab Mol Immunol, 32 Vavilov Str, Moscow 119991, Russia.	snedos@online.ru	Kruglov, Andrey/AAP-2023-2021; Tumanov, Alexei/AAR-1607-2021; Nedospasov, Sergei/J-5936-2013; Kuprash, Dmitry/O-4899-2015; Kruglov, Andrey A/F-7543-2017; Nedospasov, Sergei/Q-7319-2016; CLAUSEN, Björn Erik/A-8229-2010; Grivennikov, Sergei/AAE-7365-2019; Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/L-1990-2015; Förster, Irmgard/P-8545-2016	Tumanov, Alexei/0000-0001-6042-0152; Kuprash, Dmitry/0000-0002-1488-4148; Kruglov, Andrey A/0000-0002-4597-2087; CLAUSEN, Björn Erik/0000-0002-2484-7842; Grivennikov, Sergei/0000-0003-2987-0555; Förster, Irmgard/0000-0002-7644-5642	DIVISION OF BASIC SCIENCES - NCI [Z01BC009371, Z01BC010601] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe K, 2003, BLOOD, V101, P1477, DOI 10.1182/blood.V101.4.1477; Anderson MR, 2001, CLIN IMMUNOL, V98, P85, DOI 10.1006/clim.2000.4960; Baeten D, 2003, ANN RHEUM DIS, V62, P829, DOI 10.1136/ard.62.9.829; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DiTirro J, 1998, INFECT IMMUN, V66, P2284, DOI 10.1128/IAI.66.5.2284-2289.1998; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Faust N, 2000, BLOOD, V96, P719; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 1995, ANN NY ACAD SCI, V766, P272, DOI 10.1111/j.1749-6632.1995.tb26675.x; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gantner F, 1996, EXP CELL RES, V229, P137, DOI 10.1006/excr.1996.0351; GIROIR BP, 1992, J CLIN INVEST, V90, P693, DOI 10.1172/JCI115939; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; KINKHABWALA M, 1990, J EXP MED, V171, P941, DOI 10.1084/jem.171.3.941; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leist M, 1996, MOL MED, V2, P109, DOI 10.1007/BF03402207; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mohan AK, 2003, CURR OPIN RHEUMATOL, V15, P179, DOI 10.1097/00002281-200305000-00002; Muhlen KA, 2004, J IMMUNOL, V172, P3034, DOI 10.4049/jimmunol.172.5.3034; Muller M, 1996, MOL MED, V2, P247, DOI 10.1007/BF03401621; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Saunders BM, 2004, CLIN EXP IMMUNOL, V137, P279, DOI 10.1111/j.1365-2249.2004.02518.x; Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; Tumanov AV, 2004, J IMMUNOL, V173, P86, DOI 10.4049/jimmunol.173.1.86; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Wang Y, 2001, J IMMUNOL, V166, P330, DOI 10.4049/jimmunol.166.1.330; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721	57	266	280	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2005	22	1					93	104		10.1016/j.immuni.2004.11.016	http://dx.doi.org/10.1016/j.immuni.2004.11.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664162	Bronze			2022-12-18	WOS:000226682900010
J	vonFreedenJeffry, U; Solvason, N; Howard, M; Murray, R				vonFreedenJeffry, U; Solvason, N; Howard, M; Murray, R			The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression	IMMUNITY			English	Article							MICE LACKING JAK3; LYMPHOID DEVELOPMENT; V(D)J REARRANGEMENT; POSITIVE SELECTION; POLYCYSTIC KIDNEY; LYMPHOCYTES; THYMOCYTES; APOPTOSIS; INTERLEUKIN-7; GROWTH	Interleukin-7 (IL-7)-deficient mice exhibit an early defect in lymphopoiesis. We examined Bcl-2 expression and the cell cycle status of immature thymocyte subsets in these mice. In IL-7-deficient mice, developmental transition to a T cell-committed fate was accompanied by a striking loss of Bcl-2 protein expression and an increased relative proportion of cells in the G0/G1 stage of the cell cycle. Short-term culture of immature thymocytes with rIL-7 caused up-regulation of Bcl-2 protein and cell survival. These data specify a T cell lineage developmental transition point, prior to T cell antigen receptor rearrangement, where IL-7 signal transduction is linked to an anti-apoptosis mechanism and the cell cycle.	DNAX RES INST MOL & CELLULAR BIOL INC,DEPT IMMUNOBIOL,PALO ALTO,CA 94304	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.								Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CONLON PJ, 1989, BLOOD, V74, P1368; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; GODFREY DJ, 1993, IMMUNOL TODAY, V14, P647; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; GRATIOTDEANS J, 1993, J IMMUNOL, V151, P83; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; HAWKINS CJ, 1994, IMMUNOL REV, V142, P127, DOI 10.1111/j.1600-065X.1994.tb00886.x; KAMADA S, 1995, CANCER RES, V55, P354; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MATSUZAKI Y, 1997, BLOOD, V89, P1011; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOORE NC, 1994, IMMUNOLOGY, V81, P115; Moore TA, 1996, J IMMUNOL, V157, P2366; Moore TA, 1997, J IMMUNOL, V158, P4187; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; MUEGGE K, 1993, SCIENCE, V261, P93, DOI 10.1126/science.7686307; Murray R, 1996, Curr Opin Hematol, V3, P230; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Oosterwegel MA, 1997, IMMUNITY, V6, P351, DOI 10.1016/S1074-7613(00)80337-4; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PENIT C, 1995, J IMMUNOL, V154, P5103; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; RODEWALD HR, 1997, IMMUNITY, V6, P266; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WATSON JD, 1989, J IMMUNOL, V143, P1215; WELCH PA, 1989, J IMMUNOL, V143, P3562; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1	49	266	268	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					147	154		10.1016/S1074-7613(00)80517-8	http://dx.doi.org/10.1016/S1074-7613(00)80517-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252127	Bronze			2022-12-18	WOS:A1997XN69300013
J	Cui, WG; Liu, Y; Weinstein, JS; Craft, J; Kaech, SM				Cui, Weiguo; Liu, Ying; Weinstein, Jason S.; Craft, Joseph; Kaech, Susan M.			An Interleukin-21-Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8(+) T Cells	IMMUNITY			English	Article							EFFECTOR; GENERATION; RESPONSES; STAT3; BET; DIFFERENTIATION; ACTIVATION; IL-21; INTERLEUKIN-21; MAINTENANCE	Memory CD8(+) T cells are critical for long-term immunity, but the genetic pathways governing their formation remain poorly defined. This study shows that the IL-10-IL-21-STAT3 pathway is critical for memory CD8(+) T cell development after acute LCMV infection. In the absence of either interleukin-10 (IL-10) and IL-21 or STAT3, virus-specific CD8(+) T cells retain terminal effector (TE) differentiation states and fail to mature into protective memory T cells that contain self-renewing central memory T cells. Expression of Eomes, BCL-6, Blimp-1, and SOCS3 was considerably reduced in STAT3-deficient memory CD8(+) T cells, and BCL-6- or SOCS3-deficient CD8(+) T cells also had perturbed memory cell development. Reduced SOCS3 expression rendered STAT3-deficient CD8(+) T cells hyperresponsive to IL-12, suggesting that the STAT3-SOCS3 pathway helps to insulate memory precursor cells from inflammatory cytokines that drive TE differentiation. Thus, memory CD8(+) T cell precursor maturation is an active process dependent on IL-10-IL-21-STAT3 signaling.	[Cui, Weiguo; Liu, Ying; Weinstein, Jason S.; Craft, Joseph; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu		Liu, Ying/0000-0001-7915-7294	NIH [RO1AI066232, R21AI081150, R01AR40072, AR44076, AI075157]; Arthritis Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075157, R01AI066232, R01AI074699, R21AI081150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044076, R01AR040072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the members of the Kaech laboratory, N. Joshi, and T. Hand for helpful comments and suggestions. We also thank X.-Y. Fu and A. Dent for providing us with the Stat3<SUP>f/f</SUP> and Bcl6<SUP>-/-</SUP> mice, respectively, and J.M.M. den Haan with the kind gift of alpha IL-10 mAb. This work was supported by grants from the NIH (RO1AI066232 [S.M.K.], R21AI081150 (S.M.K.], R01AR40072 [J.C.], AR44076 [J.C.], AI075157 [J.C.]), the Arthritis Foundation (J.S.W.) and the Howard Hughes Medical Institute (S.M.K.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barker BR, 2010, EUR J IMMUNOL, V40, P3085, DOI 10.1002/eji.200939939; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Maris CH, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-8; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yi JS, 2010, J IMMUNOL, V185, P4835, DOI 10.4049/jimmunol.1001032; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	55	265	273	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					792	805		10.1016/j.immuni.2011.09.017	http://dx.doi.org/10.1016/j.immuni.2011.09.017			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118527	Green Accepted, Bronze			2022-12-18	WOS:000297390800018
J	Procaccini, C; De Rosa, V; Galgani, M; Abanni, L; Cali, G; Porcellini, A; Carbone, F; Fontana, S; Horvath, TL; La Cava, A; Matarese, G				Procaccini, Claudio; De Rosa, Veronica; Galgani, Mario; Abanni, Luisa; Cali, Gaetano; Porcellini, Antonio; Carbone, Fortunata; Fontana, Silvia; Horvath, Tamas L.; La Cava, Antonio; Matarese, Giuseppe			An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness	IMMUNITY			English	Article							ENERGY HOMEOSTASIS; IMMUNE-RESPONSE; FOOD-INTAKE; ACTIVATION; DIFFERENTIATION; IMMUNOTHERAPY; TRANSCRIPTION; POPULATION; INHIBITION; LEPTIN	There is a discrepancy between the in vitro anergic state of CD4(+)CD25(hi)FoxP3(+) regulatory T (Treg) cells and their in vivo proliferative capability. The underlying mechanism of this paradox is unknown. Here we show that the anergic state of Treg cells depends on the elevated activity of the mammalian target of rapamycin (mTOR) pathway induced by leptin: a transient inhibition of mTOR with rapamycin, before T cell receptor (TCR) stimulation, made Treg cells highly proliferative in the absence of exogenous interleukin-2 (IL-2). This was a dynamic and oscillatory phenomenon characterized by an early downregulation of the leptin-mTOR pathway followed by an increase in mTOR activation necessary for Treg cell expansion to occur. These data suggest that energy metabolism, through the leptin-mTOR-axis, sets responsiveness of Treg cells that use this information to control immune tolerance and autoimmunity.	[Procaccini, Claudio; De Rosa, Veronica; Abanni, Luisa; Cali, Gaetano; Fontana, Silvia; Matarese, Giuseppe] CNR, IEOS, Immunol Lab, I-80131 Naples, Italy; [Galgani, Mario; Carbone, Fortunata; Matarese, Giuseppe] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Porcellini, Antonio] Univ Molise, Dipartimento Sci Salute, I-86100 Campobasso, Italy; [Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Molise; Yale University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Matarese, G (corresponding author), CNR, IEOS, Immunol Lab, I-80131 Naples, Italy.	gmatarese@napoli.com	Carbone, Fortunata/K-3176-2016; Matarese, Giuseppe/AAO-4077-2021; Porcellini, Antonio/AAC-6097-2019; /AAG-9576-2020; De Rosa, Veronica/K-6534-2016; Galgani, Mario/AAC-3298-2022; Porcellini, Antonio/E-1900-2011; Procaccini, Claudio/AAB-3696-2019	Carbone, Fortunata/0000-0003-4299-6515; Matarese, Giuseppe/0000-0001-9429-0616; /0000-0002-8839-0933; De Rosa, Veronica/0000-0002-9477-0991; Porcellini, Antonio/0000-0001-6882-9518; Galgani, Mario/0000-0001-8414-1676; PROCACCINI, CLAUDIO/0000-0002-2184-0442	EU; ERC [202579]; Telethon-JDRF [GJT08004]; NIH [AR53239, DP1OD006850]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053239] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	EU(European Commission); ERC(European Research Council (ERC)European Commission); Telethon-JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G.M. is supported by grants from the EU Ideas Programme, ERC-Starting Independent Grant "LeptinMS" n. 202579, and Telethon-JDRF Grant n. GJT08004. A.L.C. is supported in part by the NIH grant n. AR53239. T.L.H. is supported by the NIH Director's Pioneer Award n. DP1OD006850. The authors thank S. De Simone and F. D'Agnello for technical help in the cell sorting MoFlo Core Facility. This work is dedicated to the memory of E. Papa and S. Zappacosta.	Abizaid A, 2006, NEURON, V51, P691, DOI 10.1016/j.neuron.2006.08.025; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bour-Jordan H, 2009, J IMMUNOL, V183, P4147, DOI 10.4049/jimmunol.0990078; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gao Q, 2008, FEBS LETT, V582, P132, DOI 10.1016/j.febslet.2007.11.063; Gregori Silvia, 2007, Methods Mol Biol, V380, P83; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Kwon G, 2004, DIABETES, V53, pA81; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Matarese G, 2004, TRENDS IMMUNOL, V25, P193, DOI 10.1016/j.it.2004.02.009; Matarese G, 2008, TRENDS IMMUNOL, V29, P12, DOI 10.1016/j.it.2007.10.006; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sato K, 2009, CYTOTHERAPY, V11, P936, DOI 10.3109/14653240903219114; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	41	265	270	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					929	941		10.1016/j.immuni.2010.11.024	http://dx.doi.org/10.1016/j.immuni.2010.11.024			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21145759	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000286293900013
J	Hill, JA; Hall, JA; Sun, CM; Cai, Q; Ghyselinck, N; Chambon, P; Belkaid, Y; Mathis, D; Benoist, C				Hill, Jonathan A.; Hall, Jason A.; Sun, Cheng-Ming; Cai, Qi; Ghyselinck, Norbert; Chambon, Pierre; Belkaid, Yasmine; Mathis, Diane; Benoist, Christophe			Retinoic Acid Enhances Foxp3 Induction Indirectly by Relieving Inhibition from CD4(+)CD44(hi) Cells	IMMUNITY			English	Article							REGULATORY T-CELLS; IOXP-FLANKED ALLELE; TRANSCRIPTION FACTOR FOXP3; TGF-BETA; SIGNALING PATHWAY; NUCLEAR RECEPTORS; DENDRITIC CELLS; ORAL TOLERANCE; RAR-GAMMA; DIFFERENTIATION	CD4(+)Foxp3(+) regulatory T (Treg) cells originate primarily from thymic differentiation, but conversion of mature T lymphocytes to Foxp3 positivity can be elicited by several means, including in vitro activation in the presence of TGF-beta. Retinoic acid (RA) increases TGF-beta-induced expression of Foxp3, through unknown molecular mechanisms. We showed here that, rather than enhancing TGF-beta signaling directly in naive CD4(+) T cells, RA negatively regulated an accompanying population of CD4(+) T cells with a CD44(hi) memory and effector phenotype. These memory cells actively inhibited the TGF-beta-induced conversion of naive CD4(+) T cells through the synthesis of a set of cytokines (IL-4, IL-21, IFN-gamma) whose expression was coordinately curtailed by RA. This indirect effect was evident in vivo and required the expression of the RA receptor alpha. Thus, cytokine-producing CD44(hi) cells actively restrain TGF-beta-mediated Foxp3 expression in naive T cells, and this balance can be shifted or fine-tuned by RA.	[Hill, Jonathan A.; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA; [Hall, Jason A.; Sun, Cheng-Ming; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, Jason A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Cai, Qi; Ghyselinck, Norbert; Chambon, Pierre] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mathis, D (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu; cbdm@joslin.harvard.edu	Sun, Cheng-Ming/G-6505-2018; Cai, Qi/E-4357-2014; GHYSELINCK, Norbert/I-6999-2015	Sun, Cheng-Ming/0000-0002-2392-7701; Cai, Qi/0000-0002-2598-542X; GHYSELINCK, Norbert/0000-0003-4042-6818; Belkaid, Yasmine/0000-0001-9962-3571	Juvenile Diabetes Research Foundation [4-2007-1057]; National Institutes of Health (NIH) [1R01A151530-5]; Young Chair; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000955, R01AI051530, ZIAAI001061] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Young Chair; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Vitolo and K. Hattori for assistance with mice, J. LaVecchio and G. Buruzala for help with cytometry, J. Perez and K. Leatherbee for microarrays, and C. Laplace for graphics. This work was supported by grants from the Juvenile Diabetes Research Foundation (4-2007-1057) and the National Institutes of Health (NIH) (1R01A151530-5), by Young Chair funds to D.M. and C.B., and by the National Institute of Diabetes and Digestive and Kidney Diseases-funded Joslin Diabetes and Endocrinology Research Center core facilities. J.A. Hill was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research, and C.M.S. and J.A. Hall were supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH.	ABB J, 1982, INT J CANCER, V30, P307, DOI 10.1002/ijc.2910300309; ABB J, 1982, IMMUNOPHARMACOLOGY, V4, P303, DOI 10.1016/0162-3109(82)90051-0; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Chapellier B, 2002, GENESIS, V32, P87, DOI 10.1002/gene.10071; Chapellier B, 2002, GENESIS, V32, P95, DOI 10.1002/gene.10072; Chapellier B, 2002, GENESIS, V32, P91, DOI 10.1002/gene.10073; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; MUCIDA D, 2007, SCIENCE, V13, P56; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; WONG J, 2007, J EXP MED IN PRESS; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	54	265	270	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2008	29	5					758	770		10.1016/j.immuni.2008.09.018	http://dx.doi.org/10.1016/j.immuni.2008.09.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006694	Bronze, Green Accepted			2022-12-18	WOS:000261036000013
J	Laiosa, CV; Stadtfeld, M; Xie, HF; de Andres-Aguayo, L; Graf, T				Laiosa, Catherine V.; Stadtfeld, Matthias; Xie, Huafeng; de Andres-Aguayo, Luisa; Graf, Thomas			Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; BINDING PROTEIN-ALPHA; LINEAGE COMMITMENT; FACTOR GATA-3; EXPRESSION; DIFFERENTIATION; GENE; LYMPHOPOIESIS; SPECIFICATION	The differentiation potential of T lineage cells becomes restricted soon after entry of multipotent precursors into the thymus and is accompanied by a downregulation of the transcription factors C/EBP alpha and PU.1. To investigate this restriction point, we have expressed C/EBP alpha and PU.1. in fully committed pre-T cells and found that C/EBP alpha (and C/EBP beta) induced the formation of functional macrophages. In contrast, PU.1 converted them into myeloid dendritic cells under identical culture conditions. C/EBP alpha-induced reprogramming is complex because upregulation of some but not all myelomonocytic markers required endogenous PU.1. Notch signaling partially inhibited C/EBP alpha-induced macrophage formation and completely blocked PU.1-induced dendritic cell formation. Likewise, expression of intracellular Notch or the transcription factor GATA-3 inhibited C/EBP alpha-induced lineage conversion. Our data show that committed T cell progenitors remain susceptible to the lineage instructive effects of myeloid transcription factors and suggest that Notch signaling induces T lineage restriction by downregulating C/EBP alpha and PU.1 in multilineage precursors.	Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Ctr Gene Regulat, Programme Differentiat & Canc, Barcelona, Spain	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Graf, T (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	thomas.graf@crg.es	Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117; de Andres-Aguayo, Luisa/0000-0001-6717-242X; Stadtfeld, Matthias/0000-0002-5852-9906	NCI NIH HHS [R01 CA89590-01] Funding Source: Medline; NIGMS NIH HHS [T32GM007288] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DESTGROTH SF, 1982, J IMMUNOL METHODS, V49, pR11, DOI 10.1016/0022-1759(82)90269-1; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Faust N, 2000, BLOOD, V96, P719; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gounari F, 2002, NAT IMMUNOL, V3, P489, DOI 10.1038/ni778; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; HENDERSON AJ, 1990, J IMMUNOL, V145, P423; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lefebvre JM, 2005, J IMMUNOL, V174, P6184, DOI 10.4049/jimmunol.174.10.6184; Lucas K, 1998, DEV COMP IMMUNOL, V22, P339, DOI 10.1016/S0145-305X(98)00012-3; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Spain LM, 1999, J IMMUNOL, V163, P2681; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	61	265	288	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					731	744		10.1016/j.immuni.2006.09.011	http://dx.doi.org/10.1016/j.immuni.2006.09.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17088084	Bronze			2022-12-18	WOS:000242063100007
J	Sato, K; Yamashita, N; Yamashita, N; Baba, M; Matsuyama, T				Sato, K; Yamashita, N; Yamashita, N; Baba, M; Matsuyama, T			Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; BONE-MARROW TRANSPLANTATION; T-CELLS; IN-VITRO; ACTIVATION; CD4(+); VIVO; PREVENTION; INDUCTION; ANTIGEN	We have established a novel immunotherapeutic approach involving dendritic cells (DCs) with potent immunoregulatory property (designated as regulatory DCs [rDCs]) for acute graft-versus-host disease (GVHD) and leukemia relapse in allogeneic bone marrow (BM) transplantation (BMT) in mice bearing leukemia. rDCs displayed high levels of MHC molecules and extremely low levels of costimulatory molecules. A single injection of rDCs following allogeneic BMT controlled the ability of the transplanted T cells to induce acute GVHD and graft-versus-leukemia (GVL) effect in the recipients bearing leukemia, and that resulted in protection from the lethality caused by acute GVHD and tumor burden. Thus, the use of rDCs may be therapeutically useful for the treatment of acute GVHD and leukemia relapse in allogeneic BMT.	Kagoshima Univ, Sch Med, Dept Immunol & Med Zool, Kagoshima 8908520, Japan; Univ Tokyo, Inst Med Sci, Dept Adv Med Sci, Minato Ku, Tokyo 1088639, Japan; Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1738605, Japan; Kagoshima Univ, Sch Med, Div Human Retroviruses, Ctr Chron Viral Dis, Kagoshima 8908520, Japan	Kagoshima University; University of Tokyo; Teikyo University; Kagoshima University	Sato, K (corresponding author), Kagoshima Univ, Sch Med, Dept Immunol & Med Zool, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	katsuaki@m3.kufm.kagoshima-u.ac.jp	Baba, Masanori/G-3867-2011					Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Lu Y, 2001, BLOOD, V97, P1123, DOI 10.1182/blood.V97.4.1123; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sato K, 1999, J IMMUNOL, V162, P4464; Sato K, 2002, CELL IMMUNOL, V215, P186, DOI 10.1016/S0008-8749(02)00021-7; SATO K, 2003, IN PRESS BLOOD, V101; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tsukada N, 1999, BLOOD, V93, P2738, DOI 10.1182/blood.V93.8.2738.408k30_2738_2747; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waldmann H, 2001, IMMUNITY, V14, P399, DOI 10.1016/S1074-7613(01)00120-0	24	265	283	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2003	18	3					367	379		10.1016/S1074-7613(03)00055-4	http://dx.doi.org/10.1016/S1074-7613(03)00055-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648454	Bronze			2022-12-18	WOS:000181713700007
J	Flajnik, MF; Kasahara, M				Flajnik, MF; Kasahara, M			Comparative genomics of the MHC: Glimpses into the evolution of the adaptive immune system	IMMUNITY			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I LOCUS; CHROMOSOMAL DUPLICATION; VERTEBRATE GENOME; T-CELL; ECTOTHERMIC VERTEBRATES; LINKAGE RELATIONSHIPS; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; XENOPUS MHC	MHC gene organization (size, complexity, gene order) differs markedly among different species, and yet all nonmammalian vertebrates examined to date have a true "class I region" with tight linkage of genes encoding the class I presenting and processing molecules. Three paralogous regions of the human genome contain sets of linked genes homologous to various loci in the MHC class I, class II, and/or class III regions, providing insight into the organization of the "proto MHC" before the emergence of the adaptive immune system in the jawed vertebrates.	Grad Univ Adv Studies, Sch Adv Sci, Dept Biosyst Sci, Hayama 2400193, Japan; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21021 USA	Graduate University for Advanced Studies - Japan; University System of Maryland; University of Maryland Baltimore	Flajnik, MF (corresponding author), Grad Univ Adv Studies, Sch Adv Sci, Dept Biosyst Sci, Hayama 2400193, Japan.	mflajnik@som.umaryland.edu	Kasahara, Masanori/G-7651-2011	Flajnik, Martin Francis/0000-0002-2792-5084				Abi Rached L, 1999, IMMUNOL REV, V167, P33; Abi Rached Laurent, 2000, P45; Afanassieff M, 2001, J IMMUNOL, V166, P3324, DOI 10.4049/jimmunol.166.5.3324; Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alcami A, 2000, TRENDS MICROBIOL, V8, P410, DOI 10.1016/S0966-842X(00)01830-8; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bartl S, 1998, IMMUNOL REV, V166, P317, DOI 10.1111/j.1600-065X.1998.tb01272.x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BERNSTEIN RM, 1996, CURR BIOL, V8, P535; Charlemagne J, 1998, IMMUNOL REV, V166, P87, DOI 10.1111/j.1600-065X.1998.tb01255.x; Clark MS, 2001, IMMUNOGENETICS, V52, P174, DOI 10.1007/s002510000285; Clark MS, 2000, J IMMUNOL, V165, P4446, DOI 10.4049/jimmunol.165.8.4446; Clow LA, 2000, IMMUNOGENETICS, V51, P1021, DOI 10.1007/s002510000233; Courtet M, 2001, DEV COMP IMMUNOL, V25, P149, DOI 10.1016/S0145-305X(00)00045-8; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEPASQUIER L, 2000, CURR TOP MICROBIOL I, V248, P160; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; DUPASQUIER L, 1977, IMMUNOGENETICS, V5, P129; FLAJNIK MF, 1991, IMMUNOGENETICS, V33, P295, DOI 10.1007/BF00216688; Flajnik MF, 1999, J IMMUNOL, V163, P3826; Flajnik MF, 1999, IMMUNOL REV, V167, P59, DOI 10.1111/j.1600-065X.1999.tb01382.x; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Gruen JR, 1997, BLOOD, V90, P4252; Hansen JD, 1999, J IMMUNOL, V163, P774; Hansen JD, 1996, DEV COMP IMMUNOL, V20, P417, DOI 10.1016/S0145-305X(96)00030-4; Horton JD, 1998, IMMUNOL REV, V166, P245, DOI 10.1111/j.1600-065X.1998.tb01267.x; Hughes AL, 1997, BIOESSAYS, V19, P777, DOI 10.1002/bies.950190907; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Hughes AL, 1998, MOL BIOL EVOL, V15, P854, DOI 10.1093/oxfordjournals.molbev.a025990; Joly E, 1998, IMMUNOL TODAY, V19, P580, DOI 10.1016/S0167-5699(98)01348-6; Kandil E, 1996, J IMMUNOL, V156, P4245; Kasahara M, 1995, Transpl Immunol, V3, P1, DOI 10.1016/0966-3274(95)80001-8; Kasahara M, 1997, TRENDS GENET, V13, P90, DOI 10.1016/S0168-9525(97)01065-2; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; Katsanis N, 1996, GENOMICS, V35, P101, DOI 10.1006/geno.1996.0328; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; KAUFMAN JF, 1989, VERH DTSCH ZOOL GES, V81, P131; Klein J, 1998, SCAND J IMMUNOL, V47, P199; Klein J, 1993, PROGR IMMUNOLOGY, V8, P137; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Laird DJ, 2000, P NATL ACAD SCI USA, V97, P6924, DOI 10.1073/pnas.97.13.6924; Laurens V, 2001, EUR J IMMUNOL, V31, P506, DOI 10.1002/1521-4141(200102)31:2<506::AID-IMMU506>3.0.CO;2-P; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Malaga-Trillo E, 1998, GENETICS, V149, P1527; Michalova V, 2000, J IMMUNOL, V164, P5296, DOI 10.4049/jimmunol.164.10.5296; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; Murray BW, 2000, MAR BIOTECHNOL, V2, P437; Naruse K, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P91; Nonaka M, 2000, IMMUNOGENETICS, V51, P186, DOI 10.1007/s002510050030; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohta Y, 2000, P NATL ACAD SCI USA, V97, P4712, DOI 10.1073/pnas.97.9.4712; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Rast JP, 2000, MAJOR HISTOCOMPATIBILITY COMPLEX, P66; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Robey E, 1997, CURR OPIN GENET DEV, V7, P551, DOI 10.1016/S0959-437X(97)80085-8; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; SALTERCID L, 1995, CRIT REV IMMUNOL, V15, P31, DOI 10.1615/CritRevImmunol.v15.i1.20; Sammut B, 1999, EUR J IMMUNOL, V29, P2897, DOI 10.1002/(SICI)1521-4141(199909)29:09<2897::AID-IMMU2897>3.0.CO;2-2; Shum BP, 2001, J IMMUNOL, V166, P3297, DOI 10.4049/jimmunol.166.5.3297; SHUM BP, 1993, J IMMUNOL, V151, P5376; SILVER LM, 1991, MAMM GENOME, V1, P1, DOI 10.1007/BF00350840; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Sultmann H, 2000, J IMMUNOL, V165, P6984, DOI 10.4049/jimmunol.165.12.6984; Thorpe KL, 1996, IMMUNOGENETICS, V44, P391, DOI 10.1007/s002510050142; Trachtulec Z, 1997, GENOMICS, V44, P1, DOI 10.1006/geno.1997.4839; TROWSDALE J, 2001, IN PRESS IMMUNITY; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volpi EV, 2000, J CELL SCI, V113, P1565; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Yokoyama WM, 1998, CURR OPIN IMMUNOL, V10, P298, DOI 10.1016/S0952-7915(98)80168-4	78	265	272	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		351	362		10.1016/S1074-7613(01)00198-4	http://dx.doi.org/10.1016/S1074-7613(01)00198-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567626	Bronze			2022-12-18	WOS:000171211800003
J	Chen, WS; Anton, LC; Bennink, JR; Yewdell, JW				Chen, WS; Anton, LC; Bennink, JR; Yewdell, JW			Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses	IMMUNITY			English	Article							RECEPTOR REPERTOIRE; ANTIVIRAL CTL; INFECTION; EPITOPE; MEMORY; ANTIGEN	Following influenza virus infection, the numbers of mouse T-CD8+ cells responding to five different determinants vary more than 50-fold in primary responses but less so in secondary responses. Surprisingly, each determinant elicits a highly diverse and highly sensitive T-CD8+ response. Inefficient antigen processing by virus-infected cells accounts for the poor immunogenicity of just one of the subdominant determinants. Over-expressing class I-peptide complexes using vaccinia virus revealed that the poor immunogenicity of two subdominant determinants reflects limitations in T cell responses unrelated to TCR diversity or sensitivity. Despite greatly enhanced expression, the immunodominant determinant is actually less immunogenic when overexpressed by vaccinia virus. Immunodominance is also modulated by determinant-specific variations in the capacity of T-CD8+ to suppress responses to other determinants.	NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bennink, JR (corresponding author), NIAID, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Chen, Weisan/E-7828-2012; Antón, Luis C/C-4740-2013; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Chen, Weisan/0000-0002-5221-9771; Antón, Luis C/0000-0001-9665-011X; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000542, Z01AI000542] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anton LC, 1997, J IMMUNOL, V158, P2535; BENNINK JR, 1981, CELL IMMUNOL, V61, P220, DOI 10.1016/0008-8749(81)90368-3; Bousso P, 1999, J EXP MED, V189, P1591, DOI 10.1084/jem.189.10.1591; BURROWS SR, 1995, J EXP MED, V182, P1703, DOI 10.1084/jem.182.6.1703; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; Cole GA, 1997, J IMMUNOL, V158, P4301; Deng YP, 1997, J IMMUNOL, V158, P1507; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; JAMIESON BD, 1989, J EXP MED, V169, P1993, DOI 10.1084/jem.169.6.1993; JONES CM, 1997, B INT IMMUNOL, V9, P1319; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; Sourdive DJD, 1998, J EXP MED, V188, P71, DOI 10.1084/jem.188.1.71; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Weidt G, 1998, J IMMUNOL, V160, P2923; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zinkernagel R.M., 1979, ADV IMMUNOL, V27, P52	22	265	272	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					83	93		10.1016/S1074-7613(00)80161-2	http://dx.doi.org/10.1016/S1074-7613(00)80161-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661408	Bronze			2022-12-18	WOS:000085011900009
J	Fowell, DJ; Shinkai, K; Liao, XC; Beebe, AM; Coffman, RL; Littman, DR; Locksley, RM				Fowell, DJ; Shinkai, K; Liao, XC; Beebe, AM; Coffman, RL; Littman, DR; Locksley, RM			Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4(+) T cells	IMMUNITY			English	Article							BRUTONS TYROSINE KINASE; LEISHMANIA-MAJOR; PHOSPHATIDYLINOSITOL 3-KINASE; SUBSET DIFFERENTIATION; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; GENE-EXPRESSION; ACTIVATION; MICE; CALCIUM	Naive Itk-deficient CD4(+) T cells were unable to establish stable IL-4 production, even when primed in Th2-inducing conditions. In contrast, IFN gamma production was little affected. Failure to express IL-4 occurred even among cells that had gone through multiple cell divisions and was associated with a delay in the kinetics and magnitude of NFATc nuclear localization. IL-4 production was restored genetically by retroviral reconstitution of Itk or biochemically by augmenting the calcium flux with ionomycin, In vivo, Itk-deficient mice were unable to establish functional Th2 cells. Development of protective Th1 cells was unimpeded. These data define a nonredundant role for Itk in modulating signals from the TCR/CD28 pathways that are specific for the establishment of stable IL-4 but not IFN gamma expression.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; NYU Med Ctr, Skirball Inst Biomol Med, Howard Hughes Med Inst, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Howard Hughes Medical Institute; New York University	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026918, R01AI026918] Funding Source: NIH RePORTER; NIAID NIH HHS [AI26918] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; BERENS RL, 1978, J PARASITOL, V64, P160, DOI 10.2307/3279633; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Bix M, 1998, J EXP MED, V188, P2289, DOI 10.1084/jem.188.12.2289; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Brown DR, 1996, J EXP MED, V184, P803, DOI 10.1084/jem.184.3.803; Brown KA, 1997, J NUCL CARDIOL, V4, P101; Cooley L, 1998, CELL, V93, P913, DOI 10.1016/S0092-8674(00)81196-4; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gibson S, 1996, J IMMUNOL, V156, P2716; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guler ML, 1997, J IMMUNOL, V159, P1767; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liao XC, 1997, J EXP MED, V186, P221, DOI 10.1084/jem.186.2.221; Liao XC, 1997, J EXP MED, V186, P2069, DOI 10.1084/jem.186.12.2069; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lu YL, 1998, J IMMUNOL, V161, P5404; MOCCI S, 1995, J IMMUNOL, V154, P3779; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Pingel S, 1999, J EXP MED, V189, P1111, DOI 10.1084/jem.189.7.1111; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; RINCON M, 1997, CURR BIOL, V94, P13152; Satterthwaite AB, 1997, P NATL ACAD SCI USA, V94, P13152, DOI 10.1073/pnas.94.24.13152; Satterthwaite AB, 1998, J EXP MED, V188, P833, DOI 10.1084/jem.188.5.833; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaw NJ, 1997, KNEE, V4, P185, DOI 10.1016/S0968-0160(97)00264-0; SUZUKI Y, 1990, J IMMUNOL, V144, P1954; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VARKILA K, 1993, EUR J IMMUNOL, V23, P262, DOI 10.1002/eji.1830230141; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	68	265	277	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					399	409		10.1016/S1074-7613(00)80115-6	http://dx.doi.org/10.1016/S1074-7613(00)80115-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549622	Bronze			2022-12-18	WOS:000083343100002
J	Kersh, GJ; Kersh, EN; Fremont, DH; Allen, PM				Kersh, GJ; Kersh, EN; Fremont, DH; Allen, PM			High- and low-potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling	IMMUNITY			English	Article							T-CELL-RECEPTOR; HISTOCOMPATIBILITY COMPLEX LIGANDS; BOUND SINGLE PEPTIDES; ANTAGONIST LIGANDS; DISSOCIATION RATE; ANTIGEN RECEPTOR; ACTIVATION; PHOSPHORYLATION; MOLECULE; IDENTIFICATION	We have examined binding characteristics for a single TCR interacting with five of its different peptide/MHC ligands using surface plasmon resonance. We find that very small structural changes produce ligands with similar equilibrium binding affinities (K-D) for the TCR, but vastly different potencies for T cell activation. Ligands with similar K(D)s induce similar amounts of total phospho-zeta but distinct patterns of zeta phosphorylation. Lower potency ligands induce only incomplete phosphorylation of TCR zeta and generally have faster off-rates. Therefore, the potency of TCR ligands is primarily determined by the half-life of the TCR-ligand complex and the consequent ability to induce complete phosphorylation of zeta.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	allen@immunology.wustl.edu		Fremont, Daved/0000-0002-8544-2689	NIAID NIH HHS [AI24157] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024157, R01AI024157] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GAVIN MA, 1994, EUR J IMMUNOL, V24, P2124, DOI 10.1002/eji.1830240929; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Hudrisier D, 1998, J IMMUNOL, V161, P553; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Kersh GJ, 1998, J IMMUNOL, V161, P585; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KOYASU S, 1992, J BIOL CHEM, V267, P3375; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Lesage S, 1997, J IMMUNOL, V159, P2078; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043	37	265	267	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					817	826		10.1016/S1074-7613(00)80647-0	http://dx.doi.org/10.1016/S1074-7613(00)80647-0			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881972	Bronze			2022-12-18	WOS:000077836600007
J	Taccioli, GE; Amatucci, AG; Beamish, HJ; Gell, D; Xiang, XH; Arzayus, MIT; Priestley, A; Jackson, SP; Rothstein, AM; Jeggo, PA; Herrera, VLM				Taccioli, GE; Amatucci, AG; Beamish, HJ; Gell, D; Xiang, XH; Arzayus, MIT; Priestley, A; Jackson, SP; Rothstein, AM; Jeggo, PA; Herrera, VLM			Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; COMBINED IMMUNE-DEFICIENCY; X-RAY RESISTANCE; PRE-B CELLS; V(D)J RECOMBINATION; IONIZING-RADIATION; SCID MICE; NONSENSE MUTATION; KU AUTOANTIGEN	The DNA-dependent protein kinase is a mammalian protein complex composed of Ku70, Ku80, and DNA-PKcs subunits that has been implicated in DNA double-strand break repair and V(D)J recombination. Here, by gene targeting, we have constructed a mouse with a disruption in the kinase domain of DNA-PKcs, generating an animal model completely devoid of DNA-PK activity. Our results demonstrate that DNA-PK activity is required for coding but not for signal join formation in mice. Although our DNA-PKcs defective mice closely resemble Scid mice, they differ by having elevated numbers of CD4(+)CD8(+) thymocytes. This suggests that the Scid mice may not represent a null phenotype and may retain some residual DNA-PKcs function.	Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England; Univ Cambridge, Wellcome, CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England	Boston University; Boston University; Boston University; University of Sussex; University of Cambridge; University of Cambridge	Taccioli, GE (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.		Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Herrera, Victoria/0000-0001-8991-2134; Gell, David/0000-0003-0382-1181	NCI NIH HHS [CA 76409] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076409] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson CW, 1996, CURR TOP MICROBIOL, V217, P91; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; BLACKWELL TK, 1989, EMBO J, V8, P735, DOI 10.1002/j.1460-2075.1989.tb03433.x; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BOUBNOV NV, 1995, P NATL ACAD SCI USA, V92, P890, DOI 10.1073/pnas.92.3.890; CARROLL AM, 1991, GENE DEV, V5, P1357, DOI 10.1101/gad.5.8.1357; CARROLL AM, 1993, MOL CELL BIOL, V13, P3632, DOI 10.1128/MCB.13.6.3632; CARROLL AM, 1993, J IMMUNOL, V150, P2222; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CHEN J, 1994, RAG 2 DEFICIENT BLAS; DANSKA JS, 1994, SCIENCE, V266, P450, DOI 10.1126/science.7524150; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Errami A, 1996, MOL CELL BIOL, V16, P1519; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; GETTS RC, 1994, J BIOL CHEM, V269, P15981; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lin JYD, 1997, RADIAT RES, V147, P166, DOI 10.2307/3579417; Livak F, 1996, J EXP MED, V184, P419, DOI 10.1084/jem.184.2.419; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; Mizuta R, 1996, INT IMMUNOL, V8, P1467, DOI 10.1093/intimm/8.9.1467; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MURPHY WJ, 1994, J IMMUNOL, V153, P1004; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; Peterson SR, 1997, J BIOL CHEM, V272, P10227; PETERSON SR, 1995, P NATL ACAD SCI USA, V87, P3450; PETRINI JHJ, 1990, P NATL ACAD SCI USA, V87, P3450, DOI 10.1073/pnas.87.9.3450; POLTORATSKY VP, 1995, J IMMUNOL, V155, P4529; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Ramsden DA, 1997, CURR OPIN IMMUNOL, V9, P114, DOI 10.1016/S0952-7915(97)80167-7; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHULER W, 1990, MOL BASIS B CELL DEV, V3, P132; Shin EK, 1997, J IMMUNOL, V158, P3565; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; Taccioli G E, 1992, Curr Top Microbiol Immunol, V182, P107; TACCIOLI GE, 1994, J BIOL CHEM, V269, P7439; TACCIOLI GE, 1995, CURR OPIN IMMUNOL, V7, P436, DOI 10.1016/0952-7915(95)80085-9; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Zhu CM, 1996, EUR J IMMUNOL, V26, P2859, DOI 10.1002/eji.1830261209; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7; ZUNIGAPFLUCKER JC, 1994, J EXP MED, V180, P1517, DOI 10.1084/jem.180.4.1517	74	265	271	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1998	9	3					355	366		10.1016/S1074-7613(00)80618-4	http://dx.doi.org/10.1016/S1074-7613(00)80618-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	124VA	9768755	Bronze			2022-12-18	WOS:000076202300008
J	Pape, KA; Catron, DM; Itano, AA; Jenkins, MK				Pape, Kathryn A.; Catron, Drew M.; Itano, Andrea A.; Jenkins, Marc K.			The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles	IMMUNITY			English	Article							CD4 T-CELLS; SPLENIC MARGINAL ZONE; DENDRITIC CELLS; ANTIBODY-RESPONSES; IN-SITU; VISUALIZATION; MICROENVIRONMENTS; INDUCTION; INJECTION; CONDUITS	The initial step in a humoral immune response involves the acquisition of antigens by B cells via surface immunoglobulin. Surprisingly, anatomic studies indicate that lymph-borne proteins do not have access to the follicles where naive B cells reside. Thus, it is unclear how B cells acquire antigens that drain to lymph nodes. By tracking a fluorescent antigen and a peptide:MHC II complex derived from it, we show that antigen-specific B cells residing in the follicles acquire antigen within minutes of injection, first in the region closest to the subcapsular sinus where lymph enters the lymph node. Antigen acquisition, presentation, and subsequent T cell-dependent activation did not require B cell migration through the T cell area or exposure to dendritic cells. These results indicate that the humoral response is initiated as soluble antigens diffuse directly from lymph in the subcapsular sinus to be acquired by antigen-specific B cells in the underlying follicles.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; Amgen Inc, Newbury Pk, CA 91320 USA	University of Minnesota System; University of Minnesota Twin Cities; Amgen	Pape, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	papex001@umn.edu; catro001@umn.edu	Eckhardt, Erik/G-1567-2010; Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Itano, Andrea/0000-0002-4766-6876				Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; CLARK SL, 1962, AM J ANAT, V110, P217, DOI 10.1002/aja.1001100303; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; FARR AG, 1980, AM J ANAT, V157, P265, DOI 10.1002/aja.1001570304; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Goodnow CC, 1997, IMMUNOL REV, V156, P5, DOI 10.1111/j.1600-065X.1997.tb00954.x; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MARIUZZA RA, 1983, J MOL BIOL, V170, P1055, DOI 10.1016/S0022-2836(83)80206-X; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324, DOI 10.1152/ajpheart.1996.270.1.H324; VANEWIJK W, 1988, SCANNING MICROSCOPY, V2, P2129; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Wykes M, 1998, J IMMUNOL, V161, P1313; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	44	264	284	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					491	502		10.1016/j.immuni.2007.02.011	http://dx.doi.org/10.1016/j.immuni.2007.02.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17379546	Bronze			2022-12-18	WOS:000246126400013
J	Tanigaki, K; Tsuji, M; Yamamoto, N; Han, H; Tsukada, J; Inoue, H; Kubo, M; Honjo, T				Tanigaki, K; Tsuji, M; Yamamoto, N; Han, H; Tsukada, J; Inoue, H; Kubo, M; Honjo, T			Regulation of alpha beta/gamma delta, T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling	IMMUNITY			English	Article							ZONE B-CELLS; GAMMA-DELTA; THYMOCYTE DEVELOPMENT; GENE REARRANGEMENTS; FATE SPECIFICATION; MAMMALIAN NOTCH; DROSOPHILA EYE; RBP-J; RECEPTOR; EXPRESSION	RBP-J is a key mediator of Notch signaling that regulates a large spectrum of cell fate determinations. To elucidate the functions of Notch signaling in T cell development, we inactivated RBP-J specifically at two stages of T cell development by crossing RBP-J floxed mice with Ick-cre or CD4-cre transgenic mice. The loss of RBP-J at an earlier developmental stage resulted in enhanced generation and accelerated emigration of gammadelta T cells, whereas alphabeta T cell development was arrested at the double-negative 3 stage. The loss of RBP-J at a later stage did not affect the absolute number or the production rate of CD4 or CD8-positive mature T cells but enhanced Th1 cell response and reduced CD4(+) T cell proliferation. Our data demonstrated that Notch/RBP-J signaling regulates gammadelta T cell generation and migration, up T cell maturation, terminal differentiation of CD4(+) T cells into Th1/Th2 cells, and activation of T cells.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Higashi Ku, Fukuoka 8128582, Japan	Kyoto University; Tokyo University of Science; Kyushu University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Kubo, Masato/A-5918-2016; Honjo, Tasuku/N-4470-2016	Yamamoto, Norio/0000-0001-8924-0710				Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; AMSEN D, 2004, IN PRESS CELL; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kato H, 1997, DEVELOPMENT, V124, P4133; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Lawrence N, 2001, CURR BIOL, V11, P375, DOI 10.1016/S0960-9822(01)00120-8; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li YX, 2001, CURR BIOL, V11, P330, DOI 10.1016/S0960-9822(01)00093-8; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Livak F, 1999, J IMMUNOL, V162, P2575; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MacDonald HR, 2001, CURR OPIN IMMUNOL, V13, P219, DOI 10.1016/S0952-7915(00)00207-7; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rodewald HR, 1998, ADV IMMUNOL, V69, P1, DOI 10.1016/S0065-2776(08)60606-9; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shawber C, 1996, DEVELOPMENT, V122, P3765; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigaki K, 2003, SEMIN IMMUNOL, V15, P113, DOI 10.1016/S1044-5323(03)00008-3; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Warren LA, 2003, CURR OPIN IMMUNOL, V15, P166, DOI 10.1016/S0952-7915(03)00011-6; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	66	264	273	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					611	622		10.1016/S1074-7613(04)00109-8	http://dx.doi.org/10.1016/S1074-7613(04)00109-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142529	Bronze			2022-12-18	WOS:000221631900011
J	Townsend, MJ; Fallon, PG; Matthews, DJ; Smith, P; Jolin, HE; McKenzie, ANJ				Townsend, MJ; Fallon, PG; Matthews, DJ; Smith, P; Jolin, HE; McKenzie, ANJ			IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development	IMMUNITY			English	Article							AIRWAY MUCUS PRODUCTION; SCHISTOSOMA-MANSONI; TRANSGENIC MICE; MAST-CELLS; CYTOKINE RESPONSES; INTERLEUKIN-9; MURINE; ASTHMA; EOSINOPHILS; EXPRESSION	Interleukin-9 is a cytokine produced by Th2 cells and is a candidate gene for asthma and atopy. We have generated IL-9-deficient mice to delineate the specific roles of IL-9 in Th2 responses. Using a pulmonary granuloma model, we have demonstrated a distinct requirement for IL-9 in the rapid and robust generation of pulmonary goblet cell hyperplasia and mastocytosis in response to lung challenge. In contrast, eosinophilia and granuloma formation were not affected. IL-9 was not required for T cell development or differentiation, the generation of naive or antigen-driven antibody responses, or the expulsion of the intestinal parasitic nematode Nippostrongylus brasiliensis. Thus, deletion of IL-9 manifests as a highly defined phenotype in Th2 responses modulating mucus production and mast cell proliferation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	MRC Laboratory Molecular Biology; University of Cambridge	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	anm@mrc-lmb.cam.ac.uk	Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293; Townsend, Michael/0000-0003-0240-4562				BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BOURETTE RP, 1992, EXP HEMATOL, V20, P868; Cohn L, 1999, J IMMUNOL, V162, P6178; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Costa JJ, 1997, JAMA-J AM MED ASSOC, V278, P1815, DOI 10.1001/jama.278.22.1815; DiSanto JP, 1995, IMMUNOL REV, V148, P19; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; Fallon PG, 1998, EUR J IMMUNOL, V28, P1408, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt;1408::AID-IMMU1408&gt;3.0.CO;2-H; Fallon PG, 1999, J IMMUNOL, V162, P4122; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Galli S J, 1994, Curr Opin Hematol, V1, P33; Godfraind C, 1998, J IMMUNOL, V160, P3989; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; LEDER L-D, 1979, American Journal of Dermatopathology, V1, P39; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Louahed J, 2000, AM J RESP CELL MOL, V22, P649, DOI 10.1165/ajrcmb.22.6.3927; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; McKelvey R. D., 1998, Experimental Economics, V1, P9, DOI 10.1007/BF01426213; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; MILLER HRP, 1994, PARASITE IMMUNOL, V16, P145, DOI 10.1111/j.1365-3024.1994.tb00334.x; MOCK BA, 1990, IMMUNOGENETICS, V31, P265, DOI 10.1007/BF00204898; NAWA Y, 1994, PARASITE IMMUNOL, V16, P333, DOI 10.1111/j.1365-3024.1994.tb00358.x; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; PETITFRERE C, 1993, IMMUNOLOGY, V79, P146; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; RENAULD J-C, 1990, Cytokine, V2, P9, DOI 10.1016/1043-4666(90)90037-T; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1994, ONCOGENE, V9, P1327; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; vanHalteren AGS, 1997, J ALLERGY CLIN IMMUN, V99, P94, DOI 10.1016/S0091-6749(97)81049-4; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Vink A, 1999, J EXP MED, V189, P1413, DOI 10.1084/jem.189.9.1413; WARREN KS, 1970, AM J TROP MED HYG, V19, P292, DOI 10.4269/ajtmh.1970.19.292; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; WYNN TA, 1993, J IMMUNOL, V151, P1430	48	264	270	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					573	583		10.1016/S1074-7613(00)00056-X	http://dx.doi.org/10.1016/S1074-7613(00)00056-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070175	Bronze			2022-12-18	WOS:000090079100016
J	Barnes, MJ; Powrie, F				Barnes, Michael J.; Powrie, Fiona			Regulatory T Cells Reinforce Intestinal Homeostasis	IMMUNITY			English	Review							GROWTH-FACTOR-BETA; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTIONAL REPRESSOR BLIMP-1; DENDRITIC CELLS; RETINOIC-ACID; LAMINA-PROPRIA; ORAL TOLERANCE; CUTTING EDGE; DEPENDENT MECHANISM; SCID MICE	Regulatory T cells help maintain intestinal homeostasis by preventing inappropriate innate and adaptive immune responses. CD4(+) T cells that express Foxp3 and Tr1-like cells that produce IL-10 comprise the major regulatory populations in the intestine. CD4(+)Foxp3(+) T cells play an important functional role in promoting tolerance of the flora and dietary proteins. Tr1-like cells can be generated in conditions that also promote effector T cell responses and may serve a similar function. In this review, we discuss the signals specific to the gastrointestinal tract that support both regulatory cell types and their distinct modes of action in the mesenteric lymph nodes and intestinal tissues. Dysregulation of intestinal immune homeostasis occurs in inflammatory bowel disease and can also be observed in graft-versus-host disease, tumor immunotherapy regimens, and acute HIV infection.	[Barnes, Michael J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	fiona.powrie@path.ox.ac.uk		Barnes, Michael/0000-0003-0846-3352	Wellcome Trust; Skaggs Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Skaggs Foundation	F.P. and her lab are supported by the Wellcome Trust. M.J.B. is also supported by a scholarship from the Skaggs Foundation. We thank P. Ahern, A. Johnson, and members of the Powrie lab for critically reading the manuscript and apologize to those authors whose work we could not cite because of space limitations.	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Aranda R, 1997, J IMMUNOL, V158, P3464; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Cerovic V, 2009, J IMMUNOL, V182, P2405, DOI 10.4049/jimmunol.0802318; Chan V, 2005, HELICOBACTER, V10, P114, DOI 10.1111/j.1523-5378.2005.00298.x; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; CHAUDHRY A, 2009, SCIENCE IN PRESS; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2005, J IMMUNOL, V174, P7487, DOI 10.4049/jimmunol.174.12.7487; Diebold RJ, 1995, P NATL ACAD SCI USA, V92, P12215, DOI 10.1073/pnas.92.26.12215; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fowler S, 2002, EUR J IMMUNOL, V32, P2997, DOI 10.1002/1521-4141(2002010)32:10<2997::AID-IMMU2997>3.0.CO;2-D; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kraus TA, 2006, INFLAMM BOWEL DIS, V12, P82, DOI 10.1097/01.MIB.0000200343.61707.52; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; POWELL BR, 1982, J PEDIATR-US, V100, P731, DOI 10.1016/S0022-3476(82)80573-8; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rieger K, 2006, BLOOD, V107, P1717, DOI 10.1182/blood-2005-06-2529; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Villarino AV, 2008, INT IMMUNOL, V20, P739, DOI 10.1093/intimm/dxn032; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wirnsberger G, 2009, P NATL ACAD SCI USA, V106, P10278, DOI 10.1073/pnas.0901877106; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	133	263	281	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					401	411		10.1016/j.immuni.2009.08.011	http://dx.doi.org/10.1016/j.immuni.2009.08.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766083	Bronze			2022-12-18	WOS:000270525900006
J	Fallon, PG; Jolin, HE; Smith, P; Emson, CL; Townsend, MJ; Fallon, R; Smith, P; McKenzie, ANJ				Fallon, PG; Jolin, HE; Smith, P; Emson, CL; Townsend, MJ; Fallon, R; Smith, P; McKenzie, ANJ			IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13	IMMUNITY			English	Article							MATERNAL-FETAL INTERFACE; NIPPOSTRONGYLUS-BRASILIENSIS; CYTOKINE RESPONSES; CELL-DEVELOPMENT; MAST-CELLS; MICE; INTERLEUKIN-5; EOSINOPHILS; INFECTION; EXPULSION	Functional redundancy is highly prevalent among the Th2 interleukins (IL)-4, IL-5, IL-9, and IL-13. To define the critical functions of these cytokines, we have generated a novel panel of compound Th2 cytokine-deficient mice (from single to quadruple cytokine knockouts). We find that these Th2 cytokines are not essential for fetal survival even during allogeneic pregnancy. Using intestinal parasite infection and a pulmonary granuloma model, we demonstrate cryptic roles for IL-4, IL-5, IL-9, and IL-13 in these responses. Significantly, although IL-5, IL-9, and IL-13 add to the speed and magnitude of the response, a threshold is reached at which IL-4 alone can activate all Th2 effector functions. These mice reveal distinct spatial, temporal, and hierarchical cytokine requirements in immune function.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Trinity Coll Dublin, Immunomodulat Grp, Dept Biochem, Dublin 2, Ireland	MRC Laboratory Molecular Biology; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293; Townsend, Michael/0000-0003-0240-4562				BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; Cohn L, 1999, J IMMUNOL, V162, P6178; Dent LA, 1999, INFECT IMMUN, V67, P989, DOI 10.1128/IAI.67.2.989-993.1999; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fallon PG, 2001, J IMMUNOL, V166, P2712, DOI 10.4049/jimmunol.166.4.2712; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Galli S J, 1994, Curr Opin Hematol, V1, P33; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; LIN H, 1993, J IMMUNOL, V151, P4562; Louahed J, 2000, AM J RESP CELL MOL, V22, P649, DOI 10.1165/ajrcmb.22.6.3927; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Mellor AL, 2000, ANNU REV IMMUNOL, V18, P367, DOI 10.1146/annurev.immunol.18.1.367; MOCK BA, 1990, IMMUNOGENETICS, V31, P265, DOI 10.1007/BF00204898; NAWA Y, 1994, PARASITE IMMUNOL, V16, P333, DOI 10.1111/j.1365-3024.1994.tb00358.x; Piccinni MP, 2000, BIOCHEM SOC T, V28, P212, DOI 10.1042/bst0280212; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	41	263	270	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					7	17		10.1016/S1074-7613(02)00332-1	http://dx.doi.org/10.1016/S1074-7613(02)00332-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150887	Bronze, Green Published			2022-12-18	WOS:000177187500002
